PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sharma, A; Kumar, S				Sharma, A; Kumar, S			Induced damage in the developing brain	SCIENCE			English	Letter							ANTIEPILEPTIC DRUGS; TERATOGENESIS; RATS		Cent Inst Med & Aromat Plants, Lucknow 226015, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP)	Sharma, A (corresponding author), Cent Inst Med & Aromat Plants, Picnic Spot Rd, Lucknow 226015, Uttar Pradesh, India.		; Kivisild, Toomas/P-5889-2017	Sharma, Abhay/0000-0003-1306-1497; Kivisild, Toomas/0000-0002-6297-7808				Brodie MJ, 1996, NEW ENGL J MED, V334, P168, DOI 10.1056/NEJM199601183340308; DOW KE, 1989, NEW ENGL J MED, V321, P1480; FINNELL RH, 1987, TERATOLOGY, V35, P177, DOI 10.1002/tera.1420350203; MINCK DR, 1991, TERATOLOGY, V43, P279, DOI 10.1002/tera.1420430402; Samren EB, 1997, EPILEPSIA, V38, P981, DOI 10.1111/j.1528-1157.1997.tb01480.x; VORHEES CV, 1987, TERATOLOGY, V35, P195, DOI 10.1002/tera.1420350205; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114	7	42	42	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2000	288	5468					977	977						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	313EY	10841717				2022-12-24	WOS:000086988400018
J	Valleroy, LA; MacKellar, DA; Karon, JM; Rosen, DH; McFarland, W; Shehan, DA; Stoyanoff, SR; LaLota, M; Celentano, DD; Koblin, BA; Thiede, H; Katz, MH; Torian, LV; Janssen, RS				Valleroy, LA; MacKellar, DA; Karon, JM; Rosen, DH; McFarland, W; Shehan, DA; Stoyanoff, SR; LaLota, M; Celentano, DD; Koblin, BA; Thiede, H; Katz, MH; Torian, LV; Janssen, RS		Young Mens Survey Study Grp	HIV prevalence and associated risks in young men who have sex with men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; UNPROTECTED ANAL INTERCOURSE; SAN-FRANCISCO; BISEXUAL MEN; VACCINE TRIALS; UNITED-STATES; GAY MEN; BEHAVIORS; SEROCONVERSION; HEALTH	Context Studies conducted in the late 1980s on human immunodeficiency virus (HIV) infection among older men who have sex with men (MSM) suggested the epidemic had peaked; however, more recent studies in younger MSM have suggested continued high HIV incidence. Objective To investigate the current state of the HIV epidemic among adolescent and young adult MSM in the United States by assessing the prevalence of HIV infection and associated risks in this population in metropolitan areas. Design The Young Men's Survey, a cross-sectional, multisite, venue-based survey conducted from 1994 through 1998. Setting One hundred ninety-four public venues frequented by young MSM in Baltimore, Md; Dallas, Tex; Los Angeles, Calif; Miami, Fla; New York, NY; the San Francisco (Calif) Bay Area; and Seattle, Wash. Subjects A total of 3492 15- to 22-year-old MSM who consented to an interview and HIV testing. Main Outcome Measures Prevalence of HIV infection and associated characteristics and risk behaviors. Results Prevalence of HIV infection was high (overall, 7.2%; range for the 7 areas, 2.2%-12.1%) and increased with age, from 0% among 15-year-olds to 9.7% among 22-year-olds. Multivariate-adjusted HIV infection prevalence was higher among blacks (odds ratio [OR], 6.3; 95% confidence interval [CI], 4.1-9.8), young men of mixed or other race (OR, 4.8; 95% CI, 3.0-7.6), and Hispanics (OR, 2.3; 95% CI, 1.5-3.4), compared with whites (referent) and Asian Americans and Pacific Islanders (OR, 1.1; 95% CI, 0.5-2.8). Factors most strongly associated with HIV infection were being black, mixed, or other race; having ever had anal sex with a man (OR, 5.0; 95% CI, 1.8-13.8); or having had sex with 20 or more men (OR, 3.0; 95% CI, 2.0-4.7). Only 46 (18%) of the 249 HIV-positive men knew they were infected before this testing; 37 (15%) were receiving medical care for HIV, and 19 (8%) were receiving medical drug therapy for HIV. Prevalence of unprotected anal sex during the past 6 months was high (overall, 41%; range, 33%-49%). Conclusions Among these young MSM, HIV prevalence was high, underscoring the need to evaluate and intensify prevention efforts for young MSM, particularly blacks, men of mixed race or ethnicity, Hispanics, and adolescents.	Ctr Dis Control & Prevent, Div HIV AIDS Prevent Surveillance & Epidemiol, Natl Ctr HIV STD & TB Prevent, Atlanta, GA USA; San Francisco Dept Publ Hlth, San Francisco, CA USA; Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA; Univ Texas, SW Med Ctr, Dallas, TX USA; Florida Dept Hlth, Tallahassee, FL USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD USA; New York Blood Ctr, New York, NY 10021 USA; New York City Dept Hlth, New York, NY 10013 USA; Publ Hlth Seattle & King Cty, Seattle, WA USA	Centers for Disease Control & Prevention - USA; San Francisco Department of Public Health; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Florida Department of Health; Johns Hopkins University; New York Blood Center; New York City Department of Health & Mental Hygiene	Valleroy, LA (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, NCHSTP, Mailstop E-46,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	lav0@cdc.gov						ASCHER DP, 1993, J ACQ IMMUN DEF SYND, V6, P241; Breslow NE, 1980, STAT METHODS CANC RE; Buchbinder SP, 1996, J INFECT DIS, V174, P954, DOI 10.1093/infdis/174.5.954; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P45; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P773; Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1; DEAN L, 1995, J ACQ IMMUN DEF SYND, V8, P208; DETELS R, 1989, J ACQ IMMUN DEF SYND, V2, P77; EKSTRAND ML, 1990, AM J PUBLIC HEALTH, V80, P973, DOI 10.2105/AJPH.80.8.973; HAYS RB, 1990, AIDS, V4, P901, DOI 10.1097/00002030-199009000-00011; HESSOL NA, 1989, AM J EPIDEMIOL, V130, P1167, DOI 10.1093/oxfordjournals.aje.a115445; Katz MH, 1998, J ACQ IMMUN DEF SYND, V19, P178, DOI 10.1097/00042560-199810010-00012; KINGSLEY LA, 1991, AM J EPIDEMIOL, V134, P331, DOI 10.1093/oxfordjournals.aje.a116094; Koblin BA, 1996, AIDS, V10, P1555, DOI 10.1097/00002030-199611000-00015; LEMP GF, 1994, JAMA-J AM MED ASSOC, V272, P449, DOI 10.1001/jama.272.6.449; MacKellar D, 1996, PUBLIC HEALTH REP, V111, P138; MANTEL N, 1959, J NATL CANCER I, V22, P719; MCKUSICK L, 1990, AM J PUBLIC HEALTH, V80, P978, DOI 10.2105/AJPH.80.8.978; OSMOND DH, 1994, AM J PUBLIC HEALTH, V84, P1933, DOI 10.2105/AJPH.84.12.1933; Ruiz J, 1998, SEX TRANSM DIS, V25, P100, DOI 10.1097/00007435-199802000-00007; Seage GR, 1997, PUBLIC HEALTH REP, V112, P158; STALL R, 1992, J ACQ IMMUN DEF SYND, V5, P682; Unger T F, 1995, J Perinatol, V15, P152; Valleroy LA, 1998, J ACQ IMMUN DEF SYND, V19, P67, DOI 10.1097/00042560-199809010-00011; Weinstock H, 1998, J ACQ IMMUN DEF SYND, V19, P506, DOI 10.1097/00042560-199812150-00010; WINKELSTEIN W, 1988, AM J PUBLIC HEALTH, V78, P1472, DOI 10.2105/AJPH.78.11.1472	26	467	473	1	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 12	2000	284	2					198	204		10.1001/jama.284.2.198	http://dx.doi.org/10.1001/jama.284.2.198			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	329XE	10889593				2022-12-24	WOS:000087933100024
J	Glowatzki, E; Fuchs, PA				Glowatzki, E; Fuchs, PA			Cholinergic synaptic inhibition of inner hair cells in the neonatal mammalian cochlea	SCIENCE			English	Article							ACETYLCHOLINE-RECEPTOR SUBUNIT; POTASSIUM CURRENT; WAITING PERIOD; RAT COCHLEA; RT-PCR; EXPRESSION; ALPHA-9; INNERVATION; RESPONSES; SYSTEM	Efferent feedback onto sensory organs provides a means to modulate input to the central nervous system. In the developing mammalian cochlea, inner hair cells are transiently innervated by efferent fibers, even before sensory function begins. Here, we show that neonatal inner hair cells are inhibited by cholinergic synaptic input before the onset of hearing. The synaptic currents, as well as the inner hair cell's response to acetylcholine, are mediated by a nicotinic (alpha 9-containing) receptor and result in the activation of small-conductance calcium-dependent potassium channels.	Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Ctr Hearing Sci, Baltimore, MD 21205 USA	Johns Hopkins University	Glowatzki, E (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Ctr Hearing Sci, Baltimore, MD 21205 USA.			Glowatzki, Elisabeth/0000-0003-3135-658X	NIDCD NIH HHS [DC 00276] Funding Source: Medline	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ART JJ, 1984, J PHYSIOL-LONDON, V356, P525, DOI 10.1113/jphysiol.1984.sp015481; Blanchet C, 1996, J NEUROSCI, V16, P2574; BOULTER J, AF196344 GENB; Dulon D, 1996, EUR J NEUROSCI, V8, P1945, DOI 10.1111/j.1460-9568.1996.tb01338.x; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; EMMERLING MR, 1990, J ELECTRON MICR TECH, V15, P123, DOI 10.1002/jemt.1060150205; Evans MG, 1996, J PHYSIOL-LONDON, V491, P563, DOI 10.1113/jphysiol.1996.sp021240; FUCHS PA, 1992, P ROY SOC B-BIOL SCI, V248, P35, DOI 10.1098/rspb.1992.0039; GINZBERG RD, 1984, HEARING RES, V14, P109, DOI 10.1016/0378-5955(84)90011-X; GLOWATZKI E, 1995, P ROY SOC B-BIOL SCI, V262, P141, DOI 10.1098/rspb.1995.0188; GUMMER AW, 1994, NEUROREPORT, V5, P685, DOI 10.1097/00001756-199402000-00006; He DZZ, 1999, J NEUROPHYSIOL, V81, P1162, DOI 10.1152/jn.1999.81.3.1162; Hiel H, 2000, BRAIN RES, V858, P215, DOI 10.1016/S0006-8993(00)01947-8; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; LENOIR M, 1980, ANAT EMBRYOL, V160, P253, DOI 10.1007/BF00305106; LIPPE WR, 1994, J NEUROSCI, V14, P1486, DOI 10.1523/JNEUROSCI.14-03-01486.1994; Lustig LR, 1999, J VESTIBUL RES-EQUIL, V9, P359; LUSTIG LR, AF199235 GENB; Morley BJ, 1998, MOL BRAIN RES, V53, P78, DOI 10.1016/S0169-328X(97)00272-6; Park HJ, 1997, HEARING RES, V112, P95, DOI 10.1016/S0378-5955(97)00111-1; PUJOL R, 1996, J PHYSIOL-PARIS, V61, P411; SANES DH, 1998, DEV AUDITORY SYSTEM, P271; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; Simmons DD, 1998, J COMP NEUROL, V397, P281; Simmons DD, 1998, MOL BRAIN RES, V56, P287, DOI 10.1016/S0169-328X(98)00056-4; Simmons DD, 1996, J COMP NEUROL, V370, P551, DOI 10.1002/(SICI)1096-9861(19960708)370:4<551::AID-CNE10>3.0.CO;2-M; SOBKOWICZ HM, 1994, HEARING RES, V75, P81, DOI 10.1016/0378-5955(94)90059-0; SPOENDLIN H, 1972, ACTA OTO-LARYNGOL, V73, P235, DOI 10.3109/00016487209138937; UZIEL A, 1981, AUDIOLOGY, V20, P89; WALSH EJ, 1997, DIVERSITY AUDITORY M, P376	30	229	236	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 30	2000	288	5475					2366	2368		10.1126/science.288.5475.2366	http://dx.doi.org/10.1126/science.288.5475.2366			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329NP	10875922				2022-12-24	WOS:000087913400040
J	Smith, KJ; Roberts, MS				Smith, KJ; Roberts, MS			The cost-effectiveness of sildenafil	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ERECTILE DYSFUNCTION; ORAL SILDENAFIL; PROSTATE-CANCER; VIAGRA; MEN; DECISION; PREFERENCES; ALPROSTADIL; EFFICACY	Background: Coverage of sildenafil by health insurance plans is a contentious issue. Objective: To evaluate the cost-effectiveness of sildenafil treatment for erectile dysfunction. Design: A Markov decision model to estimate the incremental cost-effectiveness of sildenafil compared with no drug therapy. Data Sources: Values for the efficacy and safety of sildenafil and quality-of-life utilities were obtained from the published medical literature. Base-case values were chosen to bias against sildenafil use. Target Population: Men 60 years of age with erectile dysfunction. Time Horizon: Lifetime. Perspective: Societal and third-party payer. Intervention: Sildenafil or no treatment in identical hypothetical cohorts. Outcome Measures: Cost per quality-adjusted life-year (QALY) gained. Results of Base-Case Analysis: The cost per QALY gained for sildenafil treatment compared with no therapy was $11 290 from the societal perspective and $11 230 from the third-party payer perspective. Results of Sensitivity Analysis: From the societal perspective, the cost per QALY gained associated with sildenafil was less than $50 000 if treatment-related morbidity was less than 0.8% per year, mortality was less than 0.55% per year, treatment was successful in more than 40.2% of patients, or sildenafil cost less than $244 per month. The results were sensitive to variation of erectile dysfunction utilities, but cost per QALY gained was less than $50 000 if successful treatment increased utility values by 0.05 or more on a scale of 0 (death) to 1 (perfect health). Conclusions: In an analysis biased against use of sildenafil, the cost-effectiveness of sildenafil treatment compared favorably with that of accepted therapies for other medical conditions.	Mercy Hosp, Dept Med, Pittsburgh, PA 15219 USA; Univ Pittsburgh, Sch Med, Ctr Res Hlth Care, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Smith, KJ (corresponding author), Mercy Hosp, Dept Med, 1400 Locust St, Pittsburgh, PA 15219 USA.	ksmith@pmhs.mercy.org						Aldridge J, 1999, BRIT MED J, V318, P669, DOI 10.1136/bmj.318.7184.669; BARRY MJ, 1988, JAMA-J AM MED ASSOC, V259, P3010, DOI 10.1001/jama.259.20.3010; BECK JR, 1983, MED DECIS MAKING, V3, P419, DOI 10.1177/0272989X8300300403; Brooks A, 1998, BRIT MED J, V317, P765, DOI 10.1136/bmj.317.7161.765; CHANG CF, 1999, AM J MANAG CARE, V5, pS15; Cheitlin MD, 1999, CIRCULATION, V99, P168, DOI 10.1161/01.CIR.99.1.168; Chisholm J, 1999, BMJ-BRIT MED J, V318, P273, DOI 10.1136/bmj.318.7179.273; Dinsmore WW, 1999, UROLOGY, V53, P800, DOI 10.1016/S0090-4295(98)00586-X; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; EISENBERG JM, 1989, JAMA-J AM MED ASSOC, V262, P2879, DOI 10.1001/jama.262.20.2879; Feenstra J, 1998, LANCET, V352, P957, DOI 10.1016/S0140-6736(98)00015-4; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gold MR, 1996, COST EFFECTIVENESS H; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; GORMAN C, 1998, TIME             JUL, V13, P22; Jhaveri FM, 1998, INT J IMPOT RES, V10, P251, DOI 10.1038/sj.ijir.3900359; KRAHN MD, 1994, JAMA-J AM MED ASSOC, V272, P773, DOI 10.1001/jama.272.10.773; La Puma J, 1998, Manag Care, V7, P55; Lamberg L, 1998, JAMA-J AM MED ASSOC, V280, P867, DOI 10.1001/jama.280.10.867; LAPUMA J, 1998, MANAG CARE, V7, P55; Linet OI, 1996, NEW ENGL J MED, V334, P873, DOI 10.1056/NEJM199604043341401; MARK DB, 1995, NEW ENGL J MED, V332, P1418, DOI 10.1056/NEJM199505253322106; MCDOWELL I, 1996, MEASURING HLTH GUIDE, P483; MOLD JW, 1992, J FAM PRACTICE, V34, P561; Montague DK, 1996, J UROLOGY, V156, P2007, DOI 10.1016/S0022-5347(01)65419-3; Montorsi F, 1999, UROLOGY, V53, P1011, DOI 10.1016/S0090-4295(98)00643-8; *NAT CTR HLTH STAT, 1991, 1988 VIT STAT US A, V2; PadmaNathan H, 1997, NEW ENGL J MED, V336, P1, DOI 10.1056/NEJM199701023360101; PARHAM W, 1999, AM J MANAG CARE S, V5, pS23; SACKETT DL, 1978, J CHRON DIS, V31, P697, DOI 10.1016/0021-9681(78)90072-3; *US FOOD DRUG ADM, 1998, POSTM SAF SLID CITR; Volk RJ, 1997, ARCH FAM MED, V6, P72, DOI 10.1001/archfami.6.1.72; 1998, BMJ, V317, P836	35	54	55	1	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2000	132	12					933	+		10.7326/0003-4819-132-12-200006200-00002	http://dx.doi.org/10.7326/0003-4819-132-12-200006200-00002			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325HU	10858175				2022-12-24	WOS:000087670800001
J	Leinders-Zufall, T; Lane, AP; Puche, AC; Ma, WD; Novotny, MV; Shipley, MT; Zufall, F				Leinders-Zufall, T; Lane, AP; Puche, AC; Ma, WD; Novotny, MV; Shipley, MT; Zufall, F			Ultrasensitive pheromone detection by mammalian vomeronasal neurons	NATURE			English	Article							OLFACTORY RECEPTOR NEURONS; FEMALE MICE; RESPONSE PROPERTIES; SYNTHETIC ANALOGS; MULTIGENE FAMILY; HOUSE MOUSE; PUBERTY; SYSTEM; IDENTIFICATION; ORGANIZATION	The vomeronasal organ (VNO) is a chemoreceptive organ that is thought to transduce pheromones into electrical responses that regulate sexual, hormonal and reproductive function in mammals(1-5). The characteristics of pheromone signal detection by vomeronasal neurons remain unclear(3,5). Here we use a mouse VNO slice preparation to show that six putative pheromones evoke excitatory responses in single vomeronasal neurons, leading to action potential generation and elevated calcium entry. The detection threshold for some of these chemicals is remarkably low, near 10(-11) M, placing these neurons among the most sensitive chemodetectors in mammals. Using confocal calcium imaging, we map the epithelial representation of the pheromones to show that each of the ligands activates a unique, nonoverlapping subset of vomeronasal neurons located in apical zones of the epithelium. These neurons show highly selective tuning properties and their tuning curves do not broaden with increasing concentrations of ligand, unlike those of receptor neurons in the main olfactory epithelium. These findings provide a basis for understanding chemical signals that regulate mammalian communication and sexual behaviour.	Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; Indiana Univ, Dept Chem, Bloomington, IN 47405 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Indiana University System; Indiana University Bloomington	Zufall, F (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.		Leinders-Zufall, Trese/B-4103-2009; Leinders-Zufall, Trese/S-3664-2019; Zufall, Frank/AAE-5290-2021	Leinders-Zufall, Trese/0000-0002-0678-362X; Leinders-Zufall, Trese/0000-0002-0678-362X; Zufall, Frank/0000-0002-4383-8618				Bargmann CI, 1997, CELL, V90, P585, DOI 10.1016/S0092-8674(00)80518-8; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Berghard A, 1996, J NEUROSCI, V16, P909; Bozza TC, 1998, J NEUROSCI, V18, P4560; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Inamura K, 1997, CHEM SENSES, V22, P93, DOI 10.1093/chemse/22.1.93; JEMIOLO B, 1989, PHYSIOL BEHAV, V46, P293, DOI 10.1016/0031-9384(89)90270-9; JEMIOLO B, 1986, P NATL ACAD SCI USA, V83, P4576, DOI 10.1073/pnas.83.12.4576; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; KAUER JS, 1991, TRENDS NEUROSCI, V14, P79, DOI 10.1016/0166-2236(91)90025-P; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Leinders-Zufall T, 1998, J NEUROSCI, V18, P5630; LeindersZufall T, 1997, J NEUROSCI, V17, P4136; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; MORI K, 1995, PROG NEUROBIOL, V45, P585, DOI 10.1016/0301-0082(94)00058-P; NOVOTNY M, 1984, EXPERIENTIA, V40, P217, DOI 10.1007/BF01963608; NOVOTNY M, 1986, SCIENCE, V231, P722, DOI 10.1126/science.3945805; Novotny MV, 1999, CHEM BIOL, V6, P377, DOI 10.1016/S1074-5521(99)80049-0; Novotny MV, 1999, P ROY SOC B-BIOL SCI, V266, P2017, DOI 10.1098/rspb.1999.0880; RESTREPO D, 1993, J GEN PHYSIOL, V102, P907, DOI 10.1085/jgp.102.5.907; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Tirindelli R, 1998, TRENDS NEUROSCI, V21, P482, DOI 10.1016/S0166-2236(98)01274-0; Wysocki C.J., 1987, P125; ZIDEK L, UNPUB CHEM SENSES	30	446	458	2	40	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					792	796		10.1038/35015572	http://dx.doi.org/10.1038/35015572			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866200				2022-12-24	WOS:000087620600051
J	Morris, J; Lehmann, R; Navarro, C				Morris, J; Lehmann, R; Navarro, C			Development - PARallels in axis formation	SCIENCE			English	Editorial Material							CAENORHABDITIS-ELEGANS; POLARITY; LOCALIZATION; PAR-1		NYU, Sch Med, Dept Cell Biol,Dev Genet Program, Howard Hughes Med Inst,Skirball Inst, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University	Morris, J (corresponding author), NYU, Sch Med, Dept Cell Biol,Dev Genet Program, Howard Hughes Med Inst,Skirball Inst, 540 1st Ave, New York, NY 10016 USA.			Navarro, Caryn/0000-0002-9701-477X				Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; ETERNADMOGHADAM B, 1995, CELL, V83, P743; Gruidl ME, 1996, P NATL ACAD SCI USA, V93, P13837, DOI 10.1073/pnas.93.24.13837; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; Jansen RP, 1999, FASEB J, V13, P455, DOI 10.1096/fasebj.13.3.455; Nelson WJ, 1997, CURR BIOL, V7, pR562, DOI 10.1016/S0960-9822(06)00282-X; POKRYWKA NJ, 1995, DEV BIOL, V167, P363, DOI 10.1006/dbio.1995.1030; Ray RP, 1996, GENE DEV, V10, P1711, DOI 10.1101/gad.10.14.1711; Rose LS, 1998, ANNU REV GENET, V32, P521, DOI 10.1146/annurev.genet.32.1.521; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; TOMANCAK P, IN PRESS NATURE CELL; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128	16	3	12	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 9	2000	288	5472					1759	1760		10.1126/science.288.5472.1759	http://dx.doi.org/10.1126/science.288.5472.1759			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	322HH	10877696				2022-12-24	WOS:000087503800034
J	Castelo-Branco, M; Goebel, R; Neuenschwander, S; Singer, W				Castelo-Branco, M; Goebel, R; Neuenschwander, S; Singer, W			Neural synchrony correlates with surface segregation rules	NATURE			English	Article							CAT VISUAL-CORTEX; NEURONAL RESPONSES; MOTION PERCEPTION; PLAID PATTERNS; COHERENCE; ORGANIZATION; TRANSPARENCY; ORIENTATION; NUCLEUS	To analyse an image, the visual system must decompose the scene into its relevant parts. Identifying distinct surfaces is a basic operation in such analysis, and is believed to precede object recognition(1,2). Two superimposed gratings moving in different directions (plaid stimuli) may be perceived either as two surfaces, one being transparent and sliding on top of the other (component motion) or as a single pattern whose direction of motion is intermediate to the component vectors (pattern motion)(3-6). The degree of transparency, and hence the perception, can be manipulated by changing only the luminance of the grating intersections(7-12). Here we show that neurons in two visual cortical areas-A18 and PMLS-synchronize their discharges when responding to contours of the same surface but not when responding to contours belonging to different surfaces. The amplitudes of responses correspond to previously described rate predictions(3,13-16) for component and pattern motion, but, in contrast to synchrony, failed to reflect the transition from component to pattern motion induced by manipulating the degree of transparency. Thus, dynamic changes in synchronization could encode, in a context-dependent way, relations among simultaneous responses to spatially superimposed contours and thereby bias their association with distinct surfaces.	Max Planck Inst Hirnforsch, D-60528 Frankfurt, Germany	Max Planck Society	Singer, W (corresponding author), Max Planck Inst Hirnforsch, Deutschordenstr 46, D-60528 Frankfurt, Germany.	singer@mpih-frankfurt.mpg.de	Singer, Wolf/D-6874-2012; Castelo-Branco, Miguel/F-3866-2019; Castelo-Branco, Miguel/E-5689-2010	Castelo-Branco, Miguel/0000-0003-4364-6373; NEUENSCHWANDER, Sergio/0000-0001-7493-121X				ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; ALBRIGHT TD, 1995, P NATL ACAD SCI USA, V92, P2433, DOI 10.1073/pnas.92.7.2433; BATSCHELET E, 1993, CIRCULAR STAT BIOL; BECK J, 1988, PERCEPT PSYCHOPHYS, V44, P585, DOI 10.3758/BF03207492; Brecht M., 1997, Society for Neuroscience Abstracts, V23, P843; Brecht M, 1998, J NEUROPHYSIOL, V79, P2394, DOI 10.1152/jn.1998.79.5.2394; Castelo-Branco M., 1997, Society for Neuroscience Abstracts, V23, P460; Castelo-Branco M, 1998, J NEUROSCI, V18, P6395; Edwards A. L., 1985, MULTIPLE REGRESSION; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; Freiwald WA, 1995, NEUROREPORT, V6, P2348, DOI 10.1097/00001756-199511270-00018; GIZZI MS, 1990, J NEUROPHYSIOL, V63, P1529, DOI 10.1152/jn.1990.63.6.1529; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; KONIG P, 1994, J NEUROSCI METH, V54, P31, DOI 10.1016/0165-0270(94)90157-0; Kreiter AK, 1996, J NEUROSCI, V16, P2381; Merabet L, 1998, NATURE, V396, P265, DOI 10.1038/24382; METELLI F, 1974, SCI AM, V230, P91, DOI 10.1038/scientificamerican0474-90; MOVSHON JA, 1985, STUDY GROUP PATTERN; PALMER LA, 1978, J COMP NEUROL, V177, P237, DOI 10.1002/cne.901770205; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; Scannell JW, 1996, J NEUROPHYSIOL, V76, P895, DOI 10.1152/jn.1996.76.2.895; SHIMOJO S, 1988, NATURE, V333, P265, DOI 10.1038/333265a0; SMITH AT, 1991, EXP BRAIN RES, V86, P324; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; Stoner GR, 1998, VISION RES, V38, P387, DOI 10.1016/S0042-6989(97)00132-6; STONER GR, 1990, NATURE, V344, P153, DOI 10.1038/344153a0; Stoner GR, 1996, VISION RES, V36, P1291, DOI 10.1016/0042-6989(95)00195-6; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411	29	119	121	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2000	405	6787					685	689		10.1038/35015079	http://dx.doi.org/10.1038/35015079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864325				2022-12-24	WOS:000087465800047
J	Super, M				Super, M			CFTR and disease: implications for drug development	LANCET			English	Editorial Material							CYSTIC-FIBROSIS GENE; REGULATOR; CLONING		Royal Manchester Childrens Hosp, Reg Cyst Fibrosis Ctr, Manchester M27 4HA, Lancs, England	Royal Manchester Children's Hospital	Super, M (corresponding author), Royal Manchester Childrens Hosp, Reg Cyst Fibrosis Ctr, Manchester M27 4HA, Lancs, England.							AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; BAXTER PS, 1988, NATURE, V335, P211, DOI 10.1038/335211a0; Cai Z, 1999, BRIT J PHARMACOL, V128, P108, DOI 10.1038/sj.bjp.0702748; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; O'Sullivan DA, 1998, AM J KIDNEY DIS, V32, P976, DOI 10.1016/S0272-6386(98)70072-1; Pier GB, 1998, NATURE, V393, P79, DOI 10.1038/30006; Reddy MM, 1999, NATURE, V402, P301, DOI 10.1038/46297; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schultz B. D., 1999, Physiological Reviews, V79, pS109; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; SUPER M, 1999, PAEDIAT PULMONOL, V19, P208; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Wilschanski M, 2000, AM J RESP CRIT CARE, V161, P860, DOI 10.1164/ajrccm.161.3.9904116; 1999, PAEDIAT PULMONOL S, V19, P87	15	4	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 27	2000	355	9218					1840	1842		10.1016/S0140-6736(00)02282-0	http://dx.doi.org/10.1016/S0140-6736(00)02282-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	318VZ	10866434				2022-12-24	WOS:000087306500004
J	Nagaya, K; Fetters, MD; Ishikawa, M; Kubo, T; Koyanagi, T; Saito, Y; Sameshima, H; Sugimoto, M; Takagi, K; Chiba, Y; Honda, H; Mukubo, M; Kawamura, M; Satoh, S; Neki, R				Nagaya, K; Fetters, MD; Ishikawa, M; Kubo, T; Koyanagi, T; Saito, Y; Sameshima, H; Sugimoto, M; Takagi, K; Chiba, Y; Honda, H; Mukubo, M; Kawamura, M; Satoh, S; Neki, R			Causes of maternal mortality in Japan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADVERSE DRUG EVENTS; HOSPITALIZED-PATIENTS	Context Japan's maternal mortality rate is higher than that of other developed countries. Objectives To identify causes of maternal mortality in Japan, examine attributes of treating facilities associated with maternal mortality, and assess the preventability of such deaths. Design and Setting Cross-sectional study of maternal deaths occurring in Japan between January 1, 1991, and December 31, 1992, Subjects Of 230 women who died while pregnant or within 42 days of being pregnant, 197 died in a hospital and had medical records available, 22 died outside of a medical facility, and 11 did not have records available. Main Outcome Measures Maternal mortality rates per 100000 live births by cause (identified by death certificate review and information from treating physicians or coroners); resources and staffing patterns of facilities where deaths occurred; and preventability of death, as determined by a 42-member panel of medical specialists. Results Overall maternal mortality was 9.5 per 100000 births. Hemorrhage was the most common cause of death, occurring in 86 (39%) of 219 women. Seventy-two (37%) of 197 deaths occurring in facilities were deemed preventable and another 32 (16%) possibly preventable. Among deaths that occurred in a medical facility with an obstetrician on duty, the highest rate of preventable deaths (4.09/100000 live births) occurred in facilities with 1 obstetrician. Among the 72 preventable deaths, 49 were attributed to 1 physician functioning as the obstetrician and anesthetist. While the unpreventable maternal death rate was highest in referral facilities, the preventable maternal death rate was 14 times lower in referral facilities than in transferring facilities. Conclusions Inadequate obstetric services are associated with maternal mortality in Japan. Reducing single-obstetrician only delivery patterns and establishing regional 24-hour inpatient obstetrics facilities for high-risk cases may reduce maternal mortality in Japan.	Sayama Hlth Ctr, Sayama, Osaka 3501324, Japan; Univ Michigan Hlth Syst, Dept Family Med, Ann Arbor, MI USA; Asahikawa Med Coll, Dept Obstet & Gynecol, Asahikawa, Hokkaido 078, Japan; Kochi Med Sch, Matern & Perinatal Intens Care Unit, Nankoku, Japan; Kyushu Univ Hosp, Matern & Perinatal Care Unit, Fukuoka 812, Japan; Hirosaki Univ, Sch Med, Dept Obstet & Gynecol, Hirosaki, Aomori 036, Japan; Miyazaki Med Coll, Dept Obstet & Gynecol, Miyazaki 88916, Japan; Japanese Red Cross Med Ctr, Dept Obstet & Gynecol, Tokyo, Japan; Tokyo Womens Med Coll, Daini Hosp, Dept Obstet & Gynecol, Tokyo, Japan; Natl Cardiovasc Ctr, Dept Perinatol, Osaka, Japan; Mitsui Mem Hosp, Dept Obstet & Gynecol, Tokyo 101, Japan; Yodogawa Christians Hosp, Dept Obstet & Gynecol, Osaka, Japan	University of Michigan System; University of Michigan; Asahikawa Medical College; Kochi University; Kyushu University; Hirosaki University; University of Miyazaki; Japanese Red Cross Medical Center; University of Tokyo; Tokyo Women's Medical University; National Cerebral & Cardiovascular Center - Japan; Mitsui Memorial Hospital	Nagaya, K (corresponding author), Sayama Hlth Ctr, 2-16-1 Inariyama, Sayama, Osaka 3501324, Japan.	NagayaKen@aol.com		Sameshima, Hiroshi/0000-0001-8898-4857				BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Brennan T A, 1992, Qual Manag Health Care, V1, P29; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; BRENNAN TA, 1990, ANN INTERN MED, V112, P221, DOI 10.7326/0003-4819-112-3-221; *DEP HLTH ENGL, 1996, REP ENQ MAT DEATHS U; Fischer G, 1997, J FAM PRACTICE, V45, P40; FORTNEY J A, 1990, World Health Statistics Quarterly, V43, P246; GURWITZ JH, 1994, J AM GERIATR SOC, V42, P33, DOI 10.1111/j.1532-5415.1994.tb06070.x; ICHIJYO M, 1991, NIPPON SANKA FUJINHA, V46, P59; *JAP ASS OBST GYN, 1996, NIPP SANK FUJ GAKK M; *JINTS SOK YOR HIG, 1997, ANZENNA OSAN NETTOWA, V54, P17; Leape L L, 1993, QRB Qual Rev Bull, V19, P144; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; *MAT CHILD HLTH DI, 1993, BOSH EIS NO OM TOUK; *NAT HLTH MRS AUST, 1993, REP MAT DEATHS AUSTR, P90; *PHS, 1988, INT CLASS DIS; *STAT INF DEP, 1993, IR SHIS CHOUS BYOUIN; *STAT INF DEP, 1994, ISH SHIK YAK CHOUS; TADA H, 1994, PERINATAL MED, V24, P17; TAKEDA Y, 1994, NIPPON SANKA FUJINHA, V46, P1279	22	68	71	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2000	283	20					2661	2667		10.1001/jama.283.20.2661	http://dx.doi.org/10.1001/jama.283.20.2661			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314FP	10819948	Bronze			2022-12-24	WOS:000087046000033
J	Li, XY; Bhaumik, SR; Green, MR				Li, XY; Bhaumik, SR; Green, MR			Distinct classes of yeast promoters revealed by differential TAF recruitment	SCIENCE			English	Article							IN-VIVO; TRANSCRIPTIONAL ACTIVATION; BINDING; TBP; REQUIREMENT; SELECTIVITY; CELLS	The transcription factor TFIID contains the TATA box binding protein (TBP) and multiple TBP-associated factors (TAFs), Here, the association of TFIID components with promoters that either are dependent on multiple TAFs (TAF(dep)) or have no apparent TAF requirement (TAF(ind)) is analyzed in yeast. At TAF(dep) promoters, TAFs are present at Levels comparable to that of TBP, whereas at TAF(ind) promoters, TAFs are present at Levels that approximate background. After inactivation of several general transcription factors, including TBP, TAFs are still recruited by activators to TAF(dep) promoters. The results reveal two classes of promoters: at TAF(ind) promoters, TBP is recruited in the apparent absence of TAFs, whereas at TAF(dep) promoters, TAFs are co-recruited with TBP in a manner consistent with direct activator-TAF interactions.	Univ Massachusetts, Sch Med, Program Mol Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Green, MR (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.				NIGMS NIH HHS [GM33977] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033977] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apone LM, 1996, GENE DEV, V10, P2368, DOI 10.1101/gad.10.18.2368; Apone LM, 1998, MOL CELL, V2, P653, DOI 10.1016/S1097-2765(00)80163-X; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; Green MR, 2000, TRENDS BIOCHEM SCI, V25, P59, DOI 10.1016/S0968-0004(99)01527-3; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kuras L, 2000, SCIENCE, V288, P1244, DOI 10.1126/science.288.5469.1244; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; LEE TI, IN PRESS NATURE; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; Michel B, 1998, MOL CELL, V2, P663, DOI 10.1016/S1097-2765(00)80164-1; Moqtaderi Z, 1996, P NATL ACAD SCI USA, V93, P14654, DOI 10.1073/pnas.93.25.14654; Moqtaderi Z, 1996, NATURE, V383, P188, DOI 10.1038/383188a0; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Shen WC, 1997, CELL, V90, P615, DOI 10.1016/S0092-8674(00)80523-1; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X; Walker SS, 1996, NATURE, V383, P185, DOI 10.1038/383185a0	18	154	154	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 19	2000	288	5469					1242	1244		10.1126/science.288.5469.1242	http://dx.doi.org/10.1126/science.288.5469.1242			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315KH	10817999				2022-12-24	WOS:000087112600051
J	Bildirici, L; Smith, P; Tzavelas, C; Horefti, E; Rickwood, D				Bildirici, L; Smith, P; Tzavelas, C; Horefti, E; Rickwood, D			Biotechniques - Transfection of cells by immunoporation	NATURE			English	Article							GENE-TRANSFER; DNA; ELECTROPORATION; EXPRESSION		Univ Essex, Dept Biol, Colchester CO4 3SQ, Essex, England	University of Essex	Bildirici, L (corresponding author), Univ Essex, Dept Biol, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	rickd@essex.ac.uk		Horefti, Elina/0000-0002-9527-4420				Ambrosini E, 1999, J NEUROSCI RES, V55, P569; FROMM M, 1987, METHOD ENZYMOL, V153, P351; Hargest R, 1998, ADV EXP MED BIOL, V451, P385; Mack KD, 1998, J IMMUNOL METHODS, V211, P79, DOI 10.1016/S0022-1759(97)00194-4; NIELSEN T, 1994, MOL GEN GENET, V242, P280, DOI 10.1007/BF00280417; PFAU J, 1990, NUCLEIC ACIDS RES, V18, P6165, DOI 10.1093/nar/18.20.6165; WATANABE Y, 1994, J BIOCHEM-TOKYO, V116, P1220, DOI 10.1093/oxfordjournals.jbchem.a124667; Yang YW, 1997, BIOTECHNOL APPL BIOC, V25, P47, DOI 10.1111/j.1470-8744.1997.tb00413.x	8	16	17	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2000	405	6784					298	298		10.1038/35012701	http://dx.doi.org/10.1038/35012701			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314YT	10830950	Bronze			2022-12-24	WOS:000087085700033
J	Li, K; Li, YC; Shelton, JM; Richardson, JA; Spencer, E; Chen, ZJ; Wang, XD; Williams, RS				Li, K; Li, YC; Shelton, JM; Richardson, JA; Spencer, E; Chen, ZJ; Wang, XD; Williams, RS			Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis	CELL			English	Article							LACKING MITOCHONDRIAL-DNA; CELL-DEATH; TRANSCRIPTION FACTOR; MESSENGER-RNA; ACTIVATION; MICE; RELEASE; CASPASE-3; PATHWAY; MOUSE	Cytochrome c released from mitochondria has been proposed to be an essential component of an apoptotic pathway responsive to DNA damage and other forms of cell stress. Murine embryos devoid of cytochrome c die in utero by midgestation, but cell lines established from early cytochrome c null embryos are viable under conditions that compensate for defective oxidative phosphorylation. As compared to cell lines established from wild-type embryos, cells lacking cytochrome c show reduced caspase-3 activation and are resistant to the proapoptotic effects of UV irradiation, serum withdrawal, or staurosporine. In contrast, cells lacking cytochrome c demonstrate increased sensitivity to cell death signals triggered by TNF alpha. These results define the role of cytochrome c in different apoptotic signaling cascades.	Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Williams, RS (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA.			Wang, Xiaodong/0000-0001-9885-356X				ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HAKE LE, 1990, DEVELOPMENT, V110, P249; HAKE LE, 1993, J BIOL CHEM, V268, P4788; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; JACOBSON MD, 1993, NATURE, V361, P365, DOI 10.1038/361365a0; Jiang SN, 1999, J BIOL CHEM, V274, P29905, DOI 10.1074/jbc.274.42.29905; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Li F, 1997, J BIOL CHEM, V272, P30299, DOI 10.1074/jbc.272.48.30299; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; LI K, 1995, J BIOL CHEM, V270, P25281, DOI 10.1074/jbc.270.42.25281; LIMBACH KJ, 1985, NUCLEIC ACIDS RES, V13, P617, DOI 10.1093/nar/13.2.617; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; Narula J, 1999, P NATL ACAD SCI USA, V96, P8144, DOI 10.1073/pnas.96.14.8144; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; SALEMME FR, 1977, ANNU REV BIOCHEM, V46, P299, DOI 10.1146/annurev.bi.46.070177.001503; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Suzuki A, 1999, MOL CELL BIOL, V19, P3842; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhivotovsky B, 1998, NATURE, V391, P449, DOI 10.1038/35060; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	41	404	432	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 12	2000	101	4					389	399		10.1016/S0092-8674(00)80849-1	http://dx.doi.org/10.1016/S0092-8674(00)80849-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	313QM	10830166	Bronze			2022-12-24	WOS:000087010400007
J	Aronson, RB; Precht, WF; Macintyre, IG; Murdoch, TJT				Aronson, RB; Precht, WF; Macintyre, IG; Murdoch, TJT			Ecosystems - Coral bleach-out in Belize	NATURE			English	Article							REEF		Dauphin Isl Sea Lab, Dauphin Island, AL 36528 USA; PBS&J, Miami, FL 33172 USA; Smithsonian Inst, Museum Natl Hist Nat, Dept Paleobiol, Washington, DC 20560 USA	Dauphin Island Sea Lab; Smithsonian Institution; Smithsonian National Museum of Natural History	Aronson, RB (corresponding author), Dauphin Isl Sea Lab, 1-1 Bienville Blvd, Dauphin Island, AL 36528 USA.			Murdoch, Thaddeus/0000-0002-1297-1694; Aronson, Richard/0000-0003-0383-3844				Aronson RB, 1997, PALEOBIOLOGY, V23, P326, DOI 10.1017/S0094837300019710; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Glynn PW, 1990, GLOBAL ECOLOGICAL CO, P55; Hansen J, 1999, J GEOPHYS RES-ATMOS, V104, P30997, DOI 10.1029/1999JD900835; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; *INT SOC REEF STUD, 1998, REEF ENCOUNTER, V24, P19; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Macintyre I. G., 1995, ATOLL RES B, V430, P1, DOI DOI 10.5479/si.00775630.430.1; McField MD, 1999, B MAR SCI, V64, P155; Mumby PJ, 1999, MAR ECOL PROG SER, V190, P27, DOI 10.3354/meps190027; OLIVER J, 1985, 5TH P INT COR REEF C, V4, P201; PORTER JW, 1989, P NATL ACAD SCI USA, V86, P9342, DOI 10.1073/pnas.86.23.9342; SMITH SV, 1992, ANNU REV ECOL SYST, V23, P89, DOI 10.1146/annurev.es.23.110192.000513	14	111	123	0	35	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2000	405	6782					36	36		10.1038/35011132	http://dx.doi.org/10.1038/35011132			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311TK	10811207	Bronze			2022-12-24	WOS:000086901600039
J	Wallingford, JB; Rowning, BA; Vogeli, KM; Rothbacher, U; Fraser, SE; Harland, RM				Wallingford, JB; Rowning, BA; Vogeli, KM; Rothbacher, U; Fraser, SE; Harland, RM			Dishevelled controls cell polarity during Xenopus gastrulation	NATURE			English	Article							SIGNALING PATHWAYS; LAEVIS; ORGANIZER; MOVEMENT; MESODERM; MOTILITY; KINASE; AXIS	Although cell movements are vital for establishing the normal architecture of embryos, it is unclear how these movements are regulated during development in vertebrates. Inhibition of Xenopus Dishevelled (Xdsh) function disrupts convergent extension movements of cells during gastrulation, but the mechanism of this effect is unclear, as cell fates are not affected(1). In Drosophila, Dishevelled controls both cell fate and cell polarity(2-4), but whether Dishevelled is involved in controlling cell polarity in vertebrate embryos has not been investigated. Here we show, using time-lapse confocal microscopy, that the failure of cells lacking Xdsh function to undergo convergent extension results from defects in cell polarity. Furthermore, Xdsh mutations that inhibit convergent extension correspond to mutations in Drosophila Dishevelled that selectively perturb planar cell polarity. Finally, the localization of Xdsh at the membrane of normal dorsal mesodermal cells is consistent with Xdsh controlling cell polarity. Our results show that polarized cell behaviour is essential for convergent extension and is controlled by vertebrate Dishevelled. Thus, a vertebrate equivalent of the Drosophila planar cell polarity signalling cascade may be required for normal gastrulation.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Life Sci Div MS6 2100, Berkeley, CA 94720 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Beckman Inst, Pasadena, CA 91125 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; California Institute of Technology; California Institute of Technology	Harland, RM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 401 Barker Hall, Berkeley, CA 94720 USA.	harland@socrates.berkeley.edu	Rothbächer, Ute/AAB-6901-2022; Fraser, Scott/Y-3406-2019; Rothbächer, Ute/G-2688-2013	Rothbächer, Ute/0000-0002-9989-6139; Fraser, Scott/0000-0002-5377-0223; Rothbächer, Ute/0000-0002-9989-6139				Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; HOWARD JE, 1993, MECH DEVELOP, V43, P37, DOI 10.1016/0925-4773(93)90021-O; KELLER R, 1992, DEVELOPMENT, P81; KELLER R, 1991, 49 S SOC DEV BIOL CE, P93; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; PIERCE SB, 1995, DEVELOPMENT, V121, P755; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; SHIH J, 1992, DEVELOPMENT, V116, P901; SHIH J, 1992, DEVELOPMENT, V116, P915; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Vogt Walther, 1929, Wilhelm Roux Arch Entwickl Mech Org, V120, P384, DOI 10.1007/BF02109667; Wallingford JB, 1997, DEV BIOL, V187, P224, DOI 10.1006/dbio.1997.8571	17	610	622	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2000	405	6782					81	85		10.1038/35011077	http://dx.doi.org/10.1038/35011077			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311TK	10811222				2022-12-24	WOS:000086901600055
J	Travers, KJ; Patil, CK; Wodicka, L; Lockhart, DJ; Weissman, JS; Walter, P				Travers, KJ; Patil, CK; Wodicka, L; Lockhart, DJ; Weissman, JS; Walter, P			Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation	CELL			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; UBIQUITIN-PROTEASOME PATHWAY; SACCHAROMYCES-CEREVISIAE; TRANSMEMBRANE PROTEIN; TRANSCRIPTION FACTOR; SECRETORY PATHWAY; YEAST; NUCLEUS; KINASE; EXPRESSION	The unfolded protein response (UPR) regulates gene expression in response to stress in the endoplasmic reticulum (ER). We determined the transcriptional scope of the UPR using DNA microarrays. Rather than regulating only ER-resident chaperones and phospholipid biosynthesis, as anticipated from earlier work, the UPR affects multiple ER and secretory pathway functions. Studies of UPR targets engaged in ER-associated protein degradation (ERAD) reveal an intimate coordination between these responses: efficient ERAD requires an intact UPR, and UPR induction increases ERAD capacity. Conversely, loss of ERAD leads to constitutive UPR induction. Finally, simultaneous loss of ERAD and the UPR greatly decreases cell viability. Thus, the UPR and ERAD are dynamic responses required for the coordinated disposal of misfolded proteins even in the absence of acute stress.	Univ Calif San Francisco, Dept Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Affymetrix Inc, Santa Clara, CA 95051 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Affymetrix	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular Pharmacol, San Francisco, CA 94143 USA.	jsw1@itsa.ucsf.edu; walter@cgl.ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X				Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Boisrame A, 1999, MOL GEN GENET, V261, P601; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Chapman R, 1998, ANNU REV CELL DEV BI, V14, P459, DOI 10.1146/annurev.cellbio.14.1.459; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Doerrler WT, 1999, P NATL ACAD SCI USA, V96, P13050, DOI 10.1073/pnas.96.23.13050; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hong E, 1996, J CELL BIOL, V135, P623, DOI 10.1083/jcb.135.3.623; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; MORI K, 1993, CELL, V74, P743; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Roberg KJ, 1999, J CELL BIOL, V145, P659, DOI 10.1083/jcb.145.4.659; SCHENA M, 1991, METHOD ENZYMOL, V194, P389; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; SIKORSKI RS, 1989, GENETICS, V122, P19; Trilla JA, 1999, J CELL BIOL, V145, P1153, DOI 10.1083/jcb.145.6.1153; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Zhou MY, 1999, MOL CELL, V4, P925, DOI 10.1016/S1097-2765(00)80222-1	43	1509	1548	6	152	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 28	2000	101	3					249	258		10.1016/S0092-8674(00)80835-1	http://dx.doi.org/10.1016/S0092-8674(00)80835-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847680	Bronze			2022-12-24	WOS:000086741900005
J	Delaunay, F; Thisse, C; Marchand, O; Laudet, V; Thisse, B				Delaunay, F; Thisse, C; Marchand, O; Laudet, V; Thisse, B			An inherited functional circadian clock in zebrafish embryos	SCIENCE			English	Article							PERIOD HOMOLOGS; DROSOPHILA; GENE; EXPRESSION; RHYTHMS; TRANSCRIPTION; ENTRAINMENT; MOTHER; BRAIN; LOOP	Circadian clocks are time-keeping systems found in most organisms. In zebrafish, expression of the clock gene Period3 (Per3) oscillates throughout embryogenesis in the central nervous system and the retina. Per3 rhythmic expression was free-running and was reset by light but not by the developmental delays caused by Low temperature. The time of fertilization had no effect on Per3 expression. Per3 messenger RNA accumulates rhythmically in oocytes and persists in embryos. Our results establish that the circadian clock functions during early embryogenesis in zebrafish. Inheritance of maternal clock gene products suggests a mechanism of phase inheritance through ovogenesis.	Ecole Normale Super Lyon, CNRS, UMR 5665, F-69364 Lyon, France; Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, ULP, F-67404 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Laudet, V (corresponding author), Ecole Normale Super Lyon, CNRS, UMR 5665, 46 Allee Italie, F-69364 Lyon, France.		Weydahl, Andi/C-6391-2008	Delaunay, Franck/0000-0003-4927-1701; THISSE, Christine/0000-0002-8684-1681				Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; CITRI Y, 1987, NATURE, V326, P42, DOI 10.1038/326042a0; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; DAVIS FC, 1988, AM J PHYSIOL, V255, pR439, DOI 10.1152/ajpregu.1988.255.3.R439; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; KANE DA, 1993, DEVELOPMENT, V119, P447; Kazimi N, 1999, DEV BRAIN RES, V117, P47, DOI 10.1016/S0165-3806(99)00096-6; MIYAJIMA N, 1989, CELL, V57, P31, DOI 10.1016/0092-8674(89)90169-4; Pittendrigh C, 1993, ANNU REV PHYSIOL, V55, P17; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; REPPERT SM, 1995, CIBA F SYMP, V183, P198; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; SEHGAL A, 1992, P NATL ACAD SCI USA, V89, P1423, DOI 10.1073/pnas.89.4.1423; SERONFERRE M, 1993, ENDOCR REV, V14, P594, DOI 10.1210/er.14.5.594; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; THISSE C, 1993, DEVELOPMENT, V119, P1203; THISSE C, UNPUB; Westerfield M, 1995, ZEBRAFISH BOOK; WILSON SW, 1991, DEVELOPMENT, V112, P723; WILSON SW, 1990, DEVELOPMENT, V108, P121; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	27	95	101	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					297	300		10.1126/science.289.5477.297	http://dx.doi.org/10.1126/science.289.5477.297			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894777				2022-12-24	WOS:000088169400041
J	Rensenbrink, K				Rensenbrink, K			Pretzels and fruitcake	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Ellsworth Internal Med, Ellsworth, ME 04605 USA		Rensenbrink, K (corresponding author), Ellsworth Internal Med, Ellsworth, ME 04605 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 4	2000	133	1					71	71		10.7326/0003-4819-133-1-200007040-00013	http://dx.doi.org/10.7326/0003-4819-133-1-200007040-00013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329TB	10877743				2022-12-24	WOS:000087923100010
J	Aitman, TJ; Cooper, LD; Norsworthy, PJ; Wahid, FN; Gray, JK; Curtis, BR; McKeigue, PM; Kwiatkowski, D; Greenwood, BM; Snow, RW; Hill, AV; Scott, J				Aitman, TJ; Cooper, LD; Norsworthy, PJ; Wahid, FN; Gray, JK; Curtis, BR; McKeigue, PM; Kwiatkowski, D; Greenwood, BM; Snow, RW; Hill, AV; Scott, J			Population genetics - Malaria susceptibility and CD36 mutation	NATURE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; GLYCOPROTEIN; ANTIGENS; ASIANS		MRC, Ctr Clin Sci, Mol Med Grp, London W12 0NN, England; Hammersmith Hosp, Imperial Coll Genet, London W12 0NN, England; Hammersmith Hosp, Genom Res Inst, London W12 0NN, England; Med Coll Wisconsin, Blood Ctr SE Wisconsin, Milwaukee, WI 53201 USA; Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Sci, London WC1E 7HT, England; MRC Labs, Fajara, Gambia; KEMRI, Coastal Res Unit, Kilifi, Kenya; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	Imperial College London; Imperial College London; Medical College of Wisconsin; Versiti Blood Center of Wisconsin; University of London; London School of Hygiene & Tropical Medicine; MRC Laboratory Molecular Biology; University of Oxford; Wellcome Centre for Human Genetics	Aitman, TJ (corresponding author), MRC, Ctr Clin Sci, Mol Med Grp, London W12 0NN, England.	t.aitman@csc.mrc.ac.uk	Curtis, Brian R/AAT-7861-2020; HILL, Adrian V>S>/C-1306-2008; Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088; Kwiatkowski, Dominic/0000-0002-5023-0176; Aitman, Timothy/0000-0002-7875-4502; Norsworthy, Penny/0000-0002-5572-8491				ARMESILLA AL, 1994, J BIOL CHEM, V269, P18985; Baruch DI, 1999, BLOOD, V94, P2121, DOI 10.1182/blood.V94.6.2121.418k09_2121_2127; Curtis BR, 1996, TRANSFUSION, V36, P331, DOI 10.1046/j.1537-2995.1996.36496226147.x; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; KASHIWAGI H, 1995, J CLIN INVEST, V95, P1040, DOI 10.1172/JCI117749; LIPSKY RH, 1994, HUM MOL GENET, V3, P217, DOI 10.1093/hmg/3.1.217; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; OCKENHOUSE CF, 1989, SCIENCE, V243, P1469, DOI 10.1126/science.2467377; SNOW RW, 1993, T ROY SOC TROP MED H, V87, P386, DOI 10.1016/0035-9203(93)90007-D; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; URWIJITAROON Y, 1995, TRANSFUSION, V35, P868, DOI 10.1046/j.1537-2995.1995.351096026370.x	11	168	174	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2000	405	6790					1015	1016		10.1038/35016636	http://dx.doi.org/10.1038/35016636			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	328VN	10890433				2022-12-24	WOS:000087871700033
J	Barton, RA; Harvey, PH				Barton, RA; Harvey, PH			Mosaic evolution of brain structure in mammals	NATURE			English	Article							PRIMATES; INSECTIVORES; AMYGDALA; VOLUMES; NUCLEI	The mammalian brain comprises a number of functionally distinct systems. It might therefore be expected that natural selection on particular behavioural capacities would have caused size changes selectively, in the systems mediating those capacities(1-3). It has been claimed, however, that developmental constraints limited such mosaic evolution, causing co-ordinated size change among individual brain components(3). Here we analyse comparative data to demonstrate that mosaic change has been an important factor in brain structure evolution. First, the neocortex shows about a fivefold difference in volume between primates and insectivores even after accounting for its scaling relationship with the rest of the brain. Second, brain structures with major anatomical and functional links evolved together independently of evolutionary change in other structures. This is true at the level of both basic brain subdivisions and more fine-grained functional systems. Hence, brain evolution in these groups involved complex relationships among individual brain components.	Univ Durham, Dept Anthropol, Evolutionary Anthropol Res Grp, Durham DH1 3HN, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Durham University; University of Oxford	Barton, RA (corresponding author), Univ Durham, Dept Anthropol, Evolutionary Anthropol Res Grp, Durham DH1 3HN, England.							BARTON RA, 1995, PHILOS T ROY SOC B, V348, P381, DOI 10.1098/rstb.1995.0076; Butler A. B., 1996, COMP VERTEBRATE NEUR, DOI DOI 10.1002/0471733849.CH19; Cousens G, 1998, BEHAV NEUROSCI, V112, P1092, DOI 10.1037/0735-7044.112.5.1092; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.3.CO;2-P; Eisenberg J.F., 1981, MAMMALIAN RAD; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; FINLAY BL, IN PRESS BEHAV BRAIN; FRAHM HD, 1982, J HIRNFORSCH, V23, P375; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HARVEY PH, 1990, SCIENCE, V249, P140, DOI 10.1126/science.2196673; HOFMAN MA, 1989, PROG NEUROBIOL, V32, P137, DOI 10.1016/0301-0082(89)90013-0; INNOCENTI GM, 1995, TRENDS NEUROSCI, V18, P371, DOI 10.1016/0166-2236(95)93931-M; KAAS JH, 1995, BRAIN BEHAV EVOLUT, V46, P187, DOI 10.1159/000113273; KREBS JR, 1990, PHILOS T ROY SOC B, V329, P153, DOI 10.1098/rstb.1990.0160; MATANO S, 1986, FOLIA PRIMATOL, V47, P189, DOI 10.1159/000156277; MATANO S, 1985, FOLIA PRIMATOL, V44, P182, DOI 10.1159/000156212; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; PURVIS A, 1995, COMPUT APPL BIOSCI, V11, P247; RINGO JL, 1991, BRAIN BEHAV EVOLUT, V38, P1, DOI 10.1159/000114375; STEPHAN H, 1981, FOLIA PRIMATOL, V35, P1, DOI 10.1159/000155963; Stephan H, 1991, COMP BRAIN RES MAMMA, V1; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X	23	501	506	1	136	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 29	2000	405	6790					1055	1058		10.1038/35016580	http://dx.doi.org/10.1038/35016580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	328VN	10890446				2022-12-24	WOS:000087871700046
J	Woodward, J; Orr, M; Cordray, K; Greenbaum, E				Woodward, J; Orr, M; Cordray, K; Greenbaum, E			Biotechnology - Enzymatic production of biohydrogen	NATURE			English	Article							HYDROGEN-PRODUCTION		Oak Ridge Natl Lab, Div Chem Technol, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	Woodward, J (corresponding author), Oak Ridge Natl Lab, Div Chem Technol, Oak Ridge, TN 37831 USA.	woodwardj@ornl.gov		Orr, Mark/0000-0003-2684-4722				Benemann J, 1996, NAT BIOTECHNOL, V14, P1101, DOI 10.1038/nbt0996-1101; CHENAULT HK, 1987, APPL BIOCHEM BIOTECH, V14, P147, DOI 10.1007/BF02798431; COURI D, 1959, ARCH BIOCHEM BIOPHYS, V83, P195, DOI 10.1016/0003-9861(59)90024-4; GREENBAUM E, 1984, PHOTOBIOCH PHOTOBIOP, V8, P323; HORECKER BL, 1950, ARCH BIOCHEM, V29, P232; Keasling JD, 1998, BIOHYDROGEN, P87; Lee JW, 1996, SCIENCE, V273, P364, DOI 10.1126/science.273.5273.364; Lehninger A.L, 1975, BIOCHEMISTRY-US; Lide D., 1994, CRC HDB CHEM PHYS, p[5, 15]; MA KS, 1994, FEMS MICROBIOL LETT, V122, P245, DOI 10.1016/0378-1097(94)00330-0; NAKAJIMA H, 1991, ACS S SER, V466, P111; STULL DR, 1969, CHEM THERMODYN, P680; Woodward J, 1996, NAT BIOTECHNOL, V14, P872, DOI 10.1038/nbt0796-872	13	218	246	4	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2000	405	6790					1014	1015		10.1038/35016633	http://dx.doi.org/10.1038/35016633			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	328VN	10890432				2022-12-24	WOS:000087871700032
J	Andersen, AMN; Wohlfahrt, J; Christens, P; Olsen, J; Melbye, M				Andersen, AMN; Wohlfahrt, J; Christens, P; Olsen, J; Melbye, M			Maternal age and fetal loss: population based register Linkage study	BRITISH MEDICAL JOURNAL			English	Article							SPONTANEOUS-ABORTION; ECTOPIC PREGNANCY; RISK-FACTORS; DEATH; RATES	Objective To estimate the association between maternal age and fetal death (spontaneous abortion, ectopic pregnancy, stillbirth), taking into account a woman's reproductive history. Design Prospective register linkage study. Subjects All women with a reproductive outcome (live birth, stillbirth, spontaneous abortion leading to admission to hospital, induced abortion, ectopic pregnancy, or hydatidiform mole) in Denmark from 1978 to 1992; a total of 634 272 women and 1 221 546 pregnancy outcomes. Main outcome measures Age related risk of fetal loss, ectopic pregnancy, and stillbirth, and age related risk of spontaneous abortion stratified according to parity and previous spontaneous abortions. Results Overall, 13.5% of the pregnancies intended to be carried to term ended with fetal loss. At age 42 years, more than half of such pregnancies resulted in fetal loss. The risk of a spontaneous abortion was 8.9% in women aged 20-24 years and 74.7% in those aged 45 years or more. High maternal age was a significant risk factor for spontaneous abortion irrespective of the number of previous miscarriages, parity, or calendar period. The risk of an ectopic pregnancy and stillbirth also increased with increasing maternal age. Conclusions Fetal loss in high in women in their late 30s or older; irrespective of reproductive history. This should be taken into consideration in pregnancy planning and counselling.	Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark; Aarhus Univ, Inst Epidemiol & Social Med, Danish Epidemiol Sci Ctr, DK-8000 Aarhus, Denmark	Aarhus University; Statens Serum Institut; Aarhus University	Andersen, AMN (corresponding author), Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark.		Nybo Andersen, Anne-Marie/AAA-1997-2022; Andersen, Anne-Marie Nybo/E-4993-2013	Nybo Andersen, Anne-Marie/0000-0002-4296-8488; Andersen, Anne-Marie Nybo/0000-0002-4296-8488; melbye, mads/0000-0001-8264-6785				ALBERMAN E, 1987, SPONTANEOUS RECURREN; BERKOWITZ GS, 1990, NEW ENGL J MED, V322, P659, DOI 10.1056/NEJM199003083221004; CANO F, 1995, FERTIL STERIL, V64, P584, DOI 10.1016/S0015-0282(16)57797-8; Christiansen OB, 1997, DAN MED BULL, V44, P396; COSTE J, 1991, HUM REPROD, V6, P1332, DOI 10.1093/oxfordjournals.humrep.a137535; Egger M, 1998, BRIT MED J, V316, P1776, DOI 10.1136/bmj.316.7147.1776; FRETTS RC, 1995, NEW ENGL J MED, V333, P953, DOI 10.1056/NEJM199510123331501; HAKIM RB, 1995, AM J OBSTET GYNECOL, V172, P1510, DOI 10.1016/0002-9378(95)90489-1; HARLAP S, 1980, HUMAN EMBRYONIC FOCT; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; HEIDAM LZ, 1985, SCAND J SOC MED, V13, P159, DOI 10.1177/140349488501300406; Kline J, 1989, CONCEPTION BIRTH EPI, P43; Kline J., 1984, PERINATAL EPIDEMIOLO; Makinen J, 1998, AM J EPIDEMIOL, V148, P369; NAYLOR AF, 1979, FERTIL STERIL, V31, P282; PETITTI DB, 1987, CLIN OBSTET GYNECOL, V30, P253, DOI 10.1097/00003081-198706000-00004; RAYMOND EG, 1994, BRIT J OBSTET GYNAEC, V101, P301, DOI 10.1111/j.1471-0528.1994.tb13614.x; REGAN L, 1989, BRIT MED J, V299, P541, DOI 10.1136/bmj.299.6698.541; RISCH HA, 1988, AM J EPIDEMIOL, V128, P420, DOI 10.1093/oxfordjournals.aje.a114982; SOEGAARD P, 1996, UGESKRIFT LAEGER, V158, P759; SOERENSEN JL, 1992, UGESKRIFT LAEGER, V154, P3053; WARBURTON D, 1964, AM J HUM GENET, V16, P1; Westergaard T, 1997, BMJ-BRIT MED J, V314, P775, DOI 10.1136/bmj.314.7083.775; WILCOX AJ, 1982, EARLY HUM DEV, V7, P165, DOI 10.1016/0378-3782(82)90135-9	24	956	984	1	51	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1708	1712		10.1136/bmj.320.7251.1708	http://dx.doi.org/10.1136/bmj.320.7251.1708			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864550	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000087926400026
J	Ferrannini, E				Ferrannini, E			Insulin resistance, iron, and the liver	LANCET			English	Editorial Material							TRANSFERRIN RECEPTORS; GENETIC HEMOCHROMATOSIS; METABOLIC SYNDROME; 3T3-L1 ADIPOCYTES; FATTY LIVER; HYPERINSULINEMIA; OVERLOAD; REDISTRIBUTION; OBESITY		Univ Pisa, Sch Med, CNR, Inst Clin Physiol,Metab Unit, I-56026 Pisa, Italy; Univ Pisa, Sch Med, Dept Internal Med, I-56026 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Pisa; University of Pisa	Ferrannini, E (corresponding author), Univ Pisa, Sch Med, CNR, Inst Clin Physiol,Metab Unit, I-56026 Pisa, Italy.							BANERJI MA, 1995, INT J OBESITY, V19, P846; Conte D, 1998, ANN INTERN MED, V128, P370, DOI 10.7326/0003-4819-128-5-199803010-00005; DANDONA P, 1983, ANN CLIN BIOCHEM, V20, P77, DOI 10.1177/000456328302000203; DAVIS RJ, 1986, J BIOL CHEM, V261, P8708; DELPRATO S, 1994, DIABETOLOGIA, V37, P1025, DOI 10.1007/BF00400466; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; FERRANNINI E, 1991, DIABETOLOGIA, V34, P416, DOI 10.1007/BF00403180; Ferrannini E, 1995, DIABETES CLIN SCI PR, P200; GOTO T, 1995, INT J OBESITY, V19, P841; GUYADER D, 1992, J HEPATOL, V15, P304, DOI 10.1016/0168-8278(92)90060-3; Knobler H, 1999, QJM-MON J ASSOC PHYS, V92, P73, DOI 10.1093/qjmed/92.2.73; Marceau P, 1999, J CLIN ENDOCR METAB, V84, P1513, DOI 10.1210/jc.84.5.1513; Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4; Moirand R, 1997, LANCET, V349, P95, DOI 10.1016/S0140-6736(96)06034-5; NIEDERAU C, 1984, DIABETOLOGIA, V26, P441; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; ROWE JW, 1977, MEDICINE, V56, P197, DOI 10.1097/00005792-197705000-00002; SIBILLE JC, 1988, HEPATOLOGY, V8, P296, DOI 10.1002/hep.1840080218; TANNER LI, 1989, J CELL BIOL, V108, P1537, DOI 10.1083/jcb.108.4.1537; TANNER LI, 1987, J BIOL CHEM, V262, P8975	20	114	122	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 24	2000	355	9222					2181	2182		10.1016/S0140-6736(00)02397-7	http://dx.doi.org/10.1016/S0140-6736(00)02397-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327DX	10881887				2022-12-24	WOS:000087779000005
J	Josefsson, AM; Magnusson, PKE; Ylitalo, N; Sorensen, P; Qwarforth-Tubbin, P; Andersen, PK; Melbye, M; Adami, HO; Gyllensten, UB				Josefsson, AM; Magnusson, PKE; Ylitalo, N; Sorensen, P; Qwarforth-Tubbin, P; Andersen, PK; Melbye, M; Adami, HO; Gyllensten, UB			Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study	LANCET			English	Article							HIGH-GRADE LESIONS; INTRAEPITHELIAL NEOPLASIA; RISK-FACTORS; TYPE-16 DNA; PREDICTOR; WOMEN; PCR; SUSCEPTIBILITY; POLYMERASE; DYSPLASIA	Background Infection with certain types of human papillomavirus (HPV), which is common among young women, increases the risk of cervical cancer. However, less than 1% of young women positive for oncogenic types of HPV develop cervical cancer. We investigated whether the amount of HPV DNA is a useful predictor of progression to cervical carcinoma in situ. Methods We estimated the amount of HPV 16 DNA by a PCR that uses the 5'-exonuclease (Taqman) method, in 478 women with cervical carcinoma in situ and 608 individually matched controls. To adjust for differences in the amount bf genomic DNA between samples, we estimated the amount of a nuclear gene (beta-actin). We studied multiple smears (total 3835 archived samples) from each woman, taken over periods of up to 26 years, that covered normal cytology to development of cervical cancer. Findings The risk of cervical carcinoma in situ increased with the amount of HPV 16 DNA. Analysis of the first smear from each woman, collected a mean of 7.8 years before cancer diagnosis, showed that women with the 20% highest amount of HPV 16 DNA were at a 60-fold higher risk of developing cervical carcinoma in situ than women negative for HPV 16. The first smear samples were classified as normal by squamous-cell cytology. Interpretation Analysis of the amount of HPV DNA can predict cancer risk at a stage when current screening methods are uninformative. Testing for the amount of HPV 16 DNA during gynaecological health checks might strikingly improve our ability to distinguish between infections that have a high or low risk of progressing into cervical cancer.	Uppsala Univ, Rudbeck Lab, Unit Med Genet, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; Karolinska Inst, Dept Med Epidemiol, Stockholm, Sweden; Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; Univ Copenhagen, Dept Biostat, Copenhagen, Denmark; Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Harvard Ctr Canc Prevent, Boston, MA 02115 USA	Uppsala University; Karolinska Institutet; Aarhus University; Statens Serum Institut; University of Copenhagen; Harvard University; Harvard University	Gyllensten, UB (corresponding author), Uppsala Univ, Rudbeck Lab, Unit Med Genet, Dept Genet & Pathol, SE-75185 Uppsala, Sweden.	ulf.gyllensten@genpat.uu.se	Magnusson, Patrik KE/C-4458-2017	Magnusson, Patrik KE/0000-0002-7315-7899; melbye, mads/0000-0001-8264-6785; Sorensen, Per Soelberg/0000-0002-2818-3780	NATIONAL CANCER INSTITUTE [R01CA061197] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA61197-01A3] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allen M, 1996, TISSUE ANTIGENS, V48, P32, DOI 10.1111/j.1399-0039.1996.tb02602.x; APPLE RJ, 1995, JNCI-J NATL CANCER I, V87, P427, DOI 10.1093/jnci/87.6.427; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; BRISSON J, 1994, AM J EPIDEMIOL, V140, P700, DOI 10.1093/oxfordjournals.aje.a117318; COX JT, 1995, AM J OBSTET GYNECOL, V172, P946, DOI 10.1016/0002-9378(95)90026-8; CUZICK J, 1992, LANCET, V339, P959, DOI 10.1016/0140-6736(92)91532-D; CUZICK J, 1994, BRIT J CANCER, V69, P167, DOI 10.1038/bjc.1994.28; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hildesheim A, 1998, CANCER EPIDEM BIOMAR, V7, P1035; Ho GYF, 1998, INT J CANCER, V78, P594, DOI 10.1002/(SICI)1097-0215(19981123)78:5&lt;594::AID-IJC11&gt;3.0.CO;2-B; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Ho GYF, 1998, INT J CANCER, V78, P281, DOI 10.1002/(SICI)1097-0215(19981029)78:3&lt;281::AID-IJC3&gt;3.0.CO;2-R; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Josefsson A, 1999, J CLIN MICROBIOL, V37, P490, DOI 10.1128/JCM.37.3.490-496.1999; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; LEE LG, 1993, NUCLEIC ACIDS RES, V21, P3761, DOI 10.1093/nar/21.16.3761; Londesborough P, 1996, INT J CANCER, V69, P364; Magnusson PKE, 1999, NATURE, V400, P29, DOI 10.1038/21801; Munoz N, 1992, IARC Sci Publ, P251; Odunsi K, 1996, INT J CANCER, V67, P595, DOI 10.1002/(SICI)1097-0215(19960904)67:5<595::AID-IJC1>3.0.CO;2-P; PARKIN DM, 1993, INT J CANCER, V54, P594, DOI 10.1002/ijc.2910540413; TERRY G, 1993, ARCH VIROL, V128, P123, DOI 10.1007/BF01309793; Ylitalo N, 2000, LANCET, V355, P2194, DOI 10.1016/S0140-6736(00)02402-8; YLITALO N, 1995, J CLIN MICROBIOL, V33, P1822, DOI 10.1128/JCM.33.7.1822-1828.1995; Ylitalo N, 1999, INT J CANCER, V81, P357, DOI 10.1002/(SICI)1097-0215(19990505)81:3<357::AID-IJC8>3.3.CO;2-T; Zehbe I, 1998, CANCER RES, V58, P829	26	290	317	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2000	355	9222					2189	2193		10.1016/S0140-6736(00)02401-6	http://dx.doi.org/10.1016/S0140-6736(00)02401-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327DX	10881891				2022-12-24	WOS:000087779000009
J	Sefton, L; Timmer, JR; Zhang, Y; Beranger, F; Cline, TW				Sefton, L; Timmer, JR; Zhang, Y; Beranger, F; Cline, TW			An extracellular activator of the Drosophila JAK/STAT pathway is a sex-determination signal element	NATURE			English	Article							MELANOGASTER; TRANSCRIPTION; ENCODES; PROTEIN; KINASE; GENES; ACTS	Metazoans use diverse and rapidly evolving mechanisms to determine sex. In Drosophila melanogaster an X-chromosome-counting mechanism determines the sex of an individual by regulating the master switch gene, Sex-lethal (Sxl)(1). The X-chromosome dose is communicated to Sxl by a set of X-linked signal elements (XSEs), which activate transcription of Sxl through its 'establishment' promoter, Sxl(Pe). Here we describe a new XSE called sisterlessC (sisC) whose mode of action differs from that of previously characterized XSEs, all of which encode transcription factors that activate Sxl(Pe) directly. In contrast, sisC encodes a secreted ligand for the Drosophila Janus kinase (JAK) and 'signal transducer and activator of transcription' (STAT) signal transduction pathway and is allelic to outstretched (os, also called unpaired). We conclude that sisC works indirectly on Sxl through this signalling pathway because mutations in sisC or in the genes encoding Drosophila JAK or STAT reduce expression of Sxl(Pe) similarly. The involvement of os in sex determination confirms that secreted ligands can function in cell-autonomous processes. Unlike sex signals for other organisms, sisC has acquired its sex-specific function while maintaining non-sex-specific roles in development, a characteristic that it shares with all other Drosophila XSEs2.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Cline, TW (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 401 Barker Hall, Berkeley, CA 94720 USA.		Beranger, Florence/R-7581-2019	Timmer, John/0000-0002-6021-5199				ANAND A, 1994, J GENET, V73, P81, DOI 10.1007/BF02927944; BINARI R, 1994, GENE DEV, V8, P300, DOI 10.1101/gad.8.3.300; Carmi I, 1998, NATURE, V396, P168, DOI 10.1038/24164; Chou TB, 1996, GENETICS, V144, P1673; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; Erickson JW, 1998, DEVELOPMENT, V125, P3259; ESTES PA, 1995, MOL CELL BIOL, V15, P904; FERRUS A, 1990, GENETICS, V125, P383; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; HOU XS, 1996, CELL, V85, pA290; John S, 1999, MOL CELL BIOL, V19, P1910; KEYES LN, 1992, CELL, V68, P933, DOI 10.1016/0092-8674(92)90036-C; Kuo YM, 1996, DEVELOPMENT, V122, P1909; SANCHEZ L, 1994, DEV GENET, V15, P251; TIMMER JR, 1995, THESIS U CALIFORNIA; Walker JJ, 2000, GENETICS, V155, P191; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8	18	63	63	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2000	405	6789					970	973		10.1038/35016119	http://dx.doi.org/10.1038/35016119			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326JT	10879541				2022-12-24	WOS:000087732700056
J	Saether, BE				Saether, BE			Ecology - Weather ruins winter vacations	SCIENCE			English	Editorial Material							RAINFALL		Norwegian Univ Sci & Technol, Inst Zool, N-7491 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Saether, BE (corresponding author), Norwegian Univ Sci & Technol, Inst Zool, N-7491 Trondheim, Norway.							DENHELD JJ, 1981, ARDEA, V69, P185; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; *INT PAN CLIM CHAN, 1996, SCI CLIM CHANGE; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; PEACH W, 1991, IBIS, V133, P300, DOI 10.1111/j.1474-919X.1991.tb04573.x; ROBBINS CS, 1989, P NATL ACAD SCI USA, V86, P7658, DOI 10.1073/pnas.86.19.7658; Saether BE, 2000, SCIENCE, V287, P854, DOI 10.1126/science.287.5454.854; Sherry Thomas W., 1995, P85; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Stone RC, 1996, NATURE, V384, P252, DOI 10.1038/384252a0	10	9	9	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2000	288	5473					1975	1976						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10877716				2022-12-24	WOS:000087687000025
J	Aly, N; McDonald, K; Leathley, M; Sharma, A; Watkins, C				Aly, N; McDonald, K; Leathley, M; Sharma, A; Watkins, C			Retrospective note case review of acute and inpatient stroke outcomes	BRITISH MEDICAL JOURNAL			English	Article									Univ Hosp Aintree, Dept Med Elderly, Aintree Stroke Unit, Liverpool L9 7AL, Merseyside, England		Sharma, A (corresponding author), Univ Hosp Aintree, Dept Med Elderly, Aintree Stroke Unit, Liverpool L9 7AL, Merseyside, England.		Watkins, Caroline L/E-6898-2013	Watkins, Caroline L/0000-0002-9403-3772				AZZIMONDI G, 1994, STROKE, V25, P1752, DOI 10.1161/01.STR.25.9.1752; BAMFORD J, 1988, J NEUROL NEUROSUR PS, V51, P1371; Mahaffey KW, 1998, CIRCULATION, V97, P757, DOI 10.1161/01.CIR.97.8.757	3	18	19	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 3	2000	320	7248					1511	1512		10.1136/bmj.320.7248.1511	http://dx.doi.org/10.1136/bmj.320.7248.1511			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321TP	10834893	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000087471000025
J	Dalmay, T; Hamilton, A; Rudd, S; Angell, S; Baulcombe, DC				Dalmay, T; Hamilton, A; Rudd, S; Angell, S; Baulcombe, DC			An RNA-Dependent RNA polymerase gene in Arabidopsis is required for posttranscriptional gene silencing mediated by a transgene but not by a virus	CELL			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; NEUROSPORA-CRASSA; CHALCONE SYNTHASE; ANTISENSE RNA; C-ELEGANS; PLANTS; DNA; INTERFERENCE; SUPPRESSION	Posttranscriptional gene silencing is a defense mechanism in plants that is similar to quelling in fungi and RNA interference in animals. Here, we describe four genetic loci that are required for posttranscriptional gene silencing in Arabidopsis. One of these, SDE1, is a plant homolog of QDE-1 in Neurospora crassa that encodes an RNA-dependent RNA polymerase. The sde1 mutation was specific for posttranscriptional gene silencing induced by transgenes rather than by viruses. We propose that the role of SDE1 is to synthesize a double-stranded RNA initiator of posttranscriptional gene silencing. According to this idea, when a virus induces posttranscriptional gene silencing, the virus-encoded RNA polymerase would produce the double-stranded RNA and SDE1 would be redundant.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; John Innes Ctr Plant Sci Res, Dept Virus Res, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Baulcombe, DC (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	david.baulcombe@bbsrc.ac.uk	Dalmay, Tamas/E-1377-2011; Rudd, Stephen A/A-6434-2013	Dalmay, Tamas/0000-0003-1492-5429; Rudd, Stephen A/0000-0002-0344-7487; Baulcombe, David/0000-0003-0780-6878				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Baulcombe DC, 1999, CURR BIOL, V9, pR599, DOI 10.1016/S0960-9822(99)80383-2; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1997, P NATL ACAD SCI USA, V94, P10233, DOI 10.1073/pnas.94.19.10233; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Covey SN, 1997, NATURE, V385, P781, DOI 10.1038/385781a0; Dalmay T, 2000, PLANT CELL, V12, P369, DOI 10.1105/tpc.12.3.369; DEHIO C, 1994, P NATL ACAD SCI USA, V91, P5538, DOI 10.1073/pnas.91.12.5538; DOROKHOV YL, 1994, FEBS LETT, V350, P5, DOI 10.1016/0014-5793(94)00721-7; Elmayan T, 1998, PLANT CELL, V10, P1747, DOI 10.1105/tpc.10.10.1747; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hamilton AJ, 1998, PLANT J, V15, P737, DOI 10.1046/j.1365-313X.1998.00251.x; HAMILTON WDO, 1989, J GEN VIROL, V70, P963, DOI 10.1099/0022-1317-70-4-963; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Kooter JM, 1999, TRENDS PLANT SCI, V4, P340, DOI 10.1016/S1360-1385(99)01467-3; LINDBO JA, 1993, PLANT CELL, V5, P1749, DOI 10.1105/tpc.5.12.1749; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; MUELLER E, 1995, PLANT J, V7, P1001, DOI 10.1046/j.1365-313X.1995.07061001.x; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Palauqui JC, 1998, P NATL ACAD SCI USA, V95, P9675, DOI 10.1073/pnas.95.16.9675; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Ratcliff FG, 1999, PLANT CELL, V11, P1207, DOI 10.1105/tpc.11.7.1207; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11851; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Sharp PA, 1999, GENE DEV, V13, P139, DOI 10.1101/gad.13.2.139; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Stam M, 1998, MOL CELL BIOL, V18, P6165, DOI 10.1128/MCB.18.11.6165; Stam M, 1997, PLANT J, V12, P63, DOI 10.1046/j.1365-313X.1997.12010063.x; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Vaucheret H, 1998, PLANT J, V16, P651, DOI 10.1046/j.1365-313x.1998.00337.x; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Waterhouse PM, 1999, TRENDS PLANT SCI, V4, P452, DOI 10.1016/S1360-1385(99)01493-4; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	44	796	914	1	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 26	2000	101	5					543	553		10.1016/S0092-8674(00)80864-8	http://dx.doi.org/10.1016/S0092-8674(00)80864-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850496	Bronze			2022-12-24	WOS:000087375400011
J	Kiefer, JR; Pawlitz, JL; Moreland, KT; Stegeman, RA; Hood, WF; Gierse, JK; Stevens, AM; Goodwin, DC; Rowlinson, SW; Marnett, LJ; Stallings, WC; Kurumbail, RG				Kiefer, JR; Pawlitz, JL; Moreland, KT; Stegeman, RA; Hood, WF; Gierse, JK; Stevens, AM; Goodwin, DC; Rowlinson, SW; Marnett, LJ; Stallings, WC; Kurumbail, RG			Structural insights into the stereochemistry of the cyclooxygenase reaction	NATURE			English	Article							PROSTAGLANDIN-H SYNTHASE; HIGHER OXIDATION-STATES; X-RAY-DIFFRACTION; ENDOPEROXIDE SYNTHASE; PEROXIDASE REACTION; ARACHIDONIC-ACID; ACTIVE-SITE; CATALYSIS; ACTIVATION; BINDING	Cyclooxygenases are bifunctional enzymes that catalyse the first committed step in the synthesis of prostaglandins, thromboxanes and other eicosanoids(1-3). The two known cyclooxygenases isoforms share a high degree of amino-acid sequence similarity(1-4), structural topology(5-7) and an identical catalytic mechanism(1-3). Cyclooxygenase enzymes catalyse two sequential reactions in spatially distinct, but mechanistically coupled active sites(8-11). The initial cyclooxygenase reaction converts arachidonic acid (which is achiral) to prostaglandin G(2) (which has five chiral centres). The subsequent peroxidase reaction reduces prostaglandin G(2) to prostaglandin H-2. Here we report the co-crystal structures of murine apo-cyclooxygenase-2 in complex with arachidonic acid and prostaglandin. These structures suggest the molecular basis for the stereospecificity of prostaglandin G(2) synthesis.	Monsanto Co, Searle Discovery Res, St Louis, MO 63198 USA; Vanderbilt Univ, Vanderbilt Sch Med, Dept Biochem, Nashville, TN 37232 USA	Monsanto; Vanderbilt University	Kurumbail, RG (corresponding author), Monsanto Co, Searle Discovery Res, 700 Chesterfield Pkwy N, St Louis, MO 63198 USA.		Moreland, Trent/I-5497-2013	Moreland, Trent/0000-0002-8996-832X; Kiefer, James/0000-0001-6317-0902; Goodwin, Douglas/0000-0002-7869-7704				Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; Brunger A. T., 1992, XPLOR VERSION 3 1 SY; CAPDEVILA JH, 1995, BIOCHEMISTRY-US, V34, P3325, DOI 10.1021/bi00010a023; DIETZ R, 1988, EUR J BIOCHEM, V171, P321, DOI 10.1111/j.1432-1033.1988.tb13793.x; ELING TE, 1991, J BIOL CHEM, V266, P12348; HAMBERG M, 1967, J BIOL CHEM, V242, P5336; Hamberg M, 1998, ARCH BIOCHEM BIOPHYS, V349, P376, DOI 10.1006/abbi.1997.0443; Herschman HR, 1996, BBA-LIPID LIPID MET, V1299, P125, DOI 10.1016/0005-2760(95)00194-8; HSI LC, 1993, J LIPID MEDIATOR, V6, P131; JIANG JS, 1994, J MOL BIOL, V243, P100, DOI 10.1006/jmbi.1994.1633; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KARTHEIN R, 1988, EUR J BIOCHEM, V171, P313, DOI 10.1111/j.1432-1033.1988.tb13792.x; KULMACZ RJ, 1994, J BIOL CHEM, V269, P5527; Kulmacz RJ, 1998, FEBS LETT, V430, P154, DOI 10.1016/S0014-5793(98)00657-7; Kurumbail RG, 1997, NATURE, V385, P555, DOI 10.1038/385555b0; Landino LM, 1997, J BIOL CHEM, V272, P21565, DOI 10.1074/jbc.272.34.21565; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rieke CJ, 1999, J BIOL CHEM, V274, P17109, DOI 10.1074/jbc.274.24.17109; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; SHIMOKAWA T, 1990, J BIOL CHEM, V265, P20073; SMITH WL, 1992, BIOCHEMISTRY-US, V31, P3, DOI 10.1021/bi00116a001; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Stevens AM, 1999, J CRYST GROWTH, V196, P350, DOI 10.1016/S0022-0248(98)00847-1; Tsai AL, 1998, J BIOL CHEM, V273, P3888, DOI 10.1074/jbc.273.7.3888; UENO R, 1982, J BIOL CHEM, V257, P5584; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400	30	171	177	1	28	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2000	405	6782					97	101		10.1038/35011103	http://dx.doi.org/10.1038/35011103			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311TK	10811226				2022-12-24	WOS:000086901600059
J	Vorosmarty, CJ; Green, P; Salisbury, J; Lammers, RB				Vorosmarty, CJ; Green, P; Salisbury, J; Lammers, RB			Global water resources: Vulnerability from climate change and population growth	SCIENCE			English	Article							SCALE	The future adequacy of freshwater resources is difficult to assess, owing to a complex and rapidly changing geography of water supply and use. Numerical experiments combining climate model outputs, water budgets, and socioeconomic information along digitized river networks demonstrate that (i) a large proportion of the world's population is currently experiencing water stress and (ii) rising water demands greatly outweigh greenhouse warming in defining the state of global water systems to 2025. Consideration of direct human impacts on global water supply remains a poorly articulated but potentially important facet of the larger global change question.	Univ New Hampshire, Water Syst Anal Grp, Durham, NH 03824 USA; Univ New Hampshire, Complex Syst Res Ctr, Durham, NH 03824 USA; Univ New Hampshire, Ocean Proc Analyt Lab, Durham, NH 03824 USA; Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; Univ New Hampshire, Dept Earth Sci, Durham, NH 03824 USA	University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire	Vorosmarty, CJ (corresponding author), Univ New Hampshire, Water Syst Anal Grp, Durham, NH 03824 USA.		Quinn, Patrick/B-5489-2010	Choudhury, Aloshree/0000-0002-8986-5881				ALCAMO J, 2000, WORLD WATER SCENARIO, P204; [Anonymous], 1990, EARTH TRANSFORMED HU; Arnell N, 1996, CLIMATE CHANGE 1995, P325; Bonell M, 1993, HYDROLOGY WATER MANA, V1993; Conway D, 1996, AMBIO, V25, P336; Doll P., 1999, A9901 U KASS; Elvidge CD, 1997, INT J REMOTE SENS, V18, P1373, DOI 10.1080/014311697218485; FALKENMARK M, 1993, AMBIO, V22, P427; FALKENMARK M, 1991, WATER INT, V16, P229, DOI 10.1080/02508069108686116; FEKETE B, 1999, 22 WORLD MET ORG GLO; Gleick P. H., 2000, WORLD WATER SCENARIO, P27; Gleick P.H., 1998, WORLDS WATER BIENNIA; HOMERDIXON TF, 1994, INT SECURITY, V19, P5, DOI 10.2307/2539147; Kaczmarek Z, 1996, CLIMATE CHANGE 1995, P469; Milliman J.D., 1995, CLIMATE CHANGE IMPAC, P57; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; POSTEL SL, 1985, INTERCIENCIA, V10, P290; RODDA JC, 1998, WATER LOOMING CRISIS; Shiklomanov, 1996, ASSESSMENT WATER RES; STRZEPEK KM, 2000, WORLD WATER SCENARIO, P120; TOBLER W, 1995, TR956 NAT CTR GEOGR; United Nations, 1997, COMPREHENSIVE ASSESS; van Dam J. C, 1999, IMPACTS CLIMATE CHAN; Vorosmarty CJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P599, DOI 10.1029/1999GB900092; Vorosmarty CJ, 1998, J HYDROL, V207, P147, DOI 10.1016/S0022-1694(98)00109-7; *WORLD RES I, 1998, WORLD RES GUID GLOB; World Resources Institute, 1996, WORLD RES GUID GLOB; 1995, GLOBAL BIOGEOCHEM CY, V9, P407	28	2936	3077	82	1759	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					284	288		10.1126/science.289.5477.284	http://dx.doi.org/10.1126/science.289.5477.284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894773				2022-12-24	WOS:000088169400037
J	Haydel, MJ; Preston, CA; Mills, TJ; Luber, S; Blaudeau, E; DeBlieux, PMC				Haydel, MJ; Preston, CA; Mills, TJ; Luber, S; Blaudeau, E; DeBlieux, PMC			Indications for computed tomography in patients with minor head injury.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRACRANIAL INJURY; SELECTION CRITERIA; BRAIN INJURY; CT SCANS; TRAUMA; MILD; PREDICTORS; RADIOGRAPHY; ADMISSION; UTILITY	Background: Computed tomography (CT) is widely used as a screening test in patients with minor head injury, although the results are often normal. We performed a study to develop and validate a set of clinical criteria that could be used to identify patients with minor head injury who do not need to undergo CT. Methods: In the first phase of the study, we recorded clinical findings in 520 consecutive patients with minor head injury who had a normal score on the Glasgow Coma Scale and normal findings on a brief neurologic examination; the patients then underwent CT. Using recursive partitioning, we derived a set of criteria to identify all patients who had abnormalities on CT scanning. In the second phase, the sensitivity and specificity of the criteria for predicting a positive scan were evaluated in a group of 909 patients. Results: Of the 520 patients in the first phase, 36 (6.9 percent) had positive scans. All patients with positive CT scans had one or more of seven findings: headache, vomiting, an age over 60 years, drug or alcohol intoxication, deficits in short-term memory, physical evidence of trauma above the clavicles, and seizure. Among the 909 patients in the second phase, 57 (6.3 percent) had positive scans. In this group of patients, the sensitivity of the seven findings combined was 100 percent (95 percent confidence interval, 95 to 100 percent). All patients with positive CT scans had at least one of the findings. Conclusions: For the evaluation of patients with minor head injury, the use of CT can be safely limited to those who have certain clinical findings. (N Engl J Med 2000;343:100-5.) (C) 2000, Massachusetts Medical Society.	Louisiana State Univ, Hlth Sci Ctr, Sect Emergency Med, New Orleans, LA USA; Louisiana State Univ, Hlth Sci Ctr, Sect Emergency Radiol, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Haydel, MJ (corresponding author), Charity Hosp, 13th Floor,1532 Tulane Ave, New Orleans, LA 70112 USA.							BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; BROWN FD, 1978, J NEUROSURG, V48, P1019, DOI 10.3171/jns.1978.48.6.1019; Cook L S, 1994, Acad Emerg Med, V1, P227; DIROCCO A, 1991, NEURORADIOLOGY, V33, P253, DOI 10.1007/BF00588229; DOEZEMA D, 1991, ANN EMERG MED, V20, P1281, DOI 10.1016/S0196-0644(05)81065-0; DUUS BR, 1993, BRIT J SURG, V80, P988, DOI 10.1002/bjs.1800800817; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Graham ID, 1998, ACAD EMERG MED, V5, P134, DOI 10.1111/j.1553-2712.1998.tb02598.x; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LEE ST, 1992, J NEUROSURG, V76, P435, DOI 10.3171/jns.1992.76.3.0435; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; MADDEN C, 1995, ACAD EMERG MED, V2, P248, DOI 10.1111/j.1553-2712.1995.tb03217.x; Miller EC, 1996, ANN EMERG MED, V27, P290, DOI 10.1016/S0196-0644(96)70261-5; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; MOHANTY SK, 1991, J TRAUMA, V31, P801, DOI 10.1097/00005373-199106000-00010; MORAN SG, 1994, AM SURGEON, V60, P533; Nagurney JT, 1998, ACAD EMERG MED, V5, P678, DOI 10.1111/j.1553-2712.1998.tb02485.x; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; REINUS WR, 1993, ANN EMERG MED, V22, P1148, DOI 10.1016/S0196-0644(05)80981-3; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; *SPSS, 1997, SPSS WIND VERS 8 0 S; STEIN SC, 1993, BRAIN INJURY, V7, P425, DOI 10.3109/02699059309029685; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1991, ANN EMERG MED, V20, P1286, DOI 10.1016/S0196-0644(05)81066-2; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; TAHERI PA, 1993, ARCH SURG-CHICAGO, V128, P289; Vollmer D G, 1991, Neurosurg Clin N Am, V2, P437	33	684	702	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2000	343	2					100	105		10.1056/NEJM200007133430204	http://dx.doi.org/10.1056/NEJM200007133430204			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	333EP	10891517				2022-12-24	WOS:000088116500004
J	Koranda, M; Schleiffer, A; Endler, L; Ammerer, G				Koranda, M; Schleiffer, A; Endler, L; Ammerer, G			Forkhead-like transcription factors recruit Ndd1 to the chromatin of G2/M-specific promoters	NATURE			English	Article							YEAST-CELL CYCLE; SACCHAROMYCES-CEREVISIAE; GENES; MCM1; IDENTIFICATION; EXPRESSION; REPRESSOR; COMPLEX; DOMAIN; ROX1	Many cell-cycle-specific events are supported by stage-specific gene expression. In budding yeast, at least three different nuclear factors seem to cooperate in the periodic activation of G2/M-specific genes(1-3). Here we show, by using chromatin immunoprecipitation polymerase chain reaction assays, that a positive regulator, Ndd1, becomes associated with G2/M promoter regions in manner that depends on the stage in cell cycle. Its recruitment depends on a permanent protein-DNA complex consisting of the MADS box protein, Mcm1, and a recently identified partner Fkh2, a forkhead/winged helix related transcription factor(4,5). The lethality of Ndd1 depletion is suppressed by fkh2 null mutations, which indicates that Fkh2 may also have a negative regulatory role in the transcription of G2/M-induced RNAs. We conclude that Ndd1-Fkh2 interactions may be the transcriptionally important process targeted by Cdk activity.	Univ Vienna, Ludwig Boltzmann Forsch Stelle, Dept Biochem & Mol Cell Biol, A-1030 Vienna, Austria	Ludwig Boltzmann Institute; University of Vienna	Ammerer, G (corresponding author), Univ Vienna, Ludwig Boltzmann Forsch Stelle, Dept Biochem & Mol Cell Biol, Dr Bohrgasse 9, A-1030 Vienna, Austria.		Lukas, Endler/ABD-2002-2021	Lukas, Endler/0000-0002-9115-8756; Schleiffer, Alexander/0000-0001-6251-2747				ALTHOEFER H, 1995, MOL CELL BIOL, V15, P5917; AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; DECKERT J, 1995, MOL CELL BIOL, V15, P6109; DiFlumeri C, 1996, NUCLEIC ACIDS RES, V24, P808, DOI 10.1093/nar/24.5.808; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; ERREDE B, 1989, GENE DEV, V3, P1349, DOI 10.1101/gad.3.9.1349; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Hollenhorst PC, 2000, GENETICS, V154, P1533; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; Knapp D, 1996, MOL CELL BIOL, V16, P5701; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Loy CJ, 1999, MOL CELL BIOL, V19, P3312; LYDALL D, 1991, GENE DEV, V5, P2405, DOI 10.1101/gad.5.12b.2405; MAHER M, 1995, MOL CELL BIOL, V15, P3129; Nasmyth K, 1996, TRENDS GENET, V12, P405, DOI 10.1016/0168-9525(96)10041-X; Piatti S, 1996, GENE DEV, V10, P1516, DOI 10.1101/gad.10.12.1516; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581	21	172	175	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 6	2000	406	6791					94	98		10.1038/35017589	http://dx.doi.org/10.1038/35017589			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	330ZE	10894549				2022-12-24	WOS:000087991200052
J	May, C; Rivella, S; Callegari, J; Heller, G; Gaensler, KML; Luzzatto, L; Sadelain, M				May, C; Rivella, S; Callegari, J; Heller, G; Gaensler, KML; Luzzatto, L; Sadelain, M			Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin	NATURE			English	Article							LOCUS ACTIVATION REGION; GENETIC TREATMENT; TRANSGENIC MICE; MOUSE MODEL; VECTORS; CELLS; DERIVATIVES; MEDIATE	The stable introduction of a functional beta-globin gene in haematopoietic stem cells could be a powerful approach to treat beta-thalassaemia(1) and sickle-cell disease(2). Genetic approaches aiming to increase normal beta-globin expression in the progeny of autologous haematopoietic stem cells(3) might circumvent the limitations and risks of allogeneic cell transplants(4). However, low-level expression, position effects and transcriptional silencing hampered the effectiveness of viral transduction of the human beta-globin gene when it was linked to minimal regulatory sequences(5). Here we show that the use of recombinant lentiviruses enables efficient transfer and faithful integration of the human beta-globin gene together with large segments of its locus control region. In long-term recipients of unselected transduced bone marrow cells, tetramers of two murine alpha-globin and two human beta(A)-globin molecules account for up to 13% of total haemoglobin in mature red cells of normal mice. In beta-thalassaemic heterozygous mice higher percentages are obtained (17% to 24%), which are sufficient to ameliorate anaemia and red cell morphology. Such levels should be of therapeutic benefit in patients with severe defects in haemoglobin production.	Mem Sloan Kettering Canc Ctr, Dept Human Genet, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; University of California System; University of California San Francisco	Sadelain, M (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Human Genet, 1275 York Ave, New York, NY 10021 USA.		Rivella, Stefano/A-1597-2010	Rivella, Stefano/0000-0002-0938-6558; Callegari Jr., A. John/0000-0003-3959-1947				Amado RG, 1999, SCIENCE, V285, P674, DOI 10.1126/science.285.5428.674; Boulad F, 1998, ANN NY ACAD SCI, V850, P498, DOI 10.1111/j.1749-6632.1998.tb10532.x; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Bungert J, 1995, GENE DEV, V9, P3083, DOI 10.1101/gad.9.24.3083; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Engel JD, 2000, CELL, V100, P499, DOI 10.1016/S0092-8674(00)80686-8; ESAN GJF, 1971, NATURE-NEW BIOL, V229, P143, DOI 10.1038/newbio229143a0; FABRY ME, 1995, BLOOD, V86, P2419, DOI 10.1182/blood.V86.6.2419.bloodjournal8662419; FORRESTER WC, 1987, NUCLEIC ACIDS RES, V15, P10159, DOI 10.1093/nar/15.24.10159; Gallardo HF, 1997, BLOOD, V90, P952, DOI 10.1182/blood.V90.3.952.952_952_957; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Grosveld F, 1998, SEMIN HEMATOL, V35, P105; Higgs DR, 1998, CELL, V95, P299, DOI 10.1016/S0092-8674(00)81761-4; LEBOULCH P, 1994, EMBO J, V13, P3065, DOI 10.1002/j.1460-2075.1994.tb06605.x; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Miyoshi H, 1999, SCIENCE, V283, P682, DOI 10.1126/science.283.5402.682; Nathan DG, 1998, HEMATOLOGY INFANCY C; NOVAK U, 1990, P NATL ACAD SCI USA, V87, P3386, DOI 10.1073/pnas.87.9.3386; Porcu S, 1997, BLOOD, V90, P4602, DOI 10.1182/blood.V90.11.4602.4602_4602_4609; Raftopoulos H, 1997, BLOOD, V90, P3414, DOI 10.1182/blood.V90.9.3414; Rivella S, 1998, SEMIN HEMATOL, V35, P112; Rivella S, 2000, J VIROL, V74, P4679, DOI 10.1128/JVI.74.10.4679-4687.2000; Sadelain M, 1997, BRIT J HAEMATOL, V98, P247, DOI 10.1046/j.1365-2141.1997.2313048.x; SADELAIN M, 1995, P NATL ACAD SCI USA, V92, P6728, DOI 10.1073/pnas.92.15.6728; STAMATOYANNOPOU.G, 1994, MOL BASIS BLOOD DIS; TALBOT D, 1989, NATURE, V338, P352, DOI 10.1038/338352a0; TUAN D, 1985, P NATL ACAD SCI USA, V82, P6384, DOI 10.1073/pnas.82.19.6384; Weatherall DJ, 1981, THALASSEMIA SYNDROME; YANG BL, 1995, P NATL ACAD SCI USA, V92, P11608, DOI 10.1073/pnas.92.25.11608; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	30	457	495	1	40	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 6	2000	406	6791					82	86		10.1038/35017565	http://dx.doi.org/10.1038/35017565			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	330ZE	10894546				2022-12-24	WOS:000087991200049
J	Metcalf, D; Greenhalgh, CJ; Viney, E; Willson, TA; Starr, R; Nicola, NA; Hilton, DJ; Alexander, WS				Metcalf, D; Greenhalgh, CJ; Viney, E; Willson, TA; Starr, R; Nicola, NA; Hilton, DJ; Alexander, WS			Gigantism in mice lacking suppressor of cytokine signalling-2	NATURE			English	Article							GROWTH-FACTOR-I; RECEPTOR GENE-EXPRESSION; TRANSGENIC MICE; C-MPL; HORMONE; INSULIN; LIVER; SOCS-3; DEFICIENCIES; TRANSDUCTION	Suppressor of cytokine signalling-2 (SOCS-2) is a member of the suppressor of cytokine signalling family, a group of related proteins implicated in the negative regulation of cytokine action through inhibition of the Janus kinase (JAK) signal transducers and activators of transcription (STAT) signal-transduction pathway(1). Here we use mice unable to express SOCS-2 to examine its function in vivo. SOCS-2(-/-) mice grew significantly larger than their wild-type littermates. Increased body weight became evident after weaning and was associated with significantly increased long bone lengths and the proportionate enlargement of most organs. Characteristics of deregulated growth hormone and insulin-like growth factor-I (IGF-I) signalling, including decreased production of major urinary protein, increased local IGF-I production, and collagen accumulation in the dermis, were observed in SOCS-2-deficient mice, indicating that SOCS-2 may have an essential negative regulatory role in the growth hormone/IGF-I pathway.	Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Royal Melbourne Hosp, Cooperat Res Ctr Cellular Growth Factors, Melbourne, Vic 3050, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital	Alexander, WS (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Post Off, Melbourne, Vic 3050, Australia.		Hilton, Douglas J/C-7250-2013; Nicola, Nicos/D-2989-2011	Hilton, Douglas J/0000-0002-7698-2392; Nicola, Nicos/0000-0003-1054-7889				Adams TE, 1998, J BIOL CHEM, V273, P1285, DOI 10.1074/jbc.273.3.1285; Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; ALEXANDER WS, 1995, EMBO J, V14, P5569, DOI 10.1002/j.1460-2075.1995.tb00244.x; Davey HW, 1999, MOL CELL ENDOCRINOL, V158, P111, DOI 10.1016/S0303-7207(99)00175-6; Dey BR, 1998, J BIOL CHEM, V273, P24095, DOI 10.1074/jbc.273.37.24095; Favre H, 1999, FEBS LETT, V453, P63, DOI 10.1016/S0014-5793(99)00681-X; Hansen JA, 1999, MOL ENDOCRINOL, V13, P1832, DOI 10.1210/me.13.11.1832; Hilton DJ, 1999, CELL MOL LIFE SCI, V55, P1568, DOI 10.1007/s000180050396; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kopchick JJ, 1999, ANNU REV NUTR, V19, P437, DOI 10.1146/annurev.nutr.19.1.437; Lopaczynski W, 1999, ACTA BIOCHIM POL, V46, P51, DOI 10.18388/abp.1999_4183; MATHEWS LS, 1989, J BIOL CHEM, V264, P9905; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; NORSTEDT G, 1984, CELL, V36, P805, DOI 10.1016/0092-8674(84)90030-8; QUAIFE CJ, 1989, ENDOCRINOLOGY, V124, P40, DOI 10.1210/endo-124-1-40; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; SCHOENLE E, 1982, NATURE, V296, P252, DOI 10.1038/296252a0; Shoba L, 1999, MOL CELL ENDOCRINOL, V152, P125, DOI 10.1016/S0303-7207(99)00045-3; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Tollet-Egnell P, 1999, ENDOCRINOLOGY, V140, P3693, DOI 10.1210/en.140.8.3693; Wanke R, 1999, J INVEST DERMATOL, V113, P967, DOI 10.1046/j.1523-1747.1999.00807.x; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; [No title captured]	25	381	401	1	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 29	2000	405	6790					1069	1073		10.1038/35016611	http://dx.doi.org/10.1038/35016611			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	328VN	10890450				2022-12-24	WOS:000087871700050
J	Collinson, PO; Premachandram, S; Hashemi, K				Collinson, PO; Premachandram, S; Hashemi, K			Prospective audit of incidence of prognostically important myocardial damage in patients discharged from emergency department	BRITISH MEDICAL JOURNAL			English	Article							CARDIAC TROPONIN-T; CHEST PAIN; RISK STRATIFICATION; UNSTABLE ANGINA; EARLY DIAGNOSIS; INFARCTION; MULTICENTER; ADMISSION; DISEASE	Objective To assess the incidence of prognostically important myocardial damage in patients with chest pain discharged from the emergency department. Design Prospective observational study. Setting District general hospital emergency department. Participants 110 patients presenting with chest pain of unknown cause who were subsequently discharged home after cardiac causes of chest pain were ruled out by clinical and electrocardiographic investigation. Interventions Patients were reviewed 12-48 hours after presentation by repeat electrocardiography and measurement of cardiac troponin T. Main outcome measures Incidence of missed myocardial damage. Results Eight (7%) patients had detectable cardiac troponin T on review and seven had concentrations greater than or equal to 0.1 mu g/l. The repeat electrocardiogram showed no abnormality in any patient. Conclusion 6% of the patients discharged from the emergency department had missed prognostically important myocardial damage. Follow up measurement of cardiac troponin T allows convenient audit of clinical performance in the emergency department.	Mayday Univ Hosp, Dept Chem Pathol, Croydon CR7 7YE, England; Mayday Univ Hosp, Dept Accid & Emergency Med, Croydon, England	Croydon University Hospital; Croydon University Hospital	Collinson, PO (corresponding author), St George Hosp, Dept Clin Biochem, 2nd Floor,Jenner Wing, London SW17 0QT, England.							APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; BAKKER AJ, 1993, LANCET, V342, P1220, DOI 10.1016/0140-6736(93)92192-V; BRUSH JE, 1985, NEW ENGL J MED, V312, P1137, DOI 10.1056/NEJM198505023121801; COLLINSON PO, 1993, ANN CLIN BIOCHEM, V30, P11, DOI 10.1177/000456329303000102; COLLINSON PO, 1995, ANN CLIN BIOCHEM, V32, P450, DOI 10.1177/000456329503200503; Collinson PO, 1996, ANN CLIN BIOCHEM, V33, P308, DOI 10.1177/000456329603300405; EMERSON PA, 1989, Q J MED, V70, P213; GIBLER WB, 1995, ANN EMERG MED, V25, P1, DOI 10.1016/S0196-0644(95)70347-0; GOLDMAN L, 1988, NEW ENGL J MED, V318, P797, DOI 10.1056/NEJM198803313181301; Hamm CW, 1997, NEW ENGL J MED, V337, P1648, DOI 10.1056/NEJM199712043372302; HAMM CW, 1992, NEW ENGL J MED, V327, P146, DOI 10.1056/NEJM199207163270302; KARCZ A, 1993, ANN EMERG MED, V22, P553, DOI 10.1016/S0196-0644(05)81941-9; LEE TH, 1991, NEW ENGL J MED, V324, P1239, DOI 10.1056/NEJM199105023241803; LEE TH, 1987, AM J CARDIOL, V60, P220; LINDAHL B, 1995, CORONARY ARTERY DIS, V6, P321, DOI 10.1097/00019501-199504000-00009; Lindahl B, 1996, CIRCULATION, V93, P1651, DOI 10.1161/01.CIR.93.9.1651; MCCARTHY BD, 1993, ANN EMERG MED, V22, P579, DOI 10.1016/S0196-0644(05)81945-6; MCQUEEN MJ, 1983, AM HEART J, V105, P258, DOI 10.1016/0002-8703(83)90524-0; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; POZEN MW, 1984, NEW ENGL J MED, V310, P1273, DOI 10.1056/NEJM198405173102001; Stubbs P, 1996, BRIT MED J, V313, P262, DOI 10.1136/bmj.313.7052.262; SULLIVAN DJ, 1996, ED LEGAL LETT, V7, P45; YUSUF S, 1984, EUR HEART J, V5, P690, DOI 10.1093/oxfordjournals.eurheartj.a061728; ZARLING EJ, 1983, JAMA-J AM MED ASSOC, V250, P1177	24	96	97	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1702	1704		10.1136/bmj.320.7251.1702	http://dx.doi.org/10.1136/bmj.320.7251.1702			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864545	Green Published, Bronze			2022-12-24	WOS:000087926400022
J	He, XW; Asthana, S; Sorger, PK				He, XW; Asthana, S; Sorger, PK			Transient sister chromatid separation and elastic deformation of chromosomes during mitosis in budding yeast	CELL			English	Article							NEWT LUNG-CELLS; SACCHAROMYCES-CEREVISIAE; MITOTIC SPINDLE; DIRECTIONAL INSTABILITY; KINETOCHORE MOTILITY; MICROTUBULE CAPTURE; ANAPHASE ONSET; TENSION; PROTEIN; ATTACHMENT	The accurate segregation of chromosomes at mitosis requires that all pairs of chromatids bind correctly to microtubules prior to the dissolution of sister cohesion and the initiation of anaphase. By analyzing the motion of GFP-tagged S. cerevisiae chromosomes, we show that kinetochore-microtubule attachments impose sufficient tension on sisters during prometaphase to transiently separate centromeric chromatin toward opposite sides of the spindle. Transient separations of 2-10 min duration occur in the absence of cohesin proteolysis, are characterized by independent motion of the sisters along the spindle, and are followed by the apparent reestablishment of sister linkages. The existence of transient sister separation in yeast explains the unusual bilobed localization of kinetochore proteins and supports an alternative model for spindle structure. By analogy with animal cells, we propose that yeast centromeric chromatin acts as a tensiometer.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sorger, PK (corresponding author), MIT, Dept Biol, Room 68-371,77 Massachusetts Ave, Cambridge, MA 02139 USA.			Sorger, Peter/0000-0002-3364-1838	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051464] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM19483, GM51464] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDER SP, 1991, J CELL BIOL, V113, P805, DOI 10.1083/jcb.113.4.805; AULT JG, 1989, CHROMOSOMA, V98, P33, DOI 10.1007/BF00293332; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; BLOOM KS, 1982, CELL, V29, P305, DOI 10.1016/0092-8674(82)90147-7; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Choo KHA., 1997, CENTROMERE; CIOSK R, 1998, THESIS U VIENNA VIEN; Cohen-Fix O, 1999, GENE DEV, V13, P1950, DOI 10.1101/gad.13.15.1950; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Donaldson AD, 1996, J CELL BIOL, V132, P887, DOI 10.1083/jcb.132.5.887; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; GUACCI V, 1994, J CELL BIOL, V125, P517, DOI 10.1083/jcb.125.3.517; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; HIETER P, 1985, CELL, V40, P381, DOI 10.1016/0092-8674(85)90152-7; Hunt AJ, 1998, MOL BIOL CELL, V9, P2857, DOI 10.1091/mbc.9.10.2857; Hyland KM, 1999, J CELL BIOL, V145, P15, DOI 10.1083/jcb.145.1.15; HYMAN AA, 1990, J CELL BIOL, V110, P1607, DOI 10.1083/jcb.110.5.1607; KOSHLAND DE, 1988, NATURE, V331, P499, DOI 10.1038/331499a0; MCGREW JT, 1992, MOL BIOL CELL, V3, P1443, DOI 10.1091/mbc.3.12.1443; Megee PC, 1999, MOL CELL, V4, P445, DOI 10.1016/S1097-2765(00)80347-0; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MITCHISON TJ, 1985, J CELL BIOL, V101, P766, DOI 10.1083/jcb.101.3.766; NICKLAS RB, 1995, J CELL BIOL, V130, P929, DOI 10.1083/jcb.130.4.929; NICKLAS RB, 1994, J CELL BIOL, V126, P1241, DOI 10.1083/jcb.126.5.1241; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; RIEDER CL, 1994, J CELL BIOL, V124, P223, DOI 10.1083/jcb.124.3.223; Shelby RD, 1996, J CELL BIOL, V135, P545, DOI 10.1083/jcb.135.3.545; SKIBBENS RV, 1995, J CELL SCI, V108, P2537; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Waters JC, 1996, J CELL SCI, V109, P2823; Waters JC, 1996, MOL BIOL CELL, V7, P1547, DOI 10.1091/mbc.7.10.1547; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; YEH E, 1995, J CELL BIOL, V130, P687, DOI 10.1083/jcb.130.3.687; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415; ZINKOWSKI RP, 1991, J CELL BIOL, V113, P1091, DOI 10.1083/jcb.113.5.1091	48	229	232	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 23	2000	101	7					763	775		10.1016/S0092-8674(00)80888-0	http://dx.doi.org/10.1016/S0092-8674(00)80888-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	327YE	10892747	Bronze			2022-12-24	WOS:000087821400010
J	Bassing, CH; Alt, FW; Hughes, MM; D'Auteuil, M; Wehrly, TD; Woodman, BB; Gartner, F; White, JM; Davidson, L; Sleckman, BP				Bassing, CH; Alt, FW; Hughes, MM; D'Auteuil, M; Wehrly, TD; Woodman, BB; Gartner, F; White, JM; Davidson, L; Sleckman, BP			Recombination signal sequences restrict chromosomal V(D)J recombination beyond the 12/23 rule	NATURE			English	Article							MEDIATE RECOMBINATION; T-CELLS; BETA; GENE; REARRANGEMENT; CHAIN; DIFFERENTIATION; INITIATION; SEGMENTS; PROMOTER	The genes encoding the variable regions of lymphocyte antigen receptors are assembled from variable (V), diversity (D) and joining (J) gene segments(1), V(D)J recombination is initiated by the recombinase activating gene (RAG)-1 and -2 proteins, which introduce DNA double-strand breaks between the V, D and J segments and their flanking recombination signal sequences (RSSs), Generally expressed DNA repair proteins then carry out the joining reaction(2,3), The conserved heptamer and nonamer sequences of the RSSs are separated by non-conserved spacers of 12 or 23 base pairs (forming 12-RSSs and 23-RSSs). The 12/23 rule, which is mediated at the level of RAG-1/2 recognition and cutting(4,5), specifies that V(D)J recombination occurs only between a gene segment flanked by a 12-RSS and one flanked by a 23-RSS1, V beta segments are appended to DJ beta rearrangements, with little or no direct V beta to J beta joining, despite 12/23 compatibility of V beta 23-RSSs and J beta 12-RSSs(6,7). Here we use embryonic stem cells and mice with a modified T-cell receptor (TCR)beta locus containing only one D beta (D beta 1) gene segment and one J beta (J beta 1) gene cluster to show that the 5' D beta 1 12-RSS, but not the J beta 1 12-RSSs, targets rearrangement of a diverse V beta repertoire, This targeting is precise and position-independent. This additional restriction on V(D)J recombination has important implications for the regulation of variable region gene assembly and repertoire development.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Harvard Univ, Childrens Hosp, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Ctr Blood Res, Boston, MA 02115 USA	Washington University (WUSTL); Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Sleckman, BP (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 S Euclid Ave,Campus Box 8118, St Louis, MO 63110 USA.	sleckman@immunology.WUSTL.edu		White, James Michael/0000-0001-5110-6567				AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; BOUBNOV NV, 1995, NUCLEIC ACIDS RES, V23, P1060, DOI 10.1093/nar/23.6.1060; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; CONNOR AM, 1995, J IMMUNOL, V155, P5268; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Doty RT, 1999, BLOOD, V93, P3017; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; FERRIER P, 1990, EMBO J, V9, P117, DOI 10.1002/j.1460-2075.1990.tb08087.x; Gartner F, 1999, IMMUNITY, V10, P537, DOI 10.1016/S1074-7613(00)80053-9; GAUSS GH, 1992, GENE DEV, V6, P1553, DOI 10.1101/gad.6.8.1553; GERSTEIN RM, 1993, GENE DEV, V7, P1459, DOI 10.1101/gad.7.7b.1459; HESSE JE, 1989, GENE DEV, V3, P1053, DOI 10.1101/gad.3.7.1053; Jeggo PA, 1998, RADIAT RES, V150, pS80, DOI 10.2307/3579810; JOUVINMARCHE E, 1990, EMBO J, V9, P2141, DOI 10.1002/j.1460-2075.1990.tb07383.x; Nadel B, 1998, J EXP MED, V187, P1495, DOI 10.1084/jem.187.9.1495; RAMSDEN DA, 1994, NUCLEIC ACIDS RES, V22, P1785, DOI 10.1093/nar/22.10.1785; RAMSDEN DA, 1991, P NATL ACAD SCI USA, V88, P10721, DOI 10.1073/pnas.88.23.10721; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Sikes ML, 1999, MOL CELL BIOL, V19, P2773; Sleckman BP, 1997, IMMUNITY, V7, P505, DOI 10.1016/S1074-7613(00)80372-6; SLECKMAN BP, IN PRESS P NATL ACAD; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4; VanDyk LF, 1996, J IMMUNOL, V157, P4005; vanGent DC, 1996, CELL, V85, P107, DOI 10.1016/S0092-8674(00)81086-7; WEAVER DT, 1995, ADV IMMUNOL, V58, P29, DOI 10.1016/S0065-2776(08)60619-7; WEI Z, 1993, J BIOL CHEM, V268, P3180; Whitehurst CE, 1999, IMMUNITY, V10, P313, DOI 10.1016/S1074-7613(00)80031-X; Willerford DM, 1996, CURR OPIN GENET DEV, V6, P603, DOI 10.1016/S0959-437X(96)80090-6; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0	31	131	139	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2000	405	6786					583	586		10.1038/35014635	http://dx.doi.org/10.1038/35014635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850719				2022-12-24	WOS:000087449500054
J	Qvarnstrom, A; Part, T; Sheldon, BC				Qvarnstrom, A; Part, T; Sheldon, BC			Adaptive plasticity in mate preference linked to differences in reproductive effort	NATURE			English	Article							FLYCATCHER FICEDULA-ALBICOLLIS; SECONDARY SEXUAL CHARACTER; MALE COLLARED FLYCATCHERS; MATING PREFERENCES; MALE COMPETITION; PARENTAL CARE; BADGE SIZE; CHOICE; CONSEQUENCES; SELECTION	There is abundant evidence for the existence of marked mate preferences in natural populations, but the occurrence of within-population variation in mate preferences has received little attention(1-3) and is often regarded as nonadaptive deviation from the optimal norm(2,3). Here we show experimentally that the preference of female collared flycatchers Ficedula albicollis for male forehead patch size, a sexually selected trait(4-6), varies with the time of breeding, an environmental factor with strong effects on reproductive success. Contrary to expectations based on time-constrained choice models(7,8), only late-breeding females prefer males with a large patch size. The variation in mate preference matches a seasonal change in female reproductive success: longterm data reveal a positive relationship between female reproductive success and male patch size exclusively in late breeders. In addition, female reproductive effort, as assessed by clutch size, appears to be adjusted relative to both timing of breeding and male phenotype. We conclude that not only can mate preferences display adaptive plasticity within populations, but this plasticity can also be linked to differences in reproductive investment.	Uppsala Univ, Evolutionary Biol Ctr, Dept Anim Ecol, SE-75236 Uppsala, Sweden; Swedish Univ Agr Sci, Dept Conservat Biol, SE-75007 Uppsala, Sweden; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Uppsala University; Swedish University of Agricultural Sciences; University of Oxford	Qvarnstrom, A (corresponding author), Univ Calif San Diego, Dept Biol 0116, La Jolla, CA 92093 USA.	annaq@biomail.ucsd.edu	Sheldon, Ben C/A-8056-2010	Sheldon, Ben C/0000-0002-5240-7828; Qvarnstrom, Anna/0000-0002-1178-4053; Part, Tomas/0000-0001-7388-6672				Andersson Malte, 1994; Bakker TCM, 1999, NATURE, V401, P234, DOI 10.1038/45727; CRICK HQP, 1993, J ANIM ECOL, V62, P263, DOI 10.2307/5357; Gibson RM, 1996, TRENDS ECOL EVOL, V11, P468, DOI 10.1016/0169-5347(96)10050-1; Griffith SC, 1999, P ROY SOC B-BIOL SCI, V266, P765; GUSTAFSSON L, 1988, NATURE, V335, P813, DOI 10.1038/335813a0; GUSTAFSSON L, 1995, NATURE, V375, P311, DOI 10.1038/375311a0; Gustafsson L., 1989, P75; GUSTAFSSON L, 1990, NATURE, V347, P279, DOI 10.1038/347279a0; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Kokko H, 1998, P ROY SOC B-BIOL SCI, V265, P1871, DOI 10.1098/rspb.1998.0515; Part T, 1997, ANIM BEHAV, V54, P893, DOI 10.1006/anbe.1997.0514; PART T, 1989, J ANIM ECOL, V58, P305, DOI 10.2307/5002; Qvarnstrom A, 1999, EVOLUTION, V53, P1564, DOI 10.1111/j.1558-5646.1999.tb05419.x; Qvarnstrom A, 1999, P ROY SOC B-BIOL SCI, V266, P2089; Qvarnstrom A, 1997, P ROY SOC B-BIOL SCI, V264, P1225, DOI 10.1098/rspb.1997.0169; REAL L, 1990, AM NAT, V136, P376, DOI 10.1086/285103; Sheldon BC, 1997, P ROY SOC B-BIOL SCI, V264, P297, DOI 10.1098/rspb.1997.0042; Sheldon BC, 1999, ANIM BEHAV, V57, P285, DOI 10.1006/anbe.1998.0968; Widemo F, 1999, TRENDS ECOL EVOL, V14, P26, DOI 10.1016/S0169-5347(98)01531-6; WIGGINS DA, 1994, OIKOS, V70, P359, DOI 10.2307/3545773	21	155	155	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2000	405	6784					344	347		10.1038/35012605	http://dx.doi.org/10.1038/35012605			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314YT	10830962				2022-12-24	WOS:000087085700046
J	Helmlinger, G; Endo, M; Ferrara, N; Hlatky, L; Jain, RK				Helmlinger, G; Endo, M; Ferrara, N; Hlatky, L; Jain, RK			Growth factors - Formation of endothelial cell networks	NATURE			English	Article							TUMOR ANGIOGENESIS; HYPOXIA; PROLIFERATION		Harvard Univ, Massachusetts Gen Hosp, Sch Med, Steele Lab,Dept Radiat Oncol, Boston, MA 02114 USA; Genentech Inc, S San Francisco, CA 94080 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dana Farber Canc Inst,Dept Radiat Oncol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Roche Holding; Genentech; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School	Helmlinger, G (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Steele Lab,Dept Radiat Oncol, Boston, MA 02114 USA.		Jain, Rakesh K/I-1384-2017	Jain, Rakesh K/0000-0001-7571-3548				Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FILHO IPT, 1993, AM J PHYSIOL, V265, pH1434; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; HLATKY L, 1994, CANCER RES, V54, P6083; HLATKY L, 1985, CELL TISSUE KINET, V18, P597, DOI 10.1111/j.1365-2184.1985.tb00703.x; Hlatky L, 1996, BRIT J CANCER, V74, pS151; Kimura H, 1996, CANCER RES, V56, P5522; Liu YX, 1998, J BIOL CHEM, V273, P15257, DOI 10.1074/jbc.273.24.15257; Namiki A, 1995, J BIOL CHEM, V270, P31189, DOI 10.1074/jbc.270.52.31189; NOMURA M, 1995, J BIOL CHEM, V270, P28316; Patan S, 1996, MICROVASC RES, V51, P260, DOI 10.1006/mvre.1996.0025; SHOLLEY MM, 1984, LAB INVEST, V51, P624	13	128	133	2	13	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 11	2000	405	6783					139	141		10.1038/35012132	http://dx.doi.org/10.1038/35012132			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WG	10821260				2022-12-24	WOS:000087080100037
J	Huigens, ME; Luck, RF; Klaassen, RHG; Maas, MFPM; Timmermans, MJTN; Stouthamer, R				Huigens, ME; Luck, RF; Klaassen, RHG; Maas, MFPM; Timmermans, MJTN; Stouthamer, R			Infectious parthenogenesis	NATURE			English	Article							MICROBE-ASSOCIATED PARTHENOGENESIS; TRICHOGRAMMA HYMENOPTERA; WOLBACHIA; SUPERPARASITISM; ALLOCATION; PRETIOSUM; WASPS; SEX	Parthenogenesis-inducing Wolbachia bacteria are reproductive parasites that cause infected female wasps to produce daughters without mating(1,2). This manipulation of the host's reproduction enhances the transmission of Wolbachia to future generations because the bacteria are passed on vertically only from mothers to daughters. Males are dead ends for cytoplasmically inherited bacteria: they do not pass them on to their offspring. Vertical transmission of Wolbachia has been previously considered to be the main mode of transmission. Here we report frequent horizontal transmission from infected to uninfected wasp larvae sharing a common food source. The transferred Wolbachia are then vertically transmitted to the new host's offspring. This natural and unexpectedly frequent horizontal transfer of parthenogensis-inducing Wolbachia intraspecifically has important implications for the co-evolution of Wolbachia and their host.	Wageningen Univ Agr, Entomol Lab, Dept Plant Sci, NL-6700 EH Wageningen, Netherlands; Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	Wageningen University & Research; University of California System; University of California Riverside	Stouthamer, R (corresponding author), Wageningen Univ Agr, Entomol Lab, Dept Plant Sci, NL-6700 EH Wageningen, Netherlands.		Klaassen, Raymond/K-3027-2013					Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Ewald PW, 1994, EVOLUTION INFECT DIS; KAZMER DJ, 1992, EVOLUTION REPROD STR; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; PAK GA, 1982, ENTOMOL EXP APPL, V32, P68, DOI 10.1111/j.1570-7458.1982.tb03183.x; Pinto JD, 1997, P ENTOMOL SOC WASH, V99, P238; RIGAUD T, 1995, J EVOLUTION BIOL, V8, P249, DOI 10.1046/j.1420-9101.1995.8020249.x; Schilthuizen M, 1998, ANN ENTOMOL SOC AM, V91, P410, DOI 10.1093/aesa/91.4.410; Schilthuizen M, 1997, P ROY SOC B-BIOL SCI, V264, P361, DOI 10.1098/rspb.1997.0052; STOUTHAMER R, 1993, NATURE, V361, P66, DOI 10.1038/361066a0; STOUTHAMER R, 1994, HEREDITY, V73, P317, DOI 10.1038/hdy.1994.139; Stouthamer R, 1997, INFLUENTIAL PASSENGERS, P102; STOUTHAMER R, 1993, ENTOMOL EXP APPL, V67, P183, DOI 10.1007/BF02386524; STOUTHAMER R, 1990, P NATL ACAD SCI USA, V87, P2424, DOI 10.1073/pnas.87.7.2424; SUZUKI Y, 1984, ANIM BEHAV, V32, P478, DOI 10.1016/S0003-3472(84)80284-5; VANALPHEN JJM, 1992, FUNCT ECOL, V6, P528, DOI 10.2307/2390049	16	208	230	1	60	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 11	2000	405	6783					178	179		10.1038/35012066	http://dx.doi.org/10.1038/35012066			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WG	10821272				2022-12-24	WOS:000087080100049
J	Clark, CM; Fradkin, JE; Hiss, RG; Lorenz, RA; Vinicor, F; Warren-Boulton, E				Clark, CM; Fradkin, JE; Hiss, RG; Lorenz, RA; Vinicor, F; Warren-Boulton, E			Promoting early diagnosis and treatment of type 2 diabetes - The National Diabetes Education Program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NON-HISPANIC WHITES; GLYCEMIC CONTROL; CARE; MANAGEMENT; NIDDM; MELLITUS; ADULTS; POPULATION; BENEFITS; QUALITY		NIDDKD, NIH, Bethesda, MD 20892 USA; Regenstrief Inst Hlth Care, Indianapolis, IN 46202 USA; Univ Michigan Hlth Syst, Michigan Diabet Res & Training Ctr, Demonstrat & Educ Div, Ann Arbor, MI USA; Univ Illinois, Coll Med, Dept Pediat, Peoria, IL 61656 USA; Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA; Hager Sharp, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Peoria; Centers for Disease Control & Prevention - USA	Clark, CM (corresponding author), Natl Diabet Educ Program, Box JAMA Reprint,1 Diabet Way, Bethesda, MD 20892 USA.							Amer Diabet Assoc, 2000, DIABETES CARE, V23, pS32; Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004; Beckles GLA, 1998, DIABETES CARE, V21, P1432, DOI 10.2337/diacare.21.9.1432; Buse JB, 1999, DIABETES CARE, V22, pC65; Cowie CC, 1995, NIH PUBLICATION, V95-1468, P117; Eastman RC, 1997, DIABETES CARE, V20, P735, DOI 10.2337/diacare.20.5.735; Etzwiler DD, 1997, DIABETES EDUCATOR, V23, P569, DOI 10.1177/014572179702300509; Gavin JR, 2000, DIABETES CARE, V23, pS4; Gilmer TP, 1997, DIABETES CARE, V20, P1847, DOI 10.2337/diacare.20.12.1847; HAFFNER SM, 1989, DIABETES CARE, V12, P530, DOI 10.2337/diacare.12.8.530; Haffner SM, 1998, DIABETES CARE, V21, P160, DOI 10.2337/diacare.21.1.160; HAMMAN RF, 1989, DIABETES, V38, P1231, DOI 10.2337/diabetes.38.10.1231; HARRIS MI, 1992, DIABETES CARE, V15, P815, DOI 10.2337/diacare.15.7.815; Harris MI, 1999, DIABETES CARE, V22, P403, DOI 10.2337/diacare.22.3.403; Marshall CL, 2000, AM J MED QUAL, V15, P65, DOI 10.1177/106286060001500205; Mundinger MO, 2000, JAMA-J AM MED ASSOC, V283, P59, DOI 10.1001/jama.283.1.59; *NAT DIAB ED PROGR, 1998, NIH PUBL; *NAT I DIAB DIAGN, 1990, SURV PHYS PRACT BEH; Peterson K A, 1998, J Fam Pract, V47, pS55; Ray NF, 1998, DIABETES CARE, V21, P296; Roman SH, 1997, ENDOCRIN METAB CLIN, V26, P443, DOI 10.1016/S0889-8529(05)70260-7; RUBIN RJ, 1994, J CLIN ENDOCR METAB, V78, pA809, DOI 10.1210/jcem.78.4.8157701; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; SHAFFER J, 1995, ARCH INTERN MED, V155, P2330, DOI 10.1001/archinte.155.21.2330; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stearne MR, 1998, BRIT MED J, V317, P713; Testa MA, 1998, JAMA-J AM MED ASSOC, V280, P1490, DOI 10.1001/jama.280.17.1490; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Wagner E H, 1996, Manag Care Q, V4, P12; WEINER JP, 1995, JAMA-J AM MED ASSOC, V273, P1503, DOI 10.1001/jama.273.19.1503; Zimmet P, 1999, DIABETES CARE, V22, pB59	32	52	55	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2000	284	3					363	365		10.1001/jama.284.3.363	http://dx.doi.org/10.1001/jama.284.3.363			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	333GR	10891969				2022-12-24	WOS:000088123000030
J	Hu, FZ; Preston, RA; Post, JC; White, GJ; Kikuchi, LW; Wang, X; Leal, SM; Levenstien, MA; Ott, J; Self, TW; Allen, G; Stiffler, RS; McGraw, C; Pulsifer-Anderson, EA; Ehrlich, GD				Hu, FZ; Preston, RA; Post, JC; White, GJ; Kikuchi, LW; Wang, X; Leal, SM; Levenstien, MA; Ott, J; Self, TW; Allen, G; Stiffler, RS; McGraw, C; Pulsifer-Anderson, EA; Ehrlich, GD			Mapping of a gene for severe pediatric gastroesophageal reflux to chromosome 13q14	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BARRETTS-ESOPHAGUS; SUBGLOTTIC STENOSIS; RESPIRATORY-DISEASE; CHILDREN; INFANTS; MAPS; ADENOCARCINOMA; ADULT	Context Gastroesophageal reflux (CER) has not previously been widely regarded as a hereditary disease, A few reports have suggested, however, that a genetic component may contribute to the incidence of GER, especially in its severe or chronic forms. Objective To identify a genetic locus that cosegregates with a severe pediatric GER phenotype in families with multiple affected members. Design A genome-wide scan of families affected by severe pediatric GER using polymorphic microsatellite markers spaced at an average of 8 centimorgans (cM), followed by haplotyping and by pairwise and multipoint linkage analyses. Setting General US community, with research performed in a university tertiary care hospital. Subjects Affected and unaffected family members from 5 families having multiple individuals affected by severe pediatric GER, identified through a patient support group. Main Outcome Measures Determination of inheritance patterns and linkage of a genetic locus with the severe pediatric GER phenotype by logarithm-of-odds (lod) score analysis, considering a lod score of 3 or greater as evidence of linkage. Results In these families, severe pediatric GER followed an autosomal dominant hereditary pattern with high penetrance. A gene for severe pediatric GER was mapped to a 13-cM region on chromosome 13q between microsatellite markers D13S171 and D13S263. A maximum multifamily 2-point lod score of 5.58 and a maximum multifamily multipoint lod score of 7.15 were obtained for marker D13S1253 at map position 35 cM when presumptively affected persons were modeled as unknown (a maximum multipoint score of 4.88 was obtained when presumptively affected persons were modeled as unaffected). Conclusion These data suggest that a gene for severe pediatric GER maps to chromosome 13q14.	Allegheny Gen Hosp, Ctr Genome Sci, Pittsburgh, PA 15212 USA; Allegheny Gen Hosp, Dept Human Genet, Pittsburgh, PA 15212 USA; MCP Hahnemann Univ, Pittsburgh, PA USA; Rockefeller Univ, Lab Stat Gen, New York, NY 10021 USA; Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA; Univ Colorado, Hlth Sci Ctr, Dept Otolaryngol, Denver, CO USA; Pediat Adolescent Gastroesophageal Reflux Assoc, Germantown, MD USA	Allegheny General Hospital; Allegheny General Hospital; Drexel University; Rockefeller University; University of California System; University of California San Diego; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Ehrlich, GD (corresponding author), Allegheny Gen Hosp, Ctr Genome Sci, Room 1030,320 E North Ave, Pittsburgh, PA 15212 USA.	gehrlich@wpahs.org		Ehrlich, Garth/0000-0003-1140-6594	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002398, R01DC003594, R01DC002148, R29DC002398, R01DC004591] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG000008] Funding Source: Medline; NIDCD NIH HHS [DC02148, R01 DC003594, R01 DC002148, DC02398, R01 DC002398, R29 DC002398, DC04591, R01 DC004591] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Altman KW, 1999, ARCH OTOLARYNGOL, V125, P525, DOI 10.1001/archotol.125.5.525; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Callahan CW, 1998, ACTA PAEDIATR, V87, P1219, DOI 10.1080/080352598750030861; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CRABB DW, 1985, ANN INTERN MED, V103, P52, DOI 10.7326/0003-4819-103-1-52; del Rosario J F, 1998, Gastroenterologist, V6, P104; Euler AR, 1998, DIGEST DIS, V16, P111, DOI 10.1159/000016854; FAHMY N, 1993, AM J GASTROENTEROL, V88, P1262; Faubion WA, 1998, MAYO CLIN PROC, V73, P166; Fonkalsrud EW, 1996, CURR PROB SURG, V33, P6; Giannoni C, 1998, INT J PEDIATR OTORHI, V43, P11, DOI 10.1016/S0165-5876(97)00151-1; Halstead LA, 1999, OTOLARYNG HEAD NECK, V120, P683, DOI 10.1053/hn.1999.v120.a91766; Halstead LA, 1999, OTOLARYNG HEAD NECK, V120, P208, DOI 10.1016/S0194-5998(99)70408-0; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Little JP, 1997, ANN OTO RHINOL LARYN, V106, P1; MALFROOT A, 1987, PEDIATR PULM, V3, P208, DOI 10.1002/ppul.1950030403; Marcon Margaret A., 1997, Current Opinion in Pediatrics, V9, P490, DOI 10.1097/00008480-199710000-00008; McMurray JS, 1997, OTOLARYNG HEAD NECK, V116, P575, DOI 10.1016/S0194-5998(97)70230-4; Orenstein SR, 1997, AM J MED, V103, p114S, DOI 10.1016/S0002-9343(97)00335-5; ORENSTEIN SR, 1988, J PEDIATR-US, V112, P847, DOI 10.1016/S0022-3476(88)80204-X; ORENSTEIN SR, 1993, PEDIAT GASTROINTESTI, P337; Ott J., 1999, ANAL HUMAN GENETIC L; PRESTON RA, 1994, NAT GENET, V7, P149, DOI 10.1038/ng0694-149; Romero Y, 1999, AM J GASTROENTEROL, V94, P1127, DOI 10.1111/j.1572-0241.1999.01127.x; Romero Y, 1997, GASTROENTEROLOGY, V113, P1449, DOI 10.1053/gast.1997.v113.pm9352846; Seri M, 1999, AM J HUM GENET, V64, P586, DOI 10.1086/302241; Stephen T C, 1994, J Ky Med Assoc, V92, P188; STEPHEN TC, 1998, W V MED J, V94, P22; Terwilliger J., 1994, HDB HUMAN GENETIC LI; Trudgill NJ, 1999, AM J GASTROENTEROL, V94, P1172, DOI 10.1016/S0002-9270(99)00116-1; Walner DL, 1998, ARCH OTOLARYNGOL, V124, P551, DOI 10.1001/archotol.124.5.551; Whitcomb DC, 1996, GASTROENTEROLOGY, V110, P1975, DOI 10.1053/gast.1996.v110.pm8964426	32	64	66	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2000	284	3					325	334		10.1001/jama.284.3.325	http://dx.doi.org/10.1001/jama.284.3.325			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	333GR	10891964	Green Accepted, Bronze			2022-12-24	WOS:000088123000025
J	Tsai, RJ; Li, LM; Chen, JK				Tsai, RJ; Li, LM; Chen, JK			Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO)	MAY 10-15, 1998	FT LAUDERDALE, FL	Assoc Res Vis & Ophthalmol			OCULAR-SURFACE DISORDERS; AMNIOTIC MEMBRANE TRANSPLANTATION; STEM-CELLS; AUTOGRAFT; DEFICIENCY	Background: The Stevens-Johnson syndrome, ocular pemphigoid, and thermal or chemical burns can cause scarring and opacification of the cornea and loss of vision. Transplantation of epithelial cells from the limbus of the contralateral cornea can restore useful vision. However, this procedure requires a large limbal graft from the healthy eye and is not possible in patients who have bilateral lesions. Methods: We took specimens of limbal epithelial cells from the healthy contralateral eyes of six patients with severe unilateral corneal disease. The epithelial cells were cultured and expanded on amniotic membrane. The amniotic membrane, together with the sheet of limbal epithelial cells, was transplanted to the denuded corneal surface of the damaged eye after superficial keratectomy to remove fibrovascular ingrowth. The mean (+/-SD) follow-up period was 15+/-2 months. Results: Complete reepithelialization of the corneal surface occurred within two to four days of transplantation in all six eyes receiving transplants. By one month, the ocular surface was covered with corneal epithelium, and the clarity of the cornea was improved. In five of the six eyes receiving transplants (83 percent), the mean visual acuity improved from 20/112 to 20/45. In one patient with a chemical burn who had total opacification of the cornea, the acuity improved from the ability to count fingers at 40 cm to 20/200. No patient had recurrent neovascularization or inflammation in the transplanted area during the follow-up period. Conclusions: Transplantation of autologous limbal epithelial cells cultured on amniotic membrane is a simple and effective method of reconstructing the corneal surface and restoring useful vision in patients with unilateral deficiency of limbal epithelial cells. (N Engl J Med 2000;343:86-93.) (C) 2000, Massachusetts Medical Society.	Chang Gung Mem Hosp, Dept Ophthalmol, Tao Yuan, Taiwan; Chang Gung Univ, Dept Physiol, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Tsai, RJ (corresponding author), 2F 350 Sect 4 Cheng Kung Rd, Taipei, Taiwan.	raytsai@ms4.hinet.net						CHEN JJY, 1990, INVEST OPHTH VIS SCI, V31, P1301; CHEN JJY, 1991, INVEST OPHTH VIS SCI, V32, P2219; COPELAND RA, 1990, AM J OPHTHALMOL, V110, P412, DOI 10.1016/S0002-9394(14)77023-0; Holland E J, 1996, Trans Am Ophthalmol Soc, V94, P677; Kenyon K R, 1989, Dev Ophthalmol, V18, P53; Kenyon KR, 1995, OPHTHALMOLOGY, V102, P101; KIM JC, 1995, CORNEA, V14, P473; KIM JC, 1997, ADV CORNEAL RES SELE, V4, P117; KIM JS, 1998, INVEST OPHTHALMO S90, V39; KRUSE FE, 1989, INVEST OPHTHALM S520, V30; KWITKO S, 1995, OPHTHALMOLOGY, V102, P1020; Lee SH, 1997, AM J OPHTHALMOL, V123, P303, DOI 10.1016/S0002-9394(14)70125-4; Mashima Y, 1993, JPN J CLIN OPHTHALMO, V47, P607; Meller D, 1999, INVEST OPHTH VIS SCI, V40, pS329; Morgan S, 1996, EYE, V10, P349, DOI 10.1038/eye.1996.72; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Shimazaki J, 1998, BRIT J OPHTHALMOL, V82, P235, DOI 10.1136/bjo.82.3.235; Tan DTH, 1996, OPHTHALMOLOGY, V103, P29, DOI 10.1016/S0161-6420(96)30737-9; Thang JTS, 1997, OPHTHALMIC SURG LAS, V28, P765; TSAI RJF, 1990, OPHTHALMOLOGY, V97, P446, DOI 10.1016/S0161-6420(90)32575-7; TSAI RJF, 1995, CORNEA, V14, P439; TSAI RJF, 1994, CORNEA, V13, P389, DOI 10.1097/00003226-199409000-00003; TSAI RJF, 1988, INVEST OPHTH VIS SCI, V29, P1565; TSAI RJF, 1994, INVEST OPHTH VIS SCI, V35, P2865; Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431; Tseng SCG, 1996, MOL BIOL REP, V23, P47, DOI 10.1007/BF00357072; TSENG SCG, 1989, EYE, V3, P141, DOI 10.1038/eye.1989.22; Tseng SCG, 1990, OPHTHALMOL CLIN N AM, V3, P595; Tsubota K, 1996, AM J OPHTHALMOL, V122, P38, DOI 10.1016/S0002-9394(14)71962-2; TSUBOTA K, 1995, OPHTHALMOLOGY, V102, P1486; Tsubota K, 1999, NEW ENGL J MED, V340, P1697, DOI 10.1056/NEJM199906033402201	31	734	813	2	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2000	343	2					86	93		10.1056/NEJM200007133430202	http://dx.doi.org/10.1056/NEJM200007133430202			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	333EP	10891515	Bronze			2022-12-24	WOS:000088116500002
J	Backman, V; Wallace, MB; Perelman, LT; Arendt, JT; Gurjar, R; Muller, MG; Zhang, Q; Zonios, G; Kline, E; McGillican, T; Shapshay, S; Valdez, T; Badizadegan, K; Crawford, JM; Fitzmaurice, M; Kabani, S; Levin, HS; Seiler, M; Dasari, RR; Itzkan, I; Van Dam, J; Feld, MS				Backman, V; Wallace, MB; Perelman, LT; Arendt, JT; Gurjar, R; Muller, MG; Zhang, Q; Zonios, G; Kline, E; McGillican, T; Shapshay, S; Valdez, T; Badizadegan, K; Crawford, JM; Fitzmaurice, M; Kabani, S; Levin, HS; Seiler, M; Dasari, RR; Itzkan, I; Van Dam, J; Feld, MS			Detection of preinvasive cancer cells	NATURE			English	Article									MIT, George R Harrison Spect Lab, Laser Biomed Res Ctr, Cambridge, MA 02139 USA; Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; Cleveland Clin Fdn, Dept Urol, Cleveland, OH 44106 USA; New England Med Ctr, Boston, MA 02132 USA; Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; Univ Hosp Cleveland, Dept Pathol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Cleveland Clin Fdn, Dept Pathol, Cleveland, OH 44106 USA; US Vet Adm Hosp, W Roxbury, MA 02132 USA	Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Cleveland Clinic Foundation; Tufts Medical Center; Harvard University; Boston Children's Hospital; Yale University; University Hospitals of Cleveland; Case Western Reserve University; Cleveland Clinic Foundation	Backman, V (corresponding author), MIT, George R Harrison Spect Lab, Laser Biomed Res Ctr, Cambridge, MA 02139 USA.		Backman, Vadim/B-6689-2009					Backman V, 1999, IEEE J SEL TOP QUANT, V5, P1019, DOI 10.1109/2944.796325; Crawford J.M., 1994, ROBBINS PATHOLOGIC B, V5th, P910; Hulst H.C., 1957, LIGHT SCATTERING SMA; Perelman LT, 1998, PHYS REV LETT, V80, P627, DOI 10.1103/PhysRevLett.80.627	4	492	515	1	52	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 6	2000	406	6791					35	36		10.1038/35017638	http://dx.doi.org/10.1038/35017638			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	330ZE	10894529				2022-12-24	WOS:000087991200032
J	Irving, RJ; Oram, SH; Boyd, J; Rutledge, P; McRae, F; Bloomfield, P				Irving, RJ; Oram, SH; Boyd, J; Rutledge, P; McRae, F; Bloomfield, P			Ten year audit of secondary prevention in coronary bypass patients	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHOLESTEROL LEVELS; EVENTS		Royal Infirm Edinburgh NHS Trust, Dept Cardiol, Edinburgh EH3 9YW, Midlothian, Scotland; Western Gen Hosp, Dept Med Sci, Edinburgh EH4 2XU, Midlothian, Scotland; Royal Infirm Edinburgh NHS Trust, Dept Clin Audit, Edinburgh EH3 9YW, Midlothian, Scotland; Lothian Hlth, Edinburgh BH8 9RS, Midlothian, Scotland; Broxburn Med Ctr, Broxburn EH52 5JZ, W Lothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Bloomfield, P (corresponding author), Royal Infirm Edinburgh NHS Trust, Dept Cardiol, Edinburgh EH3 9YW, Midlothian, Scotland.	PSBloomfield@compuserve.com		Irving, John/0000-0002-5687-8133				Bowker TJ, 1996, HEART, V75, P334, DOI 10.1136/hrt.75.4.334; Campeau L, 1997, NEW ENGL J MED, V336, P153; CAVENDER JB, 1992, J AM COLL CARDIOL, V20, P287, DOI 10.1016/0735-1097(92)90092-2; PEDERSEN TR, 1994, LANCET, V344, P1383; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401	5	14	14	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2000	321	7252					22	+		10.1136/bmj.321.7252.22	http://dx.doi.org/10.1136/bmj.321.7252.22			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331QQ	10875829	Bronze, Green Published			2022-12-24	WOS:000088030100022
J	de Forges, BR; Koslow, JA; Poore, GCB				de Forges, BR; Koslow, JA; Poore, GCB			Diversity and endemism of the benthic seamount fauna in the southwest Pacific	NATURE			English	Article							BIOGEOGRAPHY; COMMUNITY; SLOPE	Seamounts comprise a unique deep-sea environment, characterized by substantially enhanced currents and a fauna that is dominated by suspension feeders, such as corals(1-4). The potential importance of these steep-sided undersea mountains, which are generally of volcanic origin, to ocean biogeography and diversity was recognized over 40 years ago(5), but this environment has remained very poorly explored. A review(3) of seamount biota and biogeography reported a total of 597 invertebrate species recorded from seamounts worldwide since the Challenger expedition of 1872. Most reports, based on a single taxonomic group, were extremely limited: 5 seamounts of the estimated more than 30,000 seamounts in the world's oceans(4,6) accounted for 72% of the species recorded. Only 15% of the species occurring on seamounts were considered potential seamount endemics. Here we report the discovery of more than 850 macro- and megafaunal species from seamounts in the Tasman Sea and southeast Coral Sea, of which 29-34% are new to science and potential seamount endemics. Low species overlap between seamounts in different portions of the region indicates that the seamounts in clusters or along ridge systems function as 'island groups' or 'chains,' leading to highly localized species distributions and apparent speciation between groups or ridge systems that is exceptional for the deep sea. These results have substantial implications for the conservation of this fauna, which is threatened by fishing activity(7).	CSIRO, Hobart, Tas 7001, Australia; Ctr IRD Noumea, Noumea 98848, New Caledonia; Museum Victoria, Abbotsford, Vic 3067, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Institut de Recherche pour le Developpement (IRD); Museum Victoria	Koslow, JA (corresponding author), CSIRO, GPO Box 1538, Hobart, Tas 7001, Australia.	tony.koslow@marine.csiro.au						AMEZIANECOMINARDI N, 1987, CR ACAD SCI III-VIE, V304, P15; [Anonymous], 1943, GEOLOGICAL SOC AM SP, V44, P1, DOI DOI 10.1130/SPE44-P1; BOUCHET P, 1982, NEW ZEAL J ZOOL, V9, P309, DOI 10.1080/03014223.1982.10423862; DEFORGES BR, 1990, MEMOIRES MUSEUM NATL, V145, P9; DEFORGES BR, 1993, MEM MUS NATL HIST NA, V156, P475; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; GRIGG RW, 1984, PSZNI MAR ECOL, V5, P57, DOI 10.1111/j.1439-0485.1984.tb00307.x; HUBBS CARL L., 1959, PACIFIC SCI, V13, P311; JOHANNESSON K, 1988, MAR BIOL, V99, P507, DOI 10.1007/BF00392558; KOSLOW JA, 1994, DEEP-SEA RES PT I, V41, P113; KOSLOW JA, 1993, PROG OCEANOGR, V31, P321; KOSLOW JA, UNPUB MAR ECOL PROG; LAURIN B, 1992, CR ACAD SCI III-VIE, V314, P343; LUTJEHARMS JRE, 1981, DEEP-SEA RES, V28, P631, DOI 10.1016/0198-0149(81)90123-0; Mullineaux LS, 1997, DEEP-SEA RES PT I, V44, P745, DOI 10.1016/S0967-0637(96)00130-6; PARKER T, 1994, BIOL BULL-US, V187, P336, DOI 10.2307/1542290; PIELOU EC, 1974, POPULATION COMMUNITY, P311; POORE GCB, 1994, DEEP-SEA RES PT I, V41, P677, DOI 10.1016/0967-0637(94)90049-3; Richer de Forges B, 1998, THESIS MUSEUM NATL H; Roden G.I., 1986, NOAA TECHNICAL REPOR, V43, P3; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; SMITH DK, 1988, J GEOPHYS RES-SOLID, V93, P2899, DOI 10.1029/JB093iB04p02899; Tunnicliffe V, 1998, ADV MAR BIOL, V34, P353, DOI 10.1016/S0065-2881(08)60213-8; VACELET J, 1992, CR ACAD SCI III-VIE, V314, P379; Wilson RR., 2013, GEOPHYS MONOGR SER, V43, P355, DOI DOI 10.1029/GM043P0355	26	259	268	3	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2000	405	6789					944	947		10.1038/35016066	http://dx.doi.org/10.1038/35016066			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326JT	10879534				2022-12-24	WOS:000087732700049
J	Luz, B; Barkan, E				Luz, B; Barkan, E			Assessment of oceanic productivity with the triple-isotope composition of dissolved oxygen	SCIENCE			English	Article							FRACTIONATION; RESPIRATION; MECHANISMS; BALANCE; BERMUDA; CARBON	Plant production in the sea is a primary mechanism of global oxygen formation and carbon fixation, For this reason, and also because the ocean is a major sink for fossil fuel carbon dioxide, much attention has been given to estimating marine primary production. Here, we describe an approach for estimating production of photosynthetic oxygen, based on the isotopic composition of dissolved oxygen of seawater. This method allows the estimation of integrated oceanic productivity on a time scale of weeks.	Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Luz, B (corresponding author), Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel.							Barber RT, 1996, DEEP-SEA RES PT II, V43, P933, DOI 10.1016/0967-0645(96)00035-5; BENDER M, 1992, DEEP-SEA RES, V39, P1707, DOI 10.1016/0198-0149(92)90025-O; BENDER M, 1987, LIMNOL OCEANOGR, V32, P1085, DOI 10.4319/lo.1987.32.5.1085; BENSON BB, 1984, LIMNOL OCEANOGR, V29, P620, DOI 10.4319/lo.1984.29.3.0620; BERHENFELD MJ, 1997, LIMNOL OCEANOGR, V42, P1; Clark J.F., 1995, AIR WATER GAS TRANSF, P785, DOI DOI 10.5281/ZENODO.10571; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; CRAIG H, 1987, SCIENCE, V235, P199, DOI 10.1126/science.235.4785.199; Craig H., 1965, DEUTERIUM OXYGEN 18, P9, DOI DOI 10.1109/ISSRE.1993.624301; Doney SC, 1996, DEEP-SEA RES PT II, V43, P591, DOI 10.1016/0967-0645(95)00104-2; EMERSON S, 1995, J GEOPHYS RES-OCEANS, V100, P15873, DOI 10.1029/95JC01333; GUY RD, 1993, PLANT PHYSIOL, V101, P37, DOI 10.1104/pp.101.1.37; JENKINS WJ, 1985, J MAR RES, V43, P465, DOI 10.1357/002224085788438702; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; Luz B, 1999, NATURE, V400, P547, DOI 10.1038/22987; MATSUHISA Y, 1978, GEOCHIM COSMOCHIM AC, V42, P173, DOI 10.1016/0016-7037(78)90130-8; McCarthy JJ, 1999, DEEP-SEA RES PT II, V46, P1623, DOI 10.1016/S0967-0645(99)00038-7; Meijer HAJ, 1998, ISOT ENVIRON HEALT S, V34, P349, DOI 10.1080/10256019808234072; Michaels AF, 1996, DEEP-SEA RES PT II, V43, P157, DOI 10.1016/0967-0645(96)00004-5; Nightingale PD, 2000, GLOBAL BIOGEOCHEM CY, V14, P373, DOI 10.1029/1999GB900091; SPITZER WS, 1989, J MAR RES, V47, P169, DOI 10.1357/002224089785076370; THIEMENS MH, 1995, GEOPHYS RES LETT, V22, P255, DOI 10.1029/94GL02996; WANNINKHOF R, 1992, J GEOPHYS RES-OCEANS, V97, P7373, DOI 10.1029/92JC00188; Williams PJL, 1998, NATURE, V394, P55	24	172	177	4	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2000	288	5473					2028	2031		10.1126/science.288.5473.2028	http://dx.doi.org/10.1126/science.288.5473.2028			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856212				2022-12-24	WOS:000087687000045
J	Wu, WJ; Erickson, JW; Lin, R; Cerione, RA				Wu, WJ; Erickson, JW; Lin, R; Cerione, RA			The gamma-subunit of the coatomer complex binds Cdc42 to mediate transformation	NATURE			English	Article							GOLGI-APPARATUS; ENDOPLASMIC-RETICULUM; CELL POLARITY; PROTEIN; TRANSPORT; ACTIN; MEMBRANE; GTPASE; RHO; IDENTIFICATION	The Ras-related GTP-binding protein Cdc42 is implicated in a variety of biological activities including the establishment of cell polarity in yeast, the regulation of cell morphology, motility and cell-cycle progression in mammalian cells and the induction of malignant transformation(1,2). We identified a Cdc42 mutant (Cdc42F28L) which binds GTP in the absence of a guanine nucleotide exchange factor, but still hydrolyses GTP with a turnover number identical to that for wild-type Cdc42 (ref. 3). Expression of this mutant in NIH 3T3 fibroblasts causes cellular transformation, mimicking many of the characteristics of cells transformed by the Dbl oncoprotein, a known guanine nucleotide exchange factor for Cdc42 (ref. 4). Here we searched for new Cdc42 targets in an effort to understand how Cdc42 mediates cellular transformation. We identified the gamma-subunit of the coatomer complex (gamma COP) as a specific binding partner for activated Cdc42. The binding of Cdc42 to gamma COP is essential for a transforming signal distinct from those elicited by Ras.	Cornell Univ, VMC, Dept Mol Med, Ithaca, NY 14853 USA; Cornell Univ, VMC, Dept Chem & Biol Chem, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cerione, RA (corresponding author), Cornell Univ, VMC, Dept Mol Med, Ithaca, NY 14853 USA.							BAGRODIA S, 1995, J BIOL CHEM, V270, P22731, DOI 10.1074/jbc.270.39.22731; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; BERSHADSKY AD, 1994, P NATL ACAD SCI USA, V91, P5686, DOI 10.1073/pnas.91.12.5686; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Erickson JW, 1997, J BIOL CHEM, V272, P24443, DOI 10.1074/jbc.272.39.24443; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Harter C, 1996, P NATL ACAD SCI USA, V93, P1902, DOI 10.1073/pnas.93.5.1902; Harter C, 1998, P NATL ACAD SCI USA, V95, P11649, DOI 10.1073/pnas.95.20.11649; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Lowe M, 1995, J BIOL CHEM, V270, P31364, DOI 10.1074/jbc.270.52.31364; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; McCallum SJ, 1998, J BIOL CHEM, V273, P22537, DOI 10.1074/jbc.273.35.22537; Musch A, 1996, J CELL BIOL, V133, P543, DOI 10.1083/jcb.133.3.543; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; Westwick JK, 1997, MOL CELL BIOL, V17, P1324, DOI 10.1128/MCB.17.3.1324; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Wu WJ, 1998, J BIOL CHEM, V273, P16655, DOI 10.1074/jbc.273.27.16655	30	179	180	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					800	804		10.1038/35015585	http://dx.doi.org/10.1038/35015585			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866202				2022-12-24	WOS:000087620600053
J	Welch, HG; Schwartz, LM; Woloshin, S				Welch, HG; Schwartz, LM; Woloshin, S			Are increasing 5-year survival rates evidence of success against cancer?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Increased 5-year survival for cancer patients is generally inferred to mean that cancer treatment has improved and that fewer patients die of cancer. Increased 5-year survival, however, may also reflect changes in diagnosis: finding more people with early-stage cancer, including some who would never have become symptomatic from their cancer. Objective To determine the relationship over time between 5-year cancer survival and 2 other measures of cancer burden, mortality and incidence. Design and Setting Using population-based statistics reported by the National Cancer Institute Surveillance, Epidemiology, and End Results Program, we calculated the change in 5-year survival from 1950 to 1995 for the 20 most common solid tumor types. Using the tumor as the unit of analysis, we correlated changes in 5-year survival with changes in mortality and incidence. Main outcome Measure The association between changes in 5-year survival and changes in mortality and incidence measured using simple correlation coefficients (Pearson and Spearman). Results From 1950 to 1995, there was an increase in 5-year survival for each of the 20 tumor types. The absolute increase in 5-year survival ranged from 3% (pancreatic cancer) to 50% (prostate cancer). During the same period, mortality rates declined for 12 types of cancer and increased for the remaining 8 types. There was little correlation between the change in 5-year survival for a specific tumor and the change in tumor-related mortality (Pearson r=.00; Spearman r=-.07). On the other hand, the change in 5-year survival was positively correlated with the change in the tumor incidence rate (Pearson r=+.49; Spearman r=+.37). Conclusion Although 5-year survival is a valid measure for comparing cancer therapies in a randomized trial, our analysis shows that changes in 5-year survival over time bear little relationship to changes in cancer mortality. Instead, they appear primarily related to changing patterns of diagnosis.	Vet Adm Hosp, VA Outcomes Grp, White River Junction, VT USA; Dartmouth Med Sch, Ctr Evaluat Clin Sci, Hanover, NH USA; Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA	VA Outcomes Group; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Welch, HG (corresponding author), Dept Vet Affairs Med Ctr, VA Outcomes Grp 111B, White River Junction, VT 05009 USA.			Welch, H. Gilbert/0000-0002-3448-1207				BAILAR JC, 1986, NEW ENGL J MED, V314, P1226, DOI 10.1056/NEJM198605083141905; BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; KOLATA G, 1999, NY TIMES        1027, pA19; *SEER, 2000, SEER CANC STAT REV 1; SONDIK EJ, 1990, J NATL CANCER I, V82, P825; *US DEPT HHS, 1999, CANC SURV	6	314	317	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2000	283	22					2975	2978		10.1001/jama.283.22.2975	http://dx.doi.org/10.1001/jama.283.22.2975			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XL	10865276				2022-12-24	WOS:000087480600038
J	Singleton, MR; Sawaya, MR; Ellenberger, T; Wigley, DB				Singleton, MR; Sawaya, MR; Ellenberger, T; Wigley, DB			Crystal structure of T7 gene 4 ring helicase indicates a mechanism for sequential hydrolysis of nucleotides	CELL			English	Article							TERMINATION FACTOR-RHO; SINGLE-STRANDED-DNA; BINDING CHANGE MECHANISM; CONFORMATIONAL-CHANGES; OLIGOMERIC STRUCTURE; HEXAMER FORMATION; PRIMASE ACTIVITY; PCRA HELICASE; PROTEIN-RHO; BACTERIOPHAGE-T7	We have determined the crystal structure of arl active, hexameric fragment of the gene 4 helicase from bacteriophage T7. The structure reveals how subunit contacts stabilize the hexamer. Deviation from expected six-fold symmetry of the hexamer indicates that the structure is of an intermediate on the catalytic pathway. The structural consequences of the asymmetry suggest a "binding change" mechanism to explain how cooperative binding and hydrolysis of nucleotides are coupled to conformational changes in the ring that most likely accompany duplex unwinding. The structure of a complex with a nonhydrolyzable ATP analog provides additional evidence for this hypothesis, with only four of the six possible nucleotide binding sites being occupied in this conformation of the hexamer. This model suggests a mechanism for DNA translocation.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of Oxford; Harvard University; Harvard Medical School	Wigley, DB (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	wigley@eric.path.ox.ac.uk		Singleton, Martin/0000-0001-5716-7715; Sawaya, Michael/0000-0003-0874-9043				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Ahnert P, 1997, J BIOL CHEM, V272, P32267, DOI 10.1074/jbc.272.51.32267; Allison TJ, 1998, NAT STRUCT BIOL, V5, P352, DOI 10.1038/nsb0598-352; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bird LE, 1997, NUCLEIC ACIDS RES, V25, P2620, DOI 10.1093/nar/25.13.2620; Bird LE, 1998, CURR OPIN STRUC BIOL, V8, P14, DOI 10.1016/S0959-440X(98)80004-3; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUJALOWSKI W, 1993, BIOCHEMISTRY-US, V32, P5888, DOI 10.1021/bi00073a023; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dillingham MS, 1999, NUCLEIC ACIDS RES, V27, P3310, DOI 10.1093/nar/27.16.3310; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Fass D, 1999, STRUCTURE, V7, P691, DOI 10.1016/S0969-2126(99)80090-2; Frick DN, 1998, P NATL ACAD SCI USA, V95, P7957, DOI 10.1073/pnas.95.14.7957; GOGOL EP, 1991, J MOL BIOL, V221, P1127, DOI 10.1016/0022-2836(91)80116-C; Guo SY, 1999, J BIOL CHEM, V274, P30303, DOI 10.1074/jbc.274.42.30303; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; Hingorani MM, 1997, P NATL ACAD SCI USA, V94, P5012, DOI 10.1073/pnas.94.10.5012; Hingorani MM, 1996, BIOCHEMISTRY-US, V35, P2218, DOI 10.1021/bi9521497; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2129, DOI 10.1021/bi952345d; Kaplan DL, 1999, J BIOL CHEM, V274, P6889, DOI 10.1074/jbc.274.11.6889; Kim DE, 1999, J BIOL CHEM, V274, P11623, DOI 10.1074/jbc.274.17.11623; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; NOTARNICOLA SM, 1993, J BIOL CHEM, V268, P27198; NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215; ODA T, 1972, J MOL BIOL, V71, P799; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATEL SS, 1993, J BIOL CHEM, V268, P10668; PATEL SS, 1994, BIOCHEMISTRY-US, V33, P7857, DOI 10.1021/bi00191a013; Picha KM, 1998, J BIOL CHEM, V273, P27315, DOI 10.1074/jbc.273.42.27315; ROUSSEL A, 1989, SILICON GRAPHICS GEO, P77; San Martin C, 1998, STRUCTURE, V6, P501; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Shirakihara Y, 1997, STRUCTURE, V5, P825, DOI 10.1016/S0969-2126(97)00236-0; Soultanas P, 1999, J MOL BIOL, V290, P137, DOI 10.1006/jmbi.1999.2873; Stitt BL, 1998, J BIOL CHEM, V273, P26477, DOI 10.1074/jbc.273.41.26477; STITT BL, 1988, J BIOL CHEM, V263, P11130; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825; Wittinghofer A, 1998, BIOL CHEM, V379, P933; YARRANTON GT, 1979, P NATL ACAD SCI USA, V76, P1658, DOI 10.1073/pnas.76.4.1658; Yu X, 1996, NAT STRUCT BIOL, V3, P740, DOI 10.1038/nsb0996-740; Yu X, 1997, NAT STRUCT BIOL, V4, P101, DOI 10.1038/nsb0297-101; Yu X, 1996, J MOL BIOL, V259, P7, DOI 10.1006/jmbi.1996.0297	54	410	412	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 9	2000	101	6					589	600		10.1016/S0092-8674(00)80871-5	http://dx.doi.org/10.1016/S0092-8674(00)80871-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	322HQ	10892646	Bronze			2022-12-24	WOS:000087504500006
J	Autumn, K; Liang, YA; Hsieh, ST; Zesch, W; Chan, WP; Kenny, TW; Fearing, R; Full, RJ				Autumn, K; Liang, YA; Hsieh, ST; Zesch, W; Chan, WP; Kenny, TW; Fearing, R; Full, RJ			Adhesive force of a single gecko foot-hair	NATURE			English	Article								Geckos are exceptional in their ability to climb rapidly up smooth vertical surfaces(1-3). Microscopy has shown that a gecko's foot has nearly five hundred thousand keratinous hairs or setae. Each 30-130 mu m long seta is only one-tenth the diameter of a human hair and contains hundreds of projections terminating in 0.2-0.5 mu m spatula-shaped structures(2,4). After nearly a century of anatomical description(2,4-6), here we report the first direct measurements of single setal force by using a two-dimensional micro-electromechanical systems force sensor(7) and a wire as a force gauge. Measurements revealed that a seta is ten times more effective at adhesion than predicted from maximal estimates on whole animals. Adhesive force values support the hypothesis that individual seta operate by van der Waals forces(8,9). The gecko's peculiar behaviour of toe uncurling and peeling(2) led us to discover two aspects of setal function which increase their effectiveness. A unique macroscopic orientation and preloading of the seta increased attachment force 600-fold above that of frictional measurements of the material. Suitably orientated setae reduced the forces necessary to peel the toe by simply detaching above a critical angle with the substratum.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA; Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Stanford University; University of California System; University of California Berkeley	Full, RJ (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.			Hsieh, Shi-Tong/0000-0003-2233-3327; Fearing, Ronald/0000-0001-6242-5379				[Anonymous], 1992, INTERMOLECULAR SURFA; Bellairs, 1970, LIFE REPTILES; Cartmill M., 1985, P73; Chui BW, 1998, APPL PHYS LETT, V72, P1388, DOI 10.1063/1.121064; DELLIT WOLF-DIETRICH, 1934, JENAISCHE ZEITSCHR NATURWISS, V68, P613; GADOW H, 1901, CAMBRIDGE NATURAL HI, V8; Gay C, 1999, PHYS REV LETT, V82, P936, DOI 10.1103/PhysRevLett.82.936; Gennaro JGJ, 1969, NAT HIST, V78, P36; HILLER U, 1968, Zeitschrift fuer Morphologie der Tiere, V62, P307, DOI 10.1007/BF00401561; HILLER U, 1971, Forma et Functio, V4, P240; Hora SL., 1923, J ASIAT SOC BEGAL, V19, P137; Irschick DJ, 1996, BIOL J LINN SOC, V59, P21, DOI 10.1111/j.1095-8312.1996.tb01451.x; Kinloch A.J, 1987, ADHESION ADHESIVES S, V1st ed.; MADERSON PF, 1964, NATURE, V203, P780, DOI 10.1038/203780a0; MAHENDRA BENI CHARAN, 1941, PROC INDIAN ACAD SCI SECT B, V13, P288; RUIBAL R, 1965, J MORPHOL, V117, P271, DOI 10.1002/jmor.1051170302; RUSSELL AP, 1975, J ZOOL, V176, P437, DOI 10.1111/j.1469-7998.1975.tb03215.x; Schmidt H.R., 1904, JENA Z NATURW, V39, P551; STORK NE, 1980, J EXP BIOL, V88, P91	19	2021	2178	52	1328	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					681	685		10.1038/35015073	http://dx.doi.org/10.1038/35015073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864324				2022-12-24	WOS:000087465800046
J	Lively, CM; Dybdahl, MF				Lively, CM; Dybdahl, MF			Parasite adaptation to locally common host genotypes	NATURE			English	Article							COEVOLUTION; POPULATION; SEX; METAPOPULATION; MAINTENANCE; SELECTION; PATHOGEN; SNAIL; MODEL	According to the Red Queen hypothesis-which states that interactions among species (such as hosts and parasites) lead to constant natural selection for adaptation and counter-adaptation-the disproportionate evolutionary success of parasites on common host genotypes leads to correlated selection for sexual reproduction(1-8) and local adaptation by the parasite population(9-14). Here we determined whether local adaptation is due to disproportionate infection of common host genotypes, and, if so, whether infection of common host genotypes is due to commonness per se, or some other aspect of these genotypes. In a reciprocal cross-inoculation experiment parasites occupying the same geographical area (sympatric) infected locally common host genotypes significantly more often than rare host genotypes, whereas parasites occupying separate geographical areas (allopatric) showed no such significant difference. A mixed source of parasites (containing F-1 hybrids) also showed no difference in infection between rare and common host genotypes. These results show that local adaptation results from parasite tracking of locally common host genotypes, and, as such, a necessary condition of the Red Queen hypothesis is met.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Dybdahl, MF (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.		Lively, Curtis M/A-8057-2011; Dybdahl, Mark/B-8649-2012					BREMERMANN HJ, 1980, J THEOR BIOL, V87, P671, DOI 10.1016/0022-5193(80)90111-3; Dybdahl MF, 1998, EVOLUTION, V52, P1057, DOI 10.1111/j.1558-5646.1998.tb01833.x; Dybdahl MF, 1996, EVOLUTION, V50, P2264, DOI [10.2307/2410696, 10.1111/j.1558-5646.1996.tb03615.x]; DYBDAHL MF, 1995, J EVOLUTION BIOL, V8, P385, DOI 10.1046/j.1420-9101.1995.8030385.x; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; Gandon S, 1996, P ROY SOC B-BIOL SCI, V263, P1003, DOI 10.1098/rspb.1996.0148; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; HOWARD RS, 1994, NATURE, V367, P554, DOI 10.1038/367554a0; JAENIKE J, 1978, Evolutionary Theory, V3, P191; JUDSON OP, 1995, GENET RES, V65, P175, DOI 10.1017/S0016672300033267; Lively CM, 1999, AM NAT, V153, pS34, DOI 10.1086/303210; LIVELY CM, 1989, EVOLUTION, V43, P1663, DOI 10.1111/j.1558-5646.1989.tb02616.x; NEE S, 1989, J THEOR BIOL, V140, P499, DOI 10.1016/S0022-5193(89)80111-0; NORUSIS MJ, 1990, SPSS ADV STAT USERS; PARKER MA, 1985, EVOLUTION, V39, P713, DOI 10.1111/j.1558-5646.1985.tb00414.x; Peters AD, 1999, AM NAT, V154, P393, DOI 10.1086/303247; SEGER J, 1988, EVOLUTION SEX, P176	18	378	386	1	221	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					679	681		10.1038/35015069	http://dx.doi.org/10.1038/35015069			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864323				2022-12-24	WOS:000087465800045
J	Elderfield, H; Ganssen, G				Elderfield, H; Ganssen, G			Past temperature and delta O-18 of surface ocean waters inferred from foraminiferal Mg/Ca ratios	NATURE			English	Article							MAGNESIUM; PALEOTEMPERATURE; MG; STRONTIUM; ATLANTIC; CALCITE; SHELLS; PROXY	Determining the past record of temperature and salinity of ocean surface waters is essential for understanding past changes in climate, such as those which occur across glacial-interglacial transitions. As a useful proxy, the oxygen isotope composition (delta(18)O) of calcite from planktonic foraminifera has been shown to reflect both surface temperature and seawater delta(18)O, itself an indicator of global ice volume and salinity(1,2). In addition, magnesium/calcium (Mg/Ca) ratios in foraminiferal calcite show a temperature dependence(3-5) due to the partitioning of Mg during calcification. Here we demonstrate, in a field-based calibration experiment, that the variation of Mg/Ca ratios with temperature is similar for eight species of planktonic foraminifera (when accounting for Mg dissolution effects). Using a multi-species record from the Last Glacial Maximum in the North Atlantic Ocean we found that past temperatures reconstructed from Mg/Ca ratios followed the two other palaeotemperature proxies: faunal abundance(6,7) and alkenone saturation(8). Moreover, combining Mg/Ca and delta(18)O data from the same faunal assemblage, we show that reconstructed surface water delta(18)O from all foraminiferal species record the same glacial-interglacial change-representing changing hydrography and global ice volume. This reinforces the potential of this combined technique in probing past ocean-climate interactions.	Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Free Univ Amsterdam, Inst Earth Sci, NL-1081 HV Amsterdam, Netherlands	University of Cambridge; Vrije Universiteit Amsterdam	Elderfield, H (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.							Bard E, 1999, SCIENCE, V284, P1133, DOI 10.1126/science.284.5417.1133; Brown SJ, 1996, PALEOCEANOGRAPHY, V11, P543, DOI 10.1029/96PA01491; Chapman MR, 1996, PALEOCEANOGRAPHY, V11, P343, DOI 10.1029/96PA00041; *CLIMAP PROJ MEMB, 1981, GEOLOGICAL SOC AM MA; DELANEY ML, 1985, GEOCHIM COSMOCHIM AC, V49, P1327, DOI 10.1016/0016-7037(85)90284-4; GANSSEN GM, IN PRESS SPECIAL PUB; Hastings DW, 1998, PALEOCEANOGRAPHY, V13, P161, DOI 10.1029/97PA03147; Lea DW, 1999, GEOCHIM COSMOCHIM AC, V63, P2369, DOI 10.1016/S0016-7037(99)00197-0; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; Levitus S., 1994, WORLD OCEAN ATLAS 19, V4; Mashiotta TA, 1999, EARTH PLANET SC LETT, V170, P417, DOI 10.1016/S0012-821X(99)00116-8; Mix AC, 1999, PALEOCEANOGRAPHY, V14, P350, DOI 10.1029/1999PA900012; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; NURNBERG D, 1995, J FORAMIN RES, V25, P350; Nurnberg D, 1996, GEOCHIM COSMOCHIM AC, V60, P803, DOI 10.1016/0016-7037(95)00446-7; Rosenthal Y, 2000, PALEOCEANOGRAPHY, V15, P135, DOI 10.1029/1999PA000415; Rosenthal Y, 1997, GEOCHIM COSMOCHIM AC, V61, P3633, DOI 10.1016/S0016-7037(97)00181-6; ROSENTHAL Y, 1993, GEOCHIM COSMOCHIM AC, V57, P355; ROSTEK F, 1993, NATURE, V364, P319, DOI 10.1038/364319a0; Schrag D. P., 1996, SCIENCE, V272, P637; Shackleton N.J., 1974, Colloques int Cent natn Res Scient, VNo. 219,1974, P203	21	555	580	5	192	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					442	445		10.1038/35013033	http://dx.doi.org/10.1038/35013033			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839536				2022-12-24	WOS:000087212000044
J	Lecky, F; Woodford, M; Yates, DW				Lecky, F; Woodford, M; Yates, DW		UK Trauma Audit Res Network	Trends in trauma care in England and Wales 1989-97	LANCET			English	Article							INJURY SEVERITY SCORE; REVISION	Background In 1988, the Royal College of Surgeons reported major deficiencies in trauma care in UK hospitals. We investigated whether and how that care has changed in the last decade by use of data collected by the UK Trauma Audit and Research Network. Methods We analysed injury-severity, process, and outcome variables from 91 602 patients' records on the database at the end of 1997, collected from 97 (49% of trauma-receiving) hospitals in England, Wales, and two In Ireland. We did longitudinal analyses of odds of death, process variables, and individual hospitals' performance. We took account of potential selection bias from missing data and recruitment of new hospitals. Findings The severity-adjusted odds of death after trauma declined gradually from 1989 (odds ratio 1997/1989 0.63 [95% CI [0.49-0.82]). In 1997, the reduction in odds of death was significant even after adjustment for missing data (ratio 1997/1989 0.72 [0.55-0.92]) and recruitment of new hospitals (0.64 [0.44-0.93]). There was significant variability in the proportion of survivors (adjusted for severity of injury and age) between the highest and lowest 10% of UK hospitals. The time between the call to the emergency services and arrival at hospital increased from 32 min in 1989 to 45 min in 1997, irrespective of injury severity. The proportion of severely injured patients seen first by senior doctors increased from 32% to 60%. Interpretation Hospital care has made a valuable but variable contribution to reductions in case fatality after injury in the UK in the past 10 years, though further improvement is possible.	Univ Manchester, Hope Hosp, NW Injury Res Collaborat, UK Trauma Audit & Res Network, Salford M6 8HD, Lancs, England	University of Manchester	Lecky, F (corresponding author), Univ Manchester, Hope Hosp, NW Injury Res Collaborat, UK Trauma Audit & Res Network, Salford M6 8HD, Lancs, England.							BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CAMPBELL FA, 1996, RELIABILITY STUDY IN; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; *COMM INF SCAL, 1990, ABBR INJ SCAL; COPES WS, 1995, J TRAUMA, V38, P432, DOI 10.1097/00005373-199503000-00027; HOLLIS S, 1995, J TRAUMA, V38, P763, DOI 10.1097/00005373-199505000-00015; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Roberts I, 1996, BRIT MED J, V313, P1239, DOI 10.1136/bmj.313.7067.1239; *ROYAL COLL SURG E, 1988, REP WORK PART MAN PA; Rutledge R, 1998, J TRAUMA, V44, P41, DOI 10.1097/00005373-199801000-00003; Wang CY, 1997, BIOMETRICS, V53, P131, DOI 10.2307/2533103; YATES DW, 1992, BRIT MED J, V305, P737, DOI 10.1136/bmj.305.6856.737; YATES DW, 1990, ABC MAJOR TRAUMA; 1993, HLTH NATION	16	122	123	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2000	355	9217					1771	1775		10.1016/S0140-6736(00)02264-9	http://dx.doi.org/10.1016/S0140-6736(00)02264-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	315RE	10832827				2022-12-24	WOS:000087126100011
J	Hattori, M; Fujiyama, A; Taylor, TD; Watanabe, H; Yada, T; Park, HS; Toyoda, A; Ishii, K; Totoki, Y; Choi, DK; Soeda, E; Ohki, M; Takagi, T; Sakaki, Y; Taudien, S; Blechschmidt, K; Polley, A; Menzel, U; Delabar, J; Kumpf, K; Lehmann, R; Patterson, D; Reichwald, K; Rump, A; Schillhabel, M; Schudy, A; Zimmermann, W; Rosenthal, A; Kudoh, J; Shibuya, K; Kawasaki, K; Asakawa, S; Shintani, A; Sasaki, T; Nagamine, K; Mitsuyama, S; Antonarakis, SE; Minoshima, S; Shimizu, N; Nordsiek, G; Hornischer, K; Brandt, P; Scharfe, M; Schon, O; Desario, A; Reichelt, J; Kauer, G; Blocker, H; Ramser, J; Beck, A; Klages, S; Hennig, S; Riesselmann, L; Dagand, E; Haaf, T; Wehrmeyer, S; Borzym, K; Gardiner, K; Nizetic, D; Francis, F; Lehrach, H; Reinhardt, R; Yaspo, ML; Groner, Y				Hattori, M; Fujiyama, A; Taylor, TD; Watanabe, H; Yada, T; Park, HS; Toyoda, A; Ishii, K; Totoki, Y; Choi, DK; Soeda, E; Ohki, M; Takagi, T; Sakaki, Y; Taudien, S; Blechschmidt, K; Polley, A; Menzel, U; Delabar, J; Kumpf, K; Lehmann, R; Patterson, D; Reichwald, K; Rump, A; Schillhabel, M; Schudy, A; Zimmermann, W; Rosenthal, A; Kudoh, J; Shibuya, K; Kawasaki, K; Asakawa, S; Shintani, A; Sasaki, T; Nagamine, K; Mitsuyama, S; Antonarakis, SE; Minoshima, S; Shimizu, N; Nordsiek, G; Hornischer, K; Brandt, P; Scharfe, M; Schon, O; Desario, A; Reichelt, J; Kauer, G; Blocker, H; Ramser, J; Beck, A; Klages, S; Hennig, S; Riesselmann, L; Dagand, E; Haaf, T; Wehrmeyer, S; Borzym, K; Gardiner, K; Nizetic, D; Francis, F; Lehrach, H; Reinhardt, R; Yaspo, ML; Groner, Y		Chromosome 21 mapping sequencing consortium	The DNA sequence of human chromosome 21	NATURE			English	Article							RADIATION HYBRID MAP; HUMAN GENOME; DOWN-SYNDROME; LONG ARM; PHYSICAL MAP; ALLELIC LOSS; GENE; REGION; HUMAN-CHROMOSOME-21; LINKAGE	Chromosome 21 is the smallest human autosome. An extra copy of chromosome 21 causes Down syndrome, the most frequent genetic cause of significant mental retardation, which affects up to 1 in 700 live births. Several anonymous loci for monogenic disorders and predispositions for common complex disorders have also been mapped to this chromosome, and loss of heterozygosity has been observed in regions associated with solid tumours. Here we report the sequence and gene catalogue of the long arm of chromosome 21. We have sequenced 33,546,361 base pairs (bp) of DNA with very high accuracy, the largest contig being 25,491,867 bp. Only three small clone gaps and seven sequencing gaps remain, comprising about 100 kilobases. Thus, we achieved 99.7% coverage of 21q. We also sequenced 281,116 bp from the short arm. The structural features identified include duplications that are probably involved in chromosomal abnormalities and repeat structures in the telomeric and pericentromeric regions. Analysis of the chromosome revealed 127 known genes, 98 predicted genes and 59 pseudogenes.	RIKEN, Genom Sci Ctr, Sagamihara, Kanagawa 2288555, Japan; Inst Mol Biotechnol, D-07745 Jena, Germany; Keio Univ, Sch Med, Dept Mol Biol, Tokyo 1608582, Japan; GBF German Res Ctr Biotechnol, D-38124 Braunschweig, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; RIKEN, Tsukuba Life Sci Res Ctr, Tsukuba, Ibaraki 3050074, Japan; Natl Canc Ctr, Res Inst, Canc Genom Div, Tokyo 1040045, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo 1088639, Japan; UFR Necker Enfants Malad, CNRS, UMR 8602, F-75730 Paris, France; Eleanor Roosevelt Inst Canc Res, Denver, CO 80206 USA; Univ Geneva, Sch Med, Div Med Genet, CH-1211 Geneva, Switzerland; Inst Biol, CNRS, UPR 1142, F-34060 Montpellier, France; Univ London, Sch Pharm, London WC1N 1AX, England	RIKEN; Keio University; Helmholtz Association; Helmholtz-Center for Infection Research; Max Planck Society; RIKEN; National Cancer Center - Japan; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); University of Geneva; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of London; University College London; University of London School of Pharmacy	Sakaki, Y (corresponding author), RIKEN, Genom Sci Ctr, Sagamihara, Kanagawa 2288555, Japan.		Nizetic, Dean/F-9509-2015; Francis, Fiona/B-5854-2016; Hattori, Masahira/AAD-3785-2019; Sasaki, Takashi/AAD-1461-2019; Antonarakis, Stylianos E/N-8866-2014; Ishii, Kazuo/N-9946-2019; Taylor, Todd/A-7121-2009; Hattori, Masahira/C-6958-2016; ishii, kazuo/K-7428-2014	Antonarakis, Stylianos E/0000-0001-8907-5823; Taylor, Todd/0000-0003-4247-6253; Hattori, Masahira/0000-0001-9467-0344; Sasaki, Takashi/0000-0002-6275-046X; Choi, Dong-Kug/0000-0001-7041-1524; Ishii, Kazuo/0000-0002-8363-8266; Rump, Andreas/0000-0001-7116-6364; Reinhardt, Richard/0000-0001-9376-2132; ishii, kazuo/0000-0001-7801-1891; Nizetic, Dean/0000-0001-5486-5761; Francis, Fiona/0000-0001-8542-7537; DE SARIO, Albertina/0000-0002-9997-1645				Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Antonarakis SE, 1998, GENOMICS, V51, P1, DOI 10.1006/geno.1998.5335; Bockmuhl U, 1998, HEAD NECK-J SCI SPEC, V20, P145, DOI 10.1002/(SICI)1097-0347(199803)20:2<145::AID-HED8>3.0.CO;2-2; BonneTamir B, 1996, AM J HUM GENET, V58, P1254; Chaib H, 1997, HUM MOL GENET, V6, P27, DOI 10.1093/hmg/6.1.27; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; DUTRIAUX A, 1994, GENOMICS, V22, P472, DOI 10.1006/geno.1994.1414; Epstein C.J., 1995, METABOLIC MOL BASES, P749; ESTABROOKS LL, 1990, AM J MED GENET, V36, P306, DOI 10.1002/ajmg.1320360312; FIELDS C, 1994, NAT GENET, V7, P345, DOI 10.1038/ng0794-345; Gardiner K, 1995, SOMAT CELL MOLEC GEN, V21, P399, DOI 10.1007/BF02310207; Ghadimi BM, 1999, AM J PATHOL, V154, P525, DOI 10.1016/S0002-9440(10)65298-4; Graw SL, 1995, SOMAT CELL MOLEC GEN, V21, P415, DOI 10.1007/BF02310208; Gyapay G, 1996, HUM MOL GENET, V5, P339, DOI 10.1093/hmg/5.3.339; Hasle H, 2000, LANCET, V355, P165, DOI 10.1016/S0140-6736(99)05264-2; Hattori M, 1997, NUCLEIC ACIDS RES, V25, P1802, DOI 10.1093/nar/25.9.1802; Hildmann T, 1999, GENOME RES, V9, P360; ICHIKAWA H, 1993, NAT GENET, V4, P361, DOI 10.1038/ng0893-361; Jackson MS, 1999, HUM MOL GENET, V8, P205, DOI 10.1093/hmg/8.2.205; Kohno T, 1998, GENE CHROMOSOME CANC, V21, P236, DOI 10.1002/(SICI)1098-2264(199803)21:3<236::AID-GCC8>3.0.CO;2-0; Kola I, 1997, HUM MOL GENET, V6, P1713, DOI 10.1093/hmg/6.10.1713; Korenberg JR, 1995, GENOME RES, V5, P427, DOI 10.1101/gr.5.5.427; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; MCINNIS MG, 1993, GENOMICS, V16, P562, DOI 10.1006/geno.1993.1231; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; NIZETIC D, 1994, HUM MOL GENET, V3, P759, DOI 10.1093/hmg/3.5.759; Ohgaki K, 1998, GENE CHROMOSOME CANC, V23, P244, DOI 10.1002/(SICI)1098-2264(199811)23:3<244::AID-GCC6>3.3.CO;2-#; Pajukanta P, 1999, AM J HUM GENET, V64, P1453, DOI 10.1086/302365; Ruault M, 1999, GENE, V239, P55, DOI 10.1016/S0378-1119(99)00381-9; SACCONE S, 1993, P NATL ACAD SCI USA, V90, P11929, DOI 10.1073/pnas.90.24.11929; Sakata K, 1997, GENE CHROMOSOME CANC, V18, P318, DOI 10.1002/(SICI)1098-2264(199704)18:4<318::AID-GCC12>3.3.CO;2-#; Satge D, 1998, CANCER RES, V58, P448; Satge D, 1998, AM J MED GENET, V78, P207, DOI 10.1002/(SICI)1096-8628(19980707)78:3<207::AID-AJMG1>3.3.CO;2-Q; Schwendel A, 1998, BRIT J CANCER, V78, P806, DOI 10.1038/bjc.1998.583; Sertie AL, 1996, HUM MOL GENET, V5, P843, DOI 10.1093/hmg/5.6.843; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; STRATENWERTH G, 1994, PSYCHIAT PRAX, V21, P3; Veske A, 1996, HUM MOL GENET, V5, P165, DOI 10.1093/hmg/5.1.165; Wan TSK, 1999, LEUKEMIA RES, V23, P1079, DOI 10.1016/S0145-2126(99)00117-4; Yamamoto N, 1999, ONCOL REP, V6, P1223; Zoubak S, 1996, GENE, V174, P95, DOI 10.1016/0378-1119(96)00393-9	46	853	1104	1	60	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 18	2000	405	6784					311	319		10.1038/35012518	http://dx.doi.org/10.1038/35012518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314YT	10830953	hybrid, Green Published			2022-12-24	WOS:000087085700037
J	Head, JF; Inouye, S; Teranishi, K; Shimomura, O				Head, JF; Inouye, S; Teranishi, K; Shimomura, O			The crystal structure of the photoprotein aequorin at 2.3 angstrom resolution	NATURE			English	Article							CALCIUM-BINDING PROTEIN; RECOMBINANT AEQUORIN; BIOLUMINESCENCE; CRYSTALLOGRAPHY; PURIFICATION; REGENERATION; IONS	Aequorin is a calcium-sensitive photoprotein originally obtained from the jellyfish Aequorea aequorea(1). Because it has a high sensitivity to calcium ions and is biologically harmless, aequorin is widely used as a probe to monitor intracellular levels of free calcium. The aequorin molecule contains four helix-loop-helix 'EF-hand' domains, of which three can bind calcium(2). The molecule also contains coelenterazine as its chromophoric ligand(3). When calcium is added, the protein complex decomposes into apoaequorin, coelenteramide and CO2, accompanied by the emission of light(4). Apoaequorin can be regenerated into active aequorin in the absence of calcium by incubation with coelenterazine, oxygen and a thiol agent(5). Cloning and expression of the complementary DNA for aequorin were first reported in 1985 (refs 2, 6), and growth of crystals of the recombinant protein has been described(7); however, techniques have only recently been developed to prepare recombinant aequorin of the highest purity(8), permitting a full crystallographic study. Here we report the structure of recombinant aequorin determined by X-ray crystallography. Aequorin is found to be a globular molecule containing a hydrophobic core cavity that accommodates the ligand coelenterazine-2-hydroperoxide. The structure shows protein components stabilizing the peroxide and suggests a mechanism by which calcium activation may occur.	Boston Univ, Sch Med, Struct Biol Grp, Dept Physiol, Boston, MA 02118 USA; Chisso Corp, Yokohama Res Ctr, Kanazawa Ku, Yokohama, Kanagawa 236, Japan; Mie Univ, Fac Bioresources, Tsu, Mie 514, Japan; Marine Biol Lab, Woods Hole, MA 02543 USA	Boston University; Chisso Corporation; Mie University; Marine Biological Laboratory - Woods Hole	Head, JF (corresponding author), Boston Univ, Sch Med, Struct Biol Grp, Dept Physiol, Boston, MA 02118 USA.	jfh@medxtal.bu.edu	Inouye, Sharon/R-7216-2019	Inouye, Satoshi/0000-0001-8732-7839; Head, James/0000-0002-6226-4146				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COOK WJ, 1993, J MOL BIOL, V229, P461, DOI 10.1006/jmbi.1993.1046; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HANNICK LI, 1993, PROTEINS, V15, P103, DOI 10.1002/prot.340150113; INOUYE S, 1985, P NATL ACAD SCI USA, V82, P3154, DOI 10.1073/pnas.82.10.3154; INOUYE S, 1989, J BIOCHEM-TOKYO, V105, P473, DOI 10.1093/oxfordjournals.jbchem.a122689; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; MUSICKI B, 1986, J CHEM SOC CHEM COMM, V126, P1256; NOMURA M, 1991, FEBS LETT, V295, P63, DOI 10.1016/0014-5793(91)81385-L; OHMIYA Y, 1992, FEBS LETT, V301, P197, DOI 10.1016/0014-5793(92)81247-J; OHMIYA Y, 1993, FEBS LETT, V320, P267, DOI 10.1016/0014-5793(93)80600-Y; OTWINOWSKI Z, 1993, P CCP 4 STUD WEEK DA; PRASHER D, 1985, BIOCHEM BIOPH RES CO, V126, P1259, DOI 10.1016/0006-291X(85)90321-3; SHIMOMUR.O, 1973, TETRAHEDRON LETT, P2963; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Shimomura O, 1999, PROTEIN EXPRES PURIF, V16, P91, DOI 10.1006/prep.1999.1049; Shimomura O, 1996, BIOCHEM BIOPH RES CO, V221, P77, DOI 10.1006/bbrc.1996.0548; SHIMOMURA O, 1995, BIOCHEM BIOPH RES CO, V211, P359, DOI 10.1006/bbrc.1995.1821; SHIMOMURA O, 1975, NATURE, V256, P236, DOI 10.1038/256236a0; SHIMOMURA O, 1988, BIOCHEM J, V251, P405, DOI 10.1042/bj2510405; SHIMOMURA O, 1989, BIOCHEM J, V261, P913, DOI 10.1042/bj2610913; SHIMOMURA O, 1990, BIOCHEM J, V270, P309, DOI 10.1042/bj2700309; SHIMOMURA O, 1978, P NATL ACAD SCI USA, V75, P2611, DOI 10.1073/pnas.75.6.2611; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; TSUJI FI, 1986, P NATL ACAD SCI USA, V83, P8107, DOI 10.1073/pnas.83.21.8107; VIJAYKUMAR S, 1992, J MOL BIOL, V224, P413, DOI 10.1016/0022-2836(92)91004-9	29	252	282	3	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2000	405	6784					372	376		10.1038/35012659	http://dx.doi.org/10.1038/35012659			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314YT	10830969				2022-12-24	WOS:000087085700053
J	Briscoe, J; Pierani, A; Jessell, TM; Ericson, J				Briscoe, J; Pierani, A; Jessell, TM; Ericson, J			A homeodomain protein code specifies progenitor cell identity and neuronal fate in the ventral neural tube	CELL			English	Article							FLOOR PLATE; SPINAL-CORD; GENE-EXPRESSION; MORPHOGEN GRADIENT; HEDGEHOG; DROSOPHILA; SPECIFICATION; INDUCTION; MESODERM; BRINKER	Distinct classes of neurons are generated at defined positions in the ventral neural tube in response to a gradient of Sonic Hedgehog (Shh) activity. A set of homeodomain transcription factors expressed by neural progenitors act as intermediaries in Shh-dependent neural patterning. These homeodomain factors fall into two classes: class I proteins are repressed by Shh and class II proteins require Shh signaling for their expression. The profile of class I and class II protein expression defines five progenitor domains, each of which generates a distinct class of postmitotic neurons. Cross-repressive interactions between class I and class II proteins appear to refine and maintain these progenitor domains. The combinatorial expression of three of these proteins-Nkx6.1, Nkx2.2, and Irx3-specifies the identity of three classes of neurons generated in the ventral third of the neural tube.	Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA; Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden	Columbia University; Howard Hughes Medical Institute; Karolinska Institutet	Jessell, TM (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA.	tmj1@columbia.edu	Pierani, Alessandra/O-6136-2017	Pierani, Alessandra/0000-0002-4872-4791; Briscoe, James/0000-0002-1020-5240; Ericson, Johan/0000-0002-8019-7127				Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dasen JS, 1999, CURR OPIN GENET DEV, V9, P566, DOI 10.1016/S0959-437X(99)00015-5; Ding Q, 1998, DEVELOPMENT, V125, P2533; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Erskine L, 1998, DEV BIOL, V199, P26, DOI 10.1006/dbio.1998.8912; Funayama N, 1999, DEVELOPMENT, V126, P4129; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Huang AM, 1997, GENE DEV, V11, P1963, DOI 10.1101/gad.11.15.1963; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1; KRAUT R, 1991, DEVELOPMENT, V111, P601; Krishnan V, 1997, SCIENCE, V278, P1947, DOI 10.1126/science.278.5345.1947; LANGMAN J, 1966, J COMP NEUROL, V127, P399, DOI 10.1002/cne.901270308; Lawrence P., 1992, MAKING FLY GENETICS; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; LEBER SM, 1995, J NEUROSCI, V15, P1236; Lewis KE, 1999, DEVELOPMENT, V126, P2397; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Mansouri A, 1998, MECH DEVELOP, V78, P171, DOI 10.1016/S0925-4773(98)00168-3; MARTI E, 1995, DEVELOPMENT, V121, P2537; Matise MP, 1998, DEVELOPMENT, V125, P2759; McDowell N, 1999, SEMIN CELL DEV BIOL, V10, P311, DOI 10.1006/scdb.1999.0307; Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Muramatsu T, 1997, BIOCHEM BIOPH RES CO, V230, P376, DOI 10.1006/bbrc.1996.5882; Pabst O, 1998, MECH DEVELOP, V73, P85, DOI 10.1016/S0925-4773(98)00035-5; Papin C, 2000, DEV BIOL, V217, P166, DOI 10.1006/dbio.1999.9531; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Qiu MS, 1998, MECH DEVELOP, V72, P77, DOI 10.1016/S0925-4773(98)00018-5; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; SMITH JC, 1995, CURR OPIN CELL BIOL, V7, P856, DOI 10.1016/0955-0674(95)80070-0; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wu XL, 1998, DEVELOPMENT, V125, P3765; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O	48	882	902	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 12	2000	101	4					435	445		10.1016/S0092-8674(00)80853-3	http://dx.doi.org/10.1016/S0092-8674(00)80853-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	313QM	10830170	Bronze			2022-12-24	WOS:000087010400011
J	Pearson, MA; Reczek, D; Bretscher, A; Karplus, PA				Pearson, MA; Reczek, D; Bretscher, A; Karplus, PA			Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain	CELL			English	Article							NEUROFIBROMATOSIS-2 TUMOR-SUPPRESSOR; F-ACTIN; INTRAMOLECULAR ASSOCIATION; TERMINAL DOMAIN; FAMILY MEMBERS; CELL-ADHESION; EZRIN FAMILY; PTB DOMAINS; IN-VIVO; PHOSPHORYLATION	The ezrin-radixin-moesin (ERM) protein family link actin filaments of cell surface structures to the plasma membrane, using a C-terminal F-actin binding segment and an N-terminal FERM domain, a common membrane binding module. ERM proteins are regulated by an intramolecular association of the FERM and C-terminal tail domains that masks their binding sites. The crystal structure of a dormant moesin FERM/tail complex reveals that the FERM domain has three compact lobes including an integrated PTB/PH/ EVH1 fold, with the C-terminal segment bound as an extended peptide masking a large surface of the FERM domain. This extended binding mode suggests a novel mechanism for how different signals could produce varying levels of activation. Sequence conservation suggests a similar regulation of the tumor suppressor merlin.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Cornell University; Oregon State University	Bretscher, A (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	apb5@cornell.edu; karplusp@ucs.orst.edu		Karplus, Paul/0000-0001-8725-6292	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036652, T32GM008500] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-01646] Funding Source: Medline; NIGMS NIH HHS [GM08500, GM36652] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; BERRYMAN M, 1993, J CELL SCI, V105, P1025; Borg JP, 1998, CURR TOP MICROBIOL, V228, P23; BRETSCHER A, 1983, J CELL BIOL, V97, P425, DOI 10.1083/jcb.97.2.425; Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; BRUNGER AT, 1996, X PLOR VERSION 3 8; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Doi Y, 1999, J BIOL CHEM, V274, P2315, DOI 10.1074/jbc.274.4.2315; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Fedorov AA, 1999, NAT STRUCT BIOL, V6, P661, DOI 10.1038/10717; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; FERSHT A, 1999, STRUCTURE MECH PROTE, P345; Forman-Kay JD, 1999, CURR OPIN STRUC BIOL, V9, P690, DOI 10.1016/S0959-440X(99)00031-7; FUNAYAMA N, 1991, J CELL BIOL, V115, P1039, DOI 10.1083/jcb.115.4.1039; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Girault JA, 1999, TRENDS BIOCHEM SCI, V24, P54, DOI 10.1016/S0968-0004(98)01331-0; Girault JA, 1998, MOL MED, V4, P751, DOI 10.1007/BF03401769; GOULD KL, 1986, J CELL BIOL, V102, P660, DOI 10.1083/jcb.102.2.660; Gronholm M, 1999, J CELL SCI, V112, P895; Gusella JF, 1999, BBA-REV CANCER, V1423, pM29, DOI 10.1016/S0304-419X(99)00005-0; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Helander TS, 1996, NATURE, V382, P265, DOI 10.1038/382265a0; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Huang LQ, 1999, J BIOL CHEM, V274, P12803, DOI 10.1074/jbc.274.18.12803; Huang LQ, 1998, BIOCHEM BIOPH RES CO, V248, P548, DOI 10.1006/bbrc.1998.9009; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KRAGELUND BB, 1993, J MOL BIOL, V230, P1260, DOI 10.1006/jmbi.1993.1240; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; LANKES WT, 1991, P NATL ACAD SCI USA, V88, P8297, DOI 10.1073/pnas.88.19.8297; LESLIE AGW, 1993, P CCP4 STUD WEEK DAT, P44; Matsui T, 1999, CURR BIOL, V9, P1259, DOI 10.1016/S0960-9822(99)80508-9; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; Nakamura F, 1999, MOL BIOL CELL, V10, P2669, DOI 10.1091/mbc.10.8.2669; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; PAKKANEN R, 1989, J CELL BIOCHEM, V41, P1, DOI 10.1002/jcb.240410102; PESTONJAMASP K, 1995, MOL BIOL CELL, V6, P247, DOI 10.1091/mbc.6.3.247; Pietromonaco SF, 1998, J BIOL CHEM, V273, P7594, DOI 10.1074/jbc.273.13.7594; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Reczek D, 1998, J BIOL CHEM, V273, P18452, DOI 10.1074/jbc.273.29.18452; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Sack JS, 1997, METHOD ENZYMOL, V277, P158, DOI 10.1016/S0076-6879(97)77011-3; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; SHELDRICK GM, 1993, ACTA CRYSTALLOGR D, V49, P18, DOI 10.1107/S0907444992007364; Sherman L, 1997, ONCOGENE, V15, P2505, DOI 10.1038/sj.onc.1201418; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; TAKEUCHI K, 1994, J CELL BIOL, V125, P1371, DOI 10.1083/jcb.125.6.1371; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; TSUKITA S, 1989, J CELL BIOL, V108, P2369, DOI 10.1083/jcb.108.6.2369; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; TURUNEN O, 1994, J CELL BIOL, V126, P1445, DOI 10.1083/jcb.126.6.1445; Turunen O, 1998, BBA-PROTEIN STRUCT M, V1387, P1, DOI 10.1016/S0167-4838(98)00103-4; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zhou MM, 1996, NAT STRUCT BIOL, V3, P388, DOI 10.1038/nsb0496-388	74	472	492	4	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 28	2000	101	3					259	270		10.1016/S0092-8674(00)80836-3	http://dx.doi.org/10.1016/S0092-8674(00)80836-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847681	Bronze			2022-12-24	WOS:000086741900006
J	van der Fits, L; Memelink, J				van der Fits, L; Memelink, J			ORCA3, a jasmonate-responsive transcriptional regulator of plant primary and secondary metabolism	SCIENCE			English	Article							CATHARANTHUS-ROSEUS; ALKALOID BIOSYNTHESIS; GENE; ELEMENT; FAMILY; TISSUE; CELLS	Biosynthesis of many classes of secondary metabolites in plants is induced by the stress hormone jasmonate. The gene for ORCA3, a jasmonate-responsive APETALA2 (AP2)-domain transcription factor from Catharanthus roseus, was isolated by transferred DNA activation tagging. Orca3 overexpression resulted in enhanced expression of several metabolite biosynthetic genes and, consequently, in increased accumulation of terpenoid indole alkaloids, Regulation of metabolite biosynthetic genes by jasmonate-responsive AP2-domain transcription factors may link plant stress responses to changes in metabolism.	Leiden State Univ, Inst Mol Plant Sci, Clusius Lab, NL-2333 AL Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Memelink, J (corresponding author), Leiden State Univ, Inst Mol Plant Sci, Clusius Lab, Wassenaarseweg 64, NL-2333 AL Leiden, Netherlands.			Memelink, Johan/0000-0002-4767-506X				AERTS RJ, 1994, PLANT J, V5, P635, DOI 10.1111/j.1365-313X.1994.00635.x; Furini A, 1997, EMBO J, V16, P3599, DOI 10.1093/emboj/16.12.3599; GODDIJN OJM, 1993, PLANT MOL BIOL, V22, P907, DOI 10.1007/BF00027376; Kakimoto T, 1996, SCIENCE, V274, P982, DOI 10.1126/science.274.5289.982; KUTCHAN TM, 1995, PLANT CELL, V7, P1059, DOI 10.2307/3870057; Menke FLH, 1999, EMBO J, V18, P4455, DOI 10.1093/emboj/18.16.4455; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; NEUTEBOOM STC, 1993, PLANT J, V4, P525, DOI 10.1046/j.1365-313X.1993.04030525.x; Riechmann JL, 1998, BIOL CHEM, V379, P633; St-Pierre B, 1999, PLANT CELL, V11, P887, DOI 10.1105/tpc.11.5.887; vanderFits L, 1997, PLANT MOL BIOL, V33, P943, DOI 10.1023/A:1005763605355; Whitmer S, 1998, PLANT PHYSIOL, V116, P853, DOI 10.1104/pp.116.2.853; Zhao JM, 1996, PLANT CELL, V8, P2235, DOI 10.1105/tpc.8.12.2235	13	654	701	7	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					295	297		10.1126/science.289.5477.295	http://dx.doi.org/10.1126/science.289.5477.295			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894776				2022-12-24	WOS:000088169400040
J	Gulbis, JM; Zhou, M; Mann, S; MacKinnon, R				Gulbis, JM; Zhou, M; Mann, S; MacKinnon, R			Structure of the cytoplasmic beta subunit - T1 assembly of voltage-dependent K+ channels	SCIENCE			English	Article							SHAKER POTASSIUM CHANNEL; TETRAMERIZATION DOMAIN; ALPHA-SUBUNITS; INACTIVATION; PORE	The structure of the cytoplasmic assembly of voltage-dependent K+ channels was solved by x-ray crystallography at 2.1 angstrom resolution. The assembly includes the cytoplasmic (T1) domain of the integral membrane or subunit together with the oxidoreductase beta subunit in a fourfold symmetric T1(4)beta(4) complex. An electrophysiological assay showed that this complex is oriented with four T1 domains facing the transmembrane pore and four beta subunits facing the cytoplasm. The transmembrane pore communicates with the cytoplasm through lateral, negatively charged openings above the T1(4)beta(4) complex. The inactivation peptides of voltage-dependent K+ channels reach their site of action by entering these openings.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.		Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047400] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47400] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; *AX INSTR, CLAMP VERS 8; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; GOMEZLAGUNAS F, 1995, BIOPHYS J, V68, P89, DOI 10.1016/S0006-3495(95)80162-1; GULBIS JM, UNPUB; Heinemann SH, 1996, J PHYSIOL-LONDON, V493, P625, DOI 10.1113/jphysiol.1996.sp021409; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kobertz WR, 1999, NAT STRUCT BIOL, V6, P1122; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Lee TE, 1996, J MEMBRANE BIOL, V151, P225, DOI 10.1007/s002329900073; LU Z, 1994, J GEN PHYSIOL, V104, P477, DOI 10.1085/jgp.104.3.477; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; Nagaya N, 1997, J BIOL CHEM, V272, P3022, DOI 10.1074/jbc.272.5.3022; Nakahira K, 1996, J BIOL CHEM, V271, P7084, DOI 10.1074/jbc.271.12.7084; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Sewing S, 1996, NEURON, V16, P455, DOI 10.1016/S0896-6273(00)80063-X; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; *WARN INSTR, OC725B WARN INSTR; Yu WF, 1996, NEURON, V16, P441, DOI 10.1016/S0896-6273(00)80062-8; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	33	261	270	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2000	289	5476					123	127		10.1126/science.289.5476.123	http://dx.doi.org/10.1126/science.289.5476.123			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332TW	10884227				2022-12-24	WOS:000088090400047
J	Howard, AD; Wang, RP; Pong, SS; Mellin, TN; Strack, A; Guan, XM; Zeng, ZZ; Williams, DL; Feighner, SD; Nunes, CN; Murphy, B; Stair, JN; Yu, H; Jiang, QP; Clements, MK; Tan, CP; McKee, KK; Hreniuk, DL; McDonald, TP; Lynch, KR; Evans, JF; Austin, CP; Caskey, CT; Van der Ploeg, LHT; Liu, QY				Howard, AD; Wang, RP; Pong, SS; Mellin, TN; Strack, A; Guan, XM; Zeng, ZZ; Williams, DL; Feighner, SD; Nunes, CN; Murphy, B; Stair, JN; Yu, H; Jiang, QP; Clements, MK; Tan, CP; McKee, KK; Hreniuk, DL; McDonald, TP; Lynch, KR; Evans, JF; Austin, CP; Caskey, CT; Van der Ploeg, LHT; Liu, QY			Identification of receptors for neuromedin U and its role in feeding	NATURE			English	Article							PORCINE SPINAL-CORD; RAT; PURIFICATION; EXPRESSION; U-25; GENE	Neuromedin U (NMU) is a neuropeptide with potent activity on smooth muscle which was isolated first from porcine spinal cord and later from other species(1-8). It is widely distributed in the gut and central nervous system(9,10). Peripheral activities of NMU include stimulation of smooth muscle(1), increase of blood pressure(1), alteration of ion transport in the gut(11), control of local blood flow(12,13) and regulation of adrenocortical function(14). An NMU receptor has not been molecularly identified. Here we show that the previously described orphan G-protein-coupled receptor FM-3 (ref. 15) and a newly discovered one (FM-4) are cognate receptors for NMU. FM-3, designated NMU1R, is abundantly expressed in peripheral tissues whereas FM-4, designated NMU2R, is expressed in specific regions of the brain. NMU is expressed in the ventromedial hypothalamus in the rat brain, and its level is significantly reduced following fasting. Intracerebroventricular administration of NMU markedly suppresses food intake in rats. These findings provide a molecular basis for the biochemical activities of NMU and may indicate that NMU is involved in the central control of feeding.	Merck Sharp & Dohme Ltd, Dept Pharmacol, W Point, PA 19486 USA; Merck Res Labs, Dept Metab Disorders, Rahway, NJ 07065 USA; Merck Res Labs, Dept Anim Pharmacol, Rahway, NJ 07065 USA; Merck Res Labs, W Point, PA 19486 USA; Univ Virginia, Hlth Sci Ctr, Dept Pharmacol, Charlottesville, VA 22908 USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; University of Virginia	Liu, QY (corresponding author), Merck Sharp & Dohme Ltd, Dept Pharmacol, Wp26-265, W Point, PA 19486 USA.							BALLESTA J, 1988, NEUROSCIENCE, V25, P797, DOI 10.1016/0306-4522(88)90037-1; BRADY LS, 1990, NEUROENDOCRINOLOGY, V52, P441, DOI 10.1159/000125626; BROWN DR, 1988, EUR J PHARMACOL, V155, P159, DOI 10.1016/0014-2999(88)90415-3; BUTTON D, 1993, CELL CALCIUM, V14, P663, DOI 10.1016/0143-4160(93)90091-J; CHAVEZ M, 1995, BEHAV NEUROSCI, V109, P547, DOI 10.1037/0735-7044.109.3.547; CONLON JM, 1988, J NEUROCHEM, V51, P988, DOI 10.1111/j.1471-4159.1988.tb01837.x; DOMIN J, 1992, REGUL PEPTIDES, V41, P1, DOI 10.1016/0167-0115(92)90508-R; DOMIN J, 1989, J BIOL CHEM, V264, P20881; DOMIN J, 1986, BIOCHEM BIOPH RES CO, V140, P1127, DOI 10.1016/0006-291X(86)90752-7; GARDINER SM, 1990, AM J PHYSIOL, V258, pR32, DOI 10.1152/ajpregu.1990.258.1.R32; Guan XM, 1998, MOL BRAIN RES, V59, P273, DOI 10.1016/S0169-328X(98)00150-8; HONZAWA M, 1987, NEUROSCIENCE, V23, P1103, DOI 10.1016/0306-4522(87)90185-0; KAGE R, 1991, REGUL PEPTIDES, V33, P191, DOI 10.1016/0167-0115(91)90213-Z; KISSILEFF HR, 1969, J COMP PHYSIOL PSYCH, V67, P284, DOI 10.1037/h0026773; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Liu QY, 1999, BIOCHEM BIOPH RES CO, V266, P174, DOI 10.1006/bbrc.1999.1796; MALENDOWICZ LK, 1994, NEUROPEPTIDES, V26, P47, DOI 10.1016/0143-4179(94)90092-2; MINAMINO N, 1988, BIOCHEM BIOPH RES CO, V156, P355, DOI 10.1016/S0006-291X(88)80848-9; MINAMINO N, 1985, BIOCHEM BIOPH RES CO, V130, P1078, DOI 10.1016/0006-291X(85)91726-7; Murphy B, 1998, NEUROPEPTIDES, V32, P491, DOI 10.1016/S0143-4179(98)90077-4; OHARTE F, 1991, PEPTIDES, V12, P809, DOI 10.1016/0196-9781(91)90138-F; Retief JD, 1999, GENOME RES, V9, P373; STRICKER EM, 1990, HDB BEHAVIORAL NEURO, V10, P45; SUMI S, 1987, LIFE SCI, V41, P1585, DOI 10.1016/0024-3205(87)90725-9; Tan CP, 1998, GENOMICS, V52, P223, DOI 10.1006/geno.1998.5441; Ungrin MD, 1999, ANAL BIOCHEM, V272, P34, DOI 10.1006/abio.1999.4145; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	27	337	366	0	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 6	2000	406	6791					70	74		10.1038/35017610	http://dx.doi.org/10.1038/35017610			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	330ZE	10894543				2022-12-24	WOS:000087991200046
J	Lewis, FD; Liu, XY; Liu, JQ; Miller, SE; Hayes, RT; Wasielewski, MR				Lewis, FD; Liu, XY; Liu, JQ; Miller, SE; Hayes, RT; Wasielewski, MR			Direct measurement of hole transport dynamics in DNA	NATURE			English	Article							ELECTRON-TRANSFER; DISTANCE; MECHANISM; HAIRPINS; SEQUENCE; DAMAGE	Our understanding of oxidative damage to double helical DNA and the design of DNA-based devices for molecular electronics is crucially dependent upon elucidation of the mechanism and dynamics of electron and hole transport in DNA(1-4). Electrons and holes can migrate from the locus of formation to trap sites(1,5), and such migration can occur through either a single-step "superexchange'' mechanism or a multistep charge transport "hopping'' mechanism(6-17). The rates of single-step charge separation and charge recombination processes are found to decrease rapidly with increasing transfer distances(6-9), whereas multistep hole transport processes are only weakly distance dependent(10-13). However, the dynamics of hole transport has not yet been directly determined. Here we report spectroscopic measurements of photoinduced electron transfer in synthetic DNA that yield rate constants of similar to 5 x 10(7) s(-1) and 5 x 10(6) s(-1), respectively, for the forward and return hole transport from a single guanine base to a double guanine base step across a single adenine. These rates are faster than processes leading to strand cleavage, such as the reaction of guanine cation radical with water(2), thus permitting holes to migrate over long distances in DNA. However, they are too slow to compete with charge recombination in contact ion pairs(6,7), a process which protects DNA from photochemical damage.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University	Lewis, FD (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	lewis@chem.nwu.edu		Miller, Scott/0000-0003-4254-0788				Anderson RF, 1999, PHYS CHEM CHEM PHYS, V1, P4827, DOI 10.1039/a905550i; Armitage B, 1998, CHEM REV, V98, P1171, DOI 10.1021/cr960428+; BECKER D, 1993, ADV RADIAT BIOL, V17, P121; Berlin YA, 2000, J PHYS CHEM A, V104, P443, DOI 10.1021/jp9933323; Bixon M, 1999, P NATL ACAD SCI USA, V96, P11713, DOI 10.1073/pnas.96.21.11713; Burrows CJ, 1998, CHEM REV, V98, P1109, DOI 10.1021/cr960421s; Fukui K, 1999, J PHOTOCH PHOTOBIO B, V50, P18, DOI 10.1016/S1011-1344(99)00063-9; Giese B, 1999, ANGEW CHEM INT EDIT, V38, P996, DOI 10.1002/(SICI)1521-3773(19990401)38:7<996::AID-ANIE996>3.0.CO;2-4; Harriman A, 1999, ANGEW CHEM INT EDIT, V38, P945, DOI 10.1002/(SICI)1521-3773(19990401)38:7<945::AID-ANIE945>3.0.CO;2-S; Henderson PT, 1999, P NATL ACAD SCI USA, V96, P8353, DOI 10.1073/pnas.96.15.8353; Jortner J, 1998, P NATL ACAD SCI USA, V95, P12759, DOI 10.1073/pnas.95.22.12759; Langenbacher T, 1997, J AM CHEM SOC, V119, P10532, DOI 10.1021/ja9721024; LETSINGER RL, 1995, J AM CHEM SOC, V117, P7323, DOI 10.1021/ja00133a005; Lewis FD, 1999, J AM CHEM SOC, V121, P9746, DOI 10.1021/ja9924997; Lewis FD, 2000, J AM CHEM SOC, V122, P2889, DOI 10.1021/ja993689k; Lewis FD, 1999, J AM CHEM SOC, V121, P9905, DOI 10.1021/ja991934u; Lewis FD, 1997, SCIENCE, V277, P673, DOI 10.1126/science.277.5326.673; Meggers E, 1998, J AM CHEM SOC, V120, P12950, DOI 10.1021/ja983092p; Nunez ME, 1999, CHEM BIOL, V6, P85, DOI 10.1016/S1074-5521(99)80005-2; Priyadarshy S, 1996, J PHYS CHEM-US, V100, P17678, DOI 10.1021/jp961731h; Ratner MA, 1997, MOLECULAR ELECTRONICS, P5; Steenken S, 1997, BIOL CHEM, V378, P1293	22	300	304	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2000	406	6791					51	53		10.1038/35017524	http://dx.doi.org/10.1038/35017524			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	330ZE	10894536				2022-12-24	WOS:000087991200039
J	Stampfer, MJ; Hu, FB; Manson, JE; Rimm, EB; Willett, WC				Stampfer, MJ; Hu, FB; Manson, JE; Rimm, EB; Willett, WC			Primary prevention of coronary heart disease in women through diet and lifestyle.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MODERATE ALCOHOL-CONSUMPTION; PHYSICAL-ACTIVITY QUESTIONNAIRE; MIDDLE-AGED WOMEN; PROSPECTIVE COHORT; CIGARETTE-SMOKING; VITAMIN-E; RISK; MORTALITY; STROKE; REPRODUCIBILITY	Background: Many lifestyle-related risk factors for coronary heart disease have been identified, but little is known about their effect on the risk of disease when they are considered together. Methods: We followed 84,129 women participating in the Nurses' Health Study who were free of diagnosed cardiovascular disease, cancer, and diabetes at base line in 1980. Information on diet and lifestyle was updated periodically. During 14 years of follow-up, we documented 1128 major coronary events (296 deaths from coronary heart disease and 832 nonfatal infarctions). We defined subjects at low risk as those who were not currently smoking, had a body-mass index (the weight in kilograms divided by the square of the height in meters) under 25, consumed an average of at least half a drink of an alcoholic beverage per day, engaged in moderate-to-vigorous physical activity (which could include brisk walking) for at least half an hour per day, on average, and scored in the highest 40 percent of the cohort for consumption of a diet high in cereal fiber, marine n-3 fatty acids, and folate, with a high ratio of polyunsaturated to saturated fat, and low in trans fat and glycemic load, which reflects the extent to which diet raises blood glucose levels. Results: Many of the factors were correlated, but each independently and significantly predicted risk, even after further adjustment for age, family history, presence or absence of diagnosed hypertension or diagnosed high cholesterol level, and menopausal status. Women in the low-risk category (who made up 3 percent of the population) had a relative risk of coronary events of 0.17 (95 percent confidence interval, 0.07 to 0.41) as compared with all the other women. Eighty-two percent of coronary events in the study cohort (95 percent confidence interval, 58 to 93 percent) could be attributed to lack of adherence to this low-risk pattern. Conclusions: Among women, adherence to lifestyle guidelines involving diet, exercise, and abstinence from smoking is associated with a very low risk of coronary heart disease. (N Engl J Med 2000;343:16-22.) (C) 2000, Massachusetts Medical Society.	Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Stampfer, MJ (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060712, R01HL034594] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL24074, HL60712, HL34594] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; COLDITZ GA, 1988, NEW ENGL J MED, V318, P937, DOI 10.1056/NEJM198804143181501; Grodstein F, 1997, NEW ENGL J MED, V336, P1769, DOI 10.1056/NEJM199706193362501; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hu F B, 1999, Curr Atheroscler Rep, V1, P204, DOI 10.1007/s11883-999-0033-7; Hu FB, 1999, AM J CLIN NUTR, V69, P890; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hu FB, 1998, BMJ-BRIT MED J, V317, P1341, DOI 10.1136/bmj.317.7169.1341; KAWACHI I, 1993, ANN INTERN MED, V119, P992, DOI 10.7326/0003-4819-119-10-199311150-00005; KAWACHI I, 1994, ARCH INTERN MED, V154, P169, DOI 10.1001/archinte.154.2.169; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; National Center for Chronic Disease Prevention and Health Promotion, 1996, PHYS ACT HLTH REP SU; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; Rimm EB, 1996, BRIT MED J, V312, P731, DOI 10.1136/bmj.312.7033.731; ROSENBERG L, 1990, NEW ENGL J MED, V322, P213, DOI 10.1056/NEJM199001253220401; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sacco RL, 1999, JAMA-J AM MED ASSOC, V281, P53, DOI 10.1001/jama.281.1.53; Smith-Warner SA, 1998, JAMA-J AM MED ASSOC, V279, P535, DOI 10.1001/jama.279.7.535; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; STONE PH, 1996, PREVENTION MYOCARDIA, P463; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; VANGIJN J, 1993, HLTH ISSUES RELATED, P43; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P668; Walker AE, 1981, STROKE S1, V12, P13; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WILLETT WC, 1987, NEW ENGL J MED, V317, P1303, DOI 10.1056/NEJM198711193172102; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; WILLETT WC, 1993, LANCET, V341, P581, DOI 10.1016/0140-6736(93)90350-P; Willett WC, 1998, OXFORD SCHOLARSHIP O; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Wolk A, 1999, JAMA-J AM MED ASSOC, V281, P1998, DOI 10.1001/jama.281.21.1998	39	1146	1179	0	156	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2000	343	1					16	22		10.1056/NEJM200007063430103	http://dx.doi.org/10.1056/NEJM200007063430103			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330XW	10882764				2022-12-24	WOS:000087987600003
J	Streit, A; Berliner, AJ; Papanayotou, C; Sirulnik, A; Stern, CD				Streit, A; Berliner, AJ; Papanayotou, C; Sirulnik, A; Stern, CD			Initiation of neural induction by FGF signalling before gastrulation	NATURE			English	Article							FIBROBLAST GROWTH-FACTOR; CHICK-EMBRYO; AVIAN EMBRYOS; ORGANIZER; RECEPTOR; CHORDIN; NOGGIN; INHIBITORS; EPIBLAST; INDUCERS	During neural induction, the 'organizer' of the vertebrate embryo instructs neighbouring ectodermal cells to become nervous system rather than epidermis. This process is generally thought to occur around the mid-gastrula stage of embryogenesis(1). Here we report the isolation of ERNI, an early response gene to signals from the organizer (Hensen's node). Using ERNI as a marker, we present evidence that neural induction begins before gastrulation - much earlier in development than previously thought. We show that the organizer and some of its precursor cells produce a fibroblast growth factor signal, which can initiate, and is required for, neural induction.	Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Columbia University	Stern, CD (corresponding author), Columbia Univ, Dept Genet & Dev, 701 W 168th St 1602, New York, NY 10032 USA.		Stern, Claudio/AAZ-7381-2021; Stern, Claudio D/C-6265-2008; Streit, Andrea/F-2683-2010	Stern, Claudio/0000-0002-9907-889X; Stern, Claudio D/0000-0002-9907-889X; Streit, Andrea/0000-0001-7664-7917				Alvarez IS, 1998, DEV BIOL, V199, P42, DOI 10.1006/dbio.1998.8903; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Baker JC, 1999, GENE DEV, V13, P3149, DOI 10.1101/gad.13.23.3149; Biehs B, 1996, GENE DEV, V10, P2922, DOI 10.1101/gad.10.22.2922; Chambers D, 2000, MECH DEVELOP, V91, P361, DOI 10.1016/S0925-4773(99)00288-9; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; GARCIAMARTINEZ V, 1993, J EXP ZOOL, V267, P431, DOI 10.1002/jez.1402670409; GURDON JB, 1987, DEVELOPMENT, V99, P285; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; HATADA Y, 1994, DEVELOPMENT, V120, P2879; Hongo I, 1999, DEV BIOL, V216, P561, DOI 10.1006/dbio.1999.9515; IZPISUABELMONTE JC, 1993, CELL, V74, P645, DOI 10.1016/0092-8674(93)90512-O; Klingensmith J, 1999, DEV BIOL, V216, P535, DOI 10.1006/dbio.1999.9525; LAMB TM, 1995, DEVELOPMENT, V121, P3627; Launay C, 1996, DEVELOPMENT, V122, P869; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Sasai Y, 1996, EMBO J, V15, P4547, DOI 10.1002/j.1460-2075.1996.tb00832.x; Schier AF, 1998, CURR OPIN GENET DEV, V8, P464, DOI 10.1016/S0959-437X(98)80119-6; Stern CD, 1998, CURR TOP DEV BIOL, V36, P223; STERN CD, 1981, ANAT EMBRYOL, V163, P245, DOI 10.1007/BF00315703; Storey KG, 1998, DEVELOPMENT, V125, P473; Streit A, 1999, TRENDS GENET, V15, P20, DOI 10.1016/S0168-9525(98)01620-5; Streit A, 1999, MECH DEVELOP, V85, P85, DOI 10.1016/S0925-4773(99)00085-4; Streit A, 1998, DEVELOPMENT, V125, P507; Streit A, 1999, MECH DEVELOP, V82, P51, DOI 10.1016/S0925-4773(99)00013-1; STREIT A, 1997, DEVELOPMENT, V124, P119; Wilson PA, 1997, NEURON, V18, P699, DOI 10.1016/S0896-6273(00)80311-6; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	30	386	396	2	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 6	2000	406	6791					74	78		10.1038/35017617	http://dx.doi.org/10.1038/35017617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	330ZE	10894544				2022-12-24	WOS:000087991200047
J	Berek, JS				Berek, JS			Interferon plus chemotherapy for primary treatment of ovarian cancer	LANCET			English	Editorial Material							RECOMBINANT GAMMA-INTERFERON; GYNECOLOGIC-ONCOLOGY-GROUP; TUMOR-NECROSIS-FACTOR; ALPHA-INTERFERON; CARCINOMA CELLS; EXPRESSION; CISPLATIN; TRIAL		Univ Calif Los Angeles, Sch Med, Div Gynecol Oncol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Berek, JS (corresponding author), Univ Calif Los Angeles, Sch Med, Div Gynecol Oncol, Los Angeles, CA 90095 USA.							ALLAVENA P, 1990, CANCER RES, V50, P7318; BEREK JS, 1990, J CLIN ONCOL, V8, P1610, DOI 10.1200/JCO.1990.8.10.1610; Berek JS, 1999, GYNECOL ONCOL, V74, P48, DOI 10.1006/gyno.1999.5455; BEREK JS, 1992, EUR J CANCER, V28A, P719, DOI 10.1016/0959-8049(92)90100-G; BEREK JS, 1991, GYNECOL ONCOL, V40, P237; Berek JS, 1999, GYNECOL ONCOL, V75, P10, DOI 10.1006/gyno.1999.5532; BEREK JS, 2000, PRACTICAL GYNECOLOGI, P457; COLOMBO N, 1992, INT J CANCER, V51, P42, DOI 10.1002/ijc.2910510109; DACQUISTO R, 1988, J CLIN ONCOL, V6, P689, DOI 10.1200/JCO.1988.6.4.689; Duda DG, 2000, CANCER RES, V60, P1111; MARKMAN M, 1992, INT J GYNECOL CANCER, V2, P30; MARTH C, 1990, CANCER RES, V50, P7037; Marth C, 1997, BRIT J CANCER, V76, P1328, DOI 10.1038/bjc.1997.556; Marth C, 1996, INT J CANCER, V67, P826, DOI 10.1002/(SICI)1097-0215(19960917)67:6<826::AID-IJC12>3.0.CO;2-#; NARDI M, 1990, J CLIN ONCOL, V8, P1036, DOI 10.1200/JCO.1990.8.6.1036; NEHME A, 1994, EUR J CANCER, V30A, P520, DOI 10.1016/0959-8049(94)90430-8; PujadeLauraine E, 1996, J CLIN ONCOL, V14, P343, DOI 10.1200/JCO.1996.14.2.343; SAITO T, 1986, CANCER RES, V46, P1142; WILLEMSE PHB, 1990, EUR J CANCER, V26, P353, DOI 10.1016/0277-5379(90)90233-J; Windbichler GH, 2000, BRIT J CANCER, V82, P1138	20	16	18	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 1	2000	356	9223					6	7		10.1016/S0140-6736(00)02422-3	http://dx.doi.org/10.1016/S0140-6736(00)02422-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329XH	10892754				2022-12-24	WOS:000087933400004
J	Schwartz, LM; Woloshin, S; Sox, HC; Fischhoff, B; Welch, HG				Schwartz, LM; Woloshin, S; Sox, HC; Fischhoff, B; Welch, HG			US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER; IN-SITU; SCREENING MAMMOGRAPHY; HEALTH	Objective To determine women's attitudes to and knowledge of both false positive mammography results and the detection of ductal carcinoma in situ after screening mammography. Design Cross sectional survey. Setting United States. Participants 479 women aged 18-97 years who did not report a history of breast cancer. Main outcome measures Attitudes to and knowledge of false positive results and the detection of ductal carcinoma in situ after screening mammography. Results Women were aware that false positive results do occur. Their median estimate of the false positive rate for 10 years of annual screening was 20% (25th percentile estimate, 10%; 75th percentile estimate, 45%). The women were highly tolerant of false positives: 63% thought that 500 or more false positives per life saved was reasonable and 37% would tolerate 10 000 or more. Women who had had a false positive result (n=76) expressed the same high tolerance: 39% would tolerate 10 000 or more false positives. 62% of women did not want to take false positive results into account when deciding about screening. Only 8% of women thought that mammography could harm a woman without breast cancer, and 94% doubted the possibility of non-progressive breast cancers. Few had heard about ductal carcinoma in situ, a cancer that may not progress, but when informed, 60% of women wanted to take into account the possibility of it being detected when deciding about screening. Conclusions Women are aware of false positives and seem to view them as an acceptable consequence of screening mammography. In contrast, most women are unaware that screening can detect cancers that may never progress but feel that such information would be relevant Education should perhaps focus less on false positives and more on the less familiar outcome of detection of ductal carcinoma in situ.	Vet Adm Med Ctr, Vet Adm Outcomes Grp 111B, White River Jct, VT 05009 USA; Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03756 USA; Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Dartmouth College; Carnegie Mellon University	Schwartz, LM (corresponding author), Vet Adm Med Ctr, Vet Adm Outcomes Grp 111B, White River Jct, VT 05009 USA.	lisa.schwartz@dartmouth.edu	Fischhoff, Baruch/I-9859-2014	Fischhoff, Baruch/0000-0002-3030-6874				*AM CANC SOC, 1988, SUMM CURR GUID CANC; [Anonymous], 1997, STAT ABSTR US; Blackman D K, 1999, MMWR CDC Surveill Summ, V48, P1; BLENDON RJ, 1995, JAMA-J AM MED ASSOC, V273, P341, DOI 10.1001/jama.273.4.341; Burman ML, 1999, ANN INTERN MED, V131, P1, DOI 10.7326/0003-4819-131-1-199907060-00002; ELLMAN R, 1989, BRIT J CANCER, V60, P781, DOI 10.1038/bjc.1989.359; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Ernster VL, 1996, JAMA-J AM MED ASSOC, V275, P913, DOI 10.1001/jama.275.12.913; ERNSTER VL, 1997, MONOGR NATL CANC I, V22, P151; Fletcher SW, 1999, ANN INTERN MED, V131, P60, DOI 10.7326/0003-4819-131-1-199907060-00011; Fowler FJ., 2013, SURV RES METHODS-GER, V5; Gotzsche PC, 2000, LANCET, V355, P129, DOI 10.1016/S0140-6736(99)06065-1; GRAM IT, 1990, BRIT J CANCER, V62, P1018, DOI 10.1038/bjc.1990.430; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P33, DOI 10.1001/jama.276.1.33; LERMAN C, 1991, ANN INTERN MED, V114, P657, DOI 10.7326/0003-4819-114-8-657; LERMAN C, 1991, HEALTH PSYCHOL, V10, P259, DOI 10.1037/0278-6133.10.4.259; Lidbrink E, 1996, BRIT MED J, V312, P273; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; National Cancer Advisory Board, 1997, NAT CANC ADV BOARD M; *NIH CONS STAT, 1997, BREAST CANC SCREEN W; NYSTROM L, 1993, LANCET, V341, P973, DOI 10.1016/0140-6736(93)91067-V; PAGE DL, 1995, CANCER, V76, P1197, DOI 10.1002/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0; Ransohoff DF, 1997, ANN INTERN MED, V127, P1029, DOI 10.7326/0003-4819-127-11-199712010-00016; RUGGLES S, 1997, INTEGRATED PUBLIC US; SUTTON S, 1995, J EPIDEMIOL COMMUN H, V49, P413, DOI 10.1136/jech.49.4.413; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Welch HG, 1997, ANN INTERN MED, V127, P1023, DOI 10.7326/0003-4819-127-11-199712010-00014; WOLOSHIN S, 2000, IN PRESS MED DECIS M	29	162	165	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2000	320	7250					1635	1640		10.1136/bmj.320.7250.1635	http://dx.doi.org/10.1136/bmj.320.7250.1635			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KG	10856064	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000087734200022
J	Guo, ZH; Zhou, DM; Schultz, PG				Guo, ZH; Zhou, DM; Schultz, PG			Designing small-molecule switches for protein-protein interactions	SCIENCE			English	Article							HUMAN GROWTH-HORMONE; RECEPTOR INTERACTIONS; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; PHAGE; MUTAGENESIS; RESOLUTION; INTERFACE; AFFINITY; EPITOPE	Mutations introduced into human growth hormone (hGH) (Thr(175) --> Gly-hGH) and the extracellular domain of the hGH receptor (Trp(104) --> Gly-hGHbp) created a cavity at the protein-protein interface that resulted in binding affinity being reduced by a factor of 10(6). A small Library of indole analogs was screened for small molecules that bind the cavity created by the mutations and restore binding affinity. The ligand 5-chloro-2-trichloromethylimidazole was found to increase the affinity of the mutant hormone for its receptor more than 1000-fold. Cell proliferation and JAK2 phosphorylation assays showed that the mutant hGH activates growth hormone signaling in the presence of added ligand. This approach may allow other protein-protein and protein-nucleic acid interactions to be switched on or off by the addition or depletion of exogenous small molecules.	Scripps Res Inst, Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Schultz, PG (corresponding author), Scripps Res Inst, Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Guo, Zhihong/0000-0003-0374-8412				Atwell S, 1997, SCIENCE, V278, P1125, DOI 10.1126/science.278.5340.1125; BASS S, 1990, PROTEINS, V8, P309, DOI 10.1002/prot.340080405; BASS SH, 1991, P NATL ACAD SCI USA, V88, P4498, DOI 10.1073/pnas.88.10.4498; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; COLOSI P, 1993, J BIOL CHEM, V268, P12617; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; ERIKSSON AE, 1992, NATURE, V355, P371, DOI 10.1038/355371a0; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; Gonzalez L, 1996, NAT STRUCT BIOL, V3, P510, DOI 10.1038/nsb0696-510; LIM WA, 1989, NATURE, V339, P31, DOI 10.1038/339031a0; LOWMAN HB, 1991, BIOCHEMISTRY-US, V30, P10832, DOI 10.1021/bi00109a004; ORUM H, 1993, NUCLEIC ACIDS RES, V21, P4491, DOI 10.1093/nar/21.19.4491; Pearce KH, 1999, BIOCHEMISTRY-US, V38, P81, DOI 10.1021/bi9817008; REIDHAAROLSON JF, 1988, SCIENCE, V241, P53, DOI 10.1126/science.3388019; Spencer DM, 1996, CURR BIOL, V6, P839, DOI 10.1016/S0960-9822(02)00607-3; Sundstrom M, 1996, J BIOL CHEM, V271, P32197, DOI 10.1074/jbc.271.50.32197; ULRICH HD, 1995, P NATL ACAD SCI USA, V92, P11907, DOI 10.1073/pnas.92.25.11907; WANG YD, 1995, MOL ENDOCRINOL, V9, P303, DOI 10.1210/me.9.3.303; WELLS JA, 1993, RECENT PROG HORM RES, V48, P253	21	79	86	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2000	288	5473					2042	+		10.1126/science.288.5473.2042	http://dx.doi.org/10.1126/science.288.5473.2042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856217				2022-12-24	WOS:000087687000050
J	Grobner, G; Burnett, IJ; Glaubitz, C; Choi, G; Mason, AJ; Watts, A				Grobner, G; Burnett, IJ; Glaubitz, C; Choi, G; Mason, AJ; Watts, A			Observations of light-induced structural changes of retinal within rhodopsin	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; SOLID-STATE NMR; TRANSMEMBRANE HELICES; BOVINE RHODOPSIN; ABSOLUTE SENSE; C-12-C-13 BOND; CHROMOPHORE; BACTERIORHODOPSIN; ORIENTATION; MEMBRANES	Photo-isomerization of the 11-cis retinal chromophore activates the mammalian light-receptor rhodopsin(1), a representative member of a major superfamily of transmembrane G-protein-coupled receptor proteins (GPCRs) responsible for many cell signal communication pathways. Although low-resolution (5 Angstrom) electron microscopy studies(2,3) confirm a seven transmembrane helix bundle as a principal structural component of rhodopsin, the structure of the retinal within this helical bundle is not known in detail. Such information is essential for any theoretical or functional understanding of one of the fastest occurring photoactivation processes in nature, as well as the general mechanism behind GPCR activation(4-6). Here we determine the three-dimensional structure of 11-cis retinal bound to bovine rhodopsin in the ground state at atomic level using a new high-resolution solid-state NMR method(7). Significant structural changes are observed in the retinal following activation by light to the photo-activated M-I state of rhodopsin giving the all-trans isomer of the chromophore. These changes are linked directly to the activation of the receptor, providing an insight into the activation mechanism of this class of receptors at a molecular level.	Univ Oxford, Dept Biochem, Biomembrane Struct Unit, Oxford OX1 3QU, England	University of Oxford	Watts, A (corresponding author), Umea Univ, Dept Chem, SE-90187 Umea, Sweden.	awatts@bioch.ox.ac.uk	Glaubitz, Clemens/D-5714-2011; Mason, James/J-2273-2012	Glaubitz, Clemens/0000-0002-3554-6586; Mason, James/0000-0003-0411-602X				Altenbach C, 1999, BIOCHEMISTRY-US, V38, P7931, DOI 10.1021/bi9900121; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; BALDWIN JM, 1994, CURR OPIN CELL BIOL, V6, P180, DOI 10.1016/0955-0674(94)90134-1; BIRGE RR, 1990, BIOCHIM BIOPHYS ACTA, V1016, P293, DOI 10.1016/0005-2728(90)90163-X; Buss V, 1998, ANGEW CHEM INT EDIT, V37, P1893, DOI 10.1002/(SICI)1521-3773(19980803)37:13/14<1893::AID-ANIE1893>3.0.CO;2-M; DONNELLY D, 1994, CURR OPIN STRUC BIOL, V4, P582, DOI 10.1016/S0959-440X(94)90221-6; Eilers M, 1999, P NATL ACAD SCI USA, V96, P487, DOI 10.1073/pnas.96.2.487; Feng X, 2000, J BIOMOL NMR, V16, P1, DOI 10.1023/A:1008377231625; Feng X, 1997, J AM CHEM SOC, V119, P6853, DOI 10.1021/ja970710d; Glaubitz C, 1999, J AM CHEM SOC, V121, P5787, DOI 10.1021/ja990350p; Grobner G, 1998, FEBS LETT, V422, P201, DOI 10.1016/S0014-5793(97)01591-3; Grobner G, 1997, ANAL BIOCHEM, V254, P132, DOI 10.1006/abio.1997.2415; Herzyk P, 1998, J MOL BIOL, V281, P741, DOI 10.1006/jmbi.1998.1981; Hudson BS, 1999, J PHYS CHEM A, V103, P2274, DOI 10.1021/jp9836271; Jager S, 1997, P NATL ACAD SCI USA, V94, P8557, DOI 10.1073/pnas.94.16.8557; Ji TH, 1998, J BIOL CHEM, V273, P17299, DOI 10.1074/jbc.273.28.17299; Krebs A, 1998, J MOL BIOL, V282, P991, DOI 10.1006/jmbi.1998.2070; ROTHSCHILD KJ, 1980, BIOPHYS J, V31, P53, DOI 10.1016/S0006-3495(80)85040-5; Shieh T, 1997, J MOL BIOL, V269, P373, DOI 10.1006/jmbi.1997.1035; SMITH SO, 1987, BIOCHEMISTRY-US, V26, P1606, DOI 10.1021/bi00380a018; Tan Q, 1997, ANGEW CHEM INT EDIT, V36, P2089, DOI 10.1002/anie.199720891; Verdegem PJE, 1999, BIOCHEMISTRY-US, V38, P11316, DOI 10.1021/bi983014e	22	113	115	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2000	405	6788					810	813		10.1038/35015604	http://dx.doi.org/10.1038/35015604			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866205				2022-12-24	WOS:000087620600056
J	Scheiffele, P; Fan, JH; Choih, J; Fetter, R; Serafini, T				Scheiffele, P; Fan, JH; Choih, J; Fetter, R; Serafini, T			Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons	CELL			English	Article							STOP SIGNAL; SYNAPTIC CONNECTIONS; HIPPOCAMPAL-NEURONS; PROTEIN COMPLEX; SYNAPSIN-I; ADHESION; NEUREXINS; SYNAPTOTAGMIN; RECEPTOR; SURFACE	Most neurons form synapses exclusively with other neurons, but little is known about the molecular mechanisms mediating synaptogenesis in the central nervous system. Using an in vitro system, we demonstrate that neuroligin-1 and -2, postsynaptically localized proteins, can trigger the de novo formation of presynaptic structure. Nonneuronal cells engineered to express neuroligins induce morphological and functional presynaptic differentiation in contacting axons. This activity can be inhibited by addition of a soluble version of beta-neurexin, a receptor for neuroligin. Furthermore, addition of soluble beta-neurexin to a coculture of defined pre- and postsynaptic CNS neurons inhibits synaptic vesicle clustering in axons contacting target neurons. Our results suggest that neuroligins are part of the machinery employed during the formation and remodeling of CNS synapses.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Serafini, T (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	scheiffe@uclink4.berkeley.edu; tito@socrates.berkeley.edu						BAIRD DH, 1992, J NEUROSCI, V12, P619; Barth AL, 1997, NEURON, V19, P359, DOI 10.1016/S0896-6273(00)80945-9; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; Botti SA, 1998, PROTEIN ENG, V11, P415, DOI 10.1093/protein/11.6.415; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; BURRY RW, 1982, BRAIN RES, V247, P1, DOI 10.1016/0006-8993(82)91022-8; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Campagna JA, 1995, NEURON, V15, P1365, DOI 10.1016/0896-6273(95)90014-4; DAI ZS, 1995, J NEUROSCI, V15, P5466; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; Grifman M, 1998, P NATL ACAD SCI USA, V95, P13935, DOI 10.1073/pnas.95.23.13935; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; Hata Y, 1996, J NEUROSCI, V16, P2488; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; LI Y, 1991, J BIOL CHEM, V266, P23083; Martin KC, 1996, NEURON, V17, P567, DOI 10.1016/S0896-6273(00)80188-9; MASON CA, 1986, NEUROSCIENCE, V19, P1319, DOI 10.1016/0306-4522(86)90146-6; Missler M, 1998, J NEUROCHEM, V71, P1339; MIYATANI S, 1989, SCIENCE, V245, P631, DOI 10.1126/science.2762814; PORTER BE, 1995, NEURON, V14, P549, DOI 10.1016/0896-6273(95)90311-9; Powell SK, 1997, J NEUROBIOL, V32, P223, DOI 10.1002/(SICI)1097-4695(199702)32:2<223::AID-NEU7>3.0.CO;2-A; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Sherrington CS, 1906, INTEGRATIVE ACTION N, DOI 10.1037/13798-000; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094	44	887	910	2	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 9	2000	101	6					657	669		10.1016/S0092-8674(00)80877-6	http://dx.doi.org/10.1016/S0092-8674(00)80877-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	322HQ	10892652	Bronze			2022-12-24	WOS:000087504500012
J	Gaidos, EJ; Nimmo, F				Gaidos, EJ; Nimmo, F			Planetary science - Tectonics and water on Europa	NATURE			English	Article							GEOLOGICAL EVIDENCE; FRACTURE		CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Cambridge, Dept Earth Sci, Bullard Labs, Cambridge CB3 0EZ, England	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Cambridge	Gaidos, EJ (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.			Gaidos, Eric/0000-0002-5258-6846				Cottier F, 1999, J GEOPHYS RES-OCEANS, V104, P15859, DOI 10.1029/1999JC900128; Duval P., 1977, INT ASS HYDROLOGICAL, V118, P29; Greenberg R, 1998, ICARUS, V135, P64, DOI 10.1006/icar.1998.5986; MCKENZIE D, 1985, EARTH PLANET SC LETT, V74, P81, DOI 10.1016/0012-821X(85)90168-2; Pappalardo RT, 1999, J GEOPHYS RES-PLANET, V104, P24015, DOI 10.1029/1998JE000628; Pappalardo RT, 1998, NATURE, V391, P365, DOI 10.1038/34862; Rist MA, 1997, J PHYS CHEM B, V101, P6263, DOI 10.1021/jp963175x; STEVENSON D, 1996, EUROPA OCEAN C CAPIS, V5, P69; Sullivan R, 1998, NATURE, V391, P371, DOI 10.1038/34874; Tufts BR, 1999, ICARUS, V141, P53, DOI 10.1006/icar.1999.6168; Turcotte D. L., 1982, GEODYNAMICS APPL CON, DOI 10.1017/CBO9780511843877; Vorobyova E, 1997, FEMS MICROBIOL REV, V20, P277, DOI 10.1111/j.1574-6976.1997.tb00314.x	12	65	66	0	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					637	+		10.1038/35015170	http://dx.doi.org/10.1038/35015170			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864313				2022-12-24	WOS:000087465800035
J	Hersh, BS; Tambini, G; Nogueira, AC; Carrasco, P; de Quadros, CA				Hersh, BS; Tambini, G; Nogueira, AC; Carrasco, P; de Quadros, CA			Review of regional measles surveillance data in the Americas, 1996-99	LANCET			English	Article							LINKED-IMMUNOSORBENT-ASSAY; ENZYME IMMUNOASSAYS; VIRUS; DIAGNOSIS; ANTIBODY; VACCINATION; ELIMINATION; OUTBREAK; ENGLAND; WALES	Background In 1994, ministers of health of countries of North and South America established the goal of measles eradication from the western hemisphere by 2000. To accomplish this goal, the Pan American Health Organization (PAHO) developed an enhanced measles vaccination strategy. Methods PAHO's measles eradication vaccination strategy has evolved into three principal components; a catch-up measles Vaccination campaign, maintenance of high vaccination coverage (keep-up), and periodic follow-up measles vaccination campaigns. ro monitor progress towards measles eradication, measles surveillance has been strengthened, including the laboratory investigation of suspected measles cases. and periodic follow-up To monitor progress Findings Both the catch-up and follow-up mass campaigns achieved high vaccination coverages in the respective targeted age groups. In 1996, only 2109 confirmed measles cases were reported in the Americas. In 1997, there was a resurgence of measles in the Americas, mostly as a result of a large measles outbreak with over 42000 cases, which occurred mainly among unvaccinated young adults in Sao Paulo State, Brazil. By 1998, there was a reduction in the number of reported confirmed measles cases, with a total of 14474 cases. Reduction of cases continued to the end of 1999, with a total of only 2828 confirmed cases. Interpretation PAHO's measles eradication strategy has been effective in interrupting transmission and maintaining the absence of measles Virus circulation in most parts of the Americas. The PAHO experience provides strong evidence that with full implementation of an appropriate Vaccination strategy, measles transmission can be effectively interrupted.	Pan Amer Hlth Org, Div Vaccines & Immunizat, Washington, DC USA	Pan American Health Organization	de Quadros, CA (corresponding author), Pan Amer Hlth Org, Div Vaccines & Immunizat, Washington, DC USA.	quadrosc@paho.org						[Anonymous], 1998, MMWR Recomm Rep, V47, P1; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P429; BABAD HR, 1995, EPIDEMIOL INFECT, V114, P319, DOI 10.1017/S0950268800057976; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P273; CHERRY JD, 1980, HOSP PRACT, V15, P49, DOI 10.1080/21548331.1980.11946629; Cutts FT, 1999, VACCINE, V17, pS47, DOI 10.1016/S0264-410X(99)00309-6; deQuadros CA, 1997, J INFECT DIS, V175, pS37, DOI 10.1093/infdis/175.Supplement_1.S37; ERDMAN DD, 1991, J CLIN MICROBIOL, V29, P1466, DOI 10.1128/JCM.29.7.1466-1471.1991; FERSON MJ, 1995, MED J AUSTRALIA, V163, P364, DOI 10.5694/j.1326-5377.1995.tb124630.x; Galindo M. A., 1998, PAN AM J PUBLIC HLTH, V4, P171; GUSTAFSON TL, 1987, NEW ENGL J MED, V316, P771, DOI 10.1056/NEJM198703263161303; Helfand RF, 1996, J INFECT DIS, V173, P1470, DOI 10.1093/infdis/173.6.1470; HERSH BS, 1991, AM J PUBLIC HEALTH, V81, P360, DOI 10.2105/AJPH.81.3.360; HUMMEL KB, 1992, J CLIN MICROBIOL, V30, P2874, DOI 10.1128/JCM.30.11.2874-2880.1992; Kumate J, 1997, ARCH MED RES, V28, P155; LIEVENS AW, 1986, J CLIN MICROBIOL, V24, P391, DOI 10.1128/JCM.24.3.391-394.1986; LOUTAN L, 1992, B WORLD HEALTH ORGAN, V70, P741; MATZKIN H, 1985, ISRAEL J MED SCI, V21, P351; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nokes DJ, 1997, TRENDS MICROBIOL, V5, P14, DOI 10.1016/S0966-842X(97)81769-6; Oliveira SA, 1998, T ROY SOC TROP MED H, V92, P636, DOI 10.1016/S0035-9203(98)90793-3; OZANNE G, 1992, J CLIN MICROBIOL, V30, P564, DOI 10.1128/JCM.30.3.564-569.1992; Ramsay M, 1996, BRIT MED J, V313, P231, DOI 10.1136/bmj.313.7051.231; Ramsay M, 1997, B WORLD HEALTH ORGAN, V75, P515; Robbins FC, 1997, J INFECT DIS, V175, pS281, DOI 10.1093/infdis/175.Supplement_1.S281; Rota JS, 1996, J INFECT DIS, V173, P32, DOI 10.1093/infdis/173.1.32; Vitek CR, 1997, JAMA-J AM MED ASSOC, V277, P1952, DOI 10.1001/jama.277.24.1952; WILLIAMS PJ, 1983, REV INFECT DIS, V5, P391	29	85	93	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2000	355	9219					1943	1948		10.1016/S0140-6736(00)02325-4	http://dx.doi.org/10.1016/S0140-6736(00)02325-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859039				2022-12-24	WOS:000087381900010
J	James, P; Ellis, CJ; Whitlock, RML; McNeil, AR; Henley, J; Anderson, NE				James, P; Ellis, CJ; Whitlock, RML; McNeil, AR; Henley, J; Anderson, NE			Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study	BRITISH MEDICAL JOURNAL			English	Article							SERUM	Objective To assess whether a raised serum troponin T concentration would be an independent predictor of death in patients with an acute ischaemic stroke. Design Observational study. Setting Auckland Hospital, Auckland, New Zealand. Subjects All 181 patients with an acute ischaemic stroke admitted over nine months in 1997-8, from a total of 8057 patients admitted to the acute medical service. Main outcome measures Blood samples for measuring troponin T concentration were collected 12-72 hours after admission; other variables previously associated with severity of stroke were also recorded and assessed as independent predictors of inpatient mortality: Results Troponin T concentration was raised(>0.1 mu g/l) in 17% (30) of patients admitted with an acute ischaemic stroke. Thirty one patients died in hospital (12/30 (40%,) patients with a raised troponin T concentration v 19/151 (13%) patients with a normal concentration (relative risk 3.2 (95% confidence 1.7 to 5.8: p = 0.0025)). Of 17 possible predictors of death, assessed in a multivariate stepwise model, only a raised troponin T concentration (P = 0.0002), age (P = 0.0008), and an altered let:ei of consciousness at presentation (P = 0.0074) independently predicted an adverse outcome. Conclusions Serum troponin T concentration at hospital admission is a powerful predictor of mortality in patients admitted with an acute ischaemic stroke.	Auckland Hosp, Dept Gen Med, Auckland 1001, New Zealand; Auckland Hosp, Dept Med, Auckland 1001, New Zealand; Green Lane Hosp, Dept Physiol, Auckland 1003, New Zealand; Auckland Hosp, Dept Chem Pathol, Auckland 1001, New Zealand	Auckland City Hospital; Auckland City Hospital; Auckland City Hospital	Ellis, CJ (corresponding author), Auckland Hosp, Dept Med, 4th Floor, Auckland 1001, New Zealand.		James, Paul/G-2943-2014	James, Paul/0000-0002-4361-4657				Anderson NE, 1997, AUST NZ J MED, V27, P561, DOI 10.1111/j.1445-5994.1997.tb00965.x; ASPLUND K, 1985, STROKE, V16, P885; BONITA R, 1993, LANCET, V341, P1510, DOI 10.1016/0140-6736(93)90640-3; Brickner ME, 1996, AM J MED, V100, P465; Christenson RH, 1998, CLIN CHEM, V44, P494; Donnelly R, 1998, LANCET, V351, P537, DOI 10.1016/S0140-6736(05)78549-4; McNeil AR, 1998, CLIN CHEM, V44, P2377; MYERS MG, 1981, STROKE, V12, P200, DOI 10.1161/01.STR.12.2.200; MYERS MG, 1982, STROKE, V13, P838, DOI 10.1161/01.STR.13.6.838; NORRIS JW, 1979, STROKE, V10, P548, DOI 10.1161/01.STR.10.5.548; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; SAMUELS MA, 1993, NEUROL CLIN, V11, P273, DOI 10.1016/S0733-8619(18)30153-1; Saver JL, 1999, STROKE, V30, P293, DOI 10.1161/01.STR.30.2.293; Weir CJ, 1997, BMJ-BRIT MED J, V314, P1303, DOI 10.1136/bmj.314.7090.1303	14	156	161	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 3	2000	320	7248					1502	1504		10.1136/bmj.320.7248.1502	http://dx.doi.org/10.1136/bmj.320.7248.1502			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321TP	10834890	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000087471000020
J	Russo, C; Schettini, G; Saido, TC; Hulette, C; Lippall, C; Lannfelt, L; Ghetti, B; Gambetti, P; Tabaton, M; Teller, JK				Russo, C; Schettini, G; Saido, TC; Hulette, C; Lippall, C; Lannfelt, L; Ghetti, B; Gambetti, P; Tabaton, M; Teller, JK			Neurobiology - Presenilin-1 mutations in Alzheimer's disease	NATURE			English	Article							AMYLOID PRECURSOR PROTEIN; SENILE PLAQUES; DOWNS-SYNDROME; BETA-PROTEIN; PEPTIDE; INCREASE		Case Western Reserve Univ, Inst Pathol, Div Neuropathol, Cleveland, OH 44106 USA; Univ Genoa, Natl Inst Canc Res, Dept Neurosci, Adv Biotechnol Ctr,Sect Pharmacol, Genoa, Italy; RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama, Japan; Duke Univ, Med Ctr, Kathleen Price Bryan Brain Bank & Neuropathol Cor, Durham, NC 27710 USA; Med Coll Penn & Hahnemann Univ, Dept Neurol, Philadelphia, PA 19129 USA; Karolinska Inst, Huddinge Hosp, Geriatr Lab, S-14146 Huddinge, Sweden; Indiana Univ, Med Ctr, Dept Pathol, Indianapolis, IN 46202 USA	Case Western Reserve University; University of Genoa; IRCCS AOU San Martino IST; RIKEN; Duke University; Drexel University; Karolinska Institutet; Indiana University System; Indiana University-Purdue University Indianapolis	Russo, C (corresponding author), Case Western Reserve Univ, Inst Pathol, Div Neuropathol, Cleveland, OH 44106 USA.		Russo, Claudio/AIA-1429-2022; Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015	Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903; russo, claudio/0000-0002-2520-2958				Ancolio K, 1999, P NATL ACAD SCI USA, V96, P4119, DOI 10.1073/pnas.96.7.4119; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Crook R, 1998, NAT MED, V4, P452, DOI 10.1038/nm0498-452; Lippa CF, 1996, NEUROLOGY, V46, P406, DOI 10.1212/WNL.46.2.406; Russo C, 1997, FEBS LETT, V409, P411, DOI 10.1016/S0014-5793(97)00564-4; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Sudoh S, 1998, J NEUROCHEM, V71, P1535; Teller JK, 1996, NAT MED, V2, P93, DOI 10.1038/nm0196-93; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	13	135	158	2	10	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					531	532		10.1038/35014735	http://dx.doi.org/10.1038/35014735			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850703				2022-12-24	WOS:000087449500038
J	Moller, LA; Lose, G; Jorgensen, T				Moller, LA; Lose, G; Jorgensen, T			Incidence and remission rates of lower urinary tract symptoms at one year in women aged 40-60: longitudinal study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INCONTINENCE; PREVALENCE; POPULATION; QUESTIONNAIRE; PATTERNS	Objectives To determine the incidence and rates of remission of lower urinary tract symptoms at one year in women aged 40-60, and to assess factors associated with remission. Design Ongoing longitudinal cohort study. Setting One rural and one urban county in Denmark. Participants 4000 women recruited on a random basis, 2860 of whom were followed up at one year. Measurements Incidence and rates of remission of lower urinary tract symptoms. Results Prevalence, incidence, and rates of remission of lower urinary tract symptoms in 2284 women were respectively 28.5% (95% confidence interval 26.7% to 30.4%), 10.0% (8.5% to 11.4%), and 27.8% (25.6% to 30.0%). Overall, symptoms were not significantly associated with events performed or initiated in the study period: medical consultation (1.6, 0.8 to 2.8), pelvic floor physiotherapy (0.9, 0.5 to 1.8), treatment with antibiotics on suspicion of a lower urinary tract infection (1.3, 0.8 to 2.2), or other treatment (1.7, 0.7 to 4.1). Many of the individual symptoms were, however, associated with seeking professional help. Conclusions Lower urinary tract symptoms constitute dynamic conditions, with women experiencing more or fewer symptoms, and eventually a cessation of symptoms. The distinction between permanent and fluctuating cases may have important clinical and scientific implications.	Univ Copenhagen, Glostrup Cty Hosp, Dept Obstet & Gynaecol, DK-2600 Glostrup, Denmark; Glostrup Cty Hosp, Ctr Prevent Med, Med Dept CF, Glostrup, Denmark	University of Copenhagen; University of Copenhagen	Moller, LA (corresponding author), Univ Copenhagen, Glostrup Cty Hosp, Dept Obstet & Gynaecol, DK-2600 Glostrup, Denmark.	LarsAM@Dadlnet.dk	Jørgensen, Torben/Z-1335-2018	Jorgensen, Torben/0000-0001-9453-2830				[Anonymous], 1990, Br J Obstet Gynaecol, V97 Suppl 6, P1; Bernstein I, 1996, Int Urogynecol J Pelvic Floor Dysfunct, V7, P37, DOI 10.1007/BF01895104; BUMP RC, 1992, AM J OBSTET GYNECOL, V167, P1213, DOI 10.1016/S0002-9378(11)91691-3; BURGIO KL, 1991, J UROLOGY, V146, P1255, DOI 10.1016/S0022-5347(17)38063-1; CAMPBELL AJ, 1985, AGE AGEING, V14, P65, DOI 10.1093/ageing/14.2.65; CREIGHTON SM, 1990, BRIT J UROL, V66, P613, DOI 10.1111/j.1464-410X.1990.tb07192.x; DIOKNO AC, 1990, UROLOGY, V36, P129, DOI 10.1016/0090-4295(90)80211-5; ELVING LB, 1989, SCAND J UROL NEPHROL, P37; HERZOG AR, 1990, J GERONTOL, V45, pM67, DOI 10.1093/geronj/45.2.M67; Holtedahl K, 1998, MATURITAS, V28, P205, DOI 10.1016/S0378-5122(97)00085-6; Holtedahl K, 1998, ACTA OBSTET GYN SCAN, V77, P671, DOI 10.1034/j.1600-0412.1998.770616.x; Jackson S, 1996, BRIT J UROL, V77, P805, DOI 10.1046/j.1464-410X.1996.00186.x; JOZWIK M, 1993, MED HYPOTHESES, V40, P381, DOI 10.1016/0306-9877(93)90225-F; MILSOM I, 1993, J UROLOGY, V149, P1459, DOI 10.1016/S0022-5347(17)36415-7; Moller LA, 2000, ACTA OBSTET GYN SCAN, V79, P298, DOI 10.1080/j.1600-0412.2000.079004298.x; MOMMSEN S, 1994, WORLD J UROL, V12, P319; Nygaard IE, 1996, J AM GERIATR SOC, V44, P1049, DOI 10.1111/j.1532-5415.1996.tb02936.x; NYGAARD IE, 1994, OBSTET GYNECOL, V84, P183; Samuelsson E, 1997, ACTA OBSTET GYN SCAN, V76, P74, DOI 10.3109/00016349709047789; SOMMER P, 1990, BRIT J UROL, V66, P12, DOI 10.1111/j.1464-410X.1990.tb14855.x; THOMAS TM, 1980, BRIT MED J, V281, P1243, DOI 10.1136/bmj.281.6250.1243; YARNELL JWG, 1981, J EPIDEMIOL COMMUN H, V35, P71, DOI 10.1136/jech.35.1.71	22	69	70	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2000	320	7247					1429	1432		10.1136/bmj.320.7247.1429	http://dx.doi.org/10.1136/bmj.320.7247.1429			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320RT	10827042	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000087414700020
J	Kim, TK; Ebright, RH; Reinberg, D				Kim, TK; Ebright, RH; Reinberg, D			Mechanism of ATP-dependent promoter melting by transcription factor IIH	SCIENCE			English	Article							RNA-POLYMERASE-II; MAJOR LATE PROMOTER; TERMINAL-DOMAIN; BASAL TRANSCRIPTION; COMPLEX-FORMATION; CRYSTAL-STRUCTURE; DNA; TFIIH; INITIATION; HELICASE	We show that transcription factor IIH ERCC3 subunit, the DNA helicase responsible for adenosine triphosphate (ATP)-dependent promoter melting during transcription initiation, does not interact with the promoter region that undergoes melting but instead interacts with DNA downstream of this region. We show further that promoter melting does not change protein-DNA interactions upstream of the region that undergoes melting but does change interactions within and downstream of this region. Our results rule out the proposal that IIH functions in promoter melting through a conventional DNA-helicase mechanism. We propose that IIH functions as a molecular wrench: rotating downstream DNA relative to fixed upstream protein-DNA interactions, thereby generating torque on, and melting, the intervening DNA.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Howard Hughes Med Inst,Div Nucl Acids Enzymol, Piscataway, NJ 08854 USA; Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Waksman Inst, Dept Chem, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Reinberg, D (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Howard Hughes Med Inst,Div Nucl Acids Enzymol, Piscataway, NJ 08854 USA.		Kim, Tae-Kyung/AAX-4230-2020; Ebright, Richard/O-3321-2019	Kim, Tae-Kyung/0000-0001-5161-9864; Ebright, Richard/0000-0001-8915-7140; Reinberg, Danny/0000-0003-4288-2016	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037120, R01GM037120] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM53665, GM37120] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Coin F, 1998, COLD SPRING HARB SYM, V63, P105, DOI 10.1101/sqb.1998.63.105; Dvir A, 1996, J BIOL CHEM, V271, P23352, DOI 10.1074/jbc.271.38.23352; Dvir A, 1997, J BIOL CHEM, V272, P28175, DOI 10.1074/jbc.272.45.28175; Dvir A, 1997, P NATL ACAD SCI USA, V94, P9006, DOI 10.1073/pnas.94.17.9006; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; GUZDER SN, 1994, NATURE, V369, P578, DOI 10.1038/369578a0; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; JIANG Y, 1995, J BIOL CHEM, V270, P1277, DOI 10.1074/jbc.270.3.1277; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Kim TK, 1997, P NATL ACAD SCI USA, V94, P12268, DOI 10.1073/pnas.94.23.12268; KIM TK, IN PRESS PROTEIN DNA; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Kumar KP, 1998, P NATL ACAD SCI USA, V95, P9767, DOI 10.1073/pnas.95.17.9767; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Lagrange T, 1996, P NATL ACAD SCI USA, V93, P10620, DOI 10.1073/pnas.93.20.10620; LeRoy G, 1998, J BIOL CHEM, V273, P7134, DOI 10.1074/jbc.273.12.7134; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; MALODONADO E, 1996, METHOD ENZYMOL, V274, P72; Moreland RJ, 1999, J BIOL CHEM, V274, P22127, DOI 10.1074/jbc.274.32.22127; OHKUMA Y, 1995, MOL CELL BIOL, V15, P4856; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Reinberg D, 1998, COLD SPRING HARB SYM, V63, P83, DOI 10.1101/sqb.1998.63.83; Robert F, 1996, J BIOL CHEM, V271, P8517, DOI 10.1074/jbc.271.15.8517; Robert F, 1998, MOL CELL, V2, P341, DOI 10.1016/S1097-2765(00)80278-6; ROY R, 1994, J BIOL CHEM, V269, P9826; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SERIZAWA H, 1992, P NATL ACAD SCI USA, V89, P7476, DOI 10.1073/pnas.89.16.7476; THOMPSON NE, 1990, J BIOL CHEM, V265, P7069; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; WANG WD, 1992, SCIENCE, V255, P450, DOI 10.1126/science.1310361; ZAWEL L, 1995, GENE DEV, V9, P1479, DOI 10.1101/gad.9.12.1479	35	206	212	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 26	2000	288	5470					1418	1421		10.1126/science.288.5470.1418	http://dx.doi.org/10.1126/science.288.5470.1418			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318EL	10827951				2022-12-24	WOS:000087270900049
J	Kieffer, SW; Lopes-Gautier, R; McEwen, A; Smythe, W; Keszthelyi, L; Carlson, R				Kieffer, SW; Lopes-Gautier, R; McEwen, A; Smythe, W; Keszthelyi, L; Carlson, R			Prometheus: Io's wandering plume	SCIENCE			English	Article								Unlike any volcanic behavior ever observed on Earth, the plume from Prometheus on Io has wandered 75 to 95 kilometers west over the last 20 years since it was first discovered by Voyager and more recently observed by Galileo. Despite the source motion, the geometric and optical properties of the plume have remained constant. We propose that this can be explained by vaporization of a sulfur dioxide and/or sulfur "snowfield" over which a Lava flow is moving. Eruption of a boundary-layer slurry through a rootless conduit with sonic conditions at the intake of the melted snow can account for the constancy of plume properties.	SW Kieffer Sci Consulting Inc, Bolton, ON L7E 5T4, Canada; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Arizona	Kieffer, SW (corresponding author), SW Kieffer Sci Consulting Inc, 6 Queen St,Suite 206,POB 520, Bolton, ON L7E 5T4, Canada.		Lopes, Rosaly M.C./D-1608-2016	Lopes, Rosaly M.C./0000-0002-7928-3167; Kestay, Laszlo/0000-0003-1879-4331				Carslaw H.S., 1959, CONDUCTION HEAT SOLI, P88; Fisher R.V., 1968, GEOL RUNDSCH, V57, P837, DOI DOI 10.1007/BF01845368; FISHER RV, 1984, PYROCLASTIC ROCKS, P263; JAMES MR, 1998, LUNAR PLANET SCI, V29, P1349; JOHNSON TV, 1982, SATELLITES JUPITER, P637; JuradoChichay Z, 1996, B VOLCANOL, V57, P471, DOI 10.1007/BF00304433; KAMB B, 1991, J GEOPHYS RES-SOL EA, V96, P16585, DOI 10.1029/91JB00946; KIEFFER SW, 1982, SATELLITES JUPITER; Lopes-Gautier R, 2000, SCIENCE, V288, P1201, DOI 10.1126/science.288.5469.1201; McEwen AS, 2000, SCIENCE, V288, P1193, DOI 10.1126/science.288.5469.1193; McEwen AS, 1998, ICARUS, V135, P181, DOI 10.1006/icar.1998.5972; MORRISSEY MM, 1991, EOS, V72, P566; Ozisik M.N., 1968, BOUNDARY VALUE PROBL; SMITH BA, 1979, NATURE, V280, P738, DOI 10.1038/280738a0; WILSON L, 1981, J GEOPHYS RES, V86, P2971, DOI 10.1029/JB086iB04p02971; WILSON L, 1981, LUNAR PLANET SCI, V12, P1191; WOHLETZ K, 1984, STUDIES GEOPHYSICS, pCH12; Wohletz K. H., 1986, B VOLCANOL, V48, P245, DOI [10.1007/BF01081754, DOI 10.1007/BF01081754]	18	68	69	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 19	2000	288	5469					1204	1208		10.1126/science.288.5469.1204	http://dx.doi.org/10.1126/science.288.5469.1204			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315KH	10817989				2022-12-24	WOS:000087112600041
J	Milan, D; Jeon, JT; Looft, C; Amarger, V; Robic, A; Thelander, M; Rogel-Gaillard, C; Paul, S; Iannuccelli, N; Rask, L; Ronne, H; Lundstrom, K; Reinsch, N; Gellin, J; Kalm, E; Le Roy, P; Chardon, P; Andersson, L				Milan, D; Jeon, JT; Looft, C; Amarger, V; Robic, A; Thelander, M; Rogel-Gaillard, C; Paul, S; Iannuccelli, N; Rask, L; Ronne, H; Lundstrom, K; Reinsch, N; Gellin, J; Kalm, E; Le Roy, P; Chardon, P; Andersson, L			A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASE; MEAT QUALITY; GENE; CHROMOSOME-15; ALIGNMENT; TOOL	A high proportion of purebred Hampshire pigs carries the dominant RN- mutation, which causes high glycogen content in skeletal muscle. The mutation has beneficial effects on meat content but detrimental effects on processing yield. Here, it is shown that the mutation is a nonconservative substitution (R200Q) in the PRKAG3 gene, which encodes a muscle-specific isoform of the regulatory gamma subunit of adenosine monophosphate-activated protein kinase (AMPK). Loss-of-function mutations in the homologous gene in yeast (SNF4) cause defects in glucose metabolism, including glycogen storage. Further analysis of the PRKAG3 signaling pathway may provide insights into muscle physiology as well as the pathogenesis of noninsulin-dependent diabetes mellitus in humans, a metabolic disorder associated with impaired glycogen synthesis.	Swedish Univ Agr Sci, Dept Anim Breeding & Genet, SE-75124 Uppsala, Sweden; Swedish Univ Agr Sci, Dept Plant Biol, SE-75124 Uppsala, Sweden; Swedish Univ Agr Sci, Dept Food Sci, SE-75124 Uppsala, Sweden; INRA, Lab Genet Cellulaire, F-31326 Castanet Tolosan, France; Univ Kiel, Inst Anim Breeding & Husb, D-24098 Kiel, Germany; INRA, Genet Quantitat & Appl Stn, F-78352 Jouy En Josas, France; Univ Uppsala, Dept Med Biochem & Microbiol, SE-75223 Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; INRAE; University of Kiel; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Uppsala University	Andersson, L (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Box 597, SE-75124 Uppsala, Sweden.		Rask, Lars B/L-4177-2013; robic, annie/AAM-6932-2021	Ronne, Hans/0000-0002-1645-6091; robic, annie/0000-0003-3071-8614; ROGEL-GAILLARD, Claire/0000-0002-2174-1962; Amarger, Valerie/0000-0001-9258-6675				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; BOEHNKE M, 1991, AM J HUM GENET, V49, P1174; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Enfalt AC, 1997, LIVEST PROD SCI, V47, P221, DOI 10.1016/S0301-6226(96)01409-1; ESTRADE M, 1993, COMP BIOCHEM PHYS B, V104, P321, DOI 10.1016/0305-0491(93)90375-F; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Green P., 1990, DOCUMENTATION CRIMAP; Greiwe JS, 1999, J APPL PHYSIOL, V87, P222, DOI 10.1152/jappl.1999.87.1.222; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; Holmes BF, 1999, J APPL PHYSIOL, V87, P1990, DOI 10.1152/jappl.1999.87.5.1990; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kluijtmans LAJ, 1996, J CLIN INVEST, V98, P285, DOI 10.1172/JCI118791; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; LANDEGREN U, 1988, SCIENCE, V241, P1077, DOI 10.1126/science.3413476; LEROY P, 1990, GENET RES, V55, P33, DOI 10.1017/S0016672300025179; Looft C, 1996, GENET SEL EVOL, V28, P437, DOI 10.1051/gse:19960503; Mariani P, 1996, MAMM GENOME, V7, P52, DOI 10.1007/s003359900012; MILAN D, 1996, MAMM GENOME, V7, P45; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Sun HFS, 1999, CYTOGENET CELL GENET, V85, P273, DOI 10.1159/000015312; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yerle M, 1998, CYTOGENET CELL GENET, V82, P182, DOI 10.1159/000015095	29	578	639	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 19	2000	288	5469					1248	1251		10.1126/science.288.5469.1248	http://dx.doi.org/10.1126/science.288.5469.1248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315KH	10818001				2022-12-24	WOS:000087112600053
J	Montrasio, F; Frigg, R; Glatzel, M; Klein, MA; Mackay, F; Aguzzi, A; Weissmann, C				Montrasio, F; Frigg, R; Glatzel, M; Klein, MA; Mackay, F; Aguzzi, A; Weissmann, C			Impaired prion replication in spleens of mice lacking functional follicular dendritic cells	SCIENCE			English	Article							CREUTZFELDT-JAKOB-DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; SCRAPIE-INFECTED MICE; BETA-DEFICIENT MICE; LYMPHOTOXIN-BETA; MOUSE SPLEEN; AGENT REPLICATION; INCUBATION PERIOD; DISTINCT ROLES; BONE-MARROW	In scrapie-infected mice, prions are found associated with splenic but not circulating B and T lymphocytes and in the stroma, which contains follicular dendritic cells (FDCs), Formation and maintenance of mature FDCs require the presence of B cells expressing membrane-bound Lymphotoxin-alpha/beta. Treatment of mice with soluble lymphotoxin-beta receptor results in the disappearance of mature FDCs from the spleen. We show that this treatment abolishes splenic prion accumulation and retards neuroinvasion after intraperitoneal scrapie inoculation. These data provide evidence that FDCs are the principal sites for prion replication in the spleen.	Univ London Imperial Coll Sci Technol & Med, Sch Med St Marys, MRC, Prion Unit, London W2 1PG, England; Biogen Inc, Cambridge Ctr 14, Cambridge, MA 02142 USA; Univ Zurich, Dept Pathol, Inst Neuropathol, CH-8091 Zurich, Switzerland	Imperial College London; Biogen; University of Zurich	Weissmann, C (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Med St Marys, MRC, Prion Unit, Norfolk Pl, London W2 1PG, England.		Glatzel, Markus/G-3356-2011; Aguzzi, Adriano/A-3351-2008; Mackay, Fabienne/B-7440-2008; Glatzel, Markus/V-8844-2019	Glatzel, Markus/0000-0002-7720-8817; Mackay, Fabienne/0000-0002-6074-2693; Glatzel, Markus/0000-0002-7720-8817; Montrasio, Fabio/0000-0002-6069-1937; Aguzzi, Adriano/0000-0002-0344-6708				Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; Beekes M, 1996, J GEN VIROL, V77, P1925, DOI 10.1099/0022-1317-77-8-1925; Beekes M, 1998, J GEN VIROL, V79, P601, DOI 10.1099/0022-1317-79-3-601; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brown KL, 1997, J GEN VIROL, V78, P2707, DOI 10.1099/0022-1317-78-10-2707; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; BROWNING JL, 1995, J IMMUNOL, V154, P33; BRUCE ME, 1985, J GEN VIROL, V66, P2517, DOI 10.1099/0022-1317-66-12-2517; BUELER H, 1994, MOL MED, V1, P19; CLARKE MC, 1971, RES VET SCI, V12, P195; CROWE PD, 1994, J IMMUNOL METHODS, V168, P79, DOI 10.1016/0022-1759(94)90212-7; FARQUHAR CF, 1989, J VIROL METHODS, V24, P215, DOI 10.1016/0166-0934(89)90023-2; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Fraser H, 1996, J GEN VIROL, V77, P1935, DOI 10.1099/0022-1317-77-8-1935; FRASER H, 1987, VET MICROBIOL, V13, P211, DOI 10.1016/0378-1135(87)90084-8; FRASER H, 1989, PROG CLIN BIOL RES, V317, P63; Gonzalez M, 1998, J EXP MED, V187, P997, DOI 10.1084/jem.187.7.997; Grathwohl KUD, 1996, ARCH VIROL, V141, P1863, DOI 10.1007/BF01718200; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; KIMBERLIN RH, 1989, VIRUS RES, V12, P213, DOI 10.1016/0168-1702(89)90040-3; KIMBERLIN RH, 1989, VIRUS RES, V12, P201, DOI 10.1016/0168-1702(89)90039-7; KITAMOTO T, 1991, J VIROL, V65, P6292, DOI 10.1128/JVI.65.11.6292-6295.1991; Klein MA, 1998, NAT MED, V4, P1429, DOI 10.1038/4022; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; KOSCOVILBOIS M, COMMUNICATION; Lasmezas CI, 1996, J VIROL, V70, P1292; Mackay F, 1997, EUR J IMMUNOL, V27, P2033, DOI 10.1002/eji.1830270830; Mackay F, 1998, NATURE, V395, P26, DOI 10.1038/25630; Matsumoto M, 1997, J EXP MED, V186, P1997, DOI 10.1084/jem.186.12.1997; MCBRIDE PA, 1992, J PATHOL, V168, P413, DOI 10.1002/path.1711680412; MONTRASIO F, UNPUB; MURAMOTO T, 1992, AM J PATHOL, V140, P1411; OROURKE KI, 1994, J GEN VIROL, V75, P1511, DOI 10.1099/0022-1317-75-6-1511; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; QU W, 1999, J EXP MED, V190, P629; RACE RE, 1992, J GEN VIROL, V73, P3319, DOI 10.1099/0022-1317-73-12-3319; Raeber AJ, 1999, EMBO J, V18, P2702, DOI 10.1093/emboj/18.10.2702; RUBENSTEIN R, 1991, J INFECT DIS, V164, P29, DOI 10.1093/infdis/164.1.29; Ware CF, 1996, J CELL BIOCHEM, V60, P47, DOI 10.1002/(SICI)1097-4644(19960101)60:1<47::AID-JCB8>3.3.CO;2-H	41	293	299	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 19	2000	288	5469					1257	1259		10.1126/science.288.5469.1257	http://dx.doi.org/10.1126/science.288.5469.1257			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315KH	10818004				2022-12-24	WOS:000087112600056
J	Tilman, D				Tilman, D			Causes, consequences and ethics of biodiversity	NATURE			English	Article							STATISTICAL INEVITABILITY; GRASSLAND ECOSYSTEMS; PLANT DIVERSITY; PRODUCTIVITY; STABILITY	The existence of so great a diversity of species on Earth remains a mystery, the solution to which may also explain why and how biodiversity influences the functioning of ecosystems. The answer may lie in quantifying the trade-offs that organisms face in dealing with the constraints of their environment. Societal responses to the loss of biodiversity also involve trade-offs, and the elaboration of these will be essential in developing wiser environmental ethics and policy.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	tilman@lter.umn.edu	Tilman, David/ABD-5309-2021					Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; [Anonymous], 2013, THE FUTURE OF NATURE, DOI DOI 10.12987/9780300188479-039; ARMSTRONG RA, 1980, AM NAT, V115, P151, DOI 10.1086/283553; Darwin C., 1859, ORIGIN SPECIES MEANS; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Elton C. S., 1958, ECOLOGY INVASIONS AN; Fehr WR, 1984, GENETIC CONTRIBUTION, V7; HASTINGS A, 1980, THEOR POPUL BIOL, V18, P363, DOI 10.1016/0040-5809(80)90059-3; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Maddison A., 1995, MONITORING WORLD EC; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; ROELFS AP, 1988, ANNU REV PHYTOPATHOL, V26, P351, DOI 10.1146/annurev.py.26.090188.002031; Schulze E.D., 1993, BIODIVERSITY ECOSYST; Tilman D, 1998, AM NAT, V151, P277, DOI 10.1086/286118; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D., 1982, Monographs in Population Biology, pi; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494	26	321	439	11	210	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2000	405	6783					208	211		10.1038/35012217	http://dx.doi.org/10.1038/35012217			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WG	10821280				2022-12-24	WOS:000087080100057
J	Kasiske, BL; Cohen, D; Lucey, MR; Neylan, JF				Kasiske, BL; Cohen, D; Lucey, MR; Neylan, JF		Amer Soc Transplantation	Payment for immunosuppression after organ transplantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Conference of the American-Society-of-Transplantation-Immunosuppression	DEC   04, 1998	PHILADELPHIA, PENNSYLVANIA	Amer Soc Transplantat Immunosuppress			RENAL-TRANSPLANT; NONCOMPLIANCE; CYCLOSPORINE; RECIPIENTS; THERAPY	Dramatic improvements in organ transplantation have meant that a growing number of patients must take expensive immunosuppressive medications for the rest of their lives, Currently, Medicare covers most transplantation procedures in the United States, but ends coverage for outpatient immunosuppressive medications after 36 months. Evidence suggests that at least some patients have reduced immunosuppression and their transplants fail because they cannot afford these medication costs, In the years since the advent of effective immunosuppressive therapy, the US Congress has struggled with this issue, and in 1999 temporarily extended medication coverage for eligible patients (based on age and disability) by 8 months, However, a more permanent solution is needed. We advocate that Medicare should cover the cost of all immunosuppressive therapy for all solid organ transplant recipients who cannot afford to pay, A number of potentially cost-effective approaches could be taken, but, in any case, something must be done to ensure that transplants do not fail because recipients cannot pay for immunosuppression.	Hennepin Cty Med Ctr, Dept Med, Minneapolis, MN 55415 USA; Columbia Presbyterian Med Ctr, Dept Med, New York, NY 10032 USA; Univ Penn, Div Gastroenterol, Philadelphia, PA USA; Emory Univ, Sch Med, Div Nephrol, Atlanta, GA USA	Hennepin County Medical Center; Columbia University; NewYork-Presbyterian Hospital; University of Pennsylvania; Emory University	Kasiske, BL (corresponding author), Amer Soc Transplantat, 236 Route 38 W,Suite 100, Moorestown, NJ 08057 USA.		Lucey, Michael/AAR-4571-2020					BERGMANN LS, 1993, TRANSPLANT P, V25, P1340; BUTKUS DE, 1992, NEW ENGL J MED, V327, P840, DOI 10.1056/NEJM199209173271203; DEGEEST S, 1995, TRANSPLANTATION, V59, P340; DIDLAKE RH, 1988, TRANSPLANT P, V20, P63; DUNN J, 1990, TRANSPLANTATION, V49, P349, DOI 10.1097/00007890-199002000-00024; EGGERS P, 1992, SEMIN NEPHROL, V12, P284; FIELD MJ, 1999, EXTENDING MED COVERA; FRAZIER PA, 1994, CLIN TRANSPLANT, V8, P550; Gaston RS, 1999, TRANSPLANT P, V31, p21S, DOI 10.1016/S0041-1345(99)00118-9; Greenstein S, 1998, TRANSPLANTATION, V66, P1718, DOI 10.1097/00007890-199812270-00026; HILBRANDS LB, 1995, TRANSPLANTATION, V60, P914, DOI 10.1097/00007890-199511150-00006; KILEY DJ, 1993, TRANSPLANTATION, V55, P51, DOI 10.1097/00007890-199301000-00010; OWENS ML, 1975, ARCH SURG-CHICAGO, V110, P1450; RETTIG RA, 1991, KIDNEY FAILURE FEDER, P191; ROVELLI M, 1989, TRANSPLANT P, V21, P3979; Sanders CE, 1996, AM J KIDNEY DIS, V28, P572, DOI 10.1016/S0272-6386(96)90469-2; SANDERS CE, 1993, AM J KIDNEY DIS, V21, P9, DOI 10.1016/S0272-6386(12)80713-X; SCHWEIZER RT, 1990, TRANSPLANTATION, V49, P374, DOI 10.1097/00007890-199002000-00029; SKETRIS I, 1994, TRANSPLANT P, V26, P2538; Soumerai SB, 1999, NEW ENGL J MED, V340, P722, DOI 10.1056/NEJM199903043400909; *TASK FORC ORG TRA, 1986, ORG TRANSPL ISS REC, P99; UEHLING DT, 1976, SURGERY, V79, P278; WOODWARD RS, IN PRESS J AM SOC NE; ZOLLER KM, 1980, KIDNEY INT, V18, P110, DOI 10.1038/ki.1980.116	24	77	77	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2000	283	18					2445	2450		10.1001/jama.283.18.2445	http://dx.doi.org/10.1001/jama.283.18.2445			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310CD	10815094				2022-12-24	WOS:000086808200046
J	Pharoah, POD; Adi, Y				Pharoah, POD; Adi, Y			Consequences of in-utero death in a twin pregnancy	LANCET			English	Article							SPASTIC CEREBRAL-PALSY; INTRAUTERINE DEATH; MONOZYGOTIC TWINS; FETUS PAPYRACEUS; MULTIPLE BIRTHS; VANISHING TWIN; BRAIN-DAMAGE; MORTALITY; COTWIN; HYPOTHESIS	Background Twins have a higher mortality and morbidity than singletons and, among twins, the surviving co-twin of a fetus that dies in utero is particularly at risk. We did a cohort study to quantify mortality and serious morbidity in co-twin survivors of fetuses that died in utero. Methods We collected data of all registered twin births in England and Wales between 1993 and 1995 in which one twin was registered as having died in utero. Copies of all death certificates of these fetuses and death certificates of live-born co-twins of fetuses that died in utero were obtained from the Office for National Statistics. A questionnaire was sent to the general practitioners of all surviving co-twins to find out if the child had any disability. Findings There were 434 fetal death/live-birth same-sex twin pairs. Among the live births, there were 59 neonatal deaths, seven postneonatal deaths (first 28 days), and five infant deaths (<1 year). In three of the five deaths, the cause of death was cerebral palsy. Ten of the children who survived infancy were lost. to follow up. Responses were received from general practitioners for 241 of 353 survivors (68% response). Of the 241 respondents, 23 had cerebral palsy and 28 had other cerebral impairment. Among the children who survived to infancy, the prevalence of cerebral palsy was 106 (95% CI 70-150) per 1000 and prevalence of other cerebral impairment was 114 (80-160) per 1000. There were 163 fetal death/live-birth different-sex twin pairs. Of the live births, 13 died in the neonatal period and four were lost to follow up. Of the 146 survivors, responses were received from the general practitioners for 102 (70% response). Three of the 102 had cerebral palsy and 12 had other cerebral impairment. The prevalence of cerebral palsy was 29 (95% CI 6-83) per 1000 and of other cerebral impairment 118 (62-196) per 1000 infant survivors. Interpretation The live-birth cc-twin of a fetus that died in utero is at increased risk of cerebral impairment, the overall risk is 20% (95% CI 16-25). The gestational-age-specific prevalence of cerebral palsy after fetal death of the co-twin is much higher than that reported for the general twin population.	Univ Liverpool, Dept Publ Hlth, Fdn Study Infant Death, Unit Perinatal & Paediat Epidemiol, Liverpool L69 3GB, Merseyside, England	University of Liverpool	Pharoah, POD (corresponding author), Univ Liverpool, Dept Publ Hlth, Fdn Study Infant Death, Unit Perinatal & Paediat Epidemiol, Muspratt Bldg, Liverpool L69 3GB, Merseyside, England.		Adi, Yaser A/S-5100-2016	Adi, Yaser A/0000-0002-3989-2873				ANDERSON RL, 1990, PRENATAL DIAG, V10, P513, DOI 10.1002/pd.1970100806; Baldwin VJ, 1993, PATHOLOGY MULTIPLE P; BEJAR R, 1990, AM J OBSTET GYNECOL, V162, P1230, DOI 10.1016/0002-9378(90)90024-2; BENSON CB, 1994, RADIOLOGY, V192, P765, DOI 10.1148/radiology.192.3.8058944; Blickstein I, 1998, DEV MED CHILD NEUROL, V40, P358; BOTTING BJ, 1987, ARCH DIS CHILD, V62, P941, DOI 10.1136/adc.62.9.941; BURN J, 1988, TWINNING TWINS; ELLIS RF, 1979, ACTA GENET MED GEMEL, V28, P347, DOI 10.1017/S0001566000008904; ENBOM JA, 1985, AM J OBSTET GYNECOL, V152, P424, DOI 10.1016/S0002-9378(85)80152-6; FUSI L, 1990, BRIT J OBSTET GYNAEC, V97, P511, DOI 10.1111/j.1471-0528.1990.tb02521.x; GRETHER JK, 1993, PEDIATRICS, V92, P854; HAGAY ZJ, 1986, J REPROD MED, V8, P717; Heys RF, 1996, BRIT MED J, V313, P1004; ISHIMATSU J, 1994, J MATERN-FETAL INVES, V4, P141; JUNG JH, 1984, PEDIATRICS, V73, P467; KELSEY JL, 1986, METHODS OBSERVATIONA; LARROCHE JC, 1990, BIOL NEONATE, V57, P261; MELNICK M, 1977, LANCET, V2, P1287; MOORE CM, 1969, J PEDIATR, V74, P523, DOI 10.1016/S0022-3476(69)80034-X; MYRIANTHOPOULOS N C, 1970, American Journal of Human Genetics, V22, P611; NYLANDER PPS, 1979, ACTA GENET MED GEMEL, V28, P363, DOI 10.1017/S000156600000893X; Pharoah POD, 1997, DEV MED CHILD NEUROL, V39, P292; Pharoah POD, 1998, ARCH DIS CHILD-FETAL, V79, pF21, DOI 10.1136/fn.79.1.F21; Pharoah POD, 1996, ARCH DIS CHILD-FETAL, V75, pF174, DOI 10.1136/fn.75.3.F174; Pharoah POD, 1997, BRIT MED J, V314, P441, DOI 10.1136/bmj.314.7078.441a; POTTER EL, 1963, AM J OBSTET GYNECOL, V87, P566, DOI 10.1016/0002-9378(63)90050-4; RYDHSTROM H, 1993, J REPROD MED, V38, P142; SCHINZEL AAGL, 1979, J PEDIATR-US, V95, P921, DOI 10.1016/S0022-3476(79)80278-4; Sebire NJ, 1997, BRIT J OBSTET GYNAEC, V104, P1203, DOI 10.1111/j.1471-0528.1997.tb10948.x; SZYMONOWICZ W, 1986, ARCH DIS CHILD, V61, P454, DOI 10.1136/adc.61.5.454; VanBogaert P, 1996, DEV MED CHILD NEUROL, V38, P166; Weig SG, 1995, PEDIATR NEUROL, V13, P279, DOI 10.1016/0887-8994(95)00219-7; West CR, 1999, ARCH DIS CHILD-FETAL, V80, pF217, DOI 10.1136/fn.80.3.F217; Williams K, 1996, ARCH DIS CHILD-FETAL, V75, pF178, DOI 10.1136/fn.75.3.F178; YOSHIDA K, 1986, ACTA GENET MED GEMEL, V35, P91, DOI 10.1017/S0001566000006292	35	146	154	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 6	2000	355	9215					1597	1602		10.1016/S0140-6736(00)02215-7	http://dx.doi.org/10.1016/S0140-6736(00)02215-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CD	10821363				2022-12-24	WOS:000086981200010
J	Greyson, B				Greyson, B			Dissociation in people who have near-death experiences: out of their bodies or out of their minds?	LANCET			English	Article							PSYCHODYNAMICS; RELIABILITY; VALIDITY; SCALE	Background Some people who come close to death report having experiences in which they transcend the boundaries of the ego and the confines of time and space. Such near-death experiences (NDEs) share some features with the phenomenon of dissociation, in which a person's self identity becomes detached from bodily sensation. This study explored the frequency of dissociative symptoms in people who had come close to death. Methods 96 individuals who had had self-reported NDEs, and 38 individuals who had come close to death but who had not had NDEs completed a mailed questionnaire that included a measure of "depth" of near-death experience (the NDE scale) and a measure of dissociative symptoms (the Dissociative Experiences Scale). Median scores in the two groups were compared with Mann-Whitney U tests. The association between depth of NDE and dissociative symptoms was tested by Spearman's rank-order correlation between scores on the NDE scale and the dissociative experiences scale. Findings People who reported NDEs also reported significantly more dissociative symptoms than did the comparison group. Among those who reported NDEs, the depth of the experience was positively correlated with dissociative symptoms, although the level of symptoms was substantially lower than that of patients with pathological dissociative disorders. Interpretation The pattern of dissociative symptoms reported by people who have had NDEs is consistent with a non-pathological dissociative response to stress, and not with a psychiatric disorder. A greater understanding of the mechanism of dissociation may shed further light on near-death and other mystical or transcendental experiences.	Univ Virginia Hlth Syst, Dept Psychiat Med, Div Personal Studies, Charlottesville, VA 22908 USA	University of Virginia	Greyson, B (corresponding author), Univ Virginia Hlth Syst, Dept Psychiat Med, Div Personal Studies, POB 800152, Charlottesville, VA 22908 USA.			Greyson, Bruce/0000-0002-2192-7898				American Psychological Association, 1994, DIAGN STAT MAN MENT, V4th; [Anonymous], 1998, MED PSYCHIAT, V1, P92; BERNSTEIN EM, 1986, J NERV MENT DIS, V174, P727, DOI 10.1097/00005053-198612000-00004; Blackmore SJ, 1996, J ROY SOC MED, V89, P73, DOI 10.1177/014107689608900204; Carlson E.B., 1993, DISSOCIATION, V6, P16, DOI DOI 10.1177/1073191116645904; Cook E. W., 1998, J SCI EXPLORATION, V12, P377; GABBARD GO, 1984, WITH EYES MIND EMPIR; GREYSON B, 1983, J NERV MENT DIS, V171, P376, DOI 10.1097/00005053-198306000-00008; Greyson B, 1998, PERSPECT BIOL MED, V42, P14; GREYSON B, 1983, J NERV MENT DIS, V171, P369, DOI 10.1097/00005053-198306000-00007; Greyson B, 1997, J NERV MENT DIS, V185, P327, DOI 10.1097/00005053-199705000-00007; GREYSON B, 1997, BROKEN IMAGES BROKEN; Heim A., 1892, JB SCHWEIZER ALPENCL, V27, P327; Irwin H., 1985, FLIGHT MIND PSYCHOL; Irwin H. J., 1993, J NEAR DEATH STUDIES, V12, P95; James W., 1983, PRINCIPLES PSYCHOL; Janet P, 1889, AUTOMATISME PSYCHOL; JANSEN KLR, 1990, MED HYPOTHESES, V31, P25, DOI 10.1016/0306-9877(90)90048-J; KELLEHEAR A, 1993, J NERV MENT DIS, V181, P148, DOI 10.1097/00005053-199303000-00002; NOYES R, 1977, COMPR PSYCHIAT, V18, P375, DOI 10.1016/0010-440X(77)90010-4; OWENS JE, 1990, LANCET, V336, P1175, DOI 10.1016/0140-6736(90)92780-L; Pfister O, 1930, INT Z PSYCHOANAL, V16, P430; Prince M., 1978, DISSOCIATION PERSONA; Ray William J., 1996, P51; Ring K., 1992, OMEGA PROJECT NEAR D; ROBERTS G, 1988, BRIT J PSYCHIAT, V153, P607, DOI 10.1192/bjp.153.5.607; ROSE DS, 1986, AM J PSYCHIAT, V143, P817; SPIEGEL D, 1991, J ABNORM PSYCHOL, V100, P366, DOI 10.1037/0021-843X.100.3.366; Waller NG, 1996, PSYCHOL METHODS, V1, P300, DOI 10.1037/1082-989X.1.3.300; Wiltse A. S., 1889, ST LOUIS MEDICAL SUR, V57, P355; 1894, BMJ, V2, P823	31	69	76	1	26	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2000	355	9202					460	463						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	283ZW	10841127				2022-12-24	WOS:000085306800013
J	McMaster, P				McMaster, P			Transplantation for alcoholic liver disease in an era of organ shortage	LANCET			English	Editorial Material							CIRRHOSIS		Univ Hosp Birmingham NHS Trust, Liver & Hepatobiliary Unit, Birmingham B15 2TH, W Midlands, England		McMaster, P (corresponding author), Univ Hosp Birmingham NHS Trust, Liver & Hepatobiliary Unit, Birmingham B15 2TH, W Midlands, England.							Anand AC, 1997, HEPATOLOGY, V25, P1478, DOI 10.1002/hep.510250628; BERESFORD TP, 1994, LIVER TRANSPLANTATIO, P90; BERLAKOVICH GA, 1994, TRANSPLANTATION, V58, P560, DOI 10.1097/00007890-199409150-00006; HOWARD L, 1994, Q J MED, V87, P731, DOI 10.1093/oxfordjournals.qjmed.a068890; KNECHTLE SJ, 1993, TRANSPLANT P, V25, P1916; Lucey M R, 1997, Liver Transpl Surg, V3, P628; Neuberger J, 1998, BMJ-BRIT MED J, V317, P172, DOI 10.1136/bmj.317.7152.172; Pageaux GP, 1999, GUT, V45, P421, DOI 10.1136/gut.45.3.421; Poynard T, 1999, J HEPATOL, V30, P1130, DOI 10.1016/S0168-8278(99)80269-4; Roizen R, 1999, BRIT MED J, V319, P666, DOI 10.1136/bmj.319.7211.666; VANLEMMENS C, 1995, HEPATOLOGY, V22, P375	11	36	38	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2000	355	9202					424	425						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841118				2022-12-24	WOS:000085306800004
J	Ho, AM; Johnson, MD; Kingsley, DM				Ho, AM; Johnson, MD; Kingsley, DM			Role of the mouse ank gene in control of tissue calcification and arthritis	SCIENCE			English	Article							POSTERIOR LONGITUDINAL LIGAMENT; MURINE PROGRESSIVE ANKYLOSIS; OSTEO-ARTHRITIS; CHROMOSOME 5P; CHONDROCALCINOSIS; PYROPHOSPHATE; ASSOCIATION; DEPOSITION; CRYSTALS; OSTEOARTHRITIS	Mutation at the mouse progressive ankylosis (ank) locus causes a generalized, progressive form of arthritis accompanied by mineral deposition, formation of bony outgrowths, and joint destruction. Here, we show that the ank Locus encodes a multipass transmembrane protein (ANK) that is expressed in joints and other tissues and controls pyrophosphate levels in cultured cells. A highly conserved gene is present in humans and other vertebrates. These results identify ANK-mediated control of pyrophosphate levels as a possible mechanism regulating tissue calcification and susceptibility to arthritis in higher animals.	Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Howard Hughes Med Inst, Sch Med, Beckman Ctr B300, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Kingsley, DM (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	kingsley@cmgm.stanford.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER; NIGMS NIH HHS [5T32GM07365] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrew LJ, 1999, AM J HUM GENET, V64, P136, DOI 10.1086/302186; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; CASWELL AM, 1991, CRIT REV CL LAB SCI, V28, P175, DOI 10.3109/10408369109106862; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Concoff A L, 1999, Curr Opin Rheumatol, V11, P436; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; DIEPPE P, 1985, CLIN RHEUM DIS, V11, P367; DOHERTY M, 1982, LANCET, V1, P1207; FELSON DT, 1989, J RHEUMATOL, V16, P1241; FLEISCH H, 1981, METAB BONE DIS RELAT, V3, P279, DOI 10.1016/0221-8747(81)90044-8; FLEISCH H, 1962, NATURE, V195, P911, DOI 10.1038/195911a0; FLEISCH H, 1965, NATURE, V207, P1300, DOI 10.1038/2071300b0; FLEISCH H, 1966, AM J PHYSIOL, V211, P821, DOI 10.1152/ajplegacy.1966.211.3.821; *GENB, AF001533 GENB; *GENB, AF001532 GENB; GIBILISCO PA, 1985, ARTHRITIS RHEUM, V28, P511, DOI 10.1002/art.1780280507; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GUGGINO SE, 1983, AM J PHYSIOL, V244, pF612, DOI 10.1152/ajprenal.1983.244.6.F612; HAKIM FT, 1984, ARTHRITIS RHEUM, V27, P1411, DOI 10.1002/art.1780271212; HAKIM FT, 1986, ARTHRITIS RHEUM, V29, P114, DOI 10.1002/art.1780290115; Helmick C G, 1995, Arthritis Care Res, V8, P203, DOI 10.1002/art.1790080403; HO AF, UNPUB, P42707; HUGHES AE, 1995, HUM MOL GENET, V4, P1225, DOI 10.1093/hmg/4.7.1225; KRUG HE, 1993, ARTHRITIS RHEUM, V36, P1603, DOI 10.1002/art.1780361116; Krug HE, 1997, J RHEUMATOL, V24, P115; LUST G, 1981, SCIENCE, V214, P809, DOI 10.1126/science.6270793; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; MAHOWALD ML, 1989, J RHEUMATOL, V16, P60; Nakamura I, 1999, HUM GENET, V104, P492, DOI 10.1007/s004390050993; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; Rojas K, 1999, GENOMICS, V62, P177, DOI 10.1006/geno.1999.5997; ROSENTHAL AK, 1994, J RHEUMATOL, V21, P896; Ryan LM, 1999, RHEUM DIS CLIN N AM, V25, P257, DOI 10.1016/S0889-857X(05)70066-1; SAMPSON HW, 1988, SPINE, V13, P650; Spector TD, 1996, BRIT MED J, V312, P940; Storm EE, 1996, DEVELOPMENT, V122, P3969; SWAN A, 1994, ANN RHEUM DIS, V53, P467, DOI 10.1136/ard.53.7.467; SWEET HO, 1981, J HERED, V72, P87, DOI 10.1093/oxfordjournals.jhered.a109459; TEW WP, 1980, BIOCHEMISTRY-US, V19, P1983, DOI 10.1021/bi00550a039; White D. J., 1996, Journal of Clinical Dentistry, V7, P46; WORDSWORTH P, 1995, BRIT MED BULL, V51, P249, DOI 10.1093/oxfordjournals.bmb.a072959; YELIN E, 1995, ARTHRITIS RHEUM, V38, P1351, DOI 10.1002/art.1780381002	43	485	511	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2000	289	5477					265	270		10.1126/science.289.5477.265	http://dx.doi.org/10.1126/science.289.5477.265			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894769				2022-12-24	WOS:000088169400033
J	Frary, A; Nesbitt, TC; Frary, A; Grandillo, S; van der Knaap, E; Cong, B; Liu, JP; Meller, J; Elber, R; Alpert, KB; Tanksley, SD				Frary, A; Nesbitt, TC; Frary, A; Grandillo, S; van der Knaap, E; Cong, B; Liu, JP; Meller, J; Elber, R; Alpert, KB; Tanksley, SD			fw2.2: A quantitative trait locus key to the evolution of tomato fruit size	SCIENCE			English	Article							WEIGHT; MAIZE	Domestication of many plants has correlated with dramatic increases in fruit size. In tomato, one quantitative trait Locus (QTL), fw2.2, was responsible for a Large step in this process. When transformed into large-fruited cultivars, a cosmid derived from the fw2.2 region of a small-fruited wild species reduced fruit size by the predicted amount and had the gene action expected for fw2.2. The cause of the QTL effect is a single gene, ORFX, that is expressed early in floral development, controls carpel cell number, and has a sequence suggesting structural similarity to the human oncogene c-H-ras p21. Alterations in fruit size, imparted by fw2.2 alleles, are most Likely due to changes in regulation rather than in the sequence and structure of the encoded protein.	Cornell Univ, Dept Plant Breeding, Ithaca, NY 14853 USA; Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA; Cornell Univ, Dept Comp Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Tanksley, SD (corresponding author), Cornell Univ, Dept Plant Breeding, 252 Emerson Hall, Ithaca, NY 14853 USA.		van der Knaap, Esther/D-6307-2012; Frary, Anne/A-5417-2015; Meller, Jaroslaw/A-1971-2011	Frary, Anne/0000-0002-8973-0100; Meller, Jaroslaw/0000-0002-1162-8253; LIU, JIPING/0000-0002-7558-0025; van der Knaap, Esther/0000-0003-4963-7427				ALPERT KB, 1995, THEOR APPL GENET, V91, P994, DOI 10.1007/BF00223911; Alpert KB, 1996, P NATL ACAD SCI USA, V93, P15503, DOI 10.1073/pnas.93.26.15503; DOEBLEY J, 1990, P NATL ACAD SCI USA, V87, P9888, DOI 10.1073/pnas.87.24.9888; Frary A, 1996, PLANT CELL REP, V16, P235, DOI 10.1007/BF01890875; Grandillo S, 1999, THEOR APPL GENET, V99, P978, DOI 10.1007/s001220051405; MELLER J, UNPUB; PATERSON AH, 1991, GENETICS, V127, P181; Phillips PC, 1999, TRENDS GENET, V15, P6, DOI 10.1016/S0168-9525(98)01622-9; RICK CM, 1974, P NATL ACAD SCI USA, V71, P835, DOI 10.1073/pnas.71.3.835; Smartt J., 1995, EVOLUTION CROP PLANT, V2nd; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435	13	973	1114	14	318	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2000	289	5476					85	88		10.1126/science.289.5476.85	http://dx.doi.org/10.1126/science.289.5476.85			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332TW	10884229	Green Submitted			2022-12-24	WOS:000088090400035
J	van den Akker, F; Zhang, XL; Miyagi, M; Huo, XW; Misono, KS; Yee, VC				van den Akker, F; Zhang, XL; Miyagi, M; Huo, XW; Misono, KS; Yee, VC			Structure of the dimerized hormone-binding domain of a guanylyl-cyclase-coupled receptor	NATURE			English	Article							NATRIURETIC-PEPTIDE RECEPTOR; DIRECTED MUTATIONAL ANALYSIS; SITE; PROTEIN; IDENTIFICATION; LOCATION; INSIGHTS	The atrial natriuretic peptide (ANP) hormone is secreted by the heart in response to an increase in blood pressure. ANP exhibits several potent anti-hypertensive actions in the kidney, adrenal gland and vascular system. These actions are induced by hormone binding extracellularly to the ANPreceptor(1), thereby activating its intracellular guanylyl cyclase domain for the production of cyclic GMP(2). Here we present the crystal structure of the glycosylated dimerized hormone-binding domain of the ANP receptor at 2.0-Angstrom resolution. The monomer comprises two interconnected subdomains, each encompassing a central beta-sheet flanked by alpha-helices, and exhibits the type I periplasmic binding protein fold. Dimerization is mediated by the juxtaposition of four parallel helices, arranged two by two, which brings the two protruding carboxy termini into close relative proximity. From affinity labelling and mutagenesis studies, the ANP-binding site maps to the side of the dimer crevice and extends to near the dimer interface. A conserved chloride-binding site is located in the membrane distal domain, and we found that hormone binding is chloride dependent. These studies suggest mechanisms for hormone activation and the allostery of the ANP receptor.	Cleveland Clin Fdn, Lerner Res Inst, Struct Biol Ctr, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Biol, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Yee, VC (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Struct Biol Ctr, 9500 Euclid Ave, Cleveland, OH 44195 USA.	misonok@ccf.org; yeev@ccf.org						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; DUDA T, 1991, P NATL ACAD SCI USA, V88, P7882, DOI 10.1073/pnas.88.17.7882; ENGEL AM, 1995, FEBS LETT, V360, P169, DOI 10.1016/0014-5793(95)00096-R; Foster D C, 1999, Rev Physiol Biochem Pharmacol, V135, P1, DOI 10.1007/BFb0033668; HE XL, 1995, BIOCONJUGATE CHEM, V6, P541, DOI 10.1021/bc00035a007; Huo XW, 1999, BIOCHEMISTRY-US, V38, P16941, DOI 10.1021/bi9919448; Itakura M, 1997, BIOCHEM J, V322, P585, DOI 10.1042/bj3220585; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KATAFUCHI T, 1992, J BIOL CHEM, V267, P7624; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Labrecque J, 1999, J BIOL CHEM, V274, P9752, DOI 10.1074/jbc.274.14.9752; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lo Conte L, 1999, J MOL BIOL, V285, P2177; LOWE DG, 1992, BIOCHEMISTRY-US, V31, P10421, DOI 10.1021/bi00158a001; McNicoll N, 1996, BIOCHEMISTRY-US, V35, P12950, DOI 10.1021/bi960818q; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Misono KS, 2000, CIRC RES, V86, P1135; Misono KS, 1999, BIOCHEMISTRY-US, V38, P516, DOI 10.1021/bi982127v; MIYAGI M, UNPUB EUR J BIOCH; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; O'Hara BP, 1999, EMBO J, V18, P5175, DOI 10.1093/emboj/18.19.5175; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SAPER MA, 1983, J BIOL CHEM, V258, P1057; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Veress AT, 1997, AM J PHYSIOL-RENAL, V272, pF545, DOI 10.1152/ajprenal.1997.272.4.F545; Wada A, 1996, INFECT IMMUN, V64, P5144, DOI 10.1128/IAI.64.12.5144-5150.1996; Wedel BJ, 1997, FEBS LETT, V410, P29, DOI 10.1016/S0014-5793(97)00358-X; WILSON EM, 1995, BIOCHEMISTRY-US, V34, P4696, DOI 10.1021/bi00014a025	31	127	130	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2000	406	6791					101	104		10.1038/35017602	http://dx.doi.org/10.1038/35017602			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	330ZE	10894551				2022-12-24	WOS:000087991200054
J	Binswanger, HP				Binswanger, HP			Scaling up HIV/AIDS programs to national coverage	SCIENCE			English	Editorial Material								The most important issue in the fight against HIV/AIDS is how to scale up existing programs that are only reaching small numbers of people to the national Level. Here, I present suggestions on how to tackle the daunting challenge of building truly national HIV/AIDS programs, based on insights gained from participatory, decentralized rural development experiences and from HIV/AIDS programs.	World Bank, Rural Dev & Environm Africa, Washington, DC 20005 USA	The World Bank	Binswanger, HP (corresponding author), World Bank, Rural Dev & Environm Africa, Washington, DC 20005 USA.		Binswanger, Hans/M-6883-2013	Binswanger, Hans/0000-0002-6323-1418				Caldwell JC, 2000, POPUL DEV REV, V26, P117, DOI 10.1111/j.1728-4457.2000.00117.x; FOSTER G, 1999, SAFAIDS NEWS, V7, P3; NGWESHEMI J, 1997, HIV PREVENTION AIDS; Rojanapithayakorn W, 1996, AIDS, V10, P1, DOI 10.1097/00002030-199601000-00001; SCHAPNIK D, 2000, STRATEGIC PRINCIPLES; *TANESA PLANN DIST, 1996, COMP COND CONT COSTS; *U ZIMB, 2000, REG PARTN RED HIV IN; *WORLD BANK, 1998, INT RUR DEV WORLD BA; *WORLD BANK, 1997, RUR DEV VIS ACT	9	33	33	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2000	288	5474					2173	2176		10.1126/science.288.5474.2173	http://dx.doi.org/10.1126/science.288.5474.2173			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	327FH	10864859				2022-12-24	WOS:000087782900048
J	Catteruccia, F; Nolan, T; Loukeris, TG; Blass, C; Savakis, C; Kafatos, FC; Crisanti, A				Catteruccia, F; Nolan, T; Loukeris, TG; Blass, C; Savakis, C; Kafatos, FC; Crisanti, A			Stable germline transformation of the malaria mosquito Anopheles stephensi	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; YELLOW-FEVER MOSQUITO; TRANSPOSABLE ELEMENT; AEDES-AEGYPTI; GENE; EXPRESSION; GAMBIAE; MARKER	Anopheline mosquito species are obligatory vectors for human malaria, an infectious disease that affects hundreds of millions of people living in tropical and subtropical countries. The lack of a suitable gene transfer technology for these mosquitoes has hampered the molecular genetic analysis of their physiology, including the molecular interactions between the vector and the malaria parasite. Here we show that a transposon, based on the Minos element(1) and bearing exogenous DNA, can integrate efficiently and stably into the germ line of the human malaria vector Anopheles stephensi, through a transposase-mediated process.	Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; European Mol Biol Lab, D-69117 Heidelberg, Germany; Fdn Res & Technol Hellas, Res Ctr Crete, Inst Mol Biol & Biotechnol, Heraklion, Crete, Greece	Imperial College London; European Molecular Biology Laboratory (EMBL); Foundation for Research & Technology - Hellas (FORTH)	Crisanti, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Imperial Coll Rd, London SW7 2AZ, England.		Savakis, Babis/D-3633-2009; Nolan, Tony/I-4925-2012	Nolan, Tony/0000-0002-2982-8333; Catteruccia, Flaminia/0000-0003-3295-6683; Crisanti, Andrea/0000-0002-2406-4426				Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463; Catteruccia F, 2000, P NATL ACAD SCI USA, V97, P2157, DOI 10.1073/pnas.040568397; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; FRANCE A, 1991, HLTH PROM J AUST, V1, P19; Jasinskiene N, 1998, P NATL ACAD SCI USA, V95, P3743, DOI 10.1073/pnas.95.7.3743; KLINAKIS AG, IN PRESS INSECT MOL; Kumar V., 1994, Insect Molecular Biology, V3, P41, DOI 10.1111/j.1365-2583.1994.tb00149.x; LOUKERIS TG, 1995, P NATL ACAD SCI USA, V92, P9485, DOI 10.1073/pnas.92.21.9485; LOUKERIS TG, 1995, SCIENCE, V270, P2002, DOI 10.1126/science.270.5244.2002; MILLER LH, 1987, SCIENCE, V237, P779, DOI 10.1126/science.3039658; Pinkerton AC, 2000, INSECT MOL BIOL, V9, P1, DOI 10.1046/j.1365-2583.2000.00133.x; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978	14	299	324	0	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2000	405	6789					959	962		10.1038/35016096	http://dx.doi.org/10.1038/35016096			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326JT	10879538				2022-12-24	WOS:000087732700053
J	Page, NM; Woods, RJ; Gardiner, SM; Lomthaisong, K; Gladwell, RT; Butlin, DJ; Manyonda, IT; Lowry, PJ				Page, NM; Woods, RJ; Gardiner, SM; Lomthaisong, K; Gladwell, RT; Butlin, DJ; Manyonda, IT; Lowry, PJ			Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia	NATURE			English	Article							PORCINE SPINAL-CORD; SUBSTANCE-P; RECEPTOR ANTAGONISTS; RAT; PREECLAMPSIA; RESPONSES; SEQUENCE; VESSELS; PLASMA; POTENT	Pre-eclampsia is a principal cause of maternal morbidity and mortality, affecting 5-10% of first pregnancies worldwide. Manifestations include increased blood pressure, proteinuria, coagulopathy and peripheral and cerebral oedema. Although the aetiology and pathogenesis remain to be elucidated, the placenta is undoubtedly involved, as termination of pregnancy eradicates the disease. Here we have cloned a complementary DNA from human placental messenger RNA encoding a precursor protein of 121 amino acids which gives rise to a mature peptide identical to the neuropeptide neurokinin B (NKB)(1) of other mammalian species. In female rats, concentrations of NKB several-fold above that of an animal 20 days into pregnancy caused substantial pressor activity. In human pregnancy, the expression of NKB was confined to the outer syncytiotrophoblast of the placenta, significant concentrations of NKB could be detected in plasma as early as week 9, and plasma concentrations of NKB were grossly elevated in pregnancy-induced hypertension and pre-eclampsia. We conclude that elevated levels of NKB in early pregnancy may be an indicator of hypertension and pre-eclampsia, and that treatment with certain neurokinin receptor antagonists may be useful in alleviating the symptoms.	Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England; Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2UH, England; Univ London St Georges Hosp, Dept Obstet & Gynaecol, London SW17 0QT, England	University of Reading; University of Nottingham; St Georges University London	Lowry, PJ (corresponding author), Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England.			Lomthaisong, Khomsorn/0000-0002-0645-5757; Page, Nigel/0000-0002-7147-1550				ADAMS MD, 1995, NATURE, V377, P3; Baigent SM, 2000, J MOL ENDOCRINOL, V24, P53, DOI 10.1677/jme.0.0240053; BAUMANN H, 1991, AM J OBSTET GYNECOL, V165, P237, DOI 10.1016/0002-9378(91)90265-S; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; CAMPBELL EA, 1987, J CLIN ENDOCR METAB, V64, P1054, DOI 10.1210/jcem-64-5-1054; Cellier E, 1997, BRIT J PHARMACOL, V122, P643, DOI 10.1038/sj.bjp.0701435; CLEMENTJONES V, 1980, NATURE, V283, P295, DOI 10.1038/283295a0; Conrad KP, 1999, AM J PHYSIOL-RENAL, V277, pF48, DOI 10.1152/ajprenal.1999.277.1.F48; COUTURE R, 1989, N-S ARCH PHARMACOL, V340, P547; DORLEANSJUSTE P, 1991, EUR J PHARMACOL, V204, P329, DOI 10.1016/0014-2999(91)90860-S; Gecse A, 1996, IMMUNOPHARMACOLOGY, V33, P167, DOI 10.1016/0162-3109(96)00035-5; Hayman R, 1999, J SOC GYNECOL INVEST, V6, P3, DOI 10.1016/S1071-5576(98)00044-6; JANSEN I, 1991, J CEREBR BLOOD F MET, V11, P567, DOI 10.1038/jcbfm.1991.105; KANGAWA K, 1983, BIOCHEM BIOPH RES CO, V114, P533, DOI 10.1016/0006-291X(83)90813-6; KIMURA S, 1983, P JPN ACAD B-PHYS, V59, P101, DOI 10.2183/pjab.59.101; Kobari M, 1996, EUR J PHARMACOL, V317, P269, DOI 10.1016/S0014-2999(96)00725-X; Lim KH, 1997, AM J PATHOL, V151, P1809; Longmore J, 1997, CAN J PHYSIOL PHARM, V75, P612, DOI 10.1139/cjpp-75-6-612; Lyall F, 1996, Rev Reprod, V1, P107, DOI 10.1530/ror.0.0010107; MASTRANGELO D, 1987, EUR J PHARMACOL, V134, P321, DOI 10.1016/0014-2999(87)90363-3; MOUSSAOUI SM, 1992, NEUROSCIENCE, V48, P969, DOI 10.1016/0306-4522(92)90285-A; Page N. M., 1998, Journal of Endocrinology, V156, pP257; PERIANIN A, 1989, BIOCHEM BIOPH RES CO, V161, P520, DOI 10.1016/0006-291X(89)92630-2; PERRETTI M, 1993, IMMUNOLOGY, V80, P73; Roccon A, 1996, BRIT J PHARMACOL, V118, P1095, DOI 10.1111/j.1476-5381.1996.tb15511.x; Shimizu T, 1999, BRAIN RES, V830, P372, DOI 10.1016/S0006-8993(99)01386-4; STABLES JM, 1994, NEUROPEPTIDES, V27, P333, DOI 10.1016/0143-4179(94)90059-0; Thompson GW, 1998, AM J PHYSIOL-REG I, V44, P1683; von Euler US, 1931, J PHYSIOL-LONDON, V72, P74, DOI 10.1113/jphysiol.1931.sp002763	29	212	228	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					797	800		10.1038/35015579	http://dx.doi.org/10.1038/35015579			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866201				2022-12-24	WOS:000087620600052
J	Pizzari, T; Birkhead, TR				Pizzari, T; Birkhead, TR			Female feral fowl eject sperm of subdominant males	NATURE			English	Article							MATING-BEHAVIOR; COMPETITION; CHOICE; POLYANDRY	Paternity is often determined by competition between the ejaculates of different males(1). Males can also use particular behaviours or structures to manipulate how females use sperm(2-5). However, the ability of females to bias sperm utilization in favour of preferred males independently of male manipulation has not been demonstrated(6). Females are predicted to respond differentially to the sperm of different males when the reproductive interests of the sexes differ and when females are coerced into copulating(4,6). Here we show that in female feral fowl most copulations are coerced, and that females consistently bias sperm retention in favour of the preferred male phenotype. Females prefer to copulate with dominant males, but when sexually coerced by subordinate males, they manipulate the behaviour of dominant males to reduce the likelihood of insemination. If this fails, females differentially eject ejaculates according to male status in the absence of any male manipulation and preferentially retain the sperm of dominant males.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Pizzari, T (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.							ALLEN T. E., 1957, AUSTRALIAN JOUR AGRIC RES, V8, P788, DOI 10.1071/AR9570788; Bakst M.R., 1997, TECHNIQUES SEMEN EVA; Birkhead TR, 1998, EVOLUTION, V52, P1212, DOI [10.2307/2411251, 10.1111/j.1558-5646.1998.tb01848.x]; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; CHENG KM, 1988, CONDOR, V90, P697, DOI 10.2307/1368360; Clark AG, 1999, SCIENCE, V283, P217, DOI 10.1126/science.283.5399.217; CLUTTONBROCK TH, 1979, ANIM BEHAV, V27, P211, DOI 10.1016/0003-3472(79)90141-6; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; CRAIG JV, 1965, ANIM BEHAV, V13, P114, DOI 10.1016/0003-3472(65)90081-3; Cunningham EJA, 1999, P ROY SOC B-BIOL SCI, V266, P905, DOI 10.1098/rspb.1999.0722; Darwin C., 1871, P423; DAVIES NB, 1983, NATURE, V302, P334, DOI 10.1038/302334a0; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Edvardsson M, 2000, P ROY SOC B-BIOL SCI, V267, P559, DOI 10.1098/rspb.2000.1037; Etches R. J., 1996, REPROD POULTRY; Harrison B., 1987, SVEN RASF TIDSKRIFT, V1, P12; ISHIKAWA H, 1930, P WORLD POULT J C, P90; JONES MEJ, 1991, POULTRY SCI, V70, P1493, DOI 10.3382/ps.0701493; MARTIN PA, 1974, J REPROD FERTIL, V39, P251, DOI 10.1530/jrf.0.0390251; OTRONEN M, 1990, BEHAV ECOL SOCIOBIOL, V26, P349, DOI 10.1007/BF00171101; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Parker J. E., 1942, MISSOURI AGR EXPT ST, V347, P1; PIZZARI T, 1999, THESIS U SHEFFIELD; SHELDON BC, 1993, P R SOC LOND B, V39, P491; SIMMONS LW, 1987, BEHAV ECOL SOCIOBIOL, V21, P197, DOI 10.1007/BF00303211; Sokal R. R, 1981, BIOMETRY; THORNHILL R, 1992, SPERM COMPETITION BI, P82; Wiley RH, 1996, EVOLUTION, V50, P1371, DOI 10.1111/j.1558-5646.1996.tb03911.x; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010	30	272	273	1	84	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					787	789		10.1038/35015558	http://dx.doi.org/10.1038/35015558			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866198				2022-12-24	WOS:000087620600049
J	Chin, DP; Crane, CM; Diul, MY; Sun, SJ; Agraz, R; Taylor, S; Desmond, E; Wise, F				Chin, DP; Crane, CM; Diul, MY; Sun, SJ; Agraz, R; Taylor, S; Desmond, E; Wise, F			Spread of Mycobacterium tuberculosis in a community implementing recommended elements of tuberculosis control	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PULMONARY TUBERCULOSIS; SAN-FRANCISCO; TRANSMISSION; OUTBREAK; EPIDEMIOLOGY; DIAGNOSIS; STRAIN; DELAY; CITY	Context Despite improvements in tuberculosis (TB) control during the past decade, Mycobacterium tuberculosis transmission and resulting disease continue to occur in the United States. Objective To determine the primary reasons for disease development from a particular strain of M tuberculosis. Design Population-based, molecular epidemiological study. Setting Urban community in the San Francisco Bay area of California with recommended elements of TB control in place. Patients Seventy-three TB cases were reported in 1996-1997 that resulted from 1 strain of M tuberculosis as identified by TB genotyping and epidemiological linkage. Main Outcome Measures Transmission patterns involving source and secondary case-patients; primary reasons for disease development. Results Seventy-three (33%) of 221 TB case-patients in this community resulted from this strain of M tuberculosis. Thirty-nine (53%) of the 73 case-patients developed TB because they were not identified as contacts of source case-patients; 20 case-patients (27%) developed TB because of delayed diagnosis of their sources; and 13 case-patients (18%) developed TB because of problems associated with the evaluation or treatment of contacts; and 1 case-patient (1%) developed TB because of delay in being elicited as a contact. Of the 51 TB cases identified with sources, 49 (96%) were infected within the 2 years prior to diagnosis. Conclusions Our results indicate that in a community that has implemented the essential elements of TB control, TB from ongoing transmission of M tuberculosis will continue to develop unless patients are diagnosed earlier and contacts are more completely identified.	Calif Dept Hlth Serv, TB Control Branch, Berkeley, CA 94704 USA; Calif Dept Hlth Serv, Microbial Dis Lab, Berkeley, CA 94704 USA; Contra Costa Publ Hlth, TB Programs, Martinez, CA USA; WHO, CH-1211 Geneva, Switzerland	California Department of Health Care Services; California Department of Health Care Services; World Health Organization	Chin, DP (corresponding author), 2151 Berkeley Way,Room 608, Berkeley, CA 94704 USA.	chind@chn.wpro.who.int			PHS HHS [U52/CCU900515-18] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; Asch S, 1998, AM J RESP CRIT CARE, V157, P1244, DOI 10.1164/ajrccm.157.4.9709071; Barnes PF, 1997, JAMA-J AM MED ASSOC, V278, P1159, DOI 10.1001/jama.278.14.1159; Behr MA, 1998, AM J RESP CRIT CARE, V158, P465, DOI 10.1164/ajrccm.158.2.9801062; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Bishai WR, 1998, JAMA-J AM MED ASSOC, V280, P1679, DOI 10.1001/jama.280.19.1679; Bradford WZ, 1998, J INFECT DIS, V177, P1104, DOI 10.1086/517405; Burman WJ, 1997, AM J RESP CRIT CARE, V155, P1140, DOI 10.1164/ajrccm.155.3.9117000; *CA DEP HLTH SERV, 1998, CONT INV GUID; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P39; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P79; Chaves F, 1996, J CLIN MICROBIOL, V34, P1118, DOI 10.1128/JCM.34.5.1118-1123.1996; COUNSELL SR, 1989, ARCH INTERN MED, V149, P1274, DOI 10.1001/archinte.149.6.1274; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; Frieden TR, 1996, JAMA-J AM MED ASSOC, V276, P1229, DOI 10.1001/jama.276.15.1229; Jasmer RM, 1999, ANN INTERN MED, V130, P971, DOI 10.7326/0003-4819-130-12-199906150-00004; KLOVDAHL AS, 1985, SOC SCI MED, V21, P1203, DOI 10.1016/0277-9536(85)90269-2; MATHUR P, 1994, ARCH INTERN MED, V154, P306, DOI 10.1001/archinte.154.3.306; MOUDGIL H, 1994, RESP MED, V88, P507, DOI 10.1016/S0954-6111(05)80332-4; Raffalli J, 1996, ARCH INTERN MED, V156, P1053, DOI 10.1001/archinte.156.10.1053; ROTHENBERG RB, 1996, INVESTIGATION CONTAC, P34; RUBEL AJ, 1992, PUBLIC HEALTH REP, V107, P626; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Valway SE, 1998, NEW ENGL J MED, V338, P633, DOI 10.1056/NEJM199803053381001; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Woelffer GB, 1996, AM J MED SCI, V311, P17, DOI 10.1097/00000441-199601000-00004	27	60	64	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2000	283	22					2968	2974		10.1001/jama.283.22.2968	http://dx.doi.org/10.1001/jama.283.22.2968			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XL	10865275	Bronze			2022-12-24	WOS:000087480600037
J	Traber, MG; Jialal, I				Traber, MG; Jialal, I			Measurement of lipid-soluble vitamins - further adjustment needed?	LANCET			English	Editorial Material							CORONARY-DISEASE; HEART-DISEASE; E CONSUMPTION; TOCOPHEROL; RISK		Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; Univ Texas, Hlth Sci Ctr, Dept Pathol & Internal Med, Dallas, TX 75235 USA	Oregon State University; University of Texas System; University of Texas Dallas	Traber, MG (corresponding author), Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA.		Traber, Maret G./ABI-2511-2020; Jialal, Ishwarlal/AAG-6218-2019	Traber, Maret G./0000-0002-2892-4024; 				Booth SL, 1998, J NUTR, V128, P785, DOI 10.1093/jn/128.5.785; Cavalier L, 1998, AM J HUM GENET, V62, P301, DOI 10.1086/301699; Cham BE, 1999, CLIN CHIM ACTA, V287, P45, DOI 10.1016/S0009-8981(99)00117-5; Devaraj S, 1998, CURR OPIN LIPIDOL, V9, P11, DOI 10.1097/00041433-199802000-00004; GEY KF, 1991, AM J CLIN NUTR, V53, pS326, DOI 10.1093/ajcn/53.1.326S; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; SHEARER MJ, 1995, LANCET, V345, P229, DOI 10.1016/S0140-6736(95)90227-9; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Stephens NG, 1996, LANCET, V347, P781, DOI 10.1016/S0140-6736(96)90866-1; THURNHAM DI, 1986, ANN CLIN BIOCHEM, V23, P514, DOI 10.1177/000456328602300505; TRABER MG, 1999, MODERN NUTR HLTH DIS, P347; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; 2000, DIETARY REFERENCE IN	14	90	94	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 10	2000	355	9220					2013	2014		10.1016/S0140-6736(00)02345-X	http://dx.doi.org/10.1016/S0140-6736(00)02345-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	322QC	10885350				2022-12-24	WOS:000087519400006
J	Keeling, PJ; Palmer, JD				Keeling, PJ; Palmer, JD			Phylogeny - Parabasalian flagellates are ancient eukaryotes	NATURE			English	Article							EVOLUTION; HYDROGENOSOMES		Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Keeling, PJ (corresponding author), Univ British Columbia, Canadian Inst Adv Res, Vancouver, BC V6T 1Z4, Canada.		Palmer, Jeffrey/P-6747-2014	Palmer, Jeffrey/0000-0002-4626-2220; Keeling, Patrick/0000-0002-7644-0745				BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; Embley TM, 1997, TRENDS ECOL EVOL, V12, P437, DOI 10.1016/S0169-5347(97)01208-1; Embley TM, 1998, CURR OPIN GENET DEV, V8, P624, DOI 10.1016/S0959-437X(98)80029-4; Fast NM, 1999, MOL BIOCHEM PARASIT, V99, P275, DOI 10.1016/S0166-6851(99)00017-1; Keeling PJ, 1998, BIOESSAYS, V20, P87, DOI 10.1002/(SICI)1521-1878(199801)20:1<87::AID-BIES12>3.0.CO;2-4; Liston DR, 1999, MOL CELL BIOL, V19, P2380; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Muller M, 1997, PARASITOL TODAY, V13, P166, DOI 10.1016/S0169-4758(97)01036-3; Philippe H, 1998, CURR OPIN GENET DEV, V8, P616, DOI 10.1016/S0959-437X(98)80028-2; Roger AJ, 1999, MOL BIOL EVOL, V16, P218, DOI 10.1093/oxfordjournals.molbev.a026104; Stiller JW, 1999, MOL BIOL EVOL, V16, P1270, DOI 10.1093/oxfordjournals.molbev.a026217	11	62	63	0	3	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					635	637		10.1038/35015167	http://dx.doi.org/10.1038/35015167			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864312				2022-12-24	WOS:000087465800034
J	Lee, TI; Causton, HC; Holstege, FCP; Shen, WC; Hannett, N; Jennings, EG; Winston, F; Green, NR; Young, RA				Lee, TI; Causton, HC; Holstege, FCP; Shen, WC; Hannett, N; Jennings, EG; Winston, F; Green, NR; Young, RA			Redundant roles for the TFIID and SAGA complexes in global transcription	NATURE			English	Article							POLYMERASE-II TRANSCRIPTION; TATA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; IN-VIVO; HISTONE ACETYLTRANSFERASE; NUCLEOSOME ACETYLATION; ADA-COMPLEX; YEAST; GCN5; ACTIVATION	The transcription factors TFIID and SAGA are multi-subunit complexes involved in transcription by RNA polymerase II1,2. TFIID and SAGA contain common TATA-binding protein (TBP)-associated factor (TAF(II)) subunits and each complex contains a subunit with histone acetyltransferase activity(3). These observations have raised questions about whether the functions of the two complexes in vivo are unique or overlapping. Here we use genome-wide expression analysis to investigate how expression of the yeast genome depends on both shared and unique subunits of these two complexes. We find that expression of most genes requires one or more of the common TAF(II) subunits, indicating that the functions of TFIID and SAGA are widely required for gene expression. Among the subunits shared by TFIID and SAGA are three histone-like TAF(II)s, which have been proposed to forma sub-complex and mediate a common function in global transcription. Unexpectedly, we find that the histonelike TAF(II)s have distinct roles in expression of the yeast genome. Most importantly, we show that the histone acetylase components of TFIID and SAGA (TAF(II)145 and Gcn5) are functionally redundant, indicating that expression of a large fraction of yeast genes can be regulated through the action of either complex.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Utrecht, Med Ctr, Dept Med Genet, NL-3584 EA Utrecht, Netherlands; Univ Massachusetts, Med Ctr, Program Mol Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Utrecht University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Holstege, Frank/AAM-9944-2021; Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Causton, Helen/0000-0003-4630-6569				Apone LM, 1996, GENE DEV, V10, P2368, DOI 10.1101/gad.10.18.2368; Apone LM, 1998, MOL CELL, V2, P653, DOI 10.1016/S1097-2765(00)80163-X; Biggar SR, 1999, EMBO J, V18, P2254, DOI 10.1093/emboj/18.8.2254; Eberharter A, 1999, MOL CELL BIOL, V19, P6621; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Hahn S, 1998, CELL, V95, P579, DOI 10.1016/S0092-8674(00)81625-6; Hoffmann A, 1996, NATURE, V380, P356, DOI 10.1038/380356a0; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Horiuchi J, 1997, MOL CELL BIOL, V17, P3220, DOI 10.1128/MCB.17.6.3220; Komarnitsky PB, 1999, GENE DEV, V13, P2484, DOI 10.1101/gad.13.19.2484; Lee TI, 1998, GENE DEV, V12, P1398, DOI 10.1101/gad.12.10.1398; Michel B, 1998, MOL CELL, V2, P663, DOI 10.1016/S1097-2765(00)80164-1; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Moqtaderi Z, 1998, MOL CELL, V2, P675, DOI 10.1016/S1097-2765(00)80165-3; Moqtaderi Z, 1996, NATURE, V383, P188, DOI 10.1038/383188a0; Natarajan K, 1998, MOL CELL, V2, P683, DOI 10.1016/S1097-2765(00)80166-5; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; Roberts SM, 1996, MOL CELL BIOL, V16, P3206; Roberts SM, 1997, GENETICS, V147, P451; Sanders SL, 1999, J BIOL CHEM, V274, P18847, DOI 10.1074/jbc.274.27.18847; Shen WC, 1997, CELL, V90, P615, DOI 10.1016/S0092-8674(00)80523-1; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Sudarsanam P, 1999, EMBO J, V18, P3101, DOI 10.1093/emboj/18.11.3101; Walker SS, 1996, NATURE, V383, P185, DOI 10.1038/383185a0; Walker SS, 1997, CELL, V90, P607, DOI 10.1016/S0092-8674(00)80522-X; Winston F, 1998, COLD SPRING HARB SYM, V63, P553, DOI 10.1101/sqb.1998.63.553; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0	29	297	301	1	23	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					701	704		10.1038/35015104	http://dx.doi.org/10.1038/35015104			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864329				2022-12-24	WOS:000087465800051
J	Uhlen, P; Laestadius, A; Jahnukainen, T; Soderblom, T; Backhed, F; Celsi, G; Brismar, H; Normark, S; Aperia, A; Richter-Dahlfors, A				Uhlen, P; Laestadius, A; Jahnukainen, T; Soderblom, T; Backhed, F; Celsi, G; Brismar, H; Normark, S; Aperia, A; Richter-Dahlfors, A			alpha-Haemolysin of uropathogenic E-coli induces Ca2+ oscillations in renal epithelial cells	NATURE			English	Article							ESCHERICHIA-COLI; ACUTE PYELONEPHRITIS; HEMOLYSIN; CALCIUM; ACTIVATION; EXPRESSION	Pyelonephritis is one of the most common febrile diseases in children. If not treated appropriately, it causes irreversible renal damage and accounts for a large proportion of end stage renal failures(1). Renal scarring can occur in the absence of inflammatory cells, indicating that bacteria may have a direct signalling effect on renal cells(2). Intracellular calcium ([Ca2+](i)) oscillations can protect cells from the cytotoxic effects of prolonged increases in intracellular calcium(3,4). However, no pathophysiologically relevant protein that induces such oscillations has been identified. Here we show that infection by uropathogenic Escherichia coli induces a constant, low-frequency oscillatory [Ca2+](i) response in target primary rat renal epithelial cells induced by the secreted RTX (repeats-in-toxin) toxin alpha-haemolysin. The response depends on calcium influx through L-type calcium channels as well as from internal stores gated by inositol triphosphate. Internal calcium oscillations induced by alpha-haemolysin in a renal epithelial cell line stimulated production of cytokines interleukin (IL)-6 and IL-8. Our findings indicate a novel role for alpha-haemolysin in pyelonephritis: as an inducer of an oscillating second messenger response in target cells, which fine-tunes gene expression during the inflammatory response.	Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden; Karolinska Inst, Astrid Lindgren Childrens Hosp, Dept Women & Child Hlth, S-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Richter-Dahlfors, A (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, S-17177 Stockholm, Sweden.	agneta.richter.dahlfors@mtc.ki.se	Backhed, Fredrik/ABE-6613-2020; Brismar, Hjalmar/E-8524-2011	Backhed, Fredrik/0000-0002-4871-8818; Brismar, Hjalmar/0000-0003-0578-4003; Uhlen, Per/0000-0003-1446-1062; Richter-Dahlfors, Agneta/0000-0002-5479-7591				BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Berridge MJ, 1997, J PHYSIOL-LONDON, V499, P291, DOI 10.1113/jphysiol.1997.sp021927; BHAKDI S, 1986, INFECT IMMUN, V52, P63, DOI 10.1128/IAI.52.1.63-69.1986; BLUM G, 1994, INFECT IMMUN, V62, P606, DOI 10.1128/IAI.62.2.606-614.1994; BOLSOVER SR, 1993, ELECT LIGHT MICROSCO, P181; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; HACKER J, 1983, INFECT IMMUN, V42, P57, DOI 10.1128/IAI.42.1.57-63.1983; JACOBSON SH, 1994, NEPHRON, V67, P172, DOI 10.1159/000187923; Jenkins G. M., 1969, SPECTRAL ANAL ITS AP, P1; LARSSON S, 1986, AM J PHYSIOL, V251, pC455, DOI 10.1152/ajpcell.1986.251.3.C455; LUDWIG A, 1987, MOL GEN GENET, V206, P238, DOI 10.1007/BF00333579; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; MATTSBYBALTZER I, 1982, INFECT IMMUN, V35, P639, DOI 10.1128/IAI.35.2.639-646.1982; Meldolesi J, 1998, NATURE, V392, P863, DOI 10.1038/31804; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Serlachius E, 1997, KIDNEY INT, V51, P1855, DOI 10.1038/ki.1997.253; Stanley P, 1998, MICROBIOL MOL BIOL R, V62, P309, DOI 10.1128/MMBR.62.2.309-333.1998; TULLUS K, 1984, J INFECT DIS, V150, P728, DOI 10.1093/infdis/150.5.728; VOGEL M, 1988, MOL GEN GENET, V212, P76, DOI 10.1007/BF00322447; WING AJ, 1992, OXFORD TXB CLIN NEPH, V2, P1227	25	190	197	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2000	405	6787					694	697		10.1038/35015091	http://dx.doi.org/10.1038/35015091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864327				2022-12-24	WOS:000087465800049
J	Rivara, FP; Koepsell, TD; Grossman, DC; Mock, C				Rivara, FP; Koepsell, TD; Grossman, DC; Mock, C			Effectiveness of automatic shoulder belt systems in motor vehicle crashes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MULTIPLE IMPUTATION; SEAT-BELT; RATES	Context Approximately 10 million cars with automatic shoulder belt systems are currently in use in the United States. However, reports on the effectiveness of such restraints have yielded conflicting results. Objective To determine the effectiveness of automatic shoulder belt systems in reducing the risk of injury and death among front-seat passenger vehicle occupants. Design, Setting, and Subjects Analysis of data collected from the 1993-1996 National Highway Traffic Safety Administration Crashworthiness Data System on front-seat occupants involved in 25 811 tow-away crashes of passenger cars, light trucks, vans, and sport utility vehicles, Main Outcome Measures Death and serious injury to specific body areas by use of manual lap and shoulder belts, automatic shoulder belts with manual lap belts, or automatic shoulder belts without lap belts, compared with no restraint use. Results Use of automatic shoulder belts without lap belts was associated with a decrease in the risk of death vs no restraint use but was not statistically significant for all crashes (odds ratio [OR], 0.66; 95% confidence interval [CI], 0.42-1.06) or for frontal crashes (OR, 0.71; 95% CI, 0.38-1.35) after adjustment for occupant age, sex, vehicle year, airbag deployment, estimated change in vehicle speed during the crash, and principal direction of force. This association was significantly weaker than the 86% lower risk observed for use of automatic shoulder belts with lap belts (OR, 0.14; 95% CI, 0.07-0.26 vs no restraint; P<.05). Use of automatic shoulder belts without lap belts was associated with an increased risk of serious chest (OR, 2.66; 95% CI, 1.11-6.35) and abdominal (OR, 2.06; 95% CI, 1.004-4.22) injuries for all crashes. Conclusions These data indicate that improperly used automatic restraint systems may be less effective than properly used systems and are associated with an increased risk of serious chest and abdominal injuries. Given the continued widespread use of these automatic systems, educational programs may be warranted.	Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; Univ Washington, Dept Pediat, Seattle, WA 98104 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98104 USA; Crash Injury Res & Engn Network, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rivara, FP (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Box 359960,325 9th Ave, Seattle, WA 98104 USA.			Mock, Charles/0000-0002-0564-568X				Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Barnard J, 1999, STAT METHODS MED RES, V8, P17, DOI 10.1191/096228099666230705; EVANS L, 1991, ACCIDENT ANAL PREV, V23, P165, DOI 10.1016/0001-4575(91)90046-8; McConnell EJ, 1997, J TRAUMA, V43, P150, DOI 10.1097/00005373-199707000-00038; NASH CE, 1989, ACCIDENT ANAL PREV, V21, P517, DOI 10.1016/0001-4575(89)90067-5; *NAT HIGHW TRAFF S, 1992, HS PUBL; *NAT HIGHW TRAFF S, 1996, HS PUBL; REINFURT DW, 1991, ACCIDENT ANAL PREV, V23, P521, DOI 10.1016/0001-4575(91)90017-Y; ROH LS, 1993, J FORENSIC SCI, V38, P972; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; SALDEEN T, 1967, J TRAUM, V7, P856, DOI 10.1097/00005373-196711000-00007; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; TAYLOR TKF, 1976, J BONE JOINT SURG BR, V58, P328, DOI 10.1302/0301-620X.58B3.956250; Veenema Kenneth R., 1994, Journal of Emergency Medicine, V12, P317, DOI 10.1016/0736-4679(94)90272-0; WILLIAMS AF, 1989, ACCIDENT ANAL PREV, V21, P427, DOI 10.1016/0001-4575(89)90003-1; YARBROUGH BE, 1990, SOUTHERN MED J, V83, P843, DOI 10.1097/00007611-199007000-00029; 1999, NATL VEHICLE POPULAT	17	41	42	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2000	283	21					2826	2828		10.1001/jama.283.21.2826	http://dx.doi.org/10.1001/jama.283.21.2826			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	320BQ	10838652	Bronze			2022-12-24	WOS:000087381500038
J	DeKoter, RP; Singh, H				DeKoter, RP; Singh, H			Regulation of B lymphocyte and macrophage development by graded expression of PU.1	SCIENCE			English	Article							TRANSCRIPTION FACTOR PU.1; MURINE FETAL LIVER; T-CELL; CHROMOSOMAL POSITION; ETS ONCOGENE; STEM-CELLS; DIFFERENTIATION; LINEAGE; PROGENITORS; PRECURSORS	The ets family transcription factor PU.1 is required for the development of multiple lineages of the immune system. Using retroviral transduction of PU.1 complementary DNA into mutant hematopoietic progenitors, we demonstrate that differing concentrations of the protein regulate the development of B lymphocytes as compared with macrophages. A low concentration of PU.1 protein induces the B cell fate, whereas a high concentration promotes macrophage differentiation and blocks B cell development. Conversely, a transcriptionally weakened mutant protein preferentially induces B cell generation. Our results suggest that graded expression of a transcription factor can be used to specify distinct cell fates in the hematopoietic system.	Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago	Singh, H (corresponding author), Univ Chicago, Howard Hughes Med Inst, 5841 S Maryland Ave, Chicago, IL 60637 USA.	hsingh@midway.uchicago.edu	DeKoter, Rodney/A-9415-2009	DeKoter, Rodney/0000-0002-9201-1983				Anderson KL, 1998, BLOOD, V92, P1576, DOI 10.1182/blood.V92.5.1576.417k29_1576_1585; COLLINS LS, 1987, J IMMUNOL, V138, P1082; CROSS MA, 1994, ONCOGENE, V9, P3013; CUMANO A, 1992, NATURE, V356, P612, DOI 10.1038/356612a0; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DEKOTER RP, UNPUB; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; FEINSTEIN SC, 1982, J MOL BIOL, V156, P549, DOI 10.1016/0022-2836(82)90266-2; Fisher RC, 1998, MOL CELL BIOL, V18, P4347, DOI 10.1128/MCB.18.7.4347; Glimcher LH, 1999, CELL, V96, P13, DOI 10.1016/S0092-8674(00)80955-1; HOEBEN RC, 1991, J VIROL, V65, P904, DOI 10.1128/JVI.65.2.904-912.1991; HROMAS R, 1993, BLOOD, V82, P2998; Kawamoto H, 1997, INT IMMUNOL, V9, P1011, DOI 10.1093/intimm/9.7.1011; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Klemsz MJ, 1996, MOL CELL BIOL, V16, P390; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Lacaud G, 1998, IMMUNITY, V9, P827, DOI 10.1016/S1074-7613(00)80648-2; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; NELSEN B, 1993, SCIENCE, V261, P82, DOI 10.1126/science.8316859; Olson MC, 1995, IMMUNITY, V3, P703, DOI 10.1016/1074-7613(95)90060-8; RAMKUMAR S, UNPUB; ROSS IL, 1994, ONCOGENE, V9, P121; Scott EW, 1997, IMMUNITY, V6, P437, DOI 10.1016/S1074-7613(00)80287-3; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Singh H, 1999, COLD SPRING HARB SYM, V64, P13, DOI 10.1101/sqb.1999.64.13; Spain LM, 1999, J IMMUNOL, V163, P2681; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; VOSO MT, 1994, P NATL ACAD SCI USA, V91, P7932, DOI 10.1073/pnas.91.17.7932; WALSH JC, UNPUB; WINKLER TH, 1995, BLOOD, V85, P2045, DOI 10.1182/blood.V85.8.2045.bloodjournal8582045	33	542	554	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2000	288	5470					1439	1441		10.1126/science.288.5470.1439	http://dx.doi.org/10.1126/science.288.5470.1439			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318EL	10827957				2022-12-24	WOS:000087270900055
J	Dobson, A; Lyles, A				Dobson, A; Lyles, A			Ecology - Black-footed ferret recovery	SCIENCE			English	Editorial Material									Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Wildlife Conservat Soc, New York, NY 10010 USA	Princeton University; Wildlife Conservation Society	Dobson, A (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.							Biggins DE, 1999, BIOL CONSERV, V89, P121, DOI 10.1016/S0006-3207(98)00158-X; Vargas A, 1998, CAN J ZOOL, V76, P1696, DOI 10.1139/cjz-76-9-1696; WILCOVE D. S., 1999, CONDORS SHADOW LOSS	3	52	55	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2000	288	5468					985	+		10.1126/science.288.5468.985	http://dx.doi.org/10.1126/science.288.5468.985			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	313EY	10841720				2022-12-24	WOS:000086988400024
J	Entwistle, VA; Watt, IS; Johnson, F				Entwistle, VA; Watt, IS; Johnson, F			The case of Norplant as an example of media coverage over the life of a new health technology	LANCET			English	Article								Background The contraceptive implant Norplant (levonorgestrel) had a fairly short life in the UK. This made it a convenient subject for a case study of how media coverage alters over time. We set out to produce a critical description of national newspaper coverage of Norplant over the course of its use in the UK. Methods We searched newspaper databases and press-clippings files for articles about Norplant printed between 1992 and 1996. For those that met our inclusion criteria, we extracted bibliographical data, made a standardised judgment about the "slant" of the article towards Norplant, and used qualitative techniques to analyse the content of the articles. Findings 101 national newspaper articles were included in the study. Norplant attracted media coverage over the course of its career, but the slant of articles shifted dramatically over time from a favourable to a negative presentation. This reflected the use of different story types over the course of time. Early reports presented Norplant very positively as either a clear improvement on existing contraceptive methods or a valuable addition to the range. Any disadvantages were down-played. The positive image of Norplant was reinforced immediately after its official launch by reports that it was in great demand but women might be denied access to it. Less than a year later, however, newspaper reports about Norplant were dominated by the stories of individual women who had had bad experiences with the product. Interpretation Three main reporting themes were seen. At first, Norplant was presented as a positive new development, and one that might be denied to people. In later coverage it became a flawed and damaging product. These themes recur in media reporting of health technologies, and the fact that they occur at different stages in a product's career means that a balanced assessment of the technology is not usually feasible from media reporting at any one time. An appreciation of the forms and implications of these reporting frameworks could help health-care providers and users to appraise media reports more critically.	Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; Univ York, Dept Hlth Studies, York YO1 5DD, N Yorkshire, England; Univ Coll, Imperial Canc Res Fund, Hlth Behav Unit, London, England	University of Aberdeen; University of York - UK; Cancer Research UK; University of London; University College London	Entwistle, VA (corresponding author), Univ Aberdeen, Hlth Serv Res Unit, Polwarth Bldg, Aberdeen AB25 2ZD, Scotland.		Entwistle, Vikki Ann/I-9266-2019; Johnson, Fiona/F-1305-2014	Entwistle, Vikki Ann/0000-0002-0856-4025; Johnson, Fiona/0000-0002-4271-1834				Anderson P, 1999, BRIT MED J, V318, P1578, DOI 10.1136/bmj.318.7198.1578; Berger A, 1998, BMJ, V317, P824; BOWER H, 1995, DOCTOR          1005, P20; Brindle D., 1999, SOCIAL POLICY MEDIA, P39; Bromham DR, 1996, BRIT MED J, V312, P1555, DOI 10.1136/bmj.312.7046.1555; Draper P., 1977, HLTH MASS MEDIA NATL; Entwhistle V., 1999, SOCIAL POLICY MEDIA, P118; ENTWISTLE V, 1995, BRIT MED J, V310, P920, DOI 10.1136/bmj.310.6984.920; ERIKSON R, 1989, NEGOTIATING CONTROL; FOWLER R, 1991, LANGUAGE NEWS DISCOU, P10; FRANKLIN R, 1999, SOCIAL POLICY MEDIA, P1; Galtung J., 1973, MANUFACTURE NEWS SOC, P62; GRILLI R, 1998, COCHRANE LIB; Karpf Anne, 1988, DOCTORING MEDIA REPO, P4; LAWLER PG, 1998, BRIT MED J, V317, P882; MCCOMBS ME, 1993, J COMMUN, V43, P58, DOI 10.1111/j.1460-2466.1993.tb01262.x; MCQUAIL D, 1987, MASS COMMUNICATION T, P135; Offringa M, 1998, BMJ-BRIT MED J, V317, P223, DOI 10.1136/bmj.317.7153.223; Rogers EM, 1983, DIFFUSION INNOVATION	19	15	15	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 6	2000	355	9215					1633	1636		10.1016/S0140-6736(00)02226-1	http://dx.doi.org/10.1016/S0140-6736(00)02226-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CD	10821380				2022-12-24	WOS:000086981200038
J	Hayreh, SS				Hayreh, SS			Steroid therapy for visual loss In patients with giant-cell arteritis	LANCET			English	Editorial Material							TEMPORAL ARTERITIS; OCULAR MANIFESTATIONS; CRITERIA		Univ Iowa, Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA	University of Iowa	Hayreh, SS (corresponding author), Univ Iowa, Coll Med, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA.		Hayreh, Sohan Singh/AFU-1623-2022	Hayreh, Sohan/0000-0002-0709-886X				BLUMBERG S, 1980, JAMA-J AM MED ASSOC, V244, P1713, DOI 10.1001/jama.244.15.1713; Cohen D N, 1973, Trans Am Acad Ophthalmol Otolaryngol, V77, pOP74; GOUET D, 1986, PRESSE MED, V15, P603; GRAHAM E, 1981, BRIT MED J, V282, P269, DOI 10.1136/bmj.282.6260.269; Hayreh S S, 1962, Br J Ophthalmol, V46, P212, DOI 10.1136/bjo.46.4.212; Hayreh SS, 1997, AM J OPHTHALMOL, V123, P285, DOI 10.1016/S0002-9394(14)70123-0; HAYREH SS, 1980, OPHTHALMOLOGY, V87, P75, DOI 10.1016/s0161-6420(80)35283-4; Hayreh SS, 1998, AM J OPHTHALMOL, V125, P509, DOI 10.1016/S0002-9394(99)80192-5; Hayreh SS, 1998, AM J OPHTHALMOL, V125, P521, DOI 10.1016/S0002-9394(99)80193-7; HAYREH SS, 1996, OPHTHALMOL CLIN N AM, V9, P404; HAYREH SS, 1995, EXP EYE RES, V61, P257; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Kearns TP, 1975, EYE SYSTEMIC DIS, P105; Kupersmith MJ, 1999, BRIT J OPHTHALMOL, V83, P796, DOI 10.1136/bjo.83.7.796; KYLE V, 1991, BAILLIERE CLIN RHEUM, V5, P485, DOI 10.1016/S0950-3579(05)80067-6; WADMAN B, 1972, ACTA MED SCAND, V192, P377	16	21	21	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 6	2000	355	9215					1572	1573		10.1016/S0140-6736(00)02210-8	http://dx.doi.org/10.1016/S0140-6736(00)02210-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CD	10821358				2022-12-24	WOS:000086981200005
J	Baker, D				Baker, D			A surprising simplicity to protein folding	NATURE			English	Article							SINGLE-DOMAIN PROTEINS; TRANSITION-STATE; LATTICE MODELS; CONTACT ORDER; DYNAMICS; SIMULATIONS; LANDSCAPE; SEQUENCES; PATHWAYS; KINETICS	The polypeptide chains that make up proteins have thousands of atoms and hence millions of possible inter-atomic interactions. It might be supposed that the resulting complexity would make prediction of protein structure and protein-folding mechanisms nearly impossible. But the fundamental physics underlying folding may be much simpler than this complexity would lead us to expect: folding rates and mechanisms appear to be largely determined by the topology of the native (folded) state, and new methods have shown great promise in predicting protein-folding mechanisms and the three-dimensional structures of proteins.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, J567 Hlth Sci Bldg,Box 357350, Seattle, WA 98195 USA.		Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217				ABKEVICH VI, 1994, BIOCHEMISTRY-US, V33, P10026, DOI 10.1021/bi00199a029; Alm E, 1999, P NATL ACAD SCI USA, V96, P11305, DOI 10.1073/pnas.96.20.11305; Alm E, 1999, CURR OPIN STRUC BIOL, V9, P189, DOI 10.1016/S0959-440X(99)80027-X; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Burton RE, 1998, BIOCHEMISTRY-US, V37, P5337, DOI 10.1021/bi980245c; Chan HS, 1998, PROTEINS, V30, P2, DOI 10.1002/(SICI)1097-0134(19980101)30:1<2::AID-PROT2>3.0.CO;2-R; Chiti F, 1999, NAT STRUCT BIOL, V6, P1005; Debe DA, 1999, J MOL BIOL, V294, P619, DOI 10.1006/jmbi.1999.3278; Dobson Christopher M., 1999, Current Opinion in Structural Biology, V9, P92, DOI 10.1016/S0959-440X(99)80012-8; Fersht A. R., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Galzitskaya OV, 1999, P NATL ACAD SCI USA, V96, P11299, DOI 10.1073/pnas.96.20.11299; GO N, 1983, ANNU REV BIOPHYS BIO, V12, P183, DOI 10.1146/annurev.bb.12.060183.001151; Horwich AL, 1999, P NATL ACAD SCI USA, V96, P11033, DOI 10.1073/pnas.96.20.11033; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Kim DE, 1998, P NATL ACAD SCI USA, V95, P4982, DOI 10.1073/pnas.95.9.4982; Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928; Li AJ, 1996, J MOL BIOL, V257, P412, DOI 10.1006/jmbi.1996.0172; LopezHernandez E, 1996, FOLD DES, V1, P43, DOI 10.1016/S1359-0278(96)00011-9; Martinez JC, 1999, NAT STRUCT BIOL, V6, P1010; Micheletti C, 1999, PHYS REV LETT, V82, P3372, DOI 10.1103/PhysRevLett.82.3372; Moult J, 1999, PROTEINS, P2; Munoz V, 1999, P NATL ACAD SCI USA, V96, P11311, DOI 10.1073/pnas.96.20.11311; Murzin AG, 1999, PROTEINS, P88; Onuchic JN, 2000, ADV PROTEIN CHEM, V53, P87; Orengo CA, 1999, PROTEINS, P149; Ortiz AR, 1999, PROTEINS, P177; Pande VS, 1998, CURR OPIN STRUC BIOL, V8, P68, DOI 10.1016/S0959-440X(98)80012-2; Perl D, 1998, NAT STRUCT BIOL, V5, P229, DOI 10.1038/nsb0398-229; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Portman JJ, 1998, PHYS REV LETT, V81, P5237, DOI 10.1103/PhysRevLett.81.5237; Rhee S, 1998, P NATL ACAD SCI USA, V95, P10413, DOI 10.1073/pnas.95.18.10413; Riddle DS, 1999, NAT STRUCT BIOL, V6, P1016; Riddle DS, 1997, NAT STRUCT BIOL, V4, P805, DOI 10.1038/nsb1097-805; Samudrala R, 1999, PROTEINS, P194; Shakhnovich EI, 1998, FOLD DES, V3, pR108, DOI 10.1016/S1359-0278(98)00056-X; Shea JE, 1999, P NATL ACAD SCI USA, V96, P12512, DOI 10.1073/pnas.96.22.12512; Sheinerman FB, 1997, PROTEINS, V29, P193, DOI 10.1002/(SICI)1097-0134(199710)29:2<193::AID-PROT7>3.0.CO;2-E; Simons KT, 1999, PROTEINS, P171; Slupsky CM, 1998, P NATL ACAD SCI USA, V95, P12129, DOI 10.1073/pnas.95.21.12129; Thirumalai D, 1998, FOLD DES, V3, pR112, DOI 10.1016/S1359-0278(98)00057-1; Villegas V, 1998, J MOL BIOL, V283, P1027, DOI 10.1006/jmbi.1998.2158; Weigelt J, 1999, STRUCT FOLD DES, V7, P681, DOI 10.1016/S0969-2126(99)80089-6	44	606	631	3	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2000	405	6782					39	42		10.1038/35011000	http://dx.doi.org/10.1038/35011000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311TK	10811210				2022-12-24	WOS:000086901600043
J	Maron, BJ				Maron, BJ			Role of alcohol septal ablation in treatment of obstructive hypertrophic cardiomyopathy	LANCET			English	Editorial Material							REDUCTION		Minneapolis Heart Inst Fdn, Cardiovasc Res Div, Minneapolis, MN 55407 USA	Minneapolis Heart Institute Foundation	Maron, BJ (corresponding author), Minneapolis Heart Inst Fdn, Cardiovasc Res Div, Minneapolis, MN 55407 USA.							Gietzen FH, 1999, EUR HEART J, V20, P1342, DOI 10.1053/euhj.1999.1520; Henein MY, 1999, J AM COLL CARDIOL, V34, P1117, DOI 10.1016/S0735-1097(99)00332-0; Knight C, 1997, CIRCULATION, V95, P2075, DOI 10.1161/01.CIR.95.8.2075; Lakkis NM, 1998, CIRCULATION, V98, P1750, DOI 10.1161/01.CIR.98.17.1750; Maron BJ, 1998, CIRCULATION, V98, P2505, DOI 10.1161/01.CIR.98.23.2505; Maron BJ, 1999, CIRCULATION, V99, P2927, DOI 10.1161/01.CIR.99.22.2927; Maron BJ, 1997, LANCET, V350, P127, DOI 10.1016/S0140-6736(97)01282-8; MARON BJ, IN PRESS N ENGL J ME; Nagueh SF, 1999, CIRCULATION, V99, P344, DOI 10.1161/01.CIR.99.3.344; Rubin David N., 1999, Journal of the American College of Cardiology, V33, p502A; Seggewiss H, 1998, J AM COLL CARDIOL, V31, P252, DOI 10.1016/S0735-1097(97)00508-1; SIGWART U, 1995, LANCET, V346, P211, DOI 10.1016/S0140-6736(95)91267-3; Spirito P, 1999, J AM COLL CARDIOL, V33, P1071	13	51	54	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2000	355	9202					425	426		10.1016/S0140-6736(00)82005-X	http://dx.doi.org/10.1016/S0140-6736(00)82005-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841119				2022-12-24	WOS:000085306800005
J	Tabar, L; Chen, HH; Duffy, SW; Yen, MF; Chiang, CF; Dean, PB; Smith, RA				Tabar, L; Chen, HH; Duffy, SW; Yen, MF; Chiang, CF; Dean, PB; Smith, RA			A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study	LANCET			English	Article							CARCINOMA-IN-SITU; MAMMOGRAPHIC FEATURES; MUCINOUS CARCINOMA; CLASSIFICATION; TRIAL; PURE	Background Women with small mammographically detected breast cancers generally have good long-term outcomes, but a few with T1a (1-5 mm) and T1b (6-10 mm) tumours will eventually die from breast cancer. We investigated whether Women at high risk of breast-cancer death could be identified with mammographic criteria and differentiated from women with small cancers of the breast and good outcomes. Methods We prospectively applied mammographic classifications of tumour type to a consecutive series of 343 mammograms of invasive breast cancers of size 1-14 mm, Classifications were: stellate (spiculated) mass with no calcifications; circular or oval lesions with no calcifications; spiculated or circular lesions with non-casting-type calcifications; and casting-type calcifications. Findings 20-year survival for women with 1-14 mm invasive tumours with casting-type calcifications was 55%. 14% of 138 women with 1-9 mm tumours had casting-type calcifications-on mammography, which accounted for 73% of ail breast-cancer deaths (p<0.001). T1a, T1b, and 10-14 mm tumours with casting-type calcifications behaved as if they were larger lesions, since the rate of death was similar to that for women with advanced high-grade tumours, Most women who died were node-negative. The long-term survival of women who had tumours of 1-9 mm with no casting-type calcifications was about 95%. Interpretation Mammographic classification seemed to reliably predict good and bad long-term outcomes for survival in tumours of 14 mm or smaller, and especially for those smaller than 10 mm. The implications for therapy are substantial.	Falun Cent Hosp, Dept Mammog, S-79182 Falun, Sweden; Uppsala Univ, Fac Med, Dept Radiol, Uppsala, Sweden; Natl Taiwan Univ, Coll Publ Hlth, Dept Epidemiol, Taipei 10764, Taiwan; Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England; Univ Turku, Turku, Finland; Amer Canc Soc, Dept Canc Control, Atlanta, GA 30329 USA	Falun Hospital; Uppsala University; National Taiwan University; MRC Biostatistics Unit; University of Cambridge; University of Turku; American Cancer Society	Tabar, L (corresponding author), Falun Cent Hosp, Dept Mammog, S-79182 Falun, Sweden.	laszlo@mammographic.com	Tabar, Laszlo Kornel/AGT-3287-2022	Dean, Peter/0000-0003-0757-9054; Chen, Hsiu-Hsi/0000-0002-5799-6705				*AM COLL RAD, 1998, MAMM BREAST IM REP D; EUSEBI V, 1994, SEMIN DIAGN PATHOL, V11, P223; EVANS AJ, 1994, CLIN RADIOL, V49, P559, DOI 10.1016/S0009-9260(05)82937-X; Evans AJ, 1997, BRIT J CANCER, V75, P542, DOI 10.1038/bjc.1997.94; GOODMAN DNF, 1995, CAN ASSOC RADIOL J, V46, P296; Hendrick R E, 1997, J Natl Cancer Inst Monogr, P87; Hermann G, 1999, CAN ASSOC RADIOL J, V50, P235; HILLEREN DJ, 1991, RADIOLOGY, V178, P149, DOI 10.1148/radiology.178.1.1984294; HOLLAND R, 1990, LANCET, V335, P519, DOI 10.1016/0140-6736(90)90747-S; HOLLAND R, 1994, SEMIN DIAGN PATHOL, V11, P167; Joensuu H, 1999, CANCER-AM CANCER SOC, V85, P2183, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2183::AID-CNCR12>3.0.CO;2-K; LAGIOS MD, 1989, CANCER, V63, P618, DOI 10.1002/1097-0142(19890215)63:4<618::AID-CNCR2820630403>3.0.CO;2-J; Lanyi M., 1988, DIAGNOSIS DIFFERENTI; Moss SM, 1999, LANCET, V353, P1909, DOI 10.1016/S0140-6736(98)07412-1; SILVERSTEIN MJ, 1995, LANCET, V345, P1154; Silverstein MJ, 1999, NEW ENGL J MED, V340, P1455, DOI 10.1056/NEJM199905133401902; Simpson JF, 1996, SEMIN ONCOL, V23, P428; Tabar L, 1999, CANCER, V86, P449, DOI 10.1002/(SICI)1097-0142(19990801)86:3<449::AID-CNCR13>3.0.CO;2-Q; TABAR L, 1992, RADIOL CLIN N AM, V30, P187; TABAR L, 1989, J EPIDEMIOL COMMUN H, V43, P107, DOI 10.1136/jech.43.2.107; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; TABAR L, 1999, RSNA CATEGORICAL COU, P9; TABAR L, 1983, TEACHING ATLAS MAMMO; TABAR L, 1997, DUCTAL CARCINOMA IN, P95; TUBIANA M, 1991, BREAST CANCER RES TR, V18, P125, DOI 10.1007/BF01990028; Tubiana M, 1999, ACTA ONCOL, V38, P295; WILSON TE, 1995, AM J ROENTGENOL, V165, P285, DOI 10.2214/ajr.165.2.7618541	28	132	143	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2000	355	9202					429	433						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841122				2022-12-24	WOS:000085306800008
J	Stamler, J; Daviglus, ML; Garside, DB; Dyer, AR; Greenland, P; Neaton, JD				Stamler, J; Daviglus, ML; Garside, DB; Dyer, AR; Greenland, P; Neaton, JD			Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; FOLLOW-UP; ADULTS; DISEASE; LIFE	Context Based on observational and interventional data for middle-aged cohorts (aged 40-64 years), serum cholesterol level is known to be an established major risk factor for coronary heart disease (CHD). However, findings for younger people are limited, and the value of detecting and treating hypercholesterolemia in younger adults is debated. Objective To evaluate the long-term impact of unfavorable serum cholesterol levels on risk of death from CHD, cardiovascular disease (CVD), and all causes, Design, Setting, and Participants Three prospective studies, from which were selected 3 cohorts of younger men with baseline serum cholesterol level measurements and no history of diabetes mellitus or myocardial infarction. A total of 11 017 men aged 18 through 39 years screened in 1967-1973 for the Chicago Heart Association Detection Project in Industry (CHA); 1266 men aged 25 through 39 years examined in 1959-1963 in the Peoples Cas Company Study (PCI); and 69 205 men aged 35 through 39 years screened in 1973-1975 for the Multiple Risk Factor Intervention Trial (MRFIT). Main Outcome Measures Cause-specific mortality during 25 (CHA), 34 (PCI), and 16 (MRFIT) years of follow-up; mortality risks; and estimated life expectancy in relation to baseline serum cholesterol levels. Results Death due to CHD accounted for 26%, 34%, and 28% of all deaths in the CHA, PC, and MRFIT cohorts, respectively; and CVD death for 34%, 42%, and 39% of deaths in the same cohorts, respectively. Men in all 3 cohorts with unfavorable serum cholesterol levels (200-239 mg/dL [5.17-6.18 mmol/L] and greater than or equal to 240 mg/dl [greater than or equal to 6.21 mmol/L]) had strong gradients of relative mortality risk. For men with serum cholesterol levels of 240 mg/dL or greater (greater than or equal to 6.21 mmol/L) vs favorable levels (<200 mg/dL [<5.17 mmol/L]), CHD mortality risk was 2.15 to 3.63 times greater; CVD disease mortality risk was 2.10 to 2.87 times greater; and all-cause mortality was 1.31 to 1.49 times greater, Hypercholesterolemic men had age-adjusted absolute risk of CHD death of 59 per 1000 men in 25 years (CHA cohort), 90 per 1000 men in 34 years (PCI cohort), and 15 per 1000 men in 16 years (MRFIT cohort). Absolute excess risk was 43.6 per 1000 men (CHA), 81.4 per 1000 men (PCI), and 12.1 per 1000 men (MRFIT). Men with favorable baseline serum cholesterol levels had an estimated greater life expectancy of 3.8 to 8.7 years. Conclusions These results demonstrate a continuous, graded relationship of serum cholesterol level to long-term risk of CHD, CVD, and all-cause mortality, substantial absolute risk and absolute excess risk of CHD and CVD death for younger men with elevated serum cholesterol levels, and longer estimated life expectancy for younger men with favorable serum cholesterol levels.	Northwestern Univ, Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA	Northwestern University; University of Minnesota System; University of Minnesota Twin Cities	Stamler, J (corresponding author), Northwestern Univ, Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.	hwe216@nwu.edu	Greenland, Philip/ABD-5528-2021		NHLBI NIH HHS [HL 21010, HL 21785] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021010] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABELL LL, 1952, J BIOL CHEM, V195, P357; ANDERSON KM, 1987, JAMA-J AM MED ASSOC, V257, P2176, DOI 10.1001/jama.257.16.2176; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Cleeman JI, 1997, CIRCULATION, V95, P1646; Davidoff F, 1996, ANN INTERN MED, V124, P513, DOI 10.7326/0003-4819-124-5-199603010-00011; Deckelbaum R. J., 1999, Circulation, V100, P450; Garber AM, 1996, ANN INTERN MED, V124, P518, DOI 10.7326/0003-4819-124-5-199603010-00013; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; HULLEY SB, 1992, CIRCULATION, V86, P1026, DOI 10.1161/01.CIR.86.3.1026; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; LaRosa JC, 1996, ANN INTERN MED, V124, P505, DOI 10.7326/0003-4819-124-5-199603010-00008; LEVINE JB, 1964, CLIN CHIM ACTA, V10, P381, DOI 10.1016/0009-8981(64)90073-7; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; NAT'L ACAD. ON AN AGING SOC'Y, 1999, HLTH EFF EXP POW LIN, P1; *POOL PROJ RES GRO, 1978, J CHRON DIS, V31, P201, DOI DOI 10.1016/0021-9681(78)90073-5; PRINEAS RJ, 1983, HYPERTENSION, V5, P160; STAMLER J, 1993, CIRCULATION, V88, P1954, DOI 10.1161/01.CIR.88.4.1954; STAMLER J, 1993, CARDIOLOGY, V82, P191, DOI 10.1159/000175868; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; STAMLER J, 1994, CIRCULATION, V90, P2573; Stamler J., 1967, LECT PREVENTIVE CARD; The Inter-Society Commission for Heart Disease Resources, 1970, CIRCULATION, V42, pA55; [No title captured]	24	395	415	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2000	284	3					311	318		10.1001/jama.284.3.311	http://dx.doi.org/10.1001/jama.284.3.311			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	333GR	10891962	Bronze			2022-12-24	WOS:000088123000023
J	Huelsenbeck, JP; Rannala, B; Masly, JP				Huelsenbeck, JP; Rannala, B; Masly, JP			Accommodating phylogenetic uncertainty in evolutionary studies	SCIENCE			English	Article							INFERENCE	Many evolutionary studies use comparisons across species to detect evidence of natural selection and to examine the rate of character evolution, Statistical analyses in these studies are usually performed by means of a species phylogeny to accommodate the effects of shared evolutionary history. The phylogeny is usually treated as known without error; this assumption is problematic because inferred phylogenies are subject to both stochastic and systematic errors. We describe methods for accommodating phylogenetic uncertainty in evolutionary studies by means of Bayesian inference. The methods are computationally intensive but general enough to be applied in most comparative evolutionary studies.	Univ Rochester, Dept Biol, Rochester, NY 14627 USA; Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada	University of Rochester; University of Alberta	Huelsenbeck, JP (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	johnh@brahms.biology.rochester.edu	Rannala, Bruce/M-3188-2014; Huelsenbeck, John P/C-6398-2013	Rannala, Bruce/0000-0002-8355-9955; 	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001988] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01-HG01988] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Donoghue MJ, 1996, PHILOS T R SOC B, V351, P1241, DOI 10.1098/rstb.1996.0107; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.1093/biomet/57.1.97; HUELSENBECK JP, 1995, SYST BIOL, V44, P17, DOI 10.2307/2413481; Martins EP, 1996, EVOLUTION, V50, P12, DOI 10.1111/j.1558-5646.1996.tb04468.x; Mau B, 1999, BIOMETRICS, V55, P1, DOI 10.1111/j.0006-341X.1999.00001.x; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/PL00006090; Simon D, 1999, BAYESIAN ANAL MOL BI; Stern DL, 1998, EVOLUTION, V52, P155, DOI [10.1111/j.1558-5646.1998.tb05148.x, 10.2307/2410930]	13	238	245	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2000	288	5475					2349	2350		10.1126/science.288.5475.2349	http://dx.doi.org/10.1126/science.288.5475.2349			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329NP	10875916				2022-12-24	WOS:000087913400034
J	Muir, G; Fleming, CC; Schlotterer, C				Muir, G; Fleming, CC; Schlotterer, C			Taxonomy - Species status of hybridizing oaks	NATURE			English	Article							QUERCUS-PETRAEA		Queens Univ Belfast, Dept Appl Plant Sci, Belfast BT9 5PX, Antrim, North Ireland; Vet Med Univ Wien, Inst Tierzucht & Genet, A-1210 Vienna, Austria	Queens University Belfast; University of Veterinary Medicine Vienna	Muir, G (corresponding author), Queens Univ Belfast, Dept Appl Plant Sci, Newforge Lane, Belfast BT9 5PX, Antrim, North Ireland.		Schlötterer, Christian/G-6326-2010; Schlötterer, Christian/Q-5264-2019	Schlötterer, Christian/0000-0003-4710-6526; Schlötterer, Christian/0000-0003-4710-6526				Bacilieri R, 1996, EVOLUTION, V50, P900, DOI [10.2307/2410861, 10.1111/j.1558-5646.1996.tb03898.x]; Bodenes C, 1997, HEREDITY, V78, P433, DOI 10.1038/hdy.1997.67; Burger W. C., 1975, Taxon, V24, P45, DOI 10.2307/1218998; Cornuet JM, 1999, GENETICS, V153, P1989; Dumolin-Lapegue S, 1999, EVOLUTION, V53, P1406, DOI 10.1111/j.1558-5646.1999.tb05405.x; Felsenstein J, 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FERRIS C, 1993, MOL ECOL, V2, P337, DOI 10.1111/j.1365-294X.1993.tb00026.x; Harr B, 1998, CURR BIOL, V8, P1183, DOI 10.1016/S0960-9822(07)00490-3; Rushton B. S., 1983, Irish Forestry, V40, P52; Samuel R, 1999, PLANT SYST EVOL, V217, P137, DOI 10.1007/BF00984926; Zanetto A., 1994, Forest Genetics, V1, P111	11	116	119	0	27	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 29	2000	405	6790					1016	1016		10.1038/35016640	http://dx.doi.org/10.1038/35016640			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	328VN	10890434	Bronze			2022-12-24	WOS:000087871700034
J	Leon, DA; Smith, GD				Leon, DA; Smith, GD			Infant mortality, stomach cancer, stroke, and coronary heart disease: ecological analysis	BRITISH MEDICAL JOURNAL			English	Article									Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of London; London School of Hygiene & Tropical Medicine; University of Bristol	Leon, DA (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.		Davey Smith, George/A-7407-2013; Leon, David A/G-2195-2010	Davey Smith, George/0000-0002-1407-8314; Leon, David A/0000-0001-9747-1762				Elford J, 1997, LIFE COURSE APPROACH TO CHRONIC DISEASE EPIDEMIOLOGY, P220; Gale CR, 1997, J ROY SOC MED, V90, P138, DOI 10.1177/014107689709000307; Parsonnet J, 1999, MICROBES AND MALIGNANCY, P372; Smith GD, 1998, BMJ-BRIT MED J, V316, P1631, DOI 10.1136/bmj.316.7145.1631; *UN, 1948, IUN DEM YB, P70	5	57	59	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1705	1706		10.1136/bmj.320.7251.1705	http://dx.doi.org/10.1136/bmj.320.7251.1705			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864546	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000087926400024
J	Hopfner, KP; Karcher, A; Shin, DS; Craig, L; Arthur, LM; Carney, JP; Tainer, JA				Hopfner, KP; Karcher, A; Shin, DS; Craig, L; Arthur, LM; Carney, JP; Tainer, JA			Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-strand break repair and the ABC-ATPase superfamily	CELL			English	Article							GTPASE-ACTIVATING PROTEINS; NUCLEOTIDE-BINDING FOLD; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; HISTIDINE PERMEASE; IONIZING-RADIATION; CRYSTAL-STRUCTURE; CHROMOSOMES SMC; MULTIDRUG-RESISTANCE; TRANSITION-STATE	To clarify the key role of Rad50 in DNA double-strand break repair (DSBR), we biochemically and structurally characterized ATP-bound and ATP-free Rad50 catalytic domain (Rad50cd) from Pyrococcus furiosus. Rad50cd displays ATPase activity plus ATP-controlled dimerization and DNA binding activities. Rad50cd crystal structures identify probable protein and DNA interfaces and reveal an ABC-ATPase fold, linking Rad50 molecular mechanisms to ABC transporters, including P glycoprotein and cystic fibrosis transmembrane conductance regulator. Binding of ATP gamma-phosphates to conserved signature motifs in two opposing Rad50cd molecules promotes dimerization that likely couples ATP hydrolysis to dimer dissociation and DNA release. These results, validated by mutations, suggest unified molecular mechanisms for ATP-driven cooperativity and allosteric control of ABC-ATPases in DSBR, membrane transport, and chromosome condensation by SMC proteins.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Dept Radiat Oncol,Radiat Oncol Res Lab, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Mol & Cell Biol Grad Program, Baltimore, MD 21201 USA	Scripps Research Institute; Scripps Research Institute; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Tainer, JA (corresponding author), Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.	jat@scripps.edu	Tainer, John/GWQ-4878-2022; Hopfner, Karl-Peter/B-6864-2014	Tainer, John/0000-0003-1659-2429; Hopfner, Karl-Peter/0000-0002-4528-8357; Craig, Lisa/0000-0001-8515-9915	PHS HHS [H1076950] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; ARMSTRONG S, 1998, PEDIAT PULMONOL, V17, P91; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Bierne H, 1997, EMBO J, V16, P3332, DOI 10.1093/emboj/16.11.3332; Bressan DA, 1999, MOL CELL BIOL, V19, P7681; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Connelly JC, 1997, J BIOL CHEM, V272, P19819, DOI 10.1074/jbc.272.32.19819; Connelly JC, 1998, P NATL ACAD SCI USA, V95, P7969, DOI 10.1073/pnas.95.14.7969; DAVIDSON AL, 1990, J BIOL CHEM, V265, P4254; Davidson AL, 1997, J BACTERIOL, V179, P5458, DOI 10.1128/jb.179.17.5458-5464.1997; DOIGE CA, 1993, ANNU REV MICROBIOL, V47, P291, DOI 10.1146/annurev.micro.47.1.291; Dolganov GM, 1996, MOL CELL BIOL, V16, P4832; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Gamblin SJ, 1998, CURR OPIN STRUC BIOL, V8, P195, DOI 10.1016/S0959-440X(98)80038-9; GAME JC, 1993, SEMIN CANCER BIOL, V4, P73; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Holmes VF, 2000, P NATL ACAD SCI USA, V97, P1322, DOI 10.1073/pnas.040576797; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; KADYK LC, 1992, GENETICS, V132, P387; Kimura K, 1999, CELL, V98, P239, DOI 10.1016/S0092-8674(00)81018-1; LEACH DRF, 1996, GENETIC RECOMBINATIO; Liu CE, 1997, J BIOL CHEM, V272, P859, DOI 10.1074/jbc.272.2.859; Liu PQ, 1999, J BIOL CHEM, V274, P18310, DOI 10.1074/jbc.274.26.18310; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; MANAVALAN P, 1995, FEBS LETT, V366, P87, DOI 10.1016/0014-5793(95)00463-J; McKee AHZ, 1997, GENETICS, V146, P797; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nikaido K, 1999, J BIOL CHEM, V274, P26727, DOI 10.1074/jbc.274.38.26727; OTWINOWSKI Z, 1993, DATA COLLECTION PROC; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Petrini J H, 1997, Semin Immunol, V9, P181, DOI 10.1006/smim.1997.0067; PHILLIPS JW, 1994, MOL CELL BIOL, V14, P5794, DOI 10.1128/MCB.14.9.5794; RAYMOND WE, 1993, NUCLEIC ACIDS RES, V21, P3851, DOI 10.1093/nar/21.16.3851; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rosenberg MF, 1997, J BIOL CHEM, V272, P10685; Roth D., 1988, GENETIC RECOMBINATIO, P621; SAITOH N, 1995, BIOESSAYS, V17, P759, DOI 10.1002/bies.950170905; Sawitzke JA, 2000, P NATL ACAD SCI USA, V97, P1671, DOI 10.1073/pnas.030528397; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schmiesing JA, 1998, P NATL ACAD SCI USA, V95, P12906, DOI 10.1073/pnas.95.22.12906; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Strunnikov AV, 1999, EUR J BIOCHEM, V263, P6, DOI 10.1046/j.1432-1327.1999.00509.x; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; TURK D, 1992, THESIS TU MUNCHEN; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; van den Ent F, 1999, STRUCTURE, V7, P1181, DOI 10.1016/S0969-2126(00)80052-0; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Zdzienicka MZ, 1996, CANCER SURV, V28, P281; Zhang BL, 1999, J BIOL CHEM, V274, P2609, DOI 10.1074/jbc.274.5.2609; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	73	797	810	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 23	2000	101	7					789	800		10.1016/S0092-8674(00)80890-9	http://dx.doi.org/10.1016/S0092-8674(00)80890-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	327YE	10892749	Bronze			2022-12-24	WOS:000087821400012
J	Li, BY; Yu, H; Zheng, WP; Voll, R; Na, SQ; Roberts, AW; Williams, DA; Davis, RJ; Ghosh, S; Flavell, RA				Li, BY; Yu, H; Zheng, WP; Voll, R; Na, SQ; Roberts, AW; Williams, DA; Davis, RJ; Ghosh, S; Flavell, RA			Role of the guanosine triphosphatase Rac2 in T helper 1 cell differentiation	SCIENCE			English	Article							GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVITY; TRANSGENIC MICE; KAPPA-B; ACTIVATION; PROTEIN; RHO; LYMPHOCYTES; KINASE; REQUIRES	T helper 1 (T(H)1) cells mediate cellular immunity, whereas T(H)2 cells potentiate antiparasite and humoral immunity. We used a complementary DNA subtraction method, representational display analysis, to show that the small guanosine triphosphatase Rac2 is expressed selectively in murine T(H)1 cells. Rac induces the interferon-gamma (IFN-gamma) promoter through cooperative activation of the nuclear factor kappa B and p38 mitogen-activated protein kinase pathways. Tetracycline-regulated transgenic mice expressing constitutively active Rac2 in T cells exhibited enhanced IFN-gamma production. Dominant-negative pac inhibited IFN-gamma production in murine T cells. Moreover, T cells from Rac2(-/-) mice showed decreased IFN-gamma production under T(H)1 conditions in vitro. Thus, Rac2 activates T(H)1-specific signaling and IFN-gamma gene expression.	Yale Univ, Sch Med, Immunol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Indiana Univ, Sch Med, Howard Hughes Med Inst, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; Univ Massachusetts, Med Ctr, Howard Hughes Med Inst, Worcester, MA 01605 USA; Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Indiana University System; Indiana University-Purdue University Indianapolis; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunol Sect, 310 Cedar St, New Haven, CT 06520 USA.	fran.manzo@yale.edu	Roberts, Andrew W./C-6736-2012	Roberts, Andrew W./0000-0002-7341-5720				Aune TM, 1997, MOL CELL BIOL, V17, P199, DOI 10.1128/MCB.17.1.199; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; Kaga S, 1998, J IMMUNOL, V160, P24; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; Li B. A., UNPUB; Lores P, 1997, ONCOGENE, V15, P601, DOI 10.1038/sj.onc.1201378; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Phillips RJ, 1996, MOL CELL BIOL, V16, P7089; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Reif K, 1998, IMMUNITY, V8, P395, DOI 10.1016/S1074-7613(00)80545-2; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; SHOCKETT P, 1995, P NATL ACAD SCI USA, V92, P6522, DOI 10.1073/pnas.92.14.6522; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; YU H, UNPUB; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	24	132	144	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2000	288	5474					2219	+		10.1126/science.288.5474.2219	http://dx.doi.org/10.1126/science.288.5474.2219			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864872				2022-12-24	WOS:000087782900060
J	Magavi, SS; Leavitt, BR; Macklis, JD				Magavi, SS; Leavitt, BR; Macklis, JD			Induction of neurogenesis in the neocortex of adult mice	NATURE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; MAMMALIAN FOREBRAIN; EMBRYONIC NEURONS; GENERATED NEURONS; GROWTH-FACTOR; MOUSE BRAIN; RAT; MIGRATION	Neurogenesis normally only occurs in limited areas of the adult mammalian brain-the hippocampus(1), olfactory bulb(2-4) and epithelium(5), and at low levels in some regions of macaque cortex(6). Here we show that endogenous neural precursors can be induced in situ to differentiate into mature neurons, in regions of adult mammalian neocortex that do not normally undergo any neurogenesis. This differentiation occurs in a layer- and region-specific manner, and the neurons can re-form appropriate corticothalamic connections. We induced synchronous apoptotic degeneration(7,8) of corticothalamic neurons in layer VI of anterior cortex of adult mice and examined the fates of dividing cells within cortex, using markers for DNA replication (5-bromodeoxyuridine; BrdU) and progressive neuronal differentiation. Newly made, BrdU-positive cells expressed NeuN, a mature neuronal marker, in regions of cortex undergoing targeted neuronal death and survived for at least 28 weeks. Subsets of BrdU+ precursors expressed Doublecortin, a protein found exclusively in migrating neurons(9,10), and Hu, an early neuronal marker(11,12). Retrograde labelling from thalamus demonstrated that BrdU+ neurons can form long-distance corticothalamic connections. Our results indicate that neuronal replacement therapies for neurodegenerative disease and CNS injury may be possible through manipulation of endogenous neural precursors in situ.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Macklis, JD (corresponding author), Childrens Hosp, Div Neurosci, Enders 350,320 Longwood Ave, Boston, MA 02115 USA.		Magavi, Sanjay/N-1551-2019; Leavitt, Blair R/G-1934-2012					ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BARAMI K, 1995, J NEUROBIOL, V28, P82, DOI 10.1002/neu.480280108; Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.0.CO;2-B; Craig CG, 1996, J NEUROSCI, V16, P2649; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gould E, 1996, DEV NEUROSCI-BASEL, V18, P22, DOI 10.1159/000111392; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Guillery RW, 1997, J COMP NEUROL, V386, P2, DOI 10.1002/(SICI)1096-9861(19970915)386:1<2::AID-CNE2>3.0.CO;2-6; HernitGrant CS, 1996, EXP NEUROL, V139, P131, DOI 10.1006/exnr.1996.0088; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; KIRN JR, 1993, J NEUROSCI, V13, P1654; Kuhn HG, 1997, J NEUROSCI, V17, P5820; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MACKLIS JD, 1993, J NEUROSCI, V13, P3848; MARUSICH MF, 1994, J NEUROBIOL, V25, P143, DOI 10.1002/neu.480250206; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Palmer TD, 1999, J NEUROSCI, V19, P8487; Parent JM, 1997, J NEUROSCI, V17, P3727; REH TA, 1987, J NEUROSCI, V7, P3317; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; Sheen VL, 1995, J NEUROSCI, V15, P8378; SHIN JS, IN PRESS J NEUROSCI; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; Wang YZ, 1998, EXP NEUROL, V154, P389, DOI 10.1006/exnr.1998.6965; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	31	1006	1082	0	80	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2000	405	6789					951	955		10.1038/35016083	http://dx.doi.org/10.1038/35016083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326JT	10879536				2022-12-24	WOS:000087732700051
J	Packham, C; Pearson, J; Robinson, J; Gray, D				Packham, C; Pearson, J; Robinson, J; Gray, D			Use of statins in general practices, 1996-8: cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Nottingham Hosp, Queens Med Ctr, Div Publ Hlth Med, Nottingham NG7 2UH, England; Univ Nottingham Hosp, Queens Med Ctr, Div Epidemiol, Nottingham NG7 2UH, England; Univ Nottingham Hosp, Queens Med Ctr, Div Cardiovasc Med, Nottingham NG7 2UH, England; Nottingham Hlth Author, Nottingham NG1 6GN, England	University of Nottingham; University of Nottingham; University of Nottingham	Packham, C (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Div Publ Hlth Med, Nottingham NG7 2UH, England.	chris.packham@nottingham.ac.uk						BAXTER C, 1998, BMJ-BRIT MED J, V317, P134; Packham C, 1999, J PUBLIC HEALTH MED, V21, P60, DOI 10.1093/pubmed/21.1.60; PEDERSEN TR, 1994, LANCET, V344, P1383; PICKEN DM, 1996, STATIN THERAPY HMG C; TOWNSEND P, 1998, HLTH DEPRIVATION INE	5	32	32	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2000	320	7249					1583	1584		10.1136/bmj.320.7249.1583	http://dx.doi.org/10.1136/bmj.320.7249.1583			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	324PW	10845969	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000087631400025
J	Li, YM; Xu, M; Lai, MT; Huang, Q; Castro, JL; DiMuzio-Mower, J; Harrison, T; Lellis, C; Nadin, JL; Neduvelil, JG; Register, RB; Sardana, MK; Shearman, MS; Smith, AL; Shi, XP; Yin, KC; Shafer, JA; Gardell, SJ				Li, YM; Xu, M; Lai, MT; Huang, Q; Castro, JL; DiMuzio-Mower, J; Harrison, T; Lellis, C; Nadin, JL; Neduvelil, JG; Register, RB; Sardana, MK; Shearman, MS; Smith, AL; Shi, XP; Yin, KC; Shafer, JA; Gardell, SJ			Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1	NATURE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; AMYLOID PRECURSOR PROTEIN; IN-VIVO; CELL BIOLOGY; ENDOPROTEOLYSIS; MUTATIONS; PEPTIDES; GENE	Cleavage of amyloid precursor protein (APP) by the beta- and gamma-secretases generates the amino and carboxy termini, respectively, of the A beta amyloidogenic peptides A beta 40 and A beta 42-the major constituents of the amyloid plaques in the brain parenchyma of Alzheimer's disease patients(1). There is evidence that the polytopic membrane-spanning proteins, presenilin 1 and 2 (PS1 and PS2), are important determinants of gamma-secretase activity: mutations in PS1 and PS2 that are associated with early-onset familial Alzheimer's disease(2,3) increase the production of A beta 42 (refs 4-6), the more amyloidogenic peptide; gamma-secretase activity is reduced in neuronal cultures derived from PS1-deficient mouse embryos(7); and directed mutagenesis of two conserved aspartates in transmembrane segments of PS1 inactivates the ability of gamma-secretase to catalyse processing of APP within its transmembrane domain(8). It is unknown, however, whether PS1 (which has little or no homology to any known aspartyl protease) is itself a transmembrane aspartyl protease or a gamma-secretase cofactor, or helps to colocalize gamma-secretase and APP. Here we report photoaffinity labelling of PS1 (and PS2) by potent gamma-secretase inhibitors that were designed to function as transition state analogue inhibitors directed to the active site of an aspartyl protease. This observation indicates that PS1 (and PS2) may contain the active site of gamma-secretase. Interestingly, the intact, single-chain form of wild-type PS1 is not labelled by an active-site-directed photoaffinity probe, suggesting that intact wild-type PS1 may be an aspartyl protease zymogen.	Merck Res Labs, Dept Biol Chem, West Point, PA 19486 USA; Merck Sharp & Dohme Res Labs, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England	Merck & Company; Merck & Company	Li, YM (corresponding author), Merck Res Labs, Dept Biol Chem, West Point, PA 19486 USA.	yueming_li@merck.com; steve_gardell@merck.com						Barelli HL, 1997, MOL MED, V3, P695, DOI 10.1007/BF03401708; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; EVANS BE, 1985, J ORG CHEM, V50, P4615, DOI 10.1021/jo00223a037; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Khorkova OE, 1998, J NEUROSCI METH, V82, P159, DOI 10.1016/S0165-0270(98)00053-3; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LI YM, IN PRESS P NATL ACAD; PerezTur J, 1995, NEUROREPORT, V7, P297; RICH DH, 1986, INHIBITORS ASPARTIC, P179; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Seeger M, 1997, P NATL ACAD SCI USA, V94, P5090, DOI 10.1073/pnas.94.10.5090; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; SHEARMAN MS, IN PRESS BIOCHEMISTR; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; WOLFENDEN R, 1972, ACCOUNTS CHEM RES, V5, P10, DOI 10.1021/ar50049a002; YANG HJ, 1994, BIO-TECHNOL, V12, P193, DOI 10.1038/nbt0294-193	23	830	870	5	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2000	405	6787					689	694		10.1038/35015085	http://dx.doi.org/10.1038/35015085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864326				2022-12-24	WOS:000087465800048
J	Whaley, SR; English, DS; Hu, EL; Barbara, PF; Belcher, AM				Whaley, SR; English, DS; Hu, EL; Barbara, PF; Belcher, AM			Selection of peptides with semiconductor binding specificity for directed nanocrystal assembly	NATURE			English	Article							NANOPARTICLES; ORGANIZATION; DNA	In biological systems, organic molecules exert a remarkable level of control over the nucleation and mineral phase of inorganic materials such as calcium carbonate and silica, and over the assembly of crystallites and other nanoscale building blocks into complex structures required for biological function(1-4). This ability to direct the assembly of nanoscale components into controlled and sophisticated structures has motivated intense efforts to develop assembly methods that mimic or exploit the recognition capabilities and interactions found in biological systems(5-10). Of particular value would be methods that could be applied to materials with interesting electronic or optical properties, but natural evolution has not selected for interactions between biomolecules and such materials. However, peptides with limited selectivity for binding to metal surfaces and metal oxide surfaces have been successfully selected(10,11). Here we extend this approach and show that combinatorial phage-display libraries can be used to evolve peptides that bind to a range of semiconductor surfaces with high specificity, depending on the crystallographic orientation and composition of the structurally similar materials we have used. As electronic devices contain structurally related materials in close proximity, such peptides may rnd use for the controlled placement and assembly of a variety of practically important materials, thus broadening the scope for 'bottom-up' fabrication approaches.	Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas, Texas Mat Inst, Austin, TX 78712 USA; Univ Calif Santa Barbara, Ctr Quantized Elect Struct, Santa Barbara, CA 93106 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of California System; University of California Santa Barbara	Belcher, AM (corresponding author), Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA.		Bishnoi, Sandra/F-2762-2011; English, Douglas/B-9382-2009					Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Brown S, 1997, NAT BIOTECHNOL, V15, P269, DOI 10.1038/nbt0397-269; BROWN S, 1992, P NATL ACAD SCI USA, V89, P8651, DOI 10.1073/pnas.89.18.8651; BRUST M, 1995, ADV MATER, V7, P795, DOI 10.1002/adma.19950070907; Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361; COLVIN VL, 1992, J AM CHEM SOC, V114, P5221, DOI 10.1021/ja00039a038; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Li M, 1999, CHEM MATER, V11, P23, DOI 10.1021/cm980610m; Meldrum F. C., 1993, P ROY SOC LOND B BIO, V251, P238; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; PARMLEY SF, 1988, GENE, V73, P305, DOI 10.1016/0378-1119(88)90495-7; SWAMINATHAN V, 1991, MAT ASPECTAS GAAS IN	13	1075	1182	6	444	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					665	668		10.1038/35015043	http://dx.doi.org/10.1038/35015043			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864319				2022-12-24	WOS:000087465800041
J	Rust, J				Rust, J			Palaeontology - Fossil record of mass moth migration	NATURE			English	Article									Univ Gottingen, Inst Zool & Anthropol, D-37073 Gottingen, Germany	University of Gottingen	Rust, J (corresponding author), Univ Gottingen, Inst Zool & Anthropol, Berliner Str 28, D-37073 Gottingen, Germany.							Bonde Niels, 1997, Aarhus Geoscience, V6, P33; HEYDEMANN BERNDT, 1967, DEUT ENTOMOL Z, V14, P185; Johnson C.G., 1969, MIGRATION DISPERSAL; KRISTENSEN NP, 1999, HDB ZOOL, V35, P7; LARSSON S G, 1975, Bulletin of the Geological Society of Denmark, V24, P193; MARTINEZDELCLOS X, 1993, DARMSTADTER BEITRAGE, V2, P133; Rust J, 1999, ZOOL J LINN SOC-LOND, V125, P331; Rust J, 1999, ENTOMOL SCAND, V30, P35; Rust Jes, 1998, Palaeontologische Zeitschrift, V72, P41; Williams CB, 1930, MIGRATION BUTTERFLIE	10	13	13	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					530	531		10.1038/35014733	http://dx.doi.org/10.1038/35014733			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850702				2022-12-24	WOS:000087449500037
J	Gascon, C; Williamson, GB; da Fonseca, GAB				Gascon, C; Williamson, GB; da Fonseca, GAB			Ecology - Receding forest edges and vanishing reserves	SCIENCE			English	Editorial Material							TROPICAL RAIN-FOREST; HABITAT FRAGMENTATION; EASTERN AMAZON; FIRE; DEFORESTATION; RECRUITMENT; RESPONSES; BIOMASS		Conservat Int, Ctr Appl Biodivers Sci, Washington, DC 20037 USA; Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; Inst Nacl Pesquisas Amazonia, Biol Dynam Forest Fragments Project, BR-69011970 Manaus, Amazonas, Brazil; Univ Fed Minas Gerais, Dept Zool, BR-31270 Belo Horizonte, MG, Brazil	Conservation International; Louisiana State University System; Louisiana State University; Institute Nacional de Pesquisas da Amazonia; Universidade Federal de Minas Gerais	Gascon, C (corresponding author), Conservat Int, Ctr Appl Biodivers Sci, 2501 M St NW,Suite 200, Washington, DC 20037 USA.							AYRES MJ, 1997, OS CORREDORES ECOLOG; Cochrane MA, 1999, BIOTROPICA, V31, P2, DOI 10.1111/j.1744-7429.1999.tb00112.x; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Curran LM, 1999, SCIENCE, V286, P2184, DOI 10.1126/science.286.5447.2184; DEAN W, 1995, BROADAX FIREBRAND DE; Enserink M, 1999, SCIENCE, V285, P1834, DOI 10.1126/science.285.5435.1834; Ferrer EJ, 1997, MOD PHYS LETT B, V11, P1, DOI 10.1142/S0217984997000025; Gascon C, 1998, ZOOL-ANAL COMPLEX SY, V101, P273; KAPOS V, 1993, J ECOL, V81, P425, DOI 10.2307/2261521; KAPOS V, 1989, J TROP ECOL, V5, P173, DOI 10.1017/S0266467400003448; Laurance WF, 1997, CONSERV BIOL, V11, P577, DOI 10.1046/j.1523-1739.1997.96385.x; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; Laurance WF, 1998, CONSERV BIOL, V12, P460, DOI 10.1046/j.1523-1739.1998.97175.x; Laurance WF, 1998, FOREST ECOL MANAG, V110, P173, DOI 10.1016/S0378-1127(98)00291-6; LAURANCE WF, 1994, BIOL CONSERV, V69, P23, DOI 10.1016/0006-3207(94)90325-5; Laurance William F., 1997, P502; Leopold A, 1933, GAME MANAGEMENT; Mesquita RCG, 1999, BIOL CONSERV, V91, P129, DOI 10.1016/S0006-3207(99)00086-5; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Nichol J. E., 1999, Progress in Environmental Science, V1, P97; PARSONS JJ, 1972, J RANGE MANAGE, V25, P12, DOI 10.2307/3896654; Sizer N, 1999, BIOL CONSERV, V91, P135, DOI 10.1016/S0006-3207(99)00076-2; SKOLE D, 1993, SCIENCE, V260, P1905, DOI 10.1126/science.260.5116.1905; Soulu M., 1999, CONTINENTAL CONSERVA; Tabarelli M, 1999, BIOL CONSERV, V91, P119, DOI 10.1016/S0006-3207(99)00085-3; UHL C, 1990, ECOLOGY, V71, P437, DOI 10.2307/1940299; Vega A, 1994, CORREDORES CONSERVAC; Viana Virgilio M., 1997, P351; WILLIAMSON BG, LESSONS AMAZONIA ECO; WILLIAMSON GB, 1998, FLORESTA AMAZONICA D, P131; [No title captured]	32	305	330	3	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 26	2000	288	5470					1356	1358		10.1126/science.288.5470.1356	http://dx.doi.org/10.1126/science.288.5470.1356			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318EL	10847849				2022-12-24	WOS:000087270900032
J	Liu, SQJ; Cull-Candy, SG				Liu, SQJ; Cull-Candy, SG			Synaptic activity at calcium-permeable AMPA receptors induces a switch in receptor subtype	NATURE			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL INTERNEURONS; RECTIFICATION; NEURONS; BLOCK; MODULATION; DETERMINES; ACTIVATION; DEPRESSION; DENDRITES	Activity-dependent change in the efficacy of transmission is a basic feature of many excitatory synapses in the central nervous system. The best understood postsynaptic modification involves a change in responsiveness of AMPAR (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor)-mediated currents following activation of NMDA (N-methyl-D-aspartate) receptors(1,2) or Ca(2+)-permeable AMPARs(3-6). This process is thought to involve alteration in the number and phosphorylation state of postsynaptic AMPARs(2). Here we describe a new form of synaptic plasticity-a rapid and lasting change in the subunit composition and Ca(2+) permeability of AMPARs at cerebellar stellate cell synapses following synaptic activity. AMPARs lacking the edited GluR2 subunit not only exhibit high Ca(2+) permeability(7) but also are blocked by intracellular polyamines(8-11). These properties have allowed us to follow directly the involvement of GluR2 subunits in synaptic transmission. Repetitive synaptic activation of Ca(2+)-permeable AMPARs causes a rapid reduction in Ca(2+) permeability and a change in the amplitude of excitatory postsynaptic currents, owing to the incorporation of GluR2-containing AMPARs. Our experiments show that activity-induced Ca(2+) influx through GluR2-lacking AMPARs controls the targeting of GluR2-containing AMPARs, implying the presence of a self-regulating mechanism.	UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Cull-Candy, SG (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	s.cull-candy@ulc.ac.uk		Cull-Candy, Stuart G/0000-0002-0831-8326				Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Clark Beverley A., 1999, Journal of Physiology (Cambridge), V518P, p156P; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Laezza F, 1999, SCIENCE, V285, P1411, DOI 10.1126/science.285.5432.1411; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Seidenbecher CI, 1998, J BIOL CHEM, V273, P21324, DOI 10.1074/jbc.273.33.21324; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; YAMKURA T, 1995, FEBS LETT, V374, P412	30	360	367	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					454	458		10.1038/35013064	http://dx.doi.org/10.1038/35013064			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839540				2022-12-24	WOS:000087212000048
J	Smahi, A; Courtois, G; Vabres, P; Yamaoka, S; Heuertz, S; Munnich, A; Israel, A; Heiss, NS; Klauck, SM; Kioschis, P; Wiemann, S; Poustka, A; Esposito, T; Bardaro, T; Gianfrancesco, F; Ciccodicola, A; D'Urso, M; Woffendin, H; Jakins, T; Donnai, D; Stewart, H; Kenwrick, SJ; Aradhya, S; Yamagata, T; Levy, M; Lewis, RA; Nelson, DL				Smahi, A; Courtois, G; Vabres, P; Yamaoka, S; Heuertz, S; Munnich, A; Israel, A; Heiss, NS; Klauck, SM; Kioschis, P; Wiemann, S; Poustka, A; Esposito, T; Bardaro, T; Gianfrancesco, F; Ciccodicola, A; D'Urso, M; Woffendin, H; Jakins, T; Donnai, D; Stewart, H; Kenwrick, SJ; Aradhya, S; Yamagata, T; Levy, M; Lewis, RA; Nelson, DL		Int Incontinentia Pigmenti IP Cons	Genomic rearrangement in NEMO impairs NF-KAPPAB activation and is a cause of incontinentia pigmenti	NATURE			English	Article							ALPHA-INDUCED APOPTOSIS; B KINASE COMPLEX; MICE LACKING; EMBRYONIC LETHALITY; LIVER DEGENERATION; RAPID DETECTION; DEFICIENT MICE; IKK COMPLEX; COMPONENT; MODULATOR	Familial incontinentia pigmenti (IP; MIM 308310) is a genodermatosis that segregates as an X-linked dominant disorder and is usually lethal prenatally in males. In affected females it causes highly variable abnormalities of the skin, hair, nails, teeth, eyes and central nervous system. The prominent skin signs occur in four classic cutaneous stages: perinatal inflammatory vesicles, verrucous patches, a distinctive pattern of hyperpigmentation and dermal scarring(1). Cells expressing the mutated X chromosome are eliminated selectively around the time of birth, so females with IP exhibit extremely skewed X-inactivation(2). The reasons for cell death in females and in utero lethality in males are unknown. The locus for IP has been linked genetically to the factor VIII gene in Xq28 (ref. 3). The gene for NEMO (NF-kappa B essential modulator)/IKK gamma (I kappa B kinase-gamma) has been mapped to a position 200 kilobases proximal to the factor VIII locus(4). NEMO is required for the activation of the transcription factor NF-kappa B and is therefore central to many immune, inflammatory and apoptotic pathways(5-9). Here we show that most cases of IP are due to mutations of this locus and that a new genomic rearrangement accounts for 80% of new mutations. As a consequence, NF-kappa B activation is defective in IP cells.	Hop Necker Enfants Malad, Dept Genet, INSERM, U393,Unite Rech Handicaps Genet Enfant, F-75015 Paris, France; Inst Pasteur, CNRS, URA 1773, Unite Biol Mol Express Gen, F-75724 Paris 15, France; Deutsch Krebsforschungszentrum, Dept Mol Genome Anal, D-69120 Heidelberg, Germany; CNR, Int Inst Genet & Biophys, I-80125 Naples, Italy; Addenbrookes Hosp, Wellcome Trust, Ctr Mol Mechanisms Dis, Cambridge CB2 2XY, England; Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2XY, England; St Marys Hosp, Manchester M13 0JH, Lancs, England; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Dermatol, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Helmholtz Association; German Cancer Research Center (DKFZ); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Manchester; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Kenwrick, SJ (corresponding author), Hop Necker Enfants Malad, Dept Genet, INSERM, U393,Unite Rech Handicaps Genet Enfant, F-75015 Paris, France.	SJK12@mole.bio.cam.ac.uk	Esposito, Teresa/AAA-5488-2019; Smahi, Asma/J-4184-2017; Vabres, Pierre/V-3850-2019; Wiemann, Stefan/E-4424-2013; Gianfrancesco, Fernando/P-6853-2014	Esposito, Teresa/0000-0002-7879-8441; Smahi, Asma/0000-0002-6002-0981; Vabres, Pierre/0000-0001-8693-3183; Wiemann, Stefan/0000-0003-4683-3174; Ciccodicola, Alfredo/0000-0002-9924-1482; ARADHYA, SWAROOP/0000-0001-6219-2931; Gianfrancesco, Fernando/0000-0002-3812-2471; COURTOIS, Gilles/0000-0003-3117-9595	Telethon [E.0927] Funding Source: Medline	Telethon(Fondazione Telethon)		Alonso A, 1996, ELECTROPHORESIS, V17, P1299, DOI 10.1002/elps.1150170804; Attar RM, 1997, SEMIN CANCER BIOL, V8, P93, DOI 10.1006/scbi.1997.0060; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Courtois G, 1997, MOL CELL BIOL, V17, P1441, DOI 10.1128/MCB.17.3.1441; Doi TS, 1999, P NATL ACAD SCI USA, V96, P2994, DOI 10.1073/pnas.96.6.2994; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Hughes AE, 2000, NAT GENET, V24, P45, DOI 10.1038/71667; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Jin DY, 1999, J BIOMED SCI, V6, P115, DOI 10.1007/BF02256442; Jouet M, 1997, EUR J HUM GENET, V5, P168, DOI 10.1159/000484753; LANDY SJ, 1993, J MED GENET, V30, P53, DOI 10.1136/jmg.30.1.53; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li YG, 1999, P NATL ACAD SCI USA, V96, P1042, DOI 10.1073/pnas.96.3.1042; Lopes J, 1997, NAT GENET, V17, P136, DOI 10.1038/ng1097-136; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; Parrish JE, 1996, HUM MOL GENET, V5, P1777, DOI 10.1093/hmg/5.11.1777; RICE NR, 1992, CELL, V71, P243, DOI 10.1016/0092-8674(92)90353-E; Rothwarf D.M., 1999, SCI SIGNAL TRANSDUCT; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rudolph D, 2000, GENE DEV, V14, P854; SMAHI A, 1994, HUM MOL GENET, V3, P273, DOI 10.1093/hmg/3.2.273; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Weil R, 1997, J BIOL CHEM, V272, P9942; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X	30	529	553	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					466	472						8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839543				2022-12-24	WOS:000087212000051
J	Ross, GW; Abbott, RD; Petrovitch, H; Morens, DM; Grandinetti, A; Tung, KH; Tanner, CM; Masaki, KH; Blanchette, PL; Curb, JD; Popper, JS; White, LR				Ross, GW; Abbott, RD; Petrovitch, H; Morens, DM; Grandinetti, A; Tung, KH; Tanner, CM; Masaki, KH; Blanchette, PL; Curb, JD; Popper, JS; White, LR			Association of coffee and caffeine intake with the risk of Parkinson disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; JAPANESE ANCESTRY; MEN; HAWAII; EPIDEMIOLOGY; RECEPTORS; SMOKING; ALCOHOL; SYSTEM	Context The projected expansion in the next several decades of the elderly population at highest risk for Parkinson disease (PD) makes identification of factors that promote or prevent the disease an important goat. Objective To explore the association of coffee and dietary caffeine intake with risk of PD. Design, Setting, and Participants Data were analyzed from 30 years of fallow-up of 8004 Japanese American men (aged 45-68 years) enrolled in the prospective longitudinal Honolulu Heart Program between 1965 and 1968. Main Outcome Measure Incident PD, by amount of coffee intake (measured at study enrollment and 6-year follow-up) and by total dietary caffeine intake (measured at enrollment). Results During follow-up, 102 men were identified as having PD. Age-adjusted incidence of PD declined consistently with increased amounts of coffee intake, from 10.4 per 10000 person-years in men who drank no coffee to 1.9 per 10000 person-years in men who drank at least 28 oz/d (P<.001 for trend). Similar relationships were observed with total caffeine intake (P<.001 for trend) and caffeine from noncoffee sources (P = .03 for trend). Consumption of increasing amounts of coffee was also associated with lower risk of PD in men who were never, past, and current smokers at baseline (P = .049, P = .22, and P = .02, respectively, for trend). Other nutrients in coffee, including niacin, were unrelated to PD incidence. The relationship between caffeine and PD was unaltered by intake of milk and sugar. Conclusions Our findings indicate that higher coffee and caffeine intake is associated with a significantly lower incidence of PD, This effect appears to be independent of smoking. The data suggest that the mechanism is related to caffeine intake and not to other nutrients contained in coffee.	Dept Vet Affairs, Honolulu, HI 96850 USA; Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96822 USA; Univ Hawaii, John A Burns Sch Med, Pacific Biomed Res Ctr, Honolulu, HI 96822 USA; Univ Virginia, Sch Med, Dept Hlth Evaluat Sci, Div Biostat & Epidemiol, Charlottesville, VA 22908 USA; Pacific Hlth Res Inst, Honolulu, HI USA; NIAID, NIH, Bethesda, MD 20892 USA; Parkinsons Inst, Sunnyvale, CA USA; Kuakini Med Ctr Honolulu Asia Aging Study, Honolulu, HI USA; Univ Hawaii, Sch Publ Hlth, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii System; University of Virginia; Pacific Health Research & Education Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Hawaii System	Ross, GW (corresponding author), Dept Vet Affairs, Honolulu 151,POB 50188, Honolulu, HI 96850 USA.		Grandinetti, Andrew/P-7436-2015; Abdullah, J/C-2828-2011	Grandinetti, Andrew/0000-0002-7257-5773; Abdullah, J/0000-0002-0258-7410	NHLBI NIH HHS [N01-HC-05102] Funding Source: Medline; NIA NIH HHS [N01-AG-4-2149] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC005102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG042149] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		COX DR, 1972, J R STAT SOC B, V34, P187; CURB JD, 1986, AM J EPIDEMIOL, V123, P648, DOI 10.1093/oxfordjournals.aje.a114284; Day J. C., 1996, CURRENT POPULATION R; Fall PA, 1999, MOVEMENT DISORD, V14, P28, DOI 10.1002/1531-8257(199901)14:1&lt;28::AID-MDS1007&gt;3.0.CO;2-O; GRANDINETTI A, 1994, AM J EPIDEMIOL, V139, P1129, DOI 10.1093/oxfordjournals.aje.a116960; Heilbrun L K, 1985, Hawaii Med J, V44, P294; Hellenbrand W, 1996, NEUROLOGY, V47, P644, DOI 10.1212/WNL.47.3.644; JIMENEZJIMENEZ FJ, 1992, MOVEMENT DISORD, V7, P339, DOI 10.1002/mds.870070407; Kanda T, 1998, NEUROREPORT, V9, P2857, DOI 10.1097/00001756-199808240-00032; KARTZINEL R, 1976, NEUROLOGY, V26, P741, DOI 10.1212/WNL.26.8.741; LANE PW, 1982, BIOMETRICS, V38, P613, DOI 10.2307/2530043; Lang A. E. T., 1989, QUANTIFICATION NEURO, P285; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Langston JW, 1998, ANN NEUROL, V44, pS45, DOI 10.1002/ana.410440707; MALLY J, 1994, J PHARM PHARMACOL, V46, P515, DOI 10.1111/j.2042-7158.1994.tb03840.x; MCGEE D, 1982, AM J CLIN NUTR, V36, P657, DOI 10.1093/ajcn/36.4.657; Morens DM, 1996, NEUROLOGY, V46, P1044, DOI 10.1212/WNL.46.4.1044; NEFZGER MD, 1968, AM J EPIDEMIOL, V88, P149, DOI 10.1093/oxfordjournals.aje.a120874; NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B; POPOLI P, 1991, J PHARM PHARMACOL, V43, P280, DOI 10.1111/j.2042-7158.1991.tb06685.x; Richardson PJ, 1997, TRENDS PHARMACOL SCI, V18, P338, DOI 10.1016/S0165-6147(97)90660-X; SHOULSON I, 1975, NEUROLOGY, V25, P722, DOI 10.1212/WNL.25.8.722; TANNER CM, 1992, NEUROL CLIN, V10, P317, DOI 10.1016/S0733-8619(18)30212-3; Tanner CM, 1999, JAMA-J AM MED ASSOC, V281, P341, DOI 10.1001/jama.281.4.341; WARD CD, 1990, ADV NEUROL, V53, P245; WATANABE H, 1986, NEUROPHARMACOLOGY, V25, P577, DOI 10.1016/0028-3908(86)90208-X; White L, 1996, JAMA-J AM MED ASSOC, V276, P955, DOI 10.1001/jama.276.12.955; WORTH RM, 1970, J CHRON DIS, V23, P389, DOI 10.1016/0021-9681(70)90022-6; YANO K, 1984, AM J EPIDEMIOL, V119, P653, DOI 10.1093/oxfordjournals.aje.a113787; YANO K, 1977, NEW ENGL J MED, V297, P405, DOI 10.1056/NEJM197708252970801; ZHANG ZX, 1993, NEUROEPIDEMIOLOGY, V12, P195, DOI 10.1159/000110318	31	509	527	1	80	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2000	283	20					2674	2679		10.1001/jama.283.20.2674	http://dx.doi.org/10.1001/jama.283.20.2674			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314FP	10819950	Bronze			2022-12-24	WOS:000087046000035
J	Spencer, JR; Rathbun, JA; Travis, LD; Tamppari, LK; Barnard, L; Martin, TZ; McEwen, AS				Spencer, JR; Rathbun, JA; Travis, LD; Tamppari, LK; Barnard, L; Martin, TZ; McEwen, AS			Io's thermal emission from the Galileo photopolarimeter-radiometer	SCIENCE			English	Article							ACTIVE VOLCANISM; HOT-SPOTS; TEMPERATURE; EUROPA; PHOTOMETRY; SSI	Galileo's photopolarimeter-radiometer instrument mapped to's thermal emission during the 124, 125, and 127 flybys with a spatial resolution of 2.2 to 300 kilometers. Mapping of Loki in 124 shows uniform temperatures for most of Loki Patera and high temperatures in the southwest corner, probably resulting from an eruption that began 1 month before the observation. Most of Loki Patera was resurfaced before 127. Pele's caldera floor has a low temperature of 160 kelvin, whereas flows at Pillan and Zamama have temperatures of up to 200 kelvin, Global maps of nighttime temperatures provide a means for estimating global heat flow.	Lowell Observ, Flagstaff, AZ 86001 USA; NASA, Goddard Space Flight Ctr, Inst Space Studies, New York, NY 10025 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Arizona	Spencer, JR (corresponding author), Lowell Observ, 1400 W Mars Hill Rd, Flagstaff, AZ 86001 USA.							Davies AG, 1997, GEOPHYS RES LETT, V24, P2447, DOI 10.1029/97GL02310; GOGUEN JD, 1988, ICARUS, V76, P465, DOI 10.1016/0019-1035(88)90015-2; GOGUEN JD, 1998, B AM ASTRON SOC, V29, P978; HANSEN OL, 1973, ICARUS, V18, P237, DOI 10.1016/0019-1035(73)90208-X; Howell RR, 1997, ICARUS, V127, P394, DOI 10.1006/icar.1997.5686; HOWELL RR, 2000, LUNAR PLANET SCI, V31, P1974; Lopes-Gautier R, 2000, SCIENCE, V288, P1201, DOI 10.1126/science.288.5469.1201; Lopes-Gautier R, 1999, ICARUS, V140, P243, DOI 10.1006/icar.1999.6129; MACINTOSH B, UNPUB; McEwen A.S., 1992, LUNAR PLANET SCI, VXXIII, P881; McEwen AS, 2000, SCIENCE, V288, P1193, DOI 10.1126/science.288.5469.1193; McEwen AS, 1998, ICARUS, V135, P181, DOI 10.1006/icar.1998.5972; McEwen AS, 1998, SCIENCE, V281, P87, DOI 10.1126/science.281.5373.87; RUSSELL EE, 1992, SPACE SCI REV, V60, P531; SEGATZ M, 1988, ICARUS, V75, P187, DOI 10.1016/0019-1035(88)90001-2; SPENCER J, UNPUB; Spencer JR, 1999, SCIENCE, V284, P1514, DOI 10.1126/science.284.5419.1514; SPENCER JR, 1994, ICARUS, V107, P195, DOI 10.1006/icar.1994.1016; Spencer JR, 2000, SCIENCE, V288, P1208, DOI 10.1126/science.288.5469.1208; Spencer JR, 1997, GEOPHYS RES LETT, V24, P2451, DOI 10.1029/97GL02591; VEEDER GJ, 1994, J GEOPHYS RES-PLANET, V99, P17095, DOI 10.1029/94JE00637; [No title captured]	22	97	98	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 19	2000	288	5469					1198	1201		10.1126/science.288.5469.1198	http://dx.doi.org/10.1126/science.288.5469.1198			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315KH	10817987				2022-12-24	WOS:000087112600039
J	Darling, KF; Wade, CM; Stewart, IA; Kroon, D; Dingle, R; Brown, AJL				Darling, KF; Wade, CM; Stewart, IA; Kroon, D; Dingle, R; Brown, AJL			Molecular evidence for genetic mixing of Arctic and Antarctic subpolar populations of planktonic foraminifers	NATURE			English	Article							CRYPTIC SPECIATION; FOSSIL RECORD; EVOLUTION; TEMPERATURE; RATES; SEA; PHYLOGENY; SEQUENCES; BINDIN; OCEAN	Bipolarity, the presence of a species in the high latitudes separated by a gap in distribution across the tropics, is a well-known pattern of global species distribution. But the question of whether bipolar species have evolved independently at the poles since the establishment of the cold-water provinces 16-8 million years ago, or if genes have been transferred across the tropics since that time, has not been addressed. Here we examine genetic variation in the small subunit ribosomal RNA gene of three bipolar planktonic foraminiferal morphospecies. We identify at least one identical genotype in all three morphospecies in both the Arctic and Antarctic subpolar provinces, indicating that trans-tropical gene flow must have occurred. Our genetic analysis also reveals that foraminiferal morphospecies can consist of a complex of genetic types. Such occurrences of genetically distinct populations within one morphospecies may affect the use of planktonic foraminifers as a palaeoceanographic proxy for climate change and necessitate a reassessment of the species concept for the group.	Univ Edinburgh, Dept Geol & Geophys, Edinburgh EH9 3JW, Midlothian, Scotland; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Nottingham, Inst Genet, Nottingham NG7 2UH, England; British Antarctic Survey, Cambridge CB3 0ET, England	University of Edinburgh; University of Edinburgh; University of Nottingham; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Darling, KF (corresponding author), Univ Edinburgh, Dept Geol & Geophys, Edinburgh EH9 3JW, Midlothian, Scotland.		Brown, Andrew Leigh/ABF-8269-2020; Leigh Brown, Andrew/F-3802-2010	Brown, Andrew Leigh/0000-0002-5700-3128; Leigh Brown, Andrew/0000-0002-5700-3128; Wade, Christopher/0000-0002-1269-9694				Be A.W.H., 1977, OCEANIC MICROPALEONT; Biermann CH, 1998, MOL BIOL EVOL, V15, P1761, DOI 10.1093/oxfordjournals.molbev.a025902; BIJMA J, 1990, J FORAMIN RES, V20, P117, DOI 10.2113/gsjfr.20.2.117; BRUMMER GJA, 1988, PLANKTONIC FORAMINIF, P293; *CLIMAP PROJ MEMB, 1981, GEOLOGICAL SOC AM MA; Coyne JA, 1998, PHILOS T ROY SOC B, V353, P287, DOI 10.1098/rstb.1998.0210; CRAME JA, 1993, J BIOGEOGR, V20, P145, DOI 10.2307/2845668; Darling KF, 1999, PALEOCEANOGRAPHY, V14, P3, DOI 10.1029/1998PA900002; Darling KF, 1996, J FORAMIN RES, V26, P324, DOI 10.2113/gsjfr.26.4.324; Darling KF, 1997, MAR MICROPALEONTOL, V30, P251, DOI 10.1016/S0377-8398(96)00057-6; Darwin C., 1859, ORIGIN SPECIES MEANS; de Vargas C, 1998, MOL PHYLOGENET EVOL, V9, P463, DOI 10.1006/mpev.1998.0491; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; deVargas C, 1997, J MOL EVOL, V45, P285, DOI 10.1007/PL00006232; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GUILDERSON TP, 1994, SCIENCE, V263, P663, DOI 10.1126/science.263.5147.663; Hilbrecht H, 1997, MAR MICROPALEONTOL, V31, P31, DOI 10.1016/S0377-8398(96)00054-0; Hooker JD, 1847, BOT ANTARCTIC VOYAGE; Huber BT, 1997, PALEOBIOLOGY, V23, P33, DOI 10.1017/S0094837300016638; Kennett J.P., 1983, NEOGENE PLANKTONIC F; KENNETT JP, 1985, GEOL SOC AM MEM, V163, P197; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; LINDBERG DR, 1991, PALEOBIOLOGY, V17, P308, DOI 10.1017/S0094837300010629; McIntyre A, 1989, PALEOCEANOGRAPHY, V4, P19, DOI 10.1029/PA004i001p00019; Metz EC, 1996, MOL BIOL EVOL, V13, P397, DOI 10.1093/oxfordjournals.molbev.a025598; Mix AC, 1996, SOUTH ATLANTIC, P503; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; Pawlowski J, 1997, MOL BIOL EVOL, V14, P498, DOI 10.1093/oxfordjournals.molbev.a025786; Ross James Clark, 1847, VOYAGE DISCOVERY RES; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schrag DP, 1996, SCIENCE, V272, P1930, DOI 10.1126/science.272.5270.1930; SMITH SW, 1994, COMPUT APPL BIOSCI, V10, P671; Spezzaferri Silvia, 1994, Palaeontographia Italica, V81, P1; STUTE M, 1995, SCIENCE, V269, P379, DOI 10.1126/science.269.5222.379; SWOFFORD DL, 1998, PAUP PHYLOGENETIC AN; TAPPAN H, 1988, J PALEONTOL, V62, P695; Tregenza T, 1999, NATURE, V400, P311, DOI 10.1038/22419; Wolff T, 1998, GEOLOGY, V26, P675, DOI 10.1130/0091-7613(1998)026<0675:OIVCKT>2.3.CO;2; ZHAO M, 1995, PALEOCEANOGRAPHY, V10, P661, DOI 10.1029/94PA03354	40	262	284	1	44	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2000	405	6782					43	47		10.1038/35011002	http://dx.doi.org/10.1038/35011002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311TK	10811211				2022-12-24	WOS:000086901600044
J	Checkley, W; Epstein, LD; Gilman, RH; Figueroa, D; Cama, RI; Patz, JA; Black, RE				Checkley, W; Epstein, LD; Gilman, RH; Figueroa, D; Cama, RI; Patz, JA; Black, RE			Effects of El Nino and ambient temperature on hospital admissions for diarrhoeal diseases in Peruvian children	LANCET			English	Article							SOUTHERN OSCILLATION; RURAL BANGLADESH; INFECTION; CLIMATE; GROWTH	Introduction To investigate whether the El Nino phenomenon and ambient temperature had an effect on the epidemiology of childhood diarrhoea, we analysed data on daily number of admissions of children with diarrhoea to the Oral Rehydration Unit of the Institute de Salud del Nino in Lima, Peru, between January, 1993, and November, 1998. Methods We obtained daily data on hospital admissions from the Oral Rehydration Unit, and meteororological data from the Peruvian Weather Service, and used time-series linear regression models to assess the effects of the 1997-98 El Nino event on admissions for diarrhoea. Findings 57 331 children under 10 years old were admitted to the unit during the study. During the 1997-98 El Nino episode, mean ambient temperature in Lima increased up to 5 degrees C above normal, and the number of daily admissions for diarrhoea increased to 200% of the previous rate. 6225 excess admissions were attributable to El Nino, and these cost US$277 000. During the period before the El Nino episode, admissions for diarrhoea increased by 8% per 1 degrees C increase in mean ambient temperature. The effects of El Nino and ambient temperature on the number of admissions for diarrhoea were greatest during the winter months. Interpretation El Nino had an effect on hospital admissions greater than that explained by the regular seasonal variability in ambient temperature. The excess increase in ambient temperature was the main environmental variable affecting admissions. If our findings are reproducible in other regions, diarrhoeal diseases may increase by millions of cases worldwide with each degree of increase in ambient temperature above normal.	Johns Hopkins Univ, Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA; Proyectos Informat Salud Med & Agr, Lima, Peru; Catholic Univ Chile, Dept Estadist, Santiago, Chile; Inst Natl Salud Nino, Unidad Rehidratac Oral, Lima, Peru	Johns Hopkins University; Johns Hopkins University; Pontificia Universidad Catolica de Chile	Gilman, RH (corresponding author), Johns Hopkins Univ, Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St,Room W3503, Baltimore, MD 21205 USA.			Black, Robert/0000-0001-9926-7984; Checkley, William/0000-0003-1106-8812	NICHD NIH HHS [F31-HD08488] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F31HD008488] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Armitage P, 1996, STAT METHODS MED RES; Bell GD, 1998, B AM METEOROL SOC, V79, pS1, DOI 10.1175/1520-0477-79.5s.S1; BERN C, 1992, B WORLD HEALTH ORGAN, V70, P705; BLACK RE, 1982, AM J EPIDEMIOL, V115, P315, DOI 10.1093/oxfordjournals.aje.a113308; BLACK RE, 1980, J INFECT DIS, V142, P660, DOI 10.1093/infdis/142.5.660; Black Robert E., 1995, P13; Bouma MJ, 1997, JAMA-J AM MED ASSOC, V278, P1772, DOI 10.1001/jama.278.21.1772; Bouma MJ, 1996, TROP MED INT HEALTH, V1, P86, DOI 10.1046/j.1365-3156.1996.d01-7.x; Cama RI, 1999, J INFECT DIS, V179, P1139, DOI 10.1086/314701; Checkley W, 1998, AM J EPIDEMIOL, V148, P497, DOI 10.1093/oxfordjournals.aje.a009675; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Diggle P. J., 1995, TIME SERIES BIOSTATI; GILLES HM, 1993, BRUCECHWATTS ESSENTI; GUERRANT RL, 1983, J INFECT DIS, V148, P986, DOI 10.1093/infdis/148.6.986; GUERRANT RL, 1996, EDGE DEV HLTH CRISIS, P91; Hales S, 1999, ENVIRON HEALTH PERSP, V107, P99, DOI 10.2307/3434364; HALES S, 1996, LANCET, V348, P1665; KONNO T, 1983, J INFECT DIS, V147, P125, DOI 10.1093/infdis/147.1.125; Madico G, 1996, J CLIN MICROBIOL, V34, P2968, DOI 10.1128/JCM.34.12.2968-2972.1996; Madico G, 1997, CLIN INFECT DIS, V24, P977, DOI 10.1093/clinids/24.5.977; NICHOLLS N, 1993, LANCET, V342, P1284, DOI 10.1016/0140-6736(93)92368-4; *PAN HLTH ORG, 1994, HLTH COND AM SCI PUB, V549; Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217; Rice JA, 1988, MATH STAT DATA ANAL; SalazarLindo E, 1997, LANCET, V350, P1597, DOI 10.1016/S0140-6736(05)64013-5; Tibshirani R., 1995, GEN ADDITIVE MODELS; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; *WHO, 1996, CLI CHANG HUM HLTH; World Health Organization, 1995, 854 WHO	29	303	315	3	42	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2000	355	9202					442	450						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841124				2022-12-24	WOS:000085306800010
J	de Martino, M; Tovo, PA; Balducci, M; Galli, L; Gabiano, C; Rezza, G; Pezzotti, P				de Martino, M; Tovo, PA; Balducci, M; Galli, L; Gabiano, C; Rezza, G; Pezzotti, P		Italian Register HIV Infect Childr	Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DISEASE PROGRESSION; AIDS; TRANSMISSION; SURVIVAL; INFANTS; RISK; MORBIDITY; DURATION; IMPACT	Context Since the introduction of combined antiretroviral therapy, mortality rates in adults with human immunodeficiency virus type 1 (HIV-1) infection have decreased. However, little information is available outside the setting of controlled trials on survival of perinatally HIV-infected children treated with antiretroviral therapy. Objective To assess effect of availability of antiretroviral therapy on decreasing mortality in perinatally HIV-infected children, Design Population-based, multicenter longitudinal study involving data collected by the Italian Register for HIV Infection in Children. Setting A network of 106 pediatric clinical centers. Subjects A total of 1142 children born between November 1980 and December 1997 with perinatally acquired HIV infection with a median follow-up of 5.9 years. Main Outcome Measure Time to HIV-related death calculated for birth cohort and calendar period and grouped by distribution of predominant type of antiretroviral therapy administered over time. Results Survival was longer in the 1996-1997 birth cohort (crude relative hazard [RH] of death, 0.39; 95% confidence interval [CI], 0.15-0.96) and 1996-1998 calendar period (crude RH of death, 0.65; 95% CI, 0.45-0.95) than in birth cohort and calendar period 1980-1995, but not when adjusted for maternal antiretroviral treatment during pregnancy and clinical condition at time of delivery, gestational age, and birth weight (adjusted RH of death, 0.55; 95% CI, 0.20-1.50, for birth cohort; and adjusted RH of death, 0.71, 95% CI, 0.43-1.16, for calendar period). in a multivariate model with 1980-1995 as comparison, the 1996-1997 birth cohort had an RH of 0.57 (95% CI, 0.22-1.47; P=.27) but RH for calendar period 1996-1998 was 0.63 (95% CI, 0.47-0.85; P<.01). When the effects of birth cohort, calendar period, and type of antiretroviral therapy were evaluated simultaneously in the same model, the RH of death was not significantly different from 1.0 for the 1996-1997 birth cohort (P=.19) and calendar period 1996-1998 (P=.83) suggesting a causal relationship between decreased risk of death and use of combination therapy. The RH of death in children receiving monotherapy or double or triple combination therapy was 0.77 (95% CI, 0.55-1.08), 0.70 (95% CI, 0.42-1.17), and 0.29 (95% CI, 0.13-0.67), respectively, vs no antiretroviral therapy. Conclusion Survival of perinatally HIV-infected children improved in 1996-1998 as a result of the introduction of combined antiretroviral therapies.	Univ Florence, Dept Pediat, I-50132 Florence, Italy; Univ Turin, Dept Pediat, I-10124 Turin, Italy; Ist Super Sanita, Ctr Operat AIDS, I-00161 Rome, Italy	University of Florence; University of Turin; Istituto Superiore di Sanita (ISS)	de Martino, M (corresponding author), Univ Florence, Dept Pediat, Via Luca Giordano 13, I-50132 Florence, Italy.	mdm@ao-meyer.toscana.it	Marchisio, Paola G/J-7342-2016; Dodi, Icilio/ABD-9197-2020; Colafati, Giovanna Stefania/J-8937-2018; Canani, Roberto Berni/AAC-4810-2022; PEZZOTTI, PATRIZIO/C-6480-2016; rezza, giovanni/D-4393-2016; Zuccotti, Gianvincenzo/H-8572-2017	Marchisio, Paola G/0000-0002-5691-3920; Dodi, Icilio/0000-0002-6772-4180; Colafati, Giovanna Stefania/0000-0002-1142-4904; Canani, Roberto Berni/0000-0002-5169-9574; PEZZOTTI, PATRIZIO/0000-0002-0805-2927; rezza, giovanni/0000-0003-0268-6790; Zuccotti, Gianvincenzo/0000-0002-2795-9874; Castelli-Gattinara, Guido/0000-0002-3282-7462; Tovo, Pier Angelo/0000-0002-0192-3240; GENOVESE, Orazio/0000-0002-1989-1363; Guarino, Alfredo/0000-0003-0199-0336; Pontali, Emanuele/0000-0002-1085-0442; Bernardi, Stefania/0000-0001-5672-0881				Aboulker JP, 1998, AIDS, V12, pF151; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 1994, Morbidity and Mortality Weekly Report, V43, P1; [Anonymous], 1996, Lancet, V348, P283; Beck EJ, 1999, AIDS, V13, P2157, DOI 10.1097/00002030-199910220-00020; BLANCHE S, 1994, NEW ENGL J MED, V330, P308, DOI 10.1056/NEJM199402033300502; Burns DN, 1999, LANCET, V354, pS1, DOI 10.1016/S0140-6736(99)90249-0; CLAYTON C, 1993, STAT MODELS EPIDEMIO; de Martino M, 1999, AIDS, V13, P927, DOI 10.1097/00002030-199905280-00008; de Martino M, 1999, ACTA PAEDIATR, V88, P228, DOI 10.1080/08035259950170457; DEMARTINO M, 1992, AIDS, V6, P991, DOI 10.1097/00002030-199209000-00013; DEMARTINO M, 1991, J PEDIATR-US, V119, P702, DOI 10.1016/S0022-3476(05)80283-5; DEMARTINO M, 1994, LANCET, V343, P191; DEMARTINO M, 1993, AIDS, V7, P134, DOI 10.1097/00002030-199301000-00027; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Englund JA, 1997, NEW ENGL J MED, V336, P1704, DOI 10.1056/NEJM199706123362403; GABIANO C, 1992, PEDIATRICS, V90, P369; GALLI L, 1995, AIDS, V9, P455, DOI 10.1097/00002030-199509050-00007; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Haynes BF, 1999, CLIN IMMUNOL, V92, P3, DOI 10.1006/clim.1999.4738; *IT REG HIV INF CH, 1994, ACTA PAEDIATR, V400, P15; Kline MW, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.4.e47; Krogstad P, 1999, CLIN IMMUNOL, V92, P25, DOI 10.1006/clim.1999.4728; Kuhn L, 1999, J INFECT DIS, V179, P52, DOI 10.1086/314551; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Moore RD, 1999, AIDS, V13, P1933, DOI 10.1097/00002030-199910010-00017; MUNOZ A, 1995, AIDS CLIN TRIALS, P423; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pezzotti P, 1999, AIDS, V13, P249, DOI 10.1097/00002030-199902040-00013; Porta D, 1999, AIDS, V13, P2125, DOI 10.1097/00002030-199910220-00016; Sabin CA, 1999, AIDS, V13, P2165, DOI 10.1097/00002030-199910220-00021; Sharland M, 1998, LANCET, V352, P577, DOI 10.1016/S0140-6736(05)79289-8; Shearer WT, 1997, NEW ENGL J MED, V336, P1337, DOI 10.1056/NEJM199705083361901; Stuart JWTC, 1998, AIDS, V12, P2155, DOI 10.1097/00002030-199816000-00010; TOVO PA, 1988, LANCET, V2, P1043; Tovo PA, 1996, J ACQ IMMUN DEF SYND, V11, P88, DOI 10.1097/00042560-199601010-00012; TOVO PA, 1992, LANCET, V339, P1249, DOI 10.1016/0140-6736(92)91592-V	39	257	268	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 12	2000	284	2					190	197		10.1001/jama.284.2.190	http://dx.doi.org/10.1001/jama.284.2.190			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329XE	10889592	Bronze			2022-12-24	WOS:000087933100023
J	Elmore-Meegan, MK				Elmore-Meegan, MK			I held him in my arms and wept	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 12	2000	284	2					152	152		10.1001/jama.284.2.152	http://dx.doi.org/10.1001/jama.284.2.152			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329XE	10889571				2022-12-24	WOS:000087933100001
J	Brooks, R				Brooks, R			Negative genetic correlation between male sexual attractiveness and survival	NATURE			English	Article							POECILIA-RETICULATA; SELECTION; CHROMOSOME; EVOLUTION; GUPPIES; POPULATION; VIABILITY; GROWTH	Indirect selection of female mating preferences may result from a genetic association between male attractiveness and offspring fitness(1,2). The offspring of attractive males may have enhanced growth(3-5), fecundity(3,4), viability(5-8) or attractiveness(4,9-11). However, the extent to which attractive males bear genes that reduce other fitness components has remained unexplored. Here I show that sexual attractiveness in male guppies (Poecilia reticulata) is heritable and genetically correlated with ornamentation. Like ornamentation(12-14), attractiveness may be substantially Y-linked. The benefit of mating with attractive males, and thus having attractive sons, is opposed by strong negative genetic correlation between attractiveness and both offspring survival and the number of sons maturing. Such correlations suggest either antagonistic pleiotropy between attractiveness and survival or linkage disequilibrium between attractive and deleterious alleles. The presence of many colour pattern genes on or near the nonrecombining section of the Y chromosome may facilitate the accumulation of deleterious mutations by genetic hitchhiking(15,16). These findings show that genes enhancing sexual attractiveness may be associated with pleiotropic costs or heavy mutational loads.	James Cook Univ N Queensland, Sch Trop Biol, Townsville, Qld 4811, Australia	James Cook University	Brooks, R (corresponding author), James Cook Univ N Queensland, Sch Trop Biol, Townsville, Qld 4811, Australia.	rob.brooks@jcu.edu.au	Langerhans, R. Brian/A-7205-2009; Brooks, Robert/A-1251-2008	Brooks, Robert/0000-0001-6926-0781				Andersson Malte, 1994; Angus R.A., 1989, P51; Blows MW, 1998, AM NAT, V152, P826, DOI 10.1086/286211; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Etges WJ, 1996, EVOLUTION, V50, P2095, DOI 10.1111/j.1558-5646.1996.tb03596.x; FARR JA, 1981, HEREDITY, V47, P237, DOI 10.1038/hdy.1981.79; Fisher R. A., 1930, GENETICAL THEORY NAT, DOI 10.5962/bhl.title.27468; GILMOUR AR, 1999, ASREML SOFTWARE; HASKINS CP, 1970, HEREDITY, V25, P575, DOI 10.1038/hdy.1970.64; Houde A.E., 1997, SEX COLOR MATE CHOIC; HOUDE AE, 1992, HEREDITY, V69, P229, DOI 10.1038/hdy.1992.120; Jones TM, 1998, P ROY SOC B-BIOL SCI, V265, P1651, DOI 10.1098/rspb.1998.0484; Lynch M., 1998, AM J HUM GENET; Moller AP, 1999, P ROY SOC B-BIOL SCI, V266, P85, DOI 10.1098/rspb.1999.0607; MOORE AJ, 1994, BEHAV ECOL SOCIOBIOL, V35, P235, DOI 10.1007/s002650050093; NAYUDU PL, 1979, COPEIA, P225, DOI 10.2307/1443407; NORRIS K, 1993, NATURE, V362, P537, DOI 10.1038/362537a0; PETRIE M, 1994, NATURE, V371, P598, DOI 10.1038/371598a0; REYNOLDS JD, 1992, P ROY SOC B-BIOL SCI, V250, P57, DOI 10.1098/rspb.1992.0130; Reznick DN, 1996, EVOLUTION, V50, P1651, DOI 10.1111/j.1558-5646.1996.tb03937.x; RICE WR, 1994, SCIENCE, V263, P230, DOI 10.1126/science.8284674; RICE WR, 1992, SCIENCE, V256, P1436, DOI 10.1126/science.1604317; RICE WR, 1987, GENETICS, V116, P161; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; RODLAN ERS, 1999, TRENDS ECOL EVOL, V14, P58; Sheldon BC, 1997, P ROY SOC B-BIOL SCI, V264, P297, DOI 10.1098/rspb.1997.0042; VONSCHANTZ T, 1995, HEREDITY, V75, P518, DOI 10.1038/hdy.1995.168; Wedell N, 1999, EVOLUTION, V53, P620, DOI 10.1111/j.1558-5646.1999.tb03797.x; YAMAMOTO T, 1975, HDB GENETICS	29	206	208	1	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2000	406	6791					67	70		10.1038/35017552	http://dx.doi.org/10.1038/35017552			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	330ZE	10894542				2022-12-24	WOS:000087991200045
J	Wu, H; Wang, ZH; Yan, A; Lyle, S; Fakharzadeh, S; Wahl, JK; Wheelock, MJ; Ishikawa, H; Uitto, J; Amagai, M; Stanley, JR				Wu, H; Wang, ZH; Yan, A; Lyle, S; Fakharzadeh, S; Wahl, JK; Wheelock, MJ; Ishikawa, H; Uitto, J; Amagai, M; Stanley, JR			Protection against pemphigus foliaceus by desmoglein 3 in neonates.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VULGARIS ANTIGEN; EXPRESSION; MICE; AUTOANTIBODIES; LOCALIZATION; EPIDERMIS; FOLLICLE; DISEASE; DSG3; HAIR		Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA; Univ Toledo, Toledo, OH 43606 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan	University of Pennsylvania; University System of Ohio; University of Toledo; Jefferson University; Keio University	Stanley, JR (corresponding author), Univ Penn, Sch Med, Dept Dermatol, 211B Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.		Amagai, Masayuki/K-5325-2013; Ishikawa, Hiroshi/ABC-6293-2020	Amagai, Masayuki/0000-0003-3314-7052; Ishikawa, Hiroshi/0000-0001-6310-5748				AMAGAI M, 1994, J CLIN INVEST, V94, P59, DOI 10.1172/JCI117349; Amagai M, 1996, J INVEST DERMATOL, V106, P351, DOI 10.1111/1523-1747.ep12343081; BYSTRYN JC, 1978, J CLIN INVEST, V61, P339, DOI 10.1172/JCI108944; CARROLL JM, 1993, P NATL ACAD SCI USA, V90, P10270, DOI 10.1073/pnas.90.21.10270; Chowdhury MMU, 1998, BRIT J DERMATOL, V139, P500; EYRE RW, 1988, ARCH DERMATOL, V124, P25, DOI 10.1001/archderm.124.1.25; HOPP TP, 1988, BIOTECHNOLOGY, V6, P1205; Irvine AD, 1999, BRIT J DERMATOL, V140, P815, DOI 10.1046/j.1365-2133.1999.02810.x; ISHIKAWA H, 1994, MAMM GENOME, V5, P803, DOI 10.1007/BF00292018; Koch PJ, 1998, J CELL SCI, V111, P2529; Lyle S, 1998, J CELL SCI, V111, P3179; Mahoney MG, 1999, J INVEST DERMATOL, V113, P22, DOI 10.1046/j.1523-1747.1999.00632.x; Mahoney MG, 1999, J CLIN INVEST, V103, P461, DOI 10.1172/JCI5252; Montone KT, 1997, MODERN PATHOL, V10, P939; Proby CM, 2000, BRIT J DERMATOL, V142, P321, DOI 10.1046/j.1365-2133.2000.03328.x; ROCHAALVAREZ R, 1992, J INVEST DERMATOL, V99, P78, DOI 10.1111/1523-1747.ep12611868; ROSCOE JT, 1985, J INVEST DERMATOL, V85, P538, DOI 10.1111/1523-1747.ep12277362; Shirakata Y, 1998, J INVEST DERMATOL, V110, P76, DOI 10.1046/j.1523-1747.1998.00085.x; STANLEY JR, 1999, FITZPATRICKS DERMATO, V1, P654; Wu H, 1998, J HISTOCHEM CYTOCHEM, V46, P1189, DOI 10.1177/002215549804601011	20	89	89	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2000	343	1					31	35		10.1056/NEJM200007063430105	http://dx.doi.org/10.1056/NEJM200007063430105			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330XW	10882766				2022-12-24	WOS:000087987600005
J	Seto, TB; Kwiat, D; Taira, DA; Douglas, PS; Manning, WJ				Seto, TB; Kwiat, D; Taira, DA; Douglas, PS; Manning, WJ			Physicians' recommendations to patients for use of antibiotic prophylaxis to prevent endocarditis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MITRAL-VALVE PROLAPSE; AMERICAN-HEART-ASSOCIATION; BACTERIAL-ENDOCARDITIS; INFECTIVE ENDOCARDITIS; GUIDELINES; ECHOCARDIOGRAPHY; EPIDEMIOLOGY; NETHERLANDS; MANAGEMENT; AWARENESS	Context The American Heart Association recommendations for infectious endocarditis (IE) prophylaxis, published in June 1997, sought to improve patient and physician compliance by simplifying the dosing regimen and clarifying endocarditis risk. Adherence to these updated recommendations in patients with echocardiographic verification of their endocarditis risk profile is unknown. Objective To determine the recommended and actual use of IE prophylaxis as reported by patients undergoing echocardiography. Design, Setting, and Participants All patients who underwent outpatient transthoracic echocardiography at a university-based tertiary hospital in Boston, Mass, during December 1997 were contacted 6 to 9 months rater to respond to a survey, completed by 218 (80%) eligible subjects. Main Outcome Measure Patients' report of their physicians' instructions on actual use of IE prophylaxis in accordance with patient risk category, determined by echocardiographic data. Results One hundred eight patients (49.5%) had clinical or echocardiographic findings for which prophylaxis was indicated. Of these 108 patients, 71 (65.7%) reported that they were instructed to take IE prophylaxis. Sixteen high-risk patients (88.9%) but only 55 moderate-risk patients (61.1%) reported that they were instructed to take prophylaxis. Among the 110 negligible-risk patients, 29 (26.4%) reported that they had been instructed to take IE prophylaxis. Overall, 100 patients (45.9%) reported that they received physician instructions to take IE prophylaxis. Of those who subsequently underwent a procedure for which IE prophylaxis was indicated (n = 68), 9 (13.2%) elected not to follow their physician's advice to take prophylaxis. Conclusions We found that although most patients reported receiving instructions for IE prophylaxis use consistent with American Heart Association guidelines, IE prophylaxis overuse among negligible-risk patients and underuse among moderate-risk patients was common. Continued physician and patient education may lead to improved adherence to the current American Heart Association recommendations.	Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiovasc, Harvard Thorndike Lab,Charles A Dana Res Lab, Boston, MA 02215 USA; Queens Med Ctr, Ctr Best Healthcare Practices, Honolulu, HI USA; Univ Hawaii, Dept Med, Div Cardiol, Honolulu, HI 96822 USA; Univ Hawaii, Div Clin Epidemiol, John A Burns Sch Med, Honolulu, HI 96822 USA; Hawaii Med Serv Assoc, Honolulu, HI USA	Harvard University; Beth Israel Deaconess Medical Center; The Queen's Medical Center; University of Hawaii System; University of Hawaii System	Manning, WJ (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiovasc, Harvard Thorndike Lab,Charles A Dana Res Lab, 330 Brookline Ave, Boston, MA 02215 USA.			Douglas, Pamela/0000-0001-9876-4049				BAYLISS R, 1983, BRIT HEART J, V50, P506, DOI 10.1136/hrt.50.6.506; BOR DH, 1984, AM J MED, V76, P711, DOI 10.1016/0002-9343(84)90300-0; BROOKS SL, 1980, J AM DENT ASSOC, V101, P41, DOI 10.14219/jada.archive.1980.0361; CLEMENS JD, 1984, J CHRON DIS, V37, P531, DOI 10.1016/0021-9681(84)90004-3; Dajani AS, 1997, JAMA-J AM MED ASSOC, V277, P1794, DOI 10.1001/jama.277.22.1794; Delahaye F, 1999, J AM COLL CARDIOL, V33, P788, DOI 10.1016/S0735-1097(98)00624-X; DURACK DT, 1995, NEW ENGL J MED, V332, P38, DOI 10.1056/NEJM199501053320107; ELKODT AG, 1995, ANN INTERN MED, V122, P277; HASHWAY T, 1982, CIRCULATION, V66, P1110, DOI 10.1161/01.CIR.66.5.1110; Heidenreich PA, 1997, AM J MED, V102, P337, DOI 10.1016/S0002-9343(97)00084-3; IVERT TSA, 1984, CIRCULATION, V69, P223, DOI 10.1161/01.CIR.69.2.223; LAVIE CJ, 1989, JAMA-J AM MED ASSOC, V262, P3308, DOI 10.1001/jama.262.23.3308; Meyers DG, 1997, AM J PREV MED, V13, P45, DOI 10.1016/S0749-3797(18)30224-1; Muhlestein JB, 1999, J AM COLL CARDIOL, V33, P794; NELSON CL, 1989, J AM DENT ASSOC, V118, P169, DOI 10.14219/jada.archive.1989.0215; OLIVE KE, 1990, J GEN INTERN MED, V5, P470, DOI 10.1007/BF02600871; ORMISTON JA, 1981, AUST NZ J MED, V11, P620, DOI 10.1111/j.1445-5994.1981.tb03536.x; RETCHIN SM, 1985, MED CARE, V23, P1156, DOI 10.1097/00005650-198510000-00004; SADOWSKY D, 1989, J AM DENT ASSOC, V118, P175, DOI 10.14219/jada.archive.1989.0242; Tomos MP, 1992, ANN INTERN MED, V117, P567; *US DEP HHS, 1997, MMWR-MORBID MORTAL W, V46, P1061; VANDERMEER JTM, 1992, LANCET, V339, P135, DOI 10.1016/0140-6736(92)90207-J; VANDERMEER JTM, 1992, ARCH INTERN MED, V152, P1869, DOI 10.1001/archinte.152.9.1869; VANDERMEER JTM, 1992, J ANTIMICROB CHEMOTH, V29, P187, DOI 10.1093/jac/29.2.187; VANDERMEER JTM, 1992, ARCH INTERN MED, V152, P1863, DOI 10.1001/archinte.152.9.1863	25	25	26	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2000	284	1					68	71		10.1001/jama.284.1.68	http://dx.doi.org/10.1001/jama.284.1.68			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328GX	10872015	Bronze			2022-12-24	WOS:000087843000027
J	Poses, RM; McClish, DK; Smith, WR; Huber, EC; Clemo, FLW; Schmitt, BP; Alexander, D; Racht, EM; Colenda, CC				Poses, RM; McClish, DK; Smith, WR; Huber, EC; Clemo, FLW; Schmitt, BP; Alexander, D; Racht, EM; Colenda, CC			Results of report cards for patients with congestive heart failure depend on the method used to adjust for severity	ANNALS OF INTERNAL MEDICINE			English	Article							III PROGNOSTIC SYSTEM; BYPASS GRAFT-SURGERY; HOSPITAL MORTALITY; RISK ADJUSTMENT; APACHE-II; CASE-MIX; QUALITY; ADMISSION; OUTCOMES; PREDICTION	Background: The validity of outcome report cards may depend on the ways in which they are adjusted for risk. Objectives: To compare the predictive ability of generic and disease-specific survival prediction models appropriate for use in patients with heart failure, to simulate outcome report cards by comparing survival across hospitals and adjusting for severity of illness using these models, and to assess the ways in which the results of these comparisons depend on the adjustment method. Design: Analysis of data from a prospective cohort, study. Setting: A university hospital, a Veterans Affairs (VA) medical center, and a community hospital. Patients: Sequential patients presenting in the emergency department with acute congestive heart failure. Measurements: Unadjusted 30-day and 1-year mortality across hospitals and 30-day and 1-year mortality adjusted by using disease-specific survival prediction models (two sickness-at-admission models, the Cleveland Health Quality Choice model, the Congestive Heart Failure Mortality Time-independent Predictive Instrument) and generic models (Acute Physiology and Chronic Health Evaluation [APACHE] II, APACHE III, the mortality prediction model, and the Charlson comorbidity index). Results: The community hospital's unadjusted 30-day survival rate (85.0%) and the VA medical center's unadjusted 1-year survival rate (60.9%) were significantly lower than corresponding rates at the university hospital (92.7% and 67.5%, respectively). No severity model had excellent ability to discriminate patients by survival rates tall areas under the receiver-operating characteristic curve < 0.73). Whether the VA medical center, the community hospital, both, or neither had worse survival rates on simulated report cards than the university hospital depended on the prediction model used for adjustment. Conclusions: Results of simulated outcome report cards for survival in patients with congestive heart failure depend on the method used to adjust for severity.	Brown Univ, Pawtucket, RI USA; Memorial Hosp Rhode Isl, Pawtucket, RI USA; Virginia Commonwealth Univ, Richmond, VA USA; Northwestern Univ, Sch Med, Chicago, IL USA; No Virginia Community Coll, Manassas, VA USA; Emergency Med Serv, Austin, TX USA; Michigan State Univ, E Lansing, MI 48824 USA	Brown University; Virginia Commonwealth University; Northwestern University; Michigan State University	Poses, RM (corresponding author), Brown Univ, Mem Hosp Rhode Isl, Ctr Primary Care & Prevent, 111 Brewster St, Pawtucket, RI 02860 USA.	royposes@brownvm.brown.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006274] Funding Source: NIH RePORTER; AHRQ HHS [HS-06274] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AM HLTH LIN, 1996, CONN HOSP REP CARD C; [Anonymous], 1994, CMAJ, V150, P1575; [Anonymous], 1994, CMAJ, V150, P1249; BOYD O, 1994, CRIT CARE MED, V22, P1706; Braitman LE, 1996, ANN INTERN MED, V125, P406, DOI 10.7326/0003-4819-125-5-199609010-00008; Covinsky KE, 1997, J GEN INTERN MED, V12, P203, DOI 10.1007/s11606-006-5041-5; DUBOIS RW, 1987, NEW ENGL J MED, V317, P1674, DOI 10.1056/NEJM198712243172626; FIELDS J, 1999, RECORD          0306, pA1; FINE MJ, 1995, J GEN INTERN MED, V10, P359, DOI 10.1007/BF02599830; GREEN J, 1995, NEW ENGL J MED, V332, P1229, DOI 10.1056/NEJM199505043321812; Hannan EL, 1997, HEALTH SERV RES, V31, P659; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Hughes JS, 1996, J GEN INTERN MED, V11, P303, DOI 10.1007/BF02598273; IEZZONI LI, 1995, ANN INTERN MED, V123, P763, DOI 10.7326/0003-4819-123-10-199511150-00004; Iezzoni LI, 1996, MED DECIS MAKING, V16, P348, DOI 10.1177/0272989X9601600405; IEZZONI LI, 1995, J INVEST MED, V43, P136; Iezzoni LI, 1998, MED CARE, V36, P28, DOI 10.1097/00005650-199801000-00005; Iezzoni LI, 1996, MED CARE, V34, P11, DOI 10.1097/00005650-199601000-00002; Iezzoni LI, 1996, AM J PUBLIC HEALTH, V86, P1379, DOI 10.2105/AJPH.86.10.1379; Iezzoni LI, 1997, ANN INTERN MED, V127, P666, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00048; Iezzoni LI, 1997, JAMA-J AM MED ASSOC, V278, P1600, DOI 10.1001/jama.278.19.1600; *JOINT COMM ACCR H, 1997, OR OUTC NEXT EV ACC; Jollis JG, 1998, NEW ENGL J MED, V338, P983, DOI 10.1056/NEJM199804023381410; KASSIRER JP, 1994, NEW ENGL J MED, V330, P634, DOI 10.1056/NEJM199403033300910; KEELER EB, 1992, JAMA-J AM MED ASSOC, V268, P1709, DOI 10.1001/jama.268.13.1709; KEELER EB, 1990, JAMA-J AM MED ASSOC, V264, P1962, DOI 10.1001/jama.264.15.1962; KNAUS W, 1989, CRIT CARE MED, V17, pS181, DOI 10.1097/00003246-198912001-00006; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; KrouselWood MA, 1996, J GEN INTERN MED, V11, P32, DOI 10.1007/BF02603483; LANDRY S, 1996, STPETERSBURG TI 0226, pB1; MAZZOLINI J, 1998, CLEVELAND PLAIN 1203, pB4; MCNEIL BJ, 1992, INQUIRY-J HEALTH CAR, V29, P298; MRQUIS J, 1997, LA TIMES        1215, pB1; *NHS, 1999, QUAL PERF NHS CLIN I; ORCHARD C, 1994, BRIT MED J, V308, P1493, DOI 10.1136/bmj.308.6942.1493; ORR RK, 1995, ARCH SURG-CHICAGO, V130, P301; OXMAN AD, 1994, CAN MED ASSOC J, V150, P1417; PALLARITO K, 1995, MOD HEALTHCARE, V25, P35; PAPP L, 1999, TORONTO STAR    0224, pA8; Pappachan JV, 1999, CHEST, V115, P802, DOI 10.1378/chest.115.3.802; Poses RM, 1996, J CLIN EPIDEMIOL, V49, P743, DOI 10.1016/0895-4356(96)00021-2; PRAGER LO, 1999, AM MED NEWS, V42, P1; PRAGER LO, 1999, AM MED NEWS, V42, P31; PRAGER LO, 1999, AM MED NEWS, V42, P32; Rosenthal GE, 2000, HEALTH SERV RES, V34, P1449; SELKER HP, 1994, MED CARE, V32, P1040, DOI 10.1097/00005650-199410000-00005; Sirio CA, 1999, CHEST, V115, P793, DOI 10.1378/chest.115.3.793; Taylor DH, 1999, NEW ENGL J MED, V340, P293, DOI 10.1056/NEJM199901283400408; TRILLO RA, 1997, AM MED NEWS, V40, P17; WONG DT, 1995, CRIT CARE MED, V23, P1177, DOI 10.1097/00003246-199507000-00005; 1994, CMAJ, V150, P1793; 1999, INTELLIGENCER J 0629, pB1; 1993, LANCET, V341, P1183	54	27	27	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 4	2000	133	1					10	20		10.7326/0003-4819-133-1-200007040-00003	http://dx.doi.org/10.7326/0003-4819-133-1-200007040-00003			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329TB	10877735				2022-12-24	WOS:000087923100002
J	Siegel, RM; Frederiksen, JK; Zacharias, DA; Chan, FKM; Johnson, M; Lynch, D; Tsien, RY; Lenardo, MJ				Siegel, RM; Frederiksen, JK; Zacharias, DA; Chan, FKM; Johnson, M; Lynch, D; Tsien, RY; Lenardo, MJ			Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations	SCIENCE			English	Article							AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; FAS GENE-MUTATIONS; LYMPHOCYTE APOPTOSIS; TNF-RECEPTOR; DEATH DOMAIN; MECHANISM; DISORDER; CASPASES; PROTEIN; BINDING	Heterozygous mutations encoding abnormal forms of the death receptor Fas dominantly interfere with Fas-induced Lymphocyte apoptosis in human autoimmune Lymphoproliferative syndrome. This effect, rather than depending on ligand-induced receptor oligomerization, was found to stem from ligand-independent interaction of wild-type and mutant Fas receptors through a specific region in the extracellular domain. Preassociated Fas complexes were found in living cells by means of fluorescence resonance energy transfer between variants of green fluorescent protein. These results show that formation of preassociated receptor complexes is necessary for Fas signaling and dominant interference in human disease.	NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Immunex Res & Dev Corp, Seattle, WA 98101 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Lenardo, MJ (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	lenardo@nih.gov	Chan, Francis Ka-Ming/E-9647-2014; Chan, Francis/ABB-1895-2021; Siegel, Richard/C-7592-2009; Frederiksen, John Karl/C-4946-2012	Chan, Francis Ka-Ming/0000-0002-4803-8353; Siegel, Richard/0000-0001-5953-9893; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000769, Z01AI000718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027177, R37NS027177] Funding Source: NIH RePORTER; NINDS NIH HHS [NS27177] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; Chan FKM, 2000, SCIENCE, V288, P2351, DOI 10.1126/science.288.5475.2351; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Cosma MP, 1998, MOL CELL BIOL, V18, P3321, DOI 10.1128/MCB.18.6.3321; Drappa J, 1996, NEW ENGL J MED, V335, P1643, DOI 10.1056/NEJM199611283352204; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; Jackson CE, 1999, AM J HUM GENET, V64, P1002, DOI 10.1086/302333; Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701; KISCHKEL FC, 1995, EMBO J, V14, P5579, DOI 10.1002/j.1460-2075.1995.tb00245.x; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; LEVYTOLEDANO R, 1994, EMBO J, V13, P835, DOI 10.1002/j.1460-2075.1994.tb06326.x; Mahajan NP, 1999, CHEM BIOL, V6, P401, DOI 10.1016/S1074-5521(99)80051-9; Martin DA, 1999, P NATL ACAD SCI USA, V96, P4552, DOI 10.1073/pnas.96.8.4552; Martin DA, 1998, J BIOL CHEM, V273, P4345, DOI 10.1074/jbc.273.8.4345; MIYAWAKI A, 1978, IN PRESS METHODS ENZ, V47, P819; Naismith JH, 1998, TRENDS BIOCHEM SCI, V23, P74, DOI 10.1016/S0968-0004(97)01164-X; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Orlinick JR, 1997, J BIOL CHEM, V272, P28889, DOI 10.1074/jbc.272.46.28889; Papoff G, 1996, J IMMUNOL, V156, P4622; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Siegel R. M., 2000, SCI STKE, V2000, ppl1; SIEGEL RM, UNPUB; Starling GC, 1997, J EXP MED, V185, P1487, DOI 10.1084/jem.185.8.1487; Straus SE, 1999, ANN INTERN MED, V130, P591, DOI 10.7326/0003-4819-130-7-199904060-00020; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Vaishnaw AK, 1999, J CLIN INVEST, V103, P355, DOI 10.1172/JCI5121; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331	30	505	530	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2000	288	5475					2354	2357		10.1126/science.288.5475.2354	http://dx.doi.org/10.1126/science.288.5475.2354			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329NP	10875918				2022-12-24	WOS:000087913400036
J	Bell, CE; Frescura, P; Hochschild, A; Lewis, M				Bell, CE; Frescura, P; Hochschild, A; Lewis, M			Crystal structure of the lambda repressor C-terminal domain provides a model for cooperative operator binding	CELL			English	Article							RECA-MEDIATED CLEAVAGE; TRANSCRIPTIONAL ACTIVATION FUNCTION; SINGLE-SITE MUTATIONS; BACTERIOPHAGE-LAMBDA; PHAGE REPRESSOR; GENE-REGULATION; UMUD' PROTEIN; MOLECULAR REPLACEMENT; POSITIVE CONTROL; P22 REPRESSORS	Interactions between transcription factors bound to separate operator sites commonly play an important role in gene regulation by mediating cooperative binding to the DNA. However, few detailed structural models for understanding the molecular basis of such cooperativity are available. The cl repressor of bacteriophage lambda is a classic example of a protein that binds to its operator sites cooperatively. The C-terminal domain of the repressor mediates dimerization as well as a dimer-dimer interaction that results in the cooperative binding of two repressor dimers to adjacent operator sites. Here, we present the x-ray crystal structure of the lambda repressor C-terminal domain determined by multiwavelength anomalous diffraction. Remarkably, the interactions that mediate cooperativity are captured in the crystal, where two dimers associate about a 2-fold axis of symmetry. Based on the structure and previous genetic and biochemical data, we present a model for the cooperative binding of two lambda repressor dimers at adjacent operator sites.	Johnson Fdn, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Brookhaven Natl Lab, NSLS Beamline X25, Upton, NY 11973 USA; Brookhaven Natl Lab, NSLS Beamline X12B, Upton, NY 11973 USA	University of Pennsylvania; Harvard University; Harvard Medical School; United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory	Lewis, M (corresponding author), Johnson Fdn, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044025] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; BEAMER LJ, 1992, J MOL BIOL, V227, P177, DOI 10.1016/0022-2836(92)90690-L; BECKETT D, 1993, BIOCHEMISTRY-US, V32, P9073, DOI 10.1021/bi00086a012; BENSON N, 1994, MOL MICROBIOL, V11, P567, DOI 10.1111/j.1365-2958.1994.tb00337.x; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURZ DS, 1994, BIOCHEMISTRY-US, V33, P8399, DOI 10.1021/bi00194a003; BURZ DS, 1994, BIOCHEMISTRY-US, V33, P8406, DOI 10.1021/bi00194a004; BUSHMAN FD, 1989, CELL, V58, P1163, DOI 10.1016/0092-8674(89)90514-X; Chang G, 1997, ACTA CRYSTALLOGR D, V53, P279, DOI 10.1107/S0907444996014990; CHANG G, 1994, ACTA CRYSTALLOGR D, V50, P667, DOI 10.1107/S0907444994000727; COHEN S, 1981, NATURE, V294, P182, DOI 10.1038/294182a0; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Ferentz AE, 1997, NAT STRUCT BIOL, V4, P979, DOI 10.1038/nsb1297-979; GIMBLE FS, 1985, J BACTERIOL, V162, P147, DOI 10.1128/JB.162.1.147-154.1985; GIMBLE FS, 1986, J MOL BIOL, V192, P39, DOI 10.1016/0022-2836(86)90462-6; GIMBLE FS, 1989, J MOL BIOL, V206, P29, DOI 10.1016/0022-2836(89)90521-4; GRIFFITH J, 1986, NATURE, V322, P750, DOI 10.1038/322750a0; GUARENTE L, 1982, P NATL ACAD SCI-BIOL, V79, P2236, DOI 10.1073/pnas.79.7.2236; HOCHSCHILD A, 1983, CELL, V32, P319, DOI 10.1016/0092-8674(83)90451-8; HOCHSCHILD A, 1986, CELL, V44, P681, DOI 10.1016/0092-8674(86)90833-0; JOHNSON AD, 1979, P NATL ACAD SCI USA, V76, P5061, DOI 10.1073/pnas.76.10.5061; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KULDELL N, 1994, J BACTERIOL, V176, P2991, DOI 10.1128/JB.176.10.2991-2998.1994; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LI M, 1994, SCIENCE, V263, P75, DOI 10.1126/science.8272867; LIN LL, 1989, J MOL BIOL, V210, P439, DOI 10.1016/0022-2836(89)90121-6; LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375; MANIATIS T, 1975, CELL, V5, P109, DOI 10.1016/0092-8674(75)90018-5; MANIATIS T, 1973, P NATL ACAD SCI USA, V70, P1531, DOI 10.1073/pnas.70.5.1531; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MEYER BJ, 1980, J MOL BIOL, V139, P163, DOI 10.1016/0022-2836(80)90303-4; MEYER BJ, 1980, J MOL BIOL, V139, P195, DOI 10.1016/0022-2836(80)90304-6; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PABO CO, 1979, P NATL ACAD SCI USA, V76, P1608, DOI 10.1073/pnas.76.4.1608; PABO CO, 1982, NATURE, V298, P443, DOI 10.1038/298443a0; Peat TS, 1996, STRUCTURE, V4, P1401, DOI 10.1016/S0969-2126(96)00148-7; Peat TS, 1996, NATURE, V380, P727, DOI 10.1038/380727a0; Ptashne M., 1992, A GENETIC SWITCH; Revet B, 1999, CURR BIOL, V9, P151, DOI 10.1016/S0960-9822(99)80069-4; SAUER RT, 1982, J BIOL CHEM, V257, P4458; SAUER RT, 1979, THESIS HARVARD U CAM; SENEAR DF, 1993, BIOCHEMISTRY-US, V32, P6179, DOI 10.1021/bi00075a010; SLILATY SN, 1987, P NATL ACAD SCI USA, V84, P3987, DOI 10.1073/pnas.84.12.3987; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WEISS MA, 1983, J BIOMOL STRUCT DYN, V1, P151, DOI 10.1080/07391102.1983.10507431; Whipple FW, 1998, GENE DEV, V12, P2791, DOI 10.1101/gad.12.17.2791; WHIPPLE FW, 1994, GENE DEV, V8, P1212, DOI 10.1101/gad.8.10.1212	54	106	107	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 23	2000	101	7					801	811		10.1016/S0092-8674(00)80891-0	http://dx.doi.org/10.1016/S0092-8674(00)80891-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	327YE	10892750	Bronze			2022-12-24	WOS:000087821400013
J	Oldenborg, PA; Zheleznyak, A; Fang, YF; Lagenaur, CF; Gresham, HD; Lindberg, FP				Oldenborg, PA; Zheleznyak, A; Fang, YF; Lagenaur, CF; Gresham, HD; Lindberg, FP			Role of CD47 as a marker of self on red blood cells	SCIENCE			English	Article							INTEGRIN-ASSOCIATED PROTEIN; SIGNAL-REGULATORY PROTEIN; OVARIAN TUMOR-MARKER; INHIBITORY RECEPTORS; MONOCLONAL-ANTIBODY; MYELOID CELLS; FAMILY MEMBER; MOUSE SPLEEN; ADHESION; MICE	The immune system recognizes invaders as foreign because they express determinants that are absent on host cells or because they lack "markers of self" that are normally present. Here we show that CD47 (integrin-associated protein) functions as a marker of self on murine red blood cells. Red blood cells that lacked CD47 were rapidly cleared from the bloodstream by splenic red pulp macrophages,CD47 on normal rea blood,cells prevented this elimination by binding to the inhibitory receptor signal regulatory protein alpha (SIRP alpha). Thus, macrophages may use a number of nonspecific activating receptors and rely on the presence or absence of CD47 to distinguish self from foreign. CD47-SIRP alpha may represent a potential pathway for the control of hemolytic anemia.	Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA; Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; Vet Adm Med Ctr, Res Serv, Albuquerque, NM 87108 USA	Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Lindberg, FP (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, Campus Box 8051, St Louis, MO 63110 USA.				NIGMS NIH HHS [GM57573-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057573] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams S, 1998, J IMMUNOL, V161, P1853; Avent ND, 2000, BLOOD, V95, P375, DOI 10.1182/blood.V95.2.375; BROWN E, 1990, J CELL BIOL, V111, P2785, DOI 10.1083/jcb.111.6.2785; CAMPBELL IG, 1992, CANCER RES, V52, P5416; Colonna M, 1999, CURR TOP MICROBIOL, V244, P115; FRIDMAN WH, 1999, J BIOL CHEM, V274, P32493; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Hoglund P, 1998, EUR J IMMUNOL, V28, P370, DOI 10.1002/(SICI)1521-4141(199801)28:01<370::AID-IMMU370>3.0.CO;2-W; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; KRAAL G, 1986, IMMUNOLOGY, V58, P665; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; LINDBERG FP, 1994, J BIOL CHEM, V269, P1567; LINDBERG FP, 1993, J CELL BIOL, V123, P485, DOI 10.1083/jcb.123.2.485; LINDBERG FP, UNPUB; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; MAWBY WJ, 1994, BIOCHEM J, V304, P525, DOI 10.1042/bj3040525; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; POELS LG, 1986, JNCI-J NATL CANCER I, V76, P781; Roach T, 1997, CURR BIOL, V7, P408, DOI 10.1016/S0960-9822(06)00188-6; Samaridis J, 1997, EUR J IMMUNOL, V27, P660, DOI 10.1002/eji.1830270313; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; VANROOIJEN N, 1989, J LEUKOCYTE BIOL, V45, P97, DOI 10.1002/jlb.45.2.97; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; WITMER MD, 1984, AM J ANAT, V170, P465, DOI 10.1002/aja.1001700318; YOKOYAMA WM, 1995, CURR OPIN IMMUNOL, V7, P110, DOI 10.1016/0952-7915(95)80036-0	30	1188	1274	19	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2000	288	5473					2051	+		10.1126/science.288.5473.2051	http://dx.doi.org/10.1126/science.288.5473.2051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856220				2022-12-24	WOS:000087687000053
J	Rasmussen, B				Rasmussen, B			Filamentous microfossils in a 3,235-million-year-old volcanogenic massive sulphide deposit	NATURE			English	Article							WESTERN-AUSTRALIA; BACTERIA; LIFE; MINERALIZATION; HYDROCARBONS; PILBARA; VENTS	The record of Archaean microfossils is sparse(1). Of the few bona fide fossil assemblages, most are from shallow-water settings, and they are typically associated with laminated, stromatolitic sedimentary rocks(2-4). Microfossils from deep-sea hydrothermal systems have not been reported in Precambrian rocks (>544 million years old), although thermophilic microbes are ubiquitous in modern sea-floor hydrothermal settings(5,6), and apparently have the most ancient lineages(7,8). Here, I report the discovery of pyritic filaments, the probable fossil remains of thread-like microorganisms, in a 3,235-million-year-old deep-sea volcanogenic massive sulphide deposit from the Pilbara Craton of Australia. From their mode of occurrence, the micro-organisms were probably thermophilic chemotropic prokaryotes, which inhabited sub-sea-floor hydrothermal environments. They represent the first fossil evidence for microbial life in a Precambrian submarine thermal spring system, and extend the known range of submarine hydrothermal biota by more than 2,700 million years(9). Such environments may have hosted the first living systems on Earth, consistent with proposals for a thermophilic origin of life(10-13).	Univ Western Australia, Dept Geol & Geophys, Nedlands, WA 6907, Australia	University of Western Australia	Rasmussen, B (corresponding author), Univ Western Australia, Dept Geol & Geophys, Nedlands, WA 6907, Australia.			Rasmussen, Birger/0000-0002-2745-0904				AWRAMIK SM, 1983, PRECAMBRIAN RES, V20, P357, DOI 10.1016/0301-9268(83)90081-5; BAULD J, 1992, PROTEROZOIC BIOSPHER, P261; BAZYLINSKI DA, 1989, APPL ENVIRON MICROB, V55, P2832, DOI 10.1128/AEM.55.11.2832-2836.1989; Brauhart CW, 1998, ECON GEOL BULL SOC, V93, P292, DOI 10.2113/gsecongeo.93.3.292; BUICK R, 1990, Palaios, V5, P441, DOI 10.2307/3514837; BUICK R, IUNPUB PRECAMBR RES; Corliss J. B., 1981, Oceanologica Acta, V4, P59; DUHIG NC, 1992, GEOLOGY, V20, P511, DOI 10.1130/0091-7613(1992)020<0511:MIITFO>2.3.CO;2; FERRIS FG, 1986, NATURE, V320, P609, DOI 10.1038/320609a0; Huber C, 1998, SCIENCE, V281, P670, DOI 10.1126/science.281.5377.670; JANNASCH HW, 1985, SCIENCE, V229, P717, DOI 10.1126/science.229.4715.717; Jones B, 1997, J SEDIMENT RES, V67, P88; JUNIPER SK, 1988, CAN MINERAL, V26, P859; KANDLER O, 1994, NOBEL S, V84, P152; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; KNOLL AH, 1974, P NATL ACAD SCI USA, V71, P2329, DOI 10.1073/pnas.71.6.2329; KNOLL AH, 1988, PRECAMBRIAN RES, V38, P257, DOI 10.1016/0301-9268(88)90005-8; MORANT P, 1995, B AUST I GEOSCI, V16, P75; Nisbet E.G., 1996, Geological Society Special Publication, V118, P239, DOI 10.1144/GSL.SP.1996.118.01.15; RASMUSSEN B, IN PRESS GEOLOGY; RUETER P, 1994, NATURE, V372, P455, DOI 10.1038/372455a0; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; Schopf J.W., 1983, P214; Schopf J. W., 1992, PROTEROZOIC BIOSPHER, P25; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; Stetter KO, 1996, CIBA F SYMP, V202, P1; TEWIN NH, 1999, PALAIOS, V14, P288; VEARNCOMBE S, 1995, J GEOL SOC LONDON, V152, P587, DOI 10.1144/gsjgs.152.4.0587; WALSH MM, 1985, NATURE, V314, P530, DOI 10.1038/314530a0; Winn C.D., 1995, MICROBIOLOGY DEEP SE, P255	30	269	295	0	62	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					676	679		10.1038/35015063	http://dx.doi.org/10.1038/35015063			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864322				2022-12-24	WOS:000087465800044
J	Sheikh, A; Alves, B				Sheikh, A; Alves, B			Hospital admissions for acute anaphylaxis: time trend study	BRITISH MEDICAL JOURNAL			English	Article									Imperial Coll Sch Med, Dept Primary Hlth Care & Gen Practice, London W2 1PG, England	Imperial College London	Sheikh, A (corresponding author), Imperial Coll Sch Med, Dept Primary Hlth Care & Gen Practice, London W2 1PG, England.		Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				Dibs S D, 1997, Pediatrics, V99, pE7, DOI 10.1542/peds.99.1.e7; Ewan PW, 1998, BRIT MED J, V316, P1442, DOI 10.1136/bmj.316.7142.1442; HYNDMAN SJ, 1994, BRIT MED J, V308, P1596, DOI 10.1136/bmj.308.6944.1596; *NHS CTR COD CLASS, 1995, GUID US TABL EQ ICD; Tariq SM, 1996, BRIT MED J, V313, P514, DOI 10.1136/bmj.313.7056.514	5	138	142	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 27	2000	320	7247					1441	1441		10.1136/bmj.320.7247.1441	http://dx.doi.org/10.1136/bmj.320.7247.1441			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320RT	10827045	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000087414700025
J	Zahn, S; Canary, JW				Zahn, S; Canary, JW			Electron-induced inversion of helical chirality in copper complexes of N,N-dialkylmethionines	SCIENCE			English	Article							REDOX; SWITCH; DRIVEN; LIGAND; LIGHT	Stereodynamic complexes of copper were found to undergo inversion of a helical chiral element upon oxidation or reduction. The amino acid methionine was derivatized by the attachment of two chromophores to the nitrogen atom, The resultant ligands formed stable complexes with Cu-1 and Cu-11 salts. For a derivative of a given absolute chirality, the complexes afford nearly mirror image circular dichroism spectra. The spectral changes originate from reorientation of the nitrogen-attached chromophores due to a conformation interconversion driven by the exchange of a carboxylate for a sulfide ligand. The electrically induced chirality inversion coupled with strong interactions with polarized light is unique and may Lead to novel chiral molecular devices.	NYU, Dept Chem, New York, NY 10003 USA	New York University	Canary, JW (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.	james.canary@nyu.edu			NIGMS NIH HHS [GM49170] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM049170] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armaroli N, 1999, J AM CHEM SOC, V121, P4397, DOI 10.1021/ja984051w; Ashton PR, 1999, J AM CHEM SOC, V121, P3951, DOI 10.1021/ja984341c; BISSELL RA, 1994, NATURE, V369, P133, DOI 10.1038/369133a0; CANARY JW, 1995, J AM CHEM SOC, V117, P8484, DOI 10.1021/ja00137a032; Canary JW, 1998, INORG CHEM, V37, P6255, DOI 10.1021/ic9803098; CANARY JW, IN PRESS ENANTIOMER; Castagnetto JM, 1997, CHIRALITY, V9, P616, DOI 10.1002/(SICI)1520-636X(1997)9:5/6<616::AID-CHIR32>3.3.CO;2-6; DESANTIS G, 1992, J CHEM SOC DALTON, P3283, DOI 10.1039/dt9920003283; GOULLE V, 1993, J CHEM SOC CHEM COMM, P1034, DOI 10.1039/c39930001034; Huck NPM, 1996, SCIENCE, V273, P1686, DOI 10.1126/science.273.5282.1686; JANICKI SZ, 1995, J AM CHEM SOC, V117, P8524, DOI 10.1021/ja00138a005; Koumura N, 1999, NATURE, V401, P152, DOI 10.1038/43646; Mao CD, 1999, NATURE, V397, P144, DOI 10.1038/16437; MUNOZ S, 1993, J AM CHEM SOC, V115, P4899, DOI 10.1021/ja00064a064; Nakanishi K., 1994, CIRCULAR DICHROISM P, P361; Porsch M, 1997, ADV MATER, V9, P635, DOI 10.1002/adma.19970090809; SHINKAI S, 1985, J AM CHEM SOC, V107, P3950, DOI 10.1021/ja00299a034; SIEGRIST AE, 1980, HELV CHIM ACTA, V63, P1311, DOI 10.1002/hlca.19800630524; SUAREZ M, 1995, J AM CHEM SOC, V117, P6732, DOI 10.1021/ja00130a013; TYEKLAR Z, 1993, BIOINORGANIC CHEM CO, P277; Westermeier C, 1999, CHEM COMMUN, P2427, DOI 10.1039/a907454f; Yang DK, 1997, ANNU REV MATER SCI, V27, P117, DOI 10.1146/annurev.matsci.27.1.117; Zahn S, 1999, ORG LETT, V1, P861, DOI 10.1021/ol990715a; Zahn S, 1998, ANGEW CHEM INT EDIT, V37, P305, DOI 10.1002/(SICI)1521-3773(19980216)37:3<305::AID-ANIE305>3.0.CO;2-T; ZELIKOVICH L, 1995, NATURE, V374, P790, DOI 10.1038/374790a0	25	192	195	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2000	288	5470					1404	1407		10.1126/science.288.5470.1404	http://dx.doi.org/10.1126/science.288.5470.1404			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318EL	10827947				2022-12-24	WOS:000087270900045
J	Ackers, ML; Puhr, ND; Tauxe, RV; Mintz, ED				Ackers, ML; Puhr, ND; Tauxe, RV; Mintz, ED			Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States - Antimicrobial resistance on the rise	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	35th Annual Meeting of the Infectious-Diseases-Society-of-America	SEP 07-16, 1997	SAN FRANCISCO, CA	Infect Dis Soc Amer			DRUG-RESISTANCE; PHAGE TYPES; FEVER; INDIA; TRAVEL	Context Multidrug-resistant Salmonella serotype Typhi infections have been reported worldwide, but data on the incidence of resistant strains in the United States are lacking. Objectives To determine the incidence of antimicrobial-resistant Salmonella Typhi infections and to identify risk factors for infection, Design Cross-sectional laboratory-based surveillance study. Setting and Participants A total of 293 persons with symptomatic typhoid fever who had Salmonella Typhi isolates and epidemiological information submitted to US public health departments and laboratories from June 1, 1996, to May 31, 1997, Main Outcome Measures Proportion of Salmonella Typhi isolates demonstrating resistance to 12 antimicrobial agents; patient epidemiological factors associated with drug-resistant infections. Results Median age was 21 years (range, 3 months to 84 years); 56% were male, Two hundred twenty-eight (80%) were hospitalized; 2 died. In the 6 weeks before illness onset, 81% of patients had traveled abroad. Seventy-four Salmonella Typhi isolates (25%) were resistant to 1 or more antimicrobial agent, and 51 (17%) were resistant to 5 or more agents, including ampicillin, chloramphenicol, and trimethoprimsulfamethoxazole (multidrug-resistant Salmonella Typhi [MDRST]). Although no resistance to ciprofloxacin or ceftriaxone was observed, 20 isolates (7%) were nalidixic acid-resistant (NARST). Patients with MDRST and NARST infections were more likely to report travel outside the United States, particularly to the Indian subcontinent (Bangladesh, India, and Pakistan) (odds ratio [OR], 29.3; 95% confidence interval [CI], 6.8-126.7; P<.001 and OR, 35.9; 95% CI, 3.4-377.3; P<.001, respectively). Conclusions Our data suggest that ciprofloxacin and ceftriaxone are appropriate empirical therapy for suspected typhoid fever; however, resistance may be anticipated. Continued monitoring of antimicrobial resistance among Salmonella Typhi strains will help determine vaccination and treatment policies.	Ctr Dis Control & Prevent, Food & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Epidemiol Program Off, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Mintz, ED (corresponding author), Ctr Dis Control & Prevent, Food & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Mail Stop A-38,1600 Clifton Rd, Atlanta, GA 30333 USA.							AGARWAL V, 1992, INDIAN J MED RES-A, V95, P14; AM NT, 1993, B SOC PATHOL EXOT, V86, P476; Atkins BL, 1998, JAMA-J AM MED ASSOC, V279, P579, DOI 10.1001/jama.279.8.579; Bhatia R S, 1992, J Assoc Physicians India, V40, P705; BHUTTA ZA, 1991, REV INFECT DIS, V13, P832; *CDCP, 1997, HLTH INF INT TRAV 19, P199; CHANDRA R, 1992, J TROP MED HYG, V95, P284; COOVADIA YM, 1992, Q J MED, V82, P91; Daga M K, 1994, J Assoc Physicians India, V42, P599; GULATI S, 1992, ANN TROP PAEDIATR, V12, P137, DOI 10.1080/02724936.1992.11747558; HUANG MB, 1992, J CLIN MICROBIOL, V30, P3243, DOI 10.1128/JCM.30.12.3243-3248.1992; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P419; Mahon BE, 1996, JAMA-J AM MED ASSOC, V276, P307, DOI 10.1001/jama.276.4.307; Mermin JH, 1998, ARCH INTERN MED, V158, P633, DOI 10.1001/archinte.158.6.633; *NAT COMM CLIN LAB, 1995, PUBL NAT COMM CLIN L; PILLAI PK, 1993, INDIAN J MED RES-A, V97, P154; RAO PS, 1993, AM J TROP MED HYG, V48, P108, DOI 10.4269/ajtmh.1993.48.108; RICE PA, 1977, AM J EPIDEMIOL, V106, P160, DOI 10.1093/oxfordjournals.aje.a112446; Rowe B, 1997, CLIN INFECT DIS, V24, pS106, DOI 10.1093/clinids/24.Supplement_1.S106; ROWE B, 1991, LANCET, V337, P1422, DOI 10.1016/0140-6736(91)93116-Q; RYAN CA, 1989, REV INFECT DIS, V11, P1; Saha SK, 1999, PEDIATR INFECT DIS J, V18, P387, DOI 10.1097/00006454-199904000-00018; SUDARSANA J, 1992, INDIAN J MED RES-A, V95, P68; Threlfall EJ, 1999, LANCET, V353, P1590, DOI 10.1016/S0140-6736(99)01001-6; UMASANKAR S, 1992, BUR, V2, pR139; *US TRAV TOUR ADM, 1998, INT TRAV US 1996 US, P4; Wain J, 1997, CLIN INFECT DIS, V25, P1404, DOI 10.1086/516128; Zhang L, 1991, Zhonghua Yi Xue Za Zhi, V71, P314; ZHANG L, 1991, CHUNG HUA HSUEH TSA, V71, P324	29	130	134	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2000	283	20					2668	2673		10.1001/jama.283.20.2668	http://dx.doi.org/10.1001/jama.283.20.2668			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	314FP	10819949	Bronze			2022-12-24	WOS:000087046000034
J	Lopes-Gautier, R; Doute, S; Smythe, WD; Kamp, LW; Carlson, RW; Davies, AG; Leader, FE; McEwen, AS; Geissler, PE; Kieffer, SW; Keszthelyi, L; Barbinis, E; Mehlman, R; Segura, M; Shirley, J; Soderblom, LA				Lopes-Gautier, R; Doute, S; Smythe, WD; Kamp, LW; Carlson, RW; Davies, AG; Leader, FE; McEwen, AS; Geissler, PE; Kieffer, SW; Keszthelyi, L; Barbinis, E; Mehlman, R; Segura, M; Shirley, J; Soderblom, LA			A close-up look at Io from Galileo's near-infrared mapping spectrometer	SCIENCE			English	Article							ACTIVE VOLCANISM; SILICATE	Infrared spectral images of Jupiter's volcanic moon lo, acquired during the October and November 1999 and February 2000 flybys of the Galileo spacecraft, were used to study the thermal structure and sulfur dioxide distribution of active volcanoes. Loki Patera, the solar system's most powerful known volcano, exhibits Large expanses of dark, cooling lava on its caldera floor. Prometheus, the site of long-lived plume activity, has two major areas of thermal emission, which support ideas of plume migration. Sulfur dioxide deposits were mapped at local scales and show a more complex relationship to surface colors than previously thought, indicating the presence of other sulfur compounds.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Calif Los Angeles, IGPP, Los Angeles, CA 90095 USA; SW Kieffer Sci Consulting Inc, Bolton, ON L7E 5T4, Canada; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; US Geol Survey, Flagstaff, AZ 86001 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California Los Angeles; University of Arizona; United States Department of the Interior; United States Geological Survey	Lopes-Gautier, R (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	rlopes@lively.jpl.nasa.gov	Shirley, James/AAR-1264-2020; Lopes, Rosaly M.C./D-1608-2016; Davies, Ashley/S-5588-2018	Lopes, Rosaly M.C./0000-0002-7928-3167; Davies, Ashley/0000-0003-1747-8142; Kestay, Laszlo/0000-0003-1879-4331				Carlson RW, 1997, GEOPHYS RES LETT, V24, P2479, DOI 10.1029/97GL02609; Davies AG, 1996, ICARUS, V124, P45, DOI 10.1006/icar.1996.0189; DAVIES AG, 1999, LUNAR PLANET SCI, V30; DOUTE S, UNPUB; Geissler PE, 1999, ICARUS, V140, P265, DOI 10.1006/icar.1999.6128; HOWELL R, 2000, LUNAR PLANET SCI, V31; Kieffer SW, 2000, SCIENCE, V288, P1204, DOI 10.1126/science.288.5469.1204; Lopes-Gautier R, 1999, ICARUS, V140, P243, DOI 10.1006/icar.1999.6129; McEwen AS, 2000, SCIENCE, V288, P1193, DOI 10.1126/science.288.5469.1193; McEwen AS, 1998, ICARUS, V135, P181, DOI 10.1006/icar.1998.5972; McEwen AS, 1998, SCIENCE, V281, P87, DOI 10.1126/science.281.5373.87; Pearl J.S., 1982, SATELLITES JUPITER, P724; Schmitt B, 1998, ASTROPHYS SPACE SC L, V227, P199, DOI 10.1007/978-94-011-5252-5_9; SCHMITT B, 1994, ICARUS, V111, P79, DOI 10.1006/icar.1994.1135; Spencer JR, 1997, ICARUS, V127, P221, DOI 10.1006/icar.1996.5670; Spencer JR, 2000, SCIENCE, V288, P1208, DOI 10.1126/science.288.5469.1208; Strom R. G., 1982, SATELLITES JUPITER, P598	17	74	74	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2000	288	5469					1201	1204		10.1126/science.288.5469.1201	http://dx.doi.org/10.1126/science.288.5469.1201			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315KH	10817988				2022-12-24	WOS:000087112600040
J	Goodman, WG; Goldin, J; Kuizon, BD; Yoon, C; Gales, B; Sider, D; Wang, Y; Chung, J; Emerick, A; Greaser, L; Elashoff, RM; Salusky, IB				Goodman, WG; Goldin, J; Kuizon, BD; Yoon, C; Gales, B; Sider, D; Wang, Y; Chung, J; Emerick, A; Greaser, L; Elashoff, RM; Salusky, IB			Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BEAM COMPUTED-TOMOGRAPHY; NONINVASIVE DETECTION; HEMODIALYSIS-PATIENTS; PEDIATRIC-PATIENTS; CALCIUM; MORTALITY; ATHEROSCLEROSIS; TRANSPLANT; ASSOCIATION; THERAPY	Background: Cardiovascular disease is common in older adults with end-stage renal disease who are undergoing regular dialysis, but little is known about the prevalence and extent of cardiovascular disease in children and young adults with end-stage renal disease. Methods: We used electron-beam computed tomography (CT) to screen for coronary-artery calcification in 39 young patients with end-stage renal disease who were undergoing dialysis (mean [+/-SD] age, 19+/-7 years; range, 7 to 30) and 60 normal subjects 20 to 30 years of age. In those with evidence of calcification on CT scanning, we determined its extent. The results were correlated with the patients' clinical characteristics, serum calcium and phosphorus concentrations, and other biochemical variables. Results: None of the 23 patients who were younger than 20 years of age had evidence of coronary-artery calcification, but it was present in 14 of the 16 patients who were 20 to 30 years old. Among those with calcification, the mean calcification score was 1157+/-1996, and the median score was 297. By contrast, only 3 of the 60 normal subjects had calcification. As compared with the patients without coronary-artery calcification, those with calcification were older (26+/-3 vs. 15+/-5 years, P<0.001) and had been undergoing dialysis for a longer period (14+/-5 vs. 4+/-4 years, P<0.001). The mean serum phosphorus concentration, the mean calcium-phosphorus ion product in serum, and the daily intake of calcium were higher among the patients with coronary-artery calcification. Among 10 patients with calcification who underwent follow-up CT scanning, the calcification score nearly doubled (from 125+/-104 to 249+/-216, P=0.02) over a mean period of 20+/-3 months. Conclusions: Coronary-artery calcification is common and progressive in young adults with end-stage renal disease who are undergoing dialysis. (N Engl J Med 2000;342:1478-83.) (C)2000, Massachusetts Medical Society.	Univ Calif Los Angeles, Med Ctr, Div Nephrol, Sch Med,Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Biomath, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Goodman, WG (corresponding author), Univ Calif Los Angeles, Med Ctr, Div Nephrol, Sch Med,Dept Med, 7-155 Factor Bldg,10833 Le Conte Ave, Los Angeles, CA 90095 USA.			Goldin, Jonathan/0000-0003-3007-9947	NCRR NIH HHS [RR-00865] Funding Source: Medline; NIDDK NIH HHS [DK-35423, DK-52905] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052905, R01DK035423] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Achenbach S, 1998, NEW ENGL J MED, V339, P1964, DOI 10.1056/NEJM199812313392702; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; AVRAM MM, 1992, AM J KIDNEY DIS, V20, P324, DOI 10.1016/S0272-6386(12)70294-9; Bergstrom J, 1998, AM J KIDNEY DIS, V32, P834, DOI 10.1016/S0272-6386(98)70148-9; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Bostom AG, 1996, ATHEROSCLEROSIS, V125, P91, DOI 10.1016/0021-9150(96)05865-0; Braun J, 1996, AM J KIDNEY DIS, V27, P394, DOI 10.1016/S0272-6386(96)90363-7; Celermajer DS, 1998, NEW ENGL J MED, V339, P2014, DOI 10.1056/NEJM199812313392709; DEFRONZO RA, 1978, METABOLISM, V27, P1866, DOI 10.1016/S0026-0495(78)80005-5; Dixon WJ., 1983, INTRO STAT ANAL; Fiorino AS, 1998, ANN INTERN MED, V128, P839, DOI 10.7326/0003-4819-128-10-199805150-00008; Hsu CH, 1997, AM J KIDNEY DIS, V29, P641, DOI 10.1016/S0272-6386(97)90352-8; KAUFMANN RB, 1995, MAYO CLIN PROC, V70, P223, DOI 10.4065/70.3.223; LINDNER A, 1974, NEW ENGL J MED, V290, P697, DOI 10.1056/NEJM197403282901301; Maher JE, 1999, MAYO CLIN PROC, V74, P347, DOI 10.4065/74.4.347; Mailloux LU, 1998, AM J KIDNEY DIS, V32, P705, DOI 10.1016/S0272-6386(98)70146-5; MAUTNER SL, 1994, RADIOLOGY, V192, P625, DOI 10.1148/radiology.192.3.8058925; MILLINER DS, 1990, KIDNEY INT, V38, P931, DOI 10.1038/ki.1990.293; *NAT I DIAB DIG KI, 1998, REN DAT SYST USRDS 1, V1999, P63; Owen WF, 1996, AM J KIDNEY DIS, V28, P931, DOI 10.1016/S0272-6386(96)90397-2; PENNISI AJ, 1976, AM J DIS CHILD, V130, P957, DOI 10.1001/archpedi.1976.02120100047007; Rosner B., 1986, FUNDAMENTALS BIOSTAT, V2nd, P442; Rumberger JA, 1999, MAYO CLIN PROC, V74, P538; RUMBERGER JA, 1995, CIRCULATION, V91, P1363, DOI 10.1161/01.CIR.91.5.1363; RUMBERGER JA, 1994, AM J CARDIOL, V73, P1169, DOI 10.1016/0002-9149(94)90176-7; Rumberger JA, 1999, MAYO CLIN PROC, V74, P243, DOI 10.4065/74.3.243; Salusky IB, 1998, KIDNEY INT, V54, P907, DOI 10.1046/j.1523-1755.1998.00045.x; SALUSKY IB, 1988, KIDNEY INT, V33, P975, DOI 10.1038/ki.1988.96; Warady BA, 1997, PEDIATR NEPHROL, V11, P49, DOI 10.1007/s004670050232; Watson KE, 1997, CIRCULATION, V96, P1755, DOI 10.1161/01.CIR.96.6.1755; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Zager PG, 1998, KIDNEY INT, V54, P1417; Zager PG, 1998, KIDNEY INT, V54, P561, DOI 10.1046/j.1523-1755.1998.00005.x	34	2215	2332	0	74	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2000	342	20					1478	1483		10.1056/NEJM200005183422003	http://dx.doi.org/10.1056/NEJM200005183422003			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314QT	10816185	Bronze			2022-12-24	WOS:000087068200003
J	Iribarren, C; Sidney, S; Bild, DE; Liu, K; Markovitz, JH; Roseman, JM; Matthews, K				Iribarren, C; Sidney, S; Bild, DE; Liu, K; Markovitz, JH; Roseman, JM; Matthews, K			Association of hostility with coronary artery calcification in young adults - The CARDIA study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Meeting of the Conference on Cardiovascular Disease, Epidemiology, and Prevention	MAR 24-27, 1999	ORLANDO, FLORIDA				DENSITY-LIPOPROTEIN-CHOLESTEROL; ACUTE MYOCARDIAL-INFARCTION; ELECTRON-BEAM CT; HEART-DISEASE; CAROTID ATHEROSCLEROSIS; POSTMENOPAUSAL WOMEN; ADRENALINE INFUSION; TOTAL MORTALITY; RISK-FACTORS; A BEHAVIOR	Context Psychosocial factors, including personality and character traits, may play a role in the development and expression of coronary artery disease. Objective To evaluate whether hostility, a previously reported predictor of clinical coronary artery disease, is associated with coronary calcification, which is a marker of subclinical atherosclerosis. Design Prospective cohort study. Setting and Participants Volunteer subsample from Chicago, ill, and Oakland, Calif, consisting of 374 white and black men and women, aged 18 to 30 years at baseline, who participated in the Coronary Artery Risk Development in You ng Adults (CARDIA) study. Cook-Medley hostility assessment data were collected at baseline from 1985 to 1986 and at year 5 examinations from 1990 to 1992. After the 10-year examinations in the 1995-1996 year, electron-beam computed tomographic scans were performed. Main Outcome Measures Presence of any detectable coronary artery calcification (coronary calcium score >0), and coronary artery calcium scores of 20 or higher. Results In logistic regression analysis adjusting for age, sex, race, and field center comparing those with hostility scores above and below the median of the distribution of the present sample, the odds ratio of having any coronary calcification was 2.57 (95% confidence interval, 1.31-5.22), and the odds ratio of having a calcium score of 20 or higher was 9.56 (95% confidence interval. 2.29-65.9) for calcium scores of 20 or higher. The associations with any coronary artery calcification persisted after adjusting for demographic, lifestyle, and physiological variables. Results using a cynical distrust subscale were somewhat weaker than for those using the global hostility score. Power was inadequate to perform sex- or race-specific analyses. Conclusion These results suggest that a high hostility level may predispose young adults to coronary artery calcification.	Kaiser Permanente Med Care Program, Oakland, CA 94611 USA; NHLBI, Dept Epidemiol & Clin Applicat, Bethesda, MD 20892 USA; Northwestern Univ, Sch Med, Dept Family & Community Med, Chicago, IL USA; Univ Alabama, Sch Publ Hlth, Birmingham, AL 35294 USA; Univ Alabama, Div Prevent Med, Birmingham, AL USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA	Kaiser Permanente; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Northwestern University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Iribarren, C (corresponding author), Kaiser Permanente Div Res, 3505 Broadway, Oakland, CA 94611 USA.				DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048048, N01HC048049, N01HC048047] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-48048, N01-HC-48049, N01-HC-48047] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; ALEXANDERSEN P, 1996, ATHEROSCLEROSIS, V125, P11; ARCHER J, 1991, BRIT J PSYCHOL, V82, P12; BAREFOOT JC, 1994, AM J CARDIOL, V74, P439, DOI 10.1016/0002-9149(94)90899-0; BAREFOOT JC, 1995, AM J EPIDEMIOL, V142, P477, DOI 10.1093/oxfordjournals.aje.a117663; BAREFOOT JC, 1983, PSYCHOSOM MED, V45, P59, DOI 10.1097/00006842-198303000-00008; BAREFOOT JC, 1989, PSYCHOSOM MED, V51, P46, DOI 10.1097/00006842-198901000-00005; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; BIELAK LF, 1994, RADIOLOGY, V192, P631, DOI 10.1148/radiology.192.3.8058926; Bild DE, 1996, ANN EPIDEMIOL, V6, P235, DOI 10.1016/1047-2797(96)00005-1; Bild DE, 1997, CAN J CARDIOL SB, V13, p241B; Blankenhorn DH, 1961, AM J MED SCI, V42, P1; Cook W, 1954, J APPL PSYCHOL, V386, P414; DEMBROSKI TM, 1985, PSYCHOSOM MED, V47, P219, DOI 10.1097/00006842-198505000-00001; DEMBROSKI TM, 1989, PSYCHOSOM MED, V51, P514, DOI 10.1097/00006842-198909000-00003; DIAMOND EL, 1982, PSYCHOL BULL, V92, P410, DOI 10.1037/0033-2909.92.2.410; DOUMA S, 1992, NOUV REV FR HEMATOL, V34, P73; DYER AR, 1990, J CLIN EPIDEMIOL, V43, P11; Everson SA, 1997, AM J EPIDEMIOL, V146, P142; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; FRIEDMAN M, 1986, AM HEART J, V112, P653, DOI 10.1016/0002-8703(86)90458-8; Goodman M, 1996, MAYO CLIN PROC, V71, P729; Guyll M, 1998, HEALTH PSYCHOL, V17, P30, DOI 10.1037/0278-6133.17.1.30; HEARN MD, 1989, J BEHAV MED, V12, P105, DOI 10.1007/BF00846545; HELMER DC, 1991, AM J EPIDEMIOL, V133, P112, DOI 10.1093/oxfordjournals.aje.a115850; HUGHES GH, 1987, CONTROL CLIN TRIA S4, V8, pSB68; Jacobs DR, 1989, J CARDIOPULM REHABIL, V9, p448B; JULKUNEN J, 1994, PSYCHOSOM MED, V56, P519, DOI 10.1097/00006842-199411000-00007; KAUFMANN RB, 1994, RADIOLOGY, V190, P347, DOI 10.1148/radiology.190.2.8284380; Kennedy J, 1998, AM HEART J, V135, P696, DOI 10.1016/S0002-8703(98)70288-1; KOSKENVUO M, 1988, PSYCHOSOM MED, V50, P330, DOI 10.1097/00006842-198807000-00002; Lahad A, 1997, J PSYCHOSOM RES, V43, P183, DOI 10.1016/S0022-3999(96)00369-8; LARSSON PT, 1989, BRIT J CLIN PHARMACO, V28, P663, DOI 10.1111/j.1365-2125.1989.tb03559.x; Lavie CJ, 1999, MAYO CLIN PROC, V74, P959; LEON GR, 1988, J CONSULT CLIN PSYCH, V56, P597, DOI 10.1037/0022-006X.56.4.597; Markovitz JH, 1998, PSYCHOSOM MED, V60, P586, DOI 10.1097/00006842-199809000-00013; Matthews KA, 1998, PSYCHOSOM MED, V60, P633, DOI 10.1097/00006842-199809000-00021; Pasic J, 1998, AM J HYPERTENS, V11, P245, DOI 10.1016/S0895-7061(97)00464-0; Rumberger JA, 1996, MAYO CLIN PROC, V71, P369, DOI 10.4065/71.4.369; SCHERWITZ L, 1991, PSYCHOSOM MED, V53, P36, DOI 10.1097/00006842-199101000-00004; SCHERWITZ LW, 1992, AM J EPIDEMIOL, V136, P136, DOI 10.1093/oxfordjournals.aje.a116480; SECCI A, 1997, CIRCULATION, V96, P112; SHEKELLE RB, 1983, PSYCHOSOM MED, V45, P109, DOI 10.1097/00006842-198305000-00003; SMITH TW, 1992, HEALTH PSYCHOL, V11, P139, DOI 10.1037/0278-6133.11.3.139; Suarez EC, 1997, PSYCHOSOM MED, V59, P481, DOI 10.1097/00006842-199709000-00004; Suarez EC, 1998, PSYCHOSOM MED, V60, P78, DOI 10.1097/00006842-199801000-00017; Suarez EC, 1998, J PSYCHOSOM RES, V44, P261, DOI 10.1016/S0022-3999(97)00201-8; Warnick G R, 1986, Methods Enzymol, V129, P101; WARNICK GR, 1982, CLIN CHEM, V28, P1379; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175	51	163	169	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2000	283	19					2546	2551		10.1001/jama.283.19.2546	http://dx.doi.org/10.1001/jama.283.19.2546			6	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	312VL	10815118	Bronze			2022-12-24	WOS:000086964600035
J	Swan, SK; Rudy, DW; Lasseter, KC; Ryan, CF; Buechel, KL; Lambrecht, LJ; Pinto, MB; Dilzer, SC; Obrda, O; Sundblad, KJ; Gumbs, CP; Ebel, DL; Quan, H; Larson, PJ; Schwartz, JI; Musliner, TA; Gertz, BJ; Brater, DC; Yao, SL				Swan, SK; Rudy, DW; Lasseter, KC; Ryan, CF; Buechel, KL; Lambrecht, LJ; Pinto, MB; Dilzer, SC; Obrda, O; Sundblad, KJ; Gumbs, CP; Ebel, DL; Quan, H; Larson, PJ; Schwartz, JI; Musliner, TA; Gertz, BJ; Brater, DC; Yao, SL			Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GLOMERULAR-FILTRATION RATE; SODIUM-BALANCE; H SYNTHASE; INSUFFICIENCY; INDOMETHACIN; PROSTAGLANDINS; HOMEOSTASIS; ISOFORM; ASPIRIN	Background: Most nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit both cyclooxygenase-1 (COX-1), whose inhibition is associated with gastrointestinal ulceration, and COX-2, whose inhibition is associated with therapeutic benefits. Although agents that do not produce COX-1 activity may have fewer adverse effects, targeted disruption of the COX-2 allele in mice has resulted in severe renal problems, suggesting that COX-2 inhibition may also produce adverse effects. Objective: To determine the effect of rofecoxib, a member of the coxib class of drugs and a specific inhibitor of the COX-2 enzyme, on renal function in elderly patients. Design: A randomized, three-period, single-dose crossover study and a randomized, parallel-group, multiple-dose study. Setting: Clinical research units. Patients: 75 patients 60 to 80 years of age. Intervention: In the first study, single doses of rofecoxib, 250 mg (about Ei-fold to 20-fold the recommended dose); indomethacin, 75 mg; and placebo were administered to 15 patients. In the second study, multiple doses of rofecoxib, 12.5 or 25 mg/d; indomethacin, 50 mg three times daily; or placebo were administered to 60 patients. Patients in both studies received a low-sodium diet Measurements: Glomerular filtration rate, creatinine clearance, and urinary and serum sodium and potassium values. Results: Compared with placebo, single doses of rofecoxib and indomethacin decreased the glomerular filtration rate by 0.23 mL/s (P < 0.001) and 0.18 mL/s (P = 0.003), respectively. In contrast, respective decreases of 0.14, 0.13, and 0.10 mL/s were observed after multiple doses of rofecoxib, 12.5 mg/d (P = 0.019); rofecoxib, 25 mg (P = 0.029), and indomethacin (P = 0.086) were administered. Changes in creatinine clearance and serum and urinary sodium and potassium were less pronounced. Conclusions: The effects of COX-2 inhibition on renal function are similar to those observed with nonselective NSAIDs. Thus, COX-2 seems to play an important role in human renal function.	Hennepin Cty Med Ctr, Div Nephrol, Minneapolis, MN 55415 USA; Total Renal Res Inc, Minneapolis, MN USA; Indiana Univ, Indianapolis, IN 46204 USA; Clin Pharmacol Associates, Miami, FL USA; PPD, Austin, TX USA; Merck Res Labs, Rahway, NJ USA	Hennepin County Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; Merck & Company	Yao, SL (corresponding author), Hennepin Cty Med Ctr, Div Nephrol, 701 Pk Ave, Minneapolis, MN 55415 USA.	siulong_yao@merck.com						BRATER DC, 1985, CLIN PHARMACOL THER, V38, P674, DOI 10.1038/clpt.1985.244; BRATER DC, 1979, CLIN PHARMACOL THER, V25, P322; Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735; CROFFORD LJ, 1994, J CLIN INVEST, V93, P1095, DOI 10.1172/JCI117060; Cryer B, 1998, AM J MED, V104, P413, DOI 10.1016/S0002-9343(98)00091-6; DONKER AJM, 1976, NEPHRON, V17, P288, DOI 10.1159/000180733; DUSING R, 1982, KLIN WOCHENSCHR, V60, P1229, DOI 10.1007/BF01716728; Ehrich EW, 1999, CLIN PHARMACOL THER, V65, P336, DOI 10.1016/S0009-9236(99)70113-X; FJELDBO W, 1968, J LAB CLIN MED, V72, P353; HARRIS RC, 1994, J CLIN INVEST, V94, P2504, DOI 10.1172/JCI117620; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; HOLTZMAN MJ, 1992, J BIOL CHEM, V267, P21438; Komhoff M, 1997, AM J PHYSIOL-RENAL, V272, pF460, DOI 10.1152/ajprenal.1997.272.4.F460; KRAMER HJ, 1985, CLIN SCI, V68, P387, DOI 10.1042/cs0680387; MEADE EA, 1993, J BIOL CHEM, V268, P6610; Murray MD, 1997, AM J MED SCI, V314, P80, DOI 10.1097/00000441-199708000-00009; MURRAY MD, 1992, BRIT J CLIN PHARMACO, V33, P385, DOI 10.1111/j.1365-2125.1992.tb04056.x; MURRAY MD, 1995, AM J MED SCI, V310, P188, DOI 10.1097/00000441-199511000-00003; MURRAY MD, 1990, ANN INTERN MED, V112, P559, DOI 10.7326/0003-4819-112-8-559; MUTHER RS, 1981, ANN INTERN MED, V94, P317, DOI 10.7326/0003-4819-94-3-317; Rossat J, 1999, CLIN PHARMACOL THER, V66, P76, DOI 10.1016/S0009-9236(99)70056-1; SIGMAN EM, 1966, J NUCL MED, V7, P60; SIGMAN EUGENE M., 1965, INVEST UROL, V2, P432; SIROIS J, 1992, J BIOL CHEM, V267, P11586; TOTO RD, 1986, KIDNEY INT, V30, P760, DOI 10.1038/ki.1986.253	25	274	287	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 4	2000	133	1					1	9		10.7326/0003-4819-133-1-200007040-00002	http://dx.doi.org/10.7326/0003-4819-133-1-200007040-00002			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329TB	10877734				2022-12-24	WOS:000087923100001
J	Falciatore, A; d'Alcala, MR; Croot, P; Bowler, C				Falciatore, A; d'Alcala, MR; Croot, P; Bowler, C			Perception of environmental signal by a marine diatom	SCIENCE			English	Article							EQUATORIAL PACIFIC-OCEAN; IRON LIMITATION; PHYTOPLANKTON; TRANSFORMATION; TRANSPORT; OSMOREGULATION; FLAVODOXIN; KINETICS; STRESS	Diatoms are a key component of marine ecosystems and are extremely important for the biogeochemical cycling of silica and as contributors to global fixed carbon. However, the answers to fundamental questions such as what diatoms can sense in their environment, how they respond to external signals, and what factors control their Life strategies are largely unknown. We generated transgenic diatom cells containing the calcium-sensitive photoprotein aequorin to determine whether changes in calcium homeostasis are used to respond to relevant environmental stimuli. Our results reveal sensing systems for detecting and responding to fluid motion (shear stress), osmotic stress, and iron, a key nutrient that controls diatom abundance in the ocean.	Staz Zool Anton Dohrn, Plant Mol Biol Lab, I-80121 Naples, Italy; Staz Zool Anton Dohrn, Lab Biol Oceanog, I-80121 Naples, Italy; Netherlands Inst Sea Res, Dept Marine Chem & Geol, NL-1790 AB Den Burg, Netherlands	Stazione Zoologica Anton Dohrn di Napoli; Stazione Zoologica Anton Dohrn di Napoli; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Bowler, C (corresponding author), Staz Zool Anton Dohrn, Plant Mol Biol Lab, Villa Comunale, I-80121 Naples, Italy.	chris@alpha.szn.it	d'Alcala', Maurizio Ribera/B-7114-2012; Falciatore, Angela/Q-6161-2018; Croot, Peter L/C-8460-2009; Bowler, Chris/AAC-6256-2019; Croot, Peter/U-5296-2019	d'Alcala', Maurizio Ribera/0000-0002-5492-9961; Croot, Peter L/0000-0003-1396-0601; Bowler, Chris/0000-0003-3835-6187; Falciatore, Angela/0000-0003-3318-9578				Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; Dunahay TG, 1995, J PHYCOL, V31, P1004, DOI 10.1111/j.0022-3646.1995.01004.x; EILERTSEN HC, 1995, MAR ECOL PROG SER, V116, P303, DOI 10.3354/meps116303; Falciatore A, 1999, MAR BIOTECHNOL, V1, P239, DOI 10.1007/PL00011773; FARIAS PAM, 1992, ANAL LETT, V25, P1929, DOI 10.1080/00032719208018263; HUDSON RJM, 1993, DEEP-SEA RES PT I, V40, P129, DOI 10.1016/0967-0637(93)90057-A; HUDSON RJM, 1990, LIMNOL OCEANOGR, V35, P1002, DOI 10.4319/lo.1990.35.5.1002; JENKINSON IR, 1986, NATURE, V323, P435, DOI 10.1038/323435a0; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; KOSHLAND DE, 1981, ANNU REV BIOCHEM, V50, P765, DOI 10.1146/annurev.bi.50.070181.004001; LAROCHE J, 1995, J PHYCOL, V31, P520; LaRoche J, 1996, NATURE, V382, P802; LERUDULIER D, 1984, SCIENCE, V224, P1064, DOI 10.1126/science.224.4653.1064; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; MARTIN JH, 1988, DEEP-SEA RES, V35, P177, DOI 10.1016/0198-0149(88)90035-0; MARTIN JH, 1990, NATURE, V345, P156, DOI 10.1038/345156a0; McKay RML, 1997, PLANT PHYSIOL, V114, P615, DOI 10.1104/pp.114.2.615; Plieth C, 1999, PLANT J, V18, P491, DOI 10.1046/j.1365-313X.1999.00471.x; SHIMOMUR.O, 1973, BIOCHEM BIOPH RES CO, V53, P490, DOI 10.1016/0006-291X(73)90688-8; Stryer L, 1996, P NATL ACAD SCI USA, V93, P557, DOI 10.1073/pnas.93.2.557; SVERDRUP HU, 1942, OCEANS, P281; Villareal TA, 1999, NATURE, V397, P423, DOI 10.1038/17103	27	136	140	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2000	288	5475					2363	2366		10.1126/science.288.5475.2363	http://dx.doi.org/10.1126/science.288.5475.2363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329NP	10875921				2022-12-24	WOS:000087913400039
J	Yu, L; Frey, EA; Pfuetzner, RA; Creagh, AL; Knoechel, DG; Haynes, CA; Finlay, BB; Strynadka, NCJ				Yu, L; Frey, EA; Pfuetzner, RA; Creagh, AL; Knoechel, DG; Haynes, CA; Finlay, BB; Strynadka, NCJ			Crystal structure of enteropathogenic Escherichia coli intimin-receptor complex	NATURE			English	Article							BINDING PROTEIN; MODELS; CELLS; TIR; REPLACEMENT; DIFFRACTION; INFECTION; ADHESION	Intimin and its translocated intimin receptor (Tir) are bacterial proteins that mediate adhesion between mammalian cells and attaching and effacing (A/E) pathogens. Enteropathogenic Escherichia coli (EPEC) causes significant paediatric morbidity and mortality world-wide(1). A related A/E pathogen, enterohaemorrhagic E. coli (EHEC; O157:H7) is one of the most important food-borne pathogens in North America, Europe and Japan. A unique and essential feature of A/E bacterial pathogens is the formation of actin-rich pedestals beneath the intimately adherent bacteria and localized destruction of the intestinal brush border(2). The bacterial outer membrane adhesin, intimin(3), is necessary for the production of the A/E lesion and diarrhoea(4). The A/E bacteria translocate their own receptor for intimin, Tir(5), into the membrane of mammalian cells using the type III secretion system. The translocated Tir triggers additional host signalling events and actin nucleation, which are essential for lesion formation. Here we describe the the crystal structures of an EPEC intimin carboxyterminal fragment alone and in complex with the EPEC Tir intimin-binding domain, giving insight into the molecular mechanisms of adhesion of A/E pathogens.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Biotechnol Lab, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Strynadka, NCJ (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.							Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANNER DW, 1987, J MOL BIOL, V196, P657, DOI 10.1016/0022-2836(87)90039-8; Betz SF, 1997, BIOCHEMISTRY-US, V36, P2450, DOI 10.1021/bi961704h; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CARSON M, 1986, J MOL GRAPHICS, V4, P121, DOI 10.1016/0263-7855(86)80010-8; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeVinney R, 1999, INFECT IMMUN, V67, P2389, DOI 10.1128/IAI.67.5.2389-2398.1999; DONNENBERG MS, 1993, J CLIN INVEST, V92, P1412, DOI 10.1172/JCI116717; GOOSNEY DL, IN PRESS CURR BIOL; Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291; Hartland EL, 1999, MOL MICROBIOL, V32, P151, DOI 10.1046/j.1365-2958.1999.01338.x; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kelly G, 1999, NAT STRUCT BIOL, V6, P313; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Knutton S, 1997, INFECT IMMUN, V65, P1644, DOI 10.1128/IAI.65.5.1644-1652.1997; Knutton S, 1995, BIOSCIENCE REP, V15, P469, DOI 10.1007/BF01204350; Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5; Liu H, 1999, MOL MICROBIOL, V34, P67, DOI 10.1046/j.1365-2958.1999.01574.x; McRee D.E., 1999, PRACTICAL PROTEIN CR, V2nd ed., P91; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; Schirmer T, 1998, J STRUCT BIOL, V121, P101, DOI 10.1006/jsbi.1997.3946; Todd Ewen C. D., 1997, World Health Statistics Quarterly, V50, P30; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0	30	237	244	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2000	405	6790					1073	1077		10.1038/35016618	http://dx.doi.org/10.1038/35016618			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	328VN	10890451				2022-12-24	WOS:000087871700051
J	Bloom, DE				Bloom, DE		River Path Ass	Something to be done: Treating HIV/AIDS	SCIENCE			English	Editorial Material								Largely because of disparities in access to drug treatment and care, AIDS morbidity and mortality have fallen in the developed world but continue to rise among developing countries. Achieving more equitable access to AIDS drugs is hindered by high drug prices, technical complexities related to the provision of health care, and conflict among stakeholders. Recognition that health is vital to the prospects of the emerging global society must be combined with new mechanisms to help all stakeholders work together cooperatively. Tiered drugs pricing should be coupled with investment in health services. An independent "Global Task Force," able to act as an "active think tank," could build consensus about the way forward.	Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Bloom, DE (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Populat & Int Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							[Anonymous], INV HLTH RES DEV; Binswanger HP, 2000, SCIENCE, V288, P2173, DOI 10.1126/science.288.5474.2173; Bloom DE, 2000, SCIENCE, V287, P1207, DOI 10.1126/science.287.5456.1207; BLOOM DE, IN PRESS AFRICA COMP; BLOOM DE, 1999, MEMENT TIME AIDS BUI; Gellman Barton, 2000, WASH POST, pA01; HARTLEY W, 2000, BUSINESS DAY    0510; LAURENCE J, IN PRESSS AIDS READE; LOVE J, 1999, COMMUNICATION   0801; MALETSKY C, 2000, NAMIBIAN        0511; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; PILLING D, 2000, FINANCIAL TIMES 0519; REICH MR, 2000, NAT MED, V6, P3; *RIV PATH ASS, 1998, YOU  MAD AFR BOR NEW; SACHS J, 1999, ECONOMIST       0814; SCHOOFS M, 1999, VILLAGE VOICE   1229; SIDLEY P, 2000, BUSINESS DAY    0515; WALDHOLZ M, 2000, WALL STREET J   0511; ZUNIGA J, 1998, INT ASS PHYSICIANS A, V4, P23; 2000, PRESIDENTIAL ORDER A	20	11	11	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2171	2173		10.1126/science.288.5474.2171	http://dx.doi.org/10.1126/science.288.5474.2171			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864858				2022-12-24	WOS:000087782900047
J	Huppert, SS; Le, A; Schroeter, EH; Mumm, JS; Saxena, MT; Milner, LA; Kopan, R				Huppert, SS; Le, A; Schroeter, EH; Mumm, JS; Saxena, MT; Milner, LA; Kopan, R			Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1	NATURE			English	Article							INTRACELLULAR DOMAIN; SIGNAL-TRANSDUCTION; PRESENILIN; EXPRESSION; REDUNDANT; LACKING; PATHWAY; RELEASE; SEL-12; DELTA	The Notch genes encode single-pass transmembrane receptors that transduce the extracellular signals responsible for cell fate determination during several steps of metazoan development. The mechanism by which extracellular signals affect gene transcription and ultimately cell fate decisions is beginning to emerge for the Notch signalling pathway. One paradigm is that ligand binding to Notch triggers a Presenilin1-dependent proteolytic release of the Notch intracellular domain from the membrane(1), resulting in low amounts of Notch intracellular domain which form a nuclear complex with CBF1/Su(H)/Lag1 to activate transcription of downstream targets(2). Not all observations clearly support this processing model, and the most rigorous test of it is to block processing in vivo and then determine the ability of unprocessed Notch to signal. Here we report that the phenotypes associated with a single point mutation at the intramembranous processing site of Notch1, Val1,744-->Gly, resemble the null Notch1 phenotype(3,4). Our results show that efficient intramembranous processing of Notch1 is indispensable for embryonic viability and proper early embryonic development in vivo.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, Div Dermatol, St Louis, MO 63110 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Sch Med, Seattle, WA 98109 USA	Washington University (WUSTL); Washington University (WUSTL); Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Kopan, R (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.	kopan@molecool.wustl.edu	Huppert, Stacey S/A-4103-2010; Kopan, Raphael/AAF-1357-2022; Kopan, Raphael/AFG-3275-2022; Mumm, Jeff S/F-3125-2013	Huppert, Stacey S/0000-0003-3977-8728; Kopan, Raphael/0000-0002-0350-2730; Mumm, Jeff/0000-0002-2575-287X				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Berechid BE, 1999, CURR BIOL, V9, P1493, DOI 10.1016/S0960-9822(00)80121-9; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chan YM, 1998, CELL, V94, P423, DOI 10.1016/S0092-8674(00)81583-4; CONLON RA, 1995, DEVELOPMENT, V121, P1533; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Girard L, 1996, GENE DEV, V10, P1930, DOI 10.1101/gad.10.15.1930; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Krebs LT, 2000, GENE DEV, V14, P1343; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Li XJ, 1997, P NATL ACAD SCI USA, V94, P12204, DOI 10.1073/pnas.94.22.12204; Milner LA, 1996, P NATL ACAD SCI USA, V93, P13014, DOI 10.1073/pnas.93.23.13014; Neidhardt LM, 1997, DEV GENES EVOL, V207, P330, DOI 10.1007/s004270050120; REAUME AG, 1992, DEV BIOL, V154, P377, DOI 10.1016/0012-1606(92)90076-S; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Schweisguth F, 1999, P NATL ACAD SCI USA, V96, P11382, DOI 10.1073/pnas.96.20.11382; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Westlund B, 1999, P NATL ACAD SCI USA, V96, P2497, DOI 10.1073/pnas.96.5.2497; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371	28	276	286	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2000	405	6789					966	970		10.1038/35016111	http://dx.doi.org/10.1038/35016111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326JT	10879540				2022-12-24	WOS:000087732700055
J	Strong, DR; Pemberton, RW				Strong, DR; Pemberton, RW			Ecology - Biological control of invading species - Risk and reform	SCIENCE			English	Editorial Material							NORTH-AMERICA; FLORIDA		Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; ARS, Invas Plant Res Lab, USDA, Ft Lauderdale, FL 33314 USA	University of California System; University of California Davis; United States Department of Agriculture (USDA)	Strong, DR (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA.	drstrong@ucdavis.edu; bobpem@ars.usda.gov						ANDRES LA, 1980, P 5 INT S BIOL CONTR, P11; BAX N, IN PRESS CONSERV BIO; Bellotti AC, 1999, ANNU REV ENTOMOL, V44, P343, DOI 10.1146/annurev.ento.44.1.343; BOETTNER GH, IN PRESS CONSERV BIO; Bright C., 1998, LIFE OUT BOUNDS BIOI; Center Ted D., 1997, P245; Civeyrel L, 1996, BIODIVERS CONSERV, V5, P1231, DOI 10.1007/BF00051574; DELFOSSE ES, 1996, P BIOL CONTR WEEDS S; GOODMAN B, 1993, SCIENCE, V260, P887, DOI 10.1126/science.260.5110.887; Hager HA, 1998, BIODIVERS CONSERV, V7, P1069, DOI 10.1023/A:1008861115557; Hawkins BA, 1997, OECOLOGIA, V112, P566, DOI 10.1007/s004420050346; HODEK I, 1973, BIOL COCCINELIDAE; HOWARTH FG, 1991, ANNU REV ENTOMOL, V36, P485, DOI 10.1146/annurev.en.36.010191.002413; Johnson DM, 1996, ENVIRON ENTOMOL, V25, P743, DOI 10.1093/ee/25.4.743; Julien M.H., 1998, BIOL CONTROL WEEDS W; Lockwood JA, 2000, NONTARGET EFFECTS OF BIOLOGICAL CONTROL, P15; Louda SM, 1997, SCIENCE, V277, P1088, DOI 10.1126/science.277.5329.1088; Mabberley D.J., 1997, PLANT BOOK; McEvoy PB, 2000, NONTARGET EFFECTS OF BIOLOGICAL CONTROL, P167; MEDIEROS AC, 1997, BISHOP MUS OCCAS PAP, V48, P23; Miller M., 1993, Rutgers Law Review, V45, P285; MURRAY E, 1993, ENDEAVOUR, V17, P78, DOI 10.1016/0160-9327(93)90200-M; NICO LG, 1996, RISK ASSESSMENT BLAC, P1; OBRYCKI J, 2000, NONTARGET EFFECTS BI, P31; Pemberton Robert W., 1995, American Entomologist, V41, P230; Pemberton RW, 1998, AM FERN J, V88, P176, DOI 10.2307/1547770; PEMBERTON RW, IN PRESS OECOLOGIA; PEMBERTON RW, 1985, P 6 INT S BIOL CONTR, P55; QULSENBERRY SS, 1998, RESPONSE MODEL INTRO; QULSENBERRY SS, 1993, UNPUB; Stiling P, 2000, NONTARGET EFFECTS OF BIOLOGICAL CONTROL, P31; Strong DR, 1997, SCIENCE, V277, P1058, DOI 10.1126/science.277.5329.1058; STRONG DR, IN PRESS EVALUATING; Turner C. E., 1985, Proceedings of the VI International Symposium on Biological Control of Weeds., P203; TURNER CE, 1998, WETLANDS ECOL MANAGE, V4, P165; *US OFF TECHN ASS, 1995, BIOL BASED TECHN PES; Wagner WL, 1999, MANUAL FLOWERING PLA, V1	37	104	121	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2000	288	5473					1969	1970		10.1126/science.288.5473.1969	http://dx.doi.org/10.1126/science.288.5473.1969			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10877714				2022-12-24	WOS:000087687000021
J	Gulcher, JR; Stefansson, K				Gulcher, JR; Stefansson, K			The Icelandic Healthcare Database and informed consent.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GENETIC RESEARCH; PRIVACY		deCODE Genet, IS-110 Reykjavik, Iceland		Gulcher, JR (corresponding author), deCODE Genet, IS-110 Reykjavik, Iceland.		Stefansson, Kari/AAE-7187-2019					ANNAS GJ, 1995, AM J PUBLIC HEALTH, V85, P1196, DOI 10.2105/AJPH.85.9.1196; ANNAS GJ, 1993, JAMA-J AM MED ASSOC, V270, P2346, DOI 10.1001/jama.270.19.2346; CLAYTON EW, 1995, JAMA-J AM MED ASSOC, V274, P1786, DOI 10.1001/jama.274.22.1786; ELIAS S, 1994, NEW ENGL J MED, V330, P1611, DOI 10.1056/NEJM199406023302213; Foster MW, 1998, AM J HUM GENET, V63, P696, DOI 10.1086/302013; Gulcher J, 1998, CLIN CHEM LAB MED, V36, P523, DOI 10.1515/CCLM.1998.089; GULCHER J, 1999, MEDSCAPE; *HUGO ETH LEG SOC, 1996, STAT PRINC COND GEN; HUGO Ethics Committee, 1998, STAT DNA SAMPL CONTR; Knoppers BM, 1996, GENOMICS, V34, P272, DOI 10.1006/geno.1996.0287; *MANNVERND, 1999, ASS ICELAND ETH SCI; Miller HI, 2000, SCIENCE, V287, P591; *MIN HLTH SOC SEC, 1998, BILL HLTH SEC DAT; *NAT BIOETH ADV CO, 1999, RES INV HUM BIOL MAT, V1, P63; Strass E, 1996, AM J HUM GENET, V59, P471; World Health Organization (WHO), 1997, PROP INT GUID ETH IS	16	47	49	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2000	342	24					1827	1830		10.1056/NEJM200006153422411	http://dx.doi.org/10.1056/NEJM200006153422411			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PG	10853008				2022-12-24	WOS:000087573700011
J	Wang, J; Hannon, GJ; Beach, DH				Wang, J; Hannon, GJ; Beach, DH			Cell biology - Risky immortalization by telomerase	NATURE			English	Article							HUMAN FIBROBLASTS; EPITHELIAL-CELLS; MYC; ACTIVATION; CANCER		Genet Inc, Cambridge, MA 02139 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11743 USA; UCL, Wolfson Inst Biomed Res, London WC1B 6BT, England	Cold Spring Harbor Laboratory; University of London; University College London	Wang, J (corresponding author), Genet Inc, 1 Kendall Sq,Bldg 600, Cambridge, MA 02139 USA.	d.beach@ucl.ac.uk	Hannon, Gregory/AAB-3568-2019					ALITALO K, 1987, BIOCHIM BIOPHYS ACTA, V907, P1, DOI 10.1016/0304-419X(87)90016-3; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Foster SA, 1996, ONCOGENE, V12, P1773; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Sun PQ, 1998, SCIENCE, V282, P2270, DOI 10.1126/science.282.5397.2270; Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010	12	110	129	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					755	756		10.1038/35015674	http://dx.doi.org/10.1038/35015674			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866187				2022-12-24	WOS:000087620600037
J	Setou, M; Nakagawa, T; Seog, DH; Hirokawa, N				Setou, M; Nakagawa, T; Seog, DH; Hirokawa, N			Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor - Containing vesicle transport	SCIENCE			English	Article							GLUTAMATE RECEPTORS; NEURONAL POLARITY; LOCALIZATION; COMPLEX; CHANNEL; SUBUNIT; LIN-7; IDENTIFICATION; HOMOLOGS; SYNAPSES	Experiments with vesicles containing N-methyl-D-aspartate (NMDA) receptor 2B (NR2B subunit) show that they are transported along microtubules by KIF17, a neuron-specific molecular motor in neuronal dendrites. Selective transport is accomplished by direct interaction of the KIF17 tail with a PDZ domain of mLin-10 (Mintl1/X11), which is a constituent of a large protein complex including mLin-2 (CASK), mLin-7 (MALS/VeLis), and the NR2B subunit. This interaction, specific for a neurotransmitter receptor critically important for plasticity in the postsynaptic terminal, may be a regulatory point for synaptic plasticity and neuronal morphogenesis.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo, Japan.							Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; Bredt DS, 1998, CELL, V94, P691, DOI 10.1016/S0092-8674(00)81727-4; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Ehlers MD, 1996, CURR OPIN CELL BIOL, V8, P484, DOI 10.1016/S0955-0674(96)80024-X; Foletti DL, 1999, NEURON, V23, P641, DOI 10.1016/S0896-6273(01)80022-2; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Irie M, 1999, ONCOGENE, V18, P2811, DOI 10.1038/sj.onc.1202652; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; Mori H, 1998, NEURON, V21, P571, DOI 10.1016/S0896-6273(00)80567-X; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Nakagawa T, 1997, P NATL ACAD SCI USA, V94, P9654, DOI 10.1073/pnas.94.18.9654; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; Rubio ME, 1999, J NEUROSCI, V19, P5549; Rubio ME, 1997, NEURON, V18, P939, DOI 10.1016/S0896-6273(00)80333-5; Saito N, 1997, NEURON, V18, P425, DOI 10.1016/S0896-6273(00)81243-X; SETOU M, 1996, J BIOL CHEM, V271, P15669; SHAKIR MA, 1993, NEUROREPORT, V4, P891, DOI 10.1097/00001756-199307000-00013; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 1996, CURR OPIN NEUROBIOL, V6, P602, DOI 10.1016/S0959-4388(96)80091-2; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Smith SJ, 1999, SCIENCE, V283, P1860, DOI 10.1126/science.283.5409.1860; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; TABISH M, 1995, J MOL BIOL, V247, P377, DOI 10.1006/jmbi.1994.0146; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x	31	571	595	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 9	2000	288	5472					1796	1802		10.1126/science.288.5472.1796	http://dx.doi.org/10.1126/science.288.5472.1796			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	322HH	10846156				2022-12-24	WOS:000087503800042
J	Posey, JE; Gherardini, FC				Posey, JE; Gherardini, FC			Lack of a role for iron in the Lyme disease pathogen	SCIENCE			English	Article							BORRELIA-BURGDORFERI; LACTOBACILLUS-PLANTARUM; SUPEROXIDE-DISMUTASE; BACILLUS-SUBTILIS; SEQUENCE; IDENTIFICATION; ACQUISITION; SPIROCHETE; MANGANESE; INFECTION	A fundamental tenet of microbial pathogenesis is that bacterial pathogens must overcome host iron limitation to establish a successful infection. Surprisingly, the Lyme disease pathogen Borrelia burgdorferi has bypassed this host defense by eliminating the need for iron. B. burgdorferi grew normally and did not alter gene expression in the presence of iron chelators. Furthermore, typical bacterial iron-containing proteins were not detected in cell lysates, nor were the genes encoding such proteins identified in the genome sequence. The intracellular concentration of iron in B. burgdorferi was estimated to be less than 10 atoms per cell, well below a physiologically relevant concentration.	Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Gherardini, FC (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000905, ZIAAI000905, Z01AI000906, ZIAAI000906, R29AI033501] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33501, AI144911] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMANO A, 1990, J BACTERIOL, V172, P1457, DOI 10.1128/jb.172.3.1457-1463.1990; ARCHIBALD F, 1983, FEMS MICROBIOL LETT, V19, P29, DOI 10.1111/j.1574-6968.1983.tb00504.x; ARCHIBALD FS, 1984, J BACTERIOL, V158, P1; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BLEDSOE HA, 1994, J BACTERIOL, V176, P7447, DOI 10.1128/JB.176.24.7447-7455.1994; Bsat N, 1998, MOL MICROBIOL, V29, P189, DOI 10.1046/j.1365-2958.1998.00921.x; BULLEN JJ, 1981, REV INFECT DIS, V3, P1127; CHEN L, 1993, J BACTERIOL, V175, P5428, DOI 10.1128/JB.175.17.5428-5437.1993; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; GRAEFFWOHLLEBEN H, 1997, J BACTERIOL, V179, P21941; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Jurado RL, 1997, CLIN INFECT DIS, V25, P888, DOI 10.1086/515549; Ma JF, 1999, J BACTERIOL, V181, P3730, DOI 10.1128/JB.181.12.3730-3742.1999; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MARTIN ME, 1986, J BIOL CHEM, V261, P9361; Payne Shelley M., 1993, Trends in Microbiology, V1, P66, DOI 10.1016/0966-842X(93)90036-Q; WEINBERG ED, 1978, MICROBIOL REV, V42, P45, DOI 10.1128/MMBR.42.1.45-66.1978; Whitehouse CA, 1997, INFECT IMMUN, V65, P4865, DOI 10.1128/IAI.65.11.4865-4868.1997; WOOLDRIDGE KG, 1993, FEMS MICROBIOL REV, V12, P325, DOI 10.1016/0168-6445(93)90011-W	20	374	384	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2000	288	5471					1651	1653		10.1126/science.288.5471.1651	http://dx.doi.org/10.1126/science.288.5471.1651			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	320BZ	10834845				2022-12-24	WOS:000087382300043
J	Zhao, S; Weng, YC; Yuan, SSF; Lin, YT; Hsu, HC; Lin, SCJ; Gerbino, E; Song, MH; Zdzienicka, MZ; Gatti, RA; Shay, JW; Ziv, Y; Shiloh, Y; Lee, EYHP				Zhao, S; Weng, YC; Yuan, SSF; Lin, YT; Hsu, HC; Lin, SCJ; Gerbino, E; Song, MH; Zdzienicka, MZ; Gatti, RA; Shay, JW; Ziv, Y; Shiloh, Y; Lee, EYHP			Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products	NATURE			English	Article							DNA-DAMAGE RESPONSE; DOUBLE-STRAND BREAKS; CELL-CYCLE; C-ABL; CHECKPOINT PATHWAYS; IONIZING-RADIATION; PHOSPHORYLATION; COMPLEX; REPAIR; ATM	Ataxia-telangiectasia (A-T) and Nijmegen breakage syndrome (NBS) are recessive genetic disorders with susceptibility to cancer and similar cellular phenotypes(1). The protein product of the gene responsible for A-T, designated ATM, is a member of a family of kinases characterized by a carboxy-terminal phosphatidylinositol 3-kinase-like domain(2,3). The NBS1 protein is specifically mutated in patients with Nijmegen breakage syndrome and forms a complex with the DNA repair proteins Rad50 and Mre11(4-7). Here we show that phosphorylation of NBS1, induced by ionizing radiation, requires catalytically active ATM. Complexes containing ATM and NBS1 exist in vivo in both untreated cells and cells treated with ionizing radiation. We have identified two residues of NBS1, Ser 278 and Ser 343 that are phosphorylated in vitro by ATM and whose modification in vivo is essential for the cellular response to DNA damage. This response includes S-phase checkpoint activation, formation of the NBS1/Mre11/Rad50 nuclear foci and rescue of hypersensitivity to ionizing radiation. Together, these results demonstrate a biochemical link between cell-cycle checkpoints activated by DNA damage and DNA repair in two genetic diseases with overlapping phenotypes.	Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA; Leiden Univ, LUMC, MGC Dept Radiat Genet & Chem Mutagenesis, Leiden, Netherlands; Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90095 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, Tel Aviv, Israel	University of Texas System; University of Texas Health San Antonio; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California Los Angeles; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Tel Aviv University; Sackler Faculty of Medicine	Lee, EYHP (corresponding author), Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA.		Shay, Jerry W/F-7878-2011	yuan, shyng-shiou/0000-0002-4753-788X				Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; CANMAN CE, 1994, CANCER RES, V54, P5054; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Caspari T, 1999, BIOCHIMIE, V81, P173, DOI 10.1016/S0300-9084(99)80050-9; Chen G, 1999, J BIOL CHEM, V274, P12748, DOI 10.1074/jbc.274.18.12748; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Dasika GK, 1999, ONCOGENE, V18, P7883, DOI 10.1038/sj.onc.1203283; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Kraakman-van der Zwet M, 1999, MUTAT RES-DNA REPAIR, V434, P17, DOI 10.1016/S0921-8777(99)00009-9; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; SAVITSKY K, 1995, HUM MOL GENET, V4, P2025, DOI 10.1093/hmg/4.11.2025; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; YOUNG BR, 1989, HUM GENET, V82, P113, DOI 10.1007/BF00284040; Yuan ZM, 1998, J BIOL CHEM, V273, P3799, DOI 10.1074/jbc.273.7.3799; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319; ZIV Y, 1999, EXPERSSION ASSAY REC	29	407	420	0	12	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					473	477		10.1038/35013083	http://dx.doi.org/10.1038/35013083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839544				2022-12-24	WOS:000087212000052
J	Bianco, PR; Kowalczykowski, SC				Bianco, PR; Kowalczykowski, SC			Translocation step size and mechanism of theRecBC DNA helicase	NATURE			English	Article							COLI RECBCD ENZYME; ESCHERICHIA-COLI; ATP HYDROLYSIS; CRYSTAL-STRUCTURES; DUPLEX DNA; PROCESSIVITY; COMPLEXES; SEQUENCE; BINDING; STRAND	DNA helicases are ubiquitous enzymes that unwind double-stranded DNA(1-3). They are a diverse group of proteins that move in a linear fashion along a one-dimensional polymer lattice-DNA-by using a mechanism that couples nucleoside triphosphate hydrolysis to both translocation and double-stranded DNA unwinding to produce separate strands of DNA. The RecBC enzyme is a processive DNA helicase that functions in homologous recombination in Escherichia coli; it unwinds up to 6,250 base pairs per binding event and hydrolyses slightly more than one ATP molecule per base pair unwound. Here we show, by using a series of gapped oligonucleotide substrates, that this enzyme translocates along only one strand of duplex DNA in the 3' --> 5' direction. The translocating enzyme will traverse, or 'step' across, single-stranded DNA gaps in defined steps that are 23 (+/-2) nucleotides in length. This step is much larger than the amount of double-stranded DNA that can be unwound using the free energy derived from hydrolysis of one molecule of ATP, implying that translocation and DNA unwinding are separate events. We propose that the RecBC enzyme both translocates and unwinds by a quantized, two-step, inchworm-like mechanism that may have parallels for translocation by other linear motor proteins.	Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA; Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA.							Ali JA, 1997, SCIENCE, V276, P21; Bianco PR, 1997, P NATL ACAD SCI USA, V94, P6706, DOI 10.1073/pnas.94.13.6706; Bird LE, 1998, CURR OPIN STRUC BIOL, V8, P14, DOI 10.1016/S0959-440X(98)80004-3; Chamberlin M J, 1992, Harvey Lect, V88, P1; GANESAN S, 1993, J MOL BIOL, V229, P67, DOI 10.1006/jmbi.1993.1008; KORANGY F, 1992, J BIOL CHEM, V267, P3088; KORANGY F, 1994, BIOCHEMISTRY-US, V33, P9552, DOI 10.1021/bi00198a022; KORANGY F, 1993, BIOCHEMISTRY-US, V32, P4873, DOI 10.1021/bi00069a024; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; MATSON SW, 1994, BIOESSAYS, V16, P13, DOI 10.1002/bies.950160103; Mechanic LE, 1999, J BIOL CHEM, V274, P12488, DOI 10.1074/jbc.274.18.12488; ROMAN LJ, 1989, BIOCHEMISTRY-US, V28, P2873, DOI 10.1021/bi00433a019; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; TAYLOR AF, 1995, J BIOL CHEM, V270, P24451, DOI 10.1074/jbc.270.41.24451; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; West SC, 1996, CELL, V86, P177, DOI 10.1016/S0092-8674(00)80088-4	17	88	90	0	10	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 18	2000	405	6784					368	372		10.1038/35012652	http://dx.doi.org/10.1038/35012652			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314YT	10830968				2022-12-24	WOS:000087085700052
J	Zheng, J; Shen, WX; He, DZZ; Kevin, BL; Madison, LD; Dallos, P				Zheng, J; Shen, WX; He, DZZ; Kevin, BL; Madison, LD; Dallos, P			Prestin is the motor protein of cochlear outer hair cells	NATURE			English	Article							GUINEA-PIG COCHLEA; ELECTROKINETIC SHAPE CHANGES; MOTILITY VOLTAGE SENSOR; MECHANICAL RESPONSES; MEMBRANE CAPACITANCE; FORCE GENERATION; ELECTROMOTILITY; SALICYLATE; IDENTIFICATION; TRANSPORTER	The outer and inner hair cells of the mammalian cochlea perform different functions. In response to changes in membrane potential, the cylindrical outer hair cell rapidly alters its length and stiffness. These mechanical changes, driven by putative molecular motors, are assumed to produce amplification of vibrations in the cochlea that are transduced by inner hair cells. Here we have identified an abundant complementary DNA from a gene, designated Prestin, which is specifically expressed in outer hair cells. Regions of the encoded protein show moderate sequence similarity to pendrin and related sulphate/anion transport proteins. Voltage-induced shape changes can be elicited in cultured human kidney cells that express prestin. The mechanical response of outer hair cells to voltage change is accompanied by a 'gating current', which is manifested as nonlinear capacitance. We also demonstrate this nonlinear capacitance in transfected kidney cells. We conclude that prestin is the motor protein of the cochlear outer hair cell.	Northwestern Univ, Auditory Physiol Lab, Hugh Knowles Ctr, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Northwestern Univ, Auditory Physiol Lab, Hugh Knowles Ctr, Dept Commun Sci & Disorders, Evanston, IL 60208 USA; Northwestern Univ, Sch Med, Dept Med, Ctr Endocrinol Metab & Mol Med, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University	Dallos, P (corresponding author), Northwestern Univ, Auditory Physiol Lab, Hugh Knowles Ctr, Dept Neurobiol & Physiol, Evanston, IL 60208 USA.	p-dallos@nwu.edu	Zheng, Jing/F-5273-2017; Dallos, Peter/Q-9360-2019	Zheng, Jing/0000-0003-2790-1143; Dallos, Peter/0000-0002-9731-6591; He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634				Adachi M, 1999, P NATL ACAD SCI USA, V96, P7244, DOI 10.1073/pnas.96.13.7244; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; ASHMORE JF, 1992, SOC GEN PHY, V47, P395; ASHMORE JF, 1999, MECH HEARING, P107; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; DALLOS P, 1991, NATURE, V350, P155, DOI 10.1038/350155a0; DALLOS P, 1995, SCIENCE, V267, P2006, DOI 10.1126/science.7701325; Dallos P., 1996, COCHLEA, P1; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Evans B.N., 1989, COCHLEAR MECHANISMS, P205; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Everett LA, 1999, HUM MOL GENET, V8, P1883, DOI 10.1093/hmg/8.10.1883; FORGE A, 1991, CELL TISSUE RES, V265, P473, DOI 10.1007/BF00340870; Frank G, 1999, P NATL ACAD SCI USA, V96, P4420, DOI 10.1073/pnas.96.8.4420; Geleoc GSG, 1999, NAT NEUROSCI, V2, P713, DOI 10.1038/11174; GRAHAM FL, 1973, VIROLOGY, V54, P536, DOI 10.1016/0042-6822(73)90163-3; Greinwald JH, 1998, AM J MED GENET, V78, P107, DOI 10.1002/(SICI)1096-8628(19980630)78:2<107::AID-AJMG2>3.3.CO;2-9; He DZZ, 1999, P NATL ACAD SCI USA, V96, P8223, DOI 10.1073/pnas.96.14.8223; He DZZ, 1997, J NEUROSCI, V17, P3634; HE DZZ, 1994, HEARING RES, V78, P77, DOI 10.1016/0378-5955(94)90046-9; Hofmann K., 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; HOLLEY MC, 1988, PROC R SOC SER B-BIO, V232, P413, DOI 10.1098/rspb.1988.0004; HOLLEY MC, 1992, J CELL SCI, V102, P569; HUANG GJ, 1994, P NATL ACAD SCI USA, V91, P12268, DOI 10.1073/pnas.91.25.12268; HUANG GJ, 1993, BIOPHYS J, V65, P2228, DOI 10.1016/S0006-3495(93)81248-7; Hudspeth AJ, 1997, CURR OPIN NEUROBIOL, V7, P480, DOI 10.1016/S0959-4388(97)80026-8; Iwasa KH, 1997, BIOPHYS J, V73, P546, DOI 10.1016/S0006-3495(97)78092-5; IWASA KH, 1993, BIOPHYS J, V65, P492, DOI 10.1016/S0006-3495(93)81053-1; KACHAR B, 1986, NATURE, V322, P365, DOI 10.1038/322365a0; Kakehata S, 1996, J NEUROSCI, V16, P4881; KALINEC F, 1992, P NATL ACAD SCI USA, V89, P8671, DOI 10.1073/pnas.89.18.8671; KALINEC F, 1993, NEUROSCI LETT, V157, P231, DOI 10.1016/0304-3940(93)90744-6; KNIPPER M, 1995, HEARING RES, V86, P100, DOI 10.1016/0378-5955(95)00060-H; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; Moseley RH, 1999, AM J PHYSIOL-GASTR L, V276, pG185, DOI 10.1152/ajpgi.1999.276.1.G185; Mustapha M, 1998, EUR J HUM GENET, V6, P548, DOI 10.1038/sj.ejhg.5200261; SANDAL NN, 1994, TRENDS BIOCHEM SCI, V19, P19, DOI 10.1016/0968-0004(94)90168-6; SANTOS-SACCHI J, 1988, HEARING RES, V35, P143, DOI 10.1016/0378-5955(88)90113-X; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Scott DA, 1999, NAT GENET, V21, P440, DOI 10.1038/7783; SHEHATA WE, 1991, ACTA OTO-LARYNGOL, V111, P707, DOI 10.3109/00016489109138403; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Souter M, 1995, HEARING RES, V91, P43, DOI 10.1016/0378-5955(95)00163-8; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; TUNSTALL MJ, 1995, J PHYSIOL-LONDON, V485, P739, DOI 10.1113/jphysiol.1995.sp020765	47	918	967	0	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2000	405	6783					149	155		10.1038/35012009	http://dx.doi.org/10.1038/35012009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WG	10821263				2022-12-24	WOS:000087080100040
J	Fields, SA; Usatine, R; Steiner, E				Fields, SA; Usatine, R; Steiner, E			Teaching medical students in the ambulatory setting - Strategies for success	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMMUNITY PRECEPTORS; CARE; PARTICIPATION; EDUCATION		Oregon Hlth Sci Univ, Dept Family Med, Portland, OR 97201 USA; Univ Calif Los Angeles, Dept Family Med, Los Angeles, CA USA	Oregon Health & Science University; University of California System; University of California Los Angeles	Fields, SA (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.							*ASS AM MED COLL, 1999, MED TEACH PHYS DOC I; BROOK RH, 1996, JAMA-J AM MED ASSOC, V276, P479; Devera-Sales A, 1999, ACAD MED, V74, P550, DOI 10.1097/00001888-199905000-00024; Ferenchick G, 1997, ACAD MED, V72, P277, DOI 10.1097/00001888-199704000-00011; Fields SA, 1998, ACAD MED, V73, P95, DOI 10.1097/00001888-199801000-00019; Fields SA, 1998, ACAD MED, V73, P25, DOI 10.1097/00001888-199801000-00008; Hunt CE, 1999, ARCH PEDIAT ADOL MED, V153, P297; KALET A, 1997, ACAD MED, V72, P766; Lawrence SL, 1999, ACAD MED, V74, P715, DOI 10.1097/00001888-199906000-00020; Ludmerer KM, 1999, TIME HEAL; Neher J O, 1992, J Am Board Fam Pract, V5, P419; Seifer SD, 1998, ACAD MED, V73, P273, DOI 10.1097/00001888-199803000-00015; SIMONS RJ, 1995, J GEN INTERN MED, V10, P251, DOI 10.1007/BF02599880; STANGL S, 1995, ACAD MED, V70, P459, DOI 10.1097/00001888-199505000-00066; USATINE R, IN PRESS ACAD MED; Usatine R P, 1995, Fam Med, V27, P566; Vinson DC, 1996, J FAM PRACTICE, V42, P243; Wilkes MS, 1998, ACAD MED, V73, P32, DOI 10.1097/00001888-199801000-00009	18	26	29	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2000	283	18					2362	2364		10.1001/jama.283.18.2362	http://dx.doi.org/10.1001/jama.283.18.2362			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310CD	10815060				2022-12-24	WOS:000086808200002
J	Gustafson, DE; Stoecker, DK; Johnson, MD; Van Heukelem, WF; Sneider, K				Gustafson, DE; Stoecker, DK; Johnson, MD; Van Heukelem, WF; Sneider, K			Cryptophyte algae are robbed of their organelles by the marine ciliate Mesodinium rubrum	NATURE			English	Article							PHOTOTROPHIC CILIATE; SOUTHAMPTON WATER; MYRIONECTA-RUBRA; LABOEA-STROBILA; CHLOROPLASTS; CILIOPHORA; ABUNDANCE; ESTUARY; MAINE; GULF	Mesodinium rubrum (Lohmann 1908) Jankowski 1976 (= Myrionecta rubra)(1,2) is a common photosynthetic marine planktonic ciliate which can form coastal red-tides(3). It may represent a 'species complex'(4,5) and since Darwin's voyage on the Beagle, it has been of great cytological, physiological and evolutionary interest(4). It is considered to be functionally a phytoplankter because it was thought to have lost the capacity to feed and possesses a highly modified algal endosymbiont(5,6). Whether M. rubrum is the result of a permanent endosymbiosis or a transient association between a ciliate and an alga is controversial(7). We conducted 'feeding' experiments to determine how exposure to a cryptophyte alga affects M. rubrum. Here we show that although M. rubrum lacks a cytostome (oral cavity)(8), it ingests cryptophytes and steals their organelles, and may not maintain a permanent endosymbiont. M. rubrum does not fall into recognized cellular or functional categories, but may be a chimaera partially supported by organelle robbery.	Univ Maryland, Ctr Environm Sci, Horn Point Environm Lab, Cambridge, MD 21613 USA	University System of Maryland; University of Maryland Center for Environmental Science	Gustafson, DE (corresponding author), Univ Maryland, Ctr Environm Sci, Horn Point Environm Lab, POB 775, Cambridge, MD 21613 USA.		Johnson, Matthew/B-4344-2012; stoecker, diane k/F-9341-2013	Johnson, Matthew/0000-0003-4853-2674; 				BARBER RT, 1969, J PHYCOL, V5, P86, DOI 10.1111/j.1529-8817.1969.tb02583.x; Crawford DW, 1997, ESTUAR COAST SHELF S, V45, P799, DOI 10.1006/ecss.1997.0242; Crawford DW, 1997, AQUAT MICROB ECOL, V13, P267, DOI 10.3354/ame013267; CRAWFORD DW, 1989, MAR ECOL PROG SER, V58, P161, DOI 10.3354/meps058161; Hargraves P., 1991, Maritimes, V35, P6; HIBBERD DJ, 1977, J MAR BIOL ASSOC UK, V57, P45, DOI 10.1017/S0025315400021226; KIFLE D, 1993, J PLANKTON RES, V15, P823, DOI 10.1093/plankt/15.7.823; KRAINER KH, 1990, J PROTOZOOL, V37, P414, DOI 10.1111/j.1550-7408.1990.tb01166.x; Laval-Peuto M., 1986, MAR MICROB FD WEBS, V1, P81; Lindholm T., 1985, Advances in Aquatic Microbiology, V3, P1; LINDHOLM T, 1988, BIOSYSTEMS, V21, P141, DOI 10.1016/0303-2647(88)90007-X; LINDHOLM T, 1989, Memoranda Societatis pro Fauna et Flora Fennica, V65, P17; MONTAGNES DJS, 1989, J PLANKTON RES, V11, P193, DOI 10.1093/plankt/11.2.193; OAKLEY BR, 1978, BIOSYSTEMS, V10, P361, DOI 10.1016/0303-2647(78)90019-9; Packard T.T., 1978, UPWELLING ECOSYSTEMS, P73; Sanders RW, 1995, AQUAT MICROB ECOL, V9, P237, DOI 10.3354/ame009237; Small E.B., 1985, P393; SMITH WO, 1979, J PHYCOL, V15, P27, DOI 10.1111/j.0022-3646.1979.00027.x; Stoecker D.K., 1991, NATO ASI Series Series G Ecological Sciences, V25, P161; STOECKER DK, 1991, MAR ECOL PROG SER, V73, P245, DOI 10.3354/meps073245; STOECKER DK, 1990, MAR BIOL, V107, P491, DOI 10.1007/BF01313434; STOECKER DK, 1988, MAR BIOL, V99, P415, DOI 10.1007/BF02112135; STOECKER DK, 1987, NATURE, V326, P790, DOI 10.1038/326790a0; STOECKER DK, 1989, MAR ECOL PROG SER, V50, P241, DOI 10.3354/meps050241; TAYLOR FJR, 1971, J FISH RES BOARD CAN, V28, P391, DOI 10.1139/f71-052; WHITE AW, 1977, J FISH RES BOARD CAN, V34, P413, DOI 10.1139/f77-066; WILKERSON FP, 1990, J PLANKTON RES, V12, P973, DOI 10.1093/plankt/12.5.973; Yih W, 1997, J MAR BIOTECHNOL, V5, P82	28	167	177	0	40	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 29	2000	405	6790					1049	1052		10.1038/35016570	http://dx.doi.org/10.1038/35016570			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	328VN	10890444				2022-12-24	WOS:000087871700044
J	Queller, DC; Zacchi, F; Cervo, R; Turillazzi, S; Henshaw, MT; Santorelli, LA; Strassmann, JE				Queller, DC; Zacchi, F; Cervo, R; Turillazzi, S; Henshaw, MT; Santorelli, LA; Strassmann, JE			Unrelated helpers in a social insect	NATURE			English	Article							TRINUCLEOTIDE MICROSATELLITE LOCI; POLISTES-GALLICUS L; REPRODUCTIVE SKEW; GENETIC-MARKERS; RELATEDNESS; WASP; FOUNDRESS; HYMENOPTERA; SOCIETIES; VESPIDAE	High-resolution genetic markers have revolutionized our understanding of vertebrate mating systems(1), but have so far yielded few comparable surprises about kinship in social insects. Here we use microsatellite markers to reveal an unexpected and unique social system in what is probably the best-studied social wasp, Polistes dominulus. Social insect colonies are nearly always composed of close relatives(2,3); therefore, non-reproductive helping behaviour can be favoured by kin selection, because the helpers aid reproductives who share their genes(4). In P. dominulus, however, 35% of foundress nestmates are unrelated and gain no such advantage. The P. dominulus system is unlike all other cases of unrelated social insects, because one individual has nearly complete reproductive dominance over subordinates who could have chosen other reproductive options. The only significant advantage that subordinates obtain is a chance at later reproduction, particularly if the queen dies. Thus, P. dominulus societies are functionally unlike other social insects, but similar to certain vertebrate societies(5,6), in which the unrelated helpers gain through inheritance of a territory or a mate.	Rice Univ, Dept Ecol & Evolut, Houston, TX 77251 USA; Univ Florence, Dipartimento Biol Anim & Genet, I-50125 Florence, Italy	Rice University; University of Florence	Queller, DC (corresponding author), Rice Univ, Dept Ecol & Evolut, POB 1892, Houston, TX 77251 USA.		; CERVO, Rita/B-5441-2018	Santorelli, Lorenzo/0000-0002-8392-801X; CERVO, Rita/0000-0002-0405-6402; Strassmann, Joan/0000-0003-0638-8440				Bernasconi G, 1999, TRENDS ECOL EVOL, V14, P477, DOI 10.1016/S0169-5347(99)01722-X; Bourke A, 1995, SOCIAL EVOLUTION ANT, DOI DOI 10.1186/s12862-015-0383-4; CREEL SR, 1994, BEHAV ECOL, V5, P339, DOI 10.1093/beheco/5.3.339; Crozier R.H., 1996, EVOLUTION SOCIAL INS; GAMBOA GJ, 1986, ANNU REV ENTOMOL, V31, P431, DOI 10.1146/annurev.en.31.010186.002243; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hughes C, 1998, ECOLOGY, V79, P383, DOI 10.1890/0012-9658(1998)079[0383:IMTWFM]2.0.CO;2; Kokko H, 1999, P ROY SOC B-BIOL SCI, V266, P571, DOI 10.1098/rspb.1999.0674; KUKUK PF, 1994, INSECT SOC, V41, P443, DOI 10.1007/BF01240647; LORENZI MC, 1995, J INSECT BEHAV, V8, P443, DOI 10.1007/BF01995318; PARDI L, 1948, PHYSIOL ZOOL, V21, P1; PARDI L, 1948, ATTI SOC TOSC SCI, V55, P3; PRATTE M, 1982, INSECT SOC, V29, P352, DOI 10.1007/BF02228762; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Ragsdale JE, 1999, EVOL ECOL RES, V1, P859; Reeve H.K., 1991, P99; Reeve Hudson K., 1993, P45; REYER HU, 1984, ANIM BEHAV, V32, P1163, DOI 10.1016/S0003-3472(84)80233-X; RISSING SW, 1989, NATURE, V338, P420, DOI 10.1038/338420a0; ROSELER PF, 1985, EXPT BEHAV ECOLOGY S, P259; Strassmann JE, 1996, MOL ECOL, V5, P459, DOI 10.1111/j.1365-294X.1996.tb00338.x; STRASSMANN JE, 1989, NATURE, V342, P268, DOI 10.1038/342268a0; Strassmann JE, 1997, MOL ECOL, V6, P97, DOI 10.1046/j.1365-294X.1997.00158.x; Strassmann JE, 1997, BIOCHEM GENET, V35, P273, DOI 10.1023/A:1021849100346; Strassmann Joan E.., 1996, P163; TURILLAZZI S, 1982, MONIT ZOOL ITAL, V16, P75; VEHRENCAMP SL, 1983, AM ZOOL, V23, P327; ZACCHI F, 1998, THESIS RICE U HOUSTO	30	209	213	0	46	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					784	787		10.1038/35015552	http://dx.doi.org/10.1038/35015552			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866197				2022-12-24	WOS:000087620600048
J	Friedrich, MJ				Friedrich, MJ			HAART stopping news: Experts examine structured therapy interruption for HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2000	283	22					2917	2918		10.1001/jama.283.22.2917	http://dx.doi.org/10.1001/jama.283.22.2917			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XL	10865250				2022-12-24	WOS:000087480600002
J	Buttery, JP; Moxon, ER				Buttery, JP; Moxon, ER			Varicella vaccine in renal failure	LANCET			English	Editorial Material							CHILDREN		Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 9DU, England	University of Oxford	Buttery, JP (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 9DU, England.							Broyer M, 1997, PEDIATRICS, V99, P35, DOI 10.1542/peds.99.1.35; Furth S L, 1997, Pediatr Transplant, V1, P37; GERSHON AA, 1986, PEDIATRICS, V78, P757; Kamiya Hitoshi, 1999, Current Opinion in Pediatrics, V11, P3, DOI 10.1097/00008480-199902000-00002; KITAI IC, 1993, CLIN INFECT DIS, V17, P441, DOI 10.1093/clinids/17.3.441; TAKAHASH.M, 1974, LANCET, V2, P1288, DOI 10.1016/S0140-6736(74)90144-5; Watson B, 2000, PEDIATRICS, V105, P84, DOI 10.1542/peds.105.1.84; Webb NJA, 2000, ARCH DIS CHILD, V82, P141, DOI 10.1136/adc.82.2.141; ZAMORA I, 1994, PEDIATR NEPHROL, V8, P190, DOI 10.1007/BF00865476	9	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2000	355	9219					1930	1930		10.1016/S0140-6736(00)02322-9	http://dx.doi.org/10.1016/S0140-6736(00)02322-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859036				2022-12-24	WOS:000087381900007
J	Rowe, JB; Toni I; Josephs, O; Frackowiak, RSJ; Passingham, RE				Rowe, JB; Toni, I; Josephs, O; Frackowiak, RSJ; Passingham, RE			The prefrontal cortex: Response selection or maintenance within working memory?	SCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; LATERAL FRONTAL-CORTEX; FUNCTIONAL-ORGANIZATION; NEURONAL-ACTIVITY; DELAYED-RESPONSE; RHESUS-MONKEYS; UNIT-ACTIVITY; TASK; FMRI; DISSOCIATION	It is controversial whether the dorsolateral prefrontal cortex is involved in the maintenance of items in working memory or in the selection of responses. We used event-related functional magnetic resonance imaging to study the performance of a spatial working memory task by humans, We distinguished the maintenance of spatial items from the selection of an item from memory to guide a response. Selection, but not maintenance, was associated with activation of prefrontal area 46 of the dorsal lateral prefrontal cortex, In contrast, maintenance was associated with activation of prefrontal area 8 and the intraparietal cortex The results support a role for the dorsal prefrontal cortex in the selection of representations. ntis accounts for the fact that this area is activated both when subjects select between items on working memory tasks and when they freely select between movements on tasks of willed action.	Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Forschungszentrum Julich, Inst Med, D-52425 Julich, Germany	University of London; University College London; Helmholtz Association; Research Center Julich	Rowe, JB (corresponding author), Inst Neurol, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.	j.rowe@fil.ion.ucl.ac.uk	Frackowiak, Richard/H-4383-2011; Frackowiak, Richard S/I-1809-2013; rowe, james B/C-3661-2013; Toni, Ivan/D-1980-2009; Tick, Beata/ABA-1728-2020	Frackowiak, Richard/0000-0002-3151-822X; rowe, james B/0000-0001-7216-8679; Toni, Ivan/0000-0003-0936-3601; 	Wellcome Trust [077029] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Aguirre GK, 1997, NEUROIMAGE, V5, P199, DOI 10.1006/nimg.1997.0264; Baker SC, 1996, NEUROPSYCHOLOGIA, V34, P515, DOI 10.1016/0028-3932(95)00133-6; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; Belger A, 1998, HUM BRAIN MAPP, V6, P14, DOI 10.1002/(SICI)1097-0193(1998)6:1<14::AID-HBM2>3.0.CO;2-O; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; D'Esposito M, 1998, NEUROIMAGE, V8, P274, DOI 10.1006/nimg.1998.0364; Desmond JE, 1998, NEUROIMAGE, V7, P368, DOI 10.1006/nimg.1998.0340; DIAMOND A, 1989, EXP BRAIN RES, V74, P24; FRISTON KJ, 1995, HUMAN BRAIN MAPPING, V2, P165; FRITH C, IN PRESS CONTROL COG, V18; FRITH CD, 1991, P ROY SOC B-BIOL SCI, V244, P241, DOI 10.1098/rspb.1991.0077; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; GoldmanRakic P. S., 1998, PREFRONTAL CORTEX EX, P87; GOLDMANRAKIC PS, 1987, CIBA F SYMP, V132, P187; Hadland K. A., 1999, Society for Neuroscience Abstracts, V25, P1893; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1325, DOI 10.1152/jn.1997.77.3.1325; Jueptner M, 1997, J NEUROPHYSIOL, V77, P1313, DOI 10.1152/jn.1997.77.3.1313; KOJIMA S, 1984, BRAIN RES, V291, P229, DOI 10.1016/0006-8993(84)91255-1; Levy R, 1999, J NEUROSCI, V19, P5149; Luna B, 1998, CEREB CORTEX, V8, P40, DOI 10.1093/cercor/8.1.40; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; NIKI H, 1976, BRAIN RES, V105, P79, DOI 10.1016/0006-8993(76)90924-0; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Owen AM, 1996, CEREB CORTEX, V6, P31, DOI 10.1093/cercor/6.1.31; Owen AM, 1999, EUR J NEUROSCI, V11, P567, DOI 10.1046/j.1460-9568.1999.00449.x; Owen AM, 1998, P NATL ACAD SCI USA, V95, P7721, DOI 10.1073/pnas.95.13.7721; Passingham RE., 1993, FRONTAL LOBES VOLUNT; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P873, DOI 10.1073/pnas.90.3.873; Petrides M, 1994, HDB NEUROPSYCHOLOGY, V9, P59; PETRIDES M, 1995, HDB NEUROPSYCHOLOGY, V9, P17; Postle BR, 1999, J COGNITIVE NEUROSCI, V11, P585, DOI 10.1162/089892999563652; Quintana J, 1999, CEREB CORTEX, V9, P213, DOI 10.1093/cercor/9.3.213; RAJKOWSKA G, 1995, CEREB CORTEX, V5, P307, DOI 10.1093/cercor/5.4.307; Sawaguchi T, 1999, J NEUROPHYSIOL, V82, P2070, DOI 10.1152/jn.1999.82.5.2070; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; Spence SA, 1998, BRIT J PSYCHIAT, V172, P316, DOI 10.1192/bjp.172.4.316; TALALRACH J, 1988, COPLANAR STEREOTACTI; *WELLC DEP COGN NE, 1999, STAT PAR MAPP	45	667	679	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2000	288	5471					1656	1660		10.1126/science.288.5471.1656	http://dx.doi.org/10.1126/science.288.5471.1656			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	320BZ	10834847				2022-12-24	WOS:000087382300045
J	Einum, S; Fleming, IA				Einum, S; Fleming, IA			Highly fecund mothers sacrifice offspring survival to maximize fitness	NATURE			English	Article							EGG SIZE; ATLANTIC SALMON; NATURAL-SELECTION; CLUTCH SIZE; EVOLUTION; NUMBER; STRATEGIES; QUALITY	Why do highly fecund organisms apparently sacrifice offspring size for increased numbers when offspring survival generally increases with size(1-3)? The theoretical tools for understanding this evolutionary trade-off between number and size of offspring have developed over the past 25 years(1,4-10); however, the absence of data on the relation between offspring size and fitness in highly fecund species, which would control for potentially confounding variables, has caused such models to remain largely hypothetical(11,12). Here we manipulate egg size, controlling for maternal trait interactions, and determine the causal consequences of offspring size in a wild population of Atlantic salmon. The joint effect of egg size on egg number and offspring survival resulted in stabilizing phenotypic selection for an optimal size. The optimal egg size differed only marginally from the mean value observed in the population, suggesting that it had evolved mainly in response to selection on maternal rather than offspring fitness. We conclude that maximization of maternal fitness by sacrificing offspring survival may well be a general phenomenon among highly fecund organisms.	Norwegian Inst Nat Res, N-7485 Trondheim, Norway; Norwegian Univ Sci & Technol, Dept Zool, N-7034 Trondheim, Norway	Norwegian Institute Nature Research; Norwegian University of Science & Technology (NTNU)	Einum, S (corresponding author), Norwegian Inst Nat Res, Tungasletta 2, N-7485 Trondheim, Norway.	sigurd.einum@ninatrd.ninaniku.no	Fleming, Ian/I-7217-2012	Einum, Sigurd/0000-0002-3788-7800				Bernardo J, 1996, AM ZOOL, V36, P216; BROCKELMAN WY, 1975, AM NAT, V109, P677, DOI 10.1086/283037; Einum S, 1997, J FISH BIOL, V50, P634, DOI 10.1006/jfbi.1996.0330; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Einum S, 1999, P ROY SOC B-BIOL SCI, V266, P2095, DOI 10.1098/rspb.1999.0893; ELGAR MA, 1990, OIKOS, V59, P283, DOI 10.2307/3545546; Fleming IA, 1996, REV FISH BIOL FISHER, V6, P379, DOI 10.1007/BF00164323; GERITZ SAH, 1995, AM NAT, V146, P685, DOI 10.1086/285820; Jonsson N, 1996, FUNCT ECOL, V10, P89, DOI 10.2307/2390266; Kamler E., 1992, EARLY LIFE HIST FISH; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; LLOYD DG, 1987, AM NAT, V129, P800, DOI 10.1086/284676; MCGINLEY MA, 1987, AM NAT, V130, P370, DOI 10.1086/284716; PARKER GA, 1986, AM NAT, V128, P573, DOI 10.1086/284589; Roff Derek A., 1992; SARGENT RC, 1987, AM NAT, V129, P32, DOI 10.1086/284621; SINERVO B, 1991, SCIENCE, V252, P1300, DOI 10.1126/science.252.5010.1300; SINERVO B, 1992, SCIENCE, V258, P1927, DOI 10.1126/science.258.5090.1927; Sinervo B, 1998, OIKOS, V83, P432, DOI 10.2307/3546671; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; WADE MJ, 1990, EVOLUTION, V44, P1947, DOI [10.2307/2409605, 10.1111/j.1558-5646.1990.tb04301.x]	21	323	329	0	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2000	405	6786					565	567		10.1038/35014600	http://dx.doi.org/10.1038/35014600			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850714				2022-12-24	WOS:000087449500049
J	Stockler, M; Beith, J				Stockler, M; Beith, J			Youth and hormone receptors in breast cancer: good or bad news first?	LANCET			English	Editorial Material									Univ Sydney, Natl Hlth & Med Res Council, Clin Trials Ctr, Dept Med, Sydney, NSW 2006, Australia; Royal Prince Alfred Hosp, Sydney Canc Ctr, Dept Med Oncol, Camperdown, NSW 2050, Australia	University of Sydney; University of Sydney	Stockler, M (corresponding author), Univ Sydney, Natl Hlth & Med Res Council, Clin Trials Ctr, Dept Med, Sydney, NSW 2006, Australia.		Stockler, Martin R/N-3859-2016	Stockler, Martin R/0000-0003-3793-8724; Beith, Jane/0000-0002-4946-2789				Abe O, 1998, LANCET, V352, P930; Barley V, 1996, LANCET, V348, P1184, DOI 10.1016/S0140-6736(05)65474-8; BARTLETT K, 1993, LANCET, V341, P1293; Clarke M, 1998, LANCET, V351, P1451; DAVIDSON N, 1999, P AM SOC CLIN ONCOL, V18; EJLERTSEN B, 1999, P AM SOC CLIN ONCOL, V18; JAKESZ R, 1999, P AM SOC CLIN ONCOL, V18; Kroman N, 2000, BRIT MED J, V320, P474, DOI 10.1136/bmj.320.7233.474; Taniguchi S, 1996, LANCET, V348, P1451, DOI 10.1016/S0140-6736(04)70096-3	9	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 27	2000	355	9218					1839	1840		10.1016/S0140-6736(00)02281-9	http://dx.doi.org/10.1016/S0140-6736(00)02281-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	318VZ	10866433				2022-12-24	WOS:000087306500003
J	Chua, KB; Bellini, WJ; Rota, PA; Harcourt, BH; Tamin, A; Lam, SK; Ksiazek, TG; Rollin, PE; Zaki, SR; Shieh, WJ; Goldsmith, CS; Gubler, DJ; Roehrig, JT; Eaton, B; Gould, AR; Olson, J; Field, H; Daniels, P; Ling, AE; Peters, CJ; Anderson, LJ; Mahy, BWJ				Chua, KB; Bellini, WJ; Rota, PA; Harcourt, BH; Tamin, A; Lam, SK; Ksiazek, TG; Rollin, PE; Zaki, SR; Shieh, WJ; Goldsmith, CS; Gubler, DJ; Roehrig, JT; Eaton, B; Gould, AR; Olson, J; Field, H; Daniels, P; Ling, AE; Peters, CJ; Anderson, LJ; Mahy, BWJ			Nipah virus: A recently emergent deadly paramyxovirus	SCIENCE			English	Article							INFECTION; PROTEIN	A paramyxovirus virus termed Nipah virus has been identified as the etiologic agent of an outbreak of severe encephalitis in people with close contact exposure to pigs in Malaysia and Singapore. The outbreak was first noted in late September 1998 and by mid-June 1999, more than 265 encephalitis cases, including 105 deaths, had been reported in Malaysia, and 11 cases of encephalitis or respiratory illness with one death had been reported in Singapore. Electron microscopic, serologic, and genetic studies indicate that this virus belongs to the family Paramyxoviridae and is mast closely related to the recently discovered Hendra virus. We suggest that these two viruses are representative of a new genus within the family Paramyxoviridae. Like Hendra virus. Nipah virus is unusual among the paramyxoviruses in its ability to infect and cause potentially fatal disease in a number of host species, including humans.	Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Univ Malaya, Med Ctr, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia; Ctr Dis Control, Div Vector Borne Dis, NCID, Ft Collins, CO 80522 USA; CSIRO, Australian Anim Hlth Lab, Geelong, Vic 3220, Australia; Queensland Dept Primary Ind, Anim Res Inst, Yeerongpilly, Qld 4105, Australia; Singapore Gen Hosp, Dept Pathol, Singapore 0316, Singapore	Centers for Disease Control & Prevention - USA; Universiti Malaya; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Queensland Department of Agriculture & Fisheries; Singapore General Hospital	Bellini, WJ (corresponding author), Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, 1600 Clifton Rd, Atlanta, GA 30333 USA.		LAM, SAI KIT/B-5231-2010; Eaton, Bryan Thomas/AAV-2103-2021; Daniels, Peter W/H-1966-2013	Rollin, Pierre/0000-0002-4608-2641				BRANDT WE, 1967, AM J TROP MED HYG, V16, P339, DOI 10.4269/ajtmh.1967.16.339; Centers for Disease Control and Prevention, 1999, MMWR MORB MORTAL WKL, V48, P265; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P335; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; DUERMEYER W, 1979, J MED VIROL, V4, P25, DOI 10.1002/jmv.1890040104; Enserink M, 1999, SCIENCE, V284, P407, DOI 10.1126/science.284.5413.407; HALPIN K, 1998, COMMUN DIS INTELL, V20, P476; HARCOURT BH, IN PRESS; Hausmann S, 1999, J VIROL, V73, P5568, DOI 10.1128/JVI.73.7.5568-5576.1999; Ksiazek TG, 1999, J INFECT DIS, V179, pS177, DOI 10.1086/514321; MONATH TP, 1996, FIELDS VIROLOGY, P961; Murray K., 1998, EMERG INFECT DIS, V1, P43; Nordin MN, 1999, OIE DIS INF, V12, P20; PATERSON G, 1989, GENETICS PATHOGENICI, P232; Paton NI, 1999, LANCET, V354, P1253, DOI 10.1016/S0140-6736(99)04379-2; ROTA JS, 1994, VIRUS RES, V31, P317, DOI 10.1016/0168-1702(94)90025-6; SINNIAH M, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P581; THOMAS SM, 1988, CELL, V54, P891, DOI 10.1016/S0092-8674(88)91285-8; Tidona CA, 1999, VIROLOGY, V258, P425, DOI 10.1006/viro.1999.9693; Wang LF, 1998, J VIROL, V72, P1482, DOI 10.1128/JVI.72.2.1482-1490.1998; WANG LF, 1995, J IMMUNOL METHODS, V178, P1, DOI 10.1016/0022-1759(94)00235-O; Yu M, 1998, VIROLOGY, V251, P227, DOI 10.1006/viro.1998.9302	23	827	908	4	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2000	288	5470					1432	1435		10.1126/science.288.5470.1432	http://dx.doi.org/10.1126/science.288.5470.1432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318EL	10827955				2022-12-24	WOS:000087270900053
J	Pless, B				Pless, B			The nonexistent role of injury prevention in medical practice	LANCET			English	Editorial Material							CHILDHOOD INJURY; PRIMARY-CARE		Montreal Childrens Hosp, Montreal, PQ H3H 1PE, Canada	McGill University	Pless, B (corresponding author), Montreal Childrens Hosp, Montreal, PQ H3H 1PE, Canada.							BASS JL, 1993, PEDIATRICS, V92, P544; Carnall D, 1999, BRIT MED J, V318, P1505, DOI 10.1136/bmj.318.7197.1505a; DiGuiseppi C, 2000, FUTURE CHILD, V10, P53, DOI 10.2307/1602825; FINCH CF, 1993, 54 MON U ACC RES CTR; Kendrick D, 1999, BRIT MED J, V318, P980, DOI 10.1136/bmj.318.7189.980; Roberts I, 1996, BRIT MED J, V312, P29, DOI 10.1136/bmj.312.7022.29; Robinson D, 1998, Inj Prev, V4, P170	7	1	2	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2000	355	9217					1807	1807		10.1016/S0140-6736(00)02311-4	http://dx.doi.org/10.1016/S0140-6736(00)02311-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	315RE	10832847				2022-12-24	WOS:000087126100045
J	Spencer, JR; Jessup, KL; McGrath, MA; Ballester, GE; Yelle, R				Spencer, JR; Jessup, KL; McGrath, MA; Ballester, GE; Yelle, R			Discovery of gaseous S-2 in Io's Pele plume	SCIENCE			English	Article							HUBBLE-SPACE-TELESCOPE; GLOBAL DISTRIBUTION; SO2; ATMOSPHERE; STABILITY; VOLCANISM; COLOR	Spectroscopy of Io's Pele plume against Jupiter by the Hubble Space Telescope in October 1999 revealed absorption due to S-2 gas, with a column density of 1.0 +/- 0.2 x 10(16) per square centimeter, and probably also SO2 gas with a column density of 7 +/- 3 x 10(16) per square centimeter. This SO2/S-2 ratio (3 to 12) is expected from equilibration with silicate magmas near the quartz-fayalite-magnetite or wustite-magnetite buffers. Condensed S-3 and S-4, probable coloring agents in Pele's red plume deposits, may form by polymerization of the S-2, which is unstable to ultraviolet photolysis. Diffuse red deposits near other to volcanoes suggest that venting and polymerization of S-2 gas is a widespread feature of Io volcanism.	Lowell Observ, Flagstaff, AZ 86001 USA; Univ Michigan, Space Res Lab, Ann Arbor, MI 48109 USA; Space Telescope Sci Inst, Baltimore, MD 21218 USA; No Arizona Univ, Dept Phys & Astron, Flagstaff, AZ 86011 USA	University of Michigan System; University of Michigan; Space Telescope Science Institute; Northern Arizona University	Spencer, JR (corresponding author), Lowell Observ, 1400 W Mars Hill Rd, Flagstaff, AZ 86001 USA.							AHEARN MF, 1983, ASTROPHYS J, V274, pL99, DOI 10.1086/184158; AHEARN MF, 1999, B AM ASTRON SOC, V31, P1124; BALLESTER GE, 1994, ICARUS, V111, P2, DOI 10.1006/icar.1994.1129; COLLINS SA, 1981, J GEOPHYS RES-SPACE, V86, P8621, DOI 10.1029/JA086iA10p08621; DAVIES AG, 1999, LUNAR PLANET SCI, V30, P1462; DOUTE S, IN PRESS ICARUS; Edgington SG, 1999, ICARUS, V142, P342, DOI 10.1006/icar.1999.6228; Geissler PE, 1999, ICARUS, V140, P265, DOI 10.1006/icar.1999.6128; HUBER KP, 1979, CONSTANTS ORGANIC MO; LELLOUCH E, 1992, ICARUS, V98, P271, DOI 10.1016/0019-1035(92)90095-O; MANNATT SL, 1993, J QUANT SPECTROSC RA, V50, P267; MCEWEN AB, COMMUNICATION; MCEWEN AS, 1983, ICARUS, V55, P191, DOI 10.1016/0019-1035(83)90075-1; McEwen AS, 1998, ICARUS, V135, P181, DOI 10.1006/icar.1998.5972; McEwen AS, 1998, SCIENCE, V281, P87, DOI 10.1126/science.281.5373.87; MCEWEN AS, 1988, ICARUS, V73, P385, DOI 10.1016/0019-1035(88)90053-X; MCEWEN AS, 1988, ICARUS, V75, P450, DOI 10.1016/0019-1035(88)90157-1; MCEWEN AS, 1999, AM GEOPH UN FALL M S, V17; MCGRATH MA, IN PRESS ICARUS; MERCHANT VE, 1980, APPL OPTICS, V19, P3113, DOI 10.1364/AO.19.003113; MEYER KA, 1973, CAN J PHYS, V51, P2119, DOI 10.1139/p73-277; NOLL KS, 1995, SCIENCE, V267, P1307, DOI 10.1126/science.7871428; PEARL J, 1979, NATURE, V280, P755, DOI 10.1038/280755a0; Sartoretti P, 1996, ICARUS, V122, P273, DOI 10.1006/icar.1996.0125; SMITH AL, 1981, J CHEM PHYS, V75, P2080, DOI 10.1063/1.442328; Spencer JR, 1997, ICARUS, V127, P221, DOI 10.1006/icar.1996.5670; Spencer JR, 1997, GEOPHYS RES LETT, V24, P2471, DOI 10.1029/97GL02592; Stark G, 1999, J GEOPHYS RES-PLANET, V104, P16585, DOI 10.1029/1999JE001022; STROM RG, 1981, J GEOPHYS RES-SPACE, V86, P8593, DOI 10.1029/JA086iA10p08593; TATUM JB, 1971, CAN J PHYS, V49, P2693, DOI 10.1139/p71-325; Woods TN, 1996, J GEOPHYS RES-ATMOS, V101, P9541, DOI 10.1029/96JD00225; Zolotov MY, 1999, ICARUS, V141, P40, DOI 10.1006/icar.1999.6164; ZOLOTOV MY, 2000, LUNAR PLANET SCI, V31, P2098	33	148	148	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 19	2000	288	5469					1208	1210		10.1126/science.288.5469.1208	http://dx.doi.org/10.1126/science.288.5469.1208			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315KH	10817990				2022-12-24	WOS:000087112600042
J	Nimchuk, Z; Marois, E; Kjemtrup, S; Leister, RT; Katagiri, F; Dangl, JL				Nimchuk, Z; Marois, E; Kjemtrup, S; Leister, RT; Katagiri, F; Dangl, JL			Eukaryotic fatty acylation drives plasma membrane targeting and enhances function of several type III effector proteins from Pseudomonas syringae	CELL			English	Article							DISEASE RESISTANCE GENE; HYPERSENSITIVE CELL-DEATH; AVIRULENCE GENE; PLANT-CELLS; BACTERIAL PATHOGENS; SECRETION SYSTEM; ESCHERICHIA-COLI; PV PHASEOLICOLA; AVR PROTEINS; ARABIDOPSIS	Bacterial pathogens of plants and animals utilize conserved type III delivery systems to traffic effector proteins into host cells. Plant innate immune systems evolved disease resistance (R) genes to recognize some type III effecters, termed avirulence (Avr) proteins. On disease-susceptible (r) plants, Avr proteins can contribute to pathogen virulence. We demonstrate that several type III effecters from Pseudomonas syringae are targeted to the host plasma membrane and that efficient membrane association enhances function. Efficient localization of three Avr proteins requires consensus myristoylation sites, and Avr proteins can be myristoylated inside the host cell. These prokaryotic type III effecters thus utilize a eukaryote-specific posttranslational modification to access the subcellular compartment where they function.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; Univ Maryland, Dept Biol Sci, Baltimore, MD 21250 USA; Novartis Agr Discovery Inst Inc, San Diego, CA 92121 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Maryland; University of Maryland Baltimore	Dangl, JL (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	dangl@email.unc.edu	Marois, Eric/AAZ-5549-2021; Marois, Eric/H-9246-2016	Marois, Eric/0000-0003-4147-3747; Marois, Eric/0000-0003-4147-3747; Katagiri, Fumiaki/0000-0001-6893-3788	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM017612] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32GM17612] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alfano JR, 1997, J BACTERIOL, V179, P5655, DOI 10.1128/jb.179.18.5655-5662.1997; Anderson DM, 1999, P NATL ACAD SCI USA, V96, P12839, DOI 10.1073/pnas.96.22.12839; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; BERTHIAUME L, 1995, J BIOL CHEM, V38, P22039; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Boyes DC, 1998, P NATL ACAD SCI USA, V95, P15849, DOI 10.1073/pnas.95.26.15849; Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x; DANGL JL, 1992, PLANT CELL, V4, P1359, DOI 10.1105/tpc.4.11.1359; DANIELS MJ, 1994, PLANT PHYSIOL, V106, P1325, DOI 10.1104/pp.106.4.1325; DASILVA AM, 1990, J CELL BIOL, V111, P401, DOI 10.1083/jcb.111.2.401; DEBENER T, 1991, PLANT J, V1, P289, DOI 10.1046/j.1365-313X.1991.t01-7-00999.x; Dunphy JT, 1996, J BIOL CHEM, V271, P7154, DOI 10.1074/jbc.271.12.7154; Ellard-Ivey M, 1999, PLANT MOL BIOL, V39, P199, DOI 10.1023/A:1006125918023; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Glover CJ, 1997, J BIOL CHEM, V272, P28680, DOI 10.1074/jbc.272.45.28680; Gopalan S, 1996, PLANT CELL, V8, P1095, DOI 10.1105/tpc.8.7.1095; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Ham JH, 1998, P NATL ACAD SCI USA, V95, P10206, DOI 10.1073/pnas.95.17.10206; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; JENNER C, 1991, MOL PLANT MICROBE IN, V4, P553, DOI 10.1094/MPMI-4-553; JOHNSON DR, 1994, ANNU REV BIOCHEM, V63, P869, DOI 10.1146/annurev.bi.63.070194.004253; KEARNEY B, 1990, NATURE, V346, P385, DOI 10.1038/346385a0; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Leister RT, 1996, P NATL ACAD SCI USA, V93, P15497, DOI 10.1073/pnas.93.26.15497; Loh YT, 1998, MOL PLANT MICROBE IN, V11, P572, DOI 10.1094/MPMI.1998.11.6.572; LORANG JM, 1994, MOL PLANT MICROBE IN, V7, P508, DOI 10.1094/MPMI-7-0508; McCabe JB, 1999, MOL BIOL CELL, V10, P3771, DOI 10.1091/mbc.10.11.3771; McNellis TW, 1998, PLANT J, V14, P247, DOI 10.1046/j.1365-313X.1998.00106.x; Morales J, 1998, MOL BIOL CELL, V9, P1, DOI 10.1091/mbc.9.1.1; Mudgett MB, 1999, MOL MICROBIOL, V32, P927, DOI 10.1046/j.1365-2958.1999.01403.x; Mudgett MB, 1998, CURR OPIN MICROBIOL, V1, P109, DOI 10.1016/S1369-5274(98)80150-1; OLSON EN, 1986, J BIOL CHEM, V261, P2458; Puri N, 1997, MOL PLANT MICROBE IN, V10, P247, DOI 10.1094/MPMI.1997.10.2.247; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; RITTER C, 1995, MOL PLANT MICROBE IN, V8, P444, DOI 10.1094/MPMI-8-0444; ROMMENS CMT, 1995, PLANT CELL, V7, P249, DOI 10.1105/tpc.7.3.249; Rossier O, 1999, P NATL ACAD SCI USA, V96, P9368, DOI 10.1073/pnas.96.16.9368; SALMERON JM, 1993, MOL GEN GENET, V239, P6, DOI 10.1007/BF00281595; Scheel D, 1998, CURR OPIN PLANT BIOL, V1, P305, DOI 10.1016/1369-5266(88)80051-7; Scofield SR, 1996, SCIENCE, V274, P2063, DOI 10.1126/science.274.5295.2063; TAMAKI S, 1988, J BACTERIOL, V170, P4846, DOI 10.1128/jb.170.10.4846-4854.1988; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; Tu YP, 1997, SCIENCE, V278, P1132, DOI 10.1126/science.278.5340.1132; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; VandenAckerveken G, 1996, CELL, V87, P1307, DOI 10.1016/S0092-8674(00)81825-5; Warren RF, 1998, PLANT CELL, V10, P1439, DOI 10.1105/tpc.10.9.1439; WILCOX C, 1987, SCIENCE, V238, P1275, DOI 10.1126/science.3685978; Wood MW, 1996, MOL MICROBIOL, V22, P327, DOI 10.1046/j.1365-2958.1996.00116.x; YANG YN, 1995, MOL PLANT MICROBE IN, V8, P627, DOI 10.1094/MPMI-8-0627; Yang YO, 1997, GENE DEV, V11, P1621, DOI 10.1101/gad.11.13.1621; Zhu WG, 1999, PLANT CELL, V11, P1665, DOI 10.1105/tpc.11.9.1665	54	264	271	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 12	2000	101	4					353	363		10.1016/S0092-8674(00)80846-6	http://dx.doi.org/10.1016/S0092-8674(00)80846-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	313QM	10830163	Bronze, Green Published			2022-12-24	WOS:000087010400004
J	Murtra, P; Sheasby, AM; Hunt, SP; De Felipe, C				Murtra, P; Sheasby, AM; Hunt, SP; De Felipe, C			Rewarding effects of opiates are absent in mice lacking the receptor for substance P	NATURE			English	Article							MU-OPIOID-RECEPTOR; IMMUNOHISTOCHEMICAL LOCALIZATION; CHOLINERGIC NEURONS; BRAIN; RAT; WITHDRAWAL; EXPRESSION; ADDICTION; ANALGESIA; STRIATUM	Modulation of substance P activity offers a radical new approach to the management of depression, anxiety and stress(1-3). The substance P receptor is highly expressed in areas of the brain that are implicated in these behaviours, but also in other areas such as the nucleus accumbens which mediate the motivational properties of both natural rewards such as food and of drugs of abuse such as opiates(4-7). Here we show a loss of the rewarding properties of morphine in mice with a genetic disruption of the substance P receptor. The loss was specific to morphine, as both groups of mice responded when cocaine or food were used as rewards. The physical response to opiate withdrawal was also reduced in substance P receptor knockout mice. We conclude that substance P has an important and specific role in mediating the motivational aspects of opiates and may represent a new pharmacological route for the control of drug abuse.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Univ Miguel Hernandez, Inst Neurosci, Alicante 03550, Spain	University of London; University College London; Universidad Miguel Hernandez de Elche	Hunt, SP (corresponding author), UCL, Dept Anat & Dev Biol, Medawar Bldg,Gower St, London WC1E 6BT, England.	hunt@ucl.ac.uk	HUNT, STEPHEN P/C-1646-2008; de Felipe, Carmen/D-3813-2012	Hunt, Stephen/0000-0001-9453-5505				AUBRY JM, 1993, NEUROSCIENCE, V53, P417, DOI 10.1016/0306-4522(93)90205-T; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; BECHARA A, 1992, BEHAV NEUROSCI, V106, P351, DOI 10.1037/0735-7044.106.2.351; BOIX F, 1995, NEUROSCIENCE, V64, P1054; BOZARTH MA, 1994, NEUROSCI BIOBEHAV R, V18, P373, DOI 10.1016/0149-7634(94)90050-7; Culman J, 1997, J PHARMACOL EXP THER, V280, P238; De Felipe C, 1998, NATURE, V392, P394, DOI 10.1038/32904; ELLIOTT PJ, 1986, BRAIN RES, V381, P68, DOI 10.1016/0006-8993(86)90691-8; GERFEN CR, 1991, BRAIN RES, V556, P165, DOI 10.1016/0006-8993(91)90563-B; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; IZENWASSER S, 1993, J PHARMACOL EXP THER, V267, P145; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; KIEFFER BL, 1992, P NATL ACAD SCI USA, V89, P12048, DOI 10.1073/pnas.89.24.12048; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Kramer MS, 1998, SCIENCE, V281, P1640, DOI 10.1126/science.281.5383.1640; MALDONADO R, 1993, NEUROSCI LETT, V156, P135, DOI 10.1016/0304-3940(93)90457-V; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; MALDONADO R, 1992, J PHARMACOL EXP THER, V261, P669; MANSOUR A, 1995, J CHEM NEUROANAT, V8, P283, DOI 10.1016/0891-0618(95)00055-C; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; NAKAYA Y, 1994, J COMP NEUROL, V347, P249, DOI 10.1002/cne.903470208; Nye HE, 1996, MOL PHARMACOL, V49, P636; Robbins TW, 1999, NATURE, V398, P567, DOI 10.1038/19208; RUPNIAK NMJ, IN PRESS NEUROPHARMA; SHAHAM Y, 1995, PSYCHOPHARMACOLOGY, V119, P334, DOI 10.1007/BF02246300; Wise RA, 1996, CURR OPIN NEUROBIOL, V6, P243, DOI 10.1016/S0959-4388(96)80079-1; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469	28	182	192	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 11	2000	405	6783					180	183		10.1038/35012069	http://dx.doi.org/10.1038/35012069			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WG	10821273				2022-12-24	WOS:000087080100050
J	Wilf, P; Labandeira, CC; Kress, WJ; Staines, CL; Windsor, DM; Allen, AL; Johnson, KR				Wilf, P; Labandeira, CC; Kress, WJ; Staines, CL; Windsor, DM; Allen, AL; Johnson, KR			Timing the radiations of leaf beetles: Hispines on gingers from latest Cretaceous to recent	SCIENCE			English	Article							ANGIOSPERM RADIATION; NORTH-AMERICA; EVOLUTION; CHRYSOMELIDAE; COLEOPTERA; HELICONIA; DIVERSITY; GENUS; ASSOCIATIONS; COMMUNITIES	Stereotyped feeding damage attributable solely to rolled-leaf hispine beetles is documented on latest Cretaceous and early Eocene ginger leaves from North Dakota and Wyoming. Hispine beetles (6000 extant species) therefore evolved at least 20 million years earlier than suggested by insect body fossils, and their specialized associations with gingers and ginger relatives are ancient and phylogenetically conservative. The latest Cretaceous presence of these relatively derived members of the hyperdiverse leaf-beetle clade (Chrysomelidae, more than 38,000 species) implies that many of the adaptive radiations that account for the present diversity of leaf beetles occurred during the Late Cretaceous, contemporaneously with the ongoing rapid evolution of their angiosperm hosts.	Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA; Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; Smithsonian Trop Res Inst, Balboa, Panama; Denver Museum Nat Hist, Dept Earth & Space Sci, Denver, CO 80205 USA; Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA; Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Maryland; University of Maryland College Park; Smithsonian Institution; Smithsonian Tropical Research Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History	Wilf, P (corresponding author), Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA.	pwilf@umich.edu						[Anonymous], 1997, BIOL COLEOPTERES CHR; ARCHIBALD SB, IN PRESS CAN J ZOOL; ASKEVOLD IS, 1990, CAN J ZOOL, V68, P2135, DOI 10.1139/z90-297; AUERBACH MJ, 1981, ECOL MONOGR, V51, P63, DOI 10.2307/2937307; Becerra JX, 1997, SCIENCE, V276, P253, DOI 10.1126/science.276.5310.253; BOROWIEC L, 1987, Polskie Pismo Entomologiczne, V57, P3; Borowiec L., 1995, P541; CALL V B, 1988, American Journal of Botany, V75, P104; Chase M.W., 1995, MONOCOTYLEDONS SYSTE, P109, DOI DOI 10.1016/0378-8741(87)90103-6; Coley PD, 1999, SCIENCE, V284, P2098, DOI 10.1126/science.284.5423.2098; Collinson M. E., 1988, TERTIARY RES, V9, P67; Crowson R. A., 1955, NATURAL CLASSIFICATI; DAVIS JI, 1995, SYST BOT, V20, P503, DOI 10.2307/2419806; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Futuyma DJ, 1996, PHILOS T R SOC B, V351, P1361, DOI 10.1098/rstb.1996.0119; FUTUYMA DJ, 1990, EVOLUTION, V44, P1885, DOI 10.1111/j.1558-5646.1990.tb04298.x; GAGE DA, 1981, BIOCHEM SYST ECOL, V9, P79, DOI 10.1016/0305-1978(81)90063-6; Givnish TJ, 1999, MOL PHYLOGENET EVOL, V12, P360, DOI 10.1006/mpev.1999.0601; Herendeen P.S., 1995, MONOCOTYLEDONS SYSTE, P1; HICKEY LJ, 1978, CAN J BOT, V56, P1136, DOI 10.1139/b78-128; Hickey LJ., 1977, GEOL SOC AM MEM, V150, P1, DOI DOI 10.1130/MEM150-P1; HICKS JF, 1999, GEOL SOC AM ABSTR, V31, P71; Hsiao TH, 1999, ADV CHRYSOMELIDAE BI, V1, P321; HSIAO TH, 1999, ADV CHRYSOMELIDAE BI, V1, P39; JOHNSON KR, 1990, GEOL S AM S, V247, P433; JOHNSON KR, 1996, GEOL SOC AM ABSTR, V29, P432; JOLIVET P, 1989, Bulletin Mensuel de la Societe Linneenne de Lyon, V58, P297; Jolivet P., 1995, HOST PLANTS CHRYSOME; Kalshoven L. G. E., 1957, Tijdschrift voor Entomologie Leiden, V100, P5; KNOBLOCH E, 1979, Vestnik Ustredniho Ustavu Geologickeho, V54, P297; Kopf A, 1998, EVOLUTION, V52, P517, DOI 10.1111/j.1558-5646.1998.tb01651.x; KRESS WJ, UNPUB; Kress WJ, 1995, MONOCOTYLEDONS SYSTE, P443; LABANDEIRA CC, 1994, P NATL ACAD SCI USA, V91, P12278, DOI 10.1073/pnas.91.25.12278; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; LIDGARD S, 1988, NATURE, V331, P344, DOI 10.1038/331344a0; Lupia R, 1999, PALEOBIOLOGY, V25, P305, DOI 10.1017/S009483730002131X; Magallon S, 1999, ANN MO BOT GARD, V86, P297, DOI 10.2307/2666180; MANN JS, 1981, J NAT HIST, V15, P727, DOI 10.1080/00222938100770531; MAULIK S, 1931, P ZOOL SOC LOND, P1137; MCCOY ED, 1984, BIOTROPICA, V16, P10, DOI 10.2307/2387887; MCCOY ED, 1985, BIOTROPICA, V17, P326, DOI 10.2307/2388596; MENDONCA VLM, 1991, MEM I OSWALDO CRUZ, V86, P93, DOI 10.1590/S0074-02761991000600023; Meurer-Grimes B, 1997, BOT REV, V63, P356, DOI 10.1007/BF02856597; Meyer H. W., 1997, U CALIF PUBL GEOL SC, V141, P1; Ngo KS, 1998, PHYTOCHEMISTRY, V47, P1117, DOI 10.1016/S0031-9422(97)00606-7; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; POINAR GO, 1999, ADV CHRYSOMELIDAE BI, V1, P1; Poinar GO., 1999, AMBER FOREST; Reid C.A.M., 1995, P559; Ride WDJL, 1999, INT CODE ZOOLOGICAL; SANTIAGOBLAY JA, 1994, NOVEL ASPECTS BIOL C, P1, DOI DOI 10.1007/978-94-011-1781-4_1; SCHAARSCHMIDT F, 1986, COUR FORSCHINST SENC, V85, P205; Schmitt M., 1985, Zoologische Beitraege, V29, P35; Schoonhoven LM, 1998, INSECT PLANT BIOL; SEIFERT RP, 1979, BIOTROPICA, V11, P51, DOI 10.2307/2388173; STAINES CL, 1996, REV BIOL TROP SPEC P, V3, P1; Stevenson D. W., 1995, MONOCOTYLEDONS SYSTE, P543; STORK NE, 1988, BIOL J LINN SOC, V35, P321, DOI 10.1111/j.1095-8312.1988.tb00474.x; Strong D.R., 1984, INSECTS PLANTS; STRONG DR, 1977, BIOTROPICA, V9, P156, DOI 10.2307/2387878; STRONG DR, 1977, ECOLOGY, V58, P573, DOI 10.2307/1939006; STRONG DR, 1982, ECOL ENTOMOL, V7, P217, DOI 10.1111/j.1365-2311.1982.tb00660.x; STRONG DR, 1977, EVOLUTION, V31, P854, DOI 10.1111/j.1558-5646.1977.tb01078.x; STRONG DR, 1982, ECOLOGY, V63, P1039, DOI 10.2307/1937243; SUZUKI K, 1996, CHRYSOMELIDAE BIOL, V1, P3; Wilf P, 2000, GEOL SOC AM BULL, V112, P292, DOI 10.1130/0016-7606(2000)112<0292:LPEECC>2.3.CO;2; Wilf P, 1999, SCIENCE, V284, P2153, DOI 10.1126/science.284.5423.2153; WINDSOR DM, UNPUB; Wing SL, 1998, ANNU REV EARTH PL SC, V26, P379, DOI 10.1146/annurev.earth.26.1.379	70	121	132	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 14	2000	289	5477					291	294		10.1126/science.289.5477.291	http://dx.doi.org/10.1126/science.289.5477.291			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894775				2022-12-24	WOS:000088169400039
J	Oberhummer, H; Csoto, A; Schlattl, H				Oberhummer, H; Csoto, A; Schlattl, H			Stellar production rates of carbon and its abundance in the universe	SCIENCE			English	Article							EVOLUTION; C-12	The bulk of the carbon in our universe is produced in the triple-alpha process in helium-burning red giant stars. We calculated the change of the triple-alpha reaction rate in a microscopic 12-nucleon model of the C-12 nucleus and Looked for the effects of minimal variations of the strengths of the underlying interactions. Stellar model calculations were performed with the alternative reaction rates. Here, we show that outside a narrow window of 0.5 and 4% of the values of the strong and Coulomb forces, respectively, the stellar production of carbon or oxygen is reduced by factors of 30 to 1000.	Vienna Univ Technol, Inst Nucl Phys, A-1040 Vienna, Austria; Eotvos Lorand Univ, Dept Atom Phys, H-1117 Budapest, Hungary; Max Planck Inst Astrophys, D-85741 Garching, Germany	Technische Universitat Wien; Eotvos Lorand University; Max Planck Society	Oberhummer, H (corresponding author), Vienna Univ Technol, Inst Nucl Phys, Wiedner Hauptstr 8-10, A-1040 Vienna, Austria.	ohu@kph.tuwien.ac.at	Schlattl, Helmut/M-9846-2014	Schlattl, Helmut/0000-0002-3365-7821				Barrow J., 1998, ANTHROPIC COSMOLOGIC; COOK CW, 1957, PHYS REV, V107, P508, DOI 10.1103/PhysRev.107.508; DUNBAR DNF, 1953, PHYS REV, V92, P649, DOI 10.1103/PhysRev.92.649; Furutani H., 1980, PROG THEOR PHYS SUPP, V68, P193; HENRY RBC, IN PRESS ASTROPHYS J; HOGAN CJ, ASTROPH9909295; HOYLE F, 1953, PHYS REV, V92, P1095; IBEN I, 1983, ANNU REV ASTRON ASTR, V21, P271, DOI 10.1146/annurev.aa.21.090183.001415; Jeltema TE, 2000, PHYS REV D, V61, DOI 10.1103/PhysRevD.61.017301; Kippenhahn R., 1990, STELLAR STRUCTURE EV; LIVIO M, 1989, NATURE, V340, P281, DOI 10.1038/340281a0; MAEDER A, 1992, ASTRON ASTROPHYS, V264, P105; Nomoto K, 1997, NUCL PHYS A, V616, pC79, DOI 10.1016/S0375-9474(97)00076-6; OBERHUMMER H, ASTROPH908247; Pichler R, 1997, NUCL PHYS A, V618, P55, DOI 10.1016/S0375-9474(97)00057-2; REICHSTEIN I, 1970, NUCL PHYS A, VA158, P529, DOI 10.1016/0375-9474(70)90201-0; Rolfs C. E., 1988, CAULDRONS COSMOS; Schlattl H, 1999, ASTRON ASTROPHYS, V347, P272; SCHWARZS.M, 1965, ASTROPHYS J, V142, P855, DOI 10.1086/148358; SHIRLEY VS, 1996, TABLE ISOTOPES, V1; THOMPSON DR, 1977, NUCL PHYS A, V286, P53, DOI 10.1016/0375-9474(77)90007-0; TIMMES FX, 1995, ASTROPHYS J SUPPL S, V98, P617, DOI 10.1086/192172; VOLKOV AB, 1965, NUCL PHYS, V74, P33, DOI 10.1016/0029-5582(65)90244-0; WAGENHUBER J, 1994, ASTRON ASTROPHYS, V286, P121; Weiss A, 2000, ASTRON ASTROPHYS SUP, V144, P487, DOI 10.1051/aas:2000223; Weiss A, 2000, ASTRON ASTROPHYS, V356, P181; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237	27	59	60	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2000	289	5476					88	90		10.1126/science.289.5476.88	http://dx.doi.org/10.1126/science.289.5476.88			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332TW	10884230	Green Submitted			2022-12-24	WOS:000088090400036
J	Schneider, D; Shahabuddin, M				Schneider, D; Shahabuddin, M			Malaria parasite development in a Drosophila model	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; MOSQUITO MIDGUT; SPOROZOITES; TRANSMISSION; HOST	Malaria is a devastating public health menace, killing over one million people every year and infecting about half a billion. Here it is shown that the protozoan Plasmodium gallinaceum, a close relative of the human malaria parasite Plasmodium falciparum, can develop in the fruit fly Drosophila melanogaster. Plasmodium gallinaceum ookinetes injected into the fly developed into sporozoites infectious to the vertebrate host with similar kinetics as seen in the mosquito host Aedes aegypti. In the fly, a component of the insect's innate immune system, the macrophage, can destroy Plasmodia. These experiments suggest that Drosophila can be used as a surrogate mosquito for defining the genetic pathways involved in both vector competence and part of the parasite sexual cycle.	Whitehead Inst, Cambridge, MA 02142 USA; NIAID, NIH, Bethesda, MD 20892 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Schneider, D (corresponding author), Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000811] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Dimopoulos G, 1998, EMBO J, V17, P6115, DOI 10.1093/emboj/17.21.6115; ELRODERICKSON M, IN PRESS CURR BIOL; GARNHAM PCC, 1966, MALARIA PARASITES OT, P609; KAUSHAL DC, 1983, J IMMUNOL, V131, P2557; KRETTLI AU, 1988, PARASITE IMMUNOL, V10, P523, DOI 10.1111/j.1365-3024.1988.tb00240.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; OZAKI LS, 1984, J PARASITOL, V70, P831, DOI 10.2307/3281779; Richman AM, 1998, NAT MED, V4, P552, DOI 10.1038/nm0598-552; Richman AM, 1997, EMBO J, V16, P6114, DOI 10.1093/emboj/16.20.6114; SHAHABUDDIN M, 1994, B I PASTEUR, V92, P119; Shahabuddin M, 1998, PARASITOL TODAY, V14, P493, DOI 10.1016/S0169-4758(98)01348-9; TOURAY MG, 1992, J EXP MED, V175, P1607, DOI 10.1084/jem.175.6.1607; VAUGHAN JA, 1994, AM J TROP MED HYG, V51, P233, DOI 10.4269/ajtmh.1994.51.233; Vernick KD, 1996, AM J TROP MED HYG, V54, P430, DOI 10.4269/ajtmh.1996.54.430; WATERS AP, 1991, P NATL ACAD SCI USA, V88, P3140, DOI 10.1073/pnas.88.8.3140	16	83	84	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 30	2000	288	5475					2376	2379		10.1126/science.288.5475.2376	http://dx.doi.org/10.1126/science.288.5475.2376			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329NP	10875925				2022-12-24	WOS:000087913400043
J	Liu, YJ; Gao, JH; Liu, HL; Fox, PT				Liu, YJ; Gao, JH; Liu, HL; Fox, PT			The temporal response of the brain after eating revealed by functional MRI	NATURE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; TASTE PERCEPTION; HYPOTHALAMUS; SATIATION; CORTEX; HUMANS; FOOD	After eating, the human brain senses a biochemical change and then signals satiation, but precisely when this occurs is unknown. Even for well-established physiological systems like glucose-insulin regulation, the timing of interaction between hormonal processes and neural events is inferred mostly from blood sampling(1-6). Recently, neuroimaging studies have provided in vivo information about the neuroanatomical correlates of the regulation of energy intake(7-10). Temporal orchestration of such systems, however, is crucial to the integration of neuronal and hormonal signals that control eating behaviour(11). The challenge of this functional magnetic resonance imaging study is to map not only where but also when the brain will respond after food ingestion. Here we use a temporal clustering analysis technique to demonstrate that eating-related neural activity peaks at two different times with distinct localization. Importantly, the differentiated responses are interacting with an internal signal, the plasma insulin. These results support the concept of temporal parcellation of brain activity(12), which reflects the different natures of stimuli and responses. Moreover, this study provides a neuroimaging basis for detecting dynamic processes without prior knowledge of their timing, such as the acute effects of medication and nutrition in the brain.	Univ Florida, Dept Psychiat, Gainesville, FL 32610 USA; Univ Florida, Inst Brain, Gainesville, FL 32610 USA; Univ Texas, Hlth Sci Ctr, Res Imaging Ctr, San Antonio, TX 78284 USA; Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78284 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Liu, YJ (corresponding author), Univ Florida, Dept Psychiat, 100 Newell Dr, Gainesville, FL 32610 USA.	yijunliu@ufl.edu; gao@uthscsa.edu	Fox, Peter/B-4725-2010	Fox, Peter/0000-0002-0465-2028				[Anonymous], 1987, HDB PHYSL 1 NERVOUS; BENDETTINI PA, 1993, MAGNET RESON MED, V30, P161; BENZO CA, 1983, LIFE SCI, V32, P2509, DOI 10.1016/0024-3205(83)90231-X; Buchel C, 1999, SCIENCE, V283, P1538, DOI 10.1126/science.283.5407.1538; Denton D, 1999, P NATL ACAD SCI USA, V96, P2532, DOI 10.1073/pnas.96.5.2532; FOX PT, 1986, NATURE, V323, P806, DOI 10.1038/323806a0; FOX PT, 1988, J CEREBR BLOOD F MET, V8, P642, DOI 10.1038/jcbfm.1988.111; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; Gautier JF, 1999, AM J CLIN NUTR, V70, P806; GROSSMAN SP, 1975, PSYCHOL REV, V82, P200, DOI 10.1037/0033-295X.82.3.200; KINOMURA S, 1994, BRAIN RES, V659, P263, DOI 10.1016/0006-8993(94)90890-7; LIU HL, 1999, P INT SOC MAGN RESON, V7, P271; LIU Y, 1999, NEUROIMAGE, V9, pS120; Liu YY, 1999, NATURE, V400, P364, DOI 10.1038/22547; Matsuda M, 1999, DIABETES, V48, P1801, DOI 10.2337/diabetes.48.9.1801; Ngan SC, 1999, MAGNET RESON MED, V41, P939, DOI 10.1002/(SICI)1522-2594(199905)41:5<939::AID-MRM13>3.0.CO;2-Q; OOMURA Y, 1981, HDB HYPOTHALAMUS PHY, P557; Reiman EM, 1997, J CLIN PSYCHIAT, V58, P4; Rohner-Jeanrenaud F, 1983, Adv Metab Disord, V10, P193; ROLLS ET, 1998, NEURAL NETWORK BRAIN, P17; Rosen BR, 1998, P NATL ACAD SCI USA, V95, P773, DOI 10.1073/pnas.95.3.773; Saper C.B., 1990, HUMAN NERVOUS SYSTEM, P389, DOI DOI 10.1016/B978-0-12-547625-6.50020-9; Scott T. R., 1995, Neurobiology (Budapest), V3, P281; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; WORSLEY KJ, 1994, ADV APPL PROBAB, V26, P13, DOI 10.2307/1427576; Xiong JH, 1996, HUM BRAIN MAPP, V4, P153, DOI 10.1002/(SICI)1097-0193(1996)4:3<153::AID-HBM1>3.0.CO;2-2; ZATORRE RJ, 1992, NATURE, V360, P339, DOI 10.1038/360339a0	30	220	233	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2000	405	6790					1058	1062		10.1038/35016590	http://dx.doi.org/10.1038/35016590			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	328VN	10890447				2022-12-24	WOS:000087871700047
J	Eberhardt, MV; Lee, CY; Liu, RH				Eberhardt, MV; Lee, CY; Liu, RH			Nutrition - Antioxidant activity of fresh apples	NATURE			English	Article							ASSAY		Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA	Cornell University	Eberhardt, MV (corresponding author), Cornell Univ, Dept Food Sci, 108 Stocking Hall, Ithaca, NY 14853 USA.	RL23@cornell.edu	Liu, Rui Hai/C-2865-2008; Liu, Rui Hai/AAE-4865-2019	Liu, Rui Hai/0000-0002-7018-7929				BURDA S, 1990, J AGR FOOD CHEM, V38, P945, DOI 10.1021/jf00094a006; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Herbert V, 1996, J NUTR, V126, pS1213, DOI 10.1093/jn/126.suppl_4.1213S; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; LUNEC J, 1992, J INT FED CLIN CHEM, V4, P58; Podmore ID, 1998, NATURE, V392, P559, DOI 10.1038/33308; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; *USDA, 1998, USDA NUTR DAT STAND; Wang H, 1996, J AGR FOOD CHEM, V44, P701, DOI 10.1021/jf950579y; Winston GW, 1998, FREE RADICAL BIO MED, V24, P480, DOI 10.1016/S0891-5849(97)00277-3	10	854	912	5	299	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2000	405	6789					903	904		10.1038/35016151	http://dx.doi.org/10.1038/35016151			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326JT	10879522				2022-12-24	WOS:000087732700036
J	Koronakis, V; Sharff, A; Koronakis, E; Luisi, B; Hughes, C				Koronakis, V; Sharff, A; Koronakis, E; Luisi, B; Hughes, C			Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export	NATURE			English	Article							ESCHERICHIA-COLI; SECRETION; CHANNEL; SYSTEM; TRANSLOCATION; RECEPTOR; FHUA	Diverse molecules, from small antibacterial drugs to large protein toxins, are exported directly across both cell membranes of Gram-negative bacteria. This export is brought about by the reversible interaction of substrate-specific inner-membrane proteins with an outer-membrane protein of the TolC family, thus bypassing the intervening periplasm. Here we report the 2.1-Angstrom crystal structure of TolC from Escherichia coli, revealing a distinctive and previously unknown fold. Three TolC protomers assemble to form a continuous, solvent-accessible conduit-a 'channel-tunnel' over 140 Angstrom long that spans both the outer membrane and periplasmic space. The periplasmic or proximal end of the tunnel is sealed by sets of coiled helices. We suggest these could be untwisted by an allosteric mechanism, mediated by protein-protein interactions, to open the tunnel. The structure provides an explanation of how the cell cytosol is connected to the external environment during export, and suggests a general mechanism for the action of bacterial efflux pumps.	Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; Univ Cambridge, Dept Biochem, Crystallog & Biocomp Unit, Cambridge CB2 1QP, England	University of Cambridge; University of Cambridge	Koronakis, V (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	vk103@mole.bio.cam.ac.uk		Koronakis, Vassilis/0000-0002-1353-1092				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENZ R, 1993, ZBL BAKT-INT J MED M, V278, P187, DOI 10.1016/S0934-8840(11)80836-4; BRICOGNE G, 1993, ACTA CRYSTALLOGR D, V49, P37, DOI 10.1107/S0907444992010400; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Duong F, 1997, CELL, V91, P567, DOI 10.1016/S0092-8674(00)80444-4; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; GILSON L, 1990, EMBO J, V9, P3875, DOI 10.1002/j.1460-2075.1990.tb07606.x; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; Johnson JM, 1999, J MOL BIOL, V287, P695, DOI 10.1006/jmbi.1999.2630; Koronakis V, 1993, Semin Cell Biol, V4, P7, DOI 10.1006/scel.1993.1002; KORONAKIS V, 1991, EMBO J, V10, P3263, DOI 10.1002/j.1460-2075.1991.tb04890.x; Koronakis V, 1997, MOL MICROBIOL, V23, P617, DOI 10.1046/j.1365-2958.1997.d01-1880.x; KORONAKIS V, 1989, EMBO J, V8, P595, DOI 10.1002/j.1460-2075.1989.tb03414.x; KREUSCH A, 1994, PROTEIN SCI, V3, P58; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; Lupas A, 1997, CURR OPIN STRUC BIOL, V7, P388, DOI 10.1016/S0959-440X(97)80056-5; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; OAS TG, 1994, TRENDS BIOCHEM SCI, V19, P51, DOI 10.1016/0968-0004(94)90030-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paulsen IT, 1997, FEMS MICROBIOL LETT, V156, P1, DOI 10.1111/j.1574-6968.1997.tb12697.x; Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Schulz GE, 1996, CURR OPIN STRUC BIOL, V6, P485, DOI 10.1016/S0959-440X(96)80113-8; SEO J, 1993, PROTEINS, V15, P223, DOI 10.1002/prot.340150302; Sharff AJ, 2000, ACTA CRYSTALLOGR D, V56, P785, DOI 10.1107/S090744490000370X; Snijder HJ, 1999, NATURE, V401, P717, DOI 10.1038/44890; STONE BJ, 1995, MOL MICROBIOL, V17, P701, DOI 10.1111/j.1365-2958.1995.mmi_17040701.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190	40	838	873	1	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2000	405	6789					914	919		10.1038/35016007	http://dx.doi.org/10.1038/35016007			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326JT	10879525				2022-12-24	WOS:000087732700040
J	Miller, PJO; Biassoni, N; Samuels, A; Tyack, PL				Miller, PJO; Biassoni, N; Samuels, A; Tyack, PL			Whale songs lengthen in response to sonar	NATURE			English	Article							HUMPBACK WHALES		Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Chicago Zool Soc, Daniel F & Ada L Rice Conservat Biol & Res Ctr, Brookfield, IL 60513 USA	Woods Hole Oceanographic Institution	Miller, PJO (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.		Tyack, Peter L/D-6209-2013; Tyack, Peter/AAC-4513-2019	Tyack, Peter L/0000-0002-8409-4790; Tyack, Peter/0000-0002-8409-4790				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Katona S., 1979, Behavior of Marine Animals, V3, P33; LEHMANN EL, 1958, ANN MATH STAT, V29, P1167, DOI 10.1214/aoms/1177706448; Miller PJ, 1998, DEEP-SEA RES PT II, V45, P1389, DOI 10.1016/S0967-0645(98)00028-9; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; RICHARDSON WJ, 1995, MARINEMAMMALS NOISE; TYACK P, 1981, BEHAV ECOL SOCIOBIOL, V8, P105, DOI 10.1007/BF00300822; WATERS MA, 1996, US FED REG, V61, P37452; Zar JH., 1999, BIOSTAT ANAL	9	167	169	0	79	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2000	405	6789					903	903		10.1038/35016148	http://dx.doi.org/10.1038/35016148			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326JT	10879521	Bronze			2022-12-24	WOS:000087732700035
J	Biering-Sorensen, F; Bendix, AF				Biering-Sorensen, F; Bendix, AF			Working off low back pain	LANCET			English	Editorial Material									Univ Copenhagen Hosp, Rigshosp, Ctr Neurosci, Dept Med TH, DK-2100 Copenhagen, Denmark; Odense Univ Hosp, Dept Planning & Qual Dev, Odense, Denmark	Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Biering-Sorensen, F (corresponding author), Univ Copenhagen Hosp, Rigshosp, Ctr Neurosci, Dept Med TH, DK-2100 Copenhagen, Denmark.			Biering-Sorensen, Fin/0000-0002-2186-0144				Abenhaim L, 2000, SPINE, V25, p1S, DOI 10.1097/00007632-200002151-00001; ALTMAIER EM, 1992, PAIN, V49, P329, DOI 10.1016/0304-3959(92)90240-C; BALAGUE F, 1995, SPINE, V20, P1265, DOI 10.1097/00007632-199506000-00012; Carter JT., 2000, OCCUPATIONAL HLTH GU; Feyer AM, 2000, OCCUP ENVIRON MED, V57, P116, DOI 10.1136/oem.57.2.116; FORD WE, 1995, BACK PAIN WORKPLACE; Hansen FR, 1995, SPINE, V20, P2716, DOI 10.1097/00007632-199512150-00013; Schade V, 1999, PAIN, V80, P239, DOI 10.1016/S0304-3959(98)00210-3; TULDER MW, 2000, COCHRANE DATABASE SY; WADDELL G, 1994, EPIDEMIOLOGY REV EPI; Williams RA, 1998, ARCH PHYS MED REHAB, V79, P366, DOI 10.1016/S0003-9993(98)90135-6	11	9	10	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2000	355	9219					1929	1930		10.1016/S0140-6736(00)02321-7	http://dx.doi.org/10.1016/S0140-6736(00)02321-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859035				2022-12-24	WOS:000087381900006
J	McKenna, RM; Takemoto, SK				McKenna, RM; Takemoto, SK			Improving HLA matching for kidney transplantation by use of CREGs	LANCET			English	Editorial Material							ALLOCATION; PRIVATE		Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada; Calgary Lab Serv, Calgary, AB, Canada; Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90095 USA	University of Calgary; University of Calgary; University of California System; University of California Los Angeles	Takemoto, SK (corresponding author), Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada.							FULLER AA, 1990, HUM IMMUNOL, V28, P306, DOI 10.1016/0198-8859(90)90059-X; Fuller TC, 1999, TRANSPLANTATION, V68, P173, DOI 10.1097/00007890-199907270-00002; Hata Y, 1998, TRANSPLANTATION, V65, P208; KONOEDA Y, 1986, TRANSPLANTATION, V41, P253, DOI 10.1097/00007890-198602000-00023; McKenna RM, 1998, TRANSPLANTATION, V66, P38, DOI 10.1097/00007890-199807150-00006; McKenna RM, 2000, TRANSPLANTATION, V69, P319, DOI 10.1097/00007890-200002150-00001; Morris PJ, 1999, LANCET, V354, P1147, DOI 10.1016/S0140-6736(99)01104-6; SANFILIPPO F, 1984, TRANSPLANTATION, V38, P483, DOI 10.1097/00007890-198411000-00008; Sijpkens YWJ, 1999, KIDNEY INT, V56, P1920, DOI 10.1046/j.1523-1755.1999.00753.x; Starzl TE, 1997, TRANSPLANTATION, V64, P983, DOI 10.1097/00007890-199710150-00009; TAKEMOTO S, 1994, NEW ENGL J MED, V331, P760, DOI 10.1056/NEJM199409223311202; Wujciak T, 1999, TRANSPLANTATION, V68, P1097, DOI 10.1097/00007890-199910270-00006	12	18	21	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 27	2000	355	9218					1842	1843		10.1016/S0140-6736(00)02283-2	http://dx.doi.org/10.1016/S0140-6736(00)02283-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	318VZ	10866435				2022-12-24	WOS:000087306500005
J	Arber, S; Ladle, DR; Lin, JH; Frank, E; Jessell, TM				Arber, S; Ladle, DR; Lin, JH; Frank, E; Jessell, TM			ETS gene Er81 controls the formation of functional connections between group Ia sensory afferents and motor neurons	CELL			English	Article							DORSAL-ROOT GANGLIA; SPINAL-CORD; SYNAPTIC CONNECTIONS; NT-3 ACTIVATION; IN-VIVO; MUSCLE; EXPRESSION; MOUSE; CELLS; NEUROTROPHIN	The connections formed between sensory and motor neurons (MNs) play a critical role in the control of motor behavior. During development, the axons of proprioceptive sensory neurons project into the spinal cord and form both direct and indirect connections with MNs. Two ETS transcription factors, ER81 and PEAS, are expressed by developing proprioceptive neurons and MNs, raising the possibility that these genes are involved in the formation of sensory-motor connections. Er81 mutant mice exhibit a severe motor discoordination, yet the specification of MNs and induction of muscle spindles occurs normally. The motor defect in Er81 mutants results from a failure of group la proprioceptive afferents to form a discrete termination zone in the ventral spinal cord. As a consequence there is a dramatic reduction in the formation of direct connections between proprioceptive afferents and MNs. ER81 therefore controls a late step in the establishment of functional sensory-motor circuitry in the developing spinal cord.	Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA; Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15261 USA	Columbia University; Howard Hughes Medical Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jessell, TM (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA.			Arber, Silvia/0000-0002-6261-250X; Lin, Jonathan/0000-0002-7438-6941				ARBER S, 1995, J CELL BIOL, V131, P1083, DOI 10.1083/jcb.131.4.1083; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bang AG, 1996, CURR OPIN NEUROBIOL, V6, P25, DOI 10.1016/S0959-4388(96)80005-5; Brown A. G., 1981, ORG SPINAL CORD, P154; BROWN MC, 1967, J PHYSIOL-LONDON, V192, P773, DOI 10.1113/jphysiol.1967.sp008330; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Chen HH, 1999, CURR OPIN NEUROBIOL, V9, P405, DOI 10.1016/S0959-4388(99)80061-0; Coutte L, 1999, ONCOGENE, V18, P6278, DOI 10.1038/sj.onc.1203020; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5; Frank E, 1988, MESSAGE MIND, P180; Goulding M, 1998, NEURON, V21, P943, DOI 10.1016/S0896-6273(00)80612-1; HONDA CN, 1995, NEUROSCIENCE, V68, P883, DOI 10.1016/0306-4522(95)00180-Q; Huang EJ, 1999, DEVELOPMENT, V126, P2191; JANSEN JKS, 1964, ACTA PHYSIOL SCAND, V62, P364, DOI 10.1111/j.1748-1716.1964.tb10435.x; Kopp DM, 1997, J NEUROSCI, V17, P6697; Kucera J, 1998, NEUROREPORT, V9, P905, DOI 10.1097/00001756-199803300-00026; KUNO M, 1970, J PHYSIOL-LONDON, V210, P823, DOI 10.1113/jphysiol.1970.sp009244; LANCEJONES C, 1979, J MORPHOL, V162, P275; Landgraf M, 1999, NEURON, V22, P43, DOI 10.1016/S0896-6273(00)80677-7; LICHTMAN JW, 1984, J NEUROSCI, V4, P1745; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; Mears SC, 1997, J NEUROSCI, V17, P3128; MILLER DM, 1995, DEVELOPMENT, V121, P2877; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; MU XJ, 1993, J NEUROSCI, V13, P4029; O'Donovan KJ, 1998, J NEUROCHEM, V70, P1241; Ozaki S, 1997, J COMP NEUROL, V380, P215; RiveroMelian C, 1996, J COMP NEUROL, V364, P651, DOI 10.1002/(SICI)1096-9861(19960122)364:4<651::AID-CNE4>3.0.CO;2-2; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Saueressig H, 1999, DEVELOPMENT, V126, P4201; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Tourtellotte WG, 1998, NAT GENET, V20, P87, DOI 10.1038/1757; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; WATT DGD, 1976, J NEUROPHYSIOL, V39, P1375, DOI 10.1152/jn.1976.39.6.1375; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; ZELENA J, 1994, NERVES MECHANORECEPT, P1	43	374	375	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 26	2000	101	5					485	498		10.1016/S0092-8674(00)80859-4	http://dx.doi.org/10.1016/S0092-8674(00)80859-4			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850491	Bronze			2022-12-24	WOS:000087375400006
J	Balter, S; Benin, A; Wyton, S; Pinto, L; Teixeira, LM; Alvim, GG; Luna, E; Jackson, D; LaClaire, L; Elliott, J; Facklam, R; Schuchat, A				Balter, S; Benin, A; Wyton, S; Pinto, L; Teixeira, LM; Alvim, GG; Luna, E; Jackson, D; LaClaire, L; Elliott, J; Facklam, R; Schuchat, A			Epidemic nephritis in Nova Serrana, Brazil	LANCET			English	Article							FOOD-BORNE OUTBREAK; STREPTOCOCCUS-ZOOEPIDEMICUS; GROUP-C; ACUTE GLOMERULONEPHRITIS; PHARYNGITIS; DYSGALACTIAE; INFECTION; CHILDREN	Background Outbreaks of nephritis have been rare since the 1970s. From December, 1997, to July, 1998, 253 cases of acute nephritis were identified in Nova Serrana, Brazil. Seven patients required dialysis, and three patients died. We did a case-control study to investigate the cause of the outbreak. Methods Using a matched cluster design, we examined seven recent patients, their family members (n=23), and members of neighbourhood-matched control households (n=22). We subsequently interviewed 50 patients and 50 matched controls about exposure to various dairy products. We also cultured daily foods and took udder-swab and milk samples from cows. Findings associated with group C Streptococcus equi subspecies zooepidemicus, a cause of bovine mastitis. S zooepidemicus was detected in four of seven case households (six of 30 people) and no control households (p=0.09). Patients were more likely than matched controls to have consumed a locally produced cheese called queijo fresco (matched odds ratio 2.1, p=0.05). The nephritis attach rate was 4.5 per 1000 in Nova Serrana but 18 per 1000 in the village Quilombo do Gaia (p=0.003). The largest supplier of unpasteurised queijo fresco was a farm in Quilombo do Gaia. S zooepidemicus was not detected in food samples or in swabs collected from cows in August, 1998, although mastitis was evident among cows on the suspected farm. Throat cultures of the two women who prepared cheese on this farm yielded the outbreak strain of S zooepidemicus. After the cheese was removed from the distribution system, no further cases were reported. Interpretation A large outbreak of glomerulonephritis was attributed to S zooepidemicus in unpasteurised cheese. This outbreak highlights the dangers of consuming unpasteurised daily products and need for global efforts to promote food safety.	Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA; Hosp Sao Joao de Deus, Dept Nephrol, Divinopolis, Brazil; Univ Fed Rio de Janeiro, Inst Microbiol, Rio De Janeiro, Brazil; Dept Hlth, Nova Serrana, Brazil; Ctr Nacl Epidemiol, Brasilia, DF, Brazil	Centers for Disease Control & Prevention - USA; Universidade Federal do Rio de Janeiro	Balter, S (corresponding author), Ctr Dis Control & Prevent, Resp Dis Branch, 1600 Clifton Rd,MS E-61, Atlanta, GA 30333 USA.		Teixeira, Lucia Martins/AAO-7988-2020; Balter, S/P-6211-2019; Luna, Expedito J A/B-7948-2012	Teixeira, Lucia Martins/0000-0002-4017-7076; Luna, Expedito J A/0000-0002-1145-9672				BarDayan Y, 1996, SCAND J INFECT DIS, V28, P563, DOI 10.3109/00365549609037961; Barham M, 1983, LANCET, V1, P945; BARHAM M, 1987, EPIDEMIOL INFECT, V98, P183; Bryans J. T., 1972, Streptococci and streptococcal diseases,, P327; *CDC, 1983, MMWR-MORBID MORTAL W, V32, P510; COLLAZOS J, 1992, CLIN INFECT DIS, V15, P744, DOI 10.1093/clind/15.4.744-a; DUCA E, 1969, J HYG-CAMB, V67, P691, DOI 10.1017/S0022172400042145; EDWARDS AT, 1988, EPIDEMIOL INFECT, V101, P43, DOI 10.1017/S0950268800029204; Elliott JA, 1998, J CLIN MICROBIOL, V36, P2115, DOI 10.1128/JCM.36.7.2115-2116.1998; Ferrandiere M, 1998, EUR J CLIN MICROBIOL, V17, P290, DOI 10.1007/BF01699990; FRANCIS AJ, 1993, J INFECTION, V27, P317, DOI 10.1016/0163-4453(93)92358-4; GALLO G, 1992, EUR J EPIDEMIOL, V8, P292; Headrick ML, 1998, AM J PUBLIC HEALTH, V88, P1219, DOI 10.2105/AJPH.88.8.1219; KLEINMAN H, 1954, Minn Med, V37, P479; KODAMA T, 1958, Yokohama Med Bull, V9, P105; LOSSOS IS, 1992, ARCH INTERN MED, V152, P853, DOI 10.1001/archinte.152.4.853; MARTINEZLUENGAS F, 1982, CAN MED ASSOC J, V127, P13; MCKEAGE MJ, 1990, AUST NZ J MED, V20, P177, DOI 10.1111/j.1445-5994.1990.tb01299.x; *NAT COMM CLIN LAB, 1998, M100S8 NAT COMM CLIN, P70; POONKING T, 1967, NEW ENGL J MED, V277, P728, DOI 10.1056/NEJM196710052771403; RAMMELKAMP CH, 1954, T ASSOC AM PHYSICIAN, V67, P276; ROSE HD, 1980, J CLIN MICROBIOL, V11, P76, DOI 10.1128/JCM.11.1.76-78.1980; ROY S, 1990, PEDIATR NEPHROL, V4, P585, DOI 10.1007/BF00858626; Ruoff Kathryn L., 1995, P299; Vandamme P, 1996, INT J SYST BACTERIOL, V46, P774, DOI 10.1099/00207713-46-3-774; Vieira VV, 1998, INT J SYST BACTERIOL, V48, P1231, DOI 10.1099/00207713-48-4-1231; WOOLCOCK JB, 1975, RES VET SCI, V18, P113, DOI 10.1016/S0034-5288(18)33642-7; YAP HK, 1990, PEDIATR NEPHROL, V4, P482, DOI 10.1007/BF00869825; 1994, CDR WKLY, V4, P241	29	64	68	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2000	355	9217					1776	1780						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	315RE	10832828				2022-12-24	WOS:000087126100012
J	Elsaleh, H; Joseph, D; Grieu, F; Zeps, N; Spry, N; Iacopetta, B				Elsaleh, H; Joseph, D; Grieu, F; Zeps, N; Spry, N; Iacopetta, B			Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer	LANCET			English	Article							REPLICATION ERROR PHENOTYPE; MICROSATELLITE INSTABILITY; MONONUCLEOTIDE REPEAT; COLON-CARCINOMA; CELL-LINES; METHYLATION; DNA; FLUOROURACIL; EXPRESSION; LEVAMISOLE	Background Adjuvant chemotherapy can improve 5-year survival in Dukes' C colorectal carcinoma. Improved selection of patients who will respond to adjuvant treatments is required. We investigated whether site of tumour origin, sex, and presence of microsatellite instability (MSI) phenotype were associated with a survival benefit from adjuvant chemotherapy. Methods We analysed data for 656 consecutive patients with Dukes' C colorectal carcinoma, with median follow-up of 54 months (range 7-104) and mean age 66.7 years (SD 12.9). We screened tumour samples by PCR for deletions in the BAT-26 mononucleotide repeat to establish MSI status. Details of chemotherapy and survival were obtained by review of hospital and health-department records. Adjuvant chemotherapy (fluorouracil and levamisole) was given with curative intent to 272 (42%) patients. Findings Striking survival benefits were seen for patients who had right-sided tumours and who received adjuvant chemotherapy compared with those who did not (48 vs 27% alive at end of study [95% CI 0.25-0.56], p<0.0001), for women (53 vs 33% [0.25-0.56], p<0.0001), and for patients with MSI tumours (90 vs 35% [0.01-0.53], p=0.0007). MSI-positive tumours were slightly more frequent in women than in men (10 vs 7%). Right-sided tumours were more frequently MSI positive than left-sided tumours (20 vs 1%). Men with right-sided tumours benefited from chemotherapy (37 vs 12% [0.24-0.69], p=0.0007) but men with left-sided tumours did not. Interpretation The survival benefits seen in patients treated with adjuvant chemotherapy suggest that data from previous trials of adjuvant chemotherapy should be reassessed and the predictive value of MSI status confirmed. Validation of our results will allow better selection of patients for chemotherapy.	Sir Charles Gairdner Hosp, Dept Radiat Oncol, Nedlands, WA 6009, Australia; Univ Western Australia, Dept Surg, Nedlands, WA, Australia	University of Western Australia; University of Western Australia	Elsaleh, H (corresponding author), Sir Charles Gairdner Hosp, Dept Radiat Oncol, Nedlands, WA 6009, Australia.		Zeps, Nikolajs/C-4180-2013; Zeps, Nikolajs/AAF-3186-2021	Zeps, Nikolajs/0000-0002-6404-6839; Zeps, Nikolajs/0000-0002-6404-6839; Spry, Nigel/0000-0001-8659-5065; Elsaleh, Hany/0000-0003-2083-4961				Ahuja N, 1997, CANCER RES, V57, P3370; Bubb VJ, 1996, ONCOGENE, V12, P2641; BUFILL JA, 1990, ANN INTERN MED, V113, P779, DOI 10.7326/0003-4819-113-10-779; DELATTRE O, 1989, LANCET, V2, P353; Erlichman C, 1999, J CLIN ONCOL, V17, P1356, DOI 10.1200/JCO.1999.17.5.1356; Feeley KM, 1999, J PATHOL, V188, P14, DOI 10.1002/(SICI)1096-9896(199905)188:1<14::AID-PATH323>3.0.CO;2-Q; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; Halling KC, 1999, JNCI-J NATL CANCER I, V91, P1295, DOI 10.1093/jnci/91.15.1295; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Hoang JM, 1997, CANCER RES, V57, P300; Iacopetta B, 1998, HUM MUTAT, V12, P355, DOI 10.1002/(SICI)1098-1004(1998)12:5<355::AID-HUMU9>3.0.CO;2-C; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jass JR, 1998, GUT, V42, P673, DOI 10.1136/gut.42.5.673; Kane MF, 1997, CANCER RES, V57, P808; KIM HG, 1994, AM J PATHOL, V145, P148; KUNE S, 1986, INT J EPIDEMIOL, V15, P483, DOI 10.1093/ije/15.4.483; Liu LU, 1999, GUT, V45, P45, DOI 10.1136/gut.45.1.45; LOTHE RA, 1993, CANCER RES, V53, P5849; Mamounas E, 1999, J CLIN ONCOL, V17, P1349, DOI 10.1200/JCO.1999.17.5.1349; MATHERS C, 1998, HLTH SYSTEM COSTS CA; MOERTEL CG, 1990, NEW ENGL J MED, V322, P352, DOI 10.1056/NEJM199002083220602; MOERTEL CG, 1995, ANN INTERN MED, V122, P321, DOI 10.7326/0003-4819-122-5-199503010-00001; Salahshor S, 1999, BRIT J CANCER, V81, P190, DOI 10.1038/sj.bjc.6690676; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; THOMAS PRM, 1988, RADIOTHER ONCOL, V13, P245, DOI 10.1016/0167-8140(88)90219-8; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Wiencke JK, 1999, CANCER EPIDEM BIOMAR, V8, P501; Zhou XP, 1998, GENE CHROMOSOME CANC, V21, P101, DOI 10.1002/(SICI)1098-2264(199802)21:2<101::AID-GCC4>3.0.CO;2-4	28	462	474	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2000	355	9217					1745	1750		10.1016/S0140-6736(00)02261-3	http://dx.doi.org/10.1016/S0140-6736(00)02261-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	315RE	10832824				2022-12-24	WOS:000087126100008
J	Freigang, J; Proba, K; Leder, L; Diederichs, K; Sonderegger, P; Welte, W				Freigang, J; Proba, K; Leder, L; Diederichs, K; Sonderegger, P; Welte, W			The crystal structure of the ligand binding module of axonin-1/TAG-1 suggests a zipper mechanism for neural cell adhesion	CELL			English	Article							RAY-DIFFRACTION DATA; IMMUNOGLOBULIN SUPERFAMILY; NEURITE OUTGROWTH; NR-CAM; NG-CAM; MOLECULE; DOMAINS; FASCICULATION; NGCAM; FIBRONECTIN	We have determined the crystal structure of the ligand binding fragment of the neural cell adhesion molecule axonin-1/TAG-1 comprising the first four immunoglobulin (Ig) domains. The overall structure of axonin-1(Ig1-4) is U-shaped due to contacts between domains 1 and 4 and domains 2 and 3. In the crystals, these molecules are aligned in a string with adjacent molecules oriented in an anti-parallel fashion and their C termini perpendicular to the string. This arrangement suggests that cell adhesion by hemophilic axonin-1 interaction occurs by the formation of a linear zipper-like array in which the axonin-1 molecules are alternately provided by the two apposed membranes. In accordance with this model, mutations in a loop critical for the formation of the zipper resulted in the loss of the hemophilic binding capacity of axonin-1.	Univ Konstanz, Fac Biol, D-78457 Constance, Germany; Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland	University of Konstanz; University of Zurich	Welte, W (corresponding author), Univ Konstanz, Fac Biol, Box M656, D-78457 Constance, Germany.							Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Brummendorf T, 1996, CURR OPIN NEUROBIOL, V6, P584, DOI 10.1016/S0959-4388(96)80089-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUCHNER J, 1991, BIO-TECHNOL, V9, P157, DOI 10.1038/nbt0291-157; Buchstaller A, 1996, J CELL BIOL, V135, P1593, DOI 10.1083/jcb.135.6.1593; BURGOON MP, 1995, J CELL BIOL, V130, P733, DOI 10.1083/jcb.130.3.733; Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Denzinger T, 1997, EUR MASS SPECTROM, V3, P379, DOI 10.1255/ejms.170; FELSENFELD DP, 1994, NEURON, V12, P675, DOI 10.1016/0896-6273(94)90222-4; FITZLI D, 2000, IN PRESS J CELL BIOL; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; HOLDEN HM, 1992, J MOL BIOL, V227, P840, DOI 10.1016/0022-2836(92)90226-A; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kunz S, 1996, J CELL BIOL, V135, P253, DOI 10.1083/jcb.135.1.253; Kunz S, 1998, J CELL BIOL, V143, P1673, DOI 10.1083/jcb.143.6.1673; Lustig M, 1999, DEV BIOL, V209, P340, DOI 10.1006/dbio.1999.9250; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; OI VT, 1983, P NATL ACAD SCI-BIOL, V80, P825, DOI 10.1073/pnas.80.3.825; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; RADER C, 1993, EUR J BIOCHEM, V215, P133, DOI 10.1111/j.1432-1033.1993.tb18015.x; Rader C, 1996, EMBO J, V15, P2056, DOI 10.1002/j.1460-2075.1996.tb00559.x; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SINGER SJ, 1992, SCIENCE, V255, P1671, DOI 10.1126/science.1313187; Stoeckli ET, 1996, DEV BIOL, V177, P15, DOI 10.1006/dbio.1996.0141; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tsiotra PC, 1996, J BIOL CHEM, V271, P29216, DOI 10.1074/jbc.271.46.29216; VANDERMERWE PA, 1994, TRENDS BIOCHEM SCI, V19, P354; ZUELLIG RA, 1992, EUR J BIOCHEM, V204, P453, DOI 10.1111/j.1432-1033.1992.tb16655.x	38	129	132	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 12	2000	101	4					425	433		10.1016/S0092-8674(00)80852-1	http://dx.doi.org/10.1016/S0092-8674(00)80852-1			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	313QM	10830169	Bronze, Green Submitted, Green Accepted			2022-12-24	WOS:000087010400010
J	Post, DM; Pace, ML; Hairston, NG				Post, DM; Pace, ML; Hairston, NG			Ecosystem size determines food-chain length in lakes	NATURE			English	Article							TROPHIC STRUCTURE; STABLE ISOTOPES; ARCTIC LAKES; WEBS; PRODUCTIVITY; ENRICHMENT; PATTERNS	Food-chain length is an important characteristic of ecological communities(1) : it influences community structure(2), ecosystem functions(1-4) and contaminant concentrations in top predators(5,6). Since Elton(7) first noted that food-chain length was variable among natural systems, ecologists have considered many explanatory hypotheses(1,4,8,9), but few are supported by empirical evidence(4,10,11). Here we test three hypotheses that predict food-chain length to be determined by productivity alone (productivity hypothesis)(4,10,12,13), ecosystem size alone (ecosystem-size hypothesis)(14,15) or a combination of productivity and ecosystem size (productive-space hypothesis)(7,16-18). The productivity and productive-space hypotheses propose that food-chain length should increase with increasing resource availability; however, the productivity hypothesis does not include ecosystem size as a determinant of resource availability. The ecosystem-size hypothesis is based on the relationship between ecosystem size and species diversity, habitat availability and habitat heterogeneity(14,15). We find that food-chain length increases with ecosystem size, but that the length of the food chain is not related to productivity. Our results support the hypothesis that ecosystem size, and not resource availability, determines food-chain length in these natural ecosystems.	Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; Inst Ecosyst Studies, Millbrook, NY 12545 USA	Cornell University; Cary Institute of Ecosystem Studies	Post, DM (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Corson Hall, Ithaca, NY 14853 USA.	dmp18@cornell.edu	Post, David M/A-6987-2009	Post, David M/0000-0003-1434-7729; Pace, Michael/0000-0001-5945-6131				BRIAND F, 1987, SCIENCE, V238, P956, DOI 10.1126/science.3672136; CABANA G, 1994, NATURE, V372, P255, DOI 10.1038/372255a0; Carpenter S.R., 1993, TROPHIC CASCADE LAKE; COHEN JE, 1991, AM NAT, V138, P1542, DOI 10.1086/285299; DeAngelis D. L., 1992, DYNAMICS NUTR CYCLIN; delGiorgio PA, 1996, LIMNOL OCEANOGR, V41, P359, DOI 10.4319/lo.1996.41.2.0359; Elton C., 1927, ANIMAL ECOLOGY; France RL, 1995, LIMNOL OCEANOGR, V40, P1310, DOI 10.4319/lo.1995.40.7.1310; France RL, 1997, CAN J FISH AQUAT SCI, V54, P1255, DOI 10.1139/cjfas-54-6-1255; HAIRSTON NG, 1993, AM NAT, V142, P379, DOI 10.1086/285546; Holt Robert D., 1993, P77; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; JENKINS B, 1992, OIKOS, V65, P249, DOI 10.2307/3545016; Kaunzinger CMK, 1998, NATURE, V395, P495, DOI 10.1038/26741; Kidd KA, 1998, CAN J FISH AQUAT SCI, V55, P869, DOI 10.1139/cjfas-55-4-869; KLING GW, 1992, ECOLOGY, V73, P561, DOI 10.2307/1940762; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; PAINE RT, 1988, ECOLOGY, V69, P1648, DOI 10.2307/1941141; PERSSON L, 1992, AM NAT, V140, P59, DOI 10.1086/285403; Persson Lennart, 1996, P396; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; PIMM SL, 1978, NATURE, V275, P542, DOI 10.1038/275542a0; SCHINDLER DW, 1978, LIMNOL OCEANOGR, V23, P478, DOI 10.4319/lo.1978.23.3.0478; SCHOENER TW, 1989, ECOLOGY, V70, P1559, DOI 10.2307/1938088; SLOBODKIN LAWRENCE B., 1961; Sterner RW, 1997, ECOLOGY, V78, P2258, DOI 10.1890/0012-9658(1997)078[2258:TEOFCL]2.0.CO;2; Vander Zanden MJ, 1999, AM NAT, V154, P406, DOI 10.1086/303250; VOLLENWEIDER RA, 1979, Z WASSER ABWASS FOR, V12, P46	29	495	529	13	226	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2000	405	6790					1047	1049		10.1038/35016565	http://dx.doi.org/10.1038/35016565			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	328VN	10890443				2022-12-24	WOS:000087871700043
J	Teale, GR; Moffitt, DD; Mann, CH; Luesley, DM				Teale, GR; Moffitt, DD; Mann, CH; Luesley, DM			Management guidelines for women with normal colposcopy after low grade cervical abnormalities: population study	BRITISH MEDICAL JOURNAL			English	Article							INTRAEPITHELIAL NEOPLASIA	Objectives To develop an evidence based protocol for the follow up of women with low grade cervical abnormalities for whom treatment is not immediately indicated. Design Population outcome study. Setting Colposcopy clinic of an inner city teaching hospital. Participants 566 women with low grade cytological abnormalities who were not treated at a first visit to the colposcopy clinic, followed up for a total of 881 years. Main outcome measures Resolution of abnormalities, persistence of disease, and treated disease. Results Abnormalities resolved in 306 (54.1%) women, whereas 138 (24.4%,) had persistent disease and 122 (21.5%) were subsequently treated. Colposcopic opinion, smear test results, as, smoking history, and number of pregnancies were all significantly related to outcome. Logistic regression analysis produced a model that correctly identified 70% of women whose abnormalities resolved. Only 23 of 295 women (7.8%) with a normal cervix on colposcopy and a smear without dyskaryosis at a first visit were treated by the end of the observation period. Conclusions Women referred with low gr-ade cytological abnormalities who have a normal cervix on colposcopy and a negative or borderline repeat smear test result may be discharged from the colposcopy clinic. We propose a follow up protocol that could safely avoid unnecessary visits to a clinic.	Birmingham Womens NHS Trust, Birmingham B15 2TG, W Midlands, England; Univ Birmingham, Sch Med, Inst Canc Studies, Canc Res Campaign Trials Unit, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Div Gynaecol Oncol, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham	Teale, GR (corresponding author), Birmingham Womens NHS Trust, Birmingham B15 2TG, W Midlands, England.							CAMPION MJ, 1986, LANCET, V2, P237; DUNCAN ID, 1997, NATL HLTH SERVICE CE, V8; MARTEAU TM, 1990, BRIT J OBSTET GYNAEC, V97, P859, DOI 10.1111/j.1471-0528.1990.tb02586.x; Mitchell MF, 1998, OBSTET GYNECOL, V91, P626, DOI 10.1016/S0029-7844(98)00006-4; *NAT AUD OFF, 1998, PERF NHS CERV SCREEN; RICHART RM, 1969, AM J OBSTET GYNECOL, V105, P386, DOI 10.1016/0002-9378(69)90268-3; Shafi MI, 1997, BRIT J OBSTET GYNAEC, V104, P590, DOI 10.1111/j.1471-0528.1997.tb11538.x; Sideri M, 1998, CANCER EPIDEM BIOMAR, V7, P237; Soutter WP, 1997, LANCET, V349, P978, DOI 10.1016/S0140-6736(96)08295-5; SPRIGGS AI, 1980, J CLIN PATHOL, V33, P517, DOI 10.1136/jcp.33.6.517; STERN E, 1964, CANCER, V17, P508, DOI 10.1002/1097-0142(196404)17:4<508::AID-CNCR2820170412>3.0.CO;2-S	11	17	17	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1693	1696		10.1136/bmj.320.7251.1693	http://dx.doi.org/10.1136/bmj.320.7251.1693			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864542	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000087926400020
J	Buckley, GA; Brochu, CA; Krause, DW; Pol, D				Buckley, GA; Brochu, CA; Krause, DW; Pol, D			A pug-nosed crocodyliform from the Late Cretaceous of Madagascar	NATURE			English	Article							DINOSAUR	Although the image of crocodyliforms as 'unchanged living fossils' is naive, several morphological features of the group are thought to have varied only within narrow limits during the course of evolution(1). These include an elongate snout with an array of conical teeth, a dorsoventrally flattened skull and a posteriorly positioned jaw articulation, which provides a powerful bite force. Here we report an exquisitely preserved specimen of a new taxon from the Late Cretaceous of Madagascar that deviates profoundly from this Bauplan, possessing an extremely blunt snout, a tall, rounded skull, an anteriorly shifted jaw joint and clove-shaped, multicusped teeth reminiscent of those of some ornithischian dinosaurs. This last feature implies that the diet of the new taxon may have been predominantly if not exclusively herbivorous. A close relationship with notosuchid crocodyliforms, particularly Uruguaysuchus (Late Cretaceous, Uruguay)(2) is suggested by several shared derived features; this supports a biogeographical hypothesis that Madagascar and South America were linked during the Late Cretaceous(3).	Roosevelt Univ, Evelyn T Stone Univ Coll, Chicago, IL 60605 USA; Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA	Field Museum of Natural History (Chicago); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; American Museum of Natural History (AMNH)	Buckley, GA (corresponding author), Roosevelt Univ, Evelyn T Stone Univ Coll, Chicago, IL 60605 USA.		Pol, Diego/A-8007-2008	Pol, Diego/0000-0002-9690-7517				BALOUET JC, 1987, CR ACAD SCI II, V304, P853; Benton M.J., 1988, PHYLOGENY CLASSIFICA, V35A, P295, DOI DOI 10.1017/S0016756800006476; BONAPARTE JF, 1991, PALEONTOLOGIA, V4, P16; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Buckley Gregory A., 1997, Journal of Vertebrate Paleontology, V17, p35A; CARVALHO I D S, 1988, Anais da Academia Brasileira de Ciencias, V60, P437; Carvalho Ismar De Souza, 1994, Anais da Academia Brasileira de Ciencias, V66, P331; CLARK JM, 1989, SCIENCE, V244, P1064, DOI 10.1126/science.244.4908.1064; Coombs W.P. Jr, 1990, P456; GALTON PM, 1990, DINOSAURIA, P456; Gans C., 1974, BIOMECHANICS APPROAC, DOI 10.3998/mpub.7275; Gomani EM, 1997, J VERTEBR PALEONTOL, V17, P280, DOI 10.1080/02724634.1997.10010975; HOTTON NICHOLAS, 1955, AMER MIDLAND NAT, V53, P88; Iordansky N.N., 1973, P201; Krause D.W., 1999, GSA TODAY, V9, P1; Krause DW, 1997, NATURE, V390, P504, DOI 10.1038/37343; Langston W. Jr., 1973, P263; MEDEM F., 1963, REV ACAD COLOMBIANA CIENC EXACTAS FIS Y NAT, V12, P5; Pol D., 1999, Journal of Vertebrate Paleontology, V19, p69A; RUSCONI C, 1932, B I GEOLOGIA PERFORA, V19, P3; Sampson SD, 1998, SCIENCE, V280, P1048, DOI 10.1126/science.280.5366.1048; Schumacher GH, 1973, BIOL REPTILIA, V4, P101; Sues HD, 1998, TRENDS ECOL EVOL, V13, P141, DOI 10.1016/S0169-5347(97)01257-3; SWOFFORD DL, 1999, PAUP PHYLOGENETIC AN; Wake Marvalee H., 1993, P197; Willis Paul M. A., 1997, Memoirs of the Queensland Museum, V41, P423; WU XC, 1995, NATURE, V376, P678, DOI 10.1038/376678a0	27	174	184	0	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2000	405	6789					941	944		10.1038/35016061	http://dx.doi.org/10.1038/35016061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326JT	10879533				2022-12-24	WOS:000087732700048
J	Jarvis, P; Linder, S				Jarvis, P; Linder, S			Botany - Constraints to growth of boreal forests	NATURE			English	Article							CARBON BALANCE; NORWAY SPRUCE; WATER		Univ Edinburgh, Inst Ecol & Resource Management, Edinburgh EH9 3JU, Midlothian, Scotland; Swedish Univ Agr Sci, Dept Prod Engn, SE-75007 Uppsala, Sweden	University of Edinburgh; Swedish University of Agricultural Sciences	Jarvis, P (corresponding author), Univ Edinburgh, Inst Ecol & Resource Management, Kings Bldg,Mayfield Rd, Edinburgh EH9 3JU, Midlothian, Scotland.							Bergh J, 1998, FOREST ECOL MANAG, V110, P127, DOI 10.1016/S0378-1127(98)00280-1; Bergh J, 1999, FOREST ECOL MANAG, V119, P51, DOI 10.1016/S0378-1127(98)00509-X; Bergh J, 1999, GLOB CHANGE BIOL, V5, P245, DOI 10.1046/j.1365-2486.1999.00205.x; Goulden ML, 1998, SCIENCE, V279, P214, DOI 10.1126/science.279.5348.214; Gower ST, 1997, J GEOPHYS RES-ATMOS, V102, P29029, DOI [10.1029/97JD02317, 10.1029/97JD01440]; Jarvis PG, 1997, J GEOPHYS RES-ATMOS, V102, P28953, DOI 10.1029/97JD01176; JARVIS PG, 1996, BOREAS DATA; Linder S, 1995, ECOL B COPENHAGEN, V44, P178, DOI DOI 10.2307/20113161; Malhi Y, 1999, PLANT CELL ENVIRON, V22, P715, DOI 10.1046/j.1365-3040.1999.00453.x; Vaganov EA, 1999, NATURE, V400, P149, DOI 10.1038/22087	10	303	325	2	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2000	405	6789					904	905		10.1038/35016154	http://dx.doi.org/10.1038/35016154			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326JT	10879523				2022-12-24	WOS:000087732700037
J	Dobles, M; Liberal, V; Scott, ML; Benezra, R; Sorger, PK				Dobles, M; Liberal, V; Scott, ML; Benezra, R; Sorger, PK			Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2	CELL			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; ANAPHASE-PROMOTING COMPLEX; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; UNATTACHED KINETOCHORES; CELL-DEATH; GENE; MITOSIS; BUB1; MUTATIONS	The initiation of chromosome segregation at anaphase is linked by the spindle assembly checkpoint to the completion of chromosome-microtubule attachment during metaphase. To determine the function of the mitotic checkpoint protein Mad2 during normal cell division and when mitosis goes awry, we have knocked out Mad2 in mice. We find that E5.5 embryonic cells lacking Mad2, like mad2 yeast, grow normally but are unable to arrest in response to spindle disruption. At E6.5, the cells of the epiblast begin rapid cell division and the absence of a checkpoint results in widespread chromosome missegregation and apoptosis. In contrast, the postmitotic trophoblast giant cells survive without Mad2. Thus, the spindle assembly checkpoint is required for accurate chromosome segregation in mitotic mouse cells, and for embryonic viability, even in the absence of spindle damage.	MIT, Dept Biol, Cambridge, MA 02139 USA; Mem Sloan Kettering Canc Ctr, Dept Cell Biol, New York, NY 10021 USA	Massachusetts Institute of Technology (MIT); Memorial Sloan Kettering Cancer Center	Sorger, PK (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			Sorger, Peter/0000-0002-3364-1838	NCI NIH HHS [R01 CA84179] Funding Source: Medline; NIGMS NIH HHS [R01 GM 54601] Funding Source: Medline; FDA HHS [BD18587/98] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA084179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054601] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FDA HHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; BACHVAROVA R, 1980, DEV BIOL, V74, P1, DOI 10.1016/0012-1606(80)90048-2; Basu J, 1998, CHROMOSOMA, V107, P376, DOI 10.1007/s004120050321; Basu J, 1999, J CELL BIOL, V146, P13, DOI 10.1083/jcb.146.1.13; Bernard P, 1998, J CELL BIOL, V143, P1775, DOI 10.1083/jcb.143.7.1775; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Chen RH, 1999, MOL BIOL CELL, V10, P2607, DOI 10.1091/mbc.10.8.2607; Chen RH, 1998, J CELL BIOL, V143, P283, DOI 10.1083/jcb.143.2.283; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Fraschini R, 1999, J CELL BIOL, V145, P979, DOI 10.1083/jcb.145.5.979; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Gorbsky GJ, 1998, J CELL BIOL, V141, P1193, DOI 10.1083/jcb.141.5.1193; GOSSLER A, 1986, P NATL ACAD SCI USA, V83, P9065, DOI 10.1073/pnas.83.23.9065; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hartwell LW, 1982, RECENT ADV YEAST MOL, V1, P28; He XW, 1997, P NATL ACAD SCI USA, V94, P7965, DOI 10.1073/pnas.94.15.7965; Hogan B, 1994, MANIPULATING MOUSE E; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Jordan MA, 1996, CANCER RES, V56, P816; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kitagawa R, 1999, NAT CELL BIOL, V1, P514, DOI 10.1038/70309; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Li R, 1999, P NATL ACAD SCI USA, V96, P4989, DOI 10.1073/pnas.96.9.4989; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Li Y, 1997, P NATL ACAD SCI USA, V94, P12431, DOI 10.1073/pnas.94.23.12431; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; Martinez-Exposito MJ, 1999, P NATL ACAD SCI USA, V96, P8493, DOI 10.1073/pnas.96.15.8493; MCGREW JT, 1992, MOL BIOL CELL, V3, P1443, DOI 10.1091/mbc.3.12.1443; MITELMAN F, 1971, HEREDITAS-GENETISK A, V69, P155; Nelson KK, 1999, BIOCHEM J, V343, P673, DOI 10.1042/0264-6021:3430673; Nomoto S, 1999, ONCOGENE, V18, P7180, DOI 10.1038/sj.onc.1203141; NOTHIAS JY, 1995, J BIOL CHEM, V270, P22077, DOI 10.1074/jbc.270.38.22077; ONeill TJ, 1997, J BIOL CHEM, V272, P10035; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; RUGH R, 1990, MOUSE, P44; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; SNOW MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Taylor TE, 1998, TROP MED INT HEALTH, V3, P3, DOI 10.1046/j.1365-3156.1998.00166.x; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; WOODS CM, 1995, MOL MED, V1, P506, DOI 10.1007/BF03401588; Yamamoto A, 1996, J CELL BIOL, V133, P85, DOI 10.1083/jcb.133.1.85	61	435	447	0	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 9	2000	101	6					635	645		10.1016/S0092-8674(00)80875-2	http://dx.doi.org/10.1016/S0092-8674(00)80875-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	322HQ	10892650	Bronze			2022-12-24	WOS:000087504500010
J	Henney, JE				Henney, JE			Implant for chronic nausea	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									Commissioner Food & Drugs, Rockville, MD 20857 USA		Henney, JE (corresponding author), Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2000	283	21					2779	2779		10.1001/jama.283.21.2779-b	http://dx.doi.org/10.1001/jama.283.21.2779-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BQ	10896520				2022-12-24	WOS:000087381500007
J	Phillips, RL; Ernst, RE; Brunk, B; Ivanova, N; Mahan, MA; Deanehan, JK; Moore, KA; Overton, GC; Lemischka, IR				Phillips, RL; Ernst, RE; Brunk, B; Ivanova, N; Mahan, MA; Deanehan, JK; Moore, KA; Overton, GC; Lemischka, IR			The genetic program of hematopoietic stem cells	SCIENCE			English	Article							SUBTRACTIVE HYBRIDIZATION; HISTONE MACROH2A1; RECEPTOR; DNMT3B; MOUSE; CDNA	Blood cell production originates from a rare population of multipotent, self-renewing stem cells. A genome-wide gene expression analysis was performed in order to define regulatory pathways in stem cells as well as their global genetic program. Subtracted complementary DNA Libraries from highly purified murine fetal liver stem cells were analyzed with bioinformatic and array hybridization strategies. A large percentage of the several thousand gene products that have been characterized correspond to previously undescribed molecules with properties suggestive of regulatory functions. The complete data, available in a biological process-oriented database, represent the molecular phenotype of the hematopoietic stem cell.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Penn, Computat Biol & Informat Lab, Philadelphia, PA 19104 USA	Princeton University; University of Pennsylvania	Lemischka, IR (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	ilemischka@molbio.princeton.edu			NCRR NIH HHS [R01-RR04026] Funding Source: Medline; NIDDK NIH HHS [R01-DK42989] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR004026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042989] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Chenchik A, 1996, BIOTECHNIQUES, V21, P526; Choi K, 1998, DEVELOPMENT, V125, P725; Cong F, 1999, MOL CELL BIOL, V19, P8314; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Diatchenko L, 1999, METHOD ENZYMOL, V303, P349; Ema H, 2000, BLOOD, V95, P2284, DOI 10.1182/blood.V95.7.2284.007k14_2284_2288; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; Mermoud JE, 1999, J CELL BIOL, V147, P1399, DOI 10.1083/jcb.147.7.1399; Milner LA, 1999, BLOOD, V93, P2431, DOI 10.1182/blood.V93.8.2431.408k33_2431_2448; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; OTTMANN OG, 1988, J IMMUNOL, V140, P2661; Pehrson JR, 1997, J CELL BIOCHEM, V65, P107, DOI 10.1002/(SICI)1097-4644(199704)65:1<107::AID-JCB11>3.0.CO;2-H; RUBENSTEIN JLR, 1990, NUCLEIC ACIDS RES, V18, P4833, DOI 10.1093/nar/18.16.4833; SPANGRUDE GJ, 1990, P NATL ACAD SCI USA, V87, P7433, DOI 10.1073/pnas.87.19.7433; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Voura EB, 1997, EXP HEMATOL, V25, P1172; Wiesmann A, 2000, IMMUNITY, V12, P193, DOI 10.1016/S1074-7613(00)80172-7; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6	28	316	337	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2000	288	5471					1635	1640		10.1126/science.288.5471.1635	http://dx.doi.org/10.1126/science.288.5471.1635			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	320BZ	10834841				2022-12-24	WOS:000087382300039
J	Franz, WM; Muller, M; Muller, OJ; Herrmann, R; Rothmann, T; Cremer, M; Cohn, RD; Voit, T; Katus, HA				Franz, WM; Muller, M; Muller, OJ; Herrmann, R; Rothmann, T; Cremer, M; Cohn, RD; Voit, T; Katus, HA			Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy	LANCET			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; GLYCOPROTEIN; IDENTIFICATION; ORGANIZATION; DEFICIENCY; COMPONENT; DELETION; LINKAGE; FAMILY; REGION	Background In a systematic analysis of inherited forms of cardiomyopathy, we previously identified a family with X-linked dilated cardiomyopathy characterised by a mutation in the rod region of dystrophin. We have now attempted to eludicate the genetic mechanism involved in this disease, as well as the role of dystrophin-associated glycoproteins. Methods The affected dystrophin epitope, which lacks binding to the dys-1 antibody, was analysed by single-strand conformation polymorphism analysis, reverse-transcription PCR, and DNA sequencing. Effects on dystrophin-associated glycoproteins were studied by immunohistochemistry and western blotting. Findings A translation-termination mutation (C4148T) in exon 29 of the dystrophin gene was found in all affected family members. Alternative splicing rescued the reading frame and led to the expression of a dystrophin molecule lacking 50 aminoacids both in cardiac and skeletal muscle. Immunohistochemical analysis of the dystrophin-associated proteins revealed a reduction of beta-sarcoglycan and delta-sarcoglycan in the sarcolemma of cardiac muscle but not skeletal muscle tissue. However, western blotting revealed similar amounts of sarcoglycan subunits in both tissues. Interpretation The molecular mechanism of this subtype of X-linked cardiomyopathy may be explained by a conformational change in exon-29-deleted dystrophin, resulting in disruption of the sarcoglycan assembly in heart muscle but not skeletal muscle.	Med Univ Lubeck, Med Klin 2, Lubeck, Germany; Univ Essen Gesamthsch, Kinderklin, Essen, Germany; Deutsch Krebsforschungszentrum, Heidelberg, Germany; Univ Heidelberg, Dept Human Genet, D-6900 Heidelberg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Franz, WM (corresponding author), Med Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany.		Cremer, Marion/P-8524-2014; Müller, Oliver J./H-4739-2016; Cohn, Ronald/AAC-5835-2021; Müller, Oliver/AAA-4399-2021	Cremer, Marion/0000-0002-1830-9589; Müller, Oliver/0000-0001-8223-2638; Muller, Mathias/0000-0002-7879-3552				Badorff C, 1999, NAT MED, V5, P320, DOI 10.1038/6543; Beggs AH, 1997, CIRCULATION, V95, P2344, DOI 10.1161/01.CIR.95.10.2344; Bies RD, 1997, J MOL CELL CARDIOL, V29, P3175, DOI 10.1006/jmcc.1997.0568; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Chan YM, 1998, J CELL BIOL, V143, P2033, DOI 10.1083/jcb.143.7.2033; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; ENGLAND SB, 1992, NEW ENGL J MED, V326, P77; Fadic R, 1996, NEW ENGL J MED, V334, P362, DOI 10.1056/NEJM199602083340604; Ferlini A, 1998, AM J HUM GENET, V63, P436, DOI 10.1086/301952; FRANZ WM, 1995, ANN NY ACAD SCI, V752, P470, DOI 10.1111/j.1749-6632.1995.tb17457.x; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; HUNSAKER RH, 1982, AM J MED, V73, P235, DOI 10.1016/0002-9343(82)90184-X; Jung D, 1996, J BIOL CHEM, V271, P32321, DOI 10.1074/jbc.271.50.32321; KOENIG M, 1990, J BIOL CHEM, V265, P4560; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; Melacini P, 1996, CIRCULATION, V94, P3168, DOI 10.1161/01.CIR.94.12.3168; Meng HP, 1996, J BIOL CHEM, V271, P12364, DOI 10.1074/jbc.271.21.12364; MUNTONI F, 1995, J CLIN INVEST, V96, P693, DOI 10.1172/JCI118112; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; Nigro V, 1996, HUM MOL GENET, V5, P1179, DOI 10.1093/hmg/5.8.1179; Nigro V, 1997, HUM MOL GENET, V6, P601, DOI 10.1093/hmg/6.4.601; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; OrtizLopez R, 1997, CIRCULATION, V95, P2434, DOI 10.1161/01.CIR.95.10.2434; PALEK J, 1990, SEMIN HEMATOL, V27, P290; PRIOR TW, 1995, AM J HUM GENET, V57, P22; Rybakova IN, 1996, J CELL BIOL, V135, P661, DOI 10.1083/jcb.135.3.661; Shiga N, 1997, J CLIN INVEST, V100, P2204, DOI 10.1172/JCI119757; Stevenson S, 1997, CIRC RES, V80, P269, DOI 10.1161/01.RES.80.2.269; TOWBIN JA, 1993, CIRCULATION, V87, P1854, DOI 10.1161/01.CIR.87.6.1854; VOIT T, 1989, J NEUROL SCI, V89, P199, DOI 10.1016/0022-510X(89)90022-1; WATAKABE A, 1993, GENE DEV, V7, P407, DOI 10.1101/gad.7.3.407; YOSHIDA K, 1993, MUSCLE NERVE, V16, P1161, DOI 10.1002/mus.880161104	33	32	35	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2000	355	9217					1781	1785		10.1016/S0140-6736(00)02266-2	http://dx.doi.org/10.1016/S0140-6736(00)02266-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	315RE	10832829				2022-12-24	WOS:000087126100013
J	Lee, MS; Kwon, YT; Li, MW; Peng, JM; Friedlander, RM; Tsai, LH				Lee, MS; Kwon, YT; Li, MW; Peng, JM; Friedlander, RM; Tsai, LH			Neurotoxicity induces cleavage of p35 to p25 by calpain	NATURE			English	Article							NEUTRAL PROTEINASE CALPAIN; CYCLIN-DEPENDENT KINASE-5; ALZHEIMERS-DISEASE; NEURONAL DEGENERATION; CDK5; ACTIVATOR; PATHOLOGY; DEATH; BRAIN	Cyclin-dependent kinase 5 (cdk5) and its neuron-specific activator p35 are required for neurite outgrowth and cortical lamination(1-3). Proteolytic cleavage of p35 produces p25, which accumulates in the brains of patients with Alzheimer's disease(4). Conversion of p35 to p25 causes prolonged activation and mislocalization of cdk5. Consequently, the p25/cdk5 kinase hyperphosphorylates tau, disrupts the cytoskeleton and promotes the death (apoptosis) of primary neurons. Here we describe the mechanism of conversion of p35 to p25. In cultured primary cortical neurons, excitotoxins, hypoxic stress and calcium influx induce the production of p25. In fresh brain lysates, addition of calcium can stimulate cleavage of p35 to p25. Specific inhibitors of calpain, a calcium-dependent cysteine protease, effectively inhibit the calcium-induced cleavage of p35. In vitro, calpain directly cleaves p35 to release a fragment with relative molecular mass 25,000. The sequence of the calpain cleavage product corresponds precisely to that of p25. Application of the amyloid beta-peptide A beta(1-42) induces the conversion of p35 to p25 in primary cortical neurons. Furthermore, inhibition of cdk5 or calpain activity reduces cell death in A beta-treated cortical neurons. These observations indicate that cleavage of p35 to p25 by calpain may be involved in the pathogenesis of Alzheimer's disease.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Neurapoptosis Lab,Neurosurg Serv,Dept Surg, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Tsai, LH (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 200 Longwood Ave, Boston, MA 02115 USA.		Friedlander, Robert M/A-2845-2016; Peng, Junmin/N-2614-2018	Friedlander, Robert M/0000-0003-4423-9219; Peng, Junmin/0000-0003-0472-7648				Alvarez A, 1999, FEBS LETT, V459, P421, DOI 10.1016/S0014-5793(99)01279-X; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P10573, DOI 10.1073/pnas.90.22.10573; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Grynspan F, 1997, BRAIN RES, V763, P145, DOI 10.1016/S0006-8993(97)00384-3; HARTMANN H, 1993, BIOCHEM BIOPH RES CO, V194, P1216, DOI 10.1006/bbrc.1993.1952; IWAMOTO N, 1991, BRAIN RES, V561, P177, DOI 10.1016/0006-8993(91)90766-O; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; NIXON RA, 1994, ANN NY ACAD SCI, V747, P77; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Pascale A, 1999, PHARMACOL RES, V39, P81, DOI 10.1006/phrs.1998.0411; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; SEISJO BK, 1978, BRAIN ENERGY METABOL, P454; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; WANG KKW, 1999, CALPAIN PHARM TOXICO, P77; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4	20	872	924	0	63	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 18	2000	405	6784					360	364		10.1038/35012636	http://dx.doi.org/10.1038/35012636			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314YT	10830966				2022-12-24	WOS:000087085700050
J	Pozniak, CD; Radinovic, S; Yang, A; McKeon, F; Kaplan, DR; Miller, FD				Pozniak, CD; Radinovic, S; Yang, A; McKeon, F; Kaplan, DR; Miller, FD			An anti-apoptotic role for the p53 family member, p73, during developmental neuron death	SCIENCE			English	Article							TUMOR-SUPPRESSOR; CELL-DEATH; SURVIVAL; RECEPTORS; PATHWAY; GROWTH; TRKA; P63	p53 plays an essential pro-apoptotic role, a function thought to be shared with its family members p73 and p63. Here, we show that p73 is primarily present in developing neurons as a truncated isoform whose levels are dramatically decreased when sympathetic neurons apoptose after nerve growth factor (NGF) withdrawal. Increased expression of truncated p73 rescues these neurons from apoptosis induced by NCF withdrawal or p53 overexpression. In p73-/- mice, all isoforms of p73 are deleted and the apoptosis of developing sympathetic neurons is greatly enhanced. Thus, truncated p73 is an essential anti-apoptotic protein in neurons, serving to counteract the pro-apoptotic function of p53.	McGill Univ, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; McGill Univ, Montreal Neurol Inst, Brain Tumor Res Ctr, Montreal, PQ H3A 2B4, Canada; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	McGill University; McGill University; Harvard University; Harvard Medical School	Miller, FD (corresponding author), McGill Univ, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada.							Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; Fagan AM, 1996, J NEUROSCI, V16, P6208; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kaelin WG, 1999, ONCOGENE, V18, P7701, DOI 10.1038/sj.onc.1202955; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Mazzoni IE, 1999, J NEUROSCI, V19, P9716; Morrison RS, 1996, J NEUROSCI, V16, P1337; Slack RS, 1996, J CELL BIOL, V135, P1085, DOI 10.1083/jcb.135.4.1085; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang XM, 1998, J NEUROSCI, V18, P8369	17	391	408	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					304	306		10.1126/science.289.5477.304	http://dx.doi.org/10.1126/science.289.5477.304			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894779				2022-12-24	WOS:000088169400043
J	Shonn, MA; McCarroll, R; Murray, AW				Shonn, MA; McCarroll, R; Murray, AW			Requirement of the spindle checkpoint for proper chromosome segregation in budding yeast meiosis	SCIENCE			English	Article							SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; RECOMBINATION; NONDISJUNCTION; ANAPHASE; PROTEIN; KINETOCHORES; SEPARATION; ATTACHMENT; COMPLEX	The spindle checkpoint was characterized in meiosis of budding yeast. In the absence of the checkpoint, the frequency of meiosis I missegregation increased with increasing chromosome Length, reaching 19% for the longest chromosome. Meiosis I nondisjunction in spindle checkpoint mutants could be prevented by delaying the onset of anaphase. In a recombination-defective mutant (spo11 Delta), the checkpoint delays the biochemical events of anaphase I, suggesting that chromosomes that are attached to microtubules but are not under tension can activate the spindle checkpoint. Spindle checkpoint mutants reduce the accuracy of chromosome segregation in meiosis I much more than that in meiosis II, suggesting that checkpoint defects may contribute to Down syndrome.	Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Cereon Genom LLC, Cambridge, MA 02139 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Murray, AW (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.							BIGGINS S, UNPUB; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Cha RS, 2000, GENE DEV, V14, P493; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Galbraith AM, 1997, GENETICS, V146, P481; HAWLEY RS, 1994, HUM MOL GENET, V3, P1521, DOI 10.1093/hmg/3.9.1521; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; KLAPHOLZ S, 1980, GENETICS, V96, P589; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Koehler KE, 1996, NAT GENET, V14, P406, DOI 10.1038/ng1296-406; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MORGAN G, COMMUNICATION; NICKLAS RB, 1974, GENETICS, V78, P205; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; PIATTI S, 1995, EMBO J, V14, P3788, DOI 10.1002/j.1460-2075.1995.tb00048.x; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Rose MD., 1990, METHODS YEAST GENETI; Ross LO, 1996, P NATL ACAD SCI USA, V93, P4979, DOI 10.1073/pnas.93.10.4979; SHERMAN SL, 1994, HUM MOL GENET, V3, P1529, DOI 10.1093/hmg/3.9.1529; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; SORA S, 1982, GENETICS, V101, P17; STERN BM, UNPUB; STRAIGHT A, UNPUB; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Waters JC, 1996, J CELL SCI, V109, P2823; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601	34	178	183	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					300	303		10.1126/science.289.5477.300	http://dx.doi.org/10.1126/science.289.5477.300			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894778				2022-12-24	WOS:000088169400042
J	Bilder, D; Li, M; Perrimon, N				Bilder, D; Li, M; Perrimon, N			Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors	SCIENCE			English	Article							EPITHELIAL-CELLS; HUMAN HOMOLOG; PLASMA-MEMBRANE; SHAPE CHANGE; DISCS LARGE; PROTEIN; GENE; MELANOGASTER; COMPLEX; EXOCYTOSIS	Loss of cell polarity and tissue architecture are characteristics of malignant cancers derived from epithelial tissues. We provide evidence from Drosophila that a group of membrane-associated proteins act in concert to regulate both epithelial structure and cell proliferation. Scribble (Scrib) is a cell junction-localized protein required for polarization of embryonic and, as demonstrated here, imaginal disc and follicular epithelia. We show that the tumor suppressors lethal giant larvae (lgl) and discs-large (dlg) have identical effects on all three epithelia, and that scrib also acts as a tumor suppressor. Scrib and Dlg colocalize and overlap with Lgl in epithelia; activity of all three genes is required for cortical localization of Lgl and junctional Localization of Scrib and Dlg. scrib, dlg, and lgl show strong genetic interactions. Our data indicate that the three tumor suppressors act together in a common pathway to regulate cell polarity and growth control.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Bilder, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, 200 Longwood Ave, Boston, MA 02115 USA.	bilder@rascal.med.harvard.edu		Perrimon, Norbert/0000-0001-7542-472X; Bilder, David/0000-0002-1842-4966				Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bryant PJ, 1997, DEV GENET, V20, P75, DOI 10.1002/(SICI)1520-6408(1997)20:2<75::AID-DVG1>3.3.CO;2-G; Chou TB, 1996, GENETICS, V144, P1673; DAVIS I, 1995, DEV BIOL, V170, P726, DOI 10.1006/dbio.1995.1251; Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; GATEFF E, 1969, NATL CANCER I MONOGR, P365; *GENBANK, NM004524 GENBANK; Goode S, 1997, GENE DEV, V11, P2532, DOI 10.1101/gad.11.19.2532; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; JACOB L, 1987, CELL, V50, P215, DOI 10.1016/0092-8674(87)90217-0; Koyama K, 1996, CYTOGENET CELL GENET, V72, P78, DOI 10.1159/000134167; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Manfruelli P, 1996, DEVELOPMENT, V122, P2283; MARTIN PF, 1982, J EXP ZOOL, V222, P97, DOI 10.1002/jez.1402220113; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; MUKHERJEE A, 1995, MECH DEVELOP, V51, P227, DOI 10.1016/0925-4773(95)00367-3; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PERRIMON N, 1988, DEV BIOL, V127, P392, DOI 10.1016/0012-1606(88)90326-0; STRAND D, 1994, J CELL BIOL, V127, P1345, DOI 10.1083/jcb.127.5.1345; STRAND D, 1995, ONCOGENE, V11, P291; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1997, BIOESSAYS, V19, P673, DOI 10.1002/bies.950190807; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; WATSON KL, 1994, J CELL SCI, P19; WOODS DF, 1989, DEV BIOL, V134, P222, DOI 10.1016/0012-1606(89)90092-4; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X	30	721	731	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2000	289	5476					113	116		10.1126/science.289.5476.113	http://dx.doi.org/10.1126/science.289.5476.113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332TW	10884224				2022-12-24	WOS:000088090400044
J	Hudson, JJ; Taylor, WD; Schindler, DW				Hudson, JJ; Taylor, WD; Schindler, DW			Phosphate concentrations in lakes	NATURE			English	Article							PHOSPHORUS; PLANKTON; WATERS; REGENERATION; LIMITATION; PACIFIC; RELEASE	Phosphate is an important nutrient that restricts microbial production in many freshwater(1-3) and marine environments(4-6). The actual concentration of phosphate in phosphorus-limited waters is largely unknown because commonly used chemical and radiochemical techniques overestimate the concentration(7,8). Here, using a new steady-state radiobioassay to survey a diverse set of lakes, we report phosphate concentrations in lakes that are orders of magnitude lower than estimates made spectrophotometrically or with the frequently used Rigler radiobioassay. Our results, combined with those from the literature, indicate that microbes can achieve rapid turnover rates at picomolar nutrient concentrations. This occurs even though these concentrations are about two orders of magnitude below the level where phosphate uptake is estimated to be half the saturation level for the picoplankton community. Also, while phosphate concentration increased with the concentration of total phosphorus and soluble reactive phosphorus in the lakes we sampled, the proportion of phosphate in the total phosphorus pool decreased from oligotrophic to eutrophic lakes. Such information, as revealed by the phosphate assay that we use here, should allow us to address hypotheses concerning the concentration of phosphate available to planktonic microorganisms in aquatic systems.	Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Alberta; University of Waterloo	Hudson, JJ (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.		hudson, jeff/G-6171-2012; Schindler, David/A-3752-2014	hudson, jeff/0000-0002-0256-3240; Taylor, William/0000-0001-8555-945X				Abakumov V.A, 1983, GUIDANCE METHODS HYD; Atkins W., 1923, J MAR BIOL ASSOC UK, V13, P119; Baldwin DS, 1998, WATER RES, V32, P2265, DOI 10.1016/S0043-1354(97)00474-0; BENTZEN E, 1991, CAN J FISH AQUAT SCI, V48, P73, DOI 10.1139/f91-011; BENTZEN E, 1991, J PLANKTON RES, V13, P1223, DOI 10.1093/plankt/13.6.1223; BRULAND KW, 1991, LIMNOL OCEANOGR, V36, P1555, DOI 10.4319/lo.1991.36.8.1555; *CAN PARK SERV, 1986, PRINCE ALBERT NATL P, V2, P4; Cotner JB, 1997, AQUAT MICROB ECOL, V13, P141, DOI 10.3354/ame013141; DODDS WK, 1993, AQUAT SCI, V55, P132, DOI 10.1007/BF00877441; Edmondson WT., 1991, USES ECOLOGY LAKE WA; FERRANTE JG, 1976, HYDROBIOLOGIA, V50, P11, DOI 10.1007/BF00016836; FISHER TR, 1992, CAN J FISH AQUAT SCI, V49, P252, DOI 10.1139/f92-029; HARRISON WG, 1993, ICES MAR SC, V197, P149; Hudson JJ, 1996, LIMNOL OCEANOGR, V41, P1560, DOI 10.4319/lo.1996.41.7.1560; Hudson JJ, 1999, NATURE, V400, P659, DOI 10.1038/23240; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Landry MR, 1997, LIMNOL OCEANOGR, V42, P405, DOI 10.4319/lo.1997.42.3.0405; LEAN DRS, 1987, CAN J FISH AQUAT SCI, V44, P2069, DOI 10.1139/f87-256; PETERS R, 1973, LIMNOL OCEANOGR, V18, P270, DOI 10.4319/lo.1973.18.2.0270; PETERS RH, 1973, LIMNOL OCEANOGR, V18, P821, DOI 10.4319/lo.1973.18.6.0821; PREPAS EE, 1983, CAN J FISH AQUAT SCI, V40, P1412, DOI 10.1139/f83-163; RIGLER FH, 1966, VERH INT VER LIMNOL, V16, P465, DOI DOI 10.1080/03680770.1965.11895717; SCHINDLER DW, 1977, SCIENCE, V195, P260, DOI 10.1126/science.195.4275.260; SCHINDLER DW, 1972, P IBP UNESCO S PROD, P303; TARPCHAK SJ, 1988, CAN J FISH AQUAT SCI, V45, P2230; TAYLOR WD, 1991, CAN J FISH AQUAT SCI, V48, P1293, DOI 10.1139/f91-155; TAYLOR WD, 1981, CAN J FISH AQUAT SCI, V38, P1316, DOI 10.1139/f81-177; Thingstad TF, 1998, LIMNOL OCEANOGR, V43, P88, DOI 10.4319/lo.1998.43.1.0088; Wetzel R.G., 1983, LIMNOLOGY, V2nd	29	201	216	8	149	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 6	2000	406	6791					54	56		10.1038/35017531	http://dx.doi.org/10.1038/35017531			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	330ZE	10894537				2022-12-24	WOS:000087991200040
J	Schrag, A; Ben-Shlomo, Y; Quinn, NP				Schrag, A; Ben-Shlomo, Y; Quinn, NP			Cross sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in London	BRITISH MEDICAL JOURNAL			English	Article							DISTRICT		Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Inst Neurol, Dept Clin Neurol, London WC1N 3BG, England	University of Bristol; University of London; University College London	Ben-Shlomo, Y (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.		Ben-Shlomo, Yoav/ABD-2004-2021; Schrag, Anette E/B-4181-2011; Schrag, Anette/AAA-9344-2020	Ben-Shlomo, Yoav/0000-0001-6648-3007; Schrag, Anette E/0000-0002-9872-6680; Schrag, Anette/0000-0002-9872-6680				MUTCH WJ, 1986, BRIT MED J, V292, P534, DOI 10.1136/bmj.292.6519.534; Schrag A, 1999, LANCET, V354, P1771, DOI 10.1016/S0140-6736(99)04137-9; Sutcliffe RLG, 1995, ACTA NEUROL SCAND, V92, P443; SUTCLIFFE RLG, 1985, ACTA NEUROL SCAND, V72, P363; [No title captured]	5	185	188	0	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 1	2000	321	7252					21	+		10.1136/bmj.321.7252.21	http://dx.doi.org/10.1136/bmj.321.7252.21			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331QQ	10875828	Green Published, Bronze			2022-12-24	WOS:000088030100021
J	Ylitalo, N; Sorensen, P; Josefsson, AM; Magnusson, PKE; Andersen, PK; Ponten, J; Adami, HO; Gyllensten, UB; Melbye, M				Ylitalo, N; Sorensen, P; Josefsson, AM; Magnusson, PKE; Andersen, PK; Ponten, J; Adami, HO; Gyllensten, UB; Melbye, M			Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study	LANCET			English	Article							INTRAEPITHELIAL NEOPLASIA; TYPE-16 DNA; IN-SITU; CANCER; GRADE; POLYMERASE; INFECTION; SMEARS; PCR; PREDICTOR	Background Persistent infection with certain types of human papillomavirus (HPV) is believed to be a prerequisite for the development of cervical neoplasia. Persistence may depend on certain characteristics, such as viral load, which has so far been given little attention. We investigated the association between HPV 16 viral load and cervical carcinoma in situ. Methods We did a nested case-control study of women participating in cytological screening in Sweden. We used a sensitive quantitative PCR assay to estimate HPV 16 load in multiple smears for each woman, taken during a period of up to 26 years before diagnosis. We calculated C-t values, which decrease as the number of viral DNA copies increases. Findings 2081 smears from 478 cases and 1754 smears from 608 controls were tested. Among cases, we found a consistently increased load of HPV 16 already 13 years or more before diagnosis, and when many smears were still cytologically normal. Women with high HPV 16 viral loads were at least 30 times the relative risk of HPV-16-negative women more than a decade before diagnosis. The increase in relative risk was constant over time. About 25% of women (95% CI 0.12-0.32) infected with a high viral load before age 25 years developed cervical carcinoma in situ within 15 years. Interpretation Cervical carcinoma in situ associated with HPV 16 occurs mainly in HPV-16-positive women who have consistently high viral loads long term. Women at high risk could be identified by use of a quantitative HPV test in addition to cytological screening.	Karolinska Inst, Dept Med Epidemiol, SE-17177 Stockholm, Sweden; Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; Uppsala Univ, Dept Genet & Pathol, Uppsala, Sweden; Univ Copenhagen, Dept Biostat, Copenhagen, Denmark; Harvard Univ, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Harvard Ctr Canc Prevent, Boston, MA 02115 USA	Karolinska Institutet; Aarhus University; Statens Serum Institut; Uppsala University; University of Copenhagen; Harvard University; Harvard University	Ylitalo, N (corresponding author), Karolinska Inst, Dept Med Epidemiol, Box 281, SE-17177 Stockholm, Sweden.	nathalie.ylitalo@mep.ki.se	Magnusson, Patrik KE/C-4458-2017	Magnusson, Patrik KE/0000-0002-7315-7899; Sorensen, Per Soelberg/0000-0002-2818-3780; melbye, mads/0000-0001-8264-6785	NINR NIH HHS [NR 1 RO1 CA1197-01A3] Funding Source: Medline	NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; Brisson J, 1996, J INFECT DIS, V173, P794, DOI 10.1093/infdis/173.4.794; CHUA KL, 1995, ANAL QUANT CYTOL, V17, P221; Cuzick J, 1997, NEW DEVELOPMENTS IN CERVICAL CANCER SCREENING AND PREVENTION, P364; CUZICK J, 1992, LANCET, V339, P959, DOI 10.1016/0140-6736(92)91532-D; CUZICK J, 1994, BRIT J CANCER, V69, P167, DOI 10.1038/bjc.1994.28; Cuzick J, 1997, NEW DEVELOPMENTS IN CERVICAL CANCER SCREENING AND PREVENTION, P373; GUSTAFSSON L, 1995, BRIT J CANCER, V72, P498, DOI 10.1038/bjc.1995.362; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Ho GYF, 1998, INT J CANCER, V78, P594, DOI 10.1002/(SICI)1097-0215(19981123)78:5&lt;594::AID-IJC11&gt;3.0.CO;2-B; Ho GYF, 1998, INT J CANCER, V78, P281, DOI 10.1002/(SICI)1097-0215(19981029)78:3&lt;281::AID-IJC3&gt;3.0.CO;2-R; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Josefsson A, 1999, J CLIN MICROBIOL, V37, P490, DOI 10.1128/JCM.37.3.490-496.1999; Josefsson AM, 2000, LANCET, V355, P2189, DOI 10.1016/S0140-6736(00)02401-6; Langholz B, 1997, BIOMETRICS, V53, P767, DOI 10.2307/2533977; LEE LG, 1993, NUCLEIC ACIDS RES, V21, P3761, DOI 10.1093/nar/21.16.3761; Maiman M, 1998, J Natl Cancer Inst Monogr, P43; Manos MM, 1999, JAMA-J AM MED ASSOC, V281, P1605, DOI 10.1001/jama.281.17.1605; MUNOZ N, 1996, PAPILLOMAVIRUS REV C, P227; PALEFSKY J, 1991, HEMATOL ONCOL CLIN N, V5, P357, DOI 10.1016/S0889-8588(18)30447-7; PONTEN J, 1995, INT J CANCER, V60, P1, DOI 10.1002/ijc.2910600102; Quinn M, 1999, BRIT MED J, V318, P904, DOI 10.1136/bmj.318.7188.904; SASIENI P, 1995, LANCET, V346, P1566, DOI 10.1016/S0140-6736(95)92099-4; Sun XW, 1997, NEW ENGL J MED, V337, P1343, DOI 10.1056/NEJM199711063371903; Swan DC, 1999, J CLIN MICROBIOL, V37, P1030, DOI 10.1128/JCM.37.4.1030-1034.1999; TERRY G, 1993, ARCH VIROL, V128, P123, DOI 10.1007/BF01309793; YLITALO N, 1995, J CLIN MICROBIOL, V33, P1822, DOI 10.1128/JCM.33.7.1822-1828.1995; Ylitalo N, 1999, INT J CANCER, V81, P357, DOI 10.1002/(SICI)1097-0215(19990505)81:3<357::AID-IJC8>3.3.CO;2-T	28	252	266	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2000	355	9222					2194	2198		10.1016/S0140-6736(00)02402-8	http://dx.doi.org/10.1016/S0140-6736(00)02402-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327DX	10881892				2022-12-24	WOS:000087779000010
J	James, M; Turner, DA; Broadbent, DM; Vora, J; Harding, SP				James, M; Turner, DA; Broadbent, DM; Vora, J; Harding, SP			Cost effectiveness analysis of screening for sight threatening diabetic eye disease	BRITISH MEDICAL JOURNAL			English	Article							MM COLOR TRANSPARENCIES; RETINAL PHOTOGRAPHY; PRIMARY-CARE; RETINOPATHY; OPHTHALMOSCOPY; DIAGNOSIS	Objective To measure the cost effectiveness of systematic photographic screening for sight threatening diabetic eye disease compared with existing practice. Design Cost effectiveness analysis. Setting Liverpool. Subjects A target population of 5000 diabetic patients invited for screening. Main outcome measures Cost effectiveness (cost per true positive) of systematic and opportunistic programmes; incremental cost effectiveness of replacing opportunistic with systematic screening. Results Baseline prevalence of sight threatening eye disease was 14.1%. The cost effectiveness of the systematic programme was pound 209 (sensitivity 89%, specificity 86%, compliance 80%, annual cost pound 104 996) and of the opportunistic programme was pound 289 (combined sensitivity 63%, specificity 92%, compliance 78%, annual cost pound 99 981). The incremental cost effectiveness of completely replacing the opportunistic programme was pound 32. Absolute values of cost effectiveness were highly sensitive to varying prevalence, sensitivity and specificity, compliance, and programme size. Conclusion Replacing existing programmes with systematic screening for diabetic eye disease is justified.	Univ Keele, Ctr Hlth Planning & Management, Keele ST5 5BG, Staffs, England; Royal Liverpool Univ Hosp, St Pauls Eye Unit, Liverpool L7 8XP, Merseyside, England; Royal Liverpool Univ Hosp, Dept Endocrinol & Diabet, Liverpool, Merseyside, England	Keele University; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	James, M (corresponding author), Univ Keele, Ctr Hlth Planning & Management, Keele ST5 5BG, Staffs, England.		Turner, David A/E-1847-2013	Turner, David A/0000-0002-1689-4147; Harding, Simon/0000-0003-4676-1158				AWH CC, 1993, INVEST OPHTH VIS SCI, V34, P713; BRIGGS MC, 1995, DIABETIC MED S2, V12, pS44; BUXTON MJ, 1991, DIABETIC MED, V8, P371, DOI 10.1111/j.1464-5491.1991.tb01612.x; DASBACH EJ, 1991, MED CARE, V29, P20, DOI 10.1097/00005650-199101000-00003; Davies R, 1996, BRIT J OPHTHALMOL, V80, P945, DOI 10.1136/bjo.80.11.945; Fendrick A M, 1992, Int J Technol Assess Health Care, V8, P694; FINLAY R, 1991, HLTH TRENDS, V23, P104; FORREST RD, 1987, DIABETES RES CLIN EX, V5, P39; Foulds W S, 1983, Health Bull (Edinb), V41, P318; Gardner GG, 1996, BRIT J OPHTHALMOL, V80, P940, DOI 10.1136/bjo.80.11.940; GEHRS KM, 1993, INVEST OPHTH VIS SCI, V34, P1182; George LD, 1998, DIABETIC MED, V15, P250, DOI 10.1002/(SICI)1096-9136(199803)15:3<250::AID-DIA565>3.0.CO;2-G; HARDING SP, 1995, BMJ-BRIT MED J, V311, P1131, DOI 10.1136/bmj.311.7013.1131; JACOB J, 1995, DIABETIC MED, V12, P419, DOI 10.1111/j.1464-5491.1995.tb00506.x; JAVITT JC, 1989, OPHTHALMOLOGY, V96, P255; KINYOUN JL, 1992, INVEST OPHTH VIS SCI, V33, P1888; LAIRSON DR, 1992, DIABETES CARE, V15, P1369, DOI 10.2337/diacare.15.10.1369; Leese GP, 1997, J ROY COLL PHYS LOND, V31, P65; NETTEN A, 1996, UNIT COSTS COMMUNITY; OHare JP, 1996, BRIT MED J, V312, P679; Owens DR, 1998, DIABETIC MED, V15, P170, DOI 10.1002/(SICI)1096-9136(199802)15:2<170::AID-DIA518>3.0.CO;2-H; ROHAN TE, 1989, BMJ-BRIT MED J, V299, P1198, DOI 10.1136/bmj.299.6709.1198; RYDER B, 1995, BRIT MED J, V311, P207, DOI 10.1136/bmj.311.6999.207; Ryder REJ, 1998, DIABETIC MED, V15, P254; SCOTT JA, 1996, NVEST OPHTHALMOL VI, V37, pS105; Sculpher M J, 1992, Health Econ, V1, P39, DOI 10.1002/hec.4730010107; SCULPHER MJ, 1991, DIABETIC MED, V8, P644, DOI 10.1111/j.1464-5491.1991.tb01671.x; SUSSMAN EJ, 1982, JAMA-J AM MED ASSOC, V247, P3231, DOI 10.1001/jama.247.23.3231	28	125	127	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 17	2000	320	7250					1627	1631		10.1136/bmj.320.7250.1627	http://dx.doi.org/10.1136/bmj.320.7250.1627			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KG	10856062	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000087734200020
J	Sobol, RW; Prasad, R; Evenski, A; Baker, A; Yang, XP; Horton, JK; Wilson, SH				Sobol, RW; Prasad, R; Evenski, A; Baker, A; Yang, XP; Horton, JK; Wilson, SH			The lyase activity of the DNA repair protein beta-polymerase protects from DNA-damage-induced cytotoxicity	NATURE			English	Article							BASE-EXCISION-REPAIR; 5'-TERMINAL DEOXYRIBOSE-PHOSPHATE; DEOXYRIBOPHOSPHODIESTERASE DRPASE ACTIVITY; ESCHERICHIA-COLI; SITE; CELLS; IDENTIFICATION; RESIDUES; CONTAINS; RELEASE	Small DNA lesions such as oxidized or alkylated bases are repaired by the base excision repair (BER) pathway(1). BER includes removal of the damaged base by a lesion-specific DNA glycosylase, strand scission by apurinic/apyrimidinic endonuclease, DNA resynthesis and ligation(2). BER may be further subdivided into DNA beta-polymerase (beta-pol)-dependent single-nucleotide repair and beta-pol-dependent or -independent long patch repair subpathways(3-6). Two important enzymatic steps in mammalian single-nucleotide BER are contributed by beta-pol: DNA resynthesis of the repair patch and lyase removal of 5'-deoxyribose phosphate (dRP)(2). Fibroblasts from beta-pol null mice are hypersensitive to monofunctional DNA-methylating agents, resulting in increases in chromosomal damage, apoptosis and necrotic cell death(3,7). Here we show that only the dRP lyase activity of beta-pol is required to reverse methylating agent hypersensitivity in beta-pol null cells. These results indicate that removal of the dRP group is a pivotal step in BER in vivo. Persistence of the dRP moiety in DNA results in the hypersensitivity phenotype of beta-pol null cells and may signal downstream events such as apoptosis and necrotic cell death.	NIEHS, Struct Biol Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wilson, SH (corresponding author), NIEHS, Struct Biol Lab, POB 12233, Res Triangle Pk, NC 27709 USA.	wilson5@niehs.nih.gov	Sobol, Robert W./E-4125-2013; Wilson, Samuel H/E-6644-2019	Sobol, Robert W./0000-0001-7385-3563; Wilson, Samuel H/0000-0002-1702-5293	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050159, Z01ES050159] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ahn J, 1997, BIOCHEMISTRY-US, V36, P1100, DOI 10.1021/bi961653o; Beard WA, 1996, J BIOL CHEM, V271, P12141, DOI 10.1074/jbc.271.21.12141; Beard WA, 1998, CHEM BIOL, V5, pR7, DOI 10.1016/S1074-5521(98)90081-3; Biade S, 1998, J BIOL CHEM, V273, P898, DOI 10.1074/jbc.273.2.898; DIANOV G, 1994, NUCLEIC ACIDS RES, V22, P993, DOI 10.1093/nar/22.6.993; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; DYCAICO MJ, 1994, MUTAT RES, V307, P461, DOI 10.1016/0027-5107(94)90257-7; Fortini P, 1998, BIOCHEMISTRY-US, V37, P3575, DOI 10.1021/bi972999h; GRAVES RJ, 1992, J BIOL CHEM, V267, P14429; Horton JK, 2000, J BIOL CHEM, V275, P2211, DOI 10.1074/jbc.275.3.2211; Kesti T, 1999, MOL CELL, V3, P679, DOI 10.1016/S1097-2765(00)80361-5; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244; Matsumoto Y, 1998, BIOCHEMISTRY-US, V37, P6456, DOI 10.1021/bi9727545; Menge KL, 1995, BIOCHEMISTRY-US, V34, P15934, DOI 10.1021/bi00049a008; Ochs K, 1999, CANCER RES, V59, P1544; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Prasad R, 1998, J BIOL CHEM, V273, P11121, DOI 10.1074/jbc.273.18.11121; Prasad R, 1998, J BIOL CHEM, V273, P15263, DOI 10.1074/jbc.273.24.15263; PRICE A, 1991, BIOCHEMISTRY-US, V30, P8631, DOI 10.1021/bi00099a020; Sandigursky M, 1997, J BIOL CHEM, V272, P17480, DOI 10.1074/jbc.272.28.17480; SANDIGURSKY M, 1994, NUCLEIC ACIDS RES, V22, P247, DOI 10.1093/nar/22.2.247; Sandigursky M, 1997, NUCLEIC ACIDS RES, V25, P4557, DOI 10.1093/nar/25.22.4557; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0	27	281	290	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2000	405	6788					807	810		10.1038/35015598	http://dx.doi.org/10.1038/35015598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866204				2022-12-24	WOS:000087620600055
J	Emery, VC; Sabin, CA; Cope, AV; Gor, D; Hassan-Walker, AF; Griffiths, PD				Emery, VC; Sabin, CA; Cope, AV; Gor, D; Hassan-Walker, AF; Griffiths, PD			Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation	LANCET			English	Article							BONE-MARROW TRANSPLANTATION; POLYMERASE CHAIN-REACTION; LIVER-TRANSPLANTATION; CMV DISEASE; VIRUS INFECTIONS; RISK-FACTORS; RECIPIENTS; SEROSTATUS; QUANTITY; THERAPY	Background Cytomegalovirus (CMV) continues to be a major problem post-transplantation; early markers for predicting patients at risk of CMV disease are needed. Peak CMV load in the blood correlates with CMV disease but frequently occurs too late to provide prognostic information. Methods 359 transplant recipients (162 liver, 87 renal, and 110 bone marrow) were prospectively monitored for CMV DNA in the blood with qualitative and quantitative PCR. 3873 samples were analysed. The CMV load in the first PCR-positive sample and the rate of increase in CMV load in blood during the initial phase of replication were assessed as risk factors for CMV disease using logistic regression. Findings 127 of the 359 patients had CMV DNA in the blood and 49 developed CMV disease. initial viral load correlated significantly with peak CMV load (R-2=0.47, p=<0.001) and with CMV disease (odds ratio 1.82 [95% CI 1.11-2.98; p=0.02; 1.34 [1.07-1.68] p=0.01, and 1.52 [1.13-2.05], p=0.006, per 0.25 log(10) increase in viral load for liver, renal, and bone-marrow patients, respectively). The rate of increase in CMV load between the last PCR-negative and first PCR-positive sample was significantly faster in patients with CMV disease (0.33 log(10) versus 0.19 log(10) genomes/mL daily, p<0.001). In multivariate-regression analyses, both initial CMV load and rate of viral load increase were independent risk factors for CMV disease (1.28 [1.06-1.52], p=0.01, per 0.25 log(10) increase in CMV load and 1.52 [1.06-2.17], p=0.02, per 0.1 log(10) increase in CMV load/mL daily, respectively). Interpretation CMV load in the initial phase of active infection and the rate of increase in viral load both correlate with CMV disease in transplant recipients; in combination, they have the potential to identify patients at imminent risk of CMV disease.	UCL Royal Free & Univ Coll, Sch Med, Dept Virol, London NW3 2PF, England; UCL Royal Free & Univ Coll, Sch Med, Dept Primary Care & Populat Sci, London NW3 2PF, England	University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School	Emery, VC (corresponding author), UCL Royal Free & Univ Coll, Sch Med, Dept Virol, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.	v.emery@rfc.ucl.ac.uk	Sabin, Caroline/C-2464-2008; Emery, Vincent/G-8928-2013	Sabin, Caroline/0000-0001-5173-2760; Emery, Vincent/0000-0001-5893-9756				Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; BETTS RF, 1977, AM J DIS CHILD, V131, P759, DOI 10.1001/archpedi.1977.02120200041010; BOPPANA SB, 1995, J INFECT DIS, V171, P182, DOI 10.1093/infdis/171.1.182; Chang FY, 1998, CLIN INFECT DIS, V26, P59, DOI 10.1086/516265; CHOU SW, 1989, J INFECT DIS, V160, P11, DOI 10.1093/infdis/160.1.11; Cope AV, 1997, J INFECT DIS, V176, P1484, DOI 10.1086/514145; Cope AV, 1997, J MED VIROL, V52, P200, DOI 10.1002/(SICI)1096-9071(199706)52:2<200::AID-JMV14>3.0.CO;2-O; EINSELE H, 1995, BLOOD, V86, P2815; Emery VC, 1999, J EXP MED, V190, P177, DOI 10.1084/jem.190.2.177; Falagas ME, 1997, ANN INTERN MED, V126, P275, DOI 10.7326/0003-4819-126-4-199702150-00003; FOX JC, 1992, J GEN VIROL, V73, P2405, DOI 10.1099/0022-1317-73-9-2405; GOODRICH JM, 1991, NEW ENGL J MED, V325, P1601, DOI 10.1056/NEJM199112053252303; Gor D, 1998, BONE MARROW TRANSPL, V21, P597, DOI 10.1038/sj.bmt.1701139; GROB JP, 1987, LANCET, V1, P774; GRUNDY JE, 1988, LANCET, V2, P132; Hassan-Walker AF, 1999, J MED VIROL, V58, P182, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;182::AID-JMV14&gt;3.0.CO;2-Q; LJUNGMAN P, 1995, SCAND J INFECT DIS S, V99, P87; Manez R, 1996, J INFECT DIS, V173, P1072, DOI 10.1093/infdis/173.5.1072; PATEL R, 1995, J INFECT DIS, V171, P1010, DOI 10.1093/infdis/171.4.1010; PAYA CV, 1993, J HEPATOL, V18, P185, DOI 10.1016/S0168-8278(05)80245-4; PRENTICE HG, 1994, LANCET, V343, P749, DOI 10.1016/S0140-6736(94)91835-X; Riddell SR, 1997, REV MED VIROL, V7, P181, DOI 10.1002/(SICI)1099-1654(199709)7:3<181::AID-RMV200>3.0.CO;2-W; RUBIN RH, 1989, JAMA-J AM MED ASSOC, V261, P3607; TorokStorb B, 1997, BLOOD, V90, P2097, DOI 10.1182/blood.V90.5.2097; Wang FZ, 1996, BLOOD, V88, P3615, DOI 10.1182/blood.V88.9.3615.bloodjournal8893615; WINSTON DJ, 1985, ANN INTERN MED, V102, P16, DOI 10.7326/0003-4819-102-1-16	26	415	431	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2000	355	9220					2032	2036		10.1016/S0140-6736(00)02350-3	http://dx.doi.org/10.1016/S0140-6736(00)02350-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	322QC	10885354				2022-12-24	WOS:000087519400011
J	Korber, B; Muldoon, M; Theiler, J; Gao, F; Gupta, R; Lapedes, A; Hahn, BH; Wolinsky, S; Bhattacharya, T				Korber, B; Muldoon, M; Theiler, J; Gao, F; Gupta, R; Lapedes, A; Hahn, BH; Wolinsky, S; Bhattacharya, T			Timing the ancestor of the HIV-1 pandemic strains	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DEFICIENCY SYNDROME AIDS; MAXIMUM-LIKELIHOOD; DNA-SEQUENCES; TRANSMISSION HISTORY; INTERSPECIES TRANSMISSION; ANTIRETROVIRAL THERAPY; PHYLOGENETIC METHODS; POPULATION-DYNAMICS; GENETIC DIVERSITY	HIV-1 sequences were analyzed to estimate the timing of the ancestral sequence of the main group of HIV-1, the strains responsible for the AIDS pandemic. Using parallel supercomputers and assuming a constant rate of evolution, we applied maximum-likelihood phylogenetic methods to unprecedented amounts of data for this calculation. We validated our approach by correctly estimating the timing of two historically documented points. Using a comprehensive full-length envelope sequence alignment, we estimated the date of the Last common ancestor of the main group of HIV-1 to be 1931 (1915-41). Analysis of a gag gene alignment, subregions of envelope including additional sequences, and a method that relaxed the assumption of a strict molecular clock also supported these results.	Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Santa Fe Inst, Santa Fe, NM 87501 USA; Univ Manchester, Inst Sci & Technol, Dept Math, Manchester M60 1QD, Lancs, England; Univ Alabama Birmingham, Dept Med & Microbiol, Birmingham, AL 35294 USA; Northwestern Univ, Dept Med, Div Infect Dis, Chicago, IL 60611 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute; University of Manchester; University of Alabama System; University of Alabama Birmingham; Northwestern University	Korber, B (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.		Bhattacharya, Tanmoy/J-8956-2013; Wolinsky, Steven/B-2893-2012; Muldoon, Mark R/C-7505-2009; Muldoon, Mark/T-9192-2019	Bhattacharya, Tanmoy/0000-0002-1060-652X; Muldoon, Mark/0000-0002-5004-7195; Korber, Bette/0000-0002-2026-5757; Wolinsky, Steven/0000-0002-9625-6697; Hahn, Beatrice/0000-0002-9400-9887	NIAID NIH HHS [N01 AI 85338, R01 AI 44596] Funding Source: Medline; NICHD NIH HHS [R01-HD37356] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI085338, R01AI044596] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bagnarelli P, 1999, J VIROL, V73, P3764, DOI 10.1128/JVI.73.5.3764-3777.1999; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Bollyky PL, 1999, J MOL EVOL, V49, P130, DOI 10.1007/PL00006526; Bunnell RE, 1999, AIDS, V13, P509, DOI 10.1097/00002030-199903110-00010; Carr JK, 1996, J VIROL, V70, P5935, DOI 10.1128/JVI.70.9.5935-5943.1996; Centers for Disease Control (CDC), 1981, MMWR-MORBID MORTAL W, V30, P250; CHARNEAU P, 1994, VIROLOGY, V205, P247, DOI 10.1006/viro.1994.1640; Chen ZW, 1997, J VIROL, V71, P3953, DOI 10.1128/JVI.71.5.3953-3960.1997; Chen ZW, 1996, J VIROL, V70, P3617, DOI 10.1128/JVI.70.6.3617-3627.1996; CHEVRET S, 1992, J EPIDEMIOL COMMUN H, V46, P582, DOI 10.1136/jech.46.6.582; Chitnis A, 2000, AIDS RES HUM RETROV, V16, P5, DOI 10.1089/088922200309548; Cohen J, 1997, SCIENCE, V277, P312, DOI 10.1126/science.277.5324.312; Corbet S, 2000, J VIROL, V74, P529, DOI 10.1128/JVI.74.1.529-534.2000; Courgnaud V, 1998, VIROLOGY, V247, P41, DOI 10.1006/viro.1998.9217; DELEYS R, 1990, J VIROL, V64, P1207, DOI 10.1128/JVI.64.3.1207-1216.1990; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Felsenstein J, 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; FURTADO MR, 1995, J VIROL, V69, P2092, DOI 10.1128/JVI.69.4.2092-2100.1995; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; Ganeshan S, 1997, J VIROL, V71, P663, DOI 10.1128/JVI.71.1.663-677.1997; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; GAO F, 1994, J VIROL, V68, P7433, DOI 10.1128/JVI.68.11.7433-7447.1994; GAO F, 1992, NATURE, V358, P495, DOI 10.1038/358495a0; Gao F, 1996, J VIROL, V70, P7013, DOI 10.1128/JVI.70.10.7013-7029.1996; GAZZOLO L, 1984, NEW ENGL J MED, V311, P1252, DOI 10.1056/NEJM198411083111912; GOJOBORI T, 1990, P NATL ACAD SCI USA, V87, P4108, DOI 10.1073/pnas.87.11.4108; GOJOBORI T, 1990, P NATL ACAD SCI USA, V340, P1605; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Goudsmit J, 1999, NATURE, V400, P325, DOI 10.1038/22454; Grassly NC, 1999, GENETICS, V151, P427; GRMEK MD, 1990, HIST AIDS EMERGENCE, pCH10; Gunthard HF, 1999, J VIROL, V73, P9404; Gurtler L, 1996, LANCET, V348, P176, DOI 10.1016/S0140-6736(96)01036-7; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Heneine W, 1998, NAT MED, V4, P403, DOI 10.1038/nm0498-403; Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720; Heyndrickx L, 2000, J VIROL, V74, P363, DOI 10.1128/JVI.74.1.363-370.2000; Hillis David M., 1996, P515; HILLIS DM, 1994, SCIENCE, V264, P671, DOI 10.1126/science.8171318; HIRSCH VM, 1989, NATURE, V339, P389, DOI 10.1038/339389a0; HOOPER E, 1999, RIVER, P77; HUELSENBECK JP, 1995, MOL BIOL EVOL, V12, P843; Huelsenbeck JP, 1997, SCIENCE, V276, P227, DOI 10.1126/science.276.5310.227; Jonassen TO, 1997, VIROLOGY, V231, P43, DOI 10.1006/viro.1997.8510; KASPER P, 1995, AIDS RES HUM RETROV, V11, P1197, DOI 10.1089/aid.1995.11.1197; KELLY JK, 1994, GENET RES, V64, P1, DOI 10.1017/S0016672300032481; Korber B, 1998, SCIENCE, V280, P1868, DOI 10.1126/science.280.5371.1868; KORBER B, UNPUB; Korber B.T., 1998, HUMAN RETROVIRUSES A; Korber BT, 1999, NATURE, V400, P326; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; KUIKEN C, IN PRESS AM J EPIDEM; Kuiken CL, 1996, AIDS, V10, P31, DOI 10.1097/00002030-199601000-00005; Leitner T, 1999, P NATL ACAD SCI USA, V96, P10752, DOI 10.1073/pnas.96.19.10752; Leitner T, 1996, P NATL ACAD SCI USA, V93, P10864, DOI 10.1073/pnas.93.20.10864; Leitner T, 1997, J VIROL, V71, P4761, DOI 10.1128/JVI.71.6.4761-4770.1997; LI WH, 1988, MOL BIOL EVOL, V5, P313; Liitsola K, 1998, AIDS, V12, P1907, DOI 10.1097/00002030-199814000-00023; Markham RB, 1998, P NATL ACAD SCI USA, V95, P12568, DOI 10.1073/pnas.95.21.12568; MASON C, 1996, J ACQ IMMUN DEF SYND, V19, P165; McCutchan FE, 1996, J VIROL, V70, P3331, DOI 10.1128/JVI.70.6.3331-3338.1996; Meyer A, 1991, Med Trop (Mars), V51, P53; OLSEN GJ, 1994, COMPUT APPL BIOSCI, V10, P41; PAPE JW, 1983, NEW ENGL J MED, V309, P945, DOI 10.1056/NEJM198310203091603; PEETERS M, 1989, AIDS, V3, P625, DOI 10.1097/00002030-198910000-00001; PEETERS M, 1992, AIDS, V6, P447, DOI 10.1097/00002030-199205000-00002; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; ROBERTSON DL, 1995, J MOL EVOL, V40, P249, DOI 10.1007/BF00163230; ROBERTSON DL, IN PRESS HUMAN RETRO; Salemi M, 1999, P NATL ACAD SCI USA, V96, P13253, DOI 10.1073/pnas.96.23.13253; SELIK RM, 1984, AM J MED, V76, P493, DOI 10.1016/0002-9343(84)90669-7; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; SHARP PM, 1988, NATURE, V336, P315, DOI 10.1038/336315a0; Simmonds P, 1999, J VIROL, V73, P5787, DOI 10.1128/JVI.73.7.5787-5794.1999; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; Slattery JP, 1999, GENOME RES, V9, P525; Smith D G, 1990, Lancet, V335, P781, DOI 10.1016/0140-6736(90)90883-7; SMITH TF, 1988, NATURE, V333, P573, DOI 10.1038/333573a0; SOUQUIERE S, 2000, 7 C RETR OPP INF SAN; Subbarao S, 1998, AIDS RES HUM RETROV, V14, P319, DOI 10.1089/aid.1998.14.319; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Swofford David L., 1996, P407; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; *UN, 1999, REP JOINT UN PROGR H; Voevodin AF, 1997, VIROLOGY, V238, P212, DOI 10.1006/viro.1997.8826; WANGROONGSARB Y, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P517; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; YANG ZB, 1994, J MOL EVOL, V39, P105; YANG ZH, 1995, GENETICS, V139, P993; YANG ZH, 1994, MOL BIOL EVOL, V11, P316; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 1996, J MOL EVOL, V42, P587, DOI 10.1007/BF02352289; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101; Zhu TF, 1998, NATURE, V391, P594, DOI 10.1038/35400	99	639	671	3	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2000	288	5472					1789	1796		10.1126/science.288.5472.1789	http://dx.doi.org/10.1126/science.288.5472.1789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	322HH	10846155	Green Submitted			2022-12-24	WOS:000087503800041
J	Wassarman, KM; Storz, G				Wassarman, KM; Storz, G			6S RNA regulates E-coli RNA polymerase activity	CELL			English	Article							ANTI-SIGMA FACTORS; ESCHERICHIA-COLI; OXIDATIVE STRESS; STATIONARY-PHASE; GENE; GROWTH; PROMOTER; PROTEIN; 6S-RNA	The E. coli 6S RNA was discovered more than three decades ago, yet its function has remained elusive. Here, we demonstrate that 6S RNA associates with RNA polymerase in a highly specific and efficient manner. UV crosslinking experiments revealed that 6S RNA directly contacts the sigma(70) and beta/beta' subunits of RNA polymerase. 6S RNA accumulates as cells reach the stationary phase of growth and mediates growth phase-specific changes in RNA polymerase. Stable association between sigma(70) and core RNA polymerase in extracts is only observed in the presence of 6S RNA. We show 6S RNA represses expression from a sigma(70)-dependent promoter during stationary phase. Our results suggest that the interaction of 6S RNA with RNA polymerase modulates sigma(70)-holoenzyme activity.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Wassarman, KM (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.			Storz, Gisela/0000-0001-6698-1241	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001608] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001608] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTUVIA S, 1994, MOL MICROBIOL, V13, P265, DOI 10.1111/j.1365-2958.1994.tb00421.x; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Brosius J, 1996, SCIENCE, V271, P1302; BROWNLEE GG, 1971, NATURE-NEW BIOL, V229, P147, DOI 10.1038/newbio229147a0; BURGESS RR, 1971, ANNU REV BIOCHEM, V40, P711, DOI 10.1146/annurev.bi.40.070171.003431; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; GROSS CA, 1992, TRANSCRIPTIONAL REGU, P129; Helmann JD, 1999, CURR OPIN MICROBIOL, V2, P135, DOI 10.1016/S1369-5274(99)80024-1; HELMANN JD, 1994, TRANSCRIPTION MECH R, P1; Hengge-Aronis R, 1999, CURR OPIN MICROBIOL, V2, P148, DOI 10.1016/S1369-5274(99)80026-5; HINDLEY J, 1967, J MOL BIOL, V30, P125, DOI 10.1016/0022-2836(67)90248-3; HSU LM, 1985, J BACTERIOL, V161, P1162, DOI 10.1128/JB.161.3.1162-1170.1985; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; Ishihama A, 1999, GENES CELLS, V4, P135, DOI 10.1046/j.1365-2443.1999.00247.x; ISHIHAMA A, 1991, CONTROL CELL GROWTH, P121; IWAKURA Y, 1974, MOL GEN GENET, V133, P1, DOI 10.1007/BF00268673; Jishage M, 1999, J BACTERIOL, V181, P3768, DOI 10.1128/JB.181.12.3768-3776.1999; JISHAGE M, 1995, J BACTERIOL, V177, P6832, DOI 10.1128/jb.177.23.6832-6835.1995; KRAKOW JS, 1970, COLD SPRING HARB SYM, V35, P73, DOI 10.1101/SQB.1970.035.01.013; Kusano S, 1996, J BIOL CHEM, V271, P1998, DOI 10.1074/jbc.271.4.1998; LEE CA, 1985, J BACTERIOL, V161, P1156, DOI 10.1128/JB.161.3.1156-1161.1985; LEE SY, 1978, J BACTERIOL, V133, P1015, DOI 10.1128/JB.133.2.1015-1023.1978; LERNER MR, 1981, SCIENCE, V211, P400, DOI 10.1126/science.6164096; NGUYEN LH, 1993, BIOCHEMISTRY-US, V32, P11112, DOI 10.1021/bi00092a021; Siegele DA, 1996, J BACTERIOL, V178, P6352, DOI 10.1128/jb.178.21.6352-6356.1996; Silhavy T.J., 1984, EXPT GENE FUSIONS; SPASSKY A, 1979, EUR J BIOCHEM, V99, P187, DOI 10.1111/j.1432-1033.1979.tb13245.x; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; Sukhodolets MV, 1998, J BIOL CHEM, V273, P7018, DOI 10.1074/jbc.273.12.7018; VOGEL DW, 1987, NUCLEIC ACIDS RES, V15, P4583, DOI 10.1093/nar/15.11.4583; WASSARMAN DA, 1991, MOL CELL BIOL, V11, P3432, DOI 10.1128/MCB.11.7.3432; WASSARMAN KM, 1992, MOL CELL BIOL, V12, P1276, DOI 10.1128/MCB.12.3.1276; Wassarman KM, 1999, TRENDS MICROBIOL, V7, P37	33	342	353	2	24	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 9	2000	101	6					613	623		10.1016/S0092-8674(00)80873-9	http://dx.doi.org/10.1016/S0092-8674(00)80873-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	322HQ	10892648	Bronze			2022-12-24	WOS:000087504500008
J	Barber, VA; Juday, GP; Finney, BP				Barber, VA; Juday, GP; Finney, BP			Reduced growth of Alaskan white spruce in the twentieth century from temperature-induced drought stress	NATURE			English	Article							TREE-RING WIDTHS; HIGH-LATITUDES; ATMOSPHERIC CO2; NORTH-AMERICA; BOREAL FOREST; CLIMATE; CARBON; DENSITY; RECORD; WOOD	The extension of growing season at high northern latitudes seems increasingly clear from satellite observations of vegetation extent and duration(1,2). This extension is also thought to explain the observed increase in amplitude of seasonal variations in atmospheric CO2 concentration. Increased plant respiration and photosynthesis both correlate well with increases in temperature this century and are therefore the most probable link between the vegetation and CO2 observations(3). From these observations(1,2), it has been suggested that increases in temperature have stimulated carbon uptake in high latitudes(1,2) and for the boreal forest system as a whole(4). Here we present multi-proxy tree-ring data (ring width, maximum late-wood density and carbon-isotope composition) from 20 productive stands of white spruce in the interior of Alaska. The tree-ring records show a strong and consistent relationship over the past 90 years and indicate that, in contrast with earlier predictions, radial growth has decreased with increasing temperature. Our data show that temperature-induced drought stress has disproportionately affected the most rapidly growing white spruce, suggesting that, under recent climate warming, drought may have been an important factor limiting carbon uptake in a large portion of the North American boreal forest. If this limitation in growth due to drought stress is sustained, the future capacity of northern latitudes to sequester carbon may be less than currently expected.	Univ Alaska, Inst Marine Sci, Fairbanks, AK 99775 USA; Univ Alaska, Dept Forest Sci, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks	Barber, VA (corresponding author), Univ Alaska, Inst Marine Sci, Fairbanks, AK 99775 USA.	barber@ims.uaf.edu						Braswell BH, 1997, SCIENCE, V278, P870, DOI 10.1126/science.278.5339.870; Briffa KR, 1999, SCIENCE, V284, P926, DOI 10.1126/science.284.5416.926; Briffa KR, 1998, NATURE, V391, P678, DOI 10.1038/35596; Chapin FS, 1996, NATURE, V383, P585, DOI 10.1038/383585b0; CHAPMAN WL, 1993, B AM METEOROL SOC, V74, P33, DOI 10.1175/1520-0477(1993)074<0033:RVOSIA>2.0.CO;2; CONKEY LE, 1986, QUATERNARY RES, V26, P232, DOI 10.1016/0033-5894(86)90107-9; Cook E.R., 2013, METHODS DENDROCHRONO; DARRIGO RD, 1992, CAN J FOREST RES, V22, P1290, DOI 10.1139/x92-171; DENNE MP, 1976, ANN BOT-LONDON, V40, P1017, DOI 10.1093/oxfordjournals.aob.a085209; Elliot-Frisk D.L., 1988, N AM TERRESTRIAL VEG, Vfirst ed., P33; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; GARFINKEL HL, 1980, NATURE, V286, P872, DOI 10.1038/286872a0; HOGG EH, 1995, WATER AIR SOIL POLL, V82, P391, DOI 10.1007/BF01182849; JACOBY GC, 1988, PALAEOGEOGR PALAEOCL, V64, P69, DOI 10.1016/0031-0182(88)90143-5; Jacoby GC, 1996, SCIENCE, V273, P771, DOI 10.1126/science.273.5276.771; JACOBY GC, 1995, GLOBAL BIOGEOCHEM CY, V9, P227, DOI 10.1029/95GB00321; JACOBY GC, 1989, CLIMATIC CHANGE, V14, P39, DOI 10.1007/BF00140174; JACOBY GC, 1999, WORLD RES REV, V11, P21; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Kicklighter DW, 1999, TELLUS B, V51, P343, DOI 10.1034/j.1600-0889.1999.00017.x; KOZLOWSKI TT, 1997, PHYSL WOODY PLANTS, P1; LARSEN CPS, 1995, CAN J FOREST RES, V25, P1746, DOI 10.1139/x95-189; LEAVITT SW, 1984, NATURE, V311, P145, DOI 10.1038/311145a0; LEAVITT SW, 1993, ANAL CHEM, V65, P87, DOI 10.1021/ac00049a017; Livingston NJ, 1996, PLANT CELL ENVIRON, V19, P768, DOI 10.1111/j.1365-3040.1996.tb00413.x; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Patric J.H., 1968, PNW71 USDA FOR SERV; Ruess RW, 1996, CAN J FOREST RES, V26, P1326, DOI 10.1139/x26-148; THETFORD RD, 1991, CAN J FOREST RES, V21, P1544, DOI 10.1139/x91-215; VANCLEVE K, 1986, FOREST ECOSYSTEMS AL, P230	30	738	789	16	301	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 8	2000	405	6787					668	673		10.1038/35015049	http://dx.doi.org/10.1038/35015049			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864320				2022-12-24	WOS:000087465800042
J	Huiskes, R; Ruimerman, R; van Lenthe, GH; Janssen, JD				Huiskes, R; Ruimerman, R; van Lenthe, GH; Janssen, JD			Effects of mechanical forces on maintenance and adaptation of form in trabecular bone	NATURE			English	Article							WOLFFS LAW; OSTEOCYTES; ESTROGEN; ARCHITECTURE; DENSITY; HISTORY; TISSUE	The architecture of trabecular bone, the porous bone found in the spine and at articulating joints, provides the requirements for optimal load transfer, by pairing suitable strength and stiffness to minimal weight according to rules of mathematical design(1-6). But, as it is unlikely that the architecture is fully pre-programmed in the genes(7), how are the bone cells informed about these rules, which so obviously dictate architecture? A relationship exists between bone architecture and mechanical usage(8)-while strenuous exercise increases bone mass(9), disuse, as in microgravity and inactivity, reduces it(10). Bone resorption cells (osteoclasts) and bone formation cells (osteoblasts) normally balance bone mass in a coupled homeostatic process of remodelling, which renews some 25% of trabecular bone volume per year. Here we present a computational model of the metabolic process in bone that confirms that cell coupling is governed by feedback from mechanical load transfer(11-13). This model can explain the emergence and maintenance of trabecular architecture as an optimal mechanical structure, as well as its adaptation to alternative external loads.	Univ Nijmegen, Dept Orthopaed, Orthopaed Res Lab, NL-6500 HB Nijmegen, Netherlands; Eindhoven Univ Technol, Fac Biomed Engn, NL-5600 MB Eindhoven, Netherlands	Radboud University Nijmegen; Eindhoven University of Technology	Huiskes, R (corresponding author), Univ Nijmegen, Dept Orthopaed, Orthopaed Res Lab, POB 9101, NL-6500 HB Nijmegen, Netherlands.		van Lenthe, Harry (GH)/C-1030-2008	van Lenthe, Harry (GH)/0000-0001-8303-4959				Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6; CARTER DR, 1987, J BIOMECH, V20, P785, DOI 10.1016/0021-9290(87)90058-3; CHAMBERS TJ, 1985, J CELL SCI, V76, P155; CHAMBERS TJ, 1998, ADV ORG BIO A-C, V5, P627; CHOI K, 1992, J BIOMECH, V25, P1371, DOI 10.1016/0021-9290(92)90051-2; Courteix D, 1998, OSTEOPOROSIS INT, V8, P152, DOI 10.1007/BF02672512; COWIN SC, 1986, J BIOMECH ENG-T ASME, V108, P83, DOI 10.1115/1.3138584; COWIN SC, 1991, J BIOMECH ENG-T ASME, V113, P191, DOI 10.1115/1.2891234; FROST HM, 1987, CALCIFIED TISSUE INT, V45, P145; Kelly K, 1998, SCIENCE, V279, P992, DOI 10.1126/science.279.5353.992; KLEINNULEND J, 1995, FASEB J, V9, P441, DOI 10.1096/fasebj.9.5.7896017; Lanyon LE, 1996, BONE, V18, pS37, DOI 10.1016/8756-3282(95)00378-9; Mosley JR, 1998, BONE, V23, P313, DOI 10.1016/S8756-3282(98)00113-6; MULLENDER MG, 1995, J ORTHOPAED RES, V13, P503, DOI 10.1002/jor.1100130405; Noble BS, 1997, BONE, V20, P273, DOI 10.1016/S8756-3282(96)00365-1; Pazzaglia UE, 1997, J BONE JOINT SURG BR, V79-B, P1025; RODAN GA, 1991, J BONE MINER RES, V6, P527; ROESLER H, 1987, J BIOMECH, V20, P1025, DOI 10.1016/0021-9290(87)90020-0; RUBIN CT, 1987, J ORTHOPAED RES, V5, P300, DOI 10.1002/jor.1100050217; SKERRY TM, 1989, J BONE MINER RES, V4, P783, DOI 10.1002/jbmr.5650040519; Smit TH, 2000, J BONE MINER RES, V15, P301, DOI 10.1359/jbmr.2000.15.2.301; Stewart I., 1998, LIFES OTHER SECRET; Thompsons DArcy Wentworth, 1919, GROWTH FORM; TURNER CH, 1995, AM J PHYSIOL-ENDOC M, V269, pE438, DOI 10.1152/ajpendo.1995.269.3.E438; Van Rietbergen B, 1999, J BIOMECH, V32, P443; VANRIETBERGEN B, 1995, J BIOMECH, V28, P69, DOI 10.1016/0021-9290(95)80008-5; Vashishth D, 2000, BONE, V26, P147, DOI 10.1016/S8756-3282(99)00253-7; Wolff J, 1892, GESETZ TRANSFORMATIO; Zerwekh JE, 1998, J BONE MINER RES, V13, P1594, DOI 10.1359/jbmr.1998.13.10.1594	30	798	833	6	148	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					704	706		10.1038/35015116	http://dx.doi.org/10.1038/35015116			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864330				2022-12-24	WOS:000087465800052
J	Samach, A; Onouchi, H; Gold, SE; Ditta, GS; Schwarz-Sommer, Z; Yanofsky, MF; Coupland, G				Samach, A; Onouchi, H; Gold, SE; Ditta, GS; Schwarz-Sommer, Z; Yanofsky, MF; Coupland, G			Distinct roles of CONSTANS target genes in reproductive development of Arabidopsis	SCIENCE			English	Article							FLOWERING-TIME GENES; TRANSCRIPTION FACTORS; APICAL MERISTEM; LONG-DAY; PROTEIN; ACTIVATION; THALIANA; ENCODES; TRANSITION; REPRESSOR	In plants, flowering is triggered by endogenous and environmental signals, CONSTANS (CO) promotes flowering of Arabidopsis in response to day length. Four early target genes of CO were identified using a steroid-inducible version of the protein. Two of these genes, SUPPRESSOR OF OVEREXPRESSION OF CO 1 (SOC1) and FLOWERING LOCUS T (FT), are required for CO to promote flowering; the others are involved in proline or ethylene biosynthesis, The SOC1 and FT genes are also regulated by a second flowering-time pathway that acts independently of CO. Thus, early target genes of CO define common components of distinct flowering-time pathways.	John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Max Planck Inst Zuchtungsforsch, D-50829 Cologne, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of California System; University of California San Diego; Max Planck Society	Coupland, G (corresponding author), John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England.		Coupland, George/AAP-8609-2020	Coupland, George/0000-0001-6988-4172				AHN JM, UNPUB; BERNIER G, 1981, PHYSL FLOWERING, P135; Corbesier L, 1996, PLANT J, V9, P947, DOI 10.1046/j.1365-313X.1996.9060947.x; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; KOOMNEEF M, 1991, MOL GEN GENET, V229, P57; Koornneef M, 1998, ANNU REV PLANT PHYS, V49, P345, DOI 10.1146/annurev.arplant.49.1.345; Koornneef M, 1998, GENETICS, V148, P885; Levy YY, 1998, PLANT CELL, V10, P1973, DOI 10.1105/tpc.10.12.1973; Liljegren SJ, 1999, PLANT CELL, V11, P1007, DOI 10.1105/tpc.11.6.1007; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Menzel G, 1996, PLANT J, V9, P399, DOI 10.1046/j.1365-313X.1996.09030399.x; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Nanjo T, 1999, PLANT J, V18, P185, DOI 10.1046/j.1365-313X.1999.00438.x; Nilsson O, 1998, GENETICS, V150, P403; ONOUCHI H, IN PRESS PLANT CELL; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; REDEI GP, 1962, GENETICS, V47, P443; RuizGarcia L, 1997, PLANT CELL, V9, P1921, DOI 10.1105/tpc.9.11.1921; Sablowski RWM, 1998, CELL, V92, P93, DOI 10.1016/S0092-8674(00)80902-2; Samach A, 2000, BIOESSAYS, V22, P38, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;38::AID-BIES8&gt;3.0.CO;2-L; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simon R, 1996, NATURE, V384, P59, DOI 10.1038/384059a0; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Strizhov N, 1997, PLANT J, V12, P557, DOI 10.1046/j.1365-313X.1997.00557.x; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0	30	1048	1164	14	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2000	288	5471					1613	1616		10.1126/science.288.5471.1613	http://dx.doi.org/10.1126/science.288.5471.1613			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	320BZ	10834834				2022-12-24	WOS:000087382300032
J	Aubert, C; Vos, MH; Mathis, P; Eker, APM; Brettel, K				Aubert, C; Vos, MH; Mathis, P; Eker, APM; Brettel, K			Intraprotein radical transfer during photoactivation of DNA photolyase	NATURE			English	Article							ELECTRON-TRANSFER; ESCHERICHIA-COLI; ANACYSTIS-NIDULANS; CATALYSIS; PROTEINS; FADH; EPR	Amino-acid radicals play key roles in many enzymatic reactions(1). Catalysis often involves transfer of a radical character within the protein, as in class I ribonucleotide reductase where radical transfer occurs over 35 Angstrom, from a tyrosyl radical to a cysteine(1-3). It is currently debated whether this kind of long-range transfer occurs by electron transfer, followed by proton release to create a neutral radical, or by H-atom transfer, that is, simultaneous transfer of electrons and protons(4-7), The latter mechanism avoids the energetic cost of charge formation in the low dielectric protein(4,5), but it is less robust to structural changes than is electron transfer(7). Available experimental data do not clearly discriminate between these proposals. We have studied the mechanism of photoactivation (light-induced reduction of the flavin adenine dinucleotide cofactor) of Escherichia coli DNA photolyase(8-10) using time-resolved absorption spectroscopy. Here we show that the excited flavin adenine dinucleotide radical abstracts an electron from a nearby tryptophan in 30 ps. After subsequent electron transfer along a chain of three tryptophans, the most remote tryptophan (as a cation radical) releases a proton to the solvent in about 300 ns, showing that electron transfer occurs before proton dissociation. A similar process may take place in photolyase-like blue-light receptors.	CEA Saclay, Sect Bioenerget, CNRS, URA 2096, F-91191 Gif Sur Yvette, France; Ecole Polytech ENSTA, Lab Opt Appl, INSERM, U451, F-91761 Palaiseau, France; Erasmus Univ, Ctr Med Genet, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands	CEA; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; Erasmus University Rotterdam	Brettel, K (corresponding author), CEA Saclay, Sect Bioenerget, CNRS, URA 2096, F-91191 Gif Sur Yvette, France.	brettel@dsvidf.cea.fr		Vos, Marten/0000-0003-0493-4831				Aubert C, 1999, J AM CHEM SOC, V121, P8659, DOI 10.1021/ja991938z; Aubert C, 1999, P NATL ACAD SCI USA, V96, P5423, DOI 10.1073/pnas.96.10.5423; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Cheung MS, 1999, BIOPHYS J, V76, P1241, DOI 10.1016/S0006-3495(99)77287-5; CLELAND WW, 1977, ISOTOPE EFFECTS ENZY; Cukier RI, 1998, ANNU REV PHYS CHEM, V49, P337, DOI 10.1146/annurev.physchem.49.1.337; EIGEN M, 1964, ANGEW CHEM INT EDIT, V3, P1, DOI 10.1002/anie.196400011; EKER APM, 1994, PHOTOCHEM PHOTOBIOL, V60, P125, DOI 10.1111/j.1751-1097.1994.tb05078.x; Gindt YM, 1999, BIOCHEMISTRY-US, V38, P3857, DOI 10.1021/bi981191+; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HEELIS PF, 1990, BIOCHEMISTRY-US, V29, P5694, DOI 10.1021/bi00476a008; HEELIS PF, 1992, INT J RADIAT BIOL, V62, P137, DOI 10.1080/09553009214551941; KIM ST, 1995, METHOD ENZYMOL, V258, P319; KIM ST, 1993, P NATL ACAD SCI USA, V90, P8023, DOI 10.1073/pnas.90.17.8023; LI YF, 1991, BIOCHEMISTRY-US, V30, P6322, DOI 10.1021/bi00239a034; MARTIN JL, 1994, METHOD ENZYMOL, V232, P416; OKAMURA T, 1989, J AM CHEM SOC, V111, P5967, DOI 10.1021/ja00197a082; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; PARK HW, 1995, SCIENCE, V268, P1866, DOI 10.1126/science.7604260; Sancar A, 1996, SCIENCE, V272, P48, DOI 10.1126/science.272.5258.48; Siegbahn PEM, 1998, J PHYS CHEM B, V102, P10622, DOI 10.1021/jp9827835; Siegbahn PEM, 1997, THEOR CHEM ACC, V97, P289, DOI 10.1007/s002140050264; SJOBERG BM, 1994, STRUCTURE, V2, P793, DOI 10.1016/S0969-2126(94)00080-8; SOLAR S, 1991, J PHYS CHEM-US, V95, P3639, DOI 10.1021/j100162a038; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Tommos C, 1999, BIOCHEMISTRY-US, V38, P9495, DOI 10.1021/bi990609g; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Yasui A, 1998, CONT CANC RES, P9	28	357	361	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2000	405	6786					586	590		10.1038/35014644	http://dx.doi.org/10.1038/35014644			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850720				2022-12-24	WOS:000087449500055
J	Spotila, JR; Reina, RD; Steyermark, AC; Plotkin, PT; Paladino, FV				Spotila, JR; Reina, RD; Steyermark, AC; Plotkin, PT; Paladino, FV			Pacific leatherback turtles face extinction	NATURE			English	Article									Drexel Univ, Sch Environm Sci Engn & Policy, Philadelphia, PA 19104 USA; Ctr Marine Conservat, Washington, DC 20036 USA; Indiana Univ Purdue Univ, Dept Biol, Ft Wayne, IN 46805 USA	Drexel University; Purdue University System; Indiana University Purdue University Fort Wayne	Spotila, JR (corresponding author), Drexel Univ, Sch Environm Sci Engn & Policy, Philadelphia, PA 19104 USA.		Reina, Richard/AAC-7017-2019	Plotkin, Pamela/0000-0003-3973-8988				Boulon Ralf H. Jr., 1996, Chelonian Conservation and Biology, V2, P141; Chan Eng-Heng, 1996, Chelonian Conservation and Biology, V2, P196; Deraniyagala PEP., 1939, TETRAPOD REPTILES CE, V1; Eckert Scott A., 1997, Marine Turtle Newsletter, V78, P2; Hughes George R., 1996, Chelonian Conservation and Biology, V2, P153; McDonald Donna L., 1996, Chelonian Conservation and Biology, V2, P148; Pauly D, 2000, AM SCI, V88, P46; Sarti M. Laura, 1996, Marine Turtle Newsletter, V74, P2; Savage J., SOUNDS; Smith M. A., 1931, FAUNA BRIT INDIA INC, VI; Spotila James R., 1996, Chelonian Conservation and Biology, V2, P209; Steyermark Anthony C., 1996, Chelonian Conservation and Biology, V2, P173; Zug George R., 1996, Chelonian Conservation and Biology, V2, P244	13	276	304	2	80	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					529	530		10.1038/35014729	http://dx.doi.org/10.1038/35014729			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850701				2022-12-24	WOS:000087449500036
J	Canto, JG; Every, NR; Magid, DJ; Rogers, WJ; Malmgren, JA; Frederick, PD; French, WJ; Tiefenbrunn, AJ; Misra, VK; Kiefe, CI; Barron, HV				Canto, JG; Every, NR; Magid, DJ; Rogers, WJ; Malmgren, JA; Frederick, PD; French, WJ; Tiefenbrunn, AJ; Misra, VK; Kiefe, CI; Barron, HV		Natl Registry Myocardial Infarctio	The volume of primary angioplasty procedures and survival after acute myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NATIONAL REGISTRY; ASSOCIATION; HOSPITALS; CARDIOLOGY; MORTALITY; OUTCOMES; PROJECT; CARE	Background: There is an inverse relation between mortality from cardiovascular causes and the number of elective cardiac procedures (coronary angioplasty, stenting, or coronary bypass surgery) performed by individual practitioners or hospitals. However, it is not known whether patients with acute myocardial infarction fare better at centers where more patients undergo primary angioplasty or thrombolytic therapy than at centers with lower volumes. Methods: We analyzed data from the National Registry of Myocardial Infarction to determine the relation between the number of patients receiving reperfusion therapy (primary angioplasty or thrombolytic therapy) and subsequent in-hospital mortality. A total of 450 hospitals were divided into quartiles according to the volume of primary angioplasty. Multiple logistic-regression models were used to determine whether the volume of primary angioplasty procedures was an independent predictor of in-hospital mortality among patients undergoing this procedure. Similar analyses were performed for patients receiving thrombolytic therapy at 516 hospitals. Results: In-hospital mortality was 28 percent lower among patients who underwent primary angioplasty at hospitals with the highest volume than among those who underwent angioplasty at hospitals with the lowest volume (adjusted relative risk, 0.72; 95 percent confidence interval, 0.60 to 0.87; P<0.001). This lower rate, which represented 2.0 fewer deaths per 100 patients treated, was independent of the total volume of patients with myocardial infarction at each hospital, year of admission, and use or nonuse of adjunctive pharmacologic therapies. There was no significant relation between the volume of thrombolytic interventions and in-hospital mortality among patients who received thrombolytic therapy (7.0 percent for patients in the highest-volume hospitals vs. 6.9 percent for those in the lowest-volume hospitals, P=0.36). Conclusions: Among hospitals in the United States that have full interventional capabilities, a higher volume of angioplasty procedures is associated with a lower mortality rate among patients undergoing primary angioplasty, but there is no association between volume and mortality for thrombolytic therapy. (N Engl J Med 2000;342:1573-80.) (C) 2000, Massachusetts Medical Society.	Univ Alabama, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA; Univ Alabama, Ctr Outcomes & Effectiveness Res & Educ, Birmingham, AL 35294 USA; Univ Washington, Cardiovasc Outcomes Res Ctr, Seattle, WA 98195 USA; Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; Colorado Permanente Med Grp, Clin Res Unit, Denver, CO USA; Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Div Emergency Med, Denver, CO USA; Harbor UCLA Med Ctr, Torrance, CA 90509 USA; Washington Univ, Sch Med, St Louis, MO USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Genentech Inc, S San Francisco, CA 94080 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Permanente Medical Groups; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Washington University (WUSTL); University of California System; University of California San Francisco; Roche Holding; Genentech	Canto, JG (corresponding author), Univ Alabama, Dept Med, Div Cardiovasc Dis, 363 BDB,1808 7th Ave S, Birmingham, AL 35294 USA.			Frederick, Paul/0000-0002-7936-5488	AHRQ HHS [HS08843] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS008843] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Bureau of the Census, 1996, STAT ABSTR US; Canto JG, 1997, J AM COLL CARDIOL, V29, P498, DOI 10.1016/S0735-1097(96)00532-3; Chen J, 1999, NEW ENGL J MED, V340, P286, DOI 10.1056/NEJM199901283400407; Every NR, 1999, J AM COLL CARDIOL, V33, P1886, DOI 10.1016/S0735-1097(99)00113-8; HANNAN EL, 1989, JAMA-J AM MED ASSOC, V262, P503, DOI 10.1001/jama.262.4.503; Hannan EL, 1997, JAMA-J AM MED ASSOC, V277, P892, DOI 10.1001/jama.277.11.892; JOLLIS JG, 1994, NEW ENGL J MED, V331, P1625, DOI 10.1056/NEJM199412153312406; Kastrati A, 1998, J AM COLL CARDIOL, V32, P970, DOI 10.1016/S0735-1097(98)00334-9; KIMMEL SE, 1995, JAMA-J AM MED ASSOC, V274, P1137, DOI 10.1001/jama.274.14.1137; Peterson ED, 1998, J AM COLL CARDIOL, V32, P993, DOI 10.1016/S0735-1097(98)00332-5; Ritchie JL, 1999, AM J CARDIOL, V83, P493, DOI 10.1016/S0002-9149(98)00901-1; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Ryan TJ, 1998, J AM COLL CARDIOL, V32, P977; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106	15	269	283	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 25	2000	342	21					1573	1580		10.1056/NEJM200005253422106	http://dx.doi.org/10.1056/NEJM200005253422106			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	316XJ	10824077				2022-12-24	WOS:000087193100006
J	Sait, SM; Liu, WC; Thompson, DJ; Godfray, HCJ; Begon, M				Sait, SM; Liu, WC; Thompson, DJ; Godfray, HCJ; Begon, M			Invasion sequence affects predator-prey dynamics in a multi-species interaction	NATURE			English	Article							INDIAN MEAL MOTH; PLODIA-INTERPUNCTELLA; POPULATION-DYNAMICS; GRANULOSIS-VIRUS; PATHOGEN INTERACTIONS; CYCLES; MODELS; STOCHASTICITY; PERSISTENCE; DISCRETE	Ecologists seek to understand the rules that govern the assembly, coexistence and persistence of communities of interacting species. There is, however, a variety of sequences in which a multi-species community can be assembled-unlike more familiar one- and two-species systems. Ecological systems can exhibit contrasting dynamics depending on initial conditions(1), but studies have been focused on simple communities initiated at different densities, not on multi-species communities constructed in different sequences. Investigations of permanence and convergence in ecological communities(2-4) have been concerned with the flux of whole species (presence or absence)(4) but have not addressed the central issues concerning the dynamics exhibited by individual species in particular interactions. Here we examine data for replicated three-species systems and demonstrate that the dynamic trajectories of both a predator and its prey within the system are determined by the sequence in which it is constructed, and that for one construction-sequence alternative dynamic patterns are possible.	Univ Liverpool, Sch Biol Sci, Populat & Evolut Biol Res Grp, Liverpool L69 3BX, Merseyside, England; Univ London Imperial Coll Sci Technol & Med, Dept Biol, Ascot SL5 7PY, Berks, England; Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England	University of Liverpool; Imperial College London; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Sait, SM (corresponding author), Univ Liverpool, Sch Biol Sci, Populat & Evolut Biol Res Grp, Nicholson Bldg,POB 147, Liverpool L69 3BX, Merseyside, England.		Thompson, David J/C-3520-2008; Liu, Wei-chung/AAP-3893-2021	Begon, Mike/0000-0003-1715-5327				BEGON M, 1995, P ROY SOC B-BIOL SCI, V260, P131, DOI 10.1098/rspb.1995.0070; Begon M, 1996, NATURE, V381, P311, DOI 10.1038/381311a0; Bjornstad ON, 1998, J ANIM ECOL, V67, P110, DOI 10.1046/j.1365-2656.1998.00168.x; BJORNSTAD ON, UNPUB NATURE; Briggs CJ, 2000, J ANIM ECOL, V69, P352, DOI 10.1046/j.1365-2656.2000.00398.x; BRIGGS CJ, 1995, AM NAT, V145, P855, DOI 10.1086/285774; Chatfield C, 1996, ANAL TIME SERIES; Cushing JM, 1998, J ANIM ECOL, V67, P298, DOI 10.1046/j.1365-2656.1998.00194.x; Dennis B, 1997, J ANIM ECOL, V66, P704, DOI 10.2307/5923; GODFRAY HCJ, 1989, J ANIM ECOL, V58, P153, DOI 10.2307/4992; GORDON DM, 1991, J ANIM ECOL, V60, P295, DOI 10.2307/5461; GURNEY WSC, 1983, J ANIM ECOL, V52, P479, DOI 10.2307/4567; GURNEY WSC, 1985, THEOR POPUL BIOL, V28, P150, DOI 10.1016/0040-5809(85)90026-7; HARVEY JA, 1994, ECOLOGY, V75, P1420, DOI 10.2307/1937465; HASTINGS A, 1994, SCIENCE, V263, P1133, DOI 10.1126/science.263.5150.1133; HOCHBERG ME, 1990, AM NAT, V135, P74, DOI 10.1086/285033; Knell RJ, 1998, J ANIM ECOL, V67, P592, DOI 10.1046/j.1365-2656.1998.00219.x; Law R, 1996, ECOLOGY, V77, P762, DOI 10.2307/2265500; LAW R, 1999, ADV ECOLOGICAL THEOR, P143; MAY RM, 1981, AM NAT, V117, P234, DOI 10.1086/283704; RAND DA, 1991, P ROY SOC B-BIOL SCI, V246, P179, DOI 10.1098/rspb.1991.0142; SAIT SM, 1994, J INVERTEBR PATHOL, V63, P107, DOI 10.1006/jipa.1994.1020; SAIT SM, 1994, J ANIM ECOL, V63, P861, DOI 10.2307/5263; Sait SM, 1997, ECOL ENTOMOL, V22, P225, DOI 10.1046/j.1365-2311.1997.t01-1-00051.x; SAIT SM, 1994, J ANIM ECOL, V63, P541, DOI 10.2307/5220; Samuels CL, 1997, TRENDS ECOL EVOL, V12, P427, DOI 10.1016/S0169-5347(97)01182-8	26	54	56	2	41	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					448	450		10.1038/35013045	http://dx.doi.org/10.1038/35013045			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839538				2022-12-24	WOS:000087212000046
J	Thomas, RDK; Shearman, RM; Stewart, CW				Thomas, RDK; Shearman, RM; Stewart, CW			Evolutionary exploitation of design options by the first animals with hard skeletons	SCIENCE			English	Article							ANOMALOCARIS; ARTHROPODS; PLATFORM; GENES	The set of viable design elements available for animals to use in building skeletons has been fully exploited. Analysis of animal skeletons in relation to the multivariate, theoretical "Skeleton Space" has shown that a Large proportion of these options are used in each phylum. Here, we show that structural elements deployed in the skeletons of Burgess Shale animals (Middle Cambrian) incorporate 146 of 182 character pairs defined in this morphospace. Within 15 million years of the appearance of crown groups of phyla with substantial hard parts, at least 80 percent of skeletal design elements recognized among Living and extinct marine metazoans were exploited.	Franklin & Marshall Coll, Dept Geosci, Lancaster, PA 17604 USA	Franklin & Marshall College	Thomas, RDK (corresponding author), Franklin & Marshall Coll, Dept Geosci, Lancaster, PA 17604 USA.							Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; BENGTSON S., 1994, EARLY LIFE EARTH, V84, P412; Bowring S.A., 1998, GSA TODAY, V8, P1; Briggs D.E.G., 1994, FOSSILS BURGESS SHAL; Budd GE, 1999, BIOESSAYS, V21, P326, DOI 10.1002/(SICI)1521-1878(199904)21:4<326::AID-BIES9>3.0.CO;2-0; Butterfield NJ, 1997, PALEOBIOLOGY, V23, P247, DOI 10.1017/S009483730001681X; CHEN J, 1997, B NAT MUS NAT SCI TA, V10; Collins D, 1996, J PALEONTOL, V70, P280, DOI 10.1017/S0022336000023362; Conway Morris S., 1998, CRUCIBLE CREATION BU; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; Gould S.J., 1989, WONDERFUL LIFE; HALANYCH KM, 1995, SCIENCE, V267, P1641, DOI 10.1126/science.7886451; Holland P. W. H., 1994, DEVELOPMENT S, P124; JACOBS DK, 1990, P NATL ACAD SCI USA, V87, P4406, DOI 10.1073/pnas.87.11.4406; KNOLL AH, 1999, SCIENCE, V284, P2129, DOI DOI 10.1126/SCIENCE.284.5423.2129; KRUSE PD, 1995, PALAIOS, V10, P291, DOI 10.2307/3515157; Niklas KJ., 1997, EVOLUTIONARY BIOL PL; ROSA R, 1999, NATURE, V399, P772; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; SIGNOR PW, 1994, PALEOBIOLOGY, V20, P297, DOI 10.1017/S0094837300012793; Smith AB, 1999, EVOL DEV, V1, P138, DOI 10.1046/j.1525-142x.1999.99027.x; STEWART WD, 1993, GEOLOGY, V21, P687, DOI 10.1130/0091-7613(1993)021<0687:MCCPCS>2.3.CO;2; Thomas R.D.K., 1991, P283; THOMAS RDK, 1993, EVOLUTION, V47, P341, DOI 10.1111/j.1558-5646.1993.tb02098.x; Valentine JW, 1999, DEVELOPMENT, V126, P851; Valentine JW, 1997, P NATL ACAD SCI USA, V94, P8001, DOI 10.1073/pnas.94.15.8001; Valentine JW, 1996, DEV BIOL, V173, P373, DOI 10.1006/dbio.1996.0033; Whittington Harry B, 1985, BURGESS SHALE; WHITTINGTON HB, 1985, PHILOS T R SOC B, V309, P569, DOI 10.1098/rstb.1985.0096; WILLS MA, 1994, PALEOBIOLOGY, V20, P93, DOI 10.1017/S009483730001263X; [No title captured]	31	56	60	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 19	2000	288	5469					1239	1242		10.1126/science.288.5469.1239	http://dx.doi.org/10.1126/science.288.5469.1239			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315KH	10817998				2022-12-24	WOS:000087112600050
J	Espinal, MA; Kim, SJ; Suarez, PG; Kam, KM; Khomenko, AG; Migliori, GB; Baez, J; Kochi, A; Dye, C; Raviglione, MC				Espinal, MA; Kim, SJ; Suarez, PG; Kam, KM; Khomenko, AG; Migliori, GB; Baez, J; Kochi, A; Dye, C; Raviglione, MC			Standard short-course chemotherapy for drug-resistant tuberculosis - Treatment outcomes in 6 countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PULMONARY TUBERCULOSIS; RIFAMPIN	Context No large-scale study has investigated the impact of multidrug-resistant tuberculosis (TB) on the outcome of standard short-course chemotherapy under routine countrywide TB control program conditions in the World Health Organization's (WHO) directly observed treatment short-course strategy for TB control. Objective To assess the results of treatment with first-line drugs for patients enrolled in the WHO and the International Union Against Tuberculosis and Lung Disease's global project on drug-resistance surveillance. Design and Setting Retrospective cohort study of patients with TB in the Dominican Republic, Hong Kong Special Administrative Region (People's Republic of China), Italy, Ivanovo Oblast (Russian Federation), the Republic of Korea, and Peru. Patients New and retreatment TB cases who received short-course chemotherapy with isoniazid, rifampicin, pyrazinamide, and either ethambutol or streptomycin between 1994 and 1996. Main Outcome Measure Treatment response according to WHO treatment outcome categories (cured; died; completed, defaulted, or failed treatment; or transferred). Results Of the 6402 culture-positive TB cases evaluated, 5526 (86%) were new cases and 876 (14%) were retreatment cases. A total of 1148 (20.8%) new cases and 390 (44.5%) retreatment cases were drug resistant, including 184 and 169 cases of multidrug-resistant TB, respectively. Of the new cases 4585 (83%) were treated successfully, 138 (2%) died, and 151 (3%) experienced short-course chemotherapy failure. Overall, treatment failure (relative risk [RR], 15.4; 95% confidence interval [CI], 10.6-22.4; P<.001) and mortality (RR, 3.73; 95% CI, 2.13-6.53; P<.001) were higher among new multidrug-resistant TB cases than among new susceptible cases. Even in settings using 100% direct observation, cases with multidrug resistance had a significantly higher failure rate than those who were susceptible (9/94 [10%] vs 8/1410 [0.7%1; RR, 16.9; 95% CI, 6.6-42.7; P<.001). Treatment failure was also higher among patients with any rifampicin resistance (n = 115) other than multidrug resistance (RR, 5.48, 95% CI, 3.04-9.87; P<.001), any isoniazid resistance (n = 457) other than multidrug resistance (RR, 3.06; 95% CI, 1.85-5.05; P<.001), and among patients with TB resistant to rifampicin only (n = 76) (RR, 5.47; 95% CI, 2.68-11.2; P<,001). Of the retreatment cases, 497 (57%) were treated successfully, 51 (6%) died, and 124 (14%) failed short-course chemotherapy treatment. Failure rates among retreatment cases were higher in those with muitidrug-resistant TB, with any isoniazid resistance other than multidrug resistance, and in cases with TB resistant to isoniazid only. Conclusions These data suggest that standard short-course chemotherapy, based on first-line drugs, is an inadequate treatment for some patients with drug-resistant TB. Although the directly observed treatment short-course strategy is the basis of good TB control, the strategy should be modified in some settings to identify drug-resistant cases sooner, and to make use of second-line drugs in appropriate treatment regimens.	WHO, Commun Dis Programme, CH-1211 Geneva 27, Switzerland; Korean Inst TB, Seoul, South Korea; Natl TB Control Program, Lima, Peru; Hong Kong Dept Hlth, Pathol Serv, Hong Kong, Peoples R China; TB Res Ctr, Moscow, Russia; Fdn Salvatore Maugeri, Care & Res Inst, Tradate, Italy; Res Ctr Maternal & Child Hlth, Santo Domingo, Dominican Rep	World Health Organization; Istituti Clinici Scientifici Maugeri IRCCS	Espinal, MA (corresponding author), WHO, Commun Dis Programme, Ave Appla 20, CH-1211 Geneva 27, Switzerland.	espinalm@who.ch	Migliori, Giovanni Battista/AAB-8589-2020; Dye, Christopher/AIC-4659-2022; Suarez, Pedro G/AAD-2278-2019; KAM, Kai Man/K-4546-2012	Migliori, Giovanni Battista/0000-0002-2597-574X; Suarez, Pedro G/0000-0001-9825-1761; KAM, Kai Man/0000-0003-0579-0307; RAVIGLIONE, Mario/0000-0002-9331-2067; Dye, Christopher/0000-0002-2957-1793				CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; COLEBUNDERS R, 1994, ANN SOC BELG MED TR, V74, P263; Coninx R, 1999, LANCET, V353, P969, DOI 10.1016/S0140-6736(98)08341-X; DROLET G. J., 1938, American Review of Tuberculosis and Pulmonary Diseases, V37, P125; Espinal MA, 1998, INT J TUBERC LUNG D, V2, P490; Garcia-Garcia MD, 2000, ARCH INTERN MED, V160, P630, DOI 10.1001/archinte.160.5.630; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; Kumaresan JA, 1998, INT J TUBERC LUNG D, V2, P992; Laszlo A, 1997, INT J TUBERC LUNG D, V1, P231; MAHMOUDI A, 1993, JAMA-J AM MED ASSOC, V270, P65, DOI 10.1001/jama.270.1.65; MITCHISON DA, 1986, AM REV RESPIR DIS, V133, P423; NARAIN R, 1974, B WORLD HEALTH ORGAN, V51, P273; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; Park SK, 1998, INT J TUBERC LUNG D, V2, P877; *PRPGR NAC CONTR T, 1998, MIN SAL PERU PUBL; Raviglione MC, 1997, LANCET, V350, P624, DOI 10.1016/S0140-6736(97)04146-9; TELZAK EE, 1995, NEW ENGL J MED, V333, P907, DOI 10.1056/NEJM199510053331404; Trebucq A, 1999, INT J TUBERC LUNG D, V3, P455; *WHO, 1997, T937012RUS WHO; WHO, 2000, WHO PUBL; WHO, 1997, OBESITY PREVENTING M; World Bank, 1993, INV HLTH WORLD DEV R; World Health Organization, 1998, WHO PUBL, VMSA/MDN/98.2, P55; Zhao FZ, 1997, INT J TUBERC LUNG D, V1, P570	24	454	474	0	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2000	283	19					2537	2545		10.1001/jama.283.19.2537	http://dx.doi.org/10.1001/jama.283.19.2537			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	312VL	10815117	Bronze			2022-12-24	WOS:000086964600034
J	Prosser, LA; Stinnett, AA; Goldman, PA; Williams, LW; Hunink, MGM; Goldman, L; Weinstein, MC				Prosser, LA; Stinnett, AA; Goldman, PA; Williams, LW; Hunink, MGM; Goldman, L; Weinstein, MC			Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; COA REDUCTASE INHIBITORS; ARTERY DISEASE; MODERATE HYPERCHOLESTEROLEMIA; SECONDARY PREVENTION; ECONOMIC-EVALUATION; CLINICAL-TRIALS; RISK FACTOR; PRAVASTATIN	Background: The National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) recommends treatment guidelines based on cholesterol level and number of risk factors. Objective: To evaluate how the cost-effectiveness ratios of cholesterol-lowering therapies vary according to different risk factors. Design: Cost-effectiveness analysis. Data Sources: Published data. Target Population: Women and men 35 to 84 years of age with low-density lipoprotein cholesterol levels of 4.1 mmol/L or greater (greater than or equal to 160 mg/dL), divided into 240 risk subgroups according to age, sex, and the presence or absence of four coronary heart disease risk factors (smoking status, blood pressure, low-density lipoprotein cholesterol level, and high-density lipoprotein cholesterol level). Time Horizon: 30 years. Perspective: Societal. Interventions: Step I diet, statin therapy, and no preventive treatment for primary and secondary prevention. Outcome Measures: Incremental cost-effectiveness ratios. Results of Base-Case Analysis: Incremental cost-effectiveness ratios for primary prevention with step I diet ranged from $1900 per quality-adjusted life-year (QALY) gained to $500 000 per QALY depending on risk subgroup characteristics. Primary prevention with a statin compared with diet therapy was $54 000 per QALY to $1 400 000 per QALY. Secondary prevention with a statin cost less than $50 000 per QALY for all risk subgroups. Results of Sensitivity Analysis: The inclusion of niacin as a primary prevention option resulted in much less favorable incremental cost-effectiveness ratios for primary prevention with a statin (>$500 000 per QALY). Conclusions: Cost-effectiveness of treatment strategies varies significantly when adjusted for age, sex, and the presence or absence of additional risk factors. Primary prevention with a step I diet seems to be cost-effective for most risk subgroups but may not be cost-effective for otherwise healthy young women. Primary prevention with a statin may not be cost-effective for younger men and women with few risk factors, given the option of secondary prevention and of primary prevention in older age ranges. Secondary prevention with a statin seems to be cost-effective for all risk subgroups and is cost-saving in some high-risk subgroups.	Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Univ Alabama Birmingham, Birmingham, AL 35294 USA; Erasmus MC, NL-3000 DR Rotterdam, Netherlands; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; Erasmus University Rotterdam; Erasmus MC; University of California System; University of California San Francisco	Weinstein, MC (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, 718 Huntington Ave, Boston, MA 02115 USA.		Hug, Balthasar L./G-1568-2010		AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006258] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007092] Funding Source: NIH RePORTER; AHRQ HHS [R01 HS 06258] Funding Source: Medline; NLM NIH HHS [5T15LM07092-08] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		ANDRADE SE, 1995, NEW ENGL J MED, V332, P1125, DOI 10.1056/NEJM199504273321703; [Anonymous], 1993, Am J Cardiol, V72, P1031; Ashraf T, 1996, AM J CARDIOL, V78, P409, DOI 10.1016/S0002-9149(96)00328-1; Avins AL, 1998, JAMA-J AM MED ASSOC, V279, P445, DOI 10.1001/jama.279.6.445; BROWN WV, 1995, POSTGRAD MED, V98, P185, DOI 10.1080/00325481.1995.11946037; CROUSE JR, 1995, AM J CARDIOL, V75, P455, DOI 10.1016/S0002-9149(99)80580-3; DENKE MA, 1994, ARCH INTERN MED, V154, P1977, DOI 10.1001/archinte.154.17.1977; DENKE MA, 1994, ARCH INTERN MED, V154, P317, DOI 10.1001/archinte.154.3.317; DENKE MA, 1995, ARCH INTERN MED, V155, P393, DOI 10.1001/archinte.155.4.393; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gold MR, 1996, COST EFFECTIVENESS H; GOLDMAN L, 1991, JAMA-J AM MED ASSOC, V265, P1145, DOI 10.1001/jama.265.9.1145; Graham JD, 1998, ANNU REV PUBL HEALTH, V19, P125, DOI 10.1146/annurev.publhealth.19.1.125; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; GUADAGNOLI E, 1995, NEW ENGL J MED, V333, P573, DOI 10.1056/NEJM199508313330908; GUIBERT R, 1993, CAN J CARDIOL S, V9, pD28; HAMILTON VH, 1995, JAMA-J AM MED ASSOC, V273, P1032, DOI 10.1001/jama.273.13.1032; HAY JW, 1991, AM J CARDIOL, V67, P789, DOI 10.1016/0002-9149(91)90609-O; Hjalte K, 1992, Pharmacoeconomics, V1, P213; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; ILLINGWOUTH DR, 1994, ARCH INTERN MED, V154, P1586, DOI 10.1001/archinte.154.14.1586; Jacobson TA, 1996, AM J CARDIOL, V78, P32, DOI 10.1016/S0002-9149(96)00660-1; Johannesson M, 1997, NEW ENGL J MED, V336, P332, DOI 10.1056/NEJM199701303360503; JONES PH, 1991, CLIN CARDIOL, V14, P146, DOI 10.1002/clc.4960140211; JUKEMA JW, 1995, CIRCULATION, V91, P2528, DOI 10.1161/01.CIR.91.10.2528; KEENAN JM, 1991, ARCH INTERN MED, V151, P1424, DOI 10.1001/archinte.151.7.1424; KNOPP RH, 1985, METABOLISM, V34, P642, DOI 10.1016/0026-0495(85)90092-7; Kuntz KM, 1996, CIRCULATION, V94, P957, DOI 10.1161/01.CIR.94.5.957; MARTENS LL, 1989, AM J MED, V87, pS54, DOI 10.1016/S0002-9343(89)80600-X; MARTENS LL, 1994, CLIN THER, V16, P1052; Morris S, 1997, HEALTH ECON, V6, P589, DOI 10.1002/(SICI)1099-1050(199711)6:6<589::AID-HEC286>3.0.CO;2-D; MYERS RH, 1990, AM HEART J, V120, P963, DOI 10.1016/0002-8703(90)90216-K; PEDERSEN TR, 1994, LANCET, V344, P1383; Riviere M, 1997, CAN MED ASSOC J, V156, P991; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SALONEN R, 1995, CIRCULATION, V92, P1758, DOI 10.1161/01.CIR.92.7.1758; SCHULMAN KA, 1990, JAMA-J AM MED ASSOC, V264, P3025, DOI 10.1001/jama.264.23.3025; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; STINNETT AA, 1996, COST EFFECTIVNESS HL; Tang JL, 1998, BMJ-BRIT MED J, V316, P1213, DOI 10.1136/bmj.316.7139.1213; TAYLOR WC, 1990, PREVENTING DIS RHETO, P437; TOBERT JA, 1990, AM J CARDIOL, V66, pB22; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Tsalamandris C, 1994, J Cardiovasc Risk, V1, P231; VACEK JL, 1995, AM J CARDIOL, V76, P182, DOI 10.1016/S0002-9149(99)80056-3; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; Weinstein MC., 1995, VALUING HLTH CARE CO; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WOOD PD, 1991, NEW ENGL J MED, V325, P461, DOI 10.1056/NEJM199108153250703; 1996, 1997 MED CLIN LAB FE; 1995, MCGRAWHILL COMPLETE; 1997, LABOUR FORCE STAT CU; 1996, FED REG, V61, P59717; 1997, DRUG TOPICS RED BOOK; 1991, AHCRP PUBLICATION RO	56	168	170	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2000	132	10					769	779		10.7326/0003-4819-132-10-200005160-00002	http://dx.doi.org/10.7326/0003-4819-132-10-200005160-00002			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	313XN	10819699				2022-12-24	WOS:000087025100001
J	Donzeau, M; Kaldi, K; Adam, A; Paschen, S; Wanner, G; Guiard, B; Bauer, MF; Neupert, W; Brunner, M				Donzeau, M; Kaldi, K; Adam, A; Paschen, S; Wanner, G; Guiard, B; Bauer, MF; Neupert, W; Brunner, M			Tim23 links the inner and outer mitochondrial membranes	CELL			English	Article							PROTEIN IMPORT MACHINERY; INTERMEMBRANE SPACE; ELECTRON TOMOGRAPHY; DYNAMIC INTERACTION; YEAST MITOCHONDRIA; CARRIER PROTEINS; CONTACT SITES; TRANSLOCATION; COMPLEX; SYSTEM	Tim23, a key component of the mitochondrial preprotein translocase, is anchored in the inner membrane by its C-terminal domain and exposes an intermediate domain in the intermembrane space that functions as a presequence receptor. We show that the N-terminal domain of Tim23 is exposed on the surface of the outer membrane. The two-membrane-spanning topology of Tim23 is a novel characteristic in membrane biology. By the simultaneous integration into two membranes, Tim23 forms contacts between the outer and inner mitochondrial membranes. Tethering the inner membrane translocase to the outer membrane facilitates the transfer of precursor proteins from the TOM complex to the TIM23 complex and increases the efficiency of protein import.	Univ Munich, Inst Physiol Chem, D-80336 Munich, Germany; Univ Munich, Inst Bot, D-30638 Munich, Germany; Univ Paris 06, CNRS, Ctr Genet Mol, F-91190 Gif Sur Yvette, France	University of Munich; University of Munich; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Brunner, M (corresponding author), Univ Munich, Inst Physiol Chem, Goethestr 33, D-80336 Munich, Germany.		Káldi, Krisztina/X-4080-2019; Adam, Alexander/I-5713-2016	Brunner, Michael/0000-0001-9798-3047; Donzeau, Mariel/0000-0002-1145-9218; Kaldi, Krisztina/0000-0002-5724-0182				Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; Bauer MF, 2000, TRENDS CELL BIOL, V10, P25, DOI 10.1016/S0962-8924(99)01684-0; BERTHOLD J, 1995, CELL, V81, P1085, DOI 10.1016/S0092-8674(05)80013-3; Davis AJ, 1998, MOL BIOL CELL, V9, P2577, DOI 10.1091/mbc.9.9.2577; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; DEKKER PJT, 1993, FEBS LETT, V330, P66, DOI 10.1016/0014-5793(93)80921-G; EMTAGE JLT, 1993, J CELL BIOL, V122, P1003, DOI 10.1083/jcb.122.5.1003; Endres M, 1999, EMBO J, V18, P3214, DOI 10.1093/emboj/18.12.3214; FLYTLOVICH S, 1993, EMBO J, V12, P1209; HORST M, 1995, EMBO J, V14, P2293, DOI 10.1002/j.1460-2075.1995.tb07223.x; HUGHSON FM, 1997, CURR BIOL, V7, P565; HWANG S, 1989, J CELL BIOL, V109, P487, DOI 10.1083/jcb.109.2.487; JASCUR T, 1992, J BIOL CHEM, V267, P13636; Kaldi K, 1998, EMBO J, V17, P1569, DOI 10.1093/emboj/17.6.1569; KASSENBROCK CK, 1993, EMBO J, V12, P3023, DOI 10.1002/j.1460-2075.1993.tb05971.x; Kerscher O, 1997, J CELL BIOL, V139, P1663, DOI 10.1083/jcb.139.7.1663; Koehler CM, 1998, EMBO J, V17, P6477, DOI 10.1093/emboj/17.22.6477; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; KRONIDOU NG, 1994, P NATL ACAD SCI USA, V91, P12818, DOI 10.1073/pnas.91.26.12818; Leuenberger D, 1999, EMBO J, V18, P4816, DOI 10.1093/emboj/18.17.4816; Mannella CA, 1996, J BIOENERG BIOMEMBR, V28, P163, DOI 10.1007/BF02110647; Mannella CA, 1997, J BIOENERG BIOMEMBR, V29, P525, DOI 10.1023/A:1022489832594; MAYER A, 1995, CELL, V80, P127, DOI 10.1016/0092-8674(95)90457-3; Moro F, 1999, EMBO J, V18, P3667, DOI 10.1093/emboj/18.13.3667; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; Perkins GA, 1998, J BIOENERG BIOMEMBR, V30, P431, DOI 10.1023/A:1020586012561; PFANNER N, 1992, CELL, V68, P999, DOI 10.1016/0092-8674(92)90069-O; PFANNER N, 1987, J BIOL CHEM, V262, P7528; Pfanner N, 1998, CURR BIOL, V8, pR262, DOI 10.1016/S0960-9822(98)70168-X; RASSOW J, 1994, J CELL BIOL, V127, P1547, DOI 10.1083/jcb.127.6.1547; RYAN KR, 1995, CELL, V83, P517, DOI 10.1016/0092-8674(95)90089-6; Schatz G, 1996, J BIOL CHEM, V271, P31763, DOI 10.1074/jbc.271.50.31763; SCHLEYER M, 1985, CELL, V43, P339, DOI 10.1016/0092-8674(85)90039-X; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Sirrenberg C, 1996, NATURE, V384, P582, DOI 10.1038/384582a0; Sirrenberg C, 1997, J BIOL CHEM, V272, P29963, DOI 10.1074/jbc.272.47.29963; STEGMANN T, 1991, J BIOL CHEM, V266, P18404; Ungermann C, 1996, EMBO J, V15, P735, DOI 10.1002/j.1460-2075.1996.tb00409.x	40	137	141	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 12	2000	101	4					401	412		10.1016/S0092-8674(00)80850-8	http://dx.doi.org/10.1016/S0092-8674(00)80850-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	313QM	10830167	Bronze			2022-12-24	WOS:000087010400008
J	Schulteis, G; Ahmed, SH; Morse, AC; Koob, GF; Everitt, BJ				Schulteis, G; Ahmed, SH; Morse, AC; Koob, GF; Everitt, BJ			Conditioning and opiate withdrawal	NATURE			English	Article							NUCLEUS-ACCUMBENS; REINFORCEMENT; ADDICTION		Univ Calif San Diego, Sch Med, VAMC 125, Dept Anesthesiol, San Diego, CA 92161 USA; Vet Affairs Med Ctr, San Diego, CA 92161 USA; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA; Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); Scripps Research Institute; University of Cambridge	Schulteis, G (corresponding author), Univ Calif San Diego, Sch Med, VAMC 125, Dept Anesthesiol, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.		AHMED, Serge H/D-5236-2014	Everitt, Barry/0000-0003-4431-6536; Ahmed, Serge/0000-0002-1225-9234	Medical Research Council [G9537855] Funding Source: Medline; MRC [G9537855] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aston-Jones G, 1999, ANN NY ACAD SCI, V877, P486, DOI 10.1111/j.1749-6632.1999.tb09284.x; BALDWIN HA, 1993, NEUROPSYCHOPHARMACOL, V8, P15, DOI 10.1038/npp.1993.3; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; EVERITT BJ, IN PRESS AMYGDALA FU; Groenewegen HJ, 1996, PROG BRAIN RES, V107, P485; KOOB GF, 1989, PSYCHOPHARMACOLOGY, V98, P530, DOI 10.1007/BF00441954; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; OBRIEN CP, 1977, SCIENCE, V195, P1000, DOI 10.1126/science.841320; Schulteis G, 1996, NEUROCHEM RES, V21, P1437, DOI 10.1007/BF02532385; SCHULTEIS G, 1994, J PHARMACOL EXP THER, V271, P1391; Whitelaw RB, 1996, PSYCHOPHARMACOLOGY, V127, P213, DOI 10.1007/BF02805996; WIKLER A, 1973, ARCH GEN PSYCHIAT, V28, P611	12	51	55	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 29	2000	405	6790					1013	1014		10.1038/35016630	http://dx.doi.org/10.1038/35016630			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	328VN	10890431				2022-12-24	WOS:000087871700031
J	Wang, PS; Solomon, DH; Mogun, H; Avorn, J				Wang, PS; Solomon, DH; Mogun, H; Avorn, J			HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ELIMINATION HALF-LIFE; OLDER WOMEN; BENZODIAZEPINES; OSTEOPOROSIS	Context Recent animal studies have found that 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) lipid-lowering drugs (statins) substantially increase bone formation, but whether statin use in humans results in clinically meaningful bone formation or a reduction in the risk of osteoporotic fractures is not known. Objective To determine whether the use of statins is associated with reduced hip fracture risk. Design Case-control study. Setting and Patients A total of 6110 New Jersey residents aged 65 years or older and enrolled in Medicare and either Medicaid or the Pharmacy Assistance for the Aged and Disabled program. Case patients (n =1222) underwent surgical repair of a hip fracture in 1994. Control patients (n = 4888) were identified at a ratio of 4:1 and frequency-matched to case patients for age and sex. Main Outcome Measure Adjusted odds ratio (OR) of hip fracture by statin use in the 180 days and 3 years prior to the index date (the earliest date of admission for surgery), adjusted for demographic and clinical characteristics and health care utilization. Results Use of statins in either the prior 180 days (adjusted OR, 0.50; 95% confidence interval [CI], 0.33-0.76) or prior 3 years (adjusted OR, 0.57; 95% CI, 0.40-0.82) was associated with a significant reduction in the risk of hip fracture, even after controlling for variables such as race, insurance status, psychoactive medications, estrogen and thiazide use, ischemic heart disease, cancer, and diabetes mellitus. No significant relationship was observed between use of nonstatin lipid-lowering agents and hip fracture risk. Clear relationships were observed between the degree of reduction in hip fracture risk and the extent of statin use; there was no evidence of such relationships with nonstatin lipid-lowering agents. After adjusting for extent of statin use in the prior 3 years, current use ton the index date) was associated with a 71% reduction in risk (adjusted OR, 0.29; 95% CI, 0.10-0.81). The relationship between statin use and hip fracture risk persisted after controlling for variables such as the n umber of medications, the Charlson comorbidity index score, and hospitalization or nursing home stay in the last 180 days, as well as after excluding patients who were in a nursing home prior to their index date or who died in the year after their index date. Use of nonstatin lipid-lowering agents was not observed to be associated with reduction in hip fracture risk in any of these alternative models or analyses. Conclusions These findings support an association between statin use by elderly patients and reduction in the risk of hip fracture. Controlled trials are needed to exclude the possibility of unmeasured confounders.	Harvard Univ, Brigham & Womens Hosp, Sch Med,Program Anal Clin Studies, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Wang, PS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Program Anal Clin Studies, Dept Med,Div Pharmacoepidemiol & Pharmacoecon, 221 Longwood Ave, Boston, MA 02115 USA.	pwang@rics.bwh.harvard.edu						[Anonymous], 1989, PHYS CURR PROC TERM; BARON JA, 1994, EPIDEMIOLOGY, V5, P541; Bauer DC, 1999, J BONE MINER RES, V14, pS179; Chung YS, 2000, J CLIN ENDOCR METAB, V85, P1137, DOI 10.1210/jcem.85.3.6476; CUMMING RG, 1993, MED J AUSTRALIA, V158, P414, DOI 10.5694/j.1326-5377.1993.tb121839.x; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Gregg EW, 1998, ANN INTERN MED, V129, P81, DOI 10.7326/0003-4819-129-2-199807150-00002; HERINGS RMC, 1995, ARCH INTERN MED, V155, P1801, DOI 10.1001/archinte.155.16.1801; Hofer TP, 1996, AM J PUBLIC HEALTH, V86, P1755, DOI 10.2105/AJPH.86.12.1755; LACROIX AZ, 1990, NEW ENGL J MED, V322, P286, DOI 10.1056/NEJM199002013220502; LOOKER AC, 1995, J BONE MINER RES, V10, P796; Luckman SP, 1998, J BONE MINER RES, V13, P581, DOI 10.1359/jbmr.1998.13.4.581; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Orwoll ES, 1996, ANN INTERN MED, V124, P187, DOI 10.7326/0003-4819-124-2-199601150-00001; PEDERSEN TR, 1994, LANCET, V344, P1383; RAY WA, 1989, JAMA-J AM MED ASSOC, V262, P3303, DOI 10.1001/jama.262.23.3303; RAY WA, 1987, NEW ENGL J MED, V316, P363, DOI 10.1056/NEJM198702123160702; RIGGS BL, 1986, NEW ENGL J MED, V314, P1676, DOI 10.1056/NEJM198606263142605; Russell RGG, 1999, J BONE MINER RES, V14, P53, DOI 10.1002/jbmr.5650140212; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; SILVERMAN SL, 1988, AM J PUBLIC HEALTH, V78, P1482, DOI 10.2105/AJPH.78.11.1482; *ST ANTH DIAGN REL, 1993, ST ANTH DIAGN REL GR; Thapa PB, 1998, NEW ENGL J MED, V339, P875, DOI 10.1056/NEJM199809243391303; US Dept of Health and Human Services . International Classification of Diseases, 1988, INT CLASS DIS	25	337	373	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2000	283	24					3211	3216		10.1001/jama.283.24.3211	http://dx.doi.org/10.1001/jama.283.24.3211			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326TY	10866868				2022-12-24	WOS:000087753900033
J	Bashaw, GJ; Kidd, T; Murray, D; Pawson, T; Goodman, CS				Bashaw, GJ; Kidd, T; Murray, D; Pawson, T; Goodman, CS			Repulsive axon guidance: Abelson and enabled play opposing roles downstream of the roundabout receptor	CELL			English	Article							ABL TYROSINE KINASE; ACTIN-BASED MOTILITY; PHOSPHATASE DLAR; CNS MIDLINE; C-ABL; DROSOPHILA; MUTATIONS; PROTEIN; SLIT; BINDING	Drosophila Roundabout (Robo) is the founding member of a conserved family of repulsive axon guidance receptors that respond to secreted Slit proteins. Little is known about the signaling mechanisms which function downstream of Robe to mediate repulsion. Here, we present genetic and biochemical evidence that the Abelson (Abl) tyrosine kinase and its substrate Enabled (Ena) play direct and opposing roles in Robe signal transduction. Genetic interactions support a model in which Abl functions to antagonize Robe signaling, while Ena is required in part for Robe's repulsive output. Both Abl and Ena can directly bind to Robo's cytoplasmic domain. A mutant form of Robe that interferes with Ena binding is partially impaired in Robe function, while a mutation in a conserved cytoplasmic tyrosine that can be phosphorylated by Abl generates a hyperactive Robe receptor.	Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Goodman, CS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, 229 Stanley Hall, Berkeley, CA 94720 USA.		Kidd, Thomas/AAT-9993-2020; Pawson, Tony J/E-4578-2013	Kidd, Thomas/0000-0001-7190-4208	NINDS NIH HHS [NS18366] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018366] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; HENKEMEYER M, 1990, CELL, V63, P949, DOI 10.1016/0092-8674(90)90498-4; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; ROSEN MK, 1995, NATURE, V374, P477, DOI 10.1038/374477a0; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Sink H., 1994, Society for Neuroscience Abstracts, V20, P1283; Sun Q, 2000, DEVELOPMENT, V127, P801; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wills Z, 1999, NEURON, V22, P291, DOI 10.1016/S0896-6273(00)81090-9; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	31	367	384	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 23	2000	101	7					703	715		10.1016/S0092-8674(00)80883-1	http://dx.doi.org/10.1016/S0092-8674(00)80883-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	327YE	10892742	Bronze			2022-12-24	WOS:000087821400005
J	Jones, TD; Ruben, JA; Martin, LD; Kurochkin, EN; Feduccia, A; Maderson, PFA; Hillenius, WJ; Geist, NR; Alifanov, V				Jones, TD; Ruben, JA; Martin, LD; Kurochkin, EN; Feduccia, A; Maderson, PFA; Hillenius, WJ; Geist, NR; Alifanov, V			Nonavian feathers in a Late Triassic archosaur	SCIENCE			English	Article								Longisquama insignis was an unusual archosaur from the Late Triassic of central Asia. Along its dorsal axis Longisquama bore a series of paired integumentary appendages that resembled avian feathers in many details, especially in the anatomy of the basal region. The Latter is sufficiently similar to the calamus of modern feathers that each probably represents the culmination of virtually identical morphogenetic processes. The exact relationship of Longisquama to birds is uncertain. Nevertheless, we interpret Longisquama's elongate integumentary appendages as nonavian feathers and suggest that they are probably homologous with avian feathers. If so, they antedate the feathers of Archaeopteryx, the first known bird from the Late Jurassic.	Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; Univ Kansas, Museum Hist Nat, Lawrence, KS 66045 USA; Russian Acad Sci, Inst Paleontol, Moscow 117868, Russia; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA; Coll Charleston, Dept Biol, Charleston, SC 29424 USA; Sonoma State Univ, Dept Biol, Rohnert Park, CA 94928 USA	Oregon State University; University of Kansas; University of Kansas; Russian Academy of Sciences; University of North Carolina; University of North Carolina Chapel Hill; City University of New York (CUNY) System; Brooklyn College (CUNY); College of Charleston; California State University System; Sonoma State University	Jones, TD (corresponding author), Stephen F Austin State Univ, Dept Biol, Nacogdoches, TX 75962 USA.							Dobruskina IA, 1980, T GEOL I AKAD NAUK S, V346, P1; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2; HAUBOLD H, 1987, CR ACAD SCI II, V305, P65; Lillie F. R., 1941, Physiological Zoology Chicago, V14, P103; LUCAS AM, 1972, AGR HDB USDA, V362; Maderson PFA, 1998, J MORPHOL, V236, P1, DOI 10.1002/(SICI)1097-4687(199804)236:1<1::AID-JMOR1>3.0.CO;2-B; Sharov A.G., 1970, PALEONTOL ZH, V1, P127; Stettenheim P.R., 1976, PROC 16 INT 353 ORNI, P385	8	48	51	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2202	2205		10.1126/science.288.5474.2202	http://dx.doi.org/10.1126/science.288.5474.2202			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864867				2022-12-24	WOS:000087782900055
J	Zhuang, XW; Bartley, LE; Babcock, HP; Russell, R; Ha, TJ; Herschlag, D; Chu, S				Zhuang, XW; Bartley, LE; Babcock, HP; Russell, R; Ha, TJ; Herschlag, D; Chu, S			A single-molecule study of RNA catalysis and folding	SCIENCE			English	Article							TETRAHYMENA-THERMOPHILA RIBOZYME; GROUP-I RIBOZYME; ACTIVE-SITE; SUBSTRATE; BINDING; DYNAMICS; TITIN; PATHWAYS; PROTEIN; STEPS	Using fluorescence microscopy, we studied the catalysis by and folding of individual Tetrahymena thermophila ribozyme molecules. The dye-labeled and surface-immobilized ribozymes used were shown to be functionally indistinguishable from the unmodified free ribozyme in solution. A reversible Local folding step in which a duplex docks and undocks from the ribozyme core was observed directly in single-molecule time trajectories, allowing the determination of the rate constants and characterization of the transition state, A rarely populated docked state, not measurable by ensemble methods, was observed. In the overall folding process, intermediate folding states and multiple folding pathways were observed. In addition to observing previously established folding pathways, a pathway with an observed folding rate constant of 1 per second was discovered. These results establish single-molecule fluorescence as a powerful tool for examining RNA folding.	Stanford Univ, Dept Phys, Stanford, CA 94305 USA; Stanford Univ, Dept Biochem, Beckman Ctr B400, Stanford, CA 94305 USA	Stanford University; Stanford University	Herschlag, D (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.		Legros, Jean Claude/I-7472-2013; Ha, Taekjip/B-9506-2009; Russell, Rick/A-9256-2012; Bartley, Laura/AAF-2217-2020	Ha, Taekjip/0000-0003-2195-6258; Bartley, Laura/0000-0001-8610-7551; Babcock, Hazen/0000-0003-4835-3692	NIGMS NIH HHS [GM49423] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEVILACQUA PC, 1992, SCIENCE, V258, P1355, DOI 10.1126/science.1455230; CECH TR, 1996, NUCL ACIDS MOL BIOL, V10, P1; CELANDER DW, 1991, SCIENCE, V251, P401, DOI 10.1126/science.1989074; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Fang XW, 1999, NAT STRUCT BIOL, V6, P1091; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; GESTELAND RF, 1993, RNA WORLD; Golden BL, 1998, SCIENCE, V282, P259, DOI 10.1126/science.282.5387.259; Ha T, 1999, P NATL ACAD SCI USA, V96, P9077, DOI 10.1073/pnas.96.16.9077; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; HERSCHLAG D, 1992, BIOCHEMISTRY-US, V31, P1386, DOI 10.1021/bi00120a015; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10159, DOI 10.1021/bi00496a003; HERSCHLAG D, 1993, BIOCHEMISTRY-US, V32, P8299, DOI 10.1021/bi00083a034; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; LATHAM JA, 1989, SCIENCE, V245, P276, DOI 10.1126/science.2501870; Lehnert V, 1996, CHEM BIOL, V3, P993, DOI 10.1016/S1074-5521(96)90166-0; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Narlikar GJ, 1999, BIOCHEMISTRY-US, V38, P14192, DOI 10.1021/bi9914309; Narlikar GJ, 1996, NAT STRUCT BIOL, V3, P701, DOI 10.1038/nsb0896-701; Neher E., 1976, NATURE, V260, P779; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Pan J, 1998, J MOL BIOL, V280, P597, DOI 10.1006/jmbi.1998.1901; Pan J, 1997, J MOL BIOL, V273, P7, DOI 10.1006/jmbi.1997.1311; PAN T, 1995, BIOCHEMISTRY-US, V34, P902, DOI 10.1021/bi00003a024; Perkins TT, 1997, SCIENCE, V276, P2016, DOI 10.1126/science.276.5321.2016; PYLE AM, 1992, NATURE, V358, P123, DOI 10.1038/358123a0; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Russell R, 1999, J MOL BIOL, V291, P1155, DOI 10.1006/jmbi.1999.3026; RUSSELL R, UNPUB; Schutz GJ, 1998, BIOPHYS J, V74, P2223, DOI 10.1016/S0006-3495(98)77931-7; Sclavi B, 1998, SCIENCE, V279, P1940, DOI 10.1126/science.279.5358.1940; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Treiber DK, 1998, SCIENCE, V279, P1943, DOI 10.1126/science.279.5358.1943; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; WANG JF, 1993, SCIENCE, V260, P504, DOI 10.1126/science.7682726; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Zarrinkar PP, 1996, RNA, V2, P564; ZARRINKAR PP, 1994, SCIENCE, V265, P918, DOI 10.1126/science.8052848	40	615	644	1	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2000	288	5473					2048	+		10.1126/science.288.5473.2048	http://dx.doi.org/10.1126/science.288.5473.2048			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856219				2022-12-24	WOS:000087687000052
J	Melek, M; Gellert, M				Melek, M; Gellert, M			RAG1/2-mediated resolution of transposition intermediates: Two pathways and possible consequences	CELL			English	Article							DNA STRAND TRANSFER; V(D)J RECOMBINATION; RAG2 PROTEINS; IMMUNE-SYSTEM; 2 STEPS; C-MYC; GENES; MECHANISM; INTEGRATION; CLEAVAGE	During B and T cell development, the RAG1/RAG2 protein complex cleaves DNA at conserved recombination signal sequences (RSS) to initiate V(D)J recombination. RAG1/2 has also been shown to catalyze transpositional strand transfer of RSS-containing substrates into target DNA to form branched DNA intermediates. We show that RAG1/2 can resolve these intermediates by two pathways. RAG1/2 catalyzes hairpin formation on target DNA adjacent to transposed RSS ends in a manner consistent with a model leading to chromosome translocations. Alternatively, disintegration removes transposed donor DNA from the intermediate. At high magnesium concentrations, such as are present in mammalian cells, disintegration is the favored pathway of resolution. This may explain in part why RAG1/2-mediated transposition does not occur at high frequency in cells.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gellert, M (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK033001] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Alberts B., 2017, MOL BIOL CELL; BERNARD O, 1988, ONCOGENE, V2, P195; Besmer E, 1998, MOL CELL, V2, P817, DOI 10.1016/S1097-2765(00)80296-8; Bhasin A, 1999, J BIOL CHEM, V274, P37021, DOI 10.1074/jbc.274.52.37021; Bogue M, 1996, CURR OPIN IMMUNOL, V8, P175, DOI 10.1016/S0952-7915(96)80055-0; CHOW SA, 1992, SCIENCE, V255, P723, DOI 10.1126/science.1738845; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Fugmann SD, 2000, MOL CELL, V5, P97, DOI 10.1016/S1097-2765(00)80406-2; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; Gerton JL, 1999, J BIOL CHEM, V274, P33480, DOI 10.1074/jbc.274.47.33480; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; HOLLIS GF, 1984, NATURE, V307, P752, DOI 10.1038/307752a0; Jeggo PA, 1998, RADIAT RES, V150, pS80, DOI 10.2307/3579810; KABOTYANSKI EB, 1995, NUCLEIC ACIDS RES, V23, P3872, DOI 10.1093/nar/23.19.3872; Kennedy AK, 1998, CELL, V95, P125, DOI 10.1016/S0092-8674(00)81788-2; Kim DR, 1999, GENE DEV, V13, P3070, DOI 10.1101/gad.13.23.3070; Landree MA, 1999, GENE DEV, V13, P3059, DOI 10.1101/gad.13.23.3059; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; LIMPENS J, 1995, BLOOD, V85, P2528, DOI 10.1182/blood.V85.9.2528.bloodjournal8592528; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; Melek M, 1998, SCIENCE, V280, P301, DOI 10.1126/science.280.5361.301; MIZUUCHI K, 1991, CELL, V66, P129, DOI 10.1016/0092-8674(91)90145-O; MIZUUCHI K, 1992, ANNU REV BIOCHEM, V61, P1011; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Ramsden DA, 1996, EMBO J, V15, P3197, DOI 10.1002/j.1460-2075.1996.tb00682.x; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; Santagata S, 1999, MOL CELL, V4, P935, DOI 10.1016/S1097-2765(00)80223-3; Shockett PE, 1999, MOL CELL BIOL, V19, P4159; THOMPSON CB, 1995, IMMUNITY, V3, P531, DOI 10.1016/1074-7613(95)90124-8; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; vanGent DC, 1996, CELL, V85, P107, DOI 10.1016/S0092-8674(00)81086-7; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592; VANGENT DC, 1997, EMBO J, V16, P2265	36	56	58	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 9	2000	101	6					625	633		10.1016/S0092-8674(00)80874-0	http://dx.doi.org/10.1016/S0092-8674(00)80874-0			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	322HQ	10892649	Bronze			2022-12-24	WOS:000087504500009
J	Baumgartner, I; Rauh, G; Pieczek, A; Wuensch, D; Magner, M; Kearney, M; Schainfeld, R; Isner, JM				Baumgartner, I; Rauh, G; Pieczek, A; Wuensch, D; Magner, M; Kearney, M; Schainfeld, R; Isner, JM			Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor	ANNALS OF INTERNAL MEDICINE			English	Article							PERMEABILITY FACTOR; THERAPEUTIC ANGIOGENESIS; COLLATERAL DEVELOPMENT; NITRIC-OXIDE; LIMB; PHVEGF(165); EXPRESSION; DISEASE; MITOGEN; RABBIT	Background: Vascular endothelial growth factor (VEGF) promotes angiogenesis and vascular permeability. The extent to which VEGF may cause tissue edema in humans has not been established. Objective: To evaluate patients undergoing VEGF gene transfer for evidence of lower-extremity edema. Design: Prospective consecutive case series. Setting: Hospital outpatient clinic. Patients: 62 patients with critical limb ischemia and 28 patients with claudication. Intervention: Gene transfer of VECF DNA. Measurements: Semiquantitative analysis of lower-extremity edema. Results: Lower-extremity edema was observed in 31 of 90 (34%) patients. Edema was less common in patients with claudication than in those with pain at rest (P = 0.016) or ischemic ulcers (P < 0.001), and it was less common in patients with pain at rest than in those with ischemic ulcers (P = 0.017). Treatment was typically limited to a brief course of oral diuretics. Conclusions: Vascular endothelial growth factor may enhance vascular permeability in humans. At the doses of plasmid DNA used in this study, lower-extremity edema responded to oral diuretic therapy and did not seem to be associated with serious sequelae.	Tufts Univ, Sch Med, St Elizabeths Med Ctr, Boston, MA 02135 USA	St. Elizabeth's Medical Center; Tufts University	Isner, JM (corresponding author), Tufts Univ, Sch Med, St Elizabeths Med Ctr, 736 Cambridge St, Boston, MA 02135 USA.	jisner@opal.tufts.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL053354, R01HL053354, R01HL057516] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL57516, HL 02824, HL53354] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baumgartner I, 1998, CIRCULATION, V97, P1114, DOI 10.1161/01.CIR.97.12.1114; BAUTERS C, 1995, J VASC SURG, V21, P314, DOI 10.1016/S0741-5214(95)70272-5; Brogi E, 1996, J CLIN INVEST, V97, P469, DOI 10.1172/JCI118437; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; Isner JM, 1998, ADV DRUG DELIVER REV, V30, P185, DOI 10.1016/S0169-409X(97)00115-4; Isner JM, 1996, HUM GENE THER, V7, P989, DOI 10.1089/hum.1996.7.8-989; Isner JM, 1996, HUM GENE THER, V7, P959, DOI 10.1089/hum.1996.7.8-959; Isner JM, 1996, LANCET, V348, P370, DOI 10.1016/S0140-6736(96)03361-2; Isner JM, 1998, J VASC SURG, V28, P964, DOI 10.1016/S0741-5214(98)70022-9; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Murohara T, 1998, CIRCULATION, V97, P99, DOI 10.1161/01.CIR.97.1.99; ROBERTS WG, 1995, J CELL SCI, V108, P2369; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Takeshita S, 1996, LAB INVEST, V75, P487; TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018; Tsurumi Y, 1996, CIRCULATION, V94, P3281, DOI 10.1161/01.CIR.94.12.3281; Vale PR, 1998, CIRCULATION, V98, P66; vanderZee R, 1997, CIRCULATION, V95, P1030	19	152	165	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2000	132	11					880	884		10.7326/0003-4819-132-11-200006060-00005	http://dx.doi.org/10.7326/0003-4819-132-11-200006060-00005			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	319HF	10836914				2022-12-24	WOS:000087334900004
J	Mailand, N; Falck, J; Lukas, C; Syljuasen, RG; Welcker, M; Bartek, J; Lukas, L				Mailand, N; Falck, J; Lukas, C; Syljuasen, RG; Welcker, M; Bartek, J; Lukas, L			Rapid destruction of human Cdc25A in response to DNA damage	SCIENCE			English	Article							HAMSTER OVARY CELLS; S-PHASE CHECKPOINTS; G(1)/S TRANSITION; CYCLE CONTROL; P53; KINASE; PHOSPHORYLATION; PHOSPHATASE; PROTEIN; PATHWAY	To protect genome integrity and ensure survival, eukaryotic cells exposed to genotoxic stress cease proliferating to provide time for DNA repair. Human cells responded to ultraviolet light or ionizing radiation by rapid, ubiquitin- and proteasome-dependent protein degradation of Cdc25A, a phosphatase that is required for progression from G(1) to S phase of the cell cycle. This response involved activated Chk1 protein kinase but not the p53 pathway, and the persisting inhibitory tyrosine phosphorylation of Cdk2 blocked entry into S phase and DNA replication. Overexpression of Cdc25A bypassed this mechanism, leading to enhanced DNA damage and decreased cell survival. These results identify specific degradation of Cdc25A as part of the DNA damage checkpoint mechanism and suggest how Cdc25A overexpression in human cancers might contribute to tumorigenesis.	Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark	Danish Cancer Society	Bartek, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Strandblvd 49, DK-2100 Copenhagen, Denmark.		Bartek, Jiri/G-5870-2014	Welcker, Markus/0000-0001-6723-4790; Lukas, Claudia/0000-0001-7169-6883; Lukas, Jiri/0000-0001-9087-506X				Blasina A, 1999, CURR BIOL, V9, P1, DOI 10.1016/S0960-9822(99)80041-4; Blattner C, 1999, MOL CELL BIOL, V19, P3704; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; DAnna JA, 1997, RADIAT RES, V148, P260, DOI 10.2307/3579611; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Draetta G, 1997, BBA-REV CANCER, V1332, pM53, DOI 10.1016/S0304-419X(96)00049-2; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Freedman DA, 1999, CANCER RES, V59, P1; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; Gasparotto D, 1997, CANCER RES, V57, P2366; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HOFFMANN I, 1994, EMBO J, V13, P4302, DOI 10.1002/j.1460-2075.1994.tb06750.x; JINNO S, 1994, EMBO J, V13, P1549, DOI 10.1002/j.1460-2075.1994.tb06417.x; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; Lee HY, 1997, P NATL ACAD SCI USA, V94, P526, DOI 10.1073/pnas.94.2.526; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; LITTLE JB, 1968, NATURE, V218, P1064, DOI 10.1038/2181064a0; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; LUKAS J, 1994, ONCOGENE, V9, P2159; Lukas J, 1997, GENE DEV, V11, P1479, DOI 10.1101/gad.11.11.1479; LUKAS J, 1992, EUR J BIOCHEM, V207, P169, DOI 10.1111/j.1432-1033.1992.tb17034.x; Lukas J, 1999, ONCOGENE, V18, P3930, DOI 10.1038/sj.onc.1202777; MAILAND N, UNPUB; Nasmyth K, 1996, SCIENCE, V274, P1643, DOI 10.1126/science.274.5293.1643; NELSON WG, 1994, MOL CELL BIOL, V14, P1815, DOI 10.1128/MCB.14.3.1815; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Poon RYC, 1997, CANCER RES, V57, P5168; POON RYC, 1996, J BIOL CHEM, V271; Rhind N, 1998, CURR OPIN CELL BIOL, V10, P749, DOI 10.1016/S0955-0674(98)80118-X; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sehested M, 1998, CANCER RES, V58, P1460; Sexl V, 1999, ONCOGENE, V18, P573, DOI 10.1038/sj.onc.1202362; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Thullberg M, 2000, HYBRIDOMA, V19, P63, DOI 10.1089/027245700315806; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; Weinert T, 1997, SCIENCE, V277, P1450, DOI 10.1126/science.277.5331.1450; Wu WG, 1998, CANCER RES, V58, P4082; Xie GF, 1998, ONCOGENE, V16, P721, DOI 10.1038/sj.onc.1201793	45	632	655	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 26	2000	288	5470					1425	1429		10.1126/science.288.5470.1425	http://dx.doi.org/10.1126/science.288.5470.1425			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318EL	10827953				2022-12-24	WOS:000087270900051
J	Osterlund, MT; Hardtke, CS; Wei, N; Deng, XW				Osterlund, MT; Hardtke, CS; Wei, N; Deng, XW			Targeted destabilization of HY5 during light-regulated development of Arabidopsis	NATURE			English	Article							SEEDLING DEVELOPMENT; BZIP PROTEIN; COP9 COMPLEX; GENE; ENCODES; HYPOCOTYL; PHOTOMORPHOGENESIS; UBIQUITINATION; ENHANCEMENT; ELONGATION	Arabidopsis seedlings display contrasting developmental patterns depending on the ambient light. Seedlings grown in the light develop photomorphogenically, characterized by short hypocotyls and expanded green cotyledons. In contrast, seedlings grown in darkness become etiolated, with elongated hypocotyls and closed cotyledons on an apical hook. Light signals, perceived by multiple photoreceptors and transduced to downstream regulators, dictate the extent of photomorphogenic development in a quantitative manner. Two key downstream components, COP1 and HY5, act antagonistically in regulating seedling development(1). HY5 is a bZIP transcription factor that binds directly to the promoters of light-inducible genes, promoting their expression and photomorphogenic development(2,3). COP1 is a RING-finger protein with WD-40 repeats whose nuclear abundance is negatively regulated by light(4,5). COP1 interacts directly with HY5 in the nucleus to regulate its activity negatively(1). Here we show that the abundance of HY5 is directly correlated with the extent of photomorphogenic development, and that the COP1-HY5 interaction may specifically target HY5 for proteasome-mediated degradation in the nucleus.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Deng, XW (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208104,165 Prospect St,OML 301, New Haven, CT 06520 USA.		Deng, Xing Wang/ABF-4107-2020; Hardtke, Christian S/B-5861-2009	Hardtke, Christian S./0000-0003-3203-1058				AHMAD M, 1993, NATURE, V366, P162, DOI 10.1038/366162a0; AHMAD M, 1994, NATURE, V16, P720; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; BOYLAN MT, 1991, P NATL ACAD SCI USA, V88, P10806, DOI 10.1073/pnas.88.23.10806; Chattopadhyay S, 1998, PLANT CELL, V10, P673, DOI 10.1105/tpc.10.5.673; DENG XW, 1992, CELL, V71, P791, DOI 10.1016/0092-8674(92)90555-Q; DENG XW, 1991, GENE DEV, V5, P1172, DOI 10.1101/gad.5.7.1172; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Karniol B, 1998, FEBS LETT, V439, P173, DOI 10.1016/S0014-5793(98)01367-2; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kwok SF, 1999, J MOL BIOL, V285, P85, DOI 10.1006/jmbi.1998.2315; Kwok SF, 1996, PLANT PHYSIOL, V110, P731, DOI 10.1104/pp.110.3.731; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; McNellis TW, 1996, PLANT CELL, V8, P1491, DOI 10.1105/tpc.8.9.1491; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; OSERLUND MT, 1999, TRENDS CELL BIOL, V9, P113; Osterlund MT, 1998, PLANT J, V16, P201, DOI 10.1046/j.1365-313x.1998.00290.x; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; REED JW, 1994, PLANT PHYSIOL, V104, P1139, DOI 10.1104/pp.104.4.1139; Serino G, 1999, PLANT CELL, V11, P1967, DOI 10.1105/tpc.11.10.1967; Staub B, 1996, CD-ROM PROF, V9, P8; Torii KU, 1998, EMBO J, V17, P5577, DOI 10.1093/emboj/17.19.5577; vonArnim AG, 1997, PLANT PHYSIOL, V114, P779, DOI 10.1104/pp.114.3.779; VONARNIM AG, 1994, CELL, V79, P1035, DOI 10.1016/0092-8674(94)90034-5; WAGNER D, 1991, PLANT CELL, V3, P1275, DOI 10.1105/tpc.3.12.1275; Wei D, 1998, J VIS COMMUN IMAGE R, V9, P15, DOI 10.1006/jvci.1997.0369; WEI N, 1994, CELL, V78, P117, DOI 10.1016/0092-8674(94)90578-9; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757	30	926	986	16	263	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					462	466		10.1038/35013076	http://dx.doi.org/10.1038/35013076			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839542				2022-12-24	WOS:000087212000050
J	Bull, ID; Parekh, NR; Hall, GH; Ineson, P; Evershed, RP				Bull, ID; Parekh, NR; Hall, GH; Ineson, P; Evershed, RP			Detection and classification of atmospheric methane oxidizing bacteria in soil	NATURE			English	Article							FATTY-ACIDS; CH4; GAS; MICROORGANISMS; OXIDATION; SEDIMENTS	Well-drained non-agricultural soils mediate the oxidation of methane directly from the atmosphere, contributing 5 to 10% towards the global methane sink(1,2). Studies of methane oxidation kinetics in soil infer the activity of two methanotrophic populations: one that is only active at high methane concentrations (low affinity) and another that tolerates atmospheric levels of methane (high affinity). The activity of the latter has not been demonstrated by cultured laboratory strains of methanotrophs, leaving the microbiology of methane oxidation at atmospheric concentrations unclear(3,4). Here we describe a new pulse-chase experiment using long-term enrichment with (CH4)-C-12 followed by shortterm exposure to (CH4)-C-13 to isotopically label methanotrophs in a soil from a temperate forest. Analysis of labelled phospholipid fatty acids (PLFAs) provided unambiguous evidence of methane assimilation at true atmospheric concentrations (1.8-3.6 p.p.m.v.). High proportions of C-13-labelled C-18 fatty acids and the co-occurrence of a labelled, branched C-17 fatty acid indicated that a new methanotroph, similar at the PLFA level to known type II methanotrophs, was the predominant soil micro-organism responsible for atmospheric methane oxidation.	Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; Inst Terr Ecol, Merlewood Res Stn, Grange Sands LA11 6JU, Cumbria, England; Inst Freshwater Ecol, Ambleside LA22 0LP, Cumbria, England; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England	University of Bristol; UK Centre for Ecology & Hydrology (UKCEH); UK Centre for Ecology & Hydrology (UKCEH); University of York - UK	Evershed, RP (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.		Bull, Ian/AAV-1474-2020; Bull, Ian/G-7816-2012	Bull, Ian/0000-0002-5881-5654; 				Bender M, 1995, SOIL BIOL BIOCHEM, V27, P1517, DOI 10.1016/0038-0717(95)00104-M; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boschker HTS, 1998, NATURE, V392, P801, DOI 10.1038/33900; BOWMAN JP, 1991, FEMS MICROBIOL ECOL, V85, P15, DOI 10.1016/0378-1097(91)90627-M; Cicerone RJ, 1988, GLOBAL BIOGEOCHEM CY, V2, P299, DOI 10.1029/GB002i004p00299; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; CRUTZEN PJ, 1991, NATURE, V350, P380, DOI 10.1038/350380a0; Dunfield PF, 1999, APPL ENVIRON MICROB, V65, P1009; GUCKERT JB, 1985, FEMS MICROBIOL ECOL, V31, P147, DOI 10.1111/j.1574-6968.1985.tb01143.x; GUCKERT JB, 1991, J GEN MICROBIOL, V137, P2631, DOI 10.1099/00221287-137-11-2631; Hall GH, 1996, SOIL BIOL BIOCHEM, V28, P9, DOI 10.1016/0038-0717(95)00122-0; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; JONES DM, 1991, BIOL MASS SPECTROM, V20, P641, DOI 10.1002/bms.1200201009; NICHOLS PD, 1987, ENVIRON TOXICOL CHEM, V6, P89, DOI [10.1897/1552-8618(1987)6[89:DOAMCI]2.0.CO;2, 10.1002/etc.5620060203]; NICHOLS PD, 1985, FEMS MICROBIOL ECOL, V31, P327, DOI 10.1016/0378-1097(85)90028-X; RIELEY G, 1994, ANALYST, V119, P915, DOI 10.1039/an9941900915; Roslev P, 1999, APPL ENVIRON MICROB, V65, P4064; ZELLES L, 1995, BIOL FERT SOILS, V19, P115, DOI 10.1007/BF00336146	19	181	200	9	113	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 11	2000	405	6783					175	178		10.1038/35012061	http://dx.doi.org/10.1038/35012061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WG	10821271				2022-12-24	WOS:000087080100048
J	Davis, JB; Gray, J; Gunthorpe, MJ; Hatcher, JP; Davey, PT; Overend, P; Harries, MH; Latcham, J; Clapham, C; Atkinson, K; Hughes, SA; Rance, K; Grau, E; Harper, AJ; Pugh, PL; Rogers, DC; Bingham, S; Randall, A; Sheardown, SA				Davis, JB; Gray, J; Gunthorpe, MJ; Hatcher, JP; Davey, PT; Overend, P; Harries, MH; Latcham, J; Clapham, C; Atkinson, K; Hughes, SA; Rance, K; Grau, E; Harper, AJ; Pugh, PL; Rogers, DC; Bingham, S; Randall, A; Sheardown, SA			Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia	NATURE			English	Article							ROOT GANGLION NEURONS; CAPSAICIN-RECEPTOR; RAT; HEAT; CAPSAZEPINE; ANTAGONIST; RESPONSES; PHENOTYPE; SHIRPA; CELLS	The vanilloid receptor-1 (VR1) is a ligand-gated, non-selective cation channel expressed predominantly by sensory neurons. VR1 responds to noxious stimuli including capsaicin, the pungent component of chilli peppers, heat and extracellular acidification, and it is able to integrate simultaneous exposure to these stimuli(1,2). These findings and research linking capsaicin with nociceptive behaviours (that is, responses to painful stimuli in animals(3) have led to VR1 being considered as important for pain sensation. Here we have disrupted the mouse VR1 gene using standard gene targeting techniques. Small diameter dorsal root ganglion neurons isolated from VR1-null mice lacked many of the capsaicin-, acid- and heat-gated responses that have been previously well characterized in small diameter dorsal root ganglion neurons from various species. Furthermore, although the VR1-null mice appeared normal in a wide range of behavioural tests, including responses to acute noxious thermal stimuli, their ability to develop carrageenan-induced thermal hyperalgesia was completely absent. We conclude that VR1 is required for inflammatory sensitization to noxious thermal stimuli but also that alternative mechanisms are sufficient for normal sensation of noxious heat.	SmithKline Beecham Pharmaceut, Dept Neurosci Res, Harlow CM19 5AW, Essex, England; SmithKline Beecham Pharmaceut, Dept Stat Sci, Harlow CM19 5AW, Essex, England; SmithKline Beecham Pharmaceut, Dept Lab Anim Sci, Harlow CM19 5AW, Essex, England; SmithKline Beecham Pharmaceut, Dept Biotechnol & Genet, Harlow CM19 5AW, Essex, England	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Davis, JB (corresponding author), SmithKline Beecham Pharmaceut, Dept Neurosci Res, 3rd Ave, Harlow CM19 5AW, Essex, England.			Randall, Andrew/0000-0001-8852-3671				BEVAN S, 1995, J NEUROSCI, V15, P4918; BEVAN S, 1991, J PHYSIOL-LONDON, V433, P145, DOI 10.1113/jphysiol.1991.sp018419; BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Kwak JY, 1998, NEUROSCIENCE, V86, P619, DOI 10.1016/S0306-4522(98)00012-8; MILIKEN GA, 1992, ANAL MESSY DATA, P29; Nagy I, 1999, J NEUROSCI, V19, P10647, DOI 10.1523/JNEUROSCI.19-24-10647.1999; NAGY JI, 1983, J NEUROSCI, V3, P1145; Rogers DC, 1999, BEHAV BRAIN RES, V105, P207, DOI 10.1016/S0166-4328(99)00072-8; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Sasamura T, 1998, NEUROREPORT, V9, P2045, DOI 10.1097/00001756-199806220-00025; Szallasi A, 1999, PHARMACOL REV, V51, P159; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Torres RM, 1997, LAB PROTOCOLS CONDIT; Ueno S, 1999, BRIT J PHARMACOL, V126, P429, DOI 10.1038/sj.bjp.0702319; Waldmann R, 1999, ANN NY ACAD SCI, V868, P67, DOI 10.1111/j.1749-6632.1999.tb11274.x; WOOD JN, 1988, J NEUROSCI, V8, P3208; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	23	1338	1425	0	81	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 11	2000	405	6783					183	187		10.1038/35012076	http://dx.doi.org/10.1038/35012076			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WG	10821274				2022-12-24	WOS:000087080100051
J	Marples, D				Marples, D			Water channels: who needs them anyway?	LANCET			English	Editorial Material									Univ Leeds, Sch Biomed Sci, Leeds LS2 9NQ, W Yorkshire, England	University of Leeds	Marples, D (corresponding author), Univ Leeds, Sch Biomed Sci, Leeds LS2 9NQ, W Yorkshire, England.							DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; King LS, 1997, AM J PHYSIOL-CELL PH, V273, pC1541, DOI 10.1152/ajpcell.1997.273.5.C1541; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Marples D, 1999, AM J PHYSIOL-RENAL, V276, pF331, DOI 10.1152/ajprenal.1999.276.3.F331; Nielsen S, 1997, AM J PHYSIOL-CELL PH, V273, pC1549, DOI 10.1152/ajpcell.1997.273.5.C1549; Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1994, SCIENCE, V265, P1585, DOI 10.1126/science.7521540; Verkman AS, 2000, EXP PHYSIOL, V85, p233S, DOI 10.1111/j.1469-445X.2000.tb00028.x	9	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2000	355	9215					1571	1572		10.1016/S0140-6736(00)02209-1	http://dx.doi.org/10.1016/S0140-6736(00)02209-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CD	10821357				2022-12-24	WOS:000086981200004
J	Benlali, A; Draskovic, I; Hazelett, DJ; Treisman, JE				Benlali, A; Draskovic, I; Hazelett, DJ; Treisman, JE			Act up controls actin polymerization to alter cell shape and restrict hedgehog signaling in the Drosophila eye disc	CELL			English	Article							CYCLASE-ASSOCIATED PROTEIN; CUBITUS-INTERRUPTUS PROTEIN; SACCHAROMYCES-CEREVISIAE; PRONEURAL GENE; RETINAL DIFFERENTIATION; MORPHOGENETIC FURROW; NUCLEOTIDE EXCHANGE; IMAGINAL DISKS; TOUT-VELU; PROFILIN	Cells in the morphogenetic furrow of the Drosophila eye disc undergo a striking shape change immediately prior to their neuronal differentiation. We have isolated mutations in a novel gene, act up (acu), that is required for this shape change. acu encodes a homolog of yeast cyclase-associated protein, which sequesters monomeric actin; we show that acu is required to prevent actin filament polymerization in the eye disc. In contrast, profilin promotes actin filament polymerization, acting epistatically to acu. However, both acu and profilin are required to prevent premature Hedgehog-induced photoreceptor differentiation ahead of the morphogenetic furrow. These findings suggest that dynamic changes in actin filaments alter cell shape to control the movement of signals that coordinate a wave of differentiation.	NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Treisman, JE (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA.			Hazelett, Dennis/0000-0003-0749-9935; Treisman, Jessica/0000-0002-7453-107X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056131, R55GM056131] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM56131] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ayscough KR, 1998, CURR OPIN CELL BIOL, V10, P102, DOI 10.1016/S0955-0674(98)80092-6; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; Borod ER, 1998, DEV BIOL, V197, P187, DOI 10.1006/dbio.1998.8888; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROWN NL, 1995, CELL, V80, P879, DOI 10.1016/0092-8674(95)90291-0; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; CARLSSON L, 1977, J MOL BIOL, V115, P465, DOI 10.1016/0022-2836(77)90166-8; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; COOLEY L, 1992, CELL, V69, P173, DOI 10.1016/0092-8674(92)90128-Y; Dominguez M, 1999, DEVELOPMENT, V126, P2345; Dominguez M, 1997, GENE DEV, V11, P3254, DOI 10.1101/gad.11.23.3254; Edwards KA, 1996, DEVELOPMENT, V122, P1499; FEDORCHAIKEN M, 1990, CELL, V61, P329, DOI 10.1016/0092-8674(90)90813-T; FIELD J, 1990, CELL, V61, P319, DOI 10.1016/0092-8674(90)90812-S; FREEMAN NL, 1995, J BIOL CHEM, V270, P5680, DOI 10.1074/jbc.270.10.5680; Freeman NL, 1996, MOL CELL BIOL, V16, P548; GERST JE, 1991, MOL CELL BIOL, V11, P1248, DOI 10.1128/MCB.11.3.1248; GLESELMANN R, 1992, FEBS LETT, V298, P149; GOLDSCHMIDTCLERMONT PJ, 1992, MOL BIOL CELL, V3, P1015, DOI 10.1091/mbc.3.9.1015; Gottwald U, 1996, MOL BIOL CELL, V7, P261, DOI 10.1091/mbc.7.2.261; Greenwood S, 1999, DEVELOPMENT, V126, P5795; Hassan BA, 1998, GENETICS, V150, P1527; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; HEBERLEIN U, 1995, CELL, V81, P987, DOI 10.1016/S0092-8674(05)80003-0; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; HEBERLEIN U, 1995, NATURE, V373, P709, DOI 10.1038/373709a0; Horsfield J, 1998, DEVELOPMENT, V125, P5069; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; KAWAMUKAI M, 1992, MOL BIOL CELL, V3, P167, DOI 10.1091/mbc.3.2.167; Kimberly EL, 1998, DEV BIOL, V204, P235, DOI 10.1006/dbio.1998.9075; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; MASUCCI JD, 1990, GENE DEV, V4, P2011, DOI 10.1101/gad.4.11.2011; MATVIW H, 1992, MOL CELL BIOL, V12, P5033, DOI 10.1128/MCB.12.11.5033; Maurel-Zaffran C, 2000, DEVELOPMENT, V127, P1007; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; Newsome TP, 2000, DEVELOPMENT, V127, P851; PAN DJ, 1995, CELL, V80, P543, DOI 10.1016/0092-8674(95)90508-1; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Perelroizen I, 1996, J BIOL CHEM, V271, P12302, DOI 10.1074/jbc.271.21.12302; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; RONCHI E, 1993, CELL, V74, P347, DOI 10.1016/0092-8674(93)90425-P; Royet J, 1997, DEVELOPMENT, V124, P4793; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; STRUTT DI, 1995, NATURE, V373, P705, DOI 10.1038/373705a0; Suetsugu S, 1998, EMBO J, V17, P6516, DOI 10.1093/emboj/17.22.6516; Sutherland JD, 1999, CURR OPIN CELL BIOL, V11, P142, DOI 10.1016/S0955-0674(99)80018-0; Thackeray JR, 1998, DEVELOPMENT, V125, P5033; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; THERIOT JA, 1993, CELL, V75, P835, DOI 10.1016/0092-8674(93)90527-W; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TREISMAN JE, 1995, DEVELOPMENT, V121, P2835; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; VERDERAME M, 1980, P NATL ACAD SCI-BIOL, V77, P6624, DOI 10.1073/pnas.77.11.6624; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; VOJTEK A, 1991, CELL, V66, P497, DOI 10.1016/0092-8674(81)90013-1; VOJTEK AB, 1993, J CELL SCI, V105, P777; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; WOLFF T, 1991, DEVELOPMENT, V113, P841; Yang Y, 1999, DEVELOPMENT, V126, P3027; YU G, 1994, J CELL SCI, V107, P1671; Yu J, 1999, J BIOL CHEM, V274, P19985, DOI 10.1074/jbc.274.28.19985; Zelicof A, 1996, J BIOL CHEM, V271, P18243, DOI 10.1074/jbc.271.30.18243; ZHU XY, 1995, MOL BIOL CELL, V6, P273, DOI 10.1091/mbc.6.3.273	76	90	91	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 28	2000	101	3					271	281		10.1016/S0092-8674(00)80837-5	http://dx.doi.org/10.1016/S0092-8674(00)80837-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847682	Bronze			2022-12-24	WOS:000086741900007
J	Hildebrand, P; Meyer-Wyss, BM; Mossi, S; Beglinger, C				Hildebrand, P; Meyer-Wyss, BM; Mossi, S; Beglinger, C			Risk among gastroenterologists of acquiring Helicobacter pylori infection: case-control study	BRITISH MEDICAL JOURNAL			English	Article									Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland; Univ Basel Hosp, Div Gastroenterol, CH-4031 Basel, Switzerland; St Clara Hosp, Dept Internal Med, CH-4058 Basel, Switzerland	University of Basel; University of Basel	Hildebrand, P (corresponding author), Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland.		Beglinger, Christoph/D-2247-2010					Braden B, 1997, GASTROINTEST ENDOSC, V46, P305, DOI 10.1016/S0016-5107(97)70115-9; DILL S, 1990, GUT, V31, P1237, DOI 10.1136/gut.31.11.1237; MEGRAUD F, 1993, GASTROENTEROL CLIN N, V22, P73; MEYERWYSS BM, 1997, STABLE ISOTOPES PHAR; MITCHELL HM, 1989, SCAND J GASTROENTERO, V24, P396, DOI 10.3109/00365528909093065	5	23	24	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 15	2000	321	7254					149	149		10.1136/bmj.321.7254.149	http://dx.doi.org/10.1136/bmj.321.7254.149			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336MG	10894693	Green Published, Bronze			2022-12-24	WOS:000088305700022
J	Glynn, SA; Kleinman, SH; Schreiber, GB; Busch, MP; Wright, DJ; Smith, JW; Nass, CC; Williams, AE				Glynn, SA; Kleinman, SH; Schreiber, GB; Busch, MP; Wright, DJ; Smith, JW; Nass, CC; Williams, AE		Retrovirus Epidemiology Donor Stud	Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; UNITED-STATES; RISK; HEPATITIS	Context Evaluating trends in blood donor infectious disease rates is essential for monitoring blood supply safety and donor screening effectiveness. Objective To determine changes overtime in blood donor population infection rates of human immunodeficiency virus (HIV), human T-lymphotropic virus (HTLV), hepatitis C virus (HCV), and hepatitis B virus (HBV), Design Cross-sectional survey data from the National Heart, Lung, and Blood Institute-sponsored Retrovirus Epidemiology Donor Study. Setting Five blood centers in different regions of the United States. Participants A total of 1.9 million volunteer blood donors with 1 or more nonautologous donations from January 1991 to December 1996. Main Outcome Measures Changes in rates of HIV, HTLV, HCV, and HBV infections were evaluated by comparing yearly prevalence estimates (per 100 000 donations) for first-ti me allogeneic donors and period-specific incidence rates (IRs) (per 100 000 person-years) for repeat allogeneic donors between 1991 and 1996 (for HCV, from about March 1992 to June 1996). Results Prevalence of HIV decreased in first-time donors from 0.030% to 0.015% (P=.006) and HCV prevalence decreased from 0.63% to 0.40% (P<.001). Trends were not statistically significant for the proportion of first-time donors with hepatitis B surface antigen (HBsAg) or HTLV, For repeat donors, IRs did not change significantly, indicating a stable but low level of seroconversion. The overall IRs (95% confidence intervals) per 100 000 person-years were 2.92 (2.26-3.70) for HIV, 1.59 (1.12-2.19) for HTLV, 3.25 (2.36-4.36) for HCV, and an estimated 10.43 (7.99-13.37) for HBV (based on an HBsAg rate of 2.66 [2.04-3.41] with presumed false-positive results considered negative). The HBV IR estimate with presumed false-positive results considered positive (for comparability to previous analyses) was 17.83 (14.60-21.56). Conclusion The decrease in HIV and HCV prevalence rates, combined with the previously documented lower rates of infection in first-time donors compared with the general population, suggests the continued benefit of behavioral risk factor screening.	WESTAT Corp, Rockville, MD 20850 USA; Blood Ctr Pacific, San Francisco, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Blood Syst Inc, Scottsdale, AZ USA; Oklahoma Blood Inst, Oklahoma City, OK USA; Amer Red Cross, Blood Serv Greater Chesapeake & Potomac Reg, Baltimore, MD USA; Amer Red Cross, Holland Lab, Biomed Serv, Rockville, MD USA	Westat; University of California System; University of California San Francisco; Vitalant; American Red Cross; American Red Cross	Glynn, SA (corresponding author), WESTAT Corp, WB 280,1441 W Montgomery Ave, Rockville, MD 20850 USA.	GlynnS1@westat.com			DIVISION OF BLOOD DISEASES AND RESOURCES [N01HB097077, N01HB097078, N01HB047114] Funding Source: NIH RePORTER	DIVISION OF BLOOD DISEASES AND RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alter HJ, 1997, HEPATOLOGY, V26, pS29, DOI 10.1002/hep.510260705; Alter MJ, 1997, HEPATOLOGY, V26, pS62, DOI 10.1002/hep.510260711; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; ALTER MJ, 1994, GASTROENTEROL CLIN N, V23, P437; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; BASTIAANS MJS, 1982, VOX SANG, V42, P203, DOI 10.1111/j.1423-0410.1982.tb01096.x; BUSCH MP, 1994, BLOOD, V83, P1143; BUSCH MP, 1991, TRANSFUSION, V31, P4, DOI 10.1046/j.1537-2995.1991.31191096183.x; BUSCH MP, 1992, BLOOD SAFETY CURRENT, P1; BUSCH MP, 1997, APPL MOL BIOL BLOOD, P123; Coleman PJ, 1998, J INFECT DIS, V178, P954, DOI 10.1086/515696; CUMMING PD, 1989, NEW ENGL J MED, V321, P941, DOI 10.1056/NEJM198910053211405; DODD R, 1982, VIRAL HEPATITIS, P145; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; KAPLAN JE, 1989, AM FAM PHYSICIAN, V40, P189; Karon JM, 1996, JAMA-J AM MED ASSOC, V276, P126, DOI 10.1001/jama.276.2.126; KHABBAZ RF, 1992, NEW ENGL J MED, V326, P375, DOI 10.1056/NEJM199202063260604; Kleinman S, 1998, TRANSFUSION, V38, p92S; Kleinman S, 1998, TRANSFUS MED REV, V12, P288, DOI 10.1016/S0887-7963(98)80004-7; Kleinman S, 1997, TRANSFUS MED REV, V11, P155, DOI 10.1053/tmrv.1997.0110155; Kleinman S, 1998, JAMA-J AM MED ASSOC, V280, P1080, DOI 10.1001/jama.280.12.1080; Kleinman S, 1996, CLIN PRACTICE TRANSF, P245; KLEINMAN SH, 1994, J CLIN MICROBIOL, V32, P603, DOI 10.1128/JCM.32.3.603-607.1994; Korelitz JJ, 1997, TRANSFUSION, V37, P634, DOI 10.1046/j.1537-2995.1997.37697335159.x; Lackritz EM, 1995, NEW ENGL J MED, V333, P1721, DOI 10.1056/NEJM199512283332601; *SAS I INC, 1989, SAS STAT US GUID VER, P405; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; SNEDECOR GW, 1980, STAT METHODS, P75; Ward J W, 1997, AIDS Clin Rev, P1; Williams AE, 1997, JAMA-J AM MED ASSOC, V277, P967, DOI 10.1001/jama.277.12.967; Wright DJ, 1999, TRANSFUSION, V39, p106S; ZUCK TF, 1988, NEW ENGL J MED, V318, P511, DOI 10.1056/NEJM198802253180809; 1990, MMWR MORB MORTAL WKL, V39, P915	33	194	207	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 12	2000	284	2					229	235		10.1001/jama.284.2.229	http://dx.doi.org/10.1001/jama.284.2.229			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329XE	10889598	Bronze			2022-12-24	WOS:000087933100029
J	Bresnahan, WA; Shenk, T				Bresnahan, WA; Shenk, T			A subset of viral transcripts packaged within human cytomegalovirus particles	SCIENCE			English	Article							RNA-BINDING PROTEIN; STRAIN AD169; DENSE BODIES; SEQUENCE; REPEAT	A human cytomegalovirus gene array was used to identify a previously unidentified class of viral transcripts, These transcripts, termed virion RNAs, were packaged within infectious virions and were delivered to the host cell on infection, This mechanism of herpesvirus gene expression allows for viral genes to be expressed within an infected cell immediately after virus entry and in the absence of transcription from the viral genome.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Shenk, T (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	tshenk@princeton.edu			NCI NIH HHS [CA85786] Funding Source: Medline; NIAID NIH HHS [F32 AI010448] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI010448] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baldick CJ, 1996, J VIROL, V70, P6097, DOI 10.1128/JVI.70.9.6097-6105.1996; CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hirsch AJ, 1999, J VIROL, V73, P404, DOI 10.1128/JVI.73.1.404-410.1999; HUTCHINSON NI, 1986, VIROLOGY, V155, P160, DOI 10.1016/0042-6822(86)90176-5; IRMIERE A, 1983, VIROLOGY, V130, P118, DOI 10.1016/0042-6822(83)90122-8; MATHEWS MB, 1991, J VIROL, V65, P5657, DOI 10.1128/JVI.65.11.5657-5662.1991; MCDONOUGH SH, 1985, J VIROL, V53, P711, DOI 10.1128/JVI.53.3.711-718.1985; Mullberg J, 1999, J GEN VIROL, V80, P437, DOI 10.1099/0022-1317-80-2-437; PLATCHER B, 1988, J GEN VIROL, V69, P2251; RAWLINSON WD, 1993, J VIROL, V67, P5502, DOI 10.1128/JVI.67.9.5502-5513.1993; ROLLER RJ, 1990, J VIROL, V64, P3463, DOI 10.1128/JVI.64.7.3463-3470.1990; ROLLER RJ, 1992, J VIROL, V66, P3624, DOI 10.1128/JVI.66.6.3624-3632.1992; SAROV I, 1975, VIROLOGY, V66, P464, DOI 10.1016/0042-6822(75)90218-4; STINSKI MF, 1976, J VIROL, V19, P594, DOI 10.1128/JVI.19.2.594-609.1976; WATERS MG, 1992, J CELL BIOL, V118, P1015, DOI 10.1083/jcb.118.5.1015; WATHEN MW, 1982, J VIROL, V41, P462, DOI 10.1128/JVI.41.2.462-477.1982; Zhu H., UNPUB	18	129	132	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2000	288	5475					2373	2376		10.1126/science.288.5475.2373	http://dx.doi.org/10.1126/science.288.5475.2373			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329NP	10875924				2022-12-24	WOS:000087913400042
J	Takaoka, A; Mitani, Y; Suemori, H; Sato, M; Yokochi, T; Noguchi, S; Tanaka, N; Taniguchi, T				Takaoka, A; Mitani, Y; Suemori, H; Sato, M; Yokochi, T; Noguchi, S; Tanaka, N; Taniguchi, T			Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains	SCIENCE			English	Article							IFN-GAMMA; ACTIVATION; RECEPTOR; RESPONSES; PROTEIN; GENES; CELLS	Definition of cellular responses to cytokines often involves cross-communication through their respective receptors. Here, signaling by interferon-gamma (IFN-gamma) is shown to depend on the IFN-alpha/beta receptor components. Although these IFNs transmit signals through distinct receptor complexes, the IFN-alpha/beta receptor component, IFNAR1, facilitates efficient assembly of IFN-gamma-activated transcription factors. This cross talk is contingent on a constitutive subthreshold IFN-alpha/beta signaling and the association between the two nonligand-binding receptor components, IFNAR1 and IFNGR2, in the caveolar membrane domains. This aspect of signaling cross talk by IFNs may apply to other cytokines.	Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; Meiji Inst Hlth Sci, Odawara, Kanagawa 2500862, Japan	University of Tokyo	Taniguchi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.			Tanaka, Nobuyuki/0000-0002-6373-2220				Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Billiau A, 1996, ADV IMMUNOL, V62, P61, DOI 10.1016/S0065-2776(08)60428-9; Bluyssen Hans A. R., 1996, Cytokine and Growth Factor Reviews, V7, P11, DOI 10.1016/1359-6101(96)00005-6; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Demaeyer E., 1988, INTERFERONS OTHER RE; Erlandsson L, 1998, CURR BIOL, V8, P223, DOI 10.1016/S0960-9822(98)70086-7; FLEISCHMANN WR, 1979, INFECT IMMUN, V26, P248, DOI 10.1128/IAI.26.1.248-253.1979; GREENLUND AC, 1994, EMBO J, V13, P1591, DOI 10.1002/j.1460-2075.1994.tb06422.x; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; Li XX, 1997, MOL CELL BIOL, V17, P2048, DOI 10.1128/MCB.17.4.2048; Matsumoto M, 1999, BIOL CHEM, V380, P699, DOI 10.1515/BC.1999.087; Mineo C, 1996, J BIOL CHEM, V271, P11930, DOI 10.1074/jbc.271.20.11930; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; SATO M, UNPUB; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; STEWART WE, 1971, J VIROL, V7, P792, DOI 10.1128/JVI.7.6.792-801.1971; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; TAKAOKA A, UNPUB; VILCEK J, 1996, FIELDS VIROLOGY, P375; WEISSMANN C, 1986, PROG NUCLEIC ACID RE, V33, P251, DOI 10.1016/S0079-6603(08)60026-4; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yan H, 1996, EMBO J, V15, P1064, DOI 10.1002/j.1460-2075.1996.tb00444.x	31	266	272	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 30	2000	288	5475					2357	2360		10.1126/science.288.5475.2357	http://dx.doi.org/10.1126/science.288.5475.2357			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329NP	10875919				2022-12-24	WOS:000087913400037
J	Cooper, ME; Johnston, CI				Cooper, ME; Johnston, CI			Optimizing treatment of hypertension in patients with diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED TRIAL; CARDIOVASCULAR MORTALITY; SYSTOLIC HYPERTENSION; MORBIDITY; INTERVENTION; PREVENTION; DISEASE; RISK		Univ Melbourne, Austin & Repatriat Med Ctr, Dept Med, Heidelberg, Vic, Australia; Baker Med Res Inst, Melbourne, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Baker Heart and Diabetes Institute	Johnston, CI (corresponding author), Alfred Hosp, Baker Med Res Inst, Commercial Rd, Prahran, Vic 3181, Australia.		Cooper, Mark/AAC-5326-2020; Cooper, Mark E/E-8680-2010	Cooper, Mark E/0000-0002-5953-642X				Black HR, 1997, ARCH INTERN MED, V157, P2413; Chalmers J, 1999, J HYPERTENS, V17, P151; Cooper ME, 1998, LANCET, V352, P213, DOI 10.1016/S0140-6736(98)01346-4; Curb JD, 1996, JAMA-J AM MED ASSOC, V276, P1886, DOI 10.1001/jama.276.23.1886; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1; Gerstein HC, 2000, LANCET, V355, P253; Gong LS, 1996, J HYPERTENS, V14, P1237, DOI 10.1097/00004872-199610000-00013; Gustafsson I, 1999, J AM COLL CARDIOL, V34, P83, DOI 10.1016/S0735-1097(99)00146-1; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Pahor M, 1998, LANCET, V351, P689, DOI 10.1016/S0140-6736(05)78489-0; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Tatti P, 1998, DIABETES CARE, V21, P597, DOI 10.2337/diacare.21.4.597; Tuomilehto J, 1999, NEW ENGL J MED, V340, P677, DOI 10.1056/NEJM199903043400902; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Zuanetti G, 1997, CIRCULATION, V96, P4239	22	57	60	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2000	283	24					3177	3179		10.1001/jama.283.24.3177	http://dx.doi.org/10.1001/jama.283.24.3177			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326TY	10866846				2022-12-24	WOS:000087753900002
J	Bidmead, J; Cardozo, L				Bidmead, J; Cardozo, L			Short cut to continence?	LANCET			English	Editorial Material							GENUINE STRESS-INCONTINENCE; 2-YEAR FOLLOW-UP; URINARY-INCONTINENCE; COLLAGEN; SURGERY; WOMEN		Kings Coll Hosp London, Dept Urogynaecol, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Bidmead, J (corresponding author), Kings Coll Hosp London, Dept Urogynaecol, Denmark Hill, London SE5 9RS, England.							Anders K, 1999, NEUROUROL URODYNAM, V18, P297; Black NA, 1996, BRIT J UROL, V78, P497, DOI 10.1046/j.1464-410X.1996.01422.x; Burton G., 1997, Neurourology and Urodynamics, V16, P353; ECKFORD SD, 1991, BRIT J UROL, V68, P586, DOI 10.1111/j.1464-410X.1991.tb15420.x; Gorton E, 1999, BJU INT, V84, P966; Hutchings A, 1998, BRIT J UROL, V82, P634; JARVIS GJ, 1994, BRIT J OBSTET GYNAEC, V101, P371, DOI 10.1111/j.1471-0528.1994.tb11907.x; Khullar V, 1997, BRIT J OBSTET GYNAEC, V104, P96, DOI 10.1111/j.1471-0528.1997.tb10657.x; KLIGMAN AM, 1986, J DERMATOL SURG ONC, V12, P351, DOI 10.1111/j.1524-4725.1986.tb01920.x; LAYCOCK J, 1995, INVESTIGATION MANAGE; Leach GE, 1997, J UROLOGY, V158, P875, DOI 10.1016/S0022-5347(01)64346-5; MONGA AK, 1995, BRIT J UROL, V76, P156, DOI 10.1111/j.1464-410X.1995.tb07664.x; PETROS P, 1995, SCAND J UROL NEPHROL, V29, P75; Schultheiss D., 1998, Neurourology and Urodynamics, V17, P457; Ulmsten U, 1999, BRIT J OBSTET GYNAEC, V106, P345, DOI 10.1111/j.1471-0528.1999.tb08272.x	15	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2000	355	9222					2183	2184		10.1016/S0140-6736(00)02398-9	http://dx.doi.org/10.1016/S0140-6736(00)02398-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327DX	10881888				2022-12-24	WOS:000087779000006
J	Gonzalez, S; Kitchener, AC; Lister, AM				Gonzalez, S; Kitchener, AC; Lister, AM			Survival of the Irish elk into the Holocene	NATURE			English	Article							MEGALOCEROS-GIGANTEUS		Liverpool John Moores Univ, Sch Biol & Earth Sci, Liverpool L3 3AF, Merseyside, England; UCL, Dept Biol, London WC1E 6BT, England; Natl Museums Scotland, Dept Geol & Zool, Edinburgh EH1 1JF, Midlothian, Scotland	Liverpool John Moores University; University of London; University College London	Gonzalez, S (corresponding author), Liverpool John Moores Univ, Sch Biol & Earth Sci, Byrom St, Liverpool L3 3AF, Merseyside, England.	A.Lister@ucl.ac.uk		Kitchener, Andrew/0000-0003-2594-0827; Lister, Adrian/0000-0002-7985-138X				DICKSON CA, 1970, PHILOS T ROY SOC B, V258, P31, DOI 10.1098/rstb.1970.0031; GOULD SJ, 1974, EVOLUTION, V28, P191, DOI 10.1111/j.1558-5646.1974.tb00740.x; Guthrie R.D., 1984, P259; Hibbert S., 1825, EDINB J SCI, V3, P15; KERMODE PMC, 1898, GEOL MAG, V5, P116; LAMBECK K, 1995, J GEOL SOC LONDON, V152, P437, DOI 10.1144/gsjgs.152.3.0437; Lister Adrian M., 1995, Geological Society Special Publication, V96, P151, DOI 10.1144/GSL.SP.1995.096.01.12; LISTER AM, 1994, ZOOL J LINN SOC-LOND, V112, P65, DOI 10.1111/j.1096-3642.1994.tb00312.x; MITCHELL G. F., 1949, PROC ROY IRISH ACAD SECT B, V52, P291; Moen RA, 1999, EVOL ECOL RES, V1, P235; OSWALD HR, 1825, EDINB J SCI, V3, P28; REEVES GM, 1982, P IOM NAT HIST ANT S, P416; STUART AJ, 1991, BIOL REV, V66, P453, DOI 10.1111/j.1469-185X.1991.tb01149.x; VARTANYAN SL, 1993, NATURE, V362, P337, DOI 10.1038/362337a0; WOODMAN PC, 1978, 58 BR ARCH	15	23	26	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					753	754		10.1038/35015668	http://dx.doi.org/10.1038/35015668			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866185				2022-12-24	WOS:000087620600035
J	Oelgeschlager, M; Larrain, J; Geissert, D; De Robertis, EM				Oelgeschlager, M; Larrain, J; Geissert, D; De Robertis, EM			The evolutionarily conserved BMP-binding protein Twisted gastrulation promotes BMP signalling	NATURE			English	Article							DORSAL-VENTRAL PATTERN; DROSOPHILA EMBRYO; ACTIVITY GRADIENT; ZEBRAFISH EMBRYO; FAMILY MEMBER; GROWTH-FACTOR; XENOPUS; DPP; ORGANIZER; RECEPTOR	Dorsal-ventral patterning in vertebrate and Drosophila embryos requires a conserved system of extracellular proteins to generate a positional information gradient. The components involved include bone morphogenetic proteins (BMP/Dpp), a BMP antagonist (Chordin/Short gastrulation; Chd/Sog) and a secreted metalloproteinase (Xolloid/Tolloid) that cleaves Chd/Sog. Here we describe Xenopus Twisted gastrulation (xTsg), another member of this signalling pathway. xTsg is expressed ventrally as part of the BMP-4 synexpression group and encodes a secreted BMP-binding protein that is a BMP signalling agonist. The data suggest a molecular mechanism by which xTsg dislodges latent BMPs bound to Chordin BMP-binding fragments generated by Xolloid cleavage, providing a permissive signal that allows high BMP signalling in the embryo. Drosophila Tsg also binds BMPs and is expressed dorsally, supporting the proposal that the dorsal-ventral axis was inverted in the course of animal evolution.	Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	De Robertis, EM (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	derobert@hhmi.ucla.edu		De Robertis, Edward/0000-0002-7843-1869	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD021502] Funding Source: NIH RePORTER; NICHD NIH HHS [R37 HD021502-14, R37 HD021502] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ashe HL, 1999, NATURE, V398, P427, DOI 10.1038/18892; Biehs B, 1996, GENE DEV, V10, P2922, DOI 10.1101/gad.10.22.2922; Bier E, 1999, NATURE, V398, P375, DOI 10.1038/18778; Bosher JM, 2000, NAT CELL BIOL, V2, pE31, DOI 10.1038/35000102; Connors SA, 1999, DEVELOPMENT, V126, P3119; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; De Robertis E.M., 1994, P11; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Dick A, 2000, DEVELOPMENT, V127, P343; Esteban CR, 1999, NATURE, V401, P243, DOI 10.1038/45738; FAINSOD A, 1994, EMBO J, V13, P5015, DOI 10.1002/j.1460-2075.1994.tb06830.x; FERGUSON EL, 1992, DEVELOPMENT, V114, P583; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; FRANCOIS V, 1994, GENE DEV, V8, P2602, DOI 10.1101/gad.8.21.2602; Geoffroy Saint-Hilaire E., 1822, MEMOIRES DU MUSEUM D, V9, P89; Goodman SA, 1998, DEV BIOL, V195, P144, DOI 10.1006/dbio.1997.8840; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Hild M, 1999, DEVELOPMENT, V126, P2149; HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0; Holley SA, 1996, CELL, V86, P607, DOI 10.1016/S0092-8674(00)80134-8; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; JONES CM, 1992, DEVELOPMENT, V115, P639; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; KNOLL AH, 1999, SCIENCE, V284, P2129, DOI DOI 10.1126/SCIENCE.284.5423.2129; Larrain J, 2000, DEVELOPMENT, V127, P821; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; MASON ED, 1994, GENE DEV, V8, P1489, DOI 10.1101/gad.8.13.1489; Mason ED, 1997, MECH DEVELOP, V64, P61, DOI 10.1016/S0925-4773(97)00049-X; Neul JL, 1998, CELL, V95, P483, DOI 10.1016/S0092-8674(00)81616-5; Nguyen M, 1998, CELL, V95, P495, DOI 10.1016/S0092-8674(00)81617-7; Niehrs C, 1999, NATURE, V402, P483, DOI 10.1038/990025; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Schmid B, 2000, DEVELOPMENT, V127, P957; Schmidt J, 1995, DEVELOPMENT, V121, P4319; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Scott IC, 1999, DEV BIOL, V213, P283, DOI 10.1006/dbio.1999.9383; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Weinmaster G, 1998, SCIENCE, V279, P336, DOI 10.1126/science.279.5349.336; Yu K, 2000, DEVELOPMENT, V127, P2143; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6; Zhu Y, 1999, J CELL BIOL, V144, P1069, DOI 10.1083/jcb.144.5.1069; ZUSMAN SB, 1988, DEV BIOL, V129, P417, DOI 10.1016/0012-1606(88)90389-2	50	228	266	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2000	405	6788					757	763		10.1038/35015500	http://dx.doi.org/10.1038/35015500			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866189	Green Accepted			2022-12-24	WOS:000087620600040
J	Pauly, N; Knight, MR; Thuleau, P; van der Luit, AH; Moreau, M; Trewavas, AJ; Ranjeva, R; Mazars, C				Pauly, N; Knight, MR; Thuleau, P; van der Luit, AH; Moreau, M; Trewavas, AJ; Ranjeva, R; Mazars, C			Cell signalling - Control of free calcium in plant cell nuclei	NATURE			English	Article							CYTOPLASMIC CALCIUM; GENE-EXPRESSION; TOBACCO		UPS, CNRS, UMR 5546, F-31326 Castanet Tolosan, France; Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; Univ Toulouse 3, Ctr Dev Biol, CNRS, UMR 5547, F-31062 Toulouse, France; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JH, Midlothian, Scotland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Oxford; Netherlands Cancer Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Edinburgh	Pauly, N (corresponding author), UPS, CNRS, UMR 5546, Pole Biotechnol Vegetale,24 Chemin de Borde Rouge, F-31326 Castanet Tolosan, France.		Pauly, Nicolas/L-1484-2015	Pauly, Nicolas/0000-0003-2990-3150; Mazars, Christian/0000-0002-0670-6042; Knight, Marc/0000-0002-4830-8608				BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Malviya AN, 1998, CELL, V92, P17, DOI 10.1016/S0092-8674(00)80895-8; McAinsh MR, 1998, TRENDS PLANT SCI, V3, P32, DOI 10.1016/S1360-1385(97)01150-3; STOPPIN V, 1994, PLANT CELL, V6, P1099, DOI 10.1105/tpc.6.8.1099; Takahashi K, 1998, BBA-MOL CELL RES, V1401, P339, DOI 10.1016/S0167-4889(97)00134-1; van der Luit AH, 1999, PLANT PHYSIOL, V121, P705, DOI 10.1104/pp.121.3.705	9	98	106	1	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					754	755		10.1038/35015671	http://dx.doi.org/10.1038/35015671			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866186				2022-12-24	WOS:000087620600036
J	Boutros, M; Mihaly, J; Bouwmeester, T; Mlodzik, M				Boutros, M; Mihaly, J; Bouwmeester, T; Mlodzik, M			Signaling specificity by frizzled receptors in Drosophila	SCIENCE			English	Article							PLANAR POLARITY; TISSUE POLARITY; CELL FATES; WINGLESS; WNT; PATHWAYS; EXPRESSION; ACTIVATION; XENOPUS; PROTEIN	Wnt-Frizzled (Fz) signaling pathways play recurring important roles during the development and homeostasis of vertebrates and invertebrates. Fz receptors can signal through beta-catenin-dependent and -independent pathways. In Drosophila, Fr and Fz2 are redundant receptors for Wg. In addition, Fz conveys signals through a distinct pathway to organize planar polarization of epithelial structures. We demonstrate that the cytoplasmic sequences of Fz2 and Fz preferentially activate the beta-catenin and planar polarity cascade, respectively. Both receptors activate either pathway, but with different efficiencies. Intrinsic differences in signaling efficiency in closely related receptors might be a general mechanism for generating signaling specificity in vivo.	European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Mlodzik, M (corresponding author), European Mol Biol Lab, Dev Biol Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.	mlodzik@embl-heidelberg.de	Boutros, Michael/C-3566-2008	Boutros, Michael/0000-0002-9458-817X; Mihaly, Jozsef/0000-0003-3399-2424				Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Bhat KM, 1998, CELL, V95, P1027, DOI 10.1016/S0092-8674(00)81726-2; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; BOUTROS M, UNPUB RESULTS; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brannon M, 1996, DEV BIOL, V180, P344, DOI 10.1006/dbio.1996.0306; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Chen CM, 1999, DEVELOPMENT, V126, P5441; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Cox RT, 1998, CURR BIOL, V8, pR140, DOI 10.1016/S0960-9822(98)70081-8; Fagotto F, 1997, DEVELOPMENT, V124, P453; Fanto M, 1999, NATURE, V397, P523, DOI 10.1038/17389; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Itoh K, 1997, MECH DEVELOP, V61, P113, DOI 10.1016/S0925-4773(96)00627-2; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Muller HAJ, 1999, DEVELOPMENT, V126, P577; ROMANI S, 1989, GENE DEV, V3, P997, DOI 10.1101/gad.3.7.997; Sato A, 1999, DEVELOPMENT, V126, P4421; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Tomlinson A, 1999, DEVELOPMENT, V126, P5725; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; Zhang J, 1998, DEVELOPMENT, V125, P3075	31	100	102	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2000	288	5472					1825	1828		10.1126/science.288.5472.1825	http://dx.doi.org/10.1126/science.288.5472.1825			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	322HH	10846164				2022-12-24	WOS:000087503800050
J	Henney, JE				Henney, JE			New therapy for macular degeneration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									Commissioners Food & Drugs, Rockville, MD 20857 USA		Henney, JE (corresponding author), Commissioners Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2000	283	21					2779	2779		10.1001/jama.283.21.2779-b	http://dx.doi.org/10.1001/jama.283.21.2779-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BQ	10896520				2022-12-24	WOS:000087381500006
J	Ades, AE; Parker, S; Walker, J; Edginton, M; Taylor, GP; Weber, JN				Ades, AE; Parker, S; Walker, J; Edginton, M; Taylor, GP; Weber, JN			Human T cell leukaemia/lymphoma virus infection in pregnant women in the United Kingdom: population study	BRITISH MEDICAL JOURNAL			English	Article							COST-EFFECTIVENESS ANALYSIS; LEUKEMIA-LYMPHOMA VIRUS; HTLV-I INFECTION; BLOOD-DONORS; PREVALENCE; ANTIBODIES; SEROPREVALENCE; TRANSMISSION; LONDON; SWEDEN	Objective To assess the prevalence of human T cell leukaemia /lymphoma virus (HTLV) infection in pregnant women in the United Kingdom. Design Population study. Subjects Guthrie card samples from babies born in 1997-8. Samples were linked to data on mother's age and ethnic status and parents' country of birth and then anonymised. Setting North Thames Regional Health Authority Main outcome measures Presence of antibodies against HTLV in eluates tested by gelatin particle agglutination assay and results confirmed by immunoblot Results Of 126 010 samples tested, 67 had confirmed antibodies to HTLV (59 HTLV-I, 2 HTLV-II, 6 untyped) and six had indeterminate results. Seroprevalence was 17.0 per 1000 (95% confidence interval 9.2 to 28.3) in infants whose mothers were born in the Caribbean, 3.2/1000 (1.5 to 5.9) with mothers born in west and central Africa, and 6.8/1000 (3.1 to 12.9) in infants of black Caribbean mothers born in non-endemic regions. In infants with no known risk (both parents born in non-endemic regions and mother not black Caribbean) seroprevalence was 0.06-0.12 per 1000. Mother's country of birth, father's country of birth, and mother's ethnic status were all independently associated with neonatal seroprevalence. An estimated 223 (95% confidence interval 110 to 350) of the 720 000 pregnant women each year in the United Kingdom are infected with HTLV. Conclusions The prevalence of HTLV and HIV infections in pregnant women in the United Kingdom are comparable. The cost effectiveness of antenatal HTLV screening should be evaluated, and screening of blood donations should be considered.	Inst Child Hlth, Dept Epidemiol & Publ Hlth, London WC1N 1EH, England; Great Ormond St Hosp Children NHS Trust, Dept Virol, London WC1N 3JH, England; Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Sch Med, Dept Genitourinary Med & Communicable Dis, London W2 1PG, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Imperial College London	Ades, AE (corresponding author), Inst Child Hlth, Dept Epidemiol & Publ Hlth, 30 Guilford St, London WC1N 1EH, England.							Ades AE, 1999, AIDS, V13, P2437, DOI 10.1097/00002030-199912030-00016; Ades AE, 1999, BRIT MED J, V319, P1230, DOI 10.1136/bmj.319.7219.1230; Andersson S, 1999, TRANSFUSION, V39, P845, DOI 10.1046/j.1537-2995.1999.39080845.x; BANATVALA JE, 1990, LANCET, V335, P860; BHIGJEE AI, 1993, S AFR MED J, V83, P665; BRENNAN M, 1993, BRIT MED J, V307, P1235, DOI 10.1136/bmj.307.6914.1235; *DEP HLTH, 1999, PREV HIV ENGL WAL 19; Donati M, 2000, BMJ-BRIT MED J, V320, P92, DOI 10.1136/bmj.320.7227.92; DONEGAN E, 1994, TRANSFUSION, V34, P478, DOI 10.1046/j.1537-2995.1994.34694295061.x; FLANAGAN P, 1995, VOX SANG, V68, P220, DOI 10.1111/j.1423-0410.1995.tb02576.x; Foster K, 1997, INFANT FEEDING 1995; Gessain A, 1996, J ACQ IMMUN DEF SYND, V13, pS132, DOI 10.1097/00042560-199600001-00022; Goubau P, 1996, J ACQ IMMUN DEF SYND, V13, P68; Hale A, 1997, J MED VIROL, V52, P326, DOI 10.1002/(SICI)1096-9071(199707)52:3&lt;326::AID-JMV15&gt;3.0.CO;2-G; Hall WW, 1996, J ACQ IMMUN DEF SYND, V13, pS204, DOI 10.1097/00042560-199600001-00031; Hanchard B, 1996, J ACQ IMMUN DEF SYND, V13, pS20, DOI 10.1097/00042560-199600001-00005; Hino S, 1996, J ACQ IMMUN DEF SYND, V13, pS199, DOI 10.1097/00042560-199600001-00030; *INT AG RES CANC, 1996, MON EV CARC RISK HUM, V67; Kaplan JE, 1996, J ACQ IMMUN DEF SYND, V12, P193, DOI 10.1097/00042560-199606010-00014; KAPLAN JE, 1993, REV MED VIROL, V3, P137, DOI 10.1002/rmv.1980030304; KATAMINE S, 1999, J ACQ IMMUN DEF SYND, V20, pA23; LEE H, 1989, SCIENCE, V244, P472; MATHESON J, 1999, SOCIAL TRENDS, V29; MURPHY EL, 1991, AM J EPIDEMIOL, V133, P1114, DOI 10.1093/oxfordjournals.aje.a115824; NIGHTINGALE S, 1993, EPIDEMIOL INFECT, V110, P379, DOI 10.1017/S0950268800068321; *OFF NAT STAT, 1998, BIRTH STAT FM1, V25; *OFF NAT STAT, 1998, KEY POP VIT STA VS22, V18; OPCS/GRO(S), 1993, 1991 CENS ETHN GROUP; Otigbah C, 1997, BRIT J OBSTET GYNAEC, V104, P258, DOI 10.1111/j.1471-0528.1997.tb11057.x; OWEN D, 1996, ETHNICITY 1991 CENSU, V2; Parker SP, 1997, J VIROL METHODS, V68, P199, DOI 10.1016/S0166-0934(97)00127-4; PARKER SP, 1995, J CLIN PATHOL, V45, P904; Plancoulaine S, 1998, INT J CANCER, V76, P331, DOI 10.1002/(SICI)1097-0215(19980504)76:3&lt;331::AID-IJC8&gt;3.0.CO;2-W; Takezaki Toshiro, 1997, Leukemia (Basingstoke), V11, P60; Taylor GP, 1996, J ACQ IMMUN DEF SYND, V13, pS8, DOI 10.1097/00042560-199600001-00003; TAYLOR GP, 1998, VIRUSES HUMNAN CANC, P109; Tosswill JHC, 2000, BRIT MED J, V320, P611, DOI 10.1136/bmj.320.7235.611; TOSSWILL JHC, 1990, BRIT MED J, V301, P95, DOI 10.1136/bmj.301.6743.95; Tynell E, 1998, BRIT MED J, V316, P1417, DOI 10.1136/bmj.316.7142.1417; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212; WEBER JN, 1996, BRIT MED J, V312, P702; WIKTOR SZ, 1997, J HUMAN VIROL, V1, P38; Yamashita M, 1996, J ACQ IMMUN DEF SYND, V13, pS124, DOI 10.1097/00042560-199600001-00021; 1999, COMM DIS REP, V9, P340	44	34	36	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 3	2000	320	7248					1497	1501		10.1136/bmj.320.7248.1497	http://dx.doi.org/10.1136/bmj.320.7248.1497			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321TP	10834889	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000087471000019
J	Boyington, JC; Motyka, SA; Schuck, P; Brooks, AG; Sun, PD				Boyington, JC; Motyka, SA; Schuck, P; Brooks, AG; Sun, PD			Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand	NATURE			English	Article							NATURAL-KILLER-CELLS; LEUKOCYTE ANTIGEN (HLA)-CW4; HLA-C MOLECULES; INHIBITORY RECEPTOR; MEDIATED LYSIS; DIRECT BINDING; AMINO-ACID; PEPTIDE; RECOGNITION; SELECTIVITY	Target cell lysis is regulated by natural killer (NK) cell receptors that recognize class I MHC molecules, Here we report the crystal structure of the human immunoglobulin-like NK cell receptor KIR2DL2 in complex with its class I ligand HLA-Cw3 and peptide. KIR binds in a nearly orthogonal orientation across the alpha 1 and alpha 2 helices of Cw3 and directly contacts positions 7 acid 8 of the peptide. No significant conformational changes in KIR occur on complex formation. The receptor footprint on HCB overlaps with but is distinct from that of the T-cell receptor. Charge complementarity dominates the KIR/HLA interface and mutations that disrupt interface salt bridges substantially diminish binding. Most contacts in the complex are between hip and conserved HLA-C residues. but a hydrogen band between Lys 44 of KIR2DL2 and Asn 80 of Cw3 confers the allotype specificity. KIR contact requires position 8 of the peptide to be a residue smaller than valine, A second KIR/HLA interface produced an ordered receptor-ligand aggregation in the crystal which may resemble receptor clustering during immune synapse formation.	NIAAA, Struct Biol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA; Johns Hopkins Univ, Sch Med, Biochem Cellular & Mol Biol Program, Bethesda, MD 20205 USA; NIH, Bioengn & Phys Sci Program, Bethesda, MD 20892 USA; Univ Melbourne, Dept Immunol & Microbiol, Parkville, Vic 3052, Australia	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Johns Hopkins University; National Institutes of Health (NIH) - USA; University of Melbourne	Sun, PD (corresponding author), NIAAA, Struct Biol Sect, Immunogenet Lab, NIH, 12441 Parklawn Dr, Rockville, MD 20852 USA.	psun@nih.gov	Schuck, Peter/AAA-6888-2020	Schuck, Peter/0000-0002-8859-6966; Brooks, Andrew/0000-0002-4085-9683	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000697, Z01AI000697] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [Z01OD010485] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Barber LD, 1996, J EXP MED, V184, P735, DOI 10.1084/jem.184.2.735; Biassoni R, 1997, EUR J IMMUNOL, V27, P3095, DOI 10.1002/eji.1830271203; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Boyington JC, 1999, IMMUNITY, V10, P75, DOI 10.1016/S1074-7613(00)80008-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; *COLL COMP PROJ 4, 1995, ACTA CRYSTALLOGR D, V50, P760; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; Davis SJ, 1998, IMMUNOL REV, V163, P217, DOI 10.1111/j.1600-065X.1998.tb01199.x; FALK K, 1993, P NATL ACAD SCI USA, V90, P12005, DOI 10.1073/pnas.90.24.12005; Fan QR, 1999, J EXP MED, V190, P113, DOI 10.1084/jem.190.1.113; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LITTAUA RA, 1991, J VIROL, V65, P4051, DOI 10.1128/JVI.65.8.4051-4056.1991; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Maenaka K, 1999, J BIOL CHEM, V274, P28329, DOI 10.1074/jbc.274.40.28329; Maenaka K, 1999, STRUCTURE, V7, P391, DOI 10.1016/S0969-2126(99)80052-5; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; Mandelboim O, 1997, IMMUNITY, V6, P341, DOI 10.1016/S1074-7613(00)80336-2; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Orihuela M, 1996, P NATL ACAD SCI USA, V93, P11792, DOI 10.1073/pnas.93.21.11792; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pende D, 1998, EUR J IMMUNOL, V28, P2384, DOI 10.1002/(SICI)1521-4141(199808)28:08<2384::AID-IMMU2384>3.0.CO;2-L; Peruzzi M, 1996, J IMMUNOL, V157, P3350; Rajagopalan S, 1997, J EXP MED, V185, P1523, DOI 10.1084/jem.185.8.1523; RAJAGOPALAN S, 1995, J IMMUNOL, V155, P4143; Rojo S, 1997, EUR J IMMUNOL, V27, P568, DOI 10.1002/eji.1830270231; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; Vales-Gomez M, 1998, P NATL ACAD SCI USA, V95, P14326, DOI 10.1073/pnas.95.24.14326; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; Winter CC, 1997, J IMMUNOL, V158, P4026; Winter CC, 1998, J IMMUNOL, V161, P571; Ysern X, 1998, NAT STRUCT BIOL, V5, P412, DOI 10.1038/nsb0698-412; Zappacosta F, 1997, P NATL ACAD SCI USA, V94, P6313, DOI 10.1073/pnas.94.12.6313	43	320	336	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2000	405	6786					537	543		10.1038/35014520	http://dx.doi.org/10.1038/35014520			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850706				2022-12-24	WOS:000087449500041
J	Hyde, WT; Crowley, TJ; Baum, SK; Peltier, WR				Hyde, WT; Crowley, TJ; Baum, SK; Peltier, WR			Neoproterozoic 'snowball Earth' simulations with a coupled climate/ice-sheet model	NATURE			English	Article							GENERAL-CIRCULATION MODEL; ICE-AGE; SNOWLINE INSTABILITY; SEA-LEVEL; GLACIATION; RECORD; GEOGRAPHY; TECTONICS; PARADOX; HISTORY	Ice sheets may have reached the Equator in the late Proterozoic era (600-800 Myr ago), according to geological and palaeomagnetic studies, possibly resulting in a 'snowball Earth'. But this period was a critical time in the evolution of multicellular animals, posing the question of how early life survived under such environmental stress. Here we present computer simulations of this unusual climate stage with a coupled climate/ice-sheet model. To simulate a snowball Earth, we use only a reduction in the solar constant compared to present-day conditions and we keep atmospheric CO2 concentrations near present levels. We rnd rapid transitions into and out of full glaciation that are consistent with the geological evidence. When we combine these results with a general circulation model, some of the simulations result in an equatorial belt of open water that may have provided a refugium for multicellular animals.	Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada	Texas A&M University System; Texas A&M University College Station; University of Toronto	Hyde, WT (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.	hyde@rossby.tamu.edu	Peltier, William R./A-1102-2008					[Anonymous], 1959, J GLACIOL, DOI DOI 10.3189/S002214300001724X; BAUM SK, 1991, GEOPHYS RES LETT, V18, P1719, DOI 10.1029/91GL01723; BAUM SK, UNPUB J GEOPHYS RES; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI [10.1175/1520-0469(1978)035<2362:LTVODI>2.0.CO;2, 10.1016/0033-5894(78)90064-9]; BOND GC, 1984, EARTH PLANET SC LETT, V70, P325, DOI 10.1016/0012-821X(84)90017-7; BREYER JA, 1995, GEOLOGY, V23, P269, DOI 10.1130/0091-7613(1995)023<0269:PNEFTO>2.3.CO;2; Christie-Blick N., 1997, GEOLOGICAL SOC AM FI, V42, P1; CHRISTIEBLICK N, 1982, ICARUS, V50, P423, DOI 10.1016/0019-1035(82)90133-6; CROWLEY TJ, 1993, J GEOPHYS RES-ATMOS, V98, P16723, DOI 10.1029/93JD01415; CROWLEY TJ, 1994, CLIM DYNAM, V10, P363, DOI 10.1007/BF00219476; CROWLEY TJ, 1993, GEOPHYS RES LETT, V20, P1175, DOI 10.1029/93GL01119; CROWLEY TJ, 1999, J GEOPHYS RES-ATMOSP, V5, P619; Dalziel IWD, 1997, GEOL SOC AM BULL, V109, P16, DOI 10.1130/0016-7606(1997)109<0016:ONPGAT>2.3.CO;2; DEBLONDE G, 1991, J GEOPHYS RES-ATMOS, V96, P9189, DOI 10.1029/90JD02606; DEBLONDE G, 1992, GLOBAL PLANET CHANGE, V98, P37, DOI 10.1016/0921-8181(92)90021-2; EYLES N, 1993, EARTH-SCI REV, V35, P1, DOI 10.1016/0012-8252(93)90002-O; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; HAMBREY MJ, 1985, PALAEOGEOGR PALAEOCL, V51, P255, DOI 10.1016/0031-0182(85)90088-4; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; HOFFMAN PF, 1991, SCIENCE, V252, P1409, DOI 10.1126/science.252.5011.1409; Huybrechts P., 1995, ANN GLACIOL, V21, P111, DOI 10013/epic.12062.d001; Hyde WT, 1989, J CLIMATE, V2, P864, DOI 10.1175/1520-0442(1989)002<0864:COGAEB>2.0.CO;2; HYDE WT, 1990, J GEOPHYS RES-ATMOS, V95, P18653, DOI 10.1029/JD095iD11p18653; Hyde WT, 1999, CLIM DYNAM, V15, P619, DOI 10.1007/s003820050305; Jenkins GS, 1998, GEOPHYS RES LETT, V25, P3525, DOI 10.1029/98GL52588; Jenkins GS, 1999, GEOPHYS RES LETT, V26, P2263, DOI 10.1029/1999GL900538; JENKINS GS, 1993, J GEOPHYS RES-ATMOS, V98, P20803, DOI 10.1029/93JD02056; KAUFMAN AJ, 1993, EARTH PLANET SC LETT, V120, P409, DOI 10.1016/0012-821X(93)90254-7; Kaufman AJ, 1997, P NATL ACAD SCI USA, V94, P6600, DOI 10.1073/pnas.94.13.6600; Kennedy MJ, 1998, GEOLOGY, V26, P1059, DOI 10.1130/0091-7613(1998)026<1059:TOFNG>2.3.CO;2; Kirschvink J. L., 1992, PROTEROZOIC BIOSPHER, P51; KNOLL AH, 1992, NATURE, V356, P673, DOI 10.1038/356673a0; MANABE S, 1985, J GEOPHYS RES-ATMOS, V90, P2167, DOI 10.1029/JD090iD01p02167; McNamara KJ, 1996, SCIENCE, V274, P1995; NORTH GR, 1975, J ATMOS SCI, V32, P1301, DOI 10.1175/1520-0469(1975)032<1301:ASTASC>2.0.CO;2; NORTH GR, 1975, J ATMOS SCI, V41, P3990; Oglesby R. J., 1998, PALEOCLIMATES DATA M, V2, P293; PATESON WSB, 1981, PHYSICS GLACIERS; Peltier WR, 1998, REV GEOPHYS, V36, P603, DOI 10.1029/98RG02638; REEH N, 1991, POLARFORSCHUNG, V0059; SCHMIDT PW, 1995, EARTH PLANET SC LETT, V134, P107, DOI 10.1016/0012-821X(95)00106-M; Scotese C. R., 1992, PALEOGEOGRAPHIC ATLA; Tarasov L, 1999, J GEOPHYS RES-ATMOS, V104, P9517, DOI 10.1029/1998JD200120; Tarasov L, 1997, J GEOPHYS RES-ATMOS, V102, P21665, DOI 10.1029/97JD01766; THOMPSON SL, 1995, J CLIMATE, V8, P732, DOI 10.1175/1520-0442(1995)008<0732:AGCMWA>2.0.CO;2; WILLIAMS GE, 1975, GEOL MAG, V112, P441, DOI 10.1017/S0016756800046185; WILLIAMS GE, 1998, CLIMATIC CHANGE, V13, P117; Wray GA, 1996, SCIENCE, V274, P568, DOI 10.1126/science.274.5287.568	49	335	363	5	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2000	405	6785					425	429		10.1038/35013005	http://dx.doi.org/10.1038/35013005			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839531				2022-12-24	WOS:000087212000039
J	Lucking, CB; Durr, A; Bonifati, V; Vaughan, J; De Michele, G; Gasser, T; Harhangi, BS; Meco, G; Denefle, P; Wood, NW; Agid, Y; Brice, A				Lucking, CB; Durr, A; Bonifati, V; Vaughan, J; De Michele, G; Gasser, T; Harhangi, BS; Meco, G; Denefle, P; Wood, NW; Agid, Y; Brice, A		European Consortium Genetic Suscep; French Parkinsons Dis Genetics Stu	Association between early-onset Parkinson's disease and mutations in the parkin gene	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECESSIVE JUVENILE PARKINSONISM; HOMOZYGOUS DELETIONS; JAPANESE FAMILIES; EUROPE	Background: Mutations in the parkin gene have recently been identified in patients with early-onset Parkinson's disease, but the frequency of the mutations and the associated phenotype have not been assessed in a large series of patients. Methods: We studied 73 families in which at least one of the affected family members was affected at or before the age of 45 years and had parents who were not affected, as well as 100 patients with isolated Parkinson's disease that began at or before the age of 45 years. All subjects were screened for mutations in the parkin gene with use of a semiquantitative polymerase-chain-reaction assay that simultaneously amplified several exons. We sequenced the coding exons in a subgroup of patients. We also compared the clinical features of patients with parkin mutations and those without mutations. Results: Among the families with early-onset Parkinson's disease, 36 (49 percent) had parkin mutations. The age at onset ranged from 7 to 58 years. Among the patients with isolated Parkinson's disease, mutations were detected in 10 of 13 patients (77 percent) with an age at onset of 20 years or younger, but in only 2 of 64 patients (3 percent) with an age at onset of more than 30 years. The mean (+/-SD) age at onset in the patients with parkin mutations was younger than that in those without mutations (32+/-11 vs. 42+/-11 years, P<0.001), and they were more likely to have symmetric involvement and dystonia at onset, to have hyperreflexia at onset or later, to have a good response to levodopa therapy, and to have levodopa-induced dyskinesias during treatment. Nineteen different rearrangements of exons (deletions and multiplications) and 16 different point mutations were detected. Conclusions: Mutations in the parkin gene are a major cause of early-onset autosomal recessive familial Parkinson's disease and isolated juvenile-onset Parkinson's disease (at or before the age of 20 years). Accurate diagnosis of these cases cannot be based only on the clinical manifestations of the disease. (N Engl J Med 2000;342:1560-7.) (C) 2000, Massachusetts Medical Society.	Hop La Pitie Salpetriere, INSERM, U289, F-75651 Paris 13, France; Univ La Sapienza, Dipartimento Sci Neurol, Rome, Italy; Inst Neurol, London WC1N 3BG, England; Univ Naples Federico II, Dipartimento Sci Neurol, Naples, Italy; Univ Munich, Klinikum Grosshadern, Neurol Klin, D-8000 Munich, Germany; Erasmus Univ, Sch Med, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Aventis Pharma France, Evry Genom Ctr, Evry, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Sapienza University Rome; University of London; University College London; University of Naples Federico II; University of Munich; Erasmus University Rotterdam; Sanofi-Aventis; Sanofi France	Brice, A (corresponding author), Hop La Pitie Salpetriere, INSERM, U289, 47 Blvd Hop, F-75651 Paris 13, France.		Breteler, Monique M.B./J-5058-2014; brice, alexis/AAE-8275-2019; Harhangi, Biswadjiet/P-7866-2018; Brice, Alexis/A-2170-2009; Wood, Nicholas W/C-2505-2009; Gasser, Thomas/GNH-5293-2022	Breteler, Monique M.B./0000-0002-0626-9305; brice, alexis/0000-0002-0941-3990; Wood, Nicholas W/0000-0002-9500-3348; Gasser, Thomas/0000-0002-1069-1146				Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Bross P, 1999, HUM MUTAT, V14, P186, DOI 10.1002/(SICI)1098-1004(1999)14:3<186::AID-HUMU2>3.0.CO;2-J; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; Farrer M, 1999, HUM MOL GENET, V8, P81, DOI 10.1093/hmg/8.1.81; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Gasser T, 1998, NAT GENET, V18, P262, DOI 10.1038/ng0398-262; Gu WJ, 2000, J NEUROCHEM, V74, P1773, DOI 10.1046/j.1471-4159.2000.0741773.x; Hattori N, 1998, BIOCHEM BIOPH RES CO, V251, P666, DOI 10.1006/bbrc.1998.9504; Hattori N, 1998, ANN NEUROL, V44, P935, DOI 10.1002/ana.410440612; Hattori N, 1998, BIOCHEM BIOPH RES CO, V249, P754, DOI 10.1006/bbrc.1998.9134; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Ishikawa A, 1996, NEUROLOGY, V47, P160, DOI 10.1212/WNL.47.1.160; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Leroy E, 1998, HUM GENET, V103, P424, DOI 10.1007/s004390050845; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lucking CB, 1998, LANCET, V352, P1355, DOI 10.1016/S0140-6736(05)60746-5; Morett E, 1999, TRENDS BIOCHEM SCI, V24, P229, DOI 10.1016/S0968-0004(99)01381-X; Mori H, 1998, NEUROLOGY, V51, P890, DOI 10.1212/WNL.51.3.890; Piccini P, 1999, ANN NEUROL, V45, P577, DOI 10.1002/1531-8249(199905)45:5<577::AID-ANA5>3.0.CO;2-O; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; TAKAHASHI H, 1994, NEUROLOGY, V44, P437, DOI 10.1212/WNL.44.3_Part_1.437; Wood N, 1997, J NEUROL NEUROSUR PS, V62, P305, DOI 10.1136/jnnp.62.4.305	23	1106	1167	1	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 25	2000	342	21					1560	1567		10.1056/NEJM200005253422103	http://dx.doi.org/10.1056/NEJM200005253422103			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	316XJ	10824074	Bronze			2022-12-24	WOS:000087193100003
J	Marx, SO; Reiken, S; Hisamatsu, Y; Jayaraman, T; Burkhoff, D; Rosemblit, N; Marks, AR				Marx, SO; Reiken, S; Hisamatsu, Y; Jayaraman, T; Burkhoff, D; Rosemblit, N; Marks, AR			PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): Defective regulation in failing hearts	CELL			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; DEPENDENT PROTEIN-KINASE; CARDIAC-MUSCLE; A-KINASE; SARCOPLASMIC-RETICULUM; FAILURE; MYOCYTES; NOREPINEPHRINE; PHOSPHOLAMBAN; PHOSPHATASES	The ryanodine receptor (RyR)/calcium release channel on the sarcoplasmic reticulum (SR) is the major source of calcium (Ca2+) required for cardiac muscle excitation-contraction (EC) coupling. The channel is a tetramer comprised of four type 2 RyR polypeptides (RyR2) and four FK506 binding proteins (FKBP12.6). We show that protein kinase A (PKA) phosphorylation of RyR2 dissociates FKBP12.6 and regulates the channel open probability (P-o). Using cosedimentation and coimmunoprecipitation we have defined a macromolecular complex comprised of RyR2, FKBP12.6, PKA, the protein phosphatases PP1 and PP2A, and an anchoring protein, mAKAP. In failing human hearts, RyR2 is PKA hyperphosphorylated, resulting in defective channel function due to increased sensitivity to Ca2+-induced activation.	Columbia Univ Coll Phys & Surg, Ctr Mol Cardiol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Marks, AR (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Mol Cardiol, 630 W 168th St, New York, NY 10032 USA.		Tuluc, Petronel/C-2527-2011; Lima, Thaísa/AAG-6483-2021; Burkhoff, Daniel/D-7674-2011		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056180, R01HL061503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039794] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL61503, R01 HL56180] Funding Source: Medline; NIAID NIH HHS [R01 AI39794] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BOHM M, 1994, CARDIOVASC RES, V28, P1713, DOI 10.1093/cvr/28.11.1713; BRILLANTES AMB, 1994, CELL, V77, P513, DOI 10.1016/0092-8674(94)90214-3; BRISTOW MR, 1992, J CLIN INVEST, V89, P803, DOI 10.1172/JCI115659; BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401; Cameron AM, 1997, J BIOL CHEM, V272, P27582, DOI 10.1074/jbc.272.44.27582; Chen YG, 1997, EMBO J, V16, P3866, DOI 10.1093/emboj/16.13.3866; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; FOZZARD HA, 1992, BASIC RES CARDIOL, V87, P105; Fraser IDC, 1999, NEURON, V23, P423, DOI 10.1016/S0896-6273(00)80795-3; FRAZIER OH, 1994, CIRCULATION, V89, P2908, DOI 10.1161/01.CIR.89.6.2908; GO LO, 1995, J CLIN INVEST, V95, P888, DOI 10.1172/JCI117739; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; HAIN J, 1995, J BIOL CHEM, V270, P2074, DOI 10.1074/jbc.270.5.2074; Hjalmarson A, 1999, LANCET, V353, P2001; JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474; Kaftan E, 1996, CIRC RES, V78, P990, DOI 10.1161/01.RES.78.6.990; Kapiloff MS, 1999, J CELL SCI, V112, P2725; Kirchhefer U, 1999, CARDIOVASC RES, V42, P254, DOI 10.1016/S0008-6363(98)00296-X; Laflamme MA, 1999, AM J PHYSIOL-HEART C, V277, pH1841, DOI 10.1152/ajpheart.1999.277.5.H1841; Lechat P, 1999, LANCET, V353, P9; LEVIN HR, 1995, CIRCULATION, V91, P2717, DOI 10.1161/01.CIR.91.11.2717; LORENZ MC, 1995, J BIOL CHEM, V270, P27531, DOI 10.1074/jbc.270.46.27531; MACDOUGALL LK, 1991, EUR J BIOCHEM, V196, P725, DOI 10.1111/j.1432-1033.1991.tb15871.x; Marks AR, 1996, PHYSIOL REV, V76, P631, DOI 10.1152/physrev.1996.76.3.631; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; MCCARTNEY S, 1995, J BIOL CHEM, V270, P9327, DOI 10.1074/jbc.270.16.9327; MORGAN JP, 1990, CIRCULATION, V81, P21; MOSCHELLA MC, 1993, J CELL BIOL, V120, P1137, DOI 10.1083/jcb.120.5.1137; Neumann J, 1997, J MOL CELL CARDIOL, V29, P265, DOI 10.1006/jmcc.1996.0271; REGITZZAGROSEK V, 1994, EUR HEART J, V15, P7, DOI 10.1093/eurheartj/15.suppl_D.7; VALDIVIA HH, 1995, SCIENCE, V267, P1997, DOI 10.1126/science.7701323; Wang J, 1997, CIRCULATION, V96, P2683, DOI 10.1161/01.CIR.96.8.2683; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Yang JC, 1998, J CELL BIOL, V142, P511, DOI 10.1083/jcb.142.2.511	36	1538	1608	1	80	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 12	2000	101	4					365	376		10.1016/S0092-8674(00)80847-8	http://dx.doi.org/10.1016/S0092-8674(00)80847-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	313QM	10830164	Bronze			2022-12-24	WOS:000087010400005
J	Newsome, TP; Schmidt, S; Dietzl, G; Keleman, K; Asling, B; Debant, A; Dickson, BJ				Newsome, TP; Schmidt, S; Dietzl, G; Keleman, K; Asling, B; Debant, A; Dickson, BJ			Trio combines with Dock to regulate Pak activity during photoreceptor axon pathfinding in Drosophila	CELL			English	Article							EXCHANGE FACTOR DOMAINS; RHO-FAMILY GTPASES; PROTEIN-KINASE; ADAPTER PROTEIN; CYTOSKELETAL DYNAMICS; P21-ACTIVATED KINASE; TYROSINE-PHOSPHATASE; LIM-KINASE; C-ELEGANS; IN-VIVO	Correct pathfinding by Drosophila photoreceptor axons requires recruitment of p21-activated kinase (Pak) to the membrane by the SH2-SH3 adaptor Dock. Here, we identify the guanine nucleotide exchange factor (GEF) Trio as another essential component in photoreceptor axon guidance. Regulated exchange activity of one of the two Trio GEF domains is critical for accurate pathfinding. This GEF domain activates Rac, which in turn activates Pak. Mutations in trio result in projection defects similar to those observed in both Pak and dock mutants, and trio interacts genetically with Rac, Pak, and dock. These data define a signaling pathway from Trio to Rac to Pak that links guidance receptors to the growth cone cytoskeleton. We propose that distinct signals transduced via Trio and Dock act combinatorially to activate Pak in spatially restricted domains within the growth cone, thereby controlling the direction of axon extension.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Ctr Rech Biochim Macromol, CNRS, UPR1086, F-34293 Montpellier 5, France	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Dickson, Barry/AAE-7632-2019; Newsome, Timothy P/AAB-4033-2019	Dickson, Barry/0000-0003-0715-892X; Newsome, Timothy P/0000-0002-2193-596X				Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; BARTEL PL, 1995, METHOD ENZYMOL, V254, P241; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bellanger JM, 1998, ONCOGENE, V16, P147, DOI 10.1038/sj.onc.1201532; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; Deak P, 1997, GENETICS, V147, P1697; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harden N, 1996, MOL CELL BIOL, V16, P1896; HARDEN N, 1995, DEVELOPMENT, V121, P903; HARIHARAN IK, 1995, EMBO J, V14, P292, DOI 10.1002/j.1460-2075.1995.tb07003.x; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Jin T, 2000, SCIENCE, V287, P1034, DOI 10.1126/science.287.5455.1034; Jin Z, 1997, J NEUROSCI, V17, P6256; KATZAV S, 1991, MOL CELL BIOL, V11, P1912, DOI 10.1128/MCB.11.4.1912; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; LI CL, 1995, J NEUROBIOL, V28, P363, DOI 10.1002/neu.480280309; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Liu XH, 1998, CELL, V95, P269, DOI 10.1016/S0092-8674(00)81757-2; Lu Y, 1999, GENE DEV, V13, P1168, DOI 10.1101/gad.13.9.1168; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARTIN KA, 1995, NEURON, V14, P229, DOI 10.1016/0896-6273(95)90281-3; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; Murphy AM, 1996, J CELL BIOL, V133, P617, DOI 10.1083/jcb.133.3.617; Newsome TP, 2000, DEVELOPMENT, V127, P851; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; SENTI KA, 2000, IN PRESS DEVELOPMENT; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Settleman J, 1999, Prog Mol Subcell Biol, V22, P201; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Suter DM, 1998, CURR OPIN NEUROBIOL, V8, P106, DOI 10.1016/S0959-4388(98)80014-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	52	247	249	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 28	2000	101	3					283	294		10.1016/S0092-8674(00)80838-7	http://dx.doi.org/10.1016/S0092-8674(00)80838-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847683	Bronze			2022-12-24	WOS:000086741900008
J	Allwright, S; Bradley, F; Long, J; Barry, J; Thornton, L; Parry, JV				Allwright, S; Bradley, F; Long, J; Barry, J; Thornton, L; Parry, JV			Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article							BLOODBORNE VIRUSES; FACTOR ELICITATION; SURVEILLANCE; BEHAVIORS; SCOTLAND; SALIVA; MEN	Objectives To determine the prevalence of antibodies to hepatitis B core antigen, hepatitis C virus, and HIV in the prison population of the Republic of Ireland and to examine risk factors for infection. Design Cross sectional, anonymous, unlinked survey, with self completed risk factor questionnaire and provision of oral fluid specimen for antibody testing. Setting Nine of the 15 prisons in the Republic of Ireland. Participants 1366 prisoners, of whom 1205 (57 women) participated. In the smaller prisons all prisoners were surveyed, while in the three largest prisons one half of the population was randomly sampled. Three small prisons believed not to have a problem with injecting drug use were excluded. Main outcome measures Prevalence of antibodies to hepatitis B core antigen, antibodies to hepatis C virus, and antibodies to HIV. Self reported risk factor status. Results Prevalence of antibodies to hepatis B core antigen was 104/1193 (8.7%; 95% confidence interval 7.2% to 10.5%), to hepatitis C virus, 442/1193 (37%; 34.3% to 39.9%), and to HIV, 24/1193 (2%; 1.3% to 3%). The most important predictor of being positive for hepatitis B and hepatitis C was a history of injecting drug use. Thirty four women (60%) and 474 men (42%) reported ever injecting drugs. A fifth (104) of 501 injecting drug users reported first injecting in prison, and 347 (71%) users reported sharing needles in prison. Conclusions Infection with hepatitis C secondary to use of injected drugs is endemic in Irish prisons. Better access to harm reduction strategies is needed in this environment.	Univ Dublin Trinity Coll, Dept Community Hlth & Gen Practice, Dublin 2, Ireland; Dr Steevens Hosp, Eastern Reg Hlth Author, Dept Publ Hlth, Dublin 8, Ireland; Cent Publ Hlth Lab, PHLS, Hepatitis & Retrovirus Lab, London NW9 5HT, England	Trinity College Dublin; Public Health England	Allwright, S (corresponding author), Univ Dublin Trinity Coll, Dept Community Hlth & Gen Practice, Dublin 2, Ireland.		Allwright, Shane/A-1537-2012	Allwright, Shane/0000-0003-1841-4781				Bellis MA, 1997, BRIT MED J, V315, P30, DOI 10.1136/bmj.315.7099.30; BIRD AG, 1993, BRIT MED J, V307, P228, DOI 10.1136/bmj.307.6898.228; BIRD AG, 1992, AIDS, V6, P725, DOI 10.1097/00002030-199207000-00017; BIRD AG, 1995, AIDS, V9, P801, DOI 10.1097/00002030-199507000-00019; Bird AG, 1997, BRIT MED J, V315, P21, DOI 10.1136/bmj.315.7099.21; Butler TG, 1997, MED J AUSTRALIA, V166, P127, DOI 10.5694/j.1326-5377.1997.tb140041.x; Connell J A, 1994, Clin Diagn Virol, V1, P299, DOI 10.1016/0928-0197(94)90060-4; CONNELL JA, 1993, J MED VIROL, V41, P159, DOI 10.1002/jmv.1890410212; CROFTS N, 1995, BRIT MED J, V310, P285, DOI 10.1136/bmj.310.6975.285; DOLAN K, 1998, METHADONE MAINTENANC, P379; FARRELL M, 1999, REV CURRENT PRACTICE; GAUGHWIN MD, 1991, AIDS, V5, P845, DOI 10.1097/00002030-199107000-00008; Gore SM, 1997, INT J STD AIDS, V8, P166, DOI 10.1258/0956462971919831; GORE SM, 1995, BRIT MED J, V310, P293, DOI 10.1136/bmj.310.6975.293; Gore SM, 1999, QJM-MON J ASSOC PHYS, V92, P25, DOI 10.1093/qjmed/92.1.25; LAMGANI TL, 1999, COMMUN DIS PUBLIC HL, V2, P174; Malliori M, 1998, ADDICTION, V93, P243, DOI 10.1046/j.1360-0443.1998.9322438.x; *MIN TASK FORC MEA, 1997, 2 REP; OMahony Paul, 1997, MOUNTJOY PRISONERS S; PARRY JV, 1987, LANCET, V2, P72, DOI 10.1016/S0140-6736(87)92737-1; *PRINC PROD, 1997, REM OFF OMR VERS 4; ROTILY M., 1995, AIDS CARE, V7, P89; SALL J, 1996, JMP START STAT VERS; Smyth BP, 1999, J EPIDEMIOL COMMUN H, V53, P434, DOI 10.1136/jech.53.7.434	24	171	179	1	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 8	2000	321	7253					78	82		10.1136/bmj.321.7253.78	http://dx.doi.org/10.1136/bmj.321.7253.78			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334QF	10884256	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000088196600022
J	Ries, G; Heller, W; Puchta, H; Sandermann, H; Seidlitz, HK; Hohn, B				Ries, G; Heller, W; Puchta, H; Sandermann, H; Seidlitz, HK; Hohn, B			Elevated UV-B radiation reduces genome stability in plants	NATURE			English	Article							INTRACHROMOSOMAL HOMOLOGOUS RECOMBINATION; DNA-REPAIR; OZONE DEPLETION; DAMAGE; RAD51; PROTEIN; STRESS; MAIZE; LIFE	Long-term depletion of the stratospheric ozone layer contributes to an increase in terrestrial solar ultraviolet-B radiation(1-3). This has deleterious effects on living organisms, such as DNA damage(4,5). When exposed to elevated ultraviolet-B radiation (UV-B; 280-315 nm), plants display a wide variety of physiological and morphological responses characterized as acclimation and adaptation(6). Here we show, using special sun simulators, that elevated solar UV-B doses increase the frequency of somatic homologous DNA rearrangements in Arabidopsis and tobacco plants. Increases in recombination are accompanied by a strong induction of photolyase and Rad51 gene expression. These genes are putatively involved in major DNA repair pathways, photoreactivation and recombination repair(7,8). In mutant Arabidopsis plants that are deficient in photoreactivating ultraviolet-induced cyclobutane pyrimidine dimers, recombination under elevated UV-B regimes greatly exceeds wild-type levels. Our results show that homologous recombination repair pathways might be involved in eliminating UV-B-induced DNA lesions in plants. Thus, increases in terrestrial solar UV-B radiation as forecasted for the early 21st century may affect genome stability in plants.	Friedrich Miescher Inst, CH-4002 Basel, Switzerland; GSF Forschungszentrum Umwelt & Gesundheit, D-85764 Neuherberg, Germany	Friedrich Miescher Institute for Biomedical Research; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Ries, G (corresponding author), Friedrich Miescher Inst, POB 2543, CH-4002 Basel, Switzerland.		Puchta, Holger/ABE-6271-2020	Puchta, Holger/0000-0003-1073-8546				Britt AB, 1999, TRENDS PLANT SCI, V4, P20, DOI 10.1016/S1360-1385(98)01355-7; CALDWELL MM, 1994, PLANT CELL ENVIRON, V17, P267, DOI 10.1111/j.1365-3040.1994.tb00292.x; Caldwell MM., 1971, PHOTOPHYSIOLOGY, V6, P131, DOI [10.1016/b978-0-12-282606-1.50010-6, DOI 10.1016/B978-0-12-282606-1.50010-6, 10.1016/B978-0-12-282606-1.50010-6]; Dohring T, 1996, J PLANT PHYSIOL, V148, P115, DOI 10.1016/S0176-1617(96)80302-6; Doutriaux MP, 1998, MOL GEN GENET, V257, P283, DOI 10.1007/s004380050649; GALE JM, 1990, PHOTOCHEM PHOTOBIOL, V51, P411, DOI 10.1111/j.1751-1097.1990.tb01732.x; JACKSON JF, 1987, MUTAT RES, V181, P17; Jansen MAK, 1998, TRENDS PLANT SCI, V3, P131, DOI 10.1016/S1360-1385(98)01215-1; KERR JB, 1993, SCIENCE, V262, P1032, DOI 10.1126/science.262.5136.1032; LANDRY LG, 1995, PLANT PHYSIOL, V109, P1159, DOI 10.1104/pp.109.4.1159; Landry LG, 1997, P NATL ACAD SCI USA, V94, P328, DOI 10.1073/pnas.94.1.328; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; McKenzie R, 1999, SCIENCE, V285, P1709, DOI 10.1126/science.285.5434.1709; Mount DW, 1996, NATURE, V383, P763, DOI 10.1038/383763a0; Puchta H, 1996, TRENDS PLANT SCI, V1, P340; PUCHTA H, 1995, PLANT MOL BIOL, V28, P281, DOI 10.1007/BF00020247; QUAITE FE, 1992, NATURE, V358, P576, DOI 10.1038/358576a0; Rousseaux MC, 1999, P NATL ACAD SCI USA, V96, P15310, DOI 10.1073/pnas.96.26.15310; Rozema J, 1997, TRENDS ECOL EVOL, V12, P22, DOI 10.1016/S0169-5347(96)10062-8; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Stapleton A. E., 1993, Plant Molecular Biology Reporter, V11, P230, DOI 10.1007/BF02669850; STAPLETON AE, 1994, PLANT PHYSIOL, V105, P881, DOI 10.1104/pp.105.3.881; Suter B, 1997, EMBO J, V16, P2150, DOI 10.1093/emboj/16.8.2150; SWOBODA P, 1994, EMBO J, V13, P484, DOI 10.1002/j.1460-2075.1994.tb06283.x; Tevini Manfred, 1993, P125; TOVAR J, 1992, PLANT CELL, V4, P319, DOI 10.1105/tpc.4.3.319; Turunen M, 1999, ENVIRON POLLUT, V106, P219, DOI 10.1016/S0269-7491(99)00070-6; Vispe S, 1998, NUCLEIC ACIDS RES, V26, P2859, DOI 10.1093/nar/26.12.2859; WALBOT V, 1985, TRENDS GENET, V1, P165, DOI 10.1016/0168-9525(85)90071-X; Walbot V, 1999, NATURE, V397, P398, DOI 10.1038/17043	30	296	320	2	54	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 6	2000	406	6791					98	101		10.1038/35017595	http://dx.doi.org/10.1038/35017595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	330ZE	10894550	Green Accepted			2022-12-24	WOS:000087991200053
J	van Beek, JD; Beaulieu, L; Schafer, H; Demura, M; Asakura, T; Meier, BH				van Beek, JD; Beaulieu, L; Schafer, H; Demura, M; Asakura, T; Meier, BH			Solid-state NMR determination of the secondary structure of Samia cynthia ricini silk	NATURE			English	Article							C-13 CHEMICAL-SHIFT; SPIDER DRAGLINE SILK; NUCLEAR-MAGNETIC-RESONANCE; POWDER PATTERNS; TENSORS; N-15; SPECTROSCOPY; CONFORMATION; PEPTIDES; FIBERS	Silks are fibrous proteins that form heterogeneous, semi-crystalline solids. Silk proteins have a variety of physical properties reflecting their range of functions. Spider dragline silk, for example, has high tensile strength and elasticity(1), whereas other silks(2) are better suited to making housing, egg sacs or the capture spiral of spiders' webs. The differing physical properties arise from variation in the protein's primary and secondary structure, and their packing in the solid phase. The high mechanical performance of spider dragline silk, for example, is probably due to a beta-sheet conformation of poly-alanine domains(3), embedded as small crystallites within the fibre. Only limited structural information can be obtained from diffraction of silks(3-6), so further characterization requires spectroscopic studies such as NMR7-11. However, the classical approach to NMR structure determination(12) fails because the high molecular weight(13), repetitive primary structure(13) and structural heterogeneity of solid silk means that signals from individual amino-acid residues cannot be resolved. Here we adapt a recently developed solid-state NMR technique(14,15) to determine torsion angle pairs (phi, Psi) in the protein backbone, and we study the distribution of conformations in silk from the Eri silkworm, Samia cynthia ricini. Although the most probable conformation in native fibres is an anti-parallel beta-sheet, film produced from liquid directly extracted from the silk glands appears to be primarily alpha-helical.	Swiss Fed Inst Technol, Phys Chem Lab, CH-8092 Zurich, Switzerland; Catholic Univ Nijmegen, Phys Chem Lab, NL-6525 ED Nijmegen, Netherlands; Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan; Tokyo Univ Agr & Technol, Dept Biotechnol, Tokyo 1848588, Japan	Swiss Federal Institutes of Technology Domain; ETH Zurich; Radboud University Nijmegen; Hokkaido University; Tokyo University of Agriculture & Technology	Meier, BH (corresponding author), Swiss Fed Inst Technol, Phys Chem Lab, CH-8092 Zurich, Switzerland.	beme@nmr.phys.chem.ethz.ch	Meier, Beat H/K-4066-2016; Asakura, Tetsuo/B-9970-2013; Demura, Makoto/F-5272-2011	Meier, Beat H/0000-0002-9107-4464; Asakura, Tetsuo/0000-0003-4472-6105; Demura, Makoto/0000-0003-0912-9284				Antzutkin ON, 1999, J CHEM PHYS, V110, P2749, DOI 10.1063/1.477876; ARNOTT S, 1967, J MOL BIOL, V30, P201, DOI 10.1016/0022-2836(67)90252-5; Asakura T, 1999, MACROMOLECULES, V32, P4940, DOI 10.1021/ma990442z; BECKER MA, 1994, ACS SYM SER, V544, P185; Bram A, 1997, J APPL CRYSTALLOGR, V30, P390, DOI 10.1107/S0021889896012344; Denny M.W., 1980, Symposia of the Society for Experimental Biology, P247; Ernst M, 1998, STUD PHYS THEO CHEM, V84, P83, DOI 10.1016/S0167-6881(98)80007-4; HARTZELL CJ, 1987, J AM CHEM SOC, V109, P5966, DOI 10.1021/ja00254a012; Heller J, 1997, J AM CHEM SOC, V119, P7827, DOI 10.1021/ja970124k; Honerkamp J, 1990, CONTINUUM MECHANICS, V2, P17, DOI [10.1007/BF01170953, DOI 10.1007/BF01170953]; ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017; KAPLAN D, 1994, ACS SYM SER, V544, P2; Kummerlen J, 1996, MACROMOLECULES, V29, P2920, DOI 10.1021/ma951098i; OAS TG, 1987, J AM CHEM SOC, V109, P5956, DOI 10.1021/ja00254a010; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; SAITO H, 1984, MACROMOLECULES, V17, P1405, DOI 10.1021/ma00137a018; SCHAFER H, 1994, CHEM PHYS, V182, P53, DOI 10.1016/0301-0104(94)00011-5; Schmidt-Rohr K, 1998, SCIENCE, V280, P714, DOI 10.1126/science.280.5364.714; Schmidt-Rohr K, 1996, MACROMOLECULES, V29, P3975, DOI 10.1021/ma9517106; Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84; STARK RE, 1983, J MAGN RESON, V55, P266, DOI 10.1016/0022-2364(83)90238-X; TENG Q, 1992, J AM CHEM SOC, V114, P5312, DOI 10.1021/ja00039a048; Tikhonov A. N., 1977, SOLUTION ILL POSED P; VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70; WARWICKER JO, 1960, J MOL BIOL, V2, P350, DOI 10.1016/S0022-2836(60)80046-0; WEESE J, 1992, COMPUT PHYS COMMUN, V69, P99, DOI 10.1016/0010-4655(92)90132-I; Wuthrich K., 1986, NMR PROTEINS NUCL AC; Yang Z, 1997, MACROMOLECULES, V30, P8254, DOI 10.1021/ma970548z; YEN YS, 1983, J CHEM PHYS, V78, P3579, DOI 10.1063/1.445185	29	156	157	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2000	405	6790					1077	1079		10.1038/35016625	http://dx.doi.org/10.1038/35016625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	328VN	10890452				2022-12-24	WOS:000087871700052
J	Li, BB; Oestreich, S; de Lange, T				Li, BB; Oestreich, S; de Lange, T			Identification of human Rap1: Implications for telomere evolution	CELL			English	Article							BINDING-PROTEIN RAP1; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; CHROMOSOME MOVEMENT; FUNCTIONAL-ANALYSIS; CATALYTIC SUBUNIT; LENGTH REGULATION; DNA; DOMAIN	It has been puzzling that mammalian telomeric proteins, including TRF1, TRF2, tankyrase, and TIN2 have no recognized orthologs in budding yeast. Here, we describe a human protein, hRap1, that is an ortholog of the yeast telomeric protein, scRap1p. hRap1 has three conserved sequence motifs in common with scRap1, is located at telomeres, and affects telomere length. However, while scRap1 binds telomeric DNA directly, hRap1 is recruited to telomeres by TRF2. Extending the comparison of telomeric proteins to fission yeast, we identify S. pombe Taz1 as a TRF ortholog, indicating that TRFs are conserved at eukaryotic telomeres. The data suggest that ancestral telomeres, like those of vertebrates, contained a TRF-like protein as well as Rap1. We propose that budding yeast preserved Rap1 at telomeres but lost the TRF component, possibly concomitant with a change in the telomeric repeat sequence.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.		de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	NCI NIH HHS [CA76027] Funding Source: Medline; NIGMS NIH HHS [GM49046] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA076027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049046, R37GM049046] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartel P. L., 1993, CELLULAR INTERACTION, P153; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; BIANCHI A, 1999, THESIS ROCKEFELLER U; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Bilaud T, 1996, NUCLEIC ACIDS RES, V24, P1294, DOI 10.1093/nar/24.7.1294; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; BRIGATI C, 1993, MOL CELL BIOL, V13, P1306, DOI 10.1128/MCB.13.2.1306; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; BROCCOLI D, 1994, EXP CELL RES, V212, P308, DOI 10.1006/excr.1994.1148; Brun C, 1997, TRENDS CELL BIOL, V7, P317, DOI 10.1016/S0962-8924(97)01092-1; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P5086, DOI 10.1128/MCB.8.12.5086; BUCK SW, 1995, GENE DEV, V9, P370, DOI 10.1101/gad.9.3.370; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; CAPIEAUX E, 1989, J BIOL CHEM, V264, P7437; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Chikashige Y, 1997, EMBO J, V16, P193, DOI 10.1093/emboj/16.1.193; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; COCKELL M, 1995, J CELL BIOL, V129, P909, DOI 10.1083/jcb.129.4.909; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; de Lange T, 1998, NATURE, V392, P753, DOI 10.1038/33790; GILSON E, 1993, J MOL BIOL, V231, P293, DOI 10.1006/jmbi.1993.1283; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; HANISH JP, 1994, P NATL ACAD SCI USA, V91, P8861, DOI 10.1073/pnas.91.19.8861; HARDY CFJ, 1992, MOL CELL BIOL, V12, P1209, DOI 10.1128/MCB.12.3.1209; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Harlow E, 1988, ANTIBODIES LAB MANUA; HENDERSON E, 1995, TELOMERES, P11; Hiraoka Y, 1998, TRENDS BIOCHEM SCI, V23, P126, DOI 10.1016/S0968-0004(98)01176-1; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; KELEHER CA, 1989, MOL CELL BIOL, V9, P5228, DOI 10.1128/MCB.9.11.5228; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; KLEIN F, 1992, J CELL BIOL, V117, P935, DOI 10.1083/jcb.117.5.935; KOHLI J, 1994, CURR BIOL, V4, P724, DOI 10.1016/S0960-9822(00)00160-3; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Konig P, 1997, TRENDS BIOCHEM SCI, V22, P43, DOI 10.1016/S0968-0004(97)01008-6; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Kratzschmar J, 1996, J BIOL CHEM, V271, P4593; Krauskopf A, 1996, NATURE, V383, P354, DOI 10.1038/383354a0; Krauskopf A, 1998, P NATL ACAD SCI USA, V95, P12486, DOI 10.1073/pnas.95.21.12486; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; LARSON GP, 1994, GENE, V150, P35, DOI 10.1016/0378-1119(94)90854-0; Lendvay TS, 1996, GENETICS, V144, P1399; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Lipsick JS, 1996, ONCOGENE, V13, P223; LIU C, 1994, GENETICS, V138, P1025; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; MCEACHERN MJ, 1994, P NATL ACAD SCI USA, V91, P3453, DOI 10.1073/pnas.91.8.3453; MCEACHERN MJ, 1995, NATURE, V376, P403, DOI 10.1038/376403a0; MCEACHERN MJ, 1993, MOL CELL BIOL, V13, P551, DOI 10.1128/MCB.13.1.551; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; SMITH DL, 1992, CELL, V68, P133, DOI 10.1016/0092-8674(92)90212-U; Smith S, 1997, TRENDS GENET, V13, P21, DOI 10.1016/S0168-9525(96)10052-4; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Spink KG, 2000, NUCLEIC ACIDS RES, V28, P527, DOI 10.1093/nar/28.2.527; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Vassetzky NS, 1999, NUCLEIC ACIDS RES, V27, P4687, DOI 10.1093/nar/27.24.4687; WANG SS, 1990, MOL CELL BIOL, V10, P4415, DOI 10.1128/MCB.10.8.4415; Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748; Zhang XD, 1998, EMBO J, V17, P6404, DOI 10.1093/emboj/17.21.6404; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834	75	456	467	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 26	2000	101	5					471	483		10.1016/S0092-8674(00)80858-2	http://dx.doi.org/10.1016/S0092-8674(00)80858-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850490	Bronze			2022-12-24	WOS:000087375400005
J	Hark, AT; Schoenherr, CJ; Katz, DJ; Ingram, RS; Levorse, JM; Tilghman, SM				Hark, AT; Schoenherr, CJ; Katz, DJ; Ingram, RS; Levorse, JM; Tilghman, SM			CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus	NATURE			English	Article							MOUSE H19 GENE; CONTROL ELEMENT; PROTEIN CTCF; CPG ISLAND; CHROMATIN; BOUNDARIES; SEQUENCE; PROMOTER; UPSTREAM; DELETION	The Insulin-like growth factor 2 (Igf2) and H19 genes are imprinted, resulting in silencing of the maternal and paternal alleles, respectively. This event is dependent upon an imprinted-control region two kilobases upstream of H19 (refs 1, 2). On the paternal chromosome this element is methylated and required for the silencing of H19 (refs 2-4). On the maternal chromosome the region is unmethylated and required for silencing of the Igf2 gene 90 kilobases upstream(2). We have proposed that the unmethylated imprinted-control region acts as a chromatin boundary that blocks the interaction of Igf2 with enhancers that lie 3' of H19 (refs 5, 6). This enhancer-blocking activity would then be lost when the region was methylated, thereby allowing expression of Igf2 paternally. Here we show, using transgenic mice and tissue culture, that the unmethylated imprinted-control regions from mouse and human H19 exhibit enhancer-blocking activity. Furthermore, we show that CTCF, a zinc finger protein implicated in vertebrate boundary function(7), binds to several sites in the unmethylated imprinted-control region that are essential for enhancer blocking. Consistent with our model, CTCF binding is abolished by DNA methylation. This is the first example, to our knowledge, of a regulated chromatin boundary in vertebrates.	Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Princeton University; Princeton University	Tilghman, SM (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA.		Katz, David J/H-4555-2017	Katz, David J/0000-0002-3040-1142				AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; Awad TA, 1999, J BIOL CHEM, V274, P27092, DOI 10.1074/jbc.274.38.27092; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; Elson DA, 1997, MOL CELL BIOL, V17, P309, DOI 10.1128/MCB.17.1.309; Feil R, 1999, TRENDS GENET, V15, P431, DOI 10.1016/S0168-9525(99)01822-3; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Frevel MAE, 1999, TRENDS GENET, V15, P216, DOI 10.1016/S0168-9525(99)01752-7; HAGENBUCHLE O, 1992, NUCLEIC ACIDS RES, V20, P3555, DOI 10.1093/nar/20.14.3555; Hark AT, 1998, HUM MOL GENET, V7, P1979, DOI 10.1093/hmg/7.12.1979; Kellum R, 1998, CURR BIOL, V8, pR521, DOI 10.1016/S0960-9822(07)00337-5; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; Khosla S, 1999, MOL CELL BIOL, V19, P2556; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Pfeifer K, 1996, P NATL ACAD SCI USA, V93, P13876, DOI 10.1073/pnas.93.24.13876; Stadnick MP, 1999, DEV GENES EVOL, V209, P239, DOI 10.1007/s004270050248; Szabo PE, 1998, MOL CELL BIOL, V18, P6767, DOI 10.1128/MCB.18.11.6767; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Webber AL, 1998, NATURE, V391, P711, DOI 10.1038/35655	28	1175	1212	0	81	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					486	489		10.1038/35013106	http://dx.doi.org/10.1038/35013106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839547				2022-12-24	WOS:000087212000055
J	Steinhauser, KE; Clipp, EC; McNeilly, M; Christakis, NA; McIntyre, LM; Tulsky, JA				Steinhauser, KE; Clipp, EC; McNeilly, M; Christakis, NA; McIntyre, LM; Tulsky, JA			In search of a good death: Observations of patients, families, and providers	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							QUALITY-OF-LIFE; PATIENTS PERSPECTIVES; ADVANCE DIRECTIVES; CARE; END; PERSONNEL; DISEASE	Despite a recent increase in the attention given to improving end-of-life care, our understanding of what constitutes a good death is surprisingly lacking. The purpose of this study was to gather descriptions of the components of a good death from patients, families, and providers through focus group discussions and in-depth interviews. Seventy-five participants-including physicians, nurses. social workers, chaplains, hospice volunteers, patients, and recently bereaved family members-were recruited from a university medical center, a Veterans Affairs medical center, and a community hospice. Participants identified six major components of a good death: pain and symptom management, clear decision making, preparation for death, completion, contributing to others, and affirmation of the whole person. The six themes are process-oriented attributes of a good death, and each has biomedical, psychological, social, and spiritual components. Physicians' discussions of a good death differed greatly from those of other groups. Physicians offered the most biomedical perspective, and patients, families, and other health care professionals defined a broad range of attributes integral to the quality of dying. Although there is no "right" way to die, these six themes may be used as a framework for understanding what participants tend to value at the end of life. Biomedical care is critical, but it is only a point of departure toward total end-of-life care. For patients and families, psychosocial and spiritual issues are as important as physiologic concerns.	Duke Univ, Duke Vet Affairs Med Ctr 152, Durham, NC 27705 USA; Inst Multiculturalism, Durham, NC USA; Univ Chicago, Chicago, IL 60637 USA	Duke University; University of Chicago	Steinhauser, KE (corresponding author), Duke Univ, Duke Vet Affairs Med Ctr 152, 508 Fulton St, Durham, NC 27705 USA.	karensteinhauser@mindspring.com	McIntyre, Lauren/J-8414-2012; Christakis, Nicholas A/B-6690-2008; Christakis, Nicholas A/C-3205-2009	McIntyre, Lauren/0000-0002-0077-3359; 				Allen JP, 1996, JAMA-J AM MED ASSOC, V275, P474; [Anonymous], 1999, DEATH FORETOLD PROPH; ARIES P, 1980, HOUR OUR DEATH; Armstrong K, 1998, SOC WORK HEALTH CARE, V27, P33, DOI 10.1300/J010v27n01_03; BYOCK I, 1997, DYING WELL PEACE POS, P4311; CLIPP EC, 1992, CANCER, V69, P1074, DOI 10.1002/1097-0142(19920215)69:4<1074::AID-CNCR2820690440>3.0.CO;2-L; Cohen S R, 1992, J Palliat Care, V8, P40; COHEN SR, 1995, PALLIATIVE MED, V9, P207, DOI 10.1177/026921639500900306; CORBIN J, 1990, BASICS QUALITIVE RES; Cudmore J, 1996, Nurs Crit Care, V1, P120; EMANUEL LL, 1995, J AM GERIATR SOC, V43, P440, DOI 10.1111/j.1532-5415.1995.tb05821.x; EMANUEL LL, 1991, NEW ENGL J MED, V324, P889, DOI 10.1056/NEJM199103283241305; Erikson E.H., 1982, LIFE CYCLE COMPLETED; Field MJ, 1997, APPROACHING DEATH IM; FOUCAULT M, 1973, BIRHT CLIN ARCHEOLOG; Fowler FJ, 1999, J PAIN SYMPTOM MANAG, V17, P114, DOI 10.1016/S0885-3924(98)00133-X; FOWLIE M, 1989, PALLIATIVE MED, V3, P55; Hanson LC, 1997, J AM GERIATR SOC, V45, P1339, DOI 10.1111/j.1532-5415.1997.tb02933.x; Kaufman SR, 1998, GERONTOLOGIST, V38, P715, DOI 10.1093/geront/38.6.715; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Krueger R.A., 1994, FOCUS GROUPS PRACTIC, V2nd; Lo B, 1999, ANN INTERN MED, V130, P772, DOI 10.7326/0003-4819-130-9-199905040-00018; Lo B, 1999, ANN INTERN MED, V130, P744, DOI 10.7326/0003-4819-130-9-199905040-00015; MCCORMICK TR, 1995, WESTERN J MED, V163, P236; Rosebush PA, 1998, MIL MED, V163, P559, DOI 10.1093/milmed/163.8.559; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Solomon MZ, 1995, HASTINGS CENT REP, V25, pS28, DOI 10.2307/3527856; SPRANGERS MAG, 1992, J CLIN EPIDEMIOL, V45, P743, DOI 10.1016/0895-4356(92)90052-O; Starr P, 1982, SOCIAL TRANSFORMATIO; STERN P, 1985, QUALITATIVE RES METH; TULSKY JA, 1995, J GEN INTERN MED, V10, P436, DOI 10.1007/BF02599915; Tulsky JA, 1996, ARCH INTERN MED, V156, P1285, DOI 10.1001/archinte.156.12.1285; Tulsky JA, 1998, ANN INTERN MED, V129, P441, DOI 10.7326/0003-4819-129-6-199809150-00003; *VET HLTH AD, POLICY IMPLEMENTATIO	34	689	699	1	110	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2000	132	10					825	832		10.7326/0003-4819-132-10-200005160-00011	http://dx.doi.org/10.7326/0003-4819-132-10-200005160-00011			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	313XN	10819707				2022-12-24	WOS:000087025100009
J	Kennedy, AK; Haniford, DB; Mizuuchi, K				Kennedy, AK; Haniford, DB; Mizuuchi, K			Single active site catalysis of the successive phosphoryl transfer steps by DNA transposases: Insights from phosphorothioate stereoselectivity	CELL			English	Article							V(D)J RECOMBINATION; ESCHERICHIA-COLI; HIV-1 INTEGRASE; STRAND TRANSFER; RAG2 PROTEINS; POLYMERASE-I; TARGET SITE; RETROVIRAL INTEGRATION; TN10 TRANSPOSITION; SYNAPTIC COMPLEX	The transposase family of proteins mediate DNA transposition or retroviral DNA integration via multistep phosphoryl transfer reactions. For Tn10 and phage Mu a single active site of one transposase protomer catalyzes the successive transposition reaction steps. We examined phosphorothioate stereoselectivity at the scissile position for all four reaction steps catalyzed by the Tn10 transposase. The results suggest that the first three steps required for double-strand cutting at the transposon end proceed as a succession of pseudo-reverse reaction steps while the 3' end of the transposon remains bound to the same side of the active site. However, the mode of substrate binding to the active site changes for the cut transposon 3' end to target DNA strand joining. The phosphorothioate stereoselectivity of the corresponding steps of phage Mu transposition and HIV DNA integration matches that of Tn10 reaction, indicating a common mode of substrate-active site interactions for this class of DNA transposition reactions.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Western University (University of Western Ontario)	Mizuuchi, K (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033006, Z01DK033006] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Allingham JS, 1999, J MOL BIOL, V289, P1195, DOI 10.1006/jmbi.1999.2837; BAKER TA, 1993, CELL, V74, P723, DOI 10.1016/0092-8674(93)90519-V; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BENDER J, 1986, CELL, V45, P801, DOI 10.1016/0092-8674(86)90555-6; BENJAMIN HW, 1989, CELL, V59, P373, DOI 10.1016/0092-8674(89)90298-5; Besmer E, 1998, MOL CELL, V2, P817, DOI 10.1016/S1097-2765(00)80296-8; Bolland S, 1996, CELL, V84, P223, DOI 10.1016/S0092-8674(00)80977-0; Brautigam CA, 1998, J MOL BIOL, V277, P363, DOI 10.1006/jmbi.1997.1586; Brown P. O., 1997, P161; Bujacz G, 1996, STRUCTURE, V4, P89, DOI 10.1016/S0969-2126(96)00012-3; BURGERS PMJ, 1979, J BIOL CHEM, V254, P6889; CHALMERS RM, 1994, J BIOL CHEM, V269, P8029; COEN ES, 1989, MOBILE DNA, P413; Craig NL, 1996, CURR TOP MICROBIOL, V204, P27; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; ECKSTEIN F, 1985, ANNU REV BIOCHEM, V54, P367, DOI 10.1146/annurev.bi.54.070185.002055; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Gerton JL, 1999, J BIOL CHEM, V274, P33480, DOI 10.1074/jbc.274.47.33480; HALLING SM, 1982, CELL, V28, P155, DOI 10.1016/0092-8674(82)90385-3; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; Junop MS, 1997, EMBO J, V16, P2646, DOI 10.1093/emboj/16.10.2646; Kennedy AK, 1998, CELL, V95, P125, DOI 10.1016/S0092-8674(00)81788-2; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; May EW, 1996, SCIENCE, V272, P401, DOI 10.1126/science.272.5260.401; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; MIZUUCHI K, 1991, CELL, V66, P129, DOI 10.1016/0092-8674(91)90145-O; Mizuuchi K, 1999, BIOCHEMISTRY-US, V38, P4640, DOI 10.1021/bi990054p; Mizuuchi K, 1997, GENES CELLS, V2, P1, DOI 10.1046/j.1365-2443.1997.970297.x; Namgoong SY, 1998, EMBO J, V17, P3775, DOI 10.1093/emboj/17.13.3775; POLARD P, 1995, GENE DEV, V9, P2846, DOI 10.1101/gad.9.22.2846; POTTER BVL, 1983, BIOCHEMISTRY-US, V22, P1369, DOI 10.1021/bi00275a008; RICE P, 1995, CELL, V82, P209, DOI 10.1016/0092-8674(95)90308-9; Sakai J, 1997, CELL, V89, P205, DOI 10.1016/S0092-8674(00)80200-7; SAKAI J, 1995, EMBO J, V14, P4374, DOI 10.1002/j.1460-2075.1995.tb00112.x; SAVILAHTI H, 1995, EMBO J, V14, P4893, DOI 10.1002/j.1460-2075.1995.tb00170.x; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592; Williams TL, 1999, GENE DEV, V13, P2725, DOI 10.1101/gad.13.20.2725; Zheng RL, 1996, P NATL ACAD SCI USA, V93, P13659, DOI 10.1073/pnas.93.24.13659	40	68	70	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 28	2000	101	3					295	305		10.1016/S0092-8674(00)80839-9	http://dx.doi.org/10.1016/S0092-8674(00)80839-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847684	Bronze			2022-12-24	WOS:000086741900009
J	Kogan, MD; Alexander, GR; Kotelchuck, M; MacDorman, MF; Buekens, P; Martin, JA; Papiernik, E				Kogan, MD; Alexander, GR; Kotelchuck, M; MacDorman, MF; Buekens, P; Martin, JA; Papiernik, E			Trends in twin birth outcomes and prenatal care utilization in the United States, 1981-1997	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GESTATIONAL-AGE; MULTIPLE BIRTHS; PRETERM BIRTH; ASSISTED REPRODUCTION; INFANT-MORTALITY; WEIGHT; PREGNANCIES; SINGLETONS; ADEQUACY; HEALTH	Context Multiple births account for an increasing percentage of all low-birth-weight infants, preterm births, and infant mortality in the United States. Since 1981, the percentage of women with multiple births who received intensive prenatal care (defined as a high number of visits, exceeding the recommendation of the American College of Obstetricians and Gynecologists by approximately 1 SD beyond the mean number of visits for women initiating care within each trimester) has increased significantly. Objectives To explore the hypothesis that more aggressive management of twin-birth pregnancies may be associated with changes in birth outcomes in this population. Design, Setting, and Subjects Cross-sectional and trend analysis of data from the National Center for Health Statistics' birth and infant death records for all twin births occurring in the United States between 1981 and 1997, excluding those with missing or inconsistent data. Main Outcome Measures Trends in preterm birth, low birth weight, preterm and term small-for-gestational-age (SGA) births, and infant mortality, by level of prenatal care utilization. Results The preterm birth rate for twins increased from 40.9% in 1981 to 55.0% in 1997, The percentage of low-birth-weight infants increased from 51.0% to 54.0%, The preterm SGA rate also increased from 11.9% to 14.1%, while the term SGA rate decreased from 30.7% to 20.5%. For women with intensive prenatal care utilization, the preterm birth rate increased from 35.1% to 55.8%, compared with an increase from 50.6% to 592% among women with only adequate use. Twin preterm deliveries involving either induction or first cesarean delivery also increased from 21.9% to 27.3% between 1989-1991 and 1995-1997. The twin infant mortality rate for women with intensive prenatal care use declined between 1983 and 1996 and remained lower than the overall twin infant mortality rate. Conclusions An apparent increase in medical interventions in the management of twins may result in the seeming incongruity of more prenatal care and more preterm births; however, these data suggest that women with intensive prenatal care utilization also have a lower infant mortality rate.	US Hlth Resources & Serv Adm, Maternal & Chil Hlth Bur, Rockville, MD 20857 USA; Univ Alabama Birmingham, Dept Maternal & Child Hlth, Birmingham, AL USA; Univ N Carolina, Dept Maternal & Child Hlth, Chapel Hill, NC USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; Univ Paris 05, Dept Obstet & Gynecol, Paris, France	United States Health Resources & Service Administration (HRSA); University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); UDICE-French Research Universities; Universite Paris Cite	Kogan, MD (corresponding author), US Hlth Resources & Serv Adm, Maternal & Chil Hlth Bur, 5600 Fishers Ln,Room 18A-55, Rockville, MD 20857 USA.	mkogan@hrsa.gov			PHS HHS [MCJ-107, MCJ-9040] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alexander G R, 1996, J Perinatol, V16, P53; Alexander GR, 1998, CLIN OBSTET GYNECOL, V41, P115, DOI 10.1097/00003081-199803000-00017; Alexander GR, 1996, PUBLIC HEALTH REP, V111, P408; ALEXANDER GR, 1987, AM J PREV MED, V3, P243; Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; *AM COLL OBST GYN, 1974, STAND OBST GYN SERV; BERKOWITZ GS, 1993, EPIDEMIOL REV, V15, P414, DOI 10.1093/oxfordjournals.epirev.a036128; BUEKENS P, 1993, AM J OBSTET GYNECOL, V168, P937, DOI 10.1016/S0002-9378(12)90849-2; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P185; Cooperstock M, 1998, PAEDIATR PERINAT EP, V12, P347, DOI 10.1046/j.1365-3016.1998.00114.x; Daltveit AK, 1999, AM J EPIDEMIOL, V149, P1128; DEROM C, 1993, FERTIL STERIL, V60, P493; Dhont M, 1997, J ASSIST REPROD GEN, V14, P575, DOI 10.1023/A:1022576500894; Emery ES, 1997, PAEDIATR PERINAT EP, V11, P313; FISCELLA K, 1995, OBSTET GYNECOL, V85, P468, DOI 10.1016/0029-7844(94)00408-6; Fitzsimmons BP, 1998, AM J OBSTET GYNECOL, V179, P1162, DOI 10.1016/S0002-9378(98)70125-5; Friedman SA, 1997, AM J OBSTET GYNECOL, V176, P1193, DOI 10.1016/S0002-9378(97)70334-X; Gardner MO, 1996, CURR OPIN OBSTET GYN, V8, P106; GARDNER MO, 1995, OBSTET GYNECOL, V85, P553, DOI 10.1016/0029-7844(94)00455-M; GORTMAKER SL, 1979, AM J PUBLIC HEALTH, V69, P653, DOI 10.2105/AJPH.69.7.653; HACK M, 1991, PEDIATRICS, V87, P587; HACK M, 1994, NEW ENGL J MED, V331, P753, DOI 10.1056/NEJM199409223311201; Joseph KS, 1998, NEW ENGL J MED, V339, P1434, DOI 10.1056/NEJM199811123392004; KEITH LG, 1995, MULTIPLE PREGNANCY E, V163, P174; Khan-Neelofur D, 1998, PAEDIATR PERINAT EP, V12, P7, DOI 10.1046/j.1365-3016.12.s2.6.x; KIELY JL, 1990, B NEW YORK ACAD MED, V66, P618; KLEINMAN JC, 1991, AM J EPIDEMIOL, V133, P133, DOI 10.1093/oxfordjournals.aje.a115852; Kogan MD, 1998, PEDIATRICS, V102, P25, DOI 10.1542/peds.102.1.25; Kogan MD, 1998, JAMA-J AM MED ASSOC, V279, P1623, DOI 10.1001/jama.279.20.1623; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414; Kramer MS, 1999, JAMA-J AM MED ASSOC, V281, P705; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Kramer MS, 1998, JAMA-J AM MED ASSOC, V280, P1849, DOI 10.1001/jama.280.21.1849; Luke B., 1996, Acta Geneticae Medicae et Gemellologiae, V45, P333; LUKE B, 1993, AM J OBSTET GYNECOL, V169, P588, DOI 10.1016/0002-9378(93)90628-V; MacDorman M F, 1999, Natl Vital Stat Rep, V47, P1; MARTIN JA, 1999, NATL VITAL STAT REP, P47; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Misra DP, 1998, JAMA-J AM MED ASSOC, V279, P1661, DOI 10.1001/jama.279.20.1661; MURRAY JL, 1988, NEW ENGL J MED, V319, P1385, DOI 10.1056/NEJM198811243192105; MUSTARD CA, 1994, AM J PUBLIC HEALTH, V84, P1450, DOI 10.2105/AJPH.84.9.1450; *NAT CTR HLTH STAT, 1992, VIT STAT US 1992 NAT, V1; PANETH N, 1990, AM J PUBLIC HEALTH, V80, P791, DOI 10.2105/AJPH.80.7.791; PANETH NS, 1995, FUTURE CHILD, V5, P19, DOI 10.2307/1602505; ROBERTSON CMT, 1992, PEDIATRICS, V90, P750; ROBERTSON PA, 1992, AM J OBSTET GYNECOL, V166, P1629, DOI 10.1016/0002-9378(92)91551-K; SCHRAMM WF, 1992, PUBLIC HEALTH REP, V107, P647; SCHWARTZ RM, IN PRESS MAT CHILD H; TAFFEL S, 1982, VITAL HLTH STAT, V2; Ventura S J, 1999, Natl Vital Stat Rep, V47, P1; Wilcox LS, 1996, FERTIL STERIL, V65, P361, DOI 10.1016/S0015-0282(16)58100-X	51	117	119	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2000	284	3					335	341		10.1001/jama.284.3.335	http://dx.doi.org/10.1001/jama.284.3.335			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	333GR	10891965	Bronze			2022-12-24	WOS:000088123000026
J	Wongsrichanalai, C; Thimasarn, K; Sirichaisinthop, J				Wongsrichanalai, C; Thimasarn, K; Sirichaisinthop, J			Antimalarial drug combination policy: a caveat	LANCET			English	Editorial Material							RESISTANT FALCIPARUM-MALARIA; IN-VITRO ACTIVITY; PLASMODIUM-FALCIPARUM; ARTEMISININ DERIVATIVES; THAILAND		Armed Forces Res Inst Med Sci, Dept Immunol, Bangkok 10400, Thailand; Minist Publ Hlth, Dept Communicable Dis Control, Nonthaburi, Thailand; Minist Publ Hlth, Dept Communicable Dis Control, Off Vector Borne Dis Control 1, Malaria Div, Saraburi, Thailand	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Ministry of Public Health - Thailand; Ministry of Public Health - Thailand	Wongsrichanalai, C (corresponding author), Armed Forces Res Inst Med Sci, Dept Immunol, Bangkok 10400, Thailand.							BASCO LK, 1993, AM J TROP MED HYG, V49, P301, DOI 10.4269/ajtmh.1993.49.301; Brundtland G. H., 1998, 51 WORLD HLTH ASS GE; BUSTOS MDG, 1994, B WORLD HEALTH ORGAN, V72, P729; *DEP COMM DIS CONT, 1992, ANN REP MAL DIV; *DEP COMM DIS CONT, 1993, ANN REP MAL DIV; FONTANET AL, 1993, AM J TROP MED HYG, V49, P465, DOI 10.4269/ajtmh.1993.49.465; KETRANGSEE S, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P55; Kyle D E, 1998, Med Trop (Mars), V58, P38; NOSTEN F, 1991, LANCET, V337, P1140, DOI 10.1016/0140-6736(91)92798-7; Pradines B, 1998, AM J TROP MED HYG, V58, P354, DOI 10.4269/ajtmh.1998.58.354; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Thimasarn K, 1995, Southeast Asian J Trop Med Public Health, V26, P204; von Seidlein L, 2000, LANCET, V355, P352, DOI 10.1016/S0140-6736(99)10237-X; Wernsdorfer W. H., 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P11; WERNSDORFER WH, 1994, ACTA TROP, V56, P143, DOI 10.1016/0001-706X(94)90060-4; White NJ, 1998, BRIT MED BULL, V54, P703, DOI 10.1093/oxfordjournals.bmb.a011721; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; WONGSRICHANALAI C, 1992, AM J TROP MED HYG, V47, P112, DOI 10.4269/ajtmh.1992.47.112; Wongsrichanalai C, 1999, B WORLD HEALTH ORGAN, V77, P392	20	23	24	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 24	2000	355	9222					2245	2247		10.1016/S0140-6736(00)02416-8	http://dx.doi.org/10.1016/S0140-6736(00)02416-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327DX	10881909				2022-12-24	WOS:000087779000042
J	Nishiwaki, K; Hisamoto, N; Matsumoto, K				Nishiwaki, K; Hisamoto, N; Matsumoto, K			A metalloprotease disintegrin that controls cell migration in Caenorhabditis elegans	SCIENCE			English	Article							C-ELEGANS; AXON MIGRATIONS; NETRIN CUES; GENE; UNC-6; CLONING; PROTEIN	in Caenorhabditis elegans, the gonad acquires two U-shaped arms by the directed migration of its distal tip cells (DTCs) along the body wall basement membranes. Correct migration of DTCs requires the mig-17 gene, which encodes a member of the metalloprotease-disintegrin protein family. The MIG-17 protein is secreted from muscle cells of the body wall and Localizes in the basement membranes of gonad, This localization is dependent on the disintegrin-like domain of MIG-17 and its catalytic activity, These results suggest that the MIG-17 metalloprotease directs migration of DTCs by remodeling the basement membrane.	NEC Corp Ltd, Japan Sci & Technol Corp, PRESTO, Tsukuba, Ibaraki 3058501, Japan; NEC Corp Ltd, Fundamental Res Labs, Tsukuba, Ibaraki 3058501, Japan; Japan Sci & Technol Corp, CREST, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Japan Science & Technology Agency (JST); NEC Corporation; NEC Corporation; Japan Science & Technology Agency (JST); Nagoya University	Nishiwaki, K (corresponding author), NEC Corp Ltd, Japan Sci & Technol Corp, PRESTO, Tsukuba, Ibaraki 3058501, Japan.							Blelloch R, 1999, DEV BIOL, V216, P382, DOI 10.1006/dbio.1999.9491; Blelloch R, 1999, NATURE, V399, P586, DOI 10.1038/21196; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; CRABBE T, 1994, BIOCHEMISTRY-US, V33, P6684, DOI 10.1021/bi00187a039; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; HENDERSON ST, 1994, DEVELOPMENT, V120, P2913; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; MADURO M, 1995, GENETICS, V141, P977; Nishiwaki K, 1999, GENETICS, V152, P985; OKKEMA PG, 1993, GENETICS, V135, P385; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Wolfsberg TG, 1996, DEV BIOL, V180, P389, DOI 10.1006/dbio.1996.0313	16	93	102	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2205	2208		10.1126/science.288.5474.2205	http://dx.doi.org/10.1126/science.288.5474.2205			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864868				2022-12-24	WOS:000087782900056
J	Lee, HK; Barbarosie, M; Kameyama, K; Bear, MF; Huganir, RL				Lee, HK; Barbarosie, M; Kameyama, K; Bear, MF; Huganir, RL			Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity	NATURE			English	Article							LONG-TERM POTENTIATION; DEPENDENT KINASE-II; GLUTAMATE RECEPTORS; GLUR1 SUBUNIT; DEPRESSION; HIPPOCAMPUS; MEMORY; CONDUCTANCE; INVOLVEMENT; EXPRESSION	Bidirectional changes in the efficacy of neuronal synaptic transmission, such as hippocampal long-term potentiation (LTP) and long-term depression (LTD), are thought to be mechanisms for information storage in the brain(1-4). LTP and LTD may be mediated by the modulation of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazloe proprionic acid) receptor phosphorylation(5-7). Here we show that LTP and LTD reversibly modify the phosphorylation of the AMPA receptor GluR1 subunit. However, contrary to the hypothesis that LTP and LTD are the functional inverse of each other, we rnd that they are associated with phosphorylation and dephosphorylation, respectively, of distinct GluR1 phosphorylation sites. Moreover, the site modulated depends on the stimulation history of the synapse. LTD induction in naive synapses dephosphorylates the major cyclic-AMP-dependent protein kinase (PKA) site, whereas in potentiated synapses the major calcium/calmodulin-dependent protein kinase II (CaMKII) site is dephosphorylated. Conversely, LTP induction in naive synapses and depressed synapses increases phosphorylation of the CaMKII site and the PKA site, respectively. LTP is differentially sensitive to CaMKII and PKA inhibitors depending on the history of the synapse. These results indicate that AMPA receptor phosphorylation is critical for synaptic plasticity, and that identical stimulation conditions recruit different signal-transduction pathways depending on synaptic history.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Brown Univ, Dept Neurosci, Howard Hughes Med Inst, Providence, RI 02912 USA; Natl Inst Biosci & Human Technol, Mol Neurobiol Lab, Tsukuba, Ibaraki 3058566, Japan	Howard Hughes Medical Institute; Johns Hopkins University; Brown University; Howard Hughes Medical Institute; National Institute of Advanced Industrial Science & Technology (AIST)	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA.		Kameyama, Kimihiko/M-6672-2018	Kameyama, Kimihiko/0000-0003-2550-3651; Bear, Mark/0000-0002-9903-2541				ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Bear MF, 1996, P NATL ACAD SCI USA, V93, P13453, DOI 10.1073/pnas.93.24.13453; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Otmakhov N, 1997, J NEUROSCI, V17, P5357; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	27	819	847	1	68	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2000	405	6789					955	959		10.1038/35016089	http://dx.doi.org/10.1038/35016089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326JT	10879537				2022-12-24	WOS:000087732700052
J	Gatfield, J; Pieters, J				Gatfield, J; Pieters, J			Essential role for cholesterol in entry of mycobacteria into macrophages	SCIENCE			English	Article							GREEN FLUORESCENT PROTEIN; NONOPSONIC BINDING; TUBERCULOSIS; MEMBRANE; BIOLOGY	Mycobacteria are intracellular pathogens that can invade and survive within host macrophages, thereby creating a major health problem worldwide. The molecular mechanisms involved in mycobacterial entry are still poorly characterized. Here we report that cholesterol is essential for uptake of mycobacteria by macrophages. Cholesterol accumulated at the site of mycobacterial entry, and depleting plasma membrane cholesterol specifically inhibited mycobacterial uptake. Cholesterol also mediated the phagosomal association of TACO, a coat protein that prevents degradation of mycobacteria in lysosomes. Thus, by entering host cells at cholesterol-rich domains of the plasma membrane, mycobacteria may ensure their subsequent intracellular survival in TACO-coated phagosomes.	Basel Inst Immunol, CH-4005 Basel, Switzerland		Pieters, J (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.			Pieters, Jean/0000-0002-5284-9757				BLOOM BR, 1992, NATURE, V358, P538, DOI 10.1038/358538b0; BORNIG H, 1974, ACTA HISTOCHEM, V50, P110; BRAMHAM J, 1995, J INORG BIOCHEM, V57, P23, DOI 10.1016/0162-0134(94)00010-8; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; BROWN EJ, 1991, CURR OPIN IMMUNOL, V3, P76, DOI 10.1016/0952-7915(91)90081-B; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cywes C, 1997, INFECT IMMUN, V65, P4258, DOI 10.1128/IAI.65.10.4258-4266.1997; DHANDAYUTHAPANI S, 1995, MOL MICROBIOL, V17, P901, DOI 10.1111/j.1365-2958.1995.mmi_17050901.x; DRABIKOWSKI W, 1973, BIOCHIM BIOPHYS ACTA, V291, P61, DOI 10.1016/0005-2736(73)90060-6; EFTHYMIOU C, 1962, J INFECT DIS, V110, P258, DOI 10.1093/infdis/110.3.258; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; GATFIELD J, UNPUB; Hasan Z, 1997, MOL MICROBIOL, V24, P545, DOI 10.1046/j.1365-2958.1997.3591731.x; Murray CJL, 1998, P NATL ACAD SCI USA, V95, P13881, DOI 10.1073/pnas.95.23.13881; PIETERS J, 1991, J CELL BIOL, V115, P1213, DOI 10.1083/jcb.115.5.1213; RAY TK, 1983, J CELL BIOCHEM, V21, P141, DOI 10.1002/jcb.240210205; Russell DG, 1997, PHILOS T ROY SOC B, V352, P1303, DOI 10.1098/rstb.1997.0114; Schlesinger LS, 1996, CURR TOP MICROBIOL, V215, P71; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; SPECTOR AA, 1985, J LIPID RES, V26, P1015; STOKES RW, 1993, J IMMUNOL, V151, P7067; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; Valdivia RH, 1996, GENE, V173, P47, DOI 10.1016/0378-1119(95)00706-7; Valdivia RH, 1997, SCIENCE, V277, P2007, DOI 10.1126/science.277.5334.2007; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Young DB, 1998, NATURE, V393, P515, DOI 10.1038/31095	27	449	468	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2000	288	5471					1647	1650		10.1126/science.288.5471.1647	http://dx.doi.org/10.1126/science.288.5471.1647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	320BZ	10834844				2022-12-24	WOS:000087382300042
J	Turner, GC; Du, FY; Varshavsky, A				Turner, GC; Du, FY; Varshavsky, A			Peptides accelerate their uptake by activating a ubiquitin-dependent proteolytic pathway	NATURE			English	Article							N-END RULE; SACCHAROMYCES-CEREVISIAE; RECOGNITION COMPONENT; PROTEIN; DEGRADATION; TRANSPORT; RESIDUE; SYSTEM	Protein degradation by the ubiquitin system controls the intracellular concentrations of many regulatory proteins. A protein substrate of the ubiquitin system is conjugated to ubiquitin through the action of three enzymes, E1, E2 and E3, with the degradation signal (degron) of the substrate recognized by E3 (refs 1-3). The resulting multi-ubiquitylated substrate is degraded by the 26S proteasome(4). Here we describe the physiological regulation of a ubiquitin-dependent pathway through allosteric modulation of its E3 activity by small compounds. Ubr1, the E3 enzyme of the N-end rule pathway (a ubiquitin-dependent proteolytic system) in Saccharomyces cerevisiae mediates the degradation of Cup9, a transcriptional repressor of the peptide transporter Ptr2 (ref. 5). Ubr1 also targets proteins that have destabilizing amino-terminal residues(6). We show that the degradation of Cup9 is allosterically activated by dipeptides with destabilizing N-terminal residues. In the resulting positive feedback circuit, imported dipeptides bind to Ubr1 and accelerate the Ubr1-dependent degradation of Cup9, thereby de-repressing the expression of Ptr2 and increasing the cell's capacity to import peptides. These findings identify the physiological rationale for the targeting of Cup9 by Ubr1, and indicate that small compounds may regulate other ubiquitin-dependent pathways.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	avarsh@caltech.edu		Turner, Glenn/0000-0002-5341-2784				ALAGRAMAM K, 1995, MOL MICROBIOL, V15, P225, DOI 10.1111/j.1365-2958.1995.tb02237.x; Ausubel FM., 1992, CURRENT PROTOCOLS MO, V3; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BAKER RT, 1991, P NATL ACAD SCI USA, V87, P2374; Barnes D, 1998, MOL MICROBIOL, V29, P297, DOI 10.1046/j.1365-2958.1998.00931.x; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Byrd C, 1998, EMBO J, V17, P269, DOI 10.1093/emboj/17.1.269; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; KNIGHT SAB, 1994, MOL CELL BIOL, V14, P7792, DOI 10.1128/MCB.14.12.7792; Kotani S, 1999, J CELL BIOL, V146, P791, DOI 10.1083/jcb.146.4.791; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; REISS Y, 1988, J BIOL CHEM, V263, P2693; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832	29	155	161	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2000	405	6786					579	583		10.1038/35014629	http://dx.doi.org/10.1038/35014629			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850718				2022-12-24	WOS:000087449500053
J	Seelert, H; Poetsch, A; Dencher, NA; Engel, A; Stahlberg, H; Muller, DJ				Seelert, H; Poetsch, A; Dencher, NA; Engel, A; Stahlberg, H; Muller, DJ			Structural biology - Proton-powered turbine of a plant motor	NATURE			English	Article							ATP-SYNTHASE; SUBUNIT-C; STOICHIOMETRY; ENERGY; F0F1		Tech Univ Darmstadt, Dept Chem, D-64287 Darmstadt, Germany; Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Technical University of Darmstadt; University of Basel; Max Planck Society	Seelert, H (corresponding author), Tech Univ Darmstadt, Dept Chem, Petersenstr 30, D-64287 Darmstadt, Germany.		Müller, Daniel J./A-5967-2010; Stahlberg, Henning/H-1868-2011; Poetsch, Ansgar/A-1862-2013; Dencher, Norbert/G-6640-2014	Müller, Daniel J./0000-0003-3075-0665; Stahlberg, Henning/0000-0002-1185-4592; Poetsch, Ansgar/0000-0002-7540-3475; 				Cherepanov DA, 1999, FEBS LETT, V449, P1, DOI 10.1016/S0014-5793(99)00386-5; Dimroth P, 1999, P NATL ACAD SCI USA, V96, P4924, DOI 10.1073/pnas.96.9.4924; FROMME P, 1987, Z NATURFORSCH C, V42, P1239; Jones PC, 1998, J BIOL CHEM, V273, P29701, DOI 10.1074/jbc.273.45.29701; Junge W, 1999, P NATL ACAD SCI USA, V96, P4735, DOI 10.1073/pnas.96.9.4735; Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9; Neff D, 1997, J STRUCT BIOL, V119, P139, DOI 10.1006/jsbi.1997.3891; Rastogi VK, 1999, NATURE, V402, P263, DOI 10.1038/46224; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; Schemidt RA, 1998, J BACTERIOL, V180, P3205, DOI 10.1128/JB.180.12.3205-3208.1998; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700	11	401	418	2	49	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					418	419		10.1038/35013148	http://dx.doi.org/10.1038/35013148			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839529				2022-12-24	WOS:000087212000037
J	Somers, DE; Schultz, TF; Milnamow, M; Kay, SA				Somers, DE; Schultz, TF; Milnamow, M; Kay, SA			ZEITLUPE encodes a novel clock-associated PAS protein from Arabidopsis	CELL			English	Article							DISRUPTS CIRCADIAN-RHYTHMS; UBIQUITIN-DEPENDENT PROTEOLYSIS; REGULATED GENE-EXPRESSION; F-BOX PROTEINS; DROSOPHILA CLOCK; PHYTOCHROME-B; PHOTOTRANSDUCTION PATHWAYS; SIGNAL-TRANSDUCTION; PERIOD PROTEIN; DOUBLE-TIME	We have conducted genetic screens for period length mutants in Arabidopsis using a transgenic bioluminescence phenotype. This screen identified mutations at a locus, ZEITLUPE (ZTL), that lengthen the free-running period of clock-controlled gene transcription and cell expansion, and alter the timing of the daylength-dependent transition from vegetative to floral development. Map-based cloning of ZTL identified a novel 609 amino acid polypeptide consisting of an aminoterminal PAS domain, an F box and six carboxy-terminal kelch repeats. The PAS region is highly similar to the PAS domain of the Arabidopsis blue-light receptor NPH1, and the Neurospora circadian-associated protein WHITE COLLAR-1 (WC-1). The striking fluence rate-dependent effect of the ztl mutations suggests that ZTL plays a primary role in the photocontrol of circadian period in higher plants.	Scripps Res Inst, Res Inst, Dept Cell Biol, Div Plant Biol, La Jolla, CA 92037 USA; Novartis Agr Discovery Inst, San Diego, CA 92121 USA	Scripps Research Institute; Novartis	Kay, SA (corresponding author), Scripps Res Inst, Res Inst, Dept Cell Biol, Div Plant Biol, 11055 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Kay, Steve A/F-6025-2011; Somers, David E/A-9209-2010	Kay, Steve A/0000-0002-0402-2878; Schultz, Thomas/0000-0001-9694-9920	NIGMS NIH HHS [GM 56006] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Anderson SL, 1997, PLANT CELL, V9, P1727, DOI 10.1105/tpc.9.10.1727; ASCHOFF J, 1979, Z TIERPSYCHOL, V49, P225; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Ballario P, 1998, MOL MICROBIOL, V29, P719, DOI 10.1046/j.1365-2958.1998.00955.x; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; CARPENTER CD, 1994, PLANT PHYSIOL, V104, P1015, DOI 10.1104/pp.104.3.1015; Casal JJ, 1998, PLANT PHYSIOL, V118, P19, DOI 10.1104/pp.118.1.19; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; ENGELMANN W, 1998, BIOL RHYTHMS PHOTOPE, P35; Golden SS, 1997, ANNU REV PLANT PHYS, V48, P327, DOI 10.1146/annurev.arplant.48.1.327; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Green RM, 1999, P NATL ACAD SCI USA, V96, P4176, DOI 10.1073/pnas.96.7.4176; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; INGRAM GC, 1995, PLANT CELL, V7, P1501, DOI 10.1105/tpc.7.9.1501; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Kreps JA, 1997, PLANT CELL, V9, P297, DOI 10.1105/tpc.9.3.297; Levy YY, 1998, PLANT CELL, V10, P1973, DOI 10.1105/tpc.10.12.1973; MILLAR AJ, 1992, PLANT CELL, V4, P1075, DOI 10.1105/tpc.4.9.1075; Millar AJ, 1996, P NATL ACAD SCI USA, V93, P15491, DOI 10.1073/pnas.93.26.15491; MILLAR AJ, 1995, SCIENCE, V267, P1163, DOI 10.1126/science.7855596; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Mohr Hans, 1994, P353; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Neff MM, 1998, PLANT PHYSIOL, V118, P27, DOI 10.1104/pp.118.1.27; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Nozue K, 1998, P NATL ACAD SCI USA, V95, P15826, DOI 10.1073/pnas.95.26.15826; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Regan-Reimann JD, 1999, CURR BIOL, V9, pR762, DOI 10.1016/S0960-9822(00)80006-8; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Samach A, 1999, PLANT J, V20, P433, DOI 10.1046/j.1365-313x.1999.00617.x; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Somers DE, 1998, DEVELOPMENT, V125, P485; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Sugano S, 1998, P NATL ACAD SCI USA, V95, P11020, DOI 10.1073/pnas.95.18.11020; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Thomas B., 1997, PHOTOPERIODISM PLANT; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; Zylka MJ, 1998, NEURON, V21, P1115, DOI 10.1016/S0896-6273(00)80628-5	61	471	506	1	57	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 28	2000	101	3					319	329		10.1016/S0092-8674(00)80841-7	http://dx.doi.org/10.1016/S0092-8674(00)80841-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847686	Bronze			2022-12-24	WOS:000086741900011
J	Hoeflich, KP; Luo, J; Rubie, EA; Tsao, MS; Jin, O; Woodgett, JR				Hoeflich, KP; Luo, J; Rubie, EA; Tsao, MS; Jin, O; Woodgett, JR			Requirement for glycogen synthase kinase-3 beta in cell survival and NF-kappa B activation	NATURE			English	Article							INDUCED APOPTOSIS; XENOPUS EMBRYOS; KINASE; LITHIUM; DEATH; MICE; AKT; INHIBITION; LETHALITY; 3-KINASE	Glycogen synthase kinase-3 (GSK-3)-alpha and -beta are closely related protein-serine kinases, which act as inhibitory components of Wnt signalling during embryonic development and cell proliferation in adult tissues(1,2). Insight into the physiological function of GSK-3 has emerged from genetic analysis in Drosophila(3,4), Dictyostelium(5) and yeast(6,7). Here we show that disruption of the murine GSK-3 beta gene results in embryonic lethality caused by severe liver degeneration during mid-gestation, a phenotype consistent with excessive tumour necrosis factor (TNF) toxicity, as observed in mice lacking genes involved in the activation of the transcription factor activation NF-kappa B. GSK-3 beta-dercient embryos were rescued by inhibition of TNF using an anti-TNF-alpha antibody. Fibroblasts from GSK-3b-dercient embryos were hypersensitive to TNF-alpha and showed reduced NF-kappa B function. Lithium treatment (which inhibits GSK-3; refs 8, 9) sensitized wild-type fibroblasts to TNF and inhibited transactivation of NF-kappa B. The early steps leading to NF-kappa B activation (degradation of I-kappa B and translocation of NF-kappa B to the nucleus) were unaffected by the loss of GSK-3b, indicating that NF-kappa B is regulated by GSK-3b at the level of the transcriptional complex. Thus, GSK-3b facilitates NF-kappa B function.	Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Woodgett, JR (corresponding author), Princess Margaret Hosp, Ontario Canc Inst, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.	jwoodgett@uhnres.utoronto.ca	Tsao, Ming-Sound/M-3503-2017; Tsao, Ming Sound/AFQ-7332-2022; Woodgett, Jim/F-1087-2010	Tsao, Ming Sound/0000-0002-9160-5405; Woodgett, Jim/0000-0003-3731-5797				BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Beraud C, 1999, P NATL ACAD SCI USA, V96, P429, DOI 10.1073/pnas.96.2.429; BEYAERT R, 1989, P NATL ACAD SCI USA, V86, P9494, DOI 10.1073/pnas.86.23.9494; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DALE TC, 1998, BIOCHEM J, V239, P209; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; HARWOOD AJ, 1995, CELL, V80, P139, DOI 10.1016/0092-8674(95)90458-1; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Nasevicius A, 1998, DEVELOPMENT, V125, P4283; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Ozes ON, 1999, NATURE, V401, P82; Plyte SE, 1996, MOL CELL BIOL, V16, P179; PUZISS JW, 1994, MOL CELL BIOL, V14, P831, DOI 10.1128/MCB.14.1.831; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; RUEL L, 1993, NATURE, V362, P557, DOI 10.1038/362557a0; SIEGFRIED E, 1990, NATURE, V345, P825, DOI 10.1038/345825a0; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Welsh GI, 1996, TRENDS CELL BIOL, V6, P274, DOI 10.1016/0962-8924(96)10023-4; WIJSMAN JH, 1993, J HISTOCHEM CYTOCHEM, V41, P7, DOI 10.1177/41.1.7678025; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X	30	1171	1240	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2000	406	6791					86	90		10.1038/35017574	http://dx.doi.org/10.1038/35017574			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	330ZE	10894547				2022-12-24	WOS:000087991200050
J	Reid, SD; Herbelin, CJ; Bumbaugh, AC; Selander, RK; Whittam, TS				Reid, SD; Herbelin, CJ; Bumbaugh, AC; Selander, RK; Whittam, TS			Parallel evolution of virulence in pathogenic Escherichia coli	NATURE			English	Article							ENTEROCYTE EFFACEMENT; STRAINS; RECOMBINATION; MUTATION; DIARRHEA; INTIMIN; LOCUS	The mechanisms underlying the evolution and emergence of new bacterial pathogens are not well understood. To elucidate the evolution of pathogenic Escherichia coli strains, here we sequenced seven housekeeping genes to build a phylogenetic tree and trace the history of the acquisition of virulence genes. Compatibility analysis indicates that more than 70% of the informative sites agree with a single phylogeny, suggesting that recombination has not completely obscured the remnants of ancestral chromosomes(1-3). On the basis of the rate of synonymous substitution for E. coli and Salmonella enterica (4.7 x 10(-9) per site per year(3)), the radiation of clones began about 9 million years ago and the highly virulent pathogen responsible for epidemics of food poisoning, E. coli O157:H7, separated from a common ancestor of E. coli K-12 as long as 4.5 million years ago. Phylogenetic analysis reveals that old lineages of E. coli have acquired the same virulence factors in parallel, including a pathogenicity island involved in intestinal adhesion, a plasmid-borne haemolysin, and phage-encoded Shiga toxins. Such parallel evolution indicates that natural selection has favoured an ordered acquisition of genes and the progressive build-up of molecular mechanisms that increase virulence.	Penn State Univ, Inst Mol Evolutionary Genet, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Whittam, TS (corresponding author), Penn State Univ, Inst Mol Evolutionary Genet, University Pk, PA 16802 USA.	tswl@psu.edu						[Anonymous], 1993, MEGA MOL EVOLUTIONAR; Bandelt HJ, 1992, MOL PHYLOGENET EVOL, V1, P242, DOI 10.1016/1055-7903(92)90021-8; Boyd EF, 1998, J BACTERIOL, V180, P1159, DOI 10.1128/JB.180.5.1159-1165.1998; DOPAZO J, 1993, P NATL ACAD SCI USA, V90, P10320, DOI 10.1073/pnas.90.21.10320; Felsenstein J, 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feng P, 1998, J INFECT DIS, V177, P1750, DOI 10.1086/517438; GUTTMAN DS, 1994, SCIENCE, V266, P1380, DOI 10.1126/science.7973728; Holmes EC, 1999, MOL BIOL EVOL, V16, P741, DOI 10.1093/oxfordjournals.molbev.a026159; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jakobsen IB, 1996, COMPUT APPL BIOSCI, V12, P291; Karaolis DKR, 1999, NATURE, V399, P375, DOI 10.1038/20715; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; Li W-H, 1997, MOL EVOLUTION; McGraw EA, 1999, MOL BIOL EVOL, V16, P12, DOI 10.1093/oxfordjournals.molbev.a026032; MILKMAN R, 1996, ESCHERICHIA COLI SAL, P2663; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; NEWLAND JW, 1988, J CLIN MICROBIOL, V26, P1292, DOI 10.1128/JCM.26.7.1292-1297.1988; OBrien AD., 1998, ESCHERICHIA COLI O15, P183; Reid SD, 1999, J CLIN MICROBIOL, V37, P2719, DOI 10.1128/JCM.37.8.2719-2722.1999; Schmidt H, 1996, J CLIN MICROBIOL, V34, P2364, DOI 10.1128/JCM.34.10.2364-2367.1996; SCHMIDT H, 1995, INFECT IMMUN, V63, P1055, DOI 10.1128/IAI.63.3.1055-1061.1995; Sperandio V, 1998, FEMS MICROBIOL LETT, V164, P133, DOI 10.1016/S0378-1097(98)00205-5; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang FS, 1997, J BACTERIOL, V179, P6551, DOI 10.1128/jb.179.21.6551-6559.1997; Whittam T. S., 1998, ESCHERICHIA COLI O15, P195; WHITTAM TS, 1993, INFECT IMMUN, V61, P1619, DOI 10.1128/IAI.61.5.1619-1629.1993; Wieler LH, 1997, FEMS MICROBIOL LETT, V156, P49, DOI 10.1016/S0378-1097(97)00403-5	29	384	394	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2000	406	6791					64	67		10.1038/35017546	http://dx.doi.org/10.1038/35017546			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	330ZE	10894541				2022-12-24	WOS:000087991200044
J	Ainsworth, M; Teokul, W				Ainsworth, M; Teokul, W			Breaking the silence: setting realistic priorities for AIDS control in less-developed countries	LANCET			English	Article							SEXUALLY-TRANSMITTED DISEASES; SUB-SAHARAN AFRICA; HIV-INFECTION; ANTIRETROVIRAL THERAPY; UGANDA; SEROPREVALENCE; PREVENTION; PROGRAM; COHORT; TRIAL	The AIDS pandemic is a human tragedy that is threatening development in the poorest countries. There is no cure or vaccine, but the tools to control the epidemic already exist. Nevertheless, there are few examples of national AIDS control programmes that have had an impact on the epidemic. We (an economist and a planner) attribute this to the reluctance of governments to confront AIDS and a failure to prioritise activities in the face of severe financial and administrative constraints. When implementation capacity is weak, expanding the number of activities may not improve programme effectiveness. Rather, by implementing a smaller, core set of the most cost-effective activities on a national scale, policymakers could have a huge effect on the overall epidemic in a sustained way and provide a foundation for expansion. We propose three core priorities for AIDS control in poor countries for prevention, treatment, and mitigation of the impact.	World Bank, Dev Res Grp, Washington, DC 20433 USA; Off Prime Minister, Natl Econ & Social Dev Board, Bangkok, Thailand	The World Bank	Teokul, W (corresponding author), 962 Krungkasem Rd, Bangkok 10100, Thailand.							AINSWORTH M, 1999, 5 INT C AIDS AS PAC; Ainsworth M., 1998, CONFRONTING AIDS EVI; Ainsworth M, 2000, 2266 WORLD BANK DEV; Aral SO, 1998, LANCET, V351, P33; AsiimweOkiror G, 1997, AIDS, V11, P1757, DOI 10.1097/00002030-199714000-00013; Bernstein RS, 1998, INTERFACES, V28, P101, DOI 10.1287/inte.28.3.101; Caldwell JC, 2000, POPUL DEV REV, V26, P117, DOI 10.1111/j.1728-4457.2000.00117.x; Celentano DD, 1998, AIDS, V12, pF29, DOI 10.1097/00002030-199805000-00004; DESJARLAIS DC, 1995, JAMA-J AM MED ASSOC, V274, P1226, DOI 10.1001/jama.274.15.1226; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Hogg RS, 1997, LANCET, V350, P1406, DOI 10.1016/S0140-6736(05)65188-4; *KINGD CAMB, 1999, CAMB POV ASS; LAGA M, 1994, LANCET, V344, P246, DOI 10.1016/S0140-6736(94)93005-8; MAY RM, 1987, NATURE, V326, P137, DOI 10.1038/326137a0; MERSON MH, IN PRESS AIDS, V2; *MIN PUBL HLTH DIV, 1999, MONTHL EP SURV REP, V30; MOSES S, 1991, AIDS, V5, P407, DOI 10.1097/00002030-199104000-00008; MULDER D, 1995, BRIT MED J, V311, P833, DOI 10.1136/bmj.311.7009.833; Muller O, 1998, LANCET, V351, P68, DOI 10.1016/S0140-6736(05)78051-X; OVER M, 1993, DIS CONTROL PRIORITI; Over M., 1998, CONFRONTING AIDS EVI; PHOOLCHAROEN W, 1998, THAILAND LESSONS STR; Reich MR, 2000, SCIENCE, V287, P1979, DOI 10.1126/science.287.5460.1979; Rojanapithayakorn W, 1996, AIDS, V10, P1, DOI 10.1097/00002030-199601000-00001; SERWADDA D, 1995, 9 INT C AIDS STDS AF; TEOKUL W, 2000, SUBR SEM HIV AIDS EC; Thomas JC, 1996, J INFECT DIS, V174, pS134, DOI 10.1093/infdis/174.Supplement_2.S134; *UNAIDS, 1999, AIDS EP UPD DEC 1999; *UNAIDS, 1999, M UNAIDS COSP AG SEC; *UNAIDS, 1999, AIDS MOV 4TH PLAC WO; UNAIDS, 1998, EXP GLOB RESP HIV AI; *UNAIDS WELLC TRUS, 1999, TRENDS HIV INC PREV; VANVLIET C, 1998, CONFRONTING AIDS EVI; Wawer MJ, 1997, AIDS, V11, P1023, DOI 10.1097/00002030-199708000-00011; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; WHITE J, 2000, POLICY SERIES NATURA, V6; World Bank, 1999, CONFR AIDS PUBL PRIO; *WORLD BANK, 2000, WORLD DEV IND 2000; *WORLD BANK, 1999, WORLD DEV IND 1999; *WORLD BANK AIDS V, 2000, ACC AIDS VACC DEV CO	40	73	75	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 1	2000	356	9223					55	60		10.1016/S0140-6736(00)02440-5	http://dx.doi.org/10.1016/S0140-6736(00)02440-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329XH	10892777				2022-12-24	WOS:000087933400040
J	He, ZH; Wang, ZY; Li, JM; Zhu, Q; Lamb, C; Ronald, P; Chory, J				He, ZH; Wang, ZY; Li, JM; Zhu, Q; Lamb, C; Ronald, P; Chory, J			Perception of brassinosteroids by the extracellular domain of the receptor kinase BRI1	SCIENCE			English	Article							GENE ENCODES; ARABIDOPSIS; CLONING; SHOOT	An assay was developed to study plant receptor kinase activation and signaling mechanisms. The extracellular leucine-rich repeat (LRR) and transmembrane domains of the Arabidopsis receptor kinase BRI1, which is implicated in brassinosteroid signaling, were fused to the serine/threonine kinase domain of XA21, the rice disease resistance receptor. The chimeric receptor initiates plant defense responses in rice cells upon treatment with brassinosteroids. These results, which indicate that the extracellular domain of BRI1 perceives brassinosteroids, suggest a general signaling mechanism for the LRR receptor kinases of plants. This system should allow the discovery of ligands for the LRR kinases, the largest group of plant receptor kinases.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; Zhejiang Univ, Inst Biotechnol, Hangzhou 310029, Peoples R China	Salk Institute; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California Davis; Zhejiang University	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	chory@salk.edu	Ronald, Pamela/AAK-7664-2020; Wang, Zhi-Yong/E-3810-2012; Li, Jianming/O-1772-2014	Wang, Zhi-Yong/0000-0003-4602-3390; Li, Jianming/0000-0003-3231-0778; He, Zuhua/0000-0002-6098-7893				Becraft PW, 1998, TRENDS PLANT SCI, V3, P384, DOI 10.1016/S1360-1385(98)01301-6; Chen L, 1998, PLANT CELL REP, V18, P25, DOI 10.1007/s002990050526; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Feng XH, 1997, EMBO J, V16, P3912, DOI 10.1093/emboj/16.13.3912; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; FRIEDRICHSEN D, IN PRESS PLANT PHYSL; HE ZT, UNPUB; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; Lease K, 1998, CURR OPIN PLANT BIOL, V1, P388, DOI 10.1016/S1369-5266(98)80261-6; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; LIN TL, 2000, GENE DEV, V14, P108; Martin GB, 1999, CURR OPIN PLANT BIOL, V2, P273, DOI 10.1016/S1369-5266(99)80049-1; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; SONG W, UNPUB; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Yi SY, 1999, MOL CELLS, V9, P320; YOSHIKAWA M, UNPUB; Zhu Q, 1995, PLANT MOL BIOL, V29, P535, DOI 10.1007/BF00020983; ZHU Q, 1991, MOL GEN GENET, V226, P289, DOI 10.1007/BF00273615	23	324	372	4	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2000	288	5475					2360	2363		10.1126/science.288.5475.2360	http://dx.doi.org/10.1126/science.288.5475.2360			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329NP	10875920	Green Published			2022-12-24	WOS:000087913400038
J	Bear, JE; Loureiro, JJ; Libova, I; Fassler, R; Wehland, J; Gertler, FB				Bear, JE; Loureiro, JJ; Libova, I; Fassler, R; Wehland, J; Gertler, FB			Negative regulation of fibroblast motility by Ena/VASP proteins	CELL			English	Article							VASODILATOR-STIMULATED PHOSPHOPROTEIN; ACTIN-BASED MOTILITY; LISTERIA-MONOCYTOGENES; SPATIAL CONTROL; HUMAN PLATELETS; FOCAL ADHESION; EVH1 DOMAIN; VASP; BINDING; DROSOPHILA	Ena/VASP proteins have been implicated in cell motility through regulation of the actin cytoskeleton and are found at focal adhesions and the leading edge. Using overexpression, loss-of-function, and inhibitory approaches, we find that Ena/VASP proteins negatively regulate fibroblast motility. A close-dependent decrease in movement is observed when Ena/VASP proteins are overexpressed in fibroblasts. Neutralization or deletion of all Ena/VASP proteins results in increased cell movement. Selective depletion of Ena/VASP proteins from focal adhesions, but not the leading edge, has no effect on motility. Constitutive membrane targeting of Ena/VASP proteins inhibits motility. These results are in marked contrast to current models for Ena/VASP function derived mainly from their role in the actin-driven movement of Listeria monocytogenes.	MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Lund Hosp, S-22185 Lund, Sweden; Gesell Biotechnol Forsch mbH, D-38124 Braunschweig, Germany	Massachusetts Institute of Technology (MIT); Lund University; Skane University Hospital; Gesellschaft fur Biotechnologische Forschung mbH	Gertler, FB (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.	fgertler@mit.edu			NIGMS NIH HHS [GM58801] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058801] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aszodi A, 1999, EMBO J, V18, P37, DOI 10.1093/emboj/18.1.37; Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Beckerle MC, 1998, CELL, V95, P741, DOI 10.1016/S0092-8674(00)81697-9; Carl UD, 1999, CURR BIOL, V9, P715, DOI 10.1016/S0960-9822(99)80315-7; CHAKRABORTY T, 1995, EMBO J, V14, P1314, DOI 10.1002/j.1460-2075.1995.tb07117.x; DOMANN E, 1992, EMBO J, V11, P1981, DOI 10.1002/j.1460-2075.1992.tb05252.x; Drees BE, 1999, J CELL BIOL, V147, P1549, DOI 10.1083/jcb.147.7.1549; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Fedorov AA, 1999, NAT STRUCT BIOL, V6, P661, DOI 10.1038/10717; Geese M, 2000, J CELL SCI, V113, P1415; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; GERTLER FB, 1990, SCIENCE, V248, P857, DOI 10.1126/science.2188361; HALBRUGGE M, 1990, J CHROMATOGR, V521, P335, DOI 10.1016/0021-9673(90)85057-3; Hauser W, 1999, P NATL ACAD SCI USA, V96, P8120, DOI 10.1073/pnas.96.14.8120; Huttelmaier S, 1999, FEBS LETT, V451, P68, DOI 10.1016/S0014-5793(99)00546-3; Jonckheere V, 1999, FEBS LETT, V447, P257, DOI 10.1016/S0014-5793(99)00293-8; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Lanier LM, 1999, NEURON, V22, P313, DOI 10.1016/S0896-6273(00)81092-2; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433; PISTOR S, 1994, EMBO J, V13, P758, DOI 10.1002/j.1460-2075.1994.tb06318.x; PISTOR S, 1995, CURR BIOL, V5, P517, DOI 10.1016/S0960-9822(95)00104-7; Prehoda KE, 1999, CELL, V97, P471, DOI 10.1016/S0092-8674(00)80757-6; REINHARD M, 1992, EMBO J, V11, P2063, DOI 10.1002/j.1460-2075.1992.tb05264.x; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Schafer DA, 1995, ANNU REV CELL DEV BI, V11, P497, DOI 10.1146/annurev.cellbio.11.1.497; Schoenwaelder SM, 1999, CURR OPIN CELL BIOL, V11, P274, DOI 10.1016/S0955-0674(99)80037-4; Smith GA, 1996, J CELL BIOL, V135, P647, DOI 10.1083/jcb.135.3.647; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0	37	370	382	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 23	2000	101	7					717	728		10.1016/S0092-8674(00)80884-3	http://dx.doi.org/10.1016/S0092-8674(00)80884-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	327YE	10892743	Bronze, Green Published			2022-12-24	WOS:000087821400006
J	Latham, MC; Preble, EA				Latham, MC; Preble, EA			Appropriate feeding methods for infants of HIV infected mothers in sub-Saharan Africa	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TO-CHILD TRANSMISSION; MILK		Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University	Latham, MC (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	MCL6@cornell.edu						Coutsoudis A, 1999, LANCET, V354, P471, DOI 10.1016/S0140-6736(99)01101-0; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Filteau SM, 1999, IMMUNOLOGY, V97, P595, DOI 10.1046/j.1365-2567.1999.00834.x; Latham MC, 1999, BRIT MED J, V318, P1303, DOI 10.1136/bmj.318.7194.1303; LATHAM MC, 1998, IND J NUTR DIET, V36, P131; Morrison P, 1999, Breastfeed Rev, V7, P5; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; NEWBURG DS, 1992, PEDIATR RES, V31, P22, DOI 10.1203/00006450-199201000-00004; PIWOZ EG, 2000, HIV AIDS INFANT FEED; PREBLE EA, 1998, HIV INFANT FEEDING C; Semba RD, 1999, J INFECT DIS, V180, P93, DOI 10.1086/314854; Stecklov G, 1999, AM J PUBLIC HEALTH, V89, P780, DOI 10.2105/AJPH.89.5.780-a; UNAIDS, 1998, MOTH TO CHILD TRANSM; VICTORA CG, 1987, LANCET, V2, P319; WAHL SM, 1997, ORAL DIS, V3, P564; *WHO, 1998, GUID DEC MAK; *WHO COLL STUD TEA, 1999, LANCET, V355, P451; *WHO UN CONS STAT, 1992, WHO UN CONS HIV TRAN; *ZAMB NAT FOOD NUT, 2000, HIV INF FEED SUMM FO	19	30	30	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2000	320	7250					1656	1659		10.1136/bmj.320.7250.1656	http://dx.doi.org/10.1136/bmj.320.7250.1656			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KG	10856073	Green Published			2022-12-24	WOS:000087734200027
J	Herron, MJ; Nelson, CM; Larson, J; Snapp, KR; Kansas, GS; Goodman, JL				Herron, MJ; Nelson, CM; Larson, J; Snapp, KR; Kansas, GS; Goodman, JL			Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the P-selectin ligand, PSGL-1	SCIENCE			English	Article							MYELOID CELLS; GLYCOPROTEIN; AGENT; IDENTIFICATION; RECOGNITION; COMPLEMENT; EXPRESSION; RECEPTORS; INFECTION; BINDING	Human granulocytic ehrlichiosis (HGE) is a febrile tick-borne illness caused by a recently discovered intracellular bacterium remarkable for its tropism for professionally phagocytic neutrophils. Monoclonal antibodies against the P-selectin binding domain of the leukocyte P-selectin glycoprotein ligand, PSGL-1, prevented HGE cell binding and infection, as did enzymatic digestion of PSGL-1. Furthermore, simultaneous neoexpression in nonsusceptible cells of complementary DNAs for both PSGL-1 and its modifying alpha-(1,3) fucosyltransferase, Fuc-TVII, allowed binding and infection by HGE. Thus, the HGE bacterium specifically bound to fucosylated Leukocyte PSGL-1. Selectin mimicry is likely central to the organism's unique ability to target and infect neutrophils.	Univ Minnesota, Sch Med, Dept Med, Div Infect Dis, Minneapolis, MN 55455 USA; Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA	University of Minnesota System; University of Minnesota Twin Cities; Northwestern University	Goodman, JL (corresponding author), Univ Minnesota, Sch Med, Dept Med, Div Infect Dis, Minneapolis, MN 55455 USA.	goodmanj@cber.fda.gov			NIAID NIH HHS [R01AI40952] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040952] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Behl R, 2000, THROMB HAEMOSTASIS, V83, P114; BEVILACQUA MP, 1993, J CLIN INVEST, V91, P379, DOI 10.1172/JCI116210; BLACKWELL JM, 1985, J EXP MED, V162, P324, DOI 10.1084/jem.162.1.324; BLISKA JB, 1993, CELL, V73, P903, DOI 10.1016/0092-8674(93)90270-Z; CHEN SM, 1994, J CLIN MICROBIOL, V32, P589, DOI 10.1128/JCM.32.3.589-595.1994; Cossart P, 1996, SCIENCE, V271, P315, DOI 10.1126/science.271.5247.315; FURTADO GD, 1992, INFECT IMMUN, V60, P4925, DOI 10.1128/IAI.60.11.4925-4931.1992; Goodman JL, 1999, J CLIN INVEST, V103, P407, DOI 10.1172/JCI4230; Goodman JL, 1996, NEW ENGL J MED, V334, P209, DOI 10.1056/NEJM199601253340401; Hidari KIPJ, 1997, J BIOL CHEM, V272, P28750, DOI 10.1074/jbc.272.45.28750; ISBERG RR, 1991, SCIENCE, V252, P934, DOI 10.1126/science.1674624; Kansas GS, 1996, BLOOD, V88, P3259, DOI 10.1182/blood.V88.9.3259.bloodjournal8893259; Klein MB, 1997, J INFECT DIS, V176, P1405, DOI 10.1086/517332; KLEIN MB, IN PRESS J INFECT DI; LARSON J, 1998, INT C EM INF DIS ATL; Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342; MOORE KL, 1992, J CELL BIOL, V118, P445, DOI 10.1083/jcb.118.2.445; Nadelman RB, 1997, NEW ENGL J MED, V337, P27, DOI 10.1056/NEJM199707033370105; NATSUKA S, 1994, J BIOL CHEM, V269, P16789; NORGARD KE, 1993, J BIOL CHEM, V268, P12764; PAYNE NR, 1987, J EXP MED, V166, P1377, DOI 10.1084/jem.166.5.1377; Sinai AP, 1997, ANNU REV MICROBIOL, V51, P415, DOI 10.1146/annurev.micro.51.1.415; Snapp KR, 1998, BLOOD, V91, P154, DOI 10.1182/blood.V91.1.154.154_154_164; Snapp KR, 1998, J CELL BIOL, V142, P263, DOI 10.1083/jcb.142.1.263; SVEDMYR E, 1975, P NATL ACAD SCI USA, V72, P1622, DOI 10.1073/pnas.72.4.1622; Wagers AJ, 1997, J IMMUNOL, V159, P1917; Webster P, 1998, J CLIN INVEST, V101, P1932, DOI 10.1172/JCI1544; Weyrich AS, 1996, J CLIN INVEST, V97, P1525, DOI 10.1172/JCI118575	28	105	113	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2000	288	5471					1653	1656		10.1126/science.288.5471.1653	http://dx.doi.org/10.1126/science.288.5471.1653			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	320BZ	10834846				2022-12-24	WOS:000087382300044
J	Wu, XH; Ranganathan, V; Weisman, DS; Heine, WF; Ciccone, DN; O'Neill, TB; Crick, KE; Pierce, KA; Lane, WS; Rathbum, G; Livingston, DM; Weaver, DT				Wu, XH; Ranganathan, V; Weisman, DS; Heine, WF; Ciccone, DN; O'Neill, TB; Crick, KE; Pierce, KA; Lane, WS; Rathbum, G; Livingston, DM; Weaver, DT			ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response	NATURE			English	Article							ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; BRCA1; COMPLEX; KINASE; REPAIR; HETEROZYGOTES; ASSOCIATION; LINKAGE; RAD51	Nijmegen breakage syndrome (NBS) is characterized by extreme radiation sensitivity, chromosomal instability and cancer(1). The phenotypes are similar to those of ataxia telangiectasia mutated (ATM) disease, where there is a deficiency in a protein kinase that is activated by DNA damage, indicating that the Nbs and Atm proteins may participate in common pathways. Here we report that Nbs is specifically phosphorylated in response to g-radiation, ultraviolet light and exposure to hydroxyurea. Phosphorylation of Nbs mediated by g-radiation, but not that induced by hydroxyurea or ultraviolet light, was markedly reduced in ATM cells. In vivo, Nbs was phosphorylated on many serine residues, of which S343, S397 and S615 were phosphorylated by Atm in vitro. At least two of these sites were underphosphorylated in ATM cells. Inactivation of these serines by mutation partially abrogated Atm-dependent phosphorylation. Reconstituting NBS cells with a mutant form of Nbs that cannot be phosphorylated at selected, ATM-dependent serine residues led to a specific reduction in clonogenic survival after g-radiation. Thus, phosphorylation of Nbs by Atm is critical for certain responses of human cells to DNA damage.	Ctr Blood Res, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet & Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Harvard Microchem Facil, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Livingston, DM (corresponding author), Ctr Blood Res, 200 Longwood Ave, Boston, MA 02115 USA.							Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Brown AL, 1999, P NATL ACAD SCI USA, V96, P3745, DOI 10.1073/pnas.96.7.3745; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chen G, 1999, J BIOL CHEM, V274, P12748, DOI 10.1074/jbc.274.18.12748; Chittum HS, 1998, BIOCHEMISTRY-US, V37, P10866, DOI 10.1021/bi981042r; CICCONE DN, UNPUB NATURE GENET; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Hoekstra MF, 1997, CURR OPIN GENET DEV, V7, P170, DOI 10.1016/S0959-437X(97)80125-6; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Luo GB, 1999, P NATL ACAD SCI USA, V96, P7376, DOI 10.1073/pnas.96.13.7376; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; ONEILL T, IN PRESS J BIOL CHEM; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Sarkaria JN, 1998, CANCER RES, V58, P4375; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; SEEMANOVA E, 1990, MUTAT RES, V238, P321, DOI 10.1016/0165-1110(90)90024-6; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; WU XL, IN PRESS SCIENCE; Yamaguchi-Iwai Y, 1999, EMBO J, V18, P6619, DOI 10.1093/emboj/18.23.6619; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	28	366	385	0	8	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					477	482		10.1038/35013089	http://dx.doi.org/10.1038/35013089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839545				2022-12-24	WOS:000087212000053
J	Huber, KM; Kayser, MS; Bear, MF				Huber, KM; Kayser, MS; Bear, MF			Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression	SCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; AREA CA1; CELL-BODIES; LATE-PHASE; INDUCTION; SYNAPSES; FACILITATION; TRANSLATION; EXPRESSION; ACTIVATION	A hippocampal pyramidal neuron receives more than 10(4) excitatory glutamatergic synapses. Many of these synapses contain the molecular machinery for messenger RNA translation, suggesting that the protein complement (and thus function) of each synapse can be regulated on the basis of activity. Here, Local postsynaptic protein synthesis, triggered by synaptic activation of metabotropic glutamate receptors, was found to modify synaptic transmission within minutes.	Brown Univ, Howard Hughes Med Inst, Providence, RI 02912 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Brown University; Howard Hughes Medical Institute; Brown University	Bear, MF (corresponding author), Brown Univ, Howard Hughes Med Inst, Providence, RI 02912 USA.		Huber, Kimberly/X-5534-2019	Kayser, Matthew/0000-0003-2359-4967; Bear, Mark/0000-0002-9903-2541				Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; CHU LY, 1980, BIOCHEMISTRY-US, V19, P184, DOI 10.1021/bi00542a028; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Fitzjohn SM, 1999, NEUROPHARMACOLOGY, V38, P1577, DOI 10.1016/S0028-3908(99)00123-9; FREY U, 1989, NEUROSCI LETT, V97, P135, DOI 10.1016/0304-3940(89)90152-3; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Huber K. M., 1998, Society for Neuroscience Abstracts, V24, P512; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kemp N, 1999, NEUROPHARMACOLOGY, V38, P495, DOI 10.1016/S0028-3908(98)00222-6; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Linden DJ, 1996, NEURON, V17, P483, DOI 10.1016/S0896-6273(00)80180-4; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Raymond CR, 2000, J NEUROSCI, V20, P969, DOI 10.1523/JNEUROSCI.20-03-00969.2000; Sawtell NB, 1999, J NEUROPHYSIOL, V82, P3594, DOI 10.1152/jn.1999.82.6.3594; Sherff CM, 1999, SCIENCE, V285, P1911, DOI 10.1126/science.285.5435.1911; Steward O, 1996, J NEUROCYTOL, V25, P717, DOI 10.1007/BF02284837; TORRE ER, 1992, J NEUROSCI, V12, P762; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395	24	732	747	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 19	2000	288	5469					1254	1256		10.1126/science.288.5469.1254	http://dx.doi.org/10.1126/science.288.5469.1254			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315KH	10818003				2022-12-24	WOS:000087112600055
J	Petcherski, AG; Kimble, J				Petcherski, AG; Kimble, J			LAG-3 is a putative transcriptional activator in the C-elegans Notch pathway	NATURE			English	Article							OF-FUNCTION MUTATIONS; CAENORHABDITIS-ELEGANS; INTRACELLULAR DOMAIN; SIGNALING PATHWAY; ANKYRIN REPEATS; CELL FATE; GERM-LINE; GLP-1; GENE; PROTEIN	Notch signalling controls growth, differentiation and patterning during normal animal development(1,2); in humans, aberrant Notch signalling has been implicated in cancer and stroke(3,4). The mechanism of Notch signalling is thought to require cleavage of the receptor in response to ligand binding(5), movement of the receptor's intracellular domain to the nucleus(6,7), and binding of that intracellular domain to a CSL (for CBF1, Suppressor of Hairless, LAG-1)(8,9) protein. Here we identify LAG-3, a glutamine-rich protein that forms a ternary complex together with the LAG-1 DNA-binding protein(10) and the receptor's intracellular domain. Receptors with mutant ankyrin repeats that abrogate signal transduction are incapable of complex formation both in yeast and in vitro. Using RNA interference, we find that LAG-3 activity is crucial in Caenorhabditis elegans for both GLP-1 and LIN-12 signalling. LAG-3 is a potent transcriptional activator in yeast, and a Myc-tagged LAG-3 is predominantly nuclear in C. elegans. We propose that GLP-1 and LIN-12 promote signalling by recruiting LAG-3 to target promoters, where it functions as a transcriptional activator.	Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kimble, J (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 433 Babcock Dr, Madison, WI 53706 USA.	jekimble@facstaff.wisc.edu						Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; Bartel P. L., 1997, YEAST 2 HYBRID SYSTE; Berry LW, 1997, DEVELOPMENT, V124, P925; *C EL SEQ CONS, 1998, SCIENCE, V283, P2103; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; C. elegans Sequencing Consortium, 1999, SCIENCE, V283, P35; Christensen S, 1996, DEVELOPMENT, V122, P1373; CRITTENDEN SL, 1998, CELL LAB MANUAL, V108, P101; DIEDERICH RJ, 1994, DEVELOPMENT, V120, P473; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GREENWALD I, 1990, NATURE, V346, P197, DOI 10.1038/346197a0; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; Hicks GR, 1995, ANNU REV CELL DEV BI, V11, P155, DOI 10.1146/annurev.cb.11.110195.001103; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kato H, 1997, DEVELOPMENT, V124, P4133; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; KODOYIANNI V, 1992, MOL BIOL CELL, V3, P1199, DOI 10.1091/mbc.3.11.1199; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; MANGO SE, 1991, NATURE, V352, P811, DOI 10.1038/352811a0; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; Roehl H, 1996, EMBO J, V15, P7002, DOI 10.1002/j.1460-2075.1996.tb01092.x; ROEHL H, 1993, NATURE, V364, P632, DOI 10.1038/364632a0; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; SMOLLER D, 1990, GENE DEV, V4, P1688, DOI 10.1101/gad.4.10.1688; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X	32	148	162	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2000	405	6784					364	368		10.1038/35012645	http://dx.doi.org/10.1038/35012645			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314YT	10830967				2022-12-24	WOS:000087085700051
J	Walker, DW; McColl, G; Jenkins, NL; Harris, J; Lithgow, GJ				Walker, DW; McColl, G; Jenkins, NL; Harris, J; Lithgow, GJ			Natural selection - Evolution of lifespan in C-elegans	NATURE			English	Article							CAENORHABDITIS-ELEGANS; WILD-TYPE; MUTANT; THERMOTOLERANCE; LONGEVITY; AGE-1; LONG		Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Walker, DW (corresponding author), Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England.	Gordon.Lithgow@man.ac.uk	McColl, Gawain/Y-8959-2018	McColl, Gawain/0000-0002-6347-6722				DUHON SA, 1995, J GERONTOL A-BIOL, V50, pB254, DOI 10.1093/gerona/50A.5.B254; FRIEDMAN DB, 1988, J GERONTOL, V43, pB102, DOI 10.1093/geronj/43.4.B102; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; LITHGOW GJ, 1994, J GERONTOL, V49, pB270, DOI 10.1093/geronj/49.6.B270; Malone EA, 1996, GENETICS, V143, P1193; Medawar P., 1952, UNSOLVED PROBLEM BIO; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Tissenbaum HA, 1998, GENETICS, V148, P703; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x	10	142	147	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2000	405	6784					296	297		10.1038/35012693	http://dx.doi.org/10.1038/35012693			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314YT	10830948				2022-12-24	WOS:000087085700031
J	Gapstur, SM; Gann, PH; Lowe, W; Liu, K; Colangelo, L; Dyer, A				Gapstur, SM; Gann, PH; Lowe, W; Liu, K; Colangelo, L; Dyer, A			Abnormal glucose metabolism and pancreatic cancer mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASSOCIATION DETECTION PROJECT; POSTLOAD PLASMA-GLUCOSE; CORONARY HEART-DISEASE; SERUM URIC-ACID; MIDDLE-AGED MEN; GROWTH-FACTOR-I; NUTRITIONAL FACTORS; DIABETES-MELLITUS; UNITED-STATES; RISK-FACTORS	Context Previous studies reported an increased risk of pancreatic cancer among persons with diabetes. Few data exist, however, on the association of postload plasma glucose concentration with pancreatic cancer, which could provide insight into the role of abnormal glucose metabolism in the etiology of pancreatic cancer. Objective To determine the independent association between postload plasma glucose concentration and risk of pancreatic cancer mortality among persons without self-reported diabetes. Design Prospective cohort study. Setting and Participants Employees of 84 Chicago-area organizations, with an average age of 40 years at baseline, were screened from 1963 to 1973 and followed up for an average of 25 years. A total of 96 men and 43 women died of pancreatic cancer among 20475 men and 15 183 women, respectively. Main Outcome Measures Relationship of pancreatic cancer mortality with postload plasma glucose levels. Results Compared with a postload plasma glucose level of 6.6 mmol/L (119 mg/ dL) or less and after adjusting for age, race, cigarette smoking, and body mass index, the relative risks (95% confidence intervals) of pancreatic cancer mortality were 1.65 (1.05-2.60) for postload plasma glucose levels between 6.7 (120) and 8.8 (159) mmol/L (mg/dL); 1.60 (0.95-2.70) for levels between 8.9 (160) and 11.0 (199); and 2.15 (1.22-3.80) for levels of 11.1 (200) or more; P far trend = .01. An association appeared to be stronger for men than women. Estimates were only slightly lower after excluding 11 men and 2 women who died of pancreatic cancer during the first 5 years of followup. In men only, higher body mass index and serum uric acid concentration also were independently associated with an elevated risk of pancreatic cancer mortality. Conclusion These results suggest that factors associated with abnormal glucose metabolism may play an important role in the etiology of pancreatic cancer.	Northwestern Univ, Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL USA; Northwestern Univ, Sch Med, Dept Med, Ctr Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; Vet Affairs Chicago Hlth Care Syst, Lakeside Div, Chicago, IL USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University	Gapstur, SM (corresponding author), Northwestern Univ, Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.				NCI NIH HHS [R03 CA81617-01] Funding Source: Medline; NHLBI NIH HHS [R01 HL21010-21] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R03CA081617] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021010] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		American Cancer Society, 1999, CANC FACTS FIG 1999; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Anderson KE PJ, 1996, CANC EPIDEMIOLOGY PR, P725; BERGMANN U, 1995, CANCER RES, V55, P2007; Calle EE, 1998, CANCER CAUSE CONTROL, V9, P403, DOI 10.1023/A:1008819701485; CHOW WH, 1995, J NATL CANCER I, V87, P930, DOI 10.1093/jnci/87.12.930; COOPER R, 1984, AM HEART J, V108, P827, DOI 10.1016/0002-8703(84)90678-1; Criqui M H, 1991, Ann Epidemiol, V1, P385; DEMESQUITA HBB, 1990, INT J CANCER, V46, P435, DOI 10.1002/ijc.2910460319; FACCHINI F, 1991, JAMA-J AM MED ASSOC, V266, P3008, DOI 10.1001/jama.266.21.3008; Fisher WE, 1996, J SURG RES, V63, P310, DOI 10.1006/jsre.1996.0266; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; FOSTER DW, 1994, HARRISONS PRINCIPLES, P1979; FRIEDMAN GD, 1993, INT J EPIDEMIOL, V22, P30, DOI 10.1093/ije/22.1.30; GHADIRIAN P, 1991, INT J CANCER, V47, P1, DOI 10.1002/ijc.2910470102; GULLO L, 1993, ITAL J GASTROENTEROL, V25, P487; HARRIS MI, 1995, DIABETES AM, P782; HIATT RA, 1988, CANCER RES, V48, P2916; Hoffman WS, 1937, J BIOL CHEM, V120, P51; HOWE GR, 1992, INT J CANCER, V51, P365, DOI 10.1002/ijc.2910510306; Ji BT, 1996, INT J CANCER, V66, P432; KOLONEL LN, 1994, CANCER EPIDEM BIOMAR, V3, P225; Korc M, 1998, Surg Oncol Clin N Am, V7, P25; LeRoith D, 1997, NEW ENGL J MED, V336, P633, DOI 10.1056/NEJM199702273360907; LEVINE W, 1990, AM J EPIDEMIOL, V131, P254, DOI 10.1093/oxfordjournals.aje.a115495; LEVINE W, 1989, J CLIN EPIDEMIOL, V42, P257, DOI 10.1016/0895-4356(89)90061-9; LIU K, 1982, J CHRON DIS, V35, P475, DOI 10.1016/0021-9681(82)90062-5; LYON JL, 1993, CANCER EPIDEM BIOMAR, V2, P513; MOLLER H, 1994, EUR J CANCER, V30A, P344, DOI 10.1016/0959-8049(94)90254-2; MOLLO F, 1986, PATHOL RES PRACT, V181, P442, DOI 10.1016/S0344-0338(86)80080-2; MUSEY VC, 1993, AM J MED SCI, V305, P131, DOI 10.1097/00000441-199303000-00001; *NAT CTR HLTH STAT, 1967, INT CLASS DIS; NOY A, 1994, J CLIN ENDOCR METAB, V79, P1223, DOI 10.1210/jc.79.5.1223; OHMURA E, 1990, CANCER RES, V50, P103; Orencia AJ, 1997, J CLIN EPIDEMIOL, V50, P1369, DOI 10.1016/S0895-4356(97)00201-1; PAN WH, 1986, AM J EPIDEMIOL, V123, P504, DOI 10.1093/oxfordjournals.aje.a114266; PERMERT J, 1993, BRIT J SURG, V80, P1047, DOI 10.1002/bjs.1800800841; PERMERT J, 1993, EUR J SURG, V159, P101; PETERSSON B, 1983, BMJ-BRIT MED J, V287, P7, DOI 10.1136/bmj.287.6384.7; Silverman DT, 1998, JNCI-J NATL CANCER I, V90, P1710, DOI 10.1093/jnci/90.22.1710; SINDELAR WF, 1985, CANCER PRINCIPLES PR, P691; SMITH GD, 1992, AM J EPIDEMIOL, V136, P1110, DOI 10.1093/oxfordjournals.aje.a116576; SOKVERMAN DT, 1999, BRIT J CANCER, V80, P1830; STAMLER J, 1975, J CHRON DIS, V28, P499, DOI 10.1016/0021-9681(75)90059-4; SUIKKARI AM, 1988, J CLIN ENDOCR METAB, V66, P266, DOI 10.1210/jcem-66-2-266; TAKKUNEN H, 1984, BRIT MED J, V288, P1161, DOI 10.1136/bmj.288.6424.1161; Troiano RP, 1998, PEDIATRICS, V101, P497; VACCARO O, 1992, DIABETES CARE, V15, P1328, DOI 10.2337/diacare.15.10.1328; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; WILLIAMS JA, 1985, DIABETES, V34, P980, DOI 10.2337/diabetes.34.10.980	50	302	317	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2000	283	19					2552	2558		10.1001/jama.283.19.2552	http://dx.doi.org/10.1001/jama.283.19.2552			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	312VL	10815119	Bronze			2022-12-24	WOS:000086964600036
J	Shulman, JM; Benton, R; St Johnston, D				Shulman, JM; Benton, R; St Johnston, D			The Drosophila homolog of C-elegans PAR-1 organizes the oocyte cytoskeleton and directs oskar mRNA localization to the posterior pole	CELL			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; CAENORHABDITIS-ELEGANS; ANTERIOR-POSTERIOR; MESSENGER-RNA; GERM-LINE; CYTOPLASMIC LOCALIZATION; PHOSPHORYLATION SITES; ANTEROPOSTERIOR AXIS; KINASE P110(MARK); PATTERN-FORMATION	In C. elegans, the PAR-1 kinase is localized to the posterior of the zygote and is required for anterior-posterior axis formation. Here, we report that a Drosophila PAR-1 homolog localizes to the posterior of the oocyte with oskar mRNA. Furthermore, par-1 mutants show a novel polarity phenotype in which bicoid mRNA accumulates normally at the anterior, but oskar mRNA is redirected to the center of the oocyte, resulting in embryonic patterning defects. These phenotypes arise from a disorganization of the oocyte microtubule cytoskeleton, consistent with reports that mammalian PAR-1 homologs regulate microtubule dynamics. Thus, Drosophila PAR-1 may remodel the oocyte microtubule network to define the posterior as the site for oskar localization. These results identify a molecular parallel between anterior-posterior polarization in Drosophila and C. elegans.	Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge	St Johnston, D (corresponding author), Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England.	ds139@mole.bio.cam.ac.uk	St Johnston, Daniel/C-9568-2009	St Johnston, Daniel/0000-0001-5582-3301				Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; Bowerman B, 1997, DEVELOPMENT, V124, P3815; Boyd L, 1996, DEVELOPMENT, V122, P3075; Breitwieser W, 1996, GENE DEV, V10, P2179, DOI 10.1101/gad.10.17.2179; Chou TB, 1996, GENETICS, V144, P1673; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Clark IE, 1997, DEVELOPMENT, V124, P461; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.0.CO;2-4; EDDY EM, 1975, INT REV CYTOL, V43, P229; EMMONS S, 1995, GENE DEV, V9, P2482, DOI 10.1101/gad.9.20.2482; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; FASANO L, 1988, DEVELOPMENT, V104, P245; Goldstein B, 1996, DEVELOPMENT, V122, P1467; GONZALEZREYES A, 1994, SCIENCE, V266, P639, DOI 10.1126/science.7939717; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Gruidl ME, 1996, P NATL ACAD SCI USA, V93, P13837, DOI 10.1073/pnas.93.24.13837; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; HARTL DL, 1994, P NATL ACAD SCI USA, V91, P6824, DOI 10.1073/pnas.91.15.6824; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; Hird SN, 1996, DEVELOPMENT, V122, P1303; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834; Jordan P, 1997, J CELL BIOL, V139, P1805, DOI 10.1083/jcb.139.7.1805; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Kimmerly W, 1996, GENOME RES, V6, P414, DOI 10.1101/gr.6.5.414; KIRBY C, 1990, DEV BIOL, V142, P203, DOI 10.1016/0012-1606(90)90164-E; KOMIYA T, 1994, DEV BIOL, V162, P354, DOI 10.1006/dbio.1994.1093; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; LANE ME, 1994, GENE DEV, V8, P2986, DOI 10.1101/gad.8.24.2986; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; LEHMANN R, 1991, DEVELOPMENT, V112, P679; LEVIN DE, 1990, P NATL ACAD SCI USA, V87, P8272, DOI 10.1073/pnas.87.21.8272; Manseau L, 1996, DEVELOPMENT, V122, P2109; MANSEAU LJ, 1989, GENE DEV, V3, P1437, DOI 10.1101/gad.3.9.1437; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; McKim KS, 1998, GENE DEV, V12, P2932, DOI 10.1101/gad.12.18.2932; Micklem DR, 1997, CURR BIOL, V7, P468, DOI 10.1016/S0960-9822(06)00218-1; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; MOSQUERA L, 1993, DEVELOPMENT, V117, P377; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; POKRYWKA NJ, 1995, DEV BIOL, V167, P363, DOI 10.1006/dbio.1995.1030; Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838; Rongo C, 1997, COLD SPRING HARB SYM, V62, P1; Rose LS, 1998, ANNU REV GENET, V32, P521, DOI 10.1146/annurev.genet.32.1.521; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; ROUSSELL DL, 1993, P NATL ACAD SCI USA, V90, P9300, DOI 10.1073/pnas.90.20.9300; RUOHOLA H, 1991, CELL, V66, P433, DOI 10.1016/0092-8674(81)90008-8; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; SCHUPBACH T, 1986, ROUX ARCH DEV BIOL, V195, P302, DOI 10.1007/BF00376063; SCHUPBACH T, 1987, CELL, V49, P699, DOI 10.1016/0092-8674(87)90546-0; Seydoux G, 1999, DEVELOPMENT, V126, P3275; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; STROUMBAKIS ND, 1994, GENE, V143, P171, DOI 10.1016/0378-1119(94)90093-0; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; THEURKAUF WE, 1994, SCIENCE, V265, P2093, DOI 10.1126/science.8091233; THEURKAUF WE, 1992, DEVELOPMENT, V115, P923; van Eeden F, 1999, CURR OPIN GENET DEV, V9, P396, DOI 10.1016/S0959-437X(99)80060-4; Wellington A, 1999, DEVELOPMENT, V126, P5267; XU T, 1993, DEVELOPMENT, V117, P1223	70	246	250	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 12	2000	101	4					377	388		10.1016/S0092-8674(00)80848-X	http://dx.doi.org/10.1016/S0092-8674(00)80848-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	313QM	10830165	Bronze			2022-12-24	WOS:000087010400006
J	Ju, BG; Jeong, S; Bae, E; Hyun, S; Carroll, SB; Yim, J; Kim, J				Ju, BG; Jeong, S; Bae, E; Hyun, S; Carroll, SB; Yim, J; Kim, J			Fringe forms a complex with Notch	NATURE			English	Article							DROSOPHILA WING DEVELOPMENT; DORSAL-VENTRAL BOUNDARY; DORSOVENTRAL BOUNDARY; SIGNAL-TRANSDUCTION; EXPRESSION; ACTIVATION; RECEPTOR; SERRATE; GROWTH; DELTA	The Fringe protein of Drosophila and its vertebrate homologues function in boundary determination during pattern formation(1-9). Fringe has been proposed to inhibit Serrate-Notch signalling but to potentiate Delta-Notch signalling(10). Here we show that Fringe and Notch form a complex through both the Lin-Notch repeats and the epidermal growth factor repeats 22-36 (EGF22-36) of Notch when they are co-expressed. The Abruptex(59b) (Ax(59b)) and Ax(M1) mutations, which are caused by missense mutations in EGF repeats 24 and 25, respectively, abolish the Fringe-Notch interaction through EGF22-36, whereas the l(1)N-B mutation in the third Lin-Notch repeat of Notch abolishes the interaction through Lin-Notch repeats. Ax mutations also greatly affect the Notch response to ectopic Fringe in vivo. Results from in vitro protein mixing experiments and subcellular colocalization experiments indicate that the Fringe-Notch complex may form before their secretion. These findings explain how Fringe acts cell-autonomously to modulate the ligand preference of Notch and why the Fringe-Notch relationship is conserved between phyla and in the development of very diverse structures.	Seoul Natl Univ, Natl Creat Res Initiat Ctr Genet Reprogramming, Inst Mol Biol & Genet, Seoul 151742, South Korea; Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Seoul National University (SNU); Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Korea Advanced Institute of Science & Technology (KAIST)	Kim, J (corresponding author), Seoul Natl Univ, Natl Creat Res Initiat Ctr Genet Reprogramming, Inst Mol Biol & Genet, Seoul 151742, South Korea.							Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brennan K, 1997, GENETICS, V147, P177; Cho KO, 1998, NATURE, V396, P272, DOI 10.1038/24394; DECELIS JF, 1993, P NATL ACAD SCI USA, V90, P4037, DOI 10.1073/pnas.90.9.4037; deCelis JF, 1996, DEVELOPMENT, V122, P359; deCelis JF, 1997, DEVELOPMENT, V124, P3241; Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; ESTEBAN CR, 1998, NATURE, V386, P360; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Han KH, 1996, NUCLEIC ACIDS RES, V24, P4362, DOI 10.1093/nar/24.21.4362; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; JOHANSEN H, 1989, GENE DEV, V3, P882, DOI 10.1101/gad.3.6.882; Johnston SH, 1997, DEVELOPMENT, V124, P2245; KELLEY MR, 1987, CELL, V51, P539, DOI 10.1016/0092-8674(87)90123-1; Kim J, 1997, COLD SPRING HARB SYM, V62, P283; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Klein T, 1998, DEVELOPMENT, V125, P2951; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; LIEBER T, 1993, GENE DEV, V7, P1949, DOI 10.1101/gad.7.10.1949; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; LYMAN D, 1993, P NATL ACAD SCI USA, V90, P10395, DOI 10.1073/pnas.90.21.10395; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; Yuan YP, 1997, CELL, V88, P9, DOI 10.1016/S0092-8674(00)81852-8; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	29	60	60	1	8	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 11	2000	405	6783					191	195		10.1038/35012090	http://dx.doi.org/10.1038/35012090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WG	10821276				2022-12-24	WOS:000087080100053
J	Dubrova, YE; Plumb, M; Gutierrez, B; Boulton, E; Jeffreys, AJ				Dubrova, YE; Plumb, M; Gutierrez, B; Boulton, E; Jeffreys, AJ			Genome stability - Transgenerational mutation by radiation	NATURE			English	Article							INSTABILITY; MICE; TUMORS		Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow, Russia; MRC, Radiat & Genome Stabil Unit, Harwell OX11 0RD, Oxon, England	University of Leicester; Russian Academy of Sciences; Vavilov Institute of General Genetics	Dubrova, YE (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.		Dubrova, Yuri/ABA-7148-2020	Dubrova, Yuri/0000-0001-5281-7539				Burruel VR, 1997, MUTAT RES-FUND MOL M, V381, P59, DOI 10.1016/S0027-5107(97)00148-6; Dubrova YE, 1998, P NATL ACAD SCI USA, V95, P6251, DOI 10.1073/pnas.95.11.6251; GIBBS M, 1993, GENOMICS, V17, P121, DOI 10.1006/geno.1993.1292; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; KELLY R, 1989, GENOMICS, V5, P844, DOI 10.1016/0888-7543(89)90126-2; Lord BI, 1998, BRIT J CANCER, V78, P301, DOI 10.1038/bjc.1998.491; Luke GA, 1997, MUTAGENESIS, V12, P147, DOI 10.1093/mutage/12.3.147; Morgan WF, 1996, RADIAT RES, V146, P247, DOI 10.2307/3579454; NOMURA T, 1983, MUTAT RES, V121, P59, DOI 10.1016/0165-7992(83)90087-8; *UNSCEAR, 1993, UNSCEAR SOURC EFF IO; VOROBTSOVA IE, 1993, MUTAT RES, V287, P207, DOI 10.1016/0027-5107(93)90013-6; ZLOATOGORA J, 1988, HUM GENET, V102, P381	13	144	153	0	11	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2000	405	6782					37	37		10.1038/35011135	http://dx.doi.org/10.1038/35011135			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311TK	10811208	Bronze			2022-12-24	WOS:000086901600040
J	Popeijus, H; Overmars, H; Jones, J; Blok, V; Goverse, A; Helder, J; Schots, A; Bakker, J; Smant, G				Popeijus, H; Overmars, H; Jones, J; Blok, V; Goverse, A; Helder, J; Schots, A; Bakker, J; Smant, G			Enzymology - Degradation of plant cell walls by a nematode	NATURE			English	Article							CELLULASE		Agr Univ Wageningen, Dept Plant Sci, Grad Sch Expt Plant Sci, Nematol Lab, NL-6708 PD Wageningen, Netherlands; Agr Univ Wageningen, Dept Plant Sci, Grad Sch Expt Plant Sci, Lab Monoclonal Antibodies, NL-6708 PD Wageningen, Netherlands; Scottish Crop Res Inst, Dept Nematol, Dundee DD2 5DA, Scotland	Wageningen University & Research; Wageningen University & Research; James Hutton Institute	Popeijus, H (corresponding author), Agr Univ Wageningen, Dept Plant Sci, Grad Sch Expt Plant Sci, Nematol Lab, Binnenhaven 10, NL-6708 PD Wageningen, Netherlands.		Schots, Arjen/ABF-8014-2020; Schots, Arjen/U-1839-2017	Schots, Arjen/0000-0002-6036-7088; Schots, Arjen/0000-0002-6036-7088; Jones, John/0000-0003-2074-0551				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Byrne KA, 1999, GENE, V239, P317, DOI 10.1016/S0378-1119(99)00396-0; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; deBoer JM, 1996, MOL PLANT MICROBE IN, V9, P39, DOI 10.1094/MPMI-9-0039; Shevchik VE, 1997, J BACTERIOL, V179, P7321, DOI 10.1128/jb.179.23.7321-7330.1997; Smant G, 1998, P NATL ACAD SCI USA, V95, P4906, DOI 10.1073/pnas.95.9.4906; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Watanabe H, 1998, NATURE, V394, P330, DOI 10.1038/28527	8	134	150	3	47	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 6	2000	406	6791					36	37		10.1038/35017641	http://dx.doi.org/10.1038/35017641			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	330ZE	10894530				2022-12-24	WOS:000087991200033
J	Hall, W; Zador, D				Hall, W; Zador, D			Challenge of reducing drug-related deaths	LANCET			English	Editorial Material							OVERDOSE; TRENDS		Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia; Mental Hlth Serv Salford, Drugs North West, Manchester, Lancs, England	University of New South Wales Sydney	Hall, W (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia.		Hall, Wayne D/A-3283-2008	Hall, Wayne D/0000-0003-1984-0096				Advisory Council on the Misuse of Drugs, 2000, RED DRUG REL DEATHS; Darke S, 1996, ADDICTION, V91, P1765, DOI 10.1111/j.1360-0443.1996.tb03800.x; DONOGHOE M, 1998, OPIOID OVERDOSE TREN; Hall W, 2000, DRUG ALCOHOL DEPEN, V57, P247, DOI 10.1016/S0376-8716(99)00057-5; Hall WD, 1999, MED J AUSTRALIA, V171, P34, DOI 10.5694/j.1326-5377.1999.tb123495.x; Neeleman J, 1997, J EPIDEMIOL COMMUN H, V51, P435, DOI 10.1136/jech.51.4.435; *UK DEP HLTH, 1999, DRUG MIS DEP GUID CL; Ward J, 1999, LANCET, V353, P221, DOI 10.1016/S0140-6736(98)05356-2	8	11	11	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 1	2000	356	9223					7	8		10.1016/S0140-6736(00)02423-5	http://dx.doi.org/10.1016/S0140-6736(00)02423-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329XH	10892755				2022-12-24	WOS:000087933400005
J	Ruiz-Echevarria, MJ; Peltz, SW				Ruiz-Echevarria, MJ; Peltz, SW			The RNA binding protein Pub1 modulates the stability of transcripts containing upstream open reading frames	CELL			English	Article							TRANSLATIONAL TERMINATION CODON; SACCHAROMYCES-CEREVISIAE GENE; ABERRANT MESSENGER-RNAS; SURVEILLANCE COMPLEX; LEADER PEPTIDE; YEAST; NONSENSE; IDENTIFICATION; INITIATION; TURNOVER	The nonsense-mediated mRNA decay (NMD) pathway functions to degrade transcripts containing nonsense codons. Transcripts containing mutations that insert an upstream open reading frame (uORF) in the 5'-UTR are degraded through NMD. However, several naturally occurring uORF-containing transcripts are resistant to NMD. Here we demonstrate that the GCN4 and YAP1 mRNAs, which contain uORFs, harbor a stabilizer element (STE) that prevents rapid NMD by interacting with the RNA binding protein Pub1. conversely, a uORF-containing mRNA that lacks an STE, such as CPA1, is degraded by the NMD pathway. These results indicate that uORFs can play a pivotal role regulating both translation and turnover and that the Pub1p is a critical factor that modulates the stability of uORF-containing transcripts.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet & Microbiol, Piscataway, NJ 08854 USA; Canc Inst New Jersey, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Ruiz-Echevarria, MJ (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet & Microbiol, 675 Hoes Lane, Piscataway, NJ 08854 USA.			Ruiz Echevarria, Maria Jesus/0000-0001-7133-9982	NIGMS NIH HHS [GM48631] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048631] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON JT, 1993, MOL CELL BIOL, V13, P6102, DOI 10.1128/MCB.13.10.6102; Antic D, 1997, AM J HUM GENET, V61, P273, DOI 10.1086/514866; Applequist SE, 1997, NUCLEIC ACIDS RES, V25, P814, DOI 10.1093/nar/25.4.814; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Coller JM, 1998, GENE DEV, V12, P3226, DOI 10.1101/gad.12.20.3226; CUI Y, 1995, GENE DEV, V9, P423, DOI 10.1101/gad.9.4.423; Czaplinski K, 1999, BIOESSAYS, V21, P685, DOI 10.1002/(SICI)1521-1878(199908)21:8<685::AID-BIES8>3.0.CO;2-4; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; DELBECQ P, 1994, MOL CELL BIOL, V14, P2378, DOI 10.1128/MCB.14.4.2378; Dever TE, 1997, METHODS, V11, P403, DOI 10.1006/meth.1996.0437; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; GEBALLE AP, 1996, TRANSLATIONAL CONTRO, P173; Gonzalez CI, 2000, MOL CELL, V5, P489, DOI 10.1016/S1097-2765(00)80443-8; GUTHRIE C, 1991, METHOD ENZYMOL, V194, P281; HE F, 1995, GENE DEV, V9, P437, DOI 10.1101/gad.9.4.437; HE F, 1993, P NATL ACAD SCI USA, V90, P7034, DOI 10.1073/pnas.90.15.7034; Hilleren P, 1999, RNA, V5, P711, DOI 10.1017/S1355838299990519; Hinnebusch A.G., 1996, TRANSLATIONAL CONTRO, P199; HIRATA D, 1994, MOL GEN GENET, V242, P250, DOI 10.1007/BF00280413; HUSSAIN M, 1991, GENE, V101, P149, DOI 10.1016/0378-1119(91)90238-7; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; KUGE S, 1994, EMBO J, V13, P655, DOI 10.1002/j.1460-2075.1994.tb06304.x; LEE BS, 1995, P NATL ACAD SCI USA, V92, P10354, DOI 10.1073/pnas.92.22.10354; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; Lelivelt MJ, 1999, MOL CELL BIOL, V19, P6710; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; MATUNIS MJ, 1993, MOL CELL BIOL, V13, P6114, DOI 10.1128/MCB.13.10.6114; Muhlrad D, 1999, RNA, V5, P1299, DOI 10.1017/S1355838299990829; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; OLIVEIRA CC, 1995, J BIOL CHEM, V270, P8936, DOI 10.1074/jbc.270.15.8936; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; PELTZ SW, 1993, GENE DEV, V7, P1737, DOI 10.1101/gad.7.9.1737; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; Perlick HA, 1996, P NATL ACAD SCI USA, V93, P10928, DOI 10.1073/pnas.93.20.10928; PINTO I, 1992, GENETICS, V132, P97; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Ruiz-Echevarria MJ, 1998, EMBO J, V17, P575, DOI 10.1093/emboj/17.2.575; RuizEchevarria MJ, 1996, TRENDS BIOCHEM SCI, V21, P433, DOI 10.1016/S0968-0004(96)10055-4; SCHNELL N, 1991, EUR J BIOCHEM, V200, P487, DOI 10.1111/j.1432-1033.1991.tb16209.x; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Vilela C, 1998, NUCLEIC ACIDS RES, V26, P1150, DOI 10.1093/nar/26.5.1150; Wang Z, 1999, J BIOL CHEM, V274, P37565, DOI 10.1074/jbc.274.53.37565; Weighardt F, 1996, BIOESSAYS, V18, P747, DOI 10.1002/bies.950180910; Welch EM, 1999, EMBO J, V18, P6134, DOI 10.1093/emboj/18.21.6134; WERNER M, 1987, CELL, V49, P805, DOI 10.1016/0092-8674(87)90618-0; Wright MB, 1996, J BACTERIOL, V178, P7197, DOI 10.1128/jb.178.24.7197-7205.1996; YUN DF, 1995, MOL CELL BIOL, V15, P1021; ZHANG SA, 1995, MOL CELL BIOL, V15, P2231	50	141	144	1	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 23	2000	101	7					741	751		10.1016/S0092-8674(00)80886-7	http://dx.doi.org/10.1016/S0092-8674(00)80886-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	327YE	10892745	Bronze			2022-12-24	WOS:000087821400008
J	Rikken, GLJA; Raupach, E				Rikken, GLJA; Raupach, E			Enantioselective magnetochiral photochemistry	NATURE			English	Article							ABSOLUTE ASYMMETRIC-SYNTHESIS; MAGNETIC-FIELD; CHIRALITY; BIREFRINGENCE; ABSORPTION; DICHROISM; LIQUIDS	Many chemical and physical systems can occur in two forms distinguished solely by being mirror images of each other. This phenomenon, known as chirality, is important in biochemistry, where reactions involving chiral molecules often require the participation of one specific enantiomer (mirror image) of the two possible ones. In fact, terrestrial life utilizes only the L enantiomers of amino acids, a pattern that is known as the 'homochirality of life' and which has stimulated long-standing efforts to understand its origin(1). Reactions can proceed enantioselectively if chiral reactants or catalysts are involved, or if some external chiral influence is present(2). But because chiral reactants and catalysts themselves require an enantioselective production process, efforts to understand the homochirality of life have focused on external chiral influences. One such external influence is circularly polarized light, which can influence the chirality of photochemical reaction products(2,13,14). Because natural optical activity, which occurs exclusively in media lacking mirror symmetry, and magnetic optical activity, which can occur in all media and is induced by longitudinal magnetic fields, both cause polarization rotation of light, the potential for magnetically induced enantioselectivity in chemical reactions has been investigated, but no convincing demonstrations of such an effect have been found(2-4). Here we show experimentally that magnetochiral anisotropy-an effect linking chirality and magnetism(5-7)-can give rise to an enantiomeric excess in a photochemical reaction driven by unpolarized light in a parallel magnetic field, which suggests that this effect may have played a role in the origin of the homochirality of life.	Max Planck Inst Festkorperforsch, CNRS, Grenoble High Magnet Field Lab, F-38042 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); Max Planck Society	Rikken, GLJA (corresponding author), Max Planck Inst Festkorperforsch, CNRS, Grenoble High Magnet Field Lab, BP 166, F-38042 Grenoble, France.							Avalos M, 1998, CHEM REV, V98, P2391, DOI 10.1021/cr970096o; Bailey J, 1998, SCIENCE, V281, P672, DOI 10.1126/science.281.5377.672; BARANOVA NB, 1977, OPT COMMUN, V22, P243, DOI 10.1016/0030-4018(77)90028-1; BARANOVA NB, 1979, MOL PHYS, V38, P1085, DOI 10.1080/00268977900102261; BARRON LD, 1986, J AM CHEM SOC, V108, P5539, DOI 10.1021/ja00278a029; BARRON LD, 1984, MOL PHYS, V51, P715, DOI 10.1080/00268978400100481; BARRON LD, 1994, SCIENCE, V266, P1491, DOI 10.1126/science.266.5190.1491; BERNSTEIN WJ, 1972, THESIS L BERKELEY LA; BONNER WA, 1995, ORIGINS LIFE EVOL B, V25, P175, DOI 10.1007/BF01581581; CLINE DB, 1996, PHYSICAL ORIGIN HOMO; Engel MH, 1997, NATURE, V389, P265, DOI 10.1038/38460; INOUE Y, 1992, CHEM REV, V92, P741, DOI 10.1021/cr00013a001; Kleindienst P, 1998, CHEM PHYS LETT, V288, P89, DOI 10.1016/S0009-2614(98)00218-8; LYNE AG, 1984, NATURE, V308, P605, DOI 10.1038/308605b0; Mason S. F., 1994, CIRCULAR DICHROISM; MCCAFFERY AJ, 1965, J CHEM SOC, P2883, DOI 10.1039/jr9650002883; MCCAFFERY AJ, 1967, INORG CHEM, V6, P1614, DOI 10.1021/ic50055a002; PORTIGAL DL, 1971, J PHYS CHEM SOLIDS, V32, P603, DOI 10.1016/0022-3697(71)90009-6; PRACEJUS H, 1967, FORTSCHR CHEM FORSCH, V8, P493; RAU H, 1983, CHEM REV, V83, P535, DOI 10.1021/cr00057a003; Rikken GLJA, 1997, NATURE, V390, P493, DOI 10.1038/37323; Rikken GLJA, 1998, PHYS REV E, V58, P5081, DOI 10.1103/PhysRevE.58.5081; Stevenson K. L., 1969, MOL PHOTOCHEM, V1, P271; Teutsch H., 1988, THESIS U BREMEN; WAGNIERE G, 1983, EXPERIENTIA, V39, P1090, DOI 10.1007/BF01943122	25	449	456	3	175	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2000	405	6789					932	935		10.1038/35016043	http://dx.doi.org/10.1038/35016043			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326JT	10879530				2022-12-24	WOS:000087732700045
J	Wong, GCL; Tang, JX; Lin, A; Li, YL; Janmey, PA; Safinya, CR				Wong, GCL; Tang, JX; Lin, A; Li, YL; Janmey, PA; Safinya, CR			Hierarchical self-assembly of F-actin and cationic lipid complexes: Stacked three-layer tubule networks	SCIENCE			English	Article							POSITIVELY CHARGED LIPOSOMES; DNA COMPLEXES; MEMBRANES; PHASE; POLYMERIZATION; VESICLES; SURFACE; PARACRYSTALS	We describe a distinct type of spontaneous hierarchical self-assembly of cytoskeletal filamentous actin (F-actin), a highly charged polyelectrolyte, and cationic Lipid membranes. On the mesoscopic length scale,confocal microscopy reveals ribbonlike tubule structures that connect to form a network of tubules on the macroscopic scale (more than 100 micrometers). Within the tubules, on the 0.5- to 50-nanometer length scale, x-ray diffraction reveals an unusual structure consisting of osmotically swollen stacks of composite membranes with no direct analog in simple amphiphilic systems. The composite membrane is composed of three layers, a lipid bilayer sandwiched between two layers of actin, and is reminiscent of multilayered bacterial cell walls that exist far from equilibrium. Electron microscopy reveals that the actin layer consists of Laterally locked F-actin filaments forming an anisotropic two-dimensional tethered crystal that appears to be the origin of the tubule formation.	Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Biochem & Mol Biol Program, Santa Barbara, CA 93106 USA; Harvard Univ, Brigham & Womens Hosp, Div Expt Med, Boston, MA 02115 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Harvard University; Brigham & Women's Hospital	Safinya, CR (corresponding author), Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA.	safinya@mrl.ucsb.edu			NIAMS NIH HHS [AR38910] Funding Source: Medline; NIGMS NIH HHS [GM59288] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038910, R29AR038910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059288] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAM FF, 1990, SCIENCE, V249, P393, DOI 10.1126/science.249.4967.393; ARONOVITZ JA, 1988, PHYS REV LETT, V60, P2634, DOI 10.1103/PhysRevLett.60.2634; Bandyopadhyay S, 1999, J PHYS CHEM B, V103, P10075, DOI 10.1021/jp9927496; BLAUROCK AE, 1971, J MOL BIOL, V56, P35, DOI 10.1016/0022-2836(71)90082-9; Bowick M, 1999, PHYS REV E, V59, P5659, DOI 10.1103/PhysRevE.59.5659; Bowick M, 1997, PHYS REV LETT, V79, P885, DOI 10.1103/PhysRevLett.79.885; Bruinsma R, 1998, EUR PHYS J B, V4, P75, DOI 10.1007/s100510050353; CHIRUVOLU S, 1994, SCIENCE, V266, P1222, DOI 10.1126/science.7973704; Dan N, 1996, BIOPHYS J, V71, P1267, DOI 10.1016/S0006-3495(96)79326-8; Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143; FRANKS NP, 1978, NATURE, V276, P530, DOI 10.1038/276530a0; Gelbart WM, 1994, MICELLES MEMBRANES M; Hackl W, 1998, PHYS REV LETT, V80, P1786, DOI 10.1103/PhysRevLett.80.1786; HANSON J, 1973, PROC R SOC SER B-BIO, V183, P39, DOI 10.1098/rspb.1973.0003; Harries D, 1998, BIOPHYS J, V75, P159, DOI 10.1016/S0006-3495(98)77503-4; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; KANTOR Y, 1986, PHYS REV LETT, V57, P791, DOI 10.1103/PhysRevLett.57.791; KLOSGEN B, 1993, EUR BIOPHYS J, V22, P340; Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78; LALIBERTE A, 1988, J CELL BIOL, V106, P1221, DOI 10.1083/jcb.106.4.1221; Lasic DD., 1997, LIPOSOMES GENE DELIV; Lipowsky R., 1995, P521; Lodish H., 1999, MOL CELL BIOL; Miyata H, 1999, P NATL ACAD SCI USA, V96, P2048, DOI 10.1073/pnas.96.5.2048; Nelson D, 1989, STAT MECH MEMBRANES; O'Hern CS, 1999, PHYS REV LETT, V83, P2745, DOI 10.1103/PhysRevLett.83.2745; Oda R, 1999, NATURE, V399, P566, DOI 10.1038/21154; PAPAHADJOPOULOS D, 1975, BIOCHIM BIOPHYS ACTA, V394, P483, DOI 10.1016/0005-2736(75)90299-0; Radler JO, 1997, SCIENCE, V275, P810, DOI 10.1126/science.275.5301.810; Radzihovsky L, 1995, PHYS REV LETT, V75, P4752, DOI 10.1103/PhysRevLett.75.4752; Renault A, 1999, BIOPHYS J, V76, P1580, DOI 10.1016/S0006-3495(99)77317-0; RIOUX L, 1985, J ULTRA MOL STRUCT R, V93, P42, DOI 10.1016/0889-1605(85)90084-9; Safran S.A., 1994, STAT THERMODYNAMICS; Sara M, 1996, PROG BIOPHYS MOL BIO, V65, P83, DOI 10.1016/S0079-6107(96)00007-7; SCHMIDT CF, 1993, SCIENCE, V259, P952, DOI 10.1126/science.8438153; SCHNUR JM, 1993, SCIENCE, V262, P1669, DOI 10.1126/science.262.5140.1669; Spector MS, 1999, ADV MATER, V11, P337, DOI 10.1002/(SICI)1521-4095(199903)11:4<337::AID-ADMA337>3.0.CO;2-V; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; TAYLOR KA, 1992, J STRUCT BIOL, V108, P140, DOI 10.1016/1047-8477(92)90013-Z; Thomas BN, 1999, PHYS REV E, V59, P3040, DOI 10.1103/PhysRevE.59.3040; THOMAS BN, 1995, SCIENCE, V267, P1635, DOI 10.1126/science.267.5204.1635; Thomas BN, 1998, J AM CHEM SOC, V120, P12178, DOI 10.1021/ja973933c	42	194	197	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2000	288	5473					2035	+		10.1126/science.288.5473.2035	http://dx.doi.org/10.1126/science.288.5473.2035			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856215				2022-12-24	WOS:000087687000048
J	Walker, ML; Burgess, SA; Sellers, JR; Wang, F; Hammer, JA; Trinick, J; Knight, PJ				Walker, ML; Burgess, SA; Sellers, JR; Wang, F; Hammer, JA; Trinick, J; Knight, PJ			Two-headed binding of a processive myosin to F-actin	NATURE			English	Article							MOTOR PROTEIN; RESOLUTION; FILAMENTS; MOLECULES; MOVEMENT; ATP	Myosins are motor proteins in cells. They move along actin by changing shape after making stereospecific interactions with the actin subunits(1). As these are arranged helically, a succession of steps will follow a helical path. However, if the myosin heads are long enough to span the actin helical repeat (similar to 36 nm), linear motion is possible. Muscle myosin (myosin II) heads are about 16 nm long(2), which is insufficient to span the repeat(3). Myosin V, however, has heads of about 31 nm that could span 36 nm (refs 4, 5) and thus allow single two-headed molecules to transport cargo by walking straight 5. Here we use electron microscopy to show that while working, myosin V spans the helical repeat. The heads are mostly 13 actin subunits apart, with values of 11 or 15 also found. Typically the structure is polar and one head is curved, the other straighter. Single particle processing reveals the polarity of the underlying actin filament, showing that the curved head is the leading one. The shape of the leading head may correspond to the beginning of the working stroke of the motor. We also observe molecules attached by one head in this conformation.	Univ Leeds, Sch Biomed Sci, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; NHLBI, Mol Cardiol Lab, NIH, Bethesda, MD 20892 USA; NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	University of Leeds; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Knight, PJ (corresponding author), Univ Leeds, Sch Biomed Sci, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL004229, Z01HL004229] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Burgess SA, 1997, J CELL BIOL, V139, P675, DOI 10.1083/jcb.139.3.675; Burgess SA, 2000, BIOPHYS J, V78, p8A; Cheney RE, 1998, METHOD ENZYMOL, V298, P3, DOI 10.1016/S0076-6879(98)98003-X; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; CRAIG R, 1980, J MOL BIOL, V140, P35, DOI 10.1016/0022-2836(80)90355-1; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; EGELMAN EH, 1992, BIOPHYS J, V63, P1299, DOI 10.1016/S0006-3495(92)81716-2; FRANK J, 1981, ULTRAMICROSCOPY, V6, P343, DOI 10.1016/S0304-3991(81)80236-7; Frank J., 1996, 3 DIMENSIONAL ELECT, Ved, ppp 54; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Moore JR, 2000, BIOPHYS J, V78, p272A; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sellers J. R., 1999, MYOSINS; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; SUGIMOTO Y, 1995, BIOPHYS J, V68, pS29; TRINICK J, 1979, J MOL BIOL, V133, P549, DOI 10.1016/0022-2836(79)90407-8; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Veigel C, 2000, BIOPHYS J, V78, p242A; WALKER M, 1995, BIOPHYS J, V68, pS87; WALKER M, 1985, J MOL BIOL, V184, P535, DOI 10.1016/0022-2836(85)90300-6; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; WHITTAKER M, 1995, NATURE, V378, P748, DOI 10.1038/378748a0	27	257	260	0	33	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					804	+		10.1038/35015592	http://dx.doi.org/10.1038/35015592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866203				2022-12-24	WOS:000087620600054
J	Lasne, F; de Ceaurriz, J				Lasne, F; de Ceaurriz, J			Recombinant erythropoietin in urine - An artificial hormone taken to boost athletic performance can now be detected.	NATURE			English	Article									Natl Antidoping Lab, F-92290 Chatenay Malabry, France		Lasne, F (corresponding author), Natl Antidoping Lab, F-92290 Chatenay Malabry, France.							CASONI I, 1993, INT J SPORTS MED, V14, P307, DOI 10.1055/s-2007-1021183; Gareau R, 1996, NATURE, V380, P113, DOI 10.1038/380113a0; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; WIDE L, 1995, MED SCI SPORT EXER, V27, P1569	4	309	321	2	54	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					635	635		10.1038/35015164	http://dx.doi.org/10.1038/35015164			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864311				2022-12-24	WOS:000087465800033
J	Labib, K; Tercero, JA; Diffley, JFX				Labib, K; Tercero, JA; Diffley, JFX			Uninterrupted MCM2-7 function required for DNA replication fork progression	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; HELICASE ACTIVITY; PROTEINS; YEAST; CHROMATIN; MUTANTS; ORIGINS; PAUSE; CDC6P	Little is known about the DNA helicases required for the elongation phase of eukaryotic chromosome replication. Minichromosone maintenance (MCM) protein complexes have DNA helicase activity but have only been functionally implicated in initiating DNA replication. Using an improved method for constructing conditional degron mutants, we show that depletion of MCMs after initiation irreversibly blocks the progression of replication forks in Saccharomyces cerevisiae. Like the Escherichia coli dnaB and SV40 T antigen helicases, therefore, the MCM complex is loaded at origins before initiation and is essential for elongation. Restricting MCM Loading to the G(1) phase ensures that initiation and elongation occur just once per cell cycle.	Imperial Canc Res Fund, Clare Hall Labs, S Mimms EN6 3LD, Herts, England		Diffley, JFX (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.		Tercero, José Antonio/D-7489-2016	Diffley, John/0000-0001-5184-7680; Tercero, Jose Antonio/0000-0003-4829-3570				Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Donaldson AD, 1998, MOL CELL, V2, P173, DOI 10.1016/S1097-2765(00)80127-6; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; GREENFEDER SA, 1992, MOL CELL BIOL, V12, P4056, DOI 10.1128/MCB.12.9.4056; HENNESSY KM, 1990, GENE DEV, V4, P2252, DOI 10.1101/gad.4.12b.2252; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Kearsey SE, 1998, BBA-GENE STRUCT EXPR, V1398, P113, DOI 10.1016/S0167-4781(98)00033-5; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; LABIB K, 1998, GENE DEV, V12, P480; LABIB K, UNPUB; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; NASMYTH K, 1981, MOL GEN GENET, V182, P119, DOI 10.1007/BF00422777; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Weinreich M, 1999, P NATL ACAD SCI USA, V96, P441, DOI 10.1073/pnas.96.2.441; You ZY, 1999, MOL CELL BIOL, V19, P8003; Young MR, 1997, MOL BIOL CELL, V8, P1587, DOI 10.1091/mbc.8.8.1587	25	511	520	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2000	288	5471					1643	1647		10.1126/science.288.5471.1643	http://dx.doi.org/10.1126/science.288.5471.1643			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	320BZ	10834843				2022-12-24	WOS:000087382300041
J	Macleod, U; Ross, S; Twelves, C; George, WD; Gillis, C; Watt, GCM				Macleod, U; Ross, S; Twelves, C; George, WD; Gillis, C; Watt, GCM			Primary and secondary care management of women with early breast cancer from affluent and deprived areas: retrospective review of hospital and general practice records	BRITISH MEDICAL JOURNAL			English	Article							SOCIAL-CLASS; SURVIVAL; DEPRIVATION; ENGLAND	Objectives To investigate whether poorer survival of breast cancer among deprived women compared with affluent women is related to their NHS care, Design Retrospective review of hospital and general practice case records. Setting Greater Glasgow Health Board area. Subjects Women diagnosed with breast cancer in 1992-3 who lived in die most affluent (deprivation categories 1 and 2) and the most deprived areas (deprivation categories 6 and 7) of Glasgow (Carstairs and Morris deprivation index). Main outcome measures Breast cancer treatment, time from general practice consultation to clinic visit and surgery, and details of hospital admissions and follow up in primary and secondary care. Results The access to care and surgical and oncological treatment of women from affluent and deprived areas were similar, Admissions to hospital for problems not related to breast cancer were more common in those living in deprived areas (number admitted once or more: 51 (24%) v 13 (10%), P = 0.001). Consultation patterns in general practice by the second year after diagnosis showed women in deprived areas consulting more frequently than women in affluent areas (median (interquartile range) number of consultations (5 (2-10) v 7 (4-13), P = 0.01). Conclusion Women living in affluent areas did not receive better NHS care for breast cancer than women in deprived areas. However, women from deprived areas seem to have greater comorbidity, and poorer outcomes from breast cancer among these women is probably due to factors which result in deprived communities having poorer health outcomes rather than to management of their breast cancer.	Univ Glasgow, Dept Gen Practice, Glasgow G12 0RR, Lanark, Scotland; Univ Glasgow, Western Infirm, Beatson Oncol Ctr, CRC Dept Med Oncol, Glasgow G11 6NT, Lanark, Scotland; Univ Glasgow, Western Infirm, Dept Surg, Glasgow G11 6NT, Lanark, Scotland; Univ Glasgow, Dept Publ Hlth, W Scotland Canc Surveillance Unit, Glasgow G12 8RZ, Lanark, Scotland	University of Glasgow; Beatson Oncology Centre; University of Glasgow; University of Glasgow; University of Glasgow	Macleod, U (corresponding author), Univ Glasgow, Dept Gen Practice, Glasgow G12 0RR, Lanark, Scotland.							BASNETT I, 1992, EUR J CANCER, V28A, P1945, DOI 10.1016/0959-8049(92)90233-R; *BREAST SURG GROUP, 1995, EUR J SURG ONCOL SA, V21, P1; *BRIT BREAST GROUP, 1995, PROV BREAST SERV UK; CARNON AG, 1994, BRIT MED J, V309, P1054, DOI 10.1136/bmj.309.6961.1054; CARSTAIRS V, 1988, DEPRIVATION HLTH SCO; EAMES M, 1993, BRIT MED J, V307, P1097, DOI 10.1136/bmj.307.6912.1097; Gillis CR, 1996, BRIT MED J, V312, P145, DOI 10.1136/bmj.312.7024.145; GORDON NH, 1992, AM J EPIDEMIOL, V135, P609, DOI 10.1093/oxfordjournals.aje.a116340; KARJALAINEN S, 1990, CANCER-AM CANCER SOC, V66, P819, DOI 10.1002/1097-0142(19900815)66:4<819::AID-CNCR2820660437>3.0.CO;2-E; Macleod U, 2000, ANN ONCOL, V11, P105, DOI 10.1023/A:1008385321476; Nichols S, 1981, Community Med, V3, P217, DOI 10.1007/BF02549119; Pollock AM, 1998, BMJ-BRIT MED J, V317, P245, DOI 10.1136/bmj.317.7153.245; Richards MA, 1996, BRIT J CANCER, V73, P751, DOI 10.1038/bjc.1996.131; SAINSBURY R, 1995, BRIT J CANCER, V71, P1275, DOI 10.1038/bjc.1995.246; SAINSBURY R, 1995, LANCET, V345, P1265, DOI 10.1016/S0140-6736(95)90924-9; SCHRIJVERS CTM, 1995, BRIT J CANCER, V72, P738, DOI 10.1038/bjc.1995.403; Scottish Intercollegiate Guideline Network, 1998, SIGN PUBL, V29; TOMATIS L, 1990, IARC SCI PUBLICATION, V100; VAGERO D, 1987, J EPIDEMIOL COMMUN H, V41, P204, DOI 10.1136/jech.41.3.204	19	43	43	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 27	2000	320	7247					1442	1445		10.1136/bmj.320.7247.1442	http://dx.doi.org/10.1136/bmj.320.7247.1442			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320RT	10827047	Green Accepted, Green Published, Bronze, Green Submitted			2022-12-24	WOS:000087414700026
J	Helariutta, Y; Fukaki, H; Wysocka-Diller, J; Nakajima, K; Jung, J; Sena, G; Hauser, MT; Benfey, PN				Helariutta, Y; Fukaki, H; Wysocka-Diller, J; Nakajima, K; Jung, J; Sena, G; Hauser, MT; Benfey, PN			The SHORT-ROOT gene controls radial patterning of the Arabidopsis root through radial signaling	CELL			English	Article							CELL-DIFFERENTIATION; DNA-SEQUENCES; THALIANA; MERISTEM; PROTEIN; IDENTIFICATION; ORGANIZATION; PATHWAY; ENCODES; SEARCH	Asymmetric cell divisions play an important role in the establishment and propagation of the cellular pattern of plant tissues. The SHORT-ROOT (SHR) gene is required for the asymmetric cell division responsible for formation of ground tissue (endodermis and cortex) as well as specification of endodermis in the Arabidopsis root. We show that SHR encodes a putative transcription factor with homology to SCARECROW (SCR). From analyses of gene expression and cell identity in genetically stable and unstable alleles of shr, we conclude that SHR functions upstream of SCR and participates in a radial signaling pathway. Consistent with a regulatory role in radial patterning, ectopic expression of SHR results in supernumerary cell divisions and abnormal cell specification in the root meristem.	NYU, Dept Biol, New York, NY 10003 USA; Univ Bodenkultur Wien, Ctr Appl Genet, A-1190 Vienna, Austria	New York University; University of Natural Resources & Life Sciences, Vienna	Benfey, PN (corresponding author), NYU, Dept Biol, 1009 Main Bldg, New York, NY 10003 USA.	philip.benfey@nyu.edu	Sena, Giovanni/C-3297-2012; Helariutta, Yrjo/AAE-8149-2020; Hauser, Marie-Theres/J-6029-2013	Sena, Giovanni/0000-0003-3626-5038; Helariutta, Yrjo/0000-0002-7287-8459; Hauser, Marie-Theres/0000-0001-8938-2460; Nakajima, Keiji/0000-0002-1580-3354	NIGMS NIH HHS [R01-GM43778] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043778] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; BENFEY PN, 1993, DEVELOPMENT, V119, P57; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DIETRICH RA, 1992, PLANT CELL, V4, P1371, DOI 10.1105/tpc.4.11.1371; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Freshour G, 1996, PLANT PHYSIOL, V110, P1413, DOI 10.1104/pp.110.4.1413; Fukaki H, 1998, PLANT J, V14, P425, DOI 10.1046/j.1365-313X.1998.00137.x; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; KNOX JP, 1990, PLANTA, V181, P512, DOI 10.1007/BF00193004; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; LONG D, 1993, P NATL ACAD SCI USA, V90, P10370, DOI 10.1073/pnas.90.21.10370; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; Malamy JE, 1997, DEVELOPMENT, V124, P33; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; MAYER U, 1993, DEVELOPMENT, V117, P149; MeloOliveira R, 1996, P NATL ACAD SCI USA, V93, P4718, DOI 10.1073/pnas.93.10.4718; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; SCHERES B, 1995, DEVELOPMENT, V121, P53; SCHERES B, 1994, DEVELOPMENT, V120, P2475; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Schumacher K, 1999, P NATL ACAD SCI USA, V96, P290, DOI 10.1073/pnas.96.1.290; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; VANDENBERG C, 1995, NATURE, V378, P62, DOI 10.1038/378062a0; Wisman E, 1998, PLANT MOL BIOL, V37, P989, DOI 10.1023/A:1006082009151; Wysocka-Diller JW, 2000, DEVELOPMENT, V127, P595	35	750	805	5	138	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 26	2000	101	5					555	567		10.1016/S0092-8674(00)80865-X	http://dx.doi.org/10.1016/S0092-8674(00)80865-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850497	Bronze			2022-12-24	WOS:000087375400012
J	Mata, J; Curado, S; Ephrussi, A; Rorth, P				Mata, J; Curado, S; Ephrussi, A; Rorth, P			Tribbles coordinates mitosis and morphogenesis in Drosophila by regulating string/CDC25 proteolysis	CELL			English	Article							CELL-CYCLE REGULATORS; BAG-OF-MARBLES; CHECKPOINT MONITORS; FEMALE GERMLINE; GENE-EXPRESSION; CYST FORMATION; FISSION YEAST; PROTEIN; CDC25; DIVISION	Morphogenesis and cell differentiation in multicellular organisms often require accurate control of cell divisions. We show that a novel cell cycle regulator, tribbles, is critical for this control during Drosophila development. During oogenesis, the level of tribbles affects the number of germ cell divisions as well as oocyte determination. The mesoderm anlage enters mitosis prematurely in tribbles mutant embryos, leading to gastrulation defects. We show that Tribbles acts by specifically inducing degradation of the CDC25 mitotic activators String and Twine via the proteosome pathway. By regulating CDC25, Tribbles serves to coordinate entry into mitosis with morphogenesis and cell fate determination.	European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Rorth, P (corresponding author), European Mol Biol Lab, Dev Biol Programme, D-69117 Heidelberg, Germany.		Ephrussi, Anne/AAG-4075-2020; Ephrussi, Anne/ABD-4393-2021; Rørth, Pernille/H-3020-2011	Ephrussi, Anne/0000-0002-5061-4620; Mata, Juan/0000-0002-5514-3653				ALPHEY L, 1992, CELL, V69, P977, DOI 10.1016/0092-8674(92)90616-K; Baldin V, 1997, J BIOL CHEM, V272, P32731, DOI 10.1074/jbc.272.52.32731; BRAND AH, 1993, DEVELOPMENT, V118, P401; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; deCuevas M, 1996, DEVELOPMENT, V122, P3959; DUCOMMUN B, 1990, BIOCHEM BIOPH RES CO, V167, P301, DOI 10.1016/0006-291X(90)91765-K; Edgar BA, 1996, GENE DEV, V10, P1966, DOI 10.1101/gad.10.15.1966; Edgar BA, 1996, SCIENCE, V274, P1646, DOI 10.1126/science.274.5293.1646; EDGAR BA, 1994, DEVELOPMENT, V120, P3131; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; Foe Victoria E., 1993, P149; Fogarty P, 1997, CURR BIOL, V7, P418, DOI 10.1016/S0960-9822(06)00189-8; Hawkins NC, 1996, DEVELOPMENT, V122, P281; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Lehner CF, 1997, J CELL SCI, V110, P523; LEW DJ, 1995, J CELL BIOL, V129, P739, DOI 10.1083/jcb.129.3.739; Lilly MA, 1996, GENE DEV, V10, P2514, DOI 10.1101/gad.10.19.2514; Lilly MA, 2000, DEV BIOL, V218, P53, DOI 10.1006/dbio.1999.9570; LIN HF, 1994, DEVELOPMENT, V120, P947; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; McMillan JN, 1998, J CELL BIOL, V142, P1487, DOI 10.1083/jcb.142.6.1487; Milan M, 1996, P NATL ACAD SCI USA, V93, P640, DOI 10.1073/pnas.93.2.640; MORENO S, 1990, NATURE, V344, P549, DOI 10.1038/344549a0; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; Nefsky B, 1996, EMBO J, V15, P1301, DOI 10.1002/j.1460-2075.1996.tb00472.x; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Ohi R, 1999, CURR OPIN CELL BIOL, V11, P267, DOI 10.1016/S0955-0674(99)80036-2; Pepling ME, 1999, TRENDS CELL BIOL, V9, P257, DOI 10.1016/S0962-8924(99)01594-9; Pines J, 1998, Results Probl Cell Differ, V22, P57; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Rorth P, 1998, DEVELOPMENT, V125, P1049; Royet J, 1998, EMBO J, V17, P7351, DOI 10.1093/emboj/17.24.7351; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Spradling Allan C., 1993, P1; Van Doren M, 1998, CURR BIOL, V8, P243; Wilkin F, 1997, EUR J BIOCHEM, V248, P660, DOI 10.1111/j.1432-1033.1997.t01-1-00660.x; Wilkin F, 1996, J BIOL CHEM, V271, P28451, DOI 10.1074/jbc.271.45.28451; YUE L, 1992, GENE DEV, V6, P2443, DOI 10.1101/gad.6.12b.2443	43	301	314	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 26	2000	101	5					511	522		10.1016/S0092-8674(00)80861-2	http://dx.doi.org/10.1016/S0092-8674(00)80861-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850493	Bronze			2022-12-24	WOS:000087375400008
J	Zhang, CM; Clarke, PR				Zhang, CM; Clarke, PR			Chromatin-independent nuclear envelope assembly induced by Ran GTPase in Xenopus egg extracts	SCIENCE			English	Article							CHROMOSOME CONDENSATION; MICROTUBULE ASTERS; DNA-REPLICATION; RCC1 PROTEIN; BINDING; REGULATOR; MITOSIS; FUSION	The nuclear envelope (NE) forms a controlled boundary between the cytoplasm and the nucleus of eukaryotic cells. To facilitate investigation of mechanisms controlling NE assembly, we developed a cell-free system made from Xenopus laevis eggs to study the process in the absence of chromatin. NEs incorporating nuclear pores were assembled around beads coated with the guanosine triphosphatase Ran, forming pseudo-nuclei that actively imported nuclear proteins. NE assembly required the cycling of guanine nucleotides on Ran and was promoted by RCC1, a nucleotide exchange factor recruited to beads by Ran-guanosine diphosphate (Ran-GDP). Thus, concentration of Ran-GDP followed by generation of Ran-GTP is sufficient to induce NE assembly.	Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; Peking Univ, Coll Life Sci, Dept Cell Biol & Genet, Beijing 100871, Peoples R China	University of Dundee; Peking University	Zhang, CM (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Level 5, Dundee DD1 9SY, Scotland.	c.zhang@icrf.icnet.uk; p.clarke@icrf.icnet.uk	Clarke, Paul R./AAA-6803-2020; Clarke, Paul/B-1684-2009	Clarke, Paul/0000-0003-3525-2622				BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; BOMAN AL, 1992, J CELL BIOL, V116, P281, DOI 10.1083/jcb.116.2.281; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; CLARKE PR, 1995, J CELL SCI, V108, P1217; DASSO M, 1994, EMBO J, V13, P5732, DOI 10.1002/j.1460-2075.1994.tb06911.x; DEMETER J, 1995, P NATL ACAD SCI USA, V92, P1436, DOI 10.1073/pnas.92.5.1436; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Hughes M, 1998, J CELL SCI, V111, P3017; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; KORNBLUTH S, 1994, J CELL BIOL, V125, P705, DOI 10.1083/jcb.125.4.705; LEE A, 1993, J CELL SCI, V106, P287; Macaulay C, 1996, J CELL BIOL, V132, P5, DOI 10.1083/jcb.132.1.5; Marshall ICB, 1997, TRENDS CELL BIOL, V7, P69, DOI 10.1016/S0962-8924(96)10047-7; NEWPORT J, 1992, J CELL BIOL, V116, P295, DOI 10.1083/jcb.116.2.295; Nicolas FJ, 1997, J CELL SCI, V110, P3019; Ohba T, 1999, SCIENCE, V284, P1356, DOI 10.1126/science.284.5418.1356; Pu RT, 1997, MOL BIOL CELL, V8, P1955, DOI 10.1091/mbc.8.10.1955; Sazer S, 1996, TRENDS CELL BIOL, V6, P81, DOI 10.1016/0962-8924(96)80992-5; SEINO H, 1992, J CELL SCI, V102, P393; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Zhang C., UNPUB; Zhang CM, 1999, J CELL SCI, V112, P2453	24	162	173	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2000	288	5470					1429	1432		10.1126/science.288.5470.1429	http://dx.doi.org/10.1126/science.288.5470.1429			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318EL	10827954				2022-12-24	WOS:000087270900052
J	Bobak, M; Skodova, Z; Marmot, M				Bobak, M; Skodova, Z; Marmot, M			Effect of beer drinking on risk of myocardial infarction: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; ALCOHOL-CONSUMPTION		UCL, Dept Epidemiol & Publ Hlth, Int Ctr Hlth & Soc, London WC1E 6BT, England; Inst Clin & Expt Med, Dept Prevent Cardiol, Prague 14000, Czech Republic	University of London; University College London; Institute for Clinical & Experimental Medicine (IKEM)	Bobak, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Int Ctr Hlth & Soc, Mortimer St, London WC1E 6BT, England.	martinb@public-health.ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419; Bobak, Martin/0000-0002-2633-6851	Medical Research Council [G19/35, G8802774] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bobak M, 2000, J EPIDEMIOL COMMUN H, V54, P91, DOI 10.1136/jech.54.2.91; Keil U, 1997, EPIDEMIOLOGY, V8, P150, DOI 10.1097/00001648-199703000-00005; Rehm J, 1999, INT J EPIDEMIOL, V28, P219, DOI 10.1093/ije/28.2.219; Rimm EB, 1996, BRIT MED J, V312, P731, DOI 10.1136/bmj.312.7033.731; *WHO, 1987, MULT MON TRENDS DET	5	30	31	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 20	2000	320	7246					1378	1379		10.1136/bmj.320.7246.1378	http://dx.doi.org/10.1136/bmj.320.7246.1378			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317NY	10818027	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000087232500022
J	Menzies-Gow, A; Robinson, DS				Menzies-Gow, A; Robinson, DS			Eosinophil chemokines and their receptors: an attractive target in asthma?	LANCET			English	Editorial Material							ATOPIC ASTHMA; EOTAXIN; CCR3; CELLS; INFLAMMATION; EXPRESSION		Natl Heart & Lung Inst, Imperial Coll Sch Med, London SW3 6LY, England	Imperial College London	Menzies-Gow, A (corresponding author), Natl Heart & Lung Inst, Imperial Coll Sch Med, Dovehouse St, London SW3 6LY, England.							Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Grimaldi JC, 1999, J LEUKOCYTE BIOL, V65, P846, DOI 10.1002/jlb.65.6.846; Hanazawa T, 2000, J ALLERGY CLIN IMMUN, V105, P58, DOI 10.1016/S0091-6749(00)90178-7; JOSE PJ, 1994, J EXP MED, V179, P881, DOI 10.1084/jem.179.3.881; Leckie MJ, 1999, AM J RESP CRIT CARE, V159, pA624; Lloyd CM, 2000, J EXP MED, V191, P265, DOI 10.1084/jem.191.2.265; Luttichau HR, 2000, J EXP MED, V191, P171, DOI 10.1084/jem.191.1.171; Nibbs RJB, 2000, J IMMUNOL, V164, P1488, DOI 10.4049/jimmunol.164.3.1488; Ponath PD, 1996, J EXP MED, V183, P2437, DOI 10.1084/jem.183.6.2437; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Romagnani P, 1999, AM J PATHOL, V155, P1195, DOI 10.1016/S0002-9440(10)65222-4; Sabroe I, 1999, J IMMUNOL, V162, P2946; Ying S, 1999, J IMMUNOL, V163, P6321; Ying S, 1997, EUR J IMMUNOL, V27, P3507, DOI 10.1002/eji.1830271252; Zimmermann N, 1998, BBA-GENE STRUCT EXPR, V1442, P170, DOI 10.1016/S0167-4781(98)00162-6; Zingoni A, 1998, J IMMUNOL, V161, P547	17	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 20	2000	355	9217					1741	1743		10.1016/S0140-6736(00)02258-3	http://dx.doi.org/10.1016/S0140-6736(00)02258-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	315RE	10832821				2022-12-24	WOS:000087126100005
J	Schock, F; Reischl, J; Wimmer, E; Taubert, H; Purnell, BA; Jackle, H				Schock, F; Reischl, J; Wimmer, E; Taubert, H; Purnell, BA; Jackle, H			Phenotypic suppression of empty spiracles is prevented by buttonhead	NATURE			English	Article							DROSOPHILA HEAD DEVELOPMENT; FUNCTIONAL HIERARCHY; SEGMENT IDENTITY; HUMAN SP1; GENE; EXPRESSION; COMPLEX; EMBRYO	Unlike the trunk segments, the anterior head segments of Drosophila are formed in the absence of pair-rule(1,2) and HOX-cluster gene(3) expression, by the activities of the gap-like genes orthodenticle (otd), empty spiracles (ems) and buttonhead (btd)(4,5). The products of these genes are transcription factors(6,7), but only EMS has a HOX-like homeodomain(8,9). Indeed, ems can confer identity to trunk segments(10) when other HOX-cluster gene activities are absent(3,11). In trunk segments of wild-type embryos, however, ems activity is prevented by phenotypic suppression(10), in which more posterior HOX-cluster genes inactivate the more anterior without affecting transcription or translation(12). ems is suppressed by all other Hox-cluster genes and so is placed at the bottom of their hierarchy(10). Here we show that misexpression of EMS in the head transforms segment identity in a btd-dependent manner, that misexpression of BTD in the trunk causes ems-dependent structures to develop, and that EMS and BTD interact in vitro. The data indicate that this interaction may allow ems to escape from the bottom of the HOX-cluster gene hierarchy and cause a dominant switch of homeotic prevalence in the anterior-posterior direction.	Max Planck Inst Biophys Chem, Abt Mol Entwicklungsbiol, D-37077 Gottingen, Germany; Univ Bayreuth, Lehrstuhl Genet, D-95440 Bayreuth, Germany	Max Planck Society; University of Bayreuth	Jackle, H (corresponding author), Max Planck Inst Biophys Chem, Abt Mol Entwicklungsbiol, Fassberg 11, D-37077 Gottingen, Germany.		Schock, Frieder/A-9990-2009	Schock, Frieder/0000-0002-1351-0574; Wimmer, Ernst A./0000-0002-2480-2804				ARIAS AM, 1993, DEV DROSOPHILA MELAN, P517; COHEN SM, 1990, NATURE, V346, P482, DOI 10.1038/346482a0; DALTON D, 1989, GENE DEV, V3, P1940, DOI 10.1101/gad.3.12a.1940; DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5; FINKELSTEIN R, 1990, GENE DEV, V4, P1516, DOI 10.1101/gad.4.9.1516; Gallitano-Mendel A, 1998, DEV BIOL, V199, P125, DOI 10.1006/dbio.1998.8917; Janody F, 2000, DEVELOPMENT, V127, P1573; JONES B, 1993, GENE DEV, V7, P229, DOI 10.1101/gad.7.2.229; Jurgens G., 1993, DEV DROSOPHILA MELAN, P687; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Macias A, 1996, EMBO J, V15, P334, DOI 10.1002/j.1460-2075.1996.tb00363.x; MANAK JR, 1994, DEVELOPMENT, P61; Pankratz Michael J., 1993, P467; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Rogers BT, 1996, DEVELOPMENT, V122, P3419; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SAUER F, 1995, SCIENCE, V270, P1783, DOI 10.1126/science.270.5243.1783; SCHMIDTOTT U, 1994, P NATL ACAD SCI USA, V91, P8363, DOI 10.1073/pnas.91.18.8363; Schock F, 1999, P NATL ACAD SCI USA, V96, P5061, DOI 10.1073/pnas.96.9.5061; Thummel CS, 1992, DROS INF SERV, V71, P150; WALLDORF U, 1992, EMBO J, V11, P2247, DOI 10.1002/j.1460-2075.1992.tb05284.x; WHITE RAH, 1984, CELL, V39, P163, DOI 10.1016/0092-8674(84)90202-2; WIMMER EA, 1993, NATURE, V366, P690, DOI 10.1038/366690a0; Wimmer EA, 1996, MECH DEVELOP, V59, P53, DOI 10.1016/0925-4773(96)00575-8; Wimmer EA, 1997, DEVELOPMENT, V124, P1509; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	27	27	27	1	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 18	2000	405	6784					351	354		10.1038/35012620	http://dx.doi.org/10.1038/35012620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314YT	10830964				2022-12-24	WOS:000087085700048
J	Pelaz, S; Ditta, GS; Baumann, E; Wisman, E; Yanofsky, MF				Pelaz, S; Ditta, GS; Baumann, E; Wisman, E; Yanofsky, MF			B and C floral organ identity functions require SEPALLATA MADS-box genes	NATURE			English	Article							HOMEOTIC GENE; FLOWER DEVELOPMENT; ANTIRRHINUM-MAJUS; ARABIDOPSIS; TRANSCRIPTION; FAMILY; EXPRESSION; PISTILLATA; DEFICIENS; PROTEINS	Abnormal flowers have been recognized for thousands of years, but only in the past decade have the mysteries of flower development begun to unfold. Among these mysteries is the differentiation of four distinct organ types (sepals, petals, stamens and carpels), each of which may be a modified leaf(1). A landmark accomplishment in plant developmental biology is the ABC model of flower organ identity(2,3). This simple model provides a conceptual framework for explaining how the individual and combined activities of the ABC genes produce the four organ types of the typical eudicot flower. Here we show that the activities of the B and C organ-identity genes require the activities of three closely related and functionally redundant MADS-box genes, SEPALLATA1/2/3 (SEP1/2/3). Triple mutant Arabidopsis plants lacking the activity of all three SEP genes produce flowers in which all organs develop as sepals. Thus SEP1/2/3 are a class of organ-identity genes that is required for development of petals, stamens and carpels.	Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Max Planck Inst Zuchtungsforsch, D-50829 Cologne, Germany	Max Planck Society	Yanofsky, MF (corresponding author), Sect Cell & Dev Biol, La Jolla, CA 92093 USA.		Pelaz, Soraya/F-3431-2015	Pelaz, Soraya/0000-0001-7699-9330				AMBROSE BA, IN PRESS MOL CELL; ANGENENT GC, 1994, PLANT J, V5, P33, DOI 10.1046/j.1365-313X.1994.5010033.x; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Davies B, 1996, EMBO J, V15, P4330, DOI 10.1002/j.1460-2075.1996.tb00807.x; DREWS GN, 1991, CELL, V65, P991, DOI 10.1016/0092-8674(91)90551-9; Egea-Cortines M, 1999, EMBO J, V18, P5370, DOI 10.1093/emboj/18.19.5370; Fan HY, 1997, PLANT J, V12, P999, DOI 10.1046/j.1365-313X.1997.12050999.x; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; FLANAGAN CA, 1994, PLANT MOL BIOL, V26, P581, DOI 10.1007/BF00013745; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; IRISH VF, 1990, PLANT CELL, V2, P741, DOI 10.1105/tpc.2.8.741; JACK T, 1992, CELL, V68, P683, DOI 10.1016/0092-8674(92)90144-2; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Kang HG, 1997, MOL CELLS, V7, P45; KEMPIN SA, 1995, SCIENCE, V267, P522, DOI 10.1126/science.7824951; Krizek BA, 1996, DEVELOPMENT, V122, P11; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; MA H, 1991, GENE DEV, V5, P484, DOI 10.1101/gad.5.3.484; Mandel MA, 1998, SEX PLANT REPROD, V11, P22, DOI 10.1007/s004970050116; MANDEL MA, 1992, NATURE, V360, P273, DOI 10.1038/360273a0; MEYEROWITZ EM, 1989, DEVELOPMENT, V106, P209; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; Mouradov A, 1998, PLANT PHYSIOL, V117, P55, DOI 10.1104/pp.117.1.55; PNUELI L, 1994, PLANT CELL, V6, P175, DOI 10.1105/tpc.6.2.175; SAVIDGE B, 1995, PLANT CELL, V7, P721, DOI 10.1105/tpc.7.6.721; SCHWARZSOMMER Z, 1990, SCIENCE, V250, P931, DOI 10.1126/science.250.4983.931; TROBNER W, 1992, EMBO J, V11, P4693, DOI 10.1002/j.1460-2075.1992.tb05574.x; Wisman E, 1998, P NATL ACAD SCI USA, V95, P12432, DOI 10.1073/pnas.95.21.12432; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0	30	1043	1199	17	277	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 11	2000	405	6783					200	203		10.1038/35012103	http://dx.doi.org/10.1038/35012103			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WG	10821278				2022-12-24	WOS:000087080100055
J	Newman, DK; Kolter, R				Newman, DK; Kolter, R			A role for excreted quinones in extracellular electron transfer	NATURE			English	Article							SHEWANELLA-PUTREFACIENS MR-1; C-TYPE CYTOCHROME; GEOBACTER-SULFURREDUCENS; HUMIC SUBSTANCES; REDUCTION; BACTERIA; ACCEPTORS; FE(III); IRON; MANGANESE(IV)	Respiratory processes in bacteria are remarkable because of their ability to use a variety of compounds, including insoluble minerals, as terminal electron acceptors(1). Although much is known about microbial electron transport to soluble electron acceptors, little is understood about electron transport to insoluble compounds such as ferric oxides(2,3). In anaerobic environments, humic substances can serve as electron acceptors and also as electron shuttles to ferric oxides(4-6). To explore this process, we identified mutants in Shewanella putrefaciens that are unable to respire on humic substances. Here we show that these mutants contain disruptions in a gene that is involved in the biosynthesis of menaquinone. During growth, the wild type releases a menaquinone-related redox-active small molecule into the medium that complements the mutants. This finding raises the possibility that electron transfer to a variety of oxidants, including poorly soluble minerals, may be mediated by microbially excreted quinones that have yet to be identified.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Newman, DK (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.							ALEXEYEV MF, 1995, GENE, V160, P59, DOI 10.1016/0378-1119(95)00141-R; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARNOLD RG, 1988, BIOTECHNOL BIOENG, V32, P1081, DOI 10.1002/bit.260320902; Beliaev AS, 1998, J BACTERIOL, V180, P6292; Benz M, 1998, APPL ENVIRON MICROB, V64, P4507; Brock T.P., 1991, BIOL MICROORGANISMS, V340; Caccavo F, 1997, APPL ENVIRON MICROB, V63, P3837, DOI 10.1128/AEM.63.10.3837-3843.1997; Coates JD, 1998, APPL ENVIRON MICROB, V64, P1504; Collins MD, 1985, METHODS MICROBIOLOGY, P329, DOI 10.1016/S0580-9517(08)70480-X; GASPARD S, J BACTERIOL, V64, P3188; GENNIS RB, 1996, ESCHERICHIA COLI SAL, V1, P217; Lloyd JR, 1999, J BACTERIOL, V181, P7647, DOI 10.1128/JB.181.24.7647-7649.1999; LOVLEY DR, 1991, MICROBIOL REV, V55, P259, DOI 10.1128/MMBR.55.2.259-287.1991; LOVLEY DR, 1988, APPL ENVIRON MICROB, V54, P1472, DOI 10.1128/AEM.54.6.1472-1480.1988; Lovley DR, 1996, NATURE, V382, P445, DOI 10.1038/382445a0; Meganathan R., 1996, ESCHERICHIA COLI SAL, P642; MYERS CR, 1992, J BACTERIOL, V174, P3429, DOI 10.1128/JB.174.11.3429-3438.1992; MYERS CR, 1993, FEMS MICROBIOL LETT, V114, P215, DOI 10.1111/j.1574-6968.1993.tb06576.x; MYERS CR, 1990, J BACTERIOL, V172, P6232, DOI 10.1128/jb.172.11.6232-6238.1990; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Scott DT, 1998, ENVIRON SCI TECHNOL, V32, P2984, DOI 10.1021/es980272q; Seeliger S, 1998, J BACTERIOL, V180, P3686, DOI 10.1128/JB.180.14.3686-3691.1998; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; TRATNYEK PG, 1989, J AGR FOOD CHEM, V37, P248, DOI 10.1021/jf00085a058	25	640	687	23	418	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2000	405	6782					94	97		10.1038/35011098	http://dx.doi.org/10.1038/35011098			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311TK	10811225				2022-12-24	WOS:000086901600058
J	Ishimoto, H; Matsumoto, A; Tanimura, T				Ishimoto, H; Matsumoto, A; Tanimura, T			Molecular identification of a taste receptor gene for trehalose in Drosophila	SCIENCE			English	Article							FUNCTIONAL EXPRESSION; ODORANT RECEPTORS; TISSUE; MELANOGASTER; PROTEINS; FAMILY	The molecular nature of sweet taste receptors has not been fully explored. Employing a differential screening strategy, we identified a taste receptor gene, Tre1, that controls the taste sensitivity to trehalose in Drosophila melanogaster. The Tre1 gene encodes a novel protein with similarity to G protein-coupled seven-transmembrane receptors. Disruption of the Tre1 gene lowered the taste sensitivity to trehalose, whereas sensitivities to other sugars were unaltered. Overexpression of the Tre1 gene restored the taste sensitivity to trehalose in the Tre1 deletion mutant. The Tre1 gene is expressed in taste sensory cells. These results provide direct evidence that Tre1 encodes a putative taste receptor for trehalose in Drosophila.	Kyushu Univ, Dept Biol, Fukuoka 8108560, Japan	Kyushu University	Tanimura, T (corresponding author), Kyushu Univ, Dept Biol, Fukuoka 8108560, Japan.							ABE K, 1993, FEBS LETT, V316, P253, DOI 10.1016/0014-5793(93)81302-G; Awasaki T, 1997, J NEUROBIOL, V32, P707, DOI 10.1002/(SICI)1097-4695(19970620)32:7<707::AID-NEU6>3.0.CO;2-8; BASLER K, 1990, GENE DEV, V4, P728, DOI 10.1101/gad.4.5.728; BASLER K, UNPUB; Bhatt TR, 1997, BIOTECHNIQUES, V23, P1000, DOI 10.2144/97236bm06; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; KIMURA K, 1986, J EXP ZOOL, V239, P393, DOI 10.1002/jez.1402390310; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MATSUOKA I, 1993, BIOCHEM BIOPH RES CO, V194, P504, DOI 10.1006/bbrc.1993.1848; NOTTEBOHM E, 1994, NEURON, V12, P25, DOI 10.1016/0896-6273(94)90149-X; ROBERTSON HM, 1988, GENETICS, V118, P461; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Singh RN, 1997, MICROSC RES TECHNIQ, V39, P547, DOI 10.1002/(SICI)1097-0029(19971215)39:6<547::AID-JEMT7>3.0.CO;2-A; STOKER RF, 1994, CELL TISSUE RES, V275, P3; TANIMURA T, 1988, GENETICS, V119, P399; TANIMURA T, 1982, J COMP PHYSIOL, V147, P433, DOI 10.1007/BF00612007; TANIMURA T, 1981, J COMP PHYSIOL, V141, P265, DOI 10.1007/BF01342672; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; WRONG GT, 1996, NATURE, V381, P796; Zhao HQ, 1998, SCIENCE, V279, P237, DOI 10.1126/science.279.5348.237	25	41	44	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2000	289	5476					116	119		10.1126/science.289.5476.116	http://dx.doi.org/10.1126/science.289.5476.116			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332TW	10884225				2022-12-24	WOS:000088090400045
J	Warren, SJP; Lin, MS; Giudice, GJ; Hoffmann, RG; Hans, G; Aoki, V; Rivitti, EA; dos Santos, V; Diaz, LA				Warren, SJP; Lin, MS; Giudice, GJ; Hoffmann, RG; Hans, G; Aoki, V; Rivitti, EA; dos Santos, V; Diaz, LA		Cooperative Grp on Fogo Selvagem R	The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; FOGO-SELVAGEM; VULGARIS AUTOANTIBODIES; AMERINDIAN RESERVATION; DISTINCT; DISEASE; FOCUS	Background: Pemphigus foliaceus is an autoimmune skin disease mediated by autoantibodies against desmoglein 1. The endemic form is thought to have an environmental cause. The Terena reservation of Limao Verde in Mato Grosso do Sul, Brazil, is a recently identified focus of the disease, with a prevalence of 3.4 percent in the population. We tested the hypothesis that normal subjects living in an endemic area have antibodies against desmoglein 1. Methods: We used an enzyme-linked immunosorbent assay to detect antibodies against desmoglein 1 in serum samples from 60 patients with endemic pemphigus foliaceus (fogo selvagem) who lived in Limao Verde or elsewhere in Brazil, 372 normal subjects (without pemphigus foliaceus) from Limao Verde and surrounding locations, and 126 normal subjects from the United States and Japan. Results: Antibodies against desmoglein 1 were detected in 59 of the 60 patients with fogo selvagem (98 percent) but in only 3 of the 126 normal subjects from the United States and Japan (2 percent). Antibodies were also detected in 51 of the 93 normal subjects from Limao Verde (55 percent) and in 54 of the 279 normal subjects from surrounding areas (19 percent). Serum samples obtained one to four years before the onset of disease were available for five patients; all five had antibodies in the initial serum samples, and the onset of disease was associated with a marked increase in antibody values. Conclusions: The prevalence of antibodies against desmoglein 1 is high among normal subjects living in an area where fogo selvagem is endemic, and the onset of the disease is preceded by a sustained antibody response. These findings support the concept that the production of antibodies against desmoglein 1 is initiated by exposure to an unknown environmental agent. (N Engl J Med 2000;343:23-30.) (C) 2000, Massachusetts Medical Society.	Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Clin Epidemiol & Biostat, Milwaukee, WI 53226 USA; Vet Affairs Med Ctr, Milwaukee, WI USA; Univ Fed Mato Grosso do Sul, Dept Dermatol, Campo Grande, Brazil; Univ Sao Paulo, Dept Dermatol, Sao Paulo, Brazil; Secretaria Estado Saude do Mato Grosso do Sul, Aquidauana, Brazil	Medical College of Wisconsin; Medical College of Wisconsin; US Department of Veterans Affairs; Veterans Health Administration (VHA); Universidade Federal de Mato Grosso do Sul; Universidade de Sao Paulo	Diaz, LA (corresponding author), Univ N Carolina, Sch Med, Dept Dermatol, Suite 3100,Thurston Bldg,CB 7287, Chapel Hill, NC 27599 USA.		Aoki, Valeria/ABD-2863-2020; HANS-FILHO, GUNTER/R-9779-2017; Aoki, Valeria/H-1415-2012	Aoki, Valeria/0000-0003-4256-4413; HANS-FILHO, GUNTER/0000-0001-9324-3703; Aoki, Valeria/0000-0003-4256-4413	NIAMS NIH HHS [R37-AR30281, R01-AR32599, R01-AR40410, R01 AR032599] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040410, R01AR032599] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AMAGAI M, 1995, J INVEST DERMATOL, V104, P895, DOI 10.1111/1523-1747.ep12606168; Amagai M, 1999, BRIT J DERMATOL, V140, P351; Cazenave PLA, 1844, ANN MAL PEU, V1, P208; DIAZ LA, 1989, J AM ACAD DERMATOL, V20, P657, DOI 10.1016/S0190-9622(89)70079-7; DIAZ LA, 1989, J INVEST DERMATOL, V92, P4, DOI 10.1111/1523-1747.ep13070394; Ding X, 1999, J INVEST DERMATOL, V112, P739, DOI 10.1046/j.1523-1747.1999.00585.x; Ding X, 1997, J INVEST DERMATOL, V109, P592, DOI 10.1111/1523-1747.ep12337524; Eaton DP, 1998, J MED ENTOMOL, V35, P120, DOI 10.1093/jmedent/35.2.120; EMERY DJ, 1995, J INVEST DERMATOL, V104, P323, DOI 10.1111/1523-1747.ep12665364; FRIEDMAN H, 1995, J AM ACAD DERMATOL, V32, P949, DOI 10.1016/0190-9622(95)91330-0; Hans G, 1996, J INVEST DERMATOL, V107, P68, DOI 10.1111/1523-1747.ep12298213; Ishii K, 1997, J IMMUNOL, V159, P2010; LEHMANN PV, 1993, IMMUNOL TODAY, V14, P203, DOI 10.1016/0167-5699(93)90163-F; Liebman JM, 1999, BIOTECHNIQUES, V26, P36, DOI 10.2144/99261bm05; MATIS WL, 1987, J INVEST DERMATOL, V89, P302, DOI 10.1111/1523-1747.ep12471587; Moraes ME, 1997, TISSUE ANTIGENS, V49, P35, DOI 10.1111/j.1399-0039.1997.tb02707.x; MORINI JP, 1993, ARCH DERMATOL, V129, P69, DOI 10.1001/archderm.129.1.69; Oldstone MB, 1987, CELL, V51, P878; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; PAESLEME C, 1903, THESIS FM RIO DE JAN; ROBLEDO MA, 1988, BRIT J DERMATOL, V118, P737, DOI 10.1111/j.1365-2133.1988.tb02590.x; STANLEY JR, 1986, J INVEST DERMATOL, V87, P197, DOI 10.1111/1523-1747.ep12695334; Vieira J, 1937, CONTRIBUICAO AO ESTU; WALLER RA, 1969, J AM STAT ASSOC, V64, P1484, DOI 10.2307/2286085; Zillikens D, 1997, J INVEST DERMATOL, V109, P679, DOI 10.1111/1523-1747.ep12338088	25	109	115	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2000	343	1					23	30		10.1056/NEJM200007063430104	http://dx.doi.org/10.1056/NEJM200007063430104			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330XW	10882765				2022-12-24	WOS:000087987600004
J	Lubowich, DA; Pasachoff, JM; Balonek, TJ; Millar, TJ; Tremonti, C; Roberts, H; Galloway, RP				Lubowich, DA; Pasachoff, JM; Balonek, TJ; Millar, TJ; Tremonti, C; Roberts, H; Galloway, RP			Deuterium in the Galactic Centre as a result of recent infall of low-metallicity gas	NATURE			English	Article							HOT MOLECULAR CORES; GAMMA-RAY EMISSION; ABUNDANCE; GALAXY; CLOUD; NUCLEOSYNTHESIS; ELEMENTS; REGIONS; LIGHT	The Galactic Centre is the most active and heavily processed region of the Milky Way, so it can be used as a stringent test for the abundance of deuterium (a sensitive indicator of conditions in the first 1,000 seconds in the life of the Universe). As deuterium is destroyed in stellar interiors, chemical evolution models 1 predict that its Galactic Centre abundance relative to hydrogen is D/H = 5 x 10(-12), unless there is a continuous source of deuterium from relatively primordial (low-metallicity) gas. Here we report the detection of deuterium (in the molecule DCN) in a molecular cloud only 10 parsecs from the Galactic Centre. Our data, when combined with a model of molecular abundances, indicate that D/H = (1.7 +/- 0.3) x 10(-6), five orders of magnitude larger than the predictions of evolutionary models with no continuous source of deuterium. The most probable explanation is recent infall of relatively unprocessed metal-poor gas into the Galactic Centre (at the rate inferred by Wakker(2)). Our measured D/H is nine times less than the local interstellar value, and the lowest D/H observed in the Galaxy. We conclude that the observed Galactic Centre deuterium is cosmological, with an abundance reduced by stellar processing and mixing, and that there is no significant Galactic source of deuterium.	Hofstra Univ, Dept Phys & Astron, Hempstead, NY 11550 USA; Amer Inst Phys, Melville, NY 11747 USA; Williams Coll, Hopkins Observ, Williamstown, MA 01267 USA; Colgate Univ, Dept Phys & Astron, Hamilton, NY 13346 USA; Univ Manchester, Inst Sci & Technol, Dept Phys, Manchester M60 1QD, Lancs, England	Hofstra University; Johns Hopkins University; Williams College; Colgate University; University of Manchester	Lubowich, DA (corresponding author), Hofstra Univ, Dept Phys & Astron, Hempstead, NY 11550 USA.	dlubowic@aip.org		Millar, Tom/0000-0001-5178-3656; Balonek, Thomas/0000-0002-9844-1730				AUDOUZE J, 1976, ASTROPHYS J, V208, pL51, DOI 10.1086/182231; BOYD RN, 1989, ASTROPHYS J, V336, pL1, DOI 10.1086/185347; Chengalur JN, 1997, ASTRON ASTROPHYS, V318, pL35; COPI CJ, 1995, PHYS REV LETT, V75, P3981, DOI 10.1103/PhysRevLett.75.3981; FUKUI Y, 1977, PUBL ASTRON SOC JPN, V29, P643; GENZEL R, 1990, ASTROPHYS J, V356, P160, DOI 10.1086/168827; GUSTEN R, 1985, ASTRON ASTROPHYS, V145, P241; Hatchell J, 1998, ASTRON ASTROPHYS, V332, P695; Jacq T, 1999, ASTRON ASTROPHYS, V347, P957; Linsky JL, 1998, SPACE SCI REV, V84, P285, DOI 10.1023/A:1005048124341; LOVAS FJ, 1992, J PHYS CHEM REF DATA, V21, P181, DOI 10.1063/1.555920; Lubowich DA, 1998, ASTROPHYS J, V508, P729, DOI 10.1086/306411; LUBOWICH DA, 1989, ASTROPHYS J, V345, P770, DOI 10.1086/167948; MASTICHIADIS A, 1994, ASTROPHYS J, V426, P599, DOI 10.1086/174096; Matteucci F, 1999, ASTRON ASTROPHYS, V341, P458; Mayer-Hasselwander HA, 1998, ASTRON ASTROPHYS, V335, P161; MILLAR TJ, IN PRESS PHIL T R A; MINH YC, 1992, ASTRON ASTROPHYS, V258, P489; MORRIS M, 1993, ASTROPHYS J, V408, P496, DOI 10.1086/172607; Ozernoi L. M., 1976, Soviet Astronomy, V19, P693; Pasachoff J. M., 1989, Comments on Astrophysics. Comments on Modern Physics: Part C, V14, P61; PENZIAS AA, 1979, ASTROPHYS J, V228, P430, DOI 10.1086/156862; POGLITSCH A, 1991, ASTROPHYS J, V374, pL33, DOI 10.1086/186065; Prantzos N, 1996, ASTRON ASTROPHYS, V310, P106; Rodgers SD, 1996, MON NOT R ASTRON SOC, V280, P1046, DOI 10.1093/mnras/280.4.1046; Schramm DN, 1998, REV MOD PHYS, V70, P303, DOI 10.1103/RevModPhys.70.303; SERABYN E, 1992, ASTROPHYS J, V395, P166, DOI 10.1086/171640; SIMPSON JP, 1995, ASTROPHYS J, V444, P721, DOI 10.1086/175645; Wakker BP, 1999, NATURE, V402, P388, DOI 10.1038/46498; Yusef-Zadeh F, 2000, SCIENCE, V287, P85, DOI 10.1126/science.287.5450.85	30	57	57	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 29	2000	405	6790					1025	1027		10.1038/35016506	http://dx.doi.org/10.1038/35016506			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	328VN	10890436				2022-12-24	WOS:000087871700036
J	Macpherson, AJ; Gatto, D; Sainsbury, E; Harriman, GR; Hengartner, H; Zinkernagel, RM				Macpherson, AJ; Gatto, D; Sainsbury, E; Harriman, GR; Hengartner, H; Zinkernagel, RM			A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria	SCIENCE			English	Article							CHOLERA-TOXIN; AFFINITY MATURATION; GERMINAL-CENTERS; DEFICIENT MICE; MUTANT MICE; LYMPHOCYTES; IMMUNITY; GUT; DIFFERENTIATION; IMMUNIZATION	The immunoglobulin A (IgA) is produced to defend mucosal surfaces from environmental organisms, but host defenses against the very heavy load of intestinal commensal microorganisms are poorly understood. The IgA against intestinal commensal bacterial antigens was analyzed; it was not simply "natural antibody" but was specifically induced and responded to antigenic changes within an established gut flora. In contrast to IgA responses against exotoxins, a significant proportion of this specific anti-commensal IgA induction was through a pathway that was independent of T cell help and of follicular lymphoid tissue organization, which may reflect an evolutionarily primitive form of specific immune defense.	Univ Spital Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland; GKT Sch Med, London SE5 9PJ, England; Centocor Inc, Malvern, PA 19355 USA	University of Zurich; University Zurich Hospital; University of London; King's College London; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Macpherson, AJ (corresponding author), Univ Spital Zurich, Inst Expt Immunol, Schmetzbergstr 12, CH-8091 Zurich, Switzerland.							Bos NA, 1996, INFECT IMMUN, V64, P616, DOI 10.1128/IAI.64.2.616-623.1996; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; ELSON CO, 1984, J IMMUNOL, V132, P2736; Franco MA, 1997, VIROLOGY, V238, P169, DOI 10.1006/viro.1997.8843; Gardby E, 1998, J IMMUNOL, V161, P49; Harriman GR, 1999, J IMMUNOL, V162, P2521; Haury M, 1997, EUR J IMMUNOL, V27, P1557, DOI 10.1002/eji.1830270635; HORNQUIST CE, 1995, J IMMUNOL, V155, P2877; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; LANE P, 1994, J EXP MED, V179, P819, DOI 10.1084/jem.179.3.819; Londono LP, 1996, VACCINE, V14, P545; LYCKE N, 1987, SCAND J IMMUNOL, V25, P413, DOI 10.1111/j.1365-3083.1987.tb02208.x; MACPHERSON AJ, UNPUB; Matsumoto M, 1996, NATURE, V382, P462, DOI 10.1038/382462a0; Medaglini D, 1997, VACCINE, V15, P1330, DOI 10.1016/S0264-410X(97)00026-1; MEGA J, 1991, INT IMMUNOL, V3, P793, DOI 10.1093/intimm/3.8.793; MOMBAERTS P, 1994, INT IMMUNOL, V6, P1061, DOI 10.1093/intimm/6.7.1061; NANNO M, 1994, J IMMUNOL, V153, P2014; Pasparakis M, 1997, P NATL ACAD SCI USA, V94, P6319, DOI 10.1073/pnas.94.12.6319; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; Saito H, 1998, SCIENCE, V280, P275, DOI 10.1126/science.280.5361.275; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Snider DP, 1999, INT IMMUNOL, V11, P191, DOI 10.1093/intimm/11.2.191; VAJDY M, 1995, J EXP MED, V181, P41, DOI 10.1084/jem.181.1.41; WESTPHAL O, 1966, ADV CARBOHYD CHEM, V25, P83	25	794	833	11	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2222	+		10.1126/science.288.5474.2222	http://dx.doi.org/10.1126/science.288.5474.2222			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864873				2022-12-24	WOS:000087782900061
J	Park, YC; Ye, H; Hsia, C; Segal, D; Rich, RL; Liou, HC; Myszka, DG; Wu, H				Park, YC; Ye, H; Hsia, C; Segal, D; Rich, RL; Liou, HC; Myszka, DG; Wu, H			A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction	CELL			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; INDUCED CELL-DEATH; FACTOR RECEPTOR; ANOMALOUS DIFFRACTION; KINASE RIP; TNF; ACTIVATION; PROTEIN; INDUCTION	TRAP proteins are major mediators for the cell activation, cell survival, and antiapoptotic functions of the TNF receptor superfamily. They can be recruited to activated TNF receptors either by direct interactions with the receptors or indirectly via the adaptor protein TRADD. We now report the structure of the TRADD-TRAF2 complex, which is highly distinct from receptor-TRAF2 interactions. This interaction is significantly stronger and we show by an in vivo signaling assay that TRAF2 signaling is more readily initiated by TRADD than by direct receptor-TRAF2 interactions. TRADD is specific for TRAF1 and TRAF2, which ensures the recruitment of cIAPs for the direct inhibition of caspase activation in the signaling complex. The stronger affinity and unique specificity of the TRADD-TRAF2 interaction are crucial for the suppression of apoptosis and provide a mechanistic basis for the perturbation of TRAP recruitment in sensitizing cell death induction.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, New York, NY 10021 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84132 USA	Cornell University; Cornell University; Cornell University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Wu, H (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA.	haowu@med.cornell.edu			NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047831] Funding Source: NIH RePORTER; NCI NIH HHS [CA42014] Funding Source: Medline; NIAID NIH HHS [AI47831] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chan FKM, 2000, EUR J IMMUNOL, V30, P652; Duckett CS, 1997, GENE DEV, V11, P2810, DOI 10.1101/gad.11.21.2810; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Gravestein LA, 1998, SEMIN IMMUNOL, V10, P423, DOI 10.1006/smim.1998.0144; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Haridas V, 1998, J IMMUNOL, V160, P3152; HELLER RA, 1992, CELL, V70, P47; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hodgkin P D, 1997, Int Rev Immunol, V15, P101, DOI 10.3109/08830189709068173; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Jiang YP, 1999, SCIENCE, V283, P543, DOI 10.1126/science.283.5401.543; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kehry M R, 1994, Semin Immunol, V6, P287, DOI 10.1006/smim.1994.1037; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Liou ML, 1999, J BIOL CHEM, V274, P10145, DOI 10.1074/jbc.274.15.10145; Liu HZ, 1999, CURR BIOL, V9, P101, DOI 10.1016/S0960-9822(99)80023-2; Loenen WAM, 1998, SEMIN IMMUNOL, V10, P417, DOI 10.1006/smim.1998.0159; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; McWhirter SM, 1999, P NATL ACAD SCI USA, V96, P8408, DOI 10.1073/pnas.96.15.8408; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; Morton TA, 1998, METHOD ENZYMOL, V295, P268; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Myszka DG, 1999, MOL RECOGNIT, V12, P1; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Newton RC, 1999, J MED CHEM, V42, P2295, DOI 10.1021/jm980541n; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; ORENGO CA, 1993, STRUCTURE, V1, P105, DOI 10.1016/0969-2126(93)90026-D; Otwinowski Z., 1990, DENZO DATA PROCESSIN; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; REGNIER CH, 1995, J BIOL CHEM, V270, P25715, DOI 10.1074/jbc.270.43.25715; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; SARIN A, 1995, J IMMUNOL, V155, P3716; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; TONG L, 1993, J APPL CRYSTALLOGR, V26, P748, DOI 10.1107/S0021889893005631; VANDENABEELE P, 1995, J IMMUNOL, V154, P2904; Wajant H, 1998, J MOL EVOL, V47, P656, DOI 10.1007/PL00006423; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Weiss T, 1998, J IMMUNOL, V161, P3136; Weiss T, 1997, J IMMUNOL, V158, P2398; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; YE H, 2000, IN PRESS P NATL ACAD; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; ZHENG LX, 1995, NATURE, V377, P348, DOI 10.1038/377348a0	64	140	178	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 23	2000	101	7					777	787		10.1016/S0092-8674(00)80889-2	http://dx.doi.org/10.1016/S0092-8674(00)80889-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	327YE	10892748	Bronze			2022-12-24	WOS:000087821400011
J	Takahashi, K; Chen, ES; Yanagida, M				Takahashi, K; Chen, ES; Yanagida, M			Requirement of Mis6 centromere connector for localizing a CENP-A-like protein in fission yeast	SCIENCE			English	Article							CHROMOSOME SEGREGATION; GENE; DIVISION; MUTATION; SEQUENCE; MITOSIS	Mammalian kinetochores contain the centromere-specific histone H3 Variant CENP-A, whose incorporation into limited chromosomal regions may be important for centromere function and chromosome segregation during mitosis. However, regulation of CENP-A localization and its role have not been clear. Here we report that the fission yeast homolog SpCENP-A is essential for establishing centromere chromatin associated with equal chromosome segregation. SpCENP-A binding to the nonrepetitious inner centromeres depended on Mis6, an essential centromere connector protein acting during G(1)-S phase of the cell cycle. Mis6 is likely required for recruiting SpCENP-A to form proper connection of sister centromeres.	Kyoto Univ, Grad Sch Biostudies, Japan Sci & Technol Corp, CREST Res Project,Sakyo Ku, Kyoto, Japan; Kyoto Univ, Grad Sch Biostudies, Dept Biophys, Sakyo Ku, Kyoto, Japan; Kyoto Univ, Grad Sch Biostudies, Dept Gene Mechanisms, Sakyo Ku, Kyoto, Japan	Japan Science & Technology Agency (JST); Kyoto University; Kyoto University; Kyoto University	Yanagida, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Japan Sci & Technol Corp, CREST Res Project,Sakyo Ku, Kyoto, Japan.							Adams CR, 1999, CURR OPIN GENET DEV, V9, P185, DOI 10.1016/S0959-437X(99)80028-8; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; FANTES P, 1979, NATURE, V279, P428, DOI 10.1038/279428a0; Furuya K, 1998, GENE DEV, V12, P3408, DOI 10.1101/gad.12.21.3408; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; MATSUMOTO S, 1985, EMBO J, V4, P3531, DOI 10.1002/j.1460-2075.1985.tb04113.x; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Tatebayashi K, 1998, GENETICS, V148, P49	17	325	331	2	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2215	2219		10.1126/science.288.5474.2215	http://dx.doi.org/10.1126/science.288.5474.2215			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864871				2022-12-24	WOS:000087782900059
J	Hahnloser, RHR; Sarpeshkar, R; Mahowald, MA; Douglas, RJ; Seung, HS				Hahnloser, RHR; Sarpeshkar, R; Mahowald, MA; Douglas, RJ; Seung, HS			Digital selection and analogue amplification coexist in a cortex-inspired silicon circuit	NATURE			English	Article							VISUAL-CORTEX; NETWORKS; ORIENTATION; ATTENTION; DYNAMICS; NEURONS; FIELDS; MODEL	Digital circuits such as the flip-flop use feedback to achieve multistability and nonlinearity to restore signals to logical levels, for example 0 and 1. Analogue feedback circuits are generally designed to operate linearly, so that signals are over a range, and the response is unique. By contrast, the response of cortical circuits to sensory stimulation can be both multistable and graded(1-4). We propose that the neocortex combines digital selection of an active set of neurons with analogue response by dynamically varying the positive feedback inherent in its recurrent connections. Strong positive feedback causes differential instabilities that drive the selection of a set of active neurons under the constraints embedded in the synaptic weights. Once selected, the active neurons generate weaker, stable feedback that provides analogue amplification of the input. Here we present our model of cortical processing as an electronic circuit that emulates this hybrid operation, and so is able to perform computations that are similar to stimulus selection, gain modulation and spatiotemporal pattern generation in the neocortex.	Univ Zurich, ETHZ, Inst Neuroinformat, CH-8057 Zurich, Switzerland; Bell Labs, Murray Hill, NJ 07974 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; AT&T; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Hahnloser, RHR (corresponding author), Univ Zurich, ETHZ, Inst Neuroinformat, Winterthurerstr 190, CH-8057 Zurich, Switzerland.			Hahnloser, Richard/0000-0002-4039-7773				ABBOTT LF, 1994, Q REV BIOPHYS, V27, P291, DOI 10.1017/S0033583500003024; Amari S, 1977, SYSTEMS NEUROSCIENCE, V119, P165, DOI [DOI 10.1016/B978-0-12-491850-4.50009-X, 10.1007/978-3-642-46466-9]; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ANDREOU AG, 1989, NEURAL COMPUTAT, V1; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; DEWEERTH SP, 1995, ELECTRON LETT, V31, P1051, DOI 10.1049/el:19950729; GEORGOPOULOS AP, 1993, SCIENCE, V260, P47, DOI 10.1126/science.8465199; Hahnloser RLT, 1998, NEURAL NETWORKS, V11, P691, DOI 10.1016/S0893-6080(98)00012-4; Hansel D., 1998, METHODS NEURONAL MOD, P499; HOPFIELD JJ, 1985, BIOL CYBERN, V52, P141; Horn R., 1985, MATRIX ANAL; Indiveri G, 1997, ANALOG INTEGR CIRC S, V13, P185, DOI 10.1023/A:1008200515504; KOPECZ K, 1995, BIOL CYBERN, V73, P49, DOI 10.1007/BF00199055; Lazzaro J., 1988, ADV NEURAL INFORMATI, V1, P703; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Mead C. A., 1991, Analog Integrated Circuits and Signal Processing, V1, P93, DOI 10.1007/BF00161303; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Salinas E, 1996, P NATL ACAD SCI USA, V93, P11956, DOI 10.1073/pnas.93.21.11956; Sarpeshkar R, 1998, ANALOG INTEGR CIRC S, V16, P245, DOI 10.1023/A:1008218308069; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Zhang K, 1996, J NEUROSCI, V16, P2112	27	684	702	5	57	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2000	405	6789					947	951		10.1038/35016072	http://dx.doi.org/10.1038/35016072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326JT	10879535				2022-12-24	WOS:000087732700050
J	Chen, KS; Hirst, J; Camba, R; Bonagura, CA; Stout, CD; Burgess, BK; Armstrong, FA				Chen, KS; Hirst, J; Camba, R; Bonagura, CA; Stout, CD; Burgess, BK; Armstrong, FA			Atomically defined mechanism for proton transfer to a buried redox centre in a protein	NATURE			English	Article							AZOTOBACTER-VINELANDII FERREDOXIN; CYTOCHROME-C-OXIDASE; RHODOBACTER-SPHAEROIDES; STRUCTURAL-CHANGES; FILM VOLTAMMETRY; BACTERIORHODOPSIN; RESOLUTION; DYNAMICS; PATHWAYS; ATOMS	The basis of the chemiosmotic theory is that energy from light or respiration is used to generate a trans-membrane proton gradient(1). This is largely achieved by membrane-spanning enzymes known as 'proton pumps'(2-5). There is intense interest in experiments which reveal, at the molecular level, how protons are drawn through proteins(6-13). Here we report the mechanism, at atomic resolution, for a single long-range electron-coupled proton transfer. In Azotobacter vinelandii ferredoxin I, reduction of a buried iron-sulphur cluster draws in a solvent proton, whereas re-oxidation is 'gated' by proton release to the solvent. Studies of this 'proton-transferring module' by fast-scan protein film voltammetry, high-resolution crystallography, site-directed mutagenesis and molecular dynamics, reveal that proton transfer is exquisitely sensitive to the position and pK of a single amino acid. The proton is delivered through the protein matrix by rapid penetrative excursions of the side-chain carboxylate of a surface residue (Asp 15), whose pK shifts in response to the electrostatic charge on the iron-sulphur cluster. Our analysis defines the structural, dynamic and energetic requirements for proton courier groups in redox-driven proton-pumping enzymes.	Univ Oxford, Dept Chem, Oxford OX1 3QR, England; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92612 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of Oxford; University of California System; University of California Irvine; Scripps Research Institute	Armstrong, FA (corresponding author), Univ Oxford, Dept Chem, S Parks Rd, Oxford OX1 3QR, England.	fraser.armstrong@chem.ox.ac.uk	Hirst, Judy/F-4803-2011	Hirst, Judy/0000-0001-8667-6797				Aono S, 1998, BIOCHEMISTRY-US, V37, P9812, DOI 10.1021/bi972818b; Armstrong FA, 1997, CHEM SOC REV, V26, P169, DOI 10.1039/cs9972600169; BANCI L, 1992, J AM CHEM SOC, V114, P10683, DOI 10.1021/ja00053a001; BERATAN DN, 1992, SCIENCE, V258, P1740, DOI 10.1126/science.1334572; Gao-Sheridan HS, 1998, J BIOL CHEM, V273, P33692, DOI 10.1074/jbc.273.50.33692; Gennis RB, 1998, P NATL ACAD SCI USA, V95, P12747, DOI 10.1073/pnas.95.22.12747; Guthrie JP, 1996, J AM CHEM SOC, V118, P12886, DOI 10.1021/ja9618614; GUTMAN M, 1995, BBA-BIOENERGETICS, V1231, P123, DOI 10.1016/0005-2728(95)00074-S; Hirst J, 1998, J AM CHEM SOC, V120, P7085, DOI 10.1021/ja980380c; HU ZG, 1994, BIOCHEMISTRY-US, V33, P14475, DOI 10.1021/bi00252a014; Junemann S, 1999, BIOCHEMISTRY-US, V38, P5248, DOI 10.1021/bi9830112; KLINMAN JP, 1989, TRENDS BIOCHEM SCI, V14, P368, DOI 10.1016/0968-0004(89)90010-8; Konstantinov AA, 1997, P NATL ACAD SCI USA, V94, P9085, DOI 10.1073/pnas.94.17.9085; Lubben M, 1999, BIOCHEMISTRY-US, V38, P2048, DOI 10.1021/bi981859k; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Malmstrom BG, 1998, J BIOL INORG CHEM, V3, P339, DOI 10.1007/s007750050242; MEYER E, 1992, PROTEIN SCI, V1, P1543, DOI 10.1002/pro.5560011203; Michel H, 1998, P NATL ACAD SCI USA, V95, P12819, DOI 10.1073/pnas.95.22.12819; Nabedryk E, 1998, BIOCHEMISTRY-US, V37, P14457, DOI 10.1021/bi981139d; Nicholls D.G., 1992, BIOENERGETICS, V2, P22; NOODLEMAN L, 1985, J AM CHEM SOC, V107, P3418, DOI 10.1021/ja00298a004; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Rammelsberg R, 1998, BIOCHEMISTRY-US, V37, P5001, DOI 10.1021/bi971701k; Schipke CG, 1999, BIOCHEMISTRY-US, V38, P8228, DOI 10.1021/bi983008i; SHEN BH, 1993, J BIOL CHEM, V268, P25928; STEPHENS PJ, 1991, BIOCHEMISTRY-US, V30, P3200, DOI 10.1021/bi00227a007; STOUT CD, 1993, J BIOL CHEM, V268, P25920; Stout CD, 1998, J MOL BIOL, V278, P629, DOI 10.1006/jmbi.1998.1732; Wikstrom M, 1998, CURR OPIN STRUC BIOL, V8, P480, DOI 10.1016/S0959-440X(98)80127-9; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	30	138	139	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2000	405	6788					814	817		10.1038/35015610	http://dx.doi.org/10.1038/35015610			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866206				2022-12-24	WOS:000087620600057
J	Meijers-Heijboer, EJ; Verhoog, LC; Brekelmans, CTM; Seynaeve, C; Tilanus-Linthorst, MMA; Wagner, A; Dukel, L; Devilee, P; van den Ouweland, AMW; van Geel, AN; Klijn, JGM				Meijers-Heijboer, EJ; Verhoog, LC; Brekelmans, CTM; Seynaeve, C; Tilanus-Linthorst, MMA; Wagner, A; Dukel, L; Devilee, P; van den Ouweland, AMW; van Geel, AN; Klijn, JGM			Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation	LANCET			English	Article							HEREDITARY BREAST-CANCER; OVARIAN-CANCER; GERMLINE MUTATIONS; DECISION-MAKING; WOMEN; RISK; MASTECTOMY; TAMOXIFEN; SURVIVAL; HISTORY	Background Germline mutations in the BRCA1. and BRCA2 genes highly predispose to breast and ovarian cancer. In families with BRCA1 or BRCA2 mutations, identification of mutation carriers is clinically relevant in view of the options for surveillance and prevention. Methods We assessed presymptomatic DNA testing and prophylactic surgery in 53 consecutive families presenting to the Rotterdam Family Cancer Clinic with a known BRCA1 or BRCA2 mutation. We identified predictors for DNA testing and prophylactic surgery with univariate and multivariate analysis. Findings 682 unaffected individuals with a 50% risk (275 women and 271 men) or with a 25% risk (136 women) for carrying a mutation were identified and offered a DNA test. Presymptomatic DNA testing was requested by 48% (198 of 411) of women and 22% (59 of 271) of men (odds ratio for difference between sexes 3.21 [95% CI 2.27-4.51]; p<0.001). In women, DNA testing was significantly more frequent at young age, in the presence of children, and at high pre-test genetic risk for a mutation. Of the unaffected women with an identified mutation who were eligible for prophylactic surgery, 51% (35 of 68) opted for bilateral mastectomy and 64% (29 of 45) for oophorectomy. Parenthood was a predictor for prophylactic mastectomy but not for prophylactic oophorectomy. Age was significantly associated with prophylactic oophorectomy, but not with prophylactic mastectomy, although there was a tendency towards mastectomy at younger ages. Interpretation In a clinical setting, we show a high demand for BRCA1 and BRCA2 testing by unaffected women at risk, and of prophylactic surgery by unaffected women with the mutation. Young women with children especially opt for DNA testing and prophylactic mastectomy.	Erasmus Univ, Med Ctr Rotterdam, Dr Daniel dan Hoed Klin,Rotterdam Canc Inst, Dept Med Oncol,Family Canc Clin, NL-3075 EA Rotterdam, Netherlands; Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Acad Hosp Rotterdam Dijkzigt, Rotterdam, Netherlands; Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Klijn, JGM (corresponding author), Erasmus Univ, Med Ctr Rotterdam, Dr Daniel dan Hoed Klin,Rotterdam Canc Inst, Dept Med Oncol,Family Canc Clin, Groene Hilledyk 301, NL-3075 EA Rotterdam, Netherlands.		DEVILEE, PETER/ABR-2140-2022					Borgen PI, 1998, ANN SURG ONCOL, V5, P603, DOI 10.1007/BF02303829; Easton DF, 1997, AM J HUM GENET, V61, P120, DOI 10.1086/513891; EASTON DF, 1995, AM J HUM GENET, V56, P265; Eisen A, 1999, NEW ENGL J MED, V340, P137, DOI 10.1056/NEJM199901143400209; Eisinger F, 1999, LANCET, V353, P919, DOI 10.1016/S0140-6736(98)07516-3; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FORD D, 1994, LANCET, V343, P992; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; Jacobsen PB, 1997, PSYCHOSOM MED, V59, P459, DOI 10.1097/00006842-199709000-00001; Klijn JGM, 1997, EUR J CANCER, V33, P2149, DOI 10.1016/S0959-8049(97)00360-2; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; Lerman C, 1998, J CLIN ONCOL, V16, P1650, DOI 10.1200/JCO.1998.16.5.1650; LERMAN C, 1995, AM J MED GENET, V57, P385, DOI 10.1002/ajmg.1320570304; Lynch HT, 1997, CANCER, V79, P2219, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2219::AID-CNCR21>3.0.CO;2-Y; Lynch HT, 1999, CANCER GENET CYTOGEN, V109, P91, DOI 10.1016/S0165-4608(98)00165-4; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Offit K, 1996, J CLIN ONCOL, V14, P1730, DOI 10.1200/JCO.1996.14.5.1730; PIVER MS, 1993, CANCER-AM CANCER SOC, V71, P2751, DOI 10.1002/1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO;2-J; Powles T, 1998, LANCET, V352, P98; Rosenthal A, 1998, SEMIN ONCOL, V25, P315; SHRAG D, 1997, NEW ENGL J MED, V336, P1465; STEFANEK ME, 1995, PREV MED, V24, P412, DOI 10.1006/pmed.1995.1066; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Verhoog LC, 1998, LANCET, V351, P316, DOI 10.1016/S0140-6736(97)07065-7; Verhoog LC, 1999, J CLIN ONCOL, V17, P3396, DOI 10.1200/JCO.1999.17.11.3396; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; 1999, BREAST CANC INFORMAT; 1999, J NATL CANC I, V91, P1310	29	224	225	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 10	2000	355	9220					2015	2020		10.1016/S0140-6736(00)02347-3	http://dx.doi.org/10.1016/S0140-6736(00)02347-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	322QC	10885351				2022-12-24	WOS:000087519400008
J	Ichise, T; Kano, M; Hashimoto, K; Yanagihara, D; Nakao, K; Shigemoto, R; Katsuki, M; Aiba, A				Ichise, T; Kano, M; Hashimoto, K; Yanagihara, D; Nakao, K; Shigemoto, R; Katsuki, M; Aiba, A			mGLuR1 in cerebellar Purkinje cells essential for long-term depression, synapse elimination, and motor coordination	SCIENCE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; CLIMBING FIBER INNERVATION; MICE LACKING MGLUR1; MUTANT MICE; TRANSGENE EXPRESSION; FUNCTIONAL SYNAPSES; NERVOUS-SYSTEM; IMPAIRMENT; PLASTICITY; REGRESSION	Targeted deletion of metabotropic glutamate receptor-subtype 1 (mGluR1) gene can cause defects in development and function in the Cerebellum, We introduced the mGluR1 alpha transgene into mGluR1-null mutant [mGluR1 (-/-)] mice with a Purkinje cell (PC)-specific promoter, mGluR1-rescue mice showed normal cerebellar long-term depression and regression of multiple climbing fiber innervation, events significantly impaired in mGluR1 (-/-) mice. The impaired motor coordination was rescued by this transgene, in a dose-dependent manner. We propose that mGluR1 in PCs is a key molecule for normal synapse formation, synaptic plasticity, and motor control in the cerebellum.	Univ Tokyo, Inst Med Sci, Ctr Med Expt, Lab DNA Biol & Embryo Engn, Tokyo 1088639, Japan; Kanazawa Univ, CREST, Kanazawa, Ishikawa 9208640, Japan; Kanazawa Univ, Sch Med, Dept Physiol, Kanazawa, Ishikawa 9208640, Japan; Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan; RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; Natl Inst Physiol Sci, Lab Cerebral Struct, Okazaki, Aichi 4448585, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Kanazawa University; Kanazawa University; Toyohashi University of Technology; RIKEN; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Aiba, A (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Med Expt, Lab DNA Biol & Embryo Engn, Tokyo 1088639, Japan.	aiba@ims.u-tokyo.ac.jp	Shigemoto, Ryuichi/E-3628-2013	Shigemoto, Ryuichi/0000-0001-8761-9444; Hashimoto, Kouichi/0000-0002-3884-8213; Kano, Masanobu/0000-0002-0725-3292; Ichise, Taeko/0000-0002-1441-1463; Aiba, Atsu/0000-0002-8192-0778; zhong wei, he gui/0000-0002-3066-3564				AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; CHANGEUX JP, 1973, P NATL ACAD SCI USA, V70, P2974, DOI 10.1073/pnas.70.10.2974; Chen L, 1996, J NEUROSCI, V16, P2829; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; CREPEL F, 1982, TRENDS NEUROSCI, V5, P266, DOI 10.1016/0166-2236(82)90168-0; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FORTIER PA, 1987, EXP BRAIN RES, V66, P271, DOI 10.1007/bf00243304; GRUNER JA, 1980, EXP BRAIN RES, V40, P361; Ito M, 1984, CEREBELLUM NEURAL CO; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Levenes C, 1997, NEUROREPORT, V8, P571, DOI 10.1097/00001756-199701200-00038; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MARIANI J, 1987, NEWS PHYSIOL SCI, V2, P93; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; OKAMOTO N, 1994, J BIOL CHEM, V269, P1231; ORLOVSKII G. N., 1966, BIOFIZIKA, V11, P509; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; SMEYNE RJ, 1991, SCIENCE, V254, P719, DOI 10.1126/science.1948052; SMEYNE RJ, 1995, MOL CELL NEUROSCI, V6, P230, DOI 10.1006/mcne.1995.1019; Smitt PS, 2000, NEW ENGL J MED, V342, P21, DOI 10.1056/NEJM200001063420104; UDO M, 1980, J NEUROPHYSIOL, V44, P119, DOI 10.1152/jn.1980.44.1.119	29	317	320	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2000	288	5472					1832	1835		10.1126/science.288.5472.1832	http://dx.doi.org/10.1126/science.288.5472.1832			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	322HH	10846166				2022-12-24	WOS:000087503800052
J	MacDonald, AW; Cohen, JD; Stenger, VA; Carter, CS				MacDonald, AW; Cohen, JD; Stenger, VA; Carter, CS			Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control	SCIENCE			English	Article							ERROR-DETECTION; WORKING-MEMORY; NEURAL SYSTEM; STROOP TASK; ATTENTION; COMPENSATION; PERFORMANCE; ACTIVATION; SELECTION; BEHAVIOR	Theories of the regulation of cognition suggest a system with two necessary components: one to implement control and another to monitor performance and signal when adjustments in control are needed. Event-related functional magnetic resonance imaging and a task-switching version of the Stroop task were used to examine whether these components of cognitive control have distinct neural bases in the human brain. A double dissociation was found. During task preparation, the left dorsolateral prefrontal cortex (Brodmann's area 9) was more active for color naming than for word reading, consistent with a role in the implementation of control. In contrast, the anterior cingulate cortex (Brodmann's areas 24 and 32) was more active when responding to incongruent stimuli, consistent with a role in performance monitoring.	Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Med Ctr, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Dept Radiol, Pittsburgh, PA 15213 USA; Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Princeton University	Carter, CS (corresponding author), Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA.	cartercs@msx.upmc.edu	MacDonald, Angus/M-9855-2016	MacDonald, Angus/0000-0003-4588-931X				Baddeley Alan, 1996, Quarterly Journal of Experimental Psychology Section A Human Experimental Psychology, V49, P5, DOI 10.1080/027249896392784; Baker SC, 1996, CEREB CORTEX, V6, P612, DOI 10.1093/cercor/6.4.612; Barch DM, 1997, NEUROPSYCHOLOGIA, V35, P1373, DOI 10.1016/S0028-3932(97)00072-9; BENCH CJ, 1993, NEUROPSYCHOLOGIA, V31, P907, DOI 10.1016/0028-3932(93)90147-R; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 1995, NEUROIMAGE, V2, P264, DOI 10.1006/nimg.1995.1034; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Cohen JD, 2000, NAT NEUROSCI, V3, P421, DOI 10.1038/74783; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; COHEN JD, 1990, PSYCHOL REV, V97, P332, DOI 10.1037/0033-295X.97.3.332; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Fletcher PC, 1998, BRAIN, V121, P1239, DOI 10.1093/brain/121.7.1239; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; George M S, 1994, Hum Brain Mapp, V1, P194, DOI 10.1002/hbm.460010305; GOLDMANRAKIC PS, 1991, AM PSYCHOP, P1; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; MCLEOD CM, 1991, PSYCHOL BULL, V109, P163; NOLL DC, 1995, JMRI-J MAGN RESON IM, V5, P49, DOI 10.1002/jmri.1880050112; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; PETRIDES M, 1995, J NEUROSCI, V15, P359; POWERS WT, 1973, SCIENCE, V179, P351, DOI 10.1126/science.179.4071.351; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; TZELGOV J, 1992, MEM COGNITION, V20, P727, DOI 10.3758/BF03202722; VENDRELL P, 1995, NEUROPSYCHOLOGIA, V33, P341, DOI 10.1016/0028-3932(94)00116-7; Weiner N., 1948, CYBERNETICS; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027	34	2718	2771	13	356	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2000	288	5472					1835	1838		10.1126/science.288.5472.1835	http://dx.doi.org/10.1126/science.288.5472.1835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	322HH	10846167				2022-12-24	WOS:000087503800053
J	Xu, RX; Hassell, AM; Vanderwall, D; Lambert, MH; Holmes, WD; Luther, MA; Rocque, WJ; Milburn, MV; Zhao, YD; Ke, HM; Nolte, RT				Xu, RX; Hassell, AM; Vanderwall, D; Lambert, MH; Holmes, WD; Luther, MA; Rocque, WJ; Milburn, MV; Zhao, YD; Ke, HM; Nolte, RT			Atomic structure of PDE4: Insights into phosphodiesterase mechanism and specificity	SCIENCE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; AMP PHOSPHODIESTERASE; DEPENDENT ACTIVATION; CATALYTIC DOMAIN; BINDING; (R)-ROLIPRAM; EXPRESSION; INHIBITORS	Cyclic nucleotides are second messengers that are essential in vision, muscle contraction, neurotransmission, exocytosis, cell growth, and differentiation. These molecules are degraded by a family of enzymes known as phosphodiesterases, which serve a critical function by regulating the intracellular concentration of cyclic nucleotides. We have determined the three-dimensional structure of the catalytic domain of phosphodiesterase 4B2B to 1.77 angstrom resolution. The active site has been identified and contains a cluster of two metal atoms. The structure suggests the mechanism of action and basis for specificity and will provide a framework for structure-assisted drug design for members of the phosphodiesterase family.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Glaxo Wellcome Res & Dev Ltd, Dept Struct Chem, Res Triangle Pk, NC 27709 USA; Glaxo Wellcome Res & Dev Ltd, Dept Mol Sci, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; GlaxoSmithKline; GlaxoSmithKline	Nolte, RT (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.		ID, IMCACAT/D-5867-2014	Vanderwall, Dana/0000-0003-1076-8788	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI133072, R01AI033072] Funding Source: NIH RePORTER; NIAID NIH HHS [AI33072] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Atienza JM, 1999, J BIOL CHEM, V274, P4839, DOI 10.1074/jbc.274.8.4839; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUTT E, 1995, MOL PHARMACOL, V47, P340; CALLAHAN SM, 1995, J BIOL CHEM, V270, P17627, DOI 10.1074/jbc.270.29.17627; Conti M, 2000, PROG NUCLEIC ACID RE, V63, P1; CONTI M, 1991, ENDOCR REV, V12, P218, DOI 10.1210/edrv-12-3-218; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; FRANCIS SH, 1994, J BIOL CHEM, V269, P22477; Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5; Houslay MD, 1998, ADV PHARMACOL, V44, P225, DOI 10.1016/S1054-3589(08)60128-3; Houslay MD, 1998, SEMIN CELL DEV BIOL, V9, P161, DOI 10.1006/scdb.1997.0221; JIN SLC, 1992, J BIOL CHEM, V267, P18929; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LIVI GP, 1990, MOL CELL BIOL, V10, P2678, DOI 10.1128/MCB.10.6.2678; LONDESBOROUGH J, 1985, BIOCHEM J, V225, P143, DOI 10.1042/bj2250143; Loughney K, 1999, GENE, V234, P109, DOI 10.1016/S0378-1119(99)00171-7; MANGANIELLO VC, 1995, ARCH BIOCHEM BIOPHYS, V322, P1, DOI 10.1006/abbi.1995.1429; MARCEL MM, 1981, INVAS METAST, V1, P195; MARCHMONT RJ, 1980, NATURE, V286, P904, DOI 10.1038/286904a0; Omburo GA, 1998, CELL SIGNAL, V10, P491, DOI 10.1016/S0898-6568(97)00175-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Percival MD, 1997, BIOCHEM BIOPH RES CO, V241, P175, DOI 10.1006/bbrc.1997.7542; Rocque WJ, 1997, BIOCHEMISTRY-US, V36, P14250, DOI 10.1021/bi971112e; Rocque WJ, 1997, PROTEIN EXPRES PURIF, V9, P191, DOI 10.1006/prep.1996.0683; Teixeira MM, 1997, TRENDS PHARMACOL SCI, V18, P164, DOI 10.1016/S0165-6147(97)90613-1; TORPHY TJ, 1997, ASTHMA, V2, P1755; Turko IV, 1998, J BIOL CHEM, V273, P6460, DOI 10.1074/jbc.273.11.6460; WEISHAAR RE, 1985, J MED CHEM, V28, P537, DOI 10.1021/jm50001a001; WILKINSON I, 1997, PHARM REV COMMUN, V9, P215; Zhao AZ, 1997, ADV SEC MESS PHOSPH, V31, P237	33	283	300	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2000	288	5472					1822	1825		10.1126/science.288.5472.1822	http://dx.doi.org/10.1126/science.288.5472.1822			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	322HH	10846163				2022-12-24	WOS:000087503800049
J	Mourrain, P; Beclin, C; Elmayan, T; Feuerbach, F; Godon, C; Morel, JB; Jouette, D; Lacombe, AM; Nikic, S; Picault, N; Remoue, K; Sanial, M; Vo, TA; Vaucheret, H				Mourrain, P; Beclin, C; Elmayan, T; Feuerbach, F; Godon, C; Morel, JB; Jouette, D; Lacombe, AM; Nikic, S; Picault, N; Remoue, K; Sanial, M; Vo, TA; Vaucheret, H			Arabidopsis SGS2 and SGS3 genes are required for posttranscriptional gene silencing and natural virus resistance	CELL			English	Article							DEPENDENT RNA-POLYMERASE; DOUBLE-STRANDED-RNA; CHALCONE SYNTHASE; DNA METHYLATION; CO-SUPPRESSION; ANTISENSE RNA; TOMATO LEAVES; TRANSGENE; PLANTS; EXPRESSION	Posttranscriptional gene silencing (PTGS) in plants results from the degradation of mRNAs and shows phenomenological similarities with quelling in fungi and RNAi in animals. Here, we report the isolation of sgs2 and sgs3 Arabidopsis mutants impaired in PTGS. We establish a mechanistic link between PTGS, quelling, and RNAi since the Arabidopsis SGS2 protein is similar to an RNA-dependent RNA polymerase like N. crassa QDE-1, controlling quelling, and C. elegans EGO-1, controlling RNAi. In contrast, SGS3 shows no significant similarity with any known or putative protein, thus defining a specific step of PTGS in plants. Both sgs2 and sgs3 mutants show enhanced susceptibility to virus, definitively proving that PTGS is an antiviral defense mechanism that can also target transgene RNA for degradation.	INRA, Biol Cellulaire Lab, F-78026 Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Beclin, C (corresponding author), INRA, Biol Cellulaire Lab, F-78026 Versailles, France.	beclin@versailles.inra.fr	PICAULT, Nathalie N/M-1476-2015; Mourrain, Philippe/N-4671-2017; PICAULT, Nathalie/ABB-1755-2021	PICAULT, Nathalie N/0000-0003-2770-9688; PICAULT, Nathalie/0000-0003-2770-9688; feuerbach, frank/0000-0002-8631-5120; sanial, matthieu/0000-0002-0301-4710; VAUCHERET, HERVE/0000-0002-9986-0988; beclin, christophe/0000-0003-1923-7238				Al-Kaff NS, 1998, SCIENCE, V279, P2113, DOI 10.1126/science.279.5359.2113; Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; Anandalakshmi R, 1998, P NATL ACAD SCI USA, V95, P13079, DOI 10.1073/pnas.95.22.13079; ASTIERMA.S, 1971, BIOCHIM BIOPHYS ACTA, V232, P484, DOI 10.1016/0005-2787(71)90602-2; Baulcombe DC, 1996, PLANT MOL BIOL, V32, P79, DOI 10.1007/BF00039378; BECKER D, 1990, NUCLEIC ACIDS RES, V18, P203, DOI 10.1093/nar/18.1.203; Beclin C, 1998, VIROLOGY, V252, P313, DOI 10.1006/viro.1998.9457; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; CHOI S, 1995, PLANT MOL BIOL REP, V13, P124, DOI 10.1007/BF02668782; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; DOUGHERTY WG, 1995, CURR OPIN CELL BIOL, V7, P399, DOI 10.1016/0955-0674(95)80096-4; Elmayan T, 1996, PLANT J, V9, P787, DOI 10.1046/j.1365-313X.1996.9060787.x; Elmayan T, 1998, PLANT CELL, V10, P1747, DOI 10.1105/tpc.10.10.1747; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hamilton AJ, 1998, PLANT J, V15, P737, DOI 10.1046/j.1365-313X.1998.00251.x; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; Lohmann JU, 1999, DEV BIOL, V214, P211, DOI 10.1006/dbio.1999.9407; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Martienssen R, 1998, TRENDS GENET, V14, P263, DOI 10.1016/S0168-9525(98)01518-2; Matallana E., 1992, Methods in Arabidopsis research., P144; Metzlaff M, 1997, CELL, V88, P845, DOI 10.1016/S0092-8674(00)81930-3; Mozo T, 1999, NAT GENET, V22, P271, DOI 10.1038/10334; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Palauqui JC, 1996, PLANT PHYSIOL, V112, P1447, DOI 10.1104/pp.112.4.1447; Palauqui JC, 1998, P NATL ACAD SCI USA, V95, P9675, DOI 10.1073/pnas.95.16.9675; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; PROUD CG, 1995, TRENDS BIOCHEM SCI, V20, P241, DOI 10.1016/S0968-0004(00)89025-8; Que QD, 1997, PLANT CELL, V9, P1357, DOI 10.1105/tpc.9.8.1357; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Ratcliff FG, 1999, PLANT CELL, V11, P1207, DOI 10.1105/tpc.11.7.1207; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Scheid OM, 1998, P NATL ACAD SCI USA, V95, P632, DOI 10.1073/pnas.95.2.632; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11851; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Stam M, 1997, PLANT J, V12, P63, DOI 10.1046/j.1365-313X.1997.12010063.x; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; VANBLOKLAND R, 1994, PLANT J, V6, P861, DOI 10.1046/j.1365-313X.1994.6060861.x; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; VANDERMEER J, 1984, VIROLOGY, V132, P413, DOI 10.1016/0042-6822(84)90046-1; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016	57	807	903	1	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 26	2000	101	5					533	542		10.1016/S0092-8674(00)80863-6	http://dx.doi.org/10.1016/S0092-8674(00)80863-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850495	Bronze			2022-12-24	WOS:000087375400010
J	Borovikova, LV; Ivanova, S; Zhang, MH; Yang, H; Botchkina, GI; Watkins, LR; Wang, HC; Abumrad, N; Eaton, JW; Tracey, KJ				Borovikova, LV; Ivanova, S; Zhang, MH; Yang, H; Botchkina, GI; Watkins, LR; Wang, HC; Abumrad, N; Eaton, JW; Tracey, KJ			Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; SUBDIAPHRAGMATIC VAGOTOMY; TRANSDERMAL NICOTINE; BRAIN COMMUNICATION; ULCERATIVE-COLITIS; MONONUCLEAR-CELLS; ACTIVATION; ALPHA; INTERLEUKIN-1; MEDIATION	Vertebrates achieve internal homeostasis during infection or injury by balancing the activities of proinflammatory and anti-inflammatory pathways. Endotoxin (lipopolysaccharide), produced by all gram-negative bacteria, activates macrophages to release cytokines that are potentially lethal(1-4). The central nervous system regulates systemic inflammatory responses to endotoxin through humoral mechanisms(5-8). Activation of afferent vagus nerve fibres by endotoxin or cytokines stimulates hypothalamic-pituitary-adrenal anti-inflammatory responses(9-11). However, comparatively little is known about the role of efferent vagus nerve signalling in modulating inflammation. Here, we describe a previously unrecognized, parasympathetic anti-inflammatory pathway by which the brain modulates systemic inflammatory responses to endotoxin. Acetylcholine, the principle vagal neurotransmitter, significantly attenuated the release of cytokines (tumour necrosis factor (TNF), interleukin (IL)-1 beta, IL-6 and IL-18), but not the anti-inflammatory cytokine IL-10, in lipopolysaccharide-stimulated human macrophage cultures. Direct electrical stimulation of the peripheral vagus nerve in vivo during lethal endotoxaemia in rats inhibited TNF synthesis in liver, attenuated peak serum TNF amounts, and prevented the development of shock.	Picower Inst Med Res, Manhasset, NY 11030 USA; Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; N Shore Univ Hosp, Dept Emergency Med, Manhasset, NY 11030 USA; N Shore Univ Hosp, Dept Surg, Manhasset, NY 11030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Northwell Health; University of Colorado System; University of Colorado Boulder; Northwell Health; North Shore University Hospital; Northwell Health; North Shore University Hospital; Baylor College of Medicine	Borovikova, LV (corresponding author), Picower Inst Med Res, Manhasset, NY 11030 USA.	lborovikova@mindspring.com; kjtracey@sprynet.com	Wang, Haichao/K-6310-2012; Wang, Haichao/AAU-2237-2021	Wang, Haichao/0000-0002-0211-9000; Wang, Haichao/0000-0002-0211-9000; Tracey, Kevin J/0000-0003-1884-6314				ANTONICA A, 1994, J AUTONOM NERV SYST, V48, P187, DOI 10.1016/0165-1838(94)90047-7; BESEDOVSKY H, 1986, SCIENCE, V233, P652, DOI 10.1126/science.3014662; DINARELLO CA, 1994, FASEB J, V8, P1314, DOI 10.1096/fasebj.8.15.8001745; Fleshner M, 1998, J NEUROIMMUNOL, V86, P134, DOI 10.1016/S0165-5728(98)00026-5; GAYKEMA RPA, 1995, ENDOCRINOLOGY, V136, P4717, DOI 10.1210/en.136.10.4717; Gregory SH, 1998, IMMUNOL TODAY, V19, P507, DOI 10.1016/S0167-5699(98)01319-X; Guslandi M, 1999, BRIT J CLIN PHARMACO, V48, P481; HU XX, 1991, J NEUROIMMUNOL, V31, P35, DOI 10.1016/0165-5728(91)90084-K; Kumins NH, 1996, SHOCK, V5, P385, DOI 10.1097/00024382-199605000-00012; Lipton JM, 1997, IMMUNOL TODAY, V18, P140, DOI 10.1016/S0167-5699(97)01009-8; Madretsma GS, 1996, IMMUNOPHARMACOLOGY, V35, P47, DOI 10.1016/0162-3109(96)00122-1; NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815; Romanovsky AA, 1997, AM J PHYSIOL-REG I, V273, pR407, DOI 10.1152/ajpregu.1997.273.1.R407; Sandborn WJ, 1997, ANN INTERN MED, V126, P364, DOI 10.7326/0003-4819-126-5-199703010-00004; Sato E, 1998, AM J PHYSIOL-LUNG C, V274, pL970, DOI 10.1152/ajplung.1998.274.6.L970; Sato KZ, 1999, NEUROSCI LETT, V266, P17, DOI 10.1016/S0304-3940(99)00259-1; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Sher ME, 1999, INFLAMM BOWEL DIS, V5, P73, DOI 10.1097/00054725-199905000-00001; Sternberg EM, 1997, J CLIN INVEST, V100, P2641, DOI 10.1172/JCI119807; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; van Dijk APM, 1998, EUR J CLIN INVEST, V28, P664; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; WATHEY JC, 1979, BIOPHYS J, V27, P145, DOI 10.1016/S0006-3495(79)85208-X; WATKINS LR, 1995, NEUROSCI LETT, V183, P27, DOI 10.1016/0304-3940(94)11105-R; Watkins LR, 1999, P NATL ACAD SCI USA, V96, P7710, DOI 10.1073/pnas.96.14.7710; WHALEY K, 1981, NATURE, V293, P580, DOI 10.1038/293580a0; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808	28	2645	3001	25	303	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					458	462		10.1038/35013070	http://dx.doi.org/10.1038/35013070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839541				2022-12-24	WOS:000087212000049
J	Peipert, JF				Peipert, JF			Ambulatory gynecology	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BACTERIAL VAGINOSIS; COST-EFFECTIVENESS; PRETERM BIRTH; HIV-INFECTION; VAGINAL FLORA; METRONIDAZOLE; TECHNOLOGIES; DISTURBANCES; PREGNANCY; WOMEN		Brown Univ, Sch Med, Women & Infants Hosp,Div Res Womens Hlth, Dept Obstet Gynecol & Community Hlth, Providence, RI 02912 USA	Brown University; Women & Infants Hospital Rhode Island	Peipert, JF (corresponding author), Women & Infants Hosp, Dept Obstet & Gynecol, 101 Dudley St, Providence, RI 02905 USA.							*AG HLTH CAR POL R, 1999, 5 AG HLTH CAR POL RE; Brown AD, 1999, JAMA-J AM MED ASSOC, V281, P347, DOI 10.1001/jama.281.4.347; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; Diaz-Rosario LA, 1999, ARCH PATHOL LAB MED, V123, P817; Grimes D, 1998, LANCET, V352, P428; Hauth JC, 1995, NEW ENGL J MED, V333, P1732, DOI 10.1056/NEJM199512283332603; HILLIER S, 1999, SEXUALLY TRANSMITTED, P563; MARTIUS J, 1988, OBSTET GYNECOL, V71, P89; MORALES WJ, 1994, AM J OBSTET GYNECOL, V171, P345, DOI 10.1016/S0002-9378(94)70033-8; Oleen-Burkey M A, 1995, Infect Dis Obstet Gynecol, V3, P149, DOI 10.1155/S1064744995000500; Raab SS, 1999, AM J CLIN PATHOL, V111, P259; Royce RA, 1999, J ACQ IMMUN DEF SYND, V20, P382, DOI 10.1097/00042560-199904010-00009; Sawaya GF, 1999, CLIN OBSTET GYNECOL, V42, P922, DOI 10.1097/00003081-199912000-00020; Sawaya GF, 1999, OBSTET GYNECOL, V94, P307, DOI 10.1016/S0029-7844(99)00289-6; Taha TE, 1999, J ACQ IMMUN DEF SYND, V20, P52, DOI 10.1097/00042560-199901010-00008; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Trussell J, 2000, OBSTET GYNECOL, V95, P267, DOI 10.1016/S0029-7844(99)00518-9; *US PREV SERV TASK, 1995, GUID CLIN PREV SERV	18	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2000	283	20					2630	2632		10.1001/jama.283.20.2630	http://dx.doi.org/10.1001/jama.283.20.2630			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314FP	10819923				2022-12-24	WOS:000087046000002
J	Boot, BP; McGregor, LS; Hall, W				Boot, BP; McGregor, LS; Hall, W			MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks	LANCET			English	Editorial Material							POSITRON-EMISSION-TOMOGRAPHY; BRAIN-SEROTONIN NEURONS; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; (+/-)3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; COGNITIVE PERFORMANCE; RECREATIONAL USE; MEMORY DEFICITS; HUMANS; MOOD; DRUG		Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia; Univ Sydney, Dept Psychol, Sydney, NSW 2006, Australia; Univ Sydney, Fac Med, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney; University of Sydney	Hall, W (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia.	w.hall@unsw.edu.au	Hall, Wayne D/A-3283-2008	Hall, Wayne D/0000-0003-1984-0096				ALLEN RP, 1993, SLEEP, V16, P560, DOI 10.1093/sleep/16.6.560; Bolla KI, 1998, NEUROLOGY, V51, P1532, DOI 10.1212/WNL.51.6.1532; Brody S, 1998, PSYCHOPHARMACOLOGY, V136, P390, DOI 10.1007/s002130050582; CALAFAT A, 1998, CHARACTERISTICS SOCI; Chappell W, 1991, ADV DRUG RES; Cohen Richard, 1998, LOVE DRUG MARCHING B; Colado MI, 1999, BRIT J PHARMACOL, V126, P911, DOI 10.1038/sj.bjp.0702373; Curran HV, 1997, ADDICTION, V92, P821, DOI 10.1111/j.1360-0443.1997.tb02951.x; Dafters RI, 1998, PSYCHOPHARMACOLOGY, V138, P207, DOI 10.1007/s002130050664; Dafters RI, 1999, PSYCHOPHARMACOLOGY, V145, P82, DOI 10.1007/s002130051035; FEACHEM RGA, 1995, VALUING PAST INVESTI; FISCHER C, 1995, J NEUROSCI, V15, P5476; Frederick DL, 1997, NEUROSCI BIOBEHAV R, V21, P67, DOI 10.1016/0149-7634(95)00064-X; Gerra G, 1998, INT CLIN PSYCHOPHARM, V13, P1, DOI 10.1097/00004850-199801000-00001; Gerra G, 2000, BIOL PSYCHIAT, V47, P127, DOI 10.1016/S0006-3223(99)00180-8; Gijsman HJ, 1999, NEUROPSYCHOPHARMACOL, V21, P597; Hatzidimitriou G, 1999, J NEUROSCI, V19, P5096; Hegadoren KM, 1999, NEUROSCI BIOBEHAV R, V23, P539, DOI 10.1016/S0149-7634(98)00046-3; Malberg JE, 1998, J NEUROSCI, V18, P5086; Marston HM, 1999, PSYCHOPHARMACOLOGY, V144, P67, DOI 10.1007/s002130050978; MCCANN UD, 1993, J CLIN PSYCHOPHARM, V13, P214; McCann UD, 1999, PSYCHOPHARMACOLOGY, V147, P56, DOI 10.1007/s002130051142; McCann UD, 1997, JAMA-J AM MED ASSOC, V278, P666, DOI 10.1001/jama.278.8.666; McCann UD, 1999, PSYCHOPHARMACOLOGY, V143, P417, DOI 10.1007/s002130050967; McCann UD, 1998, LANCET, V352, P1433, DOI 10.1016/S0140-6736(98)04329-3; MCCANN UD, 1994, NEUROPSYCHOPHARMACOL, V10, P129, DOI 10.1038/npp.1994.15; McElhatton PR, 1999, LANCET, V354, P1441, DOI 10.1016/S0140-6736(99)02423-X; Morgan MJ, 1998, NEUROPSYCHOPHARMACOL, V19, P252, DOI 10.1016/S0893-133X(98)00012-8; Morgan MJ, 1999, PSYCHOPHARMACOLOGY, V141, P30, DOI 10.1007/s002130050803; Obrocki J, 1999, BRIT J PSYCHIAT, V175, P186, DOI 10.1192/bjp.175.2.186; Parrott AC, 1998, J PSYCHOPHARMACOL, V12, P79, DOI 10.1177/026988119801200110; Parrott AC, 1998, PSYCHOPHARMACOLOGY, V139, P261, DOI 10.1007/s002130050714; PEROUTKA SJ, 1987, RES COMMUN SUBSTANCE, V8, P125; PRICE LH, 1989, ARCH GEN PSYCHIAT, V46, P20; Reed LJ, 1999, LANCET, V353, P1268, DOI 10.1016/S0140-6736(99)80066-X; RICAURTE GA, 1988, BRAIN RES, V446, P165, DOI 10.1016/0006-8993(88)91309-1; RICAURTE GA, 1990, ANN NY ACAD SCI, V600, P699; SAUNDERS N., 1996, ECSTASY DANCE TRANCE; Scheffel U, 1998, SYNAPSE, V29, P183, DOI 10.1002/(SICI)1098-2396(199806)29:2<183::AID-SYN9>3.0.CO;2-3; Schifano F, 1998, DRUG ALCOHOL DEPEN, V52, P85, DOI 10.1016/S0376-8716(98)00051-9; SEMLE DM, 1999, BRIT J PSYCHIAT, V175, P63; SOLOWIJ N, 1992, BRIT J ADDICT, V87, P1161; SOUBRIE P, 1986, BEHAV BRAIN SCI, V9, P319, DOI 10.1017/S0140525X00022871; Sprague JE, 1998, NEUROTOXICOLOGY, V19, P427; Staley JK, 1998, BIOL PSYCHIAT, V44, P534, DOI 10.1016/S0006-3223(98)00185-1; Topp L, 1999, DRUG ALCOHOL DEPEN, V55, P105, DOI 10.1016/S0376-8716(99)00002-2; Vollenweider FX, 1999, NEUROPSYCHOPHARMACOL, V21, P598	47	66	66	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2000	355	9217					1818	1821		10.1016/S0140-6736(00)02276-5	http://dx.doi.org/10.1016/S0140-6736(00)02276-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	315RE	10832852				2022-12-24	WOS:000087126100049
J	Hotopf, M; David, A; Hull, L; Ismail, K; Unwin, C; Wessely, S				Hotopf, M; David, A; Hull, L; Ismail, K; Unwin, C; Wessely, S			Role of vaccinations as risk factors for ill health in veterans of the Gulf war: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article								Objectives To explore the relation between ill health after the Gulf war and vaccines received before or during the conflict To test the hypothesis that such ill health is limited to military personnel who received multiple vaccines during deployment and that pesticide use modifies any effect. Design Cross sectional study of Gulf war veterans followed for six to eight years after deployment Setting UK armed forces. Participants Military personnel who served in the Gulf and who still had their vaccine records. Main outcome measures Multisymptom illness as classified by the Centers for Disease Control and Prevention; fatigue; psychological distress; post-traumatic stress reaction; health perception; and physical functioning Results The response rate for the original survey was 70.4% (n = 3284). Of these, 28% (923) had vaccine records. Receipt of multiple vaccines before deployment was associated with only one of the six health outcomes (post-traumatic stress reaction). By contrast five of the six outcomes tall but post-traumatic stress reaction) were associated with multiple vaccines received during deployment. The strongest association was for the multisymptom illness (odds ratio 5.0; 95% confidence interval 2.5 to 9.8). Conclusion Among veterans of the Gulf war there is a specific relation between multiple vaccinations given during deployment and later ill health. Multiple vaccinations in themselves do not seem to be harmful but combined with the "stress" of deployment they may be associated with adverse health outcomes. These results imply that every effort should be made to maintain routine vaccines during peacetime.	Kings Coll London, Guys Kings Coll, Gulf War Res Unit, London SE5 8AZ, England; Kings Coll London, St Thomass Sch Med, London SE5 8AZ, England	University of London; King's College London; University of London; King's College London	Hotopf, M (corresponding author), Kings Coll London, Guys Kings Coll, Gulf War Res Unit, London SE5 8AZ, England.	m.hotopf@iop.kcl.ac.uk	David, Anthony/O-1750-2019; Wessely, Simon C/A-8713-2008; Hotopf, Matthew/E-4971-2010; David, Anthony S/C-1315-2011	David, Anthony/0000-0003-0967-774X; David, Anthony S/0000-0003-0967-774X; Wessely, Simon Charles/0000-0002-6743-9929; Hotopf, Matthew/0000-0002-3980-4466; Ismail, Khalida/0000-0001-6084-449X				CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Goldberg DP., 1972, DETECTION PSYCHIAT I; GRIFFITHS GD, 1999, C FED SPONS GULF WAR; Rook GAW, 1997, LANCET, V349, P1831, DOI 10.1016/S0140-6736(97)01164-1; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; Wessely S, 1998, CHRONIC FATIGUE ITS	8	122	124	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 20	2000	320	7246					1363	1367		10.1136/bmj.320.7246.1363	http://dx.doi.org/10.1136/bmj.320.7246.1363			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	317NY	10818024	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000087232500019
J	Dong, C; Yang, DD; Tournier, C; Whitmarsh, AJ; Xu, J; Davis, RJ; Flavell, RA				Dong, C; Yang, DD; Tournier, C; Whitmarsh, AJ; Xu, J; Davis, RJ; Flavell, RA			JNK is required for effector T-cell function but not for T-cell activation	NATURE			English	Article							KINASE; DIFFERENTIATION	The hallmark of T-cell activation is the production of interleukin 2 (IL-2). c-Jun amino-terminal kinase (JNK), a MAP kinase that phosphorylates c-Jun and other components of the AP-1 group of transcription factors(1,2), has been implicated in the activation of IL-2 expression(3,4). Previously, we found that T cells from mice deficient in the Jnk1 or Jnk2 gene can be activated and produce IL-2 normally, but are deficient in functional differentiation into Th1 or Th2 subsets(5,6). However, studies of mice with compound mutations indicate that JNK1 and JNK2 are redundant during mouse development(7). Here we use three new mouse models in which peripheral T cells completely lack JNK proteins or signalling, to test whether the JNK signalling pathway is crucial for IL-2 expression and T-cell activation. Unexpectedly, these T cells made more IL-2 and proliferated better than wild-type cells. However, production of effector T-cell cytokines did require JNK. Thus, JNK is necessary for T-cell differentiation but not for naive T-cell activation.	Yale Univ, Sch Med, Immunobiol Sect, Howard Hughes Med Inst, New Haven, CT 06520 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Program Mol Med,Howard Hughes Med Inst, Worcester, MA 01605 USA	Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.		dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130; Whitmarsh, Alan/0000-0003-1184-6610				CHOW CW, IN PRESS MOL CELL BI; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Gomez J, 1998, CRIT REV IMMUNOL, V18, P185, DOI 10.1615/CritRevImmunol.v18.i3.20; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Matsuda S, 1998, J BIOL CHEM, V273, P12378, DOI 10.1074/jbc.273.20.12378; NISHINA H, 1997, J EXP MED, V186, P9541; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Rincon M, 1998, J EXP MED, V188, P1817, DOI 10.1084/jem.188.10.1817; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Swat W, 1998, IMMUNITY, V8, P625, DOI 10.1016/S1074-7613(00)80567-1; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Weiss L, 2000, J EXP MED, V191, P139, DOI 10.1084/jem.191.1.139; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8	16	276	291	0	6	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2000	405	6782					91	94		10.1038/35011091	http://dx.doi.org/10.1038/35011091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311TK	10811224				2022-12-24	WOS:000086901600057
J	Biggar, RJ; Frisch, M; Goedert, JJ				Biggar, RJ; Frisch, M; Goedert, JJ		AIDS-Canc Match Registry Study Grp	Risk of cancer in children with AIDS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							KAPOSIS-SARCOMA; HIV-INFECTION; LYMPHOMA; EPIDEMIOLOGY; PEOPLE	Context Population-based data on cancers associated with acquired immunodeficiency syndrome (AIDS) in children are lacking. Objective To determine risk of pediatric AIDS-associated cancers. Design, Setting, and Participants Using records from 11 locations in the United States for varying periods between 1978 and 1996, we linked data for children aged 14 years and younger at AIDS diagnosis to local cancer registry data. Main Outcome Measures Cancer frequency and, in the 2-year post-AIDS onset period, cancer incidence and relative risk (RR; measured as standardized incidence ratio), by cancer type. Results Among 4954 children with AIDS, 124 (2.5%) were identified as having cancer before, at, or after AIDS onset, including 100 cases of non-Hodgkin lymphoma (NHL), 8 of Kaposi sarcoma (KS), 4 of leiomyosarcoma, and 2 of Hodgkin disease; there were 10 other or unspecified cancers. Expected numbers for all cancers identified in the study sample, based on population rates (using area-specific registry data), were less than 1. In the first 2 years after AIDS diagnosis (5485 person-years), NHL incidence was 510 per 100 000 person-years (RR, 651; 95% confidence interval [CI], 432-941). Median time for developing NHL after AIDS diagnosis was 14 months (range, 3-107 months). The most common type of NHL was Burkitt lymphoma. However, the risk of primary brain lymphoma (91 per 100 000 person-years) was especially high (RR, 7143; 95% CI, 2321-16692), and 4 cases were diagnosed more than 2 years (range, 37-98 months) after AIDS onset. Leiomyosarcomas also tended to occur several years after AIDS onset, with 3 of the 4 cases occurring 33 to 76 months after AIDS diagnosis, whereas KS was reported only at or within 2 years of AIDS diagnosis. Hodgkin disease risk was also significantly increased (RR, 62; 95% CI, 2-342). Conclusions The spectrum of AIDS-associated pediatric cancers resembled that seen in adults, with the addition of leiomyosarcoma. Both primary brain lymphomas and leiomyosarcomas tended to occur in children surviving several years after AIDS onset. Because the expected numbers of these cancers in this population were less than 1 and because of the small numbers of some types of observed cancers, the RR estimates are imprecise and caution is warranted in their interpretation.	NCI, VEB, Rockville, MD 20852 USA; Statens Serum Inst, Danish Epidemiol Sci Ctr, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Aarhus University; Statens Serum Institut	Biggar, RJ (corresponding author), NCI, VEB, 6120 Execut Blvd,Room 8014, Rockville, MD 20852 USA.		Frisch, Morten/E-9206-2016	Frisch, Morten/0000-0002-3864-8860	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [Z01CP005781] Funding Source: NIH RePORTER	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics)		BERAL V, 1991, LANCET, V337, P805, DOI 10.1016/0140-6736(91)92513-2; Biggar RJ, 1996, HEMATOL ONCOL CLIN N, V10, P997, DOI 10.1016/S0889-8588(05)70380-4; Breslow NE., 1987, STAT METHODS CANC RE, P81; *CDCP, 1995, HIV AIDS SURV REP, V7, P13; Cote TR, 1996, J NATL CANCER I, V88, P675, DOI 10.1093/jnci/88.10.675; Cote TR, 1997, INT J CANCER, V73, P645, DOI 10.1002/(SICI)1097-0215(19971127)73:5&lt;645::AID-IJC6&gt;3.0.CO;2-X; Evans JA, 1997, ARCH DIS CHILD, V76, P330, DOI 10.1136/adc.76.4.330; Gao SJ, 1996, NAT MED, V2, P925, DOI 10.1038/nm0896-925; Goedert JJ, 1998, LANCET, V351, P1833, DOI 10.1016/S0140-6736(97)09028-4; Granovsky MO, 1998, J CLIN ONCOL, V16, P1729, DOI 10.1200/JCO.1998.16.5.1729; KROGHJENSEN M, 1994, ANN ONCOL, V5, P349, DOI 10.1093/oxfordjournals.annonc.a058839; McClain KL, 1996, HEMATOL ONCOL CLIN N, V10, P1189, DOI 10.1016/S0889-8588(05)70393-2; MELBYE M, 1994, LANCET, V343, P636, DOI 10.1016/S0140-6736(94)92636-0; Percy C., 1990, INT CLASSIFICATION D; PETERMAN TA, 1993, AIDS, V7, P605, DOI 10.1097/00002030-199305000-00001; Serraino D, 1996, AIDS, V10, P643, DOI 10.1097/00002030-199606000-00010	16	99	105	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 12	2000	284	2					205	209		10.1001/jama.284.2.205	http://dx.doi.org/10.1001/jama.284.2.205			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329XE	10889594	Bronze			2022-12-24	WOS:000087933100025
J	Paterson, DL; Swindells, S; Mohr, J; Brester, M; Vergis, EN; Squier, C; Wagener, MM; Singh, N				Paterson, DL; Swindells, S; Mohr, J; Brester, M; Vergis, EN; Squier, C; Wagener, MM; Singh, N			Adherence to protease inhibitor therapy and outcomes in patients with HIV infection	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; MORBIDITY; DISEASE; AIDS	Background: Combination antiretroviral therapy with protease inhibitors has transformed HIV infection from a terminal condition into one that is manageable. However, the complexity of regimens makes adherence to therapy difficult. Objective: To assess the effects of different levels of adherence to therapy on virologic, immunologic, and clinical outcome; to determine modifiable conditions associated with suboptimal adherence; and to determine how well clinicians predict patient adherence. Design: Prospective, observational study. Setting: HIV clinics in a Veterans Affairs medical center and a university medical center. Patients: 99 HIV-infected patients who were prescribed a protease inhibitor and who neither used a medication organizer nor received their medications in an observed setting (such as a jail or nursing home). Measurements: Adherence was measured by using a microelectronic monitoring system. The adherence rate was calculated as the number of doses taken divided by the number prescribed. Patients were followed for a median of 6 months (range, 3 to 15 months). Results: During the study period, 45 397 doses of protease inhibitor were monitored in 81 evaluable patients. Adherence was significantly associated with successful virologic: outcome (P < 0.001) and increase in CD4 lymphocyte count (P = 0.006). Virologic failure was documented in 22% of patients with adherence of 95% or greater, 61% of those with 80% to 94.9% adherence, and 80% of those with less than 80% adherence. Patients with adherence of 95% or greater had fewer days in the hospital (26 days per 1000 days of follow-up) than those with less than 95% adherence (12.9 days per 1000 days of follow-up; P = 0.001). No opportunistic infections or deaths occurred in patients with 95% or greater adherence. Active psychiatric illness was an independent risk factor for adherence less than 95% (P = 0.04), Physicians predicted adherence incorrectly for 41% of patients, and clinic nurses predicted it incorrectly for 30% of patients. Conclusions: Adherence to protease inhibitor therapy of 95% or greater optimized virologic outcome for patients with HIV infection. Diagnosis and treatment of psychiatric illness should be further investigated as a means to improve adherence to therapy.	Univ Pittsburgh, Med Ctr, European Med Div, Pittsburgh, PA 15213 USA; Vet Affairs Med Ctr, Pittsburgh, PA USA; Univ Nebraska, Med Ctr, Omaha, NE USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Nebraska System; University of Nebraska Medical Center	Singh, N (corresponding author), Univ Pittsburgh, Med Ctr, European Med Div, 10th Floor,Forbes Tower,200Lothrop St, Pittsburgh, PA 15213 USA.		Paterson, David L/A-9258-2010	Paterson, David/0000-0003-2079-4437				ANDERSON RJ, 1982, ARCH INTERN MED, V142, P1673, DOI 10.1001/archinte.142.9.1673; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; BANGSBERG DR, 1999, 6 C RETR OPP INF CHI, P84; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BESCH CL, 1997, 4 NAT C RETR OPP INF, P111; BUCHSBAUM DG, 1992, J AM GERIATR SOC, V40, P662, DOI 10.1111/j.1532-5415.1992.tb01956.x; CARNEY RM, 1995, HEALTH PSYCHOL, V14, P88, DOI 10.1037/0278-6133.14.1.88; COONS SJ, 1994, CLIN THER, V16, P110; Deeks S., 1997, 37 INT C ANT AG CHEM; DRAINE J, 1994, J NERV MENT DIS, V182, P50, DOI 10.1097/00005053-199401000-00009; Eldred LJ, 1998, J ACQ IMMUN DEF SYND, V18, P117, DOI 10.1097/00042560-199806010-00003; FERNANDEZ F, 1989, SOUTHERN MED J, V82, P999, DOI 10.1097/00007611-198908000-00018; Gallant J E, 1998, J Int Assoc Physicians AIDS Care, V4, P32; Gatley M S, 1968, J R Coll Gen Pract, V16, P39; Hecht F M, 1998, AIDS Clin Care, V10, P57; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Kastrissios H, 1998, AIDS, V12, P2295, DOI 10.1097/00002030-199817000-00011; Lopez-Suarez A, 1998, AIDS, V12, P685; Lyketsos CG, 1996, AIDS, V10, P1033, DOI 10.1097/00002030-199610090-00015; Malahy B, 1966, Am J Hosp Pharm, V23, P283; Mehta S, 1997, AIDS, V11, P1665, DOI 10.1097/00002030-199714000-00002; Montaner JSG, 1998, LANCET, V352, P1919, DOI 10.1016/S0140-6736(98)07532-1; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PORTER AMW, 1969, BMJ-BRIT MED J, V1, P218, DOI 10.1136/bmj.1.5638.218; PUGH R, 1983, BRIT J MED PSYCHOL, V56, P205, DOI 10.1111/j.2044-8341.1983.tb01548.x; Rodriguez-Rosado R, 1998, AIDS, V12, P1112; SAMET JH, 1992, AM J MED, V92, P495, DOI 10.1016/0002-9343(92)90746-X; Singh N, 1996, AIDS CARE, V8, P261, DOI 10.1080/09540129650125696; Wainberg MA, 1998, JAMA-J AM MED ASSOC, V279, P1977, DOI 10.1001/jama.279.24.1977; WATERHOUSE DM, 1993, J CLIN ONCOL, V11, P1189, DOI 10.1200/JCO.1993.11.6.1189; Young J L, 1986, Bull Am Acad Psychiatry Law, V14, P105; ZICH J, 1987, J APPL SOC PSYCHOL, V17, P193, DOI 10.1111/j.1559-1816.1987.tb00310.x	32	2387	2448	5	119	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 4	2000	133	1					21	30		10.7326/0003-4819-133-1-200007040-00004	http://dx.doi.org/10.7326/0003-4819-133-1-200007040-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329TB	10877736				2022-12-24	WOS:000087923100003
J	Gray, RD; Jordan, FM				Gray, RD; Jordan, FM			Language trees support the express-train sequence of Austronesian expansion	NATURE			English	Article							POLYNESIA; HISTORY; PACIFIC; MTDNA; ANTHROPOLOGY; PREHISTORY; PHYLOGENY; SPEAKING; PATTERNS; ORIGIN	Languages, like molecules, document evolutionary history. Darwin(1) observed that evolutionary change in languages greatly resembled the processes of biological evolution: inheritance from a common ancestor and convergent evolution operate in both. Despite many suggestions(2-4), few attempts have been made to apply the phylogenetic methods used in biology to linguistic data. Here we report a parsimony analysis of a large language data set. We use this analysis to test competing hypotheses - the "express-train''(5) and the "entangled-bank''(6,7) models - for the colonization of the Pacific by Austronesian-speaking peoples. The parsimony analysis of a matrix of 77 Austronesian languages with 5,185 lexical items produced a single most-parsimonious tree. The express-train model was converted into an ordered geographical character and mapped onto the language tree. We found that the topology of the language tree was highly compatible with the express-train model.	Univ Auckland, Dept Psychol, Auckland 92019, New Zealand	University of Auckland	Gray, RD (corresponding author), Univ Auckland, Dept Psychol, Auckland 92019, New Zealand.		Gray, Russell/H-2078-2015	Gray, Russell/0000-0002-9858-0191				[Anonymous], 1997, GUNS GERMS STEEL; BATEMAN R, 1990, CURR ANTHROPOL, V31, P1, DOI 10.1086/203800; BELLWOOD P, 1991, SCI AM, V265, P88, DOI 10.1038/scientificamerican0791-88; Bellwood Peter, 1997, PREHISTORY INDOMALAY; BLUST R, 1995, J WORLD PREHIST, V9, P453, DOI 10.1007/BF02221119; BLUST R, 1991, CURRENTS PACIFIC LIN, P27; Crowley T., 1997, INTRO HIST LINGUISTI, V3; Cunningham CW, 1998, TRENDS ECOL EVOL, V13, P361, DOI 10.1016/S0169-5347(98)01382-2; Darwin C., 1871, P423; DIAMOND JM, 1988, NATURE, V336, P307, DOI 10.1038/336307a0; Green RC., 1999, B INDOPACIFIC PREHIS, V18, P3; HILLIS DM, 1994, SCIENCE, V264, P671, DOI 10.1126/science.8171318; KIRCH PV, 1987, CURR ANTHROPOL, V28, P431, DOI 10.1086/203547; KIRCH PV, 1997, LAPITA PEOPLES; Lum JK, 1998, AM J PHYS ANTHROPOL, V105, P109, DOI 10.1002/(SICI)1096-8644(199802)105:2<109::AID-AJPA1>3.0.CO;2-Q; MACE R, 1994, CURR ANTHROPOL, V35, P549, DOI 10.1086/204317; Maddison W. P., 1992, MACCLADE ANAL PHYLOG; MARTIN A, 1993, NATURE, V364, P494, DOI 10.1038/364494a0; Matisoo-Smith E, 1998, P NATL ACAD SCI USA, V95, P15145, DOI 10.1073/pnas.95.25.15145; MELTON T, 1995, AM J HUM GENET, V57, P403; MOORE JH, 1994, AM ANTHROPOL, V96, P925, DOI 10.1525/aa.1994.96.4.02a00110; Rossabi Morris, 1994, CENTRAL ASIA HIST PE, P27; Ruvolo M., 1987, P193; SANDERSON MJ, 1989, EVOLUTION, V43, P1781, DOI 10.1111/j.1558-5646.1989.tb02626.x; Swofford D.L., 1999, PHYLOGENETIC ANAL US; TERRELL J, 1988, ANTIQUITY, V62, P642, DOI 10.1017/S0003598X00075049; Terrell J., 1986, PREHISTORY PACIFIC I; Terrell JE, 1997, CURR ANTHROPOL, V38, P155, DOI 10.1086/204604; Warnow T, 1997, P NATL ACAD SCI USA, V94, P6585, DOI 10.1073/pnas.94.13.6585; Weisler MI, 1998, CURR ANTHROPOL, V39, P521, DOI 10.1086/204768	30	242	247	1	39	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 29	2000	405	6790					1052	1055		10.1038/35016575	http://dx.doi.org/10.1038/35016575			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	328VN	10890445	Green Published			2022-12-24	WOS:000087871700045
J	Salonen, JT; Tuomainen, TP; Kontula, K				Salonen, JT; Tuomainen, TP; Kontula, K			Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							INCREASED RISK; HEMOCHROMATOSIS		Univ Kuopio, Publ Hlth Res Inst, FIN-70211 Kuopio, Finland; Univ Kuopio, Dept Publ Hlth & Gen Practice, FIN-70211 Kuopio, Finland; Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland	University of Eastern Finland; University of Eastern Finland; University of Helsinki; Helsinki University Central Hospital	Salonen, JT (corresponding author), Univ Kuopio, Publ Hlth Res Inst, POB 1627, FIN-70211 Kuopio, Finland.				NHLBI NIH HHS [HL44199] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; MerryweatherClarke AT, 1997, J MED GENET, V34, P275, DOI 10.1136/jmg.34.4.275; SALONEN JT, 1995, BRIT MED J, V311, P1124, DOI 10.1136/bmj.311.7013.1124; Tuomainen TP, 1999, CIRCULATION, V100, P1274, DOI 10.1161/01.CIR.100.12.1274; Yaouanq JM, 1995, DIABETES METAB, V21, P319	5	32	34	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1706	1707		10.1136/bmj.320.7251.1706	http://dx.doi.org/10.1136/bmj.320.7251.1706			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10864547	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000087926400025
J	Tevosian, SG; Deconinck, AE; Tanaka, M; Schinke, M; Litovsky, SH; Izumo, S; Fujiwara, Y; Orkin, SH				Tevosian, SG; Deconinck, AE; Tanaka, M; Schinke, M; Litovsky, SH; Izumo, S; Fujiwara, Y; Orkin, SH			FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium	CELL			English	Article							ZINC-FINGER PROTEIN; CARDIAC DEVELOPMENT; SMOOTH-MUSCLE; RXR-ALPHA; VENTRAL MORPHOGENESIS; TRANSGENIC MICE; TUBE FORMATION; MOUSE EMBRYO; AVIAN HEART; DIFFERENTIATION	We disrupted the FOG-2 gene in mice to define its requirement in vivo. FOG-2(-/-) embryos die at midgestation with a cardiac defect characterized by a thin ventricular myocardium, common atrioventricular canal, and the tetralogy of Fallot malformation. Remarkably, coronary vasculature is absent in FOG-2(-/-) hearts. Despite formation of an intact epicardial layer and expression of epicardium-specific genes, markers of cardiac vessel development (ICAM-2 and FLK-1) are not detected, indicative of failure to activate their expression and/or to initiate the epithelial to mesenchymal transformation of epicardial cells. Transgenic reexpression of FOG-2 in cardiomyocytes rescues the FOG-2(-/-) vascular phenotype, demonstrating that FOG-2 function in myocardium is required and sufficient for coronary vessel development. Our findings provide the molecular inroad into the induction of coronary vasculature by myocardium in the developing heart.	Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Cardiol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	orkin@rascal.med.harvard.edu						BALDWIN HS, 1994, DEVELOPMENT, V120, P2539; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Charron F, 1999, SEMIN CELL DEV BIOL, V10, P85, DOI 10.1006/scdb.1998.0281; Chen J, 1998, DEVELOPMENT, V125, P1943; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; Cubadda Y, 1997, GENE DEV, V11, P3083, DOI 10.1101/gad.11.22.3083; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Donovan MJ, 1996, NAT GENET, V14, P210, DOI 10.1038/ng1096-210; DYSON E, 1995, P NATL ACAD SCI USA, V92, P7386, DOI 10.1073/pnas.92.16.7386; Firulli AB, 1998, NAT GENET, V18, P266, DOI 10.1038/ng0398-266; Fishman MC, 1997, DEVELOPMENT, V124, P2099; Gao XP, 1998, MOL CELL BIOL, V18, P2901, DOI 10.1128/MCB.18.5.2901; GELB BD, 1991, AM J MED GENET, V40, P471, DOI 10.1002/ajmg.1320400420; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Gruber PJ, 1996, J CLIN INVEST, V98, P1332, DOI 10.1172/JCI118920; HARVEY RP, 1999, HEART DEV, P111; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; HONG X, 1992, J IMMUNOL, V149, P2650; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; KOMIYAMA M, 1987, ANAT EMBRYOL, V176, P183, DOI 10.1007/BF00310051; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; KWEE L, 1995, DEVELOPMENT, V121, P489; Landerholm TE, 1999, DEVELOPMENT, V126, P2053; Lee RY, 1997, CIRC RES, V80, P757; Lu JR, 1999, MOL CELL BIOL, V19, P4495; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Markwald R, 1996, ACTA ANAT, V156, P173; MIKAWA T, 1992, P NATL ACAD SCI USA, V89, P9504, DOI 10.1073/pnas.89.20.9504; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Moore AW, 1999, DEVELOPMENT, V126, P1845; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; ORKIN SH, 1998, MOL BIOL B CELL T CE; PARMACEK MS, 1999, HEART DEV, P291; Peeters MPFMV, 1999, ANAT EMBRYOL, V199, P367, DOI 10.1007/s004290050235; Pehlivan T, 1999, AM J MED GENET, V83, P201, DOI 10.1002/(SICI)1096-8628(19990319)83:3<201::AID-AJMG11>3.0.CO;2-V; Perez-Pomares JM, 1998, DEV BIOL, V200, P57, DOI 10.1006/dbio.1998.8949; POELMANN RE, 1993, CIRC RES, V73, P559, DOI 10.1161/01.RES.73.3.559; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Shalaby F, 1997, CELL, V89, P981, DOI 10.1016/S0092-8674(00)80283-4; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SRIVASTAVA D, 1999, HEART DEV, P143; Subbarayan V, 2000, J CLIN INVEST, V105, P387, DOI 10.1172/JCI8150; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Svensson EC, 1999, P NATL ACAD SCI USA, V96, P956, DOI 10.1073/pnas.96.3.956; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Tevosian SG, 1999, P NATL ACAD SCI USA, V96, P950, DOI 10.1073/pnas.96.3.950; Tomanek RJ, 1996, CARDIOVASC RES, V31, pE46; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Van Praagh R, 1989, Eur J Cardiothorac Surg, V3, P381, DOI 10.1016/1010-7940(89)90044-4; VIRAGH S, 1981, ANAT REC, V201, P157, DOI 10.1002/ar.1092010117; Visvader JE, 1998, GENE DEV, V12, P473, DOI 10.1101/gad.12.4.473; Waltenberger J, 1996, CIRCULATION, V94, P1647, DOI 10.1161/01.CIR.94.7.1647; Wilkinson DG, 1992, SITU HYBRIDIZATION P; Wu H, 1999, DEVELOPMENT, V126, P3597; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; YANG JT, 1995, DEVELOPMENT, V121, P549; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407; Zou YM, 1997, DEVELOPMENT, V124, P793	64	317	325	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 23	2000	101	7					729	739		10.1016/S0092-8674(00)80885-5	http://dx.doi.org/10.1016/S0092-8674(00)80885-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	327YE	10892744	Bronze			2022-12-24	WOS:000087821400007
J	Morrison, SJ; Perez, SE; Qiao, Z; Verdi, JM; Hicks, C; Weinmaster, G; Anderson, DJ				Morrison, SJ; Perez, SE; Qiao, Z; Verdi, JM; Hicks, C; Weinmaster, G; Anderson, DJ			Transient notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells	CELL			English	Article							INTRACELLULAR DOMAIN; NERVOUS-SYSTEM; C-ELEGANS; IN-VIVO; EXPRESSION; DIFFERENTIATION; DROSOPHILA; FATE; RECEPTOR; DELTA	The genesis of vertebrate peripheral ganglia poses the problem of how multipotent neural crest stem cells (NCSCs) can sequentially generate neurons and then glia in a local environment containing strong instructive neurogenic factors, such as BMP2. Here we show that Notch ligands, which are normally expressed on differentiating neuroblasts, can inhibit neurogenesis in NCSCs in a manner that is completely dominant to BMP2. Contrary to expectation, Notch activation did not maintain these stem cells in an uncommitted state or promote their self-renewal. Rather, even a transient activation of Notch was sufficient to cause a rapid and irreversible loss of neurogenic capacity accompanied by accelerated glial differentiation. These data suggest that Notch ligands expressed by neuroblasts may act positively to instruct a cell-heritable switch to gliogenesis in neighboring stem cells.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Western Ontario, Dept Physiol, Program Neurosci, Robarts Res Inst,Howard Hughes Med Inst, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Physiol, Program Neurosci, Robarts Res Inst,Neurodegenerat Grp, London, ON N6A 5K8, Canada; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	California Institute of Technology; Western University (University of Western Ontario); Western University (University of Western Ontario); University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Anderson, DJ (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.		Morrison, Sean/ABD-5326-2021	Zhou, Qiao/0000-0002-0099-3909; Morrison, Sean/0000-0003-1587-8329	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023476] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS23476] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bao ZZ, 1997, J NEUROSCI, V17, P1425; BETTENHAUSEN B, 1995, DEVELOPMENT, V121, P2407; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; DONG Z, 1995, NEURON, V15, P585, DOI 10.1016/0896-6273(95)90147-7; Dorsky RI, 1997, NATURE, V385, P67, DOI 10.1038/385067a0; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Hagedorn L, 1999, DEVELOPMENT, V126, P3781; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harris WA, 1997, CURR OPIN GENET DEV, V7, P651, DOI 10.1016/S0959-437X(97)80013-5; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; KATZ WS, 1995, CELL, V82, P297, DOI 10.1016/0092-8674(95)90317-8; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; LINETTE GP, 1994, IMMUNITY, V1, P197, DOI 10.1016/1074-7613(94)90098-1; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MARUSICH MF, 1994, J NEUROBIOL, V25, P143, DOI 10.1002/neu.480250206; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Mirsky R, 1996, CURR OPIN NEUROBIOL, V6, P89, DOI 10.1016/S0959-4388(96)80013-4; MORGAN BA, 1996, METHODS AVIAN EMBRYO, P185; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Muramatsu T, 1997, BIOCHEM BIOPH RES CO, V230, P376, DOI 10.1006/bbrc.1996.5882; NYE JS, 1994, DEVELOPMENT, V120, P2421; Perez SE, 1999, DEVELOPMENT, V126, P1715; PETROPOULOS CJ, 1991, J VIROL, V65, P3728, DOI 10.1128/JVI.65.7.3728-3737.1991; Reissmann E, 1996, DEVELOPMENT, V122, P2079; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; ROHRER H, 1986, J NEUROSCI, V6, P2616; RUDEL C, 1992, DEVELOPMENT, V115, P519; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; STERNBERG PW, 1989, CELL, V58, P679, DOI 10.1016/0092-8674(89)90103-7; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Topilko P, 1996, MOL CELL NEUROSCI, V8, P71, DOI 10.1006/mcne.1996.0045; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; von Boehmer H, 1999, CURR BIOL, V9, pR186, DOI 10.1016/S0960-9822(99)80110-9; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Wang MQ, 1999, DEV BIOL, V212, P12, DOI 10.1006/dbio.1999.9357; Washburn T, 1997, CELL, V88, P833, DOI 10.1016/S0092-8674(00)81929-7; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Wettstein DA, 1997, DEVELOPMENT, V124, P693; WILLIAMS R, 1995, MECH DEVELOP, V53, P357, DOI 10.1016/0925-4773(95)00451-3; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Zhong WM, 1997, DEVELOPMENT, V124, P1887	60	562	601	0	25	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 26	2000	101	5					499	510		10.1016/S0092-8674(00)80860-0	http://dx.doi.org/10.1016/S0092-8674(00)80860-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850492	Bronze			2022-12-24	WOS:000087375400007
J	Byrne, JG; Aklog, L; Adams, DH				Byrne, JG; Aklog, L; Adams, DH			Assessment and management of functional or ischaemic mitral regurgitation	LANCET			English	Editorial Material							ECHOCARDIOGRAPHY; BYPASS		Brigham & Womens Hosp, Div Cardiac Surg, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Byrne, JG (corresponding author), Brigham & Womens Hosp, Div Cardiac Surg, 75 Francis St, Boston, MA 02115 USA.							ADLER DS, 1986, AM J CARDIOL, V58, P195, DOI 10.1016/0002-9149(86)90046-9; Armstrong GP, 2000, CORONARY ARTERY DIS, V11, P23, DOI 10.1097/00019501-200002000-00005; BACH DS, 1995, AM J CARDIOL, V76, P508, DOI 10.1016/S0002-9149(99)80140-4; Bolling SF, 1998, J THORAC CARDIOV SUR, V115, P381, DOI 10.1016/S0022-5223(98)70282-X; Chen FY, 1998, CIRCULATION, V98, pII124; Christenson J T, 1995, J Heart Valve Dis, V4, P484; COHN LH, 1995, EUR J CARDIO-THORAC, V9, P568, DOI 10.1016/S1010-7940(05)80008-9; Czer LSC, 1996, TEX HEART I J, V23, P270; Dion R, 1995, J Heart Valve Dis, V4 Suppl 2, pS124; Duarte IG, 1999, ANN THORAC SURG, V68, P426, DOI 10.1016/S0003-4975(99)00516-0; Grewal KS, 2000, AM J CARDIOL, V85, P199, DOI 10.1016/S0002-9149(99)00644-X; Izhar U, 1999, CIRCULATION, V100, P84; Takuma S, 1998, Semin Thorac Cardiovasc Surg, V10, P247	13	29	29	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2000	355	9217					1743	1744		10.1016/S0140-6736(00)02259-5	http://dx.doi.org/10.1016/S0140-6736(00)02259-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	315RE	10832822				2022-12-24	WOS:000087126100006
J	Taguchi, A; Blood, DC; del Toro, G; Canet, A; Lee, DC; Qu, W; Tanji, N; Lu, Y; Lalla, E; Fu, CF; Hofmann, MA; Kislinger, T; Ingram, M; Lu, A; Tanaka, H; Hori, O; Ogawa, S; Stern, DM; Schmidt, AM				Taguchi, A; Blood, DC; del Toro, G; Canet, A; Lee, DC; Qu, W; Tanji, N; Lu, Y; Lalla, E; Fu, CF; Hofmann, MA; Kislinger, T; Ingram, M; Lu, A; Tanaka, H; Hori, O; Ogawa, S; Stern, DM; Schmidt, AM			Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases	NATURE			English	Article							ACTIVATED-PROTEIN-KINASE; GLYCATION END-PRODUCTS; CELL-SURFACE RECEPTOR; NEURITE OUTGROWTH; PLASMINOGEN ACTIVATION; SIGNALING PATHWAYS; EPITHELIAL-CELLS; SOLUBLE RECEPTOR; BINDING-PROTEINS; OXIDANT STRESS	The receptor for advanced glycation end products (RAGE), a multi-ligand member of the immunoglobulin superfamily of cell surface molecules(1-2), interacts with distinct molecules implicated in homeostasis, development and inflammation, and certain diseases such as diabetes and Alzheimer's disease(3-8). Engagement of RAGE by a ligand triggers activation of key cell signalling pathways, such as p21(ras), MAP kinases, NF-kappa B and cdc42/rac, thereby reprogramming cellular properties(9-11). RAGE is a central cell surface receptor for amphoterin, a polypeptide linked to outgrowth of cultured cortical neurons derived from developing brain(3,12-15). Indeed, the co-localization of RAGE and amphoterin at the leading edge of advancing neurites indicated their potential contribution to cellular migration, and in pathologies such as tumour invasion. Here we demonstrate that blockade of RAGE-amphoterin decreased growth and metastases of both implanted tumours and tumours developing spontaneously in susceptible mice. Inhibition of the RAGE-amphoterin interaction suppressed activation of p44/p42, p38 and SAP/JNK MAP kinases; molecular effector mechanisms importantly linked to tumour proliferation, invasion and expression of matrix metalloproteinases(16-23).	Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; Osaka Univ, Sch Med, Osaka 5650871, Japan; Kanazawa Univ, Sch Med, Kanazawa, Ishikawa 9208640, Japan	Columbia University; Osaka University; Kanazawa University	Schmidt, AM (corresponding author), Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA.		Kislinger, Thomas/A-5934-2008; li, tao/B-2402-2008	Kislinger, Thomas/0000-0003-3525-5540				Aguirre-Ghiso JA, 1999, ONCOGENE, V18, P4718, DOI 10.1038/sj.onc.1202850; ALBINI A, 1987, CANCER RES, V47, P3239; BRETT J, 1993, AM J PATHOL, V143, P1699; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Esparza J, 1999, BLOOD, V94, P2754, DOI 10.1182/blood.V94.8.2754.420k09_2754_2766; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; LEDER A, 1990, P NATL ACAD SCI USA, V87, P9178, DOI 10.1073/pnas.87.23.9178; Montesano R, 1999, CELL GROWTH DIFFER, V10, P317; NEEPER M, 1992, J BIOL CHEM, V267, P14998; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; PARKKINEN J, 1993, J BIOL CHEM, V268, P19726; PARKKINEN J, 1991, J BIOL CHEM, V266, P16730; RAMAMURTHY NS, 1983, J PERIODONTAL RES, V18, P23, DOI 10.1111/j.1600-0765.1983.tb00331.x; RAUVALA H, 1988, J CELL BIOL, V107, P2293, DOI 10.1083/jcb.107.6.2293; RAUVALA H, 1987, J BIOL CHEM, V262, P16625; Reddy KB, 1999, INT J CANCER, V82, P268, DOI 10.1002/(SICI)1097-0215(19990719)82:2<268::AID-IJC18>3.3.CO;2-W; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Talarmin H, 1999, MOL CELL BIOL, V19, P6003; Tsang DK, 1999, INT J ONCOL, V15, P519; Valente P, 1998, INT J CANCER, V75, P246, DOI 10.1002/(SICI)1097-0215(19980119)75:2<246::AID-IJC13>3.0.CO;2-B; Wautier JL, 1996, J CLIN INVEST, V97, P238, DOI 10.1172/JCI118397; YAN SD, 1994, J BIOL CHEM, V269, P9889; Yan SD, 1997, P NATL ACAD SCI USA, V94, P5296, DOI 10.1073/pnas.94.10.5296; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yu W, 1997, J CELL BIOL, V137, P767, DOI 10.1083/jcb.137.3.767	30	1041	1163	3	66	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 18	2000	405	6784					354	360		10.1038/35012626	http://dx.doi.org/10.1038/35012626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314YT	10830965				2022-12-24	WOS:000087085700049
J	Kawasaki, H; Schiltz, L; Chiu, R; Itakura, K; Taira, K; Nakatani, Y; Yokoyama, KK				Kawasaki, H; Schiltz, L; Chiu, R; Itakura, K; Taira, K; Nakatani, Y; Yokoyama, KK			ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation	NATURE			English	Article							AMP RESPONSE ELEMENT; COACTIVATORS P300; TRANSCRIPTIONAL ACTIVATION; GENOTOXIC AGENTS; RETINOIC-ACID; DNA-BINDING; ACETYLATION; PROTEIN; CBP; NUCLEAR	Transcription factors carry functional domains, which are often physically distinct, for sequence-specific DNA binding, transcriptional activation and regulatory functions. The transcription factor ATF-2 is a DNA-binding protein that binds to cyclic AMP-response elements (CREs), forms a homodimer or heterodimer with c-Jun, and stimulates CRE-dependent transcription(1-3). Here we report that ATF-2 is a histone acetyltransferase (HAT), which specifically acetylates histones H2B and H4 in vitro. Motif A, which is located in the HAT domain, is responsible for the stimulation of CRE-dependent transcription; moreover, in response to ultraviolet irradiation, phosphorylation of ATF-2 is accompanied by enhanced HAT activity of ATF-2 and CRE-dependent transcription. These results indicate that phosphorylation of ATF-2 controls its intrinsic HAT activity and its action on CRE-dependent transcription. ATF-2 may represent a new class of sequence-specific factors, which are able to activate transcription by direct effects on chromatin components.	RIKEN, Inst Phys & Chem Res, Tsukuba Life Sci Ctr, Tsukuba, Ibaraki 3050074, Japan; AIST, Agcy Ind Sci & Technol, Natl Inst Adv Interdisciplianry Res, Tsukuba, Ibaraki 3050006, Japan; AIST, Agcy Ind Sci & Technol, Natl Inst Biosci & Human Technol, Tsukuba, Ibaraki 3050006, Japan; NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA; Univ Calif Los Angeles, Sch Med, Sch Dent Surg Oncol Oral Biol & Med, Los Angeles, CA 90095 USA; City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Genet, Duarte, CA 91010 USA; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan	RIKEN; National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; City of Hope; Beckman Research Institute of City of Hope; University of Tokyo	Yokoyama, KK (corresponding author), RIKEN, Inst Phys & Chem Res, Tsukuba Life Sci Ctr, Tsukuba, Ibaraki 3050074, Japan.	kazunari@rtc.riken.go.jp						Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bender K, 1998, EMBO J, V17, P5170, DOI 10.1093/emboj/17.17.5170; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Dutnall RN, 1998, CELL, V94, P427, DOI 10.1016/S0092-8674(00)81584-6; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Herrlich P, 1997, BIOL CHEM, V378, P1217; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Kawasaki H, 1998, GENE DEV, V12, P233, DOI 10.1101/gad.12.2.233; LIU F, 1990, CELL, V61, P1217, DOI 10.1016/0092-8674(90)90686-9; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; Martinez-Balbas MA, 1998, EMBO J, V17, P2886, DOI 10.1093/emboj/17.10.2886; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhang WJ, 1998, P NATL ACAD SCI USA, V95, P9855, DOI 10.1073/pnas.95.17.9855	29	213	220	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2000	405	6783					195	200		10.1038/35012097	http://dx.doi.org/10.1038/35012097			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WG	10821277				2022-12-24	WOS:000087080100054
J	Hafernik, J; Saul-Gershenz, L				Hafernik, J; Saul-Gershenz, L			Beetle larvae cooperate to mimic bees	NATURE			English	Article									San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	California State University System; San Francisco State University	Hafernik, J (corresponding author), San Francisco State Univ, Dept Biol, 1600 Holloway Ave, San Francisco, CA 94132 USA.		Saul-Gershenz, Leslie/AAE-1523-2019	Saul-Gershenz, Leslie/0000-0002-8492-9305				BORGKARLSON AK, 1990, PHYTOCHEMISTRY, V29, P1359, DOI 10.1016/0031-9422(90)80086-V; CLAUSEN CP, 1976, ANNU REV ENTOMOL, V21, P343, DOI 10.1146/annurev.en.21.010176.002015; Cooper K. W., 1955, Transactions of the American Entomological Society, V80, P119; Crespi Bernard J., 1997, P499; ERICKSON EH, 1974, ANN ENTOMOL SOC AM, V67, P903, DOI 10.1093/aesa/67.6.903; LIMNAEUS C, 1767, SYSTEMA NATURAE REGN; PINTO J D, 1970, P222; Southwood T.R.E., 1978, ECOLOGICAL METHODS, V2nd ed., DOI 10.1007/978-94-015-7291-0; Visscher PK, 1999, NATURE, V397, P400, DOI 10.1038/17047; von Frisch K., 1950, BEES THEIR VISION CH; Wilson EO., 1971, INSECT SOC	11	25	30	2	87	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2000	405	6782					35	36		10.1038/35011129	http://dx.doi.org/10.1038/35011129			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311TK	10811206				2022-12-24	WOS:000086901600038
J	Reed, CA; Kim, KC; Bolskar, RD; Mueller, LJ				Reed, CA; Kim, KC; Bolskar, RD; Mueller, LJ			Taming superacids: Stabilization of the fullerene cations HC60+ and C-60(.+)	SCIENCE			English	Article							SPECTROSCOPIC OBSERVATION; CHEMISTRY; ANIONS; C60; C-13; C-70; C70; NMR; ION	A new superacid, H(CB11H6X6) (where X = chlorine or bromine), whose conjugate base is the exceptionally inert CB11H6X6- carborane anion, separates Bronsted acidity from oxidizing capacity and anion nucleophilicity in a manner not previously achieved. Reaction of this superacid with C-60 gives HC60+ as a stable ion in solution and in the solid state. In a separate experiment, an oxidant was developed such that the long-sought C-60(.+) ion can be synthesized in solution. The preparation of these two fullerene carbocations is a notable departure from the prevalent chemistry of C-60, which is dominated by the formation of anions or the addition of nucleophiles. The H(CB11H6X6) superacid overcomes the major limitations of presently known superacids and has potentially wide application.	Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Reed, CA (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.			Mueller, Leonard/0000-0002-2607-9875	NIGMS NIH HHS [GM23851] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023851] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARD AJ, 1976, ADV PHYSICAL ORGANIC, V13, P155; BAUSCH JW, 1991, J AM CHEM SOC, V113, P3205, DOI 10.1021/ja00008a077; Bolskar RD, 1996, J AM CHEM SOC, V118, P13093, DOI 10.1021/ja962294n; CATALDO F, 1995, SPECTROCHIM ACTA A, V51, P405, DOI 10.1016/0584-8539(94)E0111-M; Connelly NG, 1996, CHEM REV, V96, P877, DOI 10.1021/cr940053x; deRege PJF, 1997, SCIENCE, V276, P776, DOI 10.1126/science.276.5313.776; Drews T, 1997, ANGEW CHEM INT EDIT, V36, P273, DOI 10.1002/anie.199702731; Gillespie R.J., 1975, ADV INORG CHEM RAD, V17, P49; HADDON RC, 1992, ACCOUNTS CHEM RES, V25, P127, DOI 10.1021/ar00015a005; Haw JF, 1996, ACCOUNTS CHEM RES, V29, P259, DOI 10.1021/ar950105k; HENDERSON CC, 1993, SCIENCE, V259, P1885, DOI 10.1126/science.259.5103.1885; KATO T, 1991, CHEM PHYS LETT, V180, P446, DOI 10.1016/0009-2614(91)85147-O; Kitagawa T, 1999, J AM CHEM SOC, V121, P4298, DOI 10.1021/ja9900048; MILLER GP, 1992, MATER RES SOC SYMP P, V247, P293, DOI 10.1557/PROC-247-293; O'Donnell T. A., 1993, SUPERACIDS ACIDIC ME; OLAH GA, 1978, J AM CHEM SOC, V100, P6299, DOI 10.1021/ja00488a001; OLAH GA, 1985, SUPERACIDS; Reed CA, 2000, CHEM REV, V100, P1075, DOI 10.1021/cr980017o; Reed CA, 1998, ACCOUNTS CHEM RES, V31, P133, DOI 10.1021/ar970230r; Reed CA, 1999, J AM CHEM SOC, V121, P6314, DOI 10.1021/ja981861z; Reed CA, 1998, ACCOUNTS CHEM RES, V31, P325, DOI 10.1021/ar960132q; Taylor R., 1999, LECT NOTES FULLERENE; Wang GW, 1997, NATURE, V387, P583, DOI 10.1038/42439; WILLNER H, 1997, ANGEW CHEM INT EDIT, V36, P2402; WUDL F, 1992, ACCOUNTS CHEM RES, V25, P157, DOI 10.1021/ar00015a009; XIE QS, 1993, J AM CHEM SOC, V115, P9818, DOI 10.1021/ja00074a066	26	224	226	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2000	289	5476					101	104		10.1126/science.289.5476.101	http://dx.doi.org/10.1126/science.289.5476.101			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332TW	10884220	Green Published			2022-12-24	WOS:000088090400040
J	White, B; Moore, WC; Wigley, FM; Xiao, HQ; Wise, RA				White, B; Moore, WC; Wigley, FM; Xiao, HQ; Wise, RA			Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis	ANNALS OF INTERNAL MEDICINE			English	Article							INTERSTITIAL LUNG-DISEASE; SYSTEMIC-SCLEROSIS SCLERODERMA; COLLAGEN-VASCULAR DISEASES; BRONCHOALVEOLAR LAVAGE; PULSE CYCLOPHOSPHAMIDE; FIBROSING ALVEOLITIS; INVOLVEMENT; MANAGEMENT; COMPONENT; THERAPY	Background: Lung inflammation (alveolitis) may cause lung fibrosis in scleroderma. Objective: To determine whether cyclophosphamide treatment is associated with retention of lung function and improved survival in scleroderma patients with alveolitis. Design: Retrospective cohort study, Setting: Johns Hopkins and University of Maryland Scleroderma Center. Patients: 103 patients with scleroderma who had bronchoalveolar lavage or lung biopsy. Intervention: Cyclophosphamide therapy. Measurements: 1) Serial measurement of forced vital capacity (FVC)and carbon monoxide diffusing capacity and 2) survival. Results: During a median follow-up of 13 months after bronchoalveolar ravage or biopsy, patients with alveolitis who did not receive cyclophosphamide therapy experienced a decrease in FVC (mean difference, -0.28 L [95% Cl, -0.41 to -0.16 L] and -7.1% of the predicted value [CI, -10.9% to -4.0%]). Carbon monoxide diffusing capacity also decreased in these patients (mean difference, -3.3 mmol min(-1).kPa(-1) [Cl, -4.6 to -2.1 mmol.min(-1).kPa(-1)] and -9.6% of the predicted value [CI, -16.7% to -2.4%]). During a median follow-up of 16 months, patients with alveolitis who received cyclophosphamide we re more likely to have a good outcome (stabilization or improvement) in FVC (relative risk, 2.5 [CI, 1.5 to 4.1]) and diffusing rapacity (relative risk, 1.5 [CI, 1.0 to 2.2]). These patients also had improved survival; the median survival rate was 89% (25th, 75th percentiles, 84%, 94%) compared with 71% (25th, 75th percentiles, 55%, 86%) in untreated patients (P = 0.01, log-rank test). Conclusions: The presence of lung inflammation identifies patients with scleroderma who are more likely to have worsening lung function. Lung function outcomes and survival are improved in patients with alveolitis who receive cyclophosphamide.	Univ Maryland, Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA; Johns Hopkins Univ, Inst Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University	White, B (corresponding author), Baltimore Vet Affairs Med Ctr, Res Serv, Stop 151,Room 325-A,10 N Greene, Baltimore, MD 21201 USA.			Wise, Robert/0000-0002-8353-2349	NHLBI NIH HHS [1RO1HL54163] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054163] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKESSON A, 1994, ARTHRITIS RHEUM, V37, P729, DOI 10.1002/art.1780370518; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P2185; Atamas SP, 1999, ARTHRITIS RHEUM, V42, P1168, DOI 10.1002/1529-0131(199906)42:6<1168::AID-ANR13>3.0.CO;2-L; Behr J, 1996, AM J RESP CRIT CARE, V154, P400, DOI 10.1164/ajrccm.154.2.8756813; BURROWS B, 1961, AM REV RESPIR DIS, V84, P789; CHANEZ P, 1993, AM REV RESPIR DIS, V147, P1497, DOI 10.1164/ajrccm/147.6_Pt_1.1497; COX DR, 1972, J R STAT SOC B, V34, P187; GOLDMAN HI, 1959, AM REV TUBERC PULM, V79, P457; Guillevin L, 1997, ARTHRITIS RHEUM, V40, P2187, DOI 10.1002/art.1780401213; HARRISON NK, 1991, AM REV RESPIR DIS, V144, P706, DOI 10.1164/ajrccm/144.3_Pt_1.706; Lacki Jan K., 1994, Archivum Immunologiae et Therapiae Experimentalis, V42, P291; LEROY EC, 1988, J RHEUMATOL, V15, P202; MERCHANT RK, 1992, AM REV RESPIR DIS, V146, P448, DOI 10.1164/ajrccm/146.2.448; ODONNELL K, 1987, AM REV RESPIR DIS, V136, P288, DOI 10.1164/ajrccm/136.2.288; PETERSGOLDEN M, 1984, AM J MED, V77, P1027, DOI 10.1016/0002-9343(84)90183-9; ROSSI GA, 1985, AM REV RESPIR DIS, V131, P612, DOI 10.1164/arrd.1985.131.4.612; Schnabel A, 1998, ARTHRITIS RHEUM-US, V41, P1215, DOI 10.1002/1529-0131(199807)41:7<1215::AID-ART11>3.0.CO;2-Y; SILVER RM, 1990, AM J MED, V88, P470, DOI 10.1016/0002-9343(90)90425-D; SILVER RM, 1993, J RHEUMATOL, V20, P838; SILVER RM, 1984, ARTHRITIS RHEUM, V27, P1254, DOI 10.1002/art.1780271107; STEEN VD, 1994, ARTHRITIS RHEUM-US, V37, P1290, DOI 10.1002/art.1780370904; STEEN VD, 1994, ARTHRITIS RHEUM, V37, P1283, DOI 10.1002/art.1780370903; Steen VD, 1996, SYSTEMIC SCLEROSIS, P51; STRUCK RF, 1987, CANCER RES, V47, P2723; TASHKIN DP, 1994, CHEST, V105, P489, DOI 10.1378/chest.105.2.489; WALLAERT B, 1986, AM REV RESPIR DIS, V133, P574; WELLS AU, 1994, AM J RESP CRIT CARE, V150, P462, DOI 10.1164/ajrccm.150.2.8049830; WHITE B, 1995, ARTHRITIS RHEUM, V38, P351, DOI 10.1002/art.1780380309; [No title captured]	31	276	294	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2000	132	12					947	+		10.7326/0003-4819-132-12-200006200-00004	http://dx.doi.org/10.7326/0003-4819-132-12-200006200-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325HU	10858177				2022-12-24	WOS:000087670800003
J	Willenheimer, R; Swedberg, K				Willenheimer, R; Swedberg, K			Dressing heart-failure patients on Savile row - tailored treatment?	LANCET			English	Editorial Material									Malmo Univ Hosp, Dept Cardiol, SE-20502 Malmo, Sweden; Sahlgrens Univ Hosp, Dept Med, S-41345 Gothenburg, Sweden	Lund University; Skane University Hospital; Sahlgrenska University Hospital	Willenheimer, R (corresponding author), Malmo Univ Hosp, Dept Cardiol, SE-20502 Malmo, Sweden.		Swedberg, Karl/B-2475-2008					BENEDICT CR, 1995, AM J CARDIOL, V75, P1151, DOI 10.1016/S0002-9149(99)80748-6; BOISSEL JP, 1993, J CARDIOVASC PHARM, V22, P356, DOI 10.1097/00005344-199309000-00003; CLELAND JGF, 1994, EUR HEART J, V15, P125, DOI 10.1093/oxfordjournals.eurheartj.a060364; Hjalmarson A, 1999, LANCET, V353, P2001; Lechat P, 1999, LANCET, V353, P9; Lim PO, 2000, HEART, V83, P257, DOI 10.1136/heart.83.3.257; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Roig E, 2000, EUR HEART J, V21, P53, DOI 10.1053/euhj.1999.1740; Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2; Yusuf S, 2000, NEW ENGL J MED, V342, P145	11	11	11	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 10	2000	355	9220					2012	2013		10.1016/S0140-6736(00)02344-8	http://dx.doi.org/10.1016/S0140-6736(00)02344-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	322QC	10885349				2022-12-24	WOS:000087519400005
J	Naryshkin, N; Revyakin, A; Kim, YG; Mekler, V; Ebright, RH				Naryshkin, N; Revyakin, A; Kim, YG; Mekler, V; Ebright, RH			Structural organization of the RNA polymerase-promoter open complex	CELL			English	Article							TRANSCRIPTION ELONGATION COMPLEX; ACID RESTRICTION FRAGMENTS; PHOTO-CROSS-LINKING; CAP-DNA COMPLEX; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; SIGMA(70) SUBUNIT; BETA-SUBUNIT; BINDING	We have used systematic site-specific protein-DNA photocrosslinking to define interactions between bacterial RNA polymerase (RNAP) and promoter DNA in the catalytically competent RNAP-promoter open complex (RPo). We have mapped more than 100 distinct crosslinks between individual segments of RNAP subunits and individual phosphates of promoter DNA. The results provide a comprehensive description of protein-DNA interactions in RPo, permit construction of a detailed model for the structure of RPo, and permit analysis of effects of a transcriptional activator on the structure of RPo.	Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Dept Chem, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick	Ebright, RH (corresponding author), Rutgers State Univ, Waksman Inst, Howard Hughes Med Inst, Dept Chem, POB 759, Piscataway, NJ 08854 USA.		Ebright, Richard/O-3321-2019	Ebright, Richard/0000-0001-8915-7140	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041376] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM41376] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN G, 1989, SEQUENCING PROTEINS; ARTHUR T, 2000, IN PRESS J BIOL CHEM; Arthur TM, 1998, J BIOL CHEM, V273, P31381, DOI 10.1074/jbc.273.47.31381; BLATTER EE, 1994, CELL, V78, P889, DOI 10.1016/S0092-8674(94)90682-3; Bown JA, 1999, J BIOL CHEM, V274, P2263, DOI 10.1074/jbc.274.4.2263; Brodolin K, 2000, J BIOL CHEM, V275, P3661, DOI 10.1074/jbc.275.5.3661; Buckle M, 1999, J MOL BIOL, V285, P955, DOI 10.1006/jmbi.1998.2391; Burr T, 2000, NUCLEIC ACIDS RES, V28, P1864, DOI 10.1093/nar/28.9.1864; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; BUSBY S, 1994, CELL, V79, P743, DOI 10.1016/0092-8674(94)90063-9; Callaci S, 1998, J BIOL CHEM, V273, P32995, DOI 10.1074/jbc.273.49.32995; CECH CL, 1980, BIOCHEMISTRY-US, V19, P2440, DOI 10.1021/bi00552a023; Chamberlin M., 1976, RNA POLYMERASE BOOK, P17; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; DARST SA, 1991, CELL, V66, P121, DOI 10.1016/0092-8674(91)90144-N; Darst SA, 1998, COLD SPRING HARB SYM, V63, P269, DOI 10.1101/sqb.1998.63.269; Darst SA, 1998, J STRUCT BIOL, V124, P115, DOI 10.1006/jsbi.1998.4057; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; Ebright RH, 1998, COLD SPRING HARB SYM, V63, P11, DOI 10.1101/sqb.1998.63.11; Estrem ST, 1999, GENE DEV, V13, P2134, DOI 10.1101/gad.13.16.2134; GRACHEV M, 1987, EUR J BIOCHEM, V180, P577; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; GROSS CA, 1992, TRANSCRIPTIONAL REGU, P129; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; JEON YH, 1995, SCIENCE, V270, P1495, DOI 10.1126/science.270.5241.1495; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; Kim TK, 1997, P NATL ACAD SCI USA, V94, P12268, DOI 10.1073/pnas.94.23.12268; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Lagrange T, 1996, P NATL ACAD SCI USA, V93, P10620, DOI 10.1073/pnas.93.20.10620; MELANCON P, 1983, BIOCHEMISTRY-US, V22, P5169, DOI 10.1021/bi00291a017; MELANCON P, 1982, BIOCHEMISTRY-US, V21, P4318, DOI 10.1021/bi00261a022; NARYSHKIN N, 2000, IN PRESS METHODS MOL; Niu W, 1996, CELL, V87, P1123, DOI 10.1016/S0092-8674(00)81806-1; NIU W, 1998, THESIS RUTGERS U NEW; Nudler E, 1998, SCIENCE, V281, P424, DOI 10.1126/science.281.5375.424; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; Opalka N, 2000, P NATL ACAD SCI USA, V97, P617, DOI 10.1073/pnas.97.2.617; Owens JT, 1998, BIOCHEMISTRY-US, V37, P7670, DOI 10.1021/bi980188n; Owens JT, 1998, P NATL ACAD SCI USA, V95, P6021, DOI 10.1073/pnas.95.11.6021; Parkinson G, 1996, J MOL BIOL, V260, P395, DOI 10.1006/jmbi.1996.0409; PENDERGRAST PS, 1992, P NATL ACAD SCI USA, V89, P10287, DOI 10.1073/pnas.89.21.10287; PFEFFER SR, 1977, J BIOL CHEM, V252, P5403; Poglitsch CL, 1999, CELL, V98, P791, DOI 10.1016/S0092-8674(00)81513-5; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; REZNIKOFF WS, 1984, S SOC GEN MICROBIOL, V36, P195; Rivetti C, 1999, EMBO J, V18, P4464, DOI 10.1093/emboj/18.16.4464; SASSEDWIGHT S, 1989, J BIOL CHEM, V264, P8074; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; SENTENAC A, 1992, TRANSCRIPTIONAL REGU, P27; SEVERINOV K, 1995, P NATL ACAD SCI USA, V92, P4591, DOI 10.1073/pnas.92.10.4591; Severinov K, 1996, J BIOL CHEM, V271, P27969, DOI 10.1074/jbc.271.44.27969; Smith Bryan John, 1996, P389, DOI 10.1007/978-1-60327-259-9_67; TANG H, 1995, P NATL ACAD SCI USA, V92, P4902, DOI 10.1073/pnas.92.11.4902; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; YOUNG RA, 1991, ANNU REV BIOCHEM, V60, P689, DOI 10.1146/annurev.bi.60.070191.003353; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; ZHANG XP, 1991, J BIOMOL STRUCT DYN, V9, P463, DOI 10.1080/07391102.1991.10507929	58	156	163	1	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 9	2000	101	6					601	611		10.1016/S0092-8674(00)80872-7	http://dx.doi.org/10.1016/S0092-8674(00)80872-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	322HQ	10892647	Bronze			2022-12-24	WOS:000087504500007
J	Schmucker, D; Clemens, JC; Shu, H; Worby, CA; Xiao, J; Muda, M; Dixon, JE; Zipursky, SL				Schmucker, D; Clemens, JC; Shu, H; Worby, CA; Xiao, J; Muda, M; Dixon, JE; Zipursky, SL			Drosophila Dscam is an axon guidance receptor exhibiting extraordinary molecular diversity	CELL			English	Article							GROWTH CONE GUIDANCE; ADAPTER PROTEIN; GENETIC-ANALYSIS; NERVOUS-SYSTEM; MECHANISMS; CADHERINS; REGION; KINASE; DOCK; CELL	A Drosophila homolog of human Down syndrome cell adhesion molecule (DSCAM), an immunoglobulin superfamily member, was isolated by its affinity to Dock, an SH3/SH2 adaptor protein required for axon guidance. Dscam binds directly to both Dock's SH2 and SH3 domains. Genetic studies revealed that Dscam, Dock and Pak, a serine/threonine kinase, act together to direct pathfinding of Bolwig's nerve, containing a subclass of sensory axons, to an intermediate target in the embryo. Dscam also is required for the formation of axon pathways in the embryonic central nervous system. cDNA and genomic analyses reveal the existence of multiple forms of Dscam with a conserved architecture containing variable Ig and transmembrane domains. Alternative splicing can potentially generate more than 38,000 Dscam isoforms. This molecular diversity may contribute to the specificity of neuronal connectivity.	Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Howard Hughes Med Inst, Los Angeles, CA 90024 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dixon, JE (corresponding author), Univ Michigan, Dept Biol Chem, 1301 E Catherine, Ann Arbor, MI 48109 USA.			Zipursky, Stephen/0000-0001-5630-7181	NIGMS NIH HHS [GM08042] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albright TD, 2000, CELL, V100, pS1; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Clemens JC, 1996, J BIOL CHEM, V271, P17002, DOI 10.1074/jbc.271.29.17002; CLEMENS JC, 2000, IN PRESS P NATL ACAD; COOK GP, 1995, IMMUNOL TODAY, V16, P237, DOI 10.1016/0167-5699(95)80166-9; Culotti JG, 1998, CURR OPIN CELL BIOL, V10, P609, DOI 10.1016/S0955-0674(98)80036-7; Desai CJ, 1999, DEVELOPMENT, V126, P1527; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Guthrie S, 1999, CURR BIOL, V9, pR432, DOI 10.1016/S0960-9822(99)80274-7; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HEITZLER P, 1993, GENETICS, V135, P105; Herbst R, 1996, CELL, V85, P899, DOI 10.1016/S0092-8674(00)81273-8; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; HOCH M, 1994, DEVELOPMENT, V120, P3439; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P1, DOI 10.1098/rspb.1981.0079; LIN CH, 1993, J CELL BIOL, V121, P1369, DOI 10.1083/jcb.121.6.1369; Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MARGOLIS B, 1995, DNA CLONING PRACTICA, P1; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; OKANE CJ, 1998, DROSOPHILA PRACTICAL, P139; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; PARDUE ML, 1994, DROSOPHILA MELANOGAS, P334; Rao Y, 1998, P NATL ACAD SCI USA, V95, P2077, DOI 10.1073/pnas.95.5.2077; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Schmucker D, 1997, DEVELOPMENT, V124, P937; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Serafini T, 1999, CELL, V98, P133, DOI 10.1016/S0092-8674(00)81008-9; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Sheng GJ, 1997, GENE DEV, V11, P1122, DOI 10.1101/gad.11.9.1122; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Stein E, 1998, J BIOL CHEM, V273, P1303, DOI 10.1074/jbc.273.3.1303; Suter DM, 1998, CURR OPIN NEUROBIOL, V8, P106, DOI 10.1016/S0959-4388(98)80014-7; Takeichi M, 1997, COLD SPRING HARB SYM, V62, P505; TANAKA E, 1995, CELL, V83, P171, DOI 10.1016/0092-8674(95)90158-2; TANG J, 2000, IN PRESS J BIOL CHEM; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; THOMAS JB, 1984, NATURE, V310, P203, DOI 10.1038/310203a0; Uemura T, 1998, CELL, V93, P1095, DOI 10.1016/S0092-8674(00)81452-X; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; WERNER S, 1992, MOL CELL BIOL, V12, P82, DOI 10.1128/MCB.12.1.82; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227	55	787	812	4	88	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 9	2000	101	6					671	684		10.1016/S0092-8674(00)80878-8	http://dx.doi.org/10.1016/S0092-8674(00)80878-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	322HQ	10892653	Bronze			2022-12-24	WOS:000087504500013
J	Nortier, JL; Martinez, MM; Schmeiser, HH; Arlt, VM; Bieler, CA; Petein, M; Depierreux, MF; De Pauw, L; Abramowicz, D; Vereerstraeten, P; Vanherweghem, JL				Nortier, JL; Martinez, MM; Schmeiser, HH; Arlt, VM; Bieler, CA; Petein, M; Depierreux, MF; De Pauw, L; Abramowicz, D; Vereerstraeten, P; Vanherweghem, JL			Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERSTITIAL RENAL FIBROSIS; DNA-ADDUCTS; ANALGESIC NEPHROPATHY; SLIMMING REGIMEN; ACID; RATS; IDENTIFICATION; DISEASE; TUMORS	Background: Chinese-herb nephropathy is a progressive form of renal fibrosis that develops in some patients who take weight-reducing pills containing Chinese herbs. Because of a manufacturing error, one of the herbs in these pills (Stephania tetrandra) was inadvertently replaced by Aristolochia fangchi, which is nephrotoxic and carcinogenic. Methods: The diagnosis of a neoplastic lesion in the native urinary tract of a renal-transplant recipient who had Chinese-herb nephropathy prompted us to propose regular cystoscopic examinations and the prophylactic removal of the native kidneys and ureters in all our patients with end-stage Chinese-herb nephropathy who were being treated with either transplantation or dialysis. Surgical specimens were examined histologically and analyzed for the presence of DNA adducts formed by aristolochic acid. All prescriptions written for weight-reducing compounds during the period of exposure (1990 to 1992) in these patients were obtained, and the cumulative doses were calculated. Results: Among 39 patients who agreed to undergo prophylactic surgery, there were 18 cases of urothelial carcinoma (prevalence, 46 percent; 95 percent confidence interval, 29 to 62 percent): 17 cases of carcinoma of the ureter, renal pelvis, or both and 1 papillary bladder tumor. Nineteen of the remaining patients had mild-to-moderate urothelial dysplasia, and two had normal urothelium. All tissue samples analyzed contained aristolochic acid-related DNA adducts. The cumulative dose of aristolochia was a significant risk factor for urothelial carcinoma, with total doses of more than 200 g associated with a higher risk of urothelial carcinoma. Conclusions: The prevalence of urothelial carcinoma among patients with end-stage Chinese-herb nephropathy (caused by aristolochia species) is high. (N Engl J Med 2000;342:1686-92.) (C) 2000, Massachusetts Medical Society.	Free Univ Brussels, Hop Erasme, Dept Nephrol, B-1070 Brussels, Belgium; Free Univ Brussels, Hop Erasme, Dept Pathol, B-1070 Brussels, Belgium; German Canc Res Ctr, Div Mol Toxicol, D-6900 Heidelberg, Germany	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Helmholtz Association; German Cancer Research Center (DKFZ)	Nortier, JL (corresponding author), Free Univ Brussels, Hop Erasme, Dept Nephrol, 808 Route Lennik, B-1070 Brussels, Belgium.	jnortier@ulb.ac.be	Abramowicz, Daniel/F-7578-2017	Abramowicz, Daniel/0000-0002-6556-9199; Arlt, Volker Manfred/0000-0003-4314-9318; Nortier, Joelle/0000-0003-3609-8217				Angell M, 1998, NEW ENGL J MED, V339, P839, DOI 10.1056/NEJM199809173391210; [Anonymous], 1997, J CLIN PATHOL; Bieler CA, 1997, CARCINOGENESIS, V18, P1063, DOI 10.1093/carcin/18.5.1063; BOSTWICK DG, 1997, UROLOGIC SURG PATHOL, P246; CABANNE F, 1992, PATHOLOGIE GENITALE, P354; Castegnaro M, 1998, INT J CANCER, V77, P70, DOI 10.1002/(SICI)1097-0215(19980703)77:1&lt;70::AID-IJC12&gt;3.0.CO;2-D; COSYNS JP, 1994, LANCET, V344, P188, DOI 10.1016/S0140-6736(94)92786-3; COSYNS JP, 1994, KIDNEY INT, V45, P1680, DOI 10.1038/ki.1994.220; Cosyns JP, 1999, AM J KIDNEY DIS, V33, P1011, DOI 10.1016/S0272-6386(99)70136-8; De Broe ME, 1999, AM J KIDNEY DIS, V33, P1171, DOI 10.1016/S0272-6386(99)70159-9; De Broe ME, 1998, NEW ENGL J MED, V338, P446, DOI 10.1056/NEJM199802123380707; DEPIERREUX M, 1994, AM J KIDNEY DIS, V24, P172, DOI 10.1016/S0272-6386(12)80178-8; EVERSON RB, 1986, SCIENCE, V231, P54, DOI 10.1126/science.3941892; INT AGCY RES CANC, 1993, IARC MONOG EVAL CARC, V56, P489; JACKSON L, 1964, CANCER CHEMOTH REP, P35; Kliem V, 1996, TRANSPLANT INT, V9, P231, DOI 10.1111/j.1432-2277.1996.tb00885.x; Lord GM, 1999, LANCET, V354, P481, DOI 10.1016/S0140-6736(99)03380-2; Malak J, 1998, J ALTERN COMPLEM MED, V4, P131, DOI 10.1089/acm.1998.4.131; McIntyre M, 1998, J ALTERN COMPLEM MED, V4, P15, DOI 10.1089/acm.1998.4.1-15; MENGS U, 1993, ARCH TOXICOL, V67, P307, DOI 10.1007/BF01973700; MENGS U, 1982, ARCH TOXICOL, V51, P107, DOI 10.1007/BF00302751; MURPHY WM, 1982, J UROLOGY, V127, P849, DOI 10.1016/S0022-5347(17)54105-1; Nortier J., 1998, Journal of the American Society of Nephrology, V9, p164A; Pena JM, 1996, NEPHROL DIAL TRANSPL, V11, P1359, DOI 10.1093/ndt/11.7.1359; PEZZUTO JM, 1988, MUTAT RES, V206, P447, DOI 10.1016/0165-1218(88)90052-3; Pfohl-Leszkowicz A, 1993, IARC Sci Publ, P141; POURRAT J, 1994, PRESSE MED, V23, P1669; RICHARDS B, 1991, BRIT J UROL, V67, P369, DOI 10.1111/j.1464-410X.1991.tb15164.x; SCHMEISER HH, 1985, BIOCHEM PHARMACOL, V34, P455, DOI 10.1016/0006-2952(85)90085-1; SCHMEISER HH, 1986, CARCINOGENESIS, V7, P59, DOI 10.1093/carcin/7.1.59; SCHMEISER HH, 1990, CANCER RES, V50, P5464; Schmeiser HH, 1996, CANCER RES, V56, P2025; STEFANOVIC V, 1991, AM J NEPHROL, V11, P1, DOI 10.1159/000168264; TANAKA A, 1997, JPN J NEPHROL, V39, P794; TANAKA A, 1997, JPN J NEPHROL, V39, P438; VANHAELEN M, 1994, LANCET, V343, P174, DOI 10.1016/S0140-6736(94)90964-4; VANHERWEGHEM JL, 1995, NEPHROL DIAL TRANSPL, V10, P270; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Yang CS, 2000, AM J KIDNEY DIS, V35, P313, DOI 10.1016/S0272-6386(00)70343-X	39	744	805	6	87	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2000	342	23					1686	1692		10.1056/NEJM200006083422301	http://dx.doi.org/10.1056/NEJM200006083422301			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321HD	10841870				2022-12-24	WOS:000087449300001
J	Durieux, P; Nizard, R; Ravaud, P; Mounier, N; Lepage, E				Durieux, P; Nizard, R; Ravaud, P; Mounier, N; Lepage, E			A clinical decision support system for prevention of venous thromboembolism - Effect on physician behavior	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONTINUING MEDICAL-EDUCATION; PULMONARY-EMBOLISM; QUALITY ASSURANCE; HEALTH-CARE; PERFORMANCE; GUIDELINES; TRIALS; IMPLEMENTATION; PROPHYLAXIS; OUTCOMES	Context Computer-based clinical decision support systems (CDSSs) have been promoted for their potential to improve quality of health care. However, given the limited range of clinical settings in which they have been tested, such systems must be evaluated rigorously before widespread introduction into clinical practice. Objective To determine whether presentation of venous thromboembolism prophylaxis guidelines using a CDSS increases the proportion of appropriate clinical practice decisions made. Design Time-series study conducted between December 1997 and July 1999. Setting Orthopedic surgery department of a teaching hospital in Paris, France. Participants A total of 1971 patients who underwent orthopedic surgery. Intervention A CDSS designed to provide immediate information pertaining to venous thromboembolism prevention among surgical patients was integrated into daily medical practice during three 10-week intervention periods, alternated with four 10-week control periods, with a 4-week washout between each period. Main Outcome Measure Proportion of appropriate prescriptions ordered for anticoagulation, according to preestablished clinical guidelines, during intervention vs control periods. Results Physicians complied with guidelines in 82.8% (95% confidence interval [CI], 77.6%-87.1%) of cases during control periods and in 94.9% (95% CI, 92.5%-96.6%) of cases during intervention periods. During each intervention period, the appropriateness of prescription increased significantly (P<.001). Each time the CDSS was removed, physician practice reverted to that observed before initiation of the intervention. The relative risk of inappropriate practice decisions during control periods vs intervention periods was 3.8 (95% CI, 2.7-5.4). Conclusions In our study, implementation of clinical guidelines for venous thromboembolism prophylaxis through a CDSS used routinely in an orthopedic surgery department and integrated into the hospital information system changed physician behavior and improved compliance with guidelines.	Fac Med Broussais Hotel Dieu, Dept Publ Hlth, F-75006 Paris, France; Assistance Publ Hop Paris, Lariboisiere Hosp, Dept Orthoped, Paris, France; Assistance Publ Hop Paris, Bichat Hosp, Epidemiol Unit, Paris, France; Assistance Publ Hop Paris, Henri Mondor Hosp, Dept Biostat & Med Informat, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Durieux, P (corresponding author), Fac Med Broussais Hotel Dieu, Dept Publ Hlth, 15 Rue Ecole Med, F-75006 Paris, France.	pierre.kurieux@egp.ap-hop-paris.fr	Mounier, Nicolas/X-2964-2018; Nizard, Remy/R-5845-2019; ravaud, philippe/C-1694-2009	Mounier, Nicolas/0000-0002-0707-426X; Ravaud, Philippe/0000-0001-8264-9206				ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; ANDERSON FA, 1994, ARCH INTERN MED, V154, P669, DOI 10.1001/archinte.154.6.669; Auleley GR, 1997, JAMA-J AM MED ASSOC, V277, P1935; Balas EA, 1996, ARCH FAM MED, V5, P271, DOI 10.1001/archfami.5.5.271; Brook RH, 1996, NEW ENGL J MED, V335, P966, DOI 10.1056/NEJM199609263351311; CLAGETT GP, 1995, CHEST, V108, pS312, DOI 10.1378/chest.108.4_Supplement.312S; DAVIES HTO, 1995, BRIT MED J, V311, P766, DOI 10.1136/bmj.311.7008.766; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; Durieux P, 1997, INT J QUAL HEALTH C, V9, P215, DOI 10.1093/intqhc/9.3.215; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; GOLDHABER SZ, 1992, JAMA-J AM MED ASSOC, V268, P1727, DOI 10.1001/jama.268.13.1727; HAMMERMEISTER KE, 1994, ANN THORAC SURG, V58, P1815, DOI 10.1016/0003-4975(94)91720-5; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; LOWE GDO, 1992, BMJ-BRIT MED J, V305, P567; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; McKee M, 1997, BRIT MED J, V315, P142, DOI 10.1136/bmj.315.7101.142; MCNALLY E, 1995, BRIT MED J, V310, P640, DOI 10.1136/bmj.310.6980.640; NHS Centre for Reviews and Dissemination, 1994, EFFECTIVE HLTH CARE, V8, P1; NICOLAIDES AN, 1992, INT ANGIOL, V11, P151; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Patterson R, 1998, J AM MED INFORM ASSN, P573; Randolph AG, 1999, JAMA-J AM MED ASSOC, V282, P67, DOI 10.1001/jama.282.1.67; Ravaud P, 1995, SANG THROMB VAISS, V7, P119; Ryskamp RP, 1998, CHEST, V113, P162, DOI 10.1378/chest.113.1.162; Schiff GD, 1998, JAMA-J AM MED ASSOC, V279, P1024, DOI 10.1001/jama.279.13.1024; Schriger DL, 1997, JAMA-J AM MED ASSOC, V278, P1585, DOI 10.1001/jama.278.19.1585; Shea S, 1996, J AM MED INFORM ASSN, V3, P399, DOI 10.1136/jamia.1996.97084513; SOUMERAI SB, 1989, MILBANK Q, V67, P268, DOI 10.2307/3350142; Weed LL, 1999, BRIT MED J, V319, P1279, DOI 10.1136/bmj.319.7220.1279; WEINGARTEN SR, 1994, ANN INTERN MED, V120, P257, DOI 10.7326/0003-4819-120-4-199402150-00001; WOLFINGER R, 1993, J STAT COMPUT SIM, V48, P233, DOI 10.1080/00949659308811554; 1991, ANN FR ANESTH REANIM, V10, P417	32	176	180	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2000	283	21					2816	2821		10.1001/jama.283.21.2816	http://dx.doi.org/10.1001/jama.283.21.2816			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BQ	10838650	Bronze			2022-12-24	WOS:000087381500036
J	Guzman, MG; Kouri, G; Halstead, SB				Guzman, MG; Kouri, G; Halstead, SB			Do escape mutants explain rapid increases in dengue case-fatality rates within epidemics?	LANCET			English	Article							ANTIBODY-DEPENDENT ENHANCEMENT; HEMORRHAGIC-FEVER; POLIOVIRUS; VIRUS; EVOLUTION	During the Cuban dengue epidemics of 1981 and 1997, significant monthly increases were observed in the proportion of total cases that presented as dengue haemorrhagic fever or dengue shock syndrome (DHF/DSS), and in case-fatality rates for both dengue fever and DHF/DSS. We believe that theses increases can be explained by the hypothesis that some of the population of antibodies against dengue 1 virus raised after natural primary infections react with "neutralisation" determinants found on dengue 2 viruses. These heterotypic antibodies do not prevent secondary dengue 2 infections, but serve to down-regulate the disease to mild illness or symptomless infections. A population of dengue 2 viruses that replicates in dengue-1-immune hosts escape heterotypic neutralisation. When inoculated into a new dengue-1-immune host, these viruses are free to interact with the more abundant infection-enhancing antibodies to produce severe disease.	Inst Trop Med Pedro Kouri, Havana, Cuba; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Johns Hopkins University	Guzman, MG (corresponding author), Autopista Novia del Meliodia, Inst Trop Med, Dept Virol, Km 6 POB 601, Havana 13, Cuba.							Bottiger B, 1997, CLIN DIAGN VIROL, V8, P105, DOI 10.1016/S0928-0197(97)00018-4; Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790; GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179; GUZMAN MG, 1997, IN PRESS AM J EPIDEM; HALSTEAD SB, 1980, B WORLD HEALTH ORGAN, V58, P1; HUOVILAINEN A, 1987, J GEN VIROL, V68, P1373, DOI 10.1099/0022-1317-68-5-1373; KETTERLINUS R, 1993, VIROLOGY, V192, P525, DOI 10.1006/viro.1993.1068; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444; KOURI GP, 1987, T ROY SOC TROP MED H, V81, P821, DOI 10.1016/0035-9203(87)90042-3; LAMBKIN R, 1994, J GEN VIROL, V75, P3493, DOI 10.1099/0022-1317-75-12-3493; MINOR PD, 1993, DEV BIOL STAND, V78, P17; OGRA PL, 1991, J INFECT DIS, V164, P191, DOI 10.1093/infdis/164.1.191; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Valdes L, 1999, Rev Panam Salud Publica, V6, P16, DOI 10.1590/S1020-49891999000600003	16	59	69	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 27	2000	355	9218					1902	1903		10.1016/S0140-6736(00)02303-5	http://dx.doi.org/10.1016/S0140-6736(00)02303-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	318VZ	10866460				2022-12-24	WOS:000087306500043
J	Judson, OP; Normark, BB				Judson, OP; Normark, BB			Evolutionary genetics - Sinless originals	SCIENCE			English	Editorial Material							ANCIENT ASEXUALS; DNA		Univ London Imperial Coll Sci Technol & Med, Dept Biol, Ascot SL5 7PY, Berks, England; Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Imperial College London; Harvard University	Judson, OP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol, Silwood Pk, Ascot SL5 7PY, Berks, England.			Judson, Olivia/0000-0002-1829-5973				BARRON GL, 1985, CAN J BOT, V63, P211, DOI 10.1139/b85-024; Darlington CD, 1939, EVOLUTION GENETIC SY; HICKEY DA, 1982, GENETICS, V101, P519; HURST LD, 1992, TRENDS ECOL EVOL, V7, P144, DOI 10.1016/0169-5347(92)90205-P; JAENIKE J, 1978, Evolutionary Theory, V3, P191; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; Little TJ, 1996, TRENDS ECOL EVOL, V11, P296, DOI 10.1016/S0169-5347(96)91640-7; Maynard Smith J., 1978, EVOLUTION SEX; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Schon I, 1998, J NAT HIST, V32, P943, DOI 10.1080/00222939800770481; Welch DM, 2000, SCIENCE, V288, P1211, DOI 10.1126/science.288.5469.1211	13	10	11	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 19	2000	288	5469					1185	1186		10.1126/science.288.5469.1185	http://dx.doi.org/10.1126/science.288.5469.1185			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315KH	10841738				2022-12-24	WOS:000087112600031
J	Croft, RP; Nicholls, PG; Steyerberg, EW; Richardus, JH; Smith, WCS				Croft, RP; Nicholls, PG; Steyerberg, EW; Richardus, JH; Smith, WCS			A clinical prediction rule for nerve-function impairment in leprosy patients	LANCET			English	Article							TYPE-1 REACTIONS; CONTROL PROGRAM; RISK-FACTORS; WEST NEPAL; DAMAGE; EXPERIENCE; MANAGEMENT; REGIMEN; MODELS	Background: Nerve-function impairment (NFI) commonly occurs during or after chemotherapy in leprosy and is the hey pathological process leading to disability and handicap. We describe the development of a simple clinical prediction rule for estimating the risk of NFI occurrence. Methods: New leprosy cases who presented to a centre in Bangladesh were recruited and followed up for 2 years in a field setting. We used multivariable regression analysis by Cox's proportional hazards model to identify predictive variables for NFI. Discriminative ability was measured by a concordance statistic. Internal validity was assessed with bootstrap resampling techniques. Findings: 2510 patients were followed up for 2 years, 166 developed NF. A simple model was developed with leprosy group (either paucibacillary leprosy [PB] or multibacillary leprosy [MB]) and the presence of any nerve-function loss at registration as predictive variables. Patients with PB leprosy and no nerve-function loss had a 1.3% (95% CI 0.8-1.8%) risk of developing NFI within 2 years of registration; patients with PB leprosy and nerve-function loss, or patients with MB leprosy and no nerve-function loss had a 16.0% (12-20%) risk; and patients with MB leprosy with nerve-function loss had a 65% (56-73%) risk. Interpretation: Our prediction rule can be used to plan surveillance of new leprosy patients. Patients at low risk of NFI may need no follow-up beyond their course of chemotherapy (6 months); patients with intermediate risk need a minimum of 1 year of surveillance; and patients with high risk should have at least 2 years of surveillance for new NFI. Current recommendations for surveillance of patients with leprosy (for the duration of chemotherapy only) exclude an important group of patients who are at risk of developing NFI after completion of treatment.	Danish Bangladesh Leprosy Mission, Nilphamari, Bangladesh; Univ Aberdeen, Dept Publ Hlth, Aberdeen AB9 1FX, Scotland	University of Aberdeen	Croft, RP (corresponding author), 56A St Peters Rd, Reading RG6 1PH, Berks, England.	richard@crofts32.freeserve.co.uk	Richardus, Jan Hendrik/AAE-1278-2021; Steyerberg, Ewout/C-1509-2018	Richardus, Jan Hendrik/0000-0003-0564-6313; Steyerberg, Ewout/0000-0002-7787-0122				Akaike H., 1998, P 2 INT S INF THEOR, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], 1998, Wkly Epidemiol Rec, V73, P153; BECXBLEUMINK M, 1992, INT J LEPROSY, V60, P173; Croft RP, 1997, LEPROSY REV, V68, P316; Croft RP, 1999, LEPROSY REV, V70, P140; DUNCAN ME, 1982, INT J LEPROSY, V50, P31; HARRELL FE, 1985, CANCER TREAT REP, V69, P1071; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HOGEWEG M, 1991, LEPROSY REV, V62, P143; Jiang J, 1998, LEPROSY REV, V69, P367; JOB CK, 1989, INT J LEPROSY, V57, P532; KIRAN KU, 1985, LEPROSY REV, V56, P127; LIENHARDT C, 1994, LEPROSY REV, V65, P9; LOCKWOOD DNJ, 1993, INT J LEPROSY, V61, P8; NAAFS B, 1978, LEPROSY REV, V49, P153; NAAFS B, 1992, QUAD COOP SAN, V12, P67; ROCHE PW, 1991, LANCET, V338, P654, DOI 10.1016/0140-6736(91)91232-J; Roche PW, 1997, INT J LEPROSY, V65, P450; ROSE P, 1991, LEPROSY REV, V62, P113; Schreuder PAM, 1998, INT J LEPROSY, V66, P159; STEYERBERG EW, 1996, THESIS ERASMUS U ROT; van Brakel W H, 1997, Indian J Lepr, V69, P361; Van Brakel WH, 1999, LEPROSY REV, V70, P314; VANBRAKEL WH, 1994, LEPROSY REV, V65, P190; VANBRAKEL WH, 1994, LEPROSY REV, V65, P350; VANBRAKEL WH, 1994, LEPROSY REV, V65, P204; Watson JM., 1986, ESSENTIAL ACTION MIN	27	90	98	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2000	355	9215					1603	1606		10.1016/S0140-6736(00)02216-9	http://dx.doi.org/10.1016/S0140-6736(00)02216-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CD	10821364				2022-12-24	WOS:000086981200011
J	Moreira, D; Le Guyader, H; Philippe, H				Moreira, D; Le Guyader, H; Philippe, H			The origin of red algae and the evolution of chloroplasts	NATURE			English	Article							TREE TOPOLOGIES; SEQUENCE; DNA; ALIGNMENT; PHYLOGENY; KINGDOMS; POSITION; INTRONS; PROTEIN; GENE	Chloroplast structure and genome analyses support the hypothesis that three groups of organisms originated from the primary photosynthetic endosymbiosis between a cyanobacterium and a eukaryotic host: green plants (green algae + land plants), red algae and glaucophytes (for example, Cyanophora)(1). Although phylogenies based on several mitochondrial genes support a specific green plants/red algae relationship(2,3), the phylogenetic analysis of nucleus-encoded genes yields inconclusive, sometimes contradictory results(3,4). To address this problem, we have analysed an alternative nuclear marker, elongation factor 2, and included new red algae and protist sequences. Here we provide significant support for a sisterhood of green plants and red algae. This sisterhood is also significantly supported by a multi-gene analysis of a fusion of 13 nuclear markers (5,171 amino acids). In addition, the analysis of an alternative fusion of 6 nuclear markers (1,938 amino acids) indicates that glaucophytes may be the closest relatives to the green plants/red algae group. Thus, our study provides evidence from nuclear markers for a single primary endosymbiosis at the origin of these groups, and supports a kingdom Plantae comprising green plants, red algae and glaucophytes(5).	Univ Paris 11, Equipe Phylogenie & Evolut Mol, CNRS UPRESA 8080, F-91405 Orsay, France; Univ Miguel Hernandez, Dept Microbiol, Alicante 03550, Spain	UDICE-French Research Universities; Universite Paris Saclay; Universidad Miguel Hernandez de Elche	Moreira, D (corresponding author), Univ Paris 11, Equipe Phylogenie & Evolut Mol, CNRS UPRESA 8080, Batiment 444, F-91405 Orsay, France.		Moreira, David/F-7445-2012	Moreira, David/0000-0002-2064-5354				Adachi J., 1996, COMPUT SCI MONOGR, V28, P1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bhattacharya D, 1997, CURR GENET, V31, P439, DOI 10.1007/s002940050227; BHATTACHARYA D, 1997, ORIGINS ALGAE THEIR, P139; Burger G, 1999, PLANT CELL, V11, P1675, DOI 10.1105/tpc.11.9.1675; CAVALIERSMITH T, 1981, BIOSYSTEMS, V14, P461, DOI 10.1016/0303-2647(81)90050-2; Douglas SE, 1998, CURR OPIN GENET DEV, V8, P655, DOI 10.1016/S0959-437X(98)80033-6; Embley TM, 1998, CURR OPIN GENET DEV, V8, P624, DOI 10.1016/S0959-437X(98)80029-4; Fabrizio P, 1997, EMBO J, V16, P4092, DOI 10.1093/emboj/16.13.4092; Graybeal A, 1998, SYST BIOL, V47, P9, DOI 10.1080/106351598260996; Hillis DM, 1996, NATURE, V383, P130, DOI 10.1038/383130a0; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; KISHINO H, 1990, J MOL EVOL, V31, P151, DOI 10.1007/BF02109483; Kumar S, 1996, J MOL EVOL, V42, P183, DOI 10.1007/BF02198844; Martin W, 1998, NATURE, V393, P162, DOI 10.1038/30234; Moreira D, 1998, NUCLEIC ACIDS RES, V26, P3309, DOI 10.1093/nar/26.13.3309; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Philippe H, 1998, CURR OPIN GENET DEV, V8, P616, DOI 10.1016/S0959-437X(98)80028-2; RAGAN MA, 1995, BOT J LINN SOC, V118, P81, DOI 10.1016/S0024-4074(95)80010-7; Stiller JW, 1997, P NATL ACAD SCI USA, V94, P4520, DOI 10.1073/pnas.94.9.4520; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Swofford David L., 1996, P407; SWOFFORD DL, 1993, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yamamoto A, 1997, J MOL EVOL, V44, P98, DOI 10.1007/PL00006127	26	313	333	2	101	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2000	405	6782					69	72		10.1038/35011054	http://dx.doi.org/10.1038/35011054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311TK	10811219				2022-12-24	WOS:000086901600052
J	Thier, P; Dicke, PW; Haas, R; Barash, S				Thier, P; Dicke, PW; Haas, R; Barash, S			Encoding of movement time by populations of cerebellar Purkinje cells	NATURE			English	Article							SACCADIC EYE-MOVEMENTS; FASTIGIAL NUCLEUS; OCULOMOTOR VERMIS; NEURONS; MACAQUE; PATTERNS; LESIONS; PRIMATE; MONKEY; REGION	One of the earliest computational principles attributed to the cerebellum was the measurement of time(1). This idea was originally suggested on anatomical grounds, and was taken up again to explain some of the deficits in cerebellar patients(2,3). The contribution of the cerebellum to eye movements, in contrast, has traditionally been discussed in the context of motor learning(4-7). This view has received support from the loss of saccade adaptation, one of the key examples of motor learning, following lesions of the posterior cerebellar vermis(8-11). However, the relationship between the properties of saccade-related vermal Purkinje cells and the behavioural deficits that follow lesions is unclear. Here we report results from single-unit recording experiments on monkeys that reconcile the seemingly unrelated concepts of timing and motor learning. We report that, unlike individual Purkinje cells, the population response of larger groups of Purkinje cells gives a precise temporal signature of saccade onset and offset. Thus a vermal population response may help to determine saccade duration. Modifying the time course of the population response by changing the weights of the contributing individual Purkinje cells, discharging at different times relative to the saccade, would directly translate into changes in saccade amplitude.	Univ Tubingen, Dept Cognit Neurol, D-72076 Tubingen, Germany; Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Eberhard Karls University of Tubingen; Weizmann Institute of Science	Thier, P (corresponding author), Univ Tubingen, Dept Cognit Neurol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	thier@uni-tuebingen.de		Thier, Peter/0000-0001-5909-4222				Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; BAHILL AT, 1975, MATH BIOSCI, V24, P287; Barash S, 1999, J NEUROSCI, V19, P10931, DOI 10.1523/JNEUROSCI.19-24-10931.1999; BRAITENBERG V, 1961, NATURE, V190, P539, DOI 10.1038/190539b0; Desmurget M, 1998, NAT NEUROSCI, V1, P524, DOI 10.1038/2241; Fitzgibbon E. J., 1986, ADAPTIVE PROCESSES V, P329; FUCHS AF, 1993, J NEUROPHYSIOL, V70, P1723, DOI 10.1152/jn.1993.70.5.1723; Haas R., 1999, Society for Neuroscience Abstracts, V25, P1652; HANES DP, 1995, EXP BRAIN RES, V103, P85; HELMCHEN C, 1995, EXP BRAIN RES, V103, P198; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; IVRY RB, 1991, J COGNITIVE NEUROSCI, V3, P355, DOI 10.1162/jocn.1991.3.4.355; IVRY RB, 1993, J COGNITIVE NEUROSCI, V1, P136; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KASE M, 1980, J PHYSIOL-LONDON, V300, P539, DOI 10.1113/jphysiol.1980.sp013178; KAWATO M, 1992, TRENDS NEUROSCI, V15, P445, DOI 10.1016/0166-2236(92)90008-V; LLINAS R, 1988, J PHYSIOL-LONDON, V404, P241, DOI 10.1113/jphysiol.1988.sp017288; LLINAS R, 1977, EXP BRAIN RES, V29, P1; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; NODA H, 1990, J COMP NEUROL, V302, P330, DOI 10.1002/cne.903020211; OHTSUKA K, 1991, J NEUROPHYSIOL, V65, P1422, DOI 10.1152/jn.1991.65.6.1422; OPTICAN LM, 1980, J NEUROPHYSIOL, V44, P1058, DOI 10.1152/jn.1980.44.6.1058; PRESS HW, 1992, NUMERICAL RECIPES C, P650; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; SATO H, 1992, NEUROSCI RES, V12, P583, DOI 10.1016/0168-0102(92)90065-K; Scudder Charles A., 1998, Society for Neuroscience Abstracts, V24, P147; Takagi M, 1998, J NEUROPHYSIOL, V80, P1911, DOI 10.1152/jn.1998.80.4.1911; THIELERT CD, 1996, THESIS E KARLS U TUB; THIER P, 1992, EUR J NEUROSCI, V4, P539, DOI 10.1111/j.1460-9568.1992.tb00904.x	29	115	117	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2000	405	6782					72	76		10.1038/35011062	http://dx.doi.org/10.1038/35011062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311TK	10811220				2022-12-24	WOS:000086901600053
J	McKeigue, PM; Reynard, JM				McKeigue, PM; Reynard, JM			Relation of nocturnal polyuria of the elderly to essential hypertension	LANCET			English	Article							URINARY-TRACT SYMPTOMS; ATRIAL-NATRIURETIC-PEPTIDE; NITRIC-OXIDE SYNTHESIS; URODILATIN; INFUSION; HUMANS; PROSTATECTOMY; COMMUNITY; EXCRETION; QUALITY	Nocturnal polyuria is common in the elderly. In this condition the normal circadian rhythm of urine production is reversed so that urine flow is higher at night than during the day. Elderly men with nocturnal polyuria are commonly referred for prostate surgery, which, not surprisingly, fails to relieve their symptoms. Compared with controls, patients with nocturnal polyuria have higher nocturnal sodium excretion but not higher nocturnal free-water clearance. Similar results have been obtained in children with nocturnal enuresis. Use of vasopressin analogues to induce water retention in elderly patients with nocturnal polyuria is illogical and potentially hazardous; nocturia can be more safely alleviated by diuretic therapy. Nocturnal polyuria in the elderly is associated with hypertension: this is consistent with studies in younger age groups that show that essential hypertension is associated with nocturia and with increased night/day ratios for sodium excretion. We propose that nocturnal polyuria and essential hypertension share some of the same pathophysiological determinants. Specifically, we suggest that a defect in the nitric-oxide pathway may lead to resetting of the pressure-natriuresis relation in the kidney, sodium retention, and compensatory nocturnal natriuresis. This suggestion is consistent with evidence that ageing and essential hypertension are both associated with defects in the nitric-oxide pathway. Our hypothesis has obvious therapeutic implications. More generally, studying the pathogenesis of nocturnal polyuria in the elderly may advance our understanding of the pathogenesis of essential hypertension.	Univ London London Sch Hyg & Trop Med, Epidemiol Unit, London WC1E 7HT, England; Churchill Hosp, Dept Urol, Oxford OX3 7LJ, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford	McKeigue, PM (corresponding author), Univ London London Sch Hyg & Trop Med, Epidemiol Unit, Keppel St, London WC1E 7HT, England.							Asplund R, 1999, BJU INT, V84, P297; ASPLUND R, 1996, BR J UROL INT, V83, P591; Bech JN, 1998, AM J PHYSIOL-RENAL, V274, pF914, DOI 10.1152/ajprenal.1998.274.5.F914; *BRIT NAT FORM, 1999, BRIT MED ASS ROYAL P, P340; BULPITT CJ, 1976, BRIT HEART J, V38, P121; CAMPO C, 1996, KIDNEY INT S, V55, pS126; Cannon A, 1999, BJU INT, V84, P20; Carstens J, 1997, CLIN SCI, V92, P397, DOI 10.1042/cs0920397; Carter PG, 1999, EUR UROL, V36, P213, DOI 10.1159/000068000; Debruyne FMJ, 1996, EUR UROL, V30, P369; Dijkhorst-Oei LT, 1998, NEPHROL DIAL TRANSPL, V13, P587, DOI 10.1093/ndt/13.3.587; DRUMMER C, 1991, J AM SOC NEPHROL, V1, P1109; Drummer C, 1996, AM J PHYSIOL-RENAL, V270, pF301, DOI 10.1152/ajprenal.1996.270.2.F301; Emberton M, 1996, BRIT J UROL, V77, P233, DOI 10.1046/j.1464-410X.1996.88213.x; Forte P, 1997, LANCET, V349, P837, DOI 10.1016/S0140-6736(96)07631-3; FOWLER FJ, 1988, JAMA-J AM MED ASSOC, V259, P3018, DOI 10.1001/jama.259.20.3018; Fujii T, 1999, AM J KIDNEY DIS, V33, P29, DOI 10.1016/S0272-6386(99)70254-4; Gerhard M, 1996, HYPERTENSION, V27, P849, DOI 10.1161/01.HYP.27.4.849; JOLLEYS JV, 1994, BRIT J UROL, V74, P551, DOI 10.1111/j.1464-410X.1994.tb09182.x; KANNO K, 1992, CLIN EXP PHARMACOL P, V19, P619, DOI 10.1111/j.1440-1681.1992.tb00514.x; KENTSCH M, 1992, EUR J CLIN INVEST, V22, P319, DOI 10.1111/j.1365-2362.1992.tb01469.x; KIRKLAND JL, 1983, BRIT MED J, V287, P1665, DOI 10.1136/bmj.287.6406.1665; LEPOR H, 1993, UROLOGY, V42, P36, DOI 10.1016/0090-4295(93)90332-5; Lyons D, 1997, CLIN SCI, V93, P519, DOI 10.1042/cs0930519; Matthiesen TB, 1999, BJU INT, V83, P1017; Matthiesen TB, 1996, J UROLOGY, V156, P1292, DOI 10.1016/S0022-5347(01)65572-1; Meyer M, 1996, AM J PHYSIOL-RENAL, V271, pF489, DOI 10.1152/ajprenal.1996.271.3.F489; PEDERSEN PA, 1988, BRIT J UROL, V62, P145, DOI 10.1111/j.1464-410X.1988.tb04294.x; Pinnock CB, 1997, MED J AUSTRALIA, V167, P72, DOI 10.5694/j.1326-5377.1997.tb138783.x; Reynard JM, 1998, BRIT J UROL, V81, P215; Reynard JM, 1998, BRIT J UROL, V82, P619; RICHARDS AM, 1987, CLIN SCI, V73, P489, DOI 10.1042/cs0730489; RITTIG S, 1991, SCAND J CLIN LAB INV, V51, P209, DOI 10.3109/00365519109091109; Robson WLM, 1996, EUR J PEDIATR, V155, P959, DOI 10.1007/BF02282887; SAITO M, 1993, BRIT J UROL, V72, P38, DOI 10.1111/j.1464-410X.1993.tb06453.x; SIRAGY HM, 1992, HYPERTENSION, V19, P775, DOI 10.1161/01.HYP.19.6.775; STAESSEN J, 1991, J HYPERTENS, V9, P1035, DOI 10.1097/00004872-199111000-00009; STEWART RB, 1992, J AM GERIATR SOC, V40, P1217, DOI 10.1111/j.1532-5415.1992.tb03645.x; WILCOX CS, 1974, J NEUROL NEUROSUR PS, V37, P677, DOI 10.1136/jnnp.37.6.677; WILLIAMS G, 1986, LANCET, V1, P738	40	64	67	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2000	355	9202					486	488						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841144				2022-12-24	WOS:000085306800039
J	Frost, MH; Schaid, DJ; Sellers, TA; Slezak, JM; Arnold, PG; Woods, JE; Petty, PM; Johnson, JL; Sitta, DL; McDonnell, SK; Rummans, TA; Jenkins, RB; Sloan, JA; Hartmann, LC				Frost, MH; Schaid, DJ; Sellers, TA; Slezak, JM; Arnold, PG; Woods, JE; Petty, PM; Johnson, JL; Sitta, DL; McDonnell, SK; Rummans, TA; Jenkins, RB; Sloan, JA; Hartmann, LC			Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BREAST-CANCER; OUTCOMES; QUALITY; HEALTH; LIFE	Context Prophylactic mastectomy is a preventive option for women who wish to reduce their risk of breast cancer. There has been concern about possible negative psychological sequelae following this procedure. However, few data are available regarding long-term satisfaction and psychological and social function following this procedure. Objective To evaluate patients' long-term satisfaction and psychological and social function following prophylactic mastectomy. Design, Setting, and Participants Descriptive study of all women known to be alive (n=609) who had a family history of breast cancer and elected to undergo bilateral prophylactic mastectomy at a large, tertiary US health care clinic between 1960 and 1993, 94% (n = 572) of whom completed a study questionnaire. Main Outcome Measures Satisfaction with procedure and effects on psychological and social function, based on responses to the study-specific questionnaire. Results Mean time from prophylactic mastectomy to last follow-up was 14.5 years. Most women (70%) were satisfied with the procedure; 11% were neutral; and 19% were dissatisfied. Among the psychological and social variables, the most striking finding was that 74% reported a diminished level of emotional concern about developing breast cancer. The majority of women reported no change/favorable effects in levels of emotional stability (68%/23%), level of stress (58%/28%), self-esteem (69%/ 13%), sexual relationships (73%/4%), and feelings of femininity (67%/8%). Forty-eight percent reported no change in their level of satisfaction with body appearance; 16% reported favorable effects. However, 9%, 14%, 18%, 23%, 25%, and 36% reported negative effects in these 6 variables, respectively. Conclusions This study suggests that positive outcomes following prophylactic mastectomy include decreased emotional concern about developing breast cancer and generally favorable psychological and social outcomes. These must be weighed against the irreversibility of the decision, potential problems with implants and reconstructive surgery, and occurrence of adverse psychological and social outcomes in some women.	Mayo Clin & Mayo Fdn, Div Med Oncol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Res Serv, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Biostat, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Plast & Reconstruct Surg, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Clin Epidemiol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Psychiat & Psychol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Frost, MH (corresponding author), Mayo Clin & Mayo Fdn, Div Med Oncol, 200 1st St SW, Rochester, MN 55905 USA.			McDonnell, Shannon/0000-0001-6201-369X	PHS HHS [R01-80181] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Borgen PI, 1998, ANN SURG ONCOL, V5, P603, DOI 10.1007/BF02303829; Eisen A, 1999, NEW ENGL J MED, V340, P137, DOI 10.1056/NEJM199901143400209; Eisinger F, 1997, J NATL CANCER I, V89, P731, DOI 10.1093/jnci/89.10.731; GILL TM, 1994, JAMA-J AM MED ASSOC, V272, P619, DOI 10.1001/jama.272.8.619; Grana G., 1994, Breast Cancer Research and Treatment, V32, P72; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; KRAUSE NM, 1994, MED CARE, V32, P930, DOI 10.1097/00005650-199409000-00004; Lerman C, 1996, JAMA-J AM MED ASSOC, V275, P1885, DOI 10.1001/jama.275.24.1885; LOVE SM, 1995, S LOVES BREAST BOOK, P247; MARGOLIS GJ, 1989, PSYCHOSOMATICS, V30, P192, DOI 10.1016/S0033-3182(89)72300-8; SPITZER WO, 1987, J CHRON DIS, V40, P465, DOI 10.1016/0021-9681(87)90002-6; Stefanek M E, 1995, J Natl Cancer Inst Monogr, P37; STEFANEK ME, 1995, PREV MED, V24, P412, DOI 10.1006/pmed.1995.1066; WARE JE, 1991, CANCER, V67, P774, DOI 10.1002/1097-0142(19910201)67:3+<774::AID-CNCR2820671404>3.0.CO;2-I; Wolberg W H, 1990, Oncology (Williston Park), V4, P101	15	226	228	0	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2000	284	3					319	324		10.1001/jama.284.3.319	http://dx.doi.org/10.1001/jama.284.3.319			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	333GR	10891963	Bronze			2022-12-24	WOS:000088123000024
J	Neil, HAW; Hammond, T; Huxley, R; Matthews, DR; Humphries, SE				Neil, HAW; Hammond, T; Huxley, R; Matthews, DR; Humphries, SE			Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study	BRITISH MEDICAL JOURNAL			English	Article									Radcliffe Infirm, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX2 6HE, England; Univ Oxford, Inst Hlth Sci, Div Publ Hlth & Primary Hlth Care, Oxford OX3 7LF, England; Royal Free & UCL, Rayne Inst, Ctr Cardiovasc Genet, London WC1E 6JJ, England	Radcliffe Infirmary; University of Oxford; University of Oxford; University of London; King's College London; University College London	Neil, HAW (corresponding author), Radcliffe Infirm, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX2 6HE, England.	andrew.neil@dphpc.ox.ac.uk	Huxley, Rachel R/C-7032-2013; Humphries, Stephen E/C-5075-2008; Huxley, Rachel R/J-4638-2013	Huxley, Rachel R/0000-0002-2705-6616; Huxley, Rachel R/0000-0002-2705-6616; Humphries, Stephen E/0000-0002-8221-6547				Goldstein J, 1995, FAMILIAL HYPERCHOLES, P1981; MARKS D, IN PRESS HLTH TECHNO; Neil HAW, 1999, ATHEROSCLEROSIS, V142, P105; SLACK J, 1969, LANCET, V2, P1380; STONE NJ, 1974, CIRCULATION, V49, P476, DOI 10.1161/01.CIR.49.3.476	5	140	143	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 15	2000	321	7254					148	148		10.1136/bmj.321.7254.148	http://dx.doi.org/10.1136/bmj.321.7254.148			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336MG	10894692	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000088305700021
J	Lederman, MM; Valdez, H				Lederman, MM; Valdez, H			Immune restoration with antiretroviral therapies - Implications for clinical management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY-VIRUS INFECTION; ADVANCED HIV-1 DISEASE; T-CELL FUNCTION; PNEUMOCYSTIS-CARINII PNEUMONIA; PROTEASE-INHIBITOR THERAPY; CYTOMEGALOVIRUS RETINITIS; CONTROLLED TRIAL; MAINTENANCE THERAPY; LOAD REDUCTION; AIDS	Recent dramatic decreases in acquired immunodeficiency syndrome-related mortality are largely due to the introduction of highly active antiretroviral therapy (HAART). Although immune restoration due to suppression of human immunodeficiency virus (HIV) replication is a critical determinant of these trends, the magnitude of immune restoration seen after treatment with HAART varies substantially among treated persons and is generally incomplete. Nonetheless, even partial immune restoration is sufficient to provide protection from most major opportunistic infections; these risks can be largely predicted by the number of circulating CD4 cells. Limited data suggest that treatment earlier during the course of HIV infection may result in greater preservation of immune function, though this has not been studied in great detail. Preliminary studies performed among persons with multidrug-resistant virus whose treatment regimens are failing suggest that there is likely a benefit to continuation of therapy that may be related to diminished pathogenicity of drug-resistant virus, As deaths related to opportunistic infections diminish, the spectrum of causes of mortality in HIV infection is changing. Except for Kaposi sarcoma, there is insufficient information to conclude that the risks of non-Hodgkin lymphoma and other malignancies are diminishing among persons with HIV infection. How much immune restoration will be enough,to ensure long-term survival in persons with HIV infection remains an open question.	Univ Hosp Cleveland, Div Infect Dis, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr AIDS Res, Cleveland, OH USA	University Hospitals of Cleveland; Case Western Reserve University	Lederman, MM (corresponding author), Univ Hosp Cleveland, Div Infect Dis, 2061 Cornell Rd, Cleveland, OH 44106 USA.	MXL6@po.cwru.edu			NIAID NIH HHS [AI25879, AI36219, AI85388] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, U01AI025879, R21AI085388] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABERG J, 2000, 7 C RETR OPP INF JAN; Aberg JA, 1998, J INFECT DIS, V178, P1446, DOI 10.1086/314469; Al-Harthi L, 1998, J CLIN IMMUNOL, V18, P124, DOI 10.1023/A:1023246800353; Al-Harthi L, 2000, AIDS, V14, P761, DOI 10.1097/00002030-200005050-00001; Andersson J, 1998, AIDS, V12, pF123, DOI 10.1097/00002030-199811000-00004; Angel JB, 1998, J INFECT DIS, V177, P898, DOI 10.1086/515244; [Anonymous], 1999, MMWR Recomm Rep, V48, P1; Arno A, 1999, J INFECT DIS, V180, P56, DOI 10.1086/314831; Arno A, 1998, AIDS, V12, P697, DOI 10.1097/00002030-199807000-00005; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Badley AD, 1998, J CLIN INVEST, V102, P79, DOI 10.1172/JCI2691; Bisset LR, 1998, AIDS, V12, P2115, DOI 10.1097/00002030-199816000-00006; BRITES EA, 1998, 12 INT C AIDS JUN 28; Bucy RP, 1999, J CLIN INVEST, V103, P1391, DOI 10.1172/JCI5863; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Canzano JC, 1998, RETINA-J RET VIT DIS, V18, P443; Carr A, 2000, AIDS, V14, pF25, DOI 10.1097/00002030-200002180-00001; Chehimi J, 1997, J IMMUNOL, V158, P5978; CHOWDRY TVH, 2000, 7 C RETR OPP INF JAN; Connick E, 2000, J INFECT DIS, V181, P358, DOI 10.1086/315171; Davey RT, 1997, J INFECT DIS, V175, P781, DOI 10.1086/513971; DEEKS S, 2000, 7 C RETR OPP INF JAN; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; Deresinski SC, 1999, AIDS, V13, P633, DOI 10.1097/00002030-199904160-00003; El-Sadr WM, 2000, NEW ENGL J MED, V342, P1085, DOI 10.1056/NEJM200004133421503; Furrer H, 1999, NEW ENGL J MED, V340, P1301, DOI 10.1056/NEJM199904293401701; Garcia F, 2000, CLIN INFECT DIS, V30, P392, DOI 10.1086/313660; Giorgi JV, 1998, AIDS, V12, P1833, DOI 10.1097/00002030-199814000-00015; Gorochov G, 1998, NAT MED, V4, P215, DOI 10.1038/nm0298-215; Gray CM, 1998, AIDS RES HUM RETROV, V14, P561, DOI 10.1089/aid.1998.14.561; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; HILL A, 1999, 3 INT WORKSH DRUG RE; Jacobson LP, 1999, J ACQ IMMUN DEF SYND, V21, pS34; JOHNSON S, 2000, 7 C RETR OPP INF JAN; Jones JL, 1999, J ACQ IMMUN DEF SYND, V21, pS11; Kanai T, 1996, J IMMUNOL, V157, P3681; Karavellas MP, 1999, J INFECT DIS, V179, P697, DOI 10.1086/314639; KATLAMA C, 2000, 7 C RETR OPP INF JAN; Kees UR, 1999, IMMUNOLOGY, V96, P202; Kelleher AD, 1996, J INFECT DIS, V173, P321, DOI 10.1093/infdis/173.2.321; KINLOCHDELOES S, 1995, NEW ENGL J MED, V333, P408, DOI 10.1056/NEJM199508173330702; Kostense S, 1998, AIDS, V12, pF235, DOI 10.1097/00002030-199818000-00001; Kovacs JA, 2000, NEW ENGL J MED, V342, P1416, DOI 10.1056/NEJM200005113421907; Ledergerber B, 1999, BRIT MED J, V319, P23, DOI 10.1136/bmj.319.7201.23; LEDERGERBER B, 2000, 7 C RETR OPP INF JAN; Lederman MM, 1998, J INFECT DIS, V178, P70, DOI 10.1086/515591; Li TS, 1998, LANCET, V351, P1682, DOI 10.1016/S0140-6736(97)10291-4; Malhotra U, 2000, J INFECT DIS, V181, P121, DOI 10.1086/315202; MCGOVERN B, 1999, 37 ANN M INF DIS SOC; Mezzaroma I, 1999, AIDS, V13, P1187, DOI 10.1097/00002030-199907090-00006; Miller V, 1999, ANN INTERN MED, V130, P570, DOI 10.7326/0003-4819-130-7-199904060-00005; MILLER V, 1999, 39 INT  ANT AG CHEM; MIRO J, 2000, 7 C RETR OPP INF JAN; Mocroft A, 1999, J ACQ IMMUN DEF SYND, V21, P401; Morris L, 1998, J EXP MED, V188, P233, DOI 10.1084/jem.188.2.233; Notermans DW, 1999, J INFECT DIS, V180, P1050, DOI 10.1086/315013; OKAMOTO Y, 2000, 7 C RETR OPP INF JAN; Pakker NG, 1997, J ACQ IMMUN DEF SYND, V16, P318, DOI 10.1097/00042560-199712150-00002; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Patki AH, 1999, AIDS, V13, P1177, DOI 10.1097/00002030-199907090-00005; Patki AH, 1996, J CLIN INVEST, V98, P616, DOI 10.1172/JCI118831; Pezzotti P, 1999, INT J EPIDEMIOL, V28, P975, DOI 10.1093/ije/28.5.975; Piketty C, 1998, AIDS, V12, P745, DOI 10.1097/00002030-199807000-00011; Rabkin CS, 1999, J ACQ IMMUN DEF SYND, V21, pS31; Race EM, 1998, LANCET, V351, P252, DOI 10.1016/S0140-6736(97)04352-3; Renaud M, 1999, AIDS, V13, P669, DOI 10.1097/00002030-199904160-00007; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; ROSENBERG ES, 1999, 37 ANN M INF DIS SOC; TEIXEIRA L, 2000, 7 C RETR OPP INF JAN; Tural C, 1998, J INFECT DIS, V177, P1080, DOI 10.1086/517399; Valdez H, 2000, AIDS, V14, P11, DOI 10.1097/00002030-200001070-00002; Valdez H, 1999, ARCH INTERN MED, V159, P1771, DOI 10.1001/archinte.159.15.1771; VALENTINE F, 1999, 6 C RETR OPP INF JAN; VALENTINE F, 2000, 7 C RETR OPP INF JAN; Vrabec TR, 1998, OPHTHALMOLOGY, V105, P1259, DOI 10.1016/S0161-6420(98)97031-2; Weiss L, 1999, J INFECT DIS, V180, P1057, DOI 10.1086/315025; Wendland T, 1999, AIDS, V13, P1857, DOI 10.1097/00002030-199910010-00007; Weverling GJ, 1999, LANCET, V353, P1293, DOI 10.1016/S0140-6736(99)03287-0; Whitcup SM, 2000, JAMA-J AM MED ASSOC, V283, P653, DOI 10.1001/jama.283.5.653; Whitcup SM, 1999, JAMA-J AM MED ASSOC, V282, P1633, DOI 10.1001/jama.282.17.1633; WU H, 2000, 7 C RETR OPP INF JAN; Wu HL, 1999, J INFECT DIS, V179, P799, DOI 10.1086/314670; Yangco BG, 2000, ANN INTERN MED, V132, P201, DOI 10.7326/0003-4819-132-3-200002010-00005	84	97	100	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 12	2000	284	2					223	228		10.1001/jama.284.2.223	http://dx.doi.org/10.1001/jama.284.2.223			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329XE	10889597				2022-12-24	WOS:000087933100028
J	Schink, B; Friedrich, M				Schink, B; Friedrich, M			Bacterial metabolism - Phosphite oxidation by sulphate reduction	NATURE			English	Article							ACIDS		Univ Constance, Fac Biol, D-78457 Constance, Germany; Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	University of Konstanz; Max Planck Society	Schink, B (corresponding author), Univ Constance, Fac Biol, POB 5560, D-78457 Constance, Germany.		Friedrich, Michael W./B-3151-2013	Friedrich, Michael W./0000-0002-8055-3232				COOPER GW, 1992, GEOCHIM COSMOCHIM AC, V56, P4109, DOI 10.1016/0016-7037(92)90023-C; DEVAI I, 1988, NATURE, V333, P343, DOI 10.1038/333343a0; FOSTER TL, 1978, APPL ENVIRON MICROB, V35, P937, DOI 10.1128/AEM.35.5.937-944.1978; GASSMANN G, 1993, ANGEW CHEM INT EDIT, V32, P761, DOI 10.1002/anie.199307611; GASSMANN G, 1993, NATURWISSENSCHAFTEN, V80, P78, DOI 10.1007/BF01140420; MALACINSKI G, 1966, J BACTERIOL, V91, P578, DOI 10.1128/JB.91.2.578-582.1966; Metcalf WW, 1998, J BACTERIOL, V180, P5547, DOI 10.1128/JB.180.21.5547-5558.1998; Schwartz AW, 1997, J THEOR BIOL, V187, P523, DOI 10.1006/jtbi.1996.0386; Ternan NG, 1998, WORLD J MICROB BIOT, V14, P635, DOI 10.1023/A:1008848401799; TSUBOTA G., 1959, Soil and Plant Food, V5, P10; WEAST RC, 1988, CRC HDB CHEM PHYSICS; WIDDEL F, 1981, ARCH MICROBIOL, V129, P395, DOI 10.1007/BF00406470	12	100	112	3	60	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 6	2000	406	6791					37	37		10.1038/35017644	http://dx.doi.org/10.1038/35017644			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	330ZE	10894531	Green Submitted, Bronze			2022-12-24	WOS:000087991200034
J	Graham, HK				Graham, HK			Pendulum test in cerebral palsy	LANCET			English	Editorial Material							RANDOMIZED CLINICAL-TRIAL; BOTULINUM TOXIN; RHIZOTOMY; LIMB		Royal Childrens Hosp, Dept Orthopaed Surg, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne	Graham, HK (corresponding author), Royal Childrens Hosp, Dept Orthopaed Surg, Parkville, Vic 3052, Australia.		Graham, Kerr/AAK-4383-2020					Corry IS, 1997, DEV MED CHILD NEUROL, V39, P185; COSGROVE AP, 1994, DEV MED CHILD NEUROL, V36, P386; Fowler EG, 2000, DEV MED CHILD NEUROL, V42, P182; KIRSCHNER B, 1985, J CHRON DIS, V40, P171; McLaughlin JF, 1998, DEV MED CHILD NEUROL, V40, P220; ROSENBAUM PL, 1991, DIPLEGIC CHILD; RUSSELL D, 1989, DEV MED CHILD NEUROL, V18, P341; Stanley FJ, 2000, CEREBRAL PALSIES EPI; Steinbok P, 1997, DEV MED CHILD NEUROL, V39, P178; WARTENBERG R, 1951, NEUROLOGY, V1, P18, DOI 10.1212/WNL.1.1.18	10	7	7	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 24	2000	355	9222					2184	2184		10.1016/S0140-6736(00)02399-0	http://dx.doi.org/10.1016/S0140-6736(00)02399-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327DX	10881889				2022-12-24	WOS:000087779000007
J	Leroy, EM; Baize, S; Volchkov, VE; Fisher-Hoch, SP; Georges-Courbot, MC; Lansoud-Soukate, J; Capron, M; Debre, P; McCormick, JB; Georges, AJ				Leroy, EM; Baize, S; Volchkov, VE; Fisher-Hoch, SP; Georges-Courbot, MC; Lansoud-Soukate, J; Capron, M; Debre, P; McCormick, JB; Georges, AJ			Human asymptomatic Ebola infection and strong inflammatory response	LANCET			English	Article							TUMOR-NECROSIS-FACTOR; VIRUS-INFECTION; INTERLEUKIN-1; LYMPHOCYTES; DISEASE; CELLS	Background Ebola virus is one of the most virulent pathogens, killing a very high proportion of patients within 5-7 days. Two outbreaks of fulminating haemorrhagic fever occurred in northern Gabon in 1996, with a 70% case-fatality rate. During both outbreaks we identified some individuals in direct contact with sick patients who never developed symptoms. We aimed to determine whether these individuals were indeed infected with Ebola virus, and how they maintained asymptomatic status. Methods Blood was collected from 24 close contacts of symptomatic patients. These asymptomatic individuals were sampled 2, 3, or 4 times during a 1-month period after the first exposure to symptomatic patients. Serum samples were analysed for the presence of Ebola antigens, virus-specific IgM and IgG (by ELISA and western blot), and different cytokines and chemokines. RNA was extracted from peripheral blood mononuclear cells, and reverse-transcriptase-PCR assays were done to amplify RNA of Ebola virus. PCR products were then sequenced. Findings 11 of 24 asymptomatic individuals developed both IgM and IgG responses to Ebola antigens, indicating viral infection. Western-blot analysis showed that IgG responses were directed to nucleoprotein and viral protein of 40 kDa. The glycoprotein and viral protein of 24 kDa genes showed no nucleotide differences between symptomatic and asymptomatic individuals. Asymptomatic individuals had a strong inflammatory response characterised by high circulating concentrations of cytokines and chemokines. Interpretation This study showed that asymptomatic, replicative Ebola infection can and does occur in human beings. The lack of genetic differences between symptomatic and asymptomatic individuals suggest that asymptomatic Ebola infection did not result from viral mutations. Elucidation of the factors related to the genesis of the strong inflammatory response occurring early during the infectious process in these asymptomatic individuals could increase our understanding of the disease.	Ctr Int Rech Med Franceville, Franceville, Gabon; Univ Marburg, Inst Virol, D-35037 Marburg, Germany; Fdn Marcel Merieux, F-69002 Lyon, France; Inst Pasteur, Ctr Immunol & Biol Parasitaire, INSERM, U167, F-59019 Lille, France; Hop La Pitie Salpetriere, CNRS, Lab Cent Immunol Cellulaire & Tissulaire, Paris, France; Hop La Pitie Salpetriere, Unite U625, Paris, France	Philipps University Marburg; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Leroy, EM (corresponding author), Ctr Int Rech Med Franceville, BP 769, Franceville, Gabon.	leroy@cirmf.sci.ga	LEROY, Eric M/I-4347-2016; Volchkov, Viktor/M-7846-2014	LEROY, Eric M/0000-0003-0022-0890; Volchkov, Viktor/0000-0001-7896-8706; McCormick, Joseph/0000-0002-5844-8102; Baize, Sylvain/0000-0002-3234-7477				Baize S, 1999, NAT MED, V5, P423, DOI 10.1038/7422; BARON RC, 1983, B WORLD HEALTH ORGAN, V61, P997; BOWEN ETW, 1977, LANCET, V1, P571; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; EMOND RTD, 1977, BMJ-BRIT MED J, V2, P541, DOI 10.1136/bmj.2.6086.541; Feldmann H, 1996, J VIROL, V70, P2208, DOI 10.1128/JVI.70.4.2208-2214.1996; Feldmann H, 1996, ADV VIRUS RES, V47, P1, DOI 10.1016/S0065-3527(08)60733-2; FELDMANN H, 1993, ARCH VIROL, V7, pS81; GEISBERT TW, 1992, J COMP PATHOL, V106, P137, DOI 10.1016/0021-9975(92)90043-T; Georges AJ, 1999, J INFECT DIS, V179, pS65, DOI 10.1086/514290; Gunn MD, 1997, J IMMUNOL, V158, P376; Ksiazek TG, 1999, J INFECT DIS, V179, pS192, DOI 10.1086/514313; LE JM, 1987, J IMMUNOL, V139, P3330; Leroy EM, 2000, J MED VIROL, V60, P463, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;463::AID-JMV15&gt;3.0.CO;2-M; Martini G.A., 1971, MARBURG VIRUS DIS; Orange JS, 1996, J IMMUNOL, V156, P4746; Peters CJ, 1999, CURR TOP MICROBIOL, V235, P85; Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291; Rowe AK, 1999, J INFECT DIS, V179, pS28, DOI 10.1086/514318; Ruby J, 1997, J EXP MED, V186, P1591, DOI 10.1084/jem.186.9.1591; Ryabchikova E, 1996, ARCH VIROL, V141, P909, DOI 10.1007/BF01718165; Sanchez A, 1999, J INFECT DIS, V179, pS164, DOI 10.1086/514282; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; SMITH DIH, 1978, B WORLD HEALTH ORGAN, V56, P2447; TAUB DD, 1993, SCIENCE, V260, P355, DOI 10.1126/science.7682337; UNANUE ER, 1987, SCIENCE, V236, P551, DOI 10.1126/science.2437650; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Xu L, 1998, NAT MED, V4, P37, DOI 10.1038/nm0198-037; Yang ZY, 1998, SCIENCE, V279, P1034, DOI 10.1126/science.279.5353.1034; Zaki SR, 1999, J INFECT DIS, V179, pS36, DOI 10.1086/514319	33	301	313	2	71	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2000	355	9222					2210	2215		10.1016/S0140-6736(00)02405-3	http://dx.doi.org/10.1016/S0140-6736(00)02405-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	327DX	10881895	Bronze			2022-12-24	WOS:000087779000013
J	Thornhill, S; Teasdale, GM; Murray, GD; McEwen, J; Roy, CW; Penny, KI				Thornhill, S; Teasdale, GM; Murray, GD; McEwen, J; Roy, CW; Penny, KI			Disability in young people and adults one year after head injury: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							GLASGOW OUTCOME SCALE; TRAUMATIC BRAIN INJURY; CONTROLLED TRIAL; MODERATE; MILD	Objective To determine the frequency of disability in young people and adults admitted to hospital with a head injury and to estimate the annual incidence in the community. Design Prospective, hospital based cohort study, with one year follow up of sample stratified by coma score. Setting Five acute hospitals in Glasgow. Subjects 2962 patients (aged 14 years or more) with head injury; 549 (71%) of the 769 patients selected for follow up participated. Main outcome measures Glasgow outcome scale and problem orientated questionnaire. Results Survival with moderate or severe disability was common after mild head injury (47%, 95% confidence interval 42% to 52%) and similar to that after moderate (45%, 35% to 56%) or severe injury (48%, 36% to 60%). By extrapolation from the population identified (90% of whom had mild injuries), it was estimated that annually in Glasgow (population 909 498) 1400 young people and adults are still disabled one year after head injury. Conclusion The incidence of disability in young people and adults admitted with a head injury is higher than expected. This reflects die high rate of sequelae previously unrecognised in the large number of patients admitted to hospital with an apparently mild head injury.	Univ Glasgow, So Gen NHS Trust, Dept Neurosurg, Glasgow G51 4TF, Lanark, Scotland; Univ Edinburgh, Dept Community Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland; So Gen NHS Trust, Glasgow G51 4TF, Lanark, Scotland; Univ Edinburgh, Dept Community Hlth Sci, Edinburgh, Midlothian, Scotland	University of Glasgow; University of Edinburgh; University of Glasgow; University of Edinburgh	Teasdale, GM (corresponding author), Univ Glasgow, So Gen NHS Trust, Dept Neurosurg, Glasgow G51 4TF, Lanark, Scotland.			Murray, Gordon/0000-0001-9866-4734	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; *BRIT SOC REH MED, 1998, REH TRAUM BRAIN INJ; Bryden J, 1989, MODELS BRAIN INJURY, P17; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; FIELD JH, 1975, EPIDEMIOLOGY HEAD IN; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; JENNETT B, 1975, LANCET, V2, P81; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; Kraus JF, 1993, HEAD INJURY, P1; MacMillan R, 1979, Health Bull (Edinb), V37, P75; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Masson F, 1997, J CLIN EPIDEMIOL, V50, P595, DOI 10.1016/S0895-4356(97)00012-7; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; RELANDER M, 1972, BMJ-BRIT MED J, V4, P777, DOI 10.1136/bmj.4.5843.777; Rice-Oxley M, 1999, CLIN REHABIL, V13, P7, DOI 10.1191/026921599668051623; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; *ROYAL COLL SURG E, 1999, WORK PART MAN PAT HE; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tellier A, 1999, BRAIN INJURY, V13, P463; Wade D T, 1987, Int Rehabil Med, V8, P129; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	24	407	412	1	25	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 17	2000	320	7250					1631	1635		10.1136/bmj.320.7250.1631	http://dx.doi.org/10.1136/bmj.320.7250.1631			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KG	10856063	Green Submitted, Green Published, Green Accepted, Bronze			2022-12-24	WOS:000087734200021
J	Volarevic, S; Stewart, MJ; Ledermann, B; Zilberman, F; Terracciano, L; Montini, E; Grompe, M; Kozma, SC; Thomas, G				Volarevic, S; Stewart, MJ; Ledermann, B; Zilberman, F; Terracciano, L; Montini, E; Grompe, M; Kozma, SC; Thomas, G			Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6	SCIENCE			English	Article							LIVER-REGENERATION; C-MYC; TRANSCRIPTION; MICE; FIBROBLASTS; PROGRESSION; IDENTITY; KINASE; MODEL	Because ribosome biogenesis plays an essential role in cell proliferation, control mechanisms may have evolved to recognize Lesions in this critical anabolic process. To test this possibility, we conditionally deleted the gene encoding 40S ribosomal protein S6 in the Liver of adult mice. Unexpectedly, Livers from fasted animals deficient in S6 grew in response to nutrients even though biogenesis of 40S ribosomes was abolished. However, Liver cells failed to proliferate or induce cyclin E expression after partial hepatectomy, despite formation of active cyclin D-CDK4 complexes. These results imply that abrogation of 40S ribosome biogenesis may induce a checkpoint control that prevents cell cycle progression.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland; Univ Basel, Inst Pathol, Basel, Switzerland; Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA	Friedrich Miescher Institute for Biomedical Research; University of Zurich; University of Basel; Oregon Health & Science University	Thomas, G (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.		Terracciano, Luigi M./AAB-5335-2022; Thomas, George/K-9235-2014; Montini, Eugenio/L-1152-2016; Volarevic, Sinisa/O-4349-2018	Terracciano, Luigi M./0000-0002-9393-9660; Thomas, George/0000-0003-3518-8149; Montini, Eugenio/0000-0003-1771-6067; Volarevic, Sinisa/0000-0003-4893-389X; Grompe, Markus/0000-0002-6616-4345				BOWMAN LH, 1983, MOL CELL BIOL, V3, P1501, DOI 10.1128/MCB.3.8.1501; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CONDE RD, 1980, BIOCHEM J, V192, P935, DOI 10.1042/bj1920935; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Gourse RL, 1996, ANNU REV MICROBIOL, V50, P645, DOI 10.1146/annurev.micro.50.1.645; HUTSON NJ, 1982, J BIOL CHEM, V257, P9548; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; KOZMA SC, 1989, EMBO J, V8, P4125, DOI 10.1002/j.1460-2075.1989.tb08597.x; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LODISH HF, 1974, NATURE, V251, P385, DOI 10.1038/251385a0; MARTINEZHERNANDEZ A, 1995, FASEB J, V9, P1401, DOI 10.1096/fasebj.9.14.7589981; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; MONTINI E, UNPUB; Nasmyth K, 1996, NATURE, V382, P28, DOI 10.1038/382028a0; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Su TT, 1998, CURR BIOL, V8, pR687, DOI 10.1016/S0960-9822(98)70436-1; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; VOLAREVIC S, UNPUB; Wool I. G., 1996, TRANSLATIONAL CONTRO, P685	28	301	317	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2000	288	5473					2045	+		10.1126/science.288.5473.2045	http://dx.doi.org/10.1126/science.288.5473.2045			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856218				2022-12-24	WOS:000087687000051
J	Kremen, C; Niles, JO; Dalton, MG; Daily, GC; Ehrlich, PR; Fay, JP; Grewal, D; Guillery, RP				Kremen, C; Niles, JO; Dalton, MG; Daily, GC; Ehrlich, PR; Fay, JP; Grewal, D; Guillery, RP			Economic incentives for rain forest conservation across scales	SCIENCE			English	Article							GREENHOUSE GASES; BIODIVERSITY; MADAGASCAR; AMAZONIA; TOOL	Globally, tropical deforestation releases 20 to 30% of anthropogenic green-house gases. Conserving forests could reduce emissions, but the cost-effectiveness of this mechanism for mitigation depends on the associated opportunity costs. We estimated these costs from local, national, and global perspectives using a case study from Madagascar, Conservation generated significant benefits over logging and agriculture Locally and globally. Nationally, however, financial benefits from industrial logging were Larger than conservation benefits. Such differing economic signals across scales may exacerbate tropical deforestation. The Kyoto Protocol could potentially overcome this obstacle to conservation by creating markers for protection of tropical forests to mitigate climate change.	Stanford Univ, Dept Biol Sci, Ctr Conservat Biol, Stanford, CA 94305 USA; CSU Monterey Bay, Inst Earth Syst Sci & Policy, Seaside, CA 93955 USA; Yale Univ, Sch Law, New Haven, CT 06511 USA; Inst Agr & Trade Policy, Minneapolis, MN 55404 USA	Stanford University; California State University System; California State University Monterey Bay; Yale University	Kremen, C (corresponding author), Stanford Univ, Dept Biol Sci, Ctr Conservat Biol, Stanford, CA 94305 USA.	ckremen@stanford.edu						*AS PAC ACT GROUP, 1990, BARN REP; *AS PAC FOR SECT, 1998, AS PAC FOR 2000; Barbier E, 1994, CAUSES TROPICAL DEFO, P271; Barreto P, 1998, FOREST ECOL MANAG, V108, P9, DOI 10.1016/S0378-1127(97)00251-X; Bowles IA, 1998, SCIENCE, V280, P1899, DOI 10.1126/science.280.5371.1899; BROWN S, 1996, CLIMATE CHANGE 1995, P774; Brunner J, 1998, LOGGING BURMAS FRONT; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Fankhauser S, 1995, VALUING CLIMATE CHAN; FAO, 1999, STAT WORLDS FOR; Fearnside PM, 1997, CLIMATIC CHANGE, V35, P321, DOI 10.1023/A:1005336724350; GOLDBERG DC, 1998, CARBON CONSERVATION; HARDNER J, 1999, ASSESSMENT EC OPPORT; HARDNER JJ, IN PRESS MITIGATION; HATCHWELL MC, COMMUNICATION; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Johns AG., 1997, TIMBER PRODUCTION BI; Kramer R, 1997, LAST STAND PROTECTED; Kramer RA, 1997, J ENVIRON MANAGE, V49, P277, DOI 10.1006/jema.1995.0085; Kremen C, 1998, CONSERV BIOL, V12, P549, DOI 10.1046/j.1523-1739.1998.96374.x; Kremen C, 1999, CONSERV BIOL, V13, P1055, DOI 10.1046/j.1523-1739.1999.98374.x; LEMARAINA R, UNPUB; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; NILES JO, 2000, P IEA BIOEN TASK25 W; NORDHAUS WD, 1992, SCIENCE, V258, P1315, DOI 10.1126/science.258.5086.1315; Pearce D., 1994, CAUSES TROPICAL DEFO, P2; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; *POP REF BUR, 1997, WORLD POP DAT SHEET; RAKOTOARISOA JN, 1997, THESIS U ANTANANARIV; RAMILISON C, 1997, COMMUNICATION    DEC; RAYMOND I, 1995, THESIS U ANTANANARIV; ROBINSON JG, 1993, CONSERV BIOL, V7, P20, DOI 10.1046/j.1523-1739.1993.07010020.x; Roughgarden T, 1999, ENERG POLICY, V27, P415, DOI 10.1016/S0301-4215(99)00030-0; Ruitenbeek H.J., 1992, ECOL ECON, V6, P5778, DOI 10.1016/0921-8009(92)90038-T; Schneider SH, 1998, CLIMATIC CHANGE, V39, P1, DOI 10.1023/A:1005374030204; Schwarze R, 2000, ECOL ECON, V32, P255, DOI 10.1016/S0921-8009(99)00095-6; Trenberth KE, 1995, CLIMATE CHANGE 1995: THE SCIENCE OF CLIMATE CHANGE, P51; Walker B. H., 1999, ENVIRON DEV ECON, V4, P204; Wolfire D., 1998, FORESTS DEMOCRATIC R; *WORLD BANK, 1993, 1993 EV RES WORLD BA; *WORLD BANK, 1996, WORLD DEV REP 1996	41	185	198	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2000	288	5472					1828	1832		10.1126/science.288.5472.1828	http://dx.doi.org/10.1126/science.288.5472.1828			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	322HH	10846165				2022-12-24	WOS:000087503800051
J	Toyoshima, C; Nakasako, M; Nomura, H; Ogawa, H				Toyoshima, C; Nakasako, M; Nomura, H; Ogawa, H			Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 angstrom resolution	NATURE			English	Article							CA2+ TRANSPORT ATPASE; NUCLEOTIDE-BINDING; ACTIVE-SITE; L-2-HALOACID DEHALOGENASE; FUNCTIONAL CONSEQUENCES; SKELETAL-MUSCLE; CA2+-ATPASE; CA-2+-ATPASE; DOMAIN; MECHANISM	Calcium ATPase is a member of the P-type ATPases that transport ions across the membrane against a concentration gradient. Here we have solved the crystal structure of the calcium ATPase of skeletal muscle sarcoplasmic reticulum (SERCA1a) at 2.6 Angstrom resolution with two calcium ions bound in the transmembrane domain, which comprises ten alpha-helices. The two calcium ions are located side by side and are surrounded by four transmembrane helices, two of which are unwound for efficient coordination geometry. The cytoplasmic region consists of three well separated domains, with the phosphorylation site in the central catalytic domain and the adenosine-binding site on another domain. The phosphorylation domain has the same fold as haloacid dehalogenase. Comparison with a low-resolution electron density map of the enzyme in the absence of calcium and with biochemical data suggests that large domain movements take place during active transport.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Inst Phys & Chem Res, Harima Inst, Hyogo 6795143, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi 3320012, Japan	University of Tokyo; RIKEN; Japan Science & Technology Agency (JST)	Toyoshima, C (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	ct@iam.u-tokyo.ac.jp	Toyoshima, Chikashi/R-4153-2019	Toyoshima, Chikashi/0000-0001-9640-0778				ADACHI S, 1996, SPRING 8 ANN REPORT, V1, P239; ANDERSEN JP, 1986, J MEMBRANE BIOL, V93, P85, DOI 10.1007/BF01871021; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Champeil P, 1998, J BIOL CHEM, V273, P6619, DOI 10.1074/jbc.273.12.6619; CLARKE DM, 1989, J BIOL CHEM, V264, P11246; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; CLARKE DM, 1990, J BIOL CHEM, V265, P22223; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DUX L, 1987, J BIOL CHEM, V262, P6439; DUX L, 1983, J BIOL CHEM, V258, P2599; EBASHI S, 1962, J CELL BIOL, V14, P389, DOI 10.1083/jcb.14.3.389; Falson P, 1997, J BIOL CHEM, V272, P17258, DOI 10.1074/jbc.272.28.17258; Goldshleger R, 1997, P NATL ACAD SCI USA, V94, P9596, DOI 10.1073/pnas.94.18.9596; Hisano T, 1996, J BIOL CHEM, V271, P20322, DOI 10.1074/jbc.271.34.20322; Huang SH, 1998, BIOCHEMISTRY-US, V37, P18064, DOI 10.1021/bi981997+; INESI G, 1980, J BIOL CHEM, V255, P3025; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAMIYA N, 1995, REV SCI INSTRUM, V66, P1703, DOI 10.1063/1.1145888; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LESLIE AGW, 1998, CCP4 NEWSLETTER PROT, V35, P18; Li YF, 1998, J BIOL CHEM, V273, P15035, DOI 10.1074/jbc.273.24.15035; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; McIntosh D.B., 1998, ADV MOL CEL A&B, V23A, P33; MCINTOSH DB, 1992, J BIOL CHEM, V267, P22328; MCINTOSH DB, 1992, J BIOL CHEM, V267, P5301; McIntosh DB, 1996, J BIOL CHEM, V271, P25778, DOI 10.1074/jbc.271.42.25778; MISRA M, 1991, BIOCHIM BIOPHYS ACTA, V1077, P107, DOI 10.1016/0167-4838(91)90532-5; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; NAKAMOTO RK, 1984, J BIOL CHEM, V259, P2961; NAYAL M, 1994, P NATL ACAD SCI USA, V91, P817, DOI 10.1073/pnas.91.2.817; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ogawa H, 1998, BIOPHYS J, V75, P41, DOI 10.1016/S0006-3495(98)77493-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OVCHINNIKOV YA, 1987, FEBS LETT, V217, P111, DOI 10.1016/0014-5793(87)81253-X; PICK U, 1981, EUR J BIOCHEM, V121, P187, DOI 10.1111/j.1432-1033.1981.tb06448.x; Rice WJ, 1997, J BIOL CHEM, V272, P31412, DOI 10.1074/jbc.272.50.31412; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Soulie S, 1999, BIOCHEMISTRY-US, V38, P5813, DOI 10.1021/bi983039d; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; TOYOFUKU T, 1994, J BIOL CHEM, V269, P22929; TOYOSHIMA C, 1993, NATURE, V362, P469, DOI 10.1038/362469a0; YAMAMOTO H, 1989, J BIOCHEM-TOKYO, V106, P1121, DOI 10.1093/oxfordjournals.jbchem.a122976; Yu MH, 1998, J BIOL CHEM, V273, P3542, DOI 10.1074/jbc.273.6.3542; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959	50	1535	1571	6	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2000	405	6787					647	655		10.1038/35015017	http://dx.doi.org/10.1038/35015017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864315				2022-12-24	WOS:000087465800037
J	Singh, N; Singh, PN; Hershman, JM				Singh, N; Singh, PN; Hershman, JM			Effect of calcium carbonate on the absorption of levothyroxine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTESTINAL-ABSORPTION; ALUMINUM HYDROXIDE; THYROXINE; HYPOTHYROIDISM; SUCRALFATE; EFFICACY; THERAPY	Context The effect of calcium carbonate on the absorption of levothyroxine has not been studied systematically. Such a potential drug interaction merits investigation because concurrent treatment with both drugs is common, particularly in postmenopausal women. Objective To investigate the potential interference of calcium carbonate in the absorption of levothyroxine. Design Prospective cohort study conducted from November 1998 to June 1999, supplemented with an in vitro study of thyroxine (T-4) binding to calcium carbonate. Setting Veterans Affairs Medical Center in West Los Angeles, Calif. Patients Twenty patients (age range, 27-78 years; n=11 men) with hypothyroidism who were taking a stable long-term regimen of levothyroxine were included in the study. All patients had serum free T-4 and thyrotropin values in the normal range before beginning the study. Intervention Subjects were instructed to take 1200 mg/d of elemental calcium as calcium carbonate, ingested with their levothyroxine, for 3 months. Main Outcome Measures Levels of free T-4, total T-4, total triiodothyronine (T-3), and thyrotropin, measured in all subjects at baseline (while taking levothyroxine alone), at 2 and 3 months (while taking calcium carbonate and levothyroxine), and 2 months after calcium carbonate discontinuation (while continuing to take levothyroxine). Results Mean free T-4 and total T-4 levels were significantly reduced during the calcium period and increased after calcium discontinuation. Mean free T-4 levels were 17 pmol/L (1.3 ng/dL) at baseline, 15 pmol/L (1.2 ng/dL) during the calcium period, and 18 pmol/L (1.4 ng/dL) after calcium discontinuation (overall P<.001); mean total T-4 levels were 118 nmol/L (9.2 mu g/dL) at baseline, 111 nmol/L (8.6 mu g/dL) during the calcium period, and 120 nmol/L (9.3 mu g/dL) after calcium discontinuation (overall P=.03), Mean thyrotropin levels increased significantly, from 1.6 mIU/L at baseline to 2.7 mIU/L during the calcium period, and decreased to 1.4 mIU/L after calcium discontinuation (P=.008). Twenty percent of patients had serum thyrotropin levels higher than the normal range during the calcium period; the highest observed level was 7.8 mIU/L. Mean T-3 levels did not change du ring the calcium period. The in vitro study of T-4 binding to calcium showed that adsorption of T-4 to calcium carbonate occurs at acidic pH levels. Conclusions This study of 20 patients receiving long-term levothyroxine replacement therapy indicates that calcium carbonate reduces T-4 absorption and increases serum thyrotropin levels. Levothyroxine adsorbs to calcium carbonate in an acidic environment, which may reduce its bioavailability.	Univ Calif Los Angeles, Sch Med, VA Greater Los Angeles Healthcare Syst, Div Endocrinol & Metab, Los Angeles, CA 90073 USA; Loma Linda Med Ctr, Div Epidemiol, Loma Linda, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Loma Linda University	Singh, N (corresponding author), Univ Calif Los Angeles, Sch Med, VA Greater Los Angeles Healthcare Syst, Div Endocrinol & Metab, 11301 Wilshire Blvd, Los Angeles, CA 90073 USA.		Singh, Pramil/C-5285-2012	Singh, Pramil/0000-0002-9820-2887				BENVENGA S, 1995, THYROID, V5, P249, DOI 10.1089/thy.1995.5.249; CAMPBELL NRC, 1992, ANN INTERN MED, V117, P1010, DOI 10.7326/0003-4819-117-12-1010; HAVRANKOVA J, 1992, ANN INTERN MED, V117, P445, DOI 10.7326/0003-4819-117-5-445_3; Hays M T, 1991, Thyroid, V1, P241, DOI 10.1089/thy.1991.1.241; HAYS MT, 1968, J CLIN ENDOCR METAB, V28, P749, DOI 10.1210/jcem-28-6-749; Kung AWC, 1996, J CLIN ENDOCR METAB, V81, P1232, DOI 10.1210/jc.81.3.1232; LIEL Y, 1994, AM J MED, V97, P363, DOI 10.1016/0002-9343(94)90303-4; Liel Y, 1996, J CLIN ENDOCR METAB, V81, P857, DOI 10.1210/jc.81.2.857; MANDEL SJ, 1993, ANN INTERN MED, V119, P492, DOI 10.7326/0003-4819-119-6-199309150-00009; McCowen KC, 1997, NEW ENGL J MED, V337, P1010; NORTHCUTT RC, 1969, J AMER MED ASSOC, V208, P1857; READ DG, 1970, J CLIN ENDOCR METAB, V30, P798, DOI 10.1210/jcem-30-6-798; Ross Douglas S., 1996, P1010; Schneyer CR, 1998, JAMA-J AM MED ASSOC, V279, P750, DOI 10.1001/jama.279.10.750-b; SHERMAN SI, 1994, AM J MED, V96, P531, DOI 10.1016/0002-9343(94)90093-0; SPERBER AD, 1992, ARCH INTERN MED, V152, P183, DOI 10.1001/archinte.152.1.183; Tanis BC, 1996, CLIN ENDOCRINOL, V44, P643, DOI 10.1046/j.1365-2265.1996.739560.x	17	115	122	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2000	283	21					2822	2825		10.1001/jama.283.21.2822	http://dx.doi.org/10.1001/jama.283.21.2822			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BQ	10838651	Bronze			2022-12-24	WOS:000087381500037
J	Steel, N				Steel, N			Thresholds for taking antihypertensive drugs in different professional and lay groups: questionnaire survey	BRITISH MEDICAL JOURNAL			English	Article							HYPERTENSION; THERAPY		Univ E Anglia, Sch Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Steel, N (corresponding author), Univ E Anglia, Sch Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England.		Steel, Nicholas/K-1592-2014	Steel, Nicholas/0000-0003-1528-140X				Friedmann PD, 1996, ANN INTERN MED, V124, P414, DOI 10.7326/0003-4819-124-4-199602150-00005; Gueyffier F, 1996, J HUM HYPERTENS, V10, P1; MULROW C, 1998, COCHRANE LIB; Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; REED WW, 1993, J GEN INTERN MED, V8, P591, DOI 10.1007/BF02599710	5	72	73	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 27	2000	320	7247					1446	1447		10.1136/bmj.320.7247.1446	http://dx.doi.org/10.1136/bmj.320.7247.1446			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320RT	10827049	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000087414700027
J	Grosshans, J; Wieschaus, E				Grosshans, J; Wieschaus, E			A genetic link between morphogenesis and cell division during formation of the ventral furrow in Drosophila	CELL			English	Article							SHAPE CHANGES; FISSION YEAST; MITOTIC INHIBITOR; KINASE; PROTEIN; GASTRULATION; EMBRYOS; INDUCER; MITOSIS; CYCLE	Stages in development with rapid transitions between mitosis and morphogenesis may require specific mechanisms to coordinate cell shape change. Here we describe a novel mitotic inhibitor that acts during Drosophila gastrulation to counteract String/Cdc25, specifically in the cells that invaginate to form the mesoderm. We have identified two genes, fruhstart and tribbles, that are required for this ventral inhibition. tribbles encodes a kinase-related protein whose RNA, however, is also present outside of the ventral region. Effective inhibition of mitosis in the cells of the ventral furrow depends on the transcription factor Snail that triggers the ventral cell shape changes. When overexpressed in a microinjection assay, Tribbles directly inhibits mitosis. We propose that Fruhstart and Tribbles form a link between the morphogenetic movements and mitotic control.	Princeton Univ, Dept Mol Biol, Howard Hughes Med Inst, Princeton, NJ 08540 USA	Howard Hughes Medical Institute; Princeton University	Grosshans, J (corresponding author), Princeton Univ, Dept Mol Biol, Howard Hughes Med Inst, Princeton, NJ 08540 USA.	jgrosshans@molbia.princeton.edu	Großhans, Jörg/AAE-9387-2020	Großhans, Jörg/0000-0003-1114-9233	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD015587] Funding Source: NIH RePORTER; NICHD NIH HHS [5R37HD15587] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARORA K, 1992, DEVELOPMENT, V114, P1003; Ashburner M., 1989, DROSOPHILA LAB HDB; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Barrett K, 1997, CELL, V91, P905, DOI 10.1016/S0092-8674(00)80482-1; CAMPBELL SD, 1995, MOL BIOL CELL, V6, P1333, DOI 10.1091/mbc.6.10.1333; Clarkson M, 1999, DNA CELL BIOL, V18, P457, DOI 10.1089/104454999315178; COLEMAN TR, 1993, CELL, V72, P919, DOI 10.1016/0092-8674(93)90580-J; COSTA M, 1994, CELL, V76, P1075, DOI 10.1016/0092-8674(94)90384-0; Costa Michael, 1993, P425; EDGAR BA, 1994, DEVELOPMENT, V120, P3131; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; EDGAR BA, 1990, CELL, V62, P469, DOI 10.1016/0092-8674(90)90012-4; FEATHERSTONE C, 1991, NATURE, V349, P808, DOI 10.1038/349808a0; FOE VE, 1989, DEVELOPMENT, V107, P1; Foe Victoria E., 1993, P149; Grosshans J, 1999, MECH DEVELOP, V81, P127, DOI 10.1016/S0925-4773(98)00236-6; Hacker U, 1998, GENE DEV, V12, P274, DOI 10.1101/gad.12.2.274; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Johnston LA, 1998, NATURE, V394, P82, DOI 10.1038/27925; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Leptin M, 1995, ANNU REV CELL DEV BI, V11, P189; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MILLAR JBA, 1992, CELL, V68, P407, DOI 10.1016/0092-8674(92)90177-E; Morize P, 1998, DEVELOPMENT, V125, P589; Muller HAJ, 1999, DEVELOPMENT, V126, P577; PARKER LL, 1991, EMBO J, V10, P1255, DOI 10.1002/j.1460-2075.1991.tb08067.x; PARKER LL, 1993, NATURE, V363, P736, DOI 10.1038/363736a0; Robert D. G., 1998, DROSOPHILA PRACTICAL; Rorth P, 1998, DEVELOPMENT, V125, P1049; Rose RE, 1997, GENETICS, V146, P595; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; RUSSELL P, 1987, CELL, V49, P569, DOI 10.1016/0092-8674(87)90459-4; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; WU L, 1993, NATURE, V363, P738, DOI 10.1038/363738a0	37	273	284	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 26	2000	101	5					523	531		10.1016/S0092-8674(00)80862-4	http://dx.doi.org/10.1016/S0092-8674(00)80862-4			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850494	Bronze			2022-12-24	WOS:000087375400009
J	Fischer, G; James, SA; Roberts, IN; Oliver, SG; Louis, EJ				Fischer, G; James, SA; Roberts, IN; Oliver, SG; Louis, EJ			Chromosomal evolution in Saccharomyces	NATURE			English	Article							SENSU-STRICTO COMPLEX; MISMATCH REPAIR; YEAST GENOME; CEREVISIAE; POPULATIONS; REORGANIZATION; RECOMBINATION; TRANSLOCATION; DUPLICATION; ELEMENTS	The chromosomal speciation model invokes chromosomal rearrangements as the primary cause of reproductive isolation(1). In a heterozygous carrier, chromosomes bearing reciprocal translocations mis-segregate at meiosis, resulting in reduced fertility or complete sterility. Thus, chromosomal rearrangements act as a post-zygotic isolating mechanism. Reproductive isolation in yeast is due to post-zygotic barriers, as many species mate successfully but the hybrids are sterile(2,3). Reciprocal translocations are thought to be the main form of large-scale rearrangement since the hypothesized duplication of the whole yeast genome 10(8) years ago(4,5). To test the chromosomal speciation model in yeast, we have characterized chromosomal translocations among the genomes of six closely related species in the Saccharomyces 'sensu stricto' complex(6). Here we show that rearrangements have occurred between closely related species, whereas more distant ones have colinear genomes. Thus, chromosomal rearrangements are not a prerequisite for speciation in yeast and the rate of formation of translocations is not constant. These rearrangements appear to result from ectopic recombination between Ty elements or other repeated sequences.	Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Inst Food Res, Natl Collect Yeast Cultures, Norwich NR4 7UA, Norfolk, England; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Oxford; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Manchester	Louis, EJ (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	elouis@molbiol.ox.ac.uk	Roberts, Ian N/B-9743-2008; Fischer, Gilles/Q-4603-2019; Louis, Edward/B-7920-2008; Fischer, Gilles/G-6654-2016	Fischer, Gilles/0000-0001-5732-2682; Louis, Edward/0000-0003-1157-3608; 				ADAMS J, 1992, CURR GENET, V22, P13, DOI 10.1007/BF00351736; ADAMS J, 1986, P NATL ACAD SCI USA, V83, P7124, DOI 10.1073/pnas.83.18.7124; BAILIS AM, 1990, GENETICS, V126, P535; BOEKE JD, 1991, GENETICS, V129, P1043; Codon AC, 1997, CURR GENET, V32, P247; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Hani J, 1998, NUCLEIC ACIDS RES, V26, P689, DOI 10.1093/nar/26.3.689; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; James SA, 1996, INT J SYST BACTERIOL, V46, P189, DOI 10.1099/00207713-46-1-189; James SA, 1997, INT J SYST BACTERIOL, V47, P453, DOI 10.1099/00207713-47-2-453; KUPIEC M, 1988, MOL CELL BIOL, V8, P2942, DOI 10.1128/MCB.8.7.2942; Loidl J, 1998, CHROMOSOMA, V107, P247, DOI 10.1007/s004120050304; Louis Edward J., 1998, V26, P15; NAUMOV G I, 1987, Studies in Mycology, P469; NAUMOV GI, 1995, ANTON LEEUW INT J G, V67, P351, DOI 10.1007/BF00872934; Naumov GI, 1995, J GEN APPL MICROBIOL, V41, P499, DOI 10.2323/jgam.41.499; Rachidi N, 1999, MOL GEN GENET, V261, P841, DOI 10.1007/s004380050028; Ryu SL, 1998, CURR GENET, V33, P345, DOI 10.1007/s002940050346; Ryu SL, 1996, YEAST, V12, P757, DOI 10.1002/(SICI)1097-0061(19960630)12:8<757::AID-YEA970>3.0.CO;2-H; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seoighe C, 1998, P NATL ACAD SCI USA, V95, P4447, DOI 10.1073/pnas.95.8.4447; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Tamai Y, 1998, YEAST, V14, P923, DOI 10.1002/(SICI)1097-0061(199807)14:10<923::AID-YEA298>3.3.CO;2-9; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	27	244	254	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2000	405	6785					451	454		10.1038/35013058	http://dx.doi.org/10.1038/35013058			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839539				2022-12-24	WOS:000087212000047
J	Ganz, DA; Kuntz, KM; Jacobson, GA; Avorn, J				Ganz, DA; Kuntz, KM; Jacobson, GA; Avorn, J			Cost-effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor therapy in older patients with myocardial infarction	ANNALS OF INTERNAL MEDICINE			English	Article							AVERAGE CHOLESTEROL LEVELS; CORONARY HEART-DISEASE; LONG-TERM SURVIVAL; EVENTS CARE TRIAL; ELDERLY PATIENTS; CARDIOVASCULAR EVENTS; SECONDARY PREVENTION; STROKE PROJECT; PRAVASTATIN; AGE	Background: 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin) therapy has proven efficacy in reducing the rate of coronary and cerebrovascular events in patients 75 years of age or younger with a history of myocardial infarction. However, in patients older than 75 years of age, the efficacy and potential cost-effectiveness of statins are unknown. Objective: To estimate the incremental cost-effectiveness of statin therapy compared with usual care in patients 75 to 84 years of age with previous myocardial infarction. Design: Cost-effectiveness analysis. Data Sources: Published data from cohort studies. Target Population: Patients 75 to 84 years of age with a history of myocardial infarction. Time Horizon: Lifetime. Perspective: Societal. Intervention: Statin therapy. Outcome Measures: Life expectancy, quality-adjusted life expectancy, and incremental cost-effectiveness. Results of Base-Case Analysis: The incremental cost-effectiveness of statin therapy compared with usual care in patients 75 to 84 years of age with previous myocardial infarction was $18 800 per quality-adjusted life-year (QALY). Results of Sensitivity Analysis: On the basis of a probabilistic sensitivity analysis, there is a 75% chance that statin therapy costs less than $39 800 per QALY compared with usual care. If the cost of statin therapy and efficacy of statin therapy at reducing myocardial infarction were set to their most favorable values, statin therapy cost $5400 per QALY; if cost and efficacy were set to their least favorable values, statin therapy cost $97 800 per QALY. Conclusions: The cost-effectiveness ratios of statin therapy in older patients with previous myocardial infarction are reasonable under a wide variety of assumptions about drug efficacy, drug cost, and rates of cardiac and cerebrovascular events. Pending results of randomized, controlled trials of secondary prevention in patients in this age group, statin therapy seems to be as cost-effective as many routinely accepted medical interventions in this setting.	Harvard Univ, Sch Publ Hlth, Ctr Risk Anal, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Avorn, J (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 221 Longwood Ave,Suite 341, Boston, MA 02115 USA.							BENHORIN J, 1990, J AM COLL CARDIOL, V15, P253, DOI 10.1016/S0735-1097(10)80043-9; Caro J, 1997, BRIT MED J, V315, P1577, DOI 10.1136/bmj.315.7122.1577; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; DENNIS MS, 1993, STROKE, V24, P796, DOI 10.1161/01.STR.24.6.796; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Glasser SP, 1996, AM J CARDIOL, V77, P83, DOI 10.1016/S0002-9149(97)89140-0; GOLD MR, 1996, COST EFFECTIVENESS H, P198; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; Goldberg RJ, 1998, AM J CARDIOL, V82, P1311, DOI 10.1016/S0002-9149(98)00633-X; GOLDMAN L, 1991, JAMA-J AM MED ASSOC, V265, P1145, DOI 10.1001/jama.265.9.1145; GORE JM, 1995, CIRCULATION, V92, P2811, DOI 10.1161/01.CIR.92.10.2811; Graham JD, 1998, ANNU REV PUBL HEALTH, V19, P125, DOI 10.1146/annurev.publhealth.19.1.125; Grover SA, 1999, ARCH INTERN MED, V159, P593, DOI 10.1001/archinte.159.6.593; Grundy SM, 1998, ENDOCRIN METAB CLIN, V27, P655, DOI 10.1016/S0889-8529(05)70032-3; Health Care Investment Analysts Inc. Ernst and Young., 1998, DRG HDB COMP CLIN FI; Herlitz J, 1996, CARDIOLOGY, V87, P529, DOI 10.1159/000177150; Johannesson M, 1997, NEW ENGL J MED, V336, P332, DOI 10.1056/NEJM199701303360503; Kolominsky-Rabas PL, 1998, STROKE, V29, P2501, DOI 10.1161/01.STR.29.12.2501; KUNTZ KM, 1995, MED DECIS MAKING, V15, P158, DOI 10.1177/0272989X9501500209; LAVE JR, 1994, MED CARE, V32, pJS77; Lewis SJ, 1998, ANN INTERN MED, V129, P681, DOI 10.7326/0003-4819-129-9-199811010-00002; Manton KG, 1996, J GERONTOL A-BIOL, V51, pB362, DOI 10.1093/gerona/51A.5.B362; MARCUS FI, 1990, AM J CARDIOL, V65, P559, DOI 10.1016/0002-9149(90)91031-Z; Miettinen TA, 1997, CIRCULATION, V96, P4211; *NAT CTR HLTH STAT, 1995, DHHS PUBLICATION; PEDERSEN TR, 1994, LANCET, V344, P1383; Roberts WC, 1997, AM J CARDIOL, V80, P106, DOI 10.1016/S0002-9149(97)00298-1; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SANTINGA JT, 1994, AM J MED, V96, P509, DOI 10.1016/0002-9343(94)90090-6; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shepherd J, 1999, AM J CARDIOL, V84, P1192, DOI 10.1016/S0002-9149(99)00533-0; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Tung CY, 1999, CIRCULATION, V99, P370, DOI 10.1161/01.CIR.99.3.370; Whisnant JP, 1996, NEUROLOGY, V47, P1420, DOI 10.1212/WNL.47.6.1420; 1998, CLIN DIAGNOSTIC LAB; 1998, DRUG TOPICS RED BOOK; 1998, NATL PHYSICIAN FEE S	40	73	73	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2000	132	10					780	787		10.7326/0003-4819-132-10-200005160-00003	http://dx.doi.org/10.7326/0003-4819-132-10-200005160-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313XN	10819700				2022-12-24	WOS:000087025100002
J	Walter, RC; Buffler, RT; Bruggemann, JH; Guillaume, MMM; Berhe, SM; Negassi, B; Libsekal, Y; Cheng, H; Edwards, RL; von Cosel, R; Neraudeau, D; Gagnon, M				Walter, RC; Buffler, RT; Bruggemann, JH; Guillaume, MMM; Berhe, SM; Negassi, B; Libsekal, Y; Cheng, H; Edwards, RL; von Cosel, R; Neraudeau, D; Gagnon, M			Early human occupation of the Red Sea coast of Eritrea during the last interglacial	NATURE			English	Article							DATED CORAL-REEFS; STRATIGRAPHY; SINAI	The geographical origin of modern humans is the subject of ongoing scientific debate. The 'multiregional evolution' hypothesis argues that modern humans evolved semi-independently in Europe, Asia and Africa between 100,000 and 40,000 years ago 1, whereas the 'out of Africa' hypothesis contends that modern humans evolved in Africa between 200 and 100 kyr ago, migrating to Eurasia at some later time(2). Direct palaeontological, archaeological and biological evidence is necessary to resolve this debate. Here we report the discovery of early Middle Stone Age artefacts in an emerged reef terrace on the Red Sea coast of Eritrea, which we date to the last interglacial (about 125 kyr ago) using U-Th mass spectrometry techniques on fossil corals. The geological setting of these artefacts shows that early humans occupied coastal areas and exploited near-shore marine food resources in East Africa by this time. Together with similar, tentatively dated discoveries from South Africa(3) this is the earliest well-dated evidence for human adaptation to a coastal marine environment, heralding an expansion in the range and complexity of human behaviour from one end of Africa to the other. This new, widespread adaptive strategy may, in part, signal the onset of modern human behaviour, which supports an African origin for modern humans by 125 kyr ago.	Ctr Invest Cient Educ Super Ensenada, Dept Geol, Ensenada, Baja California, Mexico; Univ Texas, Inst Geophys, Austin, TX 78712 USA; Univ Groningen, Dept Marine Biol, NL-9750 AA Haren, Netherlands; Univ Asmara, Dept Fisheries & Marine Biol, Asmera, Eritrea; Wageningen Univ Agr, Wageningen Inst Anim Sci, Expt Zool Grp, NL-6700 AH Wageningen, Netherlands; Museum Natl Hist Nat, Lab Biol Invertebres Marins & Malacol, CNRS, ESA 8044, F-75005 Paris, France; African Minerals Inc, Asmera, Eritrea; Minist Energy & Mines, Dept Mines, Asmera, Eritrea; Natl Museum Eritrea, Asmera, Eritrea; Univ Asmara, Archaeol Unit, Asmera, Eritrea; Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA; Univ Rennes 1, Geosci Rennes, Lab Paleontol, F-35042 Rennes, France; Univ Toronto, Dept Anthropol, Toronto, ON M5S 3G3, Canada	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; University of Texas System; University of Texas Austin; University of Groningen; Wageningen University & Research; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); University of Minnesota System; University of Minnesota Twin Cities; Universite de Rennes; University of Toronto	Walter, RC (corresponding author), Ctr Invest Cient Educ Super Ensenada, Dept Geol, Km 107 Carr Tijuana Ensenada, Ensenada, Baja California, Mexico.	rwalter@cicese.mx	Walter, Robert/AAD-7642-2020; Edwards, R. Lawrence/I-3124-2014	Walter, Robert/0000-0001-8761-5355; Edwards, R. Lawrence/0000-0002-7027-5881; GUILLAUME, Mireille M. M./0000-0001-7249-0131				Brink J.S., 1982, Palaeoecology of Africa and the Surrounding Islands, V15, P31; CHEN JH, 1991, GEOL SOC AM BULL, V103, P82, DOI 10.1130/0016-7606(1991)103<0082:PCOTLI>2.3.CO;2; CHENG H, IN PRESS HALF LIVES; CLARK JD, 1988, J WORLD PREHIST, V2, P235, DOI 10.1007/BF00975618; CONFORTO L, 1976, SOC IT MIN PET, V32, P153; DEACON HJ, 1989, HUMAN REVOLUTION, P547; EDWARDS RL, 1987, EARTH PLANET SC LETT, V81, P175, DOI 10.1016/0012-821X(87)90154-3; El-Asmar HM, 1997, QUATERNARY SCI REV, V16, P911, DOI 10.1016/S0277-3791(96)00077-7; FAURE H, 1968, CR ACAD SCI D NAT, V267, P18; Faure H., 1980, B SOC GEOL FR, V6, P959; FREYTET P, 1993, Z GEOMORPHOL, V37, P215; GRUN R, 1991, ARCHAEOMETRY, V33, P153, DOI 10.1111/j.1475-4754.1991.tb00696.x; GVIRTZMAN G, 1992, MAR GEOL, V108, P29, DOI 10.1016/0025-3227(92)90211-Y; GVIRTZMAN G, 1977, MEMOIRES BUREAU RECH, V89, P480; Hoang CT, 1996, QUATERN INT, V31, P47, DOI 10.1016/1040-6182(95)00020-J; HOANG CT, 1991, QUATERNARY RES, V35, P264, DOI 10.1016/0033-5894(91)90072-D; HOANG CT, 1974, COL INT CNRS, V219, P103; HOROWITZ A, 1989, PALAEOGEOGR PALAEOCL, V72, P63, DOI 10.1016/0031-0182(89)90132-6; KLEIN RG, 1989, HUMAN REVOLUTION, P529; Leakey LSB., 1931, STONE AGE CULTURES K; LENEY M, 1999, DISCOV ARCHAEOL, V1, P18; Montenat C., 1986, B I FRAN ARCHEOL ORI, V86, P239; PHILIPSONDW, 1993, AFRICAN ARCHAEOLOGY; Plaziat J.-C., 1998, SEDIMENTATION TECTON, P537, DOI DOI 10.1007/978-94-011-4930-3_29; Stirling CH, 1998, EARTH PLANET SC LETT, V160, P745, DOI 10.1016/S0012-821X(98)00125-3; STRINGER CB, 1990, SCI AM           DEC, P98; Taviani M., 1998, SEDIMENTATION TECTON, P574, DOI DOI 10.1007/978-94-011-4930-3_30; Thorne Alan G., 1992, SCI AM           APR, P28; Van Peer P, 1998, CURR ANTHROPOL, V39, pS115, DOI 10.1086/204692; WALTER RC, 1997, LITHOSPHERIC STRUCTU	30	209	216	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2000	405	6782					65	69		10.1038/35011048	http://dx.doi.org/10.1038/35011048			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311TK	10811218				2022-12-24	WOS:000086901600051
J	Hull, CM; Raisner, RM; Johnson, AD				Hull, CM; Raisner, RM; Johnson, AD			Evidence for mating of the "asexual" yeast Candida albicans in a mammalian host	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; GENETICS; HOMOLOG; BIOLOGY; FUNGI	Since its classification nearly 80 years ago, the human pathogen Candida albicans has been designated as an asexual yeast. In this report, we describe the construction of C. albicans strains that were subtly altered at the mating-type-like (MTL) locus, a cluster of genes that resembles the mating-type Loci of other fungi. These derivatives were capable of mating after inoculation into a mammalian host. C. albicans is a diploid organism, but most of the mating products isolated from a mouse host were tetrasomic for the two chromosomes that could be rigorously monitored and, overall, exhibited substantially higher than 2n DNA content. These observations demonstrated that C, albicans can recombine sexually.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Johnson, AD (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037049] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM37049] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Casselton LA, 1998, MICROBIOL MOL BIOL R, V62, P55, DOI 10.1128/MMBR.62.1.55-70.1998; Diener AC, 1996, GENETICS, V143, P769; Graser Y, 1996, P NATL ACAD SCI USA, V93, P12473, DOI 10.1073/pnas.93.22.12473; HERSKOWITZ I, 1992, MOL CELLULAR BIOL YE, V2, P583; Hull CM, 1999, SCIENCE, V285, P1271, DOI 10.1126/science.285.5431.1271; HULL CM, UNPUB; JOHNSON AD, 1995, CURR OPIN GENET DEV, V5, P552, DOI 10.1016/0959-437X(95)80022-0; Kronstad JW, 1997, ANNU REV GENET, V31, P245, DOI 10.1146/annurev.genet.31.1.245; Leberer E, 1996, P NATL ACAD SCI USA, V93, P13217, DOI 10.1073/pnas.93.23.13217; Odds FC., 1988, CANDIDA CANDIDOSIS; Raymond M, 1998, MOL MICROBIOL, V27, P587, DOI 10.1046/j.1365-2958.1998.00704.x; SADHU C, 1992, MOL CELL BIOL, V12, P1977, DOI 10.1128/MCB.12.5.1977; Taylor JW, 1999, CLIN MICROBIOL REV, V12, P126, DOI 10.1128/CMR.12.1.126; Tibayrenc M, 1997, TRENDS MICROBIOL, V5, P253, DOI 10.1016/S0966-842X(97)01068-8; Turgeon BG, 1998, ANNU REV PHYTOPATHOL, V36, P115, DOI 10.1146/annurev.phyto.36.1.115; Vilgalys R, 1997, TRENDS MICROBIOL, V5, P254, DOI 10.1016/S0966-842X(97)01076-7	16	361	391	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					307	310		10.1126/science.289.5477.307	http://dx.doi.org/10.1126/science.289.5477.307			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894780				2022-12-24	WOS:000088169400044
J	Lee, K; Loros, JJ; Dunlap, JC				Lee, K; Loros, JJ; Dunlap, JC			Interconnected feedback loops in the Neurospora circadian system	SCIENCE			English	Article							LIGHT SIGNAL-TRANSDUCTION; CLOCK GENE-FREQUENCY; PROTEIN; PAS; PHOSPHORYLATION; TRANSCRIPTION; DOMAINS; COMPLEX; FORMS; TIME	In Neurospora crassa, white collar 1 (WC-1), a transcriptional activator and positive clock element, is rhythmically expressed from a nonrhythmic steady-state pool of wc-1 transcript, consistent with posttranscriptional regulation of rhythmicity. Mutations in frq influence both the level and periodicity of WC-1 expression, and driven FRQ expression not only depresses its own endogenous levels, but positively regulates WC-1 synthesis with a lag of about 8 hours, a delay similar to that seen in the wild-type clock. FRQ thus plays dual roles in the Neurospora clock and thereby, with WC-1, forms a second feedback loop that would promote robustness and stability in this circadian system. The existence also of interlocked loops in Drosophila melanogaster and mouse clocks suggests that such interlocked loops may be a conserved aspect of circadian timing systems.	Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA; Dartmouth Coll, Sch Med, Dept Genet, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Loros, JJ (corresponding author), Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA.	jennifer.loros@dartmouth.edu; jay.c.dunlap@dartmouth.edu	Lee, Kwangwon/AAC-8060-2021; Weydahl, Andi/C-6391-2008; Dunlap, Jay/L-6232-2013; Loros, Jennifer/B-6293-2014	Dunlap, Jay/0000-0003-1577-0457; Lee, Kwangwon/0000-0001-8225-4220	NIGMS NIH HHS [R37-GM 34985] Funding Source: Medline; NIMH NIH HHS [MH44651] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044651] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Ballario P, 1998, MOL MICROBIOL, V29, P719, DOI 10.1046/j.1365-2958.1998.00955.x; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; DENAULT D, UNPUB; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; Iwasaki H, 2000, CURR OPIN MICROBIOL, V3, P189, DOI 10.1016/S1369-5274(00)00074-6; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Linden H, 1999, ADV GENET, V41, P35, DOI 10.1016/S0065-2660(08)60150-9; Liu Y, 2000, P NATL ACAD SCI USA, V97, P234, DOI 10.1073/pnas.97.1.234; Loros J J, 1986, J Biol Rhythms, V1, P187, DOI 10.1177/074873048600100302; Loros JJ, 1998, CURR OPIN MICROBIOL, V1, P698, DOI 10.1016/S1369-5274(98)80118-5; LUO C, 1998, THESIS DARTMOUTH U H; Luo CH, 1998, EMBO J, V17, P1228, DOI 10.1093/emboj/17.5.1228; Merrow M, 1999, NATURE, V399, P584, DOI 10.1038/21190; Schibler U, 2000, NATURE, V404, P25, DOI 10.1038/35003674; Scully AL, 2000, CELL, V100, P297, DOI 10.1016/S0092-8674(00)80665-0; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999	31	274	282	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2000	289	5476					107	110		10.1126/science.289.5476.107	http://dx.doi.org/10.1126/science.289.5476.107			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332TW	10884222				2022-12-24	WOS:000088090400042
J	Gleicher, N; Oleske, DM; Tur-Kaspa, I; Vidali, A; Karande, V				Gleicher, N; Oleske, DM; Tur-Kaspa, I; Vidali, A; Karande, V			Reducing the risk of high-order multiple pregnancy after ovarian stimulation with gonadotropins.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Joint Annual Meeting of the American-Society-for-Reproductive-Medicine/Canadian-Fertility-and-Andrology-Society	SEP 25-30, 1999	TORONTO, CANADA	Amer Soc Reprod Med, Canadian Fertil & Androl Soc			IN-VITRO FERTILIZATION; PROSPECTIVE RANDOMIZED TRIAL; INTRAUTERINE INSEMINATION; HUMAN BLASTOCYSTS; INFERTILITY; CULTURE; BIRTHS; GESTATION; PATTERNS; COUPLES	Background: The incidence of multiple gestation after therapy for infertility is especially high among women in whom ovulation is induced with gonadotropins. Whether the number of high-order multiple pregnancies (those with three or more fetuses) can be reduced is not known. Methods: We analyzed data on 3347 consecutive treatment cycles in 1494 infertile women, 441 of which resulted in pregnancy. The data collected included the peak serum estradiol concentration, the number of follicles 16 mm or larger in diameter, and the total number of follicles on the day of induction of ovulation with human chorionic gonadotropin. Receiver-operating-characteristic curves and ordinal logistic-regression analyses were used to identify values that predicted multiple conceptions. Results: Among the 441 pregnancies, 314 resulted from the conception of singletons, 88 of twins, 22 of triplets, 10 of quadruplets, 5 of quintuplets, and 2 of sextuplets. Neither the number of follicles 16 mm or larger nor peak serum estradiol concentrations greater than 2000 or 2500 pg per milliliter (7342 or 9178 pmol per liter) (the cutoff values currently in wide use) were significantly associated with the incidence of high-order multiple pregnancy. However, increasing total numbers of follicles and increasing peak serum estradiol concentrations correlated significantly with an increasing risk of high-order multiple pregnancy (P<0.001), as did younger age (P=0.008). The risk of high-order multiple pregnancy was significantly increased in women with a peak serum estradiol concentration of 1385 pg per milliliter (5084 pmol per liter) or higher (multivariate odds ratio, 1.9; 95 percent confidence interval, 1.3 to 2.8) or with seven or more follicles (multivariate odds ratio, 2.1; 95 percent confidence interval, 1.2 to 3.9) on the day of induction of ovulation. Conclusions: Gonadotropin stimulation that is less intensive than is currently customary may reduce the incidence of high-order multiple pregnancy in infertile women, though only to a limited extent and at the expense of overall pregnancy rates. (N Engl J Med 2000;343:2-7.) (C) 2000, Massachusetts Medical Society.	Ctr Human Reprod New New, New York, NY 10022 USA; Ctr Human Reprod Illinois, Chicago, IL USA; Fdn Reprod Med, Chicago, IL USA; Rush Presbyterian St Lukes Med Ctr, Dept Prevent Med, Chicago, IL 60612 USA; Rush Presbyterian St Lukes Med Ctr, Dept Hlth Syst Management, Chicago, IL 60612 USA; Ben Gurion Univ Negev, Barzilai Med Ctr, Dept Obstet & Gynecol, In Vitro Fertilizat Unit, Ashqelon, Israel	Rush University; Rush University; Ben Gurion University; Barzilai Medical Center	Gleicher, N (corresponding author), Ctr Human Reprod New New, 635 Madison Ave, New York, NY 10022 USA.	chrjournal@aol.com						American Society for Reproductive Medicine. Practice Committee Opinion, 1998, GUID NUMB EMBR TRANS; CALLAHAN TL, 1994, NEW ENGL J MED, V331, P244, DOI 10.1056/NEJM199407283310407; COLLINS JA, 1994, NEW ENGL J MED, V331, P270, DOI 10.1056/NEJM199407283310412; Crosignani PG, 1996, EXCERPTS HUMAN REPRO, V4, P5; EVANS MI, 1995, AM J OBSTET GYNECOL, V172, P1750, DOI 10.1016/0002-9378(95)91407-2; Faber K, 1997, HUM REPROD, V12, P1614; Gardner DK, 1998, FERTIL STERIL, V69, P84, DOI 10.1016/S0015-0282(97)00438-X; Gardner DK, 1998, HUM REPROD, V13, P148, DOI 10.1093/humrep/13.suppl_3.148; Gardner DK, 1998, HUM REPROD, V13, P3434, DOI 10.1093/humrep/13.12.3434; GLEICHER N, 1995, HUM REPROD, V10, P1079, DOI 10.1093/oxfordjournals.humrep.a136098; GLEICHER N, IN PRESS J ASSIST RE; Guzick DS, 1999, NEW ENGL J MED, V340, P177, DOI 10.1056/NEJM199901213400302; JEWELL SE, 1995, OBSTET GYNECOL, V85, P229, DOI 10.1016/0029-7844(94)00354-G; Karande VC, 1999, FERTIL STERIL, V71, P468, DOI 10.1016/S0015-0282(98)00490-7; KARANDE VC, 1995, FERTIL STERIL, V64, P638, DOI 10.1016/S0015-0282(16)57805-4; *SAS I INC, 1995, LOG REGR EX US SAS S, P163; SPSS, 1999, SPSS WIND REL 10 0; Templeton A, 1998, NEW ENGL J MED, V339, P573, DOI 10.1056/NEJM199808273390901; VENTURA SJ, 1998, MON VITAL STAT REP S, V46	19	182	186	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2000	343	1					2	7		10.1056/NEJM200007063430101	http://dx.doi.org/10.1056/NEJM200007063430101			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	330XW	10882762				2022-12-24	WOS:000087987600001
J	[Anonymous]				[Anonymous]			The Durban Declaration	NATURE			English	Editorial Material							HIV-1; AIDS; TRANSMISSION; POPULATION; ZIDOVUDINE; MORTALITY; INFECTION; TRIAL											*CDCP, 1999, HIV AIDS SURVEILLANC, V11, P1; DARBY SC, 1995, NATURE, V377, P79, DOI 10.1038/377079a0; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; *JOINT UN PROGR HI, 2000, REP GLOB HIV AIDS EP; Liska V, 1999, AIDS RES HUM RETROV, V15, P445, DOI 10.1089/088922299311196; Nunn AJ, 1997, BRIT MED J, V315, P767, DOI 10.1136/bmj.315.7111.767; OBrien SJ, 1996, CURR OPIN IMMUNOL, V8, P613, DOI 10.1016/S0952-7915(96)80075-6; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; Sitas F, 1999, NEW ENGL J MED, V340, P1863, DOI 10.1056/NEJM199906173402403; SPERLING RS, 1996, NEW ENGL J MED, V335, P1678; WEISS RA, 1990, NATURE, V345, P659, DOI 10.1038/345659a0	12	30	31	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2000	406	6791					15	16		10.1038/35017662	http://dx.doi.org/10.1038/35017662			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	330ZE	10894520				2022-12-24	WOS:000087991200018
J	Kamat, S; Su, X; Ballarini, R; Heuer, AH				Kamat, S; Su, X; Ballarini, R; Heuer, AH			Structural basis for the fracture toughness of the shell of the conch Strombus gigas	NATURE			English	Article							BRITTLE	Natural composite materials are renowned for their mechanical strength and toughness: despite being highly mineralized, with the organic component constituting not more than a few per cent of the composite material, the fracture toughness exceeds that of single crystals of the pure mineral by two to three orders of magnitude(1). The judicious placement of the organic matrix, relative to the mineral phase, and the hierarchical structural architecture extending over several distinct length scales both play crucial roles in the mechanical response of natural composites to external loads(.)(2-4) Here we use transmission electron microscopy studies and beam bending experiments to show that the resistance of the shell of the conch Strombus gigas to catastrophic fracture can be understood quantitatively by invoking two energy-dissipating mechanisms: multiple microcracking in the outer layers at low mechanical loads, and crack bridging in the shell's tougher middle layers at higher loads. Both mechanisms are intimately associated with the so-called crossed lamellar microarchitecture of the shell, which provides for 'channel' cracking in the outer layers and uncracked structural features that bridge crack surfaces, thereby significantly increasing the work of fracture, and hence the toughness, of the material. Despite a high mineral content of about 99% (by volume) of aragonite, the shell of Strombus gigas can thus be considered a 'ceramic plywood', and can guide the biomimetic design of tough, lightweight structures.	Case Western Reserve Univ, Dept Mat Sci & Engn, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Civil Engn, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Heuer, AH (corresponding author), Case Western Reserve Univ, Dept Mat Sci & Engn, Cleveland, OH 44106 USA.							Boggild O. B., 1930, KGL DAN VIDENSK SELS, V9, P232; Carter JG, 1980, SKELETAL GROWTH AQUA, P69; COX BN, 1994, ACTA METALL MATER, V42, P341, DOI 10.1016/0956-7151(94)90492-8; CURREY JD, 1976, J MATER SCI, V11, P1615, DOI 10.1007/BF00737517; CURREY JD, 1974, J ZOOL, V173, P395; CURREY JD, 1980, MECH PROPERTIES BIOL, P75; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; JACKSON AP, 1990, J MATER SCI, V25, P3173, DOI 10.1007/BF00587670; Kessler H, 1996, COMP MATER SCI, V5, P157, DOI 10.1016/0927-0256(95)00067-4; KuhnSpearing LT, 1996, J MATER SCI, V31, P6583, DOI 10.1007/BF00356266; TAYLOR J D, 1972, Palaeontology (Oxford), V15, P73; WEGST UGK, 1997, CUEDCEDCTR55	12	552	574	12	303	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 29	2000	405	6790					1036	1040		10.1038/35016535	http://dx.doi.org/10.1038/35016535			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	328VN	10890440				2022-12-24	WOS:000087871700040
J	Stern, S; Altkorn, D; Levinson, W				Stern, S; Altkorn, D; Levinson, W			Anticoagulation for chronic atrial fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STROKE; WARFARIN; PREVENTION; THERAPY; ASPIRIN; RISK		Univ Chicago, Dept Internal Med, Chicago, IL 60637 USA	University of Chicago	Stern, S (corresponding author), Univ Chicago, Dept Internal Med, 5841 S Maryland,MC 5023, Chicago, IL 60637 USA.	sstern@smtp.mcis.uchicago.edu						Anderson DC, 1998, JAMA-J AM MED ASSOC, V279, P1273; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; Ezekowitz MD, 1999, JAMA-J AM MED ASSOC, V281, P1830, DOI 10.1001/jama.281.19.1830; Hart RG, 1999, STROKE, V30, P1223, DOI 10.1161/01.STR.30.6.1223; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hylek EM, 1998, JAMA-J AM MED ASSOC, V279, P657, DOI 10.1001/jama.279.9.657; Laupacis A, 1998, CHEST, V114, p579S, DOI 10.1378/chest.114.5_Supplement.579S; LAUPACIS A, 1995, CHEST, V108, pS352, DOI 10.1378/chest.108.4_Supplement.352S; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; MCBRIDE R, 1994, LANCET, V343, P687; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; PETERSEN P, 1989, LANCET, V1, P175; Stollberger C, 1998, ANN INTERN MED, V128, P630, DOI 10.7326/0003-4819-128-8-199804150-00004; Zabalgoitia M, 1998, ANN INTERN MED, V128, P639, DOI 10.7326/0003-4819-128-8-199804150-00005	14	10	12	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2000	283	22					2901	2903		10.1001/jama.283.22.2901	http://dx.doi.org/10.1001/jama.283.22.2901			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XL	10865248				2022-12-24	WOS:000087480600001
J	Weaver, JC; Vaughan, TE; Astumian, RD				Weaver, JC; Vaughan, TE; Astumian, RD			Biological sensing of small field differences by magnetically sensitive chemical reactions	NATURE			English	Article							BEHAVIORAL EVIDENCE; MIGRATORY BIRD; MAGNETORECEPTION; ORIENTATION; VERTEBRATE; MECHANISM; ANIMALS	There is evidence that animals can detect small changes in the Earth's magnetic field by two distinct mechanisms, one using the mineral magnetite as the primary sensor and one using magnetically sensitive chemical reactions(1-14). Magnetite responds by physically twisting(2,15), or even reorienting the whole organism in the case of some bacteria(16), but the magnetic dipoles of individual molecules are too small to respond in the same way. Here we assess whether reactions whose rates are affected by the orientation of reactants in magnetic fields could form the basis of a biological compass. We use a general model, incorporating biological components and design criteria, to calculate realistic constraints for such a compass. This model compares a chemical signal produced owing to magnetic field effects with stochastic noise and with changes due to physiological temperature variation(17). Our analysis shows that a chemically based biological compass is feasible with its size, for any given detection limit, being dependent on the magnetic sensitivity of the rate constant of the chemical reaction.	MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Univ Chicago, Dept Surg, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Harvard University; Massachusetts Institute of Technology (MIT); University of Chicago; University of Chicago	Weaver, JC (corresponding author), MIT, Harvard Mit Div Hlth Sci & Technol, Rm 16-319, Cambridge, MA 02139 USA.		Astumian, Raymond Dean/H-7440-2013	Astumian, Raymond Dean/0000-0001-7472-187X				ABLE KP, 1995, NATURE, V375, P320; BEASON RC, 1984, NATURE, V309, P151, DOI 10.1038/309151a0; BEASON RC, 1995, J EXP BIOL, V198, P141; BLAKEMORE RP, 1979, J BACTERIOL, V140, P720, DOI 10.1128/JB.140.2.720-729.1979; Deutschlander ME, 1999, NATURE, V400, P324, DOI 10.1038/22450; Deutschlander ME, 1999, J EXP BIOL, V202, P891; Kandel E.R., 1991, PRINC NEUROSCI; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; Lauffenburger D.A., 1993, RECEPTORS MODELS BIN; LEASK MJM, 1977, NATURE, V267, P144, DOI 10.1038/267144a0; Lohmann KJ, 1996, NATURE, V380, P59, DOI 10.1038/380059a0; PHILLIPS JB, 1986, SCIENCE, V233, P765, DOI 10.1126/science.3738508; PHILLIPS JB, 1992, NATURE, V359, P142, DOI 10.1038/359142a0; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; SCHULTEN K, 1982, FESTKOR-ADV SOLID ST, V22, P61, DOI 10.1007/BFb0107935; Schulten K, 1986, BIOPHYSICAL EFFECTS, P99; SCHULTEN Z, 1977, J CHEM PHYS, V66, P4616, DOI 10.1063/1.433719; van Kampen N.G., 1981, STOCHASTIC PROCESSES; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; Weaver JC, 1999, BIOPHYS J, V76, P3026, DOI 10.1016/S0006-3495(99)77455-2; Wiltschko W., 1995, MAGNETIC ORIENTATION; YORKE ED, 1979, J THEOR BIOL, V77, P101, DOI 10.1016/0022-5193(79)90140-1	22	73	74	1	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2000	405	6787					707	709		10.1038/35015128	http://dx.doi.org/10.1038/35015128			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864331				2022-12-24	WOS:000087465800053
J	Joffe, M				Joffe, M			Time trends in biological fertility in Britain	LANCET			English	Article							LONG-TERM RECALL; SEMEN QUALITY; CIGARETTE-SMOKING; TO-PREGNANCY; MEN; QUESTIONNAIRE; FECUNDABILITY; DETERIORATION; CONCEPTION; VALIDITY	Background There is evidence of a decline in semen quality in some countries, including Britain, in recent decades. This retrospective cohort study examined the hypothesis that biological fertility had also declined. The trend in couple fertility was assessed by means of time to pregnancy (TTP)-a sensitive and validated measure of fertility. Methods A representative sample of the British population aged 16-59 years was surveyed. TTP was obtained for all births conceived after unprotected intercourse that began during 1961-93, excluding contraceptive failures. The sample size was 1540. Findings in contrast to the original hypothesis, this study found that fertility has increased; the rising trend was accompanied by slight dips during 1976-80 and 1986-90. These results were consistent between male and female respondents, and undiminished by adjustment for possible confounding factors. A stronger and more consistent relation was found with the year when unprotected intercourse started (a period effect) than with the year of birth of either partner (a birth cohort effect). Interpretation The findings could not be explained by trends in age at first birth, increased treatment of subfertility, or changes in oral contraceptive use. If a decline in male fertility has occurred, it has been more than compensated for by a countervailing increase in couple fertility.	Imperial Coll Sch Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England	Imperial College London	Joffe, M (corresponding author), Imperial Coll Sch Med, Dept Epidemiol & Publ Hlth, St Marys Campus, London W2 1PG, England.	m.joffe@ic.ac.uk						ADAMI HO, 1994, INT J CANCER, V59, P33, DOI 10.1002/ijc.2910590108; AUGER J, 1995, NEW ENGL J MED, V332, P281, DOI 10.1056/NEJM199502023320501; BAIRD DD, 1991, AM J EPIDEMIOL, V133, P1282, DOI 10.1093/oxfordjournals.aje.a115840; Bonde JPE, 1998, LANCET, V352, P1172, DOI 10.1016/S0140-6736(97)10514-1; Botting Beverley, 1991, Popul Trends, V64, P19; Bujan L, 1996, BRIT MED J, V312, P471, DOI 10.1136/bmj.312.7029.471; CARLSEN E, 1992, BRIT MED J, V305, P609, DOI 10.1136/bmj.305.6854.609; DECOCK J, 1994, OCCUP ENVIRON MED, V51, P693, DOI 10.1136/oem.51.10.693; FILAKTI H, 1997, POPUL TRENDS, V87, P11; Fisch H, 1996, FERTIL STERIL, V65, P1009, DOI 10.1016/S0015-0282(16)58278-8; HOWE G, 1985, BRIT MED J, V290, P1697, DOI 10.1136/bmj.290.6483.1697; Irvine S, 1996, BMJ-BRIT MED J, V312, P467, DOI 10.1136/bmj.312.7029.467; JOESOEF MR, 1990, LANCET, V335, P136, DOI 10.1016/0140-6736(90)90005-P; JOFFE M, 1994, AM J EPIDEMIOL, V140, P921, DOI 10.1093/oxfordjournals.aje.a117180; JOFFE M, 1989, J EPIDEMIOL COMMUN H, V43, P268, DOI 10.1136/jech.43.3.268; Joffe M, 1997, OCCUP ENVIRON MED, V54, P289, DOI 10.1136/oem.54.5.289; Joffe M, 1996, LANCET, V347, P1519, DOI 10.1016/S0140-6736(96)90673-X; JOFFE M, 1993, FERTIL STERIL, V60, P99; JOFFE M, 1995, J EPIDEMIOL COMMUN H, V49, P314, DOI 10.1136/jech.49.3.314; MOLLER H, 1993, EUR UROL, V23, P8; OLSEN J, 1991, AM J EPIDEMIOL, V133, P734, DOI 10.1093/oxfordjournals.aje.a115948; Paulsen CA, 1996, FERTIL STERIL, V65, P1015; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, pCH29; SALLMEN M, 1995, AM J IND MED, V27, P699, DOI 10.1002/ajim.4700270506; VanWaeleghem K, 1996, HUM REPROD, V11, P325, DOI 10.1093/HUMREP/11.2.325; VESSEY MP, 1978, BRIT MED J, V1, P265, DOI 10.1136/bmj.1.6108.265; Vierula M, 1996, INT J ANDROL, V19, P11, DOI 10.1111/j.1365-2605.1996.tb00427.x; WEINBERG CR, 1994, STAT MED, V13, P671, DOI 10.1002/sim.4780130528; WILCOX AJ, 1995, NEW ENGL J MED, V333, P1517, DOI 10.1056/NEJM199512073332301; Wittmaack F M, 1992, Wis Med J, V91, P477; ZIELHUIS GA, 1992, INT J EPIDEMIOL, V21, P1151, DOI 10.1093/ije/21.6.1151	31	96	100	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2000	355	9219					1961	1965		10.1016/S0140-6736(00)02328-X	http://dx.doi.org/10.1016/S0140-6736(00)02328-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BV	10859042				2022-12-24	WOS:000087381900013
J	Becskei, A; Serrano, L				Becskei, A; Serrano, L			Engineering stability in gene networks by autoregulation	NATURE			English	Article							ESCHERICHIA-COLI; TET REPRESSOR; ROBUSTNESS; EXPRESSION; RECOGNITION; PROMOTER; BINDING; NUMBER; DOSAGE	The genetic and biochemical networks which underlie such things as homeostasis in metabolism and the developmental programs of living cells, must withstand considerable variations and random perturbations of biochemical parameters(1-3). These occur as transient changes in, for example, transcription, translation, and RNA and protein degradation. The intensity and duration of these perturbations differ between cells in a population(4). The unique state of cells, and thus the diversity in a population, is owing to the different environmental stimuli the individual cells experience and the inherent stochastic nature of biochemical processes (for example, refs 5 and 6). It has been proposed, but not demonstrated, that autoregulatory, negative feedback loops in gene circuits provide stability(7), thereby limiting the range over which the concentrations of net-work components fluctuate. Here we have designed and constructed simple gene circuits consisting of a regulator and transcriptional repressor modules in Escherichia coli and we show the gain of stability produced by negative feedback.	European Mol Biol Lab, D-69012 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Becskei, A (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69012 Heidelberg, Germany.		Smith, Barry/A-9525-2011; Yang, Chen/G-1379-2010	Smith, Barry/0000-0003-1384-116X; Becskei, Attila/0000-0002-9462-0934				Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Backes H, 1997, BIOCHEMISTRY-US, V36, P5311, DOI 10.1021/bi961527k; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BAUMEISTER R, 1992, J MOL BIOL, V226, P1257, DOI 10.1016/0022-2836(92)91065-W; Blau HM, 1999, P NATL ACAD SCI USA, V96, P797, DOI 10.1073/pnas.96.3.797; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; KO MSH, 1990, EMBO J, V9, P2835, DOI 10.1002/j.1460-2075.1990.tb07472.x; LANZER M, 1988, P NATL ACAD SCI USA, V85, P8973, DOI 10.1073/pnas.85.23.8973; Lederer T, 1996, BIOCHEMISTRY-US, V35, P7439, DOI 10.1021/bi952683e; Little JW, 1999, EMBO J, V18, P4299, DOI 10.1093/emboj/18.15.4299; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MORAN L, 1990, GENE DEV, V4, P752, DOI 10.1101/gad.4.5.752; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; OSLEY MA, 1981, CELL, V24, P377, DOI 10.1016/0092-8674(81)90327-5; RECORD J, 1996, ESCHERICHIA COLI SAL, P792; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; Schedl A, 1996, CELL, V86, P71, DOI 10.1016/S0092-8674(00)80078-1; Siegele DA, 1997, P NATL ACAD SCI USA, V94, P8168, DOI 10.1073/pnas.94.15.8168; Strogatz Steven H., 1994, NONLINEAR DYNAMICS C; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Wolf DM, 1998, J THEOR BIOL, V195, P167, DOI 10.1006/jtbi.1998.0790	24	1110	1137	4	110	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					590	593		10.1038/35014651	http://dx.doi.org/10.1038/35014651			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850721				2022-12-24	WOS:000087449500056
J	Turchin, P; Oksanen, L; Ekerholm, P; Oksanen, T; Henttonen, H				Turchin, P; Oksanen, L; Ekerholm, P; Oksanen, T; Henttonen, H			Are lemmings prey or predators?	NATURE			English	Article							POPULATION-DYNAMICS; EXPLOITATION ECOSYSTEMS; NORWEGIAN LEMMINGS; SMALL RODENTS; PHASE; CHAOS; GRADIENTS; CYCLES	Large oscillations in the populations of Norwegian lemmings have mystified both professional ecologists and lay public(1-3). Ecologists suspect that these oscillations are driven by a trophic mechanism(4,5): either an interaction between lemmings and their food supply, or an interaction between lemmings and their predators. If lemming cycles are indeed driven by a trophic interaction, can we tell whether lemmings act as the resource ('prey') or the consumer ('predator')? In trophic interaction models, peaks of resource density generally have a blunt, rounded shape, whereas peaks of consumer density are sharp and angular. Here we have applied several statistical tests to three lemming datasets and contrasted them with comparable data for cyclic voles, We find that vole peaks are blunt, consistent with their cycles being driven by the interaction with predators. In contrast, the shape of lemming peaks is consistent with the hypothesis that lemmings are functional predators, that is, their cycles are driven by their interaction with food plants. Our findings suggest that a single mechanism, such as interaction between rodents and predators, is unlikely to provide the 'universal' explanation of all cyclic rodent dynamics.	Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; Umea Univ, Dept Ecol Bot, S-90187 Umea, Sweden; Umea Univ, Dept Anim Ecol, S-90187 Umea, Sweden; Vantaa Res Ctr, Finnish Forest Res Inst, FIN-01301 Vantaa, Finland	University of Connecticut; Umea University; Umea University; Natural Resources Institute Finland (Luke)	Turchin, P (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.							Batzli G.O., 1980, ARCTIC ECOSYSTEM COA, P335, DOI DOI 10.1575/1912/222; BAZYKIN AD, 1981, ECOL MODEL, V14, P39, DOI 10.1016/0304-3800(81)90013-2; BEDDINGTON JR, 1976, NATURE, V225, P58; CHERNYAVSKY FB, 1982, CYCLES LEMMINGS ARCT; Chitty D., 1996, LEMMINGS COMMIT SUIC; Chitty D, 1996, LEMMINGS COMMIT SUIC; EKERHOLM P, IN PRESS ECOGRAPHY; Elton CS, 1924, BR J EXP BIOL, V2, P119; Framstad E, 1997, P ROY SOC B-BIOL SCI, V264, P31, DOI 10.1098/rspb.1997.0005; HANSKI I, 1991, J ANIM ECOL, V60, P353, DOI 10.2307/5465; HANSKI I, 1993, NATURE, V364, P232, DOI 10.1038/364232a0; HANSKI I, IN PRESS ECOLOGY; HANSSON L, 1985, OECOLOGIA, V67, P394, DOI 10.1007/BF00384946; HENTTONEN H, 1977, OIKOS, V29, P581, DOI 10.2307/3543596; HENTTONEN H, 1993, BIOL LEMMINGS, P157; HENTTONEN H, 2000, CHAOS REAL DATA ANAL, P73; Korpimaki E, 1998, ECOLOGY, V79, P2448, DOI 10.2307/176834; May R. M., 1981, THEOR ECOL-NETH, P78; MOEN J, 1993, ARCTIC ALPINE RES, V25, P130, DOI 10.2307/1551549; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; OKSANEN L, 1990, OIKOS, V57, P14, DOI 10.2307/3565732; OKSANEN L, 1992, ECOGRAPHY, V15, P226, DOI 10.1111/j.1600-0587.1992.tb00029.x; OSTFELD RS, 1993, NATURE, V366, P259, DOI 10.1038/366259a0; ROSENZWEIG ML, 1963, AM NAT, V97, P209, DOI 10.1086/282272; STENSETH N. C., 1993, BIOL LEMMINGS, P61; Stenseth NC, 1998, P ROY SOC B-BIOL SCI, V265, P1957, DOI 10.1098/rspb.1998.0526; STENSETH NC, 1993, BIOL LEMMINGS, P3; Turchin P, 1997, AM NAT, V149, P842, DOI 10.1086/286027; TURCHIN P, 1993, OIKOS, V68, P167, DOI 10.2307/3545323; TURCHIN P, IN PRESS ECOLOGY; Virtanen R, 1997, OIKOS, V79, P155, DOI 10.2307/3546100	31	149	155	0	71	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					562	565		10.1038/35014595	http://dx.doi.org/10.1038/35014595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850713				2022-12-24	WOS:000087449500048
J	Jacobson, RH; Ladurner, AG; King, DS; Tjian, R				Jacobson, RH; Ladurner, AG; King, DS; Tjian, R			Structure and function of a human TAF(II)250 double bromodomain module	SCIENCE			English	Article							HISTONE ACETYLTRANSFERASE; ACETYLATION SITES; H4 ACETYLATION; TRANSCRIPTION; COMPLEX; ACTIVATION; COACTIVATOR; CHROMATIN; GCN5P; CBP	TFIID is a large multiprotein complex that initiates assembly of the transcription machinery. It is unclear how TFIID recognizes promoters in vivo when templates are nucleosome-bound. Here, it is shown that TAF(II)250, the Largest subunit of TFIID, contains two tandem bromodomain modules that bind selectively to multiply acetylated histone H4 peptides. The 2.1 angstrom crystal structure of the double bromodomain reveals two side-by-side, four-helix bundles with a highly polarized surface charge distribution. Each bundle contains an N-epsilon-acetyllysine binding pocket at its center, which results in a structure ideally suited for recognition of diacetylated histone H4 tails. Thus, TFIID may be targeted to specific chromatin-bound promoters and may play a role in chromatin recognition.	Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Tjian, R (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, 401 Barker Hall, Berkeley, CA 94720 USA.	jmlim@uclink4.berkeley.edu		Ladurner, Andreas/0000-0003-3835-232X				ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; CLARKE DJ, 1993, BIOCHEM J, V294, P557, DOI 10.1042/bj2940557; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOODRICH LA, 1994, CURR OPIN CELL BIOL, V6, P403, DOI 10.1016/0955-0674(94)90033-7; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; GRUNSTEIN M, 1990, ANNU REV CELL BIOL, V6, P643, DOI 10.1146/annurev.cellbio.6.1.643; HAYNES SR, 1992, NUCLEIC ACIDS RES, V20, P2603, DOI 10.1093/nar/20.10.2603; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; HOLTON J, UNPUB; Jeanmougin F, 1997, TRENDS BIOCHEM SCI, V22, P151, DOI 10.1016/S0968-0004(97)01042-6; Johnson CA, 1998, NUCLEIC ACIDS RES, V26, P994, DOI 10.1093/nar/26.4.994; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Matangkasombut O, 2000, GENE DEV, V14, P951; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; RODERICK SL, UNPUB; Roth SY, 1996, CELL, V87, P5, DOI 10.1016/S0092-8674(00)81316-1; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; TURNER BM, 1993, CELL, V75, P5, DOI 10.1016/S0092-8674(05)80078-9; Wade PA, 1997, CURR BIOL, V7, pR82, DOI 10.1016/S0960-9822(06)00042-X; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0	39	656	678	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2000	288	5470					1422	1425		10.1126/science.288.5470.1422	http://dx.doi.org/10.1126/science.288.5470.1422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318EL	10827952				2022-12-24	WOS:000087270900050
J	Bell, AC; Felsenfeld, G				Bell, AC; Felsenfeld, G			Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene	NATURE			English	Article							MOUSE H19 GENE; BECKWITH-WIEDEMANN-SYNDROME; WILMS-TUMOR; EPIGENETIC CHANGES; CONTROL ELEMENT; REGION; INSULATOR; UPSTREAM; DOMAIN; LOCUS	The expression of the insulin-like growth factor 2 (Igf2) and H19 genes is imprinted. Although these neighbouring genes share an enhancer(1), H19 is expressed only from the maternal allele, and Igf2 only from the paternally inherited allele(2,3). A region of paternal-specific methylation upstream of H19 appears to be the site of an epigenetic mark that is required for the imprinting of these genes(4,5). A deletion within this region results in loss of imprinting of both H19 and Igf2 (ref. 5). Here we show that this methylated region contains an element that blocks enhancer activity. The activity of this element is dependent upon the vertebrate enhancer-blocking protein CTCF. Methylation of CpGs within the CTCF-binding sites eliminates binding of CTCF in vitro, and deletion of these sites results in loss of enhancer-blocking activity in vivo, thereby allowing gene expression. This CTCF-dependent enhancer-blocking element acts as an insulator. We suggest that it controls imprinting of Igf 2. The activity of this insulator is restricted to the maternal allele by specific DNA methylation of the paternal allele. Our results reveal that DNA methylation can control gene expression by modulating enhancer access to the gene promoter through regulation of an enhancer boundary.	NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Felsenfeld, G (corresponding author), NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.		jia, xu/A-8386-2016					BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Frevel MAE, 1999, J BIOL CHEM, V274, P29331, DOI 10.1074/jbc.274.41.29331; Frevel MAE, 1999, TRENDS GENET, V15, P216, DOI 10.1016/S0168-9525(99)01752-7; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hark AT, 1998, HUM MOL GENET, V7, P1979, DOI 10.1093/hmg/7.12.1979; Jinno Y, 1996, HUM MOL GENET, V5, P1155, DOI 10.1093/hmg/5.8.1155; Joyce JA, 1997, HUM MOL GENET, V6, P1543, DOI 10.1093/hmg/6.9.1543; Khosla S, 1999, MOL CELL BIOL, V19, P2556; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Okamoto K, 1997, P NATL ACAD SCI USA, V94, P5367, DOI 10.1073/pnas.94.10.5367; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; Schmidt JV, 1999, P NATL ACAD SCI USA, V96, P9733, DOI 10.1073/pnas.96.17.9733; Stadnick MP, 1999, DEV GENES EVOL, V209, P239, DOI 10.1007/s004270050248; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; Szabo PE, 1998, MOL CELL BIOL, V18, P6767, DOI 10.1128/MCB.18.11.6767; TANIGUCHI T, 1995, P NATL ACAD SCI USA, V92, P2159, DOI 10.1073/pnas.92.6.2159; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; TREMBLAY KD, 1995, NAT GENET, V9, P407, DOI 10.1038/ng0495-407; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Webber AL, 1998, NATURE, V391, P711, DOI 10.1038/35655; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; YOOWARREN H, 1988, MOL CELL BIOL, V8, P4707, DOI 10.1128/MCB.8.11.4707; Zhou JM, 1999, CELL, V99, P567, DOI 10.1016/S0092-8674(00)81546-9	30	1316	1359	3	125	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2000	405	6785					482	485		10.1038/35013100	http://dx.doi.org/10.1038/35013100			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	317DX	10839546				2022-12-24	WOS:000087212000054
J	McEwen, AS; Belton, MJS; Breneman, HH; Fagents, SA; Geissler, P; Greeley, R; Head, JW; Hoppa, G; Jaeger, WL; Johnson, TV; Keszthelyi, L; Klaasen, KP; Lopes-Gautier, R; Magee, KP; Milazzo, MP; Moore, JM; Pappalardo, RT; Phillips, CB; Radebaugh, J; Schubert, G; Schuster, P; Simonelli, DP; Sullivan, R; Thomas, PC; Turtle, EP; Williams, DA				McEwen, AS; Belton, MJS; Breneman, HH; Fagents, SA; Geissler, P; Greeley, R; Head, JW; Hoppa, G; Jaeger, WL; Johnson, TV; Keszthelyi, L; Klaasen, KP; Lopes-Gautier, R; Magee, KP; Milazzo, MP; Moore, JM; Pappalardo, RT; Phillips, CB; Radebaugh, J; Schubert, G; Schuster, P; Simonelli, DP; Sullivan, R; Thomas, PC; Turtle, EP; Williams, DA			Galileo at Io: Results from high-resolution imaging	SCIENCE			English	Article							SILICATE VOLCANISM; ACTIVE VOLCANISM; KILAUEA VOLCANO; MOUNTAINS; HAWAII; EARTH; FLOW; MOON	During late 1999/early 2000, the solid state imaging experiment on the Galileo spacecraft returned more than 100 high-resolution (5 to 500 meters per pixel) images of volcanically active lo. We observed an active Lava lake, an active curtain of lava, active Lava flows, calderas, mountains, plateaus, and plains. Several of the sulfur dioxide-rich plumes are erupting from distal flows, rather than from the source of silicate Lava (caldera or fissure, often with red pyroclastic deposits). Most of the active flows in equatorial regions are being emplaced slowly beneath insulated crust, but rapidly emplaced channelized flows are also found at all latitudes. There is no evidence for high-viscosity Lava, but some bright flows may consist of sulfur rather than mafic silicates. The mountains, plateaus, and calderas are strongly influenced by tectonics and gravitational collapse. Sapping channels and scarps suggest that many portions of the upper similar to 1 kilometer are rich in volatiles.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Natl Opt Astron Observ, Tucson, AZ 85719 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Arizona State Univ, Dept Geol, Tempe, AZ 85287 USA; Brown Univ, Dept Geol Sci, Providence, RI 02913 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; DLR, Inst Weltraumsensorik & Planetenerkundung, D-12489 Berlin, Germany; Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA	University of Arizona; National Optical Astronomy Observatory; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Arizona State University; Arizona State University-Tempe; Brown University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of California System; University of California Los Angeles; Helmholtz Association; German Aerospace Centre (DLR); Cornell University	McEwen, AS (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.		Pappalardo, Robert/AAP-8953-2021; Phillips, Cynthia B/ABE-4083-2021; Turtle, Elizabeth/K-8673-2012; Fagents, Sarah/B-3983-2014; Lopes, Rosaly M.C./D-1608-2016	Pappalardo, Robert/0000-0003-2571-4627; Phillips, Cynthia B/0000-0001-8914-9562; Turtle, Elizabeth/0000-0003-1423-5751; Lopes, Rosaly M.C./0000-0002-7928-3167; Kestay, Laszlo/0000-0003-1879-4331				ACTON D, UNPUB; BRUNO BC, 1992, GEOPHYS RES LETT, V19, P305, DOI 10.1029/91GL03039; Carr MH, 1998, ICARUS, V135, P146, DOI 10.1006/icar.1998.5979; DAVIES AG, 1999, LUNAR PLANET SCI, V30; FAGENTS SA, 1999, EOS S, V80, pF625; Geissler PE, 1999, ICARUS, V140, P265, DOI 10.1006/icar.1999.6128; Geissler PE, 1999, SCIENCE, V285, P870, DOI 10.1126/science.285.5429.870; HEAD JW, 2000, LUNAR PLANET SCI, V31; HESLOP SE, 1989, B VOLCANOL, V51, P415, DOI 10.1007/BF01078809; HON K, 1994, GEOL SOC AM BULL, V106, P251; JOHNSON TV, 1982, SATELLITES JUPITER, P634; Kargel JS, 1999, ICARUS, V142, P249, DOI 10.1006/icar.1999.6183; Keszthelyi L, 1997, GEOPHYS RES LETT, V24, P2463, DOI 10.1029/97GL01368; Keszthelyi L, 1997, ICARUS, V130, P437, DOI 10.1006/icar.1997.5837; KESZTHELYI L, IN PRESS J GEOPHYS R; Kieffer SW, 2000, SCIENCE, V288, P1204, DOI 10.1126/science.288.5469.1204; KIEFFER SW, 1982, SATELLITES JUPITER, P647; Lopes-Gautier R, 2000, SCIENCE, V288, P1201, DOI 10.1126/science.288.5469.1201; Lopes-Gautier R, 1999, ICARUS, V140, P243, DOI 10.1006/icar.1999.6129; MATTOX TN, 1993, B VOLCANOL, V55, P407, DOI 10.1007/BF00302000; MCCAULEY JF, 1979, NATURE, V280, P736, DOI 10.1038/280736a0; McEwen AS, 1998, ICARUS, V135, P181, DOI 10.1006/icar.1998.5972; McEwen AS, 1998, SCIENCE, V281, P87, DOI 10.1126/science.281.5373.87; MCEWEN AS, IN PRESS ENV EFFECTS; MOORE JM, 2000, LUNAR PLANET SCI, V31; ONEIL WJ, 1997, FLIGHT PROJECT GALIL; PHILLIPS CB, 2000, THESIS U ARIZONA TUC; Schenk PM, 1998, SCIENCE, V279, P1514, DOI 10.1126/science.279.5356.1514; Self S., 1997, LARGE IGNEOUS PROVIN, V100, P381, DOI [10.1029/gm100p0381, DOI 10.1029/GM100P0381]; Spencer JR, 1997, GEOPHYS RES LETT, V24, P2471, DOI 10.1029/97GL02592; Spencer JR, 2000, SCIENCE, V288, P1208, DOI 10.1126/science.288.5469.1208; Spencer JR, 2000, SCIENCE, V288, P1198, DOI 10.1126/science.288.5469.1198; Stansberry JA, 1997, GEOPHYS RES LETT, V24, P2455, DOI 10.1029/97GL02593; Thorarinsson S., 1953, B VOLCANOL, V2, P1; Williams DA, 2000, J GEOPHYS RES-PLANET, V105, P1671, DOI 10.1029/1999JE001157; WILLIAMS DA, IN PRESS EOS S; WILSON L, 1983, NATURE, V302, P663, DOI 10.1038/302663a0	37	106	107	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 19	2000	288	5469					1193	1198		10.1126/science.288.5469.1193	http://dx.doi.org/10.1126/science.288.5469.1193			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315KH	10817986				2022-12-24	WOS:000087112600038
J	Welch, DM; Meselson, M				Welch, DM; Meselson, M			Evidence for the evolution of bdelloid rotifers without sexual reproduction or genetic exchange	SCIENCE			English	Article							POLYMERASE CHAIN-REACTION; DROSOPHILA-MELANOGASTER; NATURAL-SELECTION; POPULATIONS; ERRORS	The Class Bdelloidea of the Phylum Rotifera is the largest metazoan taxon in which males, hermaphrodites, and meiosis are unknown. We conducted a molecular genetic test: of this indication that bdelloid rotifers may have evolved without sexual reproduction or genetic exchange. The test is based on the expectation that after millions of years without these processes, genomes will no Longer contain pairs of closely similar haplotypes and instead will contain highly divergent descendants of formerly allelic nucleotide sequences. We find that genomes of individual bdelloid rotifers, representing four different species, appear to Lack pairs of closely similar sequences and contain representatives of two ancient Lineages that began to diverge before the bdelloid radiation many millions of years ago when sexual reproduction and genetic exchange may have ceased.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Meselson, M (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.							Bell G, 1982, MASTERPIECE NATURE E; CROW JF, 1994, DEV GENET, V15, P205, DOI 10.1002/dvg.1020150303; Deng HW, 1996, GENETICS, V144, P349; Donner J., 1965, ORDNUNG BDELLOIDEA; DUNNING AM, 1988, NUCLEIC ACIDS RES, V16, P10393, DOI 10.1093/nar/16.21.10393; ENNIS PD, 1990, P NATL ACAD SCI USA, V87, P2833, DOI 10.1073/pnas.87.7.2833; Garey JR, 1998, HYDROBIOLOGIA, V387, P83, DOI 10.1023/A:1017060902909; Garey JR, 1996, J MOL EVOL, V43, P287, DOI 10.1007/PL00006088; GILBERT JJ, 1989, REPROD BIOL INVERTEB, V4, P179; GILBERT W, 1986, CELL, V46, P151, DOI 10.1016/0092-8674(86)90730-0; Goddemeier ML, 1996, GENE, V174, P111, DOI 10.1016/0378-1119(96)00437-4; HOLMAN EW, 1987, SYST ZOOL, V36, P381, DOI 10.2307/2413402; HSU WS, 1956, BIOL BULL, V111, P364, DOI 10.2307/1539143; Hsu WS, 1956, CELLULE, V57, P283; Hudson CT, 1886, ROTIFERA WHEEL ANIMA; Inomata N, 1997, MOL BIOL EVOL, V14, P942, DOI 10.1093/oxfordjournals.molbev.a025837; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; KIMURA M, 1964, GENETICS, V49, P725; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; Li W-H, 1997, MOL EVOLUTION; LI WH, 1991, GENETICS, V129, P513; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; MAYNARDSMITH J, 1986, NATURE, V324, P300; Mayr E., 1963, ANIMAL SPECIES EVOLU; Melone G, 1998, HYDROBIOLOGIA, V387, P101, DOI 10.1023/A:1017057619574; Moriyama EN, 1996, MOL BIOL EVOL, V13, P261, DOI 10.1093/oxfordjournals.molbev.a025563; MUKAI T, 1972, GENETICS, V72, P335; PAGANI M, 1993, HYDROBIOLOGIA, V255, P225, DOI 10.1007/BF00025843; PALUMBI SR, 1991, MOL BIOL EVOL, V8, P227; RICCI CN, 1987, HYDROBIOLOGIA, V147, P117, DOI 10.1007/BF00025734; Richards A.J., 1986, PLANT BREEDING SYSTE; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; Shabalina SA, 1997, P NATL ACAD SCI USA, V94, P13034, DOI 10.1073/pnas.94.24.13034; WAGGONER BM, 1993, EXPERIENTIA, V49, P354, DOI 10.1007/BF01923421; Wallace R.L., 1991, P187; Wang RL, 1997, GENETICS, V147, P1091; Welch DBM, 1998, HYDROBIOLOGIA, V387, P395, DOI 10.1023/A:1017063201343; Welch DBM, 2000, INVERTEBR BIOL, V119, P17; WELCH DBM, 1999, THESIS HARVARD U CAM; Welch JLM, 1998, HYDROBIOLOGIA, V387, P403; White M.J.D., 1978, MODES SPECIATION	41	448	463	4	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 19	2000	288	5469					1211	1215		10.1126/science.288.5469.1211	http://dx.doi.org/10.1126/science.288.5469.1211			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315KH	10817991	Green Submitted			2022-12-24	WOS:000087112600043
J	Plotnikov, AN; Hubbard, SR; Schlessinger, J; Mohammadi, M				Plotnikov, AN; Hubbard, SR; Schlessinger, J; Mohammadi, M			Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity	CELL			English	Article							FIBROBLAST-GROWTH-FACTOR; HIGH-AFFINITY RECEPTOR; BINDING SPECIFICITY; SIGNAL TRANSDUCTION; FACTOR FAMILY; HEPARIN; IDENTIFICATION; MOLECULES; DIMERIZATION; MUTAGENESIS	To elucidate the structural determinants governing specificity in fibroblast growth factor (FGF) signaling, we have determined the crystal structures of FGF1 and FGF2 complexed with the ligand binding domains (immunoglobulin-like domains 2 [D2] and 3 [D3]) of FGF receptor 1 (FGFR1) and FGFR2, respectively. Highly conserved FGF-D2 and FGF-linker (between D2-D3) interfaces define a general binding site for all FGF-FGFR complexes. Specificity is achieved through interactions between the N-terminal and central regions of FGFs and two loop regions in D3 that are subject to alternative splicing. These structures provide a molecular basis for FGF1 as a universal FGFR ligand and for modulation of FGF-FGFR specificity through primary sequence variations and alternative splicing.	NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA	New York University; New York University	Mohammadi, M (corresponding author), NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA.		Mohammadi, Moosa/ABA-6745-2020; kasaei, fahime/T-7197-2018	Mohammadi, Moosa/0000-0003-2434-9437; Hubbard, Stevan/0000-0002-2707-9383				Anderson J, 1998, HUM MOL GENET, V7, P1475, DOI 10.1093/hmg/7.9.1475; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; Blaber M, 1996, BIOCHEMISTRY-US, V35, P2086, DOI 10.1021/bi9521755; BOTTARO DP, 1993, J BIOL CHEM, V268, P9180; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Burke D, 1998, TRENDS BIOCHEM SCI, V23, P59, DOI 10.1016/S0968-0004(97)01170-5; Chellaiah A, 1999, J BIOL CHEM, V274, P34785, DOI 10.1074/jbc.274.49.34785; DELL KR, 1992, J BIOL CHEM, V267, P21225; ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441; Faham S, 1998, CURR OPIN STRUC BIOL, V8, P578, DOI 10.1016/S0959-440X(98)80147-4; Gray TE, 1996, BIOCHEMISTRY-US, V35, P15640, DOI 10.1021/bi961942c; GRAY TE, 1995, BIOCHEMISTRY-US, V34, P10325, DOI 10.1021/bi00033a002; HOLDEN HM, 1992, J MOL BIOL, V227, P840, DOI 10.1016/0022-2836(92)90226-A; IMAMURA T, 1990, SCIENCE, V249, P1567, DOI 10.1126/science.1699274; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Naski M C, 1998, Front Biosci, V3, pd781; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; OTWINOWSKI Z, 1993, P CCP4 STUD WEEK; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; REICHSLOTKY R, 1995, J BIOL CHEM, V270, P29813; RON D, 1993, J BIOL CHEM, V268, P5388; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; SPRINGER BA, 1994, J BIOL CHEM, V269, P26879; Stauber DJ, 2000, P NATL ACAD SCI USA, V97, P49, DOI 10.1073/pnas.97.1.49; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VAINIKKA S, 1992, EMBO J, V11, P4273, DOI 10.1002/j.1460-2075.1992.tb05526.x; WANG F, 1995, J BIOL CHEM, V270, P10222, DOI 10.1074/jbc.270.17.10222; Wang F, 1999, BIOCHEMISTRY-US, V38, P160, DOI 10.1021/bi981758m; YAYON A, 1993, P NATL ACAD SCI USA, V90, P10643, DOI 10.1073/pnas.90.22.10643; YAYON A, 1992, EMBO J, V11, P1885, DOI 10.1002/j.1460-2075.1992.tb05240.x; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Zhu HY, 1997, PROTEIN ENG, V10, P417, DOI 10.1093/protein/10.4.417; ZHU HY, 1995, J BIOL CHEM, V270, P21869, DOI 10.1074/jbc.270.37.21869; Zhu HY, 1998, PROTEIN ENG, V11, P937, DOI 10.1093/protein/11.10.937; ZHU X, 1991, SCIENCE, V251, P90, DOI 10.1126/science.1702556	44	320	374	1	43	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 12	2000	101	4					413	424		10.1016/S0092-8674(00)80851-X	http://dx.doi.org/10.1016/S0092-8674(00)80851-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	313QM	10830168	Bronze			2022-12-24	WOS:000087010400009
J	Denning, DW				Denning, DW			Early diagnosis of invasive aspergillosis	LANCET			English	Editorial Material							LATEX AGGLUTINATION-TEST; PULMONARY ASPERGILLOSIS; FUNGAL-INFECTIONS; GALACTOMANNAN		Univ Manchester, N Manchester Gen Hosp, Dept Trop Med & Infect Dis, Manchester M8 6RB, Lancs, England	University of Manchester	Denning, DW (corresponding author), Univ Manchester, N Manchester Gen Hosp, Dept Trop Med & Infect Dis, Manchester M8 6RB, Lancs, England.		Denning, David/AAC-6931-2019	Denning, David/0000-0001-5626-2251				ASCIOGLU S, 1999, INT C ANT AG CHEM SA; BLUM U, 1994, CHEST, V106, P1156, DOI 10.1378/chest.106.4.1156; Caillot D, 1997, J CLIN ONCOL, V15, P139, DOI 10.1200/JCO.1997.15.1.139; Denning DW, 1996, CLIN INFECT DIS, V23, P608, DOI 10.1093/clinids/23.3.608; Groll AH, 1996, J INFECTION, V33, P23, DOI 10.1016/S0163-4453(96)92700-0; Horvath JA, 1996, AM J MED, V100, P171, DOI 10.1016/S0002-9343(97)89455-7; Maertens J, 1999, J CLIN MICROBIOL, V37, P3223, DOI 10.1128/JCM.37.10.3223-3228.1999; Rohrlich P, 1996, PEDIATR INFECT DIS J, V15, P232, DOI 10.1097/00006454-199603000-00011; Sulahian A, 1996, EUR J CLIN MICROBIOL, V15, P139, DOI 10.1007/BF01591487; VERWEIJ PE, 1995, J CLIN PATHOL, V48, P474, DOI 10.1136/jcp.48.5.474; Verweij PE, 1997, INT J INFECT DIS, V2, P61; Vogeser M, 1999, EUR J CLIN MICROBIOL, V18, P42, DOI 10.1007/s100960050224; VONEIFF M, 1995, ANN HEMATOL, V70, P135, DOI 10.1007/BF01682033	13	74	83	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2000	355	9202					423	424						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841117				2022-12-24	WOS:000085306800003
J	Magee, BB; Magee, PT				Magee, BB; Magee, PT			Induction of mating in Candida albicans by construction of MTLa and MTL alpha strains	SCIENCE			English	Article							GENE; IDENTIFICATION; DISRUPTION; OPAQUE; WHITE	Although the diploid fungus Candida albicans, a human pathogen, has been thought to have no sexual cycle. it normally possesses mating-type-like orthologs (Mn) of both of the Saccharomyces cerevisiae mating-type genes (MAT) a and alpha. When strains containing only MTLa or MTL alpha were constructed by the Loss of one homolog of chromosome 5, the site of the MTL Loci, MTLa and MTL alpha strains mated, but like mating types did not. Evidence for mating included formation of stable prototrophs from strains with complementing auxotrophic markers; these contained both MTL alleles and molecular markers from both parents and were tetraploid in DNA content and mononucleate.	Univ Minnesota, Dept Genet Cell Biol & Dev, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Magee, PT (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 1445 Gortner Ave, St Paul, MN 55108 USA.				NIAID NIH HHS [AI16567, AI35109, AI46351] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046351, R01AI035109, R01AI016567] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHU WS, 1993, J BACTERIOL, V175, P6637, DOI 10.1128/jb.175.20.6637-6651.1993; DIEN BS, 1994, METHOD CELL BIOL, V42, P457; FONZI WA, 1993, GENETICS, V134, P717; Forche A, 1999, FUNGAL GENET BIOL, V28, P107, DOI 10.1006/fgbi.1999.1164; Girishkumar H, 1999, POSTGRAD MED J, V75, P151, DOI 10.1136/pgmj.75.881.151; Hull CM, 1999, SCIENCE, V285, P1271, DOI 10.1126/science.285.5431.1271; Janbon G, 1998, P NATL ACAD SCI USA, V95, P5150, DOI 10.1073/pnas.95.9.5150; KAKAR SN, 1982, J BACTERIOL, V151, P1247, DOI 10.1128/JB.151.3.1247-1252.1982; Magee BB, 1997, MICROBIOL-UK, V143, P289, DOI 10.1099/00221287-143-2-289; MAGEE PT, 1992, J CLIN MICROBIOL, V30, P2674, DOI 10.1128/JCM.30.10.2674-2679.1992; MAGEE PT, 1983, MICROBIOLOGY 1983, P230; Natarajan A, 1999, METAB ENG, V1, P320, DOI 10.1006/mben.1999.0125; Negredo A, 1997, MICROBIOL-UK, V143, P297, DOI 10.1099/00221287-143-2-297; PUJOL C, 1993, P NATL ACAD SCI USA, V90, P9456, DOI 10.1073/pnas.90.20.9456; SCHERER S, 1990, MICROBIOL REV, V54, P226, DOI 10.1128/MMBR.54.3.226-241.1990; SLUTSKY B, 1987, J BACTERIOL, V169, P189, DOI 10.1128/JB.169.1.189-197.1987; SOLL DR, 1992, CLIN MICROBIOL REV, V5, P183, DOI 10.1128/CMR.5.2.183-203.1992; SUZUKI T, 1989, J GEN MICROBIOL, V135, P425; THRASHBINGHAM C, 1992, CURR GENET, V22, P93, DOI 10.1007/BF00351467; WICKES BL, 1991, INFECT IMMUN, V59, P1762, DOI 10.1128/IAI.59.5.1762-1771.1991; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999	21	347	375	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					310	313		10.1126/science.289.5477.310	http://dx.doi.org/10.1126/science.289.5477.310			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894781				2022-12-24	WOS:000088169400045
J	Holtzman, NA; Marteau, TM				Holtzman, NA; Marteau, TM			Will genetics revolutionize medicine?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COLORECTAL-CANCER; ALZHEIMER-DISEASE; BREAST-CANCER; RISK; MUTATIONS; BRCA1; POPULATIONS; PREVALENCE		Johns Hopkins Med Inst, Baltimore, MD 21205 USA; Guys Kings & St Thomas Med Sch, London SE1 9RT, England	Johns Hopkins University; Johns Hopkins Medicine; University of London; King's College London	Holtzman, NA (corresponding author), Johns Hopkins Med Inst, Baltimore, MD 21205 USA.			Marteau, Theresa/0000-0003-3025-1129				Aaltonen LA, 1998, NEW ENGL J MED, V338, P1481, DOI 10.1056/NEJM199805213382101; Balaban E, 1998, SCI CONTEXT, V11, P331, DOI 10.1017/S0269889700003069; BEKKER H, 1993, BRIT MED J, V306, P1584, DOI 10.1136/bmj.306.6892.1584; Bell J, 1998, BMJ-BRIT MED J, V316, P618, DOI 10.1136/bmj.316.7131.618; Collins FS, 1999, NEW ENGL J MED, V341, P28, DOI 10.1056/NEJM199907013410106; Dragani TA, 1997, NAT GENET, V17, P7, DOI 10.1038/ng0997-7; Dunlop MG, 1997, HUM MOL GENET, V6, P105, DOI 10.1093/hmg/6.1.105; Eisinger F, 1999, LANCET, V353, P919, DOI 10.1016/S0140-6736(98)07516-3; Evans DA, 1997, JAMA-J AM MED ASSOC, V277, P822, DOI 10.1001/jama.277.10.822; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fodor FH, 1998, AM J HUM GENET, V63, P45, DOI 10.1086/301903; Friddle C, 2000, AM J HUM GENET, V66, P205, DOI 10.1086/302697; HOLTZMAN NA, 1996, J AM HUM GENET S A, V59, pA56; INGRAM VM, 1959, BIOCHIM BIOPHYS ACTA, V36, P402, DOI 10.1016/0006-3002(59)90183-0; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; KHOURY MJ, 1985, AM J PUBLIC HEALTH, V75, P1204, DOI 10.2105/AJPH.75.10.1204; KIDD KK, 1993, AM J MED GENET, V48, P71, DOI 10.1002/ajmg.1320480202; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lendon CL, 1997, JAMA-J AM MED ASSOC, V277, P825, DOI 10.1001/jama.277.10.825; Lerman C, 1999, JAMA-J AM MED ASSOC, V281, P1618, DOI 10.1001/jama.281.17.1618; Lilienfeld AM, 1980, FDN EPIDEMIOLOGY; Mandrup-Poulsen T, 1998, BMJ-BRIT MED J, V316, P1221, DOI 10.1136/bmj.316.7139.1221; Marteau TM, 1998, BMJ-BRIT MED J, V316, P693, DOI 10.1136/bmj.316.7132.693; Martinelli I, 1998, NEW ENGL J MED, V338, P1793, DOI 10.1056/NEJM199806183382502; McKinlay JB, 1999, AM J PUBLIC HEALTH, V89, P295, DOI 10.2105/AJPH.89.3.295; *NAT CTR HLTH STAT, 1999, VIT HLTH STAT SER, V10; Owen MJ, 1999, LANCET, V354, pSI11; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Potter JD, 1999, JNCI-J NATL CANCER I, V91, P916, DOI 10.1093/jnci/91.11.916; Quoted in Lawrence M.Fisher, 1999, NY TIMES        0829, pC; Ries L. A. G., 1999, SEER CANC STAT REV 1; Risch N, 1996, NAT GENET, V12, P351, DOI 10.1038/ng0496-351; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; Senior V, 1999, PSYCHOL HEALTH, V14, P1077, DOI 10.1080/08870440008407368; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; TAMBOR ES, 1994, AM J HUM GENET, V55, P626; TODD JA, 1999, LANCET S1, V354, pS115; TREACY E, 1995, AM J HUM GENET, V56, P359; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Welcsh PL, 2000, TRENDS GENET, V16, P69, DOI 10.1016/S0168-9525(99)01930-7	43	276	278	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2000	343	2					141	144		10.1056/NEJM200007133430213	http://dx.doi.org/10.1056/NEJM200007133430213			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	333EP	10891526				2022-12-24	WOS:000088116500013
J	Gan, SC; Beaver, SK; Houck, PM; MacLehose, RF; Lawson, HW; Chan, L				Gan, SC; Beaver, SK; Houck, PM; MacLehose, RF; Lawson, HW; Chan, L			Treatment of acute myocardial infarction and 30-day mortality among women and men.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COOPERATIVE CARDIOVASCULAR PROJECT; CORONARY HEART-DISEASE; SEX-DIFFERENCES; THROMBOLYTIC THERAPY; GENDER DIFFERENCES; ELDERLY PATIENTS; INTERVENTION REGISTRY; CARDIAC PROCEDURES; NATIONAL REGISTRY; BETA-BLOCKERS	Background: Previous studies have suggested that women with acute myocardial infarction receive less aggressive therapy than men. We used data from the Cooperative Cardiovascular Project to determine whether women and men who were ideal candidates for therapy after acute myocardial infarction were treated differently. Methods: Information was abstracted from the charts of 138,956 Medicare beneficiaries (49 percent of them women) who had an acute myocardial infarction in 1994 or 1995. Multivariate analysis was used to assess differences between women and men in the medications administered, the procedures used, the assignment of do-not-resuscitate status, and 30-day mortality. Results: Among ideal candidates for therapy, women in all age groups were less likely to undergo diagnostic catheterization than men. The difference was especially pronounced among older women; for a woman 85 years of age or older, the adjusted relative risk was 0.75 (95 percent confidence interval, 0.68 to 0.83). Women were somewhat less likely than men to receive thrombolytic therapy within 60 minutes (adjusted relative risk, 0.93; 95 percent confidence interval, 0.90 to 0.96) or to receive aspirin within 24 hours after arrival at the hospital (adjusted relative risk, 0.96; 95 percent confidence interval, 0.95 to 0.97), but they were equally likely to receive beta-blockers (adjusted relative risk, 0.99; 95 percent confidence interval, 0.95 to 1.03) and somewhat more likely to receive angiotensin-converting-enzyme inhibitors (adjusted relative risk, 1.05; 95 percent confidence interval, 1.02 to 1.08). Women were more likely than men to have a do-not-resuscitate order in their records (adjusted relative risk, 1.26; 95 percent confidence interval, 1.22 to 1.29). After adjustment, women and men had similar 30-day mortality rates (hazard ratio, 1.02; 95 percent confidence interval, 0.99 to 1.04). Conclusions: As compared with men, women receive somewhat less aggressive treatment during the early management of acute myocardial infarction. However, many of these differences are small, and there is no apparent effect on early mortality. (N Engl J Med 2000;343:8-15.) (C) 2000, Massachusetts Medical Society.	Swedish Med Ctr, Dept Cardiol, Seattle, WA 98104 USA; US Hlth Care Financing Adm, Div Clin Stand & Qual, Seattle, WA USA; Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA	Swedish Medical Center; Centers for Disease Control & Prevention - USA; University of Washington; University of Washington Seattle	Gan, SC (corresponding author), Swedish Med Ctr, Dept Cardiol, 515 Minor Ave,Suite 300, Seattle, WA 98104 USA.							*AM HEART ASS, 1996, 1997 HEART STROK STA; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401; BUENO H, 1995, CIRCULATION, V92, P1133, DOI 10.1161/01.CIR.92.5.1133; Cannon CP, 1999, CLIN CARDIOL, V22, P17, DOI 10.1002/clc.4960220108; Chandra NC, 1998, ARCH INTERN MED, V158, P981, DOI 10.1001/archinte.158.9.981; Chu PH, 1998, INT J CARDIOL, V65, P75, DOI 10.1016/S0167-5273(98)00094-1; DEMIROVIC J, 1995, AM J CARDIOL, V75, P1096, DOI 10.1016/S0002-9149(99)80737-1; DITTRICH H, 1988, AM J CARDIOL, V62, P1, DOI 10.1016/0002-9149(88)91356-2; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; Every NR, 1999, J AM COLL CARDIOL, V33, P1886, DOI 10.1016/S0735-1097(99)00113-8; *FIBR THER TRIAL C, 1994, LANCET, V343, P742; FIEBACH NH, 1990, JAMA-J AM MED ASSOC, V263, P1092, DOI 10.1001/jama.263.8.1092; GILES WH, 1995, ARCH INTERN MED, V155, P318, DOI 10.1001/archinte.155.3.318; GOTTLIEB S, 1994, AM J CARDIOL, V74, P727, DOI 10.1016/0002-9149(94)90319-0; GREENLAND P, 1991, CIRCULATION, V83, P484, DOI 10.1161/01.CIR.83.2.484; Harpaz D, 1996, AM J CARDIOL, V78, P1215, DOI 10.1016/S0002-9149(96)00598-X; Huff ED, 1997, J CLIN EPIDEMIOL, V50, P1395, DOI 10.1016/S0895-4356(97)00218-7; JENKINS JS, 1994, AM J CARDIOL, V73, P319, DOI 10.1016/0002-9149(94)90001-9; Kober L, 1996, AM J CARDIOL, V77, P1052, DOI 10.1016/S0002-9149(96)00129-4; KOSTIS JB, 1994, CIRCULATION, V90, P1715, DOI 10.1161/01.CIR.90.4.1715; Krumholz HM, 1999, JAMA-J AM MED ASSOC, V281, P37; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; Krumholz HM, 1996, ANN INTERN MED, V124, P292, DOI 10.7326/0003-4819-124-3-199602010-00002; Krumholz HM, 1999, CIRCULATION, V99, P2986, DOI 10.1161/01.CIR.99.23.2986; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Krumholz HM, 1998, AM HEART J, V135, P523, DOI 10.1016/S0002-8703(98)70331-X; Kudenchuk PJ, 1996, AM J CARDIOL, V78, P9, DOI 10.1016/S0002-9149(96)00218-4; LINCOFF AM, 1993, J AM COLL CARDIOL, V22, P1780, DOI 10.1016/0735-1097(93)90757-R; LUDWIGS U, 1995, CRIT CARE MED, V23, P854, DOI 10.1097/00003246-199505000-00013; Malacrida R, 1998, NEW ENGL J MED, V338, P8, DOI 10.1056/NEJM199801013380102; MANSON JE, 1991, JAMA-J AM MED ASSOC, V266, P521, DOI 10.1001/jama.266.4.521; Marrugat J, 1998, JAMA-J AM MED ASSOC, V280, P1405, DOI 10.1001/jama.280.16.1405; MAYNARD C, 1991, AM J CARDIOL, V68, P529, DOI 10.1016/0002-9149(91)90791-I; MAYNARD C, 1992, ARCH INTERN MED, V152, P972, DOI 10.1001/archinte.152.5.972; Maynard C, 1996, CIRCULATION, V94, P93; McLaughlin TJ, 1996, ARCH INTERN MED, V156, P799, DOI 10.1001/archinte.156.7.799; MCLAUGHLIN TJ, 1996, ARCH INTERN MED, V156, P1920; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; *PRACT MAN INF, 1999, INT CLASS DIS; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; *STAT, 1999, VERS 6 0; TSUYUKI RT, 1994, CHEST, V105, P1687, DOI 10.1378/chest.105.6.1687; TunstallPedoe H, 1996, CIRCULATION, V93, P1981, DOI 10.1161/01.CIR.93.11.1981; UDVARHELYI IS, 1992, JAMA-J AM MED ASSOC, V268, P2530, DOI 10.1001/jama.268.18.2530; VACCARINO V, 1995, CIRCULATION, V91, P1861, DOI 10.1161/01.CIR.91.6.1861; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; VISCOLI CM, 1993, ANN INTERN MED, V118, P99, DOI 10.7326/0003-4819-118-2-199301150-00004; WACHOLDER S, 1986, AM J EPIDEMIOL, V123, P174, DOI 10.1093/oxfordjournals.aje.a114212; WENGER NS, 1995, ARCH INTERN MED, V155, P2063, DOI 10.1001/archinte.155.19.2063; Woodfield SL, 1997, J AM COLL CARDIOL, V29, P35, DOI 10.1016/S0735-1097(96)00449-4; Yarzebski J, 1996, AM HEART J, V131, P43, DOI 10.1016/S0002-8703(96)90049-6; 1971, MMWR MORB MORTAL WKL, V41, P526	53	265	273	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 6	2000	343	1					8	15		10.1056/NEJM200007063430102	http://dx.doi.org/10.1056/NEJM200007063430102			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	330XW	10882763	Bronze			2022-12-24	WOS:000087987600002
J	Sun, ZM; Unutmaz, D; Zou, YR; Sunshine, MJ; Pierani, A; Brenner-Morton, S; Mebius, RE; Littman, DR				Sun, ZM; Unutmaz, D; Zou, YR; Sunshine, MJ; Pierani, A; Brenner-Morton, S; Mebius, RE; Littman, DR			Requirement for ROR gamma in thymocyte survival and lymphoid organ development	SCIENCE			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; TUMOR-NECROSIS-FACTOR; ORPHAN RECEPTOR; CELL-DEATH; T-CELL; ABNORMAL-DEVELOPMENT; NEGATIVE SELECTION; DEFICIENT MICE; FAS LIGAND; ORGANOGENESIS	Most developing thymocytes undergo apoptosis because they cannot interact productively with molecules encoded by the major histocompatibility complex. Here, we show that mice lacking the orphan nuclear hormone receptor ROR gamma lose thymic expression of the anti-apoptotic factor Bcl-xL. ROR gamma thus regulates the survival of CD4(+)8(+) thymocytes and may control the temporal window during which thymocytes can undergo positive selection. ROR gamma was also required for development of lymph nodes and Peyer's patches, but not splenic follicles, In its absence, there was loss of a population of CD3(-)CD4(+)CD45(+) cells that normally express ROR gamma and that are Likely early progenitors of lymphoid organs. Hence, ROR gamma has critical functions in T cell repertoire selection and Lymphoid organogenesis.	NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program, New York, NY 10016 USA; NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; Free Univ Amsterdam, Fac Med, Dept Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands	New York University; Howard Hughes Medical Institute; New York University; Columbia University; Columbia University; Howard Hughes Medical Institute; Vrije Universiteit Amsterdam	Littman, DR (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, Mol Pathogenesis Program, New York, NY 10016 USA.	littman@saturn.med.nyu.edu	Pierani, Alessandra/O-6136-2017	Pierani, Alessandra/0000-0002-4872-4791; Sunshine, Mary Jean/0000-0002-2188-7881; Mebius, Reina/0000-0003-0451-7464				Alimzhanov MB, 1997, P NATL ACAD SCI USA, V94, P9302, DOI 10.1073/pnas.94.17.9302; CALNAN BJ, 1995, IMMUNITY, V3, P273; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Gil-Gomez G, 1998, EMBO J, V17, P7209, DOI 10.1093/emboj/17.24.7209; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; He YW, 1998, IMMUNITY, V9, P797, DOI 10.1016/S1074-7613(00)80645-7; HIROSE T, 1994, BIOCHEM BIOPH RES CO, V205, P1976, DOI 10.1006/bbrc.1994.2902; KING LB, 1995, IMMUNITY, V3, P647, DOI 10.1016/1074-7613(95)90135-3; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Littman DR, 1999, COLD SPRING HARB SYM, V64, P373, DOI 10.1101/sqb.1999.64.373; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; Mazel S, 1996, J EXP MED, V183, P2219, DOI 10.1084/jem.183.5.2219; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Neumann B, 1996, J EXP MED, V184, P259, DOI 10.1084/jem.184.1.259; ORTIZ MA, 1995, MOL ENDOCRINOL, V9, P1679, DOI 10.1210/me.9.12.1679; Sun Z., UNPUB; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812	23	579	630	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2000	288	5475					2369	2373		10.1126/science.288.5475.2369	http://dx.doi.org/10.1126/science.288.5475.2369			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329NP	10875923				2022-12-24	WOS:000087913400041
J	McCreath, KJ; Howcroft, J; Campbell, KHS; Colman, A; Schnieke, AE; Kind, AJ				McCreath, KJ; Howcroft, J; Campbell, KHS; Colman, A; Schnieke, AE; Kind, AJ			Production of gene-targeted sheep by nuclear transfer from cultured somatic cells	NATURE			English	Article							PRO-ALPHA-1(I) COLLAGEN GENE; CLONED TRANSGENIC CALVES; HOMOLOGOUS RECOMBINATION; 3'-UNTRANSLATED REGION; FETAL FIBROBLASTS; EXPRESSION; THERAPY; SEQUENCES	It is over a decade since the first demonstration that mouse embryonic stem cells could be used to transfer a predetermined genetic modification to a whole animal(1). The extension of this technique to other mammalian species, particularly livestock, might bring numerous biomedical benefits, for example, ablation of xenoreactive transplantation antigens, inactivation of genes responsible for neuropathogenic disease and precise placement of transgenes designed to produce proteins for human therapy. Gene targeting has not yet been achieved in mammals other than mice, however, because functional embryonic stem cells have not been derived. Nuclear transfer from cultured somatic cells provides an alternative means of cell-mediated transgenesis(2,3). Here we describe efficient and reproducible gene targeting in fetal fibroblasts to place a therapeutic transgene at the ovine alpha 1(I) procollagen (COL1A1) locus and the production of live sheep by nuclear transfer.	PPL Therapeut Ltd, Roslin EH25 9PP, Midlothian, Scotland		Kind, AJ (corresponding author), PPL Therapeut Ltd, Roslin EH25 9PP, Midlothian, Scotland.			Schnieke, Angelika/0000-0002-5761-9635				Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; CARVER AS, 1993, BIO-TECHNOL, V11, P1263; CHU ML, 1985, J BIOL CHEM, V260, P2315; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; EBERT KM, 1994, BIO-TECHNOL, V12, P699, DOI 10.1038/nbt0794-699; Hill JR, 1999, THERIOGENOLOGY, V51, P1451, DOI 10.1016/S0093-691X(99)00089-8; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Kay MA, 1999, P NATL ACAD SCI USA, V96, P9973, DOI 10.1073/pnas.96.18.9973; Kono T, 1998, REPROD FERT DEVELOP, V10, P593, DOI 10.1071/RD98056; Lai LW, 1999, EXP NEPHROL, V7, P11; LIN FL, 1985, P NATL ACAD SCI USA, V82, P1391, DOI 10.1073/pnas.82.5.1391; MAATTA A, 1995, BBA-GENE STRUCT EXPR, V1260, P294, DOI 10.1016/0167-4781(94)00207-J; MCCLENAGHAN M, 1991, Animal Biotechnology, V2, P161, DOI 10.1080/10495399109525756; McWhir J, 1996, NAT GENET, V14, P223, DOI 10.1038/ng1096-223; MOOSLEHNER K, 1988, NUCLEIC ACIDS RES, V16, P773, DOI 10.1093/nar/16.2.773; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Renard JP, 1999, LANCET, V353, P1489, DOI 10.1016/S0140-6736(98)12173-6; Rippe RA, 1997, J BIOL CHEM, V272, P1753, DOI 10.1074/jbc.272.3.1753; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Sedivy JM, 1999, TRENDS GENET, V15, P88, DOI 10.1016/S0168-9525(98)01689-8; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0; STACEY A, 1988, NATURE, V332, P131, DOI 10.1038/332131a0; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; WARBURTON MJ, 1986, J CELL PHYSIOL, V128, P76, DOI 10.1002/jcp.1041280113; Yanez RJ, 1998, GENE THER, V5, P149, DOI 10.1038/sj.gt.3300601	25	449	586	1	43	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 29	2000	405	6790					1066	1069		10.1038/35016604	http://dx.doi.org/10.1038/35016604			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	328VN	10890449				2022-12-24	WOS:000087871700049
J	Canto, JG; Shlipak, MG; Rogers, WJ; Malmgren, JA; Frederick, PD; Lambrew, CT; Ornato, JP; Barron, HV; Kiefe, CI				Canto, JG; Shlipak, MG; Rogers, WJ; Malmgren, JA; Frederick, PD; Lambrew, CT; Ornato, JP; Barron, HV; Kiefe, CI			Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATIONAL REGISTRY; UNITED-STATES; THROMBOLYTIC THERAPY; REPERFUSION THERAPY; EMERGENCY; WOMEN	Context Although chest pain is widely considered a key symptom in the diagnosis of myocardial infarction (MI), not all patients with MI present with chest pain. The extent to which this phenomenon occurs is largely unknown. Objectives To determine the frequency with which patients with MI present without chest pain and to examine their subsequent management and outcome. Design Prospective observational study. Setting and Patients A total of 434 877 patients with confirmed MI enrolled June 1994 to March 1998 in the National Registry of Myocardial Infarction 2, which includes 1674 hospitals in the United States. Main Outcome Measures Prevalence of presentation without chest pain; clinical characteristics, treatment, and mortality among MI patients without chest pain vs those with chest pain, Results Of all patients diagnosed as having MI, 142 445 (33%) did not have chest pain on presentation to the hospital. This group of MI patients was, on average, 7 years older than those with chest pain (74.2 vs 66.9 years), with a higher proportion of women (49.0% vs 38.0%) and patients with diabetes mellitus (32.6% vs 25.4%) or prior heart failure (26.4% vs 12.3%). Also, MI patients without chest pain had a longer delay before hospital presentation (mean, 7.9 vs 5.3 hours), were less likely to be diagnosed as having confirmed MI at the time of admission (22.2% vs 50.3%), and were less likely to receive thrombolysis or primary angioplasty (25.3% vs 74.0%), aspirin (60.4% vs 84.5%), beta-blockers (28.0% vs 48.0%), or heparin (53.4% vs 83.2%). Myocardial infarction patients without chest pain had a 23.3% in-hospital mortality rate compared with 9.3% among patients with chest pain (adjusted odds ratio for mortality, 2.21 [95% confidence interval, 2.17-2.26]). Conclusions Our results suggest that patients without chest pain on presentation represent a large segment of the MI population and are at increased risk for delays in seeking medical attention, less aggressive treatments, and in-hospital mortality.	Univ Alabama, Birmingham, AL 35294 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Genentech Inc, S San Francisco, CA 94080 USA; Univ Washington, Cardiol Outcomes Res Ctr, Seattle, WA 98195 USA; Univ Vermont, Portland, ME USA; Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA	University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Francisco; Roche Holding; Genentech; University of Washington; University of Washington Seattle; University of Vermont; Virginia Commonwealth University	Canto, JG (corresponding author), Univ Alabama, 363 BDB,1808 7th Ave S, Birmingham, AL 35294 USA.			Frederick, Paul/0000-0002-7936-5488	AHRQ HHS [HS08843] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS008843] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ACHARYA DU, 1991, AM J CARDIOL, V68, P793, DOI 10.1016/0002-9149(91)90657-7; Barron HV, 1998, CIRCULATION, V97, P1150, DOI 10.1161/01.CIR.97.12.1150; BEAN WB, 1977, LANCET, V1, P1044; BELLER GA, 1995, CLIN NUCL CARDIOLOGY, P98; Braunwald E., 1992, HEART DIS, P1214; CALIFF RM, 1988, ANN INTERN MED, V108, P658, DOI 10.7326/0003-4819-108-5-658; Canto JG, 1997, J AM COLL CARDIOL, V29, P498, DOI 10.1016/S0735-1097(96)00532-3; Chandra NC, 1998, ARCH INTERN MED, V158, P981, DOI 10.1001/archinte.158.9.981; COX DA, 1994, AM J CARDIOL, V73, P729, DOI 10.1016/0002-9149(94)90872-9; Every NR, 1999, J AM COLL CARDIOL, V33, P1886, DOI 10.1016/S0735-1097(99)00113-8; GILLUM RF, 1984, AM HEART J, V108, P150, DOI 10.1016/0002-8703(84)90558-1; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; LEE TH, 1987, AM J CARDIOL, V60, P219, DOI 10.1016/0002-9149(87)90217-7; MCCARTHY BD, 1993, ANN EMERG MED, V22, P579, DOI 10.1016/S0196-0644(05)81945-6; McLaughlin TJ, 1996, ARCH INTERN MED, V156, P799, DOI 10.1001/archinte.156.7.799; OHMAN EM, 1990, CIRCULATION, V82, P781, DOI 10.1161/01.CIR.82.3.781; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; ROUAN GW, 1987, ANN EMERG MED, V16, P1145, DOI 10.1016/S0196-0644(87)80474-2; Taylor HA, 1998, AM J CARDIOL, V82, P1019, DOI 10.1016/S0002-9149(98)00547-5; WEAVER WD, 1991, J AM COLL CARDIOL, V18, P657, DOI 10.1016/0735-1097(91)90784-7	20	476	489	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2000	283	24					3223	3229		10.1001/jama.283.24.3223	http://dx.doi.org/10.1001/jama.283.24.3223			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326TY	10866870	Green Published, Bronze			2022-12-24	WOS:000087753900035
J	Borhan, B; Souto, ML; Imai, H; Shichida, Y; Nakanishi, K				Borhan, B; Souto, ML; Imai, H; Shichida, Y; Nakanishi, K			Movement of retinal along the visual transduction path	SCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; TRANSMEMBRANE HELICES; RESONANCE RAMAN; RHODOPSIN ACTIVATION; PRIMARY PHOTOPRODUCT; LOW-TEMPERATURE; FROG RHODOPSIN; ENERGY-STORAGE; 1ST STEP; CHROMOPHORE	Movement of the ligand/receptor complex in rhodopsin (Rh) has been traced. Bleaching of diazoketo rhodopsin (DK-Rh) containing 11-cis-3-diazo-4-oxo-retinal yields batho-, lumi-, meta-I-, and meta-II-Rh intermediates corresponding to those of native kh but at lower temperatures. Photoaffinity labeling of DK-Rh and these bleaching intermediates shows that the ionone ring cross-links to tryptophan-265 on helix F in DK-Rh and batho-Rh, and to alanine-169 on helix D in lumi-, meta-I-, and meta-II-Rh intermediates, It is likely that these movements involving a flip-over of the chromophoric ring trigger changes in cytoplasmic membrane loops resulting in heterotrimeric guanine nucleotide-binding protein (G protein) activation.	Columbia Univ, Dept Chem, New York, NY 10027 USA; Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan	Columbia University; Kyoto University	Nakanishi, K (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.	kn5@columbia.edu	Souto, Maria L/L-5911-2014	Souto, Maria L/0000-0001-9123-0749; Imai, Hiroo/0000-0003-0729-0322	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034509, R37GM034509] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34509] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBECK A, 1989, BIOPHYS J, V55, P233, DOI 10.1016/S0006-3495(89)82798-5; ASENJO AB, 1994, NEURON, V12, P1131, DOI 10.1016/0896-6273(94)90320-4; BAGLEY KA, 1985, BIOCHEMISTRY-US, V24, P6055, DOI 10.1021/bi00343a006; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Borhan B, 1999, CHEM-EUR J, V5, P1172, DOI 10.1002/(SICI)1521-3765(19990401)5:4<1172::AID-CHEM1172>3.0.CO;2-Q; CALLENDER RH, 1976, BIOCHEMISTRY-US, V15, P1621, DOI 10.1021/bi00653a005; Chosrowjan H, 1998, J AM CHEM SOC, V120, P9706, DOI 10.1021/ja981659w; COOPER A, 1979, NATURE, V282, P531, DOI 10.1038/282531a0; DENG H, 1991, BIOCHEMISTRY-US, V30, P4495, DOI 10.1021/bi00232a018; EYRING G, 1982, BIOCHEMISTRY-US, V21, P384, DOI 10.1021/bi00531a028; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Han M, 1997, P NATL ACAD SCI USA, V94, P13442, DOI 10.1073/pnas.94.25.13442; Han M, 1996, J BIOL CHEM, V271, P32337, DOI 10.1074/jbc.271.50.32337; Han M, 1997, J BIOL CHEM, V272, P23081, DOI 10.1074/jbc.272.37.23081; Herzyk P, 1998, J MOL BIOL, V281, P741, DOI 10.1006/jmbi.1998.1981; HUG SJ, 1990, BIOCHEMISTRY-US, V29, P1475, DOI 10.1021/bi00458a019; ITO M, 1992, PHOTOCHEM PHOTOBIOL, V56, P915, DOI 10.1111/j.1751-1097.1992.tb09713.x; Kliger DS, 1995, ISR J CHEM, V35, P289; Lin SW, 1996, BIOCHEMISTRY-US, V35, P11149, DOI 10.1021/bi960858u; NAKAYAMA TA, 1990, J BIOL CHEM, V265, P15762; OKADA T, 1994, BIOCHEMISTRY-US, V33, P4940, DOI 10.1021/bi00182a024; OLIVEIRA L, 1994, TRENDS PHARMACOL SCI, V15, P170, DOI 10.1016/0165-6147(94)90137-6; PALINGS I, 1989, BIOCHEMISTRY-US, V28, P1498, DOI 10.1021/bi00430a012; PETEANU LA, 1993, P NATL ACAD SCI USA, V90, P11762, DOI 10.1073/pnas.90.24.11762; Pogozheva ID, 1997, BIOPHYS J, V72, P1963, DOI 10.1016/S0006-3495(97)78842-8; Rando RR, 1996, CHEM BIOL, V3, P255, DOI 10.1016/S1074-5521(96)90105-2; Sakmar TP, 1998, PROG NUCLEIC ACID RE, V59, P1; SCHERTLER GFX, 1995, P NATL ACAD SCI USA, V92, P11578, DOI 10.1073/pnas.92.25.11578; SCHICK GA, 1987, BIOCHEMISTRY-US, V26, P2556, DOI 10.1021/bi00383a022; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; SHICHIDA Y, 1987, BIOCHEMISTRY-US, V26, P4422, DOI 10.1021/bi00388a035; Shieh T, 1997, J MOL BIOL, V269, P373, DOI 10.1006/jmbi.1997.1035; SMITH SO, 1991, BIOCHEMISTRY-US, V30, P7409, DOI 10.1021/bi00244a007; Souto M., UNPUB; Tan Q, 1997, ANGEW CHEM INT EDIT, V36, P2089, DOI 10.1002/anie.199720891; YOSHIZAWA T, 1982, METHOD ENZYMOL, V81, P333; YOSHIZAWA T, 1973, BIOCH PHYSL VISUAL P; ZHANG HZ, 1994, J AM CHEM SOC, V116, P10165, DOI 10.1021/ja00101a040	38	205	208	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2000	288	5474					2209	2212		10.1126/science.288.5474.2209	http://dx.doi.org/10.1126/science.288.5474.2209			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864869				2022-12-24	WOS:000087782900057
J	Janssen, P; Vogels, R; Orban, CA				Janssen, P; Vogels, R; Orban, CA			Selectivity for 3D shape that reveals distinct areas within macaque inferior temporal cortex	SCIENCE			English	Article							INFEROTEMPORAL CORTEX; CORTICAL CONNECTIONS; VISUAL IMAGES; RHESUS-MONKEY; ARCHITECTONICS; OBJECTS; NEURONS; SULCUS	The anterior part of the macaque inferior temporal cortex, area TE, occupies a Large portion of the temporal Lobe and is critical for object recognition. Thus far, no relation between anatomical subdivisions of TE and neuronal selectivity has been described. Here, we present evidence that neurons selective for three-dimensional (3D) shape are concentrated in the lower bank of the superior temporal sulcus, whereas neurons in lateral TE are generally unselective for 3D shape, though equally selective for 2D shape. These findings reveal that TE consists of at Least two distinct areas, one of which processes a specific object property.	Katholieke Univ Leuven, Sch Med, Neuro & Psychofysiol Lab, B-3000 Louvain, Belgium	KU Leuven	Vogels, R (corresponding author), Katholieke Univ Leuven, Sch Med, Neuro & Psychofysiol Lab, B-3000 Louvain, Belgium.			Orban, Guy/0000-0002-8179-9584				BAIZER JS, 1991, J NEUROSCI, V11, P168; BAYLIS GC, 1987, J NEUROSCI, V7, P330; DESIMONE R, 1991, J COGNITIVE NEUROSCI, V3, P1, DOI 10.1162/jocn.1991.3.1.1; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; ITO M, 1994, CEREB CORTEX, V4, P499, DOI 10.1093/cercor/4.5.499; Janssen P, 1999, P NATL ACAD SCI USA, V96, P8217, DOI 10.1073/pnas.96.14.8217; JONES E G, 1970, Brain Behavior and Evolution, V93, P793, DOI 10.1093/brain/93.4.793; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Saleem KS, 1996, J NEUROSCI, V16, P4757; SALEEM KS, IN PRESS J NEUROSCI; SELTZER B, 1989, J COMP NEUROL, V290, P451, DOI 10.1002/cne.902900402; SELTZER B, 1978, BRAIN RES, V149, P1, DOI 10.1016/0006-8993(78)90584-X; Shikata E, 1996, NEUROREPORT, V7, P2389, DOI 10.1097/00001756-199610020-00022; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; Ungerleider L.G., 1982, ANAL VISUAL BEHAV; UNGERLEIDER LG, 1986, J COMP NEUROL, V248, P190, DOI 10.1002/cne.902480204	16	166	169	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2000	288	5473					2054	+		10.1126/science.288.5473.2054	http://dx.doi.org/10.1126/science.288.5473.2054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856221	Green Accepted			2022-12-24	WOS:000087687000054
J	Rinberg, D; Davidowitz, H				Rinberg, D; Davidowitz, H			Insect perception - Do cockroaches 'know' about fluid dynamics?	NATURE			English	Article									NEC Res Inst, Princeton, NJ 08540 USA	NEC Corporation	Rinberg, D (corresponding author), NEC Res Inst, 4 Independence Way, Princeton, NJ 08540 USA.							Camhi JM, 1984, NEUROETHOLOGY; GNATZY W, 1990, J COMP PHYSIOL A, V167, P551, DOI 10.1007/BF00190826; KONDOH Y, 1991, J COMP PHYSIOL A, V169, P653; PLUMMER MR, 1981, J COMP PHYSIOL, V142, P347, DOI 10.1007/BF00605447; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; TRITTON DJ, 1998, PHYSICAL FLUID DYNAM; Vedenina VY, 1998, J COMP PHYSIOL A, V183, P553, DOI 10.1007/s003590050281	7	11	11	4	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					756	756		10.1038/35015677	http://dx.doi.org/10.1038/35015677			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10866188				2022-12-24	WOS:000087620600038
J	Spirito, P; Bellone, P; Harris, KM; Bernabo, P; Bruzzi, P; Maron, BJ				Spirito, P; Bellone, P; Harris, KM; Bernabo, P; Bruzzi, P; Maron, BJ			Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL COURSE; PROGNOSIS; POPULATION; TACHYCARDIA; PREVALENCE; MUTATIONS; FEATURES; EXTENT; AGE	Background: Sudden death is a possible consequence of hypertrophic cardiomyopathy. Quantification of the risk of sudden death, however, remains imprecise for most patients with this disease. Methods: We assessed the relation between the magnitude of left ventricular hypertrophy and mortality in 480 consecutive patients with hypertrophic cardiomyopathy. The patients were categorized into five subgroups according to maximal wall thickness: 15 mm or less, 16 to 19 mm, 20 to 24 mm, 25 to 29 mm, and 30 mm or more. Their ages ranged from 1 to 89 years (median, 47). Results: Over a mean follow-up period of 6.5 years, 65 of the 480 patients (14 percent) died: 23 suddenly, 15 of heart failure, and 27 of noncardiac causes or stroke. The risk of sudden death increased progressively and in direct relation to wall thickness (P=0.001), ranging from 0 per 1000 person-years (95 percent confidence interval, 0 to 14.4) for a wall thickness of 15 mm or less to 18.2 per 1000 person-years (95 percent confidence interval, 7.3 to 37.6) for a wall thickness of 30 mm or more and almost doubling from each wall-thickness subgroup to the next. The cumulative risk 20 years after the initial evaluation was close to zero for patients with a wall thickness of 19 mm or less but almost 40 percent for wall thicknesses of 30 mm or more. As compared with the other subgroups, patients with extreme hypertrophy were the youngest (mean age, 31 years), and most (41 of 43) had mild symptoms or no symptoms; of the 12 patients who were less than 18 years old at the initial evaluation, 5 died suddenly. Conclusions: In hypertrophic cardiomyopathy, the magnitude of hypertrophy is directly related to the risk of sudden death and is a strong and independent predictor of prognosis. Young patients with extreme hypertrophy, even those with few or no symptoms, appear to be at substantial long-term risk and deserve consideration for interventions to prevent sudden death. The majority of patients with mild hypertrophy are at low risk and can be reassured regarding their prognosis. (N Engl J Med 2000;342:1778-85.) (C)2000, Massachusetts Medical Society.	Ente Osped Osped Galliera, Div Cardiol, I-16128 Genoa, Italy; Osped Santa Corona, Div Cardiol, Pietra Ligure, Savona, Italy; Ist Nazl Ric Canc, Serv Epidemiol Clin, I-16132 Genoa, Italy; Minneapolis Heart Inst Fdn, Minneapolis, MN USA	Ente Ospedaliero Ospedali Galliera; University of Genoa; IRCCS AOU San Martino IST; Minneapolis Heart Institute Foundation	Spirito, P (corresponding author), Ente Osped Osped Galliera, Div Cardiol, Via Volta 8, I-16128 Genoa, Italy.		Bruzzi, Paolo/AAU-3363-2021	Bruzzi, Paolo/0000-0002-7874-2077	Telethon [0860C] Funding Source: Medline	Telethon(Fondazione Telethon)		BRAUNWALD E, 1964, CIRCULATION, V30, P3; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; FRANK S, 1968, CIRCULATION, V37, P759, DOI 10.1161/01.CIR.37.5.759; JOSEPH S, 1972, BRIT HEART J, V34, P974; Knight C, 1997, CIRCULATION, V95, P2075, DOI 10.1161/01.CIR.95.8.2075; KOFFLARD MJ, 1993, AM J CARDIOL, V72, P939, DOI 10.1016/0002-9149(93)91111-T; LOUIE EK, 1986, J AM COLL CARDIOL, V8, P57, DOI 10.1016/S0735-1097(86)80092-4; Maron BJ, 1997, LANCET, V350, P1330; Maron BJ, 1999, JAMA-J AM MED ASSOC, V281, P650, DOI 10.1001/jama.281.7.650; Maron BJ, 1999, CIRCULATION, V99, P2927, DOI 10.1161/01.CIR.99.22.2927; Maron BJ, 2000, NEW ENGL J MED, V342, P365, DOI 10.1056/NEJM200002103420601; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maron BJ, 1997, LANCET, V350, P127, DOI 10.1016/S0140-6736(97)01282-8; MARON BJ, 1986, NEW ENGL J MED, V315, P610, DOI 10.1056/NEJM198609043151003; MARON BJ, 1999, JAMA-J AM MED ASSOC, V281, P2288; MCKENNA W, 1981, AM J CARDIOL, V47, P532, DOI 10.1016/0002-9149(81)90535-X; MCKENNA WJ, 1985, BRIT HEART J, V53, P412; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Palmieri V, 1999, J AM COLL CARDIOL, V34, P1625, DOI 10.1016/S0735-1097(99)00396-4; PANZA JA, 1992, J AM COLL CARDIOL, V19, P91, DOI 10.1016/0735-1097(92)90057-T; Sadoul N, 1997, CIRCULATION, V96, P2987, DOI 10.1161/01.CIR.96.9.2987; SCHWARTZ K, 1995, CIRCULATION, V91, P532, DOI 10.1161/01.CIR.91.2.532; SPIRITO P, 1994, CIRCULATION, V90, P2743, DOI 10.1161/01.CIR.90.6.2743; Spirito P, 1999, CIRCULATION, V99, P2132, DOI 10.1161/01.CIR.99.16.2132; SPIRITO P, 1987, AM J CARDIOL, V60, P123, DOI 10.1016/0002-9149(87)90998-2; SPIRITO P, 1989, NEW ENGL J MED, V320, P749, DOI 10.1056/NEJM198903233201201; SPIRITO P, 1989, J AM COLL CARDIOL, V13, P820, DOI 10.1016/0735-1097(89)90222-2; SPIRITO P, 1990, J AM COLL CARDIOL, V15, P1521, DOI 10.1016/0735-1097(90)92820-R; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; TEARE D, 1958, BRIT HEART J, V20, P1; WATKINS H, 1992, NEW ENGL J MED, V326, P1108, DOI 10.1056/NEJM199204233261703; WIGLE ED, 1995, CIRCULATION, V92, P1680, DOI 10.1161/01.CIR.92.7.1680	32	718	757	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2000	342	24					1778	1785		10.1056/NEJM200006153422403	http://dx.doi.org/10.1056/NEJM200006153422403			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PG	10853000				2022-12-24	WOS:000087573700003
J	Clark, CE; Coote, JM; Silver, DAT; Halpin, DMG				Clark, CE; Coote, JM; Silver, DAT; Halpin, DMG			Asthma after childhood pneumonia: six year follow up study	BRITISH MEDICAL JOURNAL			English	Article							BRONCHIOLITIS	Objective To establish the long term cum cumulative prevalence of asthma in children admitted to hospital with pneumonia and to examine the hypothesis that some children admitted to hospital with pneumonia may be presenting with undiagnosed asthma Design Prospective study of a cohort of children previously admitted to hospital with pneumonia, followed up by postal questionnaires to their general practitioners and the children or their parents. Setting General practices in southwest England. Participants 78 children admitted to the Royal Devon and Exeter Hospital between 1989 and 1991 with a diagnosis of pneumonia confirmed on independent review of x ray films. Main outcome measures Any diagnosis of asthma, use of any treatment for asthma, and asthma symptom scores. Results On the basis of a 100% response rate from general practitioners and 86% from patients or parents, the cumulative prevalence of asthma was 45%. A diagnosis of asthma was associated with a family history of asthma (odds ratio 11.23; 95% confidence interval 2.57 to 56.36; P = 0.0002). Mean symptom scores were higher for all children with asthma (mean score 2.4; chi(2) = 14.88; P = 0.0001) and for children with asthma not being treated (mean 1.4; chi(2) = 6.2; P = 0.01) than for those without asthma (mean 0.2). Conclusions A considerable proportion of children presenting to a district general hospital with pneumonia either already have unrecognised asthma or subsequently develop asthma. The high cumulative prevalence of asthma suggests that careful follow up of such children is worth while. Asthma is undertreated in these children; a structured symptom questionnaire may help to identify and reduce morbidity due to undertreatment.	Mid Devon Med Practice, Witheridge EX16 8AH, Devon, England; Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England	University of Exeter	Clark, CE (corresponding author), Mid Devon Med Practice, Witheridge EX16 8AH, Devon, England.							Bodner C, 1997, BRIT MED J, V314, P792, DOI 10.1136/bmj.314.7083.792; CLARK CE, 1997, ASTHMA GEN PRACT, V5, P9; DEAN AG, 1990, EPIINFO VERSION 5 WO; KORPPI M, 1993, AM J DIS CHILD, V147, P628, DOI 10.1001/archpedi.1993.02160300034017; KORPPI M, 1994, ARCH PEDIAT ADOL MED, V148, P1079, DOI 10.1001/archpedi.1994.02170100077015; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; MOK JYQ, 1984, ARCH DIS CHILD, V59, P306, DOI 10.1136/adc.59.4.306; SPEIGHT ANP, 1983, BRIT MED J, V286, P1253, DOI 10.1136/bmj.286.6373.1253; Strachan DP, 1996, BRIT MED J, V312, P1195; VENABLES KM, 1993, THORAX, V48, P214, DOI 10.1136/thx.48.3.214; Wlson AG, 1995, IMAGING DIS CHEST; [No title captured], DOI DOI 10.1136/THX.52.2008.S1]	12	16	17	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 3	2000	320	7248					1514	1516		10.1136/bmj.320.7248.1514	http://dx.doi.org/10.1136/bmj.320.7248.1514			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321TP	10834897	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000087471000027
J	Dodds, JP; Nardone, L; Mercey, DE; Johnson, AM				Dodds, JP; Nardone, L; Mercey, DE; Johnson, AM			Increase in high risk sexual behaviour among homosexual men, London 1996-8: cross sectional, questionnaire study	BRITISH MEDICAL JOURNAL			English	Article									UCL Royal Free & Univ Coll Med Sch, Dept Sexually Transmitted Dis, London WC1E 6AU, England	University of London; University College London; UCL Medical School	Dodds, JP (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Sexually Transmitted Dis, London WC1E 6AU, England.	JDodds@gurn.ucl.ac.uk		Nardone, Anthony/0000-0003-1138-0937; Johnson, Anne/0000-0003-1330-7100				*COMM DIS SURV CTR, 1999, COMMUN DIS REP CDR W, V9, P121; Nardone A, 1998, Commun Dis Public Health, V1, P197; Nardone A, 1997, GENITOURIN MED, V73, P198; Page-Shafer KA, 1999, JAMA-J AM MED ASSOC, V281, P696; 1998, COMMUN DIS REP CDR W, V8, P194	5	156	156	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 3	2000	320	7248					1510	1511		10.1136/bmj.320.7248.1510	http://dx.doi.org/10.1136/bmj.320.7248.1510			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321TP	10834892	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000087471000024
J	Choi, I; Aalkjaer, C; Boulpaep, EL; Boron, WF				Choi, I; Aalkjaer, C; Boulpaep, EL; Boron, WF			An electroneutral sodium/bicarbonate cotransporter NBCn1 and associated sodium channel	NATURE			English	Article							INTRACELLULAR PH; TISSUE DISTRIBUTION; BICARBONATE COTRANSPORTER; SMOOTH-MUSCLE; CLONING; TRANSPORT; EXCHANGE; PROTEIN; FAMILY; EXPRESSION	Two electroneutral, Na+-driven HCO3- transporters, the Na+-driven Cl-/HCO3- exchanger and the electroneutral Na+/HCO3- cotransporter, have crucial roles in regulating intracellular pH in a variety of cells, including cardiac myocytes(1,2), vascular smooth-muscle(3,4), neurons(5) and fibroblasts(6); however, it is difficult to distinguish their CT dependence in mammalian cells. Here we report the cloning of three variants of an electroneutral Na+/HCO3- cotransporter, NBCn1, from rat smooth muscle. They are 89-92% identical to a human skeletal muscle clone(7), 55-57% identical to the electrogenic NBCs and 33-43% identical to the anion exchangers(8). When expressed in Xenopus oocytes, NBCn1-B (which encodes 1,218 amino acids) is electroneutral, Na+-dependent and HCO3--dependent, but not Cl--dependent. Oocytes injected with low levels of NBCn1-B complementary RNA exhibit a Na+ conductance that 4,4-diisothiocyanatostilbene-2,2'-disulphonate stimulates slowly and irreversibly.	Yale Univ, Sch Med, Dept Cellular & Mol Biol, New Haven, CT 06520 USA; Aarhus Univ, Dept Physiol, DK-8000 Aarhus, Denmark; Aarhus Univ, Danish Biomembrane Res Ctr, DK-8000 Aarhus, Denmark	Yale University; Aarhus University; Aarhus University	Boron, WF (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Biol, 333 Cedar St, New Haven, CT 06520 USA.		Boron, Walter/ABI-1564-2020; choi, inyeong/AAM-4826-2021	Aalkjaer, Christian/0000-0003-2618-4015; Boron, Walter/0000-0003-4741-7287				AALKJAER C, 1991, J PHYSIOL-LONDON, V436, P57, DOI 10.1113/jphysiol.1991.sp018539; Aalkjaer C, 1996, J VASC RES, V33, P347, DOI 10.1159/000159163; Abuladze N, 1998, J BIOL CHEM, V273, P17689, DOI 10.1074/jbc.273.28.17689; AICKIN CC, 1994, J PHYSIOL-LONDON, V479, P301, DOI 10.1113/jphysiol.1994.sp020297; Bielfeld-Ackermann A, 1998, PFLUG ARCH EUR J PHY, V436, P329, DOI 10.1007/PL00008085; CABANTCHIK ZI, 1978, BIOCHIM BIOPHYS ACTA, V515, P239; Choi I, 1999, AM J PHYSIOL-CELL PH, V276, pC576, DOI 10.1152/ajpcell.1999.276.3.C576; DART C, 1992, J PHYSIOL-LONDON, V451, P365, DOI 10.1113/jphysiol.1992.sp019169; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KOPITO RR, 1985, NATURE, V316, P234, DOI 10.1038/316234a0; KOPITO RR, 1989, CELL, V59, P927, DOI 10.1016/0092-8674(89)90615-6; KUDRYCKI KE, 1990, J BIOL CHEM, V265, P462; LAGADICGOSSMANN D, 1992, J PHYSIOL-LONDON, V458, P361, DOI 10.1113/jphysiol.1992.sp019422; LALLEMAIN G, 1985, J BIOL CHEM, V260, P4877; ORCHARD CH, 1990, AM J PHYSIOL, V258, pC967, DOI 10.1152/ajpcell.1990.258.6.C967; Pushkin A, 1999, J BIOL CHEM, V274, P16569, DOI 10.1074/jbc.274.23.16569; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Romero MF, 1998, AM J PHYSIOL-RENAL, V274, pF425, DOI 10.1152/ajprenal.1998.274.2.F425; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SCHWIENING CJ, 1994, J PHYSIOL-LONDON, V475, P59, DOI 10.1113/jphysiol.1994.sp020049; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; SIEBENS AW, 1987, J GEN PHYSIOL, V90, P799, DOI 10.1085/jgp.90.6.799; Smith GL, 1998, CARDIOVASC RES, V38, P316, DOI 10.1016/S0008-6363(98)00020-0; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; TZOUNOPOULOS T, 1995, BIOPHYS J, V69, P904, DOI 10.1016/S0006-3495(95)79964-7; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Yu M, 1998, HYPERTENSION, V32, P807; ZHAO JH, 1995, NATURE, V374, P636, DOI 10.1038/374636a0	28	199	202	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					571	575		10.1038/35014615	http://dx.doi.org/10.1038/35014615			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850716				2022-12-24	WOS:000087449500051
J	Ramers, C; Billman, G; Hartin, M; Ho, S; Sawyer, MH				Ramers, C; Billman, G; Hartin, M; Ho, S; Sawyer, MH			Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CENTRAL-NERVOUS-SYSTEM; ASEPTIC-MENINGITIS; CLINICAL UTILITY; INFECTION; OUTBREAK; INFANTS; PCR; CULTURE	Context Enterovirus (EV) infection. the most common cause of aseptic meningitis, can be rapidly diagnosed with an EV-specific reverse transcriptase polymerase chain reaction (EV-PCR) test. However, no studies have examined EV-PCR in a clinical context in which it is routinely used. Objective To determine the impact of EV-PCR testing on diagnosis and clinical management of suspected aseptic meningitis cases. Design and Setting Retrospective review of electronic medical records from a 220-bed tertiary care pediatric medical center in San Diego, Calif. Patients A total of 276 pediatric patients for whom a diagnostic EV-PCR test was performed during the calendar year 1998. Main Outcome Measures Clinical parameters such as length of stay, medication use, and ancillary test use. Results One hundred thirty-seven patients (49.6%) had a positive cerebrospinal fluid EV-PCR result, Enterovirus-positive patients with results available before hospital discharge (n=95) had significantly fewer ancillary tests performed (26% vs 72% with at least 1 test performed; P<.001), received intravenous antibiotics for less time (median, 2.0 vs 3.5 days; P<.001), and had shorter hospital stays (median, 42 vs 71.5 hours; P<.001) than EV-negative patients (n=92). A positive EV-PCR result was associated with more rapid hospital discharge (median EV-PCR-to-discharge time, 5.2 hours) compared with a negative result (median EV-PCR-to-discharge time, 27.4 hours; P<.001). Conclusions Our results suggest that a positive EV-PCR result may affect clinical decision making and can promote rapid discharge of patients, and that unnecessary diagnostic and therapeutic interventions can be reduced by use of EV-PCR testing.	Univ Calif San Diego, Sch Med, Div Pediat Infect Dis, La Jolla, CA 92093 USA; Childrens Hosp & Hlth Ctr, Dept Pathol, San Diego, CA USA; Childrens Hosp & Hlth Ctr, Dept Microbiol, San Diego, CA USA	University of California System; University of California San Diego	Sawyer, MH (corresponding author), Univ Calif San Diego, Sch Med, Div Pediat Infect Dis, 9500 Gilman Dr,0927, La Jolla, CA 92093 USA.							Ahmed A, 1997, J PEDIATR-US, V131, P393, DOI 10.1016/S0022-3476(97)80064-9; BERLIN LE, 1993, J INFECT DIS, V168, P888, DOI 10.1093/infdis/168.4.888; BONADIO WA, 1992, PEDIATR INFECT DIS J, V11, P589, DOI 10.1097/00006454-199207000-00015; BONADIO WA, 1992, PEDIATR INFECT DIS J, V11, P423, DOI 10.1097/00006454-199206000-00001; Byington CL, 1999, PEDIATRICS, V103, part. no., DOI 10.1542/peds.103.3.e27; CHERRY JD, 1997, TXB PEDIAT INFECT DI, P1729; CHONMAITREE T, 1982, JAMA-J AM MED ASSOC, V247, P1843, DOI 10.1001/jama.247.13.1843; DAGAN R, 1988, J PEDIATR-US, V113, P975, DOI 10.1016/S0022-3476(88)80566-3; Dagan R, 1996, PEDIATR INFECT DIS J, V15, P67, DOI 10.1097/00006454-199601000-00015; Gorgievski-Hrisoho M, 1998, J CLIN MICROBIOL, V36, P2408, DOI 10.1128/JCM.36.9.2408-2412.1998; Hamilton MS, 1999, PEDIATR INFECT DIS J, V18, P533, DOI 10.1097/00006454-199906000-00011; LIPSON SM, 1988, J CLIN MICROBIOL, V26, P1298, DOI 10.1128/JCM.26.7.1298-1303.1988; Marshall GS, 1997, PEDIATR INFECT DIS J, V16, P1086, DOI 10.1097/00006454-199711000-00015; Read SJ, 1997, J CLIN MICROBIOL, V35, P691, DOI 10.1128/JCM.35.3.691-696.1997; RICE SK, 1995, CLIN INFECT DIS, V20, P931, DOI 10.1093/clinids/20.4.931; Riding MH, 1996, J MED VIROL, V50, P204, DOI 10.1002/(SICI)1096-9071(199610)50:2&lt;204::AID-JMV16&gt;3.0.CO;2-L; Rotbart HA, 1997, PEDIATR INFECT DIS J, V16, P409, DOI 10.1097/00006454-199704000-00014; ROTBART HA, 1994, J CLIN MICROBIOL, V32, P2590, DOI 10.1128/JCM.32.10.2590-2592.1994; ROTBART HA, 1995, CLIN INFECT DIS, V20, P971, DOI 10.1093/clinids/20.4.971; SAWYER MH, 1994, PEDIATR INFECT DIS J, V13, P177, DOI 10.1097/00006454-199403000-00002; SCHLESINGER Y, 1994, PEDIATRICS, V94, P157; SINGER JI, 1980, J PEDIATR-US, V96, P559, DOI 10.1016/S0022-3476(80)80866-3; Tanel RE, 1996, ARCH PEDIAT ADOL MED, V150, P919, DOI 10.1001/archpedi.1996.02170340033006; WILFERT CM, 1983, PEDIATR INFECT DIS J, V2, P333, DOI 10.1097/00006454-198307000-00019; Yerly S, 1996, J CLIN MICROBIOL, V34, P199, DOI 10.1128/JCM.34.1.199-201.1996	25	184	194	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2000	283	20					2680	2685		10.1001/jama.283.20.2680	http://dx.doi.org/10.1001/jama.283.20.2680			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314FP	10819951	Bronze			2022-12-24	WOS:000087046000036
J	Kuras, L; Kosa, P; Mencia, M; Struhl, K				Kuras, L; Kosa, P; Mencia, M; Struhl, K			TAF-containing and TAF-independent forms of transcriptionally active TBP in vivo	SCIENCE			English	Article							TATA-BINDING PROTEIN; YEAST TFIIA/TBP/DNA COMPLEX; RNA-POLYMERASE-II; PROMOTER SELECTIVITY; CRYSTAL-STRUCTURE; IN-VIVO; TELOMERIC HETEROCHROMATIN; NUCLEOSOME ACETYLATION; SAGA COMPLEX; CORE	Transcriptional activity in yeast strongly correlates with promoter occupancy by general factors such as TATA binding protein (TBP), TFIIA, and TFIIB, but not with occupancy by TBP-associated factors (TAFs). Thus, TBP exists in at least two transcriptionally active forms in vivo. The TAF-containing form corresponds to the TFIID complex, whereas the form lacking TAFs corresponds to TBP itself or to some other TBP complex. Heat shock treatment altered the relative utilization of these TBP forms, with TFIID being favored. Promoter-specific variations in the association of these distinct forms of TBP may explain why only some yeast genes require TFIID for transcriptional activity in vivo.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Struhl, K (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	kevin@hms.harvard.edu	Mencia, Mario/AAS-4554-2020; Mencía, Mario/F-8197-2013	Mencia, Mario/0000-0003-3936-0655; Mencía, Mario/0000-0002-3151-929X; Kuras, Laurent/0000-0003-2932-0940	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030186, R37GM030186] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30186] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apone LM, 1998, MOL CELL, V2, P653, DOI 10.1016/S1097-2765(00)80163-X; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dimova D, 1999, MOL CELL, V4, P75, DOI 10.1016/S1097-2765(00)80189-6; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Komarnitsky PB, 1999, GENE DEV, V13, P2484, DOI 10.1101/gad.13.19.2484; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Li BJ, 1999, MOL CELL BIOL, V19, P5393; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; Michel B, 1998, MOL CELL, V2, P663, DOI 10.1016/S1097-2765(00)80164-1; Moqtaderi Z, 1998, MOL CELL, V2, P675, DOI 10.1016/S1097-2765(00)80165-3; Moqtaderi Z, 1996, NATURE, V383, P188, DOI 10.1038/383188a0; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; Sanders SL, 1999, J BIOL CHEM, V274, P18847, DOI 10.1074/jbc.274.27.18847; Shen WC, 1997, CELL, V90, P615, DOI 10.1016/S0092-8674(00)80523-1; Sterner DE, 1999, MOL CELL BIOL, V19, P86; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Struhl K, 1998, CELL, V94, P1, DOI 10.1016/S0092-8674(00)81213-1; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; VERRIJZER CP, 1994, SCIENCE, V264, P933, DOI 10.1126/science.8178153; VERRIJZER CP, 1995, CELL, V81, P1115, DOI 10.1016/S0092-8674(05)80016-9; Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X; Walker SS, 1996, NATURE, V383, P185, DOI 10.1038/383185a0; Walker SS, 1997, CELL, V90, P607, DOI 10.1016/S0092-8674(00)80522-X	32	144	145	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2000	288	5469					1244	1248		10.1126/science.288.5469.1244	http://dx.doi.org/10.1126/science.288.5469.1244			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315KH	10818000				2022-12-24	WOS:000087112600052
J	Amedeo, P; Habu, Y; Afsar, K; Scheid, OM; Paszkowski, J				Amedeo, P; Habu, Y; Afsar, K; Scheid, OM; Paszkowski, J			Disruption of the plant gene MOM releases transcriptional silencing of methylated genes	NATURE			English	Article							ARABIDOPSIS-THALIANA; DNA METHYLATION; HISTONE DEACETYLASE; PROTEIN; HELICASE; CLONING; DEMETHYLATION; MAINTENANCE; REPRESSION; CHROMATIN	Epigenetic modifications change transcription patterns in multicellular organisms to achieve tissue-specific gene expression and inactivate alien DNA such as transposons or transgenes(1,2). In plants and animals, DNA methylation is involved in heritability and flexibility of epigenetic states(3), although its function is far from clear. We have isolated an Arabidopsis gene, MOM, whose product is required for the maintenance of transcriptional gene silencing. Mutation of this gene or depletion of its transcript by expression of antisense RNA reactivates transcription from several previously silent, heavily methylated loci. Despite this, the dense methylation at these reactivated loci is maintained even after nine generations, indicating that transcriptional activity and methylation pattern are inherited independently. The predicted MOM gene product is a nuclear protein of 2,001 amino acids containing a region similar to part of the ATPase region of the SWI2/SNF2 family, members of which are involved in chromatin remodelling(4). MOM is the first known molecular component that is essential for transcriptional gene silencing and does not affect methylation pattern. Thus, it may act downstream of methylation in epigenetic regulation, or be part of a new pathway that does not require methylation marks.	Friedrich Miescher Inst, CH-4002 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Habu, Y (corresponding author), Friedrich Miescher Inst, POB 2543, CH-4002 Basel, Switzerland.	habu@fmi.ch						Adams R L, 1993, EXS, V64, P120; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; CHUANG JZ, 1995, J CELL BIOL, V128, P1095, DOI 10.1083/jcb.128.6.1095; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Furner IJ, 1998, GENETICS, V149, P651; FURUKAWA K, 1995, EMBO J, V14, P1626, DOI 10.1002/j.1460-2075.1995.tb07151.x; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Hicks GR, 1995, ANNU REV CELL DEV BI, V11, P155, DOI 10.1146/annurev.cb.11.110195.001103; Jeddeloh JA, 1998, GENE DEV, V12, P1714, DOI 10.1101/gad.12.11.1714; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jiang YW, 1996, GENE DEV, V10, P604, DOI 10.1101/gad.10.5.604; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; JOST JP, 1995, J BIOL CHEM, V270, P9734, DOI 10.1074/jbc.270.17.9734; Kakutani T, 1999, GENETICS, V151, P831; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Koonin EV, 1996, PROTEIN SCI, V5, P178; MARTIN L, 1995, J BIOL CHEM, V270, P8822, DOI 10.1074/jbc.270.15.8822; Matzke AJM, 1998, CURR OPIN PLANT BIOL, V1, P142, DOI 10.1016/S1369-5266(98)80016-2; Mengiste T, 1997, PLANT J, V12, P945, DOI 10.1046/j.1365-313X.1997.12040945.x; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; Scheid OM, 1998, P NATL ACAD SCI USA, V95, P632, DOI 10.1073/pnas.95.2.632; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; WORKMAN HJ, 1990, J CELL BIOL, V111, P1535; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463	30	212	223	0	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 11	2000	405	6783					203	206		10.1038/35012108	http://dx.doi.org/10.1038/35012108			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WG	10821279				2022-12-24	WOS:000087080100056
J	Garcia, JA; Zhang, D; Estill, SJ; Michnoff, C; Rutter, J; Reick, M; Scott, K; Diaz-Arrastia, R; McKnight, SL				Garcia, JA; Zhang, D; Estill, SJ; Michnoff, C; Rutter, J; Reick, M; Scott, K; Diaz-Arrastia, R; McKnight, SL			Impaired cued and contextual memory in NPAS2-deficient mice	SCIENCE			English	Article							CLOCK GENE CLOCK; LONG-TERM-MEMORY; SUPRACHIASMATIC NUCLEUS; CONDITIONED FEAR; CIRCADIAN CLOCK; AMYGDALA; BMAL1; ORGANIZATION; HIPPOCAMPUS; EXPRESSION	Neuronal PAS domain protein 2 (NPAS2) is a basic helix-loop-helix (bHLH) PAS domain transcription factor expressed in multiple regions of the vertebrate brain. Targeted insertion of a beta-galactosidase reporter gene (lacZ) resulted in the production of an NPAS2-LacZ fusion protein and an altered form of NPAS2 Lacking the bHLH domain. The neuroanatomical expression pattern of NPAS2-lacZ was temporally and spatially coincident with formation of the mature frontal association/limbic forebrain pathway. NPAS2-deficient mice were subjected to a series of behavioral tests and were found to exhibit deficits in the Long-term memory arm of the cued and contextual fear task. Thus, NPAS2 may serve a dedicated regulatory role in the acquisition of specific types of memory.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Mol Cardiol Div, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	steven.mcknight@utsouthwestern.edu		Garcia, Joseph/0000-0002-5621-7538; Diaz-Arrastia, Ramon/0000-0001-6051-3594	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS001763, F31NS101763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012297, R03AG016450] Funding Source: NIH RePORTER; NIA NIH HHS [AG12297, AG16450] Funding Source: Medline; NINDS NIH HHS [NS01763] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abe H, 1998, NEUROSCI LETT, V258, P93, DOI 10.1016/S0304-3940(98)00877-5; Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7; Amir S, 1998, NEUROSCIENCE, V86, P345, DOI 10.1016/S0306-4522(98)00172-9; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; BLANCHARD RJ, 1969, J COMP PHYSIOL PSYCH, V67, P370, DOI 10.1037/h0026779; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Caldarone B, 1997, NAT GENET, V17, P335, DOI 10.1038/ng1197-335; CAMPBELL BA, 1972, PSYCHOL REV, V79, P215, DOI 10.1037/h0032690; CORODIMAS KP, 1995, BEHAV NEUROSCI, V109, P613, DOI 10.1037/0735-7044.109.4.613; Crawley JN, 1997, HORM BEHAV, V31, P197, DOI 10.1006/hbeh.1997.1382; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Davis M, 1998, BIOL PSYCHIAT, V44, P1239, DOI 10.1016/S0006-3223(98)00288-1; Dymecki SM, 1996, GENE, V171, P197, DOI 10.1016/0378-1119(96)00035-2; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; GREEN RJ, 1989, BEHAV NEUROSCI, V103, P98, DOI 10.1037/0735-7044.103.1.98; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; Ikeda M, 1997, BIOCHEM BIOPH RES CO, V233, P258, DOI 10.1006/bbrc.1997.6371; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; LEDOUX JE, 1990, J NEUROSCI, V10, P1043; Oishi K, 1998, BIOCHEM BIOPH RES CO, V253, P199, DOI 10.1006/bbrc.1998.9779; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; ROMANSKI LM, 1993, CEREB CORTEX, V3, P499, DOI 10.1093/cercor/3.6.499; Rosenzweig MR, 1996, ANNU REV PSYCHOL, V47, P1, DOI 10.1146/annurev.psych.47.1.1; RUDY JW, 1993, BEHAV NEUROSCI, V107, P887, DOI 10.1037/0735-7044.107.5.887; RUDY JW, 1994, BEHAV NEUROSCI, V108, P227, DOI 10.1037/0735-7044.108.2.227; SELDEN NRW, 1991, NEUROSCIENCE, V42, P335, DOI 10.1016/0306-4522(91)90379-3; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; SPEAR NE, 1990, ANNU REV PSYCHOL, V41, P169, DOI 10.1146/annurev.psych.41.1.169; TRULLAS R, 1993, PSYCHOPHARMACOLOGY, V111, P323, DOI 10.1007/BF02244948; WILSON DA, 1984, DEV BRAIN RES, V16, P61, DOI 10.1016/0165-3806(84)90063-4; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	40	173	176	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2000	288	5474					2226	2230		10.1126/science.288.5474.2226	http://dx.doi.org/10.1126/science.288.5474.2226			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	327FH	10864874				2022-12-24	WOS:000087782900062
J	Perdue, DG; Bulkow, LR; Gellin, BG; Davidson, M; Petersen, KM; Singleton, RJ; Parkinson, AJ				Perdue, DG; Bulkow, LR; Gellin, BG; Davidson, M; Petersen, KM; Singleton, RJ; Parkinson, AJ			Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REDUCES OROPHARYNGEAL CARRIAGE; HEMOPHILUS-INFLUENZAE; CONJUGATE VACCINE; B DISEASE; ADULTS; INFECTIONS; CHILDREN; EPIDEMIOLOGY; SPECTRUM; BACTEREMIA	Context The introduction of Haemophilus influenzae type b (Hib) vaccination of children has led to a decline in incidence of Hib disease in young Alaskan children, How ever, the impact of vaccination on unimmunized Alaskan adolescents and adults has not been studied. Objective To characterize trends in incidence of and mortality due to invasive H influenzae disease in Alaskan residents aged 10 years and older prior to and after the introduction of a statewide Hib infant vaccination program. Design and Setting Population-based, descriptive correlational study conducted 1980-1996 in Alaska, Subjects One hundred twenty-nine individuals (31 Alaska Natives and 98 nonnative Alaska residents) aged 10 years and older in whom H influenzae was cultured from a normally sterile site. Main Outcome Measures Incidence of H influenzae infection before (1980-1990) vs after (1991-1996) vaccination program initiation; serotype, biotype, and p-lactamase production of isolates. Results The overall annual incidence of invasive H influenzae in those aged 10 years and older declined 33%, from 2.1 per 100000 persons per year to 1.4 per 100000 persons per year (P=.03) after initiation of statewide infant Hib vaccination programs in 1991. This reduction appeared to be the result of a decrease in serotype b disease (82%; P<.001). Infection with other H influenzae serotypes and nontypeable strains increased from 0.5 per 100000 persons per year to 1.1 per 100000 persons per year (P =.01). Incidence declined from 4.2 per 100000 persons per year to 1.2 per 100000 persons per year in Alaska Natives (P=.005) and from 1.7 per 100000 persons per year to 1.4 per 100000 persons per year in non native Alaska residents (P =.37). Pneumonia (43%), sepsis (26%), and meningitis (16%) were the most common clinical presentations. Alcohol/drug abuse was comorbid in 15% of patients, while 13% of patients were pregnant women. beta-Lactamase production occurred in 35% of isolates and was stable throughout the surveillance. The overall case-fatality rate was 15%. Conclusion The overall statewide incidence of invasive H influenzae infections in unimmunized persons aged 10 years and older decreased after the initiation of an infant Hib vaccine program, perhaps by decreasing Hib carriage in child reservoirs. An increase in non-serotype b strains was observed. This trend justifies the need for continued surveillance of invasive disease caused by H influenzas.	Ctr Dis Control & Prevent, Arctic Invest Program, Natl Ctr Infect Dis, Anchorage, AK 99508 USA; Univ Washington, Sch Med, Seattle, WA USA; Alaska Native Med Ctr, Anchorage, AK USA; Alaska Native Tribal Hlth Consortium, Anchorage, AK USA; Vanderbilt Univ, Med Ctr, Nashville, TN USA	Centers for Disease Control & Prevention - USA; University of Washington; University of Washington Seattle; Alaska Native Medical Center; Alaska Native Tribal Health Consortium; Vanderbilt University	Parkinson, AJ (corresponding author), Ctr Dis Control & Prevent, Arctic Invest Program, Natl Ctr Infect Dis, 4055 Tudor Ctr Dr, Anchorage, AK 99508 USA.	ajp1@cdc.gov						Adegbola RA, 1998, J INFECT DIS, V177, P1758, DOI 10.1086/517440; BARBOUR ML, 1995, J INFECT DIS, V171, P93, DOI 10.1093/infdis/171.1.93; CASADEVALL A, 1992, AM J MED, V92, P587, DOI 10.1016/0002-9343(92)90774-6; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P657; CROWE HM, 1987, ARCH INTERN MED, V147, P241, DOI 10.1001/archinte.147.2.241; DEULOFEU F, 1994, EUR J CLIN MICROBIOL, V13, P633, DOI 10.1007/BF01973988; FARLEY MM, 1992, ANN INTERN MED, V116, P806, DOI 10.7326/0003-4819-116-10-806; Galil K, 1999, J INFECT DIS, V179, P101, DOI 10.1086/314569; HIRSCHMANN JV, 1979, MEDICINE, V58, P80, DOI 10.1097/00005792-197901000-00005; HOWARD AJ, 1991, BRIT MED J, V303, P441, DOI 10.1136/bmj.303.6800.441; HUGOSSON S, 1995, SCAND J INFECT DIS, V27, P63, DOI 10.3109/00365549509018974; KOSTMAN JR, 1993, CLIN INFECT DIS, V17, P389, DOI 10.1093/clinids/17.3.389; LEVIN DC, 1977, AM J MED, V62, P219, DOI 10.1016/0002-9343(77)90317-5; MOHLEBOETANI JC, 1993, PEDIATR INFECT DIS J, V12, P589, DOI 10.1097/00006454-199307000-00009; MUSHER DM, 1983, ANN INTERN MED, V99, P444, DOI 10.7326/0003-4819-99-4-444; NAJM WI, 1995, CLIN INFECT DIS, V21, P213, DOI 10.1093/clinids/21.1.213; NORDEN CW, 1978, MED CLIN N AM, V62, P1037, DOI 10.1016/S0025-7125(16)31753-9; Peltola H, 1999, J INFECT DIS, V179, P223, DOI 10.1086/314535; QUENTIN R, 1989, J CLIN MICROBIOL, V27, P2286, DOI 10.1128/JCM.27.10.2286-2294.1989; SINGLETON R, IN PRESS J PEDIAT; Slack MPE, 1998, PEDIATR INFECT DIS J, V17, pS204, DOI 10.1097/00006454-199809001-00026; SPAGNUOLO PJ, 1982, MEDICINE, V61, P74, DOI 10.1097/00005792-198203000-00002; STEINHART R, 1992, JAMA-J AM MED ASSOC, V268, P3350; TAKALA AK, 1990, ARCH INTERN MED, V150, P2573, DOI 10.1001/archinte.150.12.2573; TAKALA AK, 1993, PEDIATR INFECT DIS J, V12, P593, DOI 10.1097/00006454-199307000-00010; TAKALA AK, 1991, J INFECT DIS, V164, P982, DOI 10.1093/infdis/164.5.982; Urwin G, 1996, CLIN INFECT DIS, V22, P1069, DOI 10.1093/clinids/22.6.1069; WALLACE RJ, 1983, REV INFECT DIS, V5, P123; WALLACE RJ, 1981, J INFECT DIS, V144, P101, DOI 10.1093/infdis/144.2.101; WARD JI, 1986, J INFECT DIS, V153, P17, DOI 10.1093/infdis/153.1.17	30	72	73	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2000	283	23					3089	3094		10.1001/jama.283.23.3089	http://dx.doi.org/10.1001/jama.283.23.3089			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PV	10865303	Bronze			2022-12-24	WOS:000087574900033
J	Rong, YS; Golic, KG				Rong, YS; Golic, KG			Gene targeting by homologous recombination in Drosophila	SCIENCE			English	Article							INDUCED GAP REPAIR; STRAND; YEAST; MELANOGASTER; REPLACEMENT; EFFICIENT; SITE; TRANSFORMATION; INSERTION; GENOME	Drosophila offers many advantages as an experimental organism. However, in comparison with yeast and mouse, two other widely used eukaryotic model systems, Drosophila suffers from an inability to perform homologous recombination between introduced DNA and the corresponding chromosomal loci. The ability to specifically modify the genomes of yeast and mouse provides a quick and easy way to generate or rescue mutations in genes for which a DNA clone or sequence is available. A method is described that enables analogous manipulations of the Drosophila genome. This technique may also be applicable to other organisms for which gene-targeting procedures do not yet exist.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Golic, KG (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	golic@bioscience.utah.edu	rong, yikang/G-6179-2011		NIGMS NIH HHS [R21GM57792] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM057792] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bellaiche Y, 1999, GENETICS, V152, P1037; Cherbas L, 1997, GENETICS, V145, P349; COLLEAUX L, 1986, CELL, V44, P521, DOI 10.1016/0092-8674(86)90262-X; COLLEAUX L, 1988, P NATL ACAD SCI USA, V85, P6022, DOI 10.1073/pnas.85.16.6022; DENG CX, 1992, MOL CELL BIOL, V12, P3365, DOI 10.1128/MCB.12.8.3365; Dray T, 1997, GENETICS, V147, P689; FRIDELL YWC, 1991, NUCLEIC ACIDS RES, V19, P5082, DOI 10.1093/nar/19.18.5082; GEYER PK, 1990, EMBO J, V9, P2247, DOI 10.1002/j.1460-2075.1990.tb07395.x; GEYER PK, 1987, GENE DEV, V1, P996, DOI 10.1101/gad.1.9.996; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Golic KG, 1996, GENETICS, V144, P1693; Golic MM, 1997, NUCLEIC ACIDS RES, V25, P3665, DOI 10.1093/nar/25.18.3665; Gray YHM, 1996, GENETICS, V144, P1601; HASTINGS PJ, 1993, GENETICS, V135, P973; HASTY P, 1994, MOL CELL BIOL, V14, P8385, DOI 10.1128/MCB.14.12.8385; HASTY P, 1991, MOL CELL BIOL, V11, P4509, DOI 10.1128/MCB.11.9.4509; HOYLE HD, 1990, J CELL BIOL, V111, P1009, DOI 10.1083/jcb.111.3.1009; JASON M, 1988, GENE DEV, V2, P1353; Keeler KJ, 1997, MOL CELL BIOL, V17, P627, DOI 10.1128/MCB.17.2.627; KLEMENZ R, 1987, NUCLEIC ACIDS RES, V15, P3947, DOI 10.1093/nar/15.10.3947; Leung WY, 1997, P NATL ACAD SCI USA, V94, P6851, DOI 10.1073/pnas.94.13.6851; MARYON E, 1991, MOL CELL BIOL, V11, P3268, DOI 10.1128/MCB.11.6.3268; NASSIF N, 1993, P NATL ACAD SCI USA, V90, P1262, DOI 10.1073/pnas.90.4.1262; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; PETERSEN RB, 1989, CELL REGUL, V1, P135, DOI 10.1091/mbc.1.1.135; Preston CR, 1996, GENETICS, V144, P1611; Preston CR, 1996, GENETICS, V144, P1623; RONG YS, UNPUB; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; RUDIN N, 1988, MOL CELL BIOL, V8, P3918, DOI 10.1128/MCB.8.9.3918; SALZ HK, 1987, GENETICS, V117, P221; SCHEERER JB, 1994, MOL CELL BIOL, V14, P6663, DOI 10.1128/MCB.14.10.6663; SHULMAN MJ, 1990, MOL CELL BIOL, V10, P466; Spradling AC, 1999, GENETICS, V153, P135; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TOWER J, 1993, GENETICS, V133, P347; ZHANG P, 1993, GENETICS, V133, P361	40	445	486	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2000	288	5473					2013	2018		10.1126/science.288.5473.2013	http://dx.doi.org/10.1126/science.288.5473.2013			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	325QC	10856208				2022-12-24	WOS:000087687000041
J	Tallon, D; Chard, J; Dieppe, P				Tallon, D; Chard, J; Dieppe, P			Relation between agendas of the research community and the research consumer	LANCET			English	Article							HEALTH	Background Previous studies have suggested that research agendas can be biased. To determine whether there is a mismatch between available research evidence and the research preferences of consumers we examined research on interventions for the treatment of osteoarthritis of the knee joint. Methods We searched published and unpublished studies on interventions in this condition to assess the structure of the evidence base. Focus groups and a postal survey of research consumers were then undertaken to examine their views and research priorities. Findings Review of published and unpublished reports showed that the evidence base was dominated by studies of pharmaceutical (550, 59%) and surgical (238, 26%) interventions. 24 (36%) of 67 survey respondents ranked knee replacement as the highest priority for research, whereas 14 (21%) chose education and advice as their first choice. Interpretation There is a mismatch between the amount of published work on different interventions, and the degree of interest of consumers. We suggest that broadening of the research agenda would be more in line with current treatment patterns and consumer views. If this mismatch is not addressed, then evidence-based medicine will not be representative of consumer needs.	Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England	University of Bristol	Tallon, D (corresponding author), Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Canynge Hall,Whiteladies Rd, Bristol BS8 2PR, Avon, England.							CHALMERS I, 1995, BRIT MED J, V310, P1315, DOI 10.1136/bmj.310.6990.1315; CHALMERS I, 1991, BIRTH-ISS PERINAT C, V18, P137, DOI 10.1111/j.1523-536X.1991.tb00083.x; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Eachus J, 1996, BMJ-BRIT MED J, V312, P287; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Glaser B. G., 1978, AWARENESS DYING; Goodman NW, 1999, J ROY COLL PHYS LOND, V33, P249; GRANTPEARCE C, 1999, INVOLVEMENT WORKS; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; OXMAN AD, 1996, COCHRANE COLLABORATI; PAYER L, 1988, MED CULTURE VARIATIO; ROCHON PA, 1994, ARCH INTERN MED, V154, P157, DOI 10.1001/archinte.154.2.157	12	270	272	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2000	355	9220					2037	2040		10.1016/S0140-6736(00)02351-5	http://dx.doi.org/10.1016/S0140-6736(00)02351-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	322QC	10885355				2022-12-24	WOS:000087519400012
J	Sarov-Blat, L; So, WV; Liu, L; Rosbash, M				Sarov-Blat, L; So, WV; Liu, L; Rosbash, M			The Drosophila takeout gene is a novel molecular link between circadian rhythms and feeding behavior	CELL			English	Article							HORMONE-BINDING-PROTEIN; CLOCK GENE; SUPRACHIASMATIC NUCLEUS; LIGAND-BINDING; MESSENGER-RNA; PERIOD GENE; DOUBLE-TIME; EXPRESSION; MELANOGASTER; MUTANT	We report the characterization of a novel Drosophila circadian clock-regulated output gene, takeout (to). The to amino acid sequence shows similarity to two ligand binding proteins, including juvenile hormone binding protein, to mRNA is expressed in the head and the cardia, crop, and antennae-structures related to feeding. to expression is induced by starvation, which is blocked in all arrhythmic central clock mutants, suggesting a direct molecular link between the circadian clock and the feeding/starvation response. A to mutant has aberrant locomotor activity and dies rapidly in response to starvation, indicating a link between locomotor activity, survival, and food status. We propose that to participates in a novel circadian output pathway that conveys temporal and food status information to feeding-relevant metabolisms and activities.	Brandeis Univ, Howard Hughes Med Inst, Natl Sci Fdn, Ctr Biol Timing,Dept Biol, Waltham, MA 02454 USA	Brandeis University; Howard Hughes Medical Institute; National Science Foundation (NSF); NSF - Center for Biological Timing	Rosbash, M (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Natl Sci Fdn, Ctr Biol Timing,Dept Biol, Waltham, MA 02454 USA.	rosbash@brandeis.edu						Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BARGIELLO TA, 1984, P NATL ACAD SCI-BIOL, V81, P2142, DOI 10.1073/pnas.81.7.2142; BENDER W, 1983, J MOL BIOL, V168, P17, DOI 10.1016/S0022-2836(83)80320-9; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; BLOMHOFF R, 1990, SCIENCE, V250, P399, DOI 10.1126/science.2218545; Cassone VM, 1998, CHRONOBIOL INT, V15, P457, DOI 10.3109/07420529808998702; COWAN SW, 1999, PROTEIN-STRUCT FUNCT, V8, P44; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; DU GH, 1994, BIOCHEMISTRY-US, V33, P4812, DOI 10.1021/bi00182a009; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; FLOWER D, 1999, BIOCHEMISTRY-US, V318, P1; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; Green CB, 1996, P NATL ACAD SCI USA, V93, P14884, DOI 10.1073/pnas.93.25.14884; HANDLER AM, 1979, NATURE, V279, P236, DOI 10.1038/279236a0; HASAN G, 1992, DEVELOPMENT, V116, P967; HekmatScafe DS, 1997, J NEUROSCI, V17, P1616; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Krishnan B, 1999, NATURE, V400, P375, DOI 10.1038/22566; Lavery DJ, 1999, MOL CELL BIOL, V19, P6488; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; LORENZ LJ, 1989, DEVELOPMENT, V107, P869; LOROS JJ, 1989, SCIENCE, V243, P385, DOI 10.1126/science.2563175; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Marrus SB, 1996, EMBO J, V15, P6877, DOI 10.1002/j.1460-2075.1996.tb01080.x; McNeil GP, 1998, NEURON, V20, P297, DOI 10.1016/S0896-6273(00)80457-2; Miller A., 1950, BIOL DROSOPHILA, P420; NEWBY LM, 1993, GENETICS, V135, P1077; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; North MA, 1999, CURR OPIN GENET DEV, V9, P283, DOI 10.1016/S0959-437X(99)80042-2; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; PERVAIZ S, 1985, SCIENCE, V228, P335, DOI 10.1126/science.2580349; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; REDDY P, 1984, CELL, V38, P701, DOI 10.1016/0092-8674(84)90265-4; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; REPPERT SM, 1987, TRENDS NEUROSCI, V10, P76, DOI 10.1016/0166-2236(87)90029-4; Ripperger JA, 2000, GENE DEV, V14, P679; Rouyer F, 1997, EMBO J, V16, P3944, DOI 10.1093/emboj/16.13.3944; RUTILA JE, 1996, NEURON, V5, P621; RUTILA JE, 1989, MOL CLONING LAB MANU; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; STEHLE JH, 1993, NATURE, V365, P314, DOI 10.1038/365314a0; TOUHARA K, 1992, BIOCHEM BIOPH RES CO, V182, P466, DOI 10.1016/0006-291X(92)91755-F; TOUHARA K, 1993, BIOCHEMISTRY-US, V32, P2068, DOI 10.1021/bi00059a026; van Naters WMV, 1998, CHEM SENSES, V23, P351, DOI 10.1093/chemse/23.3.351; VanGelder RN, 1996, EMBO J, V15, P1625, DOI 10.1002/j.1460-2075.1996.tb00507.x; Wisor JP, 1997, J COMP NEUROL, V378, P229; WOJTASEK H, 1995, BIOCHEMISTRY-US, V34, P5234, DOI 10.1021/bi00015a037; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	59	194	204	2	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 9	2000	101	6					647	656		10.1016/S0092-8674(00)80876-4	http://dx.doi.org/10.1016/S0092-8674(00)80876-4			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	322HQ	10892651	Bronze			2022-12-24	WOS:000087504500011
J	Kolbe, M; Besir, H; Essen, LO; Oesterhelt, D				Kolbe, M; Besir, H; Essen, LO; Oesterhelt, D			Structure of the light-driven chloride pump halorhodopsin at 1.8 angstrom resolution	SCIENCE			English	Article							ELECTROSTATIC CALCULATIONS; ION TRANSLOCATION; RETINAL PROTEINS; PALMITIC ACID; ANION-BINDING; CUBIC PHASES; BACTERIORHODOPSIN; RECONSTITUTION; MECHANISM; TRANSPORT	Halorhodopsin, an archaeal rhodopsin ubiquitous in Haloarchaea, uses Light energy to pump chloride through biological membranes. Halorhodopsin crystals were grown in a cubic Lipidic phase, which allowed the x-ray structure determination of this anion pump at 1.8 angstrom resolution. Halorhodopsin assembles to trimers around a central patch consisting of palmitic acid. Next to the protonated Schiff base between Lys(242) and the isomerizable retinal chromophore, a single chloride ion occupies the transport site. Energetic calculations on chloride binding reveal a combination of ion-ion and ion-dipole interactions for stabilizing the anion 18 angstroms below the membrane surface. ion dragging across the protonated Schiff base explains why chloride and proton translocation modes are mechanistically equivalent in archaeal rhodopsins.	Max Planck Inst Biochem, Dept Membrane Biochem, D-82152 Martinsried, Germany	Max Planck Society	Oesterhelt, D (corresponding author), Max Planck Inst Biochem, Dept Membrane Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	essen@biochem.mpg.de; oesterhe@biochem.mpg.de	Essen, Lars-Oliver/L-3862-2016	Essen, Lars-Oliver/0000-0003-4272-4026; Besir, Huseyin/0000-0002-7249-4762				ALSHUTH T, 1985, FEBS LETT, V179, P55, DOI 10.1016/0014-5793(85)80190-3; ARLT T, 1995, CHEM PHYS LETT, V241, P559, DOI 10.1016/0009-2614(95)00664-P; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAMBERG E, 1993, P NATL ACAD SCI USA, V90, P639, DOI 10.1073/pnas.90.2.639; Barauskas J, 1999, CHEM PHYS LIPIDS, V97, P167, DOI 10.1016/S0009-3084(98)00107-8; BASHFORD D, 1992, J MOL BIOL, V224, P473, DOI 10.1016/0022-2836(92)91009-E; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Beroza P, 1996, J PHYS CHEM-US, V100, P20156, DOI 10.1021/jp9623709; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRAIMAN MS, 1994, BIOCHEMISTRY-US, V33, P1629, DOI 10.1021/bi00173a003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chon YS, 1999, BIOCHEMISTRY-US, V38, P9449, DOI 10.1021/bi9903042; Colella M, 1998, BBA-BIOMEMBRANES, V1370, P273, DOI 10.1016/S0005-2736(97)00276-9; Corcelli A, 1996, BBA-BIOMEMBRANES, V1281, P173, DOI 10.1016/0005-2736(96)00007-7; DUSCHL A, 1988, J BIOL CHEM, V263, P17016; Edman K, 1999, NATURE, V401, P822, DOI 10.1038/44623; Essen LO, 1998, P NATL ACAD SCI USA, V95, P11673, DOI 10.1073/pnas.95.20.11673; GUNNER MR, UNPUB; Haupts U, 1997, BIOCHEMISTRY-US, V36, P2, DOI 10.1021/bi962014g; HAVELKA WA, 1995, J MOL BIOL, V247, P726, DOI 10.1006/jmbi.1995.0176; HEYMANN JAW, 1993, MOL MICROBIOL, V7, P623, DOI 10.1111/j.1365-2958.1993.tb01153.x; Ihara K, 1999, J MOL BIOL, V285, P163, DOI 10.1006/jmbi.1998.2286; IKEDA M, 1990, BIOCHEMISTRY-US, V29, P2065, DOI 10.1021/bi00460a014; Kalaidzidis IV, 1998, FEBS LETT, V427, P59, DOI 10.1016/S0014-5793(98)00394-9; KOLBE M, UNPUB; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LESLIE AGW, 1992, JOINT CCP4 ESF EACMB, P44; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Oesterhelt D, 1995, ISR J CHEM, V35, P475; Oesterhelt D, 1998, CURR OPIN STRUC BIOL, V8, P489, DOI 10.1016/S0959-440X(98)80128-0; Okuno D, 1999, BIOCHEMISTRY-US, V38, P5422, DOI 10.1021/bi9826456; OTOMO J, 1995, BIOPHYS CHEM, V56, P137, DOI 10.1016/0301-4622(95)00025-S; PASCHER I, 1992, BIOCHIM BIOPHYS ACTA, V1113, P339, DOI 10.1016/0304-4157(92)90006-V; Reat V, 1998, P NATL ACAD SCI USA, V95, P4970, DOI 10.1073/pnas.95.9.4970; ROSEN BP, 1990, BIOCHIM BIOPHYS ACTA, V1018, P203, DOI 10.1016/0005-2728(90)90249-4; RUDIGER M, 1995, EMBO J, V14, P1599, DOI 10.1002/j.1460-2075.1995.tb07148.x; Rudiger M, 1997, EMBO J, V16, P3813, DOI 10.1093/emboj/16.13.3813; SASAKI J, 1995, SCIENCE, V269, P73, DOI 10.1126/science.7604281; SCHOBERT B, 1986, J BIOL CHEM, V261, P2690; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; TAVAN P, 1985, BIOPHYS J, V47, P415, DOI 10.1016/S0006-3495(85)83933-3; Tittor J, 1997, J MOL BIOL, V271, P405, DOI 10.1006/jmbi.1997.1204; VARO G, 1995, BIOPHYS J, V68, P2062, DOI 10.1016/S0006-3495(95)80385-1; WALTER TJ, 1994, BIOCHEMISTRY-US, V33, P1724, DOI 10.1021/bi00173a015	47	451	467	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2000	288	5470					1390	1396		10.1126/science.288.5470.1390	http://dx.doi.org/10.1126/science.288.5470.1390			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	318EL	10827943				2022-12-24	WOS:000087270900041
J	Sakamoto, K; Gouzu, H; Komiya, K; Kiga, D; Yokoyama, S; Yokomori, T; Hagiya, M				Sakamoto, K; Gouzu, H; Komiya, K; Kiga, D; Yokoyama, S; Yokomori, T; Hagiya, M			Molecular computation by DNA hairpin formation	SCIENCE			English	Article							SEQUENCE; DESIGN	Hairpin formation by single-stranded DNA molecules was exploited in a DNA-based computation in order to explore the feasibility of autonomous molecular computing. An instance of the satisfiability problem, a famous hard combinatorial problem, was solved by using molecular biology techniques. The satisfiability of a given Boolean formula was examined autonomously, on the basis of hairpin formation by the molecules that represent the formula. This computation algorithm can test several clauses in the given formula simultaneously, which could reduce the number of Laboratory steps required for computation.	Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Sci, Dept Informat Sci, Bunkyo Ku, Tokyo 1130033, Japan; Waseda Univ, Sch Educ, Dept Math, Shinjuku Ku, Tokyo 1698050, Japan	University of Tokyo; University of Tokyo; Waseda University	Sakamoto, K (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Yokoyama, Shigeyuki/N-6911-2015; Sakamoto, Kensaku/N-7496-2015; Kiga, Daisuke/T-5361-2018; Komiya, Ken/V-8462-2017	Yokoyama, Shigeyuki/0000-0003-3133-7338; Sakamoto, Kensaku/0000-0003-2866-5031; Kiga, Daisuke/0000-0003-3778-5887; Komiya, Ken/0000-0001-7385-9738				ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; BENNETT CH, 1982, INT J THEOR PHYS, V21, P905, DOI 10.1007/BF02084158; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Cantor C. R., 1980, BIOPHYSICAL CHEM 3; Faulhammer D, 2000, P NATL ACAD SCI USA, V97, P1385, DOI 10.1073/pnas.97.4.1385; Frutos AG, 1997, NUCLEIC ACIDS RES, V25, P4748, DOI 10.1093/nar/25.23.4748; Garzon MH, 1999, IEEE T EVOLUT COMPUT, V3, P236, DOI 10.1109/4235.788493; Guarnieri F, 1996, SCIENCE, V273, P220, DOI 10.1126/science.273.5272.220; Hagiya M, 1999, NEW GENERAT COMPUT, V17, P131, DOI 10.1007/BF03037433; Hopcroft J. E., 1979, INTRO AUTOMATA THEOR; JONES DH, 1992, NUCLEIC ACIDS RES, V20, P595, DOI 10.1093/nar/20.3.595; LABEAN TH, 1999, P 5 INT M DNA BAS CO, P121; LIPTON RJ, 1995, SCIENCE, V268, P542, DOI 10.1126/science.7725098; Liu QH, 2000, NATURE, V403, P175, DOI 10.1038/35003155; MITCHELL D, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P459; MORIMOTO N, 1999, DIMACS SERIES DISCRE, V48, P193; OGIHARA M, 1999, DIMACS SERIES DISCRE, V48, P255; Ouyang Q, 1997, SCIENCE, V278, P446, DOI 10.1126/science.278.5337.446; Paun G., 1998, DNA COMPUTING NEW CO, DOI DOI 10.1007/978-3-662-03563-4; REIF JH, 1999, DIMACS, V48, P217; Sakamoto K, 1999, BIOSYSTEMS, V52, P81, DOI 10.1016/S0303-2647(99)00035-0; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Winfree E., 1999, DIMACS SER DISCRETE, V44, P191; Winfree Erik, 1996, DNA BASED COMPUTERS, V27, P199; Yokomori T., 1999, P 5 INT M DNA BAS CO, P153; YOSHIDA H, 1999, P 5 INT M DNA BAS CO, P9	26	288	332	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2000	288	5469					1223	1226		10.1126/science.288.5469.1223	http://dx.doi.org/10.1126/science.288.5469.1223			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	315KH	10817993				2022-12-24	WOS:000087112600045
J	Fuster, JM; Bodner, M; Kroger, JK				Fuster, JM; Bodner, M; Kroger, JK			Cross-modal and cross-temporal association in neurons of frontal cortex	NATURE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; MACAQUE MONKEY; MEMORY TASK; PERFORMANCE; OBJECT	The prefrontal cortex is essential for the temporal integration of sensory information in behavioural and linguistic sequences(1,2). Such information is commonly encoded in more than one sense modality, notably sight and sound. Connections from sensory cortices to the prefrontal cortex support its integrative function(3-5). Here we present the first evidence that prefrontal cortex cells associate visual and auditory stimuli across time. We gave monkeys the task of remembering a tone of a certain pitch for 10 s and then choosing the colour associated with it. In this task, prefrontal cortex cells responded selectively to tones, and most of them also responded to colours according to the task rule. Thus, their reaction to a tone was correlated with their subsequent reaction to the associated colour. This correlation faltered in trials ending in behavioural error. We conclude that prefrontal cortex neurons are part of integrative networks that represent behaviourally meaningful cross-modal associations. The orderly and timely activation of neurons in such networks is crucial for the temporal transfer of information in the structuring of behaviour, reasoning and language.	Univ Calif Los Angeles, Sch Med, Inst Neuropsychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fuster, JM (corresponding author), Univ Calif Los Angeles, Sch Med, Inst Neuropsychiat, Los Angeles, CA 90095 USA.							Bodner M, 1996, NEUROREPORT, V7, P1905, DOI 10.1097/00001756-199608120-00006; COLOMBO M, 1994, BEHAV NEUROSCI, V108, P443, DOI 10.1037/0735-7044.108.3.443; DESIMONE R, 1984, J NEUROSCI, V4, P2051; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1982, J NEUROSCI, V2, P361; FUSTER JM, 1982, EXP NEUROL, V77, P679, DOI 10.1016/0014-4886(82)90238-2; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; FUSTER JM, 1997, PREFRONTAL CORTEX; Gibson JR, 1997, J NEUROPHYSIOL, V78, P1263, DOI 10.1152/jn.1997.78.3.1263; HIKOSAKA K, 1988, J NEUROPHYSIOL, V60, P1615, DOI 10.1152/jn.1988.60.5.1615; IWAMURA Y, 1993, EXP BRAIN RES, V92, P360; JONES E G, 1970, Brain Behavior and Evolution, V93, P793, DOI 10.1093/brain/93.4.793; Luria A.R., 1966, HIGHER CORTICAL FUNC, P3; MATELLI M, 1985, BEHAV BRAIN RES, V18, P125, DOI 10.1016/0166-4328(85)90068-3; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; NIKI H, 1974, BRAIN RES, V70, P346, DOI 10.1016/0006-8993(74)90324-2; Pandya DN., 1985, CEREB CORTEX, DOI [10.1007/978-1-4757-9619-3_1, DOI 10.1007/978-1-4757-9619-3_1]; PETRIDES M, 1986, J NEUROSCI, V6, P2054; Petrides M., 1994, HDB NEUROPSYCHOLOGY, V9, P17; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rao SC, 1997, SCIENCE, V276, P821, DOI 10.1126/science.276.5313.821; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; TANAKA K, 1993, SCIENCE, V262, P685, DOI 10.1126/science.8235589; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; Zhou YD, 1997, EXP BRAIN RES, V116, P551, DOI 10.1007/PL00005783	30	339	344	1	29	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 18	2000	405	6784					347	351		10.1038/35012613	http://dx.doi.org/10.1038/35012613			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314YT	10830963				2022-12-24	WOS:000087085700047
J	Foster, KR; Vecchia, P; Repacholi, MH				Foster, KR; Vecchia, P; Repacholi, MH			Risk management - Science and the precautionary principle	SCIENCE			English	Article									Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; Ist Super Sanita, Phys Lab, Natl Inst Hlth, I-00161 Rome, Italy; WHO, Dept Protect Human Environm, CH-1211 Geneva, Switzerland	University of Pennsylvania; Istituto Superiore di Sanita (ISS); World Health Organization	Foster, KR (corresponding author), WHO, CH-1211 Geneva, Switzerland.	kfoster@seas.upenn.edu						Ahlbom A, 1998, HEALTH PHYS, V74, P494; *EEE, 1999, C951 IEEE; ELWOOD JM, 1999, ENV HLTH PERSPECT S1, V107, P145; FREESTONE D, 1996, INTL ENV LAW POLICY, V31; GEE D, 1999, FINANCIAL TIMES 1216, P14; National Research Council, 1983, RISK ASS FED GOV MAN; Vanderzwaag D., 1999, J ENV LAW PRACT, V8, P355	7	264	268	3	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2000	288	5468					979	+		10.1126/science.288.5468.979	http://dx.doi.org/10.1126/science.288.5468.979			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	313EY	10841718				2022-12-24	WOS:000086988400020
J	Roos-Serote, M; Vasavada, AR; Kamp, L; Drossart, P; Irwin, P; Nixon, C; Carlson, RW				Roos-Serote, M; Vasavada, AR; Kamp, L; Drossart, P; Irwin, P; Nixon, C; Carlson, RW			Proximate humid and dry regions in Jupiter's atmosphere indicate complex local meteorology	NATURE			English	Article							CLOUD STRUCTURE; WATER-VAPOR; ABUNDANCE; SPECTRA; 5-MU-M	Models of Jupiter's formation and structure predict that its atmosphere is enriched in oxygen, relative to the Sun, and that consequently water clouds should be present globally near the 5-bar pressure level(1,2). Past attempts to confirm these predictions have led to contradictory results(3-5); in particular, the Galileo probe revealed a very dry atmosphere at the entry site, with no significant clouds at depths exceeding the 2-bar level(6,7). Although the entry site was known to be relatively cloud-free, the contrast between the observed local dryness and the expected global wetness was surprising. Here we analyse near-infrared (around 5 mu m) observations of Jupiter, a spectral region that can reveal the water vapour abundance and vertical cloud structure in the troposphere(8). We find that humid and extremely dry regions exist in close proximity, and that some humid regions are spatially correlated with bright convective clouds extending from the deep water clouds to the visible atmosphere.	Observ Astron Lisboa, P-1349018 Lisbon, Portugal; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Observ Paris, CNRS, UMR 8632, Dept Spatial, F-92915 Meudon, France; Univ Oxford, Clarendon Lab, Atmospher Phys Dept, Oxford OX1 3PU, England	Universidade de Lisboa; University of California System; University of California Los Angeles; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; University of Oxford	Roos-Serote, M (corresponding author), Observ Astron Lisboa, P-1349018 Lisbon, Portugal.		Drossart, Pierre/H-8670-2013; Nixon, Conor A/A-8531-2009	Nixon, Conor A/0000-0001-9540-9121; Irwin, Patrick Gerard Joseph/0000-0002-6772-384X				Atreya SK, 1999, PLANET SPACE SCI, V47, P1243, DOI 10.1016/S0032-0633(99)00047-1; Banfield D, 1998, ICARUS, V135, P230, DOI 10.1006/icar.1998.5985; BJORAKER GL, 1986, ASTROPHYS J, V311, P1058, DOI 10.1086/164842; CARLSON BE, 1992, ASTROPHYS J, V388, P648, DOI 10.1086/171182; DROSSART P, 1982, ICARUS, V52, P483, DOI 10.1016/0019-1035(82)90008-2; GIERASCH P, 1999, B AM ASTRON SOC, V31, P115; Gierasch PJ, 2000, NATURE, V403, P628, DOI 10.1038/35001017; Ingersoll AP, 2000, NATURE, V403, P630, DOI 10.1038/35001021; Irwin PGJ, 1998, J GEOPHYS RES-PLANET, V103, P23001, DOI 10.1029/98JE00948; LARSON HP, 1975, ASTROPHYS J, V197, pL137, DOI 10.1086/181795; LIMAYE SS, 1986, ICARUS, V65, P335, DOI 10.1016/0019-1035(86)90142-9; Little B, 1999, ICARUS, V142, P306, DOI 10.1006/icar.1999.6195; Niemann HB, 1998, J GEOPHYS RES-PLANET, V103, P22831, DOI 10.1029/98JE01050; Ragent B, 1998, J GEOPHYS RES-PLANET, V103, P22891, DOI 10.1029/98JE00353; Roos-Serote M, 1999, ICARUS, V137, P315, DOI 10.1006/icar.1998.6043; Roos-Serote M, 1998, J GEOPHYS RES-PLANET, V103, P23023, DOI 10.1029/98JE01049; Seiff A, 1998, J GEOPHYS RES-PLANET, V103, P22857, DOI 10.1029/98JE01766; Vasavada AR, 1998, ICARUS, V135, P265, DOI 10.1006/icar.1998.5984; WEIDENSCHILLING SJ, 1973, ICARUS, V20, P465, DOI 10.1016/0019-1035(73)90019-5	19	32	32	0	8	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 11	2000	405	6783					158	160		10.1038/35012023	http://dx.doi.org/10.1038/35012023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WG	10821265				2022-12-24	WOS:000087080100042
J	Lin, MZ; Greenberg, ME				Lin, MZ; Greenberg, ME			Orchestral maneuvers in the axon: Trio and the control of axon guidance	CELL			English	Review							DROSOPHILA; RHO; GTPASES; RAC; PROTEIN; ELEGANS; CELL		Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.			Lin, Michael/0000-0002-0492-1961				Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Desai CJ, 1997, CURR OPIN NEUROBIOL, V7, P70, DOI 10.1016/S0959-4388(97)80122-5; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hu S, 1999, NEURON, V22, P419, DOI 10.1016/S0896-6273(00)80696-0; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Lanier LM, 2000, CURR OPIN NEUROBIOL, V10, P80, DOI 10.1016/S0959-4388(99)00058-6; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Van Vactor D, 1999, CURR BIOL, V9, pR797; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	18	42	42	1	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 28	2000	101	3					239	242		10.1016/S0092-8674(00)80833-8	http://dx.doi.org/10.1016/S0092-8674(00)80833-8			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847678	Bronze			2022-12-24	WOS:000086741900002
J	Gill, TM; DiPietro, L; Krumholz, HM				Gill, TM; DiPietro, L; Krumholz, HM			Role of exercise stress testing and safety monitoring for older persons starting an exercise program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; AMERICAN-HEART-ASSOCIATION; ACTIVE LIFE EXPECTANCY; CARDIOVASCULAR HEALTH; PHYSICAL-ACTIVITY; RISK-FACTORS; COMMUNITY POPULATION; ELDERLY PEOPLE; ADULTS; EXERTION	While the benefits of physical activity and exercise among older persons are becoming increasingly clear, the role of exercise stress testing and safety monitoring for older persons who want to start an exercise program is unclear. Current guidelines regarding exercise stress testing likely are not applicable to the majority of persons aged 75 years or older who are interested in restoring or enhancing their physical function through a program of physical activity and exercise. In addition to being expensive and of unproven benefit, the current policy of routine exercise stress testing potentially could deter many older persons from participating in an exercise program. Research is needed to investigate current physician practices, evaluate the risk of adverse cardiac events, determine the role of pharmacological stress testing, and measure and compare absolute and relative exercise intensifies. To assist clinicians, we offer a set of recommendations regarding precautions that can be taken to minimize the risk of adverse cardiac events among previously sedentary older persons who do not have symptomatic cardiovascular disease and are interested in starting an exercise program.	Yale Univ, Sch Med, Dorothy Adler Geriatr Assessment Ctr, Dept Med, New Haven, CT 06504 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06504 USA; Yale Univ, Sch Med, John B Pierce Lab, New Haven, CT 06504 USA	Yale University; Yale University; Yale University; The John B Pierce Laboratory, Inc	Gill, TM (corresponding author), Yale Univ, Sch Med, Dorothy Adler Geriatr Assessment Ctr, Dept Med, 20 York St, New Haven, CT 06504 USA.	gill@ynhh.com	, Harlan/AAI-2875-2020; Gill, Thomas M./H-7043-2019	Gill, Thomas M./0000-0002-6450-0368	NIA NIH HHS [K32AG00759, R01AG17163, P60AG10469] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P60AG010469, R01AG017163] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ades PA, 1999, J AM GERIATR SOC, V47, P98, DOI 10.1111/j.1532-5415.1999.tb01909.x; *AM COLL SPORTS ME, 1952, MED SCI SPORTS EXERC, V30, P992; Andersen RE, 1997, ANN INTERN MED, V127, P395, DOI 10.7326/0003-4819-127-5-199709010-00010; [Anonymous], 1995, GUID EX TEST PRESCR; Bennett DA, 1996, NEW ENGL J MED, V334, P71, DOI 10.1056/NEJM199601113340202; Bijnen FCH, 1999, AM J EPIDEMIOL, V150, P1289, DOI 10.1093/oxfordjournals.aje.a009960; BORG G, 1970, ACTA MED SCAND, V187, P17; Buchner DM, 1997, J GERONTOL A-BIOL, V52, pM218, DOI 10.1093/gerona/52A.4.M218; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; CORNONIHUNTLEY J, 1993, AGING-CLIN EXP RES, V5, P27; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Ferrucci L, 1999, AM J EPIDEMIOL, V149, P645, DOI 10.1093/oxfordjournals.aje.a009865; Fiatarone M A, 1990, TOP GERIATR REHABIL, V5, P63, DOI DOI 10.1097/00013614-199001000-00009; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; FLETCHER GF, 1995, CIRCULATION, V91, P580, DOI 10.1161/01.CIR.91.2.580; FURBERG CD, 1992, AM J CARDIOL, V69, P1329, DOI 10.1016/0002-9149(92)91231-R; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Giri S, 1999, JAMA-J AM MED ASSOC, V282, P1731, DOI 10.1001/jama.282.18.1731; Glass TA, 1999, BRIT MED J, V319, P478, DOI 10.1136/bmj.319.7208.478; Hakim AA, 1998, NEW ENGL J MED, V338, P94, DOI 10.1056/NEJM199801083380204; HAKIM AA, 1999, AM J EPIDEMIOL, V149, P645; Hollenberg M, 1998, J GERONTOL A-BIOL, V53, pB259, DOI 10.1093/gerona/53A.4.B259; Jette AM, 1999, AM J PUBLIC HEALTH, V89, P66, DOI 10.2105/AJPH.89.1.66; JUDGE JO, 1994, J AM GERIATR SOC, V42, P937, DOI 10.1111/j.1532-5415.1994.tb06584.x; KAPLAN GA, 1987, AM J PUBLIC HEALTH, V77, P307, DOI 10.2105/AJPH.77.3.307; Kohrt WM, 1998, J AM GERIATR SOC, V46, P129, DOI 10.1111/j.1532-5415.1998.tb02528.x; LaCroix AZ, 1996, J AM GERIATR SOC, V44, P113, DOI 10.1111/j.1532-5415.1996.tb02425.x; LACROIX AZ, 1993, AM J EPIDEMIOL, V137, P858, DOI 10.1093/oxfordjournals.aje.a116747; LAKATTA EG, 1993, PHYSIOL REV, V73, P413, DOI 10.1152/physrev.1993.73.2.413; Leveille SG, 1999, AM J EPIDEMIOL, V149, P654; MITTELMARK MB, 1993, AM J EPIDEMIOL, V137, P311, DOI 10.1093/oxfordjournals.aje.a116678; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; MOLD JW, 1986, NEW ENGL J MED, V314, P512, DOI 10.1056/NEJM198602203140809; MOLDLICHER VF, 2000, OUUJCISE HEART; Muller JE, 1996, JAMA-J AM MED ASSOC, V275, P1405, DOI 10.1001/jama.275.18.1405; MULROW CD, 1994, JAMA-J AM MED ASSOC, V271, P519, DOI 10.1001/jama.271.7.519; National Center for Chronic Disease Prevention and Health Promotion, 1996, PHYS ACT HLTH REP SU; National Center for Chronic Disease Prevention and Health Promotion, 1997, UNR PREV OPP RED HLT; Palda VA, 1997, ANN INTERN MED, V127, P309, DOI 10.7326/0003-4819-127-4-199708150-00012; Panton LB, 1996, J GERONTOL A-BIOL, V51, pM165, DOI 10.1093/gerona/51A.4.M165; Pollock ML, 2000, CIRCULATION, V101, P828, DOI 10.1161/01.CIR.101.7.828; POSNER JD, 1986, AM J CARDIOL, V57, pC52, DOI 10.1016/0002-9149(86)91027-1; Psaty BM, 1999, ARCH INTERN MED, V159, P1339, DOI 10.1001/archinte.159.12.1339; RAUTAHARJU PM, 1995, INT J CARDIOL, V51, P165, DOI 10.1016/0167-5273(95)02414-R; Rooks DS, 1997, J GERONTOL A-BIOL, V52, pM161, DOI 10.1093/gerona/52A.3.M161; SALIVE ME, 1992, OPHTHALMOLOGY, V99, P1840; SEEMAN TE, 1995, J GERONTOL A-BIOL, V50, pM177, DOI 10.1093/gerona/50A.4.M177; SKELTON DA, 1995, J AM GERIATR SOC, V43, P1081, DOI 10.1111/j.1532-5415.1995.tb07004.x; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Welch HG, 1996, ANN INTERN MED, V124, P577, DOI 10.7326/0003-4819-124-6-199603150-00007; WENGER NK, 1995, AHCPR PUBL; Wennberg DE, 1996, JAMA-J AM MED ASSOC, V275, P1161, DOI 10.1001/jama.275.15.1161; WILLICH SN, 1993, NEW ENGL J MED, V329, P1684, DOI 10.1056/NEJM199312023292302; Wolf SL, 1996, J AM GERIATR SOC, V44, P489, DOI 10.1111/j.1532-5415.1996.tb01432.x; [No title captured]	58	88	90	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 19	2000	284	3					342	349		10.1001/jama.284.3.342	http://dx.doi.org/10.1001/jama.284.3.342			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	333GR	10891966				2022-12-24	WOS:000088123000027
J	Malin, MC; Edgett, KS				Malin, MC; Edgett, KS			Evidence for recent groundwater seepage and surface runoff on Mars	SCIENCE			English	Article							MARTIAN VALLEYS; LANDING SITE; CHANNELS; MISSION; EARTH; AGE	Relatively young Landforms on Mars, seen in high-resolution images acquired by the Mars Global Surveyor Mars Orbiter Camera since March 1999, suggest the presence of sources of liquid water at shallow depths beneath the martian surface. Found at middle and high martian latitudes (particularly in the southern hemisphere), gullies within the walls of a very small number of impact craters, south polar pits, and two of the Larger martian valleys display geomorphic features that can be explained by processes associated with groundwater seepage and surface runoff. The relative youth of the landforms is indicated by the superposition of the gullies on otherwise geologically young surfaces and by the absence of superimposed Landforms or cross-cutting features, including impact craters, small polygons, and eolian dunes. The limited size and geographic distribution of the features argue for constrained source reservoirs.	Malin Space Sci Syst, San Diego, CA 92191 USA		Malin, MC (corresponding author), Malin Space Sci Syst, POB 910148, San Diego, CA 92191 USA.			Edgett, Kenneth/0000-0001-7197-5751				ALBEE A, 1996, EOS T AGU, V77, P441; Albee AL, 1998, SCIENCE, V279, P1671, DOI 10.1126/science.279.5357.1671; Baker V.R., 1982, THE CHANNELS OF MARS, DOI [10.1029/EO063i045p00862, DOI 10.1029/EO063I045P00862]; BAKER VR, 1979, J GEOPHYS RES, V84, P7961, DOI 10.1029/JB084iB14p07961; BAKER VR, 1974, ICARUS, V23, P27, DOI 10.1016/0019-1035(74)90101-8; BAKER VR, 1983, GEOL SOC AM BULL, V94, P1035; BLACK RF, 1976, QUATERNARY RES, V6, P3, DOI 10.1016/0033-5894(76)90037-5; Bryan RB, 1997, GEOMORPHOLOGY, V20, P209, DOI 10.1016/S0169-555X(97)00024-X; Carr M.H, 1996, WATER MARS; Carr M. J., UNPUB; Edgett KS, 2000, J GEOPHYS RES-PLANET, V105, P1623, DOI 10.1029/1999JE001152; FINK JH, 1981, GEOPHYS RES LETT, V8, P43, DOI 10.1029/GL008i001p00043; Golombek MP, 1997, SCIENCE, V278, P1743, DOI 10.1126/science.278.5344.1743; Higgins C. G., 1990, Special Paper - Geological Society of America, P139; Higgins C.G., 1984, GROUNDWATER GEOMORPH, P18; HIGGINS CG, 1982, GEOLOGY, V10, P147, DOI 10.1130/0091-7613(1982)10<147:DSDBSO>2.0.CO;2; HOWARD AD, 1988, NASA SPEC PUBL NASA; KAFURA CJ, 1988, THESIS ARIZONA STATE; LACHENBRUCH AH, 1962, GEOL SOC AM SPEC PAP, V70; LAITY JE, 1985, GEOL SOC AM BULL, V96, P203, DOI 10.1130/0016-7606(1985)96<203:SPATDO>2.0.CO;2; MALIN MC, 1992, J GEOPHYS RES-PLANET, V97, P7699, DOI 10.1029/92JE00340; MALIN MC, 1976, J GEOPHYS RES, V81, P4825, DOI 10.1029/JB081i026p04825; Malin MC, 1999, NATURE, V397, P589, DOI 10.1038/17551; MALIN MC, 2000, LUNAR PLANET SCI, V31; Masursky H., 1977, Journal of Geophysical Research, V82, P4016, DOI 10.1029/JS082i028p04016; MILTON DJ, 1973, J GEOPHYS RES, V78, P4037, DOI 10.1029/JB078i020p04037; Parker G. G. Sr., 1990, Special Paper - Geological Society of America, P77; PIERI D, 1976, ICARUS, V27, P25, DOI 10.1016/0019-1035(76)90182-2; PIERI DC, 1980, SCIENCE, V210, P895, DOI 10.1126/science.210.4472.895; SAGAN C, 1973, SCIENCE, V181, P1045, DOI 10.1126/science.181.4104.1045; SHARP RP, 1975, GEOL SOC AM BULL, V86, P593, DOI 10.1130/0016-7606(1975)86<593:COM>2.0.CO;2; SHARPE CFS, 1939, LANDSLIDES RELATED P; SIDORENKO AV, 1980, SURFACE MARS; Smith PH, 1997, SCIENCE, V278, P1758, DOI 10.1126/science.278.5344.1758; Varnes D.J., 1978, LANDSLIDES ANAL CONT, V176, P11; VARNES DJ, 1958, LANDSLIDES ENG PRACT, P20; Ward AW, 1999, J GEOPHYS RES-PLANET, V104, P8555, DOI 10.1029/1998JE900021; WASHBURN AL, 1956, GEOL SOC AM BULL, V67, P823, DOI 10.1130/0016-7606(1956)67[823:COPGAR]2.0.CO;2; Zimbelman JR, 2000, GEOPHYS RES LETT, V27, P1069, DOI 10.1029/1999GL008399; [No title captured]	40	778	794	1	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 30	2000	288	5475					2330	2335		10.1126/science.288.5475.2330	http://dx.doi.org/10.1126/science.288.5475.2330			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329NP	10875910				2022-12-24	WOS:000087913400028
J	Sigrist, SJ; Thiel, PR; Reiff, DF; Lachance, PED; Lasko, P; Schuster, CM				Sigrist, SJ; Thiel, PR; Reiff, DF; Lachance, PED; Lasko, P; Schuster, CM			Postsynaptic translation affects the efficacy and morphology of neuromuscular junctions	NATURE			English	Article							PRESYNAPTIC TRANSMITTER RELEASE; TERM SYNAPTIC PLASTICITY; LOCAL PROTEIN-SYNTHESIS; MESSENGER-RNA; FUNCTIONAL COMPONENTS; GENETIC DISSECTION; RETROGRADE SIGNAL; AMPA RECEPTORS; DROSOPHILA; SYNAPSES	Long-term synaptic plasticity may be associated with structural rearrangements within the neuronal circuitry(1,2). Although the molecular mechanisms governing such activity-controlled morphological alterations are mostly elusive, polysomal accumulations at the base of developing dendritic spines(3) and the activity-induced synthesis of synaptic components suggest that localized translation is involved during synaptic plasticity(4,5). Here we show that large aggregates of translational components as well as messenger RNA of the postsynaptic glutamate receptor subunit DGluR-IIA(6) are localized within subsynaptic compartments of larval neuromuscular junctions of Drosophila melanogaster. Genetic models of junctional plasticity(7) and genetic manipulations using the translation initiation factors eIF4E(8) and poly(A)binding protein(9) showed an increased occurrence of subsynaptic translation aggregates. This was associated with a significant increase in the postsynaptic DGluR-IIA protein levels and a reduction in the junctional expression of the cell-adhesion molecule Fasciclin II. In addition, the efficacy of junctional neurotransmission and the size of larval neuromuscular junctions were significantly increased. Our results therefore provide evidence for a postsynaptic translational control of long-term junctional plasticity.	Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	Eberhard Karls University of Tubingen; Max Planck Society; McGill University	Schuster, CM (corresponding author), Max Planck Gesell, Friedrich Miescher Lab, Spemannstr 37-39, D-72076 Tubingen, Germany.		Lasko, Paul/C-6761-2014	Lasko, Paul/0000-0002-4037-3501				BAILEY CH, 1992, SCIENCE, V256, P645, DOI 10.1126/science.1585177; BALLING A, 1987, J NEUROGENET, V4, P65, DOI 10.3109/01677068709102334; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Craig AWB, 1998, NATURE, V392, P520, DOI 10.1038/33198; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Gallie DR, 1998, GENE, V216, P1, DOI 10.1016/S0378-1119(98)00318-7; GORCZYCA M, 1993, J NEUROSCI, V13, P3692; Kiebler MA, 2000, NEURON, V25, P19, DOI 10.1016/S0896-6273(00)80868-5; Lavoie CA, 1996, J BIOL CHEM, V271, P16393, DOI 10.1074/jbc.271.27.16393; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Mathews M. B., 1996, TRANSLATIONAL CONTRO, P1; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Schuman EM, 1999, NEURON, V23, P645, DOI 10.1016/S0896-6273(01)80023-4; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; Sherff CM, 1999, SCIENCE, V285, P1911, DOI 10.1126/science.285.5435.1911; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Steinbach OC, 1999, METH MOL B, V127, P41, DOI 10.1385/1-59259-678-9:41; STEWARD O, 1986, J NEUROSCI, V6, P412; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Wu J, 1998, J BIOL CHEM, V273, P34535, DOI 10.1074/jbc.273.51.34535; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3	29	133	134	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 29	2000	405	6790					1062	1065		10.1038/35016598	http://dx.doi.org/10.1038/35016598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	328VN	10890448				2022-12-24	WOS:000087871700048
J	Brauner, DJ; Muir, JC; Sachs, GA				Brauner, DJ; Muir, JC; Sachs, GA			Treating nondementia illnesses in patients with dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS-DISEASE; CONSENSUS STATEMENT; INFORMED CONSENT; CARE; ALENDRONATE; ASSOCIATION; OUTPATIENTS; CAREGIVERS; GUIDELINES; MANAGEMENT	Physicians increasingly are called on to provide primary care for the growing population of people with Alzheimer-type dementia, However, little attention has been paid to the care of nondementia illnesses in this group of patients. To illustrate how presence of dementia can alter the risk-benefit ratio of treatment of a common medical problem, we present a case study in which a patient with dementia developed disastrous adverse effects to a drug commonly used to treat osteoporosis. This case and 2 composite vignettes illuminate how presence of dementia should influence the decision-making process for treatment of nondementia illnesses. We address issues such as decreased decision-making capacity, problems with reporting adverse effects, decreased cognition leading to problems with treatment adherence, and the role of screening and basic questions about acceptable burdens of treatments in patients with limited prognosis. We Suggest ways to improve communication with patients with dementia in an effort to minimize complications and improve care, as well as policy changes to include patients with dementia in clinical trials.	Univ Chicago, Pritzker Sch Med, Dept Med, Sect Geriatr, Chicago, IL 60637 USA; Univ Chicago, Pritzker Sch Med, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA; Northwestern Univ, Sch Med, Dept Hematol Oncol Palliat Care, Chicago, IL USA	University of Chicago; University of Chicago; Northwestern University	Brauner, DJ (corresponding author), Univ Chicago Hosp, Dept Med, 5841 S Maryland,MC 6098, Chicago, IL 60637 USA.							APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; Barrett JJ, 1996, SOUTH MED J, V89, P1, DOI 10.1097/00007611-199601000-00001; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; CLARK HH, 1989, COGNITIVE SCI, V13, P259, DOI 10.1207/s15516709cog1302_7; deGroen PC, 1996, NEW ENGL J MED, V335, P1016, DOI 10.1056/NEJM199610033351403; DRANE JF, 1984, JAMA-J AM MED ASSOC, V252, P925, DOI 10.1001/jama.252.7.925; Eccles M, 1998, BMJ-BRIT MED J, V317, P802, DOI 10.1136/bmj.317.7161.802; Etchells E, 1999, J GEN INTERN MED, V14, P27, DOI 10.1046/j.1525-1497.1999.00277.x; Gambert Steven R., 1997, Comprehensive Therapy, V23, P174; Garber AM, 1996, ANN INTERN MED, V124, P518, DOI 10.7326/0003-4819-124-5-199603010-00013; Gorelick PB, 1999, JAMA-J AM MED ASSOC, V281, P1112, DOI 10.1001/jama.281.12.1112; Grisso T, 1998, ASSESSING COMPETENCE; GURWITZ JH, 1991, ANN INTERN MED, V114, P956, DOI 10.7326/0003-4819-114-11-956; Guttman R, 1999, DIAGNOSIS MANAGEMENT; Hamilton H., 1994, CONVERSATION ALZHEIM; Irvine P, 1988, Clin Geriatr Med, V4, P703; ISSAC LM, 1993, GERONTOLOGIST, V33, P772; Karlawish JHT, 1999, ANN INTERN MED, V130, P835, DOI 10.7326/0003-4819-130-10-199905180-00018; LARSON EB, 1986, WESTERN J MED, V145, P488; Larson EB, 1998, AM J GERIAT PSYCHIAT, V6, pS34, DOI 10.1097/00019442-199821001-00005; Lee V K, 1991, J Gerontol Nurs, V17, P16; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Luchins DJ, 1997, J AM GERIATR SOC, V45, P1054, DOI 10.1111/j.1532-5415.1997.tb05966.x; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P955, DOI 10.1001/archneur.1995.00540340035011; MATCHAR DB, 1994, ANN INTERN MED, V121, P41, DOI 10.7326/0003-4819-121-1-199407010-00008; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1987, J GERONTOL, V42, P412, DOI 10.1093/geronj/42.4.412; MURDOCH BE, 1987, BRAIN LANG, V31, P122, DOI 10.1016/0093-934X(87)90064-2; *NIH, 2000, POL GUID INCL CHILDR; *NIH, 2000, NIH GUID INCL WOM MI; Post SG, 1998, J AM GERIATR SOC, V46, P784, DOI 10.1111/j.1532-5415.1998.tb03819.x; RANGO N, 1985, ANN INTERN MED, V102, P835, DOI 10.7326/0003-4819-102-6-835; Rhymes JA, 2000, JAMA-J AM MED ASSOC, V283, P1061, DOI 10.1001/jama.283.8.1061; RIPICH DN, 1995, GERIATR NURS, V16, P15, DOI 10.1016/S0197-4572(05)80073-4; Sachs GA, 1998, J AM GERIATR SOC, V46, P782, DOI 10.1111/j.1532-5415.1998.tb03818.x; SACHS GA, 1994, CLIN RES, V42, P403; Small GW, 1997, JAMA-J AM MED ASSOC, V278, P1363, DOI 10.1001/jama.278.16.1363; THORPE J, 1994, AGING-CLIN EXP RES, V6, P159, DOI 10.1007/BF03324233; *US PEV SERV TASK, 1996, GUID CLIN PREV SERV; WALSH JS, 1990, ANN INTERN MED, V113, P429, DOI 10.7326/0003-4819-113-6-429; Wolf-Klein G P, 1994, Int Psychogeriatr, V6, P135, DOI 10.1017/S1041610294001705	41	115	116	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2000	283	24					3230	3235		10.1001/jama.283.24.3230	http://dx.doi.org/10.1001/jama.283.24.3230			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	326TY	10866871				2022-12-24	WOS:000087753900036
J	Stover, CK; Warrener, P; VanDevanter, DR; Sherman, DR; Arain, TM; Langhorne, MH; Anderson, SW; Towell, JA; Yuan, Y; McMurray, DN; Kreiswirth, BN; Barry, CE; Baker, WR				Stover, CK; Warrener, P; VanDevanter, DR; Sherman, DR; Arain, TM; Langhorne, MH; Anderson, SW; Towell, JA; Yuan, Y; McMurray, DN; Kreiswirth, BN; Barry, CE; Baker, WR			A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis	NATURE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; F-420-DEPENDENT GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; MYCOLIC ACIDS; METRONIDAZOLE; BIOSYNTHESIS; MECHANISM; SMEGMATIS; BACILLI	Mycobacterium tuberculosis, which causes tuberculosis, is the greatest single infectious cause of mortality worldwide, killing roughly two million people annually(1). Estimates indicate that one-third of the world population is infected with latent M. tuberculosis(2). The synergy between tuberculosis and the AIDS epidemic(3-5), and the surge of multidrug-resistant clinical isolates of M. tuberculosis have reaffirmed tuberculosis as a primary public health threat. However, new antitubercular drugs with new mechanisms of action have not been developed in over thirty years. Here we report a series of compounds containing a nitroimidazopyran nucleus that possess antitubercular activity. After activation by a mechanism dependent on M. tuberculosis F420 cofactor, nitroimidazopyrans inhibited the synthesis of protein and cell wall lipid. In contrast to current antitubercular drugs, nitroimidazopyrans exhibited bactericidal activity against both replicating and static M. tuberculosis. Lead compound PA-824 showed potent bactericidal activity against multidrug-resistant M. tuberculosis and promising oral activity in animal infection models. We conclude that nitroimidazopyrans offer the practical qualities of a small molecule with the potential for the treatment of tuberculosis.	PathoGenesis Corp, Seattle, WA 98119 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Pathobiol, Seattle, WA 98195 USA; Texas A&M Univ, Hlth Sci Ctr, Dept Med Microbiol & Immunol, College Stn, TX 77843 USA; Publ Hlth Res Inst City New York Inc, TB Ctr, New York, NY 10016 USA; NIAID, TB Res Sect, Host Def Lab, NIH, Rockville, MD 20852 USA	University of Washington; University of Washington Seattle; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Stover, CK (corresponding author), PathoGenesis Corp, 201 Elliott Ave W, Seattle, WA 98119 USA.		Barry, Clifton E/ABE-7992-2020; Barry, III, Clifton/H-3839-2012	Barry, Clifton E/0000-0002-2927-270X; Barry, III, Clifton/0000-0002-2927-270X; Stover, Charles/0000-0002-7406-1696; VanDevanter, Donald/0000-0002-5727-8164	Intramural NIH HHS [Z01 AI000693-15] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000693, Z01AI000734] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGRAWAL KC, 1979, J MED CHEM, V22, P593; Arain TM, 1996, ANTIMICROB AGENTS CH, V40, P1536, DOI 10.1128/AAC.40.6.1536; ASHTEKAR DR, 1993, ANTIMICROB AGENTS CH, V37, P183, DOI 10.1128/AAC.37.2.183; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Bloom BR, 1998, NEW ENGL J MED, V338, P677, DOI 10.1056/NEJM199803053381008; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; EDWARDS DI, 1979, J ANTIMICROB CHEMOTH, V5, P499, DOI 10.1093/jac/5.5.499; FISCHL MA, 1992, ANN INTERN MED, V117, P184, DOI 10.7326/0003-4819-117-3-184; Hickey MJ, 1996, ANTIMICROB AGENTS CH, V40, P400, DOI 10.1128/AAC.40.2.400; HOLT J. G., 1994, BERGEYS MANUAL DETER, P597; Kaufmann S H, 1993, Trends Microbiol, V1, P2, DOI 10.1016/0966-842X(93)90015-J; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; NAGARAJAN K, 1989, EUR J MED CHEM, V24, P631, DOI 10.1016/0223-5234(89)90034-2; Purwantini E, 1996, J BACTERIOL, V178, P2861, DOI 10.1128/jb.178.10.2861-2866.1996; Purwantini E, 1998, J BACTERIOL, V180, P2212, DOI 10.1128/JB.180.8.2212-2219.1998; Samuelson J, 1999, ANTIMICROB AGENTS CH, V43, P1533, DOI 10.1128/AAC.43.7.1533; SMITH DW, 1991, TUBERCLE, V72, P223, DOI 10.1016/0041-3879(91)90013-I; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; WALSH JS, 1987, J MED CHEM, V30, P150, DOI 10.1021/jm00384a025; WAYNE LG, 1994, ANTIMICROB AGENTS CH, V38, P2054, DOI 10.1128/AAC.38.9.2054; Yuan Y, 1998, MOL MICROBIOL, V29, P1449, DOI 10.1046/j.1365-2958.1998.01026.x; Yuan Y, 1996, P NATL ACAD SCI USA, V93, P12828, DOI 10.1073/pnas.93.23.12828	24	804	854	3	66	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2000	405	6789					962	966		10.1038/35016103	http://dx.doi.org/10.1038/35016103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326JT	10879539				2022-12-24	WOS:000087732700054
J	Langman, MJS; Cheng, KK; Gilman, EA; Lancashire, RJ				Langman, MJS; Cheng, KK; Gilman, EA; Lancashire, RJ			Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database	BRITISH MEDICAL JOURNAL			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ASPIRIN USE; BREAST-CANCER; RHEUMATOID-ARTHRITIS; COLORECTAL-CANCER; CYCLOOXYGENASE-2; EXPRESSION; ADENOCARCINOMAS; RATS; CARCINOGENESIS	Objective To examine whether anti-inflammatory drug treatment protects against the commoner cancers in the United Kingdom. Design Case-control study using the general practice research database. Setting Practices throughout United Kingdom providing data to the database. Subjects Patients who had a first diagnosis of five gastrointestinal (oesophagus, stomach, colon, rectum, and pancreas) cancers and four non-gastrointestinal (bladder, breast, lung, and prostate) cancers in 1993-5 for whom prescription data were available for the at least the previous 36 months. Each case was matched for age, sex, and general practice with three controls. Main outcome measure Risk of cancer. Results In 12 174 cancer cases and 34 934 controls overall risk of the nine cancers was not significantly reduced among those who had received at least seven prescriptions in the 13-36 months before cancer diagnosis (odds ratio 0.98, 95% confidence interval 0.89 to 1.07). Findings were nevertheless compatible with protective effects from anti-inflammatory drugs against cancers of the oesophagus (0.64, 0.41 to 0.98), stomach (0.51, 0.33 to 0.79), colon (0.76, 0.58 to 1.00), and rectum (0.75, 0.49 to 1.14) with dose related trends. The risk of pancreatic cancer (1.49, 1.02 to 2.18) and prostatic cancer (1.33, 1.07 to 1.64) was increased among patients who had received at least seven prescriptions, but the trend was dose related for only pancreatic cancer. Conclusions Anti-inflammatory drugs may protect against oesophageal and gastric cancer as well as colon and rectal cancer. The increased risks of pancreatic and prostatic cancer could be due to chance or to undetected biases and wan-ant further investigation.	Univ Birmingham, Dept Med, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham	Langman, MJS (corresponding author), Univ Birmingham, Dept Med, Birmingham B15 2TT, W Midlands, England.		Cheng, Kar/AAL-8899-2021	Cheng, Kar/0000-0002-1516-1857				EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1; Egan KM, 1996, J NATL CANCER I, V88, P988, DOI 10.1093/jnci/88.14.988; Farrow DC, 1998, CANCER EPIDEM BIOMAR, V7, P97; FRIEDMAN GD, 1983, J NATL CANCER I, V71, P1165; FUNKHOUSER GM, 1995, CANCER, V76, P116; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; GRIDLEY G, 1993, JNCI-J NATL CANCER I, V85, P307, DOI 10.1093/jnci/85.4.307; GustafsonSvard C, 1996, GUT, V38, P79, DOI 10.1136/gut.38.1.79; Harris RE, 1996, EPIDEMIOLOGY, V7, P203, DOI 10.1097/00001648-199603000-00017; Hwang D, 1998, J NATL CANCER I, V90, P455, DOI 10.1093/jnci/90.6.455; ISOMAKI HA, 1978, J CHRON DIS, V31, P691, DOI 10.1016/0021-9681(78)90071-1; KLAN R, 1993, J CANCER RES CLIN, V119, P482, DOI 10.1007/BF01215929; LANGMAN MJS, 1994, LANCET, V343, P1075, DOI 10.1016/S0140-6736(94)90185-6; Norrish AE, 1998, INT J CANCER, V77, P511; PAGANINIHILL A, 1989, BRIT MED J, V299, P1247, DOI 10.1136/bmj.299.6710.1247; PAGANINIHILL A, 1991, J NATL CANCER I, V83, P1182, DOI 10.1093/jnci/83.16.1182-a; REDDY BS, 1993, CARCINOGENESIS, V14, P1493, DOI 10.1093/carcin/14.8.1493; Ristimaki A, 1997, CANCER RES, V57, P1276; Robertson FM, 1998, CANCER LETT, V122, P165, DOI 10.1016/S0304-3835(97)00387-X; SCHREINEMACHERS DM, 1994, EPIDEMIOLOGY, V5, P138, DOI 10.1097/00001648-199403000-00003; THUN MJ, 1993, CANCER RES, V53, P1322; Van Staa TP, 1994, PHARMACOEPIDEM DR S, V3, P15, DOI DOI 10.1002/PDS.2630030106; Wilson KT, 1998, CANCER RES, V58, P2929	24	348	365	1	19	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 17	2000	320	7250					1642	1646		10.1136/bmj.320.7250.1642	http://dx.doi.org/10.1136/bmj.320.7250.1642			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326KG	10856067	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000087734200024
J	Inzitari, D; Eliasziw, M; Gates, P; Sharpe, BL; Chan, RKT; Meldrum, HE; Barnett, HJM				Inzitari, D; Eliasziw, M; Gates, P; Sharpe, BL; Chan, RKT; Meldrum, HE; Barnett, HJM		N Amer Symptomatic Carotid Endar	The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LONG-TERM PROGNOSIS; MEDICARE BENEFICIARIES; NATURAL-HISTORY; ENDARTERECTOMY; GUIDELINES; TRIAL; APPROPRIATENESS; PERFORMANCE; ASSOCIATION; PREVENTION	Background: The causes of stroke in patients with asymptomatic carotid-artery stenosis have not been carefully studied. Information about causes might influence decisions about the use of carotid endarterectomy in such patients. Methods: We studied patients with unilateral symptomatic carotid-artery stenosis and asymptomatic contralateral stenosis from 1988 to 1997. The causes, severity, risk, and predictors of stroke in the territory of the asymptomatic artery were examined and quantified. Results: The risk of stroke at five years after study entry in a total of 1820 patients increased with the severity of stenosis. Among 1604 patients with stenosis of less than 60 percent of the luminal diameter, the risk of a first stroke was 8.0 percent (1.6 percent annually), as compared with 16.2 percent (3.2 percent annually) among 216 patients with 60 to 99 percent stenosis. In the group with 60 to 99 percent stenosis, the five-year risk of stroke in the territory of a large artery was 9.9 percent, that of lacunar stroke was 6.0 percent, and that of cardioembolic stroke 2.1 percent. Some patients had more than one stroke of more than one cause. In the territory of an asymptomatic occluded artery (as was identified in 86 patients), the annualized risk of stroke was 1.9 percent. Strokes with different causes had different risk factors. The risk factors for large-artery stroke were silent brain infarction, a history of diabetes, and a higher degree of stenosis; for cardioembolic stroke, a history of myocardial infarction or angina and hypertension; and for lacunar stroke, age of 75 years or older, hypertension, diabetes, and a higher degree of stenosis. Conclusions: The risk of stroke among patients with asymptomatic carotid-artery stenosis is relatively low. Forty-five percent of strokes in patients with asymptomatic stenosis of 60 to 99 percent are attributable to lacunes or cardioembolism. These observations have implications for the use of endarterectomy in asymptomatic patients. Without analysis of the risk of stroke according to cause, the absolute benefit associated with endarterectomy may be overestimated. (N Engl J Med 2000;342:1693-700.) (C) 2000, Massachusetts Medical Society.	Univ Florence, Dept Neurol & Psychiat Sci, Florence, Italy; Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; John P Robarts Res Inst, London, ON N6A 5K8, Canada; Geelong Hosp, Dept Neurosci, Geelong, Vic, Australia; Univ Melbourne, Dept Med, Melbourne, Vic, Australia; SUNY Buffalo, Dept Neurol, Buffalo, NY 14260 USA	University of Florence; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Geelong Hospital; University of Melbourne; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Barnett, HJM (corresponding author), John P Robarts Res Inst, 100 Perth Dr,POB 5015, London, ON N6A 5K8, Canada.		Inzitari, Domenico/AAH-8722-2020		NINDS NIH HHS [R01-NS-24456] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024456] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barnett HJM, 2000, JAMA-J AM MED ASSOC, V283, P1429, DOI 10.1001/jama.283.11.1429; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; BARNETT HJM, 1991, STROKE, V22, P711, DOI 10.1161/01.STR.22.6.711; Barnett HJM, 1996, NEUROLOGY, V46, P603, DOI 10.1212/WNL.46.3.603; Biller J, 1998, STROKE, V29, P554, DOI 10.1161/01.STR.29.2.554; BOGOUSSLAVSKY J, 1986, NEUROLOGY, V36, P861, DOI 10.1212/WNL.36.6.861; CAPLAN LR, 1988, NEUROLOGY, V38, P791, DOI 10.1212/WNL.38.5.791; CHAMBERS BR, 1986, NEW ENGL J MED, V315, P860, DOI 10.1056/NEJM198610023151404; DEHAAN R, 1995, STROKE, V26, P2027, DOI 10.1161/01.STR.26.11.2027; DIENER HC, 1991, STROKE, V22, P1229; ELLIS MR, 1992, EUR J VASCULAR SURG, V6, P172, DOI 10.1016/S0950-821X(05)80236-1; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Findlay JM, 1997, CAN MED ASSOC J, V157, P653; FOX AJ, 1993, RADIOLOGY, V186, P316, DOI 10.1148/radiology.186.2.8421726; Frey JL, 1996, ANN NEUROL, V39, P405, DOI 10.1002/ana.410390322; GASECKI AP, 1995, J NEUROSURG, V83, P778, DOI 10.3171/jns.1995.83.5.0778; Gorelick PB, 1999, JAMA-J AM MED ASSOC, V281, P1112, DOI 10.1001/jama.281.12.1112; HALLIDAY AW, 1994, EUR J VASCULAR SURG, V8, P703; Hertzer NR, 1997, J VASC SURG, V26, P1, DOI 10.1016/S0741-5214(97)70139-3; Hertzer NR, 1996, J VASC SURG, V23, P167, DOI 10.1016/S0741-5214(05)80049-7; Hsia DC, 1998, STROKE, V29, P346, DOI 10.1161/01.STR.29.2.346; Inzitari D, 2000, NEUROLOGY, V54, P660, DOI 10.1212/WNL.54.3.660; Irvine CD, 1998, EUR J VASC ENDOVASC, V16, P245, DOI 10.1016/S1078-5884(98)80227-X; Karp HR, 1998, STROKE, V29, P46, DOI 10.1161/01.STR.29.1.46; Kucey DS, 1998, J VASC SURG, V28, P1051, DOI 10.1016/S0741-5214(98)70031-X; Mackey AE, 1997, NEUROLOGY, V48, P896, DOI 10.1212/WNL.48.4.896; MADDEN KP, 1995, NEUROLOGY, V45, P1975, DOI 10.1212/WNL.45.11.1975; MAYBERG MR, 1991, JAMA-J AM MED ASSOC, V266, P3289, DOI 10.1001/jama.266.23.3289; Morgenstern LB, 1997, NEUROLOGY, V48, P911, DOI 10.1212/WNL.48.4.911; NICOLAIDES AN, 1995, INT ANGIOL, V14, P21; NORRIS JW, 1991, STROKE, V22, P1485, DOI 10.1161/01.STR.22.12.1485; Perry JR, 1997, ARCH NEUROL-CHICAGO, V54, P25, DOI 10.1001/archneur.1997.00550130015009; ROTHWELL PM, 1995, LANCET, V345, P209; Rothwell PM, 2000, STROKE, V31, P622, DOI 10.1161/01.STR.31.3.622; Taylor DW, 1999, LANCET, V353, P2179, DOI 10.1016/S0140-6736(99)05388-X; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Wennberg DE, 1998, JAMA-J AM MED ASSOC, V279, P1278, DOI 10.1001/jama.279.16.1278; Wong JH, 1997, STROKE, V28, P891, DOI 10.1161/01.STR.28.5.891; ZHU CZ, 1991, CAN J SURG, V34, P437	40	492	517	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2000	342	23					1693	1700		10.1056/NEJM200006083422302	http://dx.doi.org/10.1056/NEJM200006083422302			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321HD	10841871				2022-12-24	WOS:000087449300002
J	Goraya, TY; Jacobsen, SJ; Pellikka, PA; Miller, TD; Khan, A; Weston, SA; Gersh, BJ; Roger, VL				Goraya, TY; Jacobsen, SJ; Pellikka, PA; Miller, TD; Khan, A; Weston, SA; Gersh, BJ; Roger, VL			Prognostic value of treadmill exercise testing in elderly persons	ANNALS OF INTERNAL MEDICINE			English	Article						prognostic value of tests; exercise test; age factors; workload; electrocardiography	CORONARY HEART-DISEASE; LOWER-EXTREMITY FUNCTION; ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; ARTERY DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; RISK ASSESSMENT; OLMSTED COUNTY; UNITED-STATES	Background: Recent exercise testing guidelines recognized a gap in knowledge about the prognostic value of treadmill exercise testing in elderly persons. Objective: To test the hypothesis that treadmill exercise testing has equal prognostic value among elderly (greater than or equal to 65 years of age) and younger (greater than or equal to 65 years of age) persons and to examine the incremental value of this testing over clinical data. Design: Inception cohort with a median follow-up of 6 years. Setting: Olmsted County, Minnesota. Patients: All elderly (n = 514) and younger (n = 2593) residents of Olmsted County who underwent treadmill exercise testing between 1987 and 1989. Measurements: Overall mortality and cardiac events (cardiac death, nonfatal myocardial infarction, and congestive heart failure). Results: Compared with younger patients, elderly patients had more comorbid conditions, achieved a lower workload (6.0 and 10.7 metabolic equivalents; P < 0.001), and had a greater likelihood of a positive exercise electrocardiogram (28% and 9%; P < 0.001), With median follow-up of 6 years, overall survival (63% and 92%; Pt 0.001) and cardiac event-free survival (66% and 95%; P ( 0.001) were worse among elderly persons than among younger persons. Workload was the only treadmill exercise testing variable associated with all-cause mortality in both age groups, and the strength of association was similar. Workload and angina with exercise testing were associated with cardiac events in both age groups, whereas a positive exercise electrocardiogram was associated with cardiac events only in younger persons (P < 0.05 for all comparisons). After adjustment for clinical variables, workload was the only additional treadmill exercise testing variable that was predictive of death (P < 0.001) and cardiac events (P < 0.05); the strength of the association was similar in both age groups. Each 1-metabolic equivalent increase in exercise capacity was associated with a 14% and 18% reduction in cardiac events among younger and elderly persons, respectively. Conclusions: In elderly persons, treadmill exercise testing provided prognostic information that is incremental to clinical data. After adjustment for clinical factors, workload was the only treadmill exercise testing variable that was strongly associated with outcome, and its prognostic effect was of the same magnitude in elderly and younger persons.	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Clin Epidemiol Sect, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Biostat Sect, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Goraya, TY (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis & Internal Med, 200 1St St Sw, Rochester, MN 55905 USA.		Pellikka, Patricia A/N-5387-2014; Roger, Veronique/AAV-5951-2020	Pellikka, Patricia A/0000-0001-6800-3521; Jacobsen, Steven/0000-0002-8174-8533	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR30582] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ANDERSON RN, 1997, MONTHLY VITAL STAT R, V45; BISHOP E, 1996, WALL STREET J   1113, P86; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BRUCE RA, 1980, AM J CARDIOL, V46, P371, DOI 10.1016/0002-9149(80)90003-X; BRUCE RA, 1973, AM HEART J, V85, P546, DOI 10.1016/0002-8703(73)90502-4; BRUCE RA, 1983, J AM COLL CARDIOL, V2, P565, DOI 10.1016/S0735-1097(83)80286-1; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DAGENAIS GR, 1982, CIRCULATION, V65, P452, DOI 10.1161/01.CIR.65.3.452; Daida H, 1996, MAYO CLIN PROC, V71, P445, DOI 10.4065/71.5.445; DESTEFANO F, 1993, ARCH INTERN MED, V153, P2489, DOI 10.1001/archinte.153.21.2489; ELLESTAD MH, 1975, CIRCULATION, V51, P363, DOI 10.1161/01.CIR.51.2.363; FLEG JL, 1990, CIRCULATION, V81, P428, DOI 10.1161/01.CIR.81.2.428; Fletcher GF, 1996, CIRCULATION, V94, P857, DOI 10.1161/01.CIR.94.4.857; FLETCHER GF, 1995, CIRCULATION, V91, P580, DOI 10.1161/01.CIR.91.2.580; Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260; GLOVER DR, 1984, EUR HEART J, V5, P59, DOI 10.1093/eurheartj/5.suppl_E.59; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hakim AA, 1998, NEW ENGL J MED, V338, P94, DOI 10.1056/NEJM199801083380204; Hakim AA, 1999, CIRCULATION, V100, P9, DOI 10.1161/01.CIR.100.1.9; HAMMERMEISTER KE, 1979, CIRCULATION, V59, P421, DOI 10.1161/01.CIR.59.3.421; KASSER IS, 1969, CIRCULATION, V39, P759, DOI 10.1161/01.CIR.39.6.759; Kushi LH, 1997, JAMA-J AM MED ASSOC, V277, P1287, DOI 10.1001/jama.277.16.1287; LEE IM, 1995, JAMA-J AM MED ASSOC, V273, P1179, DOI 10.1001/jama.273.15.1179; Leibson CL, 1998, NEUROLOGY, V51, P163, DOI 10.1212/WNL.51.1.163; Lindsted KD, 1996, J CLIN EPIDEMIOL, V49, P783, DOI 10.1016/0895-4356(96)00009-1; MARK DB, 1987, ANN INTERN MED, V106, P793, DOI 10.7326/0003-4819-106-6-793; MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204; MARK DB, 1989, J AM COLL CARDIOL, V14, P885, DOI 10.1016/0735-1097(89)90459-2; MARTINEZCARO D, 1984, EUR HEART J, V5, P63, DOI 10.1093/eurheartj/5.suppl_E.63; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; MCNEER JF, 1978, CIRCULATION, V57, P64, DOI 10.1161/01.CIR.57.1.64; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; MORROW K, 1993, ANN INTERN MED, V118, P689, DOI 10.7326/0003-4819-118-9-199305010-00005; OCONNOR GT, 1989, CIRCULATION, V80, P234, DOI 10.1161/01.CIR.80.2.234; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; PETERS RK, 1983, JAMA-J AM MED ASSOC, V249, P3052, DOI 10.1001/jama.249.22.3052; POWELL KE, 1987, ANNU REV PUBL HEALTH, V8, P253, DOI 10.1146/annurev.publhealth.8.1.253; RODEHEFFER RJ, 1984, CIRCULATION, V69, P203, DOI 10.1161/01.CIR.69.2.203; Roger VL, 1999, MAYO CLIN PROC, V74, P651, DOI 10.4065/74.7.651; Roger VL, 1998, CIRCULATION, V98, P2836, DOI 10.1161/01.CIR.98.25.2836; SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803; SCHLANT RC, 1986, J AM COLL CARDIOL, V8, P725; SLATTERY ML, 1988, AM J EPIDEMIOL, V127, P571, DOI 10.1093/oxfordjournals.aje.a114832; WEINER DA, 1984, J AM COLL CARDIOL, V3, P772, DOI 10.1016/S0735-1097(84)80254-5; WEINER DA, 1995, AM J CARDIOL, V75, P865, DOI 10.1016/S0002-9149(99)80677-8; Woo J, 1999, J AM GERIATR SOC, V47, P1257, DOI 10.1111/j.1532-5415.1999.tb05209.x	47	157	167	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2000	132	11					862	+		10.7326/0003-4819-132-11-200006060-00003	http://dx.doi.org/10.7326/0003-4819-132-11-200006060-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	319HF	10836912				2022-12-24	WOS:000087334900002
J	Laubach, M; Wessberg, J; Nicolelis, MAL				Laubach, M; Wessberg, J; Nicolelis, MAL			Cortical ensemble activity increasingly predicts behaviour outcomes during learning of a motor task	NATURE			English	Article							SUPPLEMENTARY EYE FIELD; CONDITIONAL OCULOMOTOR ASSOCIATIONS; NEURONAL-ACTIVITY; MOVEMENT DIRECTION; CORTEX; ACQUISITION; POPULATION; OSCILLATIONS; INFORMATION; MONKEYS	When an animal learns to make movements in response to different stimuli, changes in activity in the motor cortex seem to accompany and underlie this learning(1-6). The precise nature of modifications in cortical motor areas during the initial stages of motor learning, however, is largely unknown. Here we address this issue by chronically recording from neuronal ensembles located in the rat motor cortex, throughout the period required for rats to learn a reaction-time task. Motor learning was demonstrated by a decrease in the variance of the rats' reaction times and an increase in the time the animals were able to wait for a trigger stimulus. These behavioural changes were correlated with a significant increase in our ability to predict the correct or incorrect outcome of single trials based on three measures of neuronal ensemble activity: average firing rate, temporal patterns of firing, and correlated firing. This increase in prediction indicates that an association between sensory cues and movement emerged in the motor cortex as the task was learned. Such modifications in cortical ensemble activity may be critical for the initial learning of motor tasks.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Laubach, M (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.			Laubach, Mark/0000-0002-2403-4497				ALMARIC M, 1987, J NEUROSCI, V7, P2129; BUCKHEIT JB, 1995, P SOC PHOTO-OPT INS, V2569, P540, DOI 10.1117/12.217608; Chen LL, 1997, J NEUROPHYSIOL, V78, P1166, DOI 10.1152/jn.1997.78.2.1166; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1122, DOI 10.1152/jn.1995.73.3.1122; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; Chen LTL, 1996, J NEUROSCI, V16, P3067; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Efron B., 1994, INTRO BOOTSTRAP; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; GERMAIN L, 1993, BRAIN RES, V611, P175, DOI 10.1016/0006-8993(93)91792-Q; GHAZANFAR AA, IN PRESS J NEUROSCI; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Kohonen T., 1997, SELF ORGANIZING MAPS; KRIPPENDORFF K, 1986, INFORMATION THEORY S; Laubach M, 1999, J NEUROSCI METH, V94, P141, DOI 10.1016/S0165-0270(99)00131-4; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Loeb G. E., 1986, ELECTROMYOGRAPHY EXP; Maynard EM, 1999, J NEUROSCI, V19, P8083; MITZ AR, 1991, J NEUROSCI, V11, P1855; Mosteller F., 1968, HDB SOC PSYCHOL, V2, P80; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Nicolelis MAL, 1998, NAT NEUROSCI, V1, P621, DOI 10.1038/2855; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; Nicolelis MAL, 1997, NEURON, V18, P529, DOI 10.1016/S0896-6273(00)80295-0; Reyment R. A., 1993, APPL FACTOR ANAL NAT; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Seidemann E, 1996, J NEUROSCI, V16, P752; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; [No title captured]	29	207	217	0	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2000	405	6786					567	571		10.1038/35014604	http://dx.doi.org/10.1038/35014604			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850715				2022-12-24	WOS:000087449500050
J	Fonseca, PJ; Munch, D; Hennig, RM				Fonseca, PJ; Munch, D; Hennig, RM			Auditory perception - How cicadas interpret acoustic signals	NATURE			English	Article							TONOTOPIC ORGANIZATION		Fac Ciencias Lisboa, Dept Zool, P-1700 Lisbon, Portugal; Fac Ciencias Lisboa, Ctr Biol Ambiental, P-1700 Lisbon, Portugal; Humboldt Univ, Inst Biol, D-10115 Berlin, Germany	Universidade de Lisboa; Universidade de Lisboa; Humboldt University of Berlin	Fonseca, PJ (corresponding author), Fac Ciencias Lisboa, Dept Zool, Campo Grande, P-1700 Lisbon, Portugal.	matthias.hennig@rz.hu-berlin.de	Fonseca, Paulo/K-1537-2012	Fonseca, Paulo/0000-0002-2663-9385				Bradbury Jack W., 1998, pi; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; FONSECA PJ, 1994, THESIS U LISBON; Gogala Matija, 1995, Bioacoustics, V6, P101; JOY RR, 1998, COMP HEARING INSECTS; OLDFIELD BP, 1988, TRENDS NEUROSCI, V11, P267, DOI 10.1016/0166-2236(88)90108-7; POPOV AV, 1990, ADV LIF SCI, P301; ROMER H, 1983, NATURE, V306, P60, DOI 10.1038/306060a0; Romer H., 1993, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, V340, P179, DOI 10.1098/rstb.1993.0056; Stumpner A, 1998, J NEUROPHYSIOL, V79, P2408, DOI 10.1152/jn.1998.79.5.2408	10	41	43	1	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 18	2000	405	6784					297	298		10.1038/35012696	http://dx.doi.org/10.1038/35012696			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314YT	10830949				2022-12-24	WOS:000087085700032
J	Vico, L; Collet, P; Guignandon, A; Lafage-Proust, MH; Thomas, T; Rehailia, M; Alexandre, C				Vico, L; Collet, P; Guignandon, A; Lafage-Proust, MH; Thomas, T; Rehailia, M; Alexandre, C			Effects of long-term microgravity exposure on cancellous and cortical weight-bearing bones of cosmonauts	LANCET			English	Article							BED REST; SPACE-FLIGHT; SPACEFLIGHT; MASS; DENSITY; MARKERS; BODY	Background Microgravity has been thought to induce osteoporosis because of reduced weight-bearing. However, up to now, few data have been available about its precise nature and timecourse. Methods We measured bone mineral density (BMD) at the distal radius and tibia in 15 cosmonauts of the Russian MIR space station who sojourned in space either 1 (n=two), 2 (two), or 6 months (11). After recovery periods of similar duration to the space missions, BMD was measured for the 2-month and 6-month crews. Findings Neither cancellous nor cortical bone of the radius was significantly changed at any of the timepoints. On the contrary, in the weight-bearing tibial site, cancellous BMD loss was already present after the first month and deteriorated with mission duration. In tibial cortices, bone loss was noted after a 2-month flight. In the 6-month group, cortical bone loss was less pronounced than that for cancellous bone. In some individuals, tibial deterioration was great. Actual BMD did not depend on preceding cumulative periods spent in space. During recovery, tibial bone loss persisted, suggesting that the time needed to recover is longer than the mission duration. Interpretation in space, despite physical training, bone loss is an adaptive process that can become pathological after recovery on Earth. Striking interindividual variations in bone responses seem to suggest a need for adequate crew preselection. Targeted treatment or prevention strategies would be useful, not only for space purposes, but also for the increasing number of osteoporotic patients on Earth.	Fac Med St Etienne, Lab Biol & Biochim Tissu Osseux, INSERM E9901, GIP Exercice, F-42023 St Etienne 02, France; Univ St Etienne, Fac Sci, Dept Stat, St Etienne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet	Vico, L (corresponding author), Fac Med St Etienne, Lab Biol & Biochim Tissu Osseux, INSERM E9901, GIP Exercice, F-42023 St Etienne 02, France.	vico@univ-st-etienne.fr	Vico, Laurence/ABG-7239-2020; Vico, Laurence/O-1927-2018	Vico, Laurence/0000-0002-2110-287X; Vico, Laurence/0000-0002-2110-287X; GUIGNANDON, Alain/0000-0002-0745-5417; Lafage-Proust, Marie-Helene/0000-0002-2091-3961				Arden NK, 1997, J BONE MINER RES, V12, P2076, DOI 10.1359/jbmr.1997.12.12.2076; Caillot-Augusseau A, 1998, CLIN CHEM, V44, P578; Collet P, 1997, BONE, V20, P547, DOI 10.1016/S8756-3282(97)00052-5; JOUANNY P, 1995, ARTHRITIS RHEUM, V38, P61, DOI 10.1002/art.1780380110; Lafage-Proust MH, 1998, AM J PHYSIOL-REG I, V274, pR324, DOI 10.1152/ajpregu.1998.274.2.R324; LeBlanc A, 1998, BONE, V22, p113S, DOI 10.1016/S8756-3282(98)00013-1; LEBLANC A, 1996, J BONE MINER RES, V11, P323; LEBLANC AD, 1990, J BONE MINER RES, V5, P843; MINAIRE P, 1974, CALC TISS RES, V17, P57, DOI 10.1007/BF02547214; MULLER A, 1985, PHYS MED BIOL, V30, P401, DOI 10.1088/0031-9155/30/5/003; Mustalahti K, 1999, LANCET, V354, P744, DOI 10.1016/S0140-6736(99)01990-X; Oganov V. S., 1992, Aviakosmicheskaya i Ekologicheskaya Meditsina, V26, P20; OGANOV VS, 1990, KOSM BIOL AVIAK MED+, V24, P20; Ruegsegger P, 1991, Osteoporos Int, V1, P76, DOI 10.1007/BF01880447; Samaras K, 1999, ANN INTERN MED, V130, P873, DOI 10.7326/0003-4819-130-11-199906010-00002; SCHNEIDER V, 1992, J BONE MINER RES, V7, pS122; Smith SM, 1998, J CLIN ENDOCR METAB, V83, P3584, DOI 10.1210/jc.83.10.3584; STUPAKOV GP, 1984, SPACE BIOL MED, V18, P42; VOGEL JM, 1977, BIOMEDICAL RESULTS S, P183; White RJ, 1998, J APPL PHYSIOL, V85, P738, DOI 10.1152/jappl.1998.85.2.738; Zerath E, 1996, J APPL PHYSIOL, V81, P194, DOI 10.1152/jappl.1996.81.1.194; Zerwekh JE, 1998, J BONE MINER RES, V13, P1594, DOI 10.1359/jbmr.1998.13.10.1594	22	502	530	1	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2000	355	9215					1607	1611		10.1016/S0140-6736(00)02217-0	http://dx.doi.org/10.1016/S0140-6736(00)02217-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CD	10821365				2022-12-24	WOS:000086981200012
J	Fadok, VA; Bratton, DL; Rose, DM; Pearson, A; Ezekewitz, RAB; Henson, PM				Fadok, VA; Bratton, DL; Rose, DM; Pearson, A; Ezekewitz, RAB; Henson, PM			A receptor for phosphatidylserine-specific clearance of apoptotic cells	NATURE			English	Article							VITRONECTIN RECEPTOR; C-ELEGANS; MEMBRANE PHOSPHATIDYLSERINE; MACROPHAGE RECOGNITION; SPERMATOGENIC CELLS; MURINE MACROPHAGES; SERTOLI CELLS; PHAGOCYTOSIS; PROTEIN; EXPOSURE	The culmination of apoptosis in vivo is phagocytosis of cellular corpses. During apoptosis, the asymmetry of plasma membrane phospholipids is lost, which exposes phosphatidylserine externally(1-4). The phagocytosis of apoptotic cells can be inhibited stereospecifically by phosphatidylserine and its structural analogues, but not by other anionic phospholipids, suggesting that phosphatidylserine is specifically recognized(1,5-10). Using phage display, we have cloned a gene that appears to recognize phosphatidylserine on apoptotic cells. Here we show that this gene, when transfected into B and T lymphocytes, enables them to recognize and engulf apoptotic cells in a phosphatidylserine-specific manner. Flow cytometric analysis using a monoclonal antibody suggested that the protein is expressed on the surface of macrophages, fibroblasts and epithelial cells; this antibody, like phosphatidylserine liposomes, inhibited the phagocytosis of apoptotic cells and, in macrophages, induced an anti-inflammatory state. This candidate phosphatidylserine receptor is highly homologous to genes of unknown function in Caenorhabditis elegans and Drosophila melanogaster, suggesting that phosphatidylserine recognition on apoptotic cells during their removal by phagocytes is highly conserved throughout phylogeny.	Natl Jewish Med & Res Ctr, Dept Pediat, Denver, CO 80206 USA; Massachusetts Gen Hosp, Boston, MA 02115 USA	National Jewish Health; Harvard University; Massachusetts General Hospital	Fadok, VA (corresponding author), Natl Jewish Med & Res Ctr, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.							Aramaki Y, 1997, BIOCHEM BIOPH RES CO, V231, P827, DOI 10.1006/bbrc.1996.5999; Balasubramanian K, 1997, J BIOL CHEM, V272, P31113, DOI 10.1074/jbc.272.49.31113; BENNETT MR, 1995, CIRC RES, V77, P1136, DOI 10.1161/01.RES.77.6.1136; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; FADOK VA, 1992, J IMMUNOL, V149, P4029; FADOK VA, 1993, J IMMUNOL, V151, P4274; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fadok VA, 1998, J IMMUNOL, V161, P6250; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; Heijne G. V, 1992, J MOL BIOL, V225, P487; IGARASHI K, 1995, J BIOL CHEM, V270, P29075, DOI 10.1074/jbc.270.49.29075; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; McDonald PP, 1999, J IMMUNOL, V163, P6164; Nagase T, 1998, DNA Res, V5, P31, DOI 10.1093/dnares/5.1.31; Oka K, 1998, P NATL ACAD SCI USA, V95, P9535, DOI 10.1073/pnas.95.16.9535; Pradhan D, 1997, MOL BIOL CELL, V8, P767, DOI 10.1091/mbc.8.5.767; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; Ryeom SW, 1996, J CELL SCI, V109, P387; SAMBRANO GR, 1995, P NATL ACAD SCI USA, V92, P1396, DOI 10.1073/pnas.92.5.1396; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; Shiratsuchi A, 1999, J BIOL CHEM, V274, P5901, DOI 10.1074/jbc.274.9.5901; Shiratsuchi A, 1997, J BIOL CHEM, V272, P2354, DOI 10.1074/jbc.272.4.2354; van den Eijnde SM, 1998, APOPTOSIS, V3, P9, DOI 10.1023/A:1009650917818; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Wang PY, 1998, J BIOL CHEM, V273, P24309, DOI 10.1074/jbc.273.38.24309; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5	30	1181	1236	5	71	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2000	405	6782					85	90		10.1038/35011084	http://dx.doi.org/10.1038/35011084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311TK	10811223				2022-12-24	WOS:000086901600056
J	Higuchi, M; Stefan, M; Single, FN; Hartner, J; Rozov, A; Burnashev, N; Feldmeyer, D; Sprengel, R; Seeburg, PH				Higuchi, M; Stefan, M; Single, FN; Hartner, J; Rozov, A; Burnashev, N; Feldmeyer, D; Sprengel, R; Seeburg, PH			Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2	NATURE			English	Article							SUBUNIT GLUR-B; PRE-MESSENGER-RNAS; ADENOSINE-DEAMINASE; GENOMIC ORGANIZATION; CHANNELS; LOCATION	RNA editing by site-selective deamination of adenosine to inosine(1,2) alters codons(3,4) and splicing(5) in nuclear transcripts(6), and therefore protein function. ADAR2 (refs 7, 8) is a candidate mammalian editing enzyme that is widely expressed in brain and other tissues(7), but its RNA substrates are unknown. Here we have studied ADAR2-mediated RNA editing by generating mice that are homozygous for a targeted functional null allele. Editing in ADAR2(-/-) mice was substantially reduced at most of 25 positions in diverse transcripts(3-6); the mutant mice became prone to seizures and died young. The impaired phenotype appeared to result entirely from a single underedited position, as it reverted to normal when both alleles for the underedited transcript were substituted with alleles encoding the edited version exonically(9). The critical position specifies an ion channel determinant(10), the Q/R site(3,6), in AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate) receptor(10) GluR-B pre-messenger RNA. We conclude that this transcript is the physiologically most important substrate of ADAR2.	Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany	Max Planck Society; Max Planck Society	Seeburg, PH (corresponding author), Max Planck Inst Med Res, Dept Mol Neurobiol, Jahnstr 29, D-69120 Heidelberg, Germany.		Rozov, Andrei/C-1997-2015; Feldmeyer, Dirk/H-5940-2013; Burnashev, Nail/G-4056-2013	Feldmeyer, Dirk/0000-0002-1716-8972; 				BASS BL, 1995, CURR BIOL, V5, P598, DOI 10.1016/S0960-9822(95)00119-9; Bass BL, 1997, RNA, V3, P947; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Dabiri GA, 1996, EMBO J, V15, P34, DOI 10.1002/j.1460-2075.1996.tb00331.x; Dingledine R, 1999, PHARMACOL REV, V51, P7; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Herb A, 1996, P NATL ACAD SCI USA, V93, P1875, DOI 10.1073/pnas.93.5.1875; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Kask K, 1998, P NATL ACAD SCI USA, V95, P13777, DOI 10.1073/pnas.95.23.13777; KOHLER M, 1994, J BIOL CHEM, V269, P17367; Lai F, 1997, MOL CELL BIOL, V17, P2413, DOI 10.1128/MCB.17.5.2413; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Maas S, 1996, J BIOL CHEM, V271, P12221, DOI 10.1074/jbc.271.21.12221; Melcher T, 1996, J BIOL CHEM, V271, P31795, DOI 10.1074/jbc.271.50.31795; Melcher T, 1996, NATURE, V379, P460, DOI 10.1038/379460a0; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Reenan RA, 2000, NEURON, V25, P139, DOI 10.1016/S0896-6273(00)80878-8; Rueter S.M., 1998, MODIFICATION EDITING, P343; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Villard L, 1997, SOMAT CELL MOLEC GEN, V23, P135, DOI 10.1007/BF02679972; WANG Y, 1995, J MOL BIOL, V254, P184, DOI 10.1006/jmbi.1995.0610; WISDEN W, 1994, IN SITU HYBRIDIZATIO, P9; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	27	696	719	0	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 6	2000	406	6791					78	81		10.1038/35017558	http://dx.doi.org/10.1038/35017558			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	330ZE	10894545				2022-12-24	WOS:000087991200048
J	Zhu, GF; Spellman, PT; Volpe, T; Brown, PO; Botstein, D; Davis, TN; Futcher, B				Zhu, GF; Spellman, PT; Volpe, T; Brown, PO; Botstein, D; Davis, TN; Futcher, B			Two yeast forkhead genes regulate the cell cycle and pseudohyphal growth	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; FILAMENTOUS GROWTH; TRANSCRIPTION; SWI5; HEAD; EXPRESSION; PROTEIN; KINASE; MCM1; CHITINASE	There are about 800 genes in Saccharomyces cerevisiae whose transcription is cell-cycle regulated(1,2). Some of these form clusters of co-regulated genes(1). The 'CLB2' cluster contains 33 genes whose transcription peaks early in mitosis, including CLB1, CLB2, SWI5, ACE2, CDC5, CDC20 and other genes important for mitosis(1). Here we rnd that the genes in this cluster lose their cell cycle regulation in a mutant that lacks two forkhead transcription factors, Fkh1 and Fkh2. Fkh2 protein is associated with the promoters of CLB2, SWI5 and other genes of the cluster. These results indicate that Fkh proteins are transcription factors for the CLB2 cluster. The fkh1 fkh2 mutant also displays aberrant regulation of the 'SIC1' cluster(1), whose member genes are expressed in the M-G1 interval and are involved in mitotic exit. This aberrant regulation may be due to aberrant expression of the transcription factors Swi5 and Ace2, which are members of the CLB2 cluster and controllers of the SIC1 cluster. Thus, a cascade of transcription factors operates late in the cell cycle. Finally, the fkh1 fkh2 mutant displays a constitutive pseudohyphal morphology, indicating that Fkh1 and Fkh2 may help control the switch to this mode of growth.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94306 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; Stanford Univ, Med Ctr, Dept Biochem, Stanford, CA 94306 USA	Cold Spring Harbor Laboratory; University of Washington; University of Washington Seattle; Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stanford University	Futcher, B (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.		Davis, Trisha/F-8584-2010	Davis, Trisha/0000-0003-4797-3152				ALTHOEFER H, 1995, MOL CELL BIOL, V15, P5917; AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; COGSWELL JP, 1995, MOL CELL BIOL, V15, P2782; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; Edgington NP, 1999, MOL CELL BIOL, V19, P1369; GIMENO CJ, 1994, MOL CELL BIOL, V14, P2100, DOI 10.1128/MCB.14.3.2100; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Grallert A, 1998, J BACTERIOL, V180, P892, DOI 10.1128/JB.180.4.892-900.1998; Hecht A, 1999, METHOD ENZYMOL, V304, P399; HWANG A, 1995, J BIOL CHEM, V270, P28419; Kaufmann E, 1996, MECH DEVELOP, V57, P3, DOI 10.1016/0925-4773(96)00539-4; King L, 1998, CURR GENET, V34, P183, DOI 10.1007/s002940050384; Knapp D, 1996, MOL CELL BIOL, V16, P5701; Kovacech B, 1996, MOL CELL BIOL, V16, P3264; KRON SJ, 1994, MOL BIOL CELL, V5, P1003, DOI 10.1091/mbc.5.9.1003; LAI E, 1993, P NATL ACAD SCI USA, V90, P10421, DOI 10.1073/pnas.90.22.10421; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; LYDALL D, 1991, GENE DEV, V5, P2405, DOI 10.1101/gad.5.12b.2405; MAHER M, 1995, MOL CELL BIOL, V15, P3129; MOLL T, 1991, CELL, V66, P743, DOI 10.1016/0092-8674(91)90118-I; OVERDIER DG, 1994, MOL CELL BIOL, V14, P2755, DOI 10.1128/MCB.14.4.2755; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; Zhu GF, 1998, BBA-MOL CELL RES, V1448, P236, DOI 10.1016/S0167-4889(98)00135-9	26	287	295	0	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 6	2000	406	6791					90	94		10.1038/35017581	http://dx.doi.org/10.1038/35017581			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	330ZE	10894548				2022-12-24	WOS:000087991200051
J	Meier, CR; Schlienger, RG; Kraenzlin, ME; Schlegel, B; Jick, H				Meier, CR; Schlienger, RG; Kraenzlin, ME; Schlegel, B; Jick, H			HMG-CoA reductase inhibitors and the risk of fractures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRACTICE RESEARCH DATABASE; CONTROLLED TRIALS; PREVENTION; METAANALYSIS; OSTEOPOROSIS; PRAVASTATIN; EXERCISE; THERAPY; STATINS; DISEASE	Context Recent animal studies have suggested that 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) increase bone formation, volume, and density. It is unknown whether use of statins is associated with a decreased risk of fractures in humans. Objective To determine whether exposure to statins, fibrates, or other lipid-lowering drugs is associated with reduced bone fracture risk. Design Population-based, nested case-control analysis. Setting The UK-based General Practice Research Database (GPRD), comprising some 300 practices, with data collection from the late 1980s until September 1998. Subjects Within a base population of 91 611 individuals aged at least 50 years (28340 individuals taking lipid-lowering drugs, 13 271 untreated individuals with a diagnosis of hyperlipidemia, and 50 000 randomly selected individuals without diagnosis of hyperlipidemia), we identified 3940 case patients who had a bone fracture and 23 379 control patients matched for age (+/-5 years), sex, general practice attended, calendar year, and years since enrollment in the GPRD, Main Outcome Measures Use of statins, fibrates, or other lipid-lowering drugs in case patients vs control patients. Results After controlling for body mass index, smoking, number of physician visits, and corticosteroid and estrogen use, current use of statins was associated with a significantly reduced fracture risk (adjusted odds ratio [OR], 0.55; 95% confidence interval [CI], 0.44-0.69) compared with nonuse of lipid-lowering drugs. Current use of fibrates or other lipid-lowering drugs was not related to a significantly decreased bone fracture risk (adjusted OR, 0.87; 95% CI, 0.70-1.08 and adjusted OR, 0.76; 95% CI, 0.41-1.39, respectively). Conclusions This study suggests that current exposure to statins is associated with a decreased risk of bone fractures in individuals age 50 years and older. This finding has a potentially important public health impact and should be confirmed further in controlled prospective trials.	Univ Basel Hosp, Div Clin Pharmacol, Basel Pharmacoepidemiol Unit, CH-4031 Basel, Switzerland; Univ Basel Hosp, Div Endocrinol Diabet Clin Nutr, CH-4031 Basel, Switzerland; Univ Basel, Inst Pharmacotherapy, Dept Pharm, Basel, Switzerland; Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA USA	University of Basel; University of Basel; University of Basel; Boston University	Meier, CR (corresponding author), Univ Basel Hosp, Div Clin Pharmacol, Basel Pharmacoepidemiol Unit, Petersgraben 4, CH-4031 Basel, Switzerland.	Christoph.Meier@unibas.ch	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; Jick, Hershel/0000-0003-4270-5992				Bauer DC, 1999, J BONE MINER RES, V14, pS179; BYINGTON RP, 1995, CIRCULATION, V92, P2419, DOI 10.1161/01.CIR.92.9.2419; Chung YS, 2000, J CLIN ENDOCR METAB, V85, P1137, DOI 10.1210/jcem.85.3.6476; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; CUI Q, 1997, CLIN ORTHOP RELAT R, V344, P8; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; GAMERO P, 1994, J CLIN ENDOCR METAB, V79, P1693; Jick H, 1997, LANCET, V350, P1045, DOI 10.1016/S0140-6736(05)70451-7; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H., 1992, PHARMACOEPIDEM DR S, V1, P347, DOI DOI 10.1002/PDS.2630010607; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Packard CJ, 1998, CIRCULATION, V97, P1440; PEDERSEN TR, 1994, LANCET, V344, P1383; PEDRAZZONI M, 1995, CALCIFIED TISSUE INT, V57, P25, DOI 10.1007/BF00298992; PRINCE RL, 1991, NEW ENGL J MED, V325, P1189, DOI 10.1056/NEJM199110243251701; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; WANG GJ, 1995, J FORMOS MED ASSOC, V94, P589; Wolff I, 1999, OSTEOPOROSIS INT, V9, P1, DOI 10.1007/s001980050109	21	391	427	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2000	283	24					3205	3210		10.1001/jama.283.24.3205	http://dx.doi.org/10.1001/jama.283.24.3205			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	326TY	10866867	Bronze			2022-12-24	WOS:000087753900032
J	Minkoff, H; Santoro, N				Minkoff, H; Santoro, N			Ethical considerations in the treatment of infertility in women with human immunodeficiency virus infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PELVIC INFLAMMATORY DISEASE; ANTIRETROVIRAL THERAPY; HIV-INFECTION; UNITED-STATES; TRANSMISSION; IMPACT; AIDS		Maimonides Hosp, Brooklyn, NY 11219 USA; Yeshiva Univ Albert Einstein Coll Med, Bronx, NY 10461 USA	Maimonides Medical Center; Yeshiva University; Albert Einstein College of Medicine	Minkoff, H (corresponding author), Maimonides Hosp, Brooklyn, NY 11219 USA.							American Society for Reproductive Medicine, 1993, FERTIL STERIL, V59, pS1; CARPENTER CC, 2000, JAMA-J AM MED ASSOC, V383, P381; CHERVENAK FA, 1992, CLIN OBSTET GYNECOL, V35, P709, DOI 10.1097/00003081-199212000-00003; Chirgwin KD, 1996, J ACQ IMMUN DEF SYND, V12, P489, DOI 10.1097/00042560-199608150-00008; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Grinspoon S, 1997, J CLIN ENDOCR METAB, V82, P3360; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; *INT PER HIV GROUP, 1915, NEW ENGL J MED, V340, P977; KAMENGA MC, 1995, AM J OBSTET GYNECOL, V172, P919, DOI 10.1016/0002-9378(95)90022-5; Karon JM, 1996, JAMA-J AM MED ASSOC, V276, P126, DOI 10.1001/jama.276.2.126; Kimani J, 1996, J INFECT DIS, V173, P1437, DOI 10.1093/infdis/173.6.1437; Lindegren ML, 1999, JAMA-J AM MED ASSOC, V282, P531, DOI 10.1001/jama.282.6.531; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Robertson JA., 1994, CHILDREN CHOICE FREE	17	45	45	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2000	342	23					1748	1750		10.1056/NEJM200006083422312	http://dx.doi.org/10.1056/NEJM200006083422312			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321HD	10841881				2022-12-24	WOS:000087449300012
J	Iribarren, C; Sidney, S; Sternfeld, B; Browner, WS				Iribarren, C; Sidney, S; Sternfeld, B; Browner, WS			Calcification of the aortic arch - Risk factors and association with coronary heart disease, stroke, and peripheral vascular disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BEAM COMPUTED-TOMOGRAPHY; BONE-MINERAL DENSITY; CARDIOVASCULAR MORTALITY; ATHEROSCLEROTIC PLAQUE; ARTERY CALCIFICATION; FOLLOW-UP; OSTEOPOROSIS; CALCIUM; EVENTS; WOMEN	Context Calcium deposits in coronary and extracoronary arterial beds may indicate the extent of atherosclerosis, However, the incremental predictive value of vascular calcification, beyond traditional coronary risk factors, is not clearly established. Objective To evaluate risk factors for aortic arch calcification and its long-term association with cardiovascular diseases in a population-based sample. Design and Setting Cohort study conducted at a health maintenance organization in northern California. Participants A total of 60 393 women and 55 916 men, aged 30 to 89 years at baseline who attended multiphasic health checkups between 1964 and 1973 and for whom incidence of hospitalizations and/or mortality data were ascertained using discharge diagnosis codes and death records through December 31, 1997 (median follow-up, 28 years). Main Outcome Measure Hospitalization for or death due to coronary heart disease, ischemic stroke, hemorrhagic stroke, or peripheral vascular disease, as associated with aortic arch calcification found on chest radiograph at checkup from 1964-1973. Results Aortic arch calcification was present in 1.9% of men and 2.6% of women. It was independently associated with older age, no college education, current smoking, and hypertension in both sexes, but it was inversely related to body mass index and family history of myocardial infarction. In women, aortic arch calcification was also associated with black race and elevated serum cholesterol level. After adjustment for age, educational attainment, race/ethnicity, cigarette smelting, alcohol consumption, body mass index, serum cholesterol level, hypertension, diabetes, and family history of myocardial infarction, aortic arch calcification was associated with an increased risk of coronary heart disease (in men, relative risk [RR], 1.27; 95% confidence interval [CI], 1.11-1.45; in women, RR, 1.22; 95% CI, 1.07-1.38). Among women, it was also independently associated with a 1.46-fold increased risk of ischemic stroke (95% CI, 1.28-1.67). Conclusion In our population-based cohort, aortic arch calcification was independently related to coronary heart disease risk in both sexes as well as to ischemic stroke risk in women.	Kaiser Permanente Med Care Program, Div Res, Oakland, CA 94611 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, Gen Internal Med Sect, San Francisco, CA 94143 USA; Dept Vet Affairs Med Ctr, San Francisco, CA USA	Kaiser Permanente; University of California System; University of California San Francisco	Iribarren, C (corresponding author), Kaiser Permanente Med Care Program, Div Res, 3505 Broadway, Oakland, CA 94611 USA.							Arad Y, 1996, CIRCULATION, V93, P1951, DOI 10.1161/01.CIR.93.11.1951; ARELLANO MG, 1984, AM J PUBLIC HEALTH, V74, P1324, DOI 10.2105/AJPH.74.12.1324; BANKS LM, 1994, EUR J CLIN INVEST, V24, P813, DOI 10.1111/j.1365-2362.1994.tb02024.x; BERLINER JA, 1995, CIRCULATION, V91, P2488, DOI 10.1161/01.CIR.91.9.2488; BLACKSHEAR JL, 1967, STROKE, V19, P86; Blankenhorn DH, 1961, AM J MED SCI, V42, P1; BOUKHRIS R, 1972, J AMER MED ASSOC, V219, P1307, DOI 10.1001/jama.219.10.1307; BROWNER WS, 1991, LANCET, V338, P355, DOI 10.1016/0140-6736(91)90489-C; Cohen A, 1997, CIRCULATION, V96, P3838; Cohen MF, 1978, MULTIPHASIC HLTH TES; COLLEN MF, 1969, JOM-J OCCUP MED, V11, P355; COX DR, 1972, J R STAT SOC B, V34, P187; Danielsen R, 1996, J CLIN EPIDEMIOL, V49, P383, DOI 10.1016/0895-4356(95)00547-1; Detrano R, 1992, Int J Card Imaging, V8, P209, DOI 10.1007/BF01146839; Detrano RC, 1999, CIRCULATION, V99, P2633, DOI 10.1161/01.CIR.99.20.2633; Drinka P J, 1992, Wis Med J, V91, P299; FRYE MA, 1992, BONE MINER, V19, P185, DOI 10.1016/0169-6009(92)90925-4; Giachelli CM, 1999, AM J PATHOL, V154, P671, DOI 10.1016/S0002-9440(10)65313-8; GORICH J, 1989, RADIOLOGE, V29, P614; GORMSEN H, 1984, FORENSIC SCI INT, V24, P51, DOI 10.1016/0379-0738(84)90151-8; Iribarren C, 1997, ARCH INTERN MED, V157, P873, DOI 10.1001/archinte.157.8.873; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; MOON J, 1992, J AM COLL NUTR, V11, P567; NAKAO J, 1979, ATHEROSCLEROSIS, V34, P469, DOI 10.1016/0021-9150(79)90071-6; *PRACT MAN INF COR, 1989, CLIN MOD INT CLASS D; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; Secci A, 1997, CIRCULATION, V96, P1122, DOI 10.1161/01.CIR.96.4.1122; Selby JV, 1996, NEW ENGL J MED, V335, P1888, DOI 10.1056/NEJM199612193352506; Shemesh J, 1997, OBSTET GYNECOL, V89, P989, DOI 10.1016/S0029-7844(97)00143-9; SHIBATA H, 1976, JPN HEART J, V17, P452; SIMON A, 1995, CIRCULATION, V92, P1414, DOI 10.1161/01.CIR.92.6.1414; TEALE C, 1989, AGE AGEING, V18, P333, DOI 10.1093/ageing/18.5.333; Vogt MT, 1997, J AM GERIATR SOC, V45, P140, DOI 10.1111/j.1532-5415.1997.tb04498.x; von der Recke P, 1999, AM J MED, V106, P273, DOI 10.1016/S0002-9343(99)00028-5; Watson KE, 1998, ARTERIOSCL THROM VAS, V18, P1964, DOI 10.1161/01.ATV.18.12.1964; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175; WILSON PWF, 1999, 39 ANN C CARD DIS EP; WITTEMAN JCM, 1986, LANCET, V2, P1120; Zabalgoitia M, 1998, ANN INTERN MED, V128, P639, DOI 10.7326/0003-4819-128-8-199804150-00005; [No title captured]	40	368	386	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2000	283	21					2810	2815		10.1001/jama.283.21.2810	http://dx.doi.org/10.1001/jama.283.21.2810			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BQ	10838649	Bronze			2022-12-24	WOS:000087381500035
J	Peluso, P; Herschlag, D; Nock, S; Freymann, DM; Johnson, AE; Walter, P				Peluso, P; Herschlag, D; Nock, S; Freymann, DM; Johnson, AE; Walter, P			Role of 4.5S RNA in assembly of the bacterial signal recognition particle with its receptor	SCIENCE			English	Article							ESCHERICHIA-COLI; GTPASE DOMAIN; NG DOMAIN; PROTEIN; FTSY; SEQUENCE; RIBONUCLEOPROTEIN; NUCLEOTIDES; STIMULATION; CONTAINS	The mechanism by which a signal recognition particle (SRP) and its receptor mediate protein targeting to the endoplasmic reticulum or to the bacterial plasma membrane is evolutionarily conserved. in Escherichia coli, this reaction is mediated by the Ffh/4.5S RNA ribonucleoprotein complex (Ffh/4.5S RNP; the SRP) and the FtsY protein (the SRP receptor). We have quantified the effects of 4.5S RNA on Ffh-FtsY complex formation by monitoring changes in tryptophan fluorescence. Surprisingly, 4.5S RNA facilitates both assembly and disassembly of the Ffh-FtsY complex to a similar extent. These results provide an example of an RNA molecule facilitating protein-protein interactions in a catalytic fashion.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; Texas A&M Univ, Syst Hlth Sci Ctr, College Stn, TX 77843 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Walter, P (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.		Johnson, Arthur E/G-3457-2012	Freymann, Douglas/0000-0002-5231-8841	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032384, R01GM032384, R01GM026494] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 32384, GM 26494] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; Fersht A., 1985, ENZYME STRUCTURE MEC; Freymann DM, 1997, NATURE, V385, P361, DOI 10.1038/385361a0; GOODY RS, 1991, TRENDS BIOCHEM SCI, V16, P327, DOI 10.1016/0968-0004(91)90134-H; Jagath JR, 1998, BIOCHEMISTRY-US, V37, P15408, DOI 10.1021/bi981523a; Jagath JR, 2000, J MOL BIOL, V295, P745, DOI 10.1006/jmbi.1999.3427; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; LUIRINK J, 1994, EMBO J, V13, P2289, DOI 10.1002/j.1460-2075.1994.tb06511.x; Macao B, 1997, MOL MICROBIOL, V24, P523, DOI 10.1046/j.1365-2958.1997.3551729.x; MILLER JD, 1994, NATURE, V367, P657, DOI 10.1038/367657a0; Montoya G, 1997, NATURE, V385, P365, DOI 10.1038/385365a0; Moser C, 1997, P NATL ACAD SCI USA, V94, P11339, DOI 10.1073/pnas.94.21.11339; PELUSO P, UNPUB; PHILLIPS GJ, 1992, NATURE, V359, P744, DOI 10.1038/359744a0; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; POWERS T, 1995, SCIENCE, V269, P1422, DOI 10.1126/science.7660124; RIBES V, 1990, CELL, V63, P591, DOI 10.1016/0092-8674(90)90454-M; ROMISCH K, 1989, NATURE, V340, P478, DOI 10.1038/340478a0; ROMISCH K, 1990, J CELL BIOL, V111, P1793, DOI 10.1083/jcb.111.5.1793; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Walter P, 2000, SCIENCE, V287, P1212, DOI 10.1126/science.287.5456.1212; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Wilson KS, 1998, CELL, V92, P337, DOI 10.1016/S0092-8674(00)80927-7; Zheng N, 1997, MOL CELL, V1, P79, DOI 10.1016/S1097-2765(00)80009-X; ZOPF D, 1990, EMBO J, V9, P4511, DOI 10.1002/j.1460-2075.1990.tb07902.x	27	122	122	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2000	288	5471					1640	1643		10.1126/science.288.5471.1640	http://dx.doi.org/10.1126/science.288.5471.1640			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	320BZ	10834842				2022-12-24	WOS:000087382300040
J	Cockcroft, CE; den Boer, BGW; Healy, JMS; Murray, JAH				Cockcroft, CE; den Boer, BGW; Healy, JMS; Murray, JAH			Cyclin D control of growth rate in plants	NATURE			English	Article							CELL-DIVISION; DEPENDENT KINASES; PHASE; COORDINATION; EXPRESSION; TRANSITION; SINAPIS; HOMOLOG; SYSTEM	The mechanisms by which plants modulate their growth rate in response to environmental and developmental conditions are unknown, but are presumed to involve specialized regions called meristems where cell division is concentrated(1-5), The possible role of cell division in influencing meristem activity and overall plant growth rate is controversial, with a prevailing view that cell division is secondary to higher order meristem controls(1,2,6,7). Here we show that a reduction in the length of the cell-cycle G1 phase and faster cell cycling occur when the rate of cell. division in transgenic tobacco plants is increased by the plant D-type cyclin CycD2 (ref. 8), The plants have normal cell and meristem sizes, but elevated overall growth rates, an increased rate of leaf initiation and accelerated development in all stages from seedling to maturity. We conclude that cell division is a principal determinant of meristem activity and overall growth rate, and propose that modulation of plant growth rate is achieved through regulation of G1.	Univ Cambridge, Inst Biotechnol, Cambridge CB2 1QT, England; Aventis Corp, B-9000 Ghent, Belgium	University of Cambridge	Murray, JAH (corresponding author), Univ Cambridge, Inst Biotechnol, Tennis Court Rd, Cambridge CB2 1QT, England.	j.murray@biotech.cam.ac.uk	Healy, Sandra J/D-5256-2013; Murray, James AH/D-3399-2009	Murray, James AH/0000-0002-2282-3839				BARLOW PW, 1994, LINNEAN SOC, P169; Bryant ja, 1985, CELL DIVISION CYCLE, P157; Clark SE, 1997, TRENDS CELL BIOL, V7, P454, DOI 10.1016/S0962-8924(97)01152-5; Clowes F. A. L., 1976, Cell division in higher plants., P253; Doerner P, 1996, NATURE, V380, P520, DOI 10.1038/380520a0; EVANS H. J., 1957, JOUR GENETICS, V55, P487, DOI 10.1007/BF02984066; Francis D, 1995, J EXP BOT, V46, P1887, DOI 10.1093/jxb/46.12.1887; FRANCIS D, 1988, SYM SOC EXP BIOL, V42, P181; Francis D, 1998, INHERENT VARIATION IN PLANT GROWTH, P5; GALLI M G, 1983, Plant Cell Reports, V2, P156, DOI 10.1007/BF00269343; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; GONTHIER R, 1985, PLANTA, V165, P288, DOI 10.1007/BF00395053; GONTHIER R, 1987, PLANTA, V170, P55, DOI 10.1007/BF00392381; HAGEMANN W, 1992, INT J PLANT SCI, V153, pS38, DOI 10.1086/297062; HEMERLY A, 1995, EMBO J, V14, P3925, DOI 10.1002/j.1460-2075.1995.tb00064.x; Kinsman EA, 1997, PLANT CELL ENVIRON, V20, P1309, DOI 10.1046/j.1365-3040.1997.d01-21.x; LYNDON RF, 1970, ANN BOT-LONDON, V34, P1; Lyndon RF, 1998, SHOOT APICAL MERISTE; Mironov V, 1999, PLANT CELL, V11, P509; Murray JAH, 1998, PORT PR R M, V10, P99; NASH R, 1988, EMBO J, V7, P4335, DOI 10.1002/j.1460-2075.1988.tb03332.x; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; PINES J, 1995, ADV CANCER RES, V66, P181, DOI 10.1016/S0065-230X(08)60254-7; Polymenis M, 1999, CURR OPIN GENET DEV, V9, P76, DOI 10.1016/S0959-437X(99)80011-2; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; RIOUKHAMLICHI C, IN PRESS MOL CELL BI; Setiady YY, 1996, PLANT CELL PHYSIOL, V37, P369, DOI 10.1093/oxfordjournals.pcp.a028955; SONI R, 1995, PLANT CELL, V7, P85, DOI 10.1105/tpc.7.1.85	30	253	283	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2000	405	6786					575	579		10.1038/35014621	http://dx.doi.org/10.1038/35014621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321HF	10850717				2022-12-24	WOS:000087449500052
J	Heisenberg, CP; Tada, M; Rauch, GJ; Saude, L; Concha, ML; Geisler, R; Stemple, DL; Smith, JC; Wilson, SW				Heisenberg, CP; Tada, M; Rauch, GJ; Saude, L; Concha, ML; Geisler, R; Stemple, DL; Smith, JC; Wilson, SW			Silberblick/Wnt11 mediates convergent extension movements during zebrafish gastrulation	NATURE			English	Article							DANIO-RERIO; SIGNALING PATHWAYS; XENOPUS EMBRYOS; BETA-CATENIN; CELL; MORPHOGENESIS; EXPRESSION; FOREBRAIN; WNT; OVEREXPRESSION	Vertebrate gastrulation involves the specification and coordinated movement of large populations of cells that give rise to the ectodermal, mesodermal and endodermal germ layers. Although many of the genes involved in the specification of cell identity during this process have been identified, little is known of the genes that coordinate cell movement. Here we show that the zebrafish silberblick (slb) locus(1) encodes Wnt11 and that Slb/Wnt11 activity is required for cells to undergo correct convergent extension movements during gastrulation. In the absence of Slb/Wnt11 function, abnormal extension of axial tissue results in cyclopia and other midline defects in the head(2). The requirement for Slb/Wnt11 is cell non-autonomous, and our results indicate that the correct extension of axial tissue is at least partly dependent on medio-lateral cell intercalation in paraxial tissue. We also show that the slb phenotype is rescued by a truncated form of Dishevelled that does not signal through the canonical Wnt pathway(3), suggesting that, as in flies(4), Wnt signalling might mediate morphogenetic events through a divergent signal transduction cascade. Our results provide genetic and experimental evidence that Wnt activity in lateral tissues has a crucial role in driving the convergent extension movements underlying vertebrate gastrulation.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Natl Inst Med Res, Div Dev Biol, London NW7 1AA, England; Max Planck Inst Entwicklungsbiol, Genet Abt, D-72076 Tubingen, Germany	University of London; University College London; MRC National Institute for Medical Research; Max Planck Society	Heisenberg, CP (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	c.heisenberg@ucl.ac.uk; mtada@nimr.mrc.ac.uk	Tada, Masazumi/A-1431-2009; Geisler, Robert/K-6201-2013; Saúde, Leonor/D-2720-2012; Wilson, Stephen W/B-9404-2008; Zebrafish, UCL/A-3125-2009; Concha, Miguel/I-2551-2013	Geisler, Robert/0000-0002-3909-8311; Saúde, Leonor/0000-0001-5933-8872; Wilson, Stephen W/0000-0002-8557-5940; Concha, Miguel/0000-0003-3353-9398; Heisenberg, Carl-Philipp/0000-0002-0912-4566				Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Boutros M, 1999, MECH DEVELOP, V83, P27, DOI 10.1016/S0925-4773(99)00046-5; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Concha ML, 1998, DEVELOPMENT, V125, P983; DU SJ, 1995, MOL CELL BIOL, V15, P2625; Elul T, 1997, DEV BIOL, V191, P243, DOI 10.1006/dbio.1997.8711; Glinka A, 1997, NATURE, V389, P517, DOI 10.1038/39092; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Heisenberg CP, 1996, DEVELOPMENT, V123, P191; Heisenberg CP, 1997, DEV BIOL, V184, P85, DOI 10.1006/dbio.1997.8511; KELLER R, 1992, DEVELOPMENT, P81; KIMMEL CB, 1994, DEVELOPMENT, V120, P265; Knapik EW, 1996, DEVELOPMENT, V123, P451; Kobayashi M, 1998, DEVELOPMENT, V125, P2973; Makita R, 1998, MECH DEVELOP, V71, P165, DOI 10.1016/S0925-4773(98)00013-6; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; MOON RT, 1993, DEVELOPMENT, V119, P97; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Pai LM, 1997, DEVELOPMENT, V124, P2255; Pelegri F, 1998, MECH DEVELOP, V77, P63, DOI 10.1016/S0925-4773(98)00132-4; RAUCH GJ, 1997, POLYMORPHIC ZEBRAFIS; SAUDE L, UNPUB DEVELOPMENT; SolnicaKrezel L, 1996, DEVELOPMENT, V123, P67; TADA M, IN PRESS DEVELOPMENT; UNGAR AR, 1995, MECH DEVELOP, V52, P153, DOI 10.1016/0925-4773(95)00386-F; WARGA RM, 1990, DEVELOPMENT, V108, P569; WILSON PA, 1989, DEVELOPMENT, V105, P155; Yamamoto A, 1998, DEVELOPMENT, V125, P3389	30	802	817	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2000	405	6782					76	81		10.1038/35011068	http://dx.doi.org/10.1038/35011068			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311TK	10811221				2022-12-24	WOS:000086901600054
J	Nakayama, J; Klar, AJS; Grewal, SIS				Nakayama, J; Klar, AJS; Grewal, SIS			A chromodomain protein, Swi6, performs imprinting functions in fission yeast during mitosis and meiosis	CELL			English	Article							MATING-TYPE LOCI; EPIGENETIC INHERITANCE; SCHIZOSACCHAROMYCES-POMBE; DNA METHYLATION; CHROMOSOME SEGREGATION; HETEROCHROMATIN; CHROMATIN; DROSOPHILA; REPRESSION; DOMAINS	Inheritance of stable states of gene expression is essential for cellular differentiation. In fission yeast, an epigenetic imprint marking the mating-type (mat2/3) region contributes to inheritance of the silenced state, but the nature of the imprint is not known. We show that a chromodomain-containing Swi6 protein is a dosage-critical component involved in imprinting the mat locus. Transient overexpression of Swi6 alters the epigenetic imprint at the mat2/3 region and heritably converts the expressed state to the silenced state. The establishment and maintenance of the imprint are tightly coupled to the recruitment and the persistence of Swi6 at the mat2/3 region during mitosis as well as meiosis. Remarkably, Swi6 remains bound to the mat2/3 interval throughout the cell cycle and itself seems to be a component of the imprint. Our analyses suggest that the unit of inheritance at the mat2/3 locus comprises the DNA plus the associated Swi6 protein complex.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; NCI, Frederick, MD 21702 USA	Cold Spring Harbor Laboratory; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	grewal@cshl.org	Nakayama, Jun-ichi/C-6003-2011	Nakayama, Jun-ichi/0000-0002-5597-8239; Grewal, Shiv/0000-0002-4552-9261	NIGMS NIH HHS [R01 GM59772-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059772] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Ainscough J. F. X., 1996, Epigenetic mechanisms of gene regulation., P173; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; ALLSHIRE RC, 1996, EPIGENETIC MECH GENE, P443; ANTEQUERA F, 1984, J BIOL CHEM, V259, P8033; Ayoub N, 1999, GENETICS, V152, P495; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; EGEL R, 1980, COLD SPRING HARB SYM, V45, P1003, DOI 10.1101/SQB.1981.045.01.116; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Ekwall K, 1996, J CELL SCI, V109, P2637; EKWALL K, 1999, CHROMOSOME STRUCTURA, P47; ENGELKE U, 1987, CURR GENET, V12, P535, DOI 10.1007/BF00419563; Grallert B, 1996, GENE DEV, V10, P2644, DOI 10.1101/gad.10.20.2644; Grewal SIS, 1998, GENETICS, V150, P563; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Grewal SIS, 1997, GENETICS, V146, P1221; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Ivanova AV, 1998, NAT GENET, V19, P192, DOI 10.1038/566; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Klar AJS, 1998, CIBA F SYMP, V214, P87; Klein CB, 1997, MUTAT RES-REV MUTAT, V386, P163, DOI 10.1016/S1383-5742(96)00052-X; LORENTZ A, 1994, GENE, V143, P139, DOI 10.1016/0378-1119(94)90619-X; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Maloisel L, 1998, GENE DEV, V12, P1381, DOI 10.1101/gad.12.9.1381; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Ogawa Y, 1999, MOL CELL BIOL, V19, P7228; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; Paro R, 1993, CURR OPIN CELL BIOL, V5, P999, DOI 10.1016/0955-0674(93)90084-4; Reik W, 1998, CURR OPIN GENET DEV, V8, P154, DOI 10.1016/S0959-437X(98)80136-6; Riggs A.D., 1996, EPIGENETIC MECH GENE, P231; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SINGH PB, 1994, J CELL SCI, V107, P2653; THON G, 1993, GENETICS, V134, P1045; THON G, 1992, GENETICS, V131, P287; Thon G, 1997, GENETICS, V145, P685; THON G, 1994, GENETICS, V138, P29; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; WRIGHT A, 1986, PLASMID, V15, P156, DOI 10.1016/0147-619X(86)90051-X	43	150	152	2	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 28	2000	101	3					307	317		10.1016/S0092-8674(00)80840-5	http://dx.doi.org/10.1016/S0092-8674(00)80840-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847685	Bronze			2022-12-24	WOS:000086741900010
J	Nelson, DC; Lasswell, J; Rogg, LE; Cohen, MA; Bartel, B				Nelson, DC; Lasswell, J; Rogg, LE; Cohen, MA; Bartel, B			FKF1, a clock-controlled gene that regulates the transition to flowering in Arabidopsis	CELL			English	Article							DISRUPTS CIRCADIAN-RHYTHMS; BLUE-LIGHT; HYPOCOTYL ELONGATION; MOLECULAR-BASES; F-BOX; PROTEIN; THALIANA; ENCODES; MUTANTS; PHYTOCHROME	Plant reproduction requires precise control of flowering in response to environmental cues. We isolated a late-flowering Arabidopsis mutant, fkf1, that is rescued by vernalization or gibberellin treatment. We positionally cloned FKF1, which encodes a novel protein with a PAS domain similar to the flavin-binding region of certain photoreceptors, an F box characteristic of proteins that direct ubiquitin-mediated degradation, and six kelch repeats predicted to fold into a beta propeller. FKF1 mRNA levels oscillate with a circadian rhythm, and deletion of FKF1 alters the waveform of rhythmic expression of two clock-controlled genes, implicating FKF1 in modulating the Arabidopsis circadian clock.	Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA	Rice University	Bartel, B (corresponding author), Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA.	bartel@rice.edu	Bartel, Bonnie/O-8119-2019; Bartel, Bonnie/D-3550-2011	Bartel, Bonnie/0000-0002-6367-346X; Bartel, Bonnie/0000-0002-6367-346X; Nelson, David/0000-0001-9792-5015	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM054749] Funding Source: NIH RePORTER; NIGMS NIH HHS [R29 GM054749-05, R29 GM054749-04, R29 GM54749] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Aukerman MJ, 1999, PLANT J, V18, P195, DOI 10.1046/j.1365-313X.1999.00442.x; Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Bagnall DJ, 1996, PLANTA, V200, P278, DOI 10.1007/BF00208319; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Ballario P, 1998, MOL MICROBIOL, V29, P719, DOI 10.1046/j.1365-2958.1998.00955.x; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; BARTEL B, 1994, P NATL ACAD SCI USA, V91, P6649, DOI 10.1073/pnas.91.14.6649; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; BOYLAN MT, 1991, P NATL ACAD SCI USA, V88, P10806, DOI 10.1073/pnas.88.23.10806; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; Bruggemann E, 1996, PLANT J, V10, P755, DOI 10.1046/j.1365-313X.1996.10040755.x; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chon ML, 1999, PLANT CELL PHYSIOL, V40, P702, DOI 10.1093/oxfordjournals.pcp.a029596; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Clough RC, 1997, PLANT CELL ENVIRON, V20, P713, DOI 10.1046/j.1365-3040.1997.d01-107.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Davies RT, 1999, PLANT CELL, V11, P365, DOI 10.1105/tpc.11.3.365; DEHIO C, 1994, P NATL ACAD SCI USA, V91, P5538, DOI 10.1073/pnas.91.12.5538; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; ESKINS K, 1992, PHYSIOL PLANTARUM, V86, P439, DOI 10.1111/j.1399-3054.1992.tb01341.x; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Frechilla S, 1999, PLANT CELL PHYSIOL, V40, P949, DOI 10.1093/oxfordjournals.pcp.a029627; Green RM, 1999, P NATL ACAD SCI USA, V96, P4176, DOI 10.1073/pnas.96.7.4176; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; HAUGHN GW, 1986, MOL GEN GENET, V204, P430, DOI 10.1007/BF00331020; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; Jarillo JA., 1998, PLANT PHYSIOL, V117, P719; JEFFERSON RA, 1987, EMBO J, V6, P3901; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, ANNU REV PLANT PHYS, V49, P345, DOI 10.1146/annurev.arplant.49.1.345; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Mengiste T, 1997, PLANT J, V12, P945, DOI 10.1046/j.1365-313X.1997.12040945.x; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; MILLAR AJ, 1991, PLANT CELL, V3, P541, DOI 10.1105/tpc.3.5.541; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; MINET M, 1992, PLANT J, V2, P417; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Natorff R, 1998, MOL GEN GENET, V257, P255, DOI 10.1007/s004380050646; Neff MM, 2000, GENE DEV, V14, P257; Nozue K, 1998, P NATL ACAD SCI USA, V95, P15826, DOI 10.1073/pnas.95.26.15826; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; REDEI GP, 1962, GENETICS, V47, P443; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Samach A, 1999, PLANT J, V20, P433, DOI 10.1046/j.1365-313x.1999.00617.x; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Simpson GG, 1999, ANNU REV CELL DEV BI, V15, P519, DOI 10.1146/annurev.cellbio.15.1.519; Somers DE, 1999, PLANT PHYSIOL, V121, P9, DOI 10.1104/pp.121.1.9; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 1998, DEVELOPMENT, V125, P485; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Swarup K, 1999, PLANT J, V20, P67, DOI 10.1046/j.1365-313X.1999.00577.x; THOMPSON AH, 1995, CAN J PSYCHIAT, V40, P15, DOI 10.1177/070674379504000106; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; XUE FY, 1993, CELL, V72, P681, DOI 10.1016/0092-8674(93)90397-9; Zagotta MT, 1996, PLANT J, V10, P691, DOI 10.1046/j.1365-313X.1996.10040691.x; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6; Zhulin IB, 1997, TRENDS BIOCHEM SCI, V22, P331, DOI 10.1016/S0968-0004(97)01110-9	74	361	400	3	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 28	2000	101	3					331	340		10.1016/S0092-8674(00)80842-9	http://dx.doi.org/10.1016/S0092-8674(00)80842-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	308ZC	10847687	Bronze			2022-12-24	WOS:000086741900012
J	Pickup, J				Pickup, J			Sensitive glucose sensing in diabetes	LANCET			English	Editorial Material							BLOOD		Guys Hosp, Guys Kings & St Thomas Sch Med, Dept Chem Pathol, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Pickup, J (corresponding author), Guys Hosp, Guys Kings & St Thomas Sch Med, Dept Chem Pathol, London SE1 9RT, England.							Garg SK, 1999, DIABETES CARE, V22, P1708, DOI 10.2337/diacare.22.10.1708; Mastrototaro J, 1998, DIABETES, V47, pA61; Pickup J, 1999, BRIT MED J, V319, P1289, DOI 10.1136/bmj.319.7220.1289; PICKUP JC, 1993, DIABETES CARE, V16, P535, DOI 10.2337/diacare.16.2.535; Rebrin K, 1999, AM J PHYSIOL-ENDOC M, V277, pE561, DOI 10.1152/ajpendo.1999.277.3.E561; Sternberg F, 1996, DIABETOLOGIA, V39, P609, DOI 10.1007/BF00403309; Tamada JA, 1999, JAMA-J AM MED ASSOC, V282, P1839, DOI 10.1001/jama.282.19.1839; TAMADA JA, 1995, NAT MED, V1, P1198, DOI 10.1038/nm1195-1198; ThomeDuret V, 1996, ANAL CHEM, V68, P3822, DOI 10.1021/ac960069i	9	26	27	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 5	2000	355	9202					426	427						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	283ZW	10841120				2022-12-24	WOS:000085306800006
J	Lopez-Coviella, I; Berse, B; Krauss, R; Thies, RS; Blusztajn, JK				Lopez-Coviella, I; Berse, B; Krauss, R; Thies, RS; Blusztajn, JK			Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9	SCIENCE			English	Article							BONE MORPHOGENETIC PROTEINS; NEURAL CREST CULTURES; SPINAL-CORD; DOPAMINERGIC-NEURONS; SIGNALING PATHWAYS; ADRENERGIC CELLS; BASAL FOREBRAIN; GROWTH-FACTOR; EXPRESSION; DIFFERENTIATION	Bone morphogenetic proteins (BMPs) have multiple functions in the developing nervous system. A member of this family, BMP-9, was found to be highly expressed in the embryonic mouse septum and spinal cord, indicating a possible role in regulating the cholinergic phenotype. In cultured neurons, BMP-9 directly induced the expression of the cholinergic gene locus encoding choline acetyltransferase and the vesicular acetylcholine transporter and up-regulated acetylcholine synthesis. The effect was reversed upon withdrawal of BMP-9. Intracerebroventricular injection of BMP-9 increased acetylcholine levels in vivo. Although certain other BMPs also up-regulated the cholinergic phenotype in vitro, they were less effective than BMP-9. These data indicate that BMP-9 is a differentiating factor for cholinergic central nervous system neurons.	Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; Genet Inst, Cambridge, MA 02140 USA	Boston University; Boston University	Blusztajn, JK (corresponding author), Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA.			/0000-0001-8438-3122; Berse, Brygida/0000-0002-0735-2792	NATIONAL INSTITUTE ON AGING [P01AG009525] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG09525] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson DJ, 1997, COLD SPRING HARB SYM, V62, P493; Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Berse B, 1999, BIOCHEM J, V342, P301, DOI 10.1042/0264-6021:3420301; BERSE B, 1995, J BIOL CHEM, V270, P22101, DOI 10.1074/jbc.270.38.22101; Ericson J, 1998, DEVELOPMENT, V125, P1005; FANN MJ, 1994, J NEUROCHEM, V63, P2074; Galter D, 1999, EUR J NEUROSCI, V11, P2444, DOI 10.1046/j.1460-9568.1999.00667.x; Greenwood AL, 1999, DEVELOPMENT, V126, P3545; Hattori A, 1999, J NEUROCHEM, V72, P2264, DOI 10.1046/j.1471-4159.1999.0722264.x; Helm GA, 2000, J NEUROSURG, V92, P191, DOI 10.3171/spi.2000.92.2.0191; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Jordan J, 1997, EUR J NEUROSCI, V9, P1699, DOI 10.1111/j.1460-9568.1997.tb01527.x; Kalyani AJ, 1998, J NEUROSCI, V18, P7856; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Li WW, 2000, DEV NEUROSCI-BASEL, V22, P68, DOI 10.1159/000017428; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Lo LC, 1998, DEVELOPMENT, V125, P609; Mabie PC, 1999, J NEUROSCI, V19, P7077, DOI 10.1523/JNEUROSCI.19-16-07077.1999; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Ploemacher RE, 1999, LEUKEMIA, V13, P428, DOI 10.1038/sj.leu.2401363; Reiriz J, 1999, J NEUROBIOL, V38, P161, DOI 10.1002/(SICI)1097-4695(19990205)38:2<161::AID-NEU1>3.3.CO;2-V; Reissmann E, 1996, DEVELOPMENT, V122, P2079; SCHAMBRA UB, 1989, J COMP NEUROL, V288, P101, DOI 10.1002/cne.902880109; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369; Soderstrom S, 1996, CELL TISSUE RES, V286, P269, DOI 10.1007/s004410050697; SOFRONIEW MV, 1990, SCIENCE, V247, P338, DOI 10.1126/science.1688664; SONG JJ, 1995, ENDOCRINOLOGY, V136, P4293, DOI 10.1210/en.136.10.4293; Streit A, 1999, MECH DEVELOP, V82, P51, DOI 10.1016/S0925-4773(99)00013-1; SWEENEY JE, 1989, NEUROSCIENCE, V31, P413, DOI 10.1016/0306-4522(89)90384-9; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Varley JE, 1998, DEV BIOL, V196, P107, DOI 10.1006/dbio.1998.8853; Varley JE, 1996, EXP NEUROL, V140, P84, DOI 10.1006/exnr.1996.0118; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	38	184	215	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2000	289	5477					313	316		10.1126/science.289.5477.313	http://dx.doi.org/10.1126/science.289.5477.313			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	334DB	10894782				2022-12-24	WOS:000088169400046
J	Loftus, TM; Jaworsky, DE; Frehywot, GL; Townsend, CA; Ronnett, GV; Lane, MD; Kuhajda, FP				Loftus, TM; Jaworsky, DE; Frehywot, GL; Townsend, CA; Ronnett, GV; Lane, MD; Kuhajda, FP			Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors	SCIENCE			English	Article							MALONYL-COA; OXIDATION; GLUCOSE; GENE; KETOGENESIS; EXPRESSION	With the escalation of obesity-related disease, there is great interest in defining the mechanisms that control appetite and body weight. We have identified a link between anabolic energy metabolism and appetite control. Both systemic and intracerebroventricular treatment of mice with fatty acid synthase (FAS) inhibitors (cerulenin and a synthetic compound C75) Led to inhibition of feeding and dramatic weight Loss. C75 inhibited expression of the prophagic signal neuropeptide Y in the hypothalamus and acted in a leptin-independent manner that appears to be mediated by malonyl-coenzyme A. Thus, FAS may represent an important Link in feeding regulation and may be a potential therapeutic target.	Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Kuhajda, FP (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002979] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC02979] Funding Source: Medline; NIDDK NIH HHS [DK09623] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BORISYRUDIN F, UNPUB; Grossman BM, 1997, PHYSIOL BEHAV, V61, P169, DOI 10.1016/S0031-9384(96)00368-X; HALVORSON DL, 1984, LIPIDS, V19, P851, DOI 10.1007/BF02534514; KUHAJDA F, UNPUB; Kusakabe T, 2000, J HISTOCHEM CYTOCHEM, V48, P613, DOI 10.1177/002215540004800505; Loftus TM, 1999, SEMIN CELL DEV BIOL, V10, P11, DOI 10.1006/scdb.1998.0274; MARAGOUDAKIS ME, 1972, J BIOL CHEM, V247, P342; MCGARRY JD, 1979, J BIOL CHEM, V254, P8163; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; Moche M, 1999, J BIOL CHEM, V274, P6031, DOI 10.1074/jbc.274.10.6031; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; OShea D, 1997, ENDOCRINOLOGY, V138, P196, DOI 10.1210/en.138.1.196; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Scharrer E, 1999, NUTRITION, V15, P704, DOI 10.1016/S0899-9007(99)00125-2; Schwartz MW, 1998, ENDOCRINOLOGY, V139, P2629, DOI 10.1210/en.139.5.2629; Schwartz MW, 1996, DIABETES, V45, P531, DOI 10.2337/diabetes.45.4.531; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Yang XJ, 1999, DIABETES, V48, P1763, DOI 10.2337/diabetes.48.9.1763; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	19	762	838	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 30	2000	288	5475					2379	2381		10.1126/science.288.5475.2379	http://dx.doi.org/10.1126/science.288.5475.2379			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	329NP	10875926				2022-12-24	WOS:000087913400044
J	Wong, CS; Jelacic, S; Habeeb, RL; Watkins, SL; Tarr, PI				Wong, CS; Jelacic, S; Habeeb, RL; Watkins, SL; Tarr, PI			The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157 : H7 infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	35th United States -Japan Cholera and related diarrheal Disease Conference	DEC 03-05, 1999	BALTIMORE, MARYLAND				HEMORRHAGIC COLITIS; SUBINHIBITORY CONCENTRATIONS; NURSING-HOME; TOXIN; OUTBREAK; GASTROENTERITIS; ENTERITIS; DIARRHEA; THERAPY; DISEASE	Background: Children with gastrointestinal infections caused by Escherichia coli O157:H7 are at risk for the hemolytic-uremic syndrome. Whether antibiotics alter this risk is unknown. Methods: We conducted a prospective cohort study of 71 children younger than 10 years of age who had diarrhea caused by E. coli O157:H7 to assess whether antibiotic treatment in these children affects the risk of the hemolytic-uremic syndrome and to assess the influence of confounding factors on this outcome. Estimates of relative risks were adjusted for possible confounding effects with the use of logistic-regression analysis. Results: Among the 71 children, 9 (13 percent) received antibiotics and the hemolytic-uremic syndrome developed in 10 (14 percent). Five of these 10 children had received antibiotics. Factors significantly associated with the hemolytic-uremic syndrome were a higher initial white-cell count (relative risk, 1.3; 95 percent confidence interval, 1.1 to 1.5), evaluation with stool culture soon after the onset of illness (relative risk, 0.3; 95 percent confidence interval, 0.2 to 0.8), and treatment with antibiotics (relative risk, 14.3; 95 percent confidence interval, 2.9 to 70.7). The clinical and laboratory characteristics of the 9 children who received antibiotics and the 62 who did not receive antibiotics were similar. In a multivariate analysis that was adjusted for the initial white-cell count and the day of illness on which stool was obtained for culture, antibiotic administration remained a risk factor for the development of the hemolytic-uremic syndrome (relative risk, 17.3; 95 percent confidence interval, 2.2 to 137). Conclusions: Antibiotic treatment of children with E. coli O157:H7 infection increases the risk of the hemolytic-uremic syndrome. (N Engl J Med 2000;342:1930-6.) (C)2000, Massachusetts Medical Society.	Childrens Hosp & Reg Med Ctr, Div Gastroenterol, Seattle, WA 98105 USA; Univ Washington, Sch Med, Seattle, WA USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle	Tarr, PI (corresponding author), Childrens Hosp & Reg Med Ctr, Div Gastroenterol, CH-24,4800 Sand Point Way NE, Seattle, WA 98105 USA.			Jelacic, Srdjan/0000-0002-6617-9870	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052081] Funding Source: NIH RePORTER; NIDDK NIH HHS [1RO1DK52081, R01 DK052081] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2000, M2A7 NCCLS; BELL BP, 1997, PEDIATRICS, V100, P127; CARTER AO, 1987, NEW ENGL J MED, V317, P1496, DOI 10.1056/NEJM198712103172403; Chisaki Takafumi, 1997, Japanese Journal of Antibiotics, V50, P821; CIMOLAI N, 1992, PEDIATRICS, V90, P616; CIMOLAI N, 1990, J PEDIATR-US, V116, P589, DOI 10.1016/S0022-3476(05)81609-9; CIMOLAI N, 1994, CLIN NEPHROL, V42, P85; Cimolai N, 1990, J PEDIATR, V116, P1008; Colton T, 1974, STAT MED; Dryden MS, 1996, CLIN INFECT DIS, V22, P1019, DOI 10.1093/clinids/22.6.1019; Fukushima H, 1999, PEDIATR INT, V41, P213, DOI 10.1046/j.1442-200X.1999.4121041.x; GOODMAN LJ, 1990, ARCH INTERN MED, V150, P541, DOI 10.1001/archinte.150.3.541; Grif K, 1998, EUR J CLIN MICROBIOL, V17, P761, DOI 10.1007/s100960050181; Higami S, 1998, Kansenshogaku Zasshi, V72, P266; Igarashi T, 1999, J PEDIATR-US, V135, P768, DOI 10.1016/S0022-3476(99)70100-9; Ikeda K, 1999, CLIN NEPHROL, V52, P357; KARCH H, 1986, FEMS MICROBIOL LETT, V35, P141, DOI 10.1016/0378-1097(86)90080-7; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; KARMALI MA, 1983, LANCET, V1, P619, DOI 10.1016/s0140-6736(83)91795-6; Kawamura N, 1999, PEDIATR INT, V41, P218, DOI 10.1046/j.1442-200X.1999.4121040.x; Kimmitt PT, 1999, LANCET, V353, P1588, DOI 10.1016/S0140-6736(99)00621-2; Kohsaka T, 1997, Nihon Rinsho, V55, P706; MARCH SB, 1986, J CLIN MICROBIOL, V23, P869, DOI 10.1128/JCM.23.5.869-872.1986; Moriguchi Naohiko, 1997, Japanese Journal of Antibiotics, V50, P591; Neil M.A., 1998, ESCHERICHIA COLI O15, P357; Oshima Toshio, 1997, Japanese Journal of Antibiotics, V50, P855; OSTROFF SM, 1989, JAMA-J AM MED ASSOC, V262, P355, DOI 10.1001/jama.262.3.355; PAVIA AT, 1990, J PEDIATR-US, V116, P544, DOI 10.1016/S0022-3476(05)81600-2; PROULX F, 1992, J PEDIATR-US, V121, P299, DOI 10.1016/S0022-3476(05)81209-0; Rowe PC, 1998, J PEDIATR-US, V132, P777, DOI 10.1016/S0022-3476(98)70303-8; RYAN CA, 1986, J INFECT DIS, V154, P631, DOI 10.1093/infdis/154.4.631; Shiomi M, 1999, PEDIATR INT, V41, P228, DOI 10.1046/j.1442-200X.1999.4121038.x; Slutsker L, 1998, J INFECT DIS, V177, P962, DOI 10.1086/515258; TARR PI, 1990, J INFECT DIS, V162, P553, DOI 10.1093/infdis/162.2.553; WALTERSPIEL JN, 1992, INFECTION, V20, P25, DOI 10.1007/BF01704889; WISTROM J, 1992, ANN INTERN MED, V117, P202, DOI 10.7326/0003-4819-117-3-202; Yoh M, 1997, Kansenshogaku Zasshi, V71, P1144	37	704	752	1	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2000	342	26					1930	1936		10.1056/NEJM200006293422601	http://dx.doi.org/10.1056/NEJM200006293422601			7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328TZ	10874060	Green Accepted, Bronze			2022-12-24	WOS:000087867400001
J	Piot, P				Piot, P			Global AIDS epidemic: Time to turn the tide	SCIENCE			English	Editorial Material								HIV/AIDS is catastrophic both from a public health perspective and in terms of its impact on economic and social stability in many of the most severely affected nations, including virtually all of southern Africa. A public health response alone is insufficient to address this devastating epidemic. Political Leadership at the highest Levels is needed to mobilize a multisectoral response to the impact of HIV/AIDS on educational systems, industry, agriculture, the military, and other sectors. With a few notable exceptions, political response was slow to mobilize in the early years of the epidemic, but response has dramatically improved in the past 18 months. The Joint United Nations Programme on HIV/AIDS (UNAIDS) is involved in ongoing efforts to encourage political Leaders to make a multisectoral response to the epidemic a major focus of their national plans.	Joint United Nations Programme HIV AIDS, Geneva 27, Switzerland		Piot, P (corresponding author), Joint United Nations Programme HIV AIDS, 20 Ave Appla, Geneva 27, Switzerland.							*UNAIDS, 2000, REP GLOB HIV AIDS EP	1	27	27	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2176	2178		10.1126/science.288.5474.2176	http://dx.doi.org/10.1126/science.288.5474.2176			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10864860				2022-12-24	WOS:000087782900049
J	Raman, V; Martensen, SA; Reisman, D; Evron, E; Odenwald, WF; Jaffee, E; Marks, J; Sukumar, S				Raman, V; Martensen, SA; Reisman, D; Evron, E; Odenwald, WF; Jaffee, E; Marks, J; Sukumar, S			Compromised HOXA5 function can limit p53 expression in human breast tumours	NATURE			English	Article							REGULATORY REGIONS; GENE-EXPRESSION; CANCER; MUTATIONS; APOPTOSIS; ASSAY	Expression of the p53 gene protects cells against malignant transformation(1,2). Whereas control of p53 degradation has been a subject of intense scrutiny, little is known about the factors that regulate p53 synthesis(1,2). Here we show that p53 messenger RNA levels are low in a large proportion of breast tumours. Seeking potential regulators of p53 transcription, we found consensus HOX binding sites(3,4) in the p53 promoter(5). Transient transfection of Hox/HOXA5 activated the p53 promoter. Expression of HOXA5 in epithelial cancer cells expressing wild-type p53, but not in isogenic variants lacking the p53 gene(6), led to apoptotic cell death. Moreover, breast cancer cell lines and patient tumours display a coordinate loss of p53 and HOXA5 mRNA and protein expression. The HOXA5 promoter region was methylated in 16 out of 20 p53-negative breast tumour specimens. We conclude that loss of expression of p53 in human breast cancer may be primarily due to lack of expression of HOXA5.	Johns Hopkins Oncol Ctr, Breast Canc Program, Baltimore, MD 21231 USA; Univ S Carolina, Columbia, SC 29208 USA; NIH, Bethesda, MD 20892 USA; Duke Univ, Med Ctr, Durham, NC 27710 USA	Johns Hopkins University; Johns Hopkins Medicine; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; National Institutes of Health (NIH) - USA; Duke University	Sukumar, S (corresponding author), Johns Hopkins Oncol Ctr, Breast Canc Program, Baltimore, MD 21231 USA.			Evron, Ella/0000-0002-1003-5042; Jaffee, Elizabeth/0000-0003-3841-6549				Aubin J, 1998, DEV DYNAM, V212, P141, DOI 10.1002/(SICI)1097-0177(199805)212:1<141::AID-AJA13>3.0.CO;2-A; Bates S, 1999, CELL MOL LIFE SCI, V55, P28, DOI 10.1007/s000180050267; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Care A, 1996, MOL CELL BIOL, V16, P4842; Chariot A, 1996, BIOCHEM BIOPH RES CO, V222, P292, DOI 10.1006/bbrc.1996.0737; CILLO C, 1992, INT J CANCER, V51, P892, DOI 10.1002/ijc.2910510610; Cillo C, 1999, EXP CELL RES, V248, P1, DOI 10.1006/excr.1999.4451; DESCHAMPS J, 1992, Critical Reviews in Oncogenesis, V3, P117; DEVITA G, 1993, EUR J CANCER, V29A, P887, DOI 10.1016/S0959-8049(05)80432-0; GLEBOV OK, 1994, CANCER RES, V54, P3703; Gottlieb E, 1997, EMBO J, V16, P1381, DOI 10.1093/emboj/16.6.1381; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Larochelle C, 1999, DEV DYNAM, V214, P127, DOI 10.1002/(SICI)1097-0177(199902)214:2<127::AID-AJA3>3.0.CO;2-F; Li F, 1997, J BIOL CHEM, V272, P30299, DOI 10.1074/jbc.272.48.30299; PELLERIN I, 1994, MOL CELL BIOL, V14, P4532, DOI 10.1128/MCB.14.7.4532; Pharoah PDP, 1999, BRIT J CANCER, V80, P1968, DOI 10.1038/sj.bjc.6690628; Prives C, 1999, J PATHOL, V187, P112; RAMAN V, 1993, INT J DEV BIOL, V37, P499; Reisman D, 1998, SEMIN CANCER BIOL, V8, P317, DOI 10.1006/scbi.1998.0094; REISMAN D, 1988, P NATL ACAD SCI USA, V85, P5146, DOI 10.1073/pnas.85.14.5146; RUNNEBAUM IB, 1991, P NATL ACAD SCI USA, V88, P10657, DOI 10.1073/pnas.88.23.10657; Scott MP, 1997, NAT GENET, V15, P117, DOI 10.1038/ng0297-117; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; Snedecor GW, 1982, STAT METHODS, V8th; Venkatachalam S, 1998, EMBO J, V17, P4657, DOI 10.1093/emboj/17.16.4657; Zhao JJG, 1996, EMBO J, V15, P1313, DOI 10.1002/j.1460-2075.1996.tb00473.x	28	387	422	1	26	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2000	405	6789					974	978		10.1038/35016125	http://dx.doi.org/10.1038/35016125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	326JT	10879542				2022-12-24	WOS:000087732700057
J	Bell, MH				Bell, MH			Blood lines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2000	283	23					3043	3044		10.1001/jama.283.23.3043	http://dx.doi.org/10.1001/jama.283.23.3043			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	323PV	10865280				2022-12-24	WOS:000087574900001
J	Herwaldt, BL; de Arroyave, KR; Roberts, JM; Juranek, DD				Herwaldt, BL; de Arroyave, KR; Roberts, JM; Juranek, DD			A multiyear prospective study of the risk factors for and incidence of diarrheal illness in a cohort of peace corps volunteers in Guatemala	ANNALS OF INTERNAL MEDICINE			English	Article							TRAVELERS DIARRHEA; DEVELOPING-COUNTRIES; FOOD-CONSUMPTION; UNITED-STATES; MEXICO; EPIDEMIOLOGY; PREVENTION; POPULATION; RESIDENTS; LOCATION	Background: Diarrheal illness is the most common medical disorder among travelers from developed to developing countries and is common among expatriate residents in developing countries. Objective: To assess the risk factors for and incidence of diarrheal illness among Americans living in a developing country. Design: Prospective longitudinal study. Setting: Rural Guatemala. Patients: Cohort of 36 Peace Corps volunteers. Measurements: Collection of daily dietary and symptom data for more than 2 years; identification by multivariate Poisson regression analyses of risk factors for clinically defined episodes of diarrheal illness. Results: The 36 Peace Corps volunteers in this study had 307 diarrheal episodes (median, 7 per person), which lasted a median of 4 days (range, 1 to 112) and a total of 10.1% of the 23 689 person-days in the study. The incidence density (episodes per person-year) was 4.7 for the study as a whole, 6.1 for the first 6-month period, 5.2 for the second 6-month period, and 3.6 thereafter. Statistically significant risk factors for diarrheal illness included drinking water whose source (for example, the tap) and, therefore, quality, was unknown to the person; eating food prepared by a Guatemalan friend or family; eating food at a small, working-class restaurant; eating fruit peeled by someone other than a Peace Corps volunteer; drinking an iced beverage; and eating ice cream, ice milk, or flavored ices. The relative risks comparing the presence of these exposures during the first 6-month period overseas with their absence during the second year of residence ranged from 1.90 to 2.67, and the summary attributable risk percentage (that is, the percentage of diarrheal episodes that could be ascribed to the exposures) was 75.4%. Exposures generally were riskier if they occurred during travel elsewhere in Guatemala rather than in the person's usual work area. Conclusions: Diarrheal illness of mild-to-moderate severity continued to occur throughout Peace Corps service but decreased in incidence as length of stay increased. Various dietary behaviors increased the risk for diarrheal illness, which suggests that avoidance of potentially risky foods and beverages is beneficial.	Ctr Dis Control & Prevent, Div Parasit Dis, Atlanta, GA 30341 USA; Peace Corps Med Off, Guatemala City, Guatemala	Centers for Disease Control & Prevention - USA	Herwaldt, BL (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis, 4770 Buford Highway NE,Mailstop F22, Atlanta, GA 30341 USA.	bxh4@cdc.gov						Ansdell VE, 1999, MED CLIN N AM, V83, P945; BERNARD KW, 1989, INT J EPIDEMIOL, V18, P220, DOI 10.1093/ije/18.1.220; BLASER MJ, 1986, REV INFECT DIS, V8, pS142; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; BRYANT HE, 1991, CAN J PUBLIC HEALTH, V82, P316; CHANG TW, 1978, ANN INTERN MED, V89, P428, DOI 10.7326/0003-4819-89-3-428_2; DUPONT HL, 1977, AM J EPIDEMIOL, V105, P37, DOI 10.1093/oxfordjournals.aje.a112353; ERICSSON CD, 1980, GASTROENTEROLOGY, V79, P812; Hoge CW, 1996, JAMA-J AM MED ASSOC, V275, P533, DOI 10.1001/jama.275.7.533; KOZICKI M, 1985, INT J EPIDEMIOL, V14, P169, DOI 10.1093/ije/14.1.169; LOEWENSTEIN MS, 1973, LANCET, V1, P529; Mattila, 1995, J Travel Med, V2, P77, DOI 10.1111/j.1708-8305.1995.tb00631.x; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; MERSON MH, 1976, NEW ENGL J MED, V294, P1299, DOI 10.1056/NEJM197606102942401; MONTO AS, 1980, AM J EPIDEMIOL, V112, P323, DOI 10.1093/oxfordjournals.aje.a112998; PELTOLA H, 1997, TXB TRAVEL MED HLTH, P78; Shlim DR, 1999, CLIN INFECT DIS, V29, P613, DOI 10.1086/598642; STEFFEN R, 1986, REV INFECT DIS, V8, pS122; STEFFEN R, 1983, JAMA-J AM MED ASSOC, V249, P1176; Steffen R, 1999, JAMA-J AM MED ASSOC, V281, P811, DOI 10.1001/jama.281.9.811; STEFFEN R, 1987, J INFECT DIS, V156, P84, DOI 10.1093/infdis/156.1.84; TJOA WS, 1977, AM J EPIDEMIOL, V106, P61, DOI 10.1093/oxfordjournals.aje.a112433; VOLLET JJ, 1979, J MED VIROL, V4, P81, DOI 10.1002/jmv.1890040202; White GC, 1999, HDB CHLORINATION ALT, P331; WOOD LV, 1983, APPL ENVIRON MICROB, V46, P328, DOI 10.1128/AEM.46.2.328-332.1983	25	27	27	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2000	132	12					982	988		10.7326/0003-4819-132-12-200006200-00009	http://dx.doi.org/10.7326/0003-4819-132-12-200006200-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325HU	10858182				2022-12-24	WOS:000087670800008
J	Hu, FB; Stampfer, MJ; Colditz, GA; Ascherio, A; Rexrode, KM; Willett, WC; Manson, JE				Hu, FB; Stampfer, MJ; Colditz, GA; Ascherio, A; Rexrode, KM; Willett, WC; Manson, JE			Physical activity and risk of stroke in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; MIDDLE-AGED MEN; ACTIVITY QUESTIONNAIRE; ISCHEMIC STROKE; PREVENTION; EXERCISE; WALKING; MORTALITY; PROGRAM; WEIGHT	Context Persuasive evidence has demonstrated that increased physical activity is associated with substantial reduction in risk of coronary heart disease. However, the role of physical activity in the prevention of stroke is less well established. Objective To examine the association between physical activity and risk of total stroke and stroke subtypes in women. Design and Setting The Nurses' Health Study, a prospective cohort study of subjects residing in 11 US states. Subjects A total of 72 488 female nurses aged 40 to 65 years who did not have diagnosed cardiovascular disease or cancer at baseline in 1986 and who completed detailed physical activity questionnaires in 1986, 1988, and 1992. Main Outcome Measure Incident stroke occurring between baseline and June 1, 1994, compared among quintiles of physical activity level as measured by metabolic equivalent tasks (METs) in hours per week. Results During 8 years (560087 person-years) of follow-up, we documented 407 incident cases of stroke (258 ischemic strokes, 67 subarachnoid hemorrhages, 42 intracerebral hemorrhages, and 40 strokes of unknown type). In multivariate analyses controlling for age, body mass index, history of hypertension, and other covariates, increasing physical activity was strongly inversely associated with risk of total stroke. Relative risks (RRs) in the lowest to highest MET quintiles were 1.00, 0.98, 0.82, 0.74, and 0.66 (P for trend = .005). The inverse gradient was seen primarily for ischemic stroke (RRs across increasing MET quintiles, 1.00, 0.87, 0.83, 0.76, and 0.52; P for trend = .003). Physical activity was not significantly associated with subarachnoid hemorrhage or intracerebral hemorrhage. After multivariate adjustment, walking was associated with reduced risk of total stroke (RRs across increasing walking MET quintiles, 1.00, 0.76, 0.78, 0.70, and 0.66; P for trend = .01) and ischemic stroke (RRs across increasing walking MET quintiles, 1.00, 0.77, 0.75, 0.69, and 0.60; P for trend = .02). Brisk or striding walking pace was associated with lower risk of total and ischemic stroke compared with average or casual pace. Conclusion These data indicate that physical activity, including moderate-intensity exercise such as walking, is associated with substantial reduction in risk of total and ischemic stroke in a dose-response manner.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Div Prevent Med, Boston, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu	Lee, I-Min/ABD-5409-2021; Hu, Frank/C-1919-2013; Colditz, Graham/A-3963-2009; Rexrode, Kathryn M/I-1177-2018; Kurth, Tobias/A-9243-2012	Colditz, Graham/0000-0002-7307-0291; Kurth, Tobias/0000-0001-7169-2620; Rexrode, Kathryn/0000-0003-3387-8429	NCI NIH HHS [CA40356] Funding Source: Medline; NHLBI NIH HHS [HL24074, HL34594] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA040356, R01CA040356] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABBOTT RD, 1994, AM J EPIDEMIOL, V139, P881, DOI 10.1093/oxfordjournals.aje.a117094; AINSWORTH BE, 1993, J CLIN EPIDEMIOL, V46, P1403, DOI 10.1016/0895-4356(93)90140-V; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; ANDERSON CS, 1993, MED J AUSTRALIA, V158, P85, DOI 10.5694/j.1326-5377.1993.tb137529.x; [Anonymous], 1996, JAMA, V276, P241; Bijnen FCH, 1998, ARCH INTERN MED, V158, P1499, DOI 10.1001/archinte.158.14.1499; BLAIR SN, 1993, ANN INTERN MED, V119, P702, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00015; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DEVLIN JT, 1992, DIABETES CARE, V15, P1690, DOI 10.2337/diacare.15.11.1690; ELLEKJAER EF, 1992, STROKE, V23, P829, DOI 10.1161/01.STR.23.6.829; Gillum RF, 1996, AM J EPIDEMIOL, V143, P860, DOI 10.1093/oxfordjournals.aje.a008829; Gorelick PB, 1999, JAMA-J AM MED ASSOC, V281, P1112, DOI 10.1001/jama.281.12.1112; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Hakim AA, 1998, NEW ENGL J MED, V338, P94, DOI 10.1056/NEJM199801083380204; Hakim AA, 1999, CIRCULATION, V100, P9, DOI 10.1161/01.CIR.100.1.9; Henriksson J, 1995, J Cardiovasc Risk, V2, P303, DOI 10.1097/00043798-199508000-00004; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; KIELY DK, 1994, AM J EPIDEMIOL, V140, P608, DOI 10.1093/oxfordjournals.aje.a117298; Lee IM, 1998, STROKE, V29, P2049, DOI 10.1161/01.STR.29.10.2049; Lee IM, 1999, STROKE, V30, P1, DOI 10.1161/01.STR.30.1.1; LINDSTED KD, 1991, J CLIN EPIDEMIOL, V44, P355, DOI 10.1016/0895-4356(91)90074-J; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; MANSON JE, 1994, AM J PREV MED, V10, P172, DOI 10.1016/S0749-3797(18)30615-9; MENOTTI A, 1990, INT J EPIDEMIOL, V19, P309, DOI 10.1093/ije/19.2.309; Paffenbarger R S Jr, 1972, Prev Med, V1, P522, DOI 10.1016/0091-7435(72)90034-5; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Sacco RL, 1998, STROKE, V29, P380, DOI 10.1161/01.STR.29.2.380; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Walker AE, 1981, STROKE S1, V12, P13; WANNAMETHEE G, 1992, BRIT MED J, V304, P597, DOI 10.1136/bmj.304.6827.597; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; ZIEGEL PZ, 1995, AM J PUBLIC HEALTH, V85, P706	37	317	325	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2000	283	22					2961	+		10.1001/jama.283.22.2961	http://dx.doi.org/10.1001/jama.283.22.2961			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	321XL	10865274	Bronze			2022-12-24	WOS:000087480600036
J	Richardson, C; Jasin, M				Richardson, C; Jasin, M			Frequent chromosomal translocations induced by DNA double-strand breaks	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; REPAIR; CELLS; ENDS; CHROMATIDS; MECHANISM; NEOPLASIA; DAMAGE; MODEL; SITE	The faithful repair of DNA damage such as chromosomal double-strand breaks (DSBs) is crucial for genomic integrity. Aberrant repair of these lesions can result in chromosomal rearrangements, including translocations, which are associated with numerous tumours(1,2). Models predict that some translocations arise from DSB-induced recombination in differentiating lymphoid cell types(3-5) or from aberrant repair of DNA damage induced by irradiation or other agents(6-8); however, a genetic system to study the aetiology of these events has been lacking. Here we use a mouse embryonic stem cell system to examine the role of DNA damage on the formation of translocations. We rnd that two DSBs, each on different chromosomes, are sufficient to promote frequent reciprocal translocations. The results are in striking contrast with interchromosomal repair of a single DSB in an analogous system in which translocations are not recovered. Thus, while interchromosomal DNA repair does not result in genome instability per se, the presence of two DSBs in a single cell can alter the spectrum of repair products that are recovered.	Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Jasin, M (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, 1275 York Ave, New York, NY 10021 USA.	m-jasin@ski.mskcc.org	Wilson, Matthew H/K-3193-2013					Andreasson P, 1998, LEUKEMIA, V12, P1411, DOI 10.1038/sj.leu.2401108; Beumer KJ, 1998, GENETICS, V150, P173; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Coleman AE, 1999, BLOOD, V93, P4442, DOI 10.1182/blood.V93.12.4442; COLLEAUX L, 1988, P NATL ACAD SCI USA, V85, P6022, DOI 10.1073/pnas.85.16.6022; Cooper DN, 1998, GENETIC BASIS HUMAN, P65; CORNFORTH MN, 1993, ADV RADIAT BIOL, V17, P423; Gillert E, 1999, ONCOGENE, V18, P4663, DOI 10.1038/sj.onc.1202842; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Ikeda H, 1994, Adv Pharmacol, V29A, P147; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Jeggo PA, 1998, ADV GENET, V38, P185, DOI 10.1016/S0065-2660(08)60144-3; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; KADYK LC, 1992, GENETICS, V132, P387; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; LIN FL, 1984, MOL CELL BIOL, V4, P1020, DOI 10.1128/MCB.4.6.1020; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Moynahan ME, 1997, P NATL ACAD SCI USA, V94, P8988, DOI 10.1073/pnas.94.17.8988; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; Sargent RG, 1997, MOL CELL BIOL, V17, P267, DOI 10.1128/MCB.17.1.267; Strout MP, 1998, P NATL ACAD SCI USA, V95, P2390, DOI 10.1073/pnas.95.5.2390; TYCKO B, 1990, CANCER CELL-MON REV, V2, P1; Wang P, 1997, P NATL ACAD SCI USA, V94, P12018, DOI 10.1073/pnas.94.22.12018; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9	29	403	414	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2000	405	6787					697	700		10.1038/35015097	http://dx.doi.org/10.1038/35015097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	321QH	10864328				2022-12-24	WOS:000087465800050
J	Henney, JE				Henney, JE			Web site for clinical investigators	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									Commissioner Food & Drugs, Rockville, MD 20857 USA		Henney, JE (corresponding author), Commissioner Food & Drugs, HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2000	283	21					2779	2779		10.1001/jama.283.21.2779-b	http://dx.doi.org/10.1001/jama.283.21.2779-b			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	320BQ	10896520				2022-12-24	WOS:000087381500005
J	McAlister, FA; Straus, SE; Guyatt, GH; Haynes, RB				McAlister, FA; Straus, SE; Guyatt, GH; Haynes, RB		Evidence-Based Med Working Grp	Users' guides to the medical literature - XX. Integrating research evidence with the care of the individual patient	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL DECISION-MAKING; CORONARY HEART-DISEASE; CAROTID ENDARTERECTOMY; PATIENTS PREFERENCES; COST-EFFECTIVENESS; RANDOMIZED TRIALS; BREAST-CANCER; HELP ME; RISK; STROKE	Clinicians can use research results to determine optimal care for an individual patient by using a patient's baseline risk estimate, clinical prediction guidelines that quantitate an individual patient's potential for benefit, and published articles. We propose that when clinicians are determining the likelihood that treatment will prevent the target event (at the expense of adverse events) in a patient that they also incorporate the patient's values. The 3 main elements to joint clinical decision making are disclosure of information about the risks and benefits of therapeutic alternatives, exploration of the patient's values about both the therapy and potential outcomes, and the actual decision. In addressing the patient's risk of adverse events without treatment and risk of harm with therapy, clinicians must recognize that patients are rarely identical to the average study patient. Differences between study participants and patients in real-world practice tend to be quantitative (differences in degree of risk of the outcome or responsiveness to therapy) rather than qualitative (no risk or adverse response to therapy). The number needed to treat and number needed to harm can be used to generate patient-specific estimates relative to the risk of the outcome event, Clinicians must consider a patient's risk of adverse events from any intervention and incorporate the patient's values in clinical decision making by using information about the risks and benefits of therapeutic alternatives.	McMaster Univ, Hlth Sci Ctr, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; Mt Sinai Hosp Univ Hlth Network, Div Gen Internal Med, Toronto, ON, Canada; Univ Alberta Hosp, Div Gen Internal Med, Edmonton, AB T6G 2B7, Canada	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; McMaster University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University Health Network Toronto; University of Alberta	Guyatt, GH (corresponding author), McMaster Univ, Hlth Sci Ctr, Dept Clin Epidemiol & Biostat, Room 2C12,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	sstraus@mtsinai.on.ca	McAlister, Finlay/C-4151-2013	McAlister, Finlay/0000-0001-7435-3341; Haynes, Robert Brian/0000-0002-1453-3196				APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Bain DJ, 1998, BRIT J SURG, V85, P768; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Chassin MR, 1998, NEW ENGL J MED, V339, P1468, DOI 10.1056/NEJM199811123392010; Chatellier G, 1996, BRIT MED J, V312, P426; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Dans AL, 1998, JAMA-J AM MED ASSOC, V279, P545, DOI 10.1001/jama.279.7.545; DAVEYSMITH G, 1994, BRIT MED J, V308, P72; Degner LF, 1997, JAMA-J AM MED ASSOC, V277, P1485, DOI 10.1001/jama.277.18.1485; ELIASZIW M, 1994, STROKE, V25, P304, DOI 10.1161/01.STR.25.2.304; ELIASZIW M, 1995, STROKE, V26, P1747, DOI 10.1161/01.STR.26.10.1747; Elneihoum AM, 1998, STROKE, V29, P2114, DOI 10.1161/01.STR.29.10.2114; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Franzosi MG, 1998, CIRCULATION, V97, P2202, DOI 10.1161/01.CIR.97.22.2202; Gage BF, 1998, STROKE, V29, P1083, DOI 10.1161/01.STR.29.6.1083; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; Glasziou P, 1998, ACP J Club, V129, pA15; GLASZIOU PP, 1995, BMJ-BRIT MED J, V311, P1356, DOI 10.1136/bmj.311.7016.1356; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; GREENFIELD S, 1988, J GEN INTERN MED, V3, P448, DOI 10.1007/BF02595921; GROVER SA, 1995, BRIT MED J, V310, P975, DOI 10.1136/bmj.310.6985.975; Guyatt GH, 1999, JAMA-J AM MED ASSOC, V281, P1836, DOI 10.1001/jama.281.19.1836; GUYATT GH, 1995, JAMA-J AM MED ASSOC, V274, P1800, DOI 10.1001/jama.274.22.1800; GUYATT GH, 1994, JAMA-J AM MED ASSOC, V271, P59, DOI 10.1001/jama.271.1.59; GUYATT GH, 1993, JAMA-J AM MED ASSOC, V270, P2598, DOI 10.1001/jama.270.21.2598; Ioannidis JPA, 1998, AM J EPIDEMIOL, V148, P1117; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; LAUPACIS A, 1994, JAMA-J AM MED ASSOC, V272, P234, DOI 10.1001/jama.272.3.234; LEVINE MN, 1992, ANN INTERN MED, V117, P53, DOI 10.7326/0003-4819-117-1-53; Lilford RJ, 1998, BMJ-BRIT MED J, V317, P405; Llewellyn-Thomas H A, 1997, Can J Nurs Res, V29, P45; LLEWELLYNTHOMAS HA, 1991, SOC SCI MED, V32, P35, DOI 10.1016/0277-9536(91)90124-U; Margalith I, 1997, SOC SCI MED, V45, P419, DOI 10.1016/S0277-9536(96)00357-7; Mazur DJ, 1997, J GEN INTERN MED, V12, P114, DOI 10.1046/j.1525-1497.1997.00016.x; McAlister FA, 1999, J AM GERIATR SOC, V47, P811, DOI 10.1111/j.1532-5415.1999.tb03837.x; McQuay HJ, 1997, ANN INTERN MED, V126, P712, DOI 10.7326/0003-4819-126-9-199705010-00007; NEASE RF, 1995, JAMA-J AM MED ASSOC, V273, P1185, DOI 10.1001/jama.273.15.1185; O'Connor A M, 1997, Can J Nurs Res, V29, P7; O'Connor AM, 1999, BRIT MED J, V319, P731, DOI 10.1136/bmj.319.7212.731; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; PEDERSEN TR, 1995, LANCET, V345, P1274; RICHARDSON WS, 1995, JAMA-J AM MED ASSOC, V273, P1610, DOI 10.1001/jama.273.20.1610; RIEGELMAN R, 1993, MED DECIS MAKING, V13, P247, DOI 10.1177/0272989X9301300312; Rothenbacher D, 1997, EUR J CANCER, V33, P1184, DOI 10.1016/S0959-8049(97)00034-8; Rothwell PM, 1997, BMJ-BRIT MED J, V315, P1571, DOI 10.1136/bmj.315.7122.1571; Rothwell PM, 1999, LANCET, V353, P2105, DOI 10.1016/S0140-6736(98)11415-0; ROTHWELL PM, 1995, LANCET, V345, P1616, DOI 10.1016/S0140-6736(95)90120-5; Rothwell PM, 1996, STROKE, V27, P260, DOI 10.1161/01.STR.27.2.260; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Sackett D L, 1997, ACP J Club, V127, pA15; Sackett DL, 1996, EVIDENCE BASED MED, V1, P164, DOI DOI 10.1136/EBM.1996.1.164; Samsa GP, 1998, AM HEART J, V136, P703, DOI 10.1016/S0002-8703(98)70019-5; SAUVE JS, 1993, JAMA-J AM MED ASSOC, V270, P2843, DOI 10.1001/jama.270.23.2843; Schmid CH, 1998, STAT MED, V17, P1923, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1923::AID-SIM874>3.0.CO;2-6; SCHULMAN BA, 1979, MED CARE, V17, P267, DOI 10.1097/00005650-197903000-00004; Sculpher M, 1998, HEALTH ECON, V7, P129; Sharp SJ, 1996, BRIT MED J, V313, P735; SOLOMON NA, 1994, STROKE, V25, P1721, DOI 10.1161/01.STR.25.9.1721; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Stiggelbout AM, 1997, CAN MED ASSOC J, V157, P383; STRULL WM, 1984, JAMA-J AM MED ASSOC, V252, P2990, DOI 10.1001/jama.252.21.2990; Szabo E, 1997, ARCH INTERN MED, V157, P1352, DOI 10.1001/archinte.157.12.1352; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Tu JV, 1998, NEW ENGL J MED, V339, P1441, DOI 10.1056/NEJM199811123392006; VICKERY DM, 1988, MED CARE, V26, P580, DOI 10.1097/00005650-198806000-00006; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93; YUSUF S, 1990, STAT MED, V9, P73, DOI 10.1002/sim.4780090114; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	76	165	168	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2000	283	21					2829	2836		10.1001/jama.283.21.2829	http://dx.doi.org/10.1001/jama.283.21.2829			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	320BQ	10838653				2022-12-24	WOS:000087381500039
J	Takada, S; Lis, JT; Zhou, S; Tjian, R				Takada, S; Lis, JT; Zhou, S; Tjian, R			A TRF1 : BRF complex directs Drosophila RNA polymerase III transcription	CELL			English	Article							TATA-BINDING PROTEIN; GENES; TBP; SEQUENCES; SPECIFICITY; INITIATION; SUBUNIT; CELLS; DNA; ACCURATE	It has been generally accepted that the TATA binding protein (TBP) is a universal mediator of transcription by RNA polymerase I, II, and III. Here we report that the TBP-related factor TRF1 rather than TBP is responsible for RNA polymerase III transcription in Drosophila. Immunoprecipitation and in vitro transcription assays using immunodepleted extracts supplemented with recombinant proteins reveals that a TRF1:BRF complex is required to reconstitute transcription of tRNA, 5S and U6 RNA genes. In vivo, the majority of TRF1 is complexed with BRF and these two proteins colocalize at many polytene chromosome sites containing RNA pol III genes. These data suggest that in Drosophila, TRF1 rather than TBP forms a complex with BRF that plays a major role in RNA pol III transcription.	Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Cornell Univ, Biochem Mol & Cell Biol Sect, Ithaca, NY 14853 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Cornell University	Tjian, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA.							BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; BURKE DJ, 1985, J BIOL CHEM, V260, P816; Clarke EM, 1996, J BIOL CHEM, V271, P22189, DOI 10.1074/jbc.271.36.22189; CORMACK BP, 1993, SCIENCE, V262, P244, DOI 10.1126/science.8211143; CROWLEY TE, 1993, NATURE, V361, P557, DOI 10.1038/361557a0; DAS G, 1987, J BIOL CHEM, V262, P1187; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dikstein R, 1996, CELL, V87, P137, DOI 10.1016/S0092-8674(00)81330-6; DINGERMANN T, 1983, J BIOL CHEM, V258, P395; DINGERMANN T, 1982, J BIOL CHEM, V257, P4738; GEIDUSCHEK EP, 1995, CURR OPIN CELL BIOL, V7, P344, DOI 10.1016/0955-0674(95)80089-1; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; Harlow E, 1988, ANTIBODIES LAB MANUA; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Holmes MC, 2000, SCIENCE, V288, P867, DOI 10.1126/science.288.5467.867; JACQ X, 1994, CELL, V79, P107, DOI 10.1016/0092-8674(94)90404-9; Jensen RC, 1998, NUCLEIC ACIDS RES, V26, P616, DOI 10.1093/nar/26.2.616; JOHNSON DL, 1991, J BIOL CHEM, V266, P16037; KAMAKAKA RT, 1991, P NATL ACAD SCI USA, V88, P1024, DOI 10.1073/pnas.88.3.1024; KHOO B, 1994, GENE DEV, V8, P2879, DOI 10.1101/gad.8.23.2879; LOFQUIST A, 1986, J BIOL CHEM, V261, P4600; MARTIN GJ, 1995, METHODS DETECT ADULT, V1, P1; Ohbayashi T, 1999, NUCLEIC ACIDS RES, V27, P750, DOI 10.1093/nar/27.3.750; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; REDDY P, 1991, CELL, V65, P349, DOI 10.1016/0092-8674(91)90168-X; SCHENK PM, 1995, BIOTECHNIQUES, V19, P196; SHARP PA, 1992, CELL, V68, P819, DOI 10.1016/0092-8674(92)90023-6; SHARP S, 1984, NUCLEIC ACIDS RES, V12, P7617, DOI 10.1093/nar/12.20.7617; Shen YH, 1998, MOL CELL BIOL, V18, P1692, DOI 10.1128/MCB.18.3.1692; Shopland LS, 1996, CHROMOSOMA, V105, P158, DOI 10.1007/BF02509497; STRUHL K, 1994, SCIENCE, V263, P1103, DOI 10.1126/science.8108728; SUTCLIFFE JG, 1984, NATURE, V308, P237, DOI 10.1038/308237a0; TOWER J, 1988, MOL CELL BIOL, V8, P1001, DOI 10.1128/MCB.8.2.1001; Trivedi A, 1996, MOL CELL BIOL, V16, P6909; USHEVA A, 1994, CELL, V76, P1115, DOI 10.1016/0092-8674(94)90387-5; Vilalta A, 1997, J BIOL CHEM, V272, P18087, DOI 10.1074/jbc.272.29.18087; WANG Y, 1995, P NATL ACAD SCI USA, V92, P8606, DOI 10.1073/pnas.92.19.8606; WANG ZX, 1995, P NATL ACAD SCI USA, V92, P7026, DOI 10.1073/pnas.92.15.7026; WHITE RJ, 1989, CELL, V59, P1081, DOI 10.1016/0092-8674(89)90764-2; WHITE RJ, 1995, MOL CELL BIOL, V15, P6653; WHITE RJ, 1998, RNA POLYM 3 TRANSCRI; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; WILLIS IM, 1993, EUR J BIOCHEM, V212, P1, DOI 10.1111/j.1432-1033.1993.tb17626.x; YAMAMOTO T, 1992, P NATL ACAD SCI USA, V89, P2844, DOI 10.1073/pnas.89.7.2844	44	89	90	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 26	2000	101	5					459	469		10.1016/S0092-8674(00)80857-0	http://dx.doi.org/10.1016/S0092-8674(00)80857-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	319ZB	10850489	Bronze			2022-12-24	WOS:000087375400004
J	Hulot, FD; Lacroix, G; Lescher-Moutoue, FO; Loreau, M				Hulot, FD; Lacroix, G; Lescher-Moutoue, FO; Loreau, M			Functional diversity governs ecosystem response to nutrient enrichment	NATURE			English	Article							TROPHIC INTERACTIONS; RATIO-DEPENDENCE; BOTTOM-UP; FOOD WEBS; TOP-DOWN; PRODUCTIVITY; COMMUNITIES; STABILITY; PREDATORS; PATTERNS	The relationship between species diversity and ecosystem functioning is a central topic in ecology today(1,2). Classical approaches to studying ecosystem responses to nutrient enrichment have considered linear food chains(3,4). To what extent ecosystem structure, that is, the network of species interactions, affects such responses is currently unknown. This severely limits our ability to predict which species or functional groups will benefit or suffer from nutrient enrichment and to understand the underlying mechanisms(5-8). Here our approach takes ecosystem complexity into account(6,9,10) by considering functional diversity at each trophic level(11-14). We conducted a mesocosm experiment to test the effects of nutrient enrichment in a lake ecosystem. We developed a model of intermediate complexity, which separates trophic levels into functional groups according to size and diet. This model successfully predicted the experimental results, whereas linear food-chain models did not. Our model shows the importance of functional diversity and indirect interactions in the response of ecosystems to perturbations, and indicates that new approaches are needed for the management of freshwater ecosystems subject to eutrophication.	Ecole Normale Super, UMR 7625, Ecol Lab, F-75230 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite	Hulot, FD (corresponding author), Ecole Normale Super, UMR 7625, Ecol Lab, 46 Rue Ulm, F-75230 Paris 05, France.			Hulot, Florence D./0000-0002-8897-3987				ABRAMS PA, 1993, AM NAT, V141, P351, DOI 10.1086/285478; ARDITI R, 1989, J THEOR BIOL, V139, P311, DOI 10.1016/S0022-5193(89)80211-5; BENDER EA, 1984, ECOLOGY, V65, P1, DOI 10.2307/1939452; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; DEMELO R, 1992, LIMNOL OCEANOGR, V29, P941; GLEESON SK, 1994, ECOLOGY, V75, P1834, DOI 10.2307/1939642; Hamlaoui S, 1998, CR ACAD SCI III-VIE, V321, P39, DOI 10.1016/S0764-4469(97)89624-2; HUNTER MD, 1992, ECOLOGY, V73, P724; Johnson KH, 1996, TRENDS ECOL EVOL, V11, P372, DOI 10.1016/0169-5347(96)10040-9; Kaunzinger CMK, 1998, NATURE, V395, P495, DOI 10.1038/26741; Lacroix G., 1991, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V48, P53; Lacroix Gerard, 1996, P162; Leibold MA, 1997, ANNU REV ECOL SYST, V28, P467, DOI 10.1146/annurev.ecolsys.28.1.467; LEIBOLD MA, 1989, AM NAT, V134, P922, DOI 10.1086/285022; LEIBOLD MA, 1992, NATURE, V360, P341, DOI 10.1038/360341a0; LEVINS R, 1974, ANN NY ACAD SCI, V231, P123, DOI 10.1111/j.1749-6632.1974.tb20562.x; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; Menge BA, 1997, AM NAT, V149, P801, DOI 10.1086/286025; MENGE BA, 1995, ECOL MONOGR, V65, P21, DOI 10.2307/2937158; Mittelbach G. G., 1988, SIZE STRUCTURED POPU, P217; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; Persson Lennart, 1996, P396; PIMM SL, 1991, NATURE, V350, P669, DOI 10.1038/350669a0; Polis GA, 1998, NATURE, V395, P744, DOI 10.1038/27323; POLIS GA, 1994, AUST J ECOL, V19, P121; POWER ME, 1992, ECOLOGY, V73, P733, DOI 10.2307/1940153; Reynolds C.S., 1997, VEGETATION PROCESSES, V9, DOI 10.1017/S0025315400036432; SPILLER DA, 1990, NATURE, V347, P469, DOI 10.1038/347469a0; Yodzis Peter, 1996, P192; [No title captured]	30	197	213	8	186	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 18	2000	405	6784					340	344		10.1038/35012591	http://dx.doi.org/10.1038/35012591			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314YT	10830961				2022-12-24	WOS:000087085700045
J	Schliwa, M				Schliwa, M			Cell biology - Centrioles go for a stroll	NATURE			English	Editorial Material									Univ Munich, Inst Cell Biol, D-80336 Munich, Germany	University of Munich	Schliwa, M (corresponding author), Univ Munich, Inst Cell Biol, Schillerstr 42, D-80336 Munich, Germany.							Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317	1	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 18	2000	405	6784					292	292		10.1038/35012738	http://dx.doi.org/10.1038/35012738			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314YT	10858106	Bronze			2022-12-24	WOS:000087085700028
J	Bergles, DE; Roberts, JDB; Somogyi, P; Jahr, CE				Bergles, DE; Roberts, JDB; Somogyi, P; Jahr, CE			Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus	NATURE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; GLIAL-CELLS; PROGENITOR-CELL; RECEPTOR; ACTIVATION; LINEAGE; TRANSPORTER; ASTROCYTES; POPULATION; MEMBRANE	Fast excitatory neurotransmission in the central nervous system occurs at specialized synaptic junctions between neurons, where a high concentration of glutamate directly activates receptor channels. Low-affinity AMPA (alpha-amino-3-hydroxy-5-methyl isoxazole propionic acid) and kainate glutamate receptors are also expressed by some glial cells(1), including oligodendrocyte precursor cells (OPCs). However, the conditions that result in activation of glutamate receptors on these non-neuronal cells are not known. Here we report that stimulation of excitatory axons in the hippocampus elicits inward currents in OPCs that are mediated by AMPA receptors. The quantal nature of these responses and their rapid kinetics indicate that they are produced by the exocytosis of vesicles filled with glutamate directly opposite these receptors. Some of these AMPA receptors are permeable to calcium ions, providing a link between axonal activity and internal calcium levels in OPCs. Electron microscopic analysis revealed that vesicle-filled axon terminals make synaptic junctions with the processes of OPCs in both the young and adult hippocampus. These results demonstrate the existence of a rapid signalling pathway from pyramidal neurons to OPCs in the mammalian hippocampus that is mediated by excitatory, glutamatergic synapses.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA; Univ Oxford, Dept Pharmacol, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England	Oregon Health & Science University; University of Oxford	Bergles, DE (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.		Messier, Claude/A-2322-2008; Bergles, Dwight/U-8343-2019	Messier, Claude/0000-0002-4791-1763; Bergles, Dwight/0000-0002-7133-7378				AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Bergles DE, 1999, CURR OPIN NEUROBIOL, V9, P293, DOI 10.1016/S0959-4388(99)80043-9; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Dingledine R, 1999, PHARMACOL REV, V51, P7; DUNWIDDIE TV, 1985, INT REV NEUROBIOL, V27, P63, DOI 10.1016/S0074-7742(08)60556-5; Dzubay JA, 1999, J NEUROSCI, V19, P5265; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.3.CO;2-Z; KRIEGLER S, 1993, J NEUROSCI, V13, P4229, DOI 10.1523/jneurosci.13-10-04229.1993; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; McDonald JW, 1998, NEUROREPORT, V9, P2757, DOI 10.1097/00001756-199808240-00014; Miller RH, 1996, TRENDS NEUROSCI, V19, P92, DOI 10.1016/S0166-2236(96)80036-1; Ong WY, 1999, NEUROSCIENCE, V92, P83, DOI 10.1016/S0306-4522(98)00751-9; Palay S. L., 1974, CEREBELLAR CORTEX CY; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RENNER P, 1987, NEUROSCIENCE, V23, P319, DOI 10.1016/0306-4522(87)90292-2; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; STALLCUP WB, 1990, J CELL BIOL, V111, P3177, DOI 10.1083/jcb.111.6.3177; Steinhauser C, 1996, TRENDS NEUROSCI, V19, P339, DOI 10.1016/0166-2236(96)10043-6; Tillet E, 1997, J BIOL CHEM, V272, P10769; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wolswijk G, 1998, J NEUROSCI, V18, P601; WYLLIE DJA, 1991, J PHYSIOL-LONDON, V432, P235, DOI 10.1113/jphysiol.1991.sp018383; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	30	676	696	2	30	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 11	2000	405	6783					187	191		10.1038/35012083	http://dx.doi.org/10.1038/35012083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	314WG	10821275				2022-12-24	WOS:000087080100052
J	Etcoff, NL; Ekman, P; Magee, JJ; Frank, MG				Etcoff, NL; Ekman, P; Magee, JJ; Frank, MG			Lie detection and language comprehension	NATURE			English	Article							FACE		Massachusetts Gen Hosp East, Dept Psychiat, Charlestown, MA 02129 USA; Univ Calif San Francisco, Human Interact Lab, San Francisco, CA 94143 USA; Circle Com, Cambridge, MA 02138 USA; Rutgers State Univ, Sch Commun Informat & Lib Studies, New Brunswick, NJ 08901 USA	Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; Rutgers State University New Brunswick	Etcoff, NL (corresponding author), Massachusetts Gen Hosp East, Dept Psychiat, Bldg 149,13th St, Charlestown, MA 02129 USA.							CAPLAN D, 1992, LANGUAGE; EKMAN P, 1991, J NONVERBAL BEHAV, V15, P125, DOI 10.1007/BF00998267; EKMAN P, 1991, AM PSYCHOL, V46, P913, DOI 10.1037/0003-066X.46.9.913; EKMAN P, 1988, J PERS SOC PSYCHOL, V54, P414, DOI 10.1037/0022-3514.54.3.414; Etcoff NL, 1986, ADV CLIN NEUROPSYCHO, V3, P127, DOI [10.1007/978-1-4613-2211-5_5, DOI 10.1007/978-1-4613-2211-5_5]; Harrington A, 1996, APHASIA KINDRED DISO; ROCHON E, 1994, BRAIN LANG, V46, P329, DOI 10.1006/brln.1994.1018; Sacks O., 1985, MAN WHO MISTOOK HIS; YOUNG AW, 1993, BRAIN, V116, P941, DOI 10.1093/brain/116.4.941	9	50	52	1	35	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 11	2000	405	6783					139	139		10.1038/35012129	http://dx.doi.org/10.1038/35012129			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	314WG	10821259	Bronze			2022-12-24	WOS:000087080100036
J	Fang, J; Alderman, MH				Fang, J; Alderman, MH			Sevum uric acid and cardiovascular mortality - The NHANES I epidemiologic follow-up study, 1971-1992	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; BLOOD-PRESSURE; HEART-DISEASE; HYPERURICEMIA; OBESITY; INSULIN; CHOLESTEROL; ASSOCIATION; INFORMATION; POPULATION	Context Although many epidemiological studies have suggested that increased serum uric acid levels are a risk factor for cardiovascular mortality, this relationship remains uncertain. Objective To determine the association of serum uric acid levels with cardiovascular mortality. Design and Setting Cross-sectional population-based study of epidemiological follow-up data from the First National Health and Nutrition Examination Survey (NHANES I) from 1971-1975 (baseline) and data from NHANES I Epidemiologic Follow-up Study (NHEFS). Participants A total of 5926 subjects who were aged 25 to 74 years and had serum uric acid level measurements at baseline. Main Outcome Measures Ischemic heart disease mortality, total cardiovascular mortality, and all-cause mortality, compared by quartiles of serum uric acid level. Results In an average of 16.4 years of follow-up, 1593 deaths occurred, of which 731 (45.9%) were ascribed to cardiovascular disease, Increased serum uric acid levels had a positive relationship to cardiovascular mortality in men and women and in black and white persons. Deaths due to ischemic heart disease in both men and women increased when serum uric acid levels were in the highest quartile compared with the lowest quartile (men, >416 vs <321 mu mol/L; risk ratio, 1.77 [95% confidence interval {CI}, 1.08-3.98]; women, >333 vs <238 mu mol/L; risk ratio, 3.00 [95% CI, 1.45-6.28]), Cox regression analysis showed that for each 59.48-mu mol/L increase in uric acid level, cardiovascular mortality and ischemic heart disease mortality increased. Hazard ratios for men were 1.09 (95% CI, 1.02-1.18) and 1.17 (95% CI, 1.06-1.28), and for women were 1.26 (95% CI, 1.16-1.36) and 1.30 (95% CI, 1.17-1.45), respectively, after adjustment for age, race, body mass index, smoking status, alcohol consumption, cholesterol level, history of hypertension and diabetes, and diuretic use. Further analysis, stratifying by cardiovascular risk status, diuretic use, and menopausal status, confirmed a significant association of uric acid and cardiovascular mortality in all subgroups except among men using diuretics (n=79) and men with 1 or more cardiovascular risk factors (n=1140). Conclusion Our data suggest that increased serum uric acid levels are independently and significantly associated with risk of cardiovascular mortality.	Albert Einstein Coll Med, Dept Epidemiol & Social Med, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Alderman, MH (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Social Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.							BENEDEK TG, 1967, ANN INTERN MED, V66, P851, DOI 10.7326/0003-4819-66-5-851; BENGTSSON C, 1988, ACTA MED SCAND, V224, P549; Bonora E, 1996, INT J OBESITY, V20, P975; BURACK RC, 1985, J CHRON DIS, V38, P865, DOI 10.1016/0021-9681(85)90111-0; Cox C S, 1997, Vital Health Stat 1, P1; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Dzielak D J, 1998, Expert Opin Investig Drugs, V7, P85, DOI 10.1517/13543784.7.1.85; FACCHINI F, 1991, JAMA-J AM MED ASSOC, V266, P3008, DOI 10.1001/jama.266.21.3008; FESSEL WJ, 1980, AM J MED, V68, P401, DOI 10.1016/0002-9343(80)90111-4; FREEDMAN DS, 1995, AM J EPIDEMIOL, V141, P637, DOI 10.1093/oxfordjournals.aje.a117479; Grantham JJ, 1991, KIDNEY, P483; GUTMAN AB, 1952, ADV INTERNAL MED, V5, P227; KLEIN R, 1973, ARCH INTERN MED, V132, P401, DOI 10.1001/archinte.132.3.401; LELLOUCH J, 1969, J CHRON DIS, V22, P9, DOI 10.1016/0021-9681(69)90082-4; LEVINE W, 1989, J CLIN EPIDEMIOL, V42, P257, DOI 10.1016/0895-4356(89)90061-9; Low RK, 1997, UROL CLIN N AM, V24, P135, DOI 10.1016/S0094-0143(05)70359-1; MACHLIN SR, 1989, STAT MED, V8, P997, DOI 10.1002/sim.4780080810; MACLACHLAN MJ, 1967, AM J MED, V42, P38, DOI 10.1016/0002-9343(67)90005-8; MCLAUGHLIN JK, 1987, AM J EPIDEMIOL, V126, P144, DOI 10.1093/oxfordjournals.aje.a114647; MUSTARD JF, 1963, CAN MED ASSOC J, V89, P1207; *NAT CTR HLTH STAT, 1979, NAT CTR HLTH STAT PU; Newland H, 1975, Med Hypotheses, V1, P152, DOI 10.1016/0306-9877(75)90011-0; NICHOLLS A, 1973, BRIT MED J, V1, P449, DOI 10.1136/bmj.1.5851.449; Nishioka K, 1980, Adv Exp Med Biol, V122A, P155; ROUBENOFF R, 1990, RHEUM DIS CLIN N AM, V16, P539; SELBY JV, 1990, AM J EPIDEMIOL, V131, P1017, DOI 10.1093/oxfordjournals.aje.a115593; STAESSEN J, 1991, AM J MED, V90, pS50; STEELE TH, 1971, NEW ENGL J MED, V284, P1193, DOI 10.1056/NEJM197105272842106; STEELE TH, 1969, AM J MED, V47, P564, DOI 10.1016/0002-9343(69)90187-9; TWEEDDALE MG, 1979, NEPHRON, V23, P3, DOI 10.1159/000181660; VUORINENMARKKOLA H, 1994, J CLIN ENDOCR METAB, V78, P25, DOI 10.1210/jc.78.1.25; WOO J, 1994, POSTGRAD MED J, V70, P486, DOI 10.1136/pgmj.70.825.486; ZAVARONI I, 1993, J INTERN MED, V234, P25, DOI 10.1111/j.1365-2796.1993.tb00700.x	33	1201	1295	1	36	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2000	283	18					2404	2410		10.1001/jama.283.18.2404	http://dx.doi.org/10.1001/jama.283.18.2404			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310CD	10815083				2022-12-24	WOS:000086808200035
